Citrus Sinensis ID: 012762
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 457 | 2.2.26 [Sep-21-2011] | |||||||
| A2YBX5 | 589 | Protein kinase G11A OS=Or | N/A | no | 0.857 | 0.665 | 0.515 | 1e-113 | |
| Q0DCT8 | 589 | Protein kinase G11A OS=Or | no | no | 0.857 | 0.665 | 0.515 | 1e-113 | |
| Q9LFA2 | 934 | Serine/threonine-protein | no | no | 0.800 | 0.391 | 0.518 | 1e-110 | |
| Q05999 | 578 | Serine/threonine-protein | no | no | 0.829 | 0.655 | 0.502 | 1e-109 | |
| P15792 | 609 | Protein kinase PVPK-1 OS= | N/A | no | 0.846 | 0.635 | 0.495 | 1e-107 | |
| Q64FQ2 | 525 | Protein kinase PINOID 2 O | no | no | 0.905 | 0.788 | 0.423 | 1e-103 | |
| Q2QM77 | 484 | Protein kinase PINOID OS= | no | no | 0.776 | 0.733 | 0.484 | 1e-100 | |
| O64682 | 438 | Protein kinase PINOID OS= | no | no | 0.894 | 0.933 | 0.433 | 4e-96 | |
| Q94E49 | 493 | Protein kinase PINOID 2 O | no | no | 0.807 | 0.748 | 0.447 | 1e-94 | |
| Q2RBR1 | 921 | Phototropin-1B OS=Oryza s | no | no | 0.739 | 0.366 | 0.450 | 3e-87 |
| >sp|A2YBX5|G11A_ORYSI Protein kinase G11A OS=Oryza sativa subsp. indica GN=OsI_021818 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 409 bits (1051), Expect = e-113, Method: Compositional matrix adjust.
Identities = 218/423 (51%), Positives = 276/423 (65%), Gaps = 31/423 (7%)
Query: 28 TTWTTSGSNPSSSTPSAAKTHHAPPRCNDDPCWKAIKEATSEGNNNNNNNPLTLSDLRFV 87
T+ S + SS S K H A +D W+AI+ + L LS + +
Sbjct: 150 TSSDVSDESACSSISSVTKPHKA-----NDSRWEAIQMI------RTRDGILGLSHFKLL 198
Query: 88 HRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPF 147
+LG GDIGSVYL +L S +FA KVMDK L SR K RA+ E+EIL+ LDHPF
Sbjct: 199 KKLGCGDIGSVYLSELNGTKS----YFAMKVMDKASLASRKKLLRAQTEKEILQCLDHPF 254
Query: 148 LPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMM 207
LPTLY + ++SCL+ EFCPGGDLH LRQRQ K F E AV+FY +E+++A+E+LHM+
Sbjct: 255 LPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQRGKYFPEQAVKFYVAEILLAMEYLHML 314
Query: 208 GIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCA-VD 266
GIIYRDLKPENVLVR DGHIML+DFDLSL+ S + L+ +P + N+ A
Sbjct: 315 GIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPT---LIRSSNPDAEALRKNNQAYCV 371
Query: 267 QPPFGNSSCII-PNCIVPAVSCLHPK--------RRRKKKLGNPGTP--EIVAEPLDVRS 315
QP SC+I P+C P +C P+ R+ K ++ N +P E++AEP D RS
Sbjct: 372 QPACVEPSCMIQPSCATP-TTCFGPRFFSKSKKDRKPKPEVVNQVSPWPELIAEPSDARS 430
Query: 316 MSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARAL 375
MSFVGTHEYLAPEII GEGHG+AVDWWT GIF++EL +G TPFKG + TL NV+ + L
Sbjct: 431 MSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVIGQPL 490
Query: 376 EFPKEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGVNWALLRCAKPPFIP 435
FP+ P V A+DLI LLVK+P +R+G K GAT IK+H FF GVNWAL+RCA PP +P
Sbjct: 491 RFPEYPVVSFSARDLIRGLLVKEPQQRLGCKRGATEIKQHPFFEGVNWALIRCASPPEVP 550
Query: 436 RPV 438
RPV
Sbjct: 551 RPV 553
|
May play a role in the regulation of metabolism and signal transduction processes. Oryza sativa subsp. indica (taxid: 39946) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q0DCT8|G11A_ORYSJ Protein kinase G11A OS=Oryza sativa subsp. japonica GN=Os06g0291600 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 409 bits (1051), Expect = e-113, Method: Compositional matrix adjust.
Identities = 218/423 (51%), Positives = 276/423 (65%), Gaps = 31/423 (7%)
Query: 28 TTWTTSGSNPSSSTPSAAKTHHAPPRCNDDPCWKAIKEATSEGNNNNNNNPLTLSDLRFV 87
T+ S + SS S K H A +D W+AI+ + L LS + +
Sbjct: 150 TSSDVSDESACSSISSVTKPHKA-----NDSRWEAIQMI------RTRDGILGLSHFKLL 198
Query: 88 HRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPF 147
+LG GDIGSVYL +L S +FA KVMDK L SR K RA+ E+EIL+ LDHPF
Sbjct: 199 KKLGCGDIGSVYLSEL----SGTKSYFAMKVMDKASLASRKKLLRAQTEKEILQCLDHPF 254
Query: 148 LPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMM 207
LPTLY + ++SCL+ EFCPGGDLH LRQRQ K F E AV+FY +E+++A+E+LHM+
Sbjct: 255 LPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQRGKYFPEQAVKFYVAEILLAMEYLHML 314
Query: 208 GIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCA-VD 266
GIIYRDLKPENVLVR DGHIML+DFDLSL+ S + L+ +P + N+ A
Sbjct: 315 GIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPT---LIRSSNPDAEALRKNNQAYCV 371
Query: 267 QPPFGNSSCII-PNCIVPAVSCLHPK--------RRRKKKLGNPGTP--EIVAEPLDVRS 315
QP SC+I P+C P +C P+ R+ K ++ N +P E++AEP D RS
Sbjct: 372 QPACVEPSCMIQPSCATP-TTCFGPRFFSKSKKDRKPKPEVVNQVSPWPELIAEPSDARS 430
Query: 316 MSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARAL 375
MSFVGTHEYLAPEII GEGHG+AVDWWT GIF++EL +G TPFKG + TL NV+ + L
Sbjct: 431 MSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVIGQPL 490
Query: 376 EFPKEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGVNWALLRCAKPPFIP 435
FP+ P V A+DLI LLVK+P +R+G K GAT IK+H FF GVNWAL+RCA PP +P
Sbjct: 491 RFPEYPVVSFSARDLIRGLLVKEPQQRLGCKRGATEIKQHPFFEGVNWALIRCASPPEVP 550
Query: 436 RPV 438
RPV
Sbjct: 551 RPV 553
|
May play a role in the regulation of metabolism and signal transduction processes. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LFA2|KIPK_ARATH Serine/threonine-protein kinase KIPK OS=Arabidopsis thaliana GN=KIPK PE=1 SV=1 | Back alignment and function description |
|---|
Score = 397 bits (1021), Expect = e-110, Method: Compositional matrix adjust.
Identities = 209/403 (51%), Positives = 254/403 (63%), Gaps = 37/403 (9%)
Query: 52 PRCNDDPCWKAIKEATSEGNNNNNNNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNG 111
P + D W+AIK + + L L + +LG GDIG+VYL +L
Sbjct: 512 PHMSMDVRWEAIKHIKVQYGS------LGLRHFNLLKKLGCGDIGTVYLAEL----IGTN 561
Query: 112 CFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWSCLLTEFCPGG 171
C FA KVMD L R K RA+ EREIL+MLDHPFLPTLYA SCL+ E+CPGG
Sbjct: 562 CLFAIKVMDNEFLARRKKSPRAQAEREILKMLDHPFLPTLYAQFTSDNLSCLVMEYCPGG 621
Query: 172 DLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTD 231
DLHVLRQ+Q + F E A RFY +E+++ALE+LHM+GIIYRDLKPEN+LVR DGHIMLTD
Sbjct: 622 DLHVLRQKQLGRCFPEPAARFYVAEILLALEYLHMLGIIYRDLKPENILVREDGHIMLTD 681
Query: 232 FDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVP---AVSCL 288
FDLSL+ LV SPP D A P+ S+CI P CI VSC
Sbjct: 682 FDLSLR---CAVNPTLVRSNSPPG-----KDPARISGPYNTSNCIQPFCITEPSCQVSCF 733
Query: 289 HPK------RRRKKKLGN----------PGTPEIVAEPLDVRSMSFVGTHEYLAPEIISG 332
P+ + RK K G+ P++VAEP + RS SFVGTHEYLAPEII G
Sbjct: 734 SPRLSSNQQQGRKPKRGDHLSKTQQHLSRSLPQLVAEPTEARSNSFVGTHEYLAPEIIKG 793
Query: 333 EGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIA 392
EGHG AVDWWT G+ ++EL YG TPFKG +++ TLANVV + L+FP P V AKDLI
Sbjct: 794 EGHGAAVDWWTFGVLLYELLYGKTPFKGYNNDETLANVVLQNLKFPDSPLVSFQAKDLIR 853
Query: 393 QLLVKDPTRRMGSKMGATAIKRHQFFNGVNWALLRCAKPPFIP 435
LLVK+P R+GS+ G+ IKRH FF G+NWAL+RCA PP +P
Sbjct: 854 GLLVKEPENRLGSEKGSVEIKRHPFFEGLNWALIRCAIPPELP 896
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q05999|KPK7_ARATH Serine/threonine-protein kinase AtPK7 OS=Arabidopsis thaliana GN=PK7 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 395 bits (1015), Expect = e-109, Method: Compositional matrix adjust.
Identities = 203/404 (50%), Positives = 263/404 (65%), Gaps = 25/404 (6%)
Query: 49 HAPPRCNDDPCWKAIKEATSEGNNNNNNNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSS 108
+ P R N+D W AI+E S ++ L D + + +LG GDIG+VYL +L
Sbjct: 152 YKPHRDNNDKRWVAIQEVRSRVGSS-----LEAKDFKLIKKLGGGDIGNVYLAEL----I 202
Query: 109 NNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWSCLLTEFC 168
G FA KVM+K + +R K RA+ E+EIL+ LDHPFLPTLY+ + SCL+ EFC
Sbjct: 203 GTGVSFAVKVMEKAAIAARKKLVRAQTEKEILQSLDHPFLPTLYSHFETEMNSCLVMEFC 262
Query: 169 PGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIM 228
PGGDLH LRQ+Q K F E A RFY +EV++A+E+LHM+GIIYRDLKPENVLVR DGHIM
Sbjct: 263 PGGDLHSLRQKQRGKYFPEQAARFYVAEVLLAMEYLHMLGIIYRDLKPENVLVREDGHIM 322
Query: 229 LTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCII-PNCIVPAVSC 287
L+DFDLSL+ S + + + T + + + + SSCI+ P+CI P C
Sbjct: 323 LSDFDLSLRCAVSPTLVRFAAI----TLESKSSSYCIQPTCVDQSSCIVQPDCIQPV--C 376
Query: 288 LHPK---RRRKKKLGNPGT------PEIVAEPLDVRSMSFVGTHEYLAPEIISGEGHGNA 338
P+ + + +K N + PE++AEP RSMSFVGTHEYLAPEII GEGHG+A
Sbjct: 377 FTPRFLSKGKHRKKSNDMSRQIRPLPELIAEPTSARSMSFVGTHEYLAPEIIKGEGHGSA 436
Query: 339 VDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKD 398
VDWWT GIF++EL +G TPF+G D+ TL NVV + L FP+ P+V A+DLI LLVK+
Sbjct: 437 VDWWTFGIFLYELLFGITPFRGGDNRATLFNVVGQPLRFPEHPNVSFAARDLIRGLLVKE 496
Query: 399 PTRRMGSKMGATAIKRHQFFNGVNWALLRCAKPPFIPRPVTCRD 442
P R+ + GAT IK+H FF VNWAL+RC PP IP+PV D
Sbjct: 497 PQHRLAYRRGATEIKQHPFFQSVNWALIRCTSPPQIPQPVKPMD 540
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P15792|KPK1_PHAVU Protein kinase PVPK-1 OS=Phaseolus vulgaris PE=2 SV=1 | Back alignment and function description |
|---|
Score = 390 bits (1002), Expect = e-107, Method: Compositional matrix adjust.
Identities = 211/426 (49%), Positives = 273/426 (64%), Gaps = 39/426 (9%)
Query: 52 PRCNDDPCWKAIKEATSEGNNNNNNNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNG 111
P +D W+AI+ + + L + R + +LG GDIGSVYL +L ++
Sbjct: 203 PHKANDIRWEAIQAVRTR------DGMLEMRHFRLLKKLGCGDIGSVYLAELSGTRTS-- 254
Query: 112 CFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWSCLLTEFCPGG 171
FA KVM+K EL +R K RA+ EREIL+ LDHPFLPTLY + +SCL+ EFCPGG
Sbjct: 255 --FAMKVMNKTELANRKKLLRAQTEREILQSLDHPFLPTLYTHFETEIFSCLVMEFCPGG 312
Query: 172 DLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTD 231
DLH LRQRQP K F E AVRFY +EV+++LE+LHM+GIIYRDLKPENVLVR DGHIML+D
Sbjct: 313 DLHALRQRQPGKYFSEHAVRFYVAEVLLSLEYLHMLGIIYRDLKPENVLVREDGHIMLSD 372
Query: 232 FDLSLKGDNSTSTAQLVSD-QSPPTGDQQPNDCAVDQPPFGNSSCII-PNCIVPAVSCLH 289
FDLSL+ S + + ++ Q+ +G C QP +C++ P+CI P SC
Sbjct: 373 FDLSLRCSVSPTLVKSSNNLQTKSSGY-----CV--QPSCIEPTCVMQPDCIKP--SCFT 423
Query: 290 PK-----------RRRKKKLGNPGTP--EIVAEPLDVRSMSFVGTHEYLAPEIISGEGHG 336
P+ + K + N TP E++AEP + RSMSFVGTHEYLAPEII GEGHG
Sbjct: 424 PRFLSGKSKKDKKSKPKNDMHNQVTPLPELIAEPTNARSMSFVGTHEYLAPEIIKGEGHG 483
Query: 337 NAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLV 396
+AVDWWT GIF++EL +G TPFKG + TL NV+ + L FP+ P+V A+DLI LLV
Sbjct: 484 SAVDWWTFGIFLYELLFGRTPFKGSANRATLFNVIGQPLRFPESPTVSFAARDLIRGLLV 543
Query: 397 KDPTRRMGSKMGATAIKRHQFFNGVNWALLRCAKPPFIPR-----PVTCRDLTTTNSSID 451
K+P R+ + GAT IK+H FF VNWAL+RCA PP +PR P T +DL S
Sbjct: 544 KEPQHRLAYRRGATEIKQHPFFQNVNWALIRCATPPEVPRQVINLPQTEKDLGVKPSGNY 603
Query: 452 NSIEYY 457
I+++
Sbjct: 604 LDIDFF 609
|
Phaseolus vulgaris (taxid: 3885) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q64FQ2|PID2_ARATH Protein kinase PINOID 2 OS=Arabidopsis thaliana GN=PID2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 374 bits (961), Expect = e-103, Method: Compositional matrix adjust.
Identities = 208/491 (42%), Positives = 277/491 (56%), Gaps = 77/491 (15%)
Query: 23 NSGSETTWTTSG--SNPSSSTPSAAKTH------HAPPRCNDDPCWKAIKEATSEGNNNN 74
+S T+W +S ++PS S+ S H + P + W+A+
Sbjct: 23 DSSRRTSWLSSSFTASPSCSSISHLSNHGLNSYNQSKPHKANQVAWEAMARL-----RRC 77
Query: 75 NNNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRAR 134
+ L R + RLGSGDIGSVYL Q++ S F+A KV+DK + + K RA
Sbjct: 78 CGRAVGLEHFRLLKRLGSGDIGSVYLCQIRG--SPETAFYAMKVVDKEAVAVKKKLGRAE 135
Query: 135 IEREILEMLDHPFLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYA 194
+E++IL MLDHPF PTLYA + +S L+ E+CPGGDL+ +R RQP KRF S+ RFYA
Sbjct: 136 MEKKILGMLDHPFCPTLYAAFEASHYSFLVMEYCPGGDLYAVRLRQPSKRFTISSTRFYA 195
Query: 195 SEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQLVSDQSPP 254
+E +VALE+LHMMGI+YRDLKPENVL+R DGH+ML+DFDLS K D Q +SD
Sbjct: 196 AETLVALEYLHMMGIVYRDLKPENVLIREDGHVMLSDFDLSFKCD---VVPQFLSDNDRD 252
Query: 255 TGDQQPNDCAVDQPPFGNSSCIIPNCIV----PAVSCLHP--KRRRKKKLG--------- 299
G Q+ +D + C P+C P +SC P RRRKK +
Sbjct: 253 RGHQEDDDDISIR-----RKCSTPSCTTTPLNPVISCFSPTSSRRRKKNVVTTTIHENAA 307
Query: 300 --------------------------------NPGTPEIVAEPLDVRSMSFVGTHEYLAP 327
+ G P I AEP++ RS SFVGTHEYLAP
Sbjct: 308 GTSDSVKSNDVSRTFSRSPSSCSRVSNGLRDISGGCPSIFAEPINARSKSFVGTHEYLAP 367
Query: 328 EIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEF-------PKE 380
E+ISG+GHG+AVDWWT GIF++E+ +G TPFKG ++E TL N++ L F PKE
Sbjct: 368 EVISGQGHGSAVDWWTYGIFLYEMIFGRTPFKGDNNEKTLVNILKAPLTFPKVIVNSPKE 427
Query: 381 PSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGVNWALLRCAKPPFIPRPVTC 440
A+DLI +LLVK+P +R+GS G+ IKRH+FF GVNWAL+R KPP++P+ T
Sbjct: 428 YEDMVNAQDLIIKLLVKNPKKRLGSLKGSIEIKRHEFFEGVNWALIRSIKPPWVPKEETS 487
Query: 441 RDLTTTNSSID 451
N S++
Sbjct: 488 HKTKGDNRSVN 498
|
Serine/threonine-protein kinase involved in the regulation of auxin signaling. Plays a minor role in the regulation of cellular auxin efflux and cotyledon organogenesis. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q2QM77|PID_ORYSJ Protein kinase PINOID OS=Oryza sativa subsp. japonica GN=PID PE=2 SV=1 | Back alignment and function description |
|---|
Score = 364 bits (934), Expect = e-100, Method: Compositional matrix adjust.
Identities = 189/390 (48%), Positives = 244/390 (62%), Gaps = 35/390 (8%)
Query: 52 PRCNDDPCWKAIKEATSEGNNNNNNNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNG 111
P + D W AI+ A++ + PL D + V R+G GDIG+VYL +L+S
Sbjct: 84 PHRSGDVAWAAIRAAST-----TSAAPLGPRDFKLVRRIGGGDIGTVYLCRLRSSPERES 138
Query: 112 -CFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDC-PRWSCLLTEFCP 169
C +A KV+D+R + + K RA E+ IL LDHPFLPTL+A D P +SC + EFCP
Sbjct: 139 PCMYAMKVVDRRAVARKQKLGRAAAEKRILRQLDHPFLPTLFADFDATPHFSCAVMEFCP 198
Query: 170 GGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIML 229
GGDLH LR R P +RF + RFYA+EV++A+E+LHMMGI+YRDLKPENVL+R+DGHIML
Sbjct: 199 GGDLHSLRHRMPSRRFPLPSARFYAAEVLLAIEYLHMMGIVYRDLKPENVLIRADGHIML 258
Query: 230 TDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLH 289
TDFDLSL+ S S GD +D A G +SC P+ ++
Sbjct: 259 TDFDLSLQSTTSPSL----------DGDTDTDDEAS-----GGASC-FPDHLLRF----- 297
Query: 290 PKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIF 349
+RR+ + P P VAEP+D RS SFVGTHEY+APE+ SG HG AVDWW G+F++
Sbjct: 298 --KRRRNAVAAP-RPRFVAEPVDARSCSFVGTHEYVAPEVASGGAHGAAVDWWAYGVFLY 354
Query: 350 ELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGP----AKDLIAQLLVKDPTRRMGS 405
EL YG TPF G +E TL N+V R L FP GP A+DLIA+LL KDP R+GS
Sbjct: 355 ELIYGRTPFAGATNEATLRNIVRRPLAFPSGSGSCGPADADARDLIARLLAKDPAARLGS 414
Query: 406 KMGATAIKRHQFFNGVNWALLRCAKPPFIP 435
+ GA +K H FF +N ALLR ++PP +P
Sbjct: 415 RRGAADVKSHPFFKSLNLALLRSSRPPVVP 444
|
Serine/threonine-protein kinase involved in the regulation of auxin signaling. May control polar auxin transport and probably plays a role in the pattern formation and organogenesis in the rice shoot. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O64682|PID_ARATH Protein kinase PINOID OS=Arabidopsis thaliana GN=PID PE=1 SV=1 | Back alignment and function description |
|---|
Score = 352 bits (902), Expect = 4e-96, Method: Compositional matrix adjust.
Identities = 192/443 (43%), Positives = 257/443 (58%), Gaps = 34/443 (7%)
Query: 14 NLSFTSTTTNSGSETTWT---TSGSNPSSSTPSAAKTHHAPPRCNDDPCWKAIKEATSEG 70
+L T++ +SG+E+ + S P S+ P P + D + I+ +G
Sbjct: 10 SLGTTNSPISSGTESCSSFSRLSFDAPPSTIPEEESFLSLKPHRSSDFAYAEIRRRKKQG 69
Query: 71 NNNNNNNPLTLSDLRFVHRLGSGDIGSVYLVQLKS-KSSNNGCFFAAKVMDKRELVSRNK 129
LT D R + R+G+GDIG+VYL +L + + +FA KV+DK L + K
Sbjct: 70 --------LTFRDFRLMRRIGAGDIGTVYLCRLAGDEEESRSSYFAMKVVDKEALALKKK 121
Query: 130 ESRARIEREILEMLDHPFLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESA 189
RA +E+ IL+MLDHPFLPTLYA + +SC++ E+C GGDLH LR RQP +RF S+
Sbjct: 122 MHRAEMEKTILKMLDHPFLPTLYAEFEASHFSCIVMEYCSGGDLHSLRHRQPHRRFSLSS 181
Query: 190 VRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQLVS 249
RFYA+EV+VALE+LHM+GIIYRDLKPEN+LVRSDGHIML+DFDLSL D S A + S
Sbjct: 182 ARFYAAEVLVALEYLHMLGIIYRDLKPENILVRSDGHIMLSDFDLSLCSD---SIAAVES 238
Query: 250 DQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAE 309
S P Q + P R KK T VAE
Sbjct: 239 SSSSPENQQLRS----------------PRRFTRLARLFQRVLRSKKVQTLEPTRLFVAE 282
Query: 310 PLDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLAN 369
P+ RS SFVGTHEY+APE+ SG HGNAVDWW G+F++E+ YG TPF +++ L N
Sbjct: 283 PVTARSGSFVGTHEYVAPEVASGGSHGNAVDWWAFGVFLYEMIYGKTPFVAPTNDVILRN 342
Query: 370 VVARALEFPKEPSVPG---PAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGVNWALL 426
+V R L FP + A++LI+ LL KDPT+R+GS+ GA +K H FF G+N+AL+
Sbjct: 343 IVKRQLSFPTDSPATMFELHARNLISGLLNKDPTKRLGSRRGAAEVKVHPFFKGLNFALI 402
Query: 427 RCAKPPFIPRPVTCRDLTTTNSS 449
R PP IP V + + + S
Sbjct: 403 RTLTPPEIPSSVVKKPMKSATFS 425
|
Serine/threonine-protein kinase involved in the regulation of auxin signaling. Acts as a positive regulator of cellular auxin efflux and regulates organ development by enhancing polar auxin transport. Phosphorylates conserved serine residues in the PIN auxin efflux carriers. Phosphorylation of PIN proteins is required and sufficient for apical-basal PIN polarity that enables directional intercellular auxin fluxes, which mediate differential growth, tissue patterning and organogenesis. Acts in association with PIN1 to control the establishment of bilateral symmetry and promotion of cotyledon outgrowth. Regulates root gravitropism through modulation of PIN2-dependent basipetal auxin transport. Required for polarization of PIN3-dependent auxin transport for hypocotyl gravitropic response. The protein kinase activity of PID is essential for its auxin efflux regulatory function. PID kinase and PP2A phosphatase activities antagonistically regulate phosphorylation of PIN proteins, affecting PIN sorting. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q94E49|PID2_ORYSJ Protein kinase PINOID 2 OS=Oryza sativa subsp. japonica GN=PID2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 347 bits (890), Expect = 1e-94, Method: Compositional matrix adjust.
Identities = 191/427 (44%), Positives = 251/427 (58%), Gaps = 58/427 (13%)
Query: 44 AAKTHHAPPRCNDDPCWKAIKEATSEGNNNNNNNPLTLSDLRFVHRLGSGDIGSVYLVQL 103
A+ + P + N W+AI+ + + L R V RLGSGD+G+VYL +L
Sbjct: 47 ASSCRYKPHKANQAE-WEAIRRLRAGAGR------VGLEHFRLVRRLGSGDLGNVYLCRL 99
Query: 104 KSKSSNN-------GCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLD 156
+ S++ GC +A KV+DK L R K RA +ER+IL LDHPFLPTLYA +
Sbjct: 100 REPWSSSSMTTTAGGCLYAMKVVDKDALAFRKKLRRAEVERDILRTLDHPFLPTLYADFE 159
Query: 157 CPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKP 216
++CL+ EFCPGGDLHV RQRQP +RF S+ RFY +E V+ALE+LHMMG++YRDLKP
Sbjct: 160 ASHYACLVMEFCPGGDLHVARQRQPGRRFTVSSTRFYVAETVLALEYLHMMGVVYRDLKP 219
Query: 217 ENVLVRSDGHIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCI 276
ENVLVR DGHIML+DFDLSLK D P + A +PP S
Sbjct: 220 ENVLVRGDGHIMLSDFDLSLK-----------CDVVPKLLRPARSAAAGGKPPLPPPSSC 268
Query: 277 IPNCIVPAVSCL--------HPKR-----------------RRKKKLGNPGTPEIVAEPL 311
+P I P +SC+ H K + + +V EP+
Sbjct: 269 VPPTIQPVLSCIFRGVHKCHHAKECAGGGAAAGNNGDGDGNDEEAETETAEPEVVVVEPV 328
Query: 312 DVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVV 371
RS SFVGTHEYLAPE+ISG+GHG+AVDWWTLG+F++E+ YG TPFKG +E TL N++
Sbjct: 329 AARSKSFVGTHEYLAPEVISGQGHGSAVDWWTLGVFMYEMLYGRTPFKGESNEKTLINII 388
Query: 372 ARALEFPK--------EPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGVNW 423
+ + FP+ E A+DL+ QLL K+P +R+GS MG+ +KRH FF GVNW
Sbjct: 389 KQPVTFPRLAGAAAAGEWEEMKTAQDLMLQLLAKNPKKRLGSTMGSAEVKRHPFFKGVNW 448
Query: 424 ALLRCAK 430
AL+R +
Sbjct: 449 ALVRSVR 455
|
Serine/threonine-protein kinase involved in the regulation of auxin signaling. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q2RBR1|PHT1B_ORYSJ Phototropin-1B OS=Oryza sativa subsp. japonica GN=PHOT1B PE=1 SV=2 | Back alignment and function description |
|---|
Score = 322 bits (826), Expect = 3e-87, Method: Compositional matrix adjust.
Identities = 176/391 (45%), Positives = 225/391 (57%), Gaps = 53/391 (13%)
Query: 52 PRCNDDPCWKAIKEATSEGNNNNNNNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNG 111
P D W+AI++ G + + L R V LGSGD GSV+LV+L N G
Sbjct: 568 PHMKDTASWRAIQKVLESGES------IGLKHFRPVKPLGSGDTGSVHLVEL----LNTG 617
Query: 112 CFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWSCLLTEFCPGG 171
+FA K MDK +++RNK RA ER+IL++LDHPFLPTLYA+ CL+T++CPGG
Sbjct: 618 EYFAMKAMDKSIMLNRNKVHRATAERQILDLLDHPFLPTLYASFQTKTHICLITDYCPGG 677
Query: 172 DLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTD 231
+L VL QP K HE AVRFYA+EVVVALE+LH GIIYRDLKPEN+L+ DGHI LTD
Sbjct: 678 ELFVLLDNQPLKVLHEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENILLHRDGHISLTD 737
Query: 232 FDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPK 291
FDLS C +SC P +P +
Sbjct: 738 FDLS---------------------------CL--------TSC-RPQVFLPEDA----- 756
Query: 292 RRRKKKLGNPGTPEIVAEPLDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFEL 351
KK N P AEP+ S SFVGT EY+APEII+G GH +AVDWW LGI ++E+
Sbjct: 757 -DEKKGRKNGSYPIFFAEPMRA-SNSFVGTEEYIAPEIITGAGHTSAVDWWALGILLYEM 814
Query: 352 FYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATA 411
YG TPF+G + T AN++ + + FP SV A+ L+ +LL +DP R+GS GA
Sbjct: 815 LYGYTPFRGKTRQRTFANILHKDIRFPASISVSLAARQLMYRLLHRDPANRLGSYEGANE 874
Query: 412 IKRHQFFNGVNWALLRCAKPPFIPRPVTCRD 442
IK H FF G+NW L+R PP + P+ +D
Sbjct: 875 IKGHPFFRGINWPLIRATAPPKLEIPLFSKD 905
|
Protein kinase that acts as a blue-light photoreceptor in a signal-transduction pathway for phototropic responses. Regulates a wide range of physiological activities in plants that maximize the efficiency of photosynthesis, such as chloroplast relocations, stomata opening, and leaf expansion. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 457 | ||||||
| 255586454 | 514 | serine/threonine protein kinase, putativ | 0.951 | 0.846 | 0.695 | 0.0 | |
| 224100639 | 452 | predicted protein [Populus trichocarpa] | 0.971 | 0.982 | 0.690 | 0.0 | |
| 225449681 | 454 | PREDICTED: protein kinase G11A-like [Vit | 0.960 | 0.966 | 0.692 | 1e-179 | |
| 224113481 | 399 | predicted protein [Populus trichocarpa] | 0.824 | 0.944 | 0.760 | 1e-173 | |
| 449456110 | 451 | PREDICTED: protein kinase G11A-like [Cuc | 0.978 | 0.991 | 0.663 | 1e-172 | |
| 147864073 | 450 | hypothetical protein VITISV_002764 [Viti | 0.960 | 0.975 | 0.690 | 1e-172 | |
| 449496268 | 451 | PREDICTED: protein kinase G11A-like [Cuc | 0.978 | 0.991 | 0.659 | 1e-171 | |
| 359479468 | 436 | PREDICTED: serine/threonine-protein kina | 0.929 | 0.974 | 0.698 | 1e-169 | |
| 356574649 | 422 | PREDICTED: protein kinase G11A-like [Gly | 0.914 | 0.990 | 0.642 | 1e-167 | |
| 255576359 | 441 | serine/threonine protein kinase, putativ | 0.842 | 0.873 | 0.699 | 1e-162 |
| >gi|255586454|ref|XP_002533871.1| serine/threonine protein kinase, putative [Ricinus communis] gi|223526182|gb|EEF28511.1| serine/threonine protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 652 bits (1683), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 333/479 (69%), Positives = 371/479 (77%), Gaps = 44/479 (9%)
Query: 1 MQPSAEDTAEDPDNLSF---------------------TSTTTNSGSETTWTTSGSNPSS 39
M PS++D A++ DNLS T +T+SGSE TWTTS +
Sbjct: 58 MDPSSDDLADELDNLSITSTTTNATTTTTTTTTTTAQETEHSTSSGSEATWTTSNHATTF 117
Query: 40 STPSAAKTHHAPPRCNDDPCWKAIKEATSEGNNNNNNNPLTLSDLRFVHRLGSGDIGSVY 99
S K+HH PP C D CW AI + E N+ LTL+DLRFVHRLGSGDIGSVY
Sbjct: 118 S-----KSHHPPP-C--DSCWHAILRSNCE------NSTLTLADLRFVHRLGSGDIGSVY 163
Query: 100 LVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPR 159
LV+LK NGC FAAKVMDK+E+ SRNK+SRARIEREILE+LDHPFLPTLYATLD R
Sbjct: 164 LVELKE---GNGCLFAAKVMDKKEMASRNKDSRARIEREILEILDHPFLPTLYATLDSSR 220
Query: 160 WSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENV 219
WSCLLTEFCPGGDLHVLRQRQPDKRF+E+AVRFYASE+V ALE+LHMMG++YRDLKPENV
Sbjct: 221 WSCLLTEFCPGGDLHVLRQRQPDKRFNEAAVRFYASEIVAALEYLHMMGVVYRDLKPENV 280
Query: 220 LVRSDGHIMLTDFDLSLKGDNSTSTAQLVSDQSPPT-GDQQPNDCAVDQPPFGNSSCIIP 278
LVRSDGHIMLTDFDLSLK D+STSTAQ+VSDQ+ P D P D P SSCIIP
Sbjct: 281 LVRSDGHIMLTDFDLSLKDDSSTSTAQIVSDQNQPIKNDYYPPD----PPQSATSSCIIP 336
Query: 279 NCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTHEYLAPEIISGEGHGNA 338
NC+VPAVSC HP+RRRK+K GT EIVAEP+DVRSMSFVGTHEYLAPEI+SGEGHG+A
Sbjct: 337 NCMVPAVSCFHPRRRRKRKSNQRGTVEIVAEPIDVRSMSFVGTHEYLAPEIVSGEGHGSA 396
Query: 339 VDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKD 398
VDWWTLGIFIFELFYG TPFKGIDHELTLAN+VARALEFPKEP VP AKDLI QLLVKD
Sbjct: 397 VDWWTLGIFIFELFYGVTPFKGIDHELTLANIVARALEFPKEPPVPVSAKDLITQLLVKD 456
Query: 399 PTRRMGSKMGATAIKRHQFFNGVNWALLRCAKPPFIPRPVTCRDLTTTNSSIDNSIEYY 457
P RR+GS MGATAIK HQFFNG NWALLRC PP++PRPVT +S +NS+EYY
Sbjct: 457 PIRRLGSTMGATAIKHHQFFNGTNWALLRCRTPPYVPRPVTRPSFIREETS-NNSVEYY 514
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224100639|ref|XP_002311957.1| predicted protein [Populus trichocarpa] gi|222851777|gb|EEE89324.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 644 bits (1661), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 321/465 (69%), Positives = 373/465 (80%), Gaps = 21/465 (4%)
Query: 1 MQPSAEDTAEDPDNLSFTSTTTNSGSETTWTTSGSNPSSSTPSA--------AKTHHAPP 52
M+P ED +D DNLS STTT + + T ++GS ++ ++ K HH PP
Sbjct: 1 MEPVVEDLTDDLDNLSLASTTTTTTAAETRHSTGSGSETTWTTSTSSLVSNSCKPHH-PP 59
Query: 53 RCNDDPCWKAIKEATSEGNNNNNNNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGC 112
+C D CW AI+ +N +N+PLTL+DLRFVH+LGSGDIGSVYLV+LK NGC
Sbjct: 60 QC--DQCWHAIQ------RDNCDNSPLTLADLRFVHKLGSGDIGSVYLVELKE---GNGC 108
Query: 113 FFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWSCLLTEFCPGGD 172
FAAKVMDK+E+ +RNK+SRARIEREILEML+HPFLPTLYATLD PR SCLLTEFCPGGD
Sbjct: 109 LFAAKVMDKKEMATRNKDSRARIEREILEMLEHPFLPTLYATLDSPRRSCLLTEFCPGGD 168
Query: 173 LHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDF 232
LHVLRQ+QP++RF E+A+RFYASEVV ALE+LHMMGI+YRDLKPENVLVRSDGHIMLTDF
Sbjct: 169 LHVLRQQQPERRFGEAAIRFYASEVVAALEYLHMMGIVYRDLKPENVLVRSDGHIMLTDF 228
Query: 233 DLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKR 292
DLSLK DNS STAQ++SDQ+ PT D D F SSCI+P+CIVPAVSC H +R
Sbjct: 229 DLSLKDDNSPSTAQIISDQNQPTTASSTRDYPSDTSQFATSSCILPSCIVPAVSCFHHRR 288
Query: 293 RRKKKLGNPGTPEIVAEPLDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELF 352
+RKKKL GT EIVAEP+DVRSMSFVGTHEYLAPEI+SGEGHGNAVDWWTLGIF+FE+F
Sbjct: 289 KRKKKLHQRGTLEIVAEPIDVRSMSFVGTHEYLAPEIVSGEGHGNAVDWWTLGIFMFEMF 348
Query: 353 YGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAI 412
YG TPFKG+DHELTLAN+VARALEFPKEPS+P AKDLI QLL+KDP RR+GS MGATAI
Sbjct: 349 YGVTPFKGMDHELTLANIVARALEFPKEPSIPVLAKDLITQLLIKDPVRRLGSTMGATAI 408
Query: 413 KRHQFFNGVNWALLRCAKPPFIPRPVTCRDLTTTNSSIDNSIEYY 457
K HQFF+G+NWALLRC PP+IPRPVT ++L +NSIEYY
Sbjct: 409 KHHQFFDGINWALLRCRTPPYIPRPVTYKNLVVAEHG-NNSIEYY 452
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225449681|ref|XP_002264924.1| PREDICTED: protein kinase G11A-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 635 bits (1639), Expect = e-179, Method: Compositional matrix adjust.
Identities = 327/472 (69%), Positives = 368/472 (77%), Gaps = 33/472 (6%)
Query: 1 MQPSAEDTAEDPDNLSFTST------------TTNSGSETTWTTSGSNPSSSTPSAAKTH 48
MQ ++D A++ D+LS ST +++SGSE TW SSS P
Sbjct: 1 MQSCSDDIADEFDSLSLNSTTTTASTTVDIKHSSSSGSEVTWAPPSIATSSSKP------ 54
Query: 49 HAPPRCNDDPCWKAIKEATSEGNNNNNNNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSS 108
HAP + DPCW+AI+ A + +++ L L +LRF+ RLGSGDIGSVYLV+LK
Sbjct: 55 HAP---SGDPCWQAIRRAQA----SSDGGALALHELRFLRRLGSGDIGSVYLVELKCA-- 105
Query: 109 NNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWSCLLTEFC 168
GC FAAKVMDK+ELVSR KE RARIEREILEMLDHPFLPTLYATLD PRWSCLLTEFC
Sbjct: 106 -GGCMFAAKVMDKKELVSRYKEGRARIEREILEMLDHPFLPTLYATLDSPRWSCLLTEFC 164
Query: 169 PGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIM 228
PGGDLHVLRQRQPDKRFHE+ VRFYASEV+VALE+LHMMGIIYRDLKPENVLVRSDGHIM
Sbjct: 165 PGGDLHVLRQRQPDKRFHEATVRFYASEVIVALEYLHMMGIIYRDLKPENVLVRSDGHIM 224
Query: 229 LTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQ---PNDCAVDQPPFGNSSCIIPNCIVPAV 285
LTDFDLSLK DNSTSTAQ+VSDQ+P + +D + PPFG SSCIIPNCIVPAV
Sbjct: 225 LTDFDLSLKNDNSTSTAQIVSDQNPACKNSSTYPSSDYPTEPPPFGESSCIIPNCIVPAV 284
Query: 286 SCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLG 345
SC HP RRR+KK + EIVAEP+DVRSMSFVGTHEYLAPEI+SGEGHGNAVDWWTLG
Sbjct: 285 SCFHPIRRRRKKPRHRRALEIVAEPVDVRSMSFVGTHEYLAPEIVSGEGHGNAVDWWTLG 344
Query: 346 IFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDPTRRMGS 405
IFIFE+ YGTTPFKG+D+ELTLAN+VARALEFPKEP VP AKDLI QLLVK+P+RRMG+
Sbjct: 345 IFIFEMLYGTTPFKGVDNELTLANIVARALEFPKEPWVPAAAKDLITQLLVKEPSRRMGA 404
Query: 406 KMGATAIKRHQFFNGVNWALLRCAKPPFIPRPVTCRDLTTTNSSIDNSIEYY 457
MGATAIK H FFNGVNWALLRC PP +PRP C D+ + D SIEYY
Sbjct: 405 TMGATAIKHHAFFNGVNWALLRCVSPPIVPRP--CNDVVSPQGCTDISIEYY 454
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224113481|ref|XP_002316507.1| predicted protein [Populus trichocarpa] gi|222865547|gb|EEF02678.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 614 bits (1583), Expect = e-173, Method: Compositional matrix adjust.
Identities = 296/389 (76%), Positives = 327/389 (84%), Gaps = 12/389 (3%)
Query: 49 HAPPRCNDDPCWKAIKEATSEGNNNNNNNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSS 108
H PP+C D CW AI+ N N+PLTL+DLRFVH+LGSGDIGSVYLV LK
Sbjct: 23 HHPPQC--DECWHAIQ------RENCGNSPLTLADLRFVHKLGSGDIGSVYLVVLKE--- 71
Query: 109 NNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWSCLLTEFC 168
N C FAAKVMDK+E+ +RNK+SRARIEREILEML+HPFLP LYATLD PRWSCLLTEFC
Sbjct: 72 GNECLFAAKVMDKKEMATRNKDSRARIEREILEMLEHPFLPPLYATLDSPRWSCLLTEFC 131
Query: 169 PGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIM 228
PGGDLHVLRQRQPD+RF E+AVRFYASEVV ALE+LHMMGI+YRD+KPENVL+RSDGHIM
Sbjct: 132 PGGDLHVLRQRQPDRRFDEAAVRFYASEVVAALEYLHMMGIVYRDIKPENVLIRSDGHIM 191
Query: 229 LTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCL 288
LTDFDLSLK DNSTSTAQ++SDQ+PP +D D F SSCI+PNCIVPAVSCL
Sbjct: 192 LTDFDLSLKDDNSTSTAQIISDQNPPITSST-SDYPSDTSQFATSSCILPNCIVPAVSCL 250
Query: 289 HPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFI 348
P R+RKKK GT EIVAEP+DVRSMSFVGTHEYLAPEI+SGEGHG+AVDWWTLGIFI
Sbjct: 251 QPCRKRKKKFNQRGTLEIVAEPIDVRSMSFVGTHEYLAPEIVSGEGHGSAVDWWTLGIFI 310
Query: 349 FELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDPTRRMGSKMG 408
FE+FYG TPFKG DHELTLANVVARALEFPKEPSVP AKDLI QLL+KDPTRR+GS MG
Sbjct: 311 FEMFYGVTPFKGTDHELTLANVVARALEFPKEPSVPVFAKDLITQLLIKDPTRRLGSTMG 370
Query: 409 ATAIKRHQFFNGVNWALLRCAKPPFIPRP 437
ATAIK H FF +NWALLRC PP+IP+P
Sbjct: 371 ATAIKHHHFFEEINWALLRCKTPPYIPQP 399
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449456110|ref|XP_004145793.1| PREDICTED: protein kinase G11A-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 612 bits (1578), Expect = e-172, Method: Compositional matrix adjust.
Identities = 306/461 (66%), Positives = 361/461 (78%), Gaps = 14/461 (3%)
Query: 1 MQPSAEDTAEDPDNLSFTSTTTN----SGSETTWTTSGSNPSSSTPSAAKTHHAPPRCND 56
M+ S +D A+D +LSF ST TN SGSETT T S S S + PS HAP +
Sbjct: 1 MESSPDDIADDLQSLSFNSTNTNRSTSSGSETTLTASSS--SLNIPSILSKPHAP---SS 55
Query: 57 DPCWKAIKEATSEGNNNNNNNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAA 116
DPCW A+ SE + L SDL+F HRLGSGDIGSVYL LKS + +GC FAA
Sbjct: 56 DPCWSAVNRIRSESSFRQ----LAFSDLKFFHRLGSGDIGSVYLSGLKS-AGTDGCLFAA 110
Query: 117 KVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWSCLLTEFCPGGDLHVL 176
KVMDK+EL SR+KE RAR EREILE LDHPFLPTLYA++D P+W CLLTEFCPGGDLHVL
Sbjct: 111 KVMDKKELASRSKEGRARTEREILESLDHPFLPTLYASIDSPKWLCLLTEFCPGGDLHVL 170
Query: 177 RQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSL 236
RQRQP+KRFHE AVRFYASE+VVA+E+LHMMGI+YRDLKPENVLVRSDGHIMLTDFDLSL
Sbjct: 171 RQRQPNKRFHELAVRFYASEIVVAIEYLHMMGIVYRDLKPENVLVRSDGHIMLTDFDLSL 230
Query: 237 KGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKK 296
K + ST+T Q+++ ++P G D +D PPF +SSCI+PNCIVPAVSC +PKR+RKK
Sbjct: 231 KCEESTATPQVINAKNPMNGTAPLKDYQIDAPPFTSSSCILPNCIVPAVSCFNPKRKRKK 290
Query: 297 KLGNPGTPEIVAEPLDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTT 356
K G+ PE VAEP+DVRSMSFVGTHEYLAPEI+SGEGHG+AVDWWTLG+F+FELFYG T
Sbjct: 291 KSGHRNGPEFVAEPVDVRSMSFVGTHEYLAPEIVSGEGHGSAVDWWTLGVFVFELFYGVT 350
Query: 357 PFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQ 416
PF+G+D+ELTLAN+VARALEFPKEP+VP AKDLI+QLL+KDP RR+GS G++AIK H
Sbjct: 351 PFRGMDNELTLANIVARALEFPKEPAVPTAAKDLISQLLIKDPARRLGSTTGSSAIKHHS 410
Query: 417 FFNGVNWALLRCAKPPFIPRPVTCRDLTTTNSSIDNSIEYY 457
FF GVNWALLRC PPFIP P + + + S + ++YY
Sbjct: 411 FFQGVNWALLRCTSPPFIPPPFSREKIASDESCTEAPVDYY 451
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147864073|emb|CAN83229.1| hypothetical protein VITISV_002764 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 612 bits (1577), Expect = e-172, Method: Compositional matrix adjust.
Identities = 323/468 (69%), Positives = 368/468 (78%), Gaps = 29/468 (6%)
Query: 1 MQPSAEDTAEDPDNLSFTSTTT--------NSGSETTWTTSGSN---PSSSTPSAAKTHH 49
M+P ED+ +D ++SF STTT +SGSETTWTT+ S P++S P A+
Sbjct: 1 MEPWLEDSTDDSKSMSFNSTTTATDINRSTSSGSETTWTTAASGGFPPATSKPHAS---- 56
Query: 50 APPRCNDDPCWKAIKEATSEGNNNNNNNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSN 109
+ DPCW I+ A SE + L+ SDLRFV RLGSGDIGSVYLV+LK+
Sbjct: 57 -----SGDPCWDGIRRARSE----SPAGALSFSDLRFVQRLGSGDIGSVYLVELKAA--- 104
Query: 110 NGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWSCLLTEFCP 169
GC FAAKVMDK+EL RNKE RAR EREILEMLDHPFLP LYAT+D P+ SCLLTEFCP
Sbjct: 105 EGCSFAAKVMDKKELAGRNKEGRARTEREILEMLDHPFLPALYATIDSPKCSCLLTEFCP 164
Query: 170 GGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIML 229
GGDLHVLRQRQP KRFHESAVRFYASEVVVALE++HMMGI+YRDLKPENVLVRSDGHIML
Sbjct: 165 GGDLHVLRQRQPAKRFHESAVRFYASEVVVALEYVHMMGIVYRDLKPENVLVRSDGHIML 224
Query: 230 TDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLH 289
TDFDLSLK D+STS AQ++SDQ+PP P+D D PPF +SSCI+PNCIVPAVSC H
Sbjct: 225 TDFDLSLKCDHSTSVAQIISDQNPPLA-LPPSDYPADPPPFTSSSCILPNCIVPAVSCFH 283
Query: 290 PKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIF 349
PKR+RKKK G+ G PE VAEP+DVRSMSFVGTHEYLAPEI+SGEGHG+AVDWWTLGIFIF
Sbjct: 284 PKRKRKKKPGHHGGPEFVAEPVDVRSMSFVGTHEYLAPEIVSGEGHGSAVDWWTLGIFIF 343
Query: 350 ELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDPTRRMGSKMGA 409
EL YG TPF+G+D+ELTLAN+VARALEFPKEP VP KDLI+QLLVKDP RRMGS MGA
Sbjct: 344 ELLYGVTPFRGVDNELTLANIVARALEFPKEPLVPATTKDLISQLLVKDPARRMGSTMGA 403
Query: 410 TAIKRHQFFNGVNWALLRCAKPPFIPRPVTCRDLTTTNSSIDNSIEYY 457
+AIK H FF GVNWALLRC PPFIP P RD+ + S + ++YY
Sbjct: 404 SAIKHHPFFQGVNWALLRCTPPPFIPPPFN-RDVVSDESCPETPMDYY 450
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449496268|ref|XP_004160089.1| PREDICTED: protein kinase G11A-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 607 bits (1564), Expect = e-171, Method: Compositional matrix adjust.
Identities = 304/461 (65%), Positives = 359/461 (77%), Gaps = 14/461 (3%)
Query: 1 MQPSAEDTAEDPDNLSFTSTTTN----SGSETTWTTSGSNPSSSTPSAAKTHHAPPRCND 56
M+ S +D A+D +LSF ST TN SGSETT T S S S + PS HAP +
Sbjct: 1 MESSPDDIADDLQSLSFNSTNTNRSTSSGSETTLTASSS--SLNIPSILSKPHAP---SS 55
Query: 57 DPCWKAIKEATSEGNNNNNNNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAA 116
DPCW A+ SE + L SDL+F HRLGSGDIGSVYL LKS + +GC FAA
Sbjct: 56 DPCWSAVNRIRSESSFRQ----LAFSDLKFFHRLGSGDIGSVYLSGLKS-AGTDGCLFAA 110
Query: 117 KVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWSCLLTEFCPGGDLHVL 176
KVMDK+EL SR+KE RAR EREILE LDHPFLPTLYA++D P+W CLLTEFCPGGDLHVL
Sbjct: 111 KVMDKKELASRSKEGRARTEREILESLDHPFLPTLYASIDSPKWLCLLTEFCPGGDLHVL 170
Query: 177 RQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSL 236
RQRQ +KRF E AVRFYASE+VVA+E+LHMMGI+YRDLKPENVLVRSDGHIMLTDFDLSL
Sbjct: 171 RQRQANKRFDELAVRFYASEIVVAIEYLHMMGIVYRDLKPENVLVRSDGHIMLTDFDLSL 230
Query: 237 KGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKK 296
K + ST+T Q+++ ++P G D +D PPF +SSCI+PNCIVPAVSC +PKR+RKK
Sbjct: 231 KCEESTATPQVINAKNPMNGTAPLKDYQIDAPPFTSSSCILPNCIVPAVSCFNPKRKRKK 290
Query: 297 KLGNPGTPEIVAEPLDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTT 356
K G+ PE VAEP+DVRSMSFVGTHEYLAPEI+SGEGHG+AVDWWTLG+F+FELFYG T
Sbjct: 291 KSGHRNGPEFVAEPVDVRSMSFVGTHEYLAPEIVSGEGHGSAVDWWTLGVFVFELFYGVT 350
Query: 357 PFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQ 416
PF+G+D+ELTLAN+VARALEFPKEP+VP AKDLI+QLL+KDP RR+GS G++AIK H
Sbjct: 351 PFRGMDNELTLANIVARALEFPKEPAVPTAAKDLISQLLIKDPARRLGSTTGSSAIKHHS 410
Query: 417 FFNGVNWALLRCAKPPFIPRPVTCRDLTTTNSSIDNSIEYY 457
FF GVNWALLRC PPFIP P + + + S + ++YY
Sbjct: 411 FFQGVNWALLRCTSPPFIPPPFSREKIASDESCTEAPVDYY 451
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359479468|ref|XP_002266280.2| PREDICTED: serine/threonine-protein kinase KIPK-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 601 bits (1549), Expect = e-169, Method: Compositional matrix adjust.
Identities = 317/454 (69%), Positives = 359/454 (79%), Gaps = 29/454 (6%)
Query: 15 LSFTSTTT--------NSGSETTWTTSGSN---PSSSTPSAAKTHHAPPRCNDDPCWKAI 63
+SF STTT +SGSETTWTT+ S P++S P A+ + DPCW I
Sbjct: 1 MSFNSTTTATDINRSTSSGSETTWTTAASGGFPPATSKPHAS---------SGDPCWDGI 51
Query: 64 KEATSEGNNNNNNNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRE 123
+ A SE + L+ SDLRFV RLGSGDIGSVYLV+LK+ GC FAAK+MDK+E
Sbjct: 52 RRARSE----SPAGALSFSDLRFVQRLGSGDIGSVYLVELKAA---EGCSFAAKIMDKKE 104
Query: 124 LVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDK 183
L RNKE RAR EREILEMLDHPFLP LYAT+D P+ SCLLTEFCPGGDLHVLRQRQP K
Sbjct: 105 LAGRNKEGRARTEREILEMLDHPFLPALYATIDSPKCSCLLTEFCPGGDLHVLRQRQPAK 164
Query: 184 RFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTS 243
RFHESAVRFYASEVVVALE++HMMGI+YRDLKPENVLVRSDGHIMLTDFDLSLK D+STS
Sbjct: 165 RFHESAVRFYASEVVVALEYVHMMGIVYRDLKPENVLVRSDGHIMLTDFDLSLKCDHSTS 224
Query: 244 TAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGT 303
AQ++SDQ+PP P+D D PPF +SSCI+PNCIVPAVSC HPKR+RKKK G+ G
Sbjct: 225 VAQIISDQNPPLA-LPPSDYPADPPPFTSSSCILPNCIVPAVSCFHPKRKRKKKPGHHGG 283
Query: 304 PEIVAEPLDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDH 363
PE VAEP+DVRSMSFVGTHEYLAPEI+SGEGHG+AVDWWTLGIFIFEL YG TPF+G+D+
Sbjct: 284 PEFVAEPVDVRSMSFVGTHEYLAPEIVSGEGHGSAVDWWTLGIFIFELLYGVTPFRGVDN 343
Query: 364 ELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGVNW 423
ELTLAN+VARALEFPKEP VP KDLI+QLLVKDP RRMGS MGA+AIK H FF GVNW
Sbjct: 344 ELTLANIVARALEFPKEPLVPATTKDLISQLLVKDPARRMGSTMGASAIKHHPFFQGVNW 403
Query: 424 ALLRCAKPPFIPRPVTCRDLTTTNSSIDNSIEYY 457
ALLRC PPFIP P RD+ + S + ++YY
Sbjct: 404 ALLRCTPPPFIPPPFN-RDVVSDESCPETPMDYY 436
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356574649|ref|XP_003555458.1| PREDICTED: protein kinase G11A-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 595 bits (1535), Expect = e-167, Method: Compositional matrix adjust.
Identities = 296/461 (64%), Positives = 351/461 (76%), Gaps = 43/461 (9%)
Query: 1 MQPSAEDTAEDPDNLSFTSTTTNSGSETTWTTSGSNPSSSTPSAAKTHHAPPRCNDDPCW 60
M SAE ED DN + T+T + T WT S + HAP + DP W
Sbjct: 1 MHSSAE---EDSDNSATTATAS-----TEWTFSAKS------------HAP---SSDPSW 37
Query: 61 KAIKEATSEGNNNNNNNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMD 120
AI+ L L DLRFV R+GSGDIGSVYLV+LK S GC FAAKVMD
Sbjct: 38 DAIQRG--------GGATLALGDLRFVQRVGSGDIGSVYLVELKGSS---GCLFAAKVMD 86
Query: 121 KRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQ 180
K+ELV+RNK++RA++EREIL+M+DHPFLPTLYA+LD PRWSCLLTEFCPGGDLHVLRQRQ
Sbjct: 87 KKELVARNKDTRAKVEREILQMVDHPFLPTLYASLDSPRWSCLLTEFCPGGDLHVLRQRQ 146
Query: 181 PDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDN 240
PDKRFH +AVRFYASEVVVALE+LHMMGIIYRDLKPENVL+RSDGHIMLTDFDLSLKGD+
Sbjct: 147 PDKRFHLAAVRFYASEVVVALEYLHMMGIIYRDLKPENVLIRSDGHIMLTDFDLSLKGDD 206
Query: 241 STSTAQLVSDQSPPTGDQQPNDCAVD----QPPFGNSSCIIPNCIVPAVSCLHPKRRRKK 296
+ STAQ+V D+ PP+ N C+ + Q SSC++PNCIVP+V C HPKR R K
Sbjct: 207 TASTAQMVFDEDPPS-----NTCSKEHSRKQCTPTMSSCMLPNCIVPSVPCFHPKRGRSK 261
Query: 297 KLGNPGTPEIVAEPLDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTT 356
+ G+ EI+AEP+++RS SFVGTHEYLAPE+ISGEGHGNAVDWWTLG+FIFE+FYG T
Sbjct: 262 RFSRCGSLEIIAEPIEIRSTSFVGTHEYLAPEVISGEGHGNAVDWWTLGVFIFEMFYGIT 321
Query: 357 PFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQ 416
PFKG+++ELTLAN+VARALEFPKEP +PGPA+DLI+QLLVKD T R+GS MGA AIK H
Sbjct: 322 PFKGLENELTLANIVARALEFPKEPMIPGPARDLISQLLVKDSTMRLGSTMGALAIKHHP 381
Query: 417 FFNGVNWALLRCAKPPFIPRPVTCRDLTTTNSSIDNSIEYY 457
FFNGVNW LLRCA PP+IP C++L + +N+I++Y
Sbjct: 382 FFNGVNWPLLRCATPPYIPSSDKCKELLPLYNCTNNAIDFY 422
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255576359|ref|XP_002529072.1| serine/threonine protein kinase, putative [Ricinus communis] gi|223531484|gb|EEF33316.1| serine/threonine protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 576 bits (1485), Expect = e-162, Method: Compositional matrix adjust.
Identities = 275/393 (69%), Positives = 322/393 (81%), Gaps = 8/393 (2%)
Query: 71 NNNNNNNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGC------FFAAKVMDKREL 124
+ + ++ L LSDLRF RLGSGDIGSVYL +LK ++ FAAKVMDK+EL
Sbjct: 51 HTSKHHQSLCLSDLRFSLRLGSGDIGSVYLAELKKPDTSAASDITDSPIFAAKVMDKKEL 110
Query: 125 VSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKR 184
VSR+KE RA+ EREILEMLDHPFLP LYA ++ RW CLLTEFC GGDLHVLRQRQP KR
Sbjct: 111 VSRSKEGRAKTEREILEMLDHPFLPCLYACIESQRWLCLLTEFCNGGDLHVLRQRQPLKR 170
Query: 185 FHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTST 244
+SAVRFYASEVVVALE+LHM+GI+YRDLKPENVLVRSDGHIMLTDFDLSLK D+STST
Sbjct: 171 LEDSAVRFYASEVVVALEYLHMLGIVYRDLKPENVLVRSDGHIMLTDFDLSLKCDDSTST 230
Query: 245 AQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTP 304
Q+++ Q+ P + ND +D PF +SSCIIPNCIVPAVSC HPKR+RKKK G+ G P
Sbjct: 231 PQIITSQNTPNAAPK-NDYPIDHRPFTSSSCIIPNCIVPAVSCFHPKRKRKKKTGHRGGP 289
Query: 305 EIVAEPLDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHE 364
E VAEP+DVRSMSFVGTHEYLAPEI+SGEGHG+ VDWWTLGIF+FELFYG TPF+G+DHE
Sbjct: 290 EFVAEPVDVRSMSFVGTHEYLAPEIVSGEGHGSPVDWWTLGIFMFELFYGVTPFRGLDHE 349
Query: 365 LTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGVNWA 424
LTLAN+VARALEFPKEP++P AKDLI+QLLVKDP RR+GS MGA+AIK H FF GVNWA
Sbjct: 350 LTLANIVARALEFPKEPAIPSTAKDLISQLLVKDPARRLGSTMGASAIKHHPFFQGVNWA 409
Query: 425 LLRCAKPPFIPRPVTCRDLTTTNSSIDNSIEYY 457
LLRC +PP++P P T +++ + S + +EYY
Sbjct: 410 LLRCTRPPYVPPPYT-KEIVSDESCPETPVEYY 441
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 457 | ||||||
| TAIR|locus:2098120 | 451 | AT3G44610 [Arabidopsis thalian | 0.824 | 0.835 | 0.689 | 1.1e-142 | |
| UNIPROTKB|Q5I6E9 | 700 | Adi3 "AvrPto-dependent Pto-int | 0.818 | 0.534 | 0.538 | 3.6e-105 | |
| TAIR|locus:2160922 | 586 | D6PKL2 "D6 protein kinase like | 0.768 | 0.598 | 0.574 | 1.2e-104 | |
| TAIR|locus:2174885 | 499 | AT5G40030 [Arabidopsis thalian | 0.851 | 0.779 | 0.522 | 2.3e-103 | |
| TAIR|locus:2133837 | 506 | D6PKL1 "D6 protein kinase like | 0.809 | 0.731 | 0.534 | 9.8e-103 | |
| TAIR|locus:2178388 | 498 | D6PK "D6 protein kinase" [Arab | 0.824 | 0.757 | 0.527 | 2e-102 | |
| TAIR|locus:2207470 | 555 | AGC1.7 "AGC kinase 1.7" [Arabi | 0.824 | 0.679 | 0.531 | 2.6e-102 | |
| TAIR|locus:2087785 | 577 | AGC1.5 "AGC kinase 1.5" [Arabi | 0.803 | 0.636 | 0.542 | 2.6e-102 | |
| TAIR|locus:2055017 | 765 | AT2G44830 [Arabidopsis thalian | 0.803 | 0.479 | 0.531 | 5.4e-102 | |
| TAIR|locus:2091443 | 578 | ATPK7 [Arabidopsis thaliana (t | 0.822 | 0.650 | 0.515 | 3.1e-99 |
| TAIR|locus:2098120 AT3G44610 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1395 (496.1 bits), Expect = 1.1e-142, P = 1.1e-142
Identities = 269/390 (68%), Positives = 317/390 (81%)
Query: 79 LTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGC------FFAAKVMDKRELVSRNKESR 132
L+LSDLRF RLGSGDIGSV+L + KS ++ AAKVMDK+EL SR+KE R
Sbjct: 64 LSLSDLRFRLRLGSGDIGSVFLAEFKSLTAVTETTAVKLPLLAAKVMDKKELASRSKEGR 123
Query: 133 ARIEREILEMLDHPFLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRF 192
A+ EREILE LDHPFLPTLYA +D P+W CLLTEFCPGGDLHVLRQ+Q KRFHESAVRF
Sbjct: 124 AKTEREILESLDHPFLPTLYAAIDSPKWLCLLTEFCPGGDLHVLRQKQTHKRFHESAVRF 183
Query: 193 YASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQLVSDQS 252
Y SEV+VA+E+LHM+GI+YRDLKPENVLVRSDGHIMLTDFDLSLK D STST Q+V +++
Sbjct: 184 YVSEVIVAIEYLHMLGIVYRDLKPENVLVRSDGHIMLTDFDLSLKCDESTSTPQIVLNRN 243
Query: 253 P-PTG--DQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPK-RRRKKKLGNPGT-PEIV 307
P G DQ N +D +SSC+IPNCIVPAVSC HP+ RRRKKK + PE+V
Sbjct: 244 NLPNGSSDQNENQ-GMDHRQTTSSSCMIPNCIVPAVSCFHPRIRRRKKKTDHRNNGPELV 302
Query: 308 AEPLDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTL 367
AEP+DVRSMSFVGTHEYLAPEI+SGEGHG+AVDWWTLGIF+FELFYGTTPFKG+DHELTL
Sbjct: 303 AEPVDVRSMSFVGTHEYLAPEIVSGEGHGSAVDWWTLGIFMFELFYGTTPFKGMDHELTL 362
Query: 368 ANVVARALEFPKEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGVNWALLR 427
AN+VARALEFPKEP++P AKDLI+QLL KDP+RR+GS +GATA+KRH FF GVNWALL
Sbjct: 363 ANIVARALEFPKEPTIPSAAKDLISQLLAKDPSRRLGSSLGATAVKRHPFFQGVNWALLM 422
Query: 428 CAKPPFIPRPVTCRDLTTTNSSIDNSIEYY 457
C +PPF+P P ++L + + + ++YY
Sbjct: 423 CTRPPFLPPPFR-KELLSDDICPETHVDYY 451
|
|
| UNIPROTKB|Q5I6E9 Adi3 "AvrPto-dependent Pto-interacting protein 3" [Solanum lycopersicum (taxid:4081)] | Back alignment and assigned GO terms |
|---|
Score = 1041 (371.5 bits), Expect = 3.6e-105, P = 3.6e-105
Identities = 211/392 (53%), Positives = 261/392 (66%)
Query: 52 PRCNDDPCWKAIKEATSEGXXXXXXXPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNG 111
P +DP WKAI + L +S + + RLG GDIGSVYL +L S
Sbjct: 282 PHKGNDPRWKAILAIRARDGI------LGMSHFKLLKRLGCGDIGSVYLSEL----SGTR 331
Query: 112 CFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWSCLLTEFCPGG 171
C+FA KVMDK L SR K +RA+ EREIL++LDHPFLPTLY + R+SCL+ E+CPGG
Sbjct: 332 CYFAMKVMDKASLASRKKLTRAQTEREILQLLDHPFLPTLYTHFETDRFSCLVMEYCPGG 391
Query: 172 DLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTD 231
DLH LRQRQP K F E A RFYA+EV++ALE+LHM+G++YRDLKPENVLVR DGHIML+D
Sbjct: 392 DLHTLRQRQPGKHFSEYAARFYAAEVLLALEYLHMLGVVYRDLKPENVLVRDDGHIMLSD 451
Query: 232 FDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPK 291
FDLSL+ S + ++ SD G A +P + C+ P C +P + K
Sbjct: 452 FDLSLRCAVSPTLIRISSDDPSKRGAAFCVQPACIEP---TTVCMQPACFLPRLFPQKSK 508
Query: 292 RRRKKKLGNPG-----TPEIVAEPLDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGI 346
++ K + G PE+VAEP RSMSFVGTHEYLAPEII GEGHG+AVDWWT GI
Sbjct: 509 KKTPKPRADSGFQANSMPELVAEPTSARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGI 568
Query: 347 FIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDPTRRMGSK 406
F+ EL YG TPFKG + TL NVV + L+FP P+ ++DLI LLVK+P R+G K
Sbjct: 569 FLHELLYGKTPFKGSGNRATLFNVVGQQLKFPDSPATSYASRDLIRGLLVKEPQNRLGVK 628
Query: 407 MGATAIKRHQFFNGVNWALLRCAKPPFIPRPV 438
GAT IK+H FF GVNWAL+RC+ PP +PRPV
Sbjct: 629 RGATEIKQHPFFEGVNWALIRCSTPPEVPRPV 660
|
|
| TAIR|locus:2160922 D6PKL2 "D6 protein kinase like 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1036 (369.7 bits), Expect = 1.2e-104, P = 1.2e-104
Identities = 213/371 (57%), Positives = 256/371 (69%)
Query: 79 LTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIERE 138
L LS R + RLG GDIGSVYL +L S C+FA KVMDK L SR K RA+ ERE
Sbjct: 186 LGLSHFRLLKRLGCGDIGSVYLSEL----SGTKCYFAMKVMDKTSLASRKKLLRAQTERE 241
Query: 139 ILEMLDHPFLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVV 198
IL+ LDHPFLPTLY + ++SCL+ EFCPGGDLH LRQRQP K F E AV+FY +E +
Sbjct: 242 ILQSLDHPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQRQPGKHFSEQAVKFYIAESL 301
Query: 199 VALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQ 258
+ALE+LHM+GI+YRDLKPENVLVR DGHIML+DFDLSL+ S + + + +S P
Sbjct: 302 LALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCLVSPTLVKSAAIESDPL--- 358
Query: 259 QPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHP-------KRRRKKKLGNPGT----PEIV 307
+ N V QP SCI P+C VP +C P K+ RK K PE+V
Sbjct: 359 RKNVYCV-QPACIEPSCIQPSCTVPT-TCFSPRLFSSKSKKDRKPKNDTANQVRPLPELV 416
Query: 308 AEPLDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTL 367
AEP D RSMSFVGTHEYLAPEII GEGHG+AVDWWT GIF++EL +G TPFKG + TL
Sbjct: 417 AEPTDARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGRTPFKGSGNRQTL 476
Query: 368 ANVVARALEFPKEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGVNWALLR 427
NVV + L FP+ P V A+DLI LL+K+P +R+G K GAT +K+H FF GVNWAL+R
Sbjct: 477 FNVVGQPLRFPETPVVSFAARDLIRGLLMKEPQQRLGFKRGATEVKQHPFFEGVNWALIR 536
Query: 428 CAKPPFIPRPV 438
CA PP IP+PV
Sbjct: 537 CATPPEIPKPV 547
|
|
| TAIR|locus:2174885 AT5G40030 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1024 (365.5 bits), Expect = 2.3e-103, P = 2.3e-103
Identities = 212/406 (52%), Positives = 267/406 (65%)
Query: 52 PRCNDDPCWKAIKEATSEGXXXXXXXPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNG 111
P +D W AI+ L L R + +LG GDIGSVYL +L+ G
Sbjct: 87 PHKGNDLRWDAIQNVKCS-----KNEDLGLGHFRLLKKLGCGDIGSVYLAELREM----G 137
Query: 112 CFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWSCLLTEFCPGG 171
CFFA KVMDK L+ R K RA+ EREIL +LDHPFLPTLY+ + ++SCLL EFC GG
Sbjct: 138 CFFAMKVMDKGMLIGRKKLVRAQTEREILGLLDHPFLPTLYSHFETEKFSCLLMEFCSGG 197
Query: 172 DLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTD 231
DLH+LRQ+QP K F E A RFYASEV++ALE+LHMMG++YRDLKPENV+VR DGHIML+D
Sbjct: 198 DLHILRQKQPGKHFSELAARFYASEVLLALEYLHMMGVVYRDLKPENVMVREDGHIMLSD 257
Query: 232 FDLSLKGDNSTSTAQLVSDQSPPTGDQ--QPNDCAVDQPPFGNSSCIIPNCIVPAVSCLH 289
FDLSL+ S + Q S S QP C +D +CI P+C P
Sbjct: 258 FDLSLQSFVSPTLIQSTSQPSCHIASYCIQP-PC-IDPSCKLPVACIQPSCFKPRFLNNK 315
Query: 290 PKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIF 349
P++ + +K G+ P ++AEP RSMSFVGTHEYLAPEII G+GHG++VDWWT GIF++
Sbjct: 316 PRKAKTEKAGSDSLPMLIAEPTAARSMSFVGTHEYLAPEIIRGDGHGSSVDWWTFGIFLY 375
Query: 350 ELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDPTRRMGSKMGA 409
EL G TPFKG + TL NVV + L+FP E S+ AKDLI LL KDP +R+G K GA
Sbjct: 376 ELLTGKTPFKGNGNRETLFNVVGQPLKFP-EGSISFAAKDLIRGLLTKDPKKRLGFKKGA 434
Query: 410 TAIKRHQFFNGVNWALLRCAKPPFIPRPVTCRDLTTTNSSIDNSIE 455
T IK+H FFN VNWAL+R PP IP+P+ DL+ N ++ +S++
Sbjct: 435 TEIKQHPFFNNVNWALIRSTTPPEIPKPI---DLSILNETLKSSVQ 477
|
|
| TAIR|locus:2133837 D6PKL1 "D6 protein kinase like 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1018 (363.4 bits), Expect = 9.8e-103, P = 9.8e-103
Identities = 216/404 (53%), Positives = 267/404 (66%)
Query: 48 HHAPPRCNDDPCWKAIKEA-TSEGXXXXXXXPLTLSDLRFVHRLGSGDIGSVYLVQLKSK 106
++ P + ND W+AI+ T G L L+ R + RLG GDIG+V+L +L
Sbjct: 94 NNKPHKANDVR-WEAIQAVRTKHGV-------LGLNHFRLLKRLGCGDIGTVHLAELHGT 145
Query: 107 SSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWSCLLTE 166
CFFA KVMDK L SR K RA+ EREIL+ LDHPFLPTLY+ + ++SCL+ E
Sbjct: 146 R----CFFAMKVMDKGALASRKKLLRAQTEREILQCLDHPFLPTLYSHFETEKFSCLVME 201
Query: 167 FCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGH 226
FCPGGDLH LRQRQP KRF E A +FY +EV++A+E+LHM+GIIYRDLKPENVLVR DGH
Sbjct: 202 FCPGGDLHTLRQRQPGKRFSEQAAKFYVAEVLLAMEYLHMLGIIYRDLKPENVLVRDDGH 261
Query: 227 IMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCII-PNCIVPAV 285
+ML+DFDLSL+ S + + S G + CA QP +CI P+CI
Sbjct: 262 VMLSDFDLSLRCTVSPTVVR--STVLASEGQKNSGYCA--QP-----ACIQQPSCISAPT 312
Query: 286 SCLHP-----KRRRKKKLGNP-GT-----PEIVAEPLDVRSMSFVGTHEYLAPEIISGEG 334
+C P K ++ KK+ N G PE+VAEP RSMSFVGTHEYLAPEII GEG
Sbjct: 313 TCFSPRYFSSKSKKDKKMKNETGNQVSPLPELVAEPTSARSMSFVGTHEYLAPEIIKGEG 372
Query: 335 HGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQL 394
HG+AVDWWT GIF++EL +G TPFKG + TL NVV + L FP+ P V A+DLI L
Sbjct: 373 HGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRSL 432
Query: 395 LVKDPTRRMGSKMGATAIKRHQFFNGVNWALLRCAKPPFIPRPV 438
LVK+P R+ K GAT +K+H FF GVNWAL+RCA PP IP+PV
Sbjct: 433 LVKEPQHRLAYKRGATEMKQHPFFEGVNWALVRCASPPEIPKPV 476
|
|
| TAIR|locus:2178388 D6PK "D6 protein kinase" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1015 (362.4 bits), Expect = 2.0e-102, P = 2.0e-102
Identities = 217/411 (52%), Positives = 267/411 (64%)
Query: 51 PPRCNDDPCWKAIKEA-TSEGXXXXXXXPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSN 109
P + ND W+AI+ T G L L+ R + RLG GDIG+V+L +L +
Sbjct: 83 PHKANDVR-WEAIQAVRTKHGG-------LGLNHFRLLKRLGCGDIGTVHLAEL----NG 130
Query: 110 NGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWSCLLTEFCP 169
C+FA KVMDK L SR K RA+ EREIL+ LDHPFLPTLY+ + ++SCL+ EFCP
Sbjct: 131 TRCYFAMKVMDKTALASRKKLLRAQTEREILQCLDHPFLPTLYSHFETEKFSCLVMEFCP 190
Query: 170 GGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIML 229
GGDLH LRQRQP KRF E A +FY +EV++A+E+LHM+GIIYRDLKPENVLVR DGH+ML
Sbjct: 191 GGDLHTLRQRQPGKRFTEQAAKFYVAEVLLAMEYLHMLGIIYRDLKPENVLVRDDGHVML 250
Query: 230 TDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCII-PNCIVPA-VSC 287
+DFDLSL+ T + +V + + N + Q P +CI P+CI A SC
Sbjct: 251 SDFDLSLR---CTVSLSIVRSANVGSEGLSKNSVSCSQQP----ACIQQPSCISMAPTSC 303
Query: 288 LHPK--RRRKKKLGNPGT----------PEIVAEPLDVRSMSFVGTHEYLAPEIISGEGH 335
P+ + KK P T PE+VAEP RSMSFVGTHEYLAPEII GEGH
Sbjct: 304 FGPRFFSSKSKKDKKPKTENGNHQVTPLPELVAEPTGARSMSFVGTHEYLAPEIIKGEGH 363
Query: 336 GNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLL 395
G+AVDWWT GIF++EL +G TPFKG + TL NVV + L FP+ P V A+DLI LL
Sbjct: 364 GSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRSLL 423
Query: 396 VKDPTRRMGSKMGATAIKRHQFFNGVNWALLRCAKPPFIPRPVTCRDLTTT 446
VK+P R+ K GAT IK+H FF GVNWAL+RCA PP IP+PV L T
Sbjct: 424 VKEPQHRLAYKRGATEIKQHPFFEGVNWALVRCASPPEIPKPVDLEALNPT 474
|
|
| TAIR|locus:2207470 AGC1.7 "AGC kinase 1.7" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1014 (362.0 bits), Expect = 2.6e-102, P = 2.6e-102
Identities = 208/391 (53%), Positives = 258/391 (65%)
Query: 52 PRCNDDPCWKAIKEATSEGXXXXXXXPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNG 111
P D W A+ TS+G L +SD R + RLG GDIGSVYLV+L+ +
Sbjct: 120 PHTGGDIRWDAVNTLTSKGVQ------LGISDFRLLKRLGYGDIGSVYLVELRGTIT--- 170
Query: 112 CFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWSCLLTEFCPGG 171
+FA KVMDK L SRNK RA+ EREIL LDHPFLPTLY+ + ++ CL+ EFC GG
Sbjct: 171 -YFAMKVMDKASLASRNKLLRAQTEREILSQLDHPFLPTLYSHFETDKFYCLVMEFCGGG 229
Query: 172 DLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTD 231
+L+ LRQ+QP+K F E A RF+ASEV++ALE+LHM+GI+YRDLKPENVLVR DGHIML+D
Sbjct: 230 NLYSLRQKQPNKCFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDDGHIMLSD 289
Query: 232 FDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPK 291
FDLSL+ S + + S + G + CI P+ P + K
Sbjct: 290 FDLSLRCSVSPTLVKSSSVHAAGGGSGSSRPVGLIDEDAAVQGCIQPSTFFPRILQSSKK 349
Query: 292 RRRKKK-LG---NPGTPEIVAEPLDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIF 347
R+ K G N PE++AEP +V+SMSFVGTHEYLAPEII GEGHG+AVDWWT GIF
Sbjct: 350 NRKAKSDFGLFVNGSMPELMAEPTNVKSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIF 409
Query: 348 IFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDPTRRMGSKM 407
I+EL YG TPFKG + TL NV+ +AL FP+ P V A+DLI LLVK+P +R+ K
Sbjct: 410 IYELLYGATPFKGQGNRATLHNVIGQALRFPEVPHVSSAARDLIKGLLVKEPQKRIAYKR 469
Query: 408 GATAIKRHQFFNGVNWALLRCAKPPFIPRPV 438
GAT IK+H FF GVNWAL+R A PP +P PV
Sbjct: 470 GATEIKQHPFFEGVNWALIRSATPPHVPEPV 500
|
|
| TAIR|locus:2087785 AGC1.5 "AGC kinase 1.5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1014 (362.0 bits), Expect = 2.6e-102, P = 2.6e-102
Identities = 212/391 (54%), Positives = 260/391 (66%)
Query: 52 PRCNDDPCWKAIKEATSEGXXXXXXXPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNG 111
P D W AI S+G + L + R + RLG GDIGSVYL L+ ++
Sbjct: 159 PHTGGDVRWDAINSIASKGPQ------IGLDNFRLLKRLGYGDIGSVYLADLRGTNA--- 209
Query: 112 CFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWSCLLTEFCPGG 171
FA KVMDK L SRNK RA+ EREIL +LDHPFLPTLY+ + ++ CL+ EFC GG
Sbjct: 210 -VFAMKVMDKASLASRNKLLRAQTEREILSLLDHPFLPTLYSYFETDKFYCLVMEFCSGG 268
Query: 172 DLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTD 231
+LH LRQ+QP +RF E A RFYASEV++ALE+LHM+G++YRDLKPEN+LVR +GHIML+D
Sbjct: 269 NLHSLRQKQPSRRFTEEAARFYASEVLLALEYLHMLGVVYRDLKPENILVRDEGHIMLSD 328
Query: 232 FDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPK 291
FDLSL+ T LV S +G A+ F + C+ P+ +P + L K
Sbjct: 329 FDLSLR---CTFNPTLVKSSSVCSGGG-----AILNEEFAVNGCMHPSAFLPRL--LPSK 378
Query: 292 RRRKKK----LGNPGTPEIVAEPLDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIF 347
+ RK K LG PE++AEP DVRSMSFVGTHEYLAPEII GEGHG+AVDWWT GIF
Sbjct: 379 KTRKAKSDSGLGGLSMPELMAEPTDVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIF 438
Query: 348 IFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDPTRRMGSKM 407
++EL +GTTPFKG + TL NVV + L+FP P V A+DLI LLVKDP RR+
Sbjct: 439 LYELLHGTTPFKGQGNRATLHNVVGQPLKFPDTPHVSSAARDLIRGLLVKDPHRRIAYTR 498
Query: 408 GATAIKRHQFFNGVNWALLRCAKPPFIPRPV 438
GAT IK+H FF GVNWAL+R A PP IP PV
Sbjct: 499 GATEIKQHPFFEGVNWALVRSAAPPHIPDPV 529
|
|
| TAIR|locus:2055017 AT2G44830 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1011 (360.9 bits), Expect = 5.4e-102, P = 5.4e-102
Identities = 211/397 (53%), Positives = 264/397 (66%)
Query: 52 PRCNDDPCWKAIKEA-TSEGXXXXXXXPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNN 110
P +DP W AI T +G L +S + + RLG GDIGSVYL +L S
Sbjct: 337 PHKGNDPWWNAILAIRTRDGI-------LGMSHFKLLKRLGCGDIGSVYLAEL----SGT 385
Query: 111 GCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWSCLLTEFCPG 170
C FA KVMDK L R K +RA+ ER+IL++LDHPFLPTLY + R+SCL+ E+CPG
Sbjct: 386 RCHFAVKVMDKASLEDRKKLNRAQTERDILQLLDHPFLPTLYTHFETDRFSCLVMEYCPG 445
Query: 171 GDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLT 230
GDLH LRQRQP K F E A RFYA+EV++ALE+LHM+G++YRDLKPENVLVR DGHIML+
Sbjct: 446 GDLHTLRQRQPGKHFSEYAARFYAAEVLLALEYLHMLGVVYRDLKPENVLVRDDGHIMLS 505
Query: 231 DFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCII-PNCIVPAVSCLH 289
DFDLSL+ + S + + S P+ ++ C S+CII P+C +P +
Sbjct: 506 DFDLSLRC--AVSPTLIKTFDSDPS--RRGAFCVQPACMEPTSACIIQPSCFLPR--SIF 559
Query: 290 PKRRRKKKL---------GNPGT-PEIVAEPLDVRSMSFVGTHEYLAPEIISGEGHGNAV 339
P + +K K + G+ PE+VAEP + RSMSFVGTHEYLAPEII GEGHG+AV
Sbjct: 560 PNKNKKNKSRKTQADFFKSHSGSLPELVAEP-NTRSMSFVGTHEYLAPEIIKGEGHGSAV 618
Query: 340 DWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDP 399
DWWT GIF+ EL YG TPFKG + TL NVV L+FP+ P+ +DLI LLVKDP
Sbjct: 619 DWWTFGIFVHELLYGKTPFKGSGNRATLFNVVGEQLKFPESPATSYAGRDLIQALLVKDP 678
Query: 400 TRRMGSKMGATAIKRHQFFNGVNWALLRCAKPPFIPR 436
R+G+K GAT IK+H FF GVNWAL+RC+ PP +PR
Sbjct: 679 KNRLGTKRGATEIKQHPFFEGVNWALIRCSTPPEVPR 715
|
|
| TAIR|locus:2091443 ATPK7 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 985 (351.8 bits), Expect = 3.1e-99, P = 3.1e-99
Identities = 210/407 (51%), Positives = 263/407 (64%)
Query: 49 HAPPRCNDDPCWKAIKEATSEGXXXXXXXPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSS 108
+ P R N+D W AI+E S L D + + +LG GDIG+VYL +L
Sbjct: 152 YKPHRDNNDKRWVAIQEVRSR-----VGSSLEAKDFKLIKKLGGGDIGNVYLAEL----I 202
Query: 109 NNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWSCLLTEFC 168
G FA KVM+K + +R K RA+ E+EIL+ LDHPFLPTLY+ + SCL+ EFC
Sbjct: 203 GTGVSFAVKVMEKAAIAARKKLVRAQTEKEILQSLDHPFLPTLYSHFETEMNSCLVMEFC 262
Query: 169 PGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIM 228
PGGDLH LRQ+Q K F E A RFY +EV++A+E+LHM+GIIYRDLKPENVLVR DGHIM
Sbjct: 263 PGGDLHSLRQKQRGKYFPEQAARFYVAEVLLAMEYLHMLGIIYRDLKPENVLVREDGHIM 322
Query: 229 LTDFDLSLKGDNSTST---AQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCII-PNCIVPA 284
L+DFDLSL+ S + A + + + QP C VDQ SSCI+ P+CI P
Sbjct: 323 LSDFDLSLRCAVSPTLVRFAAITLESKSSSYCIQPT-C-VDQ-----SSCIVQPDCIQPV 375
Query: 285 VSCLHP----KRRRKKKLGNPGT-----PEIVAEPLDVRSMSFVGTHEYLAPEIISGEGH 335
C P K + +KK + PE++AEP RSMSFVGTHEYLAPEII GEGH
Sbjct: 376 --CFTPRFLSKGKHRKKSNDMSRQIRPLPELIAEPTSARSMSFVGTHEYLAPEIIKGEGH 433
Query: 336 GNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLL 395
G+AVDWWT GIF++EL +G TPF+G D+ TL NVV + L FP+ P+V A+DLI LL
Sbjct: 434 GSAVDWWTFGIFLYELLFGITPFRGGDNRATLFNVVGQPLRFPEHPNVSFAARDLIRGLL 493
Query: 396 VKDPTRRMGSKMGATAIKRHQFFNGVNWALLRCAKPPFIPRPVTCRD 442
VK+P R+ + GAT IK+H FF VNWAL+RC PP IP+PV D
Sbjct: 494 VKEPQHRLAYRRGATEIKQHPFFQSVNWALIRCTSPPQIPQPVKPMD 540
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server 
Original result from Ezypred Server
Fail to connect to Ezypred Server
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING 
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database part I
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 457 | |||
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-162 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 6e-89 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-78 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-73 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 3e-70 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-57 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 4e-54 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-53 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-47 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 9e-45 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 4e-44 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 6e-44 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-43 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 6e-43 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-40 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 8e-40 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 7e-38 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-37 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-36 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 3e-36 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 5e-36 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 7e-36 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-34 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-32 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-32 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 3e-31 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 5e-31 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 8e-31 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-30 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-30 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-30 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 7e-30 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-29 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 6e-29 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 7e-29 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 7e-29 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 8e-29 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-28 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-28 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-28 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 3e-28 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 5e-28 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 6e-28 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-27 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-27 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 3e-27 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 7e-27 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-26 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 4e-26 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 6e-26 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 6e-26 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 8e-26 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-25 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-25 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-25 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-25 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-25 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 3e-25 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 3e-25 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 4e-25 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 6e-25 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 7e-25 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 8e-25 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-24 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-24 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-24 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 3e-24 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-24 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 3e-24 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 4e-24 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 6e-24 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-23 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-23 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-23 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 3e-23 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 4e-23 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 5e-23 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-22 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-22 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-22 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-22 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-22 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-22 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 5e-22 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 6e-22 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 8e-22 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-21 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-21 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-21 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-21 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 3e-21 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 5e-21 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 7e-21 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 9e-21 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-20 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-20 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 3e-20 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 3e-20 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 4e-20 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 4e-20 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 5e-20 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 9e-20 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-19 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-19 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-19 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-19 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 3e-19 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 4e-19 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 4e-19 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 4e-19 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 5e-19 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 9e-19 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-18 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-18 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-18 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-18 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 5e-18 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 9e-18 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-17 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-17 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-17 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-17 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-17 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 3e-17 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 3e-17 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 4e-17 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 9e-17 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-16 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-16 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 3e-16 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 6e-16 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-15 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 3e-15 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 4e-15 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 7e-15 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 8e-15 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 9e-15 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-14 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-14 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 3e-14 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 4e-14 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 7e-14 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-13 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-13 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-13 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 5e-13 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 5e-13 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 7e-13 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 7e-13 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-12 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-12 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-12 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 4e-12 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 5e-12 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-11 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-11 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-11 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 3e-11 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 4e-11 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 5e-11 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 5e-11 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 6e-11 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 6e-11 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-10 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-10 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-10 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 4e-10 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 5e-10 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 5e-10 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 7e-10 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 8e-10 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 8e-10 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 9e-10 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-09 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-09 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-09 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-09 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-09 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-09 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-09 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 4e-09 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 4e-09 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 4e-09 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 4e-09 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 7e-09 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-08 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-08 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-08 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-08 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 2e-08 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-08 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-08 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-08 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 3e-08 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 5e-08 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 6e-08 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 6e-08 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 7e-08 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 8e-08 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-07 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-07 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-07 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-07 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-07 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-07 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-07 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-07 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-07 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-07 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-07 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-07 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 3e-07 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-07 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 3e-07 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 4e-07 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 4e-07 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 4e-07 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 5e-07 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 5e-07 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 5e-07 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 6e-07 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 7e-07 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 8e-07 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 8e-07 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 8e-07 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 9e-07 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 9e-07 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-06 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-06 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-06 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-06 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-06 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-06 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-06 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 3e-06 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 3e-06 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 3e-06 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 3e-06 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 3e-06 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 3e-06 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 3e-06 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 3e-06 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 4e-06 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 4e-06 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 4e-06 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 5e-06 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 5e-06 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 6e-06 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 6e-06 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 7e-06 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 7e-06 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 8e-06 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 9e-06 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 9e-06 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-05 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-05 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-05 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-05 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-05 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-05 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-05 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-05 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-05 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-05 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-05 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-05 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 3e-05 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 3e-05 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 3e-05 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-05 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 3e-05 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 3e-05 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 3e-05 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 3e-05 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 4e-05 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 4e-05 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 4e-05 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 4e-05 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 5e-05 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 5e-05 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 5e-05 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 5e-05 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 6e-05 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 6e-05 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 7e-05 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 7e-05 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 7e-05 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 8e-05 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 9e-05 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-04 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-04 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-04 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-04 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-04 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-04 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-04 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-04 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-04 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-04 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-04 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-04 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-04 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-04 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-04 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-04 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-04 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-04 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 3e-04 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-04 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 3e-04 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 3e-04 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 3e-04 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 3e-04 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 3e-04 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 3e-04 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-04 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 3e-04 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 3e-04 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 4e-04 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 4e-04 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 4e-04 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 5e-04 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 5e-04 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 5e-04 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 6e-04 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 6e-04 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 6e-04 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 7e-04 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 7e-04 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 9e-04 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 0.001 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 0.001 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 0.001 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 0.001 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 0.001 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 0.001 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 0.001 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 0.001 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 0.001 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 0.001 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 0.001 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 0.002 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 0.002 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 0.002 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 0.002 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 0.002 | |
| PRK09188 | 365 | PRK09188, PRK09188, serine/threonine protein kinas | 0.002 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 0.002 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 0.002 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 0.002 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 0.002 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 0.002 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 0.002 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 0.002 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 0.002 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 0.003 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 0.003 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 0.003 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 0.003 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 0.003 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 0.003 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 0.003 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 0.004 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 0.004 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 0.004 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 0.004 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 0.004 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 0.004 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 0.004 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 459 bits (1184), Expect = e-162
Identities = 167/356 (46%), Positives = 215/356 (60%), Gaps = 45/356 (12%)
Query: 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILE 141
+ + LG GD+G V+LV+LK FA KV+DK+E++ RNK R E+EIL
Sbjct: 1 KHFKKIKLLGKGDVGRVFLVRLKGTGK----LFALKVLDKKEMIKRNKVKRVLTEQEILA 56
Query: 142 MLDHPFLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVAL 201
LDHPFLPTLYA+ + CL+ ++CPGG+L L QRQP K E RFYA+EV++AL
Sbjct: 57 TLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLAL 116
Query: 202 EFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPN 261
E+LH++GI+YRDLKPEN+L+ GHIML+DFDLS S VS
Sbjct: 117 EYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSK---QSDVEPPPVSKA---------- 163
Query: 262 DCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGT 321
L RR N E +E RS SFVGT
Sbjct: 164 --------------------------LRKGSRRSSV--NSIPSETFSEEPSFRSNSFVGT 195
Query: 322 HEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEP 381
EY+APE+ISG+GHG+AVDWWTLGI ++E+ YGTTPFKG + + T +N++ + + FP P
Sbjct: 196 EEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDETFSNILKKEVTFPGSP 255
Query: 382 SVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGVNWALLRCAKPPFIPRP 437
V A+DLI +LLVKDP++R+GSK GA IK+H FF GVNWAL+R PP IPRP
Sbjct: 256 PVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVNWALIRHTTPPIIPRP 311
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 270 bits (694), Expect = 6e-89
Identities = 114/329 (34%), Positives = 161/329 (48%), Gaps = 79/329 (24%)
Query: 90 LGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLP 149
LG G G V LV+ K + G +A KV+ K++++ R + ER IL ++HPF+
Sbjct: 1 LGKGSFGKVLLVRKK----DTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIV 56
Query: 150 TLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGI 209
L+ L+ E+ PGG+L ++ RF E RFYA+E+V+ALE+LH +GI
Sbjct: 57 KLHYAFQTEEKLYLVLEYAPGGELFSHLSKE--GRFSEERARFYAAEIVLALEYLHSLGI 114
Query: 210 IYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPP 269
IYRDLKPEN+L+ +DGHI LTDF L+ + + S
Sbjct: 115 IYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRT------------------------ 150
Query: 270 FGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTHEYLAPEI 329
N+ C GTPE YLAPE+
Sbjct: 151 --NTFC--------------------------GTPE------------------YLAPEV 164
Query: 330 ISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKD 389
+ G+G+G AVDWW+LG+ ++E+ G PF D + ++ L FP+ S A+D
Sbjct: 165 LLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSP--EARD 222
Query: 390 LIAQLLVKDPTRRMGSKMGATAIKRHQFF 418
LI+ LL KDPT+R+GS GA IK H FF
Sbjct: 223 LISGLLQKDPTKRLGSG-GAEEIKAHPFF 250
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 245 bits (628), Expect = 1e-78
Identities = 108/341 (31%), Positives = 160/341 (46%), Gaps = 65/341 (19%)
Query: 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILE 141
D +F +G G +V L + K +A K++DKR+L+ K +IE+E+L
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKE----TNKEYAIKILDKRQLIKEKKVKYVKIEKEVLT 56
Query: 142 MLD-HPFLPTLYATLDCPRWSCL--LTEFCPGGDL-HVLRQRQPDKRFHESAVRFYASEV 197
L+ HP + LY T L + E+ P G+L +R+ E RFYA+E+
Sbjct: 57 RLNGHPGIIKLYYTFQDE--ENLYFVLEYAPNGELLQYIRKY---GSLDEKCTRFYAAEI 111
Query: 198 VVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGD 257
++ALE+LH GII+RDLKPEN+L+ D HI +TDF TA+++ S P +
Sbjct: 112 LLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFG----------TAKVLDPNSSPESN 161
Query: 258 QQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMS 317
+ S + RRR S
Sbjct: 162 KG--------------------DATNIDSQIEKNRRRFA--------------------S 181
Query: 318 FVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEF 377
FVGT EY++PE+++ + G + D W LG I+++ G PF+G + LT ++ F
Sbjct: 182 FVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEYSF 241
Query: 378 PKEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFF 418
P P+ P AKDLI +LLV DP R+G G +K H FF
Sbjct: 242 P--PNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 232 bits (593), Expect = 1e-73
Identities = 106/335 (31%), Positives = 159/335 (47%), Gaps = 71/335 (21%)
Query: 90 LGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLP 149
+ G G V+L + KS G +A KV+ K +++ +N+ + ER+IL P++
Sbjct: 1 ISKGAYGRVFLAKKKS----TGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVV 56
Query: 150 TLYATLDCPRWSCLLTEFCPGGDL-HVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMG 208
LY + + L+ E+ PGGDL +L E R Y +E+V+ALE+LH G
Sbjct: 57 KLYYSFQGKKNLYLVMEYLPGGDLASLLENVG---SLDEDVARIYIAEIVLALEYLHSNG 113
Query: 209 IIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQP 268
II+RDLKP+N+L+ S+GH+ LTDF LS G LV Q ++
Sbjct: 114 IIHRDLKPDNILIDSNGHLKLTDFGLSKVG--------LVRRQ-----------INLNDD 154
Query: 269 PFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTHEYLAPE 328
+ + GTP +Y+APE
Sbjct: 155 EKEDKRIV-------------------------GTP------------------DYIAPE 171
Query: 329 IISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAK 388
+I G+GH VDWW+LG ++E G PF G E N++ +E+P++ V A
Sbjct: 172 VILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAI 231
Query: 389 DLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGVNW 423
DLI++LLV DP +R+G+K IK H FF G++W
Sbjct: 232 DLISKLLVPDPEKRLGAK-SIEEIKNHPFFKGIDW 265
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 226 bits (578), Expect = 3e-70
Identities = 116/356 (32%), Positives = 172/356 (48%), Gaps = 53/356 (14%)
Query: 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILE 141
D + +G G G V+LV+ K G +A KV+ K +++ RN+ + R ER+IL
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDT----GQVYAMKVLRKSDMIKRNQIAHVRAERDILA 56
Query: 142 MLDHPFLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVAL 201
D P++ LY + L+ E+ PGGDL L R+ F E RFY +E+V+AL
Sbjct: 57 DADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRK--DVFPEETARFYIAELVLAL 114
Query: 202 EFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPN 261
+ +H +G I+RD+KP+N+L+ +DGHI L DF L K N + + S
Sbjct: 115 DSVHKLGFIHRDIKPDNILIDADGHIKLADFGLC-KKMNKAKDREYYLNDS-----HNLL 168
Query: 262 DCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGT 321
++R+ VR+ S VGT
Sbjct: 169 FRDNVLVRR------------------RDHKQRR-----------------VRANSTVGT 193
Query: 322 HEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVA--RALEFPK 379
+Y+APE++ G +G DWW+LG+ ++E+ YG PF + T ++ +L FP
Sbjct: 194 PDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYNKIINWKESLRFPP 253
Query: 380 EPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGVNWALLRCAKPPFIP 435
+P V A DLI +LL DP R+GS IK H FF G++W LR KPPF+P
Sbjct: 254 DPPVSPEAIDLICRLLC-DPEDRLGS---FEEIKSHPFFKGIDWENLRETKPPFVP 305
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 193 bits (493), Expect = 2e-57
Identities = 112/359 (31%), Positives = 178/359 (49%), Gaps = 39/359 (10%)
Query: 83 DLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEM 142
D V +G G G V LVQ K + G +A K + K E+ +++ + + ER++L
Sbjct: 2 DFHTVKVIGKGAFGEVRLVQKK----DTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAE 57
Query: 143 LDHPFLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALE 202
D P++ +LY + ++ L+ EF PGGDL + + F E RFY +E V+A+E
Sbjct: 58 SDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKY--DTFSEDVTRFYMAECVLAIE 115
Query: 203 FLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSL---KGDNSTSTAQLVSDQSPPTGDQQ 259
+H +G I+RD+KP+N+L+ GHI L+DF LS K +S +L+ +S
Sbjct: 116 AVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDN 175
Query: 260 PNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFV 319
N AVD N + + + ++ ++ + + S V
Sbjct: 176 RNSVAVDS----------INLTMSSKDQIATWKKNRRLM----------------AYSTV 209
Query: 320 GTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVA--RALEF 377
GT +Y+APEI +G+G DWW+LG +FE G PF + T ++ L F
Sbjct: 210 GTPDYIAPEIFLQQGYGQECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETLYF 269
Query: 378 PKEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGVNWALLRCAKPPFIPR 436
P + + A+DLI +L+ + R+G + GA IK H FF GV+W +R + PFIP+
Sbjct: 270 PDDIHLSVEAEDLIRRLIT-NAENRLG-RGGAHEIKSHPFFRGVDWDTIRQIRAPFIPQ 326
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 184 bits (469), Expect = 4e-54
Identities = 108/350 (30%), Positives = 170/350 (48%), Gaps = 46/350 (13%)
Query: 90 LGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLP 149
+G G G V LVQ K + G +A K + K E++ + + + R ER+IL D+P++
Sbjct: 9 IGRGAFGEVRLVQKK----DTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVV 64
Query: 150 TLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGI 209
LY + + L+ E+ PGGD+ L ++ F E RFY +E ++A++ +H +G
Sbjct: 65 KLYYSFQDENYLYLIMEYLPGGDMMTLLMKK--DTFTEEETRFYIAETILAIDSIHKLGY 122
Query: 210 IYRDLKPENVLVRSDGHIMLTDFDLS--LKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQ 267
I+RD+KP+N+L+ + GHI L+DF L LK + T +++S P N
Sbjct: 123 IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALP------SNFLDFIS 176
Query: 268 PPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTHEYLAP 327
P +S KR R+ + S VGT +Y+AP
Sbjct: 177 KPM-SSKRKAETW----------KRNRRAL-----------------AYSTVGTPDYIAP 208
Query: 328 EIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVV--ARALEFPKEPSVPG 385
E+ G+ DWW+LG+ ++E+ G PF + + T ++ L+FP E +
Sbjct: 209 EVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCSDNPQETYRKIINWKETLQFPDEVPLSP 268
Query: 386 PAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGVNWALLRCAKPPFIP 435
AKDLI +L + RR+G+ G IK H FF GV+W +R P IP
Sbjct: 269 EAKDLIKRLCC-EAERRLGNN-GVNEIKSHPFFKGVDWEHIRERPAPIIP 316
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 180 bits (458), Expect = 1e-53
Identities = 93/342 (27%), Positives = 138/342 (40%), Gaps = 89/342 (26%)
Query: 84 LRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEML 143
+ +LGSG G+VY + K G A K++ KR S+ ++ R E IL L
Sbjct: 1 YELLRKLGSGSFGTVYKAKHK----GTGKIVAVKILKKRSEKSKKDQTARR-EIRILRRL 55
Query: 144 DHPFLPTLYATLDCPRWSCLLTEFCPGGDLH-VLRQRQPDKRFHESAVRFYASEVVVALE 202
HP + L + L+ E+C GGDL L + E + A +++ LE
Sbjct: 56 SHPNIVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRG---GPLSEDEAKKIALQILRGLE 112
Query: 203 FLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPND 262
+LH GII+RDLKPEN I+L D+
Sbjct: 113 YLHSNGIIHRDLKPEN--------ILL---------------------------DENGVV 137
Query: 263 CAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTH 322
D FG + ++ + +FVGT
Sbjct: 138 KIAD---FGLAKKLLKS--------------------------------SSSLTTFVGTP 162
Query: 323 EYLAPEII-SGEGHGNAVDWWTLGIFIFELFYGTTPFKG---IDHELTLANVVARALEFP 378
Y+APE++ G G+G VD W+LG+ ++EL G PF G +D + ++ LEF
Sbjct: 163 WYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFD 222
Query: 379 KEPSVPGP--AKDLIAQLLVKDPTRRMGSKMGATAIKRHQFF 418
+ G AKDLI + L KDP++R A I +H +F
Sbjct: 223 EPKWSSGSEEAKDLIKKCLNKDPSKR----PTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 164 bits (418), Expect = 2e-47
Identities = 65/164 (39%), Positives = 96/164 (58%), Gaps = 8/164 (4%)
Query: 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILE 141
D F+ LG+G G V LV+ K +G ++A K++ K ++V + E+ IL+
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHK----GSGKYYALKILSKAKIVKLKQVEHVLNEKRILQ 56
Query: 142 MLDHPFLPTLYATLDCPRWSCLLTEFCPGGDL-HVLRQRQPDKRFHESAVRFYASEVVVA 200
+ HPFL LY + L+ E+ PGG+L LR+ RF E RFYA++VV+A
Sbjct: 57 SIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSG---RFPEPVARFYAAQVVLA 113
Query: 201 LEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTST 244
LE+LH + I+YRDLKPEN+L+ SDG+I +TDF + + T T
Sbjct: 114 LEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYT 157
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 156 bits (397), Expect = 9e-45
Identities = 59/164 (35%), Positives = 87/164 (53%), Gaps = 8/164 (4%)
Query: 85 RFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLD 144
+ +LG G G VYL + K G A KV+ K+++ + R E +IL+ L
Sbjct: 2 EILEKLGEGSFGKVYLARDK----KTGKLVAIKVIKKKKI--KKDRERILREIKILKKLK 55
Query: 145 HPFLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFL 204
HP + LY + L+ E+C GGDL L +++ R E RFY +++ ALE+L
Sbjct: 56 HPNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKR--GRLSEDEARFYLRQILSALEYL 113
Query: 205 HMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQLV 248
H GI++RDLKPEN+L+ DGH+ L DF L+ + D V
Sbjct: 114 HSKGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFV 157
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 158 bits (401), Expect = 4e-44
Identities = 107/351 (30%), Positives = 163/351 (46%), Gaps = 40/351 (11%)
Query: 90 LGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLP 149
+G G G V LV K N +A K + K +++ RN+ + + ER+IL D+ ++
Sbjct: 9 IGIGAFGEVCLV---RKVDTNA-LYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVV 64
Query: 150 TLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGI 209
LY + + ++ PGGD+ L R F E RFY +E+ A+E +H MG
Sbjct: 65 KLYYSFQDKDNLYFVMDYIPGGDMMSLLIRL--GIFEEDLARFYIAELTCAIESVHKMGF 122
Query: 210 IYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCA-VDQP 268
I+RD+KP+N+L+ DGHI LTDF L G T ++ Q D D
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLC-TGFRWTHDSKYY----------QKGDHHRQDSM 171
Query: 269 PFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTHEYLAPE 328
I C + + +RRRK++ + S VGT Y+APE
Sbjct: 172 EPSEEWSEIDRCRLKPL-----ERRRKRQ------------HQRCLAHSLVGTPNYIAPE 214
Query: 329 IISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVV--ARALEFPKEPSVPGP 386
++ G+ DWW++G+ ++E+ G PF T V+ L P + +
Sbjct: 215 VLLRTGYTQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSRE 274
Query: 387 AKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGVNWA-LLRCAKPPFIPR 436
A DLI + L R+G GA IK H FF G+++A L+R K P+IP+
Sbjct: 275 ASDLILR-LCCGAEDRLGKN-GADEIKAHPFFKGIDFASLIRRQKAPYIPK 323
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 154 bits (392), Expect = 6e-44
Identities = 95/355 (26%), Positives = 145/355 (40%), Gaps = 88/355 (24%)
Query: 90 LGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLP 149
LG G G V Q+K G +A K +DK+ L R E A E++ILE + F+
Sbjct: 1 LGKGGFGEVCACQVK----ATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIV 56
Query: 150 TLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGI 209
+L + CL+ GGDL + F E+ FYA++++ LE LH I
Sbjct: 57 SLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRI 116
Query: 210 IYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPP 269
+YRDLKPENVL+ G++ ++D L+++ + G
Sbjct: 117 VYRDLKPENVLLDDHGNVRISDLGLAVE----------LKGGKKIKG------------- 153
Query: 270 FGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPG--TPEIVAEPLDVRSMSFVGTHEYLAP 327
+ G PG PE++
Sbjct: 154 ---------------------------RAGTPGYMAPEVL-------------------- 166
Query: 328 EIISGEGHGNAVDWWTLGIFIFELFYGTTPFK----GIDHELTLANVVARALEFPKEPSV 383
GE + +VDW+ LG ++E+ G +PF+ ++ E + A+E+P + S
Sbjct: 167 ---QGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFS- 222
Query: 384 PGPAKDLIAQLLVKDPTRRMGSK-MGATAIKRHQFFNGVNWALLRCAK--PPFIP 435
AKDL LL KDP +R+G + A ++ H F +NW L PPFIP
Sbjct: 223 -PEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLNWRRLEAGMLEPPFIP 276
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 155 bits (393), Expect = 2e-43
Identities = 107/362 (29%), Positives = 165/362 (45%), Gaps = 89/362 (24%)
Query: 83 DLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEM 142
D +G G G V +V+ K+ G +A KVM K L+++ S ER+IL +
Sbjct: 2 DFDVKSLVGRGHFGEVQVVREKA----TGDIYAMKVMKKSVLLAQETVSFFEEERDILSI 57
Query: 143 LDHPFLPTL-YATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVAL 201
+ P++P L YA D L+ E+ PGGDL L R D+ F E +FY +E+V+A+
Sbjct: 58 SNSPWIPQLQYAFQDKDNLY-LVMEYQPGGDLLSLLNRYEDQ-FDEDMAQFYLAELVLAI 115
Query: 202 EFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPN 261
+H MG ++RD+KPENVL+ GHI L DF S A+L +++
Sbjct: 116 HSVHQMGYVHRDIKPENVLIDRTGHIKLADFG---------SAARLTANKM--------- 157
Query: 262 DCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGT 321
V+ P GTP+ +A
Sbjct: 158 -----------------------VNSKLPV----------GTPDYIA------------- 171
Query: 322 HEYLAPEI---ISGEG---HGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVA--R 373
PE+ ++G+G +G DWW+LG+ +E+ YG +PF T N++ R
Sbjct: 172 -----PEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQR 226
Query: 374 ALEFPKEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGVNWALLRCAKPPF 433
L+FP++P V DLI Q L+ R+G + + H FF+ ++W +R + PPF
Sbjct: 227 FLKFPEDPKVSSDFLDLI-QSLLCGQKERLGYE----GLCCHPFFSKIDWNNIRNSLPPF 281
Query: 434 IP 435
+P
Sbjct: 282 VP 283
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 153 bits (388), Expect = 6e-43
Identities = 106/354 (29%), Positives = 153/354 (43%), Gaps = 87/354 (24%)
Query: 90 LGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEML-DHPFL 148
LG G G V L +LK +G +A KV+ K ++ + E+ IL + +HPFL
Sbjct: 3 LGKGSFGKVMLARLKE----SGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFL 58
Query: 149 PTLYATLDCPRWSCLLTEFCPGGDL--HVLRQRQPDKRFHESAVRFYASEVVVALEFLHM 206
LY P + EF GGDL H+ Q +RF E+ RFYA+E+ AL FLH
Sbjct: 59 TQLYCCFQTPDRLFFVMEFVNGGDLMFHI----QKSRRFDEARARFYAAEITSALMFLHD 114
Query: 207 MGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVD 266
GIIYRDLK +NVL+ +GH L DF + +G
Sbjct: 115 KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEG---------------------------- 146
Query: 267 QPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTHEYLA 326
I N + C GTP+ +A
Sbjct: 147 ----------IFNGKTTSTFC--------------GTPDYIA------------------ 164
Query: 327 PEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGP 386
PEI+ +G +VDWW +G+ ++E+ G PF+ + + ++ + +P S
Sbjct: 165 PEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQ--D 222
Query: 387 AKDLIAQLLVKDPTRRMGSKM--GATAIKRHQFFNGVNWALL--RCAKPPFIPR 436
A D++ + K+PT R+GS G AI RH FF ++W L R +PPF PR
Sbjct: 223 AVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELDWEKLNRRQIEPPFRPR 276
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 146 bits (371), Expect = 2e-40
Identities = 105/358 (29%), Positives = 176/358 (49%), Gaps = 67/358 (18%)
Query: 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILE 141
D + + +G G+VYLV+ K FA K ++K+ L+ RN+ + +ER+IL
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETRQR----FAMKKINKQNLILRNQIQQVFVERDILT 56
Query: 142 MLDHPFLPTLYATLDCPRWSCLLTEFCPGGDL-HVLRQRQPDKRFHESAVRFYASEVVVA 200
++PF+ +++ + + R C++ E+ GGD +L+ R Y +E V+A
Sbjct: 57 FAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGA---LPVDMARMYFAETVLA 113
Query: 201 LEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQP 260
LE+LH GI++RDLKP+N+L+ S GHI LTDF LS G S +T + + ++
Sbjct: 114 LEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTT--NLYEGHIEKDTRE- 170
Query: 261 NDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVG 320
+D+ G I P I+ R+ K P+D +M +
Sbjct: 171 ---FLDKQVCGTPEYIAPEVIL---------RQGYGK------------PVDWWAMGII- 205
Query: 321 THEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPK- 379
+E+L +G F +G TP E V++ +E+P+
Sbjct: 206 LYEFL------------------VGCVPF---FGDTP------EELFGQVISDDIEWPEG 238
Query: 380 EPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGVNW-ALLRCAKPPFIPR 436
+ ++P A+DLI++LL ++P R+G+ GA +K+H+FF G++W LLR K FIP+
Sbjct: 239 DEALPADAQDLISRLLRQNPLERLGTG-GAFEVKQHRFFLGLDWNGLLR-QKAEFIPQ 294
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 146 bits (369), Expect = 8e-40
Identities = 106/367 (28%), Positives = 174/367 (47%), Gaps = 50/367 (13%)
Query: 83 DLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEM 142
D + +G G G V LVQ K + G +A K++ K +++ + + + R ER+IL
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKK----DTGHIYAMKILRKADMLEKEQVAHIRAERDILVE 57
Query: 143 LDHPFLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALE 202
D ++ ++ + R L+ EF PGGD+ L ++ E A +FY +E V+A++
Sbjct: 58 ADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKK--DTLSEEATQFYIAETVLAID 115
Query: 203 FLHMMGIIYRDLKPENVLVRSDGHIMLTDFDL--SLKGDNSTSTAQLVSDQSPPTGDQQP 260
+H +G I+RD+KP+N+L+ + GH+ L+DF L LK + T + ++ +PP+
Sbjct: 116 AIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLT-HNPPSD---- 170
Query: 261 NDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVG 320
S + +RK + ++ + S VG
Sbjct: 171 ------------------------FSFQNMNSKRKAETWKKNRRQL--------AYSTVG 198
Query: 321 THEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVV--ARALEFP 378
T +Y+APE+ G+ DWW+LG+ ++E+ G PF + T V+ L FP
Sbjct: 199 TPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYRKVMNWKETLVFP 258
Query: 379 KEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGVNWALLRCAKPPFIPRPV 438
E + AKDLI + D R+GS G IK H FF GV+W +R +P IP +
Sbjct: 259 PEVPISEKAKDLILRFCT-DSENRIGSN-GVEEIKSHPFFEGVDWGHIR-ERPAAIPIEI 315
Query: 439 TCRDLTT 445
D T+
Sbjct: 316 KSIDDTS 322
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 7e-38
Identities = 106/356 (29%), Positives = 169/356 (47%), Gaps = 40/356 (11%)
Query: 87 VHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHP 146
+ LG G G V L ++ + +A K + K++++ RN+ + + ER+IL D+
Sbjct: 6 IKTLGIGAFGEVCL----ARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNE 61
Query: 147 FLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHM 206
++ LY + + ++ PGGD+ L R F E RFY +E+ A+E +H
Sbjct: 62 WVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRM--GIFPEDLARFYIAELTCAVESVHK 119
Query: 207 MGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVD 266
MG I+RD+KP+N+L+ DGHI LTDF L G T ++ +GD D
Sbjct: 120 MGFIHRDIKPDNILIDRDGHIKLTDFGLC-TGFRWTHDSKYYQ-----SGDHVRQDSMDF 173
Query: 267 QPPFGNSSCIIPNCIVPAVSC---LHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTHE 323
+G+ + NC C L P RR + + + S VGT
Sbjct: 174 SNEWGDPA----NC-----RCGDRLKPLERRAAR-----------QHQRCLAHSLVGTPN 213
Query: 324 YLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVV--ARALEFPKEP 381
Y+APE++ G+ DWW++G+ ++E+ G PF T V+ +L P +
Sbjct: 214 YIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQA 273
Query: 382 SVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGVNWAL-LRCAKPPFIPR 436
+ A DLI + L + P R+G K GA IK H FF ++++ LR P+IP+
Sbjct: 274 KLSPEASDLIIK-LCRGPEDRLG-KNGADEIKAHPFFKTIDFSSDLRQQSAPYIPK 327
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 136 bits (346), Expect = 2e-37
Identities = 68/158 (43%), Positives = 92/158 (58%), Gaps = 10/158 (6%)
Query: 90 LGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLP 149
LG G G V LV++KSK FA K + KR +V ++ E+EILE +HPF+
Sbjct: 1 LGVGGFGRVELVKVKSK----NRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIV 56
Query: 150 TLYATLDCPRWSCLLTEFCPGGDL-HVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMG 208
LY T ++ +L E+C GG+L +LR R F E RFY + VV+A E+LH G
Sbjct: 57 KLYRTFKDKKYIYMLMEYCLGGELWTILRDR---GLFDEYTARFYIACVVLAFEYLHNRG 113
Query: 209 IIYRDLKPENVLVRSDGHIMLTDFDLS--LKGDNSTST 244
IIYRDLKPEN+L+ S+G++ L DF + LK T T
Sbjct: 114 IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT 151
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 1e-36
Identities = 56/127 (44%), Positives = 74/127 (58%), Gaps = 5/127 (3%)
Query: 314 RSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVAR 373
R+ + GT EYLAPEII +G+G AVDWW LGI I+E+ G PF + ++
Sbjct: 154 RTYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEG 213
Query: 374 ALEFPKEPSVPGPAKDLIAQLLVKDPTRRMGS-KMGATAIKRHQFFNGVNW-ALL-RCAK 430
+ FP S AKDLI LL D T+R+G+ K G IK H +F G++W ALL R +
Sbjct: 214 KVRFPSFFS--PDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDWIALLQRKIE 271
Query: 431 PPFIPRP 437
PFIP+
Sbjct: 272 APFIPKV 278
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 137 bits (346), Expect = 3e-36
Identities = 100/355 (28%), Positives = 167/355 (47%), Gaps = 38/355 (10%)
Query: 87 VHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHP 146
+ LG G G V L + + +A K + K+++++RN+ + + ER+IL D+
Sbjct: 6 IKTLGIGAFGEVCL----ACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNE 61
Query: 147 FLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHM 206
++ LY + + ++ PGGD+ L R + F E RFY +E+ +A+E +H
Sbjct: 62 WVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRM--EVFPEVLARFYIAELTLAIESVHK 119
Query: 207 MGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQ-QPNDCAV 265
MG I+RD+KP+N+L+ DGHI LTDF L G T ++ S D +P+D
Sbjct: 120 MGFIHRDIKPDNILIDLDGHIKLTDFGLC-TGFRWTHNSKYYQKGSHIRQDSMEPSDLWD 178
Query: 266 DQPPFGNSSCIIPNCIV-PAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTHEY 324
D + NC + L + ++ + + S VGT Y
Sbjct: 179 D----------VSNCRCGDRLKTLEQRATKQHQ--------------RCLAHSLVGTPNY 214
Query: 325 LAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVV--ARALEFPKEPS 382
+APE++ +G+ DWW++G+ +FE+ G PF T V+ L P +
Sbjct: 215 IAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVK 274
Query: 383 VPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGVNWAL-LRCAKPPFIPR 436
+ A DLI +L R + GA IK H FF+ V+++ +R P++P+
Sbjct: 275 LSPEAVDLITKLCCSAEERLGRN--GADDIKAHPFFSEVDFSSDIRTQPAPYVPK 327
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 131 bits (333), Expect = 5e-36
Identities = 76/318 (23%), Positives = 117/318 (36%), Gaps = 110/318 (34%)
Query: 90 LGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLP 149
LG G G+VYL + K G A K++ K + S + E EIL+ L+HP +
Sbjct: 1 LGEGGFGTVYLARDK----KTGKKVAIKIIKKED--SSSLLEELLREIEILKKLNHPNIV 54
Query: 150 TLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGI 209
LY + L+ E+C GG L L + + E + +++ LE+LH GI
Sbjct: 55 KLYGVFEDENHLYLVMEYCEGGSLKDLLKENE-GKLSEDEILRILLQILEGLEYLHSNGI 113
Query: 210 IYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPP 269
I+RDLKPEN I+L + +K ++D
Sbjct: 114 IHRDLKPEN--------ILLDSDNGKVK----------LAD------------------- 136
Query: 270 FGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTHEYLAPEI 329
FG S + + + VGT Y+APE+
Sbjct: 137 FGLSKLLTSD--------------------------------KSLLKTIVGTPAYMAPEV 164
Query: 330 ISGEGH-GNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAK 388
+ G+G+ D W+LG+ ++EL K
Sbjct: 165 LLGKGYYSEKSDIWSLGVILYEL---------------------------------PELK 191
Query: 389 DLIAQLLVKDPTRRMGSK 406
DLI ++L KDP +R +K
Sbjct: 192 DLIRKMLQKDPEKRPSAK 209
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 7e-36
Identities = 101/367 (27%), Positives = 169/367 (46%), Gaps = 50/367 (13%)
Query: 83 DLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEM 142
D + +G G G V LVQ K + G +A K++ K +++ + + R ER+IL
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKK----DTGHVYAMKILRKADMLEKEQVGHIRAERDILVE 57
Query: 143 LDHPFLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALE 202
D ++ ++ + L+ EF PGGD+ L ++ E +FY +E V+A++
Sbjct: 58 ADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKK--DTLTEEETQFYIAETVLAID 115
Query: 203 FLHMMGIIYRDLKPENVLVRSDGHIMLTDFDL--SLKGDNSTSTAQLVSDQSPPTGDQQP 260
+H +G I+RD+KP+N+L+ S GH+ L+DF L LK + T + ++ P Q
Sbjct: 116 SIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQN 175
Query: 261 NDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVG 320
+ + +R +++L + S VG
Sbjct: 176 MNSKRKAETW---------------------KRNRRQL----------------AFSTVG 198
Query: 321 THEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVV--ARALEFP 378
T +Y+APE+ G+ DWW+LG+ ++E+ G PF + T V+ L FP
Sbjct: 199 TPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMNWKETLIFP 258
Query: 379 KEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGVNWALLRCAKPPFIPRPV 438
E + AKDLI + + R+G+ G IK + FF GV+W +R +P IP +
Sbjct: 259 PEVPISEKAKDLILRFCC-EWEHRIGAP-GVEEIKTNPFFEGVDWEHIR-ERPAAIPIEI 315
Query: 439 TCRDLTT 445
D T+
Sbjct: 316 KSIDDTS 322
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 2e-34
Identities = 64/164 (39%), Positives = 94/164 (57%), Gaps = 8/164 (4%)
Query: 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILE 141
DL + +G+G G V+LV+ + + ++A KVM E++ +E E+ +L+
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRI----SEHYYALKVMAIPEVIRLKQEQHVHNEKRVLK 56
Query: 142 MLDHPFLPTLYATLDCPRWSCLLTEFCPGGDL-HVLRQRQPDKRFHESAVRFYASEVVVA 200
+ HPF+ L+ T R+ +L E+ PGG+L LR RF S FYASE+V A
Sbjct: 57 EVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNS---GRFSNSTGLFYASEIVCA 113
Query: 201 LEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTST 244
LE+LH I+YRDLKPEN+L+ +GHI LTDF + K + T T
Sbjct: 114 LEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWT 157
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 2e-32
Identities = 59/139 (42%), Positives = 80/139 (57%), Gaps = 12/139 (8%)
Query: 305 EIVAEPLDVRSMSFVGTHEYLAPEIISG--EGHGNAVDWWTLGIFIFELFYGTTPFKGID 362
E +AE + R+ SF GT EY+APE+I G GH AVDWW+LG+ FEL G +PF
Sbjct: 154 EFLAEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDG 212
Query: 363 HELTLANVVARALE----FPKEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFF 418
+ + + + R L+ FPK S A+D I +LL KDP +R+G+ GA IK H FF
Sbjct: 213 EQNSQSEISRRILKSKPPFPKTMSA--EARDFIQKLLEKDPKKRLGAN-GADEIKNHPFF 269
Query: 419 NGVNWALL--RCAKPPFIP 435
G++W L + PF P
Sbjct: 270 QGIDWDDLAAKRIPAPFKP 288
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 2e-32
Identities = 57/160 (35%), Positives = 91/160 (56%), Gaps = 13/160 (8%)
Query: 91 GSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPT 150
G G G V +VQ + + FA K M+K++ V + ER IL+ L+HPFL
Sbjct: 9 GKGAFGKVCIVQKR----DTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVN 64
Query: 151 LYATLDCPRWSCLLTEFCPGGDL--HVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMG 208
L+ + L+ + GGDL H+ ++ +F E V+F+ E+V+ALE+LH G
Sbjct: 65 LWYSFQDEENMYLVVDLLLGGDLRYHLSQKV----KFSEEQVKFWICEIVLALEYLHSKG 120
Query: 209 IIYRDLKPENVLVRSDGHIMLTDFDLSLK---GDNSTSTA 245
II+RD+KP+N+L+ GH+ +TDF+++ K +TST+
Sbjct: 121 IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTS 160
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 3e-31
Identities = 63/156 (40%), Positives = 94/156 (60%), Gaps = 7/156 (4%)
Query: 83 DLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESR-ARIEREILE 141
+ + LG+G G V+LV+ K + G +A KV+ K +V + K + R ER++LE
Sbjct: 1 NFELLRVLGTGAYGKVFLVR-KVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLE 59
Query: 142 MLDH-PFLPTLYATLDCPRWSCLLTEFCPGGDLHV-LRQRQPDKRFHESAVRFYASEVVV 199
+ PFL TL+ L+ ++ GG+L L QR+ F ES VR Y +E+V+
Sbjct: 60 AVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQRE---HFTESEVRVYIAEIVL 116
Query: 200 ALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235
AL+ LH +GIIYRD+K EN+L+ S+GH++LTDF LS
Sbjct: 117 ALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLS 152
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 5e-31
Identities = 65/128 (50%), Positives = 81/128 (63%), Gaps = 6/128 (4%)
Query: 314 RSMSFVGTHEYLAPEIISGE-GHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVA 372
R+ SF GT EY+APEII G+ GHG AVDWW+LGI IFEL G +PF T + V
Sbjct: 162 RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSR 221
Query: 373 RALEF-PKEPSVPGP-AKDLIAQLLVKDPTRRMGS-KMGATAIKRHQFFNGVNWALL--R 427
R L+ P PS GP A+DL+ +LL KDP +R+G+ GA+ IK H FF G++W L R
Sbjct: 222 RILKCDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDWEALALR 281
Query: 428 CAKPPFIP 435
PPF P
Sbjct: 282 KVNPPFRP 289
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 8e-31
Identities = 60/161 (37%), Positives = 85/161 (52%), Gaps = 14/161 (8%)
Query: 90 LGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEML-DHPFL 148
LG G G V L +LK +A KV+ K ++ + E+ +L + HPFL
Sbjct: 3 LGKGSFGKVLLAELKGTDE----LYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFL 58
Query: 149 PTLYATLDCPRWSCLLTEFCPGGDL--HVLRQRQPDKRFHESAVRFYASEVVVALEFLHM 206
L++ + E+ GGDL H+ R RF E RFYA+E+V+ L+FLH
Sbjct: 59 TQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSG----RFDEPRARFYAAEIVLGLQFLHE 114
Query: 207 MGIIYRDLKPENVLVRSDGHIMLTDFDLS---LKGDNSTST 244
GIIYRDLK +NVL+ S+GHI + DF + + G +TST
Sbjct: 115 RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTST 155
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 1e-30
Identities = 58/132 (43%), Positives = 79/132 (59%), Gaps = 5/132 (3%)
Query: 308 AEPLDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTL 367
A+ L R+ + GT EYLAPE+I +GH AVDWW LGI I+E+ G PF +
Sbjct: 148 AKKLRDRTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIY 207
Query: 368 ANVVARALEFPKEPSVPGPAKDLIAQLLVKDPTRRMGS-KMGATAIKRHQFFNGVNW--A 424
++A LEFP+ + AKDLI +LLV D TRR+G+ K GA +K H++F V+W
Sbjct: 208 EKILAGKLEFPR--HLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVDWDDV 265
Query: 425 LLRCAKPPFIPR 436
R KPP +P+
Sbjct: 266 PQRKLKPPIVPK 277
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 2e-30
Identities = 88/353 (24%), Positives = 139/353 (39%), Gaps = 81/353 (22%)
Query: 90 LGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLP 149
LG G G V Q+++ G +A K ++K+ L R A +E+ IL + F+
Sbjct: 1 LGKGGFGEVSACQMRA----TGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIV 56
Query: 150 TLYATLDCPRWSCLLTEFCPGGDL--HVLRQRQPDKRFHESAVRFYASEVVVALEFLHMM 207
+L CL+ GGDL H+ + + F E FY ++++ LE LH
Sbjct: 57 SLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR 116
Query: 208 GIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQ 267
IIYRDLKPENVL+ +DG++ ++D L++ +L QS
Sbjct: 117 RIIYRDLKPENVLLDNDGNVRISDLGLAV---------ELKDGQS--------------- 152
Query: 268 PPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTHEYLAP 327
K G GTP +A L
Sbjct: 153 ----------------------------KTKGYAGTPGFMAPEL---------------- 168
Query: 328 EIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSV--PG 385
+ GE + +VD++ LG+ ++E+ PF+ ++ + R L
Sbjct: 169 --LQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSP 226
Query: 386 PAKDLIAQLLVKDPTRRMGSKMGATA-IKRHQFFNGVNWALLRCA--KPPFIP 435
+K LL KDP +R+G + G ++ H F +NW L PPF+P
Sbjct: 227 ASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNWRQLEAGMLPPPFVP 279
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 3e-30
Identities = 47/135 (34%), Positives = 77/135 (57%), Gaps = 5/135 (3%)
Query: 312 DVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVV 371
V + +F GT +Y+APEI+S + +G AVDWW LG+ ++E+ G +PF+G D + +++
Sbjct: 150 GVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSIL 209
Query: 372 ARALEFPKEPSVPGPAKDLIAQLLVKDPTRRMG-SKMGATAIKRHQFFNGVNWALL--RC 428
+ +P+ S AK ++ L K+P +R+G G IK H FF ++W L +
Sbjct: 210 EDEVRYPRWLSK--EAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREIDWDKLERKE 267
Query: 429 AKPPFIPRPVTCRDL 443
KPPF P+ D+
Sbjct: 268 IKPPFKPKIKGRFDV 282
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 7e-30
Identities = 58/159 (36%), Positives = 92/159 (57%), Gaps = 10/159 (6%)
Query: 90 LGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREIL-EMLDHPFL 148
+G G G V L + K+ +G F+A KV+ K+ ++ + ++ ER +L + + HPFL
Sbjct: 3 IGKGSFGKVLLAKHKA----DGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFL 58
Query: 149 PTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMG 208
L+ + + ++ GG+L QR+ + F E RFYA+E+ AL +LH +
Sbjct: 59 VGLHYSFQTADKLYFVLDYVNGGELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSLN 116
Query: 209 IIYRDLKPENVLVRSDGHIMLTDFDL---SLKGDNSTST 244
IIYRDLKPEN+L+ S GH++LTDF L ++ +TST
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTST 155
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 2e-29
Identities = 63/159 (39%), Positives = 87/159 (54%), Gaps = 7/159 (4%)
Query: 90 LGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKES-RARIEREILEMLDHPFL 148
LG G G V+ V+ K ++ G FA KV+ K +V K++ + ER ILE + HPF+
Sbjct: 4 LGKGGYGKVFQVR-KVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62
Query: 149 PTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMG 208
L L+ E+ GG+L + +R+ F E FY SE+ +ALE LH G
Sbjct: 63 VDLIYAFQTGGKLYLILEYLSGGELFMHLERE--GIFMEDTACFYLSEISLALEHLHQQG 120
Query: 209 IIYRDLKPENVLVRSDGHIMLTDFDL---SLKGDNSTST 244
IIYRDLKPEN+L+ + GH+ LTDF L S+ T T
Sbjct: 121 IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT 159
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 6e-29
Identities = 55/166 (33%), Positives = 85/166 (51%), Gaps = 13/166 (7%)
Query: 85 RFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLD 144
R + LG G G V L + K G +A K + K ++++R++ E+ I E +
Sbjct: 2 RCLAVLGRGHFGKVLLAEYK----KTGELYAIKALKKGDIIARDEVESLMCEKRIFETAN 57
Query: 145 ---HPFLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVAL 201
HPFL L+A C + E+ GGDL + D F E FYA+ VV+ L
Sbjct: 58 SERHPFLVNLFACFQTEDHVCFVMEYAAGGDL--MMHIHTD-VFSEPRAVFYAACVVLGL 114
Query: 202 EFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKG---DNSTST 244
++LH I+YRDLK +N+L+ ++G + + DF L +G + TST
Sbjct: 115 QYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTST 160
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 7e-29
Identities = 62/156 (39%), Positives = 91/156 (58%), Gaps = 7/156 (4%)
Query: 83 DLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNK-ESRARIEREILE 141
+ + LG+G G V+LV+ K + G +A KV+ K LV + K R ER +LE
Sbjct: 1 NFELLKVLGTGAYGKVFLVR-KVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLE 59
Query: 142 ML-DHPFLPTLYATLDCPRWSCLLTEFCPGGDLHV-LRQRQPDKRFHESAVRFYASEVVV 199
+ PFL TL+ L+ ++ GG++ L QR F E VRFY+ E+++
Sbjct: 60 HVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRD---NFSEDEVRFYSGEIIL 116
Query: 200 ALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235
ALE LH +GI+YRD+K EN+L+ S+GH++LTDF LS
Sbjct: 117 ALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLS 152
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 113 bits (286), Expect = 7e-29
Identities = 86/343 (25%), Positives = 135/343 (39%), Gaps = 98/343 (28%)
Query: 87 VHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREI--LEMLD 144
LG G GSVYL K + G A K + EL ++E +EREI L L
Sbjct: 5 GELLGRGSFGSVYLALDK----DTGELMAVKSV---ELSGDSEEELEALEREIRILSSLQ 57
Query: 145 HPFLPTLYATLDCPRWS------CLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVV 198
HP + Y + + E+ GG L L ++ + E +R Y +++
Sbjct: 58 HPNIVRYYGS----ERDEEKNTLNIFLEYVSGGSLSSLLKKF--GKLPEPVIRKYTRQIL 111
Query: 199 VALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQ 258
L +LH GI++RD+K N+LV D D +K ++D
Sbjct: 112 EGLAYLHSNGIVHRDIKGANILV---------DSDGVVK----------LAD-------- 144
Query: 259 QPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSF 318
FG + K+LG+ T E + S
Sbjct: 145 -----------FGCA----------------------KRLGDIETGEG--------TGSV 163
Query: 319 VGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFP 378
GT ++APE+I GE +G A D W+LG + E+ G P+ + + + + + E P
Sbjct: 164 RGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPP 223
Query: 379 KEPS-VPGPAKDLIAQLLVKDPTRRMGSKMGATAIK--RHQFF 418
+ P + AKD + + L +DP +R TA + +H F
Sbjct: 224 EIPEHLSEEAKDFLRKCLRRDPKKR------PTADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 8e-29
Identities = 45/109 (41%), Positives = 63/109 (57%), Gaps = 6/109 (5%)
Query: 312 DVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVV 371
+ +FVGT EY+APE++ G+G+G AVD W+LG+ ++EL G PF G D L L +
Sbjct: 150 GEKLTTFVGTPEYMAPEVLLGKGYGKAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKI 209
Query: 372 ARALE--FPKEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFF 418
+ P E + AKDLI +LLVKDP +R + A +H FF
Sbjct: 210 GKPKPPFPPPEWDISPEAKDLIRKLLVKDPEKR----LTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 1e-28
Identities = 51/130 (39%), Positives = 72/130 (55%), Gaps = 16/130 (12%)
Query: 314 RSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFEL------FYGTTPFKGIDHELTL 367
R+ + GT EYLAPE+I +GHG AVDWWT+G+ ++E F+ TPF+
Sbjct: 171 RTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFR------IY 224
Query: 368 ANVVARALEFPKEPSVPGPAKDLIAQLLVKDPTRRMGS-KMGATAIKRHQFFNGVNWALL 426
++A L+FP G A+DL+ LL D T+R+G+ K G +K H +F+G NW L
Sbjct: 225 EKILAGRLKFPN--WFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGANWDKL 282
Query: 427 RCAK-PPFIP 435
P IP
Sbjct: 283 YARYYPAPIP 292
|
Length = 329 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 2e-28
Identities = 61/146 (41%), Positives = 88/146 (60%), Gaps = 4/146 (2%)
Query: 90 LGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLP 149
LG G G V+LV+ K + G +A KV+ K L R++ R ++ER+IL ++HPF+
Sbjct: 4 LGQGSFGKVFLVR-KITGPDAGQLYAMKVLKKATLKVRDR-VRTKMERDILAEVNHPFIV 61
Query: 150 TLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGI 209
L+ L+ +F GGDL + + F E V+FY +E+ +AL+ LH +GI
Sbjct: 62 KLHYAFQTEGKLYLILDFLRGGDL--FTRLSKEVMFTEEDVKFYLAELALALDHLHSLGI 119
Query: 210 IYRDLKPENVLVRSDGHIMLTDFDLS 235
IYRDLKPEN+L+ +GHI LTDF LS
Sbjct: 120 IYRDLKPENILLDEEGHIKLTDFGLS 145
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 2e-28
Identities = 66/182 (36%), Positives = 103/182 (56%), Gaps = 11/182 (6%)
Query: 90 LGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREIL-EMLDHPFL 148
+G G G V L + KS +G F+A KV+ K+ ++ + +++ ER +L + L HPFL
Sbjct: 3 IGKGSFGKVLLAKRKS----DGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFL 58
Query: 149 PTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMG 208
L+ + + ++ GG+L QR+ + F E RFYA+EV A+ +LH +
Sbjct: 59 VGLHYSFQTAEKLYFVLDYVNGGELFFHLQRE--RCFLEPRARFYAAEVASAIGYLHSLN 116
Query: 209 IIYRDLKPENVLVRSDGHIMLTDFDLSLKG---DNSTSTAQLVSDQ-SPPTGDQQPNDCA 264
IIYRDLKPEN+L+ S GH++LTDF L +G + +TST + +P ++P D
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDRT 176
Query: 265 VD 266
VD
Sbjct: 177 VD 178
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 3e-28
Identities = 48/117 (41%), Positives = 68/117 (58%), Gaps = 11/117 (9%)
Query: 314 RSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGID------HELTL 367
++ +F GT EY+APEII +G+ +VD+W+LGI ++EL G PF D + L
Sbjct: 148 KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDIL 207
Query: 368 ANVVARALEFPKEPSVPGPAKDLIAQLLVKDPTRRMG-SKMGATAIKRHQFFNGVNW 423
LEFP + AKDLI QLL ++P R+G K G IK+H++FNG +W
Sbjct: 208 KGN--GKLEFPN--YIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGFDW 260
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 5e-28
Identities = 80/326 (24%), Positives = 129/326 (39%), Gaps = 90/326 (27%)
Query: 88 HRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPF 147
+++G G G VY + + G A K + ++ + + A E ++LE+L HP
Sbjct: 6 NKIGGGTFGKVYTAV----NLDTGELMAVKEIRIQDNDPKTIKEIAD-EMKVLELLKHPN 60
Query: 148 LPTLYATLDCPRWS-CLLTEFCPGGDL-HVLRQRQPDKRFHESAVRFYASEVVVALEFLH 205
L Y ++ R + E+C GG L +L + E +R Y +++ L +LH
Sbjct: 61 LVKYYG-VEVHREKVYIFMEYCSGGTLEELLEHGRILD---EHVIRVYTLQLLEGLAYLH 116
Query: 206 MMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAV 265
GI++RD+KP N+ + +G I L GD
Sbjct: 117 SHGIVHRDIKPANIFLDHNGVIKL--------------------------GD-------- 142
Query: 266 DQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTHEYL 325
FG + KL N T + E + S GT Y+
Sbjct: 143 ----FGCA----------------------VKLKNNTTT--MGEEVQ----SLAGTPAYM 170
Query: 326 APEIISG---EGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPS 382
APE+I+G +GHG A D W+LG + E+ G P+ +D+E + V +P
Sbjct: 171 APEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVG----AGHKPP 226
Query: 383 VPGPA------KDLIAQLLVKDPTRR 402
+P KD + + L DP +R
Sbjct: 227 IPDSLQLSPEGKDFLDRCLESDPKKR 252
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 6e-28
Identities = 53/147 (36%), Positives = 84/147 (57%), Gaps = 7/147 (4%)
Query: 93 GDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEML-DHPFLPTL 151
G GSVYL + +S G +FA KV+ K +++++N+ + + ER I+ + + P++ L
Sbjct: 7 GAFGSVYLAKKRS----TGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKL 62
Query: 152 YATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIY 211
Y + + L+ E+ GGD L + E + Y +EVV+ +E LH GII+
Sbjct: 63 YYSFQSKDYLYLVMEYLNGGDCASLIKTL--GGLPEDWAKQYIAEVVLGVEDLHQRGIIH 120
Query: 212 RDLKPENVLVRSDGHIMLTDFDLSLKG 238
RD+KPEN+L+ GH+ LTDF LS G
Sbjct: 121 RDIKPENLLIDQTGHLKLTDFGLSRNG 147
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 1e-27
Identities = 63/149 (42%), Positives = 93/149 (62%), Gaps = 7/149 (4%)
Query: 90 LGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESR-ARIEREILEMLDH-PF 147
LG+G G V+LV+ K ++G +A KV+ K +V + K + R ER++LE + PF
Sbjct: 8 LGTGAYGKVFLVR-KVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 66
Query: 148 LPTLYATLDCPRWSCLLTEFCPGGDLHV-LRQRQPDKRFHESAVRFYASEVVVALEFLHM 206
L TL+ L+ ++ GG+L L QR+ RF E V+ Y+ E+V+ALE LH
Sbjct: 67 LVTLHYAFQTDTKLHLILDYINGGELFTHLSQRE---RFKEQEVQIYSGEIVLALEHLHK 123
Query: 207 MGIIYRDLKPENVLVRSDGHIMLTDFDLS 235
+GIIYRD+K EN+L+ S+GH++LTDF LS
Sbjct: 124 LGIIYRDIKLENILLDSNGHVVLTDFGLS 152
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 2e-27
Identities = 86/360 (23%), Positives = 134/360 (37%), Gaps = 87/360 (24%)
Query: 85 RFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLD 144
R + +LG G G VYL + + A KV+ K+ + R E +IL L+
Sbjct: 3 RILRKLGEGSFGEVYLARDRKL-------VALKVLAKKLESKSKEVERFLREIQILASLN 55
Query: 145 HP-FLPTLYATLDCPRWSCLLTEFCPGGDLH-VLRQRQPDKRFHESAVRFYASEVVVALE 202
HP + LY L+ E+ GG L +L++ ES F ++++ ALE
Sbjct: 56 HPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALE 115
Query: 203 FLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPND 262
+LH GII+RD+KPEN I+L +K + D
Sbjct: 116 YLHSKGIIHRDIKPEN--------ILLDRDGRVVK----------LID------------ 145
Query: 263 CAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTH 322
FG + + + + VGT
Sbjct: 146 -------FGLAKLL--------------------------PDPGSTSSIPALPSTSVGTP 172
Query: 323 EYLAPEIISGEGHGN---AVDWWTLGIFIFELFYGTTPFKGIDHELT-------LANVVA 372
Y+APE++ G + D W+LGI ++EL G PF+G + + +
Sbjct: 173 GYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPT 232
Query: 373 RALEFPKEPSVPGP----AKDLIAQLLVKDPTRRMGSKMGAT-AIKRHQFFNGVNWALLR 427
+L P PS P A DL+ +LL KDP R+ S + + H + + L
Sbjct: 233 PSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDLL 292
|
Length = 384 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 3e-27
Identities = 61/161 (37%), Positives = 86/161 (53%), Gaps = 14/161 (8%)
Query: 90 LGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEM-LDHPFL 148
LG G G V L +LK + FFA K + K ++ + +ER +L + +HPFL
Sbjct: 3 LGKGSFGKVMLAELKGTNE----FFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFL 58
Query: 149 PTLYATLDCPRWSCLLTEFCPGGDL--HVLRQRQPDKRFHESAVRFYASEVVVALEFLHM 206
L+ T + E+ GGDL H+ Q RF E+ RFYA+E++ L+FLH
Sbjct: 59 THLFCTFQTKEHLFFVMEYLNGGDLMFHI----QSSGRFDEARARFYAAEIICGLQFLHK 114
Query: 207 MGIIYRDLKPENVLVRSDGHIMLTDF---DLSLKGDNSTST 244
GIIYRDLK +NVL+ DGHI + DF ++ G+ ST
Sbjct: 115 KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST 155
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 7e-27
Identities = 59/165 (35%), Positives = 86/165 (52%), Gaps = 8/165 (4%)
Query: 81 LSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREIL 140
LSD LG+G G V + + K G ++A K + KRE++ + E+ IL
Sbjct: 17 LSDFEMGETLGTGSFGRVRIAKHKG----TGEYYAIKCLKKREILKMKQVQHVAQEKSIL 72
Query: 141 EMLDHPFLPTLYATLDCPRWSCLLTEFCPGGDLHV-LRQRQPDKRFHESAVRFYASEVVV 199
L HPF+ + + L EF GG+L LR+ RF +FY +E+V+
Sbjct: 73 MELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKA---GRFPNDVAKFYHAELVL 129
Query: 200 ALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTST 244
A E+LH IIYRDLKPEN+L+ + GH+ +TDF + K + T T
Sbjct: 130 AFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFT 174
|
Length = 329 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 54/154 (35%), Positives = 74/154 (48%), Gaps = 6/154 (3%)
Query: 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILE 141
D + + ++G G G V+L + K + G A K M K L N+ ER+IL
Sbjct: 1 KDFQILTQVGQGGYGQVFLAKKK----DTGEIVALKRMKKSLLFKLNEVRHVLTERDILT 56
Query: 142 MLDHPFLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVAL 201
+L L + L E+ PGGD L E RFY +E+ A+
Sbjct: 57 TTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNL--GVLSEDHARFYMAEMFEAV 114
Query: 202 EFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235
+ LH +G I+RDLKPEN L+ + GHI LTDF LS
Sbjct: 115 DALHELGYIHRDLKPENFLIDASGHIKLTDFGLS 148
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 4e-26
Identities = 65/200 (32%), Positives = 94/200 (47%), Gaps = 25/200 (12%)
Query: 90 LGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEM-LDHPFL 148
LG G G V L +LK +A KV+ K ++ + E+ IL + HPFL
Sbjct: 3 LGKGSFGKVMLAELKGTDE----VYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFL 58
Query: 149 PTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMG 208
L+ + E+ GGDL + Q Q ++F E RFYA+EV +AL FLH G
Sbjct: 59 TALHCCFQTKDRLFFVMEYVNGGDL--MFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHG 116
Query: 209 IIYRDLKPENVLVRSDGHIMLTDFDLSLKG---DNSTSTAQLVSDQ-SPPTGDQQPNDCA 264
+IYRDLK +N+L+ ++GH L DF + +G +T+T D +P + +
Sbjct: 117 VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPS 176
Query: 265 VD--------------QPPF 270
VD QPPF
Sbjct: 177 VDWWALGVLMYEMMAGQPPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 6e-26
Identities = 49/132 (37%), Positives = 77/132 (58%), Gaps = 7/132 (5%)
Query: 309 EPLD--VRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELT 366
E +D ++ SF GT EY+APE+++ GH + DWW+ G+ +FE+ G+ PF+G D + T
Sbjct: 147 ESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKET 206
Query: 367 LANVVARALEFPKEPSVPGPAKDLIAQLLVKDPTRRMGSKM-GATAIKRHQFFNGVNWAL 425
+ ++ L P+ S A+ L+ L ++P R+G+ G IKRH FF+ ++W
Sbjct: 207 MTMILKAKLGMPQFLS--PEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTIDWNK 264
Query: 426 L--RCAKPPFIP 435
L R KPPF P
Sbjct: 265 LYRREIKPPFKP 276
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 6e-26
Identities = 49/129 (37%), Positives = 65/129 (50%), Gaps = 8/129 (6%)
Query: 297 KLGNPGTPEIVAEPLDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTT 356
KL + G E FVGT +YLAPE I G G DWW+LG IFE +G
Sbjct: 137 KLTDFGLSRNGLENKK-----FVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYP 191
Query: 357 PFKGIDHELTLANVVARALEFPKE--PSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKR 414
PF + N+++R + +P+E A DLI +LL DP +R+G+ G IK
Sbjct: 192 PFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGAN-GYQEIKS 250
Query: 415 HQFFNGVNW 423
H FF +NW
Sbjct: 251 HPFFKSINW 259
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 8e-26
Identities = 60/160 (37%), Positives = 92/160 (57%), Gaps = 12/160 (7%)
Query: 90 LGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKE-SRARIEREILEML-DHPF 147
+G G V LV+LK +A KV+ K+ELV+ +++ + E+ + E +HPF
Sbjct: 3 IGRGSYAKVLLVELKKTRR----IYAMKVI-KKELVNDDEDIDWVQTEKHVFETASNHPF 57
Query: 148 LPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMM 207
L L++ + EF GGDL QRQ ++ E RFY++E+ +AL FLH
Sbjct: 58 LVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNFLHER 115
Query: 208 GIIYRDLKPENVLVRSDGHIMLTDFDL---SLKGDNSTST 244
GIIYRDLK +NVL+ ++GHI LTD+ + ++ ++TST
Sbjct: 116 GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTST 155
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 51/145 (35%), Positives = 74/145 (51%), Gaps = 9/145 (6%)
Query: 317 SFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALE 376
+F GT EYLAPE++ + + VDWW LG ++E+ YG PF D N++ + L
Sbjct: 155 TFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLR 214
Query: 377 FPKEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGVNWALL--RCAKPPFI 434
P++ A+ L+ LL KD T+R+G+K IK H FF+ +NW L + PPF
Sbjct: 215 LK--PNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSINWDDLVNKKITPPFN 272
Query: 435 PRPVTCRDLTT-----TNSSIDNSI 454
P DL T + NS+
Sbjct: 273 PNVSGPMDLKHFDPEFTEEPVPNSV 297
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 1e-25
Identities = 54/131 (41%), Positives = 75/131 (57%), Gaps = 11/131 (8%)
Query: 314 RSMSFVGTHEYLAPEIISG--EGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVV 371
R+ SF GT EY+AP+I+ G GH AVDWW++G+ ++EL G +PF + + A +
Sbjct: 162 RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEIS 221
Query: 372 ARALEFPKEPSVP---GP-AKDLIAQLLVKDPTRRMGS-KMGATAIKRHQFFNGVNWALL 426
R L+ EP P AKD+I +LL+KDP +R+G A IK+H FF +NW L
Sbjct: 222 RRILK--SEPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINWDDL 279
Query: 427 RCAK--PPFIP 435
K PF P
Sbjct: 280 AAKKVPAPFKP 290
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 47/125 (37%), Positives = 75/125 (60%), Gaps = 5/125 (4%)
Query: 314 RSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVAR 373
R+ +F GT E+LAPE+++ + AVDWW LG+ I+E+ G +PF G D E ++V
Sbjct: 157 RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVND 216
Query: 374 ALEFPKEPSVPGPAKDLIAQLLVKDPTRRMGS-KMGATAIKRHQFFNGVNWA--LLRCAK 430
+ +P+ S + ++ +LL ++P RR+GS + A +K+ FF +NW L R K
Sbjct: 217 EVRYPRFLSREAIS--IMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDINWDDLLARKIK 274
Query: 431 PPFIP 435
PPF+P
Sbjct: 275 PPFVP 279
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 2e-25
Identities = 59/161 (36%), Positives = 90/161 (55%), Gaps = 12/161 (7%)
Query: 90 LGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILE---MLDHP 146
+G G G VY V+ K + +A KV+ K+E+V++ + + ER IL + + P
Sbjct: 1 IGKGTFGQVYQVRKK----DTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESP 56
Query: 147 FLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHM 206
F+ L + L+T++ GG+L Q + RF E +FY +E+V+ALE LH
Sbjct: 57 FIVGLKFSFQTDSDLYLVTDYMSGGEL--FWHLQKEGRFSEDRAKFYIAELVLALEHLHK 114
Query: 207 MGIIYRDLKPENVLVRSDGHIMLTDFDLS---LKGDNSTST 244
I+YRDLKPEN+L+ + GHI L DF LS L + +T+T
Sbjct: 115 YDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNT 155
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 64/182 (35%), Positives = 99/182 (54%), Gaps = 11/182 (6%)
Query: 90 LGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREIL-EMLDHPFL 148
+G G G V L +K +G +A KV+ K+ +++R ++ ER +L + + HPFL
Sbjct: 3 IGKGSFGKVLL----AKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFL 58
Query: 149 PTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMG 208
L+ + + +F GG+L QR+ + F E RFYA+E+ AL +LH +
Sbjct: 59 VGLHYSFQTTEKLYFVLDFVNGGELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSIN 116
Query: 209 IIYRDLKPENVLVRSDGHIMLTDFDLSLKG----DNSTSTAQLVSDQSPPTGDQQPNDCA 264
I+YRDLKPEN+L+ S GH++LTDF L +G D +T+ +P +QP D
Sbjct: 117 IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNT 176
Query: 265 VD 266
VD
Sbjct: 177 VD 178
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 3e-25
Identities = 48/122 (39%), Positives = 73/122 (59%), Gaps = 5/122 (4%)
Query: 317 SFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALE 376
+F GT EY+APEI+ GHG AVDWW+LG ++++ G PF + + T+ ++ L
Sbjct: 159 TFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLN 218
Query: 377 FPKEPSVPGPAKDLIAQLLVKDPTRRMGSKMG-ATAIKRHQFFNGVNW--ALLRCAKPPF 433
P P + A+DL+ +LL ++P+ R+G+ G A ++ H FF VNW L R +PPF
Sbjct: 219 LP--PYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHVNWDDLLARKVEPPF 276
Query: 434 IP 435
P
Sbjct: 277 KP 278
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (262), Expect = 3e-25
Identities = 54/146 (36%), Positives = 76/146 (52%), Gaps = 7/146 (4%)
Query: 312 DVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVV 371
D ++ +F GT EYLAPE++ G G+ AVDWWTLG+ ++E+ G PF + ++
Sbjct: 147 DDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKIL 206
Query: 372 ARALEFPKEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGVNWALLRCAK- 430
L FP AKDL+ LL +DPTRR+G GA IK H FF+ ++W L K
Sbjct: 207 QEPLRFPD--GFDRDAKDLLIGLLSRDPTRRLGYN-GAQEIKNHPFFSQLSWKKL-LMKG 262
Query: 431 --PPFIPRPVTCRDLTTTNSSIDNSI 454
PPF P + D + +
Sbjct: 263 IQPPFKPAVSSAIDTSNFDEEFTREK 288
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 4e-25
Identities = 58/160 (36%), Positives = 88/160 (55%), Gaps = 14/160 (8%)
Query: 80 TLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREI 139
++ + V + G G VYL + K NN +A KV+ K +++++N + + ER+
Sbjct: 2 SIEEFVIVKPISRGAFGKVYLGRKK----NNSKLYAVKVVKKADMINKNMVHQVQAERDA 57
Query: 140 LEMLDHPFLPTLYATLDCPRWSCLLTEFCPGGD----LHVLRQRQPDKRFHESAVRFYAS 195
L + PF+ LY +L L+ E+ GGD LH+ F E Y S
Sbjct: 58 LALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIY------GYFDEEMAVKYIS 111
Query: 196 EVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235
EV +AL++LH GII+RDLKP+N+L+ ++GHI LTDF LS
Sbjct: 112 EVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLS 151
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 6e-25
Identities = 50/122 (40%), Positives = 68/122 (55%), Gaps = 5/122 (4%)
Query: 317 SFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALE 376
+F GT EYLAPE++ +G AVDWW LG+ ++E+ G PF DHE ++ +
Sbjct: 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR 213
Query: 377 FPKEPSVPGPAKDLIAQLLVKDPTRRM-GSKMGATAIKRHQFFNGVNWALLRCAK--PPF 433
FP+ S AK L+A LL KDP +R+ G A I H+FF +NW + K PPF
Sbjct: 214 FPRTLS--PEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASINWQDVVQKKLEPPF 271
Query: 434 IP 435
P
Sbjct: 272 KP 273
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 7e-25
Identities = 55/157 (35%), Positives = 88/157 (56%), Gaps = 10/157 (6%)
Query: 90 LGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLP 149
LG G G V LV+ K+ G ++A K++ K ++++++ + E +L+ HPFL
Sbjct: 3 LGKGTFGKVILVREKA----TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLT 58
Query: 150 TLYATLDCPRWSCLLTEFCPGGDL--HVLRQRQPDKRFHESAVRFYASEVVVALEFLHMM 207
L C + E+ GG+L H+ R+R F E RFY +E+V ALE+LH
Sbjct: 59 ALKYAFQTHDRLCFVMEYANGGELFFHLSRERV----FTEERARFYGAEIVSALEYLHSR 114
Query: 208 GIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTST 244
++YRD+K EN+++ DGHI +TDF L +G + +T
Sbjct: 115 DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT 151
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 8e-25
Identities = 43/128 (33%), Positives = 76/128 (59%), Gaps = 7/128 (5%)
Query: 311 LDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANV 370
+ ++ +F GT +Y+APEI+ G+ + +VDWW+ G+ ++E+ G +PF G D + ++
Sbjct: 149 GEGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSI 208
Query: 371 VARALEFPKEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGVNWALL--RC 428
+ FP+ + AKD +++L +DPT+R+G I++H FF G++W L R
Sbjct: 209 LNDRPHFPR--WISKEAKDCLSKLFERDPTKRLGVD---GDIRQHPFFRGIDWERLEKRE 263
Query: 429 AKPPFIPR 436
PPF P+
Sbjct: 264 IPPPFKPK 271
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 53/147 (36%), Positives = 83/147 (56%), Gaps = 10/147 (6%)
Query: 90 LGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLP 149
LG G G V LV+ K+ G ++A K++ K ++++++ + E +L+ HPFL
Sbjct: 3 LGKGTFGKVILVREKA----TGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLT 58
Query: 150 TLYATLDCPRWSCLLTEFCPGGDL--HVLRQRQPDKRFHESAVRFYASEVVVALEFLHMM 207
L + C + E+ GG+L H+ R+R F E RFY +E+V AL +LH
Sbjct: 59 ALKYSFQTHDRLCFVMEYANGGELFFHLSRERV----FSEDRARFYGAEIVSALGYLHSC 114
Query: 208 GIIYRDLKPENVLVRSDGHIMLTDFDL 234
++YRDLK EN+++ DGHI +TDF L
Sbjct: 115 DVVYRDLKLENLMLDKDGHIKITDFGL 141
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 104 bits (259), Expect = 1e-24
Identities = 52/129 (40%), Positives = 75/129 (58%), Gaps = 5/129 (3%)
Query: 317 SFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALE 376
+F GT EYLAPE++ +G AVDWW LG+ ++E+ G PF DHE ++ ++
Sbjct: 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIK 213
Query: 377 FPKEPSVPGPAKDLIAQLLVKDPTRRMGSKM-GATAIKRHQFFNGVNWALLRCAK--PPF 433
FP+ ++ AK L++ LL+KDP +R+G A I RH FF GVNW + K PPF
Sbjct: 214 FPR--TLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGVNWQDVYDKKLVPPF 271
Query: 434 IPRPVTCRD 442
P+ + D
Sbjct: 272 KPQVTSETD 280
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 56/159 (35%), Positives = 91/159 (57%), Gaps = 10/159 (6%)
Query: 90 LGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLP 149
LG G G V LV+ K+ +G ++A K++ K ++++++ + E +L+ HPFL
Sbjct: 3 LGKGTFGKVILVREKA----SGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLT 58
Query: 150 TLYATLDCPRWSCLLTEFCPGGDL--HVLRQRQPDKRFHESAVRFYASEVVVALEFLHMM 207
+L + C + E+ GG+L H+ R+R F E RFY +E+V AL++LH
Sbjct: 59 SLKYSFQTKDRLCFVMEYVNGGELFFHLSRERV----FSEDRTRFYGAEIVSALDYLHSG 114
Query: 208 GIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQ 246
I+YRDLK EN+++ DGHI +TDF L +G +T +
Sbjct: 115 KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMK 153
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 59/183 (32%), Positives = 90/183 (49%), Gaps = 9/183 (4%)
Query: 64 KEATSEGNNNNNNNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCF--FAAKVMDK 121
K+ + N + D F+ LG+G G V L K N F A K +K
Sbjct: 12 KKDSDSTKEPKRKNKMKYEDFNFIRTLGTGSFGRVILATYK-----NEDFPPVAIKRFEK 66
Query: 122 RELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQP 181
+++ + + ER+IL ++HPF LY + + L+ EF GG+ +R
Sbjct: 67 SKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRR-- 124
Query: 182 DKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNS 241
+KRF FYA+++V+ E+L + I+YRDLKPEN+L+ DG I +TDF + D
Sbjct: 125 NKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR 184
Query: 242 TST 244
T T
Sbjct: 185 TYT 187
|
Length = 340 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 3e-24
Identities = 49/158 (31%), Positives = 74/158 (46%), Gaps = 18/158 (11%)
Query: 83 DLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREI--L 140
+ ++G G G VY + G A KV+ KE + +I EI L
Sbjct: 1 LFEILEKIGKGGFGEVYKA----RHKRTGKEVAIKVIKLES-----KEKKEKIINEIQIL 51
Query: 141 EMLDHPFLPTLYATLDCPR--WSCLLTEFCPGGDL-HVLRQRQPDKRFHESAVRFYASEV 197
+ HP + Y + W + EFC GG L +L+ ++ ES + + E+
Sbjct: 52 KKCKHPNIVKYYGSYLKKDELWIVM--EFCSGGSLKDLLKST--NQTLTESQIAYVCKEL 107
Query: 198 VVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235
+ LE+LH GII+RD+K N+L+ SDG + L DF LS
Sbjct: 108 LKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLS 145
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 3e-24
Identities = 57/161 (35%), Positives = 85/161 (52%), Gaps = 14/161 (8%)
Query: 90 LGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEML-DHPFL 148
LG G G V+L +LK FFA K + K ++ + +E+ +L + +HPFL
Sbjct: 3 LGKGSFGKVFLAELKG----TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFL 58
Query: 149 PTLYATLDCPRWSCLLTEFCPGGDL--HVLRQRQPDKRFHESAVRFYASEVVVALEFLHM 206
LY T + E+ GGDL H+ Q +F FYA+E++ L+FLH
Sbjct: 59 THLYCTFQTKENLFFVMEYLNGGDLMFHI----QSCHKFDLPRATFYAAEIICGLQFLHS 114
Query: 207 MGIIYRDLKPENVLVRSDGHIMLTDFDL---SLKGDNSTST 244
GI+YRDLK +N+L+ +DGHI + DF + ++ GD T T
Sbjct: 115 KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCT 155
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 102 bits (254), Expect = 4e-24
Identities = 64/182 (35%), Positives = 102/182 (56%), Gaps = 11/182 (6%)
Query: 90 LGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREIL-EMLDHPFL 148
+G G G V L + K++ F+A KV+ K+ ++ + +E ER +L + + HPFL
Sbjct: 3 IGKGSFGKVLLARHKAEEK----FYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFL 58
Query: 149 PTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMG 208
L+ + + ++ GG+L QR+ + F E RFYA+E+ AL +LH +
Sbjct: 59 VGLHFSFQTADKLYFVLDYINGGELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSLN 116
Query: 209 IIYRDLKPENVLVRSDGHIMLTDFDL---SLKGDNSTSTAQLVSDQ-SPPTGDQQPNDCA 264
I+YRDLKPEN+L+ S GHI+LTDF L +++ + +TST + +P +QP D
Sbjct: 117 IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRT 176
Query: 265 VD 266
VD
Sbjct: 177 VD 178
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 6e-24
Identities = 45/136 (33%), Positives = 72/136 (52%), Gaps = 9/136 (6%)
Query: 312 DVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVV 371
+ +F GT +Y+APEII+ + +G +VDWW G+ ++E+ G PF G D + +++
Sbjct: 155 GKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIM 214
Query: 372 ARALEFPKEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATA---IKRHQFFNGVNWALL-- 426
+ +PK S+ A + LL K P +R+G G T I+ H FF ++W L
Sbjct: 215 EHNVSYPK--SLSKEAVSICKGLLTKHPAKRLGC--GPTGERDIREHAFFRRIDWEKLER 270
Query: 427 RCAKPPFIPRPVTCRD 442
R +PPF P+ R
Sbjct: 271 REIQPPFKPKVKGRRS 286
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 2e-23
Identities = 47/123 (38%), Positives = 70/123 (56%), Gaps = 5/123 (4%)
Query: 317 SFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALE 376
+F GT EYLAPE++ +G AVDWW LG+ ++E+ G PF DHE ++ +
Sbjct: 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIR 213
Query: 377 FPKEPSVPGPAKDLIAQLLVKDPTRRM-GSKMGATAIKRHQFFNGVNW--ALLRCAKPPF 433
FP+ ++ AK L+A LL KDP +R+ G A + H+FF +NW + + PPF
Sbjct: 214 FPR--TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPF 271
Query: 434 IPR 436
P+
Sbjct: 272 KPQ 274
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 98.7 bits (247), Expect = 2e-23
Identities = 48/161 (29%), Positives = 87/161 (54%), Gaps = 7/161 (4%)
Query: 90 LGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLP 149
+G G G VYLV + KS + K +D + + +E A E +IL+ L+HP +
Sbjct: 8 IGKGSFGKVYLV--RRKSDGK--LYVLKEIDLSNMSEKERE-DALNEVKILKKLNHPNII 62
Query: 150 TLYATLDCPRWSCLLTEFCPGGDL--HVLRQRQPDKRFHESAVRFYASEVVVALEFLHMM 207
Y + + C++ E+ GGDL + +Q++ K F E + + ++ +AL++LH
Sbjct: 63 KYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR 122
Query: 208 GIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQLV 248
I++RD+KP+N+ + S+G + L DF +S ++ A+ V
Sbjct: 123 KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTV 163
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 2e-23
Identities = 71/234 (30%), Positives = 107/234 (45%), Gaps = 18/234 (7%)
Query: 90 LGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLP 149
LG G G V Q+++ G +A K ++K+ + R ES A E++ILE ++ F+
Sbjct: 8 LGKGGFGEVCACQVRA----TGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVV 63
Query: 150 TLYATLDCPRWSCLLTEFCPGGDL--HVLRQRQPDKRFHESAVRFYASEVVVALEFLHMM 207
L + CL+ GGDL H+ P F E FYA+E++ LE LH
Sbjct: 64 NLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPG--FEEERALFYAAEILCGLEDLHRE 121
Query: 208 GIIYRDLKPENVLVRSDGHIMLTDFDLSLK---GDNSTSTAQLVSDQSPPTGDQQPNDCA 264
+YRDLKPEN+L+ GHI ++D L++K G++ V +P + Q +
Sbjct: 122 NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQRYTLS 181
Query: 265 VDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSF 318
P + C+I I P R RK+K+ V E +V S F
Sbjct: 182 ---PDYWGLGCLIYEMI----EGQSPFRGRKEKVKREEVDRRVLETEEVYSAKF 228
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 3e-23
Identities = 62/207 (29%), Positives = 95/207 (45%), Gaps = 25/207 (12%)
Query: 83 DLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEM 142
D F+ LG G G V L + K +A K++ K ++ + +E+ +L +
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDE----LYAIKILKKDVIIQDDDVECTMVEKRVLAL 56
Query: 143 LDHP-FLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVAL 201
P FL L++ + E+ GGDL + Q +F E FYA+E+ + L
Sbjct: 57 PGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDL--MYHIQQVGKFKEPHAVFYAAEIAIGL 114
Query: 202 EFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDL---SLKGDNSTSTAQLVSDQ-SPPTGD 257
FLH GIIYRDLK +NV++ ++GHI + DF + ++ G +T T D +P
Sbjct: 115 FFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIA 174
Query: 258 QQPNDCAVD--------------QPPF 270
QP +VD QPPF
Sbjct: 175 YQPYGKSVDWWAFGVLLYEMLAGQPPF 201
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 4e-23
Identities = 44/127 (34%), Positives = 77/127 (60%), Gaps = 7/127 (5%)
Query: 312 DVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVV 371
D ++ +F GT +Y+APEI+ G+ + +VDWW+ G+ ++E+ G +PF G D E ++
Sbjct: 150 DAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIR 209
Query: 372 ARALEFPKEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGVNWALL--RCA 429
+P+ + AKD++ +L V++P RR+G K I++H FF ++W+ L R
Sbjct: 210 MDNPCYPRWLTR--EAKDILVKLFVREPERRLGVK---GDIRQHPFFREIDWSALEEREI 264
Query: 430 KPPFIPR 436
+PPF P+
Sbjct: 265 EPPFKPK 271
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.1 bits (247), Expect = 5e-23
Identities = 51/155 (32%), Positives = 79/155 (50%), Gaps = 28/155 (18%)
Query: 313 VRSMSFVGTHEYLAPEII----SGEGH-GNAVDWWTLGIFIFELFYGTTPF--------- 358
V+S VGT +Y++PEI+ G+G G DWW+LG+ ++E+ YG TPF
Sbjct: 158 VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETY 217
Query: 359 -KGIDHELTLANVVARALEFP-KEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQ 416
K ++H+ +FP V AKDLI +L+ P R+G + G K H
Sbjct: 218 GKIMNHK--------EHFQFPPDVTDVSEEAKDLIRRLICS-PETRLG-RNGLQDFKDHP 267
Query: 417 FFNGVNWALLRCAKPPFIPRPVTCRDLTTTNSSID 451
FF G++W +R + P++P + D T+N +D
Sbjct: 268 FFEGIDWDNIRNSTAPYVPEVSSPTD--TSNFDVD 300
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 1e-22
Identities = 47/126 (37%), Positives = 67/126 (53%), Gaps = 10/126 (7%)
Query: 317 SFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLAN------V 370
S VG+ +Y+APE++ G+G+ VD+W+LG ++E G PF G T N
Sbjct: 157 SVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKET 216
Query: 371 VARALEFPKEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGVNWALLRCAK 430
+ R + ++ A DLI +L+ DP+RR GS IK H FF V+W LR K
Sbjct: 217 LQRPVYDDPRFNLSDEAWDLITKLI-NDPSRRFGSL---EDIKNHPFFKEVDWNELRELK 272
Query: 431 PPFIPR 436
PPF+P
Sbjct: 273 PPFVPE 278
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.7 bits (243), Expect = 1e-22
Identities = 58/158 (36%), Positives = 85/158 (53%), Gaps = 9/158 (5%)
Query: 90 LGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLP 149
+G G G V V+ + +A K + K +VSR++ + ER +L ++ PF+
Sbjct: 1 IGKGSFGKVMQVRKRDTQR----IYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIV 56
Query: 150 TLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGI 209
L + P L+ F GG+L QR+ RF S RFY +E++ ALE LH +
Sbjct: 57 PLKFSFQSPEKLYLVLAFINGGELFHHLQRE--GRFDLSRARFYTAELLCALENLHKFNV 114
Query: 210 IYRDLKPENVLVRSDGHIMLTDF---DLSLKGDNSTST 244
IYRDLKPEN+L+ GHI L DF L++K D+ T+T
Sbjct: 115 IYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNT 152
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 97.8 bits (243), Expect = 1e-22
Identities = 54/158 (34%), Positives = 87/158 (55%), Gaps = 7/158 (4%)
Query: 90 LGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLP 149
LG G G V LV+ K+ G ++A K++ K +V++++ + E +L+ HPFL
Sbjct: 3 LGKGTFGKVILVKEKA----TGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLT 58
Query: 150 TLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHM-MG 208
L + C + E+ GG+L R ++ F E RFY +E+V AL++LH
Sbjct: 59 ALKYSFQTHDRLCFVMEYANGGELFFHLSR--ERVFSEDRARFYGAEIVSALDYLHSEKN 116
Query: 209 IIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQ 246
++YRDLK EN+++ DGHI +TDF L +G +T +
Sbjct: 117 VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMK 154
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 1e-22
Identities = 45/124 (36%), Positives = 63/124 (50%), Gaps = 5/124 (4%)
Query: 319 VGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFP 378
VGT Y+APE++ E + + DWW LG I+E+ G +PF+ ++ V R E
Sbjct: 162 VGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQ 221
Query: 379 KEPS--VPGPAKDLIAQLLVKDPTRRMGSKM-GATAIKRHQFFNGVNWALLRCAK--PPF 433
+E S A+ + QLL KDP R+G + GA +K H FF N+ L PPF
Sbjct: 222 EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFKRLEAGMLEPPF 281
Query: 434 IPRP 437
P P
Sbjct: 282 CPDP 285
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 1e-22
Identities = 51/157 (32%), Positives = 81/157 (51%), Gaps = 4/157 (2%)
Query: 90 LGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLP 149
LG G G V VQ+K N G +A K +DK+ L ++ E A +E+EILE ++ PF+
Sbjct: 1 LGKGGFGEVCAVQVK----NTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIV 56
Query: 150 TLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGI 209
L + CL+ GGDL ++ V Y++++ + LH M I
Sbjct: 57 NLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDI 116
Query: 210 IYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQ 246
+YRD+KPENVL+ G+ L+D L+++ + + Q
Sbjct: 117 VYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQ 153
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 96.9 bits (241), Expect = 2e-22
Identities = 62/161 (38%), Positives = 86/161 (53%), Gaps = 14/161 (8%)
Query: 90 LGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEML-DHPFL 148
LG G G V L +LK K G +FA K + K ++ + +E+ +L + ++PFL
Sbjct: 3 LGKGSFGKVLLAELKGK----GEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFL 58
Query: 149 PTLYATLDCPRWSCLLTEFCPGGDL--HVLRQRQPDKRFHESAVRFYASEVVVALEFLHM 206
LY T + EF GGDL H+ Q RF FYA+E+V L+FLH
Sbjct: 59 THLYCTFQTKEHLFFVMEFLNGGDLMFHI----QDKGRFDLYRATFYAAEIVCGLQFLHS 114
Query: 207 MGIIYRDLKPENVLVRSDGHIMLTDFDL---SLKGDNSTST 244
GIIYRDLK +NV++ DGHI + DF + ++ GDN ST
Sbjct: 115 KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST 155
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 96.3 bits (239), Expect = 5e-22
Identities = 63/160 (39%), Positives = 92/160 (57%), Gaps = 12/160 (7%)
Query: 90 LGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKE-SRARIEREILEMLD-HPF 147
+G G V LV+LK N +A KV+ K+ELV +++ + E+ + E +PF
Sbjct: 3 IGRGSYAKVLLVRLK----KNDQIYAMKVV-KKELVHDDEDIDWVQTEKHVFEQASSNPF 57
Query: 148 LPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMM 207
L L++ L+ E+ GGDL QRQ ++ E RFYA+E+ +AL FLH
Sbjct: 58 LVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQ--RKLPEEHARFYAAEICIALNFLHER 115
Query: 208 GIIYRDLKPENVLVRSDGHIMLTDFDLSLKG---DNSTST 244
GIIYRDLK +NVL+ +DGHI LTD+ + +G ++TST
Sbjct: 116 GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTST 155
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 6e-22
Identities = 45/133 (33%), Positives = 74/133 (55%), Gaps = 7/133 (5%)
Query: 312 DVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVV 371
D R+ +F GT +Y+APEI+ G + +VDWW+ G+ ++E+ G +PF G D + ++
Sbjct: 150 DNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIR 209
Query: 372 ARALEFPKEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGVNWALL--RCA 429
+P+ + +KD++ +L +DPTRR+G I+ H FF +NW L R
Sbjct: 210 VDTPHYPR--WITKESKDILEKLFERDPTRRLGV---VGNIRGHPFFKTINWTALEKREL 264
Query: 430 KPPFIPRPVTCRD 442
PPF P+ + D
Sbjct: 265 DPPFKPKVKSPSD 277
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 96.4 bits (240), Expect = 8e-22
Identities = 47/151 (31%), Positives = 74/151 (49%), Gaps = 28/151 (18%)
Query: 313 VRSMSFVGTHEYLAPEIISGEGH----GNAVDWWTLGIFIFELFYGTTPF---------- 358
VR + VGT +Y++PE++ +G G DWW++G+F++E+ G TPF
Sbjct: 198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYS 257
Query: 359 KGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFF 418
K +DH+ +L FP + + AKDLI L D R+G + G IK H FF
Sbjct: 258 KIMDHK--------NSLTFPDDIEISKQAKDLICAFLT-DREVRLG-RNGVDEIKSHPFF 307
Query: 419 --NGVNWALLRCAKPPFIPRPVTCRDLTTTN 447
+ + +R P +P + D+ T+N
Sbjct: 308 KNDQWTFDNIRETVAPVVPELSS--DIDTSN 336
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 95.4 bits (237), Expect = 1e-21
Identities = 50/132 (37%), Positives = 75/132 (56%), Gaps = 5/132 (3%)
Query: 308 AEPLDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTL 367
A+ +D R+ + GT EY+APEI+ GHG A DWWTLGIFI+E+ G PF + L
Sbjct: 178 AKVVDTRTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIY 237
Query: 368 ANVVARALEFPKEPSVPGPAKDLIAQLLVKDPTRRMGS-KMGATAIKRHQFFNGVNWALL 426
++ + FPK + K L+ +LL D T+R G+ K GA +K H +F ++W L
Sbjct: 238 QKILEGIIYFPK--FLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWVSL 295
Query: 427 --RCAKPPFIPR 436
+ + P+ P+
Sbjct: 296 LHKNVEVPYKPK 307
|
Length = 340 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 1e-21
Identities = 48/123 (39%), Positives = 71/123 (57%), Gaps = 5/123 (4%)
Query: 317 SFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALE 376
+F GT EYLAPE++ +G AVDWW LG+ ++E+ G PF DHE ++ +
Sbjct: 155 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR 214
Query: 377 FPKEPSVPGPAKDLIAQLLVKDPTRRM-GSKMGATAIKRHQFFNGVNWALLRCAK--PPF 433
FP+ ++ AK L++ LL KDP +R+ G A I +H+FF G+ W + K PPF
Sbjct: 215 FPR--TLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIVWQDVYEKKLVPPF 272
Query: 434 IPR 436
P+
Sbjct: 273 KPQ 275
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.4 bits (232), Expect = 2e-21
Identities = 55/153 (35%), Positives = 82/153 (53%), Gaps = 14/153 (9%)
Query: 90 LGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLP 149
LG G G V Q+++ G +A K ++K+ + R E+ A E++ILE ++ F+
Sbjct: 8 LGKGGFGEVCACQVRA----TGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVV 63
Query: 150 TL---YATLDCPRWSCLLTEFCPGGDL--HVLRQRQPDKRFHESAVRFYASEVVVALEFL 204
+L Y T D CL+ GGDL H+ P F E FYA+E+ LE L
Sbjct: 64 SLAYAYETKDA---LCLVLTLMNGGDLKFHIYNMGNPG--FDEERAVFYAAEITCGLEDL 118
Query: 205 HMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLK 237
H I+YRDLKPEN+L+ GHI ++D L+++
Sbjct: 119 HRERIVYRDLKPENILLDDYGHIRISDLGLAVE 151
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 96.5 bits (240), Expect = 3e-21
Identities = 55/152 (36%), Positives = 83/152 (54%), Gaps = 7/152 (4%)
Query: 289 HPKRRRKKKLGNP-GTPEIVAE-PLDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGI 346
+ ++ K+G P TP+ V V +GT +YLAPE++ G+ HG AVDWW LG+
Sbjct: 509 LYQTPKQVKIGTPYRTPKSVRRGAAPVEGERILGTPDYLAPELLLGKPHGPAVDWWALGV 568
Query: 347 FIFELFYGTTPFKGIDHELTLANVVARALEFPK-EPSVPGPAKDLIAQLLVKDPTRRMGS 405
+FE G PF + N++ R + +P+ E + A++ I LL DPT+R G
Sbjct: 569 CLFEFLTGIPPFNDETPQQVFQNILNRDIPWPEGEEKLSVNAQNAIEILLTMDPTKRAGL 628
Query: 406 KMGATAIKRHQFFNGVNWALLRCAKPPFIPRP 437
K +K+H F+GV+W L+ PFIP+P
Sbjct: 629 K----ELKQHPLFHGVDWENLQNQTMPFIPQP 656
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 3e-21
Identities = 54/179 (30%), Positives = 91/179 (50%), Gaps = 10/179 (5%)
Query: 79 LTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIERE 138
+ D + +G G G V LV+ KS +A K++ K E++ R+ + ER+
Sbjct: 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQ----VYAMKLLSKFEMIKRSDSAFFWEERD 95
Query: 139 ILEMLDHPFLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVV 198
I+ + ++ L+ ++ ++ E+ PGGDL L + E RFY +EVV
Sbjct: 96 IMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNL---MSNYDIPEKWARFYTAEVV 152
Query: 199 VALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGD 257
+AL+ +H MG I+RD+KP+N+L+ GH+ L DF +K D + + D + T D
Sbjct: 153 LALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMD---ANGMVRCDTAVGTPD 208
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 5e-21
Identities = 51/147 (34%), Positives = 77/147 (52%), Gaps = 4/147 (2%)
Query: 90 LGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLP 149
LG G G V Q+++ G +A K ++K+ + R ES A E++ILE ++ F+
Sbjct: 8 LGKGGFGEVCACQVRA----TGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVV 63
Query: 150 TLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGI 209
+L + CL+ GGDL + F E FYA+E+ LE LH I
Sbjct: 64 SLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERI 123
Query: 210 IYRDLKPENVLVRSDGHIMLTDFDLSL 236
+YRDLKPEN+L+ GHI ++D L++
Sbjct: 124 VYRDLKPENILLDDHGHIRISDLGLAV 150
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 7e-21
Identities = 57/151 (37%), Positives = 87/151 (57%), Gaps = 9/151 (5%)
Query: 90 LGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKE-SRARIEREILEML-DHPF 147
+G G V LV+LK +A KV+ K+ELV+ +++ + E+ + E +HPF
Sbjct: 3 IGRGSYAKVLLVRLKKTER----IYAMKVV-KKELVNDDEDIDWVQTEKHVFEQASNHPF 57
Query: 148 LPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMM 207
L L++ + E+ GGDL QRQ ++ E RFY++E+ +AL +LH
Sbjct: 58 LVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHER 115
Query: 208 GIIYRDLKPENVLVRSDGHIMLTDFDLSLKG 238
GIIYRDLK +NVL+ S+GHI LTD+ + +G
Sbjct: 116 GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 146
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.7 bits (230), Expect = 9e-21
Identities = 50/144 (34%), Positives = 76/144 (52%), Gaps = 9/144 (6%)
Query: 317 SFVGTHEYLAPEIISGE-GHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARAL 375
+F GT EYLAPE++ E G+ VD+W+LG+ +FE+ G +PF D + N+ +
Sbjct: 155 TFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKV 214
Query: 376 EFPKEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGVNWALL--RCAKPPF 433
FPK + + + LL ++P R+G+ A +K H FF ++W LL + PPF
Sbjct: 215 RFPKN-VLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADIDWDLLSKKQITPPF 273
Query: 434 IPR-----PVTCRDLTTTNSSIDN 452
P V+ D TNSS+ N
Sbjct: 274 KPIVDSDEDVSNFDPEFTNSSLLN 297
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 92.3 bits (229), Expect = 1e-20
Identities = 51/129 (39%), Positives = 71/129 (55%), Gaps = 5/129 (3%)
Query: 309 EPLDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLA 368
EP + S +F GT EYLAPE++ E + VDWW LG ++E+ YG PF D
Sbjct: 148 EPEETTS-TFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYD 206
Query: 369 NVVARALEFPKEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGVNWALL-- 426
N++ + L+ P +V A DL+ LL KD RR+G+K IK H FF+ +NW L
Sbjct: 207 NILHKPLQLPGGKTV--AACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPINWDDLYH 264
Query: 427 RCAKPPFIP 435
+ PP+ P
Sbjct: 265 KRITPPYNP 273
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 1e-20
Identities = 52/145 (35%), Positives = 76/145 (52%), Gaps = 9/145 (6%)
Query: 317 SFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALE 376
+F GT EYLAPE++ + + VDWW LG ++E+ YG PF + N++ + L+
Sbjct: 155 TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQ 214
Query: 377 FPKEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGVNWALLRCAK--PPFI 434
+P++ A+ L+ LL KD T+R+G+K IK H FF+ +NW L K PPF
Sbjct: 215 L--KPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPINWDDLINKKITPPFN 272
Query: 435 PRPVTCRDLTT-----TNSSIDNSI 454
P DL T + NSI
Sbjct: 273 PNVSGPNDLRHFDPEFTEEPVPNSI 297
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 3e-20
Identities = 53/171 (30%), Positives = 92/171 (53%), Gaps = 5/171 (2%)
Query: 83 DLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEM 142
D + +G G G V +V++K N G +A K+++K E++ R + + R ER++L
Sbjct: 2 DFEILKVIGRGAFGEVAVVKMK----NTGQVYAMKILNKWEMLKRAETACFREERDVLVN 57
Query: 143 LDHPFLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALE 202
D ++ L+ L+ ++ GGDL L + D R E RFY +E+V+A++
Sbjct: 58 GDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFED-RLPEDMARFYLAEMVLAID 116
Query: 203 FLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQLVSDQSP 253
+H +G ++RD+KP+NVL+ +GHI L DF L+ + V+ +P
Sbjct: 117 SVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTP 167
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 3e-20
Identities = 53/155 (34%), Positives = 84/155 (54%), Gaps = 7/155 (4%)
Query: 83 DLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEM 142
D V +G G G V LV+ KS +A K++ K E++ R+ + ER+I+
Sbjct: 44 DYEVVKVIGRGAFGEVQLVRHKSTRK----VYAMKLLSKFEMIKRSDSAFFWEERDIMAF 99
Query: 143 LDHPFLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALE 202
+ P++ L+ R+ ++ E+ PGGDL L + E RFY +EVV+AL+
Sbjct: 100 ANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNL---MSNYDVPEKWARFYTAEVVLALD 156
Query: 203 FLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLK 237
+H MG I+RD+KP+N+L+ GH+ L DF +K
Sbjct: 157 AIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMK 191
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 4e-20
Identities = 49/147 (33%), Positives = 73/147 (49%), Gaps = 9/147 (6%)
Query: 315 SMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARA 374
+ +F GT EYLAPE+I + + N VDWW LG ++E+ YG PF D N++ +
Sbjct: 153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKP 212
Query: 375 LEFPKEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGVNWALLRCAK--PP 432
L P A ++ +LL KD RR+G+K I+ H FF ++W L K PP
Sbjct: 213 LVL--RPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESLSWTDLEQKKIPPP 270
Query: 433 FIPRPVTCRDLTT-----TNSSIDNSI 454
F P D++ T ++ S+
Sbjct: 271 FNPNVEGPDDISNFDAVFTEETVPYSV 297
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 4e-20
Identities = 48/150 (32%), Positives = 80/150 (53%), Gaps = 11/150 (7%)
Query: 90 LGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEML---DHP 146
+G G G VY + ++ G +A K +DK+ + + E+ A ER +L ++ D P
Sbjct: 2 IGRGGFGEVY----GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCP 57
Query: 147 FLPTLYATLDCPRWSCLLTEFCPGGDLHV-LRQRQPDKRFHESAVRFYASEVVVALEFLH 205
F+ + P + + GGDLH L Q F E+ +RFYA+E+++ LE +H
Sbjct: 58 FIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH---GVFSEAEMRFYAAEIILGLEHMH 114
Query: 206 MMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235
++YRDLKP N+L+ GH+ ++D L+
Sbjct: 115 NRFVVYRDLKPANILLDEHGHVRISDLGLA 144
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 5e-20
Identities = 52/159 (32%), Positives = 87/159 (54%), Gaps = 7/159 (4%)
Query: 83 DLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEM 142
D V +G G G V LV+ KS +A K++ K E++ R+ + ER+I+
Sbjct: 44 DYDVVKVIGRGAFGEVQLVRHKSSQK----VYAMKLLSKFEMIKRSDSAFFWEERDIMAF 99
Query: 143 LDHPFLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALE 202
+ P++ L+ ++ ++ E+ PGGDL L + E +FY +EVV+AL+
Sbjct: 100 ANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNL---MSNYDVPEKWAKFYTAEVVLALD 156
Query: 203 FLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNS 241
+H MG+I+RD+KP+N+L+ GH+ L DF +K D +
Sbjct: 157 AIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDET 195
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 9e-20
Identities = 45/124 (36%), Positives = 68/124 (54%), Gaps = 5/124 (4%)
Query: 319 VGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFP 378
VGT Y+APE+++ + + + D+W LG I+E+ G +PF+G ++ V R LE
Sbjct: 162 VGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETE 221
Query: 379 KEPSV--PGPAKDLIAQLLVKDPTRRMGSK-MGATAIKRHQFFNGVNWALLRCA--KPPF 433
+ S AK + LL KDP +R+G + GA +KRH FF +N+ L PPF
Sbjct: 222 EVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFKRLEAGMLDPPF 281
Query: 434 IPRP 437
+P P
Sbjct: 282 VPDP 285
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 1e-19
Identities = 52/153 (33%), Positives = 78/153 (50%), Gaps = 7/153 (4%)
Query: 83 DLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEM 142
D F+ LG G G V L + K +A K++ K ++ + +E+ +L +
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKG----TDELYAIKILKKDVVIQDDDVECTMVEKRVLAL 56
Query: 143 LDHP-FLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVAL 201
D P FL L++ + E+ GGDL + Q +F E FYA+E+ V L
Sbjct: 57 QDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDL--MYHIQQVGKFKEPQAVFYAAEISVGL 114
Query: 202 EFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDL 234
FLH GIIYRDLK +NV++ S+GHI + DF +
Sbjct: 115 FFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGM 147
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 2e-19
Identities = 49/138 (35%), Positives = 73/138 (52%), Gaps = 14/138 (10%)
Query: 310 PLDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGI-------D 362
P D S +F GT Y+APEI+ GE +G +VDWW LG+ +FE+ G +PF I
Sbjct: 149 PGDTTS-TFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNT 207
Query: 363 HELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDPTRRMGSKM--GATAIKRHQFFNG 420
+ ++ + + P+ SV A ++ L KDP R+G + G + IK H FF
Sbjct: 208 EDYLFQVILEKPIRIPRFLSV--KASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRS 265
Query: 421 VNWALL--RCAKPPFIPR 436
++W LL + PPF P+
Sbjct: 266 IDWDLLEKKQVTPPFKPQ 283
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 2e-19
Identities = 43/127 (33%), Positives = 72/127 (56%), Gaps = 5/127 (3%)
Query: 313 VRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVA 372
V + +F GT +Y+APEII+ + +G +VDWW G+ ++E+ G PF G D + +++
Sbjct: 156 VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIME 215
Query: 373 RALEFPKEPSVPGPAKDLIAQLLVKDPTRRMG-SKMGATAIKRHQFFNGVNWALL--RCA 429
+ +PK S+ A + L+ K P++R+G G I+ H FF ++W L R
Sbjct: 216 HNVSYPK--SLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRIDWDKLENREI 273
Query: 430 KPPFIPR 436
+PPF P+
Sbjct: 274 QPPFKPK 280
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 2e-19
Identities = 49/150 (32%), Positives = 80/150 (53%), Gaps = 11/150 (7%)
Query: 90 LGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEML---DHP 146
+G G G VY + ++ G +A K +DK+ + + E+ A ER +L ++ D P
Sbjct: 2 IGRGGFGEVY----GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCP 57
Query: 147 FLPTLYATLDCPRWSCLLTEFCPGGDLHV-LRQRQPDKRFHESAVRFYASEVVVALEFLH 205
F+ + P C + + GGDLH L Q F E +RFYA+E+++ LE +H
Sbjct: 58 FIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQH---GVFSEKEMRFYATEIILGLEHMH 114
Query: 206 MMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235
++YRDLKP N+L+ GH+ ++D L+
Sbjct: 115 NRFVVYRDLKPANILLDEHGHVRISDLGLA 144
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 3e-19
Identities = 42/127 (33%), Positives = 72/127 (56%), Gaps = 5/127 (3%)
Query: 313 VRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVA 372
V + +F GT +Y+APEII+ + +G +VDWW G+ ++E+ G PF+G D + +++
Sbjct: 156 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME 215
Query: 373 RALEFPKEPSVPGPAKDLIAQLLVKDPTRRMG-SKMGATAIKRHQFFNGVNWALL--RCA 429
+ +PK S+ A + L+ K P +R+G G IK H FF ++W L +
Sbjct: 216 HNVAYPK--SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEV 273
Query: 430 KPPFIPR 436
+PP+ P+
Sbjct: 274 QPPYKPK 280
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 4e-19
Identities = 53/148 (35%), Positives = 76/148 (51%), Gaps = 16/148 (10%)
Query: 310 PLDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGI-------- 361
P D S +F GT Y+APEI+ GE +G +VDWW LG+ +FE+ G +PF +
Sbjct: 149 PGDTTS-TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQ 207
Query: 362 DHELTLANVV-ARALEFPKEPSVPGPAKDLIAQLLVKDPTRRMGSKM--GATAIKRHQFF 418
+ E L V+ + + P+ SV A ++ L KDP R+G G IK H FF
Sbjct: 208 NTEDYLFQVILEKQIRIPRSLSV--KASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFF 265
Query: 419 NGVNWALL--RCAKPPFIPRPVTCRDLT 444
++W LL + PP+ P + RDL
Sbjct: 266 RNIDWDLLEQKQVLPPYKPNIESDRDLD 293
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 4e-19
Identities = 52/156 (33%), Positives = 79/156 (50%), Gaps = 8/156 (5%)
Query: 84 LRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEML 143
R LG G G V Q+++ G +A K ++K+ + R E+ A E+ ILE +
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRA----TGKMYACKKLEKKRIKKRKGEAMALNEKRILEKV 57
Query: 144 DHPFLPTLYATLDCPRWSCLLTEFCPGGDL--HVLRQRQPDKRFHESAVRFYASEVVVAL 201
+ F+ +L + CL+ GGDL H+ P F E FYA+E+ L
Sbjct: 58 NSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPG--FDEQRAIFYAAELCCGL 115
Query: 202 EFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLK 237
E L I+YRDLKPEN+L+ GHI ++D L+++
Sbjct: 116 EDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQ 151
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 4e-19
Identities = 52/155 (33%), Positives = 87/155 (56%), Gaps = 5/155 (3%)
Query: 83 DLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEM 142
D + +G G G V +V+LK N FA K+++K E++ R + + R ER++L
Sbjct: 2 DFEILKVIGRGAFGEVAVVKLK----NADKVFAMKILNKWEMLKRAETACFREERDVLVN 57
Query: 143 LDHPFLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALE 202
D+ ++ TL+ L+ ++ GGDL L + D R E RFY +E+V+A++
Sbjct: 58 GDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFED-RLPEDMARFYLAEMVIAID 116
Query: 203 FLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLK 237
+H + ++RD+KP+N+L+ +GHI L DF LK
Sbjct: 117 SVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLK 151
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 86.1 bits (214), Expect = 5e-19
Identities = 47/158 (29%), Positives = 78/158 (49%), Gaps = 15/158 (9%)
Query: 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILE 141
SDL V LG G G VY V+ K G +A K + V ++E R ++ RE L+
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKP----TGKIYALKKI----HVDGDEEFRKQLLRE-LK 51
Query: 142 ML---DHPFLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVV 198
L + P++ Y ++ E+ GG L L ++ + E + + A +++
Sbjct: 52 TLRSCESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKK--VGKIPEPVLAYIARQIL 109
Query: 199 VALEFLH-MMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235
L++LH II+RD+KP N+L+ S G + + DF +S
Sbjct: 110 KGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGIS 147
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 9e-19
Identities = 52/171 (30%), Positives = 90/171 (52%), Gaps = 5/171 (2%)
Query: 83 DLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEM 142
D + +G G G V +V++K +A K+++K E++ R + + R ER +L
Sbjct: 2 DFEIIKVIGRGAFGEVAVVKMKHTER----IYAMKILNKWEMLKRAETACFREERNVLVN 57
Query: 143 LDHPFLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALE 202
D ++ TL+ + L+ ++ GGDL L + D R E RFY +E+V+A+
Sbjct: 58 GDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFED-RLPEDMARFYIAEMVLAIH 116
Query: 203 FLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQLVSDQSP 253
+H + ++RD+KP+NVL+ +GHI L DF LK + + V+ +P
Sbjct: 117 SIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTP 167
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 1e-18
Identities = 52/153 (33%), Positives = 78/153 (50%), Gaps = 7/153 (4%)
Query: 83 DLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEM 142
D F+ LG G G V L + K +A K++ K ++ + +E+ +L +
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDE----LYAIKILKKDVVIQDDDVECTMVEKRVLAL 56
Query: 143 LDHP-FLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVAL 201
P FL L++ + E+ GGDL + Q Q RF E FYA+E+ + L
Sbjct: 57 SGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDL--MYQIQQVGRFKEPHAVFYAAEIAIGL 114
Query: 202 EFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDL 234
FLH GIIYRDLK +NV++ S+GHI + DF +
Sbjct: 115 FFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGM 147
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 2e-18
Identities = 46/148 (31%), Positives = 75/148 (50%), Gaps = 8/148 (5%)
Query: 90 LGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREI--LEMLDHPF 147
LGSG GSVY + ++G FFA K + + +E+ ++E+EI L L HP
Sbjct: 8 LGSGSFGSVYE----GLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPN 63
Query: 148 LPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMM 207
+ T + E PGG L L ++ F E +R Y ++++ LE+LH
Sbjct: 64 IVQYLGTEREEDNLYIFLELVPGGSLAKLLKKY--GSFPEPVIRLYTRQILLGLEYLHDR 121
Query: 208 GIIYRDLKPENVLVRSDGHIMLTDFDLS 235
++RD+K N+LV ++G + L DF ++
Sbjct: 122 NTVHRDIKGANILVDTNGVVKLADFGMA 149
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 84.1 bits (209), Expect = 2e-18
Identities = 47/164 (28%), Positives = 73/164 (44%), Gaps = 12/164 (7%)
Query: 84 LRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIERE--ILE 141
L +LG G G VY LK K A K + + +++ RE I+
Sbjct: 1 LTLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKE----DASEQQIEEFLREARIMR 56
Query: 142 MLDHPFLPTLY--ATLDCPRWSCLLTEFCPGGDLH-VLRQRQPDKRFHESAVRFYASEVV 198
LDHP + L T + P ++ E+ PGGDL LR+ +P K S + +A ++
Sbjct: 57 KLDHPNIVKLLGVCTEEEPL--MIVMEYMPGGDLLDYLRKNRP-KELSLSDLLSFALQIA 113
Query: 199 VALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNST 242
+E+L I+RDL N LV + + ++DF LS +
Sbjct: 114 RGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 3e-18
Identities = 73/352 (20%), Positives = 125/352 (35%), Gaps = 100/352 (28%)
Query: 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILE 141
D + +G G VY + A K +D + + + S + +E+
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEK----VAIKRID----LEKCQTSVDELRKEVQA 52
Query: 142 M--LDHPFLPTLYATLDCPRWSCLLTEFCPGGD-LHVLRQRQPDKRFHESAVRFYASEVV 198
M +HP + Y + L+ + GG L +++ P E+ + EV+
Sbjct: 53 MSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVL 112
Query: 199 VALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQ 258
LE+LH G I+RD+K N+L+ DG + + D
Sbjct: 113 KGLEYLHSNGQIHRDIKAGNILLGEDGSVKIAD--------------------------- 145
Query: 259 QPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSF 318
FG S+ + ++ RK +F
Sbjct: 146 -----------FGVSASLADGGDRT-------RKVRK---------------------TF 166
Query: 319 VGTHEYLAPEIIS-GEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEF 377
VGT ++APE++ G+ D W+ GI EL G P+ + V+ L+
Sbjct: 167 VGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPY----SKYPPMKVLMLTLQN 222
Query: 378 PKEPSVPGPA---------KDLIAQLLVKDPTRRMGSKMGATAIK--RHQFF 418
PS+ A + +I+ L KDP++R TA + +H+FF
Sbjct: 223 DP-PSLETGADYKKYSKSFRKMISLCLQKDPSKR------PTAEELLKHKFF 267
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 5e-18
Identities = 48/140 (34%), Positives = 78/140 (55%), Gaps = 15/140 (10%)
Query: 312 DVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVV 371
V + +F GT +Y+APEI+ +G +VDWW LG+ ++E+ G PF+ + + +++
Sbjct: 150 GVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESIL 209
Query: 372 ARALEFP----KEPSVPGPAKDLIAQLLVKDPTRRMG---SKMGATAIKRHQFFNGVNWA 424
+ +P KE A ++ + K+P +R+G S+ G AIK+H FF ++W
Sbjct: 210 HDDVLYPVWLSKE------AVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEIDWV 263
Query: 425 LL--RCAKPPFIPRPVTCRD 442
LL R KPPF P+ T RD
Sbjct: 264 LLEQRKIKPPFKPKIKTKRD 283
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 82.7 bits (205), Expect = 9e-18
Identities = 47/159 (29%), Positives = 73/159 (45%), Gaps = 16/159 (10%)
Query: 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIERE--I 139
DL ++ LG+G+ G V V + G A K + + N+ + +I RE I
Sbjct: 1 DDLEYLGELGAGNSGVVSKVLHRP----TGKIMAVKTI----RLEINEAIQKQILRELDI 52
Query: 140 LEMLDHPFLPTLYATL--DCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEV 197
L + P++ Y + C+ E+ GG L + ++ R E + A V
Sbjct: 53 LHKCNSPYIVGFYGAFYNNGDISICM--EYMDGGSLDKIL-KEVQGRIPERILGKIAVAV 109
Query: 198 VVALEFLH-MMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235
+ L +LH II+RD+KP N+LV S G I L DF +S
Sbjct: 110 LKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVS 148
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 1e-17
Identities = 53/153 (34%), Positives = 80/153 (52%), Gaps = 12/153 (7%)
Query: 87 VHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHP 146
+ LG G G VY K+K+ G AAKV++ + S + +E EIL +HP
Sbjct: 17 IGELGDGAFGKVY----KAKNKETGALAAAKVIETK---SEEELEDYMVEIEILATCNHP 69
Query: 147 FLPTLYATL--DCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFL 204
++ L D W ++ EFCPGG + + + D+ E ++ +++ AL++L
Sbjct: 70 YIVKLLGAFYWDGKLW--IMIEFCPGGAVDAI-MLELDRGLTEPQIQVICRQMLEALQYL 126
Query: 205 HMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLK 237
H M II+RDLK NVL+ DG I L DF +S K
Sbjct: 127 HSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAK 159
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 2e-17
Identities = 39/122 (31%), Positives = 62/122 (50%), Gaps = 5/122 (4%)
Query: 320 GTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFP- 378
GT+ Y+APEI+ E + VDW+ +G I+E+ G TPFK ++ + R LE
Sbjct: 156 GTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEV 215
Query: 379 --KEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGVNWALLRCA--KPPFI 434
+ + +KD+ L K P R+GS+ ++H+FF +N+ L PPF+
Sbjct: 216 KFEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTINFPRLEAGLIPPPFV 275
Query: 435 PR 436
P
Sbjct: 276 PD 277
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 2e-17
Identities = 44/124 (35%), Positives = 64/124 (51%), Gaps = 5/124 (4%)
Query: 319 VGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFP 378
VGT Y+APE+I+ E + + DWW LG I+E+ G +PF+ + V R E
Sbjct: 162 VGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQ 221
Query: 379 KEPS--VPGPAKDLIAQLLVKDPTRRMGSK-MGATAIKRHQFFNGVNWALLRC--AKPPF 433
+E S AK + LL K+P R+G + GA +K+H F +N+ L +PPF
Sbjct: 222 EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINFKRLEANMLEPPF 281
Query: 434 IPRP 437
P P
Sbjct: 282 CPDP 285
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 2e-17
Identities = 52/150 (34%), Positives = 79/150 (52%), Gaps = 12/150 (8%)
Query: 313 VRSMSFVGTHEYLAPEIIS----GEG-HGNAVDWWTLGIFIFELFYGTTPFKGIDHELTL 367
V+S VGT +Y++PEI+ G G +G DWW+LG+ ++E+ YG TPF T
Sbjct: 158 VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETY 217
Query: 368 ANVV--ARALEFPKE-PSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGVNWA 424
++ +FP V AKDLI Q L+ RR+G G K+H FF G++W
Sbjct: 218 GKIMNHEERFQFPSHITDVSEEAKDLI-QRLICSRERRLGQN-GIEDFKKHAFFEGIDWE 275
Query: 425 LLRCAKPPFIPRPVTCRDLTTTNSSIDNSI 454
+R + P+IP + D T+N +D+ +
Sbjct: 276 NIRNLEAPYIPDVSSPSD--TSNFDVDDDV 303
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 2e-17
Identities = 50/151 (33%), Positives = 74/151 (49%), Gaps = 12/151 (7%)
Query: 90 LGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLP 149
LG G G VY Q K G F AAK++ + S + +E +IL HP +
Sbjct: 13 LGDGAFGKVYKAQHK----ETGLFAAAKIIQ---IESEEELEDFMVEIDILSECKHPNIV 65
Query: 150 TLYATL--DCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMM 207
LY + W +L EFC GG L + + ++ E +R+ +++ AL FLH
Sbjct: 66 GLYEAYFYENKLW--ILIEFCDGGALDSIML-ELERGLTEPQIRYVCRQMLEALNFLHSH 122
Query: 208 GIIYRDLKPENVLVRSDGHIMLTDFDLSLKG 238
+I+RDLK N+L+ DG + L DF +S K
Sbjct: 123 KVIHRDLKAGNILLTLDGDVKLADFGVSAKN 153
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 80.8 bits (200), Expect = 3e-17
Identities = 34/110 (30%), Positives = 56/110 (50%), Gaps = 7/110 (6%)
Query: 312 DVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVV 371
D + S GT Y+APE++ +G+ AVDWW+LG+ +E G P++G H T+ + +
Sbjct: 153 DTLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRG--HSRTIRDQI 210
Query: 372 ARALEFPKEPSVPGPAK---DLIAQLLVKDPTRRMGSKMGATAIKRHQFF 418
E + D I +LL +DP +R+G + +K H +F
Sbjct: 211 RAKQETADVLYPATWSTEAIDAINKLLERDPQKRLGDNL--KDLKNHPYF 258
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 3e-17
Identities = 50/152 (32%), Positives = 75/152 (49%), Gaps = 16/152 (10%)
Query: 297 KLGNPGTPEIVAEPLDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTT 356
KL + G + P D S F GT Y+APEI+ GE +G +VDWW LG+ +FE+ G +
Sbjct: 136 KLTDYGMCKEGLRPGDTTST-FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRS 194
Query: 357 PFKGI---------DHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDPTRRMG--S 405
PF + + ++ + + P+ SV A ++ L KDP R+G
Sbjct: 195 PFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSV--KAASVLKSFLNKDPKERLGCHP 252
Query: 406 KMGATAIKRHQFFNGVNWALLRCAK--PPFIP 435
+ G I+ H FF V+W L+ + PPF P
Sbjct: 253 QTGFADIQGHPFFRNVDWDLMEQKQVVPPFKP 284
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 80.3 bits (199), Expect = 4e-17
Identities = 45/162 (27%), Positives = 73/162 (45%), Gaps = 13/162 (8%)
Query: 84 LRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIERE--ILE 141
L +LG G G VY +LK K A K + + +++ RE I+
Sbjct: 1 LTLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKE----DASEQQIEEFLREARIMR 56
Query: 142 MLDHPFLPTLY--ATLDCPRWSCLLTEFCPGGDLH-VLRQRQPDKRFHESAVRFYASEVV 198
LDHP + L T + P ++ E+ GGDL LR+ +P + S + +A ++
Sbjct: 57 KLDHPNVVKLLGVCTEEEPL--YIVMEYMEGGDLLSYLRKNRP--KLSLSDLLSFALQIA 112
Query: 199 VALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDN 240
+E+L I+RDL N LV + + ++DF LS +
Sbjct: 113 RGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYD 154
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 9e-17
Identities = 42/124 (33%), Positives = 62/124 (50%), Gaps = 5/124 (4%)
Query: 319 VGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFP 378
VGT Y+APE++ E + + DWW LG ++E+ G +PF+ ++ V E
Sbjct: 162 VGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQ 221
Query: 379 KEPS--VPGPAKDLIAQLLVKDPTRRMGSK-MGATAIKRHQFFNGVNWALLRCA--KPPF 433
+E S A+ L LL KDP R+G + GA +K H F +N+ L +PPF
Sbjct: 222 EEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQINFKRLEAGMLEPPF 281
Query: 434 IPRP 437
P P
Sbjct: 282 KPDP 285
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 79.1 bits (196), Expect = 1e-16
Identities = 43/157 (27%), Positives = 63/157 (40%), Gaps = 13/157 (8%)
Query: 84 LRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEM- 142
L +LG G G VY LK A K + K +E E M
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTL-KEGASEEEREE---FLEEASIMK 56
Query: 143 -LDHPFLPTLYA--TLDCPRWSCLLTEFCPGGDLHV-LRQRQPDKRFHESAVRFYASEVV 198
L HP + L T P ++TE+ PGGDL LR+ + + A ++
Sbjct: 57 KLSHPNIVRLLGVCTQGEP--LYIVTEYMPGGDLLDFLRKHGE--KLTLKDLLQMALQIA 112
Query: 199 VALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235
+E+L ++RDL N LV + + ++DF LS
Sbjct: 113 KGMEYLESKNFVHRDLAARNCLVTENLVVKISDFGLS 149
|
Length = 258 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 2e-16
Identities = 53/164 (32%), Positives = 87/164 (53%), Gaps = 12/164 (7%)
Query: 297 KLGNPGTPEIVAEPLDVRSMSFVGTHEYLAPEIIS----GEG-HGNAVDWWTLGIFIFEL 351
+L + G+ + E V+S VGT +Y++PEI+ G+G +G DWW+LG+ ++E+
Sbjct: 142 RLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEM 201
Query: 352 FYGTTPFKGIDHELTLANVV--ARALEFPKEPS-VPGPAKDLIAQLLVKDPTRRMGSKMG 408
YG TPF T ++ +FP + + V AKDLI +L+ R+G G
Sbjct: 202 LYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSEDAKDLIRRLICSR-EHRLGQN-G 259
Query: 409 ATAIKRHQFFNGVNWALLRCAKPPFIPRPVTCRDLTTTNSSIDN 452
K+H FF G++W +R + P+IP + D T+N +D+
Sbjct: 260 IEDFKQHPFFTGIDWDNIRNCEAPYIPEVSSPTD--TSNFDVDD 301
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 3e-16
Identities = 52/159 (32%), Positives = 81/159 (50%), Gaps = 12/159 (7%)
Query: 297 KLGNPGTPEIVAEPLDVRSMSFVGTHEYLAPEIISGEG----HGNAVDWWTLGIFIFELF 352
KL + GT + + VR + VGT +Y++PE++ +G +G DWW++G+F++E+
Sbjct: 182 KLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML 241
Query: 353 YGTTPFKGIDHELTLANVV--ARALEFPKEPSVPGPAKDLIAQLLVKDPTRRMGSKMGAT 410
G TPF T + ++ +L FP + + AK+LI L D R+G + G
Sbjct: 242 VGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLT-DREVRLG-RNGVE 299
Query: 411 AIKRHQFFNGVNWAL--LRCAKPPFIPRPVTCRDLTTTN 447
IKRH FF WA LR P +P D+ T+N
Sbjct: 300 EIKRHLFFKNDQWAWETLRDTVAPVVPD--LSSDIDTSN 336
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 6e-16
Identities = 51/159 (32%), Positives = 84/159 (52%), Gaps = 12/159 (7%)
Query: 297 KLGNPGTPEIVAEPLDVRSMSFVGTHEYLAPEIISGEG----HGNAVDWWTLGIFIFELF 352
KL + GT + E VR + VGT +Y++PE++ +G +G DWW++G+F+FE+
Sbjct: 182 KLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEML 241
Query: 353 YGTTPFKGIDHELTLANVV--ARALEFPKEPSVPGPAKDLIAQLLVKDPTRRMGSKMGAT 410
G TPF T + ++ +L FP++ + AK+LI L D R+G + G
Sbjct: 242 VGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISKHAKNLICAFLT-DREVRLG-RNGVE 299
Query: 411 AIKRHQFF--NGVNWALLRCAKPPFIPRPVTCRDLTTTN 447
IK+H FF + NW +R P +P + D+ ++N
Sbjct: 300 EIKQHPFFKNDQWNWDNIRETAAPVVPELSS--DIDSSN 336
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 1e-15
Identities = 43/149 (28%), Positives = 77/149 (51%), Gaps = 9/149 (6%)
Query: 90 LGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLP 149
LG G GSVY V+ S + F+A K +D + + +E A E IL ++HP +
Sbjct: 8 LGKGSYGSVYKVKRLSDNQ----FYALKEVDLGSMSQKERED-AVNEIRILASVNHPNII 62
Query: 150 TLY-ATLDCPRWSCLLTEFCPGGDL-HVLRQRQPDKR-FHESAVRFYASEVVVALEFLHM 206
+ A LD + C++ E+ P GDL + +R+ ++ E + +++ L+ LH
Sbjct: 63 SYKEAFLDGNKL-CIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE 121
Query: 207 MGIIYRDLKPENVLVRSDGHIMLTDFDLS 235
I++RDLK N+L+ ++ + + D +S
Sbjct: 122 QKILHRDLKSANILLVANDLVKIGDLGIS 150
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 74.9 bits (185), Expect = 3e-15
Identities = 43/162 (26%), Positives = 69/162 (42%), Gaps = 16/162 (9%)
Query: 90 LGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIERE--ILEMLDHPF 147
LG G G VY +LK K A K + + ++E R +E +++ L HP
Sbjct: 3 LGEGAFGEVYKGKLKGKD-GKTTEVAVKTLKEDA----SEEERKDFLKEARVMKKLGHPN 57
Query: 148 LPTLYATLDCPRWSCLLTEFCPGGDL-HVLRQRQPDKRFHESA-------VRFYASEVVV 199
+ L L+ E+ GGDL LR+ +P E + + F A ++
Sbjct: 58 VVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSF-AIQIAK 116
Query: 200 ALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNS 241
+E+L ++RDL N LV D + ++DF LS +
Sbjct: 117 GMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD 158
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.6 bits (184), Expect = 4e-15
Identities = 51/165 (30%), Positives = 77/165 (46%), Gaps = 18/165 (10%)
Query: 90 LGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREI--LEMLDHPF 147
+G G G VY K + G F A K + L +E+ I +EI L+ L HP
Sbjct: 8 IGRGAFGVVY----KGLNLETGDFVAIKQI---SLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 148 LPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFH---ESAVRFYASEVVVALEFL 204
+ +++ ++ E+ G L RQ K+F ES V Y +V+ L +L
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSL-----RQIIKKFGPFPESLVAVYVYQVLQGLAYL 115
Query: 205 HMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLK-GDNSTSTAQLV 248
H G+I+RD+K N+L DG + L DF ++ K D S A +V
Sbjct: 116 HEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVV 160
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 7e-15
Identities = 45/156 (28%), Positives = 73/156 (46%), Gaps = 9/156 (5%)
Query: 84 LRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREI--LE 141
L+F+ +LG G G V L + N G A K ++ S ++ R+ EREI L
Sbjct: 6 LKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLN----HSGEEQHRSDFEREIEILR 61
Query: 142 MLDHPFLPTL--YATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVV 199
LDH + R L+ E+ P G L QR D+ + + F +S++
Sbjct: 62 TLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLF-SSQICK 120
Query: 200 ALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235
+++L I+RDL N+LV S+ + ++DF L+
Sbjct: 121 GMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLA 156
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 8e-15
Identities = 70/329 (21%), Positives = 127/329 (38%), Gaps = 101/329 (30%)
Query: 90 LGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREI--LEMLDHPF 147
+G G G+VY + K G A K+++ + + + I+RE+ L L
Sbjct: 9 IGRGAYGAVY----RGKHVPTGRVVALKIIN----LDTPDDDVSDIQREVALLSQLRQSQ 60
Query: 148 LP--TLY--ATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEF 203
P T Y + L PR ++ E+ GG + L + P + S + EV+VAL++
Sbjct: 61 PPNITKYYGSYLKGPRL-WIIMEYAEGGSVRTLMKAGPIAEKYISVI---IREVLVALKY 116
Query: 204 LHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDC 263
+H +G+I+RD+K N+LV + G++ L DF ++ A L + S
Sbjct: 117 IHKVGVIHRDIKAANILVTNTGNVKLCDFGVA---------ALLNQNSS----------- 156
Query: 264 AVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNP--GTPEIVAEPLDVRSMSFVGT 321
+R +G P PE++ E
Sbjct: 157 -----------------------------KRSTFVGTPYWMAPEVITE------------ 175
Query: 322 HEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEP 381
G+ + D W+LGI I+E+ G P+ +D ++ ++ K P
Sbjct: 176 ----------GKYYDTKADIWSLGITIYEMATGNPPYSDVD-AFRAMMLIPKS----KPP 220
Query: 382 SVPGPA-----KDLIAQLLVKDPTRRMGS 405
+ ++ +A L ++P R+ +
Sbjct: 221 RLEDNGYSKLLREFVAACLDEEPKERLSA 249
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 9e-15
Identities = 43/126 (34%), Positives = 67/126 (53%), Gaps = 13/126 (10%)
Query: 319 VGTHEYLAPEIIS-GEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVAR---- 373
VGTH Y+APE++ G + ++ DW++LG +F+L G +PF+ H+ + + R
Sbjct: 156 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQ--HKTKDKHEIDRMTLT 213
Query: 374 -ALEFPKEPSVPGPAKDLIAQLLVKDPTRRMGSK-MGATAIKRHQFFNGVNW--ALLRCA 429
A+E P S + L+ LL +D RR+G GA +K H FF ++W L+
Sbjct: 214 MAVELPDSFSP--ELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQMVFLQKY 271
Query: 430 KPPFIP 435
PP IP
Sbjct: 272 PPPLIP 277
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 2e-14
Identities = 40/161 (24%), Positives = 78/161 (48%), Gaps = 8/161 (4%)
Query: 83 DLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEM 142
D ++++G G G V+ V K+ + +A K +D ++ R +E E +L
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKA----DKRVYAMKQIDLSKMNRREREEAID-EARVLAK 55
Query: 143 LDHPFLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAV-RFYASEVVVAL 201
LD ++ Y + ++ E+ GDLH L + Q + E V RF+ ++++ L
Sbjct: 56 LDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFI-QILLGL 114
Query: 202 EFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS-LKGDNS 241
LH I++RD+K N+ + + ++ + D ++ L DN+
Sbjct: 115 AHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT 155
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 72.6 bits (179), Expect = 3e-14
Identities = 46/172 (26%), Positives = 78/172 (45%), Gaps = 19/172 (11%)
Query: 62 AIKEATSEGNNNNNNNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDK 121
A+K+ SEG+ P L + + ++G G G VY K+ G A K M
Sbjct: 7 ALKDIVSEGD------PREL--YKNLEKIGEGASGEVY----KATDRATGKEVAIKKMR- 53
Query: 122 RELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWSCLLTEFCPGGDL-HVLRQRQ 180
+ + + E I++ HP + Y + ++ E+ GG L ++ Q
Sbjct: 54 ---LRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQN- 109
Query: 181 PDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDF 232
R +E + + EV+ LE+LH +I+RD+K +N+L+ DG + L DF
Sbjct: 110 -FVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADF 160
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 3e-14
Identities = 47/163 (28%), Positives = 76/163 (46%), Gaps = 9/163 (5%)
Query: 89 RLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFL 148
++G G G VY K++ G A K + R S A E ++L+ L+HP +
Sbjct: 6 KIGEGTYGVVY----KARDKLTGEIVAIKKIKLRFE-SEGIPKTALREIKLLKELNHPNI 60
Query: 149 PTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMG 208
L L+ EF +++ RQ + ES ++ Y +++ L F H G
Sbjct: 61 IKLLDVFRHKGDLYLVFEFMDTDLYKLIKDRQ--RGLPESLIKSYLYQLLQGLAFCHSHG 118
Query: 209 IIYRDLKPENVLVRSDGHIMLTDFDL--SLKGDNSTSTAQLVS 249
I++RDLKPEN+L+ ++G + L DF L S T +V+
Sbjct: 119 ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVT 161
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.2 bits (178), Expect = 4e-14
Identities = 45/156 (28%), Positives = 75/156 (48%), Gaps = 21/156 (13%)
Query: 87 VHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKE--SRARIEREI--LEM 142
+ ++G G G VY K+++ G A K + + KE I REI L+
Sbjct: 4 IAQIGEGTYGQVY----KARNKKTGELVALKKIR----MENEKEGFPITAI-REIKLLQK 54
Query: 143 LDHPFLPTLYA-TLDCPRWSC-LLTEFCPGGDLHVLRQ--RQPDKRFHESAVRFYASEVV 198
L HP + L + S ++ E+ H L P+ +F ES ++ Y +++
Sbjct: 55 LRHPNIVRLKEIVTSKGKGSIYMVFEYMD----HDLTGLLDSPEVKFTESQIKCYMKQLL 110
Query: 199 VALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDL 234
L++LH GI++RD+K N+L+ +DG + L DF L
Sbjct: 111 EGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGL 146
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.2 bits (175), Expect = 7e-14
Identities = 47/158 (29%), Positives = 71/158 (44%), Gaps = 23/158 (14%)
Query: 90 LGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEML-DHPFL 148
+G G G VY K++ G A K+MD E ++E + E IL +HP +
Sbjct: 14 IGEGTYGKVY----KARHKKTGQLVAIKIMDIIE----DEEEEIKEEYNILRKYSNHPNI 65
Query: 149 PTLY--------ATLDCPRWSCLLTEFCPGG---DLHVLRQRQPDKRFHESAVRFYASEV 197
T Y D W + E C GG DL V R+ KR E + + E
Sbjct: 66 ATFYGAFIKKNPPGNDDQLWLVM--ELCGGGSVTDL-VKGLRKKGKRLKEEWIAYILRET 122
Query: 198 VVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235
+ L +LH +I+RD+K +N+L+ + + L DF +S
Sbjct: 123 LRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVS 160
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 1e-13
Identities = 43/125 (34%), Positives = 67/125 (53%), Gaps = 11/125 (8%)
Query: 319 VGTHEYLAPEIIS-GEGHGNAVDWWTLGIFIFELFYGTTPFK----GIDHELTLANVVAR 373
VGTH Y+APE++ G + ++ DW++LG +F+L G +PF+ HE+ +
Sbjct: 156 VGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVN 215
Query: 374 ALEFPKEPSVPGPAKDLIAQLLVKDPTRRMGSK-MGATAIKRHQFFNGVNW--ALLRCAK 430
+E P S K L+ LL +D ++R+G GA +K H FF G++W L+
Sbjct: 216 -VELPD--SFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGIDWQQVYLQKYP 272
Query: 431 PPFIP 435
PP IP
Sbjct: 273 PPLIP 277
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.7 bits (174), Expect = 1e-13
Identities = 45/161 (27%), Positives = 71/161 (44%), Gaps = 22/161 (13%)
Query: 87 VHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIE--REI----- 139
+ +G G G+VY K++ N G F A K ++ E + REI
Sbjct: 4 LAEIGEGAYGTVY----KARDLNTGRFVALK-----KVRVPLSEEGIPLSTLREIALLKQ 54
Query: 140 LEMLDHPFLPTLYATLDCPRWS-----CLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYA 194
LE +HP + L PR L+ E DL + P ++
Sbjct: 55 LESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLM 113
Query: 195 SEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235
+++ ++FLH I++RDLKP+N+LV SDG + + DF L+
Sbjct: 114 RQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLA 154
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 70.0 bits (172), Expect = 2e-13
Identities = 44/176 (25%), Positives = 78/176 (44%), Gaps = 32/176 (18%)
Query: 89 RLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKE---SRARIERE-----IL 140
+G G G+V V+ KS +G K +D + + K+ S I RE I+
Sbjct: 7 TIGKGSFGTVRKVRRKS----DGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIV 62
Query: 141 EMLDHPFLP---TLYATLDCPRWSCLLTEFCPGGDLHVL--RQRQPDKRFHESAVRFYAS 195
D TLY ++ E+C GGDL L + ++ K E + +
Sbjct: 63 RYYDRIIDRSNQTLY----------IVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILT 112
Query: 196 EVVVALEFLHM-----MGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQ 246
++++AL H +++RDLKP N+ + ++ ++ L DF L+ + +S A+
Sbjct: 113 QLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAK 168
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 5e-13
Identities = 57/167 (34%), Positives = 87/167 (52%), Gaps = 21/167 (12%)
Query: 90 LGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRAR-------IEREI--L 140
+GSG GSVYL ++++G A K + EL S + S+ R + REI L
Sbjct: 8 IGSGSFGSVYL----GMNASSGELMAVK---QVELPSVSASSKDRKRSMLDALAREIALL 60
Query: 141 EMLDHP-FLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVV 199
+ L H + L ++LD + L E+ PGG + L F E+ VR + +++
Sbjct: 61 KELQHENIVQYLGSSLDADHLNIFL-EYVPGGSVAALLNNY--GAFEETLVRNFVRQILK 117
Query: 200 ALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGD-NSTSTA 245
L +LH GII+RD+K N+LV + G I ++DF +S K + NS ST
Sbjct: 118 GLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTK 164
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 5e-13
Identities = 55/162 (33%), Positives = 76/162 (46%), Gaps = 15/162 (9%)
Query: 87 VHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHP 146
+ LG G G VY K+++ G AAKV+D + S + +E +IL DHP
Sbjct: 10 IGELGDGAFGKVY----KAQNKETGVLAAAKVIDTK---SEEELEDYMVEIDILASCDHP 62
Query: 147 FLPTLYATLDCPRWSCLLTEFCPGG--DLHVLRQRQPDKRFHESAVRFYASEVVVALEFL 204
+ L +L EFC GG D +L +P E +R + + AL +L
Sbjct: 63 NIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP---LTEPQIRVVCKQTLEALNYL 119
Query: 205 HMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQ 246
H II+RDLK N+L DG I L DF +S K +T T Q
Sbjct: 120 HENKIIHRDLKAGNILFTLDGDIKLADFGVSAK---NTRTIQ 158
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 7e-13
Identities = 42/136 (30%), Positives = 68/136 (50%), Gaps = 14/136 (10%)
Query: 111 GCFFAAKVMDKRELVSRNKESRARIE--------REI--LEMLDHPFLPTLYATLDCPRW 160
G F AK + E V+ K + R+E REI L+ HP++ L
Sbjct: 14 GIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSG 73
Query: 161 SCLLTEFCPGGDLH-VLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENV 219
L+ E+ P DL VLR ++ E+ V+ Y ++ + ++H GI++RDLKP N+
Sbjct: 74 FVLVMEYMPS-DLSEVLRDE--ERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANL 130
Query: 220 LVRSDGHIMLTDFDLS 235
L+ +DG + + DF L+
Sbjct: 131 LISADGVLKIADFGLA 146
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 7e-13
Identities = 51/169 (30%), Positives = 80/169 (47%), Gaps = 13/169 (7%)
Query: 90 LGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRA-------RIEREILEM 142
+G G G VYL + + G A K ++ ++ +SR R E E L+
Sbjct: 9 IGKGTYGRVYL----ALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKD 64
Query: 143 LDHPFLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALE 202
LDH + + + E+ PGG + + RF E VRF+ +V+ L
Sbjct: 65 LDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTY--GRFEEQLVRFFTEQVLEGLA 122
Query: 203 FLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQLVSDQ 251
+LH GI++RDLK +N+LV +DG ++DF +S K D+ Q +S Q
Sbjct: 123 YLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQ 171
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 1e-12
Identities = 42/161 (26%), Positives = 83/161 (51%), Gaps = 6/161 (3%)
Query: 87 VHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHP 146
+ ++G G G +YL K+KS + C K +D ++ + KE+ ++ E +L + HP
Sbjct: 5 IKKIGEGSFGKIYLA--KAKSDSEHCVI--KEIDLTKMPVKEKEA-SKKEVILLAKMKHP 59
Query: 147 FLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHM 206
+ T +A+ ++ E+C GGDL RQ F E + + ++ + L+ +H
Sbjct: 60 NIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHD 119
Query: 207 MGIIYRDLKPENVLVRSDGHIM-LTDFDLSLKGDNSTSTAQ 246
I++RD+K +N+ + +G + L DF ++ + ++S A
Sbjct: 120 RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAY 160
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 1e-12
Identities = 43/150 (28%), Positives = 80/150 (53%), Gaps = 5/150 (3%)
Query: 88 HRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPF 147
RLG G G+VYLV+ K K+ K + EL + N+ +A E ++L LDHP
Sbjct: 6 QRLGKGSFGTVYLVKDK-KAVAEERLKVLKEIPVGEL-NPNETVQANQEAQLLSKLDHPA 63
Query: 148 LPTLYATLDCPRWSCLLTEFCPGGDL--HVLRQRQPDKRFHESAVRFYASEVVVALEFLH 205
+ +A+ C++TE+C G DL + + K E+ V + ++++ + ++H
Sbjct: 64 IVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH 123
Query: 206 MMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235
I++RDLK +N+ ++++ + + DF +S
Sbjct: 124 QRRILHRDLKAKNIFLKNN-LLKIGDFGVS 152
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 2e-12
Identities = 47/153 (30%), Positives = 70/153 (45%), Gaps = 14/153 (9%)
Query: 89 RLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIERE--ILEMLDHP 146
RLG G GSV +LK N G FA K + N + + +I RE I + P
Sbjct: 8 RLGEGAGGSVTKCRLK----NTGMIFALKTI----TTDPNPDLQKQILRELEINKSCKSP 59
Query: 147 FLPTLYATLDCPRWSCL--LTEFCPGGDLHVL--RQRQPDKRFHESAVRFYASEVVVALE 202
++ Y S + E+C GG L + + ++ R E + A V+ L
Sbjct: 60 YIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLS 119
Query: 203 FLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235
+LH II+RD+KP N+L+ G + L DF +S
Sbjct: 120 YLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVS 152
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.1 bits (162), Expect = 4e-12
Identities = 45/152 (29%), Positives = 73/152 (48%), Gaps = 19/152 (12%)
Query: 89 RLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREI--LEMLDHP 146
+G G G VY K +N A KV+D E ++ I++EI L P
Sbjct: 8 CIGKGSFGEVYKAI--DKRTNQVV--AIKVIDLEE----AEDEIEDIQQEIQFLSQCRSP 59
Query: 147 FLPTLYAT--LDCPRWSCLLTEFCPGGD-LHVLRQRQPDKRFHESAVRFYASEVVVALEF 203
++ Y + W ++ E+C GG L +L+ + E+ + F EV++ LE+
Sbjct: 60 YITKYYGSFLKGSKLW--IIMEYCGGGSCLDLLKPG----KLDETYIAFILREVLLGLEY 113
Query: 204 LHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235
LH G I+RD+K N+L+ +G + L DF +S
Sbjct: 114 LHEEGKIHRDIKAANILLSEEGDVKLADFGVS 145
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 5e-12
Identities = 42/152 (27%), Positives = 67/152 (44%), Gaps = 17/152 (11%)
Query: 86 FVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREI--LEML 143
+ +G G G V LK ++ G A K + E +++ + RE+ L L
Sbjct: 5 VLGVVGEGAYGVV----LKCRNKATGEIVAIKKFKESE---DDEDVKKTALREVKVLRQL 57
Query: 144 DHPFLPTLYATLDCPRWS---CLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVA 200
H + L + R L+ E+ L +L + P AVR Y +++ A
Sbjct: 58 RHENIVNL---KEAFRRKGRLYLVFEYVERTLLELL-EASP-GGLPPDAVRSYIWQLLQA 112
Query: 201 LEFLHMMGIIYRDLKPENVLVRSDGHIMLTDF 232
+ + H II+RD+KPEN+LV G + L DF
Sbjct: 113 IAYCHSHNIIHRDIKPENILVSESGVLKLCDF 144
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 2e-11
Identities = 48/158 (30%), Positives = 76/158 (48%), Gaps = 19/158 (12%)
Query: 83 DLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEM 142
D + R+GSG G VY K+++ N G A KV+ E A +++EI+ M
Sbjct: 10 DFELIQRIGSGTYGDVY----KARNVNTGELAAIKVIKLEP-----GEDFAVVQQEIIMM 60
Query: 143 LD--HPFLPTLYATL--DCPRWSCLLTEFCPGGDLH-VLRQRQPDKRFHESAVRFYASEV 197
D H + + + W C+ EFC GG L + P ES + + + E
Sbjct: 61 KDCKHSNIVAYFGSYLRRDKLWICM--EFCGGGSLQDIYHVTGP---LSESQIAYVSRET 115
Query: 198 VVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235
+ L +LH G ++RD+K N+L+ +GH+ L DF +S
Sbjct: 116 LQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVS 153
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 2e-11
Identities = 49/162 (30%), Positives = 74/162 (45%), Gaps = 12/162 (7%)
Query: 83 DLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEM 142
D+++ LG G+ G+VY K+ A KV+ V K+ + E EIL
Sbjct: 2 DIQYQEILGHGNGGTVY----KAYHLLTRRILAVKVIPLDITVELQKQIMS--ELEILYK 55
Query: 143 LDHPFLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALE 202
D P++ Y + TEF GG L V R + E + A VV L
Sbjct: 56 CDSPYIIGFYGAFFVENRISICTEFMDGGSLDVYR------KIPEHVLGRIAVAVVKGLT 109
Query: 203 FLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTST 244
+L + I++RD+KP N+LV + G + L DF +S + NS +
Sbjct: 110 YLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAK 151
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 63.4 bits (155), Expect = 3e-11
Identities = 33/112 (29%), Positives = 51/112 (45%), Gaps = 21/112 (18%)
Query: 315 SMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELT-------L 367
+ VGT ++APE+I+G+ + D W+LGI EL G P+ EL +
Sbjct: 154 RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPY----SELPPMKALFKI 209
Query: 368 ANVVARALEFPKEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATA--IKRHQF 417
A L P++ S KD + + L K+P +R TA + +H F
Sbjct: 210 ATNGPPGLRNPEKWSD--EFKDFLKKCLQKNPEKR------PTAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.7 bits (156), Expect = 3e-11
Identities = 42/162 (25%), Positives = 70/162 (43%), Gaps = 33/162 (20%)
Query: 87 VHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIE---------- 136
+ +LG G G VY K++ G A K + R++
Sbjct: 4 LEKLGEGTYGVVY----KARDKKTGEIVALKKI--------------RLDNEEEGIPSTA 45
Query: 137 -REI--LEMLDHPFLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFY 193
REI L+ L HP + L + R L+ E+C DL ++P + ++
Sbjct: 46 LREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRP-GPLSPNLIKSI 103
Query: 194 ASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235
+++ L + H I++RDLKP+N+L+ DG + L DF L+
Sbjct: 104 MYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLA 145
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 4e-11
Identities = 83/349 (23%), Positives = 132/349 (37%), Gaps = 107/349 (30%)
Query: 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILE 141
S L ++G G G V + KS G A K MD R+ ++ R + E++
Sbjct: 19 SYLDNFVKIGEGSTGIVCIATDKS----TGRQVAVKKMDLRK-----QQRRELLFNEVVI 69
Query: 142 MLD--HPFLPTLYAT--LDCPRWSCLLTEFCPGGDL-HVLRQRQPDKRFHESAVRFYASE 196
M D HP + +Y++ + W ++ EF GG L ++ R +E +
Sbjct: 70 MRDYQHPNIVEMYSSYLVGDELW--VVMEFLEGGALTDIVTH----TRMNEEQIATVCLA 123
Query: 197 VVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQLVSDQSPPTG 256
V+ AL FLH G+I+RD+K +++L+ SDG + L+DF AQ+ +
Sbjct: 124 VLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGF---------CAQVSKE------ 168
Query: 257 DQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNP--GTPEIVAEPLDVR 314
VP RRK +G P PE+++
Sbjct: 169 -------------------------VP---------RRKSLVGTPYWMAPEVISR----- 189
Query: 315 SMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARA 374
+G VD W+LGI + E+ G P+ + A R
Sbjct: 190 ------------------LPYGTEVDIWSLGIMVIEMVDGEPPY--FNEPPLQAMKRIRD 229
Query: 375 LEFP--KEPSVPGPA-KDLIAQLLVKDPTRRMGSKMGATAIK--RHQFF 418
P K P + + ++LV+DP +R ATA + H F
Sbjct: 230 NLPPKLKNLHKVSPRLRSFLDRMLVRDPAQR------ATAAELLNHPFL 272
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.9 bits (154), Expect = 5e-11
Identities = 42/147 (28%), Positives = 69/147 (46%), Gaps = 6/147 (4%)
Query: 89 RLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFL 148
+LG G GSVYL + K G A K M K++ S + R + + ++ +HP +
Sbjct: 6 QLGDGTFGSVYLARNKE----TGELVAIKKM-KKKFYSWEECMNLREVKSLRKLNEHPNI 60
Query: 149 PTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMG 208
L + E+ G +++ R+ K F ES +R +++ L +H G
Sbjct: 61 VKLKEVFRENDELYFVFEYMEGNLYQLMKDRKG-KPFSESVIRSIIYQILQGLAHIHKHG 119
Query: 209 IIYRDLKPENVLVRSDGHIMLTDFDLS 235
+RDLKPEN+LV + + DF L+
Sbjct: 120 FFHRDLKPENLLVSGPEVVKIADFGLA 146
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 62.3 bits (152), Expect = 5e-11
Identities = 42/160 (26%), Positives = 68/160 (42%), Gaps = 24/160 (15%)
Query: 83 DLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREI--L 140
+ +LG G GSVY K+ G A KV+ +E I +EI L
Sbjct: 4 VFDILEKLGEGSYGSVY----KAIHKETGQVVAIKVV-------PVEEDLQEIIKEISIL 52
Query: 141 EMLDHPFLPTLYATL--DCPRWSCLLTEFCPGG---DLHVLRQRQPDKRFHESAVRFYAS 195
+ D P++ Y + + W ++ E+C G D+ + K E +
Sbjct: 53 KQCDSPYIVKYYGSYFKNTDLW--IVMEYCGAGSVSDIMKITN----KTLTEEEIAAILY 106
Query: 196 EVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235
+ + LE+LH I+RD+K N+L+ +G L DF +S
Sbjct: 107 QTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVS 146
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 6e-11
Identities = 45/166 (27%), Positives = 69/166 (41%), Gaps = 14/166 (8%)
Query: 89 RLGSGDIGSVYLVQLKSKSSNNGCF-FAAKVMDKRELVSRNKESRARIEREILEMLDHPF 147
+LG G G V + + +S A K + K + +S + + E I+ LDH
Sbjct: 2 KLGDGSFGVVR--RGEWSTSGGKVIPVAVKCL-KSDKLSDIMDDFLK-EAAIMHSLDHEN 57
Query: 148 LPTLYA-TLDCPRWSCLLTEFCPGGDL-HVLRQRQPDKRFHESAVRFYASEVVVALEFLH 205
L LY L P ++TE P G L LR+ F S + YA ++ + +L
Sbjct: 58 LIRLYGVVLTHP--LMMVTELAPLGSLLDRLRKDALGH-FLISTLCDYAVQIANGMRYLE 114
Query: 206 MMGIIYRDLKPENVLVRSDGHIMLTDFDLS----LKGDNSTSTAQL 247
I+RDL N+L+ SD + + DF L D+ L
Sbjct: 115 SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHL 160
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.3 bits (152), Expect = 6e-11
Identities = 46/172 (26%), Positives = 72/172 (41%), Gaps = 26/172 (15%)
Query: 81 LSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREIL 140
D + R+GSG G VY K++ G A KV+ + I++EI
Sbjct: 2 QEDYELIQRIGSGTYGDVY----KARDIATGELVAIKVIKLEP-----GDDFEIIQQEI- 51
Query: 141 EML---DHPFLPTLYAT--LDCPRWSCLLTEFCPGGDL----HVLRQRQPDKRFHESAVR 191
ML HP + + + W + E+C GG L V R E +
Sbjct: 52 SMLKECRHPNIVAYFGSYLRRDKLWIVM--EYCGGGSLQDIYQVTRGPLS-----ELQIA 104
Query: 192 FYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTS 243
+ E + L +LH G I+RD+K N+L+ DG + L DF +S + + +
Sbjct: 105 YVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA 156
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 1e-10
Identities = 47/160 (29%), Positives = 70/160 (43%), Gaps = 7/160 (4%)
Query: 90 LGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESR-ARIEREILEMLDHPFL 148
LG G G L + S K ++ L KE R A E IL +L HP +
Sbjct: 8 LGKGAFGEATLYRRTEDDS----LVVWKEVNLTRLSE--KERRDALNEIVILSLLQHPNI 61
Query: 149 PTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMG 208
Y + E+ GG L+ RQ + F E V +Y ++V A+ ++H G
Sbjct: 62 IAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG 121
Query: 209 IIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQLV 248
I++RD+K N+ + G I L DF +S + S A+ V
Sbjct: 122 ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETV 161
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 1e-10
Identities = 42/159 (26%), Positives = 68/159 (42%), Gaps = 14/159 (8%)
Query: 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILE 141
++L + LGSG G+VY + A KV+ + NKE I E
Sbjct: 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKE----ILDEAYV 62
Query: 142 M--LDHPFLPTLYATLDCPRWS-CLLTEFCPGGDL--HVLRQRQPDKRFHESAVRFYASE 196
M +DHP + L C L+T+ P G L +V R + + +
Sbjct: 63 MASVDHPHVVRLLGI--CLSSQVQLITQLMPLGCLLDYV---RNHKDNIGSQYLLNWCVQ 117
Query: 197 VVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235
+ + +L +++RDL NVLV++ H+ +TDF L+
Sbjct: 118 IAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLA 156
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 1e-10
Identities = 47/158 (29%), Positives = 70/158 (44%), Gaps = 15/158 (9%)
Query: 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIERE--I 139
DL + LG+G+ GSV V K G A KV+ + R +I RE I
Sbjct: 5 EDLETISDLGAGNGGSVSKV----KHIPTGTVMAKKVV----HIGAKSSVRKQILRELQI 56
Query: 140 LEMLDHPFLPTLYATLDCPRWSCLLTEFCPGGDLH-VLRQRQPDKRFHESAVRFYASEVV 198
+ P++ + Y C+ EF G L + ++ P + A VV
Sbjct: 57 MHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGP---IPVEILGKIAVAVV 113
Query: 199 VALEFLH-MMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235
L +L+ + I++RD+KP N+LV S G I L DF +S
Sbjct: 114 EGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVS 151
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 4e-10
Identities = 50/176 (28%), Positives = 76/176 (43%), Gaps = 31/176 (17%)
Query: 90 LGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRN--KESRARIEREILEM----- 142
LGSG G VY V+ K +N A K ++ +E I + E+
Sbjct: 8 LGSGAFGCVYKVR---KKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKE 64
Query: 143 -LDHP--------FLPT--LYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVR 191
L HP FL LY +D L E P G+ H ++ +RF E +
Sbjct: 65 QLRHPNIVRYYKTFLENDRLYIVMD-------LIEGAPLGE-HFNSLKEKKQRFTEERIW 116
Query: 192 FYASEVVVALEFLHM-MGIIYRDLKPENVLVRSDGHIMLTDFDLS-LKGDNSTSTA 245
++V+AL +LH I++RDL P N+++ D + +TDF L+ K S T+
Sbjct: 117 NIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTS 172
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 5e-10
Identities = 43/172 (25%), Positives = 67/172 (38%), Gaps = 17/172 (9%)
Query: 79 LTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGC-FFAAKVMDKRELVSRNKESRARIER 137
+ LS +RF+ LG G G VY +L + A K + + +E R E
Sbjct: 2 IPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQ--EA 59
Query: 138 EILEMLDHPFLPTLYATLDCPRWSCLLTEFCPGGDLH---VLRQRQPDKRFHESAVRFY- 193
E++ L HP + L + +C+L E+ GDLH V D
Sbjct: 60 ELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKS 119
Query: 194 ----------ASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235
A ++ +E+L ++RDL N LV + ++DF LS
Sbjct: 120 SLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLS 171
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 5e-10
Identities = 48/171 (28%), Positives = 82/171 (47%), Gaps = 14/171 (8%)
Query: 66 ATSEGNNNNNNNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVM-DKREL 124
++S + + + +LS+L V+R+GSG G+VY V + G +A KV+ E
Sbjct: 58 SSSSASGSAPSAAKSLSELERVNRIGSGAGGTVYKVIHRP----TGRLYALKVIYGNHED 113
Query: 125 VSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKR 184
R + R E EIL ++HP + + D +L EF GG L
Sbjct: 114 TVRRQICR---EIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHI------ 164
Query: 185 FHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235
E + A +++ + +LH I++RD+KP N+L+ S ++ + DF +S
Sbjct: 165 ADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVS 215
|
Length = 353 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 7e-10
Identities = 38/149 (25%), Positives = 74/149 (49%), Gaps = 5/149 (3%)
Query: 87 VHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHP 146
V ++G G G LV KS +G + K ++ ++ + +E +R E +L + HP
Sbjct: 5 VKKIGEGSFGKAILV----KSKEDGKQYVIKEINISKMSPKERE-ESRKEVAVLSNMKHP 59
Query: 147 FLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHM 206
+ + + ++ ++C GGDL+ Q F E + + ++ +AL+ +H
Sbjct: 60 NIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHD 119
Query: 207 MGIIYRDLKPENVLVRSDGHIMLTDFDLS 235
I++RD+K +N+ + DG I L DF ++
Sbjct: 120 RKILHRDIKSQNIFLTKDGTIKLGDFGIA 148
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 8e-10
Identities = 39/152 (25%), Positives = 77/152 (50%), Gaps = 16/152 (10%)
Query: 90 LGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKR---ELVSRNKESRARIEREILEMLDHP 146
+G G G V+L + K+ V+ K+ E +++++ A+ E ++L++L HP
Sbjct: 8 VGRGAFGIVHLCRRKADQ--------KLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHP 59
Query: 147 FLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHM 206
+ Y + ++ E+ PGG L Q++ + E + + ++++AL +H
Sbjct: 60 NIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHT 119
Query: 207 MGIIYRDLKPENVLVRSDGHIM---LTDFDLS 235
I++RDLK +N+L+ D H M + DF +S
Sbjct: 120 KLILHRDLKTQNILL--DKHKMVVKIGDFGIS 149
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 8e-10
Identities = 44/167 (26%), Positives = 72/167 (43%), Gaps = 19/167 (11%)
Query: 84 LRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEML 143
V +G+G G VY K + G A KVMD V+ ++E ++E +L+
Sbjct: 18 FELVEVVGNGTYGQVY----KGRHVKTGQLAAIKVMD----VTEDEEEEIKLEINMLKKY 69
Query: 144 DH---------PFLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYA 194
H F+ D W L+ EFC G + L + E + +
Sbjct: 70 SHHRNIATYYGAFIKKSPPGHDDQLW--LVMEFCGAGSVTDLVKNTKGNALKEDWIAYIC 127
Query: 195 SEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNS 241
E++ L LH +I+RD+K +NVL+ + + L DF +S + D +
Sbjct: 128 REILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT 174
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 58.7 bits (143), Expect = 9e-10
Identities = 31/102 (30%), Positives = 49/102 (48%), Gaps = 5/102 (4%)
Query: 320 GTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFK-GIDHELTLANVVAR-ALEF 377
GT +Y +PE I G + + DWW +G+ +EL G PFK D EL L +++ R +
Sbjct: 168 GTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKL 227
Query: 378 PKEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFN 419
P +V A D + +L + R+ + I +H F
Sbjct: 228 PFIKNVSKNANDFVQSMLKYNINYRLTN---YNEIIKHPFLK 266
|
Length = 267 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 58.3 bits (142), Expect = 1e-09
Identities = 29/87 (33%), Positives = 48/87 (55%), Gaps = 3/87 (3%)
Query: 317 SFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALE 376
+ VGT YL+PE+ + + D W+LG ++EL PF+G ++ L LA + + +
Sbjct: 162 TVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEG-ENLLELALKILKG-Q 219
Query: 377 FPKEPSVPGPA-KDLIAQLLVKDPTRR 402
+P PS ++L++ LL KDP R
Sbjct: 220 YPPIPSQYSSELRNLVSSLLQKDPEER 246
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 1e-09
Identities = 32/114 (28%), Positives = 46/114 (40%), Gaps = 13/114 (11%)
Query: 316 MSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELT-----LANV 370
+FVGT Y+APE I G + D W+LG+ + EL G P+ + L +
Sbjct: 157 KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYI 216
Query: 371 VARALEFPKEPS--VPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGVN 422
V P+ PS +D + L+KDP R K + H F
Sbjct: 217 VNE--PPPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKE----LLEHPFIKKYE 264
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 1e-09
Identities = 41/153 (26%), Positives = 74/153 (48%), Gaps = 10/153 (6%)
Query: 86 FVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDH 145
FV +G G G V LV+ ++ + K ++ R R +++ A E ++L L H
Sbjct: 4 FVRVVGKGSYGEVSLVRHRTDGKQ----YVIKKLNLRNASRRERKA-AEQEAQLLSQLKH 58
Query: 146 PFLPTLYATL---DCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALE 202
P + + D + ++ FC GGDL+ + Q K E+ V + ++ +AL+
Sbjct: 59 PNIVAYRESWEGEDGLLY--IVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQ 116
Query: 203 FLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235
+LH I++RDLK +NV + I + D ++
Sbjct: 117 YLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIA 149
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 58.0 bits (141), Expect = 2e-09
Identities = 39/142 (27%), Positives = 58/142 (40%), Gaps = 20/142 (14%)
Query: 281 IVPAVSCLHPKRR---RKKKLGN-----PGTPEI-------VAEPLDVRSMSFVGTHEYL 325
I+ + LH KR R K N G +I V E + +FVGT Y+
Sbjct: 108 ILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYM 167
Query: 326 APEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPG 385
+PE I GE + A D W+LG+ + E G PF + + ++ + P
Sbjct: 168 SPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPG-QPSFFELMQAICDGPPPSLPAE 226
Query: 386 PA----KDLIAQLLVKDPTRRM 403
+D I+ L KDP +R
Sbjct: 227 EFSPEFRDFISACLQKDPKKRP 248
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.0 bits (141), Expect = 2e-09
Identities = 33/94 (35%), Positives = 43/94 (45%), Gaps = 16/94 (17%)
Query: 317 SFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARAL- 375
+FVGT ++APE+I G+ D W+LGI EL G P + R L
Sbjct: 157 TFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHP--------MRVLF 208
Query: 376 EFPKE--PSVPG-----PAKDLIAQLLVKDPTRR 402
PK PS+ G P KD ++ L KDP R
Sbjct: 209 LIPKNNPPSLEGNKFSKPFKDFVSLCLNKDPKER 242
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 2e-09
Identities = 45/156 (28%), Positives = 70/156 (44%), Gaps = 10/156 (6%)
Query: 84 LRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREI--LE 141
L+F+ +LG G+ GSV L + N G A K +L E EREI L+
Sbjct: 6 LKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVK-----KLQHSTAEHLRDFEREIEILK 60
Query: 142 MLDHPFLPTLYATLDCP--RWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVV 199
L H + R L+ E+ P G L Q+ ++ H + YAS++
Sbjct: 61 SLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLL-LYASQICK 119
Query: 200 ALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235
+E+L ++RDL N+LV S+ + + DF L+
Sbjct: 120 GMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLT 155
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 58.4 bits (142), Expect = 2e-09
Identities = 44/163 (26%), Positives = 73/163 (44%), Gaps = 36/163 (22%)
Query: 85 RFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKR----ELVSRNKESRARIEREIL 140
+ + ++G G V LK++S G ++A K M K E V+ +E +A L
Sbjct: 2 KILGKIGEGTFSEV----LKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQA------L 51
Query: 141 EML-DHPFLPTLYATLDCPRWSCL----------LTEFCPGGDLHVLRQRQPDKRFHESA 189
L HP + L L + L L E G +++P E
Sbjct: 52 RRLSPHPNILRLIEVLFDRKTGRLALVFELMDMNLYELIKG-------RKRP---LPEKR 101
Query: 190 VRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDF 232
V+ Y +++ +L+ +H GI +RD+KPEN+L++ D + L DF
Sbjct: 102 VKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKDD-ILKLADF 143
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.9 bits (138), Expect = 4e-09
Identities = 30/94 (31%), Positives = 44/94 (46%), Gaps = 9/94 (9%)
Query: 317 SFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALE 376
S VGT ++APE+I G A D W+LG + EL G P+ ++L + R ++
Sbjct: 158 SVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPY----YDLNPMAALFRIVQ 213
Query: 377 FPKEPSVPG----PAKDLIAQLLVKDPTRRMGSK 406
P +P KD + Q KDP R +K
Sbjct: 214 -DDHPPLPEGISPELKDFLMQCFQKDPNLRPTAK 246
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 4e-09
Identities = 42/159 (26%), Positives = 68/159 (42%), Gaps = 30/159 (18%)
Query: 90 LGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSR-------NKESRARI-----ER 137
LG G G VYL C+ V REL + + E++ + E
Sbjct: 10 LGQGAFGRVYL-----------CY---DVDTGRELAVKQVPFDPDSPETKKEVNALECEI 55
Query: 138 EILEMLDHPFLPTLYATLDCPRWSCLLTEFCPGGDLH-VLRQRQPDKRFHESAVRFYASE 196
++L+ L H + Y L + E+ PGG + L+ E+ R Y +
Sbjct: 56 QLLKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGA---LTETVTRKYTRQ 112
Query: 197 VVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235
++ +E+LH I++RD+K N+L S G++ L DF S
Sbjct: 113 ILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGAS 151
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 4e-09
Identities = 33/144 (22%), Positives = 63/144 (43%), Gaps = 9/144 (6%)
Query: 91 GSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEM--LDHPFL 148
D+ V+L K K +N + K L S +KE +++EI+ L HP +
Sbjct: 9 CFEDLMIVHLA--KHKPTNT-----LVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNI 61
Query: 149 PTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMG 208
+ +++ G L + + E A+ F +V+ AL+++H G
Sbjct: 62 LPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKG 121
Query: 209 IIYRDLKPENVLVRSDGHIMLTDF 232
I+R +K ++L+ DG ++L+
Sbjct: 122 FIHRSVKASHILLSGDGKVVLSGL 145
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 4e-09
Identities = 29/72 (40%), Positives = 41/72 (56%), Gaps = 6/72 (8%)
Query: 163 LLTEFCPGGDL--HVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVL 220
L+ + GG L H+ + E V+ +A+E+VVAL+ LH GI+ RDL P N+L
Sbjct: 62 LVLQHAEGGKLWSHISKF----LNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNIL 117
Query: 221 VRSDGHIMLTDF 232
+ GHI LT F
Sbjct: 118 LDDRGHIQLTYF 129
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 56.3 bits (135), Expect = 7e-09
Identities = 44/167 (26%), Positives = 72/167 (43%), Gaps = 19/167 (11%)
Query: 84 LRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEML 143
V +G+G G VY K + G A KVMD V+ ++E + E +L+
Sbjct: 8 FELVELVGNGTYGQVY----KGRHVKTGQLAAIKVMD----VTGDEEEEIKQEINMLKKY 59
Query: 144 DH---------PFLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYA 194
H F+ +D W L+ EFC G + L + E + +
Sbjct: 60 SHHRNIATYYGAFIKKNPPGMDDQLW--LVMEFCGAGSVTDLIKNTKGNTLKEEWIAYIC 117
Query: 195 SEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNS 241
E++ L LH +I+RD+K +NVL+ + + L DF +S + D +
Sbjct: 118 REILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT 164
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 56.4 bits (137), Expect = 1e-08
Identities = 35/135 (25%), Positives = 60/135 (44%), Gaps = 32/135 (23%)
Query: 134 RIEREI--LEMLDHP--------FLP-------TLYATLDCPRWSCLLTEFCPGGDLH-V 175
RI REI L L H P +Y ++TE DLH V
Sbjct: 45 RILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY----------IVTELMET-DLHKV 93
Query: 176 LRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235
++ QP + ++++ +++ L++LH +I+RDLKP N+LV S+ + + DF L+
Sbjct: 94 IKSPQP---LTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLA 150
Query: 236 LKGDNSTSTAQLVSD 250
D +++
Sbjct: 151 RGVDPDEDEKGFLTE 165
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 1e-08
Identities = 49/167 (29%), Positives = 77/167 (46%), Gaps = 24/167 (14%)
Query: 78 PLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIER 137
P L+DL + +GSG G VY ++ K A K M + + NKE RI
Sbjct: 11 PADLNDLENLGEIGSGTCGQVYKMRFKKTGH----VMAVKQMRR----TGNKEENKRILM 62
Query: 138 EILEML---DHPFLPTLYATL--DCPRWSCL-LTEFCPGGDLHVLRQRQPDKRFHESAVR 191
++ +L D P++ Y D + C+ L C D + R + P E +
Sbjct: 63 DLDVVLKSHDCPYIVKCYGYFITDSDVFICMELMSTC--LDKLLKRIQGP---IPEDILG 117
Query: 192 FYASEVVVALEFL---HMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235
+V AL +L H G+I+RD+KP N+L+ + G++ L DF +S
Sbjct: 118 KMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGIS 162
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 1e-08
Identities = 63/247 (25%), Positives = 92/247 (37%), Gaps = 85/247 (34%)
Query: 166 EFCPGGDLH-VLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSD 224
E PGG L +LR + + +E + FY +++ L++LH I++RD+
Sbjct: 85 EQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDI---------- 134
Query: 225 GHIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPA 284
KGDN LV+ S G + +D FG S
Sbjct: 135 ------------KGDNV-----LVNTYS---GVVKISD-------FGTS----------- 156
Query: 285 VSCLHPKRRRKKKLG--NPGTPEIVAEPLDVRSMSFVGTHEYLAPEIISG--EGHGNAVD 340
K+L NP T +F GT +Y+APE+I G+G D
Sbjct: 157 -----------KRLAGINPCTE------------TFTGTLQYMAPEVIDKGPRGYGAPAD 193
Query: 341 WWTLGIFIFELFYGTTPFKGIDHELTLANVVA-RALEFPKEPSVP----GPAKDLIAQLL 395
W+LG I E+ G PF EL + F P +P AK+ I +
Sbjct: 194 IWSLGCTIVEMATGKPPF----IELGEPQAAMFKVGMFKIHPEIPESLSAEAKNFILRCF 249
Query: 396 VKDPTRR 402
DP +R
Sbjct: 250 EPDPDKR 256
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 2e-08
Identities = 33/97 (34%), Positives = 49/97 (50%), Gaps = 11/97 (11%)
Query: 317 SFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPF-------KGIDHELTLAN 369
+FVGT Y++PE I G + D W+LGI I EL G PF G D + + +
Sbjct: 161 TFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILD 220
Query: 370 VVARAL--EFPKEPS--VPGPAKDLIAQLLVKDPTRR 402
++ + + P+ PS P +D + L+KDPT R
Sbjct: 221 LLQQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTER 257
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 2e-08
Identities = 39/102 (38%), Positives = 51/102 (50%), Gaps = 19/102 (18%)
Query: 324 YLAPEI--ISGEGHGNAVDWWTLGIFIFELFYGTTPFK----GIDHELTLANVVARALEF 377
Y APE+ IS E A DWW+LG +FEL G T + GI+ T L
Sbjct: 148 YCAPEVGGISEETE--ACDWWSLGAILFELLTGKTLVECHPSGINTHTT--------LNI 197
Query: 378 PKEPSVPGPAKDLIAQLLVKDPTRRMGSKM-GATAIKRHQFF 418
P+ V A+ L+ QLL +PT R+G+ + G IK H FF
Sbjct: 198 PE--WVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 2e-08
Identities = 41/150 (27%), Positives = 71/150 (47%), Gaps = 10/150 (6%)
Query: 89 RLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREI--LEMLDHP 146
++G G VY K+ +G A K + E++ + ++R +EI L+ LDHP
Sbjct: 9 KIGKGQFSVVY----KAICLLDGRVVALKKVQIFEMM--DAKARQDCLKEIDLLKQLDHP 62
Query: 147 FLPTLYATLDCPRWSCLLTEFCPGGDL-HVLRQRQPDKR-FHESAVRFYASEVVVALEFL 204
+ A+ ++ E GDL +++ + KR E + Y ++ ALE +
Sbjct: 63 NVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHM 122
Query: 205 HMMGIIYRDLKPENVLVRSDGHIMLTDFDL 234
H I++RD+KP NV + + G + L D L
Sbjct: 123 HSKRIMHRDIKPANVFITATGVVKLGDLGL 152
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 2e-08
Identities = 82/359 (22%), Positives = 126/359 (35%), Gaps = 119/359 (33%)
Query: 87 VHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMD-----KRELVSRNKESRARIEREILE 141
++G G G+VY + G A K M+ K+EL I EIL
Sbjct: 24 FEKIGQGASGTVYT----AIDVATGQEVAIKQMNLQQQPKKEL----------IINEILV 69
Query: 142 M--LDHP-FLPTLYATLDCPR-WSCLLTEFCPGGDL-HVLRQRQPDKRFHESAVRFYASE 196
M HP + L + L W ++ E+ GG L V+ + D E + E
Sbjct: 70 MRENKHPNIVNYLDSYLVGDELW--VVMEYLAGGSLTDVVTETCMD----EGQIAAVCRE 123
Query: 197 VVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQLVSDQSPPTG 256
+ ALEFLH +I+RD+K +N+L+ DG + LTDF AQ+ +QS
Sbjct: 124 CLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGF---------CAQITPEQS---- 170
Query: 257 DQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNP--GTPEIVAEPLDVR 314
+R +G P PE+V
Sbjct: 171 ------------------------------------KRSTMVGTPYWMAPEVVTR----- 189
Query: 315 SMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVAR- 373
+ +G VD W+LGI E+ G P+ ++ L ++A
Sbjct: 190 ------------------KAYGPKVDIWSLGIMAIEMVEGEPPYLN-ENPLRALYLIATN 230
Query: 374 -ALEFPKEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGVNWALLRCAKP 431
E + +D + + L D +R A + +H F L+ AKP
Sbjct: 231 GTPELQNPEKLSAIFRDFLNRCLEMDVEKR----GSAKELLQHPF--------LKIAKP 277
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 2e-08
Identities = 36/148 (24%), Positives = 62/148 (41%), Gaps = 6/148 (4%)
Query: 88 HRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPF 147
LG G+ GSV KS A K + + + + KE E ++ LDHP
Sbjct: 1 KELGHGNFGSVVKGVYLMKS-GKEVEVAVKTLKQEHIAAGKKEFLR--EASVMAQLDHPC 57
Query: 148 LPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMM 207
+ L L+ E P G L +++ + S ++ A +V + + +L
Sbjct: 58 IVRLIGVCKGEPL-MLVMELAPLGPLLKYLKKRRE--IPVSDLKELAHQVAMGMAYLESK 114
Query: 208 GIIYRDLKPENVLVRSDGHIMLTDFDLS 235
++RDL NVL+ + ++DF +S
Sbjct: 115 HFVHRDLAARNVLLVNRHQAKISDFGMS 142
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 3e-08
Identities = 53/189 (28%), Positives = 84/189 (44%), Gaps = 31/189 (16%)
Query: 77 NPLTLSDLRFVHRLGSGDIGSVYLVQLKS------KSSNNGCFFAAKVMDKRELVSRNKE 130
NP S+L F+ LGSG G V+L + ++ K+ N G ++
Sbjct: 2 NP---SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIE---------- 48
Query: 131 SRARIEREILEMLDHPFLPTLYATLDCPRWSCLLTEFCPGGDL-HVLRQRQPDKRFHESA 189
E +++ L HP L LY + ++TEF G L + LRQRQ + +
Sbjct: 49 -----EAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQ--GKLSKDM 101
Query: 190 VRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS--LKGDN--STSTA 245
+ +V +E+L I+RDL N LV S G + ++DF ++ + D S+S A
Sbjct: 102 LLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGA 161
Query: 246 QLVSDQSPP 254
+ SPP
Sbjct: 162 KFPVKWSPP 170
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 53.7 bits (130), Expect = 5e-08
Identities = 30/95 (31%), Positives = 49/95 (51%), Gaps = 3/95 (3%)
Query: 142 MLDHPFLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVAL 201
M D+P LY ++ + L+ ++ GDL L ++ + + E+ V+ ++V AL
Sbjct: 65 MKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKK--EGKLSEAEVKKIIRQLVEAL 122
Query: 202 EFLHMMGIIYRDLKPENVL-VRSDGHIMLTDFDLS 235
LH II+ D+K ENVL R+ I L D+ L
Sbjct: 123 NDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLC 157
|
Length = 267 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 6e-08
Identities = 34/143 (23%), Positives = 66/143 (46%), Gaps = 6/143 (4%)
Query: 90 LGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLP 149
+G G G LVQ + +A K + R S + +R E +L + HP +
Sbjct: 8 VGEGSFGRALLVQHVNSDQK----YAMK--EIRLPKSSSAVEDSRKEAVLLAKMKHPNIV 61
Query: 150 TLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGI 209
+ + ++ E+C GGDL + Q K F E + + ++ + ++ +H +
Sbjct: 62 AFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRV 121
Query: 210 IYRDLKPENVLVRSDGHIMLTDF 232
++RD+K +N+ + +G + L DF
Sbjct: 122 LHRDIKSKNIFLTQNGKVKLGDF 144
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 6e-08
Identities = 32/98 (32%), Positives = 47/98 (47%), Gaps = 4/98 (4%)
Query: 137 REI--LEMLDHPFLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYA 194
REI L+ L HP L L R L+ E+C L+ L + + E ++
Sbjct: 49 REIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNP--RGVPEHLIKKII 106
Query: 195 SEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDF 232
+ + A+ F H I+RD+KPEN+L+ G I L DF
Sbjct: 107 WQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDF 144
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 7e-08
Identities = 81/369 (21%), Positives = 137/369 (37%), Gaps = 111/369 (30%)
Query: 89 RLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLD--HP 146
++G G G V + + K ++G A K+MD R+ ++ R + E++ M D H
Sbjct: 28 KIGEGSTGIVCIAREK----HSGRQVAVKMMDLRK-----QQRRELLFNEVVIMRDYQHQ 78
Query: 147 FLPTLYATLDCPRWSCLLTEFCPGGDL-HVLRQRQPDKRFHESAVRFYASEVVVALEFLH 205
+ +Y + +L EF GG L ++ Q R +E + V+ AL +LH
Sbjct: 79 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ----TRLNEEQIATVCESVLQALCYLH 134
Query: 206 MMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAV 265
G+I+RD+K +++L+ DG + L+DF AQ+ D
Sbjct: 135 SQGVIHRDIKSDSILLTLDGRVKLSDFGF---------CAQISKD--------------- 170
Query: 266 DQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNP--GTPEIVAEPLDVRSMSFVGTHE 323
VP +RK +G P PE+++
Sbjct: 171 ----------------VP---------KRKSLVGTPYWMAPEVISRTP------------ 193
Query: 324 YLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFP----K 379
+G VD W+LGI + E+ G P+ + + R + P K
Sbjct: 194 -----------YGTEVDIWSLGIMVIEMVDGEPPY----FSDSPVQAMKRLRDSPPPKLK 238
Query: 380 EPSVPGPA-KDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGVNWALLRCAKPP-FIPRP 437
P +D + ++L ++P R A + H F LL+ P +P
Sbjct: 239 NAHKISPVLRDFLERMLTREPQER----ATAQELLDHPF-------LLQTGLPECLVPLI 287
Query: 438 VTCRDLTTT 446
R T+T
Sbjct: 288 QQYRKRTST 296
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 8e-08
Identities = 42/149 (28%), Positives = 69/149 (46%), Gaps = 8/149 (5%)
Query: 87 VHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHP 146
+ +LG G +VY K KS NG A KV+ +E A E +L+ L H
Sbjct: 10 LEKLGEGSYATVY----KGKSKVNGKLVALKVIRLQE--EEGTPFTAIREASLLKGLKHA 63
Query: 147 FLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHM 206
+ L+ + L+ E+ DL + P H V+ + +++ L ++H
Sbjct: 64 NIVLLHDIIHTKETLTLVFEYV-HTDLCQYMDKHPGG-LHPENVKLFLFQLLRGLSYIHQ 121
Query: 207 MGIIYRDLKPENVLVRSDGHIMLTDFDLS 235
I++RDLKP+N+L+ G + L DF L+
Sbjct: 122 RYILHRDLKPQNLLISDTGELKLADFGLA 150
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 1e-07
Identities = 42/151 (27%), Positives = 66/151 (43%), Gaps = 9/151 (5%)
Query: 87 VHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNK--ESRARIEREILEMLD 144
+ ++G G G VY K ++ G A M K L S + S A E +L+ L
Sbjct: 5 IEKIGEGTYGVVY----KGRNKKTGQIVA---MKKIRLESEEEGVPSTAIREISLLKELQ 57
Query: 145 HPFLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFL 204
HP + L L L+ EF L + V+ Y +++ + F
Sbjct: 58 HPNIVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFC 117
Query: 205 HMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235
H +++RDLKP+N+L+ + G I L DF L+
Sbjct: 118 HSRRVLHRDLKPQNLLIDNKGVIKLADFGLA 148
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 1e-07
Identities = 43/158 (27%), Positives = 76/158 (48%), Gaps = 24/158 (15%)
Query: 87 VHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHP 146
V ++G G G VY K+++ G A K + + + + S A E +L+ L+HP
Sbjct: 5 VEKIGEGTYGVVY----KARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNHP 59
Query: 147 FLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESA---------VRFYASEV 197
+ L + L+ EF LH Q K+F +++ ++ Y ++
Sbjct: 60 NIVKLLDVIHTENKLYLVFEF-----LH-----QDLKKFMDASPLSGIPLPLIKSYLFQL 109
Query: 198 VVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235
+ L F H +++RDLKP+N+L+ ++G I L DF L+
Sbjct: 110 LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLA 147
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 1e-07
Identities = 57/264 (21%), Positives = 93/264 (35%), Gaps = 85/264 (32%)
Query: 187 ESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQ 246
E + E + ALEFLH +I+RD+K +N+L+ DG + LTDF AQ
Sbjct: 115 EGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGF---------CAQ 165
Query: 247 LVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEI 306
+ +QS +R +G P
Sbjct: 166 ITPEQS----------------------------------------KRSTMVGTP----- 180
Query: 307 VAEPLDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELT 366
++APE+++ + +G VD W+LGI E+ G P+ +
Sbjct: 181 ----------------YWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA 224
Query: 367 LANVVARAL-EFPKEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGVNWAL 425
L + E + +D + + L D +R +K + +HQF
Sbjct: 225 LYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAK----ELLQHQF-------- 272
Query: 426 LRCAKP--PFIPRPVTCRDLTTTN 447
L+ AKP P ++ T N
Sbjct: 273 LKIAKPLSSLTPLIAAAKEATKNN 296
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 2e-07
Identities = 29/91 (31%), Positives = 45/91 (49%), Gaps = 9/91 (9%)
Query: 317 SFVGTHEYLAPEII-SGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARAL 375
SF G+ ++APE+I G+G A D W+LG + E+ G P+ +L V +
Sbjct: 160 SFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPW----SQLEGVAAVFKIG 215
Query: 376 EFPKEPSVP----GPAKDLIAQLLVKDPTRR 402
+ P +P AKD I + L +DP+ R
Sbjct: 216 RSKELPPIPDHLSDEAKDFILKCLQRDPSLR 246
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 52.2 bits (126), Expect = 2e-07
Identities = 36/133 (27%), Positives = 52/133 (39%), Gaps = 37/133 (27%)
Query: 317 SFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPF--------------KGID 362
S VGT ++APE+I + +G VD W+LGI E+ G P+ KGI
Sbjct: 175 SVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGI- 233
Query: 363 HELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGVN 422
L + KD + + LVKDP +R ++ + +H F
Sbjct: 234 PPLKNPEKWSPEF------------KDFLNKCLVKDPEKRPSAEE----LLQHPFLK--- 274
Query: 423 WALLRCAKPPFIP 435
C K F P
Sbjct: 275 ---KACPKEEFAP 284
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 2e-07
Identities = 34/102 (33%), Positives = 44/102 (43%), Gaps = 10/102 (9%)
Query: 315 SMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPF--KGIDH----ELTLA 368
+ +F GT Y+APE I G+ + D W+LG+ + E+ PF +G EL
Sbjct: 160 AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSY 219
Query: 369 NVVARALEFPKEPSVP----GPAKDLIAQLLVKDPTRRMGSK 406
V E EP KD I Q L KDPTRR
Sbjct: 220 IVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPW 261
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 2e-07
Identities = 82/335 (24%), Positives = 130/335 (38%), Gaps = 100/335 (29%)
Query: 90 LGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLP 149
LGSG G+V L +K ++G FA KV+D E +S ++RA+ E L D
Sbjct: 40 LGSGATGTV----LCAKRVSDGEPFAVKVVD-MEGMSEADKNRAQAEVCCLLNCDF---- 90
Query: 150 TLYATLDC--------PR------WSCLLTEFCPGGDL-HVLRQRQPDKRF---HESAVR 191
++ + C PR L+ ++ GDL ++ R R HE+ +
Sbjct: 91 --FSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLL 148
Query: 192 FYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQLVSDQ 251
F +V++A+ +H +I+RD+K N+L+ S+G + L DF S A VSD
Sbjct: 149 FI--QVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGF------SKMYAATVSDD 200
Query: 252 SPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPL 311
G + C GTP VA
Sbjct: 201 ------------------VGRTFC--------------------------GTPYYVA--- 213
Query: 312 DVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVV 371
PEI + + D ++LG+ ++EL PF G + E + +
Sbjct: 214 ---------------PEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTL 258
Query: 372 ARALEFPKEPSVPGPAKDLIAQLLVKDPTRRMGSK 406
A + P PS+ ++++ LL DP RR S
Sbjct: 259 AGRYD-PLPPSISPEMQEIVTALLSSDPKRRPSSS 292
|
Length = 496 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 52.3 bits (126), Expect = 2e-07
Identities = 21/64 (32%), Positives = 37/64 (57%), Gaps = 4/64 (6%)
Query: 170 GGDLH-VLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIM 228
DLH ++ QP E +R++ +++ L+++H +I+RDLKP N+LV D +
Sbjct: 91 ESDLHHIIHSDQP---LTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELR 147
Query: 229 LTDF 232
+ DF
Sbjct: 148 IGDF 151
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 52.6 bits (127), Expect = 2e-07
Identities = 22/64 (34%), Positives = 38/64 (59%), Gaps = 3/64 (4%)
Query: 172 DLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTD 231
DLH + + + H R+ +++ AL+++H +I+RDLKP N+L+ SD + L D
Sbjct: 94 DLHAVIRANILEDVH---KRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLAD 150
Query: 232 FDLS 235
F L+
Sbjct: 151 FGLA 154
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 2e-07
Identities = 48/159 (30%), Positives = 72/159 (45%), Gaps = 18/159 (11%)
Query: 87 VHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRA-RIEREI-----L 140
V +G G G+VY K++ ++G F A K + V N++ RE+ L
Sbjct: 5 VAEIGVGAYGTVY----KARDPHSGHFVALKSVR----VQTNEDGLPLSTVREVALLKRL 56
Query: 141 EMLDHPFLPTLY---ATLDCPRWSCLLTEF-CPGGDLHVLRQRQPDKRFHESAVRFYASE 196
E DHP + L AT R + + F DL + P ++ +
Sbjct: 57 EAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQ 116
Query: 197 VVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235
+ L+FLH I++RDLKPEN+LV S G + L DF L+
Sbjct: 117 FLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLA 155
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 2e-07
Identities = 44/161 (27%), Positives = 69/161 (42%), Gaps = 18/161 (11%)
Query: 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRAR---IERE 138
++ + LG G+ GSVY V + M +E+ ES+ +E +
Sbjct: 1 DEIEVLDELGKGNYGSVYKVLHRP---------TGVTMAMKEIRLELDESKFNQIIMELD 51
Query: 139 ILEMLDHPFLPTLYA--TLDCPRWSCLLTEFCPGGDLHVLR-QRQPDKRFHESAVRFYAS 195
IL P++ Y ++ + C+ E+ G L L + E +R
Sbjct: 52 ILHKAVSPYIVDFYGAFFIEGAVYMCM--EYMDAGSLDKLYAGGVATEGIPEDVLRRITY 109
Query: 196 EVVVALEFL-HMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235
VV L+FL II+RD+KP NVLV +G + L DF +S
Sbjct: 110 AVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVS 150
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 2e-07
Identities = 42/168 (25%), Positives = 77/168 (45%), Gaps = 6/168 (3%)
Query: 81 LSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREIL 140
L++ R ++G G VY ++ +G A K + +L+ + E ++L
Sbjct: 1 LANFRIEKKIGRGQFSEVY----RATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLL 56
Query: 141 EMLDHPFLPTLYATLDCPRWSCLLTEFCPGGDL-HVLRQRQPDKRF-HESAVRFYASEVV 198
+ L+HP + YA+ ++ E GDL +++ + KR E V Y ++
Sbjct: 57 KQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLC 116
Query: 199 VALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQ 246
ALE +H +++RD+KP NV + + G + L D L + T+ A
Sbjct: 117 SALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAH 164
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 3e-07
Identities = 45/154 (29%), Positives = 67/154 (43%), Gaps = 12/154 (7%)
Query: 83 DLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEM 142
DL F+ LG+G G V + + G + A M K +S E E +++
Sbjct: 5 DLTFLKELGTGQFGVVKYGKWR------GQYDVAIKMIKEGSMS---EDEFIEEAKVMMK 55
Query: 143 LDHPFLPTLYATLDCPRWSCLLTEFCPGGDL-HVLRQRQPDKRFHESAVRFYASEVVVAL 201
L H L LY R ++TE+ G L + LR+ KRF S + +V +
Sbjct: 56 LSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHG--KRFQPSQLLEMCKDVCEGM 113
Query: 202 EFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235
+L I+RDL N LV G + ++DF LS
Sbjct: 114 AYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLS 147
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 3e-07
Identities = 47/165 (28%), Positives = 72/165 (43%), Gaps = 27/165 (16%)
Query: 83 DLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREI-LE 141
DL + LG G G V K + G A K + R V+ ++ R ++ +I +
Sbjct: 2 DLEVIEELGRGAYGVVD----KMRHVPTGTIMAVKRI--RATVNSQEQKRLLMDLDISMR 55
Query: 142 MLDHPFLPTLYATL----DCPRWSCL------LTEFCPGGDLHVLRQRQPDKRFHESAVR 191
+D P+ T Y L D W C+ L +F V E +
Sbjct: 56 SVDCPYTVTFYGALFREGDV--WICMEVMDTSLDKFYK----KVY---DKGLTIPEDILG 106
Query: 192 FYASEVVVALEFLH-MMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235
A +V ALE+LH + +I+RD+KP NVL+ +G + L DF +S
Sbjct: 107 KIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGIS 151
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 51.2 bits (123), Expect = 3e-07
Identities = 48/147 (32%), Positives = 67/147 (45%), Gaps = 15/147 (10%)
Query: 90 LGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREI--LEMLDHPF 147
+G G G V +K K G A K + E +K + REI L+ L H
Sbjct: 9 VGEGSYGMV----MKCKHKETGQIVAIKKFLESE---DDKMVKKIAMREIRMLKQLRHEN 61
Query: 148 LPTLYATLDCPRWSCLLTEFCPGGDLHVLR--QRQPDKRFHESAVRFYASEVVVALEFLH 205
L L + L+ EF D VL ++ P+ ES VR Y +++ +EF H
Sbjct: 62 LVNLIEVFRRKKRLYLVFEFV---DHTVLDDLEKYPNG-LDESRVRKYLFQILRGIEFCH 117
Query: 206 MMGIIYRDLKPENVLVRSDGHIMLTDF 232
II+RD+KPEN+LV G + L DF
Sbjct: 118 SHNIIHRDIKPENILVSQSGVVKLCDF 144
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 4e-07
Identities = 46/155 (29%), Positives = 74/155 (47%), Gaps = 12/155 (7%)
Query: 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILE 141
S+L F+ LGSG G V+L + + K A K++ + + E E +++
Sbjct: 4 SELTFLKELGSGQFGVVHLGKWRGKID-----VAIKMIREGAM----SEDDFIEEAKVMM 54
Query: 142 MLDHPFLPTLYATLDCPRWSCLLTEFCPGGDL-HVLRQRQPDKRFHESAVRFYASEVVVA 200
L HP L LY R ++TE+ G L + LR+R+ + + S+V A
Sbjct: 55 KLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERK--GKLGTEWLLDMCSDVCEA 112
Query: 201 LEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235
+E+L G I+RDL N LV D + ++DF L+
Sbjct: 113 MEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLA 147
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 4e-07
Identities = 42/146 (28%), Positives = 70/146 (47%), Gaps = 14/146 (9%)
Query: 89 RLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLD--HP 146
++G G G V + K + G A K MD R+ ++ R + E++ M D H
Sbjct: 29 KIGEGSTGIVCIATEK----HTGKQVAVKKMDLRK-----QQRRELLFNEVVIMRDYHHE 79
Query: 147 FLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHM 206
+ +Y + ++ EF GG L + R +E + V+ AL +LH
Sbjct: 80 NVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHT---RMNEEQIATVCLSVLRALSYLHN 136
Query: 207 MGIIYRDLKPENVLVRSDGHIMLTDF 232
G+I+RD+K +++L+ SDG I L+DF
Sbjct: 137 QGVIHRDIKSDSILLTSDGRIKLSDF 162
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 4e-07
Identities = 33/92 (35%), Positives = 45/92 (48%), Gaps = 2/92 (2%)
Query: 311 LDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANV 370
LDV S SF GT YLAPE+ + + D W+LG+ ++EL PFKG + V
Sbjct: 225 LDVAS-SFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQV 283
Query: 371 VARALEFPKEPSVPGPAKDLIAQLLVKDPTRR 402
+ + P V K L+ LL K+P R
Sbjct: 284 LYGKYD-PFPCPVSSGMKALLDPLLSKNPALR 314
|
Length = 478 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 5e-07
Identities = 40/160 (25%), Positives = 73/160 (45%), Gaps = 19/160 (11%)
Query: 83 DLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEM 142
D + R+GSG G VY K+++ + G A K++ + + I++EI +
Sbjct: 10 DYELIQRVGSGTYGDVY----KARNLHTGELAAVKIIKLEP-----GDDFSLIQQEIFMV 60
Query: 143 LD--HPFLPTLYATLDCPR--WSCLLTEFCPGGDLH-VLRQRQPDKRFHESAVRFYASEV 197
+ H + + + W C+ E+C GG L + P E + + E
Sbjct: 61 KECKHCNIVAYFGSYLSREKLWICM--EYCGGGSLQDIYHVTGP---LSELQIAYVCRET 115
Query: 198 VVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLK 237
+ L +LH G ++RD+K N+L+ +G + L DF ++ K
Sbjct: 116 LQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAK 155
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 5e-07
Identities = 38/154 (24%), Positives = 67/154 (43%), Gaps = 20/154 (12%)
Query: 89 RLGSGDIGSVYLVQLKSKSSNNGCFFAAKV--MDKRELVSRNKESRARIEREILEMLDHP 146
+LG G +VY K ++ G A K +D E S A E +++ L H
Sbjct: 7 KLGEGTYATVY----KGRNRTTGEIVALKEIHLDAEE----GTPSTAIREISLMKELKHE 58
Query: 147 FLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESA-----VRFYASEVVVAL 201
+ L+ + L+ E+ DL ++ D A V+ + +++ +
Sbjct: 59 NIVRLHDVIHTENKLMLVFEYMDK-DL----KKYMDTHGVRGALDPNTVKSFTYQLLKGI 113
Query: 202 EFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235
F H +++RDLKP+N+L+ G + L DF L+
Sbjct: 114 AFCHENRVLHRDLKPQNLLINKRGELKLADFGLA 147
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 5e-07
Identities = 46/160 (28%), Positives = 70/160 (43%), Gaps = 19/160 (11%)
Query: 87 VHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRA-RIEREI-----L 140
V +G G G V+ K++ NG F A KR V +E RE+ L
Sbjct: 6 VAEIGEGAYGKVF----KARDLKNGGRFVAL---KRVRVQTGEEGMPLSTIREVAVLRHL 58
Query: 141 EMLDHPFLPTLYATLDCPRWS-----CLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYAS 195
E +HP + L+ R L+ E DL + P+ ++
Sbjct: 59 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMF 117
Query: 196 EVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235
+++ L+FLH +++RDLKP+N+LV S G I L DF L+
Sbjct: 118 QLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA 157
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 6e-07
Identities = 42/149 (28%), Positives = 70/149 (46%), Gaps = 14/149 (9%)
Query: 90 LGSGDIGSVYLVQLKSKSSNNGCFFAAK-VMDKRELVSRNKESRARIEREI--LEMLDHP 146
LG+G S Y + G A K V R S +E + +EI + L+HP
Sbjct: 8 LGTGAFSSCYQAR----DVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHP 63
Query: 147 FLPTLY-ATLDCPRWSCLLTEFCPGGDL-HVLRQRQPDKRFHESAVRFYASEVVVALEFL 204
+ + AT + ++ L E+ GG + H+L + F E+ + Y +++ L +L
Sbjct: 64 HIIRMLGATCEDSHFN-LFVEWMAGGSVSHLLSKYGA---FKEAVIINYTEQLLRGLSYL 119
Query: 205 HMMGIIYRDLKPENVLVRSDGHIM-LTDF 232
H II+RD+K N+L+ S G + + DF
Sbjct: 120 HENQIIHRDVKGANLLIDSTGQRLRIADF 148
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 7e-07
Identities = 38/151 (25%), Positives = 68/151 (45%), Gaps = 8/151 (5%)
Query: 90 LGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLP 149
LG G+ G V+ LK K+ V +E + + + + E IL+ DHP +
Sbjct: 3 LGKGNFGEVFKGTLKDKTP-------VAVKTCKEDLPQELKIKFLSEARILKQYDHPNIV 55
Query: 150 TLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGI 209
L + ++ E PGGD +++ D+ + V+F A + + +L
Sbjct: 56 KLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKF-ALDAAAGMAYLESKNC 114
Query: 210 IYRDLKPENVLVRSDGHIMLTDFDLSLKGDN 240
I+RDL N LV + + ++DF +S + D+
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSRQEDD 145
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 49.9 bits (120), Expect = 8e-07
Identities = 32/110 (29%), Positives = 54/110 (49%), Gaps = 10/110 (9%)
Query: 297 KLGNPGTPEIVAEPLDVRSM---SFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFY 353
KLG+ G +A+ L S ++VGT Y++PE ++ + D W+LG I+EL
Sbjct: 150 KLGDFG----LAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCA 205
Query: 354 GTTPFKGIDHELTLANVVARALEFPKEPSVPGPA-KDLIAQLLVKDPTRR 402
+ PF + L LA+ + +F + P ++I +L DP +R
Sbjct: 206 LSPPFTARNQ-LQLASKIKEG-KFRRIPYRYSSELNEVIKSMLNVDPDKR 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 8e-07
Identities = 41/146 (28%), Positives = 70/146 (47%), Gaps = 14/146 (9%)
Query: 89 RLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLD--HP 146
++G G G V + +KS +G A K MD R+ ++ R + E++ M D H
Sbjct: 27 KIGEGSTGIVCIATVKS----SGKLVAVKKMDLRK-----QQRRELLFNEVVIMRDYQHE 77
Query: 147 FLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHM 206
+ +Y + ++ EF GG L + R +E + V+ AL LH
Sbjct: 78 NVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH---TRMNEEQIAAVCLAVLKALSVLHA 134
Query: 207 MGIIYRDLKPENVLVRSDGHIMLTDF 232
G+I+RD+K +++L+ DG + L+DF
Sbjct: 135 QGVIHRDIKSDSILLTHDGRVKLSDF 160
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 8e-07
Identities = 43/167 (25%), Positives = 75/167 (44%), Gaps = 24/167 (14%)
Query: 78 PLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIER 137
P +L V GSG G V + + G A K + R S R E
Sbjct: 14 PDRYQNLSPV---GSGAYGQV----CSAFDTKTGRKVAIKKLS-RPFQSAIHAKRTYREL 65
Query: 138 EILEMLDHP--------FLPTLYATLDCPRWSCLLTEFCPGGDLH-VLRQRQPDKRFHES 188
+L+ +DH F P ++L+ + L+T G DL+ +++ ++ +
Sbjct: 66 RLLKHMDHENVIGLLDVFTPA--SSLEDFQDVYLVTHLM-GADLNNIVKC----QKLSDD 118
Query: 189 AVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235
++F +++ L+++H GII+RDLKP N+ V D + + DF L+
Sbjct: 119 HIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA 165
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 9e-07
Identities = 47/169 (27%), Positives = 79/169 (46%), Gaps = 16/169 (9%)
Query: 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILE 141
+D+ H+LG G G VY K A K + +E +E E +++
Sbjct: 6 TDITMKHKLGGGQYGEVYEGVWK----KYSLTVAVKTL--KEDTMEVEEFLK--EAAVMK 57
Query: 142 MLDHPFLPTLYA--TLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFY-ASEVV 198
+ HP L L T + P + ++TEF G+L + R+ +++ + V Y A+++
Sbjct: 58 EIKHPNLVQLLGVCTREPPFY--IITEFMTYGNL-LDYLRECNRQEVNAVVLLYMATQIS 114
Query: 199 VALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS--LKGDNSTSTA 245
A+E+L I+RDL N LV + + + DF LS + GD T+ A
Sbjct: 115 SAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA 163
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 9e-07
Identities = 40/165 (24%), Positives = 67/165 (40%), Gaps = 31/165 (18%)
Query: 86 FVHRLGSGDIGSVYLVQLKSKSSNNGC-------FFAAKVMDKRELVSRNKESRARIERE 138
+ LG G G V + S F+ K++ KR L RE
Sbjct: 4 LIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRAL------------RE 51
Query: 139 ILEML---DHPFLPTLYATLDCPRWSCL----LTEFCPGGDLH-VLRQRQPDKRFHESAV 190
+ + H + LY +D L E DLH ++R QP H
Sbjct: 52 LKLLRHFRGHKNITCLY-DMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAH---F 107
Query: 191 RFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235
+ + +++ L+++H +++RDLKP N+LV +D + + DF L+
Sbjct: 108 QSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLA 152
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 1e-06
Identities = 33/107 (30%), Positives = 54/107 (50%), Gaps = 4/107 (3%)
Query: 297 KLGNPGTPEIVAEPLDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTT 356
KLG+ G + + +++ + + VGT YL+PEI + N D W+LG ++EL
Sbjct: 142 KLGDFGIARQLNDSMEL-AYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKH 200
Query: 357 PFKGID-HELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDPTRR 402
PF+G + H+L L + + P P+ + LI+QL P R
Sbjct: 201 PFEGNNLHQLVLK--ICQGYFAPISPNFSRDLRSLISQLFKVSPRDR 245
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 1e-06
Identities = 24/102 (23%), Positives = 46/102 (45%), Gaps = 4/102 (3%)
Query: 317 SFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALE 376
S GT +++PE+ISGEG+G D W++G + E+ P+ + + + +
Sbjct: 166 SVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTN 225
Query: 377 FPKEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFF 418
V A++ + + V++ +R A + RH F
Sbjct: 226 PQLPSHVSPDARNFLRRTFVENAKKR----PSAEELLRHFFV 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 1e-06
Identities = 45/159 (28%), Positives = 71/159 (44%), Gaps = 20/159 (12%)
Query: 87 VHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEML-DH 145
+ +G G G VY V K +G A K++D V E+ E IL+ L +H
Sbjct: 27 IETIGKGTYGKVYKVTNK----KDGSLAAVKILDPISDVDEEIEA----EYNILQSLPNH 78
Query: 146 P----FLPTLYATLDC---PRWSCLLTEFCPGGDLHVLRQ--RQPDKRFHESAVRFYASE 196
P F Y W L+ E C GG + L + +R E+ + +
Sbjct: 79 PNVVKFYGMFYKADKLVGGQLW--LVLELCNGGSVTELVKGLLICGQRLDEAMISYILYG 136
Query: 197 VVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235
++ L+ LH II+RD+K N+L+ ++G + L DF +S
Sbjct: 137 ALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVS 175
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 49.5 bits (119), Expect = 1e-06
Identities = 33/101 (32%), Positives = 49/101 (48%), Gaps = 4/101 (3%)
Query: 137 REI--LEMLDHPFLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYA 194
REI L+ L HP + L L+ EF DL + + + ++ Y
Sbjct: 51 REIKLLQELKHPNIIGLLDVFGHKSNINLVFEFMET-DLEKV-IKDKSIVLTPADIKSYM 108
Query: 195 SEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235
+ LE+LH I++RDLKP N+L+ SDG + L DF L+
Sbjct: 109 LMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLA 149
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 1e-06
Identities = 27/101 (26%), Positives = 54/101 (53%), Gaps = 5/101 (4%)
Query: 136 EREILEMLDHPFLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQP-DKRFHESAVRFYA 194
E ++L+ L H + +L P G DLH L +P +K+F ++++
Sbjct: 59 ELKLLKHLRHENIISLSDIFISPLEDIYFVTELLGTDLHRLLTSRPLEKQF----IQYFL 114
Query: 195 SEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235
+++ L+++H G+++RDLKP N+L+ + + + DF L+
Sbjct: 115 YQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLA 155
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 48.8 bits (117), Expect = 2e-06
Identities = 32/96 (33%), Positives = 46/96 (47%), Gaps = 19/96 (19%)
Query: 317 SFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARAL- 375
+ +GT ++APE+I G+ N D W+LGI E+ G P+ I H + RA+
Sbjct: 158 TVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDI-HPM-------RAIF 209
Query: 376 EFPKEPSVPG---PAK------DLIAQLLVKDPTRR 402
P +P P P K D + + LVKDP R
Sbjct: 210 MIPNKPP-PTLSDPEKWSPEFNDFVKKCLVKDPEER 244
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 2e-06
Identities = 30/101 (29%), Positives = 46/101 (45%), Gaps = 4/101 (3%)
Query: 136 EREILEMLDHPFLPTLYATL-DCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYA 194
E I+ DHP + L + + P W ++ E P G+L Q S + Y+
Sbjct: 57 EAYIMRQFDHPHIVKLIGVITENPVW--IVMELAPLGELRSYLQVNKYSLDLASLI-LYS 113
Query: 195 SEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235
++ AL +L ++RD+ NVLV S + L DF LS
Sbjct: 114 YQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLS 154
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 3e-06
Identities = 26/89 (29%), Positives = 46/89 (51%), Gaps = 4/89 (4%)
Query: 317 SFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHEL-TLANVVARAL 375
S VGT Y++PE I G+ D W+LG ++E+ +PF G L +L + +
Sbjct: 165 SLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKC- 223
Query: 376 EFPKEPS--VPGPAKDLIAQLLVKDPTRR 402
++P P+ +DL+++ + DP +R
Sbjct: 224 DYPPLPADHYSEELRDLVSRCINPDPEKR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 3e-06
Identities = 37/172 (21%), Positives = 70/172 (40%), Gaps = 17/172 (9%)
Query: 79 LTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIERE 138
L LS +RF+ LG G +Y L ++ A K + +++ + + + E
Sbjct: 2 LPLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTL--KDINNPQQWGEFQQEAS 59
Query: 139 ILEMLDHPFLPTLYATLDCPRWSCLLTEFCPGGDLH---VLRQRQPD------------K 183
++ L HP + L + + C+L E+ GDLH ++R D
Sbjct: 60 LMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKS 119
Query: 184 RFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235
A ++ +E+L +++DL N+L+ H+ ++D LS
Sbjct: 120 SLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLS 171
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 3e-06
Identities = 45/160 (28%), Positives = 72/160 (45%), Gaps = 18/160 (11%)
Query: 261 NDCAVDQPPFGNSSCIIPNCIVPAVS--CLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSF 318
N+C V + GN+ ++PN I+ + C RR +G GT + ++SM
Sbjct: 120 NNCVVHRDIKGNNVMLMPNGIIKLIDFGC----ARRLAWVGLHGTHSNM-----LKSMH- 169
Query: 319 VGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFP 378
GT ++APE+I+ G+G D W++G +FE+ G P +D + + A P
Sbjct: 170 -GTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMP 228
Query: 379 KEP-SVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQF 417
+ P S A D + L +D R A + RH F
Sbjct: 229 RLPDSFSAAAIDFVTSCLTRDQHER----PSALQLLRHDF 264
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 3e-06
Identities = 43/173 (24%), Positives = 73/173 (42%), Gaps = 23/173 (13%)
Query: 84 LRFVHRLGSGDIGSVYLVQLK------------SKSSNNGCFFAAKVMDKRELVSRNKES 131
L F +LG G G V+L + + S N A K++ RE ++N +
Sbjct: 7 LTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKML--REDANKNARN 64
Query: 132 RARIEREILEMLDHPFLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQR--------QPDK 183
E +I+ L P + L A C++TE+ GDL+ R + D
Sbjct: 65 DFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADV 124
Query: 184 RFHE-SAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235
S + F A+++ +++L + ++RDL N LV + I + DF +S
Sbjct: 125 VTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMS 177
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 3e-06
Identities = 42/158 (26%), Positives = 72/158 (45%), Gaps = 29/158 (18%)
Query: 89 RLGSGDIGSVYLVQLKSKSSNNGCFFAAK---VMDKRELVSRNKESRARIEREILEMLDH 145
++G G G+V+ K+K+ A K + D E V S A E +L+ L H
Sbjct: 7 KIGEGTYGTVF----KAKNRETHEIVALKRVRLDDDDEGVP----SSALREICLLKELKH 58
Query: 146 PFLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHES--------AVRFYASEV 197
+ LY L + L+ E+C Q K++ +S V+ + ++
Sbjct: 59 KNIVRLYDVLHSDKKLTLVFEYC----------DQDLKKYFDSCNGDIDPEIVKSFMFQL 108
Query: 198 VVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235
+ L F H +++RDLKP+N+L+ +G + L DF L+
Sbjct: 109 LKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLA 146
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 3e-06
Identities = 45/159 (28%), Positives = 73/159 (45%), Gaps = 20/159 (12%)
Query: 87 VHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEML-DH 145
+ +G G G V+ V K NG A K++D + E+ E IL+ L DH
Sbjct: 23 IETIGKGTYGKVFKVLNKK----NGSKAAVKILDPIHDIDEEIEA----EYNILKALSDH 74
Query: 146 PFLPTLYATL---DCPR----WSCLLTEFCPGGDLHVLRQ--RQPDKRFHESAVRFYASE 196
P + Y D W L+ E C GG + L + + +R E + + E
Sbjct: 75 PNVVKFYGMYYKKDVKNGDQLW--LVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHE 132
Query: 197 VVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235
++ L+ LH+ I+RD+K N+L+ ++G + L DF +S
Sbjct: 133 ALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVS 171
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 3e-06
Identities = 34/152 (22%), Positives = 60/152 (39%), Gaps = 25/152 (16%)
Query: 89 RLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDH--P 146
L G VYL+ K + + K+ SR K + E IL++L
Sbjct: 5 LLKGGLTNRVYLLGTKDED------YVLKI-----NPSREKGADREREVAILQLLARKGL 53
Query: 147 FLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLH- 205
+P + A+ + WS LL E+ G L + + E ++ L LH
Sbjct: 54 PVPKVLASGESDGWSYLLMEWIEGETL-----DEVSEEEKEDIAE----QLAELLAKLHQ 104
Query: 206 --MMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235
++ + + DL P N+LV + + D++ +
Sbjct: 105 LPLLVLCHGDLHPGNILVDDGKILGIIDWEYA 136
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 3e-06
Identities = 39/168 (23%), Positives = 60/168 (35%), Gaps = 19/168 (11%)
Query: 83 DLRFVHRLGSGDIGSVYLVQLKSKSSNNGC-FFAAKVMDKRELVSRNKESRARIEREILE 141
+ LG G G V+L + N A K + +E S + E E+L
Sbjct: 6 TIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTL--KETASNDARKDFEREAELLT 63
Query: 142 MLDHPFLPTLYATLDCPRWSCLLT--EFCPGGDLH-VLRQRQPDKRF-----------HE 187
H + Y C + E+ GDL+ LR PD F
Sbjct: 64 NFQHENIVKFYGV--CTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTL 121
Query: 188 SAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235
S + A ++ + +L ++RDL N LV D + + DF +S
Sbjct: 122 SQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMS 169
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 4e-06
Identities = 27/92 (29%), Positives = 43/92 (46%), Gaps = 3/92 (3%)
Query: 318 FVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDH--ELTLANVVARAL 375
+GT ++APE++ GE +G + D W++G I E+ P+ H L L +A A
Sbjct: 168 LLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASAT 227
Query: 376 EFPKEPSVPGPA-KDLIAQLLVKDPTRRMGSK 406
P P P +D+ + L P R S+
Sbjct: 228 TAPSIPEHLSPGLRDVTLRCLELQPEDRPPSR 259
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 4e-06
Identities = 46/169 (27%), Positives = 73/169 (43%), Gaps = 6/169 (3%)
Query: 79 LTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIERE 138
L ++L+ V LGSG G+VY + A K++++ N E E
Sbjct: 4 LKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMD--EAL 61
Query: 139 ILEMLDHPFLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVV 198
I+ +DHP L L P L+T+ P G L D + + ++
Sbjct: 62 IMASMDHPHLVRLLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDN-IGSQLLLNWCVQIA 119
Query: 199 VALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS--LKGDNSTSTA 245
+ +L +++RDL NVLV+S H+ +TDF L+ L+GD A
Sbjct: 120 KGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNA 168
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 4e-06
Identities = 44/153 (28%), Positives = 70/153 (45%), Gaps = 16/153 (10%)
Query: 90 LGSGDIGSVYLVQLKSKSSNNGCFFAAKVM----DKRELVSRNKESRA-RIEREILEMLD 144
LG G G VYL ++ G A K + D +E +KE A E ++L+ L
Sbjct: 10 LGRGAFGEVYLCY----DADTGRELAVKQVPFDPDSQE---TSKEVNALECEIQLLKNLR 62
Query: 145 HPFLPTLYATLDCP--RWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALE 202
H + Y L P + + E+ PGG + Q + E+ R Y +++ +
Sbjct: 63 HDRIVQYYGCLRDPEEKKLSIFVEYMPGGS--IKDQLKAYGALTENVTRRYTRQILQGVS 120
Query: 203 FLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235
+LH I++RD+K N+L S G++ L DF S
Sbjct: 121 YLHSNMIVHRDIKGANILRDSAGNVKLGDFGAS 153
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 5e-06
Identities = 59/285 (20%), Positives = 94/285 (32%), Gaps = 75/285 (26%)
Query: 90 LGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIE---------REIL 140
LG G G V K+ + G A K + E+ + + R + RE+
Sbjct: 17 LGEGTYGKVE----KAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELK 72
Query: 141 EM--LDHPFLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVV 198
M + H + L + L+ + DL + R+ R ES V+ +++
Sbjct: 73 IMNEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVVDRK--IRLTESQVKCILLQIL 129
Query: 199 VALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQ 258
L LH ++RDL P N+ + S G + DF L+
Sbjct: 130 NGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLA----------------------- 166
Query: 259 QPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSF 318
P +RR + T ++V
Sbjct: 167 --------------RRYGYPPYSDTLSKDETMQRREEM------TSKVV----------- 195
Query: 319 VGTHEYLAPEIISG-EGHGNAVDWWTLGIFIFELFYGTTPFKGID 362
T Y APE++ G E + AVD W++G EL G F G +
Sbjct: 196 --TLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGEN 238
|
Length = 335 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 47.8 bits (113), Expect = 5e-06
Identities = 43/150 (28%), Positives = 66/150 (44%), Gaps = 10/150 (6%)
Query: 90 LGSGDIGSVYLVQLKSKSSNNGCFFAAKVM--DKRELVSRNKESRARIEREILEMLDHPF 147
LG G G VYL + G AAK + D + + S E ++L+ L H
Sbjct: 10 LGQGAFGRVYLCY----DVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHER 65
Query: 148 LPTLYATL--DCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLH 205
+ Y L + + E+ PGG V Q + ES R Y +++ + +LH
Sbjct: 66 IVQYYGCLRDRAEKTLTIFMEYMPGGS--VKDQLKAYGALTESVTRKYTRQILEGMSYLH 123
Query: 206 MMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235
I++RD+K N+L S G++ L DF S
Sbjct: 124 SNMIVHRDIKGANILRDSAGNVKLGDFGAS 153
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.7 bits (114), Expect = 6e-06
Identities = 40/150 (26%), Positives = 68/150 (45%), Gaps = 10/150 (6%)
Query: 87 VHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREI--LEMLD 144
V ++G G G VY K++ G A K K L + ++ + REI L+ L+
Sbjct: 4 VEKIGEGTYGVVY----KARDKLTGEIVALK---KIRLETEDEGVPSTAIREISLLKELN 56
Query: 145 HPFLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFL 204
HP + L + L+ EF DL P ++ Y +++ + +
Sbjct: 57 HPNIVRLLDVVHSENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYC 115
Query: 205 HMMGIIYRDLKPENVLVRSDGHIMLTDFDL 234
H +++RDLKP+N+L+ +G + L DF L
Sbjct: 116 HSHRVLHRDLKPQNLLIDREGALKLADFGL 145
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 6e-06
Identities = 40/168 (23%), Positives = 68/168 (40%), Gaps = 41/168 (24%)
Query: 89 RLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKES---RARIEREILEMLDH 145
++G G G V+ K++ A K + L+ KE A E +IL++L H
Sbjct: 19 KIGQGTFGEVF----KARHKKTKQIVALK----KVLMENEKEGFPITALREIKILQLLKH 70
Query: 146 P------------------FLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHE 187
+ + Y L+ EFC DL L + +F
Sbjct: 71 ENVVNLIEICRTKATPYNRYKGSFY----------LVFEFCEH-DLAGLLS-NKNVKFTL 118
Query: 188 SAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235
S ++ ++ L ++H I++RD+K N+L+ DG + L DF L+
Sbjct: 119 SEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLA 166
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 7e-06
Identities = 37/129 (28%), Positives = 54/129 (41%), Gaps = 14/129 (10%)
Query: 115 AAKVMDKRELVSRNKESRARIEREI--LEMLDHPFLPTLYATLDCPRWSCLLT--EFCPG 170
A K++ R + RAR RE L HP + L + + P L E+ PG
Sbjct: 7 AIKLL--RTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPP-GLLFAVFEYVPG 63
Query: 171 GDLHVLRQR-QPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDG---H 226
LR+ D +V+ AL H GI++RDLKP+N++V G H
Sbjct: 64 ---RTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPH 120
Query: 227 IMLTDFDLS 235
+ DF +
Sbjct: 121 AKVLDFGIG 129
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.8 bits (113), Expect = 7e-06
Identities = 33/117 (28%), Positives = 50/117 (42%), Gaps = 7/117 (5%)
Query: 158 PRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPE 217
P CL EF G + P + + ++ +V+ L LH +GI++RD+KPE
Sbjct: 282 PFPGCL-EEFMMAG--KKIPDNMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPE 338
Query: 218 NVLVRSDGHIMLTDF----DLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPF 270
N+LV DG + + DF D+ + + L SPP P C P
Sbjct: 339 NLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELVMPQSCPRAPAPA 395
|
Length = 507 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 8e-06
Identities = 41/156 (26%), Positives = 66/156 (42%), Gaps = 11/156 (7%)
Query: 84 LRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEML 143
L+ + LG G G V L + G A K + KRE +N + E IL+ L
Sbjct: 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTL-KRECGQQNTSGWKK-EINILKTL 63
Query: 144 DHPFLPTLYATLDCPRWS----CLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVV 199
H + C L+ E+ P G L R P + + + + +A ++
Sbjct: 64 YHENIVKYKGC--CSEQGGKGLQLIMEYVPLGSL---RDYLPKHKLNLAQLLLFAQQICE 118
Query: 200 ALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235
+ +LH I+RDL NVL+ +D + + DF L+
Sbjct: 119 GMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLA 154
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 9e-06
Identities = 29/110 (26%), Positives = 49/110 (44%), Gaps = 10/110 (9%)
Query: 297 KLGNPGTPEIVAEPLDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTT 356
K+G+ G ++++ + + VGT YL+PE+ + + D W LG+ ++E G
Sbjct: 141 KIGDLGVAKLLS-DNTNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKH 199
Query: 357 PFKGIDHELTLANVVARALEFPKEPSVPGPAK----DLIAQLLVKDPTRR 402
PF +++ L + R P V LI Q L KD +R
Sbjct: 200 PFD-ANNQGALILKIIRG----VFPPVSQMYSQQLAQLIDQCLTKDYRQR 244
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 9e-06
Identities = 37/135 (27%), Positives = 66/135 (48%), Gaps = 9/135 (6%)
Query: 115 AAKVMDKRELVSRNKESR-ARIEREILEMLDHPFLPTLYATLDCPRWSCLLTEFCPGGDL 173
KV+ K +++ +++ AR E L DH + + L+ E+ GGDL
Sbjct: 93 KEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDL 152
Query: 174 HV-----LRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIM 228
+ L++ P + +E + FY ++V+AL+ +H +++RDLK N+ + G I
Sbjct: 153 NKQIKQRLKEHLPFQE-YEVGLLFY--QIVLALDEVHSRKMMHRDLKSANIFLMPTGIIK 209
Query: 229 LTDFDLSLKGDNSTS 243
L DF S + +S S
Sbjct: 210 LGDFGFSKQYSDSVS 224
|
Length = 478 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 1e-05
Identities = 22/45 (48%), Positives = 29/45 (64%)
Query: 317 SFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGI 361
++VGT+ Y+APE ISGE +G D W+LGI EL G P+ I
Sbjct: 152 TYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQI 196
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 1e-05
Identities = 38/142 (26%), Positives = 60/142 (42%), Gaps = 27/142 (19%)
Query: 281 IVPAVSCLHPK---------------RRRKKKLGNPGTPEIVAEPLDVRSM--SFVGTHE 323
IV AVS +H + KLG+ G +I+ SM + VGT
Sbjct: 110 IVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILG---SEYSMAETVVGTPY 166
Query: 324 YLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSV 383
Y++PE+ G + D W LG ++EL F + N+V + ++ P V
Sbjct: 167 YMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATN----PLNLVVKIVQGNYTPVV 222
Query: 384 PGPAKDLIA---QLLVKDPTRR 402
+ +LI+ LL +DP +R
Sbjct: 223 SVYSSELISLVHSLLQQDPEKR 244
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 1e-05
Identities = 34/117 (29%), Positives = 51/117 (43%), Gaps = 30/117 (25%)
Query: 318 FVGTHEYLAPEI-ISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDH------------- 363
+V T Y APEI +S + + A+D W++G + EL FKG D+
Sbjct: 169 YVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGT 228
Query: 364 --ELTLANV-VARALEF----PKEPSVPGP---------AKDLIAQLLVKDPTRRMG 404
E TL+ + +A + P P P A DL+ +LL DPT+R+
Sbjct: 229 PDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRIS 285
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 1e-05
Identities = 45/173 (26%), Positives = 75/173 (43%), Gaps = 16/173 (9%)
Query: 90 LGSGDIGSVYLVQLKSKSSNNGCFFAAK--VMDKRELVSRNKESRA-RIEREILEMLDHP 146
LG G G+VY +N G A K +D +++ KE + E ++L+ L H
Sbjct: 8 LGKGAYGTVYC-----GLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHV 62
Query: 147 FLPTLYATLDCPRWSCLLTEFCPGGDL-HVLRQRQPDKRFHESAVRFYASEVVVALEFLH 205
+ T + EF PGG + +L + P E Y +++ + +LH
Sbjct: 63 NIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGP---LPEPVFCKYTKQILDGVAYLH 119
Query: 206 MMGIIYRDLKPENVLVRSDGHIMLTDF----DLSLKGDNSTSTAQLVSDQSPP 254
+++RD+K NV++ +G I L DF L+ G + T + L S P
Sbjct: 120 NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTP 172
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 1e-05
Identities = 37/151 (24%), Positives = 68/151 (45%), Gaps = 13/151 (8%)
Query: 87 VHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHP 146
+ ++G G G V+ K + A K++D E + ++ + E +L D P
Sbjct: 9 LEKIGKGSFGEVF----KGIDNRTQKVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSP 62
Query: 147 FLPTLYATL--DCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFL 204
++ Y + D W ++ E+ GG L + P E+ + E++ L++L
Sbjct: 63 YVTKYYGSYLKDTKLW--IIMEYLGGGSALDLLEPGP---LDETQIATILREILKGLDYL 117
Query: 205 HMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235
H I+RD+K NVL+ G + L DF ++
Sbjct: 118 HSEKKIHRDIKAANVLLSEHGEVKLADFGVA 148
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 1e-05
Identities = 24/74 (32%), Positives = 43/74 (58%), Gaps = 3/74 (4%)
Query: 170 GGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIML 229
G DL+ + + Q + + V+F +++ L+++H GII+RDLKP NV V D + +
Sbjct: 103 GADLNNIVKCQ---KLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRI 159
Query: 230 TDFDLSLKGDNSTS 243
DF L+ + D+ +
Sbjct: 160 LDFGLARQADDEMT 173
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 1e-05
Identities = 46/158 (29%), Positives = 70/158 (44%), Gaps = 10/158 (6%)
Query: 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAK-VMDKRELVSRNKESRA-RIEREI 139
++ R LG G G VYL ++ G A K V E +KE A E ++
Sbjct: 2 TNWRLGKLLGQGAFGRVYLCY----DADTGRELAVKQVQFDPESPETSKEVNALECEIQL 57
Query: 140 LEMLDHPFLPTLYATLDCP--RWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEV 197
L+ L H + Y L P R + E PGG + Q + E+ R Y ++
Sbjct: 58 LKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIK--DQLKSYGALTENVTRKYTRQI 115
Query: 198 VVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235
+ + +LH I++RD+K N+L S G++ L DF S
Sbjct: 116 LEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGAS 153
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 2e-05
Identities = 37/149 (24%), Positives = 66/149 (44%), Gaps = 9/149 (6%)
Query: 87 VHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHP 146
+ R+G G G VY K + A K++D E + ++ + E +L D P
Sbjct: 9 LERIGKGSFGEVY----KGIDNRTKEVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSP 62
Query: 147 FLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHM 206
++ Y + ++ E+ GG L + P E+ + E++ L++LH
Sbjct: 63 YITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPGP---LEETYIATILREILKGLDYLHS 119
Query: 207 MGIIYRDLKPENVLVRSDGHIMLTDFDLS 235
I+RD+K NVL+ G + L DF ++
Sbjct: 120 ERKIHRDIKAANVLLSEQGDVKLADFGVA 148
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 2e-05
Identities = 37/149 (24%), Positives = 66/149 (44%), Gaps = 9/149 (6%)
Query: 87 VHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHP 146
+ R+G G G V+ K + A K++D E + ++ + E +L D P
Sbjct: 9 LERIGKGSFGEVF----KGIDNRTQQVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSP 62
Query: 147 FLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHM 206
++ Y + ++ E+ GG L + P F E + E++ L++LH
Sbjct: 63 YVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGP---FDEFQIATMLKEILKGLDYLHS 119
Query: 207 MGIIYRDLKPENVLVRSDGHIMLTDFDLS 235
I+RD+K NVL+ G + L DF ++
Sbjct: 120 EKKIHRDIKAANVLLSEQGDVKLADFGVA 148
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 2e-05
Identities = 44/172 (25%), Positives = 76/172 (44%), Gaps = 19/172 (11%)
Query: 79 LTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIERE 138
L +D++F +G G+ G V LK++ +G A + +E S++ E E
Sbjct: 4 LEWNDIKFQDVIGEGNFGQV----LKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELE 59
Query: 139 ILEML-DHPFLPTLYATLDCPRWSCLLTEFCPGGDL-HVLRQR---QPDKRF---HESAV 190
+L L HP + L + + L E+ P G+L LR+ + D F + +A
Sbjct: 60 VLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAS 119
Query: 191 RF-------YASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235
+A++V +++L I+RDL N+LV + + DF LS
Sbjct: 120 TLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS 171
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 2e-05
Identities = 42/159 (26%), Positives = 69/159 (43%), Gaps = 23/159 (14%)
Query: 84 LRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKV-----MDKRELVSRNKESRARIERE 138
++ + +LG+G G V+ NN A K MD ++ ++ E +
Sbjct: 8 IQLLRKLGAGQFGEVW-----EGLWNNTTPVAVKTLKPGTMDPKDFLA---------EAQ 53
Query: 139 ILEMLDHPFLPTLYA--TLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASE 196
I++ L HP L LYA TL+ P + ++TE G L Q + + A++
Sbjct: 54 IMKKLRHPKLIQLYAVCTLEEPIY--IVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQ 111
Query: 197 VVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235
V + +L I+RDL NVLV + + DF L+
Sbjct: 112 VASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLA 150
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 2e-05
Identities = 19/58 (32%), Positives = 36/58 (62%)
Query: 183 KRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDN 240
++ E ++F +++ L+++H GII+RDLKP N+ V D + + DF L+ + D+
Sbjct: 113 EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDS 170
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.4 bits (108), Expect = 3e-05
Identities = 34/115 (29%), Positives = 45/115 (39%), Gaps = 26/115 (22%)
Query: 317 SFVGTHEYLAPEIISGE---GHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVAR 373
SF+GT ++APE+ + E G+ D W LGI EL P + R
Sbjct: 160 SFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLH--------PMR 211
Query: 374 ALEF-PKEPSVPGPAKD----------LIAQLLVKDPTRRMGSKMGATAIKRHQF 417
AL K P KD I + L KDP +R AT + +H F
Sbjct: 212 ALFLISKSNFPPPKLKDKEKWSPVFHDFIKKCLTKDPKKR----PTATKLLQHPF 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 3e-05
Identities = 34/112 (30%), Positives = 55/112 (49%), Gaps = 17/112 (15%)
Query: 314 RSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFEL------FYGTTPFKGIDHELTL 367
R S VGT ++APE+IS +G VD W+LGI + E+ ++ P K + ++
Sbjct: 172 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAM--KMIR 229
Query: 368 ANVVARALEFPK-EPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFF 418
N+ + K PS+ G + +LLV+DP +R A + +H F
Sbjct: 230 DNLPPKLKNLHKVSPSLKG----FLDRLLVRDPAQR----ATAAELLKHPFL 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 3e-05
Identities = 25/102 (24%), Positives = 45/102 (44%), Gaps = 5/102 (4%)
Query: 316 MSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARAL 375
S GT +++PE+ISGEG+G D W++G + E+ P+ + + + +
Sbjct: 167 KSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPT 226
Query: 376 EFPKEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQF 417
P V +D + ++ V+ R A + RH F
Sbjct: 227 NPVLPPHVSDHCRDFLKRIFVEAKLRPS-----ADELLRHTF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 3e-05
Identities = 29/105 (27%), Positives = 49/105 (46%), Gaps = 5/105 (4%)
Query: 313 VRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVA 372
++ +FVGT ++APE+I + D W+LGI EL G P + H + + ++
Sbjct: 156 IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDL-HPMRVLFLIP 214
Query: 373 RALEFPKEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQF 417
+ E P K+ + L KDP R +K + +H+F
Sbjct: 215 KNSPPTLEGQYSKPFKEFVEACLNKDPRFRPTAK----ELLKHKF 255
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 3e-05
Identities = 39/172 (22%), Positives = 73/172 (42%), Gaps = 22/172 (12%)
Query: 84 LRFVHRLGSGDIGSVYLVQLK----------SKSSNNGCFFAAKVMDKRELVSRNKESRA 133
LR +LG G G V+L + + + A K++ R V++ +
Sbjct: 7 LRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKML--RADVTKTARNDF 64
Query: 134 RIEREILEMLDHPFLPTLYATLDCPRWSCLLTEFCPGGDLHV-LRQRQPDKRFHESA--- 189
E +I+ L +P + L C++TE+ GDL+ L QR+ + F +
Sbjct: 65 LKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIP 124
Query: 190 ------VRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235
+ + A ++ +++L + ++RDL N LV + I + DF +S
Sbjct: 125 SVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMS 176
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 3e-05
Identities = 40/162 (24%), Positives = 74/162 (45%), Gaps = 14/162 (8%)
Query: 90 LGSGDIGSVY--LVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPF 147
LGSG+ G V + +++ K + A KV+ ++ E EI+ LD+P+
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQID----VAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPY 56
Query: 148 LPTLYATLDCPRWSCLLT-EFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHM 206
+ + C + +L E GG L+ + D+ + V +V + +++L
Sbjct: 57 IVRMIGV--CEAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELM-HQVSMGMKYLEG 113
Query: 207 MGIIYRDLKPENVLVRSDGHIMLTDFDLS--LKGDNSTSTAQ 246
++RDL NVL+ + + ++DF LS L D+S A+
Sbjct: 114 KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR 155
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 3e-05
Identities = 49/183 (26%), Positives = 75/183 (40%), Gaps = 38/183 (20%)
Query: 79 LTLSDLRFVHRLGSGDIGSVYLVQLKS-KSSNNGCFFAAKVM-------DKRELVSRNKE 130
L L LG G G V + + N A K++ D +LVS
Sbjct: 9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVS---- 64
Query: 131 SRARIEREILEML-DHPFLPTLYA--TLDCPRWSCLLTEFCPGGDLH-VLRQRQP----- 181
E E+++M+ H + L T + P + ++ E+ G+L LR R+P
Sbjct: 65 -----EMEMMKMIGKHKNIINLLGVCTQEGPLY--VVVEYAAHGNLRDFLRARRPPGEYA 117
Query: 182 ---DKRFHESAVRFY-----ASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIM-LTDF 232
D R E + A +V +EFL I+RDL NVLV ++ H+M + DF
Sbjct: 118 SPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLV-TEDHVMKIADF 176
Query: 233 DLS 235
L+
Sbjct: 177 GLA 179
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 3e-05
Identities = 43/161 (26%), Positives = 71/161 (44%), Gaps = 21/161 (13%)
Query: 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIERE--I 139
D + LG+G+ G V V + +G A K++ E+ R +I RE +
Sbjct: 1 DDFEKLGELGAGNGGVVTKVLHRP----SGLIMARKLI-HLEI---KPAIRNQIIRELKV 52
Query: 140 LEMLDHPFLPTLYATLDCPRWS----CLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYAS 195
L + P++ Y +S + E GG L + ++ R E+ + +
Sbjct: 53 LHECNSPYIVGFYGAF----YSDGEISICMEHMDGGSLDQVLKKA--GRIPENILGKISI 106
Query: 196 EVVVALEFLH-MMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235
V+ L +L I++RD+KP N+LV S G I L DF +S
Sbjct: 107 AVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVS 147
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 4e-05
Identities = 28/105 (26%), Positives = 47/105 (44%), Gaps = 13/105 (12%)
Query: 317 SFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALE 376
S GT +++PE+ISGEG+G D W+LG + E+ P+ + + + +
Sbjct: 168 SVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQ--- 224
Query: 377 FPKEPSVPG----PAKDLIAQLLVKDPTRRMGSKMGATAIKRHQF 417
P P +P A+D + + V+ R A + RH F
Sbjct: 225 -PTNPQLPSHISEHARDFLGCIFVEARHRP-----SAEELLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 4e-05
Identities = 44/156 (28%), Positives = 67/156 (42%), Gaps = 8/156 (5%)
Query: 85 RFVHR---LGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILE 141
RF+ R LG G G V L + + N G A K + N + + E EIL
Sbjct: 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILR 61
Query: 142 MLDHPFLPTLYA--TLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVV 199
L H + T D L+ EF P G L R +K + ++ YA ++
Sbjct: 62 NLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLK-YAVQICK 120
Query: 200 ALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235
+++L ++RDL NVLV S+ + + DF L+
Sbjct: 121 GMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLT 156
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 4e-05
Identities = 19/55 (34%), Positives = 32/55 (58%)
Query: 185 FHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGD 239
E V++ +++ L+++H GII+RDLKP N+ V D + + DF L+ D
Sbjct: 114 LSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHAD 168
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 4e-05
Identities = 18/44 (40%), Positives = 27/44 (61%)
Query: 200 ALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTS 243
++ LH GII+RDLKP N++V+SD + + DF L+ S
Sbjct: 130 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM 173
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 5e-05
Identities = 39/181 (21%), Positives = 68/181 (37%), Gaps = 27/181 (14%)
Query: 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELV----------SRNKES 131
L F +LG G G V+L ++ + F V R L+ ++N +
Sbjct: 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARN 64
Query: 132 RARIEREILEMLDHPFLPTLYATLDCPRWSCLLTEFCPGGDLH-VLRQRQPDKRFHES-- 188
E +IL L P + L C++TE+ GDL+ L D +
Sbjct: 65 DFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGND 124
Query: 189 --------------AVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDL 234
++ A ++ +++L + ++RDL N LV + I + DF +
Sbjct: 125 AVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGM 184
Query: 235 S 235
S
Sbjct: 185 S 185
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 5e-05
Identities = 40/159 (25%), Positives = 64/159 (40%), Gaps = 14/159 (8%)
Query: 90 LGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLP 149
LG G+ GSV QL + A K M E E ++ DHP +
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQL-KVAVKTMKLDIHTYSEIEEFLS-EAACMKDFDHPNVM 64
Query: 150 TLY------ATLDCPRWSCLLTEFCPGGDLH--VLRQRQPDKRFH---ESAVRFYASEVV 198
L ++L ++ F GDLH +L R ++ ++F ++
Sbjct: 65 KLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKF-MVDIA 123
Query: 199 VALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLK 237
+ +E+L I+RDL N ++R D + + DF LS K
Sbjct: 124 LGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKK 162
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 5e-05
Identities = 20/60 (33%), Positives = 37/60 (61%)
Query: 191 RFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQLVSD 250
+F+ +++ AL+++H + +RDLKP+N+L +D + + DF L+ N T TA +D
Sbjct: 106 QFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 165
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 44.6 bits (106), Expect = 5e-05
Identities = 44/166 (26%), Positives = 75/166 (45%), Gaps = 21/166 (12%)
Query: 80 TLSDLRFVHRLGSGDIGSVY-LVQLKSKSSNNGCFFAAKVMDKRELVSRNKES---RARI 135
L D + +LG G G VY Q+K+ V K+ L+ K+ A
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTG---------RVVALKKILMHNEKDGFPITALR 56
Query: 136 EREILEMLDHP-FLPTLYATLDCP------RWSCLLTEFCPGGDLHVLRQRQPDKRFHES 188
E +IL+ L HP +P + ++ P R S + DL L + P + ES
Sbjct: 57 EIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLE-NPSVKLTES 115
Query: 189 AVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDL 234
++ Y +++ + +LH I++RD+K N+L+ + G + + DF L
Sbjct: 116 QIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGL 161
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 6e-05
Identities = 32/114 (28%), Positives = 52/114 (45%), Gaps = 20/114 (17%)
Query: 317 SFVGTHEYLAPEIISGEGHGNA-----VDWWTLGIFIFELFYGTTPFKGIDHELTLANVV 371
+F+GT ++APE+++ E + D W+LGI + EL P HEL V+
Sbjct: 162 TFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPP----HHELNPMRVL 217
Query: 372 ARALEFPKEPSVPGPA------KDLIAQLLVKDPTRRMGSKMGATAIKRHQFFN 419
+ L+ P++ P+ D + LVKDP R A + +H F +
Sbjct: 218 LKILKSEP-PTLDQPSKWSSSFNDFLKSCLVKDPDDR----PTAAELLKHPFVS 266
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 44.4 bits (106), Expect = 6e-05
Identities = 36/136 (26%), Positives = 54/136 (39%), Gaps = 38/136 (27%)
Query: 318 FVGTHEYLAPEII-SGEGHGNAVDWWTLGIFIFELFYGTTPFKGID--HELTL------- 367
+V T Y APE++ S + A+D W++G EL F G D +L L
Sbjct: 166 YVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGT 225
Query: 368 ---------ANVVARA--LEFPKEPSVP--------GP-AKDLIAQLLVKDPTRRMGSKM 407
+ AR PK+P P P A DL+ ++LV DP +R+
Sbjct: 226 PSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRI---- 281
Query: 408 GATAIK--RHQFFNGV 421
TA + H + +
Sbjct: 282 --TADEALAHPYLAQL 295
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 44.2 bits (105), Expect = 7e-05
Identities = 35/130 (26%), Positives = 47/130 (36%), Gaps = 33/130 (25%)
Query: 319 VGTHEYLAPEIISGEGH-GNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVV------ 371
V T Y APE++ G VD W +G EL G+ F G + LA V
Sbjct: 161 VATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTP 220
Query: 372 -------------ARALEFPKE---------PSVPGPAKDLIAQLLVKDPTRRMGSKMGA 409
+ FP+ P A DL+ LLV DP++R + A
Sbjct: 221 NEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKR----LSA 276
Query: 410 TAIKRHQFFN 419
RH +F
Sbjct: 277 AEALRHPYFT 286
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 7e-05
Identities = 28/105 (26%), Positives = 52/105 (49%), Gaps = 5/105 (4%)
Query: 313 VRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVA 372
++ +FVGT ++APE+I + + D W+LGI EL G P + H + + ++
Sbjct: 156 IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSEL-HPMKVLFLIP 214
Query: 373 RALEFPKEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQF 417
+ E + P K+ + L K+P+ R +K + +H+F
Sbjct: 215 KNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAK----ELLKHKF 255
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 7e-05
Identities = 45/162 (27%), Positives = 71/162 (43%), Gaps = 20/162 (12%)
Query: 90 LGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLP 149
LG G+ GSV QLKS+ + A K++ S + E R E ++ DHP +
Sbjct: 7 LGKGEFGSVREAQLKSED-GSFQKVAVKMLKADIFSSSDIEEFLR-EAACMKEFDHPNVI 64
Query: 150 TLYAT---------LDCPRWSCLLTEFCPGGDLH--VLRQRQPDKRFH---ESAVRFYAS 195
L L P ++ F GDLH +L R ++ F ++ VRF
Sbjct: 65 KLIGVSLRSRAKGRLPIPM---VILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI- 120
Query: 196 EVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLK 237
++ +E+L I+RDL N ++ + + + DF LS K
Sbjct: 121 DIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKK 162
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 8e-05
Identities = 34/126 (26%), Positives = 52/126 (41%), Gaps = 40/126 (31%)
Query: 318 FVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVAR---- 373
+V T Y APE+I G G+ VD W++G + EL G+ F+G DH V+ +
Sbjct: 182 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTP 241
Query: 374 ALEF------------PKEPSVPG------------------------PAKDLIAQLLVK 397
+ EF P PG A+DL++++LV
Sbjct: 242 SAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVI 301
Query: 398 DPTRRM 403
DP +R+
Sbjct: 302 DPDKRI 307
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 9e-05
Identities = 35/119 (29%), Positives = 60/119 (50%), Gaps = 12/119 (10%)
Query: 293 RRKKKLGNPGTPEIVAEPLDVRSMSFVGTHEYLAPEIIS-----GEGHGNAVDWWTLGIF 347
+ K+ + G I+A+ +D + S VGT Y++PE I+ G G A D W+LG+
Sbjct: 204 AKNVKIADFGVSRILAQTMDPCNSS-VGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVS 262
Query: 348 IFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPA----KDLIAQLLVKDPTRR 402
I E + G PF G+ + A+++ A+ + P P A + I+ L ++P +R
Sbjct: 263 ILEFYLGRFPF-GVGRQGDWASLMC-AICMSQPPEAPATASREFRHFISCCLQREPAKR 319
|
Length = 353 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 1e-04
Identities = 25/89 (28%), Positives = 41/89 (46%), Gaps = 7/89 (7%)
Query: 319 VGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFP 378
+GT Y+APE+ G + D W+LG ++E+ PF+ + L V R ++P
Sbjct: 162 IGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ-DLRYKVQRG-KYP 219
Query: 379 KEPSVPGPAKDL---IAQLLVKDPTRRMG 404
P + ++DL I +L P R
Sbjct: 220 PIPPI--YSQDLQNFIRSMLQVKPKLRPN 246
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 1e-04
Identities = 30/96 (31%), Positives = 44/96 (45%), Gaps = 16/96 (16%)
Query: 319 VGTHEYLAPEIISGEGHGNAV------DWWTLGIFIFELFYGTTPFKGIDHELTLANVVA 372
+G Y+APE I G D W+LG+ I E+ G P+ T AN+ A
Sbjct: 162 IGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYP----PETYANIFA 217
Query: 373 R--ALEFPKEPSVP----GPAKDLIAQLLVKDPTRR 402
+ A+ P++P A+D +A+ L K P RR
Sbjct: 218 QLSAIVDGDPPTLPSGYSDDAQDFVAKCLNKIPNRR 253
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 1e-04
Identities = 19/42 (45%), Positives = 27/42 (64%)
Query: 317 SFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPF 358
S VGT ++APE+IS +G VD W+LGI + E+ G P+
Sbjct: 177 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPY 218
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 1e-04
Identities = 43/179 (24%), Positives = 79/179 (44%), Gaps = 16/179 (8%)
Query: 79 LTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARI-ER 137
L + +L+ + +G G+ G V L G + KV K + + ++A + E
Sbjct: 3 LNMKELKLLQTIGKGEFGDVML----------GDYRGNKVAVK--CIKNDATAQAFLAEA 50
Query: 138 EILEMLDHPFLPTLYATLDCPRWSC-LLTEFCPGGDL-HVLRQRQPDKRFHESAVRFYAS 195
++ L H L L + + ++TE+ G L LR R + ++F +
Sbjct: 51 SVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKF-SL 109
Query: 196 EVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQLVSDQSPP 254
+V A+E+L ++RDL NVLV D ++DF L+ + ++ T +L + P
Sbjct: 110 DVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAP 168
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 1e-04
Identities = 19/51 (37%), Positives = 31/51 (60%)
Query: 185 FHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235
F ES V+ +++ L++LH II+RDLK N+L+ G + + DF L+
Sbjct: 105 FSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLA 155
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 1e-04
Identities = 42/153 (27%), Positives = 67/153 (43%), Gaps = 16/153 (10%)
Query: 87 VHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKES----RARIEREILEM 142
+ +LG G +VY K S NG A KV +S E A E +L+
Sbjct: 10 LEKLGEGSYATVY----KGISRINGQLVALKV------ISMKTEEGVPFTAIREASLLKG 59
Query: 143 LDHPFLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALE 202
L H + L+ + + E+ DL + P H VR + +++ L
Sbjct: 60 LKHANIVLLHDIIHTKETLTFVFEYMHT-DLAQYMIQHPGG-LHPYNVRLFMFQLLRGLA 117
Query: 203 FLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235
++H I++RDLKP+N+L+ G + L DF L+
Sbjct: 118 YIHGQHILHRDLKPQNLLISYLGELKLADFGLA 150
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 2e-04
Identities = 31/109 (28%), Positives = 53/109 (48%), Gaps = 8/109 (7%)
Query: 297 KLGNPGTPEIVAEPLDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTT 356
K+G+ G ++ D+ S + +GT Y++PE+ S + + D W LG ++E+
Sbjct: 142 KVGDLGIARVLENQCDMAS-TLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKH 200
Query: 357 PFKGIDHELTLANVVARALE--FPKEPSVPGPA-KDLIAQLLVKDPTRR 402
F D + ++V R +E P P P +LIA +L K P +R
Sbjct: 201 AFNAKD----MNSLVYRIIEGKLPPMPKDYSPELGELIATMLSKRPEKR 245
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 2e-04
Identities = 22/65 (33%), Positives = 35/65 (53%), Gaps = 1/65 (1%)
Query: 295 KKKLGNPGTPEIVAEPLDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYG 354
K KLG+ G+ ++ P + ++VGT Y+ PEI + N D W+LG ++EL
Sbjct: 138 KVKLGDFGSARLLTSPGAY-ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTL 196
Query: 355 TTPFK 359
PF+
Sbjct: 197 KHPFQ 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 21/47 (44%), Positives = 26/47 (55%), Gaps = 1/47 (2%)
Query: 318 FVGTHEYLAPEIISGEGHGN-AVDWWTLGIFIFELFYGTTPFKGIDH 363
+V T Y APEI+ H N VD W++G + EL G T F G DH
Sbjct: 175 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDH 221
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 2e-04
Identities = 34/126 (26%), Positives = 51/126 (40%), Gaps = 41/126 (32%)
Query: 318 FVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDH-------------- 363
+V T Y APE+I G G+ VD W++G + E+ GT F G DH
Sbjct: 177 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTP 236
Query: 364 --------ELTLANVV-------ARALE-------FPKEPSVPGP-----AKDLIAQLLV 396
+ T+ N V + E FP + A+DL++++LV
Sbjct: 237 SDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLV 296
Query: 397 KDPTRR 402
DP +R
Sbjct: 297 IDPEKR 302
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 2e-04
Identities = 17/40 (42%), Positives = 29/40 (72%)
Query: 196 EVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235
+++ ++ LH GII+RDLKP N++V+SD + + DF L+
Sbjct: 131 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 170
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 43.2 bits (101), Expect = 2e-04
Identities = 25/66 (37%), Positives = 36/66 (54%), Gaps = 9/66 (13%)
Query: 187 ESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQ 246
E+ + E + ALEFLH +I+RD+K +NVL+ DG + LTDF AQ
Sbjct: 114 EAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGF---------CAQ 164
Query: 247 LVSDQS 252
+ +QS
Sbjct: 165 ITPEQS 170
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 2e-04
Identities = 41/154 (26%), Positives = 62/154 (40%), Gaps = 10/154 (6%)
Query: 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILE 141
S+L V +GSG G V+L K KV K E E +++
Sbjct: 4 SELTLVQEIGSGQFGLVWLGYWLEKR---------KVAIKTIREGAMSEEDFIEEAQVMM 54
Query: 142 MLDHPFLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVAL 201
L HP L LY CL+ EF G L + Q K F + + +V +
Sbjct: 55 KLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGK-FSQETLLGMCLDVCEGM 113
Query: 202 EFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235
+L +I+RDL N LV + + ++DF ++
Sbjct: 114 AYLESSNVIHRDLAARNCLVGENQVVKVSDFGMT 147
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.0 bits (102), Expect = 2e-04
Identities = 36/141 (25%), Positives = 62/141 (43%), Gaps = 10/141 (7%)
Query: 91 GSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREI--LEMLDHPFL 148
G G G VY K K+ +G +A K K + S++ REI L L H +
Sbjct: 9 GRGTYGRVYKA--KRKNGKDGKEYAIKKF-KGDKEQYTGISQSAC-REIALLRELKHENV 64
Query: 149 PTLYATL--DCPRWSCLLTEFCPGGDLHVLR-QRQPDKR-FHESAVRFYASEVVVALEFL 204
+L + LL ++ +++ RQ + S V+ +++ + +L
Sbjct: 65 VSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYL 124
Query: 205 HMMGIIYRDLKPENVLVRSDG 225
H +++RDLKP N+LV +G
Sbjct: 125 HSNWVLHRDLKPANILVMGEG 145
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-04
Identities = 22/74 (29%), Positives = 41/74 (55%), Gaps = 3/74 (4%)
Query: 170 GGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIML 229
G DL+ + + Q + + V+F +++ L+++H II+RDLKP N+ V D + +
Sbjct: 105 GADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKI 161
Query: 230 TDFDLSLKGDNSTS 243
DF L+ D+ +
Sbjct: 162 LDFGLARHTDDEMT 175
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 38/177 (21%), Positives = 70/177 (39%), Gaps = 31/177 (17%)
Query: 84 LRFVHRLGSGDIGSVYLVQ------------LKSKSSNNGCFFAAKVMDKRELVSRNKES 131
L FV +LG G G V+L + ++ +++ A KV+ + +
Sbjct: 7 LNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVL----RPDASDNA 62
Query: 132 RARIERE--ILEMLDHPFLPTLYATLDCPRWS--CLLTEFCPGGDL-HVLRQRQPDKRFH 186
R +E IL L P + L C C++ E+ GDL L++ +
Sbjct: 63 REDFLKEVKILSRLSDPNIARLLGV--CTVDPPLCMIMEYMENGDLNQFLQKHVAETSGL 120
Query: 187 ESAVR--------FYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235
+ + A+++ + +L + ++RDL N LV + I + DF +S
Sbjct: 121 ACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMS 177
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 2e-04
Identities = 40/157 (25%), Positives = 68/157 (43%), Gaps = 14/157 (8%)
Query: 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILE 141
+ +LGSG G V+ K++ A K++ K + K+ + E + L+
Sbjct: 6 EEFTLERKLGSGYFGEVWEGLWKNRVR-----VAIKIL-KSD--DLLKQQDFQKEVQALK 57
Query: 142 MLDHPFLPTLYA--TLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFY-ASEVV 198
L H L +L+A ++ P + ++TE G L R P+ + A A +V
Sbjct: 58 RLRHKHLISLFAVCSVGEPVY--IITELMEKGSLLAF-LRSPEGQVLPVASLIDMACQVA 114
Query: 199 VALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235
+ +L I+RDL N+LV D + DF L+
Sbjct: 115 EGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLA 151
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 2e-04
Identities = 44/164 (26%), Positives = 70/164 (42%), Gaps = 20/164 (12%)
Query: 90 LGSGDIGSVYLVQLKSKSSNNGCFFAAKVM-------DKRELVSRNKESRARIEREILEM 142
+G+G+ G V +LK F A K + +R+ +S E I+
Sbjct: 12 IGAGEFGEVCRGRLKLPGKRE-IFVAIKTLKSGYTEKQRRDFLS---------EASIMGQ 61
Query: 143 LDHPFLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALE 202
DHP + L + R ++TEF G L RQ D +F + + ++
Sbjct: 62 FDHPNIIHLEGVVTKSRPVMIITEFMENGALDSF-LRQNDGQFTVIQLVGMLRGIAAGMK 120
Query: 203 FLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS--LKGDNSTST 244
+L M ++RDL N+LV S+ ++DF LS L+ D S T
Sbjct: 121 YLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPT 164
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 42.4 bits (99), Expect = 3e-04
Identities = 17/49 (34%), Positives = 29/49 (59%)
Query: 310 PLDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPF 358
P + + VGT ++APE+++ + +G VD W+LGI E+ G P+
Sbjct: 167 PEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 3e-04
Identities = 37/168 (22%), Positives = 73/168 (43%), Gaps = 6/168 (3%)
Query: 81 LSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREIL 140
L++ + ++G G VY ++ + A K + E++ E ++L
Sbjct: 1 LANFQIEKKIGRGQFSEVY----RATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLL 56
Query: 141 EMLDHPFLPTLYATLDCPRWSCLLTEFCPGGDL-HVLRQRQPDKRF-HESAVRFYASEVV 198
+ L+HP + + ++ E GDL +++ + KR E V Y ++
Sbjct: 57 KQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLC 116
Query: 199 VALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQ 246
A+E +H +++RD+KP NV + + G + L D L + T+ A
Sbjct: 117 SAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAH 164
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 3e-04
Identities = 43/160 (26%), Positives = 72/160 (45%), Gaps = 10/160 (6%)
Query: 79 LTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIERE 138
L ++L+ V LGSG G+VY N A KV+ RE S E
Sbjct: 4 LKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVL--RENTSPKANKEILDEAY 61
Query: 139 ILEMLDHPFLPTLYATLDCPRWSC-LLTEFCPGGDL--HVLRQRQPDKRFHESAVRFYAS 195
++ + P++ L C + L+T+ P G L +V R+ R + +
Sbjct: 62 VMAGVGSPYVCRLLGI--CLTSTVQLVTQLMPYGCLLDYV---RENKDRIGSQDLLNWCV 116
Query: 196 EVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235
++ + +L + +++RDL NVLV+S H+ +TDF L+
Sbjct: 117 QIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLA 156
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 42.4 bits (99), Expect = 3e-04
Identities = 17/49 (34%), Positives = 29/49 (59%)
Query: 310 PLDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPF 358
P + + VGT ++APE+++ + +G VD W+LGI E+ G P+
Sbjct: 167 PEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 3e-04
Identities = 23/66 (34%), Positives = 35/66 (53%), Gaps = 9/66 (13%)
Query: 187 ESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQ 246
E + E + AL+FLH +I+RD+K +N+L+ DG + LTDF AQ
Sbjct: 114 EGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGF---------CAQ 164
Query: 247 LVSDQS 252
+ +QS
Sbjct: 165 ITPEQS 170
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 3e-04
Identities = 40/172 (23%), Positives = 69/172 (40%), Gaps = 19/172 (11%)
Query: 79 LTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAA--KVMDKRELVSRNKESRARIE 136
+ LS +RF+ LG G VY L + A + DK E R + + E
Sbjct: 2 INLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREE---FKHE 58
Query: 137 REILEMLDHPFLPTLYATLDCPRWSCLLTEFCPGGDLH-VLRQRQP--------DKRFHE 187
+ L HP + L + + ++ +C DLH L R P D + +
Sbjct: 59 AMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVK 118
Query: 188 SAVR-----FYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDL 234
S + +++ +EFL ++++DL NVLV ++ ++D L
Sbjct: 119 STLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGL 170
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 3e-04
Identities = 40/159 (25%), Positives = 72/159 (45%), Gaps = 8/159 (5%)
Query: 90 LGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLP 149
LGSG+ G+V K K S A K++ K+ R E +++ LD+P++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTV--AVKILKNDNNDPALKDELLR-EANVMQQLDNPYIV 59
Query: 150 TLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGI 209
+ + W L+ E G L+ Q+ +K E + +V + +++L
Sbjct: 60 RMIGICEAESW-MLVMELAELGPLNKFLQK--NKHVTEKNITELVHQVSMGMKYLEETNF 116
Query: 210 IYRDLKPENVLVRSDGHIMLTDFDLS--LKGDNSTSTAQ 246
++RDL NVL+ + + ++DF LS L D + A+
Sbjct: 117 VHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAK 155
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.2 bits (101), Expect = 3e-04
Identities = 41/160 (25%), Positives = 72/160 (45%), Gaps = 28/160 (17%)
Query: 81 LSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREIL 140
L++ + ++G+G G V+LV+ K FF K + R L R K S+ IE ++
Sbjct: 12 LNEYEVIKKIGNGRFGEVFLVKHKRTQE----FFCWKAISYRGLKEREK-SQLVIEVNVM 66
Query: 141 EMLDHP--------FLPTLYATLDCPRWSCLLTEFCPGGDL--HVLRQRQPDKRFHESAV 190
L H FL L +L EFC GDL ++ + + + E A+
Sbjct: 67 RELKHKNIVRYIDRFLNKANQKL------YILMEFCDAGDLSRNIQKCYKMFGKIEEHAI 120
Query: 191 RFYASEVVVALEFLHMMG-------IIYRDLKPENVLVRS 223
+++ AL + H + +++RDLKP+N+ + +
Sbjct: 121 VDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLST 160
|
Length = 1021 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 3e-04
Identities = 26/82 (31%), Positives = 47/82 (57%), Gaps = 7/82 (8%)
Query: 172 DLH-VLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLT 230
DLH ++ QP H V+ + +++ L++LH GI++RD+KP N+LV S+ + +
Sbjct: 89 DLHKIIVSPQPLSSDH---VKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKIC 145
Query: 231 DFDLSLKGDNSTS---TAQLVS 249
DF L+ + S T ++V+
Sbjct: 146 DFGLARVEEPDESKHMTQEVVT 167
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 3e-04
Identities = 37/139 (26%), Positives = 54/139 (38%), Gaps = 36/139 (25%)
Query: 297 KLGNPGTPEIVAEPLDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTT 356
KL + G ++E + +V T Y +PE++ G +G AVD W++G + EL G
Sbjct: 140 KLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQP 199
Query: 357 PFKG---IDHELTLANVVARALEFPKE----------------PSVPGPAK--------- 388
F G ID T+ V+ P E P+V P
Sbjct: 200 LFPGESEIDQLFTIQKVLG---PLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGIL 256
Query: 389 -----DLIAQLLVKDPTRR 402
DL+ LL +PT R
Sbjct: 257 SGVLLDLMKNLLKLNPTDR 275
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 3e-04
Identities = 17/40 (42%), Positives = 29/40 (72%)
Query: 196 EVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235
+++ ++ LH GII+RDLKP N++V+SD + + DF L+
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 173
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 4e-04
Identities = 20/55 (36%), Positives = 30/55 (54%), Gaps = 1/55 (1%)
Query: 182 DKRFHESAVRFYASEVVVALEFL-HMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235
E + A V AL +L + II+RD+KP N+L+ +G+I L DF +S
Sbjct: 101 KSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGIS 155
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 4e-04
Identities = 37/147 (25%), Positives = 63/147 (42%), Gaps = 8/147 (5%)
Query: 87 VHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHP 146
+H +G G G+VY + +S+ A K M + K E + L+ L HP
Sbjct: 26 LHEIGHGSFGAVYF----ATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHP 81
Query: 147 FLPTLYATLDCPRWSCLLTEFCPGGDLHVLR-QRQPDKRFHESAVRFYASEVVVALEFLH 205
+ L+ E+C G +L ++P + +A+ A + L +LH
Sbjct: 82 NTIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQ---GLAYLH 138
Query: 206 MMGIIYRDLKPENVLVRSDGHIMLTDF 232
+I+RD+K N+L+ G + L DF
Sbjct: 139 SHNMIHRDIKAGNILLTEPGQVKLADF 165
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 4e-04
Identities = 17/40 (42%), Positives = 29/40 (72%)
Query: 196 EVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235
+++ ++ LH GII+RDLKP N++V+SD + + DF L+
Sbjct: 127 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 166
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 5e-04
Identities = 30/109 (27%), Positives = 52/109 (47%), Gaps = 13/109 (11%)
Query: 313 VRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVA 372
++ +FVGT ++APE+I + + D W+LGI EL G P + ++ V+
Sbjct: 156 IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPP----NSDMHPMRVLF 211
Query: 373 RALEFPKEPSVPGP----AKDLIAQLLVKDPTRRMGSKMGATAIKRHQF 417
+ P++ G K+ I L KDP+ R +K + +H+F
Sbjct: 212 LIPKNNP-PTLTGEFSKPFKEFIDACLNKDPSFRPTAK----ELLKHKF 255
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 5e-04
Identities = 37/152 (24%), Positives = 73/152 (48%), Gaps = 18/152 (11%)
Query: 89 RLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKES---RARIEREILEMLDH 145
+LG G +VY + +SK ++N ++ +E+ ++E A E +L+ L H
Sbjct: 13 KLGEGTYATVY--KGRSKLTDN-------LVALKEIRLEHEEGAPCTAIREVSLLKDLKH 63
Query: 146 PFLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPD--KRFHESAVRFYASEVVVALEF 203
+ TL+ + + L+ E+ L+Q D + V+ + +++ L +
Sbjct: 64 ANIVTLHDIIHTEKSLTLVFEYLDKD----LKQYLDDCGNSINMHNVKLFLFQLLRGLNY 119
Query: 204 LHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235
H +++RDLKP+N+L+ G + L DF L+
Sbjct: 120 CHRRKVLHRDLKPQNLLINERGELKLADFGLA 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 5e-04
Identities = 41/168 (24%), Positives = 70/168 (41%), Gaps = 19/168 (11%)
Query: 83 DLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREIL-E 141
D++F +G G+ G V +++ +G A + +E S N E E+L +
Sbjct: 3 DIKFEDVIGEGNFGQV----IRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCK 58
Query: 142 MLDHPFLPTLYATLDCPRWSCLLTEFCPGGDL-------HVLRQRQPDKRFHESAVRF-- 192
+ HP + L + + + E+ P G+L VL + H +A
Sbjct: 59 LGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTS 118
Query: 193 -----YASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235
+AS+V +++L I+RDL NVLV + + DF LS
Sbjct: 119 QQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLS 166
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 6e-04
Identities = 37/132 (28%), Positives = 51/132 (38%), Gaps = 39/132 (29%)
Query: 321 THE-----YLAPEIISG-EGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARA 374
THE Y APEI+ G + + AVD W+LG E+ F G D E+ + R
Sbjct: 158 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPG-DSEIDQLFRIFRT 216
Query: 375 LEFPKEPSVPG----------------------------PAKDLIAQLLVKDPTRRMGSK 406
L P E PG +DL++Q+L DP +R+ +K
Sbjct: 217 LGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAK 276
Query: 407 MGATAIKRHQFF 418
H FF
Sbjct: 277 AALA----HPFF 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 6e-04
Identities = 24/89 (26%), Positives = 45/89 (50%), Gaps = 8/89 (8%)
Query: 317 SFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALE 376
S GT +++PE+ISGEG+G D W++ + E+ P+ + +A + A +
Sbjct: 168 SVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYE---AMAAIFKIATQ 224
Query: 377 FPKEPSVP----GPAKDLIAQLLVKDPTR 401
P +P +P +D + Q+ V++ R
Sbjct: 225 -PTKPMLPDGVSDACRDFLKQIFVEEKRR 252
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 6e-04
Identities = 41/165 (24%), Positives = 73/165 (44%), Gaps = 27/165 (16%)
Query: 94 DIGSVYLVQLKSKSSNNGCFFAA-------KVMDKRELVSRNKESRARIERE--ILEMLD 144
D+GS Y+ +NG F+A +V K+ +V + +S RE I+ LD
Sbjct: 2 DLGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKK-IVLTDPQSVKHALREIKIIRRLD 60
Query: 145 HPFLPTLYATL-----DCPRWSCLLTEF--------CPGGDLHVLRQRQPDKRFHESAVR 191
H + +Y L D LTE DL + ++ P E R
Sbjct: 61 HDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGP---LSEEHAR 117
Query: 192 FYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIM-LTDFDLS 235
+ +++ L+++H +++RDLKP NV + ++ ++ + DF L+
Sbjct: 118 LFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLA 162
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 7e-04
Identities = 44/152 (28%), Positives = 64/152 (42%), Gaps = 35/152 (23%)
Query: 297 KLGNPGTPEIVAEPLDVRSMSFVGTHEYLAPEIISGE-GHGNAVDWWTLGIFIFELFYGT 355
KL + G +A P +V + +V T Y APE++ G+ +G AVD W +G + E+ G
Sbjct: 140 KLCDFGFARTLAAPGEVYT-DYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGE 198
Query: 356 TPFKG---ID--HELT--LANVVAR--------------ALEFPKE--------PSVPGP 386
F G ID + + L N++ R L KE P + G
Sbjct: 199 PLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGL 258
Query: 387 AKDLIAQLLVKDPTRRMGSKMGATAIKRHQFF 418
DL Q L DP R S + + H+FF
Sbjct: 259 VLDLAKQCLRIDPDDRPSS----SQLLHHEFF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 7e-04
Identities = 28/81 (34%), Positives = 38/81 (46%), Gaps = 8/81 (9%)
Query: 307 VAEPLDVRSMSFVGTHEYLAPEIISGEGHGN-AVDWWTLGIFIFELFYGTTPFKGIDHEL 365
+A D +V T Y APE+I H N VD W++G + E+ G T FKG D+
Sbjct: 163 LARHADAEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD 222
Query: 366 TLANVVARALEFPKEPSVPGP 386
L ++ K VPGP
Sbjct: 223 QLTQIL-------KVTGVPGP 236
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 9e-04
Identities = 18/52 (34%), Positives = 31/52 (59%), Gaps = 6/52 (11%)
Query: 181 PDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDF 232
P+K VR Y +++ A+ + H I++RD+KPEN+L+ + + L DF
Sbjct: 99 PEK------VRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDF 144
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.0 bits (94), Expect = 0.001
Identities = 34/131 (25%), Positives = 51/131 (38%), Gaps = 35/131 (26%)
Query: 318 FVGTHEYLAPEIISG-EGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARAL- 375
+V T Y APE++ G +G+ VD W++G EL F G E+ + R L
Sbjct: 158 YVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPG-KSEIDQLFKIFRTLG 216
Query: 376 -------------------EFPKEPSVP---------GPAKDLIAQLLVKDPTRRMGSKM 407
FPK+ +P A DL++Q+L DP +R +
Sbjct: 217 TPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKR----I 272
Query: 408 GATAIKRHQFF 418
A H +F
Sbjct: 273 TAEQALAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.001
Identities = 31/110 (28%), Positives = 57/110 (51%), Gaps = 10/110 (9%)
Query: 297 KLGNPGTPEIVAEPLDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTT 356
K+G+ G ++ D+ + +F GT Y++PE + +G+ + D W+LG ++E+
Sbjct: 145 KIGDFGVSRLLMGSCDL-ATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAH 203
Query: 357 PFKGIDHELTLANVVARALEFPKEPSVP----GPAKDLIAQLLVKDPTRR 402
F+G + +VV R +E P PS+P ++ +L KDP+ R
Sbjct: 204 AFEGQN----FLSVVLRIVEGPT-PSLPETYSRQLNSIMQSMLNKDPSLR 248
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.2 bits (95), Expect = 0.001
Identities = 36/132 (27%), Positives = 53/132 (40%), Gaps = 39/132 (29%)
Query: 321 THE-----YLAPEIISGEGH-GNAVDWWTLGIFIFELFYGTTPFKG---IDHELT----- 366
THE Y APEI+ G H AVD W++G E+ G F G ID +L
Sbjct: 156 THEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEID-QLFKIFQI 214
Query: 367 -----------LANVVARALEFPKEPSVP---------GPAKDLIAQLLVKDPTRRMGSK 406
+ + FPK P DL++++L +P +R+ +K
Sbjct: 215 LGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAK 274
Query: 407 MGATAIKRHQFF 418
A+K H +F
Sbjct: 275 ---EALK-HPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.001
Identities = 25/91 (27%), Positives = 46/91 (50%), Gaps = 8/91 (8%)
Query: 317 SFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALE 376
S VGT Y++PE I G+ D W+LG ++E+ +PF G ++ L ++ + +E
Sbjct: 165 SLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG--DKMNLFSLCQK-IE 221
Query: 377 FPKEPSVPG-----PAKDLIAQLLVKDPTRR 402
P +P ++L++ + DP +R
Sbjct: 222 QCDYPPLPTEHYSEKLRELVSMCIYPDPDQR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.3 bits (96), Expect = 0.001
Identities = 32/106 (30%), Positives = 56/106 (52%), Gaps = 14/106 (13%)
Query: 297 KLGNPGTPEIVAEPLDVRSM--SFVGTHEYLAPEIISGE--GHGNAVDWWTLGIFIFELF 352
K+G+ G +++ + + SM S VGT Y +PE++ E + + D W LG I+EL
Sbjct: 182 KIGDFG----LSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELC 237
Query: 353 YGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKD 398
G TPF ++ L + + R + P + G +K+L +L+K+
Sbjct: 238 SGKTPFHKANNFSQLISELKRGPDLP----IKGKSKEL--NILIKN 277
|
Length = 1021 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.001
Identities = 29/109 (26%), Positives = 49/109 (44%), Gaps = 2/109 (1%)
Query: 136 EREILEMLDHPFLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYAS 195
E +L+ L H + TL+ + R L+ E+ L H V+ +
Sbjct: 53 EVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLDSDLKQYLDNCGNLMSMHN--VKIFMF 110
Query: 196 EVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTST 244
+++ L + H I++RDLKP+N+L+ G + L DF L+ T T
Sbjct: 111 QLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKT 159
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.001
Identities = 46/156 (29%), Positives = 72/156 (46%), Gaps = 13/156 (8%)
Query: 83 DLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMD-KRELVSRNKESRARIEREILE 141
D + LG+G+ G V VQ K +G A K++ + + RN+ R E ++L
Sbjct: 6 DFERISELGAGNGGVVTKVQHKP----SGLIMARKLIHLEIKPAIRNQIIR---ELQVLH 58
Query: 142 MLDHPFLPTLYATLDCPRWSCLLTEFCPGGDL-HVLRQRQPDKRFHESAVRFYASEVVVA 200
+ P++ Y + E GG L VL++ KR E + + V+
Sbjct: 59 ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEA---KRIPEEILGKVSIAVLRG 115
Query: 201 LEFL-HMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235
L +L I++RD+KP N+LV S G I L DF +S
Sbjct: 116 LAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVS 151
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 40.4 bits (95), Expect = 0.001
Identities = 36/157 (22%), Positives = 70/157 (44%), Gaps = 15/157 (9%)
Query: 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILE 141
L+ +LG+G G V++ + N A K + + + E+ + E +I++
Sbjct: 6 ESLKLERKLGAGQFGEVWM-----GTWNGTTKVAVKTLKPG---TMSPEAFLQ-EAQIMK 56
Query: 142 MLDHPFLPTLYA--TLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVV 199
L H L LYA + + P + ++TE+ G L + K+ + A+++
Sbjct: 57 KLRHDKLVQLYAVCSEEEPIY--IVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAE 114
Query: 200 ALEFLHMMGIIYRDLKPENVLVRSDGHIM-LTDFDLS 235
+ +L I+RDL N+LV + + + DF L+
Sbjct: 115 GMAYLESRNYIHRDLAARNILV-GENLVCKIADFGLA 150
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.001
Identities = 36/147 (24%), Positives = 63/147 (42%), Gaps = 6/147 (4%)
Query: 90 LGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLP 149
LGSG G+VY + A K + RE S E ++ +D+P +
Sbjct: 15 LGSGAFGTVYKGLWIPEGEKVKIPVAIKEL--REATSPKANKEILDEAYVMASVDNPHVC 72
Query: 150 TLYATLDCPRWSC-LLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMG 208
L C + L+T+ P G L + R+ + + ++ + +L
Sbjct: 73 RLLGI--CLTSTVQLITQLMPFGCL-LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERR 129
Query: 209 IIYRDLKPENVLVRSDGHIMLTDFDLS 235
+++RDL NVLV++ H+ +TDF L+
Sbjct: 130 LVHRDLAARNVLVKTPQHVKITDFGLA 156
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.001
Identities = 19/47 (40%), Positives = 27/47 (57%)
Query: 200 ALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQ 246
AL +LH GII+RD+K EN+ + + +L DF + K D T Q
Sbjct: 197 ALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQ 243
|
Length = 392 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.001
Identities = 17/55 (30%), Positives = 31/55 (56%)
Query: 190 VRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTST 244
V+ + +++ L + H +++RDLKP+N+L+ G + L DF L+ T T
Sbjct: 106 VKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKT 160
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.002
Identities = 21/87 (24%), Positives = 35/87 (40%), Gaps = 3/87 (3%)
Query: 317 SFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARAL- 375
S G+ ++APE++ + D W+LG + E+ G PF + + A
Sbjct: 171 SLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASP 230
Query: 376 EFPKEPSVPGPAKDLIAQLLVKDPTRR 402
E P S A D + + D +R
Sbjct: 231 EIPSNISS--EAIDFLEKTFEIDHNKR 255
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.002
Identities = 25/88 (28%), Positives = 39/88 (44%), Gaps = 2/88 (2%)
Query: 317 SFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALE 376
S VGT Y++PE I G+ D W+LG ++E+ +PF G L +
Sbjct: 165 SLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCD 224
Query: 377 FPKEPS--VPGPAKDLIAQLLVKDPTRR 402
+P PS + L+ + DP +R
Sbjct: 225 YPPLPSDHYSEELRQLVNMCINPDPEKR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.002
Identities = 32/127 (25%), Positives = 48/127 (37%), Gaps = 30/127 (23%)
Query: 307 VAEPLDVRSMSFVGTHEYLAPEI-ISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDH-- 363
+A D + +V T Y APEI ++ + + VD W+ G E+ G F G DH
Sbjct: 154 LARIQDPQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVN 213
Query: 364 ------------------ELTLANVVARALEFPKEPSVP---------GPAKDLIAQLLV 396
+ N + PK VP A DL+ ++LV
Sbjct: 214 QFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLV 273
Query: 397 KDPTRRM 403
DP +R+
Sbjct: 274 FDPQKRI 280
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.002
Identities = 21/47 (44%), Positives = 26/47 (55%), Gaps = 1/47 (2%)
Query: 318 FVGTHEYLAPEIISGEGHGN-AVDWWTLGIFIFELFYGTTPFKGIDH 363
+V T Y APEI+ H N VD W++G + EL G T F G DH
Sbjct: 177 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 223
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.002
Identities = 41/162 (25%), Positives = 63/162 (38%), Gaps = 14/162 (8%)
Query: 74 NNNNPLTL-SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESR 132
+ ++P L +DLR +G G G+VY ++ A K M S K
Sbjct: 9 SKDDPEKLFTDLR---EIGHGSFGAVYF----ARDVRTNEVVAIKKMSYSGKQSNEKWQD 61
Query: 133 ARIEREILEMLDHPFLPTLYATL--DCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAV 190
E L+ L HP + W L+ E+C G +L + K E +
Sbjct: 62 IIKEVRFLQQLRHPNTIEYKGCYLREHTAW--LVMEYCLGSASDILEVHK--KPLQEVEI 117
Query: 191 RFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDF 232
+ L +LH I+RD+K N+L+ G + L DF
Sbjct: 118 AAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADF 159
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|236400 PRK09188, PRK09188, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.002
Identities = 30/89 (33%), Positives = 39/89 (43%), Gaps = 14/89 (15%)
Query: 149 PTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMG 208
P L AT L+ + G LH+ R D + SA R AL LH G
Sbjct: 85 PQLLATGK----DGLVRGWTEGVPLHLARPHG-DPAWFRSAHR--------ALRDLHRAG 131
Query: 209 IIYRDL-KPENVLVRSDGHIMLTDFDLSL 236
I + DL KP+N L+ DG + DF L+
Sbjct: 132 ITHNDLAKPQNWLMGPDGEAAVIDFQLAS 160
|
Length = 365 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.002
Identities = 41/165 (24%), Positives = 66/165 (40%), Gaps = 8/165 (4%)
Query: 89 RLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFL 148
++G G+ G VY LK A K + L K + E EIL+ DHP +
Sbjct: 2 KIGKGNFGDVYKGVLKGN-----TEVAVKTC-RSTLPPDLKRKFLQ-EAEILKQYDHPNI 54
Query: 149 PTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMG 208
L + ++ E PGG L + R+ R + + + +E+L
Sbjct: 55 VKLIGVCVQKQPIYIVMELVPGGSL-LTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN 113
Query: 209 IIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQLVSDQSP 253
I+RDL N LV + + ++DF +S + + T Q P
Sbjct: 114 CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIP 158
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.002
Identities = 32/105 (30%), Positives = 49/105 (46%), Gaps = 18/105 (17%)
Query: 136 EREILEMLDHP-FLPTL----YATLDC---PRWSCLLTEFCPGGDLHVLRQRQPDKRFHE 187
E +L L HP L L L C P++ L + + + +P
Sbjct: 210 EARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYRSDLYTY-------LGARLRPLGLAQV 262
Query: 188 SAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDF 232
+AV A +++ A++++H GII+RD+K ENVLV I L DF
Sbjct: 263 TAV---ARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDF 304
|
Length = 461 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.002
Identities = 42/153 (27%), Positives = 63/153 (41%), Gaps = 11/153 (7%)
Query: 81 LSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREIL 140
SDLR +G G G+VY ++ N A K M S K E L
Sbjct: 17 FSDLR---EIGHGSFGAVYF----ARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFL 69
Query: 141 EMLDHPFLPTLYATLDCPRWSCLLTEFCPGGDLHVLR-QRQPDKRFHESAVRFYASEVVV 199
+ L HP + L+ E+C G +L ++P + +AV A +
Sbjct: 70 QKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQ--- 126
Query: 200 ALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDF 232
L +LH +I+RD+K N+L+ G + L DF
Sbjct: 127 GLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDF 159
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.002
Identities = 38/165 (23%), Positives = 73/165 (44%), Gaps = 14/165 (8%)
Query: 84 LRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARI-EREILEM 142
L+ V +LG+G G V++ N A K + + + A + E +++
Sbjct: 8 LKLVKKLGAGQFGEVWM-----GYYNGHTKVAIKSLKQGSM-----SPEAFLAEANLMKQ 57
Query: 143 LDHPFLPTLYATLDC-PRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVAL 201
L HP L LYA + P + ++TE+ G L + + + + A+++ +
Sbjct: 58 LQHPRLVRLYAVVTQEPIY--IITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGM 115
Query: 202 EFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQ 246
F+ I+RDL+ N+LV + DF L+ +++ TA+
Sbjct: 116 AFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAR 160
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.002
Identities = 29/105 (27%), Positives = 49/105 (46%), Gaps = 19/105 (18%)
Query: 136 EREILEMLDHPFLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYA- 194
E IL ++HP + L T +++CL +L + + D + +A R A
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCL-----------ILPRYKTDLYCYLAAKRNIAI 181
Query: 195 -------SEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDF 232
V+ A+++LH II+RD+K EN+ + G + L DF
Sbjct: 182 CDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDF 226
|
Length = 391 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 0.002
Identities = 39/163 (23%), Positives = 64/163 (39%), Gaps = 38/163 (23%)
Query: 88 HRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARI----EREILEML 143
+LG G +VY K +S G A K + E A E +L+ L
Sbjct: 11 DKLGEGSYATVY----KGRSKLTGQLVALKE------IRLEHEEGAPFTAIREASLLKDL 60
Query: 144 DHPFLPTLYATLDCPRWSCLLTEF-----------CPGGDLHVLRQRQPDKRFHESAVRF 192
H + TL+ + + L+ E+ C GG VR
Sbjct: 61 KHANIVTLHDIIHTKKTLTLVFEYLDTDLKQYMDDCGGG-------------LSMHNVRL 107
Query: 193 YASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235
+ +++ L + H +++RDLKP+N+L+ G + L DF L+
Sbjct: 108 FLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLA 150
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.002
Identities = 14/58 (24%), Positives = 30/58 (51%), Gaps = 1/58 (1%)
Query: 179 RQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIM-LTDFDLS 235
R P + ++ + +++ + H G+++RDLKP+N+LV ++ + D L
Sbjct: 101 RGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLG 158
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.002
Identities = 37/160 (23%), Positives = 63/160 (39%), Gaps = 17/160 (10%)
Query: 90 LGSGDIGSVYLVQLKSKS-SNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFL 148
LG G G V+L + + + A K + + +R R E E+L +L H +
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQR---EAELLTVLQHQHI 69
Query: 149 PTLYATLDCPRWSCLLTEFCPGGDLH-VLRQRQPDKRFHE------------SAVRFYAS 195
Y R ++ E+ GDL+ LR PD + + AS
Sbjct: 70 VRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIAS 129
Query: 196 EVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235
++ + +L + ++RDL N LV + + DF +S
Sbjct: 130 QIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMS 169
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 38.8 bits (91), Expect = 0.003
Identities = 37/144 (25%), Positives = 52/144 (36%), Gaps = 37/144 (25%)
Query: 307 VAEPLDVRSMSFVGTHEYLAPEIISGEG-HGNAVDWWTLGIFIFELFYGTTPFKG---ID 362
+ +V T Y APE++ G+ +G VD W +G + EL G F G ID
Sbjct: 150 LRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDID 209
Query: 363 H----------------ELTLANVVARALEFPKEPSVP------------GPAKDLIAQL 394
EL +N + FP EPS P PA D +
Sbjct: 210 QLYLIQKCLGPLPPSHQELFSSNPRFAGVAFP-EPSQPESLERRYPGKVSSPALDFLKAC 268
Query: 395 LVKDPTRRMGSKMGATAIKRHQFF 418
L DP R + + +H +F
Sbjct: 269 LRMDPKER----LTCDELLQHPYF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 38.8 bits (91), Expect = 0.003
Identities = 34/132 (25%), Positives = 50/132 (37%), Gaps = 39/132 (29%)
Query: 321 THE-----YLAPEIISGEGH-GNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARA 374
THE Y APEI+ G VD W++G E+ F G D E+ + R
Sbjct: 157 THEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPG-DSEIDQLFRIFRT 215
Query: 375 LEFPKEPSVPG--------------PAK--------------DLIAQLLVKDPTRRMGSK 406
L P E PG + DL++++LV DP +R+ +K
Sbjct: 216 LGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAK 275
Query: 407 MGATAIKRHQFF 418
+H +F
Sbjct: 276 AAL----QHPYF 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.003
Identities = 15/51 (29%), Positives = 29/51 (56%)
Query: 185 FHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235
F E ++ + +++ L + H ++RD+K N+L+ + G I L DF L+
Sbjct: 113 FSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLA 163
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 39.3 bits (91), Expect = 0.003
Identities = 38/153 (24%), Positives = 63/153 (41%), Gaps = 11/153 (7%)
Query: 81 LSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREIL 140
+DLR +G G G+VY ++ A K M S K E + L
Sbjct: 27 FTDLR---EIGHGSFGAVYF----ARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFL 79
Query: 141 EMLDHPFLPTLYATLDCPRWSCLLTEFCPGGDLHVLR-QRQPDKRFHESAVRFYASEVVV 199
+ + HP + L+ E+C G +L ++P + +A+ A +
Sbjct: 80 QRIKHPNSIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQ--- 136
Query: 200 ALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDF 232
L +LH +I+RD+K N+L+ G + L DF
Sbjct: 137 GLAYLHSHNMIHRDIKAGNILLTEPGQVKLADF 169
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.003
Identities = 40/168 (23%), Positives = 66/168 (39%), Gaps = 18/168 (10%)
Query: 83 DLRFVHRLGSGDIGSVYLVQLKSKS-SNNGCFFAAKVMDKRELVSRNKESRARIEREILE 141
D+ LG G G V+L + + S + + A K + L +R R E E+L
Sbjct: 6 DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQR---EAELLT 62
Query: 142 MLDHPFLPTLYATLDCPRWSCLLTEFCPGGDLH-VLRQRQPDK-------------RFHE 187
L H + Y ++ E+ GDL+ LR PD
Sbjct: 63 NLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGL 122
Query: 188 SAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235
S + AS++ + +L ++RDL N LV ++ + + DF +S
Sbjct: 123 SQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMS 170
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.003
Identities = 43/159 (27%), Positives = 71/159 (44%), Gaps = 19/159 (11%)
Query: 83 DLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKREL--VSRNKESRARIEREIL 140
D + LG+G+ G V+ V K A+ + E+ RN+ R E ++L
Sbjct: 6 DFEKISELGAGNGGVVFKVSHKPSG-----LIMARKLIHLEIKPAIRNQIIR---ELQVL 57
Query: 141 EMLDHPFLPTLYATLDCPRWSCLLTEFCPGGDL-HVLRQ--RQPDKRFHESAVRFYASEV 197
+ P++ Y + E GG L VL++ R P++ + ++ V
Sbjct: 58 HECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSI-----AV 112
Query: 198 VVALEFL-HMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235
+ L +L I++RD+KP N+LV S G I L DF +S
Sbjct: 113 IKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVS 151
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.2 bits (92), Expect = 0.003
Identities = 32/116 (27%), Positives = 51/116 (43%), Gaps = 30/116 (25%)
Query: 318 FVGTHEYLAPEI-ISGEGHGNAVDWWTLGIFIFELFYGTTPFKGID--HELTLANVV--- 371
+V T Y APEI ++ +G+ A+D W++G + E+ F G D H+L L V
Sbjct: 169 YVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGT 228
Query: 372 -----------ARALEF----PKEPSVP---------GPAKDLIAQLLVKDPTRRM 403
RA + P +P VP A DL+ ++L +P +R+
Sbjct: 229 PSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRI 284
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 38.7 bits (90), Expect = 0.004
Identities = 30/118 (25%), Positives = 53/118 (44%), Gaps = 15/118 (12%)
Query: 291 KRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFE 350
K + K+G+ G +I++ ++ + VGT Y++PE+ G+ + D W LG ++E
Sbjct: 136 KHKMVVKIGDFGISKILSS--KSKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYE 193
Query: 351 LFYGTTPFKGIDHELTLANVVARALEF------PKEPSVPGPAKDLIAQLLVKDPTRR 402
L F+ AN+ A L+ P + LI +L DP++R
Sbjct: 194 LASLKRAFEA-------ANLPALVLKIMSGTFAPISDRYSPDLRQLILSMLNLDPSKR 244
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 38.9 bits (90), Expect = 0.004
Identities = 19/46 (41%), Positives = 26/46 (56%)
Query: 318 FVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDH 363
+V T Y APE+I G G+ VD W++G + E+ G F G DH
Sbjct: 185 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDH 230
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 38.9 bits (90), Expect = 0.004
Identities = 17/47 (36%), Positives = 27/47 (57%)
Query: 311 LDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTP 357
+D + SFVGT Y++PE + G + D W++G+ + EL G P
Sbjct: 155 IDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 38.6 bits (90), Expect = 0.004
Identities = 35/132 (26%), Positives = 52/132 (39%), Gaps = 38/132 (28%)
Query: 321 THE-----YLAPEIISGEGH-GNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARA 374
THE Y APE++ G H VD W++G E+ F G D EL + +
Sbjct: 169 THEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPG-DSELQQLLHIFKL 227
Query: 375 LEFPKEPSVPGPAK---------------------------DLIAQLLVKDPTRRMGSKM 407
L P E PG +K DL+ ++L DP +R+ +K
Sbjct: 228 LGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAK- 286
Query: 408 GATAIKRHQFFN 419
A+ H +F+
Sbjct: 287 --AALT-HPYFD 295
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 38.9 bits (90), Expect = 0.004
Identities = 24/81 (29%), Positives = 35/81 (43%), Gaps = 6/81 (7%)
Query: 311 LDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDH---ELTL 367
+D + SFVGT Y++PE + G + D W++G+ + E+ G P D EL
Sbjct: 155 IDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMF 214
Query: 368 ANVVAR---ALEFPKEPSVPG 385
V E P PG
Sbjct: 215 GCPVEGDPAESETSPRPRPPG 235
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 38.9 bits (91), Expect = 0.004
Identities = 36/166 (21%), Positives = 66/166 (39%), Gaps = 17/166 (10%)
Query: 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARI----ER 137
+ + LG G G VY K +V K V+ N R RI E
Sbjct: 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEP---ETRVAIK--TVNENASMRERIEFLNEA 60
Query: 138 EILEMLDHPFLPTLYATLDCPRWSCLLTEFCPGGDLH-VLRQRQPDKRFHE-----SAVR 191
+++ + + L + + + ++ E GDL LR R+P+ + + +
Sbjct: 61 SVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQK 120
Query: 192 FY--ASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235
F A+E+ + +L ++RDL N +V D + + DF ++
Sbjct: 121 FIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMT 166
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 38.6 bits (90), Expect = 0.004
Identities = 22/74 (29%), Positives = 39/74 (52%), Gaps = 2/74 (2%)
Query: 163 LLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVR 222
++TE+C GDL +R+ + + ++ +V + FL I+RDL NVL+
Sbjct: 116 VITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLL- 174
Query: 223 SDGHIM-LTDFDLS 235
+ G I+ + DF L+
Sbjct: 175 THGKIVKICDFGLA 188
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 457 | |||
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.97 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.96 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.96 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.95 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.95 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.95 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.95 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.94 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.92 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.92 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.91 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.91 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.9 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.9 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.9 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.89 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.86 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.85 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.85 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.84 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.82 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.82 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.81 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.81 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.81 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.8 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.76 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.75 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.75 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.7 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.66 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.58 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.53 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.53 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.5 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.49 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.48 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.47 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.36 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.34 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.29 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.28 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.18 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.18 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.07 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.95 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.95 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.86 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.76 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.72 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.7 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.67 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.65 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.61 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.57 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.49 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.46 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.45 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.41 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.39 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.29 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.23 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.19 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.97 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.91 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.88 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.87 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.82 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.81 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.81 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.8 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.79 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.66 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.63 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.41 | |
| PLN02236 | 344 | choline kinase | 97.33 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 97.28 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.27 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.16 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 97.06 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 97.05 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.94 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.93 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.89 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.78 | |
| PTZ00384 | 383 | choline kinase; Provisional | 96.48 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.46 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 96.25 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.18 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.17 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 96.02 | |
| PF02958 | 294 | EcKinase: Ecdysteroid kinase; InterPro: IPR004119 | 95.94 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 95.86 | |
| PTZ00296 | 442 | choline kinase; Provisional | 95.74 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 95.08 |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-68 Score=505.49 Aligned_cols=358 Identities=59% Similarity=1.063 Sum_probs=304.8
Q ss_pred CCChhHHHHHHhhhcCCCCCCCCCccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHH
Q 012762 55 NDDPCWKAIKEATSEGNNNNNNNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRAR 134 (457)
Q Consensus 55 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~ 134 (457)
..|..|..+..... .....+.+++|++++.||.|.-|+||+|+++. +++.+|+||+.+..+..+.+..+..
T Consensus 55 ~~d~~w~a~~~~~~-----~~~~~l~l~~f~llk~LG~GdiG~VyL~~l~~----t~~~fAmKVmdK~~l~~rkKl~Ra~ 125 (459)
T KOG0610|consen 55 GNDVRWEAISSIRN-----SKDGSLGLRHFRLLKRLGCGDIGTVYLVELRG----TNCLFAMKVMDKESLASRKKLKRAQ 125 (459)
T ss_pred CCchhhhhhccccc-----cCCCccCHHHHHHHHHcCCCCceeEEEEEecC----CCceEEEEEecHHHHhhhhHHHHHH
Confidence 34557777765442 24566788999999999999999999999984 6789999999999999999999999
Q ss_pred HHHHHHHHcCCCCCceEEEEEEcCCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecC
Q 012762 135 IEREILEMLDHPFLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDL 214 (457)
Q Consensus 135 ~E~~il~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDI 214 (457)
.|.+||.+++||.++.+|+.|+.+.+.|||||||.||+|..++++++.+.+++..++.|+.+++.||+|||.+|||.|||
T Consensus 126 tE~eIL~~lDHPFlPTLYa~fet~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDL 205 (459)
T KOG0610|consen 126 TEREILSLLDHPFLPTLYASFETDKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDL 205 (459)
T ss_pred HHHHHHHhcCCCccchhhheeeccceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCeEEccCCCEEEeccCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcc---
Q 012762 215 KPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPK--- 291 (457)
Q Consensus 215 Kp~NIll~~~~~vkl~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 291 (457)
||+||||.++|++.|+||.|+....-.. +...... +.... .+.+|. ....+|+.+.
T Consensus 206 KPENILvredGHIMLsDFDLS~~~~~~P-t~~~s~~---~~~~~------------~~~~~~-----~~~~s~f~~r~~~ 264 (459)
T KOG0610|consen 206 KPENILVREDGHIMLSDFDLSLRCPVSP-TLVKSSS---PRSSG------------SQPSCR-----SRQPSCFSPRCLS 264 (459)
T ss_pred CcceeEEecCCcEEeeeccccccCCCCC-eeeccCC---CCCCC------------CCcccc-----cccccccccchhc
Confidence 9999999999999999999998773211 1111000 00000 011221 1222333322
Q ss_pred --hhccc--cCCCCCCCcccccCCccccccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHH
Q 012762 292 --RRRKK--KLGNPGTPEIVAEPLDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTL 367 (457)
Q Consensus 292 --~~~~~--~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~ 367 (457)
+++++ .......+..+.++.+.+.++|+||-.|+|||++.|.+++.++|+|+|||++|||++|..||.|.++++.+
T Consensus 265 ~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl 344 (459)
T KOG0610|consen 265 SSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETL 344 (459)
T ss_pred cccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhH
Confidence 21111 11113345677899999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHhcccCCCCCCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCCCCchhhhccCCCCCCCCCCccc
Q 012762 368 ANVVARALEFPKEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGVNWALLRCAKPPFIPRPVTCRD 442 (457)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~~~~~~~~~~~~~~~~~~~~~~~ 442 (457)
.+++.....+|..+.++..++|||+++|..||++|......++||.+||||++++|++++...||+||.|.....
T Consensus 345 ~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gVnWaLir~~~PP~iP~~~d~~~ 419 (459)
T KOG0610|consen 345 RNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGVNWALIRCARPPEIPKPVDGGL 419 (459)
T ss_pred HHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHHhhcCccccCCChhheeccCCCcCCCccccCc
Confidence 999999999999989999999999999999999999999999999999999999999999999999999987765
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-62 Score=462.23 Aligned_cols=290 Identities=38% Similarity=0.718 Sum_probs=260.9
Q ss_pred CccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEc
Q 012762 78 PLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDC 157 (457)
Q Consensus 78 ~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~ 157 (457)
.+..++|+++++||+|+||+||+++.+ ++++.||+|+++|+.+.........+.|..||..++||+||+++..|++
T Consensus 21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~----dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt 96 (357)
T KOG0598|consen 21 MVGPDDFEILKVIGKGSFGKVFQVRKK----DTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQT 96 (357)
T ss_pred cCChhheeeeeeeeccCCceEEEEEEc----ccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEeccc
Confidence 466789999999999999999999977 5899999999999999988888999999999999999999999999999
Q ss_pred CCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcC
Q 012762 158 PRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLK 237 (457)
Q Consensus 158 ~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~ 237 (457)
.+.+|||+||+.||.|...+++. +.++|..++.|+.+|+.||.|||++|||||||||+||||+.+|+++|+|||+++.
T Consensus 97 ~~kLylVld~~~GGeLf~hL~~e--g~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~ 174 (357)
T KOG0598|consen 97 EEKLYLVLDYLNGGELFYHLQRE--GRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKE 174 (357)
T ss_pred CCeEEEEEeccCCccHHHHHHhc--CCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchh
Confidence 99999999999999999988876 8899999999999999999999999999999999999999999999999999875
Q ss_pred CCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcccccc
Q 012762 238 GDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMS 317 (457)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (457)
.... +..+.+
T Consensus 175 ~~~~----------------------------------------------------------------------~~~t~t 184 (357)
T KOG0598|consen 175 DLKD----------------------------------------------------------------------GDATRT 184 (357)
T ss_pred cccC----------------------------------------------------------------------CCcccc
Confidence 4321 112235
Q ss_pred ccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhhh
Q 012762 318 FVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVK 397 (457)
Q Consensus 318 ~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~ 397 (457)
+|||+.|||||++.+.+|+..+|+||||+++|||++|.+||.+.+...++.+++.+....+. .-++.+++++++++|..
T Consensus 185 fcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p-~~ls~~ardll~~LL~r 263 (357)
T KOG0598|consen 185 FCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPP-GYLSEEARDLLKKLLKR 263 (357)
T ss_pred ccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCC-ccCCHHHHHHHHHHhcc
Confidence 79999999999999999999999999999999999999999999999999999888733332 23889999999999999
Q ss_pred CCCCCCCCCcChHHHhcCCCCCCCCchhh--hccCCCCCCCCCCccccc
Q 012762 398 DPTRRMGSKMGATAIKRHQFFNGVNWALL--RCAKPPFIPRPVTCRDLT 444 (457)
Q Consensus 398 dP~~Rps~~~~~~~ll~hp~f~~~~~~~~--~~~~~~~~~~~~~~~~~~ 444 (457)
||++|......+.+|.+||||.+++|..+ +...|||.|.-...++.+
T Consensus 264 dp~~RLg~~~d~~~ik~HpfF~~inW~~l~~k~l~PpF~P~~~~~~~~~ 312 (357)
T KOG0598|consen 264 DPRQRLGGPGDAEEIKRHPFFKGINWEKLLAKKLSPPFKPNVTGLEDTS 312 (357)
T ss_pred CHHHhcCCCCChHHhhcCcccccCCHHHHHhcCCCCCeecCCCCccccc
Confidence 99999865556999999999999999866 678899999876665543
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-62 Score=474.70 Aligned_cols=288 Identities=38% Similarity=0.648 Sum_probs=260.4
Q ss_pred CccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHc-CCCCCceEEEEEE
Q 012762 78 PLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEML-DHPFLPTLYATLD 156 (457)
Q Consensus 78 ~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~~~~~ 156 (457)
.....||.+.+.||+|+|++|++|+.+ .+++.|||||+.|+.+....+.+-+.+|.++|.+| +||.|++||..|+
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~----~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQ 144 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREK----ATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQ 144 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeec----CCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEee
Confidence 455679999999999999999999987 48999999999999999999999999999999999 8999999999999
Q ss_pred cCCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCc
Q 012762 157 CPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSL 236 (457)
Q Consensus 157 ~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~ 236 (457)
++..+|+|+||+++|+|..+++.. +.|++..++.++.||+.||+|||++|||||||||+||||+.||++||+|||-|+
T Consensus 145 D~~sLYFvLe~A~nGdll~~i~K~--Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK 222 (604)
T KOG0592|consen 145 DEESLYFVLEYAPNGDLLDLIKKY--GSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAK 222 (604)
T ss_pred cccceEEEEEecCCCcHHHHHHHh--CcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccc
Confidence 999999999999999999999886 889999999999999999999999999999999999999999999999999998
Q ss_pred CCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccc
Q 012762 237 KGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSM 316 (457)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (457)
.+.+...... .+..+ ...+.+..
T Consensus 223 ~l~~~~~~~~---------------------------~~~~~------------------------------~~a~s~~~ 245 (604)
T KOG0592|consen 223 ILSPSQKSQE---------------------------NPVDP------------------------------NQASSRRS 245 (604)
T ss_pred cCChhhcccc---------------------------CccCc------------------------------ccccCccc
Confidence 8865433211 00000 00111234
Q ss_pred cccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhh
Q 012762 317 SFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLV 396 (457)
Q Consensus 317 ~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~ 396 (457)
+|+||..|++||+|.....+..+|||+||||||+|+.|.+||.+.++..++.+|+...+.+|.. +++.+++||+++|.
T Consensus 246 SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~fp~~--fp~~a~dLv~KLLv 323 (604)
T KOG0592|consen 246 SFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYEFPEG--FPEDARDLIKKLLV 323 (604)
T ss_pred ceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcccCCCC--CCHHHHHHHHHHHc
Confidence 7899999999999999999999999999999999999999999999999999999999999876 89999999999999
Q ss_pred hCCCCCCCCCcChHHHhcCCCCCCCCchhhhccCCCCC
Q 012762 397 KDPTRRMGSKMGATAIKRHQFFNGVNWALLRCAKPPFI 434 (457)
Q Consensus 397 ~dP~~Rps~~~~~~~ll~hp~f~~~~~~~~~~~~~~~~ 434 (457)
.||.+|++ ++||.+||||.+++|..++...||-+
T Consensus 324 ~dp~~Rlt----~~qIk~HpFF~~Vdw~nlw~~~PP~l 357 (604)
T KOG0592|consen 324 RDPSDRLT----SQQIKAHPFFEGVDWENLWQQTPPKL 357 (604)
T ss_pred cCcccccc----HHHHhhCcccccCChhhhhhcCCCcc
Confidence 99999999 99999999999999999998887765
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-61 Score=471.27 Aligned_cols=339 Identities=35% Similarity=0.610 Sum_probs=272.9
Q ss_pred CCCccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEE
Q 012762 76 NNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATL 155 (457)
Q Consensus 76 ~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~ 155 (457)
...+..+||.++..||+|+||.||+|+.+ .+|..||+|+++|..+....+...++.|..||...++|.||+||..|
T Consensus 135 R~r~~~~DFe~Lk~IgkGAfGeVrLarKk----~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsF 210 (550)
T KOG0605|consen 135 RTRLSLDDFELLKVIGKGAFGEVRLARKK----DTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSF 210 (550)
T ss_pred cccCCcccchhheeeccccceeEEEEEEc----cCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEe
Confidence 34668899999999999999999999977 48999999999999999999999999999999999999999999999
Q ss_pred EcCCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCC
Q 012762 156 DCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235 (457)
Q Consensus 156 ~~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s 235 (457)
++.+++||||||++||++..++.+. +.+++..++.++.+++.|++-||+.|+|||||||+|+||+..|++||+||||+
T Consensus 211 QD~~~LYLiMEylPGGD~mTLL~~~--~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs 288 (550)
T KOG0605|consen 211 QDKEYLYLIMEYLPGGDMMTLLMRK--DTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLS 288 (550)
T ss_pred cCCCeeEEEEEecCCccHHHHHHhc--CcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeecccccc
Confidence 9999999999999999999999886 88999999999999999999999999999999999999999999999999998
Q ss_pred cCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCC-CCCcccccCcchhccccCCCCCCCcccccCCccc
Q 012762 236 LKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNC-IVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVR 314 (457)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (457)
.-+.......... .+..... . +....+. ..++ ..+. +... +... ...-......-
T Consensus 289 ~gl~~~~~~~~~~-------~~~~~~~-~--~~~~~~~---~~~~~~~~~-~~~~----~~~~------~~~w~~nrr~~ 344 (550)
T KOG0605|consen 289 TGLDKKHRIESYR-------LDEQMQI-N--LSEAKPS---DFPKFNTPR-STMS----RREQ------LQTWKRNRRQL 344 (550)
T ss_pred chhhhhhhhhhhc-------chhhhhh-h--hccCCCc---ccccccccc-chhh----HHHH------HHHHHhhhhhh
Confidence 5433211100000 0000000 0 0000000 0000 0000 0000 0000 00001112233
Q ss_pred cccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcc--cCCCCCCCCChHHHHHHH
Q 012762 315 SMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARA--LEFPKEPSVPGPAKDLIA 392 (457)
Q Consensus 315 ~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~ll~ 392 (457)
..+++|||.|||||++.+.+|+..+|+||||||+||||.|.+||.+.+..+.+.+|+.-. +.+|....++++++|||.
T Consensus 345 a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~ 424 (550)
T KOG0605|consen 345 AYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLIT 424 (550)
T ss_pred hhcccCCccccchHHHhcCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHH
Confidence 346799999999999999999999999999999999999999999999999999999765 777887888999999999
Q ss_pred HHhhhCCCCCCCCCcChHHHhcCCCCCCCCchhhhccCCCCCCCCCCccccccc
Q 012762 393 QLLVKDPTRRMGSKMGATAIKRHQFFNGVNWALLRCAKPPFIPRPVTCRDLTTT 446 (457)
Q Consensus 393 ~~L~~dP~~Rps~~~~~~~ll~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 446 (457)
+||. ||++|.. ...++||.+||||++++|..|....|||+|......|-+.-
T Consensus 425 rll~-d~~~RLG-~~G~~EIK~HPfF~~v~W~~l~~~~apfvP~v~~~~DT~yF 476 (550)
T KOG0605|consen 425 RLLC-DPENRLG-SKGAEEIKKHPFFKGVDWDHLREMPAPFVPQVNSELDTQYF 476 (550)
T ss_pred HHhc-CHHHhcC-cccHHHHhcCCccccCCcchhhcCCCCCCCCCCCccccccc
Confidence 9999 9999998 66799999999999999999999999999998887775543
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-60 Score=435.37 Aligned_cols=278 Identities=41% Similarity=0.779 Sum_probs=259.4
Q ss_pred CCccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEE
Q 012762 77 NPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLD 156 (457)
Q Consensus 77 ~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~ 156 (457)
.+..++||++++.||.|+||.|.+++.+ .+|..||+|+++++++..-...+...+|..+|+.+.||+++++++.|.
T Consensus 39 ~~~~l~dfe~~~tlGtGSFGrV~LVr~k----~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~ 114 (355)
T KOG0616|consen 39 NPYSLQDFERLKTLGTGSFGRVHLVREK----HSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFK 114 (355)
T ss_pred CCcchhhhhheeeeccCccceEEEEEEc----cCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeec
Confidence 3488899999999999999999999988 489999999999999988888889999999999999999999999999
Q ss_pred cCCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCc
Q 012762 157 CPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSL 236 (457)
Q Consensus 157 ~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~ 236 (457)
+.+.+||||||++||.|..++++. +++++..++.++.||+.||+|||+++|++|||||+||||+.+|.+||+|||+|+
T Consensus 115 d~~~lymvmeyv~GGElFS~Lrk~--~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK 192 (355)
T KOG0616|consen 115 DNSNLYMVMEYVPGGELFSYLRKS--GRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAK 192 (355)
T ss_pred cCCeEEEEEeccCCccHHHHHHhc--CCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceE
Confidence 999999999999999999999876 889999999999999999999999999999999999999999999999999997
Q ss_pred CCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccc
Q 012762 237 KGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSM 316 (457)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (457)
.... ++.
T Consensus 193 ~v~~-------------------------------------------------------------------------rT~ 199 (355)
T KOG0616|consen 193 RVSG-------------------------------------------------------------------------RTW 199 (355)
T ss_pred EecC-------------------------------------------------------------------------cEE
Confidence 6543 244
Q ss_pred cccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhh
Q 012762 317 SFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLV 396 (457)
Q Consensus 317 ~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~ 396 (457)
++||||.|+|||++...+|+.++|.|||||++|||+.|.+||.......++.+|+.+.+.+|.- ++.++++||.++|+
T Consensus 200 TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~~--fs~~~kdLl~~LL~ 277 (355)
T KOG0616|consen 200 TLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPSY--FSSDAKDLLKKLLQ 277 (355)
T ss_pred EecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCcc--cCHHHHHHHHHHHh
Confidence 7799999999999999999999999999999999999999999999999999999999999986 89999999999999
Q ss_pred hCCCCCCCC-CcChHHHhcCCCCCCCCchhh--hccCCCCCC
Q 012762 397 KDPTRRMGS-KMGATAIKRHQFFNGVNWALL--RCAKPPFIP 435 (457)
Q Consensus 397 ~dP~~Rps~-~~~~~~ll~hp~f~~~~~~~~--~~~~~~~~~ 435 (457)
.|-.+|..- .....+|.+||||++++|..+ +...+|+.|
T Consensus 278 vD~t~R~gnlknG~~dIk~H~wF~~v~W~~i~~r~ie~P~~p 319 (355)
T KOG0616|consen 278 VDLTKRFGNLKNGVEDIKNHPWFKGVDWEAILQRKIEPPFEP 319 (355)
T ss_pred hhhHhhhcCcCCCccccccCcccccccHHHHhhccccCCCCC
Confidence 999999543 446899999999999999877 567789988
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-60 Score=474.35 Aligned_cols=296 Identities=37% Similarity=0.720 Sum_probs=271.5
Q ss_pred CCccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHc-CCCCCceEEEEE
Q 012762 77 NPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEML-DHPFLPTLYATL 155 (457)
Q Consensus 77 ~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~~~~ 155 (457)
..+.+++|+++++||+|.||+|++++.+ .+++.||||+++|..+..++..+..+.|.+|+... +||.++.++.+|
T Consensus 363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k----~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~f 438 (694)
T KOG0694|consen 363 GPLTLDDFRLLAVLGRGSFGKVLLAELK----GTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCF 438 (694)
T ss_pred CcccccceEEEEEeccCcCceEEEEEEc----CCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeeccccc
Confidence 5788899999999999999999999998 48889999999999999999999999999999888 599999999999
Q ss_pred EcCCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCC
Q 012762 156 DCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235 (457)
Q Consensus 156 ~~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s 235 (457)
+..+++|+||||+.||++..+++ ...+++..++.|+..|+.||+|||++|||+||||.+|||||.+|++||+|||++
T Consensus 439 QT~~~l~fvmey~~Ggdm~~~~~---~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlc 515 (694)
T KOG0694|consen 439 QTKEHLFFVMEYVAGGDLMHHIH---TDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLC 515 (694)
T ss_pred ccCCeEEEEEEecCCCcEEEEEe---cccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccc
Confidence 99999999999999999654433 378999999999999999999999999999999999999999999999999998
Q ss_pred cCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcccc
Q 012762 236 LKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRS 315 (457)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (457)
+..-. .+.++
T Consensus 516 Ke~m~----------------------------------------------------------------------~g~~T 525 (694)
T KOG0694|consen 516 KEGMG----------------------------------------------------------------------QGDRT 525 (694)
T ss_pred cccCC----------------------------------------------------------------------CCCcc
Confidence 75421 12345
Q ss_pred ccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHh
Q 012762 316 MSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLL 395 (457)
Q Consensus 316 ~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L 395 (457)
.++|||+.|||||++.+..|+.++|.|||||+|||||.|+.||.+.++++++..|+.....+|.. ++.++.++|+++|
T Consensus 526 sTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP~~--ls~ea~~il~~ll 603 (694)
T KOG0694|consen 526 STFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRF--LSKEAIAIMRRLL 603 (694)
T ss_pred ccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCc--ccHHHHHHHHHHh
Confidence 58999999999999999999999999999999999999999999999999999999999999987 9999999999999
Q ss_pred hhCCCCCCCCC-cChHHHhcCCCCCCCCchhh--hccCCCCCCCCCCccccccccCCCC
Q 012762 396 VKDPTRRMGSK-MGATAIKRHQFFNGVNWALL--RCAKPPFIPRPVTCRDLTTTNSSID 451 (457)
Q Consensus 396 ~~dP~~Rps~~-~~~~~ll~hp~f~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 451 (457)
..||++|..+. .++++|.+||||+.++|..| +..+|||+|.....+|.++-..+-.
T Consensus 604 ~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~L~~r~i~PPf~P~i~~~~D~snFd~eFt 662 (694)
T KOG0694|consen 604 RKNPEKRLGSGERDAEDIKKHPFFRSIDWDDLLNRRIKPPFVPTIKGPEDVSNFDEEFT 662 (694)
T ss_pred ccCcccccCCCCCCchhhhhCCccccCCHHHHhhccCCCCCCcccCChhhhcccchhhh
Confidence 99999999973 57899999999999999987 6789999999999999887665443
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-60 Score=450.17 Aligned_cols=262 Identities=29% Similarity=0.445 Sum_probs=230.4
Q ss_pred cCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhh----hhHHHHHHHHHHHHHHcCCCCCceEEEEE
Q 012762 80 TLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVS----RNKESRARIEREILEMLDHPFLPTLYATL 155 (457)
Q Consensus 80 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~----~~~~~~~~~E~~il~~l~H~nIv~l~~~~ 155 (457)
..+.|.+.+.||+|+||.|-+|..+ .+|+.||||+++++.... .+....+++|++||++|+|||||+++++|
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~----~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f 245 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEK----KTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFF 245 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEc----ccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeee
Confidence 3457899999999999999999987 599999999999987655 23455567999999999999999999999
Q ss_pred EcCCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccC---CCEEEecc
Q 012762 156 DCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSD---GHIMLTDF 232 (457)
Q Consensus 156 ~~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~---~~vkl~DF 232 (457)
...+..||||||++||+|.+.+-.+ +.+.+...+.++.||+.||.|||++||+||||||+|||+..+ ..+||+||
T Consensus 246 ~~~ds~YmVlE~v~GGeLfd~vv~n--k~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDF 323 (475)
T KOG0615|consen 246 EVPDSSYMVLEYVEGGELFDKVVAN--KYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDF 323 (475)
T ss_pred ecCCceEEEEEEecCccHHHHHHhc--cccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEeccc
Confidence 9999999999999999999888775 778999999999999999999999999999999999999866 68999999
Q ss_pred CCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCc
Q 012762 233 DLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLD 312 (457)
Q Consensus 233 G~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (457)
|+|+.... .
T Consensus 324 GlAK~~g~-----------------------------------------------------------------------~ 332 (475)
T KOG0615|consen 324 GLAKVSGE-----------------------------------------------------------------------G 332 (475)
T ss_pred chhhcccc-----------------------------------------------------------------------c
Confidence 99976642 2
Q ss_pred cccccccCCCCccCchhhcCCCC---CccchhhhhhHHHHHHhcCCCCCCCCChHH-HHHHHHhcccCC--CCCCCCChH
Q 012762 313 VRSMSFVGTHEYLAPEIISGEGH---GNAVDWWTLGIFIFELFYGTTPFKGIDHEL-TLANVVARALEF--PKEPSVPGP 386 (457)
Q Consensus 313 ~~~~~~~gt~~y~aPE~l~~~~~---~~~sDiwSlG~il~elltG~~Pf~~~~~~~-~~~~~~~~~~~~--~~~~~~~~~ 386 (457)
..+.++|||+.|.|||++.+..+ ..++||||+||+||-+|+|.+||.+..... ..++|..+.+.+ +.+..++++
T Consensus 333 sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w~~Isee 412 (475)
T KOG0615|consen 333 SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQWDRISEE 412 (475)
T ss_pred eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhhhhhhHH
Confidence 23347899999999999987753 458899999999999999999998876555 677777777665 456789999
Q ss_pred HHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCCCC
Q 012762 387 AKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGVN 422 (457)
Q Consensus 387 ~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~~~ 422 (457)
..+||..||..||++||+ ++++|+||||+...
T Consensus 413 a~dlI~~mL~VdP~~R~s----~~eaL~hpW~~~~~ 444 (475)
T KOG0615|consen 413 ALDLINWMLVVDPENRPS----ADEALNHPWFKDAP 444 (475)
T ss_pred HHHHHHHhhEeCcccCcC----HHHHhcChhhhccc
Confidence 999999999999999999 99999999999765
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-59 Score=461.59 Aligned_cols=256 Identities=29% Similarity=0.500 Sum_probs=241.8
Q ss_pred CCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcE
Q 012762 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWS 161 (457)
Q Consensus 82 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~ 161 (457)
.+|...+.||+|+|+.||.+++. .+|..||+|++.+..+......+.+.+|++|.+.|+|||||+++++|++.+++
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~----~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nV 93 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDL----DTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNV 93 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEc----CCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCce
Confidence 57999999999999999999986 48999999999999998888999999999999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCC
Q 012762 162 CLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNS 241 (457)
Q Consensus 162 ~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~ 241 (457)
|||+|+|..++|..++++. +.++|.+++.+++||+.||.|||+++|||||||..|+||+++.+|||+|||||..+..
T Consensus 94 YivLELC~~~sL~el~Krr--k~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~- 170 (592)
T KOG0575|consen 94 YIVLELCHRGSLMELLKRR--KPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEY- 170 (592)
T ss_pred EEEEEecCCccHHHHHHhc--CCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecC-
Confidence 9999999999999999865 7899999999999999999999999999999999999999999999999999865542
Q ss_pred CcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCC
Q 012762 242 TSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGT 321 (457)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 321 (457)
.+.+.+++|||
T Consensus 171 ---------------------------------------------------------------------~~Erk~TlCGT 181 (592)
T KOG0575|consen 171 ---------------------------------------------------------------------DGERKKTLCGT 181 (592)
T ss_pred ---------------------------------------------------------------------cccccceecCC
Confidence 24566789999
Q ss_pred CCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhhhCCCC
Q 012762 322 HEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDPTR 401 (457)
Q Consensus 322 ~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~ 401 (457)
|.|+|||++.+..++..+||||+||+||-||.|++||+...-++.+.+|....+.+|.. ++.++++||.+||..||.+
T Consensus 182 PNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~~--ls~~A~dLI~~lL~~~P~~ 259 (592)
T KOG0575|consen 182 PNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPSH--LSAEAKDLIRKLLRPNPSE 259 (592)
T ss_pred CcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcccccc--cCHHHHHHHHHHhcCCccc
Confidence 99999999999999999999999999999999999999999999999999999999985 9999999999999999999
Q ss_pred CCCCCcChHHHhcCCCCC
Q 012762 402 RMGSKMGATAIKRHQFFN 419 (457)
Q Consensus 402 Rps~~~~~~~ll~hp~f~ 419 (457)
||+ +++||+|+||+
T Consensus 260 Rps----l~~vL~h~Ff~ 273 (592)
T KOG0575|consen 260 RPS----LDEVLDHPFFK 273 (592)
T ss_pred CCC----HHHHhcCHhhh
Confidence 999 99999999993
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-57 Score=426.82 Aligned_cols=261 Identities=32% Similarity=0.452 Sum_probs=229.2
Q ss_pred CCccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEE
Q 012762 77 NPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLD 156 (457)
Q Consensus 77 ~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~ 156 (457)
..+..++++.+..||+|..|+||+|.++ .+++.+|+|++... ......+++.+|++||+.++||+||.+|++|.
T Consensus 74 ~~i~~~dle~~~~lG~G~gG~V~kv~Hk----~t~~i~AlK~I~~~--~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~ 147 (364)
T KOG0581|consen 74 NGISLSDLERLGVLGSGNGGTVYKVRHK----PTGKIYALKVILLN--IDPALQKQILRELEILRSCQSPYIVGFYGAFY 147 (364)
T ss_pred cccCHHHhhhhhhcccCCCcEEEEEEEc----CCCeEEEEEeeccc--CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEE
Confidence 4467789999999999999999999988 58999999999332 44566788899999999999999999999999
Q ss_pred cCCc-EEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCceeecCCCCCeEEccCCCEEEeccCC
Q 012762 157 CPRW-SCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHM-MGIIYRDLKPENVLVRSDGHIMLTDFDL 234 (457)
Q Consensus 157 ~~~~-~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~-~~iiHrDIKp~NIll~~~~~vkl~DFG~ 234 (457)
.++. ++|+||||+||+|..+++.. ++++|.....++.++++||.|||+ ++||||||||.||||++.|.|||||||.
T Consensus 148 ~~~~~isI~mEYMDgGSLd~~~k~~--g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGV 225 (364)
T KOG0581|consen 148 SNGEEISICMEYMDGGSLDDILKRV--GRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGV 225 (364)
T ss_pred eCCceEEeehhhcCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccc
Confidence 9985 99999999999999998876 789999999999999999999995 9999999999999999999999999999
Q ss_pred CcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccc
Q 012762 235 SLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVR 314 (457)
Q Consensus 235 s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (457)
++.+.+. -
T Consensus 226 S~~lvnS------------------------------------------------------------------------~ 233 (364)
T KOG0581|consen 226 SGILVNS------------------------------------------------------------------------I 233 (364)
T ss_pred cHHhhhh------------------------------------------------------------------------h
Confidence 8766432 1
Q ss_pred cccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCC-----ChHHHHHHHHhcccCCCCCCCCChHHHH
Q 012762 315 SMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGI-----DHELTLANVVARALEFPKEPSVPGPAKD 389 (457)
Q Consensus 315 ~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (457)
..+++||..|||||.+.+..|+.++||||||+.++|+++|++||... ...+.+..|+...........+++++++
T Consensus 234 a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~fS~ef~~ 313 (364)
T KOG0581|consen 234 ANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGEFSPEFRS 313 (364)
T ss_pred cccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcccCCHHHHH
Confidence 23678999999999999999999999999999999999999999874 3445666666643332222259999999
Q ss_pred HHHHHhhhCCCCCCCCCcChHHHhcCCCCCCC
Q 012762 390 LIAQLLVKDPTRRMGSKMGATAIKRHQFFNGV 421 (457)
Q Consensus 390 ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~~ 421 (457)
||..||+.||.+|++ +.|+++|||++..
T Consensus 314 FV~~CL~Kdp~~R~s----~~qLl~Hpfi~~~ 341 (364)
T KOG0581|consen 314 FVSCCLRKDPSERPS----AKQLLQHPFIKKF 341 (364)
T ss_pred HHHHHhcCCcccCCC----HHHHhcCHHHhhc
Confidence 999999999999999 9999999999864
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-54 Score=411.45 Aligned_cols=259 Identities=26% Similarity=0.481 Sum_probs=228.0
Q ss_pred cCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCC
Q 012762 80 TLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPR 159 (457)
Q Consensus 80 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~ 159 (457)
..++|.+.++||.|+||+||+|+++. ++..||||.+.+..+ .....+.+..|++||+.++|||||.+++++..++
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~----~~~~VAIK~i~~~~l-~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~ 82 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKK----SGTEVAIKCIAKKKL-NKKLVELLLSEIKILKELKHPNIVRLLDCIEDDD 82 (429)
T ss_pred ccccceehhhccCcceEEEEEeEecc----CCceEEeeeehhhcc-CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCC
Confidence 45789999999999999999999884 778999999988765 3345566788999999999999999999999999
Q ss_pred cEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccC------CCEEEeccC
Q 012762 160 WSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSD------GHIMLTDFD 233 (457)
Q Consensus 160 ~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~------~~vkl~DFG 233 (457)
++|||||||+||+|..+++.. +.+++..++.++.||+.||++||+++||||||||+||||+.. -.+||+|||
T Consensus 83 ~i~lVMEyC~gGDLs~yi~~~--~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFG 160 (429)
T KOG0595|consen 83 FIYLVMEYCNGGDLSDYIRRR--GRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFG 160 (429)
T ss_pred eEEEEEEeCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccc
Confidence 999999999999999999986 689999999999999999999999999999999999999865 458999999
Q ss_pred CCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcc
Q 012762 234 LSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDV 313 (457)
Q Consensus 234 ~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (457)
+|+.+.+.....
T Consensus 161 fAR~L~~~~~a~-------------------------------------------------------------------- 172 (429)
T KOG0595|consen 161 FARFLQPGSMAE-------------------------------------------------------------------- 172 (429)
T ss_pred hhhhCCchhHHH--------------------------------------------------------------------
Confidence 998886433322
Q ss_pred ccccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCC-CCCChHHHHHHH
Q 012762 314 RSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKE-PSVPGPAKDLIA 392 (457)
Q Consensus 314 ~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ll~ 392 (457)
+++|++.|||||++....|+-|+|+||+|+|+|+|++|+.||...+..+.+..+..+....+.. ..++....+|+.
T Consensus 173 ---tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~~s~~~~~Ll~ 249 (429)
T KOG0595|consen 173 ---TLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPAELSNPLRELLI 249 (429)
T ss_pred ---HhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhhhccCchhhhhh
Confidence 5689999999999999999999999999999999999999999988888887766655444432 345667789999
Q ss_pred HHhhhCCCCCCCCCcChHHHhcCCCCCC
Q 012762 393 QLLVKDPTRRMGSKMGATAIKRHQFFNG 420 (457)
Q Consensus 393 ~~L~~dP~~Rps~~~~~~~ll~hp~f~~ 420 (457)
..|..|+.+|.+ ..+-+.|+|...
T Consensus 250 ~ll~~~~~~~~~----~~~~~~~~~l~~ 273 (429)
T KOG0595|consen 250 SLLQRNPKDRIS----FEDFFDHPFLAA 273 (429)
T ss_pred HHHhcCccccCc----hHHhhhhhhccc
Confidence 999999999999 888888988765
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-55 Score=399.59 Aligned_cols=258 Identities=27% Similarity=0.419 Sum_probs=219.7
Q ss_pred CCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcE
Q 012762 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWS 161 (457)
Q Consensus 82 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~ 161 (457)
+.|..+.++|+|+||+||+|+++ .+|+.||||.+...+ .+....+...+|+++|++|+|+|+|.++.+|...+.+
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk----~TgqIVAIKkF~Ese-dd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrkl 76 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNK----DTGQIVAIKKFVESE-DDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKL 76 (396)
T ss_pred cHHhhhhccccCcceEEEEeccC----CcccEEEEEeeccCC-ccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhccee
Confidence 57889999999999999999987 599999999996543 2234556778899999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCC
Q 012762 162 CLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNS 241 (457)
Q Consensus 162 ~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~ 241 (457)
+||+|||+..-|.++ ++.+ .+++...++.++.|++.|+.|+|++++|||||||+||||+..|.+||||||+|+.+..+
T Consensus 77 hLVFE~~dhTvL~eL-e~~p-~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p 154 (396)
T KOG0593|consen 77 HLVFEYCDHTVLHEL-ERYP-NGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAP 154 (396)
T ss_pred EEEeeecchHHHHHH-Hhcc-CCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCC
Confidence 999999977666554 4443 66899999999999999999999999999999999999999999999999999876521
Q ss_pred CcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCC
Q 012762 242 TSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGT 321 (457)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 321 (457)
. .-.+.++.|
T Consensus 155 g----------------------------------------------------------------------d~YTDYVAT 164 (396)
T KOG0593|consen 155 G----------------------------------------------------------------------DNYTDYVAT 164 (396)
T ss_pred c----------------------------------------------------------------------chhhhhhhh
Confidence 1 112356889
Q ss_pred CCccCchhhcC-CCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCC-------------------CCC-
Q 012762 322 HEYLAPEIISG-EGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEF-------------------PKE- 380 (457)
Q Consensus 322 ~~y~aPE~l~~-~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~-------------------~~~- 380 (457)
.+|+|||.+.| ..|+.++||||+||++.||++|++.|++.++.+.+..|+.....+ |..
T Consensus 165 RWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~ 244 (396)
T KOG0593|consen 165 RWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPE 244 (396)
T ss_pred hhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeecCCCC
Confidence 99999999998 679999999999999999999999999998887777666543322 221
Q ss_pred ---------CCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCC
Q 012762 381 ---------PSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNG 420 (457)
Q Consensus 381 ---------~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~ 420 (457)
+.++..+.||+.+||..||.+|++ .+|+|.|+||++
T Consensus 245 ~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~s----c~qll~H~yFd~ 289 (396)
T KOG0593|consen 245 HPEPLERKYPKISNVLLDLLKKCLKMDPDDRLS----CEQLLHHPYFDG 289 (396)
T ss_pred CccchhhhcccchHHHHHHHHHHhcCCcccccc----HHHHhcChHHHH
Confidence 234456889999999999999999 999999999965
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-52 Score=415.24 Aligned_cols=260 Identities=31% Similarity=0.572 Sum_probs=232.1
Q ss_pred ccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhh--hHHHHHHHHHHHHHHcC-CCCCceEEEEE
Q 012762 79 LTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSR--NKESRARIEREILEMLD-HPFLPTLYATL 155 (457)
Q Consensus 79 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~--~~~~~~~~E~~il~~l~-H~nIv~l~~~~ 155 (457)
...+.|.+.+.||+|+||+|++|++.. ++..||+|+++++..... .....+.+|+.+++++. ||||+++++++
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~----t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~ 89 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRL----TGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVF 89 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeecc----CCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEE
Confidence 456789999999999999999999873 779999998877633212 34566778999999998 99999999999
Q ss_pred EcCCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccC-CCEEEeccCC
Q 012762 156 DCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSD-GHIMLTDFDL 234 (457)
Q Consensus 156 ~~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~-~~vkl~DFG~ 234 (457)
.....+|||||||.||+|.+++... +++.|..++.+++||+.||+|||++||+||||||+|||++.+ +++||+|||+
T Consensus 90 ~t~~~~~ivmEy~~gGdL~~~i~~~--g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~ 167 (370)
T KOG0583|consen 90 ATPTKIYIVMEYCSGGDLFDYIVNK--GRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGL 167 (370)
T ss_pred ecCCeEEEEEEecCCccHHHHHHHc--CCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEecccc
Confidence 9999999999999999999999884 889999999999999999999999999999999999999999 9999999999
Q ss_pred CcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccc
Q 012762 235 SLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVR 314 (457)
Q Consensus 235 s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (457)
+...... +..
T Consensus 168 s~~~~~~----------------------------------------------------------------------~~~ 177 (370)
T KOG0583|consen 168 SAISPGE----------------------------------------------------------------------DGL 177 (370)
T ss_pred ccccCCC----------------------------------------------------------------------CCc
Confidence 8655200 112
Q ss_pred cccccCCCCccCchhhcCCC-C-CccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCCCCC-ChHHHHHH
Q 012762 315 SMSFVGTHEYLAPEIISGEG-H-GNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSV-PGPAKDLI 391 (457)
Q Consensus 315 ~~~~~gt~~y~aPE~l~~~~-~-~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ll 391 (457)
..+++||+.|+|||++.+.. | +.++||||+||+||.|++|+.||...+....+..+..+.+.+|.. + +.++++|+
T Consensus 178 l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p~~--~~S~~~~~Li 255 (370)
T KOG0583|consen 178 LKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIPSY--LLSPEARSLI 255 (370)
T ss_pred ccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCCCC--cCCHHHHHHH
Confidence 23578999999999999988 8 589999999999999999999999988888888888888888887 5 99999999
Q ss_pred HHHhhhCCCCCCCCCcChHHHhcCCCCCC
Q 012762 392 AQLLVKDPTRRMGSKMGATAIKRHQFFNG 420 (457)
Q Consensus 392 ~~~L~~dP~~Rps~~~~~~~ll~hp~f~~ 420 (457)
.+||..||.+|++ +.+|++||||+.
T Consensus 256 ~~mL~~~P~~R~t----~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 256 EKMLVPDPSTRIT----LLEILEHPWFQK 280 (370)
T ss_pred HHHcCCCcccCCC----HHHHhhChhhcc
Confidence 9999999999999 999999999996
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-52 Score=408.35 Aligned_cols=278 Identities=36% Similarity=0.707 Sum_probs=235.3
Q ss_pred EEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcEEEEEee
Q 012762 88 HRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWSCLLTEF 167 (457)
Q Consensus 88 ~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lV~E~ 167 (457)
+.||+|+||+||+|+++ .+|+.||+|++.+...........+..|+++|+.++||||+++++++...+.+||||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~----~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~ 76 (323)
T cd05571 1 KLLGKGTFGKVILVREK----ATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEY 76 (323)
T ss_pred CeeeeCCCeEEEEEEEC----CCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeC
Confidence 36899999999999976 47889999999876655555566778899999999999999999999999999999999
Q ss_pred cCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCCCccccc
Q 012762 168 CPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQL 247 (457)
Q Consensus 168 ~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~~~~~~~ 247 (457)
+.+++|..++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 77 ~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~----- 149 (323)
T cd05571 77 ANGGELFFHLSRE--RVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG----- 149 (323)
T ss_pred CCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC-----
Confidence 9999998888764 678999999999999999999999999999999999999999999999999975321100
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCCCCccCc
Q 012762 248 VSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTHEYLAP 327 (457)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 327 (457)
.....++||+.|+||
T Consensus 150 -----------------------------------------------------------------~~~~~~~gt~~y~aP 164 (323)
T cd05571 150 -----------------------------------------------------------------ATMKTFCGTPEYLAP 164 (323)
T ss_pred -----------------------------------------------------------------CcccceecCccccCh
Confidence 001134699999999
Q ss_pred hhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhhhCCCCCCCCC-
Q 012762 328 EIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDPTRRMGSK- 406 (457)
Q Consensus 328 E~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rps~~- 406 (457)
|++.+..++.++|||||||++|||++|..||...+.......+......++. .++.++.+||.+||..||++||+..
T Consensus 165 E~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p~--~~~~~~~~li~~~L~~dP~~R~~~~~ 242 (323)
T cd05571 165 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR--TLSPEAKSLLAGLLKKDPKQRLGGGP 242 (323)
T ss_pred hhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCC--CCCHHHHHHHHHHccCCHHHcCCCCC
Confidence 9999999999999999999999999999999988777777777766666554 4889999999999999999999321
Q ss_pred cChHHHhcCCCCCCCCchhhh--ccCCCCCCCCCCcccc
Q 012762 407 MGATAIKRHQFFNGVNWALLR--CAKPPFIPRPVTCRDL 443 (457)
Q Consensus 407 ~~~~~ll~hp~f~~~~~~~~~--~~~~~~~~~~~~~~~~ 443 (457)
..+.++++||||..++|..+. ...||+.|...+..+.
T Consensus 243 ~~~~~ll~h~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (323)
T cd05571 243 EDAKEIMEHRFFASINWQDVVQKKLEPPFKPQVTSETDT 281 (323)
T ss_pred CCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCCCcchh
Confidence 129999999999999998774 4556777766555443
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-53 Score=393.28 Aligned_cols=292 Identities=36% Similarity=0.699 Sum_probs=264.7
Q ss_pred CCCCccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEE
Q 012762 75 NNNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYAT 154 (457)
Q Consensus 75 ~~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~ 154 (457)
....+..++|.++++||+|.||+|.+|+-++ +++.||+|+++|.-+........-..|-++|+.++||.+..+.-.
T Consensus 161 ~~~kvTm~dFdfLKvLGkGTFGKVIL~rEKa----t~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYs 236 (516)
T KOG0690|consen 161 RKNKVTMEDFDFLKVLGKGTFGKVILCREKA----TGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYS 236 (516)
T ss_pred ccceeccchhhHHHHhcCCccceEEEEeecc----cCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhh
Confidence 4456788999999999999999999999885 899999999999888877777777889999999999999999999
Q ss_pred EEcCCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCC
Q 012762 155 LDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDL 234 (457)
Q Consensus 155 ~~~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~ 234 (457)
|+..+++|+||||++||.|...+.+. +.+++...+.+..+|+.||.|||+++||.||||.+|+|++.||++||+|||+
T Consensus 237 FQt~drlCFVMeyanGGeLf~HLsre--r~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGL 314 (516)
T KOG0690|consen 237 FQTQDRLCFVMEYANGGELFFHLSRE--RVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGL 314 (516)
T ss_pred hccCceEEEEEEEccCceEeeehhhh--hcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeeccc
Confidence 99999999999999999998777775 7899999999999999999999999999999999999999999999999999
Q ss_pred CcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccc
Q 012762 235 SLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVR 314 (457)
Q Consensus 235 s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (457)
++..-. .+..
T Consensus 315 CKE~I~----------------------------------------------------------------------~g~t 324 (516)
T KOG0690|consen 315 CKEEIK----------------------------------------------------------------------YGDT 324 (516)
T ss_pred chhccc----------------------------------------------------------------------ccce
Confidence 864321 1223
Q ss_pred cccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHH
Q 012762 315 SMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQL 394 (457)
Q Consensus 315 ~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~ 394 (457)
..+|||||.|+|||++....|+.++|.|.+||++|||++|+.||+..+....+.-|+...+++|.. ++++++.|+..+
T Consensus 325 ~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFPr~--ls~eAktLLsGL 402 (516)
T KOG0690|consen 325 TKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFPRT--LSPEAKTLLSGL 402 (516)
T ss_pred eccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCCcc--CCHHHHHHHHHH
Confidence 447899999999999999999999999999999999999999999999999999999999999986 999999999999
Q ss_pred hhhCCCCCCCCC-cChHHHhcCCCCCCCCchhh--hccCCCCCCCCCCccccc
Q 012762 395 LVKDPTRRMGSK-MGATAIKRHQFFNGVNWALL--RCAKPPFIPRPVTCRDLT 444 (457)
Q Consensus 395 L~~dP~~Rps~~-~~~~~ll~hp~f~~~~~~~~--~~~~~~~~~~~~~~~~~~ 444 (457)
|..||.+|..-. .++.+|.+|+||.+++|... +...|||.|+-.+..|-+
T Consensus 403 L~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~~~Kki~PPfKPqVtSetDTr 455 (516)
T KOG0690|consen 403 LKKDPKKRLGGGPDDAKEIMRHRFFASVDWEATYRKKIEPPFKPQVTSETDTR 455 (516)
T ss_pred hhcChHhhcCCCchhHHHHHhhhhhccCCHHHHHHhccCCCCCCCcccccchh
Confidence 999999998763 57999999999999999754 788999999877666543
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-51 Score=407.74 Aligned_cols=269 Identities=38% Similarity=0.716 Sum_probs=236.3
Q ss_pred CccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEc
Q 012762 78 PLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDC 157 (457)
Q Consensus 78 ~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~ 157 (457)
....++|.+.+.||+|+||+||+|+++ .+++.||+|++.+...........+.+|+++|+.++||||+++++++..
T Consensus 14 ~~~~~~y~~~~~lg~G~~g~V~~~~~~----~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 89 (329)
T PTZ00263 14 SWKLSDFEMGETLGTGSFGRVRIAKHK----GTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQD 89 (329)
T ss_pred CCCchheEEEEEEEecCCeEEEEEEEC----CCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEc
Confidence 345689999999999999999999987 4788999999988765555556778889999999999999999999999
Q ss_pred CCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcC
Q 012762 158 PRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLK 237 (457)
Q Consensus 158 ~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~ 237 (457)
++.+|+||||+.+++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 90 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~ 167 (329)
T PTZ00263 90 ENRVYFLLEFVVGGELFTHLRKA--GRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKK 167 (329)
T ss_pred CCEEEEEEcCCCCChHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceE
Confidence 99999999999999999888764 6789999999999999999999999999999999999999999999999999754
Q ss_pred CCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcccccc
Q 012762 238 GDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMS 317 (457)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (457)
.... ...
T Consensus 168 ~~~~-------------------------------------------------------------------------~~~ 174 (329)
T PTZ00263 168 VPDR-------------------------------------------------------------------------TFT 174 (329)
T ss_pred cCCC-------------------------------------------------------------------------cce
Confidence 3211 012
Q ss_pred ccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhhh
Q 012762 318 FVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVK 397 (457)
Q Consensus 318 ~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~ 397 (457)
..||+.|+|||++.+..++.++|||||||++|||++|..||.+......+..+......++.. ++..+++||.+||+.
T Consensus 175 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p~~--~~~~~~~li~~~L~~ 252 (329)
T PTZ00263 175 LCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNW--FDGRARDLVKGLLQT 252 (329)
T ss_pred ecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCCCC--CCHHHHHHHHHHhhc
Confidence 469999999999999999999999999999999999999999888777777777776665544 888999999999999
Q ss_pred CCCCCCCC-CcChHHHhcCCCCCCCCchhhh
Q 012762 398 DPTRRMGS-KMGATAIKRHQFFNGVNWALLR 427 (457)
Q Consensus 398 dP~~Rps~-~~~~~~ll~hp~f~~~~~~~~~ 427 (457)
||.+|++. ...+++|++||||+..+|..+.
T Consensus 253 dP~~R~~~~~~~~~~ll~hp~f~~~~~~~~~ 283 (329)
T PTZ00263 253 DHTKRLGTLKGGVADVKNHPYFHGANWDKLY 283 (329)
T ss_pred CHHHcCCCCCCCHHHHhcCCccCCCCHHHHH
Confidence 99999973 2347999999999999998764
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-51 Score=408.68 Aligned_cols=287 Identities=35% Similarity=0.676 Sum_probs=245.4
Q ss_pred CCCCccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEE
Q 012762 75 NNNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYAT 154 (457)
Q Consensus 75 ~~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~ 154 (457)
....+..++|.+.+.||+|+||.||+|.++. ..+..||+|++.+...........+..|+++++.++||||++++++
T Consensus 23 ~~~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~ 99 (340)
T PTZ00426 23 RKNKMKYEDFNFIRTLGTGSFGRVILATYKN---EDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGS 99 (340)
T ss_pred cCCCCChhhcEEEEEEeecCCeEEEEEEEEC---CCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEE
Confidence 4456778899999999999999999998763 2346899999987765555566778889999999999999999999
Q ss_pred EEcCCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCC
Q 012762 155 LDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDL 234 (457)
Q Consensus 155 ~~~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~ 234 (457)
+..++.+|+||||+.+|+|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+
T Consensus 100 ~~~~~~~~lv~Ey~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~ 177 (340)
T PTZ00426 100 FKDESYLYLVLEFVIGGEFFTFLRRN--KRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGF 177 (340)
T ss_pred EEeCCEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCC
Confidence 99999999999999999999998775 5799999999999999999999999999999999999999999999999999
Q ss_pred CcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccc
Q 012762 235 SLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVR 314 (457)
Q Consensus 235 s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (457)
+......
T Consensus 178 a~~~~~~------------------------------------------------------------------------- 184 (340)
T PTZ00426 178 AKVVDTR------------------------------------------------------------------------- 184 (340)
T ss_pred CeecCCC-------------------------------------------------------------------------
Confidence 7543210
Q ss_pred cccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHH
Q 012762 315 SMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQL 394 (457)
Q Consensus 315 ~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~ 394 (457)
..+.+||+.|||||++.+..++.++|||||||++|||++|..||.+.+....+..+......+|.. ++..+.++|.+|
T Consensus 185 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~--~~~~~~~li~~~ 262 (340)
T PTZ00426 185 TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKF--LDNNCKHLMKKL 262 (340)
T ss_pred cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCC--CCHHHHHHHHHH
Confidence 012469999999999999889999999999999999999999999888777788887776666544 889999999999
Q ss_pred hhhCCCCCCCC-CcChHHHhcCCCCCCCCchhhh--ccCCCCCCCCCCcc
Q 012762 395 LVKDPTRRMGS-KMGATAIKRHQFFNGVNWALLR--CAKPPFIPRPVTCR 441 (457)
Q Consensus 395 L~~dP~~Rps~-~~~~~~ll~hp~f~~~~~~~~~--~~~~~~~~~~~~~~ 441 (457)
|+.||++|++. ...++++++||||++++|..+. ...+|+.|+.....
T Consensus 263 l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~~~~~~~~~~~~~~p~~~~~~ 312 (340)
T PTZ00426 263 LSHDLTKRYGNLKKGAQNVKEHPWFGNIDWVSLLHKNVEVPYKPKYKNVF 312 (340)
T ss_pred cccCHHHcCCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCCCCc
Confidence 99999999621 1129999999999999998664 45678888765443
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-52 Score=402.90 Aligned_cols=313 Identities=33% Similarity=0.567 Sum_probs=248.1
Q ss_pred hhHHHHHHhhhcCCCCCCCCCccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhh----------
Q 012762 58 PCWKAIKEATSEGNNNNNNNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSR---------- 127 (457)
Q Consensus 58 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~---------- 127 (457)
..|..++................+.+|++++.||+|.||.|-+|++. .+++.||||++.+......
T Consensus 73 ~~~~~vket~k~~~~~~~~~~k~lNqy~l~~eiG~G~yGkVkLar~~----~~~~l~AiKil~K~~~~~~~~~~~~~a~~ 148 (576)
T KOG0585|consen 73 RSWRRVKETNKIVRYDDDQDRKQLNQYELIKEIGSGQYGKVKLARDE----VDGKLYAIKILPKKELRRQYGFPRQPAMK 148 (576)
T ss_pred ccccccceeeeeeeecCcccceehhheehhhhhcCCccceEEEEeec----CCCcEEEEEeechhhhhhhcccccccccc
Confidence 33444444433323334455667789999999999999999999987 4889999999988755332
Q ss_pred -hHHHHHHHHHHHHHHcCCCCCceEEEEEEcC--CcEEEEEeecCCCChHHHHHhCCCCC-CCHHHHHHHHHHHHHHHHH
Q 012762 128 -NKESRARIEREILEMLDHPFLPTLYATLDCP--RWSCLLTEFCPGGDLHVLRQRQPDKR-FHESAVRFYASEVVVALEF 203 (457)
Q Consensus 128 -~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~--~~~~lV~E~~~~~sL~~~~~~~~~~~-~~~~~~~~i~~qi~~~L~y 203 (457)
...+.+++|+.||++|+|||||+|+.+..+. +.+|||+|||..|.+.+.- .... +.+.+++.|+++++.||+|
T Consensus 149 ~~~~ekv~~EIailKkl~H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p---~d~~els~~~Ar~ylrDvv~GLEY 225 (576)
T KOG0585|consen 149 LMPIEKVRREIAILKKLHHPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCP---PDKPELSEQQARKYLRDVVLGLEY 225 (576)
T ss_pred cCcHHHHHHHHHHHHhcCCcCeeEEEEeecCcccCceEEEEEeccCCccccCC---CCcccccHHHHHHHHHHHHHHHHH
Confidence 1235788999999999999999999999764 5899999999999885432 2344 9999999999999999999
Q ss_pred HHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCC
Q 012762 204 LHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVP 283 (457)
Q Consensus 204 LH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (457)
||.+|||||||||.|+||+.+|+|||+|||.+.........
T Consensus 226 LH~QgiiHRDIKPsNLLl~~~g~VKIsDFGVs~~~~~~~~~--------------------------------------- 266 (576)
T KOG0585|consen 226 LHYQGIIHRDIKPSNLLLSSDGTVKISDFGVSNEFPQGSDE--------------------------------------- 266 (576)
T ss_pred HHhcCeeccccchhheEEcCCCcEEeeccceeeecccCCcc---------------------------------------
Confidence 99999999999999999999999999999997644211000
Q ss_pred cccccCcchhccccCCCCCCCcccccCCccccccccCCCCccCchhhcCCC----CCccchhhhhhHHHHHHhcCCCCCC
Q 012762 284 AVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTHEYLAPEIISGEG----HGNAVDWWTLGIFIFELFYGTTPFK 359 (457)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~----~~~~sDiwSlG~il~elltG~~Pf~ 359 (457)
..+......+|||.|||||.+.+.. .+.+.||||+||+||.|+.|+.||.
T Consensus 267 --------------------------~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~ 320 (576)
T KOG0585|consen 267 --------------------------GSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFF 320 (576)
T ss_pred --------------------------ccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcc
Confidence 0000111247999999999998732 3779999999999999999999999
Q ss_pred CCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCCCCchhhhccCCCCCCCCCC
Q 012762 360 GIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGVNWALLRCAKPPFIPRPVT 439 (457)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~~~~~~~~~~~~~~~~~~~~ 439 (457)
+....+.+.+|+...+.+|..+.+.++++|||.+||..||+.|.+ +.+|..|||...- -.-|..-.+-.
T Consensus 321 ~~~~~~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~----l~~ik~Hpwvt~~-------g~~~~~s~~~~ 389 (576)
T KOG0585|consen 321 DDFELELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRIT----LPDIKLHPWVTRD-------GDSPQSSEPSS 389 (576)
T ss_pred cchHHHHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheee----hhhheecceeccC-------CCCCccCCccc
Confidence 999999999999999999999889999999999999999999999 9999999997642 11123334445
Q ss_pred ccccccccCCCCCC
Q 012762 440 CRDLTTTNSSIDNS 453 (457)
Q Consensus 440 ~~~~~~~~~~~~~~ 453 (457)
|..+..+++.++|+
T Consensus 390 c~~v~v~eeev~~s 403 (576)
T KOG0585|consen 390 CSRVEVTEEEVNNS 403 (576)
T ss_pred ceeeeeeccccccc
Confidence 55555555555554
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-51 Score=409.92 Aligned_cols=315 Identities=29% Similarity=0.518 Sum_probs=239.2
Q ss_pred CCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcE
Q 012762 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWS 161 (457)
Q Consensus 82 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~ 161 (457)
++|++++.||+|+||+||+|+++ .+++.||+|++.+...........+..|++++..++|+||+++++.+.+...+
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~----~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~ 76 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKK----DTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNL 76 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEEC----CCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeE
Confidence 47999999999999999999876 47889999999887655555667788899999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCC
Q 012762 162 CLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNS 241 (457)
Q Consensus 162 ~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~ 241 (457)
|||||||+||+|..++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 77 ~lv~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~ 154 (363)
T cd05628 77 YLIMEFLPGGDMMTLLMKK--DTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA 154 (363)
T ss_pred EEEEcCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccc
Confidence 9999999999999988765 67999999999999999999999999999999999999999999999999998765422
Q ss_pred CcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCC
Q 012762 242 TSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGT 321 (457)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 321 (457)
.......... ...+.... ...... ..................+||
T Consensus 155 ~~~~~~~~~~-----~~~~~~~~----------------------~~~~~~--------~~~~~~~~~~~~~~~~~~~Gt 199 (363)
T cd05628 155 HRTEFYRNLN-----HSLPSDFT----------------------FQNMNS--------KRKAETWKRNRRQLAFSTVGT 199 (363)
T ss_pred cccccccccc-----cccccccc----------------------cccccc--------ccccchhhhccccccccccCC
Confidence 1110000000 00000000 000000 000000000011112346899
Q ss_pred CCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhc--ccCCCCCCCCChHHHHHHHHHhhhCC
Q 012762 322 HEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVAR--ALEFPKEPSVPGPAKDLIAQLLVKDP 399 (457)
Q Consensus 322 ~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~ll~~~L~~dP 399 (457)
+.|+|||++.+..++.++|||||||++|||++|+.||.+......+.+++.. ...+|....++++++++|.+|+. +|
T Consensus 200 ~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~ 278 (363)
T cd05628 200 PDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EW 278 (363)
T ss_pred ccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-Ch
Confidence 9999999999999999999999999999999999999988777777777653 34455555578999999999875 55
Q ss_pred CC---CCCCCcChHHHhcCCCCCCCCchhhhccCCCCCCCCCCccc
Q 012762 400 TR---RMGSKMGATAIKRHQFFNGVNWALLRCAKPPFIPRPVTCRD 442 (457)
Q Consensus 400 ~~---Rps~~~~~~~ll~hp~f~~~~~~~~~~~~~~~~~~~~~~~~ 442 (457)
.+ ||+ ++||++||||++++|..++...+++-++..+..+
T Consensus 279 ~~r~~r~~----~~ei~~hp~f~~~~~~~~~~~~~~~~~~~~~~~~ 320 (363)
T cd05628 279 EHRIGAPG----VEEIKTNPFFEGVDWEHIRERPAAIPIEIKSIDD 320 (363)
T ss_pred hhcCCCCC----HHHHhCCCCCCCCCHHHHHhCCCCCCccCCCcch
Confidence 54 577 9999999999999999886654444333333333
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-54 Score=390.27 Aligned_cols=252 Identities=26% Similarity=0.392 Sum_probs=218.6
Q ss_pred CccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEE-EEE
Q 012762 78 PLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYA-TLD 156 (457)
Q Consensus 78 ~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~-~~~ 156 (457)
...+.+|+++++||.|+||.||++.+. .+|..||.|.+.-. ..+....+....|+.+|++|+|||||++++ .|.
T Consensus 15 ~~~l~~y~Il~~IG~GsFg~vykv~~~----~~g~l~a~K~i~f~-~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~ 89 (375)
T KOG0591|consen 15 QKTLADYQILKKIGRGSFGEVYKVQCL----LDGKLVALKKIQFG-MMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFI 89 (375)
T ss_pred cccHHHHHHHHHHcCCcchheEEeeec----cCcchhhhhhcchh-hccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhh
Confidence 445678999999999999999999987 48999999999844 344555666777999999999999999999 555
Q ss_pred cCCc-EEEEEeecCCCChHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHH--cC--ceeecCCCCCeEEccCCCEEE
Q 012762 157 CPRW-SCLLTEFCPGGDLHVLRQRQ--PDKRFHESAVRFYASEVVVALEFLHM--MG--IIYRDLKPENVLVRSDGHIML 229 (457)
Q Consensus 157 ~~~~-~~lV~E~~~~~sL~~~~~~~--~~~~~~~~~~~~i~~qi~~~L~yLH~--~~--iiHrDIKp~NIll~~~~~vkl 229 (457)
.+.. ++||||||.+|+|..+++.. ..+.++|..++.++.|+|.||..+|. .+ |+||||||.||+|+..|.|||
T Consensus 90 ~~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKL 169 (375)
T KOG0591|consen 90 EDNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKL 169 (375)
T ss_pred ccchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceee
Confidence 5554 89999999999999998763 34679999999999999999999998 45 999999999999999999999
Q ss_pred eccCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCccccc
Q 012762 230 TDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAE 309 (457)
Q Consensus 230 ~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (457)
+|||+++.+......+
T Consensus 170 GDfGL~r~l~s~~tfA---------------------------------------------------------------- 185 (375)
T KOG0591|consen 170 GDFGLGRFLSSKTTFA---------------------------------------------------------------- 185 (375)
T ss_pred ccchhHhHhcchhHHH----------------------------------------------------------------
Confidence 9999998876544322
Q ss_pred CCccccccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHH
Q 012762 310 PLDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKD 389 (457)
Q Consensus 310 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (457)
.+++|||.||+||.+.+.+|+.++||||+||++|||+.-+.||.+.+-.+...+|..+.+..-.....+.++..
T Consensus 186 ------~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p~~~YS~~l~~ 259 (375)
T KOG0591|consen 186 ------HSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLPDEHYSTDLRE 259 (375)
T ss_pred ------HhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCcHHHhhhHHHH
Confidence 25789999999999999999999999999999999999999999997777888888776543222457889999
Q ss_pred HHHHHhhhCCCCCCC
Q 012762 390 LIAQLLVKDPTRRMG 404 (457)
Q Consensus 390 ll~~~L~~dP~~Rps 404 (457)
||..|+..||+.||+
T Consensus 260 li~~ci~vd~~~RP~ 274 (375)
T KOG0591|consen 260 LINMCIAVDPEQRPD 274 (375)
T ss_pred HHHHHccCCcccCCC
Confidence 999999999999998
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-52 Score=416.35 Aligned_cols=259 Identities=27% Similarity=0.505 Sum_probs=236.3
Q ss_pred CCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCc
Q 012762 81 LSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRW 160 (457)
Q Consensus 81 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~ 160 (457)
.+-|++.+.||.|+.|.|-+|++. .+|+.+|||++.+...........+.+|+-||+.+.||||+++|+++.+..+
T Consensus 11 iGpwkLgkTLG~Gstg~vrlakh~----~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~ 86 (786)
T KOG0588|consen 11 IGPWKLGKTLGKGSTGCVRLAKHA----ETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQH 86 (786)
T ss_pred ccceeccccccCCCCceehhhhcc----cccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCce
Confidence 456999999999999999999877 5999999999998855566667788889999999999999999999999999
Q ss_pred EEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCC
Q 012762 161 SCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDN 240 (457)
Q Consensus 161 ~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~ 240 (457)
+|+|+||++||.|++++-+. +++++.+++++++||+.|+.|+|..+|+||||||+|+||+..+++||+|||+|-...+
T Consensus 87 lylvlEyv~gGELFdylv~k--G~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~ 164 (786)
T KOG0588|consen 87 LYLVLEYVPGGELFDYLVRK--GPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVP 164 (786)
T ss_pred EEEEEEecCCchhHHHHHhh--CCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccC
Confidence 99999999999999998876 8899999999999999999999999999999999999999999999999999743321
Q ss_pred CCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccC
Q 012762 241 STSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVG 320 (457)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 320 (457)
.. -..+.||
T Consensus 165 gk-----------------------------------------------------------------------lLeTSCG 173 (786)
T KOG0588|consen 165 GK-----------------------------------------------------------------------LLETSCG 173 (786)
T ss_pred Cc-----------------------------------------------------------------------cccccCC
Confidence 11 1124589
Q ss_pred CCCccCchhhcCCCC-CccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhhhCC
Q 012762 321 THEYLAPEIISGEGH-GNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDP 399 (457)
Q Consensus 321 t~~y~aPE~l~~~~~-~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP 399 (457)
++.|.|||++.|.+| +.++||||.|||||.||+|..||++.+....+.++..+.+.+|.. ++.++++||.+||..||
T Consensus 174 SPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MPs~--Is~eaQdLLr~ml~VDp 251 (786)
T KOG0588|consen 174 SPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMPSN--ISSEAQDLLRRMLDVDP 251 (786)
T ss_pred CcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCCCc--CCHHHHHHHHHHhccCc
Confidence 999999999999998 889999999999999999999999999899999999999999965 99999999999999999
Q ss_pred CCCCCCCcChHHHhcCCCCCCCC
Q 012762 400 TRRMGSKMGATAIKRHQFFNGVN 422 (457)
Q Consensus 400 ~~Rps~~~~~~~ll~hp~f~~~~ 422 (457)
++|.| .+||++|||+.+..
T Consensus 252 ~~RiT----~~eI~kHP~l~g~~ 270 (786)
T KOG0588|consen 252 STRIT----TEEILKHPFLSGYT 270 (786)
T ss_pred ccccc----HHHHhhCchhhcCC
Confidence 99999 99999999998743
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-51 Score=397.33 Aligned_cols=279 Identities=32% Similarity=0.573 Sum_probs=231.6
Q ss_pred ceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcEEE
Q 012762 84 LRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWSCL 163 (457)
Q Consensus 84 ~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~l 163 (457)
|++.+.||+|+||+||+|.++ .+++.||+|++.+...........+.+|+++|+.++|+||+++++++..++..|+
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~----~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~l 77 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVR----ATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCL 77 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEe----cCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEE
Confidence 788999999999999999987 3788999999987665444445567789999999999999999999999999999
Q ss_pred EEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCCCc
Q 012762 164 LTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTS 243 (457)
Q Consensus 164 V~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~~~ 243 (457)
||||+++|+|..++.......+++..+..++.||+.||+|||+.||+||||||+|||++.++.++|+|||++........
T Consensus 78 v~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 157 (285)
T cd05631 78 VLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET 157 (285)
T ss_pred EEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCe
Confidence 99999999998877665445799999999999999999999999999999999999999999999999999754321100
Q ss_pred ccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCCCC
Q 012762 244 TAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTHE 323 (457)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 323 (457)
.....||..
T Consensus 158 -----------------------------------------------------------------------~~~~~g~~~ 166 (285)
T cd05631 158 -----------------------------------------------------------------------VRGRVGTVG 166 (285)
T ss_pred -----------------------------------------------------------------------ecCCCCCCC
Confidence 012358999
Q ss_pred ccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHh--cccCCCCCCCCChHHHHHHHHHhhhCCCC
Q 012762 324 YLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVA--RALEFPKEPSVPGPAKDLIAQLLVKDPTR 401 (457)
Q Consensus 324 y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~ll~~~L~~dP~~ 401 (457)
|+|||++.+..++.++|||||||++|||++|+.||.+.........+.. ..........++.++.+|+.+||..||++
T Consensus 167 y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~P~~ 246 (285)
T cd05631 167 YMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICRMLLTKNPKE 246 (285)
T ss_pred ccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHHHHHhhcCHHH
Confidence 9999999999999999999999999999999999987654322222111 11122223458899999999999999999
Q ss_pred CCCCCc-ChHHHhcCCCCCCCCchhhhcc--CCCCCCCC
Q 012762 402 RMGSKM-GATAIKRHQFFNGVNWALLRCA--KPPFIPRP 437 (457)
Q Consensus 402 Rps~~~-~~~~ll~hp~f~~~~~~~~~~~--~~~~~~~~ 437 (457)
||+... .++++++||||++++|..+... .|||.|.+
T Consensus 247 R~~~~~~~~~~~~~h~~~~~~~~~~~~~~~~~~~~~~~~ 285 (285)
T cd05631 247 RLGCRGNGAAGVKQHPIFKNINFKRLEANMLEPPFCPDP 285 (285)
T ss_pred hcCCCCCCHHHHhcCHhhcCCCHHHHHhCcCCcCCCCCC
Confidence 997432 3899999999999999988654 78999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-51 Score=399.59 Aligned_cols=274 Identities=42% Similarity=0.740 Sum_probs=236.7
Q ss_pred CCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcE
Q 012762 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWS 161 (457)
Q Consensus 82 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~ 161 (457)
++|++.+.||+|+||+||+|.++ .+++.||+|++.............+.+|+++|+.++||||+++++++.+.+.+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~----~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 76 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDR----ISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFL 76 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEc----CCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeE
Confidence 47999999999999999999986 37889999999876554444566788899999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCC
Q 012762 162 CLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNS 241 (457)
Q Consensus 162 ~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~ 241 (457)
|+||||+.+++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++......
T Consensus 77 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~ 154 (291)
T cd05612 77 YMLMEYVPGGELFSYLRNS--GRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR 154 (291)
T ss_pred EEEEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC
Confidence 9999999999999988765 57899999999999999999999999999999999999999999999999997543211
Q ss_pred CcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCC
Q 012762 242 TSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGT 321 (457)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 321 (457)
....+||
T Consensus 155 -------------------------------------------------------------------------~~~~~gt 161 (291)
T cd05612 155 -------------------------------------------------------------------------TWTLCGT 161 (291)
T ss_pred -------------------------------------------------------------------------cccccCC
Confidence 0123589
Q ss_pred CCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhhhCCCC
Q 012762 322 HEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDPTR 401 (457)
Q Consensus 322 ~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~ 401 (457)
+.|+|||++.+..++.++|||||||++|+|++|+.||.+......+..+......++.. ++..+++||.+||+.||.+
T Consensus 162 ~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~--~~~~~~~li~~~l~~dp~~ 239 (291)
T cd05612 162 PEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRH--LDLYAKDLIKKLLVVDRTR 239 (291)
T ss_pred hhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCCCcc--CCHHHHHHHHHHcCCCHHH
Confidence 99999999999999999999999999999999999999988777788887776666544 7889999999999999999
Q ss_pred CCCC-CcChHHHhcCCCCCCCCchhhh--ccCCCCCCC
Q 012762 402 RMGS-KMGATAIKRHQFFNGVNWALLR--CAKPPFIPR 436 (457)
Q Consensus 402 Rps~-~~~~~~ll~hp~f~~~~~~~~~--~~~~~~~~~ 436 (457)
|++. ...++++++||||+.++|..+. ...|+++|.
T Consensus 240 R~~~~~~~~~~~l~h~~~~~~~~~~~~~~~~~~~~~p~ 277 (291)
T cd05612 240 RLGNMKNGADDVKNHRWFKSVDWDDVPQRKLKPPIVPK 277 (291)
T ss_pred ccCCccCCHHHHhcCccccCCCHHHHhcCCCCCCEeCC
Confidence 9952 2349999999999999998653 344555553
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-51 Score=412.03 Aligned_cols=327 Identities=33% Similarity=0.577 Sum_probs=244.1
Q ss_pred CCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcE
Q 012762 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWS 161 (457)
Q Consensus 82 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~ 161 (457)
++|+++++||+|+||+||+|.++ .+++.||||++.+...........+.+|+++++.++||||+++++++.+++++
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~----~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~ 76 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKK----DTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYL 76 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEEC----CCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCee
Confidence 47999999999999999999887 47889999999877655555667788899999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCC
Q 012762 162 CLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNS 241 (457)
Q Consensus 162 ~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~ 241 (457)
||||||++||+|..++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 77 ~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~ 154 (377)
T cd05629 77 YLIMEFLPGGDLMTMLIKY--DTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ 154 (377)
T ss_pred EEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccc
Confidence 9999999999999888764 67999999999999999999999999999999999999999999999999998654321
Q ss_pred CcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCC
Q 012762 242 TSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGT 321 (457)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 321 (457)
........ ............... ..... .......+..................+||
T Consensus 155 ~~~~~~~~---------------~~~~~~~~~~~~~~~------~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 211 (377)
T cd05629 155 HDSAYYQK---------------LLQGKSNKNRIDNRN------SVAVD--SINLTMSSKDQIATWKKNRRLMAYSTVGT 211 (377)
T ss_pred cccccccc---------------ccccccccccccccc------ccccc--cccccccchhhhhhhhhcccccccccCCC
Confidence 11100000 000000000000000 00000 00000000000000000011111235799
Q ss_pred CCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHh--cccCCCCCCCCChHHHHHHHHHhhhCC
Q 012762 322 HEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVA--RALEFPKEPSVPGPAKDLIAQLLVKDP 399 (457)
Q Consensus 322 ~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~ll~~~L~~dP 399 (457)
+.|+|||++.+..++.++|||||||++|||++|.+||.+......+..+.. ..+.++....++.++.+||.+||. +|
T Consensus 212 ~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~ 290 (377)
T cd05629 212 PDYIAPEIFLQQGYGQECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NA 290 (377)
T ss_pred ccccCHHHHccCCCCCceeeEecchhhhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CH
Confidence 999999999999999999999999999999999999988776666666654 234445545678899999999997 77
Q ss_pred CCCC---CCCcChHHHhcCCCCCCCCchhhhccCCCCCCCCCCccc
Q 012762 400 TRRM---GSKMGATAIKRHQFFNGVNWALLRCAKPPFIPRPVTCRD 442 (457)
Q Consensus 400 ~~Rp---s~~~~~~~ll~hp~f~~~~~~~~~~~~~~~~~~~~~~~~ 442 (457)
.+|+ + +.++++||||++++|..++...+|++|......+
T Consensus 291 ~~r~~r~~----~~~~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (377)
T cd05629 291 ENRLGRGG----AHEIKSHPFFRGVDWDTIRQIRAPFIPQLKSITD 332 (377)
T ss_pred hhcCCCCC----HHHHhcCCCcCCCCHHHHccCCCCcccCCCCccc
Confidence 7765 7 9999999999999999999999999987644433
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-51 Score=402.83 Aligned_cols=277 Identities=35% Similarity=0.574 Sum_probs=239.5
Q ss_pred CCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcE
Q 012762 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWS 161 (457)
Q Consensus 82 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~ 161 (457)
++|++++.||+|+||.||+|+++ .+++.||+|++.+...........+..|+++|+.++||||+++++++...+..
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~----~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~ 76 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKK----DTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYL 76 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEEC----CCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEE
Confidence 47999999999999999999987 47889999999887655445566788899999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCC
Q 012762 162 CLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNS 241 (457)
Q Consensus 162 ~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~ 241 (457)
||||||++|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 77 ~lv~e~~~g~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~- 153 (333)
T cd05600 77 YLAMEYVPGGDFRTLLNNL--GVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT- 153 (333)
T ss_pred EEEEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc-
Confidence 9999999999999998764 5789999999999999999999999999999999999999999999999999754321
Q ss_pred CcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCC
Q 012762 242 TSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGT 321 (457)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 321 (457)
.....+||
T Consensus 154 ------------------------------------------------------------------------~~~~~~gt 161 (333)
T cd05600 154 ------------------------------------------------------------------------YANSVVGS 161 (333)
T ss_pred ------------------------------------------------------------------------ccCCcccC
Confidence 01134699
Q ss_pred CCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcc--cCCCCC----CCCChHHHHHHHHHh
Q 012762 322 HEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARA--LEFPKE----PSVPGPAKDLIAQLL 395 (457)
Q Consensus 322 ~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~--~~~~~~----~~~~~~~~~ll~~~L 395 (457)
+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+....+.... +..+.. ..+++++.+||.+||
T Consensus 162 ~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l 241 (333)
T cd05600 162 PDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLITKLI 241 (333)
T ss_pred ccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHHHHHHHHh
Confidence 99999999999999999999999999999999999999877666655554322 222222 246889999999999
Q ss_pred hhCCCCCCCCCcChHHHhcCCCCCCCCchhhhccCCCCCCCCCCcc
Q 012762 396 VKDPTRRMGSKMGATAIKRHQFFNGVNWALLRCAKPPFIPRPVTCR 441 (457)
Q Consensus 396 ~~dP~~Rps~~~~~~~ll~hp~f~~~~~~~~~~~~~~~~~~~~~~~ 441 (457)
..+|.+||+ +.++++||||+.++|..+....||++|......
T Consensus 242 ~~~~~rr~s----~~~ll~h~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (333)
T cd05600 242 NDPSRRFGS----LEDIKNHPFFKEVDWNELRELKPPFVPELESEI 283 (333)
T ss_pred hChhhhcCC----HHHHHhCcccCCCCHHHHhhCCCCCCCCCCCcc
Confidence 999999999 999999999999999999988999998765443
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-53 Score=406.18 Aligned_cols=258 Identities=29% Similarity=0.462 Sum_probs=222.1
Q ss_pred cCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcC-CCCCceEEEEEEcC
Q 012762 80 TLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLD-HPFLPTLYATLDCP 158 (457)
Q Consensus 80 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~-H~nIv~l~~~~~~~ 158 (457)
..++|.++++||.|+||.||+|..+ .+|..||||.++++-. ... +..-.+|+..|++|+ ||||+++.+++.+.
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~----~~~~~VAIK~MK~Kf~-s~e-e~~nLREvksL~kln~hpniikL~Evi~d~ 81 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSK----ETGELVAIKKMKKKFY-SWE-ECMNLREVKSLRKLNPHPNIIKLKEVIRDN 81 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeec----CCCceeeHHHHHhhhc-cHH-HHHHHHHHHHHHhcCCCCcchhhHHHhhcc
Confidence 4568999999999999999999876 4888999999976543 322 233456999999998 99999999999888
Q ss_pred C-cEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcC
Q 012762 159 R-WSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLK 237 (457)
Q Consensus 159 ~-~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~ 237 (457)
+ .+|+||||| ..+|+++++.+ ++.|++..++.|+.||++||+|+|.+|+.||||||+|||+.....+||+|||+|+.
T Consensus 82 ~~~L~fVfE~M-d~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARe 159 (538)
T KOG0661|consen 82 DRILYFVFEFM-DCNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLARE 159 (538)
T ss_pred CceEeeeHHhh-hhhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccc
Confidence 7 999999999 88999999987 78999999999999999999999999999999999999999888999999999987
Q ss_pred CCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcccccc
Q 012762 238 GDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMS 317 (457)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (457)
...... .+.
T Consensus 160 v~SkpP-----------------------------------------------------------------------YTe 168 (538)
T KOG0661|consen 160 VRSKPP-----------------------------------------------------------------------YTE 168 (538)
T ss_pred cccCCC-----------------------------------------------------------------------cch
Confidence 653322 224
Q ss_pred ccCCCCccCchhhcCCC-CCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhc-------------------ccCC
Q 012762 318 FVGTHEYLAPEIISGEG-HGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVAR-------------------ALEF 377 (457)
Q Consensus 318 ~~gt~~y~aPE~l~~~~-~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~-------------------~~~~ 377 (457)
++.|.+|+|||++.... |+.++|||++|||++|+++-++.|.|.++.+.+.+|..- .+++
T Consensus 169 YVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~~ 248 (538)
T KOG0661|consen 169 YVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMNFRF 248 (538)
T ss_pred hhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhccCC
Confidence 67899999999997665 899999999999999999999999999888777776642 2233
Q ss_pred CCC---------CCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCC
Q 012762 378 PKE---------PSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNG 420 (457)
Q Consensus 378 ~~~---------~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~ 420 (457)
|.. +.++.++.+||.+||.+||.+||| +.|+|+||||+.
T Consensus 249 P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpT----A~~al~~pffq~ 296 (538)
T KOG0661|consen 249 PQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPT----ASQALQHPFFQV 296 (538)
T ss_pred CcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCcc----HHHHhcCccccc
Confidence 321 335678999999999999999999 999999999986
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-51 Score=392.28 Aligned_cols=271 Identities=27% Similarity=0.390 Sum_probs=235.8
Q ss_pred CCCCccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEE
Q 012762 75 NNNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYAT 154 (457)
Q Consensus 75 ~~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~ 154 (457)
..+....++|.+..+||.|..++||+|++. ..+..||||+++..+... ..+.+++|+..|+.++||||++++..
T Consensus 19 ~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~----p~~e~VAIK~inLEkc~~--~ld~l~kE~~~msl~~HPNIv~~~~s 92 (516)
T KOG0582|consen 19 KEFPLNAKDYELQEVIGVGASAVVYLARCI----PTNEVVAIKIINLEKCNN--DLDALRKEVQTMSLIDHPNIVTYHCS 92 (516)
T ss_pred ccCCCCccceeEEEEEeccceeEeeeeeec----ccCCEEEEEEeehhhhhh--hHHHHHHHHHHhhhcCCCCcceEEEE
Confidence 446677889999999999999999999987 477999999999886643 36788999999999999999999999
Q ss_pred EEcCCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCC
Q 012762 155 LDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDL 234 (457)
Q Consensus 155 ~~~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~ 234 (457)
|..+..+|+||.||.+|++.++++.....++.|..+..+++++++||.|||.+|.||||||+.||||+.+|.|||+|||.
T Consensus 93 Fvv~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgv 172 (516)
T KOG0582|consen 93 FVVDSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGV 172 (516)
T ss_pred EEecceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCcee
Confidence 99999999999999999999999988778899999999999999999999999999999999999999999999999998
Q ss_pred CcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccc
Q 012762 235 SLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVR 314 (457)
Q Consensus 235 s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (457)
+..+..... ....+
T Consensus 173 sa~l~~~G~------------------------------------------------------------------R~~~r 186 (516)
T KOG0582|consen 173 SASLFDSGD------------------------------------------------------------------RQVTR 186 (516)
T ss_pred eeeecccCc------------------------------------------------------------------eeeEe
Confidence 755432110 00112
Q ss_pred cccccCCCCccCchhhcC--CCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCC--------CCCC
Q 012762 315 SMSFVGTHEYLAPEIISG--EGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKE--------PSVP 384 (457)
Q Consensus 315 ~~~~~gt~~y~aPE~l~~--~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~--------~~~~ 384 (457)
..+++||++|||||++.. .+|+.|+||||||++..||.+|..||......+++...+.+....+.. ..++
T Consensus 187 f~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~~d~~k~~~ 266 (516)
T KOG0582|consen 187 FNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLDKDEDKKFS 266 (516)
T ss_pred eccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccCChHHhhhhc
Confidence 246799999999999643 469999999999999999999999999998888888877776653332 2345
Q ss_pred hHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCCC
Q 012762 385 GPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGV 421 (457)
Q Consensus 385 ~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~~ 421 (457)
..++.++..||+.||.+||+ +.++|+|+||+..
T Consensus 267 ksf~e~i~~CL~kDP~kRpt----AskLlkh~FFk~~ 299 (516)
T KOG0582|consen 267 KSFREMIALCLVKDPSKRPT----ASKLLKHAFFKKA 299 (516)
T ss_pred HHHHHHHHHHhhcCcccCCC----HHHHhccHHHhhc
Confidence 57999999999999999999 9999999999874
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-52 Score=370.94 Aligned_cols=263 Identities=33% Similarity=0.583 Sum_probs=243.5
Q ss_pred CCCccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEE
Q 012762 76 NNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATL 155 (457)
Q Consensus 76 ~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~ 155 (457)
.....+++|.+.+.||.|.||.||+|+.+ +++-.||+||+-|..+.......++++|++|...|+||||+++|++|
T Consensus 16 ~~~~~l~dfeigr~LgkgkFG~vYlarek----ks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~f 91 (281)
T KOG0580|consen 16 TKTWTLDDFEIGRPLGKGKFGNVYLAREK----KSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYF 91 (281)
T ss_pred ccccchhhccccccccCCccccEeEeeec----cCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhhe
Confidence 34567789999999999999999999977 47889999999999888888889999999999999999999999999
Q ss_pred EcCCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCC
Q 012762 156 DCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235 (457)
Q Consensus 156 ~~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s 235 (457)
.+...+||++||..+|+|+..+.......+++.....++.|++.||.|+|.++||||||||+|+|++..|.+||+|||-+
T Consensus 92 hd~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGws 171 (281)
T KOG0580|consen 92 HDSKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWS 171 (281)
T ss_pred eccceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCce
Confidence 99999999999999999999999777789999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcccc
Q 012762 236 LKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRS 315 (457)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (457)
.... ..+.
T Consensus 172 V~~p------------------------------------------------------------------------~~kR 179 (281)
T KOG0580|consen 172 VHAP------------------------------------------------------------------------SNKR 179 (281)
T ss_pred eecC------------------------------------------------------------------------CCCc
Confidence 4332 2233
Q ss_pred ccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHh
Q 012762 316 MSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLL 395 (457)
Q Consensus 316 ~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L 395 (457)
.++|||..|.+||...+..++..+|+|++|+++||++.|.+||......+.+.+|....+.+|. .++.++.|+|.+||
T Consensus 180 ~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p~--~is~~a~dlI~~ll 257 (281)
T KOG0580|consen 180 KTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFPS--TISGGAADLISRLL 257 (281)
T ss_pred eeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCCc--ccChhHHHHHHHHh
Confidence 4789999999999999999999999999999999999999999999999999999999888884 49999999999999
Q ss_pred hhCCCCCCCCCcChHHHhcCCCCCC
Q 012762 396 VKDPTRRMGSKMGATAIKRHQFFNG 420 (457)
Q Consensus 396 ~~dP~~Rps~~~~~~~ll~hp~f~~ 420 (457)
..+|.+|.. +.|+++|||...
T Consensus 258 ~~~p~~r~~----l~~v~~hpwI~a 278 (281)
T KOG0580|consen 258 VKNPIERLA----LTEVMDHPWIVA 278 (281)
T ss_pred ccCcccccc----HHHHhhhHHHHh
Confidence 999999999 999999999753
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-50 Score=405.52 Aligned_cols=321 Identities=33% Similarity=0.602 Sum_probs=244.7
Q ss_pred CCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcE
Q 012762 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWS 161 (457)
Q Consensus 82 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~ 161 (457)
++|++++.||+|+||+||+|+++ .+++.||||++.+...........+..|+++|+.++|+||+++++++..++.+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~----~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~ 76 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKK----DTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYL 76 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEEC----CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeE
Confidence 47999999999999999999987 47889999999877655555566778899999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCC
Q 012762 162 CLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNS 241 (457)
Q Consensus 162 ~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~ 241 (457)
|||||||.||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.++|+|||++......
T Consensus 77 ~lv~E~~~~g~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 154 (364)
T cd05599 77 YLIMEYLPGGDMMTLLMKK--DTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS 154 (364)
T ss_pred EEEECCCCCcHHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence 9999999999999988764 56999999999999999999999999999999999999999999999999998654321
Q ss_pred CcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCC
Q 012762 242 TSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGT 321 (457)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 321 (457)
........ ............ .+....... ..............+.+||
T Consensus 155 ~~~~~~~~---------------~~~~~~~~~~~~--------~~~~~~~~~---------~~~~~~~~~~~~~~~~~gt 202 (364)
T cd05599 155 HRTEFYRI---------------LSHALPSNFLDF--------ISKPMSSKR---------KAETWKRNRRALAYSTVGT 202 (364)
T ss_pred cccccccc---------------cccccccccccc--------ccccccccc---------cccchhhcccccccccccC
Confidence 11000000 000000000000 000000000 0000000011122245799
Q ss_pred CCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcc--cCCCCCCCCChHHHHHHHHHhhhCC
Q 012762 322 HEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARA--LEFPKEPSVPGPAKDLIAQLLVKDP 399 (457)
Q Consensus 322 ~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~ll~~~L~~dP 399 (457)
+.|+|||++.+..++.++|||||||++|||++|..||.+.........++... +.++....+++++++||.+||. +|
T Consensus 203 ~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p 281 (364)
T cd05599 203 PDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EA 281 (364)
T ss_pred ccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CH
Confidence 99999999999999999999999999999999999999887776666665533 3344444578999999999996 99
Q ss_pred CCCCCCCcChHHHhcCCCCCCCCchhhhccCCCCCCCCCCccc
Q 012762 400 TRRMGSKMGATAIKRHQFFNGVNWALLRCAKPPFIPRPVTCRD 442 (457)
Q Consensus 400 ~~Rps~~~~~~~ll~hp~f~~~~~~~~~~~~~~~~~~~~~~~~ 442 (457)
.+|++. ..+.++++||||++++|..+....++++|......|
T Consensus 282 ~~R~~~-~~~~~ll~h~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (364)
T cd05599 282 ERRLGN-NGVNEIKSHPFFKGVDWEHIRERPAPIIPELKSITD 323 (364)
T ss_pred hhcCCC-CCHHHHhcCCCcCCCCHHHHhhcCCCCCCCCCCchh
Confidence 999963 349999999999999999888888888876554443
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-53 Score=378.05 Aligned_cols=258 Identities=28% Similarity=0.487 Sum_probs=230.5
Q ss_pred CCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCc
Q 012762 81 LSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRW 160 (457)
Q Consensus 81 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~ 160 (457)
-+.|.+.++||+|.|++||+|.++ .+|+.||+|+++...+... ..+.+.+|++|.++|+|||||++.+.+.....
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~----~tg~~fa~kiin~~k~~~~-~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~ 84 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHK----TTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQHPNIVRLHDSIQEESF 84 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhc----cchHHHHHHHhhhhhhccc-cHHHHHHHHHHHHhcCCCcEeehhhhhcccce
Confidence 357999999999999999988765 6899999999998877665 56677889999999999999999999999999
Q ss_pred EEEEEeecCCCChH-HHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccC---CCEEEeccCCCc
Q 012762 161 SCLLTEFCPGGDLH-VLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSD---GHIMLTDFDLSL 236 (457)
Q Consensus 161 ~~lV~E~~~~~sL~-~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~---~~vkl~DFG~s~ 236 (457)
.|||+|++.|++|. ++.++ -.++|..+-.+++||+++|.|+|.+||||||+||+|+|+.+. .-+||+|||++.
T Consensus 85 ~ylvFe~m~G~dl~~eIV~R---~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi 161 (355)
T KOG0033|consen 85 HYLVFDLVTGGELFEDIVAR---EFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAI 161 (355)
T ss_pred eEEEEecccchHHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEE
Confidence 99999999999994 55555 568999999999999999999999999999999999999743 469999999987
Q ss_pred CCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccc
Q 012762 237 KGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSM 316 (457)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (457)
....... ..
T Consensus 162 ~l~~g~~-----------------------------------------------------------------------~~ 170 (355)
T KOG0033|consen 162 EVNDGEA-----------------------------------------------------------------------WH 170 (355)
T ss_pred EeCCccc-----------------------------------------------------------------------cc
Confidence 6542111 12
Q ss_pred cccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCC--CCCCChHHHHHHHHH
Q 012762 317 SFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPK--EPSVPGPAKDLIAQL 394 (457)
Q Consensus 317 ~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ll~~~ 394 (457)
.++|||.|||||+++..+|+..+|||+.|||||-|+.|++||++.+....+++|+.+.+.++. ++.+++++++|+++|
T Consensus 171 G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~Ak~LvrrM 250 (355)
T KOG0033|consen 171 GFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEAKSLIRRM 250 (355)
T ss_pred cccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHHHHHHHHH
Confidence 468999999999999999999999999999999999999999999999999999999888764 678999999999999
Q ss_pred hhhCCCCCCCCCcChHHHhcCCCCCCC
Q 012762 395 LVKDPTRRMGSKMGATAIKRHQFFNGV 421 (457)
Q Consensus 395 L~~dP~~Rps~~~~~~~ll~hp~f~~~ 421 (457)
|..||.+|.| +.|.|+|||....
T Consensus 251 L~~dP~kRIt----a~EAL~HpWi~~r 273 (355)
T KOG0033|consen 251 LTVNPKKRIT----ADEALKHPWICNR 273 (355)
T ss_pred hccChhhhcc----HHHHhCCchhcch
Confidence 9999999999 9999999999873
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-52 Score=409.59 Aligned_cols=257 Identities=26% Similarity=0.415 Sum_probs=224.4
Q ss_pred cCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCC
Q 012762 80 TLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPR 159 (457)
Q Consensus 80 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~ 159 (457)
....|....+||+|+.|.||.|... .+++.||||.+..... ...+.+.+|+.+|+..+|+|||.+++.|...+
T Consensus 271 P~~~y~~~~kigqgaSG~vy~A~~~----~~~~~VaiK~m~l~~Q---~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~d 343 (550)
T KOG0578|consen 271 PRSKYTDFKKIGQGATGGVYVARKI----STKQEVAIKRMDLRKQ---PKKELLLNEILVMRDLHHPNIVNFLDSYLVGD 343 (550)
T ss_pred hhhhhcchhhhccccccceeeeeec----cCCceEEEEEEEeccC---CchhhhHHHHHHHHhccchHHHHHHHHhcccc
Confidence 3456888999999999999999877 4788899999987644 45566788999999999999999999998889
Q ss_pred cEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCC
Q 012762 160 WSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGD 239 (457)
Q Consensus 160 ~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~ 239 (457)
.+++||||++||+|.+++.. ..++|.++..++++++.||+|||.+||+|||||.+|||++.+|.+||+||||+..+.
T Consensus 344 eLWVVMEym~ggsLTDvVt~---~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~ 420 (550)
T KOG0578|consen 344 ELWVVMEYMEGGSLTDVVTK---TRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQIS 420 (550)
T ss_pred eeEEEEeecCCCchhhhhhc---ccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccc
Confidence 99999999999999998877 569999999999999999999999999999999999999999999999999986554
Q ss_pred CCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcccccccc
Q 012762 240 NSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFV 319 (457)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (457)
.... +..+++
T Consensus 421 ~~~~----------------------------------------------------------------------KR~TmV 430 (550)
T KOG0578|consen 421 EEQS----------------------------------------------------------------------KRSTMV 430 (550)
T ss_pred cccC----------------------------------------------------------------------cccccc
Confidence 2211 233678
Q ss_pred CCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHH-HHhcccCCCCCCCCChHHHHHHHHHhhhC
Q 012762 320 GTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLAN-VVARALEFPKEPSVPGPAKDLIAQLLVKD 398 (457)
Q Consensus 320 gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ll~~~L~~d 398 (457)
||++|||||+.....|+.++||||||++++||+-|++||........+.. .-.+...+.....++..+++||.+||+.|
T Consensus 431 GTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdFL~~cL~~d 510 (550)
T KOG0578|consen 431 GTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKDFLDRCLVVD 510 (550)
T ss_pred CCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHHHHHHHhhcc
Confidence 99999999999999999999999999999999999999986544433333 33455566667789999999999999999
Q ss_pred CCCCCCCCcChHHHhcCCCCCC
Q 012762 399 PTRRMGSKMGATAIKRHQFFNG 420 (457)
Q Consensus 399 P~~Rps~~~~~~~ll~hp~f~~ 420 (457)
+++|++ +.+||+||||+.
T Consensus 511 v~~Ras----A~eLL~HpFl~~ 528 (550)
T KOG0578|consen 511 VEQRAS----AKELLEHPFLKM 528 (550)
T ss_pred hhcCCC----HHHHhcChhhhh
Confidence 999999 999999999953
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-50 Score=403.50 Aligned_cols=310 Identities=37% Similarity=0.681 Sum_probs=249.3
Q ss_pred CCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcE
Q 012762 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWS 161 (457)
Q Consensus 82 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~ 161 (457)
++|.+.+.||+|+||+||+|++. .+++.||+|++.+...........+..|+++|+.++|+||+++++++.+++++
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~----~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 76 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDK----DTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHL 76 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEEC----CCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeE
Confidence 47999999999999999999986 37889999999887665556667788899999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCC
Q 012762 162 CLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNS 241 (457)
Q Consensus 162 ~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~ 241 (457)
|+||||+.+++|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 77 ~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 154 (350)
T cd05573 77 YLVMEYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKA 154 (350)
T ss_pred EEEEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence 9999999999999998775 67999999999999999999999999999999999999999999999999998765432
Q ss_pred CcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCC
Q 012762 242 TSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGT 321 (457)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 321 (457)
........... . ..... .... ................||
T Consensus 155 ~~~~~~~~~~~----------~---~~~~~-----------------------~~~~-----~~~~~~~~~~~~~~~~gt 193 (350)
T cd05573 155 KDREYYLNDSH----------N---LLFRD-----------------------NVLV-----RRRDHKQRRVRANSTVGT 193 (350)
T ss_pred Ccccccccccc----------c---ccccc-----------------------cccc-----cccccccccccccccccC
Confidence 21100000000 0 00000 0000 000000001112245699
Q ss_pred CCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHh--cccCCCCCCCCChHHHHHHHHHhhhCC
Q 012762 322 HEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVA--RALEFPKEPSVPGPAKDLIAQLLVKDP 399 (457)
Q Consensus 322 ~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~ll~~~L~~dP 399 (457)
+.|+|||++.+..++.++|||||||++|||++|+.||...........+.. ....++....+++++.+||.+||. ||
T Consensus 194 ~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp 272 (350)
T cd05573 194 PDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DP 272 (350)
T ss_pred ccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHHHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-Ch
Confidence 999999999999999999999999999999999999998887777777776 555666666679999999999997 99
Q ss_pred CCCCCCCcChHHHhcCCCCCCCCchhhhccCCCCCCCCCCccc
Q 012762 400 TRRMGSKMGATAIKRHQFFNGVNWALLRCAKPPFIPRPVTCRD 442 (457)
Q Consensus 400 ~~Rps~~~~~~~ll~hp~f~~~~~~~~~~~~~~~~~~~~~~~~ 442 (457)
.+|++. +.++++||||+.++|.......||++|......+
T Consensus 273 ~~R~~s---~~~ll~hp~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (350)
T cd05573 273 EDRLGS---FEEIKSHPFFKGIDWENLRETKPPFVPELSSPLD 312 (350)
T ss_pred hhcCCC---HHHHhcCCCcCCCCHHHHhhCCCCcCCCCCCchh
Confidence 999996 9999999999999999998888888886555443
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-52 Score=407.70 Aligned_cols=255 Identities=28% Similarity=0.493 Sum_probs=230.3
Q ss_pred CCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcE
Q 012762 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWS 161 (457)
Q Consensus 82 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~ 161 (457)
++|.+.+.||+|+||+||+|+-| ++.+.||+|.+.|..- .+.....+++|++|++.|+|||||.++++|+...++
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK----~t~~~vAik~i~K~gr-~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~ 76 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRK----YTIQVVAIKFIDKSGR-NEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHL 76 (808)
T ss_pred cchhHHHHhcCCccceeeecccc----cceeEEEEEEehhcCC-chHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceE
Confidence 57999999999999999999866 5889999999988653 344567788999999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCC
Q 012762 162 CLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNS 241 (457)
Q Consensus 162 ~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~ 241 (457)
|+|+|||.| +|..++... +.++|+.++.++.|++.||.|||+.+|+|||+||.|||+...|.+|+||||+++.+...
T Consensus 77 ~vVte~a~g-~L~~il~~d--~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~ 153 (808)
T KOG0597|consen 77 WVVTEYAVG-DLFTILEQD--GKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN 153 (808)
T ss_pred EEEehhhhh-hHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccC
Confidence 999999965 999999885 88999999999999999999999999999999999999999999999999999877643
Q ss_pred CcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCC
Q 012762 242 TSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGT 321 (457)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 321 (457)
+... ..+-||
T Consensus 154 t~vl----------------------------------------------------------------------tsikGt 163 (808)
T KOG0597|consen 154 TSVL----------------------------------------------------------------------TSIKGT 163 (808)
T ss_pred ceee----------------------------------------------------------------------eeccCc
Confidence 3211 134599
Q ss_pred CCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhhhCCCC
Q 012762 322 HEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDPTR 401 (457)
Q Consensus 322 ~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~ 401 (457)
|.|||||...+.+|+..+|+||||||+|||++|++||...+-.+....|+.....+|. ..+.++.+|++.+|..||..
T Consensus 164 PlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p~--~~S~~f~nfl~gLL~kdP~~ 241 (808)
T KOG0597|consen 164 PLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPPS--TASSSFVNFLQGLLIKDPAQ 241 (808)
T ss_pred ccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCcc--cccHHHHHHHHHHhhcChhh
Confidence 9999999999999999999999999999999999999988877788888877777666 48899999999999999999
Q ss_pred CCCCCcChHHHhcCCCCCC
Q 012762 402 RMGSKMGATAIKRHQFFNG 420 (457)
Q Consensus 402 Rps~~~~~~~ll~hp~f~~ 420 (457)
|.+ ..+++.|||.++
T Consensus 242 Rlt----W~~Ll~HpF~k~ 256 (808)
T KOG0597|consen 242 RLT----WTDLLGHPFWKG 256 (808)
T ss_pred ccc----HHHHhcChHHhh
Confidence 999 999999999886
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-50 Score=398.30 Aligned_cols=279 Identities=37% Similarity=0.713 Sum_probs=235.6
Q ss_pred EEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHc-CCCCCceEEEEEEcCCcEEEEEe
Q 012762 88 HRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEML-DHPFLPTLYATLDCPRWSCLLTE 166 (457)
Q Consensus 88 ~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~~~~~~~~~~~lV~E 166 (457)
+.||+|+||+||+|+++ .+++.||+|++.+...........+..|.+++..+ +||||+++++++...+.+|+|||
T Consensus 1 ~~lg~G~~g~V~~~~~~----~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~E 76 (320)
T cd05590 1 RVLGKGSFGKVMLARLK----ESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVME 76 (320)
T ss_pred CeeeeCCCeEEEEEEEc----CCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEc
Confidence 36899999999999987 47889999999876554555566677788888876 79999999999999999999999
Q ss_pred ecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCCCcccc
Q 012762 167 FCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQ 246 (457)
Q Consensus 167 ~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~~~~~~ 246 (457)
|+++++|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 77 y~~~g~L~~~i~~~--~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~---- 150 (320)
T cd05590 77 FVNGGDLMFHIQKS--RRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG---- 150 (320)
T ss_pred CCCCchHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC----
Confidence 99999999888764 679999999999999999999999999999999999999999999999999975321100
Q ss_pred cccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCCCCccC
Q 012762 247 LVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTHEYLA 326 (457)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 326 (457)
.......||+.|+|
T Consensus 151 ------------------------------------------------------------------~~~~~~~gt~~y~a 164 (320)
T cd05590 151 ------------------------------------------------------------------KTTSTFCGTPDYIA 164 (320)
T ss_pred ------------------------------------------------------------------CcccccccCccccC
Confidence 00113469999999
Q ss_pred chhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhhhCCCCCCCCC
Q 012762 327 PEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDPTRRMGSK 406 (457)
Q Consensus 327 PE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rps~~ 406 (457)
||++.+..++.++|||||||++|||++|+.||.+......+..+......++. .++.++.++|.+||+.||++|++..
T Consensus 165 PE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~--~~~~~~~~li~~~L~~dP~~R~~~~ 242 (320)
T cd05590 165 PEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPT--WLSQDAVDILKAFMTKNPTMRLGSL 242 (320)
T ss_pred HHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCC--CCCHHHHHHHHHHcccCHHHCCCCC
Confidence 99999999999999999999999999999999998888788877776655554 3889999999999999999999931
Q ss_pred c--ChHHHhcCCCCCCCCchhh--hccCCCCCCCCCCccccc
Q 012762 407 M--GATAIKRHQFFNGVNWALL--RCAKPPFIPRPVTCRDLT 444 (457)
Q Consensus 407 ~--~~~~ll~hp~f~~~~~~~~--~~~~~~~~~~~~~~~~~~ 444 (457)
. ..+++++||||+.++|..+ +...||+.|+.....+.+
T Consensus 243 ~~~~~~~~~~h~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (320)
T cd05590 243 TLGGEEAILRHPFFKELDWEKLNRRQIEPPFRPRIKSREDVS 284 (320)
T ss_pred CCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCCCcchhh
Confidence 1 1289999999999999776 356788888876655544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-50 Score=404.31 Aligned_cols=322 Identities=30% Similarity=0.528 Sum_probs=240.3
Q ss_pred CCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcE
Q 012762 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWS 161 (457)
Q Consensus 82 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~ 161 (457)
++|+++++||+|+||+||+|+++ .+++.||+|++.+...........+.+|+++|+.++|+||+++++.+..++.+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~----~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~ 76 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKV----DTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNL 76 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEEC----CCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEE
Confidence 47999999999999999999976 47889999999876655555667788899999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCC
Q 012762 162 CLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNS 241 (457)
Q Consensus 162 ~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~ 241 (457)
|||||||++|+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 77 ~lv~E~~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~ 154 (376)
T cd05598 77 YFVMDYIPGGDMMSLLIRL--GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (376)
T ss_pred EEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccc
Confidence 9999999999999998764 67899999999999999999999999999999999999999999999999998544211
Q ss_pred CcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCC
Q 012762 242 TSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGT 321 (457)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 321 (457)
......... ........ ...... .... .+......++ ............++||
T Consensus 155 ~~~~~~~~~-----~~~~~~~~--~~~~~~-----~~~~----~~~~~~~~~~-----------~~~~~~~~~~~~~~gt 207 (376)
T cd05598 155 HDSKYYQKG-----DHHRQDSM--EPSEEW-----SEID----RCRLKPLERR-----------RKRQHQRCLAHSLVGT 207 (376)
T ss_pred ccccccccc-----cccccccc--cccccc-----cccc----cccccchhhh-----------hhhhcccccccccCCC
Confidence 111000000 00000000 000000 0000 0000000000 0000011112346899
Q ss_pred CCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhc--ccCCCCCCCCChHHHHHHHHHhhhCC
Q 012762 322 HEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVAR--ALEFPKEPSVPGPAKDLIAQLLVKDP 399 (457)
Q Consensus 322 ~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~ll~~~L~~dP 399 (457)
+.|||||++.+..++.++|||||||++|||++|+.||.+.........+... ....+....++.++.++|.+|+ .+|
T Consensus 208 ~~y~aPE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p 286 (376)
T cd05598 208 PNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGA 286 (376)
T ss_pred ccccCHHHHcCCCCCcceeeeeccceeeehhhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCH
Confidence 9999999999999999999999999999999999999987766665555443 2334444568899999999976 599
Q ss_pred CCCC---CCCcChHHHhcCCCCCCCCchhh-hccCCCCCCCCCCcc
Q 012762 400 TRRM---GSKMGATAIKRHQFFNGVNWALL-RCAKPPFIPRPVTCR 441 (457)
Q Consensus 400 ~~Rp---s~~~~~~~ll~hp~f~~~~~~~~-~~~~~~~~~~~~~~~ 441 (457)
.+|+ + +.++++||||++++|..+ ....+|.+|+.....
T Consensus 287 ~~R~~~~t----~~ell~h~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (376)
T cd05598 287 EDRLGKNG----ADEIKAHPFFKGIDFASLIRRQKAPYIPKITHPT 328 (376)
T ss_pred hhcCCCCC----HHHHhCCCCcCCCCHHHHhhcCCCCCCCcCCCcc
Confidence 9999 7 999999999999999877 566677777654433
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-50 Score=405.50 Aligned_cols=323 Identities=29% Similarity=0.530 Sum_probs=237.9
Q ss_pred CceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcEE
Q 012762 83 DLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWSC 162 (457)
Q Consensus 83 ~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~ 162 (457)
.|+++++||+|+||+||+|.++ .+++.||+|++.+...........+..|+++|+.++|+||+++++++.+.+++|
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~----~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~ 77 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKV----DTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLY 77 (381)
T ss_pred CceEEEEEeecCCEEEEEEEEC----CCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEE
Confidence 6899999999999999999876 478899999998876666666778889999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCCC
Q 012762 163 LLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNST 242 (457)
Q Consensus 163 lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~~ 242 (457)
+||||++||+|.+++... ..+++..++.++.||+.||+|||+.||+||||||+||||+.++.+||+|||++.......
T Consensus 78 lv~E~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~ 155 (381)
T cd05626 78 FVMDYIPGGDMMSLLIRM--EVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH 155 (381)
T ss_pred EEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence 999999999999988765 569999999999999999999999999999999999999999999999999986543211
Q ss_pred cccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCCC
Q 012762 243 STAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTH 322 (457)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 322 (457)
..........-......... ..... ..+..... ....... ...........+++||+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~-------------~~~~~----~~~~~~~~-----~~~~~~~-~~~~~~~~~~~~~~gt~ 212 (381)
T cd05626 156 NSKYYQKGSHIRQDSMEPSD-------------LWDDV----SNCRCGDR-----LKTLEQR-ATKQHQRCLAHSLVGTP 212 (381)
T ss_pred ccccccccccccccccCccc-------------ccccc----cccccccc-----cchhhcc-ccccccccccccccCCc
Confidence 11000000000000000000 00000 00000000 0000000 00000111123568999
Q ss_pred CccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhc--ccCCCCCCCCChHHHHHHHHHhhh--C
Q 012762 323 EYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVAR--ALEFPKEPSVPGPAKDLIAQLLVK--D 398 (457)
Q Consensus 323 ~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~ll~~~L~~--d 398 (457)
.|+|||++.+..++.++|||||||++|||++|..||...........++.. ....+....++.++.+||.+||.. +
T Consensus 213 ~Y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~ 292 (381)
T cd05626 213 NYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEE 292 (381)
T ss_pred cccCHHHHcCCCCCCccceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCccc
Confidence 999999999989999999999999999999999999987766666665542 344555556889999999996654 5
Q ss_pred CCCCCCCCcChHHHhcCCCCCCCCchh-hhccCCCCCCCCC
Q 012762 399 PTRRMGSKMGATAIKRHQFFNGVNWAL-LRCAKPPFIPRPV 438 (457)
Q Consensus 399 P~~Rps~~~~~~~ll~hp~f~~~~~~~-~~~~~~~~~~~~~ 438 (457)
+..|++ +.+|++||||+.++|.. ++...+|++|...
T Consensus 293 ~~~R~~----~~~~l~hp~f~~~~~~~~~~~~~~~~~p~~~ 329 (381)
T cd05626 293 RLGRNG----ADDIKAHPFFSEVDFSSDIRTQPAPYVPKIS 329 (381)
T ss_pred ccCCCC----HHHHhcCcccCCCChhHHhhcCCCCccCcCC
Confidence 555999 99999999999999965 4555567776643
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-50 Score=398.46 Aligned_cols=274 Identities=38% Similarity=0.738 Sum_probs=230.6
Q ss_pred EEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcEEEEEee
Q 012762 88 HRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWSCLLTEF 167 (457)
Q Consensus 88 ~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lV~E~ 167 (457)
+.||+|+||+||+|+++ .+++.||+|++.+...........+.+|+++|+.++||||+++++++..++.+|+||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~----~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey 76 (328)
T cd05593 1 KLLGKGTFGKVILVREK----ASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEY 76 (328)
T ss_pred CeeeeCCCEEEEEEEEC----CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeC
Confidence 36899999999999986 47889999999876555555567778899999999999999999999999999999999
Q ss_pred cCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCCCccccc
Q 012762 168 CPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQL 247 (457)
Q Consensus 168 ~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~~~~~~~ 247 (457)
+++++|..++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 77 ~~~g~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~---- 150 (328)
T cd05593 77 VNGGELFFHLSRE--RVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA---- 150 (328)
T ss_pred CCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCccc----
Confidence 9999998887664 5799999999999999999999999999999999999999999999999999754221000
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCCCCccCc
Q 012762 248 VSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTHEYLAP 327 (457)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 327 (457)
.....+||+.|+||
T Consensus 151 ------------------------------------------------------------------~~~~~~gt~~y~aP 164 (328)
T cd05593 151 ------------------------------------------------------------------TMKTFCGTPEYLAP 164 (328)
T ss_pred ------------------------------------------------------------------ccccccCCcCccCh
Confidence 01124699999999
Q ss_pred hhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhhhCCCCCCCCC-
Q 012762 328 EIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDPTRRMGSK- 406 (457)
Q Consensus 328 E~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rps~~- 406 (457)
|++.+..++.++|||||||++|+|++|+.||...........+......++. .++.++.++|.+||..||++|++..
T Consensus 165 E~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p~--~~~~~~~~li~~~L~~dP~~R~~~~~ 242 (328)
T cd05593 165 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPR--TLSADAKSLLSGLLIKDPNKRLGGGP 242 (328)
T ss_pred hhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccCCC--CCCHHHHHHHHHHcCCCHHHcCCCCC
Confidence 9999999999999999999999999999999887777666666666555554 4889999999999999999998211
Q ss_pred cChHHHhcCCCCCCCCchhhh--ccCCCCCCCCCC
Q 012762 407 MGATAIKRHQFFNGVNWALLR--CAKPPFIPRPVT 439 (457)
Q Consensus 407 ~~~~~ll~hp~f~~~~~~~~~--~~~~~~~~~~~~ 439 (457)
..+.+|++||||.+++|..+. ...||+.|....
T Consensus 243 ~~~~~il~h~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (328)
T cd05593 243 DDAKEIMRHSFFTGVNWQDVYDKKLVPPFKPQVTS 277 (328)
T ss_pred CCHHHHhcCCCcCCCCHHHHHhCCCCCCcCCcCCC
Confidence 129999999999999998663 345666665543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-51 Score=367.92 Aligned_cols=275 Identities=26% Similarity=0.389 Sum_probs=228.6
Q ss_pred CCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcE
Q 012762 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWS 161 (457)
Q Consensus 82 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~ 161 (457)
++|..+++||+|.||+||+|++. .+|+.||||.++..+.. +.......+|+++|+.++|+||+.++++|...+.+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~----~t~~~VAIKKIkl~~~k-dGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l 76 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDT----ETGKRVAIKKIKLGNAK-DGINRTALREIKLLQELKHPNIIELIDVFPHKSNL 76 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEec----CCCcEEEEEEeeccccc-cCccHHHHHHHHHHHHccCcchhhhhhhccCCCce
Confidence 47888999999999999999977 58999999999877543 33455667799999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCC
Q 012762 162 CLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNS 241 (457)
Q Consensus 162 ~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~ 241 (457)
-||+||+ ..+|+..++.. ...++...++.|+.+++.||+|||++.|+||||||.|+||+.+|.+||+|||+++....+
T Consensus 77 ~lVfEfm-~tdLe~vIkd~-~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p 154 (318)
T KOG0659|consen 77 SLVFEFM-PTDLEVVIKDK-NIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSP 154 (318)
T ss_pred EEEEEec-cccHHHHhccc-ccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCC
Confidence 9999999 78999888764 578999999999999999999999999999999999999999999999999999877543
Q ss_pred CcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCC
Q 012762 242 TSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGT 321 (457)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 321 (457)
..... ..+-|
T Consensus 155 ~~~~~----------------------------------------------------------------------~~V~T 164 (318)
T KOG0659|consen 155 NRIQT----------------------------------------------------------------------HQVVT 164 (318)
T ss_pred Ccccc----------------------------------------------------------------------cceee
Confidence 22111 11579
Q ss_pred CCccCchhhcCCC-CCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCC--------------------
Q 012762 322 HEYLAPEIISGEG-HGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKE-------------------- 380 (457)
Q Consensus 322 ~~y~aPE~l~~~~-~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~-------------------- 380 (457)
.+|+|||.+.|.. |+..+||||.|||+.||+-|.+-|.|.++.+.+..+..... .|..
T Consensus 165 RWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LG-TP~~~~WP~~~~lpdY~~~~~~P~ 243 (318)
T KOG0659|consen 165 RWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALG-TPTPDQWPEMTSLPDYVKIQQFPK 243 (318)
T ss_pred eeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcC-CCCcccCccccccccHHHHhcCCC
Confidence 9999999999875 99999999999999999999999999888777776664321 1111
Q ss_pred -------CCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCCCCchhhhccCCCCCCCCCCccc
Q 012762 381 -------PSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGVNWALLRCAKPPFIPRPVTCRD 442 (457)
Q Consensus 381 -------~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~~~~~~~~~~~~~~~~~~~~~~~ 442 (457)
+..++++.|||.+||.+||.+|++ +.|+|+|+||+...- ...|.-+|+|.+..+
T Consensus 244 ~~~~~lf~aas~d~ldLl~~m~~ynP~~Rit----a~qaL~~~yf~~~P~----pt~~~~lp~p~~~~~ 304 (318)
T KOG0659|consen 244 PPLNNLFPAASSDALDLLSKMLTYNPKKRIT----ASQALKHPYFKSLPL----PTPPSKLPIPSTKSN 304 (318)
T ss_pred CccccccccccHHHHHHHHhhhccCchhccc----HHHHhcchhhhcCCC----CCChhhCcCCcccCC
Confidence 233457899999999999999999 999999999996322 223445566665333
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-50 Score=398.32 Aligned_cols=278 Identities=36% Similarity=0.700 Sum_probs=233.9
Q ss_pred EEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcEEEEEee
Q 012762 88 HRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWSCLLTEF 167 (457)
Q Consensus 88 ~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lV~E~ 167 (457)
+.||+|+||.||+|+++ .+|..||+|++.+...........+..|+++++.++||||+++++++...+.+||||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~----~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~ 76 (323)
T cd05595 1 KLLGKGTFGKVILVREK----ATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEY 76 (323)
T ss_pred CeeeeCCCEEEEEEEEC----CCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeC
Confidence 36899999999999976 47889999999876554445556677899999999999999999999999999999999
Q ss_pred cCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCCCccccc
Q 012762 168 CPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQL 247 (457)
Q Consensus 168 ~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~~~~~~~ 247 (457)
+++++|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 77 ~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~---- 150 (323)
T cd05595 77 ANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA---- 150 (323)
T ss_pred CCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC----
Confidence 9999998887764 5789999999999999999999999999999999999999999999999998753211000
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCCCCccCc
Q 012762 248 VSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTHEYLAP 327 (457)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 327 (457)
......||+.|+||
T Consensus 151 ------------------------------------------------------------------~~~~~~gt~~y~aP 164 (323)
T cd05595 151 ------------------------------------------------------------------TMKTFCGTPEYLAP 164 (323)
T ss_pred ------------------------------------------------------------------ccccccCCcCcCCc
Confidence 01124699999999
Q ss_pred hhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhhhCCCCCCCCC-
Q 012762 328 EIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDPTRRMGSK- 406 (457)
Q Consensus 328 E~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rps~~- 406 (457)
|++.+..++.++|||||||++|||++|+.||...+.......+......++. .+++++.++|.+||..||++|++..
T Consensus 165 E~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p~--~~~~~~~~li~~~L~~dP~~R~~~~~ 242 (323)
T cd05595 165 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR--TLSPEAKSLLAGLLKKDPKQRLGGGP 242 (323)
T ss_pred ccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCC--CCCHHHHHHHHHHccCCHHHhCCCCC
Confidence 9999999999999999999999999999999988777777777766666664 4889999999999999999998211
Q ss_pred cChHHHhcCCCCCCCCchhhhc--cCCCCCCCCCCcccc
Q 012762 407 MGATAIKRHQFFNGVNWALLRC--AKPPFIPRPVTCRDL 443 (457)
Q Consensus 407 ~~~~~ll~hp~f~~~~~~~~~~--~~~~~~~~~~~~~~~ 443 (457)
..+.++++|+||.+++|..+.. ..||+.|......+.
T Consensus 243 ~~~~~~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (323)
T cd05595 243 SDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEVDT 281 (323)
T ss_pred CCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCCChhhh
Confidence 1299999999999999987643 446777766554443
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-50 Score=396.33 Aligned_cols=282 Identities=35% Similarity=0.694 Sum_probs=237.1
Q ss_pred ceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHH---HcCCCCCceEEEEEEcCCc
Q 012762 84 LRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILE---MLDHPFLPTLYATLDCPRW 160 (457)
Q Consensus 84 ~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~---~l~H~nIv~l~~~~~~~~~ 160 (457)
|++++.||+|+||.||+|.++ .+++.||||++++...........+..|++++. .++||||+++++++...+.
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~----~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~ 76 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYK----KTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDH 76 (324)
T ss_pred CeEEEEEeecCCEEEEEEEEC----CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCE
Confidence 788999999999999999986 478899999998775544455566777777664 5679999999999999999
Q ss_pred EEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCC
Q 012762 161 SCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDN 240 (457)
Q Consensus 161 ~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~ 240 (457)
.|+||||+++++|..++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 77 ~~lv~E~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05589 77 VCFVMEYAAGGDLMMHIHT---DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG 153 (324)
T ss_pred EEEEEcCCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence 9999999999999877754 5699999999999999999999999999999999999999999999999998753211
Q ss_pred CCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccC
Q 012762 241 STSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVG 320 (457)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 320 (457)
.. .....++|
T Consensus 154 ~~----------------------------------------------------------------------~~~~~~~g 163 (324)
T cd05589 154 FG----------------------------------------------------------------------DRTSTFCG 163 (324)
T ss_pred CC----------------------------------------------------------------------Cccccccc
Confidence 00 01113569
Q ss_pred CCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhhhCCC
Q 012762 321 THEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDPT 400 (457)
Q Consensus 321 t~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~ 400 (457)
++.|+|||++.+..++.++|||||||++|||++|+.||.+.........+......++. .++.++.++|.+||..||.
T Consensus 164 ~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~p~--~~~~~~~~li~~~L~~dP~ 241 (324)
T cd05589 164 TPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPR--FLSREAISIMRRLLRRNPE 241 (324)
T ss_pred CccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC--CCCHHHHHHHHHHhhcCHh
Confidence 99999999999999999999999999999999999999988877777777776666554 4889999999999999999
Q ss_pred CCCCCCc-ChHHHhcCCCCCCCCchhh--hccCCCCCCCCCCccccc
Q 012762 401 RRMGSKM-GATAIKRHQFFNGVNWALL--RCAKPPFIPRPVTCRDLT 444 (457)
Q Consensus 401 ~Rps~~~-~~~~ll~hp~f~~~~~~~~--~~~~~~~~~~~~~~~~~~ 444 (457)
+||++.. .+.++++||||+.++|..+ +...||++|......|..
T Consensus 242 ~R~~~~~~~~~~l~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 288 (324)
T cd05589 242 RRLGSGEKDAEDVKKQPFFRDINWDDLLARKIKPPFVPTIKGPEDVS 288 (324)
T ss_pred HcCCCCCCCHHHHhhCCCcCCCCHHHHHhCCCCcCccCCCCCcchhh
Confidence 9996543 4999999999999999765 345677777655555443
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-50 Score=394.94 Aligned_cols=269 Identities=39% Similarity=0.714 Sum_probs=229.7
Q ss_pred ecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcEEEEEeecC
Q 012762 90 LGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWSCLLTEFCP 169 (457)
Q Consensus 90 LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lV~E~~~ 169 (457)
||+|+||+||+|+++ .+++.||+|++.+...........+..|+++|++++||||+++++++...+..|+||||++
T Consensus 1 lg~G~~g~Vy~~~~~----~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 76 (312)
T cd05585 1 IGKGSFGKVMQVRKR----DTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFIN 76 (312)
T ss_pred CCcCCCeEEEEEEEC----CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCC
Confidence 799999999999976 4788999999987665555566778889999999999999999999999999999999999
Q ss_pred CCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCCCccccccc
Q 012762 170 GGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQLVS 249 (457)
Q Consensus 170 ~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~~~~~~~~~ 249 (457)
+++|..++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 77 ~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~------- 147 (312)
T cd05585 77 GGELFHHLQRE--GRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD------- 147 (312)
T ss_pred CCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCC-------
Confidence 99999888764 679999999999999999999999999999999999999999999999999975422110
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCCCCccCchh
Q 012762 250 DQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTHEYLAPEI 329 (457)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 329 (457)
......+||+.|+|||+
T Consensus 148 ---------------------------------------------------------------~~~~~~~gt~~y~aPE~ 164 (312)
T cd05585 148 ---------------------------------------------------------------DKTNTFCGTPEYLAPEL 164 (312)
T ss_pred ---------------------------------------------------------------CccccccCCcccCCHHH
Confidence 00113469999999999
Q ss_pred hcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhhhCCCCCCCCCcCh
Q 012762 330 ISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDPTRRMGSKMGA 409 (457)
Q Consensus 330 l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~ 409 (457)
+.+..++.++|||||||++|||++|..||.+.........++.....++. .++.++.++|.+||..||++||+.. .+
T Consensus 165 ~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~L~~dp~~R~~~~-~~ 241 (312)
T cd05585 165 LLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPD--GFDRDAKDLLIGLLSRDPTRRLGYN-GA 241 (312)
T ss_pred HcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCCCC--cCCHHHHHHHHHHcCCCHHHcCCCC-CH
Confidence 99999999999999999999999999999988877777777776665554 4889999999999999999998632 28
Q ss_pred HHHhcCCCCCCCCchhh--hccCCCCCCCC
Q 012762 410 TAIKRHQFFNGVNWALL--RCAKPPFIPRP 437 (457)
Q Consensus 410 ~~ll~hp~f~~~~~~~~--~~~~~~~~~~~ 437 (457)
.++++||||+..+|..+ +...+++.|..
T Consensus 242 ~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~ 271 (312)
T cd05585 242 QEIKNHPFFSQLSWKKLLMKGIQPPFKPAV 271 (312)
T ss_pred HHHHcCCCcCCCCHHHHHhCCCCCCcCCCC
Confidence 99999999999999755 34455665544
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-50 Score=396.34 Aligned_cols=278 Identities=36% Similarity=0.691 Sum_probs=234.2
Q ss_pred EEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHc-CCCCCceEEEEEEcCCcEEEEEe
Q 012762 88 HRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEML-DHPFLPTLYATLDCPRWSCLLTE 166 (457)
Q Consensus 88 ~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~~~~~~~~~~~lV~E 166 (457)
+.||+|+||+||+|+++ .+++.||+|++.+...........+..|.+++..+ +||||+++++++..++.+|||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~----~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E 76 (321)
T cd05591 1 KVLGKGSFGKVMLAELK----GTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVME 76 (321)
T ss_pred CccccCCCeEEEEEEEC----CCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEe
Confidence 36899999999999976 47889999999876555555566677899998876 89999999999999999999999
Q ss_pred ecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCCCcccc
Q 012762 167 FCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQ 246 (457)
Q Consensus 167 ~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~~~~~~ 246 (457)
|+++++|..++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 77 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~---- 150 (321)
T cd05591 77 YVNGGDLMFQIQRS--RKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG---- 150 (321)
T ss_pred CCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCC----
Confidence 99999998887664 678999999999999999999999999999999999999999999999999875321100
Q ss_pred cccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCCCCccC
Q 012762 247 LVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTHEYLA 326 (457)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 326 (457)
.......||+.|+|
T Consensus 151 ------------------------------------------------------------------~~~~~~~gt~~y~a 164 (321)
T cd05591 151 ------------------------------------------------------------------VTTTTFCGTPDYIA 164 (321)
T ss_pred ------------------------------------------------------------------ccccccccCccccC
Confidence 00113469999999
Q ss_pred chhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhhhCCCCCCCCC
Q 012762 327 PEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDPTRRMGSK 406 (457)
Q Consensus 327 PE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rps~~ 406 (457)
||++.+..++.++|||||||++|||++|+.||........+..+......++.. ++.++.++|.+||..||++|++..
T Consensus 165 PE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p~~--~~~~~~~ll~~~L~~dp~~R~~~~ 242 (321)
T cd05591 165 PEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVW--LSKEAVSILKAFMTKNPNKRLGCV 242 (321)
T ss_pred HHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCC--CCHHHHHHHHHHhccCHHHcCCCC
Confidence 999999999999999999999999999999999988888888887776655543 789999999999999999999322
Q ss_pred c---ChHHHhcCCCCCCCCchhhh--ccCCCCCCCCCCcccc
Q 012762 407 M---GATAIKRHQFFNGVNWALLR--CAKPPFIPRPVTCRDL 443 (457)
Q Consensus 407 ~---~~~~ll~hp~f~~~~~~~~~--~~~~~~~~~~~~~~~~ 443 (457)
. .++++++||||..++|..+. ...+|+.|......+.
T Consensus 243 ~~~~~~~~~~~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (321)
T cd05591 243 ASQGGEDAIKQHPFFKEIDWVLLEQRKIKPPFKPKIKTKRDV 284 (321)
T ss_pred CCCCCHHHHhcCCccCCCCHHHHHhCCCCCCCCCCCCCcchh
Confidence 1 29999999999999998774 4556777766554444
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-50 Score=398.26 Aligned_cols=284 Identities=35% Similarity=0.629 Sum_probs=241.6
Q ss_pred CCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcE
Q 012762 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWS 161 (457)
Q Consensus 82 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~ 161 (457)
++|.+.+.||+|+||+||+|.++ .+++.||+|++++...........+..|+++++.++|+||+++++++.+.+..
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~----~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~ 76 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREK----ATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNL 76 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEEC----CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeE
Confidence 47999999999999999999877 47889999999887655555667788899999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCC
Q 012762 162 CLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNS 241 (457)
Q Consensus 162 ~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~ 241 (457)
||||||+++++|..++... ...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++......
T Consensus 77 ~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 155 (330)
T cd05601 77 YLVMEYQPGGDLLSLLNRY-EDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTAN 155 (330)
T ss_pred EEEECCCCCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence 9999999999999998775 256999999999999999999999999999999999999999999999999998654311
Q ss_pred CcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCC
Q 012762 242 TSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGT 321 (457)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 321 (457)
... ......||
T Consensus 156 ~~~---------------------------------------------------------------------~~~~~~gt 166 (330)
T cd05601 156 KMV---------------------------------------------------------------------NSKLPVGT 166 (330)
T ss_pred Cce---------------------------------------------------------------------eeecccCC
Confidence 100 00123589
Q ss_pred CCccCchhhc------CCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcc--cCCCCCCCCChHHHHHHHH
Q 012762 322 HEYLAPEIIS------GEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARA--LEFPKEPSVPGPAKDLIAQ 393 (457)
Q Consensus 322 ~~y~aPE~l~------~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~ll~~ 393 (457)
+.|+|||++. +..++.++|||||||++|||++|..||........+.+++... ..++....++.++.+||++
T Consensus 167 ~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~ 246 (330)
T cd05601 167 PDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSDFLDLIQS 246 (330)
T ss_pred ccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHH
Confidence 9999999997 4457899999999999999999999999877777766665432 3455555688999999999
Q ss_pred HhhhCCCCCCCCCcChHHHhcCCCCCCCCchhhhccCCCCCCCCCCccccc
Q 012762 394 LLVKDPTRRMGSKMGATAIKRHQFFNGVNWALLRCAKPPFIPRPVTCRDLT 444 (457)
Q Consensus 394 ~L~~dP~~Rps~~~~~~~ll~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 444 (457)
||. ||.+||+ ++++++||||..++|..+....|++.|......+..
T Consensus 247 ll~-~p~~R~t----~~~l~~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (330)
T cd05601 247 LLC-GQKERLG----YEGLCCHPFFSKIDWNNIRNSLPPFVPTLKSDDDTS 292 (330)
T ss_pred Hcc-ChhhCCC----HHHHhCCCCcCCCCHHHHhhCCCCccCcCCCcchhh
Confidence 998 9999999 999999999999999999888888887665555433
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-50 Score=394.20 Aligned_cols=277 Identities=33% Similarity=0.672 Sum_probs=233.8
Q ss_pred CceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCC-CCceEEEEEEcCCcE
Q 012762 83 DLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHP-FLPTLYATLDCPRWS 161 (457)
Q Consensus 83 ~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~-nIv~l~~~~~~~~~~ 161 (457)
+|++++.||+|+||.||+|.++ .+++.||+|++.+...........+..|++++..++|+ +|+.+++++...+.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~----~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~ 76 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERK----GTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 76 (324)
T ss_pred CceEEEEEeeccCeEEEEEEEC----CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEE
Confidence 5899999999999999999976 37789999999876554455566778899999999764 588999999999999
Q ss_pred EEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCC
Q 012762 162 CLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNS 241 (457)
Q Consensus 162 ~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~ 241 (457)
|+||||+++++|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 77 ~lv~E~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05587 77 YFVMEYVNGGDLMYHIQQV--GKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG 154 (324)
T ss_pred EEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence 9999999999998888764 56899999999999999999999999999999999999999999999999987532100
Q ss_pred CcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCC
Q 012762 242 TSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGT 321 (457)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 321 (457)
. ......+||
T Consensus 155 ~----------------------------------------------------------------------~~~~~~~gt 164 (324)
T cd05587 155 G----------------------------------------------------------------------KTTRTFCGT 164 (324)
T ss_pred C----------------------------------------------------------------------CceeeecCC
Confidence 0 001134699
Q ss_pred CCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhhhCCCC
Q 012762 322 HEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDPTR 401 (457)
Q Consensus 322 ~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~ 401 (457)
+.|+|||++.+..++.++|||||||++|||++|+.||.+......+..+......++. .++.++.+++.+||..||.+
T Consensus 165 ~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~--~~~~~~~~li~~~l~~~P~~ 242 (324)
T cd05587 165 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPK--SLSKEAVSICKGLLTKHPAK 242 (324)
T ss_pred ccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCC--CCCHHHHHHHHHHhhcCHHH
Confidence 9999999999999999999999999999999999999988877777777766655554 48899999999999999999
Q ss_pred CCCCC-cChHHHhcCCCCCCCCchhhh--ccCCCCCCCC
Q 012762 402 RMGSK-MGATAIKRHQFFNGVNWALLR--CAKPPFIPRP 437 (457)
Q Consensus 402 Rps~~-~~~~~ll~hp~f~~~~~~~~~--~~~~~~~~~~ 437 (457)
|++.. ...+++++||||+.++|..+. ...+|+.|..
T Consensus 243 R~~~~~~~~~~~~~hp~~~~~~~~~~~~~~~~~~~~~~~ 281 (324)
T cd05587 243 RLGCGPTGERDIREHAFFRRIDWEKLERREIQPPFKPKV 281 (324)
T ss_pred cCCCCCCCHHHHhcCCCcCCCCHHHHHhCCCCCCccCcC
Confidence 99842 234899999999999998774 3445666554
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-50 Score=403.81 Aligned_cols=327 Identities=30% Similarity=0.533 Sum_probs=241.4
Q ss_pred CceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcEE
Q 012762 83 DLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWSC 162 (457)
Q Consensus 83 ~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~ 162 (457)
+|.++++||+|+||+||+|+++ .+++.||+|++.+...........+..|+++|+.++|+||+++++++.+++++|
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~----~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~ 77 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKV----DTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLY 77 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEEC----CCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEE
Confidence 6899999999999999999986 478899999998876655566778888999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCCC
Q 012762 163 LLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNST 242 (457)
Q Consensus 163 lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~~ 242 (457)
||||||++|+|..++... +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++.......
T Consensus 78 lv~E~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~ 155 (382)
T cd05625 78 FVMDYIPGGDMMSLLIRM--GIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (382)
T ss_pred EEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence 999999999999888765 568999999999999999999999999999999999999999999999999976442111
Q ss_pred cccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCCC
Q 012762 243 STAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTH 322 (457)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 322 (457)
........ ...... ...+.........|... .... ..+.............+++||+
T Consensus 156 ~~~~~~~~-----~~~~~~-----~~~~~~~~~~~~~~~~~--~~~~-----------~~~~~~~~~~~~~~~~~~~gt~ 212 (382)
T cd05625 156 DSKYYQSG-----DHVRQD-----SMDFSNEWGDPANCRCG--DRLK-----------PLERRAARQHQRCLAHSLVGTP 212 (382)
T ss_pred cccccccc-----cccccc-----ccccccccccccccccc--cccc-----------chhhhhccccccccccccccCc
Confidence 11000000 000000 00000000000000000 0000 0000000000111123467999
Q ss_pred CccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhc--ccCCCCCCCCChHHHHHHHHHhhhCCC
Q 012762 323 EYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVAR--ALEFPKEPSVPGPAKDLIAQLLVKDPT 400 (457)
Q Consensus 323 ~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~ll~~~L~~dP~ 400 (457)
.|+|||++.+..++.++|||||||++|||++|+.||.+.........++.. ....|....+++++.++|.+|+ .||+
T Consensus 213 ~Y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~ 291 (382)
T cd05625 213 NYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPE 291 (382)
T ss_pred ccCCHHHhcCCCCCCeeeEEechHHHHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHh
Confidence 999999999999999999999999999999999999988776666666643 3344545568899999999986 5999
Q ss_pred CCCCCCcChHHHhcCCCCCCCCchh-hhccCCCCCCCCCCc
Q 012762 401 RRMGSKMGATAIKRHQFFNGVNWAL-LRCAKPPFIPRPVTC 440 (457)
Q Consensus 401 ~Rps~~~~~~~ll~hp~f~~~~~~~-~~~~~~~~~~~~~~~ 440 (457)
+|++. ..++++++||||+.++|.. +....+|++|.....
T Consensus 292 ~R~~~-~~~~ei~~hp~f~~~~~~~~~~~~~~~~~~~~~~~ 331 (382)
T cd05625 292 DRLGK-NGADEIKAHPFFKTIDFSSDLRQQSAPYIPKITHP 331 (382)
T ss_pred HcCCC-CCHHHHhcCCCcCCcChHHHHhcCCCCccCcCCCc
Confidence 99862 3489999999999999974 456677777765443
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-50 Score=400.42 Aligned_cols=307 Identities=33% Similarity=0.605 Sum_probs=236.7
Q ss_pred CCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcE
Q 012762 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWS 161 (457)
Q Consensus 82 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~ 161 (457)
++|++++.||+|+||+||+|+++ .+++.||+|++.+...........+..|++++..++|+||+++++++...+.+
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~----~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~ 76 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKK----DTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNL 76 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEEC----CCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEE
Confidence 47999999999999999999987 47889999999876655555667788899999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCC
Q 012762 162 CLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNS 241 (457)
Q Consensus 162 ~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~ 241 (457)
||||||++||+|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.++|+|||++......
T Consensus 77 ~lv~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~ 154 (360)
T cd05627 77 YLIMEFLPGGDMMTLLMKK--DTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA 154 (360)
T ss_pred EEEEeCCCCccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence 9999999999999988764 67999999999999999999999999999999999999999999999999998755322
Q ss_pred CcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCC
Q 012762 242 TSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGT 321 (457)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 321 (457)
............+ +... ++ .....++ ..............+.+||
T Consensus 155 ~~~~~~~~~~~~~-----~~~~-----~~-----------------~~~~~~~--------~~~~~~~~~~~~~~~~~gt 199 (360)
T cd05627 155 HRTEFYRNLTHNP-----PSDF-----SF-----------------QNMNSKR--------KAETWKKNRRQLAYSTVGT 199 (360)
T ss_pred cccccccccccCC-----cccc-----cc-----------------ccccccc--------ccccccccccccccccCCC
Confidence 1111000000000 0000 00 0000000 0000000111122346799
Q ss_pred CCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhc--ccCCCCCCCCChHHHHHHHHHhhhCC
Q 012762 322 HEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVAR--ALEFPKEPSVPGPAKDLIAQLLVKDP 399 (457)
Q Consensus 322 ~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~ll~~~L~~dP 399 (457)
+.|+|||++.+..++.++|||||||++|||++|+.||.+......+..++.. ...++....++.++++||.+|+ .||
T Consensus 200 ~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p 278 (360)
T cd05627 200 PDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFC-TDS 278 (360)
T ss_pred ccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCCCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhc-cCh
Confidence 9999999999999999999999999999999999999988777777666643 3344544457889999999987 499
Q ss_pred CCCCCCCcChHHHhcCCCCCCCCchhhhccCC
Q 012762 400 TRRMGSKMGATAIKRHQFFNGVNWALLRCAKP 431 (457)
Q Consensus 400 ~~Rps~~~~~~~ll~hp~f~~~~~~~~~~~~~ 431 (457)
.+|++. ..++++++||||++++|..+....+
T Consensus 279 ~~R~~~-~~~~ei~~hp~f~~~~~~~~~~~~~ 309 (360)
T cd05627 279 ENRIGS-NGVEEIKSHPFFEGVDWGHIRERPA 309 (360)
T ss_pred hhcCCC-CCHHHHhcCCCCCCCCHHHHhcCCC
Confidence 999962 2389999999999999998865443
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-51 Score=392.86 Aligned_cols=287 Identities=34% Similarity=0.628 Sum_probs=254.7
Q ss_pred CCCccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEE
Q 012762 76 NNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATL 155 (457)
Q Consensus 76 ~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~ 155 (457)
..++....|+.-++||+|+||.||-|+.++ +|+.||+|.+.|+.+..+..+....+|..||.++..+.||.+--+|
T Consensus 179 ~qpvt~n~F~~~RvlGkGGFGEV~acqvra----TGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAf 254 (591)
T KOG0986|consen 179 LQPVTKNTFRVYRVLGKGGFGEVCACQVRA----TGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAF 254 (591)
T ss_pred hhhccccceeeeEEEecccccceeEEEEec----chhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeee
Confidence 356777889999999999999999999884 8999999999999998888888899999999999999999999999
Q ss_pred EcCCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCC
Q 012762 156 DCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235 (457)
Q Consensus 156 ~~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s 235 (457)
+..+.+|+||..|+||+|.-.|....+.++++..++.++.+|+.||++||..+||.|||||+|||||..|+|+|+|.|+|
T Consensus 255 eTkd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLA 334 (591)
T KOG0986|consen 255 ETKDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLA 334 (591)
T ss_pred cCCCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceE
Confidence 99999999999999999988888777789999999999999999999999999999999999999999999999999999
Q ss_pred cCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcccc
Q 012762 236 LKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRS 315 (457)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (457)
..+......
T Consensus 335 vei~~g~~~----------------------------------------------------------------------- 343 (591)
T KOG0986|consen 335 VEIPEGKPI----------------------------------------------------------------------- 343 (591)
T ss_pred EecCCCCcc-----------------------------------------------------------------------
Confidence 766543221
Q ss_pred ccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChH----HHHHHHHhcccCCCCCCCCChHHHHHH
Q 012762 316 MSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHE----LTLANVVARALEFPKEPSVPGPAKDLI 391 (457)
Q Consensus 316 ~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~ll 391 (457)
...+||.+|||||++.+..|+...|.|||||+||||+.|+.||...... ++-.+++.....++ ..+++++++|+
T Consensus 344 ~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~--~kFS~eakslc 421 (591)
T KOG0986|consen 344 RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYS--DKFSEEAKSLC 421 (591)
T ss_pred ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcc--cccCHHHHHHH
Confidence 1237999999999999999999999999999999999999999765433 33444444555555 45899999999
Q ss_pred HHHhhhCCCCCCCCC-cChHHHhcCCCCCCCCchhhh--ccCCCCCCCCCC
Q 012762 392 AQLLVKDPTRRMGSK-MGATAIKRHQFFNGVNWALLR--CAKPPFIPRPVT 439 (457)
Q Consensus 392 ~~~L~~dP~~Rps~~-~~~~~ll~hp~f~~~~~~~~~--~~~~~~~~~~~~ 439 (457)
+.+|..||++|..-+ ..++++.+||||+++||.++. ...|||+|.|..
T Consensus 422 ~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~rleagml~PPfiPdp~a 472 (591)
T KOG0986|consen 422 EGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWRRLEAGMLEPPFIPDPGA 472 (591)
T ss_pred HHHHccCHHHhccCCCcCcchhhhCcccccCCHhHHhccCCCCCCCCCccc
Confidence 999999999999976 579999999999999999885 467999998864
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-50 Score=396.38 Aligned_cols=278 Identities=36% Similarity=0.708 Sum_probs=232.5
Q ss_pred EEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcEEEEEee
Q 012762 88 HRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWSCLLTEF 167 (457)
Q Consensus 88 ~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lV~E~ 167 (457)
+.||+|+||+||+|+++ .+++.||+|++.+...........+..|+++++.++||||+++++++...+.+||||||
T Consensus 1 ~~lG~G~~g~V~~~~~~----~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~ 76 (325)
T cd05594 1 KLLGKGTFGKVILVKEK----ATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEY 76 (325)
T ss_pred CeeeeCCCEEEEEEEEC----CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeC
Confidence 36899999999999876 47889999999876554445556777899999999999999999999999999999999
Q ss_pred cCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCceeecCCCCCeEEccCCCEEEeccCCCcCCCCCCcccc
Q 012762 168 CPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHM-MGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQ 246 (457)
Q Consensus 168 ~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~-~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~~~~~~ 246 (457)
+++++|..++... ..+++..++.++.||+.||.|||+ .||+||||||+|||++.+|.+||+|||+++.......
T Consensus 77 ~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~--- 151 (325)
T cd05594 77 ANGGELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--- 151 (325)
T ss_pred CCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc---
Confidence 9999998887664 579999999999999999999997 7999999999999999999999999998753211000
Q ss_pred cccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCCCCccC
Q 012762 247 LVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTHEYLA 326 (457)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 326 (457)
......||+.|+|
T Consensus 152 -------------------------------------------------------------------~~~~~~gt~~y~a 164 (325)
T cd05594 152 -------------------------------------------------------------------TMKTFCGTPEYLA 164 (325)
T ss_pred -------------------------------------------------------------------ccccccCCcccCC
Confidence 0112469999999
Q ss_pred chhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhhhCCCCCCCCC
Q 012762 327 PEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDPTRRMGSK 406 (457)
Q Consensus 327 PE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rps~~ 406 (457)
||++.+..++.++|||||||++|||++|..||.+.........+......++. .++.++.+||.+||..||++|++..
T Consensus 165 PE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p~--~~~~~~~~li~~~L~~dP~~R~~~~ 242 (325)
T cd05594 165 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR--TLSPEAKSLLSGLLKKDPKQRLGGG 242 (325)
T ss_pred HHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCCC--CCCHHHHHHHHHHhhcCHHHhCCCC
Confidence 99999999999999999999999999999999988777777777666666654 4889999999999999999997211
Q ss_pred -cChHHHhcCCCCCCCCchhhh--ccCCCCCCCCCCcccc
Q 012762 407 -MGATAIKRHQFFNGVNWALLR--CAKPPFIPRPVTCRDL 443 (457)
Q Consensus 407 -~~~~~ll~hp~f~~~~~~~~~--~~~~~~~~~~~~~~~~ 443 (457)
..+.++++||||+++.|.... ...||+.|......+.
T Consensus 243 ~~~~~~il~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (325)
T cd05594 243 PDDAKEIMQHKFFAGIVWQDVYEKKLVPPFKPQVTSETDT 282 (325)
T ss_pred CCCHHHHhcCCCcCCCCHHHHHhCCCCCCcCCcCCCcchh
Confidence 019999999999999998663 3457777766554443
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-50 Score=393.36 Aligned_cols=278 Identities=33% Similarity=0.671 Sum_probs=236.4
Q ss_pred CceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHc-CCCCCceEEEEEEcCCcE
Q 012762 83 DLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEML-DHPFLPTLYATLDCPRWS 161 (457)
Q Consensus 83 ~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~~~~~~~~~~ 161 (457)
+|.+++.||+|+||+||+|+++ .+++.||+|++.+...........+..|.+++..+ +|++|+.+++++...+.+
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~----~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~ 76 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERK----GTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRL 76 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEEC----CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEE
Confidence 5899999999999999999976 47889999999876554444555667788888877 589999999999999999
Q ss_pred EEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCC
Q 012762 162 CLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNS 241 (457)
Q Consensus 162 ~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~ 241 (457)
|+||||+++|+|..++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 77 ~lv~E~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~ 154 (323)
T cd05616 77 YFVMEYVNGGDLMYQIQQV--GRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD 154 (323)
T ss_pred EEEEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence 9999999999998888764 56999999999999999999999999999999999999999999999999997532110
Q ss_pred CcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCC
Q 012762 242 TSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGT 321 (457)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 321 (457)
. ......+||
T Consensus 155 ~----------------------------------------------------------------------~~~~~~~gt 164 (323)
T cd05616 155 G----------------------------------------------------------------------VTTKTFCGT 164 (323)
T ss_pred C----------------------------------------------------------------------CccccCCCC
Confidence 0 001134699
Q ss_pred CCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhhhCCCC
Q 012762 322 HEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDPTR 401 (457)
Q Consensus 322 ~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~ 401 (457)
+.|+|||++.+..++.++|||||||++|||++|+.||.+.........+......+|. .++.++.+++.+||+.||++
T Consensus 165 ~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~--~~s~~~~~li~~~l~~~p~~ 242 (323)
T cd05616 165 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK--SMSKEAVAICKGLMTKHPGK 242 (323)
T ss_pred hhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC--cCCHHHHHHHHHHcccCHHh
Confidence 9999999999999999999999999999999999999998888888888777666664 48899999999999999999
Q ss_pred CCCCC-cChHHHhcCCCCCCCCchhhh--ccCCCCCCCCC
Q 012762 402 RMGSK-MGATAIKRHQFFNGVNWALLR--CAKPPFIPRPV 438 (457)
Q Consensus 402 Rps~~-~~~~~ll~hp~f~~~~~~~~~--~~~~~~~~~~~ 438 (457)
|++.. ....++++||||+.++|..+. ...||+.|+..
T Consensus 243 R~~~~~~~~~~i~~h~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (323)
T cd05616 243 RLGCGPEGERDIKEHAFFRYIDWEKLERKEVQPPYKPKAC 282 (323)
T ss_pred cCCCCCCCHHHHhcCCCcCCCCHHHHHhCCCCCCcCCcCC
Confidence 99842 236899999999999998774 45667777654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-49 Score=392.29 Aligned_cols=276 Identities=37% Similarity=0.698 Sum_probs=231.3
Q ss_pred EEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHH-HHHHcCCCCCceEEEEEEcCCcEEEEEe
Q 012762 88 HRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIERE-ILEMLDHPFLPTLYATLDCPRWSCLLTE 166 (457)
Q Consensus 88 ~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~-il~~l~H~nIv~l~~~~~~~~~~~lV~E 166 (457)
+.||+|+||+||+|.++ .+|+.||+|++.+...........+..|.. +++.++||||+++++++...+..|+|||
T Consensus 1 ~~lg~G~~g~V~~~~~~----~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e 76 (323)
T cd05575 1 KVIGKGSFGKVLLAKHK----ADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLD 76 (323)
T ss_pred CeeeeCCCeEEEEEEEC----CCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEc
Confidence 36899999999999986 478999999998765544444455555655 4577999999999999999999999999
Q ss_pred ecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCCCcccc
Q 012762 167 FCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQ 246 (457)
Q Consensus 167 ~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~~~~~~ 246 (457)
|+++++|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 77 ~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~---- 150 (323)
T cd05575 77 YVNGGELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS---- 150 (323)
T ss_pred CCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC----
Confidence 99999998888764 679999999999999999999999999999999999999999999999999875321100
Q ss_pred cccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCCCCccC
Q 012762 247 LVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTHEYLA 326 (457)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 326 (457)
......+||+.|+|
T Consensus 151 ------------------------------------------------------------------~~~~~~~gt~~y~a 164 (323)
T cd05575 151 ------------------------------------------------------------------KTTSTFCGTPEYLA 164 (323)
T ss_pred ------------------------------------------------------------------CccccccCChhhcC
Confidence 00113469999999
Q ss_pred chhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhhhCCCCCCCCC
Q 012762 327 PEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDPTRRMGSK 406 (457)
Q Consensus 327 PE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rps~~ 406 (457)
||++.+..++.++|||||||++|||++|..||.+.+..+....++......+ ..++..+.++|.+||+.||.+||+..
T Consensus 165 PE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~--~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 165 PEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLK--PNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred hhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCC--CCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 9999999999999999999999999999999998887777777776655544 34789999999999999999999976
Q ss_pred cChHHHhcCCCCCCCCchhhh--ccCCCCCCCCCCcc
Q 012762 407 MGATAIKRHQFFNGVNWALLR--CAKPPFIPRPVTCR 441 (457)
Q Consensus 407 ~~~~~ll~hp~f~~~~~~~~~--~~~~~~~~~~~~~~ 441 (457)
..+.++++||||..++|..+. ...+|+.|......
T Consensus 243 ~~~~~il~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (323)
T cd05575 243 DDFLEIKNHVFFSSINWDDLVNKKITPPFNPNVSGPM 279 (323)
T ss_pred CCHHHHHcCCCcCCCCHHHHhhccCCCCcCCCCCCcc
Confidence 667899999999999998764 45567776655443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-49 Score=398.91 Aligned_cols=284 Identities=32% Similarity=0.609 Sum_probs=239.7
Q ss_pred CCCccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEE
Q 012762 76 NNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATL 155 (457)
Q Consensus 76 ~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~ 155 (457)
...+..++|++.+.||+|+||+||+|+++ .++..||+|++.+...........+..|+++++.++||||+++++++
T Consensus 37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~----~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~ 112 (370)
T cd05596 37 KLRMKAEDFDVIKVIGRGAFGEVQLVRHK----SSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAF 112 (370)
T ss_pred cCCCCHHHcEEEEEEeeCCCEEEEEEEEC----CCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEE
Confidence 34567789999999999999999999987 47889999999876555545556677899999999999999999999
Q ss_pred EcCCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCC
Q 012762 156 DCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235 (457)
Q Consensus 156 ~~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s 235 (457)
.+++.+|+||||++||+|..++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 113 ~~~~~~~lv~Ey~~gg~L~~~l~~---~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~ 189 (370)
T cd05596 113 QDDKYLYMVMEYMPGGDLVNLMSN---YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTC 189 (370)
T ss_pred ecCCEEEEEEcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccce
Confidence 999999999999999999998876 45899999999999999999999999999999999999999999999999997
Q ss_pred cCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcccc
Q 012762 236 LKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRS 315 (457)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (457)
........ ...
T Consensus 190 ~~~~~~~~---------------------------------------------------------------------~~~ 200 (370)
T cd05596 190 MKMDANGM---------------------------------------------------------------------VRC 200 (370)
T ss_pred eeccCCCc---------------------------------------------------------------------ccC
Confidence 54321100 001
Q ss_pred ccccCCCCccCchhhcCC----CCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcc--cCCCCCCCCChHHHH
Q 012762 316 MSFVGTHEYLAPEIISGE----GHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARA--LEFPKEPSVPGPAKD 389 (457)
Q Consensus 316 ~~~~gt~~y~aPE~l~~~----~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~ 389 (457)
...+||+.|+|||++.+. .++.++|||||||++|||++|..||.+......+..++... +.++....++.++++
T Consensus 201 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 280 (370)
T cd05596 201 DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISKQAKD 280 (370)
T ss_pred CCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCCCCHHHHH
Confidence 134699999999999754 37889999999999999999999999888777777776643 445555568999999
Q ss_pred HHHHHhhhCCCC--CCCCCcChHHHhcCCCCCCCCchh--hhccCCCCCCCCCC
Q 012762 390 LIAQLLVKDPTR--RMGSKMGATAIKRHQFFNGVNWAL--LRCAKPPFIPRPVT 439 (457)
Q Consensus 390 ll~~~L~~dP~~--Rps~~~~~~~ll~hp~f~~~~~~~--~~~~~~~~~~~~~~ 439 (457)
||.+||..+|.+ |++ ++++++||||+..+|.. ++...+|++|....
T Consensus 281 li~~~L~~~p~r~~R~s----~~ell~h~~~~~~~~~~~~~~~~~~~~~p~~~~ 330 (370)
T cd05596 281 LICAFLTDREVRLGRNG----VDEIKSHPFFKNDQWTFDNIRETVAPVVPELSS 330 (370)
T ss_pred HHHHHccChhhccCCCC----HHHHhcCcccCCCChhhHHhcCCCcCccCcCCC
Confidence 999999999987 999 99999999999988864 45666788776433
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-49 Score=398.05 Aligned_cols=286 Identities=33% Similarity=0.635 Sum_probs=237.9
Q ss_pred CCccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEE
Q 012762 77 NPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLD 156 (457)
Q Consensus 77 ~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~ 156 (457)
..+..++|++.+.||+|+||.||+|+++ .+++.||+|++.+...........+..|+++++.++||||+++++++.
T Consensus 38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~----~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~ 113 (370)
T cd05621 38 LQMKAEDYDVVKVIGRGAFGEVQLVRHK----SSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQ 113 (370)
T ss_pred cCCCHHHCeEEEEEEecCCeEEEEEEEC----CCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 3456679999999999999999999987 478899999998765555555666788999999999999999999999
Q ss_pred cCCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCc
Q 012762 157 CPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSL 236 (457)
Q Consensus 157 ~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~ 236 (457)
.++.+|+|||||++|+|..++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.
T Consensus 114 ~~~~~~lv~Ey~~gg~L~~~l~~---~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~ 190 (370)
T cd05621 114 DDKYLYMVMEYMPGGDLVNLMSN---YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCM 190 (370)
T ss_pred cCCEEEEEEcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccce
Confidence 99999999999999999998865 458999999999999999999999999999999999999999999999999986
Q ss_pred CCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccc
Q 012762 237 KGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSM 316 (457)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (457)
....... ....
T Consensus 191 ~~~~~~~---------------------------------------------------------------------~~~~ 201 (370)
T cd05621 191 KMDETGM---------------------------------------------------------------------VRCD 201 (370)
T ss_pred ecccCCc---------------------------------------------------------------------eecc
Confidence 5421100 0111
Q ss_pred cccCCCCccCchhhcCCC----CCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcc--cCCCCCCCCChHHHHH
Q 012762 317 SFVGTHEYLAPEIISGEG----HGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARA--LEFPKEPSVPGPAKDL 390 (457)
Q Consensus 317 ~~~gt~~y~aPE~l~~~~----~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~l 390 (457)
+.+||+.|+|||++.+.. ++.++|||||||++|||++|+.||.+.+....+..++... +.++....++..++++
T Consensus 202 ~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~l 281 (370)
T cd05621 202 TAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISKHAKNL 281 (370)
T ss_pred cCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcccCCHHHHHH
Confidence 346999999999997643 7889999999999999999999999888777777777643 4455555678999999
Q ss_pred HHHHhhhCCCC--CCCCCcChHHHhcCCCCCCCCch--hhhccCCCCCCCCCCccc
Q 012762 391 IAQLLVKDPTR--RMGSKMGATAIKRHQFFNGVNWA--LLRCAKPPFIPRPVTCRD 442 (457)
Q Consensus 391 l~~~L~~dP~~--Rps~~~~~~~ll~hp~f~~~~~~--~~~~~~~~~~~~~~~~~~ 442 (457)
+.+||..++.+ |++ +.++++||||+...|. .++...+|++|......+
T Consensus 282 i~~~L~~~~~r~~R~~----~~e~l~hp~~~~~~~~~~~~~~~~~~~~p~~~~~~~ 333 (370)
T cd05621 282 ICAFLTDREVRLGRNG----VEEIKQHPFFKNDQWNWDNIRETAAPVVPELSSDID 333 (370)
T ss_pred HHHHccCchhccCCCC----HHHHhcCcccCCCCcChHhcCCCCCCcCCCCCCcch
Confidence 99999855443 788 9999999999986654 445667788876654443
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-51 Score=429.15 Aligned_cols=288 Identities=38% Similarity=0.691 Sum_probs=257.6
Q ss_pred CccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEc
Q 012762 78 PLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDC 157 (457)
Q Consensus 78 ~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~ 157 (457)
.+..+||.++++||+|+||.|.+++++. +++.||+|+++|-.+........|..|..||..-+.+=|+.++-+|++
T Consensus 71 rl~~~DfeilKvIGrGaFGEV~lVr~k~----t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 71 RLKAEDFEILKVIGRGAFGEVALVRHKS----TEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred hCCHHhhHHHHHhcccccceeEEEEeec----cccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 4567899999999999999999999984 889999999999888888888899999999999999999999999999
Q ss_pred CCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcC
Q 012762 158 PRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLK 237 (457)
Q Consensus 158 ~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~ 237 (457)
++++||||||++||+|-.++... .++++..+++|+..|+.||.-||+.|+|||||||+||||+..|++||+|||.+..
T Consensus 147 ~~~LYlVMdY~pGGDlltLlSk~--~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClk 224 (1317)
T KOG0612|consen 147 ERYLYLVMDYMPGGDLLTLLSKF--DRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLK 224 (1317)
T ss_pred ccceEEEEecccCchHHHHHhhc--CCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHh
Confidence 99999999999999999999886 3799999999999999999999999999999999999999999999999998765
Q ss_pred CCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcccccc
Q 012762 238 GDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMS 317 (457)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (457)
+.... ..+...
T Consensus 225 m~~dG---------------------------------------------------------------------~V~s~~ 235 (1317)
T KOG0612|consen 225 MDADG---------------------------------------------------------------------TVRSSV 235 (1317)
T ss_pred cCCCC---------------------------------------------------------------------cEEecc
Confidence 54211 122224
Q ss_pred ccCCCCccCchhhc----C-CCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhc--ccCCCCCCCCChHHHHH
Q 012762 318 FVGTHEYLAPEIIS----G-EGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVAR--ALEFPKEPSVPGPAKDL 390 (457)
Q Consensus 318 ~~gt~~y~aPE~l~----~-~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l 390 (457)
-+|||.|++||+++ + ..|+..+|+||+||++|||++|..||+..+-.+.+.+|+.- .+.||....++.++++|
T Consensus 236 aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~~~VSeeakdL 315 (1317)
T KOG0612|consen 236 AVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDETDVSEEAKDL 315 (1317)
T ss_pred ccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCcccccCHHHHHH
Confidence 47999999999996 3 45899999999999999999999999999999999999987 77888767899999999
Q ss_pred HHHHhhhCCCCCCCCCcChHHHhcCCCCCCCCchhhhccCCCCCCCCCCccc
Q 012762 391 IAQLLVKDPTRRMGSKMGATAIKRHQFFNGVNWALLRCAKPPFIPRPVTCRD 442 (457)
Q Consensus 391 l~~~L~~dP~~Rps~~~~~~~ll~hp~f~~~~~~~~~~~~~~~~~~~~~~~~ 442 (457)
|.++| .+|+.|.. +..++++.+||||.+++|..|+...||++|.-.+-.|
T Consensus 316 I~~ll-~~~e~RLg-rngiedik~HpFF~g~~W~~iR~~~pP~vPevssd~D 365 (1317)
T KOG0612|consen 316 IEALL-CDREVRLG-RNGIEDIKNHPFFEGIDWDNIRESVPPVVPEVSSDDD 365 (1317)
T ss_pred HHHHh-cChhhhcc-cccHHHHHhCccccCCChhhhhhcCCCCCCcCCCCCc
Confidence 99987 58889987 5669999999999999999999999999997654444
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-50 Score=393.76 Aligned_cols=255 Identities=28% Similarity=0.476 Sum_probs=221.0
Q ss_pred CCCCccCCCceeEEEecccCcceEEEEEEeccCCCCCce-EEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEE
Q 012762 75 NNNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCF-FAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYA 153 (457)
Q Consensus 75 ~~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~-vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~ 153 (457)
..+.++.+++.+.+.||.|+||+||+|.++ |.. ||+|++......... ...+.+|+.+|.+|+|||||+++|
T Consensus 34 ~~~~i~~~~l~~~~~iG~G~~g~V~~~~~~------g~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~HpNIV~f~G 106 (362)
T KOG0192|consen 34 PEEEIDPDELPIEEVLGSGSFGTVYKGKWR------GTDVVAVKIISDPDFDDES-RKAFRREASLLSRLRHPNIVQFYG 106 (362)
T ss_pred cceecChHHhhhhhhcccCCceeEEEEEeC------CceeEEEEEecchhcChHH-HHHHHHHHHHHHhCCCCCeeeEEE
Confidence 345566677888888999999999999985 445 999999876554444 778999999999999999999999
Q ss_pred EEEcCC-cEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcC-ceeecCCCCCeEEccCC-CEEEe
Q 012762 154 TLDCPR-WSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMG-IIYRDLKPENVLVRSDG-HIMLT 230 (457)
Q Consensus 154 ~~~~~~-~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~-iiHrDIKp~NIll~~~~-~vkl~ 230 (457)
++.... .++|||||+++|+|..+++....+.++...+..++.||+.||.|||+++ ||||||||+||||+.++ ++||+
T Consensus 107 ~~~~~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~ 186 (362)
T KOG0192|consen 107 ACTSPPGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIA 186 (362)
T ss_pred EEcCCCCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEEC
Confidence 999887 7999999999999999998854588999999999999999999999999 99999999999999997 99999
Q ss_pred ccCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccC
Q 012762 231 DFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEP 310 (457)
Q Consensus 231 DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (457)
|||+++.......
T Consensus 187 DFGlsr~~~~~~~------------------------------------------------------------------- 199 (362)
T KOG0192|consen 187 DFGLSREKVISKT------------------------------------------------------------------- 199 (362)
T ss_pred CCccceeeccccc-------------------------------------------------------------------
Confidence 9999875542210
Q ss_pred CccccccccCCCCccCchhhc--CCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHH
Q 012762 311 LDVRSMSFVGTHEYLAPEIIS--GEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAK 388 (457)
Q Consensus 311 ~~~~~~~~~gt~~y~aPE~l~--~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (457)
..+...||+.|||||++. ...|+.++||||||++||||+||+.||.+.........++....+.+.+..++..+.
T Consensus 200 ---~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~~~~~l~ 276 (362)
T KOG0192|consen 200 ---SMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPKECPPHLS 276 (362)
T ss_pred ---cccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHH
Confidence 011135999999999999 568999999999999999999999999999887777777777777766666999999
Q ss_pred HHHHHHhhhCCCCCCCCC
Q 012762 389 DLIAQLLVKDPTRRMGSK 406 (457)
Q Consensus 389 ~ll~~~L~~dP~~Rps~~ 406 (457)
.||.+||..||+.||++.
T Consensus 277 ~l~~~CW~~dp~~RP~f~ 294 (362)
T KOG0192|consen 277 SLMERCWLVDPSRRPSFL 294 (362)
T ss_pred HHHHHhCCCCCCcCCCHH
Confidence 999999999999999943
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-49 Score=389.70 Aligned_cols=270 Identities=36% Similarity=0.720 Sum_probs=226.7
Q ss_pred EEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHc-CCCCCceEEEEEEcCCcEEEEEe
Q 012762 88 HRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEML-DHPFLPTLYATLDCPRWSCLLTE 166 (457)
Q Consensus 88 ~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~~~~~~~~~~~lV~E 166 (457)
+.||+|+||.||+|+++ .+|+.||+|++++..............|.+++..+ +||||+++++++...+++|+|||
T Consensus 1 ~~lg~G~~g~V~~~~~~----~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 76 (316)
T cd05620 1 KVLGKGSFGKVLLAELK----GKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVME 76 (316)
T ss_pred CeeeeCCCeEEEEEEEC----CCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEEC
Confidence 46999999999999987 47889999999876544444555667788888764 89999999999999999999999
Q ss_pred ecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCCCcccc
Q 012762 167 FCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQ 246 (457)
Q Consensus 167 ~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~~~~~~ 246 (457)
|+.+++|..++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||+++......
T Consensus 77 ~~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~---- 150 (316)
T cd05620 77 FLNGGDLMFHIQDK--GRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD---- 150 (316)
T ss_pred CCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCC----
Confidence 99999998888764 678999999999999999999999999999999999999999999999999875321000
Q ss_pred cccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCCCCccC
Q 012762 247 LVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTHEYLA 326 (457)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 326 (457)
......+||+.|+|
T Consensus 151 ------------------------------------------------------------------~~~~~~~gt~~y~a 164 (316)
T cd05620 151 ------------------------------------------------------------------NRASTFCGTPDYIA 164 (316)
T ss_pred ------------------------------------------------------------------CceeccCCCcCccC
Confidence 01113469999999
Q ss_pred chhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhhhCCCCCCCCC
Q 012762 327 PEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDPTRRMGSK 406 (457)
Q Consensus 327 PE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rps~~ 406 (457)
||++.+..++.++|||||||++|||++|..||.+.+.......+......++. .++.+++++|.+||..||++|++
T Consensus 165 PE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~l~~dP~~R~~-- 240 (316)
T cd05620 165 PEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPR--WITKESKDILEKLFERDPTRRLG-- 240 (316)
T ss_pred HHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC--CCCHHHHHHHHHHccCCHHHcCC--
Confidence 99999999999999999999999999999999988777777666655544444 37889999999999999999999
Q ss_pred cCh-HHHhcCCCCCCCCchhhh--ccCCCCCCCCCC
Q 012762 407 MGA-TAIKRHQFFNGVNWALLR--CAKPPFIPRPVT 439 (457)
Q Consensus 407 ~~~-~~ll~hp~f~~~~~~~~~--~~~~~~~~~~~~ 439 (457)
+ +++++||||+.++|..+. ...+|+.|+...
T Consensus 241 --~~~~~~~h~~f~~~~~~~~~~~~~~~~~~~~~~~ 274 (316)
T cd05620 241 --VVGNIRGHPFFKTINWTALEKRELDPPFKPKVKS 274 (316)
T ss_pred --ChHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCCC
Confidence 6 689999999999998663 345677766544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-50 Score=385.35 Aligned_cols=262 Identities=28% Similarity=0.464 Sum_probs=214.3
Q ss_pred CCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCC-
Q 012762 81 LSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPR- 159 (457)
Q Consensus 81 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~- 159 (457)
..++...+.||+|+||+||++..+ ++|..+|||.+..... ...+.+.+|+.+|.+|+|||||+++|......
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~----~~g~~~AvK~v~~~~~---~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~ 88 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNK----KTGELMAVKSVELEDS---PTSESLEREIRILSRLNHPNIVQYYGSSSSREN 88 (313)
T ss_pred cchhhhhccccCccceEEEEEEec----CCCcceeeeeeecccc---hhHHHHHHHHHHHHhCCCCCEEeeCCccccccC
Confidence 346888999999999999999987 3689999999976521 11566788999999999999999999854444
Q ss_pred -cEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEcc-CCCEEEeccCCCcC
Q 012762 160 -WSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRS-DGHIMLTDFDLSLK 237 (457)
Q Consensus 160 -~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~-~~~vkl~DFG~s~~ 237 (457)
.+++.|||+.+|+|.+++.+..+ .+++..++.+.+||++||.|||++||||+||||+||||+. ++.+||+|||+++.
T Consensus 89 ~~~~i~mEy~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~ 167 (313)
T KOG0198|consen 89 DEYNIFMEYAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKK 167 (313)
T ss_pred eeeEeeeeccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCccccc
Confidence 68999999999999999998755 8999999999999999999999999999999999999999 69999999999876
Q ss_pred CCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcccccc
Q 012762 238 GDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMS 317 (457)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (457)
....... ......
T Consensus 168 ~~~~~~~-------------------------------------------------------------------~~~~~~ 180 (313)
T KOG0198|consen 168 LESKGTK-------------------------------------------------------------------SDSELS 180 (313)
T ss_pred ccccccc-------------------------------------------------------------------cccccc
Confidence 5420000 011124
Q ss_pred ccCCCCccCchhhcCC-CCCccchhhhhhHHHHHHhcCCCCCCC-CChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHh
Q 012762 318 FVGTHEYLAPEIISGE-GHGNAVDWWTLGIFIFELFYGTTPFKG-IDHELTLANVVARALEFPKEPSVPGPAKDLIAQLL 395 (457)
Q Consensus 318 ~~gt~~y~aPE~l~~~-~~~~~sDiwSlG~il~elltG~~Pf~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L 395 (457)
+.||+.|||||++... ..+.++|||||||++.||+||..||.. ......+..+.........+..++.++++||.+||
T Consensus 181 ~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls~~a~~Fl~~C~ 260 (313)
T KOG0198|consen 181 VQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLSDEAKDFLRKCF 260 (313)
T ss_pred ccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcccCHHHHHHHHHHh
Confidence 5799999999999953 334599999999999999999999987 33333344444333222334458999999999999
Q ss_pred hhCCCCCCCCCcChHHHhcCCCCCCC
Q 012762 396 VKDPTRRMGSKMGATAIKRHQFFNGV 421 (457)
Q Consensus 396 ~~dP~~Rps~~~~~~~ll~hp~f~~~ 421 (457)
..||+.||| +.++|+|||.+..
T Consensus 261 ~~~p~~Rpt----a~eLL~hpf~~~~ 282 (313)
T KOG0198|consen 261 KRDPEKRPT----AEELLEHPFLKQN 282 (313)
T ss_pred hcCcccCcC----HHHHhhChhhhcc
Confidence 999999999 9999999999763
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-49 Score=388.10 Aligned_cols=269 Identities=37% Similarity=0.758 Sum_probs=224.7
Q ss_pred EEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHc-CCCCCceEEEEEEcCCcEEEEEe
Q 012762 88 HRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEML-DHPFLPTLYATLDCPRWSCLLTE 166 (457)
Q Consensus 88 ~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~~~~~~~~~~~lV~E 166 (457)
+.||+|+||+||+|+++ .+++.||+|++++..............|.+++..+ +||||+++++++..++.+|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~----~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e 76 (316)
T cd05592 1 KVLGKGSFGKVMLAELK----GTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVME 76 (316)
T ss_pred CeeeeCCCeEEEEEEEC----CCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEc
Confidence 36999999999999986 37889999999876544444555566677777754 89999999999999999999999
Q ss_pred ecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCCCcccc
Q 012762 167 FCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQ 246 (457)
Q Consensus 167 ~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~~~~~~ 246 (457)
|++|++|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 77 ~~~gg~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~---- 150 (316)
T cd05592 77 YLNGGDLMFHIQSS--GRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE---- 150 (316)
T ss_pred CCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC----
Confidence 99999999888764 579999999999999999999999999999999999999999999999999975332110
Q ss_pred cccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCCCCccC
Q 012762 247 LVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTHEYLA 326 (457)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 326 (457)
......+||+.|+|
T Consensus 151 ------------------------------------------------------------------~~~~~~~gt~~y~a 164 (316)
T cd05592 151 ------------------------------------------------------------------GKASTFCGTPDYIA 164 (316)
T ss_pred ------------------------------------------------------------------CccccccCCccccC
Confidence 00113469999999
Q ss_pred chhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhhhCCCCCCCCC
Q 012762 327 PEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDPTRRMGSK 406 (457)
Q Consensus 327 PE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rps~~ 406 (457)
||++.+..++.++|||||||++|||++|+.||.+.+.......+......++ ..++.++.++|.+||..||++||++
T Consensus 165 PE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~--~~~~~~~~~ll~~~l~~~P~~R~~~- 241 (316)
T cd05592 165 PEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFP--RWISKEAKDCLSKLFERDPTKRLGV- 241 (316)
T ss_pred HHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC--CCCCHHHHHHHHHHccCCHHHcCCC-
Confidence 9999999999999999999999999999999998887777766655544444 3488899999999999999999983
Q ss_pred cChHHHhcCCCCCCCCchhhh--ccCCCCCCCC
Q 012762 407 MGATAIKRHQFFNGVNWALLR--CAKPPFIPRP 437 (457)
Q Consensus 407 ~~~~~ll~hp~f~~~~~~~~~--~~~~~~~~~~ 437 (457)
..++++||||+.++|..+. ...|++.|..
T Consensus 242 --~~~l~~h~~~~~~~~~~~~~~~~~~~~~~~~ 272 (316)
T cd05592 242 --DGDIRQHPFFRGIDWERLEKREIPPPFKPKV 272 (316)
T ss_pred --hHHHHcCcccCCCCHHHHHhCCCCCCcCCCC
Confidence 4589999999999998764 3445665543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-49 Score=388.39 Aligned_cols=278 Identities=37% Similarity=0.712 Sum_probs=232.1
Q ss_pred EEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHc-CCCCCceEEEEEEcCCcEEEEEe
Q 012762 88 HRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEML-DHPFLPTLYATLDCPRWSCLLTE 166 (457)
Q Consensus 88 ~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~~~~~~~~~~~lV~E 166 (457)
+.||+|+||+||+|+++ .++..||+|++++...........+..|+++++.+ +||||+++++++...+.+|+|||
T Consensus 1 ~~lG~G~~g~V~~~~~~----~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e 76 (318)
T cd05570 1 KVLGKGSFGKVLLAELK----GTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVME 76 (318)
T ss_pred CeeeeCCCeEEEEEEEC----CCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEc
Confidence 46999999999999986 37889999999887655555566777899999888 79999999999999999999999
Q ss_pred ecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCCCcccc
Q 012762 167 FCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQ 246 (457)
Q Consensus 167 ~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~~~~~~ 246 (457)
|++|++|..++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 77 ~~~~~~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~---- 150 (318)
T cd05570 77 YVNGGDLMFHIQRS--GRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG---- 150 (318)
T ss_pred CCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCC----
Confidence 99999998887764 579999999999999999999999999999999999999999999999999875321100
Q ss_pred cccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCCCCccC
Q 012762 247 LVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTHEYLA 326 (457)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 326 (457)
......+||..|+|
T Consensus 151 ------------------------------------------------------------------~~~~~~~g~~~y~a 164 (318)
T cd05570 151 ------------------------------------------------------------------VTTSTFCGTPDYIA 164 (318)
T ss_pred ------------------------------------------------------------------CcccceecCccccC
Confidence 00113468999999
Q ss_pred chhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhhhCCCCCCCCC
Q 012762 327 PEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDPTRRMGSK 406 (457)
Q Consensus 327 PE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rps~~ 406 (457)
||++.+..++.++|||||||++|+|++|+.||.+.........+......++. .++.++.+||.+||..||.+||+..
T Consensus 165 PE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~~--~~~~~~~~li~~~l~~dP~~R~s~~ 242 (318)
T cd05570 165 PEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPR--WLSKEAKSILKSFLTKNPEKRLGCL 242 (318)
T ss_pred HHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCC--cCCHHHHHHHHHHccCCHHHcCCCC
Confidence 99999999999999999999999999999999988877777777766655554 4889999999999999999999921
Q ss_pred -cChHHHhcCCCCCCCCchhhh--ccCCCCCCCCCCcccc
Q 012762 407 -MGATAIKRHQFFNGVNWALLR--CAKPPFIPRPVTCRDL 443 (457)
Q Consensus 407 -~~~~~ll~hp~f~~~~~~~~~--~~~~~~~~~~~~~~~~ 443 (457)
..+.++++||||+.++|.... ...||+.|......+.
T Consensus 243 ~~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (318)
T cd05570 243 PTGEQDIKGHPFFREIDWDKLERKEIKPPFKPKIKGRFDV 282 (318)
T ss_pred CCCHHHHhcCCCcCCCCHHHHHhCCCCCCcCCCCCCcchh
Confidence 112999999999999997653 4556666655444433
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-49 Score=389.61 Aligned_cols=277 Identities=36% Similarity=0.691 Sum_probs=226.3
Q ss_pred EEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHc-CCCCCceEEEEEEcCCcEEEEEe
Q 012762 88 HRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEML-DHPFLPTLYATLDCPRWSCLLTE 166 (457)
Q Consensus 88 ~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~~~~~~~~~~~lV~E 166 (457)
+.||+|+||+||+|+++ .+++.||+|++++...........+..|+.+++.+ +||||+++++++...+.+|||||
T Consensus 1 ~~lG~G~~g~V~~~~~~----~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e 76 (329)
T cd05588 1 RVIGRGSYAKVLLVELK----KTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIE 76 (329)
T ss_pred CeEeeCCCeEEEEEEEC----CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEe
Confidence 46899999999999987 47889999999876555555566778899999988 79999999999999999999999
Q ss_pred ecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCCCcccc
Q 012762 167 FCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQ 246 (457)
Q Consensus 167 ~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~~~~~~ 246 (457)
|+++++|..++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 77 ~~~~g~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~---- 150 (329)
T cd05588 77 FVSGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG---- 150 (329)
T ss_pred CCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCC----
Confidence 99999998887664 679999999999999999999999999999999999999999999999999875321000
Q ss_pred cccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCCCCccC
Q 012762 247 LVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTHEYLA 326 (457)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 326 (457)
.....++||+.|+|
T Consensus 151 ------------------------------------------------------------------~~~~~~~gt~~y~a 164 (329)
T cd05588 151 ------------------------------------------------------------------DTTSTFCGTPNYIA 164 (329)
T ss_pred ------------------------------------------------------------------CccccccCCccccC
Confidence 01113469999999
Q ss_pred chhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCC---------hHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhhh
Q 012762 327 PEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGID---------HELTLANVVARALEFPKEPSVPGPAKDLIAQLLVK 397 (457)
Q Consensus 327 PE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~ 397 (457)
||++.+..++.++|||||||++|+|++|+.||.... .......+.......|. .++..+.++|.+||..
T Consensus 165 PE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~--~~~~~~~~li~~~L~~ 242 (329)
T cd05588 165 PEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPR--SLSVKASSVLKGFLNK 242 (329)
T ss_pred HHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCC--CCCHHHHHHHHHHhcc
Confidence 999999999999999999999999999999996321 11233444444445443 4888999999999999
Q ss_pred CCCCCCCCC--cChHHHhcCCCCCCCCchhhhc--cCCCCCCCCCCccc
Q 012762 398 DPTRRMGSK--MGATAIKRHQFFNGVNWALLRC--AKPPFIPRPVTCRD 442 (457)
Q Consensus 398 dP~~Rps~~--~~~~~ll~hp~f~~~~~~~~~~--~~~~~~~~~~~~~~ 442 (457)
||.+|++.. ..++++++||||..++|..+.. ..|++.|......+
T Consensus 243 dP~~R~~~~~~~~~~~i~~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (329)
T cd05588 243 DPKERLGCHPQTGFRDIKSHPFFRNIDWDLLEQKQVLPPYKPNIESDRD 291 (329)
T ss_pred CHHHcCCCCCCCCHHHHhcCCCCCCCCHHHHHhCCCCCCccccCCCcch
Confidence 999999732 2378999999999999987753 34566665544433
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-50 Score=389.08 Aligned_cols=263 Identities=28% Similarity=0.421 Sum_probs=221.2
Q ss_pred CccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEc
Q 012762 78 PLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDC 157 (457)
Q Consensus 78 ~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~ 157 (457)
....+.|..+++||+|+||.||+|++. .+|+.||+|.+..... .+.......+||.||++|+||||++|.+....
T Consensus 113 ~r~~~~feki~kIGeGTyg~VYkAr~~----~tgkivALKKvr~d~~-~~~~~~t~~REI~ILr~l~HpNIikL~eivt~ 187 (560)
T KOG0600|consen 113 PRRADSFEKIEKIGEGTYGQVYKARDL----ETGKIVALKKVRFDNE-KEGFPITAIREIKILRRLDHPNIIKLEEIVTS 187 (560)
T ss_pred ccchHHHHHHHHhcCcchhheeEeeec----ccCcEEEEEEeecccC-CCcchHHHHHHHHHHHhcCCCcccceeeEEEe
Confidence 455678999999999999999999876 5899999999976643 23345566779999999999999999998876
Q ss_pred C--CcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCC
Q 012762 158 P--RWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235 (457)
Q Consensus 158 ~--~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s 235 (457)
. +.+|||+||| .-+|..++.. +.-.|++.+++.|+.||+.||+|+|++||+|||||..||||+.+|.+||+|||||
T Consensus 188 ~~~~siYlVFeYM-dhDL~GLl~~-p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLA 265 (560)
T KOG0600|consen 188 KLSGSIYLVFEYM-DHDLSGLLSS-PGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLA 265 (560)
T ss_pred cCCceEEEEEecc-cchhhhhhcC-CCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccce
Confidence 5 6899999999 5678777655 3467999999999999999999999999999999999999999999999999999
Q ss_pred cCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcccc
Q 012762 236 LKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRS 315 (457)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (457)
+........ ..
T Consensus 266 r~y~~~~~~---------------------------------------------------------------------~~ 276 (560)
T KOG0600|consen 266 RFYTPSGSA---------------------------------------------------------------------PY 276 (560)
T ss_pred eeccCCCCc---------------------------------------------------------------------cc
Confidence 866532211 12
Q ss_pred ccccCCCCccCchhhcCCC-CCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccC----------CCC-----
Q 012762 316 MSFVGTHEYLAPEIISGEG-HGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALE----------FPK----- 379 (457)
Q Consensus 316 ~~~~gt~~y~aPE~l~~~~-~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~----------~~~----- 379 (457)
+..+-|.+|+|||.+.|.. |+.++|+||.||||.||++|++.|.+.++.+.+..|...... +|.
T Consensus 277 T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~~k 356 (560)
T KOG0600|consen 277 TSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATIFK 356 (560)
T ss_pred ccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCcccccC
Confidence 2346899999999999875 999999999999999999999999999888887777653211 111
Q ss_pred ------------CCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCC
Q 012762 380 ------------EPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNG 420 (457)
Q Consensus 380 ------------~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~ 420 (457)
...++....+|+..||..||.+|.| +.++|+|+||..
T Consensus 357 p~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~t----A~~aL~seyF~t 405 (560)
T KOG0600|consen 357 PQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGT----ASSALQSEYFTT 405 (560)
T ss_pred CCCcccchHHHHhccCCHHHHHHHHHHhccCcccccc----HHHHhcCccccc
Confidence 0233567889999999999999999 999999999955
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-49 Score=389.23 Aligned_cols=275 Identities=37% Similarity=0.672 Sum_probs=229.8
Q ss_pred EEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHH-HHHHcCCCCCceEEEEEEcCCcEEEEEe
Q 012762 88 HRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIERE-ILEMLDHPFLPTLYATLDCPRWSCLLTE 166 (457)
Q Consensus 88 ~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~-il~~l~H~nIv~l~~~~~~~~~~~lV~E 166 (457)
+.||+|+||+||+|.++ .+|+.||+|++.+...........+..|.. +++.++||||+++++++..++..|+|||
T Consensus 1 ~~lG~G~~g~V~~~~~~----~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e 76 (325)
T cd05604 1 KVIGKGSFGKVLLAKRK----LDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLD 76 (325)
T ss_pred CceeeCCCeEEEEEEEC----CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEc
Confidence 36899999999999876 478899999998765544445555566665 4677899999999999999999999999
Q ss_pred ecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCCCcccc
Q 012762 167 FCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQ 246 (457)
Q Consensus 167 ~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~~~~~~ 246 (457)
|+.+++|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++......
T Consensus 77 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~---- 150 (325)
T cd05604 77 FVNGGELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS---- 150 (325)
T ss_pred CCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC----
Confidence 99999998877654 679999999999999999999999999999999999999999999999999975321100
Q ss_pred cccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCCCCccC
Q 012762 247 LVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTHEYLA 326 (457)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 326 (457)
......+||+.|+|
T Consensus 151 ------------------------------------------------------------------~~~~~~~gt~~y~a 164 (325)
T cd05604 151 ------------------------------------------------------------------DTTTTFCGTPEYLA 164 (325)
T ss_pred ------------------------------------------------------------------CCcccccCChhhCC
Confidence 00113469999999
Q ss_pred chhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhhhCCCCCCCCC
Q 012762 327 PEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDPTRRMGSK 406 (457)
Q Consensus 327 PE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rps~~ 406 (457)
||++.+..++.++|||||||++|||++|..||...+..+....++......+ +..+..+.++|.+||..||.+||+..
T Consensus 165 PE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ll~~ll~~~p~~R~~~~ 242 (325)
T cd05604 165 PEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLR--PGASLTAWSILEELLEKDRQRRLGAK 242 (325)
T ss_pred HHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccCC--CCCCHHHHHHHHHHhccCHHhcCCCC
Confidence 9999999999999999999999999999999998877777777766554443 34788999999999999999999987
Q ss_pred cChHHHhcCCCCCCCCchhhhc--cCCCCCCCCCCc
Q 012762 407 MGATAIKRHQFFNGVNWALLRC--AKPPFIPRPVTC 440 (457)
Q Consensus 407 ~~~~~ll~hp~f~~~~~~~~~~--~~~~~~~~~~~~ 440 (457)
..+.++++||||+.++|..+.. ..+|+.|.....
T Consensus 243 ~~~~~i~~h~~f~~~~~~~~~~~~~~~~~~~~~~~~ 278 (325)
T cd05604 243 EDFLEIQEHPFFESLSWTDLEQKKIPPPFNPNVEGP 278 (325)
T ss_pred CCHHHHhcCCCcCCCCHHHHHhCCCCCCcCCcCCCc
Confidence 7789999999999999987653 345666655433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-49 Score=387.38 Aligned_cols=277 Identities=34% Similarity=0.674 Sum_probs=235.5
Q ss_pred CceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcC-CCCCceEEEEEEcCCcE
Q 012762 83 DLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLD-HPFLPTLYATLDCPRWS 161 (457)
Q Consensus 83 ~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~-H~nIv~l~~~~~~~~~~ 161 (457)
+|.+.+.||+|+||+||+|+++ .+++.||+|++.+...........+..|+++++.+. |++|+++++++...+.+
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~----~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~ 76 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERK----GTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRL 76 (323)
T ss_pred CceEEEEEEecCCeEEEEEEEC----CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEE
Confidence 4788999999999999999986 478899999998765545555666778999998885 57788999999999999
Q ss_pred EEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCC
Q 012762 162 CLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNS 241 (457)
Q Consensus 162 ~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~ 241 (457)
|+||||++|++|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 77 ~lv~Ey~~~g~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~ 154 (323)
T cd05615 77 YFVMEYVNGGDLMYHIQQV--GKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD 154 (323)
T ss_pred EEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence 9999999999999888764 66999999999999999999999999999999999999999999999999987532110
Q ss_pred CcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCC
Q 012762 242 TSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGT 321 (457)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 321 (457)
.. ......||
T Consensus 155 ~~----------------------------------------------------------------------~~~~~~gt 164 (323)
T cd05615 155 GV----------------------------------------------------------------------TTRTFCGT 164 (323)
T ss_pred Cc----------------------------------------------------------------------cccCccCC
Confidence 00 01124599
Q ss_pred CCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhhhCCCC
Q 012762 322 HEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDPTR 401 (457)
Q Consensus 322 ~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~ 401 (457)
+.|+|||++.+..++.++|||||||++|||++|+.||.+.........+......++. .++.++.+++.+||..||.+
T Consensus 165 ~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~--~~~~~~~~li~~~l~~~p~~ 242 (323)
T cd05615 165 PDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPK--SLSKEAVSICKGLMTKHPSK 242 (323)
T ss_pred ccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc--cCCHHHHHHHHHHcccCHhh
Confidence 9999999999989999999999999999999999999998877777887777666554 48899999999999999999
Q ss_pred CCCCC-cChHHHhcCCCCCCCCchhhhc--cCCCCCCCC
Q 012762 402 RMGSK-MGATAIKRHQFFNGVNWALLRC--AKPPFIPRP 437 (457)
Q Consensus 402 Rps~~-~~~~~ll~hp~f~~~~~~~~~~--~~~~~~~~~ 437 (457)
|++.. ...+++++||||+.++|..+.. ..+|+.|+.
T Consensus 243 R~~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~~~~~~~~ 281 (323)
T cd05615 243 RLGCGPEGERDIREHAFFRRIDWDKLENREIQPPFKPKV 281 (323)
T ss_pred CCCCCCCCHHHHhcCcccCCCCHHHHhcCCCCcCccCcc
Confidence 99853 2468999999999999987744 457777754
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-49 Score=387.93 Aligned_cols=280 Identities=37% Similarity=0.697 Sum_probs=230.2
Q ss_pred EEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhh-hHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcEEEEEe
Q 012762 88 HRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSR-NKESRARIEREILEMLDHPFLPTLYATLDCPRWSCLLTE 166 (457)
Q Consensus 88 ~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~-~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lV~E 166 (457)
+.||+|+||.||+|+... ...+++.||+|++.+...... .....+..|+++|+.++||||+++++++..++..|+|||
T Consensus 2 ~~lg~G~~g~V~~~~~~~-~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVT-GADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred ceeeecCCeEEEEEEEcc-cCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence 689999999999998642 224788999999987654322 234556789999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCCCcccc
Q 012762 167 FCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQ 246 (457)
Q Consensus 167 ~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~~~~~~ 246 (457)
|+.+++|..++... +.+.+..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++......
T Consensus 81 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~---- 154 (323)
T cd05584 81 YLSGGELFMHLERE--GIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG---- 154 (323)
T ss_pred CCCCchHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC----
Confidence 99999999888764 668899999999999999999999999999999999999999999999999875321100
Q ss_pred cccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCCCCccC
Q 012762 247 LVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTHEYLA 326 (457)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 326 (457)
.......||+.|+|
T Consensus 155 ------------------------------------------------------------------~~~~~~~gt~~y~a 168 (323)
T cd05584 155 ------------------------------------------------------------------TVTHTFCGTIEYMA 168 (323)
T ss_pred ------------------------------------------------------------------CcccccCCCccccC
Confidence 00112469999999
Q ss_pred chhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhhhCCCCCCCCC
Q 012762 327 PEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDPTRRMGSK 406 (457)
Q Consensus 327 PE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rps~~ 406 (457)
||++.+..++.++|||||||++|||++|+.||.+.........+......++. .+++++.++|.+||..||++||+..
T Consensus 169 PE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~l~~~p~~R~~~~ 246 (323)
T cd05584 169 PEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPP--YLTPEARDLLKKLLKRNPSSRLGAG 246 (323)
T ss_pred hhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCC--CCCHHHHHHHHHHcccCHhHcCCCC
Confidence 99999988999999999999999999999999988877777777776655554 4889999999999999999999321
Q ss_pred -cChHHHhcCCCCCCCCchhhh--ccCCCCCCCCCCccc
Q 012762 407 -MGATAIKRHQFFNGVNWALLR--CAKPPFIPRPVTCRD 442 (457)
Q Consensus 407 -~~~~~ll~hp~f~~~~~~~~~--~~~~~~~~~~~~~~~ 442 (457)
..++++++||||+..+|..+. ...+|+.+......+
T Consensus 247 ~~~~~~l~~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (323)
T cd05584 247 PGDAAEVQSHPFFRHVNWDDLLARKVEPPFKPLLQSEED 285 (323)
T ss_pred CCCHHHHhcCCCcCCCCHHHHhcCCCCCCcCCCCCCcch
Confidence 129999999999999997664 334555554444443
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-49 Score=381.06 Aligned_cols=280 Identities=33% Similarity=0.579 Sum_probs=228.6
Q ss_pred CceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcEE
Q 012762 83 DLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWSC 162 (457)
Q Consensus 83 ~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~ 162 (457)
.|++.++||+|+||+||++.+. .+++.||+|++.............+.+|+++++.++|+||+++++++..++.+|
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 76 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVR----ATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALC 76 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEc----CCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEE
Confidence 3889999999999999999876 378899999998765544444456678999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCCC
Q 012762 163 LLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNST 242 (457)
Q Consensus 163 lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~~ 242 (457)
+||||+++++|..++.......+++..+..++.||+.||.|||+.||+||||||+||+++.++.++|+|||++.......
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05605 77 LVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE 156 (285)
T ss_pred EEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence 99999999999888776555679999999999999999999999999999999999999999999999999975432100
Q ss_pred cccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCCC
Q 012762 243 STAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTH 322 (457)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 322 (457)
. ....+|+.
T Consensus 157 ~-----------------------------------------------------------------------~~~~~~~~ 165 (285)
T cd05605 157 T-----------------------------------------------------------------------IRGRVGTV 165 (285)
T ss_pred c-----------------------------------------------------------------------cccccCCC
Confidence 0 01235899
Q ss_pred CccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcc--cCCCCCCCCChHHHHHHHHHhhhCCC
Q 012762 323 EYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARA--LEFPKEPSVPGPAKDLIAQLLVKDPT 400 (457)
Q Consensus 323 ~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~ll~~~L~~dP~ 400 (457)
.|+|||++.+..++.++|||||||++|||++|+.||.+.........+.... ........++..+.+||.+||..||.
T Consensus 166 ~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~ 245 (285)
T cd05605 166 GYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICRQLLTKDPG 245 (285)
T ss_pred CccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHHHHHccCCHH
Confidence 9999999998889999999999999999999999998765433322222111 11122235888999999999999999
Q ss_pred CCCCCC-cChHHHhcCCCCCCCCchhhhc--cCCCCCCCC
Q 012762 401 RRMGSK-MGATAIKRHQFFNGVNWALLRC--AKPPFIPRP 437 (457)
Q Consensus 401 ~Rps~~-~~~~~ll~hp~f~~~~~~~~~~--~~~~~~~~~ 437 (457)
+||++. ..++++++||||...+|..++. ..||+.|.|
T Consensus 246 ~R~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (285)
T cd05605 246 FRLGCRGEGAEEVKAHPFFRTANFKRLEAGMLEPPFCPDP 285 (285)
T ss_pred HhcCCCCCCHHHHhcCcCccCCCHHHHhhCCCCCCCCCCC
Confidence 999321 1299999999999999987754 446777754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-48 Score=387.35 Aligned_cols=283 Identities=40% Similarity=0.733 Sum_probs=225.9
Q ss_pred CceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhh-hhHHHHHHHHHHHHHHc-CCCCCceEEEEEEcCCc
Q 012762 83 DLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVS-RNKESRARIEREILEML-DHPFLPTLYATLDCPRW 160 (457)
Q Consensus 83 ~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~-~~~~~~~~~E~~il~~l-~H~nIv~l~~~~~~~~~ 160 (457)
+|++++.||+|+||+||+|+... +..+++.||+|++.+..... ......+..|+++|+.+ +|+||+++++++..++.
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~-~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~ 79 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVT-GHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAK 79 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcc-cCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCE
Confidence 58999999999999999998642 33478899999998754332 23345677899999999 59999999999999999
Q ss_pred EEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCC
Q 012762 161 SCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDN 240 (457)
Q Consensus 161 ~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~ 240 (457)
+|+||||+.+|+|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 80 ~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~ 157 (332)
T cd05614 80 LHLILDYVSGGEMFTHLYQR--DNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLS 157 (332)
T ss_pred EEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccc
Confidence 99999999999998888764 5699999999999999999999999999999999999999999999999999754321
Q ss_pred CCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccC
Q 012762 241 STSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVG 320 (457)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 320 (457)
... .....++|
T Consensus 158 ~~~---------------------------------------------------------------------~~~~~~~g 168 (332)
T cd05614 158 EEK---------------------------------------------------------------------ERTYSFCG 168 (332)
T ss_pred cCC---------------------------------------------------------------------CccccccC
Confidence 100 01113469
Q ss_pred CCCccCchhhcCCC-CCccchhhhhhHHHHHHhcCCCCCCCCCh----HHHHHHHHhcccCCCCCCCCChHHHHHHHHHh
Q 012762 321 THEYLAPEIISGEG-HGNAVDWWTLGIFIFELFYGTTPFKGIDH----ELTLANVVARALEFPKEPSVPGPAKDLIAQLL 395 (457)
Q Consensus 321 t~~y~aPE~l~~~~-~~~~sDiwSlG~il~elltG~~Pf~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L 395 (457)
|+.|+|||++.+.. ++.++|||||||++|||++|..||..... ......+......+ ...++..+.++|.+||
T Consensus 169 t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l 246 (332)
T cd05614 169 TIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPF--PSFIGPEAQDLLHKLL 246 (332)
T ss_pred CccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCC--CCCCCHHHHHHHHHHc
Confidence 99999999998764 78999999999999999999999975322 22333333333333 3458899999999999
Q ss_pred hhCCCCCCCCC-cChHHHhcCCCCCCCCchhhh--ccCCCCCCCCCC
Q 012762 396 VKDPTRRMGSK-MGATAIKRHQFFNGVNWALLR--CAKPPFIPRPVT 439 (457)
Q Consensus 396 ~~dP~~Rps~~-~~~~~ll~hp~f~~~~~~~~~--~~~~~~~~~~~~ 439 (457)
..||++||+.. ..++++++||||+..+|..+. ...+++.|....
T Consensus 247 ~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (332)
T cd05614 247 RKDPKKRLGAGPQGASEIKEHPFFKGLDWEALALRKVNPPFRPSIRN 293 (332)
T ss_pred CCCHHHcCCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCCC
Confidence 99999999421 128999999999999997653 345666654433
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-48 Score=384.25 Aligned_cols=312 Identities=53% Similarity=0.968 Sum_probs=254.9
Q ss_pred CCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcE
Q 012762 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWS 161 (457)
Q Consensus 82 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~ 161 (457)
++|++.+.||+|+||+||+|.+.. +++.||+|.+.+...........+..|+++|++++|+||+++++.+..+...
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~----~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 76 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKG----TGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYL 76 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcC----CCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEE
Confidence 479999999999999999998763 6889999999876554444667788899999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCC
Q 012762 162 CLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNS 241 (457)
Q Consensus 162 ~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~ 241 (457)
|+||||+.+++|.+++.......+++..++.++.||+.||.|||+.|++|+||||+||+++.++.++|+|||++......
T Consensus 77 ~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 156 (316)
T cd05574 77 CLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVE 156 (316)
T ss_pred EEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence 99999999999999988766678999999999999999999999999999999999999999999999999998654321
Q ss_pred CcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCC
Q 012762 242 TSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGT 321 (457)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 321 (457)
........... +... + ..--.......+.......++||
T Consensus 157 ~~~~~~~~~~~--~~~~--------------~-------------------------~~~~~~~~~~~~~~~~~~~~~g~ 195 (316)
T cd05574 157 PPPVSKALRKG--SRRS--------------S-------------------------VNSIPSETFSEEPSFRSNSFVGT 195 (316)
T ss_pred ccccccccccc--cccc--------------c-------------------------ccccchhhhcccccCCCCCCcCc
Confidence 11000000000 0000 0 00000011111222333456799
Q ss_pred CCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhhhCCCC
Q 012762 322 HEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDPTR 401 (457)
Q Consensus 322 ~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~ 401 (457)
..|+|||++.+..++.++|||||||++|+|++|..||.+......+..+......++....++..+.++|.+||..||++
T Consensus 196 ~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 275 (316)
T cd05574 196 EEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSK 275 (316)
T ss_pred cCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHHHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhH
Confidence 99999999999889999999999999999999999999888777777777776666666567899999999999999999
Q ss_pred CCCCCcChHHHhcCCCCCCCCchhhhccCCCCCCCCC
Q 012762 402 RMGSKMGATAIKRHQFFNGVNWALLRCAKPPFIPRPV 438 (457)
Q Consensus 402 Rps~~~~~~~ll~hp~f~~~~~~~~~~~~~~~~~~~~ 438 (457)
||++...++++|+||||++.+|..+....||.+|.|.
T Consensus 276 R~s~~~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (316)
T cd05574 276 RLGSKRGAAEIKQHPFFRGVNWALIRHTTPPIIPRPD 312 (316)
T ss_pred CCCchhhHHHHHcCchhhcCChhhcccCCCCCCCCcc
Confidence 9999999999999999999999999999999998774
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-49 Score=388.26 Aligned_cols=275 Identities=35% Similarity=0.677 Sum_probs=224.4
Q ss_pred EEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHc-CCCCCceEEEEEEcCCcEEEEEe
Q 012762 88 HRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEML-DHPFLPTLYATLDCPRWSCLLTE 166 (457)
Q Consensus 88 ~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~~~~~~~~~~~lV~E 166 (457)
+.||+|+||+||+|+++ .+++.||+|++.+...........+..|+.++.++ +||||+++++++...+.+|+|||
T Consensus 1 ~~lG~G~~g~V~~~~~~----~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E 76 (329)
T cd05618 1 RVIGRGSYAKVLLVRLK----KTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIE 76 (329)
T ss_pred CeeeeCCCeEEEEEEEC----CCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEe
Confidence 46999999999999987 47889999999876554444556677888888776 89999999999999999999999
Q ss_pred ecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCCCcccc
Q 012762 167 FCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQ 246 (457)
Q Consensus 167 ~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~~~~~~ 246 (457)
|+++++|..++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 77 ~~~~~~L~~~~~~~--~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~---- 150 (329)
T cd05618 77 YVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG---- 150 (329)
T ss_pred CCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC----
Confidence 99999998877664 679999999999999999999999999999999999999999999999999975321100
Q ss_pred cccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCCCCccC
Q 012762 247 LVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTHEYLA 326 (457)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 326 (457)
.....+.||..|+|
T Consensus 151 ------------------------------------------------------------------~~~~~~~gt~~y~a 164 (329)
T cd05618 151 ------------------------------------------------------------------DTTSTFCGTPNYIA 164 (329)
T ss_pred ------------------------------------------------------------------CccccccCCccccC
Confidence 00113469999999
Q ss_pred chhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCC---------ChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhhh
Q 012762 327 PEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGI---------DHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVK 397 (457)
Q Consensus 327 PE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~ 397 (457)
||++.+..++.++|||||||++|||++|+.||... ........+......+|. .++..+.++|.+||..
T Consensus 165 PE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~--~~~~~~~~ll~~~L~~ 242 (329)
T cd05618 165 PEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR--SLSVKAASVLKSFLNK 242 (329)
T ss_pred HHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCC--CCCHHHHHHHHHHhcC
Confidence 99999999999999999999999999999999531 111233344445555554 4788999999999999
Q ss_pred CCCCCCCCC--cChHHHhcCCCCCCCCchhhh--ccCCCCCCCCCCc
Q 012762 398 DPTRRMGSK--MGATAIKRHQFFNGVNWALLR--CAKPPFIPRPVTC 440 (457)
Q Consensus 398 dP~~Rps~~--~~~~~ll~hp~f~~~~~~~~~--~~~~~~~~~~~~~ 440 (457)
||++|++.. ..++++++||||+.++|..+. ...|++.|.....
T Consensus 243 dP~~R~~~~~~~~~~~i~~hp~f~~~~~~~~~~~~~~~~~~~~~~~~ 289 (329)
T cd05618 243 DPKERLGCHPQTGFADIQGHPFFRNVDWDLMEQKQVVPPFKPNISGE 289 (329)
T ss_pred CHHHcCCCCCCCCHHHHhcCCCCCCCCHHHHHcCCCCcCccCCCCCc
Confidence 999999832 235899999999999998664 3556777655443
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-48 Score=386.19 Aligned_cols=283 Identities=34% Similarity=0.636 Sum_probs=234.7
Q ss_pred CCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcE
Q 012762 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWS 161 (457)
Q Consensus 82 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~ 161 (457)
++|++++.||+|+||+||+|+++ .+++.||+|++.+...........+..|+.+++.++|+||+++++++..++++
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~----~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 76 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMK----NTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNL 76 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEEC----CCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeE
Confidence 47999999999999999999987 47889999999876665556667788899999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCC
Q 012762 162 CLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNS 241 (457)
Q Consensus 162 ~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~ 241 (457)
|+||||+.|++|..++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 77 ~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (331)
T cd05597 77 YLVMDYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD 155 (331)
T ss_pred EEEEecCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence 9999999999999988753 356899999999999999999999999999999999999999999999999997543211
Q ss_pred CcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCC
Q 012762 242 TSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGT 321 (457)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 321 (457)
.. ......+||
T Consensus 156 ~~---------------------------------------------------------------------~~~~~~~gt 166 (331)
T cd05597 156 GT---------------------------------------------------------------------VQSNVAVGT 166 (331)
T ss_pred CC---------------------------------------------------------------------ccccceecc
Confidence 10 000123599
Q ss_pred CCccCchhhcC-----CCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhccc--CCCC-CCCCChHHHHHHHH
Q 012762 322 HEYLAPEIISG-----EGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARAL--EFPK-EPSVPGPAKDLIAQ 393 (457)
Q Consensus 322 ~~y~aPE~l~~-----~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~--~~~~-~~~~~~~~~~ll~~ 393 (457)
+.|+|||++.+ ..++.++|||||||++|||++|+.||.+....+.+..++.... .++. ...++.+++++|++
T Consensus 167 ~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~ 246 (331)
T cd05597 167 PDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEEAKDLIRR 246 (331)
T ss_pred ccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCCCHHHHHHHHH
Confidence 99999999974 3478899999999999999999999998776666666655432 2222 23478899999999
Q ss_pred HhhhCCCC--CCCCCcChHHHhcCCCCCCCCchhhhccCCCCCCCCCCccc
Q 012762 394 LLVKDPTR--RMGSKMGATAIKRHQFFNGVNWALLRCAKPPFIPRPVTCRD 442 (457)
Q Consensus 394 ~L~~dP~~--Rps~~~~~~~ll~hp~f~~~~~~~~~~~~~~~~~~~~~~~~ 442 (457)
||..++++ |++ +.++++||||.+++|..+....+|++|...+..+
T Consensus 247 ll~~~~~r~~r~~----~~~~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (331)
T cd05597 247 LICSPETRLGRNG----LQDFKDHPFFEGIDWDNIRNSTAPYVPEVSSPTD 293 (331)
T ss_pred HccCcccccCCCC----HHHHhcCCCCCCCCHHHHhhCCCCccCcCCCcch
Confidence 99754433 678 9999999999999999998888888876555443
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-49 Score=390.19 Aligned_cols=277 Identities=36% Similarity=0.670 Sum_probs=230.5
Q ss_pred ecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHc---CCCCCceEEEEEEcCCcEEEEEe
Q 012762 90 LGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEML---DHPFLPTLYATLDCPRWSCLLTE 166 (457)
Q Consensus 90 LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l---~H~nIv~l~~~~~~~~~~~lV~E 166 (457)
||+|+||+||+|+++ .+++.||+|++.+..............|..++.++ +||||+++++++......|+|||
T Consensus 1 lG~G~~g~Vy~~~~~----~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e 76 (330)
T cd05586 1 IGKGTFGQVYQVRKK----DTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTD 76 (330)
T ss_pred CCCCCceEEEEEEEC----CCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEc
Confidence 799999999999986 47889999999876654444455556677777765 79999999999999999999999
Q ss_pred ecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCCCcccc
Q 012762 167 FCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQ 246 (457)
Q Consensus 167 ~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~~~~~~ 246 (457)
|+.+++|..++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++.......
T Consensus 77 ~~~~g~L~~~l~~~--~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~---- 150 (330)
T cd05586 77 YMSGGELFWHLQKE--GRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDN---- 150 (330)
T ss_pred CCCCChHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC----
Confidence 99999998887764 679999999999999999999999999999999999999999999999999975321100
Q ss_pred cccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCCCCccC
Q 012762 247 LVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTHEYLA 326 (457)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 326 (457)
......+||+.|+|
T Consensus 151 ------------------------------------------------------------------~~~~~~~gt~~y~a 164 (330)
T cd05586 151 ------------------------------------------------------------------KTTNTFCGTTEYLA 164 (330)
T ss_pred ------------------------------------------------------------------CCccCccCCccccC
Confidence 00113469999999
Q ss_pred chhhcCC-CCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhhhCCCCCCCC
Q 012762 327 PEIISGE-GHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDPTRRMGS 405 (457)
Q Consensus 327 PE~l~~~-~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rps~ 405 (457)
||++.+. .++.++|||||||++|+|++|..||.+......+..+......++.. .+++++.++|.+||..||.+||+.
T Consensus 165 PE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~-~~~~~~~~li~~~L~~~P~~R~~~ 243 (330)
T cd05586 165 PEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKN-VLSDEGRQFVKGLLNRNPQHRLGA 243 (330)
T ss_pred HHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCCc-cCCHHHHHHHHHHcCCCHHHCCCC
Confidence 9999765 48999999999999999999999999887777777777666666543 478899999999999999999976
Q ss_pred CcChHHHhcCCCCCCCCchhhh--ccCCCCCCCCCCcccc
Q 012762 406 KMGATAIKRHQFFNGVNWALLR--CAKPPFIPRPVTCRDL 443 (457)
Q Consensus 406 ~~~~~~ll~hp~f~~~~~~~~~--~~~~~~~~~~~~~~~~ 443 (457)
...+.++++||||...+|..+. ...+|+.|......+.
T Consensus 244 ~~~~~~ll~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (330)
T cd05586 244 HRDAVELKEHPFFADIDWDLLSKKQITPPFKPIVDSDEDV 283 (330)
T ss_pred CCCHHHHhcCccccCCCHHHHHhCCCCCCccCCCCCCcch
Confidence 6669999999999999998764 3456676665444443
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-50 Score=381.43 Aligned_cols=254 Identities=29% Similarity=0.497 Sum_probs=235.4
Q ss_pred CCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCc
Q 012762 81 LSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRW 160 (457)
Q Consensus 81 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~ 160 (457)
..+|.+.+.||+|.||+|-+|+.+ ..|+.||||.+++.++.+......+++|++||..|+||||+.+|.+|++.+.
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~----~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdK 127 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEH----KSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDK 127 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhc----cCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCce
Confidence 357999999999999999998865 4899999999999999999999999999999999999999999999999999
Q ss_pred EEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCC
Q 012762 161 SCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDN 240 (457)
Q Consensus 161 ~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~ 240 (457)
+.|||||..+|.|++++.+. +.+++.+++.+++||..|+.|+|.++++|||||.+|||++.++++||+|||++..+..
T Consensus 128 IvivMEYaS~GeLYDYiSer--~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~ 205 (668)
T KOG0611|consen 128 IVIVMEYASGGELYDYISER--GSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYAD 205 (668)
T ss_pred EEEEEEecCCccHHHHHHHh--ccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhcc
Confidence 99999999999999999986 7899999999999999999999999999999999999999999999999999865543
Q ss_pred CCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccC
Q 012762 241 STSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVG 320 (457)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 320 (457)
.. -..+|||
T Consensus 206 ~k-----------------------------------------------------------------------fLqTFCG 214 (668)
T KOG0611|consen 206 KK-----------------------------------------------------------------------FLQTFCG 214 (668)
T ss_pred cc-----------------------------------------------------------------------HHHHhcC
Confidence 22 2237899
Q ss_pred CCCccCchhhcCCCC-CccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhhhCC
Q 012762 321 THEYLAPEIISGEGH-GNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDP 399 (457)
Q Consensus 321 t~~y~aPE~l~~~~~-~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP 399 (457)
++.|.+||++.|.+| ++.+|-|||||+||-|..|.+||++.+......+|..+.++-|. -|.++..||+.||-.||
T Consensus 215 SPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~---~PSdA~gLIRwmLmVNP 291 (668)
T KOG0611|consen 215 SPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPE---TPSDASGLIRWMLMVNP 291 (668)
T ss_pred CcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCC---CCchHHHHHHHHHhcCc
Confidence 999999999999998 88999999999999999999999999999999999999888776 56789999999999999
Q ss_pred CCCCCCCcChHHHhcCCCC
Q 012762 400 TRRMGSKMGATAIKRHQFF 418 (457)
Q Consensus 400 ~~Rps~~~~~~~ll~hp~f 418 (457)
++|.| +++|-.|=|.
T Consensus 292 ~RRAT----ieDiAsHWWv 306 (668)
T KOG0611|consen 292 ERRAT----IEDIASHWWV 306 (668)
T ss_pred ccchh----HHHHhhhhee
Confidence 99999 9999999663
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-48 Score=384.49 Aligned_cols=272 Identities=34% Similarity=0.729 Sum_probs=226.5
Q ss_pred EEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHc-CCCCCceEEEEEEcCCcEEEEEe
Q 012762 88 HRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEML-DHPFLPTLYATLDCPRWSCLLTE 166 (457)
Q Consensus 88 ~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~~~~~~~~~~~lV~E 166 (457)
+.||+|+||+||+|+++ .+++.||+|++++..............|..++..+ +||||+++++++.+.+.+|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~----~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~e 76 (316)
T cd05619 1 KMLGKGSFGKVFLAELK----GTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVME 76 (316)
T ss_pred CeeeeCCCEEEEEEEEC----CCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEe
Confidence 46999999999999987 37889999999876544444455666788888764 89999999999999999999999
Q ss_pred ecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCCCcccc
Q 012762 167 FCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQ 246 (457)
Q Consensus 167 ~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~~~~~~ 246 (457)
|+++|+|..++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 77 y~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~---- 150 (316)
T cd05619 77 YLNGGDLMFHIQSC--HKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD---- 150 (316)
T ss_pred CCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC----
Confidence 99999999888764 568999999999999999999999999999999999999999999999999875321000
Q ss_pred cccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCCCCccC
Q 012762 247 LVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTHEYLA 326 (457)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 326 (457)
.......||..|+|
T Consensus 151 ------------------------------------------------------------------~~~~~~~gt~~y~a 164 (316)
T cd05619 151 ------------------------------------------------------------------AKTCTFCGTPDYIA 164 (316)
T ss_pred ------------------------------------------------------------------CceeeecCCccccC
Confidence 00113469999999
Q ss_pred chhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhhhCCCCCCCCC
Q 012762 327 PEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDPTRRMGSK 406 (457)
Q Consensus 327 PE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rps~~ 406 (457)
||++.+..++.++|||||||++|||++|..||.+.+.......+......++. .++.+++++|.+||..||++|++
T Consensus 165 PE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~--~~~~~~~~li~~~l~~~P~~R~~-- 240 (316)
T cd05619 165 PEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPR--WLTREAKDILVKLFVREPERRLG-- 240 (316)
T ss_pred HHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc--cCCHHHHHHHHHHhccCHhhcCC--
Confidence 99999999999999999999999999999999988776666665544444443 47889999999999999999999
Q ss_pred cChH-HHhcCCCCCCCCchhhh--ccCCCCCCCCCCcc
Q 012762 407 MGAT-AIKRHQFFNGVNWALLR--CAKPPFIPRPVTCR 441 (457)
Q Consensus 407 ~~~~-~ll~hp~f~~~~~~~~~--~~~~~~~~~~~~~~ 441 (457)
+. ++++||||+.++|..+. ...||+.|......
T Consensus 241 --~~~~l~~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (316)
T cd05619 241 --VKGDIRQHPFFREIDWSALEEREIEPPFKPKVKSAN 276 (316)
T ss_pred --ChHHHHcCcccCCCCHHHHHhCCCCCCcCCCCCCcc
Confidence 75 99999999999998764 44567776544433
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-48 Score=391.70 Aligned_cols=282 Identities=34% Similarity=0.638 Sum_probs=235.6
Q ss_pred CCCccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEE
Q 012762 76 NNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATL 155 (457)
Q Consensus 76 ~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~ 155 (457)
...+..++|++.+.||+|+||.||+|+++ .+++.||+|++.+...........+..|+++++.++||||+++++++
T Consensus 37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~----~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~ 112 (371)
T cd05622 37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHK----STRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAF 112 (371)
T ss_pred hcCcchhhcEEEEEEeecCCeEEEEEEEC----CCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 34566789999999999999999999987 47889999999876555555556678899999999999999999999
Q ss_pred EcCCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCC
Q 012762 156 DCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235 (457)
Q Consensus 156 ~~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s 235 (457)
..++.+|+||||++||+|..++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 113 ~~~~~~~lv~Ey~~gg~L~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a 189 (371)
T cd05622 113 QDDRYLYMVMEYMPGGDLVNLMSN---YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTC 189 (371)
T ss_pred EcCCEEEEEEcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCce
Confidence 999999999999999999998876 45899999999999999999999999999999999999999999999999997
Q ss_pred cCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcccc
Q 012762 236 LKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRS 315 (457)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (457)
........ ...
T Consensus 190 ~~~~~~~~---------------------------------------------------------------------~~~ 200 (371)
T cd05622 190 MKMNKEGM---------------------------------------------------------------------VRC 200 (371)
T ss_pred eEcCcCCc---------------------------------------------------------------------ccc
Confidence 64421100 001
Q ss_pred ccccCCCCccCchhhcCCC----CCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcc--cCCCCCCCCChHHHH
Q 012762 316 MSFVGTHEYLAPEIISGEG----HGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARA--LEFPKEPSVPGPAKD 389 (457)
Q Consensus 316 ~~~~gt~~y~aPE~l~~~~----~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~ 389 (457)
...+||+.|||||++.+.. ++.++|||||||++|||++|..||.+.+....+..++... ..++....++..+++
T Consensus 201 ~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 280 (371)
T cd05622 201 DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKN 280 (371)
T ss_pred cCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCCCCHHHHH
Confidence 1346999999999997643 7889999999999999999999999887777777776543 445555678999999
Q ss_pred HHHHHhhhCCCC---CCCCCcChHHHhcCCCCCCCCc--hhhhccCCCCCCCCC
Q 012762 390 LIAQLLVKDPTR---RMGSKMGATAIKRHQFFNGVNW--ALLRCAKPPFIPRPV 438 (457)
Q Consensus 390 ll~~~L~~dP~~---Rps~~~~~~~ll~hp~f~~~~~--~~~~~~~~~~~~~~~ 438 (457)
+|.+||. +|.. |++ +++|++|+||++..| ..++...+|++|...
T Consensus 281 li~~~L~-~~~~r~~r~~----~~ei~~h~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (371)
T cd05622 281 LICAFLT-DREVRLGRNG----VEEIKRHLFFKNDQWAWETLRDTVAPVVPDLS 329 (371)
T ss_pred HHHHHcC-ChhhhcCCCC----HHHHhcCcccCCCChhHHhcCCCCCCCCCCCC
Confidence 9999998 5554 567 999999999998665 445566677777543
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-48 Score=376.88 Aligned_cols=270 Identities=32% Similarity=0.602 Sum_probs=223.0
Q ss_pred ecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcEEEEEeecC
Q 012762 90 LGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWSCLLTEFCP 169 (457)
Q Consensus 90 LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lV~E~~~ 169 (457)
||+|+||+||+++++ .+|+.||+|++.+...........+..|+++|++++||||+++++++..+.+.|+||||++
T Consensus 1 lg~G~~g~Vy~~~~~----~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~ 76 (277)
T cd05607 1 LGKGGFGEVCAVQVK----NTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMN 76 (277)
T ss_pred CCCCCceEEEEEEEc----cCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCC
Confidence 799999999999987 3788999999987655444445556679999999999999999999999999999999999
Q ss_pred CCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCCCccccccc
Q 012762 170 GGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQLVS 249 (457)
Q Consensus 170 ~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~~~~~~~~~ 249 (457)
|++|..++.......+++..+..++.||+.||+|||+.||+||||||+|||++.++.++|+|||++........
T Consensus 77 g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~------ 150 (277)
T cd05607 77 GGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT------ 150 (277)
T ss_pred CCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCce------
Confidence 99998888765556689999999999999999999999999999999999999999999999998754321100
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCCCCccCchh
Q 012762 250 DQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTHEYLAPEI 329 (457)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 329 (457)
.....|+..|+|||+
T Consensus 151 -----------------------------------------------------------------~~~~~~~~~y~aPE~ 165 (277)
T cd05607 151 -----------------------------------------------------------------ITQRAGTNGYMAPEI 165 (277)
T ss_pred -----------------------------------------------------------------eeccCCCCCccCHHH
Confidence 001248999999999
Q ss_pred hcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChH----HHHHHHHhcccCCCCCCCCChHHHHHHHHHhhhCCCCCCCC
Q 012762 330 ISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHE----LTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDPTRRMGS 405 (457)
Q Consensus 330 l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rps~ 405 (457)
+.+..++.++|||||||++|||++|..||...... .............+ ...++.++++||.+||+.||++||+.
T Consensus 166 ~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~~P~~R~~~ 244 (277)
T cd05607 166 LKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFE-HQNFTEESKDICRLFLAKKPEDRLGS 244 (277)
T ss_pred HccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccc-cccCCHHHHHHHHHHhccCHhhCCCC
Confidence 99888999999999999999999999999764332 22333333332222 23578999999999999999999996
Q ss_pred CcChHHHhcCCCCCCCCchhhhc--cCCCCCC
Q 012762 406 KMGATAIKRHQFFNGVNWALLRC--AKPPFIP 435 (457)
Q Consensus 406 ~~~~~~ll~hp~f~~~~~~~~~~--~~~~~~~ 435 (457)
++.++++++|+||++++|..++. ..|||.|
T Consensus 245 ~~~~~~~~~h~~f~~~~~~~~~~~~~~~~~~~ 276 (277)
T cd05607 245 REKNDDPRKHEFFKTINFPRLEAGLIPPPFVP 276 (277)
T ss_pred ccchhhhhcChhhcCCCHHHHhcCcCCCCCCC
Confidence 66668999999999999998874 4567665
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-48 Score=378.17 Aligned_cols=270 Identities=30% Similarity=0.593 Sum_probs=220.4
Q ss_pred ecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcEEEEEeecC
Q 012762 90 LGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWSCLLTEFCP 169 (457)
Q Consensus 90 LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lV~E~~~ 169 (457)
||+|+||+||+|.++ .+++.||+|++.+...........+..|+++|+.++|+||+++.+++..+...|+||||++
T Consensus 1 lg~G~~g~Vy~~~~~----~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 76 (280)
T cd05608 1 LGKGGFGEVSACQMR----ATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMN 76 (280)
T ss_pred CCCCCceeEEEEEEc----cCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCC
Confidence 699999999999887 3788999999987655444445667789999999999999999999999999999999999
Q ss_pred CCChHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCCCccccc
Q 012762 170 GGDLHVLRQRQ--PDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQL 247 (457)
Q Consensus 170 ~~sL~~~~~~~--~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~~~~~~~ 247 (457)
+++|..++... ....+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++........
T Consensus 77 ~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~---- 152 (280)
T cd05608 77 GGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS---- 152 (280)
T ss_pred CCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc----
Confidence 99998776432 235689999999999999999999999999999999999999999999999999754321100
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCCCCccCc
Q 012762 248 VSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTHEYLAP 327 (457)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 327 (457)
......||+.|+||
T Consensus 153 ------------------------------------------------------------------~~~~~~g~~~y~aP 166 (280)
T cd05608 153 ------------------------------------------------------------------KTKGYAGTPGFMAP 166 (280)
T ss_pred ------------------------------------------------------------------cccccCCCcCccCH
Confidence 00123589999999
Q ss_pred hhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChH----HHHHHHHhcccCCCCCCCCChHHHHHHHHHhhhCCCCCC
Q 012762 328 EIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHE----LTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDPTRRM 403 (457)
Q Consensus 328 E~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rp 403 (457)
|++.+..++.++|||||||++|||++|+.||...... .....+....... ...++.++.+++.+||..||++||
T Consensus 167 E~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~P~~R~ 244 (280)
T cd05608 167 ELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTY--PDKFSPASKSFCEALLAKDPEKRL 244 (280)
T ss_pred HHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCC--cccCCHHHHHHHHHHhcCCHHHhc
Confidence 9999999999999999999999999999999865432 2222222222222 235889999999999999999999
Q ss_pred CCCc-ChHHHhcCCCCCCCCchhhhc--cCCCCCC
Q 012762 404 GSKM-GATAIKRHQFFNGVNWALLRC--AKPPFIP 435 (457)
Q Consensus 404 s~~~-~~~~ll~hp~f~~~~~~~~~~--~~~~~~~ 435 (457)
+.+. .++++++||||++++|..+.. ..+||.|
T Consensus 245 ~~~~~~~~~~l~h~~~~~~~~~~~~~~~~~~~~~~ 279 (280)
T cd05608 245 GFRDGNCDGLRTHPLFRDLNWRQLEAGMLPPPFVP 279 (280)
T ss_pred CCCCCCHHHHhcChhhhcCCHhHHhhccCCCCCCC
Confidence 6443 499999999999999987643 4456665
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-48 Score=384.38 Aligned_cols=270 Identities=37% Similarity=0.699 Sum_probs=224.9
Q ss_pred EEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHH-HHHHcCCCCCceEEEEEEcCCcEEEEEe
Q 012762 88 HRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIERE-ILEMLDHPFLPTLYATLDCPRWSCLLTE 166 (457)
Q Consensus 88 ~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~-il~~l~H~nIv~l~~~~~~~~~~~lV~E 166 (457)
+.||+|+||+||+|+++ .+++.||+|++.+...........+..|.. +++.++|+||+++++++...+..|+|||
T Consensus 1 ~~lg~G~fg~V~~~~~~----~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e 76 (325)
T cd05602 1 KVIGKGSFGKVLLARHK----AEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLD 76 (325)
T ss_pred CeeeeCCCeEEEEEEEC----CCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEe
Confidence 36999999999999976 377899999998765443333444444544 5677899999999999999999999999
Q ss_pred ecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCCCcccc
Q 012762 167 FCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQ 246 (457)
Q Consensus 167 ~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~~~~~~ 246 (457)
|+++++|..++... ..+.+..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 77 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~---- 150 (325)
T cd05602 77 YINGGELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN---- 150 (325)
T ss_pred CCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCC----
Confidence 99999999888764 668899999999999999999999999999999999999999999999999975321100
Q ss_pred cccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCCCCccC
Q 012762 247 LVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTHEYLA 326 (457)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 326 (457)
.....++||+.|+|
T Consensus 151 ------------------------------------------------------------------~~~~~~~gt~~y~a 164 (325)
T cd05602 151 ------------------------------------------------------------------GTTSTFCGTPEYLA 164 (325)
T ss_pred ------------------------------------------------------------------CCcccccCCccccC
Confidence 00113469999999
Q ss_pred chhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhhhCCCCCCCCC
Q 012762 327 PEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDPTRRMGSK 406 (457)
Q Consensus 327 PE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rps~~ 406 (457)
||++.+..++.++|||||||++|+|++|..||.+......+..+.......+ +.++..+.++|.+||+.||.+|++..
T Consensus 165 PE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~--~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (325)
T cd05602 165 PEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLK--PNITNSARHLLEGLLQKDRTKRLGAK 242 (325)
T ss_pred HHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcCCC--CCCCHHHHHHHHHHcccCHHHCCCCC
Confidence 9999999999999999999999999999999998887777777766554443 35889999999999999999999977
Q ss_pred cChHHHhcCCCCCCCCchhhhc--cCCCCCC
Q 012762 407 MGATAIKRHQFFNGVNWALLRC--AKPPFIP 435 (457)
Q Consensus 407 ~~~~~ll~hp~f~~~~~~~~~~--~~~~~~~ 435 (457)
..+.++++|+||..++|..+.. ..+|+.|
T Consensus 243 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (325)
T cd05602 243 DDFMEIKNHIFFSPINWDDLINKKITPPFNP 273 (325)
T ss_pred CCHHHHhcCcccCCCCHHHHHhCCCCcCcCC
Confidence 7788999999999999987642 3344444
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-48 Score=383.46 Aligned_cols=270 Identities=39% Similarity=0.723 Sum_probs=225.7
Q ss_pred EEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHH-HHHHcCCCCCceEEEEEEcCCcEEEEEe
Q 012762 88 HRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIERE-ILEMLDHPFLPTLYATLDCPRWSCLLTE 166 (457)
Q Consensus 88 ~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~-il~~l~H~nIv~l~~~~~~~~~~~lV~E 166 (457)
+.||+|+||+||+|+++ .+++.||+|++.+...........+..|+. +++.++||||+++++++...+..|+|||
T Consensus 1 ~~lg~G~~g~Vy~~~~~----~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e 76 (321)
T cd05603 1 KVIGKGSFGKVLLAKRK----SDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLD 76 (321)
T ss_pred CeeeeCCCEEEEEEEEC----CCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEc
Confidence 36999999999999986 478899999998765544444455555554 5788999999999999999999999999
Q ss_pred ecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCCCcccc
Q 012762 167 FCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQ 246 (457)
Q Consensus 167 ~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~~~~~~ 246 (457)
|+++++|...+... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.......
T Consensus 77 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~--- 151 (321)
T cd05603 77 YVNGGELFFHLQRE--RCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE--- 151 (321)
T ss_pred CCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC---
Confidence 99999998877654 6789999999999999999999999999999999999999999999999998753211000
Q ss_pred cccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCCCCccC
Q 012762 247 LVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTHEYLA 326 (457)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 326 (457)
....++||+.|+|
T Consensus 152 -------------------------------------------------------------------~~~~~~gt~~y~a 164 (321)
T cd05603 152 -------------------------------------------------------------------TTSTFCGTPEYLA 164 (321)
T ss_pred -------------------------------------------------------------------ccccccCCcccCC
Confidence 0113469999999
Q ss_pred chhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhhhCCCCCCCCC
Q 012762 327 PEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDPTRRMGSK 406 (457)
Q Consensus 327 PE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rps~~ 406 (457)
||++.+..++.++|||||||++|||++|..||.+.+.......+......++. ..+.++.++|.+||+.||.+|++..
T Consensus 165 PE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~--~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 165 PEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPG--GKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred HHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCC--CCCHHHHHHHHHHccCCHhhcCCCC
Confidence 99999988999999999999999999999999988777777777766554443 4788999999999999999999976
Q ss_pred cChHHHhcCCCCCCCCchhhh--ccCCCCCC
Q 012762 407 MGATAIKRHQFFNGVNWALLR--CAKPPFIP 435 (457)
Q Consensus 407 ~~~~~ll~hp~f~~~~~~~~~--~~~~~~~~ 435 (457)
..+.++++|+||..++|..+. ...|++.|
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (321)
T cd05603 243 ADFLEIKNHVFFSPINWDDLYHKRITPPYNP 273 (321)
T ss_pred CCHHHHhCCCCcCCCCHHHHhcCCCCCCcCC
Confidence 667899999999999998764 23455544
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-48 Score=384.78 Aligned_cols=280 Identities=33% Similarity=0.631 Sum_probs=233.9
Q ss_pred CCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcE
Q 012762 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWS 161 (457)
Q Consensus 82 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~ 161 (457)
++|++.+.||+|+||+||+|+++ .+++.||+|++.+...........+..|+.++..++|+||+.+++++..++..
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~----~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~ 76 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMK----HTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYL 76 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEEC----CCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEE
Confidence 47999999999999999999876 47889999999876555555566678899999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCC
Q 012762 162 CLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNS 241 (457)
Q Consensus 162 ~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~ 241 (457)
|+||||+.||+|..++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 77 ~lv~Ey~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 155 (331)
T cd05624 77 YLVMDYYVGGDLLTLLSKF-EDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD 155 (331)
T ss_pred EEEEeCCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence 9999999999999998763 256899999999999999999999999999999999999999999999999997644311
Q ss_pred CcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCC
Q 012762 242 TSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGT 321 (457)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 321 (457)
... ......||
T Consensus 156 ~~~---------------------------------------------------------------------~~~~~~gt 166 (331)
T cd05624 156 GTV---------------------------------------------------------------------QSSVAVGT 166 (331)
T ss_pred Cce---------------------------------------------------------------------eeccccCC
Confidence 100 00123599
Q ss_pred CCccCchhhcC-----CCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCC--CC-CCCCChHHHHHHHH
Q 012762 322 HEYLAPEIISG-----EGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEF--PK-EPSVPGPAKDLIAQ 393 (457)
Q Consensus 322 ~~y~aPE~l~~-----~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~--~~-~~~~~~~~~~ll~~ 393 (457)
+.|+|||++.+ ..++.++|||||||++|||++|+.||......+.+..+.....++ +. ...++.+++++|.+
T Consensus 167 ~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~~li~~ 246 (331)
T cd05624 167 PDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEEAKDLIQR 246 (331)
T ss_pred cccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccCCHHHHHHHHH
Confidence 99999999976 457889999999999999999999999877777777766544333 22 13468899999999
Q ss_pred HhhhCCCC--CCCCCcChHHHhcCCCCCCCCchhhhccCCCCCCCCCC
Q 012762 394 LLVKDPTR--RMGSKMGATAIKRHQFFNGVNWALLRCAKPPFIPRPVT 439 (457)
Q Consensus 394 ~L~~dP~~--Rps~~~~~~~ll~hp~f~~~~~~~~~~~~~~~~~~~~~ 439 (457)
||..++.+ |++ ++++++|+||++++|..++...+|++|....
T Consensus 247 ll~~~~~~~~~~~----~~~~~~h~~f~~~~~~~~~~~~~~~~p~~~~ 290 (331)
T cd05624 247 LICSRERRLGQNG----IEDFKKHAFFEGIDWENIRNLEAPYIPDVSS 290 (331)
T ss_pred HccCchhhcCCCC----HHHHhcCCCcCCCCHHHHhhCCCCccCCCCC
Confidence 99865543 345 9999999999999999998888888876433
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-48 Score=384.61 Aligned_cols=275 Identities=37% Similarity=0.691 Sum_probs=226.0
Q ss_pred EEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHc-CCCCCceEEEEEEcCCcEEEEEe
Q 012762 88 HRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEML-DHPFLPTLYATLDCPRWSCLLTE 166 (457)
Q Consensus 88 ~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~~~~~~~~~~~lV~E 166 (457)
+.||+|+||+||+|+++ .+++.||+|++.+...........+..|+.++.++ +|+||+.+++++...+.+|||||
T Consensus 1 ~~lG~G~~g~V~~~~~~----~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e 76 (327)
T cd05617 1 RVIGRGSYAKVLLVRLK----KNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIE 76 (327)
T ss_pred CeeeeCCCeEEEEEEEC----CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEe
Confidence 47999999999999986 47889999999887655555566788899999888 69999999999999999999999
Q ss_pred ecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCCCcccc
Q 012762 167 FCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQ 246 (457)
Q Consensus 167 ~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~~~~~~ 246 (457)
|+++++|..++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 77 ~~~~~~L~~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~---- 150 (327)
T cd05617 77 YVNGGDLMFHMQRQ--RKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG---- 150 (327)
T ss_pred CCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCC----
Confidence 99999998887664 579999999999999999999999999999999999999999999999999875321100
Q ss_pred cccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCCCCccC
Q 012762 247 LVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTHEYLA 326 (457)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 326 (457)
......+||+.|+|
T Consensus 151 ------------------------------------------------------------------~~~~~~~gt~~y~a 164 (327)
T cd05617 151 ------------------------------------------------------------------DTTSTFCGTPNYIA 164 (327)
T ss_pred ------------------------------------------------------------------CceecccCCcccCC
Confidence 00113469999999
Q ss_pred chhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCC-------hHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhhhCC
Q 012762 327 PEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGID-------HELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDP 399 (457)
Q Consensus 327 PE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP 399 (457)
||++.+..++.++|||||||++|||++|..||.... .......+.......|. .++..+.++|.+||..||
T Consensus 165 PE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~--~~~~~~~~li~~~L~~dP 242 (327)
T cd05617 165 PEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPR--FLSVKASHVLKGFLNKDP 242 (327)
T ss_pred HHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCC--CCCHHHHHHHHHHhccCH
Confidence 999999999999999999999999999999996421 12233444444444443 488899999999999999
Q ss_pred CCCCCCC--cChHHHhcCCCCCCCCchhhh--ccCCCCCCCCCCc
Q 012762 400 TRRMGSK--MGATAIKRHQFFNGVNWALLR--CAKPPFIPRPVTC 440 (457)
Q Consensus 400 ~~Rps~~--~~~~~ll~hp~f~~~~~~~~~--~~~~~~~~~~~~~ 440 (457)
.+|++.. ..++++++||||+.++|..+. ...|++.|.....
T Consensus 243 ~~R~~~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~~~~~~~~~~~ 287 (327)
T cd05617 243 KERLGCQPQTGFSDIKSHTFFRSIDWDLLEKKQVTPPFKPQITDD 287 (327)
T ss_pred HHcCCCCCCCCHHHHHcCCCCCCCCHHHHHhCCCCCCccCCCCCC
Confidence 9999842 336799999999999999875 3455666665433
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-48 Score=382.72 Aligned_cols=279 Identities=34% Similarity=0.633 Sum_probs=232.8
Q ss_pred CCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcE
Q 012762 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWS 161 (457)
Q Consensus 82 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~ 161 (457)
++|++.++||+|+||+||+++++ .+++.||+|++.+...........+..|+.++..++|+||+++++++...+.+
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~----~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 76 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLK----NADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNL 76 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEEC----CCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEE
Confidence 47999999999999999999986 47789999999876555555556678899999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCC
Q 012762 162 CLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNS 241 (457)
Q Consensus 162 ~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~ 241 (457)
|+||||+.+|+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 77 ~lv~ey~~~g~L~~~l~~~-~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~ 155 (332)
T cd05623 77 YLVMDYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 155 (332)
T ss_pred EEEEeccCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence 9999999999999998763 256899999999999999999999999999999999999999999999999987543211
Q ss_pred CcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCC
Q 012762 242 TSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGT 321 (457)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 321 (457)
.. ......+||
T Consensus 156 ~~---------------------------------------------------------------------~~~~~~~gt 166 (332)
T cd05623 156 GT---------------------------------------------------------------------VQSSVAVGT 166 (332)
T ss_pred Cc---------------------------------------------------------------------ceecccccC
Confidence 00 001123699
Q ss_pred CCccCchhhcC-----CCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCC--CCC-CCCChHHHHHHHH
Q 012762 322 HEYLAPEIISG-----EGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEF--PKE-PSVPGPAKDLIAQ 393 (457)
Q Consensus 322 ~~y~aPE~l~~-----~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~--~~~-~~~~~~~~~ll~~ 393 (457)
+.|+|||++.+ ..++.++|||||||++|||++|+.||...+..+.+..+....... +.. ..++.++++||.+
T Consensus 167 ~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~~li~~ 246 (332)
T cd05623 167 PDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSEDAKDLIRR 246 (332)
T ss_pred ccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccCCHHHHHHHHH
Confidence 99999999863 357889999999999999999999999888777777776654332 222 3578999999999
Q ss_pred HhhhCCCC--CCCCCcChHHHhcCCCCCCCCchhhhccCCCCCCCCC
Q 012762 394 LLVKDPTR--RMGSKMGATAIKRHQFFNGVNWALLRCAKPPFIPRPV 438 (457)
Q Consensus 394 ~L~~dP~~--Rps~~~~~~~ll~hp~f~~~~~~~~~~~~~~~~~~~~ 438 (457)
||..++.+ |++ ++++++||||.+++|..+....+|++|...
T Consensus 247 ll~~~~~r~~r~~----~~~~~~h~~f~~~~~~~~~~~~~~~~~~~~ 289 (332)
T cd05623 247 LICSREHRLGQNG----IEDFKQHPFFTGIDWDNIRNCEAPYIPEVS 289 (332)
T ss_pred HccChhhhcCCCC----HHHHhCCCCcCCCCHHHHhhCCCCccCCCC
Confidence 99765444 577 999999999999999999887778777543
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-49 Score=367.24 Aligned_cols=266 Identities=23% Similarity=0.312 Sum_probs=221.4
Q ss_pred CCCccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEE
Q 012762 76 NNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATL 155 (457)
Q Consensus 76 ~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~ 155 (457)
...-.+++|+.+.+|++|+||.||+|+++ .+++.||+|.++.... ....----.+|+.+|.+++|||||.+-.+.
T Consensus 70 ~gCrsv~efe~lnrI~EGtyGiVYRakdk----~t~eIVALKr~kmeke-k~GFPItsLREIniLl~~~H~NIV~vkEVV 144 (419)
T KOG0663|consen 70 GGCRSVEEFEKLNRIEEGTYGVVYRAKDK----KTDEIVALKRLKMEKE-KEGFPITSLREINILLKARHPNIVEVKEVV 144 (419)
T ss_pred cCcccHHHHHHHhhcccCcceeEEEeccC----CcceeEEeeecccccc-cCCCcchhHHHHHHHHhcCCCCeeeeEEEE
Confidence 34456678999999999999999999887 4889999999976542 222333456799999999999999998887
Q ss_pred Ec--CCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccC
Q 012762 156 DC--PRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFD 233 (457)
Q Consensus 156 ~~--~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG 233 (457)
.. -+.+||||||| ..+|..++..-+ .+|...+++.++.|++.||+|||.++|+|||||++|+|++..|.+||+|||
T Consensus 145 vG~~~d~iy~VMe~~-EhDLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFG 222 (419)
T KOG0663|consen 145 VGSNMDKIYIVMEYV-EHDLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFG 222 (419)
T ss_pred eccccceeeeeHHHH-HhhHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccc
Confidence 54 35699999999 678988888754 689999999999999999999999999999999999999999999999999
Q ss_pred CCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcc
Q 012762 234 LSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDV 313 (457)
Q Consensus 234 ~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (457)
+|+....+..
T Consensus 223 LAR~ygsp~k---------------------------------------------------------------------- 232 (419)
T KOG0663|consen 223 LAREYGSPLK---------------------------------------------------------------------- 232 (419)
T ss_pred hhhhhcCCcc----------------------------------------------------------------------
Confidence 9987753311
Q ss_pred ccccccCCCCccCchhhcCCC-CCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccC----------------
Q 012762 314 RSMSFVGTHEYLAPEIISGEG-HGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALE---------------- 376 (457)
Q Consensus 314 ~~~~~~gt~~y~aPE~l~~~~-~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~---------------- 376 (457)
..+.++-|.+|+|||.+.|.. |+.++||||+|||+.||+++++.|.|..+.+.+.+|......
T Consensus 233 ~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k 312 (419)
T KOG0663|consen 233 PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVK 312 (419)
T ss_pred cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhh
Confidence 122457899999999999876 999999999999999999999999999888777777653211
Q ss_pred ---CCCC-----------CCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCCCC
Q 012762 377 ---FPKE-----------PSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGVN 422 (457)
Q Consensus 377 ---~~~~-----------~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~~~ 422 (457)
++.. ..+++...+|++.+|.+||.+|.| +.|.|+|.||....
T Consensus 313 ~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~t----A~~~L~h~~F~e~P 368 (419)
T KOG0663|consen 313 KMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRIT----AEDGLKHEYFRETP 368 (419)
T ss_pred ccccCCCCchhhhhhccccccchhHHHHHHHHhccCcccccc----HHHhhcccccccCC
Confidence 1100 013467889999999999999999 99999999999843
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-50 Score=379.23 Aligned_cols=293 Identities=32% Similarity=0.649 Sum_probs=260.6
Q ss_pred CCCCccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHc-CCCCCceEEE
Q 012762 75 NNNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEML-DHPFLPTLYA 153 (457)
Q Consensus 75 ~~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~~ 153 (457)
....+...||.++.+||+|+||+|.+|+-+ .+.+.||||++++.-+..++..+--..|.++|... +-|.++.++.
T Consensus 342 ~~d~i~~tDFnFl~VlGKGSFGKVlLaerk----gtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHS 417 (683)
T KOG0696|consen 342 KRDRIKATDFNFLMVLGKGSFGKVLLAERK----GTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHS 417 (683)
T ss_pred cccceeecccceEEEeccCccceeeeeccc----CcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHH
Confidence 344677889999999999999999999876 47789999999998887777777778899999877 4688999999
Q ss_pred EEEcCCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccC
Q 012762 154 TLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFD 233 (457)
Q Consensus 154 ~~~~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG 233 (457)
+|+.-+++|+||||+.||+|-..++.- +.+.|..+..++.+|+-||-|||++|||.||||.+||||+.+|++||+|||
T Consensus 418 cFQTmDRLyFVMEyvnGGDLMyhiQQ~--GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFG 495 (683)
T KOG0696|consen 418 CFQTMDRLYFVMEYVNGGDLMYHIQQV--GKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFG 495 (683)
T ss_pred HhhhhhheeeEEEEecCchhhhHHHHh--cccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecc
Confidence 999999999999999999997766664 889999999999999999999999999999999999999999999999999
Q ss_pred CCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcc
Q 012762 234 LSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDV 313 (457)
Q Consensus 234 ~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (457)
+++..--. +.
T Consensus 496 mcKEni~~----------------------------------------------------------------------~~ 505 (683)
T KOG0696|consen 496 MCKENIFD----------------------------------------------------------------------GV 505 (683)
T ss_pred cccccccC----------------------------------------------------------------------Cc
Confidence 98643211 22
Q ss_pred ccccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHH
Q 012762 314 RSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQ 393 (457)
Q Consensus 314 ~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~ 393 (457)
.+.+++||+.|+|||++...+|+..+|.||+||+||||+.|++||++.++.+.+..|.+....+|.. ++.++.+++..
T Consensus 506 TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyPKs--lSkEAv~ickg 583 (683)
T KOG0696|consen 506 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYPKS--LSKEAVAICKG 583 (683)
T ss_pred ceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCccc--ccHHHHHHHHH
Confidence 2347899999999999999999999999999999999999999999999999999999999998876 99999999999
Q ss_pred HhhhCCCCCCCCC-cChHHHhcCCCCCCCCchhh--hccCCCCCCCCCCcccccc
Q 012762 394 LLVKDPTRRMGSK-MGATAIKRHQFFNGVNWALL--RCAKPPFIPRPVTCRDLTT 445 (457)
Q Consensus 394 ~L~~dP~~Rps~~-~~~~~ll~hp~f~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 445 (457)
.|...|.+|.... ..-.+|..||||+.+||..+ +.+.|||.|++...++.+.
T Consensus 584 ~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek~E~~eiqPPfkPk~k~~r~~eN 638 (683)
T KOG0696|consen 584 LLTKHPGKRLGCGPEGERDIREHPFFRRIDWEKLERREIQPPFKPKIKCGRDAEN 638 (683)
T ss_pred HhhcCCccccCCCCccccchhhCcchhhccHHHHhhccCCCCCCCccccCCchhh
Confidence 9999999998753 34678999999999999988 5789999999977766543
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-48 Score=386.75 Aligned_cols=259 Identities=32% Similarity=0.553 Sum_probs=234.0
Q ss_pred CCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcC-CCCCceEEEEEEcCC
Q 012762 81 LSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLD-HPFLPTLYATLDCPR 159 (457)
Q Consensus 81 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~-H~nIv~l~~~~~~~~ 159 (457)
...|.+.+.||.|.||+||+|+.+. +|+.||+|++.+...........+.+|++||+++. |||||.++++|++..
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~----tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~ 109 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKS----TGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPD 109 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecC----CCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCC
Confidence 3579999999999999999999874 79999999999988766666678899999999998 999999999999999
Q ss_pred cEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccC----CCEEEeccCCC
Q 012762 160 WSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSD----GHIMLTDFDLS 235 (457)
Q Consensus 160 ~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~----~~vkl~DFG~s 235 (457)
.+++|||+|.||.|.+.+... .+++..+..++.|++.++.|||+.||+||||||+|+|+... +.+|++|||++
T Consensus 110 ~~~lvmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla 186 (382)
T KOG0032|consen 110 SVYLVMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLA 186 (382)
T ss_pred eEEEEEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCc
Confidence 999999999999999888775 39999999999999999999999999999999999999743 47999999998
Q ss_pred cCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcccc
Q 012762 236 LKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRS 315 (457)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (457)
..... ..+.
T Consensus 187 ~~~~~-----------------------------------------------------------------------~~~~ 195 (382)
T KOG0032|consen 187 KFIKP-----------------------------------------------------------------------GERL 195 (382)
T ss_pred eEccC-----------------------------------------------------------------------CceE
Confidence 76653 1123
Q ss_pred ccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCC--CCCCCChHHHHHHHH
Q 012762 316 MSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFP--KEPSVPGPAKDLIAQ 393 (457)
Q Consensus 316 ~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ll~~ 393 (457)
...+||+.|+|||++.+.+|+..+||||+|+++|.|++|.+||.+........++..+.+.+. .+..++..++++|.+
T Consensus 196 ~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~~akd~i~~ 275 (382)
T KOG0032|consen 196 HTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDISESAKDFIRK 275 (382)
T ss_pred eeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccCHHHHHHHHH
Confidence 356899999999999999999999999999999999999999999998888889998887665 456789999999999
Q ss_pred HhhhCCCCCCCCCcChHHHhcCCCCCCC
Q 012762 394 LLVKDPTRRMGSKMGATAIKRHQFFNGV 421 (457)
Q Consensus 394 ~L~~dP~~Rps~~~~~~~ll~hp~f~~~ 421 (457)
||..||..|++ +.++|+|||+++.
T Consensus 276 ll~~dp~~R~t----a~~~L~HpWi~~~ 299 (382)
T KOG0032|consen 276 LLEFDPRKRLT----AAQALQHPWIKSI 299 (382)
T ss_pred hcccCcccCCC----HHHHhcCccccCC
Confidence 99999999999 9999999998864
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-47 Score=383.25 Aligned_cols=259 Identities=27% Similarity=0.385 Sum_probs=207.9
Q ss_pred CCccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEE
Q 012762 77 NPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLD 156 (457)
Q Consensus 77 ~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~ 156 (457)
.....++|.++++||+|+||+||+|+++ .+++.||||++.... .......+.+|+++|+.++|+||+++++++.
T Consensus 69 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~----~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 142 (353)
T PLN00034 69 AAKSLSELERVNRIGSGAGGTVYKVIHR----PTGRLYALKVIYGNH--EDTVRRQICREIEILRDVNHPNVVKCHDMFD 142 (353)
T ss_pred CCCCHHHHhhhhhccCCCCeEEEEEEEC----CCCCEEEEEEEecCC--cHHHHHHHHHHHHHHHhCCCCCcceeeeEec
Confidence 4455678999999999999999999876 478899999986542 2234566788999999999999999999999
Q ss_pred cCCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCc
Q 012762 157 CPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSL 236 (457)
Q Consensus 157 ~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~ 236 (457)
.++.+|+||||+++++|... ....+..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 143 ~~~~~~lv~e~~~~~~L~~~------~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~ 216 (353)
T PLN00034 143 HNGEIQVLLEFMDGGSLEGT------HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSR 216 (353)
T ss_pred cCCeEEEEEecCCCCccccc------ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccce
Confidence 99999999999999998542 345678888999999999999999999999999999999999999999999976
Q ss_pred CCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccc
Q 012762 237 KGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSM 316 (457)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (457)
....... ...
T Consensus 217 ~~~~~~~----------------------------------------------------------------------~~~ 226 (353)
T PLN00034 217 ILAQTMD----------------------------------------------------------------------PCN 226 (353)
T ss_pred ecccccc----------------------------------------------------------------------ccc
Confidence 4421100 001
Q ss_pred cccCCCCccCchhhcC-----CCCCccchhhhhhHHHHHHhcCCCCCCCCChHHH--HHHHHhcccCCCCCCCCChHHHH
Q 012762 317 SFVGTHEYLAPEIISG-----EGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELT--LANVVARALEFPKEPSVPGPAKD 389 (457)
Q Consensus 317 ~~~gt~~y~aPE~l~~-----~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 389 (457)
..+||..|+|||++.. ...+.++|||||||++|||++|+.||........ ....+...........++.++++
T Consensus 227 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 306 (353)
T PLN00034 227 SSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASREFRH 306 (353)
T ss_pred ccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccCHHHHH
Confidence 2359999999999853 2345689999999999999999999974332221 11111112222233457889999
Q ss_pred HHHHHhhhCCCCCCCCCcChHHHhcCCCCCCC
Q 012762 390 LIAQLLVKDPTRRMGSKMGATAIKRHQFFNGV 421 (457)
Q Consensus 390 ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~~ 421 (457)
||.+||..||++||+ +.||++||||..-
T Consensus 307 li~~~l~~~P~~Rpt----~~ell~hp~~~~~ 334 (353)
T PLN00034 307 FISCCLQREPAKRWS----AMQLLQHPFILRA 334 (353)
T ss_pred HHHHHccCChhhCcC----HHHHhcCcccccC
Confidence 999999999999999 9999999999974
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-48 Score=381.38 Aligned_cols=272 Identities=38% Similarity=0.753 Sum_probs=228.5
Q ss_pred EEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcEEEEEee
Q 012762 88 HRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWSCLLTEF 167 (457)
Q Consensus 88 ~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lV~E~ 167 (457)
+.||+|+||.||++++.. +..+|+.||+|++.+..... .....+..|+++|++++||||+++++++..++..|+||||
T Consensus 2 ~~lg~G~~g~Vy~~~~~~-~~~~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 79 (318)
T cd05582 2 KVLGQGSFGKVFLVRKIT-GPDAGQLYAMKVLKKATLKV-RDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDF 79 (318)
T ss_pred ceeeeCCCEEEEEEEEec-cCCCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcC
Confidence 579999999999998642 22478899999998764322 2344567799999999999999999999999999999999
Q ss_pred cCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCCCccccc
Q 012762 168 CPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQL 247 (457)
Q Consensus 168 ~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~~~~~~~ 247 (457)
+++++|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 80 ~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~----- 152 (318)
T cd05582 80 LRGGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE----- 152 (318)
T ss_pred CCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC-----
Confidence 9999999888664 569999999999999999999999999999999999999999999999999975432110
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCCCCccCc
Q 012762 248 VSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTHEYLAP 327 (457)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 327 (457)
.....+.||+.|+||
T Consensus 153 -----------------------------------------------------------------~~~~~~~g~~~y~aP 167 (318)
T cd05582 153 -----------------------------------------------------------------KKAYSFCGTVEYMAP 167 (318)
T ss_pred -----------------------------------------------------------------CceecccCChhhcCH
Confidence 011134699999999
Q ss_pred hhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhhhCCCCCCCCCc
Q 012762 328 EIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDPTRRMGSKM 407 (457)
Q Consensus 328 E~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rps~~~ 407 (457)
|++.+..++.++|||||||++|||++|+.||...........+......++. .++.++.+||++||+.||++||+...
T Consensus 168 E~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~p~--~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 168 EVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQ--FLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred HHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCCCC--CCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 9999988999999999999999999999999988877777777766665554 48899999999999999999999643
Q ss_pred -ChHHHhcCCCCCCCCchhhhc--cCCCCCC
Q 012762 408 -GATAIKRHQFFNGVNWALLRC--AKPPFIP 435 (457)
Q Consensus 408 -~~~~ll~hp~f~~~~~~~~~~--~~~~~~~ 435 (457)
.+.++++||||+.++|..+.. ..|++.|
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (318)
T cd05582 246 DGVEEIKRHPFFSTIDWNKLYRREIKPPFKP 276 (318)
T ss_pred CCHHHHhCCCCcCCCCHHHHHhcCCCCCcCC
Confidence 478899999999999987643 4455554
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-49 Score=386.79 Aligned_cols=253 Identities=23% Similarity=0.374 Sum_probs=220.7
Q ss_pred CCCCCccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEE
Q 012762 74 NNNNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYA 153 (457)
Q Consensus 74 ~~~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~ 153 (457)
...|.+..+.++++++||+|.||.||+|.+. ....||+|.++.... ....+.+|++||++|+|+|||++++
T Consensus 198 ~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~-----~~~~vavk~ik~~~m----~~~~f~~Ea~iMk~L~H~~lV~l~g 268 (468)
T KOG0197|consen 198 RDPWEIPREELKLIRELGSGQFGEVWLGKWN-----GSTKVAVKTIKEGSM----SPEAFLREAQIMKKLRHEKLVKLYG 268 (468)
T ss_pred cCCeeecHHHHHHHHHhcCCccceEEEEEEc-----CCCcccceEEecccc----ChhHHHHHHHHHHhCcccCeEEEEE
Confidence 3456677778899999999999999999996 445799999976533 4456678999999999999999999
Q ss_pred EEEcCCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccC
Q 012762 154 TLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFD 233 (457)
Q Consensus 154 ~~~~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG 233 (457)
++..++.+||||||+..|+|.++++......+.....+.++.|||+|++||+++++|||||...||||+.++.|||+|||
T Consensus 269 V~~~~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFG 348 (468)
T KOG0197|consen 269 VCTKQEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFG 348 (468)
T ss_pred EEecCCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccc
Confidence 99998899999999999999999998667889999999999999999999999999999999999999999999999999
Q ss_pred CCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcc
Q 012762 234 LSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDV 313 (457)
Q Consensus 234 ~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (457)
+++...+.......
T Consensus 349 LAr~~~d~~Y~~~~------------------------------------------------------------------ 362 (468)
T KOG0197|consen 349 LARLIGDDEYTASE------------------------------------------------------------------ 362 (468)
T ss_pred cccccCCCceeecC------------------------------------------------------------------
Confidence 99854432221100
Q ss_pred ccccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHH
Q 012762 314 RSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIA 392 (457)
Q Consensus 314 ~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~ 392 (457)
.---...|.|||.+....++.+||||||||+||||+| |+.||.+.++.+.+.. +...+++|.+..+|+.+.++|.
T Consensus 363 ---~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~-le~GyRlp~P~~CP~~vY~lM~ 438 (468)
T KOG0197|consen 363 ---GGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLEL-LERGYRLPRPEGCPDEVYELMK 438 (468)
T ss_pred ---CCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHH-HhccCcCCCCCCCCHHHHHHHH
Confidence 0012557999999999999999999999999999997 9999999998877765 5677899999999999999999
Q ss_pred HHhhhCCCCCCCC
Q 012762 393 QLLVKDPTRRMGS 405 (457)
Q Consensus 393 ~~L~~dP~~Rps~ 405 (457)
.||..+|++|||+
T Consensus 439 ~CW~~~P~~RPtF 451 (468)
T KOG0197|consen 439 SCWHEDPEDRPTF 451 (468)
T ss_pred HHhhCCcccCCCH
Confidence 9999999999994
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-48 Score=372.38 Aligned_cols=279 Identities=33% Similarity=0.587 Sum_probs=229.4
Q ss_pred CceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcEE
Q 012762 83 DLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWSC 162 (457)
Q Consensus 83 ~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~ 162 (457)
.|++.+.||+|+||+||+|.++. +++.||+|.+.+...........+..|+.++++++|+||+.+++.+...+..|
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~----~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~ 76 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRA----TGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALC 76 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcC----CCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEE
Confidence 37888999999999999999873 78899999997765444444456678999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCCC
Q 012762 163 LLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNST 242 (457)
Q Consensus 163 lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~~ 242 (457)
+||||+.|++|..++.......+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++.......
T Consensus 77 lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05630 77 LVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ 156 (285)
T ss_pred EEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc
Confidence 99999999999988876555679999999999999999999999999999999999999999999999999875332100
Q ss_pred cccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCCC
Q 012762 243 STAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTH 322 (457)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 322 (457)
......|+.
T Consensus 157 -----------------------------------------------------------------------~~~~~~g~~ 165 (285)
T cd05630 157 -----------------------------------------------------------------------TIKGRVGTV 165 (285)
T ss_pred -----------------------------------------------------------------------cccCCCCCc
Confidence 001235899
Q ss_pred CccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChH---HHHHHHHhcccCCCCCCCCChHHHHHHHHHhhhCC
Q 012762 323 EYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHE---LTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDP 399 (457)
Q Consensus 323 ~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP 399 (457)
.|+|||++.+..++.++|||||||++|+|++|+.||...... ......... ........++.++.+|+.+||+.||
T Consensus 166 ~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p 244 (285)
T cd05630 166 GYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE-VQEEYSEKFSPDARSLCKMLLCKDP 244 (285)
T ss_pred cccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhh-hhhhcCccCCHHHHHHHHHHhhcCH
Confidence 999999999988999999999999999999999999875432 122222111 1112234578899999999999999
Q ss_pred CCCCCCC-cChHHHhcCCCCCCCCchhhhc--cCCCCCCCC
Q 012762 400 TRRMGSK-MGATAIKRHQFFNGVNWALLRC--AKPPFIPRP 437 (457)
Q Consensus 400 ~~Rps~~-~~~~~ll~hp~f~~~~~~~~~~--~~~~~~~~~ 437 (457)
++||+.. ..++++++||||+.++|..+.. ..|||.|.|
T Consensus 245 ~~R~s~~~~~~~~~~~h~~~~~~~~~~~~~~~~~~~~~~~~ 285 (285)
T cd05630 245 KERLGCQGGGAREVKEHPLFKQINFKRLEAGMLEPPFKPDP 285 (285)
T ss_pred HHccCCCCCchHHHHcChhhhccCHHHHhcCCCCCCCCCCC
Confidence 9999843 1378999999999999997755 778999876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-48 Score=376.25 Aligned_cols=262 Identities=25% Similarity=0.375 Sum_probs=208.8
Q ss_pred CCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCc
Q 012762 81 LSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRW 160 (457)
Q Consensus 81 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~ 160 (457)
.++|++.++||+|+||+||+|+++ .+++.||+|++..... ......+.+|+++++.++||||+++++++.....
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~----~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 77 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSK----VNGKLVALKVIRLQEE--EGTPFTAIREASLLKGLKHANIVLLHDIIHTKET 77 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEEC----CCCCEEEEEEeccccc--cccchhHHHHHHHHhhCCCCCcCeEEEEEecCCe
Confidence 368999999999999999999986 3788999999975432 2233456779999999999999999999999999
Q ss_pred EEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCC
Q 012762 161 SCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDN 240 (457)
Q Consensus 161 ~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~ 240 (457)
.|+||||+ .++|..++... ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus 78 ~~lv~e~~-~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 155 (303)
T cd07869 78 LTLVFEYV-HTDLCQYMDKH-PGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSV 155 (303)
T ss_pred EEEEEECC-CcCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccC
Confidence 99999999 56777766554 35689999999999999999999999999999999999999999999999998753321
Q ss_pred CCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccC
Q 012762 241 STSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVG 320 (457)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 320 (457)
... ......|
T Consensus 156 ~~~----------------------------------------------------------------------~~~~~~~ 165 (303)
T cd07869 156 PSH----------------------------------------------------------------------TYSNEVV 165 (303)
T ss_pred CCc----------------------------------------------------------------------cCCCCcc
Confidence 100 0012358
Q ss_pred CCCccCchhhcCC-CCCccchhhhhhHHHHHHhcCCCCCCCCChH-HHHHHHHhcccC-----------C----------
Q 012762 321 THEYLAPEIISGE-GHGNAVDWWTLGIFIFELFYGTTPFKGIDHE-LTLANVVARALE-----------F---------- 377 (457)
Q Consensus 321 t~~y~aPE~l~~~-~~~~~sDiwSlG~il~elltG~~Pf~~~~~~-~~~~~~~~~~~~-----------~---------- 377 (457)
|+.|+|||++.+. .++.++|||||||++|+|++|..||.+..+. ..+..+...... .
T Consensus 166 ~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (303)
T cd07869 166 TLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPERFTL 245 (303)
T ss_pred cCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccccccccccc
Confidence 9999999998764 4789999999999999999999999875443 222222111000 0
Q ss_pred --CC-------CCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCCCCch
Q 012762 378 --PK-------EPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGVNWA 424 (457)
Q Consensus 378 --~~-------~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~~~~~ 424 (457)
+. ....+.++.+||.+||+.||++||| +.|+++||||+.+++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s----~~~~l~h~~f~~~~~~ 297 (303)
T cd07869 246 YSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLS----AQAALSHEYFSDLPPR 297 (303)
T ss_pred cCCccHHHHhhccCCChHHHHHHHHHhccCchhccC----HHHHhcCcccccCChh
Confidence 00 0123467899999999999999999 9999999999988753
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-47 Score=369.64 Aligned_cols=279 Identities=35% Similarity=0.595 Sum_probs=232.3
Q ss_pred ceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcEEE
Q 012762 84 LRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWSCL 163 (457)
Q Consensus 84 ~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~l 163 (457)
|+..+.||+|+||+||+|.+. .+++.||+|++.+...........+.+|+++|++++|+||+.+++++..++..|+
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~----~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~l 77 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVR----ATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCL 77 (285)
T ss_pred ceEEEEEecCCCeEEEEEEEC----CCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEE
Confidence 788899999999999999887 3788999999987655444445567789999999999999999999999999999
Q ss_pred EEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCCCc
Q 012762 164 LTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTS 243 (457)
Q Consensus 164 V~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~~~ 243 (457)
||||+.+++|..++.......+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++........
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 157 (285)
T cd05632 78 VLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES 157 (285)
T ss_pred EEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCc
Confidence 99999999998888765556799999999999999999999999999999999999999999999999998753321000
Q ss_pred ccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCCCC
Q 012762 244 TAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTHE 323 (457)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 323 (457)
.....|+..
T Consensus 158 -----------------------------------------------------------------------~~~~~g~~~ 166 (285)
T cd05632 158 -----------------------------------------------------------------------IRGRVGTVG 166 (285)
T ss_pred -----------------------------------------------------------------------ccCCCCCcC
Confidence 012358999
Q ss_pred ccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhccc--CCCCCCCCChHHHHHHHHHhhhCCCC
Q 012762 324 YLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARAL--EFPKEPSVPGPAKDLIAQLLVKDPTR 401 (457)
Q Consensus 324 y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~ll~~~L~~dP~~ 401 (457)
|+|||++.+..++.++|+|||||++|+|++|..||.+.........+..... .......++.++.+|+.+||+.||++
T Consensus 167 ~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~ 246 (285)
T cd05632 167 YMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKMLLTKDPKQ 246 (285)
T ss_pred ccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHHHHHccCCHhH
Confidence 9999999988899999999999999999999999987665433333322211 11223457889999999999999999
Q ss_pred CCCCCc-ChHHHhcCCCCCCCCchhh--hccCCCCCCCC
Q 012762 402 RMGSKM-GATAIKRHQFFNGVNWALL--RCAKPPFIPRP 437 (457)
Q Consensus 402 Rps~~~-~~~~ll~hp~f~~~~~~~~--~~~~~~~~~~~ 437 (457)
||+... .+.++++|+||+.++|..+ ....|+|+|.|
T Consensus 247 R~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (285)
T cd05632 247 RLGCQEEGAGEVKRHPFFRNMNFKRLEAGMLDPPFVPDP 285 (285)
T ss_pred cCCCcccChHHHHcChhhhcCCHHHHhcCcCCCCCCCCC
Confidence 999653 4889999999999999876 45678999876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-48 Score=389.89 Aligned_cols=252 Identities=29% Similarity=0.435 Sum_probs=218.2
Q ss_pred CceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcC-C-----CCCceEEEEEE
Q 012762 83 DLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLD-H-----PFLPTLYATLD 156 (457)
Q Consensus 83 ~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~-H-----~nIv~l~~~~~ 156 (457)
+|.|++.||+|+||+|-+|+++ .+++.||||+++... ....+...|+.||..|+ | -|||+++++|.
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~----~T~e~VAIKIiKN~k----~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~ 258 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDH----KTGEIVAIKIIKNKK----RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFY 258 (586)
T ss_pred EEEEEEEecccccceeEEEEec----CCCcEEEEEeeccCh----HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccc
Confidence 6789999999999999999987 589999999998764 35566777999999996 4 47999999999
Q ss_pred cCCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccC--CCEEEeccCC
Q 012762 157 CPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSD--GHIMLTDFDL 234 (457)
Q Consensus 157 ~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~--~~vkl~DFG~ 234 (457)
..+++|||+|++ ..+|+++++.+...+++...++.++.||+.||.+||+.||||.|||||||||... ..|||+|||.
T Consensus 259 fr~HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGS 337 (586)
T KOG0667|consen 259 FRNHLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGS 337 (586)
T ss_pred cccceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEeccc
Confidence 999999999999 8999999999999999999999999999999999999999999999999999754 3799999998
Q ss_pred CcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccc
Q 012762 235 SLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVR 314 (457)
Q Consensus 235 s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (457)
+.... ..
T Consensus 338 Sc~~~-------------------------------------------------------------------------q~ 344 (586)
T KOG0667|consen 338 SCFES-------------------------------------------------------------------------QR 344 (586)
T ss_pred ccccC-------------------------------------------------------------------------Cc
Confidence 75443 22
Q ss_pred cccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCC--------------
Q 012762 315 SMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKE-------------- 380 (457)
Q Consensus 315 ~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~-------------- 380 (457)
..+++.+..|+|||++.|.+|+.+.||||||||++||++|.+.|.|.++.+.+..|+......|..
T Consensus 345 vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~kff~~ 424 (586)
T KOG0667|consen 345 VYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKAHKFFTS 424 (586)
T ss_pred ceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhccccceehhc
Confidence 236789999999999999999999999999999999999999999998888877777532211110
Q ss_pred ----------CC----------------------CC---------------hHHHHHHHHHhhhCCCCCCCCCcChHHHh
Q 012762 381 ----------PS----------------------VP---------------GPAKDLIAQLLVKDPTRRMGSKMGATAIK 413 (457)
Q Consensus 381 ----------~~----------------------~~---------------~~~~~ll~~~L~~dP~~Rps~~~~~~~ll 413 (457)
.. .| ..+.++|.+||.+||.+|+| ..++|
T Consensus 425 ~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~t----p~qal 500 (586)
T KOG0667|consen 425 LKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERIT----PAQAL 500 (586)
T ss_pred cCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCC----HHHHh
Confidence 00 01 24789999999999999999 99999
Q ss_pred cCCCCCC
Q 012762 414 RHQFFNG 420 (457)
Q Consensus 414 ~hp~f~~ 420 (457)
+||||..
T Consensus 501 ~Hpfl~~ 507 (586)
T KOG0667|consen 501 NHPFLTG 507 (586)
T ss_pred cCccccc
Confidence 9999996
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-49 Score=379.76 Aligned_cols=263 Identities=29% Similarity=0.458 Sum_probs=236.2
Q ss_pred CCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcE
Q 012762 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWS 161 (457)
Q Consensus 82 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~ 161 (457)
+=|.+.+.||+|.|++|-+|++- -+|..||||++.|.++..- ....+..|+++|+.++|||||++|.+......+
T Consensus 18 GLYDLekTlG~GHFAVVKLArHV----FTGekVAVKviDKTKlD~~-st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKl 92 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHV----FTGEKVAVKVIDKTKLDTL-STGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKL 92 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhh----cccceeEEEEecccccchh-hhhHHHHHHHHHHHhcCcCeeeeeehhcccceE
Confidence 45888999999999999999876 4899999999999876443 445566699999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEcc-CCCEEEeccCCCcCCCC
Q 012762 162 CLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRS-DGHIMLTDFDLSLKGDN 240 (457)
Q Consensus 162 ~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~-~~~vkl~DFG~s~~~~~ 240 (457)
|||+|+-++|+|++++-.+. .++.|..++.|+.||+.|+.|+|+..+|||||||+|+++-+ -|-|||.||||+..+.+
T Consensus 93 yLiLELGD~GDl~DyImKHe-~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P 171 (864)
T KOG4717|consen 93 YLILELGDGGDLFDYIMKHE-EGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP 171 (864)
T ss_pred EEEEEecCCchHHHHHHhhh-ccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCC
Confidence 99999999999999987763 67999999999999999999999999999999999988764 58999999999865542
Q ss_pred CCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccC
Q 012762 241 STSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVG 320 (457)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 320 (457)
+.+..++||
T Consensus 172 -----------------------------------------------------------------------G~kL~TsCG 180 (864)
T KOG4717|consen 172 -----------------------------------------------------------------------GKKLTTSCG 180 (864)
T ss_pred -----------------------------------------------------------------------cchhhcccc
Confidence 334457799
Q ss_pred CCCccCchhhcCCCCC-ccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhhhCC
Q 012762 321 THEYLAPEIISGEGHG-NAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDP 399 (457)
Q Consensus 321 t~~y~aPE~l~~~~~~-~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP 399 (457)
+..|.|||++.|..|+ +++||||||||||.|.+|++||+..++.+.+-.|++..+..|.- ++.++++||++||+.||
T Consensus 181 SLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvPsh--vS~eCrdLI~sMLvRdP 258 (864)
T KOG4717|consen 181 SLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVPSH--VSKECRDLIQSMLVRDP 258 (864)
T ss_pred hhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCchh--hhHHHHHHHHHHHhcCc
Confidence 9999999999999985 68999999999999999999999999999999999999988875 99999999999999999
Q ss_pred CCCCCCCcChHHHhcCCCCCCCCchhhh
Q 012762 400 TRRMGSKMGATAIKRHQFFNGVNWALLR 427 (457)
Q Consensus 400 ~~Rps~~~~~~~ll~hp~f~~~~~~~~~ 427 (457)
.+|.+ +++|..|+|++.+|....-
T Consensus 259 kkRAs----lEeI~s~~Wlq~~D~~~sT 282 (864)
T KOG4717|consen 259 KKRAS----LEEIVSTSWLQAGDRGLST 282 (864)
T ss_pred hhhcc----HHHHhccccccCCCCCccc
Confidence 99999 9999999999998886543
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-47 Score=371.73 Aligned_cols=257 Identities=25% Similarity=0.372 Sum_probs=209.9
Q ss_pred cCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCC
Q 012762 80 TLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPR 159 (457)
Q Consensus 80 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~ 159 (457)
.+++|++.++||.|+||+||+|+++ .++..||+|+++.... ......+.+|++++++++||||+++++++...+
T Consensus 3 ~~~~y~~~~~lg~G~~g~Vy~~~~~----~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 76 (288)
T cd07871 3 KLETYVKLDKLGEGTYATVFKGRSK----LTENLVALKEIRLEHE--EGAPCTAIREVSLLKNLKHANIVTLHDIIHTER 76 (288)
T ss_pred ccccceEeeEEecCCCEEEEEEEEC----CCCCEEEEEEeccccc--CCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCC
Confidence 4578999999999999999999876 4788999999865421 223345677999999999999999999999999
Q ss_pred cEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCC
Q 012762 160 WSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGD 239 (457)
Q Consensus 160 ~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~ 239 (457)
..|+||||+. ++|..++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 77 ~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~ 154 (288)
T cd07871 77 CLTLVFEYLD-SDLKQYLDNC-GNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKS 154 (288)
T ss_pred eEEEEEeCCC-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeecc
Confidence 9999999995 5898877654 2457899999999999999999999999999999999999999999999999975432
Q ss_pred CCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcccccccc
Q 012762 240 NSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFV 319 (457)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (457)
.... ......
T Consensus 155 ~~~~----------------------------------------------------------------------~~~~~~ 164 (288)
T cd07871 155 VPTK----------------------------------------------------------------------TYSNEV 164 (288)
T ss_pred CCCc----------------------------------------------------------------------cccCce
Confidence 1100 001225
Q ss_pred CCCCccCchhhcC-CCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhccc-------------------CCCC
Q 012762 320 GTHEYLAPEIISG-EGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARAL-------------------EFPK 379 (457)
Q Consensus 320 gt~~y~aPE~l~~-~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~-------------------~~~~ 379 (457)
|++.|+|||++.+ ..++.++|||||||++|+|++|+.||.+....+.+..+..... .++.
T Consensus 165 ~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (288)
T cd07871 165 VTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQ 244 (288)
T ss_pred ecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhccccCc
Confidence 8999999999876 4589999999999999999999999988776555544432111 0111
Q ss_pred ---------CCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCC
Q 012762 380 ---------EPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFF 418 (457)
Q Consensus 380 ---------~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f 418 (457)
...++.++++||.+||+.||.+||| ++|+++||||
T Consensus 245 ~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t----~~~~l~hp~f 288 (288)
T cd07871 245 YRAQPLINHAPRLDTDGIDLLSSLLLYETKSRIS----AEAALRHSYF 288 (288)
T ss_pred cCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCC----HHHHhcCCCC
Confidence 1245678999999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-48 Score=364.29 Aligned_cols=259 Identities=25% Similarity=0.368 Sum_probs=215.3
Q ss_pred CCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEc----
Q 012762 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDC---- 157 (457)
Q Consensus 82 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~---- 157 (457)
..|..++.||.|+||.|+.|.++ .+|+.||||.+.. .+......++..+|+++|+.++|+||+.+++++..
T Consensus 22 ~~y~~~~~iG~GAyGvVcsA~~~----~t~~~VAIKKi~~-~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~ 96 (359)
T KOG0660|consen 22 RYYVLIEPIGRGAYGVVCSAKDK----RTGEKVAIKKILN-PFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRD 96 (359)
T ss_pred ceecccccccCcceeeEEEEEEc----CCCCEeehhhhhh-hhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccc
Confidence 35666899999999999999987 4889999999852 34455667888999999999999999999999865
Q ss_pred -CCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCc
Q 012762 158 -PRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSL 236 (457)
Q Consensus 158 -~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~ 236 (457)
-+.+|+|+|+| +.+|..+++.+ ..+++..+..++.||+.||.|+|+.+|+||||||.|+|++.+..+||||||+|+
T Consensus 97 ~f~DvYiV~elM-etDL~~iik~~--~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR 173 (359)
T KOG0660|consen 97 KFNDVYLVFELM-ETDLHQIIKSQ--QDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLAR 173 (359)
T ss_pred ccceeEEehhHH-hhHHHHHHHcC--ccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEecccccee
Confidence 34689999999 89999999885 459999999999999999999999999999999999999999999999999997
Q ss_pred CCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccc
Q 012762 237 KGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSM 316 (457)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (457)
..... +.....+
T Consensus 174 ~~~~~--------------------------------------------------------------------~~~~~mT 185 (359)
T KOG0660|consen 174 YLDKF--------------------------------------------------------------------FEDGFMT 185 (359)
T ss_pred ecccc--------------------------------------------------------------------Ccccchh
Confidence 66422 0012234
Q ss_pred cccCCCCccCchhhcC-CCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhccc--------------------
Q 012762 317 SFVGTHEYLAPEIISG-EGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARAL-------------------- 375 (457)
Q Consensus 317 ~~~gt~~y~aPE~l~~-~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~-------------------- 375 (457)
.++.|.+|+|||++.. ..|+.+.||||+|||+.||++|++.|.|.+....+..|+.-..
T Consensus 186 eYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~ 265 (359)
T KOG0660|consen 186 EYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKARPYIK 265 (359)
T ss_pred cceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHH
Confidence 5688999999999864 4699999999999999999999999998765444433332111
Q ss_pred ---CCCC------CCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCC
Q 012762 376 ---EFPK------EPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNG 420 (457)
Q Consensus 376 ---~~~~------~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~ 420 (457)
..|. .+..++.+.+|+.+||.+||.+|+| ++|+|.||||..
T Consensus 266 slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRit----a~eAL~hPYl~~ 315 (359)
T KOG0660|consen 266 SLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRIT----AEEALAHPYLAP 315 (359)
T ss_pred hCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCC----HHHHhcChhhhh
Confidence 1111 1456678999999999999999999 999999999985
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-47 Score=370.55 Aligned_cols=257 Identities=24% Similarity=0.341 Sum_probs=210.4
Q ss_pred CCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcE
Q 012762 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWS 161 (457)
Q Consensus 82 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~ 161 (457)
++|++.+.||+|+||+||+|+++ .+++.||+|++..... .......+.+|+++++.++|+||+++++++..++..
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~----~~~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 75 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHK----ETKEIVAIKKFKDSEE-NEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKL 75 (287)
T ss_pred CCceEEEEecccCCEEEEEEEEC----CCCcEEEEEEEecccc-cccchhhHHHHHHHHHhCCCccccchhhhEecCCEE
Confidence 37999999999999999999986 4788999999976532 223445677899999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCC
Q 012762 162 CLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNS 241 (457)
Q Consensus 162 ~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~ 241 (457)
|+||||++++.|..+... ...+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++......
T Consensus 76 ~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 153 (287)
T cd07848 76 YLVFEYVEKNMLELLEEM--PNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEG 153 (287)
T ss_pred EEEEecCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccccccc
Confidence 999999988877655443 256999999999999999999999999999999999999999999999999998654211
Q ss_pred CcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCC
Q 012762 242 TSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGT 321 (457)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 321 (457)
.. .......||
T Consensus 154 ~~---------------------------------------------------------------------~~~~~~~~~ 164 (287)
T cd07848 154 SN---------------------------------------------------------------------ANYTEYVAT 164 (287)
T ss_pred cc---------------------------------------------------------------------ccccccccc
Confidence 00 001123589
Q ss_pred CCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhccc-------------------CCCC---
Q 012762 322 HEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARAL-------------------EFPK--- 379 (457)
Q Consensus 322 ~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~-------------------~~~~--- 379 (457)
+.|+|||++.+..++.++|||||||++|||++|+.||.+.........+..... ..+.
T Consensus 165 ~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (287)
T cd07848 165 RWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNH 244 (287)
T ss_pred cccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccccCcccC
Confidence 999999999998899999999999999999999999988765444333222111 0111
Q ss_pred --------CCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCC
Q 012762 380 --------EPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFF 418 (457)
Q Consensus 380 --------~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f 418 (457)
...++.++.+||++||..||++||+ ++++++||||
T Consensus 245 ~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s----~~~~l~hp~f 287 (287)
T cd07848 245 PQSLERRYLGILSGVLLDLMKNLLKLNPTDRYL----TEQCLNHPAF 287 (287)
T ss_pred cccHHHhhhcccCHHHHHHHHHHccCCcccCCC----HHHHhcCCCC
Confidence 0125778999999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-48 Score=381.66 Aligned_cols=260 Identities=25% Similarity=0.414 Sum_probs=233.0
Q ss_pred CCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCc
Q 012762 81 LSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRW 160 (457)
Q Consensus 81 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~ 160 (457)
.++|.+++++|+|+||.+++++++. .+..||+|.+...+...+.. .....|..++++++|||||.+.+.|..++.
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~----~~~~~vlK~I~l~~~t~~~r-~~A~~E~~lis~~~hP~iv~y~ds~~~~~~ 77 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKS----DDKLYVLKKINLEKLTEPER-RSAIQEMDLLSKLLHPNIVEYKDSFEEDGQ 77 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhcc----CCceEEEEEEeccccCchhh-HHHHHHHHHHHhccCCCeeeeccchhcCCc
Confidence 5689999999999999999999885 56689999998776655443 366779999999999999999999998888
Q ss_pred -EEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCC
Q 012762 161 -SCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGD 239 (457)
Q Consensus 161 -~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~ 239 (457)
+||||+||+||+|.+++..+++..++++.+..|+.||+.||.|||+++|+|||||+.|||++.++.|+|+|||+|+.+.
T Consensus 78 ~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~ 157 (426)
T KOG0589|consen 78 LLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILN 157 (426)
T ss_pred eEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcC
Confidence 9999999999999999999887889999999999999999999999999999999999999999999999999998886
Q ss_pred CCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcccccccc
Q 012762 240 NSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFV 319 (457)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (457)
+.... ..+.+
T Consensus 158 ~~~~~----------------------------------------------------------------------a~tvv 167 (426)
T KOG0589|consen 158 PEDSL----------------------------------------------------------------------ASTVV 167 (426)
T ss_pred Cchhh----------------------------------------------------------------------hheec
Confidence 54311 12468
Q ss_pred CCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhhhCC
Q 012762 320 GTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDP 399 (457)
Q Consensus 320 gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP 399 (457)
||+.||+||.+.+.+|+.++|||||||++|||++-+.+|.+.+......++.... -.|.+...+.+++.||..||..+|
T Consensus 168 GTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~-~~Plp~~ys~el~~lv~~~l~~~P 246 (426)
T KOG0589|consen 168 GTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGL-YSPLPSMYSSELRSLVKSMLRKNP 246 (426)
T ss_pred CCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhcc-CCCCCccccHHHHHHHHHHhhcCC
Confidence 9999999999999999999999999999999999999999988888888888776 445555688999999999999999
Q ss_pred CCCCCCCcChHHHhcCCCCCC
Q 012762 400 TRRMGSKMGATAIKRHQFFNG 420 (457)
Q Consensus 400 ~~Rps~~~~~~~ll~hp~f~~ 420 (457)
+.||+ +.+||.+|....
T Consensus 247 ~~RPs----a~~LL~~P~l~~ 263 (426)
T KOG0589|consen 247 EHRPS----ALELLRRPHLLR 263 (426)
T ss_pred ccCCC----HHHHhhChhhhh
Confidence 99999 999999988763
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-49 Score=357.15 Aligned_cols=258 Identities=28% Similarity=0.464 Sum_probs=224.7
Q ss_pred CceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhh-----hhHHHHHHHHHHHHHHc-CCCCCceEEEEEE
Q 012762 83 DLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVS-----RNKESRARIEREILEML-DHPFLPTLYATLD 156 (457)
Q Consensus 83 ~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~-----~~~~~~~~~E~~il~~l-~H~nIv~l~~~~~ 156 (457)
.|.-.+.||.|..++|.+|.++ .+|..+|+|++....... ....+.-+.|++||+++ .||+|+.+.++|+
T Consensus 18 ~y~pkeilgrgvss~vrRci~k----~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye 93 (411)
T KOG0599|consen 18 KYEPKEILGRGVSSVVRRCIHK----ETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE 93 (411)
T ss_pred hcChHHHhcccchhhhhhhhhc----ccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc
Confidence 4667789999999999998877 588899999986543221 11234456699999997 7999999999999
Q ss_pred cCCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCc
Q 012762 157 CPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSL 236 (457)
Q Consensus 157 ~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~ 236 (457)
.+..+++|+|+|+.|.|.+++... -.+++...+.+++|+++|++|||.++||||||||+|||++.+.++||+|||++.
T Consensus 94 s~sF~FlVFdl~prGELFDyLts~--VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~ 171 (411)
T KOG0599|consen 94 SDAFVFLVFDLMPRGELFDYLTSK--VTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFAC 171 (411)
T ss_pred CcchhhhhhhhcccchHHHHhhhh--eeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceee
Confidence 999999999999999999999875 679999999999999999999999999999999999999999999999999997
Q ss_pred CCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccc
Q 012762 237 KGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSM 316 (457)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (457)
.+.+.. +..
T Consensus 172 ~l~~Ge-----------------------------------------------------------------------kLr 180 (411)
T KOG0599|consen 172 QLEPGE-----------------------------------------------------------------------KLR 180 (411)
T ss_pred ccCCch-----------------------------------------------------------------------hHH
Confidence 765322 223
Q ss_pred cccCCCCccCchhhcCC------CCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCC--CCCCCCChHHH
Q 012762 317 SFVGTHEYLAPEIISGE------GHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEF--PKEPSVPGPAK 388 (457)
Q Consensus 317 ~~~gt~~y~aPE~l~~~------~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 388 (457)
.+||||+|+|||.+... +|+..+|+|++|||+|-|+.|.+||+-.....++..|+.+.+.+ |.+..++...+
T Consensus 181 elCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~speWadis~~~K 260 (411)
T KOG0599|consen 181 ELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPEWADISATVK 260 (411)
T ss_pred HhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcchhhccccHH
Confidence 46899999999999643 57889999999999999999999999877777888899998776 55678899999
Q ss_pred HHHHHHhhhCCCCCCCCCcChHHHhcCCCCCCC
Q 012762 389 DLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGV 421 (457)
Q Consensus 389 ~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~~ 421 (457)
|||.+||+.||.+|.| +.|+|.||||..+
T Consensus 261 dLIsrlLqVdp~~Rit----ake~LaHpff~q~ 289 (411)
T KOG0599|consen 261 DLISRLLQVDPTKRIT----AKEALAHPFFIQI 289 (411)
T ss_pred HHHHHHHeeCchhccc----HHHHhcChHHHHH
Confidence 9999999999999999 9999999999753
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-47 Score=390.47 Aligned_cols=254 Identities=22% Similarity=0.333 Sum_probs=201.3
Q ss_pred ccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCC------CCCceEE
Q 012762 79 LTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDH------PFLPTLY 152 (457)
Q Consensus 79 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H------~nIv~l~ 152 (457)
+..++|+++++||+|+||+||+|++. .+++.||||+++... ........|+++++.++| .+|+.++
T Consensus 126 ~~~~~y~i~~~lG~G~fg~V~~a~~~----~~~~~vAvK~i~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~ 197 (467)
T PTZ00284 126 VSTQRFKILSLLGEGTFGKVVEAWDR----KRKEYCAVKIVRNVP----KYTRDAKIEIQFMEKVRQADPADRFPLMKIQ 197 (467)
T ss_pred cCCCcEEEEEEEEeccCEEEEEEEEc----CCCeEEEEEEEecch----hhHHHHHHHHHHHHHHhhcCcccCcceeeeE
Confidence 34578999999999999999999986 378899999996431 123344567777777644 5588999
Q ss_pred EEEEcC-CcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCceeecCCCCCeEEccCC-----
Q 012762 153 ATLDCP-RWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHM-MGIIYRDLKPENVLVRSDG----- 225 (457)
Q Consensus 153 ~~~~~~-~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~-~~iiHrDIKp~NIll~~~~----- 225 (457)
++|..+ .++|||||++ |++|.+++... +.+++..++.++.||+.||.|||+ .|||||||||+|||++.++
T Consensus 198 ~~~~~~~~~~~iv~~~~-g~~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~ 274 (467)
T PTZ00284 198 RYFQNETGHMCIVMPKY-GPCLLDWIMKH--GPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDP 274 (467)
T ss_pred EEEEcCCceEEEEEecc-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCccccc
Confidence 988764 5789999999 88888877664 679999999999999999999997 5999999999999998765
Q ss_pred -----------CEEEeccCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhc
Q 012762 226 -----------HIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRR 294 (457)
Q Consensus 226 -----------~vkl~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (457)
.+||+|||++.....
T Consensus 275 ~~~~~~~~~~~~vkl~DfG~~~~~~~------------------------------------------------------ 300 (467)
T PTZ00284 275 VTNRALPPDPCRVRICDLGGCCDERH------------------------------------------------------ 300 (467)
T ss_pred ccccccCCCCceEEECCCCccccCcc------------------------------------------------------
Confidence 499999997642210
Q ss_pred cccCCCCCCCcccccCCccccccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcc
Q 012762 295 KKKLGNPGTPEIVAEPLDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARA 374 (457)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~ 374 (457)
....++||+.|||||++.+..|+.++|||||||++|||++|+.||.+....+.+..+....
T Consensus 301 -------------------~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~ 361 (467)
T PTZ00284 301 -------------------SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTL 361 (467)
T ss_pred -------------------ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHc
Confidence 0113469999999999999999999999999999999999999998877655444333221
Q ss_pred cCCCC----------------------------------------CCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhc
Q 012762 375 LEFPK----------------------------------------EPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKR 414 (457)
Q Consensus 375 ~~~~~----------------------------------------~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~ 414 (457)
..+|. .....+.+.+||.+||.+||++||+ ++|+|+
T Consensus 362 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t----a~e~L~ 437 (467)
T PTZ00284 362 GRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLN----ARQMTT 437 (467)
T ss_pred CCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCC----HHHHhc
Confidence 11110 0001345779999999999999999 999999
Q ss_pred CCCCCC
Q 012762 415 HQFFNG 420 (457)
Q Consensus 415 hp~f~~ 420 (457)
||||..
T Consensus 438 Hp~~~~ 443 (467)
T PTZ00284 438 HPYVLK 443 (467)
T ss_pred Cccccc
Confidence 999986
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-46 Score=363.55 Aligned_cols=276 Identities=40% Similarity=0.742 Sum_probs=235.3
Q ss_pred CCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcE
Q 012762 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWS 161 (457)
Q Consensus 82 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~ 161 (457)
++|++.+.||+|+||.||+|.+. .+++.||+|++.+...........+.+|+++|++++||||+++++++..++..
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~----~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 76 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHK----GSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNL 76 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEc----CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeE
Confidence 47999999999999999999987 37889999999876655555567788899999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCC
Q 012762 162 CLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNS 241 (457)
Q Consensus 162 ~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~ 241 (457)
|+||||+++++|.+++... ..+++..+..++.||+.||.|||+.||+|+||+|.|||++.++.+||+|||++......
T Consensus 77 ~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 154 (290)
T cd05580 77 YLVMEYVPGGELFSHLRKS--GRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR 154 (290)
T ss_pred EEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence 9999999999999988775 67999999999999999999999999999999999999999999999999987544211
Q ss_pred CcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCC
Q 012762 242 TSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGT 321 (457)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 321 (457)
.....|+
T Consensus 155 -------------------------------------------------------------------------~~~~~~~ 161 (290)
T cd05580 155 -------------------------------------------------------------------------TYTLCGT 161 (290)
T ss_pred -------------------------------------------------------------------------CCCCCCC
Confidence 0123589
Q ss_pred CCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhhhCCCC
Q 012762 322 HEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDPTR 401 (457)
Q Consensus 322 ~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~ 401 (457)
+.|+|||.+.+..++.++||||||+++|+|++|..||...........+......++. .++..++++|.+||..||.+
T Consensus 162 ~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~~l~~~p~~ 239 (290)
T cd05580 162 PEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPS--FFSPDAKDLIRNLLQVDLTK 239 (290)
T ss_pred ccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccCCc--cCCHHHHHHHHHHccCCHHH
Confidence 9999999998888899999999999999999999999887766666666655554444 47899999999999999999
Q ss_pred CCCCC-cChHHHhcCCCCCCCCchhhh--ccCCCCCCCCC
Q 012762 402 RMGSK-MGATAIKRHQFFNGVNWALLR--CAKPPFIPRPV 438 (457)
Q Consensus 402 Rps~~-~~~~~ll~hp~f~~~~~~~~~--~~~~~~~~~~~ 438 (457)
|++.. ..++++++||||+.++|..+. ....|+.|...
T Consensus 240 R~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (290)
T cd05580 240 RLGNLKNGVNDIKNHPWFAGIDWIALLQRKIEAPFIPKVK 279 (290)
T ss_pred ccCcccCCHHHHHcCcccccCCHHHHhhccCCCCccCCCC
Confidence 99321 239999999999999997664 34456665543
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-46 Score=372.38 Aligned_cols=260 Identities=26% Similarity=0.386 Sum_probs=215.1
Q ss_pred ccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcC
Q 012762 79 LTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCP 158 (457)
Q Consensus 79 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~ 158 (457)
+..++|++++.||+|+||.||+|+++ .++..||+|++.... .......+.+|+++|+.++||||+++++++..+
T Consensus 2 l~~~~y~~~~~lg~G~~g~V~~~~~~----~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 75 (331)
T cd06649 2 LKDDDFERISELGAGNGGVVTKVQHK----PSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD 75 (331)
T ss_pred CCcccceEEEeecCCCCEEEEEEEEC----CCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEEC
Confidence 45679999999999999999999987 478899999987542 223456788899999999999999999999999
Q ss_pred CcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHc-CceeecCCCCCeEEccCCCEEEeccCCCcC
Q 012762 159 RWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMM-GIIYRDLKPENVLVRSDGHIMLTDFDLSLK 237 (457)
Q Consensus 159 ~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~-~iiHrDIKp~NIll~~~~~vkl~DFG~s~~ 237 (457)
+..++||||+++++|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++..
T Consensus 76 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 153 (331)
T cd06649 76 GEISICMEHMDGGSLDQVLKEA--KRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQ 153 (331)
T ss_pred CEEEEEeecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccc
Confidence 9999999999999999998775 5689999999999999999999986 699999999999999999999999998754
Q ss_pred CCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcccccc
Q 012762 238 GDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMS 317 (457)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (457)
..... ...
T Consensus 154 ~~~~~------------------------------------------------------------------------~~~ 161 (331)
T cd06649 154 LIDSM------------------------------------------------------------------------ANS 161 (331)
T ss_pred ccccc------------------------------------------------------------------------ccc
Confidence 32110 012
Q ss_pred ccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhc------------------------
Q 012762 318 FVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVAR------------------------ 373 (457)
Q Consensus 318 ~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~------------------------ 373 (457)
..||..|+|||++.+..++.++|||||||++|||++|+.||......+... ++..
T Consensus 162 ~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (331)
T cd06649 162 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEA-IFGRPVVDGEEGEPHSISPRPRPPGRPV 240 (331)
T ss_pred CCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-HhcccccccccCCccccCcccccccccc
Confidence 358999999999999999999999999999999999999997654433221 1110
Q ss_pred -----------------------ccCCCCCCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCCCCc
Q 012762 374 -----------------------ALEFPKEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGVNW 423 (457)
Q Consensus 374 -----------------------~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~~~~ 423 (457)
.........++.++++||.+||+.||++||+ +.+|++||||+....
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt----~~ell~h~~~~~~~~ 309 (331)
T cd06649 241 SGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERAD----LKMLMNHTFIKRSEV 309 (331)
T ss_pred cccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCC----HHHHhcChHHhhccc
Confidence 0000011246788999999999999999999 999999999987443
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-49 Score=381.59 Aligned_cols=295 Identities=36% Similarity=0.652 Sum_probs=262.8
Q ss_pred CCCccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEE
Q 012762 76 NNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATL 155 (457)
Q Consensus 76 ~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~ 155 (457)
...+.+.+++++..||-|+||.|=++..+. ....+|+|+++|..+......+.+..|.+||..++.|.||++|-.|
T Consensus 414 ~a~v~l~dl~~iaTLGvGgFGRVELV~~~~----~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTf 489 (732)
T KOG0614|consen 414 FAQVKLSDLKRIATLGVGGFGRVELVKVNS----QKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTF 489 (732)
T ss_pred hcccchhhhhhhhhcccCccceEEEEEecc----cchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHh
Confidence 345677899999999999999999998753 3336999999999999988889999999999999999999999999
Q ss_pred EcCCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCC
Q 012762 156 DCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235 (457)
Q Consensus 156 ~~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s 235 (457)
.+..++||+||-|-||.|+.++... +.|.+..++.++..+++|++|||++|||.|||||+|++++.+|-+||.|||+|
T Consensus 490 rd~kyvYmLmEaClGGElWTiLrdR--g~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFA 567 (732)
T KOG0614|consen 490 RDSKYVYMLMEACLGGELWTILRDR--GSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFA 567 (732)
T ss_pred ccchhhhhhHHhhcCchhhhhhhhc--CCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhH
Confidence 9999999999999999999988775 78999999999999999999999999999999999999999999999999999
Q ss_pred cCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcccc
Q 012762 236 LKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRS 315 (457)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (457)
+.... +.++
T Consensus 568 Kki~~-----------------------------------------------------------------------g~KT 576 (732)
T KOG0614|consen 568 KKIGS-----------------------------------------------------------------------GRKT 576 (732)
T ss_pred HHhcc-----------------------------------------------------------------------CCce
Confidence 76653 2344
Q ss_pred ccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHh
Q 012762 316 MSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLL 395 (457)
Q Consensus 316 ~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L 395 (457)
-+||||+.|.|||++...+++.++|.||||+++|||++|.+||.+.+....+..|+.+.-.+..+..++..+.+||.++.
T Consensus 577 wTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k~a~~Lik~LC 656 (732)
T KOG0614|consen 577 WTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRITKTATDLIKKLC 656 (732)
T ss_pred eeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccchhHHHHHHHHH
Confidence 57899999999999999999999999999999999999999999999988998888875444444568899999999999
Q ss_pred hhCCCCCCCCC-cChHHHhcCCCCCCCCchhhh--ccCCCCCCCCCCcccccccc
Q 012762 396 VKDPTRRMGSK-MGATAIKRHQFFNGVNWALLR--CAKPPFIPRPVTCRDLTTTN 447 (457)
Q Consensus 396 ~~dP~~Rps~~-~~~~~ll~hp~f~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 447 (457)
..+|.+|.... ..+.+|.+|.||.++||..++ ...|||+|....-.|.+.-.
T Consensus 657 r~~P~ERLG~~~~gI~DIkkH~Wf~gfdweglr~~~L~pPi~~~va~ptD~s~Fd 711 (732)
T KOG0614|consen 657 RDNPTERLGYQKGGINDIKKHRWFEGFDWEGLRSRTLPPPIIPSVANPTDVSNFD 711 (732)
T ss_pred hcCcHhhhccccCChHHHHhhhhhhcCChhhhhhccCCCCccccCCCcccchhcc
Confidence 99999999864 579999999999999998774 57889998777666666543
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-48 Score=380.04 Aligned_cols=330 Identities=30% Similarity=0.525 Sum_probs=257.2
Q ss_pred CCCccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEE
Q 012762 76 NNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATL 155 (457)
Q Consensus 76 ~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~ 155 (457)
....+..-|..++.||-|+||.|.+++.. ++...||.|.+.|.++..++....++.|..||..-+.+-||+||..|
T Consensus 623 RaKMdKSmFvkik~iGvGAFGeV~Lv~Kv----DT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySF 698 (1034)
T KOG0608|consen 623 RAKMDKSMFVKIKTIGVGAFGEVCLVRKV----DTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSF 698 (1034)
T ss_pred HhhccccceEEEeeecccccceeEEEeec----chhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEe
Confidence 34456677999999999999999999865 36789999999999999999999999999999999999999999999
Q ss_pred EcCCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCC
Q 012762 156 DCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235 (457)
Q Consensus 156 ~~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s 235 (457)
++.+.+|+||+|++||++-.++-+. +.|.|..++.|+.++.+|++++|..|+|||||||+|||||.||++||+||||+
T Consensus 699 QDkdnLYFVMdYIPGGDmMSLLIrm--gIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLC 776 (1034)
T KOG0608|consen 699 QDKDNLYFVMDYIPGGDMMSLLIRM--GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLC 776 (1034)
T ss_pred ccCCceEEEEeccCCccHHHHHHHh--ccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeecccc
Confidence 9999999999999999998887765 78999999999999999999999999999999999999999999999999997
Q ss_pred cCCCCCCcccccccCCCCCCCCCCCCCC-CCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccc
Q 012762 236 LKGDNSTSTAQLVSDQSPPTGDQQPNDC-AVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVR 314 (457)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (457)
.-+.=--.... -+..++ ........+.-.....|...+.... . ..+...-
T Consensus 777 TGfRWTHdskY-----------Yq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra---~---------------~~h~r~~ 827 (1034)
T KOG0608|consen 777 TGFRWTHDSKY-----------YQEGDHHRQDSMEPSPEWADISKCLKVLERRA---M---------------RQHQRIL 827 (1034)
T ss_pred ccceecccccc-----------ccCCCccccccCCCchhhccccccchHHHHHH---H---------------hhhhhhh
Confidence 54321000000 000000 0111111111111111111111000 0 1111222
Q ss_pred cccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHh--cccCCCCCCCCChHHHHHHH
Q 012762 315 SMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVA--RALEFPKEPSVPGPAKDLIA 392 (457)
Q Consensus 315 ~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~ll~ 392 (457)
...++||+.|+|||++...+|+..+|.||.|||||||+.|++||......+...+++. ..+.++....++.++.+||+
T Consensus 828 ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~ 907 (1034)
T KOG0608|consen 828 AHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQ 907 (1034)
T ss_pred hhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHH
Confidence 3467999999999999999999999999999999999999999988766555544432 34566777789999999999
Q ss_pred HHhhhCCCCCCCCCcChHHHhcCCCCCCCCchhhhccCCCCCCCCCCccc
Q 012762 393 QLLVKDPTRRMGSKMGATAIKRHQFFNGVNWALLRCAKPPFIPRPVTCRD 442 (457)
Q Consensus 393 ~~L~~dP~~Rps~~~~~~~ll~hp~f~~~~~~~~~~~~~~~~~~~~~~~~ 442 (457)
++ ..+++.|.. +..++||..||||+++||..+++.+.|.||+..--.|
T Consensus 908 kL-c~sad~RLG-kng~d~vKaHpfFkgIDfsslRkq~ApYIP~ItHptD 955 (1034)
T KOG0608|consen 908 KL-CCSADSRLG-KNGADQVKAHPFFKGIDFSSLRKQRAPYIPRITHPTD 955 (1034)
T ss_pred HH-hcChhhhhc-ccchhhhhcCccccccchHhhhhccCCcCccccCCCc
Confidence 86 568899988 4568899999999999999999999999998654444
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-47 Score=373.69 Aligned_cols=263 Identities=24% Similarity=0.362 Sum_probs=208.3
Q ss_pred CceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcC----
Q 012762 83 DLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCP---- 158 (457)
Q Consensus 83 ~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~---- 158 (457)
+|++.++||+|+||.||+|.++ .++..||||++.... ........+.+|+++|++++||||+++++++...
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~----~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 75 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDT----HTGEKVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRRE 75 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEEC----CCCCEEEEEEechhh-ccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCC
Confidence 5899999999999999999976 478899999986432 1222345677899999999999999999988543
Q ss_pred -CcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcC
Q 012762 159 -RWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLK 237 (457)
Q Consensus 159 -~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~ 237 (457)
..+|+||||| +++|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 76 ~~~~~lv~e~~-~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~ 152 (338)
T cd07859 76 FKDIYVVFELM-ESDLHQVIKAN--DDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 152 (338)
T ss_pred CceEEEEEecC-CCCHHHHHHhc--ccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccc
Confidence 2479999999 67898888764 5699999999999999999999999999999999999999999999999999864
Q ss_pred CCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcccccc
Q 012762 238 GDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMS 317 (457)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (457)
....... ......
T Consensus 153 ~~~~~~~-------------------------------------------------------------------~~~~~~ 165 (338)
T cd07859 153 AFNDTPT-------------------------------------------------------------------AIFWTD 165 (338)
T ss_pred cccccCc-------------------------------------------------------------------cccccC
Confidence 3211000 000113
Q ss_pred ccCCCCccCchhhcC--CCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhc----------------------
Q 012762 318 FVGTHEYLAPEIISG--EGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVAR---------------------- 373 (457)
Q Consensus 318 ~~gt~~y~aPE~l~~--~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~---------------------- 373 (457)
.+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+......+..+...
T Consensus 166 ~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 245 (338)
T cd07859 166 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLS 245 (338)
T ss_pred CCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHH
Confidence 469999999999876 56899999999999999999999999876543322111110
Q ss_pred ----ccCCC---CCCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCCCCch
Q 012762 374 ----ALEFP---KEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGVNWA 424 (457)
Q Consensus 374 ----~~~~~---~~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~~~~~ 424 (457)
....+ ..+.++.++.++|.+||..||++||+ +.++++||||+++...
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt----~~e~l~hp~f~~~~~~ 299 (338)
T cd07859 246 SMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPT----AEEALADPYFKGLAKV 299 (338)
T ss_pred hhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCC----HHHHhcCchhhhcCcc
Confidence 00000 11346778999999999999999999 9999999999986663
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-47 Score=350.98 Aligned_cols=299 Identities=34% Similarity=0.641 Sum_probs=255.1
Q ss_pred CCCCCCCCCccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHc-CCCCC
Q 012762 70 GNNNNNNNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEML-DHPFL 148 (457)
Q Consensus 70 ~~~~~~~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l-~H~nI 148 (457)
.......+.+.+.+|.++++||+|+|++|.+++++ .+.+.||+|++++.-+..+...+-++.|..+...- +||.+
T Consensus 238 m~g~~~~~~l~l~df~ll~vigrgsyakvl~~~~~----~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pfl 313 (593)
T KOG0695|consen 238 MDGIKISQGLGLQDFDLLRVIGRGSYAKVLLVRLK----KTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFL 313 (593)
T ss_pred ccccccccccccccceeeeeecCcchhhhhheehc----ccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeE
Confidence 33445678899999999999999999999999988 47889999999988776666677778888888775 79999
Q ss_pred ceEEEEEEcCCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEE
Q 012762 149 PTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIM 228 (457)
Q Consensus 149 v~l~~~~~~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vk 228 (457)
|.++.+|+.+..+++|.||++||+|.-.++++ +.++++.++.+..+|+.||.|||++|||.||||.+|+|++..|++|
T Consensus 314 vglhscfqtesrlffvieyv~ggdlmfhmqrq--rklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghik 391 (593)
T KOG0695|consen 314 VGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIK 391 (593)
T ss_pred EehhhhhcccceEEEEEEEecCcceeeehhhh--hcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCcee
Confidence 99999999999999999999999996666665 7899999999999999999999999999999999999999999999
Q ss_pred EeccCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccc
Q 012762 229 LTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVA 308 (457)
Q Consensus 229 l~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (457)
|+|+|+++..-..
T Consensus 392 ltdygmcke~l~~------------------------------------------------------------------- 404 (593)
T KOG0695|consen 392 LTDYGMCKEGLGP------------------------------------------------------------------- 404 (593)
T ss_pred ecccchhhcCCCC-------------------------------------------------------------------
Confidence 9999998654321
Q ss_pred cCCccccccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCC-------CChHH-HHHHHHhcccCCCCC
Q 012762 309 EPLDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKG-------IDHEL-TLANVVARALEFPKE 380 (457)
Q Consensus 309 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~-------~~~~~-~~~~~~~~~~~~~~~ 380 (457)
+..+.+++||+.|+|||+++|..|+..+|.|+||++++||+.|+.||+- .+.++ .+.-|+.+.++.|..
T Consensus 405 ---gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiriprs 481 (593)
T KOG0695|consen 405 ---GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPRS 481 (593)
T ss_pred ---CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccccce
Confidence 1123478999999999999999999999999999999999999999952 12233 345566777888876
Q ss_pred CCCChHHHHHHHHHhhhCCCCCCCCC--cChHHHhcCCCCCCCCchhh--hccCCCCCCCCCCccccccc
Q 012762 381 PSVPGPAKDLIAQLLVKDPTRRMGSK--MGATAIKRHQFFNGVNWALL--RCAKPPFIPRPVTCRDLTTT 446 (457)
Q Consensus 381 ~~~~~~~~~ll~~~L~~dP~~Rps~~--~~~~~ll~hp~f~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 446 (457)
++-.+..+++..|..||.+|..-. ..+.++..|+||+.++|..+ ++..|||.|.....+++..-
T Consensus 482 --lsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd~leqk~v~ppf~p~i~~d~~l~~f 549 (593)
T KOG0695|consen 482 --LSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWDLLEQKQVLPPFQPQITDDYGLDNF 549 (593)
T ss_pred --eehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHHHHhhcccCCCCCCccccccCcccc
Confidence 666678899999999999997632 35889999999999999988 56789999988777776543
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-47 Score=358.52 Aligned_cols=262 Identities=29% Similarity=0.400 Sum_probs=217.0
Q ss_pred CCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCC-CceEEEEEEcCC
Q 012762 81 LSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPF-LPTLYATLDCPR 159 (457)
Q Consensus 81 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~n-Iv~l~~~~~~~~ 159 (457)
...|..+++||+|+||+||+|+.+ .+|+.||+|.+...... +..-....+|+.+|++|+|+| ||.+++++...+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~----~~g~~VALKkirl~~~~-EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~ 84 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSK----RTGKFVALKKIRLEFEE-EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSN 84 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEe----cCCCEEEEEEEeccccc-cCCCchhhHHHHHHHHhCCCcceEEEEeeeeecc
Confidence 456888899999999999999988 48899999999765321 112334567999999999999 999999998877
Q ss_pred ------cEEEEEeecCCCChHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEec
Q 012762 160 ------WSCLLTEFCPGGDLHVLRQRQPD--KRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTD 231 (457)
Q Consensus 160 ------~~~lV~E~~~~~sL~~~~~~~~~--~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~D 231 (457)
.++|||||+ .-+|..++..... ..++...++.+++||+.||+|||++||+||||||+||||+.+|.+||+|
T Consensus 85 ~~~~~~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaD 163 (323)
T KOG0594|consen 85 NHRGIGKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLAD 163 (323)
T ss_pred cccccceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeec
Confidence 789999999 8899988887653 4688899999999999999999999999999999999999999999999
Q ss_pred cCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCC
Q 012762 232 FDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPL 311 (457)
Q Consensus 232 FG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (457)
||+|+...-+..+
T Consensus 164 FGlAra~~ip~~~------------------------------------------------------------------- 176 (323)
T KOG0594|consen 164 FGLARAFSIPMRT------------------------------------------------------------------- 176 (323)
T ss_pred cchHHHhcCCccc-------------------------------------------------------------------
Confidence 9998744311110
Q ss_pred ccccccccCCCCccCchhhcCC-CCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCC-------------
Q 012762 312 DVRSMSFVGTHEYLAPEIISGE-GHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEF------------- 377 (457)
Q Consensus 312 ~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~------------- 377 (457)
...-++|..|+|||++.|. .|+..+||||+|||++||++++..|.+..+.+.+..|.......
T Consensus 177 ---yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~~~~ 253 (323)
T KOG0594|consen 177 ---YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSSLPD 253 (323)
T ss_pred ---ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCcccccc
Confidence 1123689999999999988 58999999999999999999999999998877777766532111
Q ss_pred -----CCC----------CCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCCCC
Q 012762 378 -----PKE----------PSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGVN 422 (457)
Q Consensus 378 -----~~~----------~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~~~ 422 (457)
+.. +....+..+++.+||+++|.+|.+ +..+|.||||....
T Consensus 254 ~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~S----a~~al~h~yf~~~~ 309 (323)
T KOG0594|consen 254 YKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRIS----AKGALTHPYFSELP 309 (323)
T ss_pred ccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcC----HHHHhcChhhcccc
Confidence 000 111237889999999999999999 99999999999863
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-49 Score=377.07 Aligned_cols=257 Identities=26% Similarity=0.391 Sum_probs=219.3
Q ss_pred CCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcE
Q 012762 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWS 161 (457)
Q Consensus 82 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~ 161 (457)
..|+.++.||+|.||.||+|.+. .+++.||+|++.... .......+..|+.+|..++++||.++|+.+..+..+
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~----~t~k~vAiKii~Le~--~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~L 86 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDN----KTKKVVAIKIIDLEE--AEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKL 86 (467)
T ss_pred cccccchhccccccceeeeeeec----cccceEEEEEechhh--cchhhHHHHHHHHHHHhcCcchHHhhhhheeecccH
Confidence 35778899999999999999987 589999999998763 344566778899999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCC
Q 012762 162 CLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNS 241 (457)
Q Consensus 162 ~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~ 241 (457)
+++||||.||++.++++.. ..+.+..+..++++++.||.|||..+.+|||||+.|||+..+|.|||+|||.+..+..-
T Consensus 87 wiiMey~~gGsv~~lL~~~--~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~ 164 (467)
T KOG0201|consen 87 WIIMEYCGGGSVLDLLKSG--NILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNT 164 (467)
T ss_pred HHHHHHhcCcchhhhhccC--CCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeech
Confidence 9999999999999999874 44588899999999999999999999999999999999999999999999997655321
Q ss_pred CcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCC
Q 012762 242 TSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGT 321 (457)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 321 (457)
..+..+|+||
T Consensus 165 ----------------------------------------------------------------------~~rr~tfvGT 174 (467)
T KOG0201|consen 165 ----------------------------------------------------------------------VKRRKTFVGT 174 (467)
T ss_pred ----------------------------------------------------------------------hhcccccccc
Confidence 1122478999
Q ss_pred CCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhhhCCCC
Q 012762 322 HEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDPTR 401 (457)
Q Consensus 322 ~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~ 401 (457)
+.|||||++++..|+.++||||||++.+||++|.+||........+..|-... .......+++.+++||..||..||+.
T Consensus 175 PfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~-PP~L~~~~S~~~kEFV~~CL~k~P~~ 253 (467)
T KOG0201|consen 175 PFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSA-PPRLDGDFSPPFKEFVEACLDKNPEF 253 (467)
T ss_pred ccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCC-CCccccccCHHHHHHHHHHhhcCccc
Confidence 99999999999899999999999999999999999998866532222222111 11122368889999999999999999
Q ss_pred CCCCCcChHHHhcCCCCCCC
Q 012762 402 RMGSKMGATAIKRHQFFNGV 421 (457)
Q Consensus 402 Rps~~~~~~~ll~hp~f~~~ 421 (457)
||+ |.+||+|+|.+..
T Consensus 254 Rps----A~~LLKh~FIk~a 269 (467)
T KOG0201|consen 254 RPS----AKELLKHKFIKRA 269 (467)
T ss_pred CcC----HHHHhhhHHHHhc
Confidence 999 9999999999874
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-46 Score=363.55 Aligned_cols=257 Identities=26% Similarity=0.376 Sum_probs=208.7
Q ss_pred CCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHc---CCCCCceEEEEEE--
Q 012762 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEML---DHPFLPTLYATLD-- 156 (457)
Q Consensus 82 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l---~H~nIv~l~~~~~-- 156 (457)
.+|++++.||+|+||+||+|++.. ..++.||+|++...... ......+.+|+++++.+ +||||+++++++.
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~---~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~ 76 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLK---NGGRFVALKRVRVQTGE-EGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVS 76 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcC---CCCeEEEEEEEecccCC-CCchHHHHHHHHHHHhhcccCCCCcceEEEEEecc
Confidence 379999999999999999998753 25678999998754322 22234455677777766 6999999999885
Q ss_pred ---cCCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccC
Q 012762 157 ---CPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFD 233 (457)
Q Consensus 157 ---~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG 233 (457)
....+++||||+ .++|..++.......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 77 ~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg 155 (290)
T cd07862 77 RTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFG 155 (290)
T ss_pred cCCCCCcEEEEEccC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEcccc
Confidence 345689999999 5789888877666679999999999999999999999999999999999999999999999999
Q ss_pred CCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcc
Q 012762 234 LSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDV 313 (457)
Q Consensus 234 ~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (457)
++.......
T Consensus 156 ~~~~~~~~~----------------------------------------------------------------------- 164 (290)
T cd07862 156 LARIYSFQM----------------------------------------------------------------------- 164 (290)
T ss_pred ceEeccCCc-----------------------------------------------------------------------
Confidence 975432110
Q ss_pred ccccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCC-----CC---------
Q 012762 314 RSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEF-----PK--------- 379 (457)
Q Consensus 314 ~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~-----~~--------- 379 (457)
......||+.|+|||++.+..++.++|||||||++|||++|.+||.+....+.+..++...... +.
T Consensus 165 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 244 (290)
T cd07862 165 ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAF 244 (290)
T ss_pred ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhcccchhc
Confidence 0112358999999999998889999999999999999999999999887776666665432100 00
Q ss_pred -----------CCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCC
Q 012762 380 -----------EPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFF 418 (457)
Q Consensus 380 -----------~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f 418 (457)
.+.++..+++|+.+||+.||++||+ +.++|+||||
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s----~~~~l~hp~f 290 (290)
T cd07862 245 HSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRIS----AYSALSHPYF 290 (290)
T ss_pred cCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCC----HHHHhcCCCC
Confidence 1246678899999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-46 Score=379.15 Aligned_cols=254 Identities=22% Similarity=0.327 Sum_probs=205.3
Q ss_pred CccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEc
Q 012762 78 PLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDC 157 (457)
Q Consensus 78 ~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~ 157 (457)
.+...+|.++++||+|+||.||+|.++ .+++.||+|.... ..+.+|+++|+.|+||||++++++|..
T Consensus 88 ~~~~~~y~~~~~lg~G~~g~V~~~~d~----~~~~~vaiK~~~~---------~~~~~E~~il~~l~HpnIv~~~~~~~~ 154 (391)
T PHA03212 88 GIEKAGFSILETFTPGAEGFAFACIDN----KTCEHVVIKAGQR---------GGTATEAHILRAINHPSIIQLKGTFTY 154 (391)
T ss_pred ccccCCcEEEEEEcCCCCeEEEEEEEC----CCCCEEEEechhh---------hhhHHHHHHHHhCCCCCCCCEeEEEEE
Confidence 355678999999999999999999987 4788999997532 235679999999999999999999999
Q ss_pred CCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcC
Q 012762 158 PRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLK 237 (457)
Q Consensus 158 ~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~ 237 (457)
+...|+|||++ +++|..++... ..+++..++.++.||+.||.|||++|||||||||+|||++.++.+||+|||+++.
T Consensus 155 ~~~~~lv~e~~-~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~ 231 (391)
T PHA03212 155 NKFTCLILPRY-KTDLYCYLAAK--RNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACF 231 (391)
T ss_pred CCeeEEEEecC-CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccc
Confidence 99999999999 67888777664 5689999999999999999999999999999999999999999999999999754
Q ss_pred CCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcccccc
Q 012762 238 GDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMS 317 (457)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (457)
...... .....
T Consensus 232 ~~~~~~---------------------------------------------------------------------~~~~~ 242 (391)
T PHA03212 232 PVDINA---------------------------------------------------------------------NKYYG 242 (391)
T ss_pred cccccc---------------------------------------------------------------------ccccc
Confidence 221100 01113
Q ss_pred ccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCC-------hHHHHHHHHhcccC--------------
Q 012762 318 FVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGID-------HELTLANVVARALE-------------- 376 (457)
Q Consensus 318 ~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~-------~~~~~~~~~~~~~~-------------- 376 (457)
++||+.|+|||++.+..++.++|||||||++|||++|..||.... ....+..++.....
T Consensus 243 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~ 322 (391)
T PHA03212 243 WAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLD 322 (391)
T ss_pred ccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHH
Confidence 469999999999999999999999999999999999998875422 11112222111100
Q ss_pred ------------CCC-------CCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCC
Q 012762 377 ------------FPK-------EPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNG 420 (457)
Q Consensus 377 ------------~~~-------~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~ 420 (457)
.+. ...++.++.+||.+||+.||++||| +.|+|+||||+.
T Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpt----a~elL~hp~f~~ 381 (391)
T PHA03212 323 EIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPS----AEALLDFAAFQD 381 (391)
T ss_pred HHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCC----HHHHhcChhhcc
Confidence 000 0124567899999999999999999 999999999986
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-45 Score=358.97 Aligned_cols=295 Identities=36% Similarity=0.674 Sum_probs=239.9
Q ss_pred CCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcE
Q 012762 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWS 161 (457)
Q Consensus 82 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~ 161 (457)
++|++++.||+|+||.||+|.++ ..++.||+|.+.+...........+..|+++++.++|+||+++++.+..++++
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~----~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 76 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHK----ETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHL 76 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEEC----CCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEE
Confidence 37999999999999999999987 47889999999876544444556777899999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCC
Q 012762 162 CLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNS 241 (457)
Q Consensus 162 ~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~ 241 (457)
|+||||++|++|..++... +.+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||+++.....
T Consensus 77 ~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~ 154 (305)
T cd05609 77 CMVMEYVEGGDCATLLKNI--GALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS 154 (305)
T ss_pred EEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence 9999999999999998765 56899999999999999999999999999999999999999999999999987643211
Q ss_pred CcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCC
Q 012762 242 TSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGT 321 (457)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 321 (457)
....... ... . ............|+
T Consensus 155 ~~~~~~~-~~~-------------------------------------~-----------------~~~~~~~~~~~~~~ 179 (305)
T cd05609 155 LTTNLYE-GHI-------------------------------------E-----------------KDTREFLDKQVCGT 179 (305)
T ss_pred ccccccc-ccc-------------------------------------c-----------------cchhhccccCCccC
Confidence 0000000 000 0 00000001123578
Q ss_pred CCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCC-CCCChHHHHHHHHHhhhCCC
Q 012762 322 HEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKE-PSVPGPAKDLIAQLLVKDPT 400 (457)
Q Consensus 322 ~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ll~~~L~~dP~ 400 (457)
..|+|||.+.+..++.++|||||||++|||++|..||.+....+....+.......+.. ..++.++.++|.+||+.||+
T Consensus 180 ~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~ 259 (305)
T cd05609 180 PEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGDEALPADAQDLISRLLRQNPL 259 (305)
T ss_pred ccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCccccCCHHHHHHHHHHhccChh
Confidence 89999999998889999999999999999999999999877777777766665444433 25788999999999999999
Q ss_pred CCCCCCcChHHHhcCCCCCCCCchhhhccCCCCCCCCC
Q 012762 401 RRMGSKMGATAIKRHQFFNGVNWALLRCAKPPFIPRPV 438 (457)
Q Consensus 401 ~Rps~~~~~~~ll~hp~f~~~~~~~~~~~~~~~~~~~~ 438 (457)
+||++. .+.++++||||...+|..+......++|++.
T Consensus 260 ~R~~~~-~~~~ll~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (305)
T cd05609 260 ERLGTG-GAFEVKQHRFFLGLDWNGLLRQKAEFIPQLE 296 (305)
T ss_pred hccCcc-CHHHHHhCccccCCCHHHHhhcCCCCCCCCC
Confidence 999842 3789999999999999988888888888773
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-47 Score=378.04 Aligned_cols=259 Identities=20% Similarity=0.315 Sum_probs=214.6
Q ss_pred CCCCCCccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEE
Q 012762 73 NNNNNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLY 152 (457)
Q Consensus 73 ~~~~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~ 152 (457)
....|++..+++.+...||+|.||+||+|.|.. .||||+++......+ ..+.|++|+.+|++-+|.||+-+.
T Consensus 383 s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG-------dVAVK~Lnv~~pt~~-qlqaFKnEVa~lkkTRH~NIlLFM 454 (678)
T KOG0193|consen 383 SLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG-------DVAVKLLNVDDPTPE-QLQAFKNEVAVLKKTRHENILLFM 454 (678)
T ss_pred cccccccCHHHhhccceeccccccceeeccccc-------ceEEEEEecCCCCHH-HHHHHHHHHHHHhhcchhhheeee
Confidence 446889999999999999999999999999974 499999987765544 888999999999999999999999
Q ss_pred EEEEcCCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEecc
Q 012762 153 ATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDF 232 (457)
Q Consensus 153 ~~~~~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DF 232 (457)
|++..+.. .||+.+|+|-+|+.+++... ..|.....+.|++||++|+.|||.++|||||||..||||.++++|||+||
T Consensus 455 G~~~~p~~-AIiTqwCeGsSLY~hlHv~e-tkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDF 532 (678)
T KOG0193|consen 455 GACMNPPL-AIITQWCEGSSLYTHLHVQE-TKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDF 532 (678)
T ss_pred hhhcCCce-eeeehhccCchhhhhccchh-hhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecc
Confidence 99998877 89999999999999988754 67999999999999999999999999999999999999999999999999
Q ss_pred CCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCc
Q 012762 233 DLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLD 312 (457)
Q Consensus 233 G~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (457)
|++..-..- ...
T Consensus 533 GLatvk~~w--------------------------------------------------------------------~g~ 544 (678)
T KOG0193|consen 533 GLATVKTRW--------------------------------------------------------------------SGE 544 (678)
T ss_pred cceeeeeee--------------------------------------------------------------------ccc
Confidence 997322100 000
Q ss_pred cccccccCCCCccCchhhcC---CCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCC----CCCCCh
Q 012762 313 VRSMSFVGTHEYLAPEIISG---EGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPK----EPSVPG 385 (457)
Q Consensus 313 ~~~~~~~gt~~y~aPE~l~~---~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~----~~~~~~ 385 (457)
.....-.|...|||||+++. .+|++.+|||||||++|||++|..||.. .+.+.+..++-+.+-.+. ...++.
T Consensus 545 ~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi-~~~dqIifmVGrG~l~pd~s~~~s~~pk 623 (678)
T KOG0193|consen 545 QQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSI-QNRDQIIFMVGRGYLMPDLSKIRSNCPK 623 (678)
T ss_pred cccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCC-CChhheEEEecccccCccchhhhccCHH
Confidence 11112248899999999974 4689999999999999999999999994 444333333433333332 245778
Q ss_pred HHHHHHHHHhhhCCCCCCCCCcChHHHhc
Q 012762 386 PAKDLIAQLLVKDPTRRMGSKMGATAIKR 414 (457)
Q Consensus 386 ~~~~ll~~~L~~dP~~Rps~~~~~~~ll~ 414 (457)
++++|+..||.+++++||. +.+||.
T Consensus 624 ~mk~Ll~~C~~~~~~eRP~----F~~il~ 648 (678)
T KOG0193|consen 624 AMKRLLSDCWKFDREERPL----FPQLLS 648 (678)
T ss_pred HHHHHHHHHHhcCcccCcc----HHHHHH
Confidence 9999999999999999999 666654
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-47 Score=357.41 Aligned_cols=253 Identities=27% Similarity=0.447 Sum_probs=209.5
Q ss_pred CceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcC--C-
Q 012762 83 DLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCP--R- 159 (457)
Q Consensus 83 ~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~--~- 159 (457)
.|.-.+++|.|+||+||.|.... +++.||||.+.... ..--+|++||++++|||||++..+|... .
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e----~~~~vAIKKv~~d~-------r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d 93 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRE----TEEEVAIKKVLQDK-------RYKNRELQIMRKLDHPNIVRLLYFFSSSTESD 93 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcC----CCceeEEEEecCCC-------CcCcHHHHHHHhcCCcCeeeEEEEEEecCCCc
Confidence 58888999999999999999873 58899999885432 1223599999999999999999888432 2
Q ss_pred --cEEEEEeecCCCChHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccC-CCEEEeccCC
Q 012762 160 --WSCLLTEFCPGGDLHVLRQR--QPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSD-GHIMLTDFDL 234 (457)
Q Consensus 160 --~~~lV~E~~~~~sL~~~~~~--~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~-~~vkl~DFG~ 234 (457)
+..+||||+ -.+|...++. ..+..++...++.+..||++||.|||+.||+||||||.|+|+|.+ |.+||||||.
T Consensus 94 ~~~lnlVleym-P~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGS 172 (364)
T KOG0658|consen 94 EVYLNLVLEYM-PETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGS 172 (364)
T ss_pred hhHHHHHHHhc-hHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCc
Confidence 457899999 7889887774 134679999999999999999999999999999999999999976 9999999999
Q ss_pred CcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccc
Q 012762 235 SLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVR 314 (457)
Q Consensus 235 s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (457)
|+.+.....
T Consensus 173 AK~L~~~ep----------------------------------------------------------------------- 181 (364)
T KOG0658|consen 173 AKVLVKGEP----------------------------------------------------------------------- 181 (364)
T ss_pred ceeeccCCC-----------------------------------------------------------------------
Confidence 987653221
Q ss_pred cccccCCCCccCchhhcCCC-CCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhccc-----------------C
Q 012762 315 SMSFVGTHEYLAPEIISGEG-HGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARAL-----------------E 376 (457)
Q Consensus 315 ~~~~~gt~~y~aPE~l~~~~-~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~-----------------~ 376 (457)
..++.-|..|+|||.+.|.. |+.+.||||.|||+.||+-|++.|.|.+..+.+..|+.... .
T Consensus 182 niSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~~ 261 (364)
T KOG0658|consen 182 NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTEFK 261 (364)
T ss_pred ceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCccccccc
Confidence 22467899999999999875 99999999999999999999999999887777666654211 1
Q ss_pred CCC----------CCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCCCC
Q 012762 377 FPK----------EPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGVN 422 (457)
Q Consensus 377 ~~~----------~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~~~ 422 (457)
+|. ....++++.+|+.++|+++|.+|.+ +.|++.||||+...
T Consensus 262 ~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~----~~~~l~h~fFdelr 313 (364)
T KOG0658|consen 262 FPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLS----ALEALAHPFFDELR 313 (364)
T ss_pred CcccccccceeecccCCCHHHHHHHHHHhccChhhcCC----HHHHhcchhhHHhh
Confidence 111 1345788999999999999999999 99999999998743
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-46 Score=367.31 Aligned_cols=259 Identities=25% Similarity=0.379 Sum_probs=212.2
Q ss_pred ccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcC
Q 012762 79 LTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCP 158 (457)
Q Consensus 79 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~ 158 (457)
+..++|++.++||+|+||.||+|.++ .++..+|+|++.... .......+.+|+++|+.++|+||+++++++..+
T Consensus 2 l~~~~y~~~~~lg~g~~g~V~~~~~~----~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 75 (333)
T cd06650 2 LKDDDFEKISELGAGNGGVVFKVSHK----PSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD 75 (333)
T ss_pred cchhhhheeccccCCCCEEEEEEEEC----CCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCcccceeEEEEEC
Confidence 44578999999999999999999886 478899999986542 223456678899999999999999999999999
Q ss_pred CcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHc-CceeecCCCCCeEEccCCCEEEeccCCCcC
Q 012762 159 RWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMM-GIIYRDLKPENVLVRSDGHIMLTDFDLSLK 237 (457)
Q Consensus 159 ~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~-~iiHrDIKp~NIll~~~~~vkl~DFG~s~~ 237 (457)
+++||||||+.+++|.+++... +.+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++..
T Consensus 76 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~ 153 (333)
T cd06650 76 GEISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQ 153 (333)
T ss_pred CEEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchh
Confidence 9999999999999999998764 5689999999999999999999975 799999999999999999999999998753
Q ss_pred CCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcccccc
Q 012762 238 GDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMS 317 (457)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (457)
..... ...
T Consensus 154 ~~~~~------------------------------------------------------------------------~~~ 161 (333)
T cd06650 154 LIDSM------------------------------------------------------------------------ANS 161 (333)
T ss_pred hhhhc------------------------------------------------------------------------ccc
Confidence 32100 012
Q ss_pred ccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHH---------------------------
Q 012762 318 FVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANV--------------------------- 370 (457)
Q Consensus 318 ~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~--------------------------- 370 (457)
..|+..|+|||++.+..++.++|||||||++|+|++|+.||...........+
T Consensus 162 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (333)
T cd06650 162 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLSSY 241 (333)
T ss_pred CCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccchhhhh
Confidence 35899999999999988999999999999999999999999765433221110
Q ss_pred -----------------HhcccCCCCCCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCCC
Q 012762 371 -----------------VARALEFPKEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGV 421 (457)
Q Consensus 371 -----------------~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~~ 421 (457)
............++.++++||.+||+.||++||+ +.|+++||||+..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt----~~ell~h~~~~~~ 305 (333)
T cd06650 242 GPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERAD----LKQLMVHAFIKRS 305 (333)
T ss_pred cccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcC----HHHHhhCHHHhcC
Confidence 0000000001135678999999999999999999 9999999999863
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=373.55 Aligned_cols=264 Identities=22% Similarity=0.299 Sum_probs=212.1
Q ss_pred ccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcC
Q 012762 79 LTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCP 158 (457)
Q Consensus 79 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~ 158 (457)
+...+|.+++.||+|+||.||+|..+. ...++.||+|.+... ....+|+++|++++|+||+++++++...
T Consensus 89 ~~~~~y~i~~~Lg~G~~g~Vy~~~~~~--~~~~~~v~vK~~~~~--------~~~~~E~~il~~l~h~~iv~~~~~~~~~ 158 (392)
T PHA03207 89 VVRMQYNILSSLTPGSEGEVFVCTKHG--DEQRKKVIVKAVTGG--------KTPGREIDILKTISHRAIINLIHAYRWK 158 (392)
T ss_pred hccCceEEEEeecCCCCeEEEEEEEcC--CccceeEEEEecccc--------ccHHHHHHHHHhcCCCCccceeeeEeeC
Confidence 344679999999999999999997642 235778999998643 2245699999999999999999999999
Q ss_pred CcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCC
Q 012762 159 RWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKG 238 (457)
Q Consensus 159 ~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~ 238 (457)
...|+|||++ +++|..++... ..+++..++.++.||+.||.|||++|||||||||+|||++.++.++|+|||++...
T Consensus 159 ~~~~lv~e~~-~~~l~~~l~~~--~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~ 235 (392)
T PHA03207 159 STVCMVMPKY-KCDLFTYVDRS--GPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKL 235 (392)
T ss_pred CEEEEEehhc-CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCcccccc
Confidence 9999999999 57888777543 67999999999999999999999999999999999999999999999999998644
Q ss_pred CCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccc
Q 012762 239 DNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSF 318 (457)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (457)
...... .....+
T Consensus 236 ~~~~~~--------------------------------------------------------------------~~~~~~ 247 (392)
T PHA03207 236 DAHPDT--------------------------------------------------------------------PQCYGW 247 (392)
T ss_pred Cccccc--------------------------------------------------------------------cccccc
Confidence 321100 011134
Q ss_pred cCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChH---HHHHHHHhccc----CCCC------------
Q 012762 319 VGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHE---LTLANVVARAL----EFPK------------ 379 (457)
Q Consensus 319 ~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~---~~~~~~~~~~~----~~~~------------ 379 (457)
+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.... ..+..++.... .++.
T Consensus 248 ~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (392)
T PHA03207 248 SGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQ 327 (392)
T ss_pred ccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHHHHHh
Confidence 6999999999999999999999999999999999999999765321 22222221100 0000
Q ss_pred ----------------CCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCCCCchhhh
Q 012762 380 ----------------EPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGVNWALLR 427 (457)
Q Consensus 380 ----------------~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~~~~~~~~ 427 (457)
...++.++.++|.+||..||++||+ +.++|+||||....|+.+.
T Consensus 328 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rps----a~e~l~~p~f~~~~~~~~~ 387 (392)
T PHA03207 328 YAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPS----AQDILSLPLFTKEPINLLN 387 (392)
T ss_pred hcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCC----HHHHhhCchhhccchhhhc
Confidence 0134567899999999999999999 9999999999998888663
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-46 Score=367.23 Aligned_cols=264 Identities=20% Similarity=0.295 Sum_probs=209.2
Q ss_pred CCccCCCceeEEEecccCcceEEEEEEeccC-CCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHc-CCCCCceEEEE
Q 012762 77 NPLTLSDLRFVHRLGSGDIGSVYLVQLKSKS-SNNGCFFAAKVMDKRELVSRNKESRARIEREILEML-DHPFLPTLYAT 154 (457)
Q Consensus 77 ~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~-~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~~~ 154 (457)
|.+..++|++.++||+|+||.||+|.+...+ ...+..||+|++.... .......+..|+++|+.+ +||||++++++
T Consensus 2 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~ 79 (338)
T cd05102 2 WEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA--TASEHKALMSELKILIHIGNHLNVVNLLGA 79 (338)
T ss_pred cccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc--chHHHHHHHHHHHHHHHhccCcceeeEEeE
Confidence 5677789999999999999999999864322 2356789999986432 223345678899999999 89999999998
Q ss_pred EEcC-CcEEEEEeecCCCChHHHHHhCC----------------------------------------------------
Q 012762 155 LDCP-RWSCLLTEFCPGGDLHVLRQRQP---------------------------------------------------- 181 (457)
Q Consensus 155 ~~~~-~~~~lV~E~~~~~sL~~~~~~~~---------------------------------------------------- 181 (457)
+... +.+|+||||+++|+|.+++....
T Consensus 80 ~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (338)
T cd05102 80 CTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNP 159 (338)
T ss_pred ecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCccccc
Confidence 8654 46899999999999998887532
Q ss_pred --------CCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCCCcccccccCCCC
Q 012762 182 --------DKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQLVSDQSP 253 (457)
Q Consensus 182 --------~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~~~~~~~~~~~~~ 253 (457)
...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++........
T Consensus 160 ~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~--------- 230 (338)
T cd05102 160 PQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY--------- 230 (338)
T ss_pred chhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcch---------
Confidence 124778889999999999999999999999999999999999999999999998644211000
Q ss_pred CCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCCCCccCchhhcCC
Q 012762 254 PTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTHEYLAPEIISGE 333 (457)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~ 333 (457)
.......++..|+|||++.+.
T Consensus 231 -----------------------------------------------------------~~~~~~~~~~~y~aPE~~~~~ 251 (338)
T cd05102 231 -----------------------------------------------------------VRKGSARLPLKWMAPESIFDK 251 (338)
T ss_pred -----------------------------------------------------------hcccCCCCCccccCcHHhhcC
Confidence 000112367889999999998
Q ss_pred CCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhhhCCCCCCCCCcChHHH
Q 012762 334 GHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAI 412 (457)
Q Consensus 334 ~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~l 412 (457)
.++.++|||||||++|||++ |..||.+......+...+...........++.++.+|+.+||..||++||+ +.+|
T Consensus 252 ~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs----~~el 327 (338)
T cd05102 252 VYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKERPT----FSAL 327 (338)
T ss_pred CCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcC----HHHH
Confidence 99999999999999999996 999998765444444444333333334467889999999999999999999 7777
Q ss_pred hc
Q 012762 413 KR 414 (457)
Q Consensus 413 l~ 414 (457)
++
T Consensus 328 ~~ 329 (338)
T cd05102 328 VE 329 (338)
T ss_pred HH
Confidence 65
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-46 Score=381.50 Aligned_cols=258 Identities=24% Similarity=0.372 Sum_probs=206.3
Q ss_pred cCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcC-
Q 012762 80 TLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCP- 158 (457)
Q Consensus 80 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~- 158 (457)
...+|++.++||+|+||+||+|.+. .+++.||||++.... ....+|+.+|+.++|+||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~----~~~~~vAiK~i~~~~-------~~~~~Ei~il~~l~h~niv~l~~~~~~~~ 132 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICI----DTSEKVAIKKVLQDP-------QYKNRELLIMKNLNHINIIFLKDYYYTEC 132 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEEC----CCCCEEEEEEEecCc-------chHHHHHHHHHhcCCCCCcceeeeEeecc
Confidence 3468999999999999999999976 478899999885431 2234699999999999999999887432
Q ss_pred -------CcEEEEEeecCCCChHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCC-CEE
Q 012762 159 -------RWSCLLTEFCPGGDLHVLRQR--QPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDG-HIM 228 (457)
Q Consensus 159 -------~~~~lV~E~~~~~sL~~~~~~--~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~-~vk 228 (457)
..+++||||+. ++|..++.. .....+++..++.++.||+.||.|||++||+||||||+||||+.++ .+|
T Consensus 133 ~~~~~~~~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vk 211 (440)
T PTZ00036 133 FKKNEKNIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLK 211 (440)
T ss_pred cccCCCceEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCcee
Confidence 24679999995 577666543 2346799999999999999999999999999999999999998664 799
Q ss_pred EeccCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccc
Q 012762 229 LTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVA 308 (457)
Q Consensus 229 l~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (457)
|+|||+++......
T Consensus 212 L~DFGla~~~~~~~------------------------------------------------------------------ 225 (440)
T PTZ00036 212 LCDFGSAKNLLAGQ------------------------------------------------------------------ 225 (440)
T ss_pred eeccccchhccCCC------------------------------------------------------------------
Confidence 99999986442110
Q ss_pred cCCccccccccCCCCccCchhhcCC-CCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcc-------------
Q 012762 309 EPLDVRSMSFVGTHEYLAPEIISGE-GHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARA------------- 374 (457)
Q Consensus 309 ~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~------------- 374 (457)
.....+||+.|+|||++.+. .|+.++|||||||++|||++|.+||.+....+.+..++...
T Consensus 226 -----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~ 300 (440)
T PTZ00036 226 -----RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNP 300 (440)
T ss_pred -----CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhch
Confidence 01134689999999998765 58999999999999999999999999877665555554321
Q ss_pred ----cCCCC----------CCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCCCCch
Q 012762 375 ----LEFPK----------EPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGVNWA 424 (457)
Q Consensus 375 ----~~~~~----------~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~~~~~ 424 (457)
+.++. +...+.++++||.+||..||.+||+ +.|+|+||||+.+...
T Consensus 301 ~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~t----a~e~l~hp~f~~~~~~ 360 (440)
T PTZ00036 301 NYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLN----PIEALADPFFDDLRDP 360 (440)
T ss_pred hhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcC----HHHHhCChhHHhhhcc
Confidence 11111 1235678999999999999999999 9999999999986554
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-45 Score=389.49 Aligned_cols=152 Identities=38% Similarity=0.623 Sum_probs=138.7
Q ss_pred CCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCc
Q 012762 81 LSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRW 160 (457)
Q Consensus 81 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~ 160 (457)
+++|+++++||+|+||+||+|++. .+++.||||++.+...........+..|+++++.++|+||+++++++....+
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~----~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~ 78 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKK----NNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANN 78 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEEC----CCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCE
Confidence 578999999999999999999986 3788999999987665555556778889999999999999999999999999
Q ss_pred EEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCC
Q 012762 161 SCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKG 238 (457)
Q Consensus 161 ~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~ 238 (457)
+||||||+.|++|..++... +.+++..++.++.||+.||+|||.+|||||||||+||||+.++.+||+|||+++..
T Consensus 79 ~~lVmEy~~g~~L~~li~~~--~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~~~ 154 (669)
T cd05610 79 VYLVMEYLIGGDVKSLLHIY--GYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVT 154 (669)
T ss_pred EEEEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCccc
Confidence 99999999999999998764 56899999999999999999999999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-45 Score=367.35 Aligned_cols=256 Identities=26% Similarity=0.419 Sum_probs=204.1
Q ss_pred cCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCC
Q 012762 80 TLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPR 159 (457)
Q Consensus 80 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~ 159 (457)
..++|++.+.||+|+||+||+|.++ .+|+.||+|++.+.. ........+.+|+.+++.++||||+++++++...+
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~----~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 93 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDT----VLGINVAVKKLSRPF-QNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQK 93 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEc----CCCceeEEEEecccc-cchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCC
Confidence 3578999999999999999999876 478899999996542 22334556778999999999999999999986543
Q ss_pred ------cEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccC
Q 012762 160 ------WSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFD 233 (457)
Q Consensus 160 ------~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG 233 (457)
.+|+||||++ ++|...+. ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||
T Consensus 94 ~~~~~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg 168 (359)
T cd07876 94 SLEEFQDVYLVMELMD-ANLCQVIH----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG 168 (359)
T ss_pred CccccceeEEEEeCCC-cCHHHHHh----ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCC
Confidence 5799999995 56655553 348899999999999999999999999999999999999999999999999
Q ss_pred CCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcc
Q 012762 234 LSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDV 313 (457)
Q Consensus 234 ~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (457)
+++......
T Consensus 169 ~a~~~~~~~----------------------------------------------------------------------- 177 (359)
T cd07876 169 LARTACTNF----------------------------------------------------------------------- 177 (359)
T ss_pred CccccccCc-----------------------------------------------------------------------
Confidence 975332100
Q ss_pred ccccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhc--------------------
Q 012762 314 RSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVAR-------------------- 373 (457)
Q Consensus 314 ~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~-------------------- 373 (457)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......++..
T Consensus 178 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (359)
T cd07876 178 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYV 257 (359)
T ss_pred cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHH
Confidence 001235899999999999999999999999999999999999999876543332222111
Q ss_pred --ccCCC------------------CCCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCC
Q 012762 374 --ALEFP------------------KEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNG 420 (457)
Q Consensus 374 --~~~~~------------------~~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~ 420 (457)
....+ .....+..+++||.+||..||++||+ +.|+|+||||..
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t----~~e~l~hp~~~~ 320 (359)
T cd07876 258 ENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRIS----VDEALRHPYITV 320 (359)
T ss_pred hhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCC----HHHHhcCchhhh
Confidence 00000 00123567899999999999999999 999999999984
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-45 Score=353.87 Aligned_cols=271 Identities=34% Similarity=0.609 Sum_probs=221.4
Q ss_pred ecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcEEEEEeecC
Q 012762 90 LGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWSCLLTEFCP 169 (457)
Q Consensus 90 LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lV~E~~~ 169 (457)
||+|+||+||+|.+. .+|+.||+|++.+...........+..|+++|+.++||||+++++++...+..|+||||++
T Consensus 1 lg~g~~g~vy~~~~~----~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 76 (277)
T cd05577 1 LGKGGFGEVCACQVK----ATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMN 76 (277)
T ss_pred CCCCCceeEEEEEEc----CCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCC
Confidence 699999999999876 3788999999987655444455566789999999999999999999999999999999999
Q ss_pred CCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCCCccccccc
Q 012762 170 GGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQLVS 249 (457)
Q Consensus 170 ~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~~~~~~~~~ 249 (457)
+++|..++.......+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++........
T Consensus 77 ~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~------ 150 (277)
T cd05577 77 GGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK------ 150 (277)
T ss_pred CCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCc------
Confidence 99999888776545799999999999999999999999999999999999999999999999998754321000
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCCCCccCchh
Q 012762 250 DQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTHEYLAPEI 329 (457)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 329 (457)
.....|+..|+|||+
T Consensus 151 -----------------------------------------------------------------~~~~~~~~~y~~PE~ 165 (277)
T cd05577 151 -----------------------------------------------------------------IKGRAGTPGYMAPEV 165 (277)
T ss_pred -----------------------------------------------------------------cccccCCCCcCCHHH
Confidence 001247889999999
Q ss_pred hcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcc--cCCCCCCCCChHHHHHHHHHhhhCCCCCCCCCc
Q 012762 330 ISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARA--LEFPKEPSVPGPAKDLIAQLLVKDPTRRMGSKM 407 (457)
Q Consensus 330 l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~ll~~~L~~dP~~Rps~~~ 407 (457)
+.+..++.++|||||||++|+|++|+.||...........+.... ........+++++.++|.+||+.||++||+++.
T Consensus 166 ~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~ 245 (277)
T cd05577 166 LQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRG 245 (277)
T ss_pred hcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccCChhHccCCCc
Confidence 988889999999999999999999999997754321111211111 122223457889999999999999999996655
Q ss_pred -ChHHHhcCCCCCCCCchhhhc--cCCCCCC
Q 012762 408 -GATAIKRHQFFNGVNWALLRC--AKPPFIP 435 (457)
Q Consensus 408 -~~~~ll~hp~f~~~~~~~~~~--~~~~~~~ 435 (457)
.+.++++||||...+|..+.. ..|||+|
T Consensus 246 ~~~~~ll~h~~~~~~~~~~~~~~~~~~~~~~ 276 (277)
T cd05577 246 GSADEVREHPLFKDLNWRRLEAGMLEPPFIP 276 (277)
T ss_pred ccHHHHHhChhhhcCChhhhhcCCCCCCCCC
Confidence 599999999999999987753 3466665
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-45 Score=359.20 Aligned_cols=260 Identities=23% Similarity=0.363 Sum_probs=210.2
Q ss_pred cCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCC
Q 012762 80 TLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPR 159 (457)
Q Consensus 80 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~ 159 (457)
..++|.+.++||+|+||+||+|+++ .+++.||+|+++.... ......+.+|+++++.++|+||+++++++..++
T Consensus 4 ~~~~y~~~~~lg~G~~g~Vy~~~~~----~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 77 (309)
T cd07872 4 KMETYIKLEKLGEGTYATVFKGRSK----LTENLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIVHTDK 77 (309)
T ss_pred CCCceEEEEEecccCCEEEEEEEec----CCCCeEEEEEeecccc--CCcchhHHHHHHHHHhCCCCCcceEEEEEeeCC
Confidence 4578999999999999999999876 3678899999875432 223345667999999999999999999999999
Q ss_pred cEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCC
Q 012762 160 WSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGD 239 (457)
Q Consensus 160 ~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~ 239 (457)
..|+||||++ ++|..++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 78 ~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 155 (309)
T cd07872 78 SLTLVFEYLD-KDLKQYMDDC-GNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKS 155 (309)
T ss_pred eEEEEEeCCC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecC
Confidence 9999999995 5787776554 2458999999999999999999999999999999999999999999999999975432
Q ss_pred CCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcccccccc
Q 012762 240 NSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFV 319 (457)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (457)
..... .....
T Consensus 156 ~~~~~----------------------------------------------------------------------~~~~~ 165 (309)
T cd07872 156 VPTKT----------------------------------------------------------------------YSNEV 165 (309)
T ss_pred CCccc----------------------------------------------------------------------ccccc
Confidence 11000 00124
Q ss_pred CCCCccCchhhcCC-CCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcc-------------------cCCC-
Q 012762 320 GTHEYLAPEIISGE-GHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARA-------------------LEFP- 378 (457)
Q Consensus 320 gt~~y~aPE~l~~~-~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~-------------------~~~~- 378 (457)
+|..|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....+.... ..++
T Consensus 166 ~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (309)
T cd07872 166 VTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNFPK 245 (309)
T ss_pred ccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhhcCc
Confidence 78999999998764 58999999999999999999999998876554444333211 0111
Q ss_pred --------CCCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCCC
Q 012762 379 --------KEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGV 421 (457)
Q Consensus 379 --------~~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~~ 421 (457)
....++.++++||.+||..||.+||| +.|+++||||+..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t----~~e~l~h~~~~~~ 292 (309)
T cd07872 246 YKPQPLINHAPRLDTEGIELLTKFLQYESKKRIS----AEEAMKHAYFRSL 292 (309)
T ss_pred cCCCchhhhccCCCHHHHHHHHHhccCChhhCCC----HHHHhcChhhhhc
Confidence 11246788999999999999999999 9999999999853
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-45 Score=354.76 Aligned_cols=255 Identities=26% Similarity=0.386 Sum_probs=205.7
Q ss_pred CceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHc---CCCCCceEEEEEEc--
Q 012762 83 DLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEML---DHPFLPTLYATLDC-- 157 (457)
Q Consensus 83 ~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l---~H~nIv~l~~~~~~-- 157 (457)
+|++.+.||+|+||+||+|+++ .+++.||+|+++..... ........+|+++++.+ +||||+++++++..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~----~~~~~~aiK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~ 75 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDP----HSGHFVALKSVRVQTNE-DGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSR 75 (288)
T ss_pred CceEeeEEeecCCeEEEEEEEC----CCCcEEEEEEeccCcCC-CCCchHHHHHHHHHHHhhhcCCCCeeeeeeeecccc
Confidence 5899999999999999999987 47889999998754221 12223445677777665 79999999998864
Q ss_pred ---CCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCC
Q 012762 158 ---PRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDL 234 (457)
Q Consensus 158 ---~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~ 234 (457)
....++||||+. ++|..++.......+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+
T Consensus 76 ~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~ 154 (288)
T cd07863 76 TDRETKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGL 154 (288)
T ss_pred CCCCceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCc
Confidence 345799999995 5888888776556799999999999999999999999999999999999999999999999999
Q ss_pred CcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccc
Q 012762 235 SLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVR 314 (457)
Q Consensus 235 s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (457)
+........
T Consensus 155 ~~~~~~~~~----------------------------------------------------------------------- 163 (288)
T cd07863 155 ARIYSCQMA----------------------------------------------------------------------- 163 (288)
T ss_pred cccccCccc-----------------------------------------------------------------------
Confidence 754321100
Q ss_pred cccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccC-----CC-----------
Q 012762 315 SMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALE-----FP----------- 378 (457)
Q Consensus 315 ~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~-----~~----------- 378 (457)
.....||..|+|||++.+..++.++|||||||++|+|++|.+||.+......+.++...... ++
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (288)
T cd07863 164 LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRGAFS 243 (288)
T ss_pred CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccccccccccC
Confidence 01235899999999999888999999999999999999999999887666555554432100 00
Q ss_pred ---------CCCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCC
Q 012762 379 ---------KEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFF 418 (457)
Q Consensus 379 ---------~~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f 418 (457)
..+.++..+.++|.+||+.||++||+ +.++++||||
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t----~~~~l~hp~f 288 (288)
T cd07863 244 PRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRIS----AFRALQHPFF 288 (288)
T ss_pred CCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCC----HHHHhcCCCC
Confidence 01246778899999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-45 Score=365.78 Aligned_cols=256 Identities=25% Similarity=0.383 Sum_probs=206.3
Q ss_pred cCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcC-
Q 012762 80 TLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCP- 158 (457)
Q Consensus 80 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~- 158 (457)
..++|++.+.||+|+||.||+|.+. ..++.||||++.+.. ........+.+|+.+++.++|+||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~----~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~ 96 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDA----ILERNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQK 96 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEEC----CCCcEEEEEEeCccc-cCchhHHHHHHHHHHHHhcCCCCccccceeecccc
Confidence 3578999999999999999999876 478889999986532 2223445677899999999999999999987543
Q ss_pred -----CcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccC
Q 012762 159 -----RWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFD 233 (457)
Q Consensus 159 -----~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG 233 (457)
..+|+||||++ ++|...+.. .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 97 ~~~~~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG 171 (364)
T cd07875 97 SLEEFQDVYIVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG 171 (364)
T ss_pred cccccCeEEEEEeCCC-CCHHHHHHh----cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCC
Confidence 35799999994 577666643 47889999999999999999999999999999999999999999999999
Q ss_pred CCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcc
Q 012762 234 LSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDV 313 (457)
Q Consensus 234 ~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (457)
+++.......
T Consensus 172 ~a~~~~~~~~---------------------------------------------------------------------- 181 (364)
T cd07875 172 LARTAGTSFM---------------------------------------------------------------------- 181 (364)
T ss_pred CccccCCCCc----------------------------------------------------------------------
Confidence 9854321100
Q ss_pred ccccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccC-----------------
Q 012762 314 RSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALE----------------- 376 (457)
Q Consensus 314 ~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~----------------- 376 (457)
.....||..|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......++.....
T Consensus 182 -~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (364)
T cd07875 182 -MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYV 260 (364)
T ss_pred -ccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHHHHH
Confidence 01235899999999999999999999999999999999999999887765555444331110
Q ss_pred -------------------CCC----CCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCC
Q 012762 377 -------------------FPK----EPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNG 420 (457)
Q Consensus 377 -------------------~~~----~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~ 420 (457)
++. ....+..+++||.+||..||.+||| +.|+|+||||+.
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t----~~e~L~hp~~~~ 323 (364)
T cd07875 261 ENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRIS----VDEALQHPYINV 323 (364)
T ss_pred hhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCC----HHHHhcCccccc
Confidence 000 0112457899999999999999999 999999999973
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-45 Score=377.88 Aligned_cols=261 Identities=25% Similarity=0.357 Sum_probs=218.5
Q ss_pred CCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCc
Q 012762 81 LSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRW 160 (457)
Q Consensus 81 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~ 160 (457)
...|.+.+.||+|+||.||+|.... ..+..||+|.+.... ......++.|+++|+.++|||||++++++..++.
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~---~~~~~vv~K~~~~~~---~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~ 139 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGS---DPKEKVVAKFVMLND---ERQAAYARSELHCLAACDHFGIVKHFDDFKSDDK 139 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcC---CCCeEEEEEEcccCC---HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCE
Confidence 3459999999999999999998653 226788888764432 2334567789999999999999999999999999
Q ss_pred EEEEEeecCCCChHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCC
Q 012762 161 SCLLTEFCPGGDLHVLRQRQ--PDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKG 238 (457)
Q Consensus 161 ~~lV~E~~~~~sL~~~~~~~--~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~ 238 (457)
+||||||++||+|..++... ....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 140 ~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~ 219 (478)
T PTZ00267 140 LLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQY 219 (478)
T ss_pred EEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceec
Confidence 99999999999998877542 2356899999999999999999999999999999999999999999999999998654
Q ss_pred CCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccc
Q 012762 239 DNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSF 318 (457)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (457)
...... .....+
T Consensus 220 ~~~~~~--------------------------------------------------------------------~~~~~~ 231 (478)
T PTZ00267 220 SDSVSL--------------------------------------------------------------------DVASSF 231 (478)
T ss_pred CCcccc--------------------------------------------------------------------cccccc
Confidence 321100 001134
Q ss_pred cCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhhhC
Q 012762 319 VGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKD 398 (457)
Q Consensus 319 ~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~d 398 (457)
+||+.|+|||++.+..++.++|||||||++|||++|+.||.+......+..++.+... +....++.++.++|.+||..|
T Consensus 232 ~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~~li~~~L~~d 310 (478)
T PTZ00267 232 CGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYD-PFPCPVSSGMKALLDPLLSKN 310 (478)
T ss_pred CCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC-CCCccCCHHHHHHHHHHhccC
Confidence 6999999999999999999999999999999999999999988777777776665443 223458899999999999999
Q ss_pred CCCCCCCCcChHHHhcCCCCCC
Q 012762 399 PTRRMGSKMGATAIKRHQFFNG 420 (457)
Q Consensus 399 P~~Rps~~~~~~~ll~hp~f~~ 420 (457)
|++||+ +.+++.|+|++.
T Consensus 311 P~~Rps----~~~~l~~~~~~~ 328 (478)
T PTZ00267 311 PALRPT----TQQLLHTEFLKY 328 (478)
T ss_pred hhhCcC----HHHHHhCHHHHH
Confidence 999999 999999999865
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-45 Score=365.36 Aligned_cols=260 Identities=25% Similarity=0.343 Sum_probs=209.8
Q ss_pred CceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCC---
Q 012762 83 DLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPR--- 159 (457)
Q Consensus 83 ~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~--- 159 (457)
+|++.++||+|+||+||+|.+. .+++.||+|++.... .......++.+|+++|+.++|+||+++++++...+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~----~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 75 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDP----RDGKRVALKKMPNVF-QNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDP 75 (372)
T ss_pred CCcccceeeeCCCEEEEEEEEC----CCCCEEEEEeccccc-cchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccc
Confidence 5788999999999999999876 378899999986431 12233456788999999999999999999998776
Q ss_pred --cEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcC
Q 012762 160 --WSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLK 237 (457)
Q Consensus 160 --~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~ 237 (457)
..|+||||+ +++|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 76 ~~~~~lv~e~~-~~~l~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~ 152 (372)
T cd07853 76 FEEIYVVTELM-QSDLHKIIVSP--QPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARV 152 (372)
T ss_pred cceEEEEeecc-ccCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceee
Confidence 789999999 46787776553 6799999999999999999999999999999999999999999999999999764
Q ss_pred CCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcccccc
Q 012762 238 GDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMS 317 (457)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (457)
...... .....
T Consensus 153 ~~~~~~---------------------------------------------------------------------~~~~~ 163 (372)
T cd07853 153 EEPDES---------------------------------------------------------------------KHMTQ 163 (372)
T ss_pred cccCcc---------------------------------------------------------------------ccCCC
Confidence 321100 00012
Q ss_pred ccCCCCccCchhhcCCC-CCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhc-----------------------
Q 012762 318 FVGTHEYLAPEIISGEG-HGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVAR----------------------- 373 (457)
Q Consensus 318 ~~gt~~y~aPE~l~~~~-~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~----------------------- 373 (457)
..+|..|+|||++.+.. ++.++|||||||++|||++|+.||.+.+....+..+...
T Consensus 164 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~ 243 (372)
T cd07853 164 EVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRG 243 (372)
T ss_pred CCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHHHHhC
Confidence 35889999999998754 799999999999999999999999887655444433321
Q ss_pred ccCCC-------CCCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCCCCc
Q 012762 374 ALEFP-------KEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGVNW 423 (457)
Q Consensus 374 ~~~~~-------~~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~~~~ 423 (457)
....+ .....++++.+||.+||+.||++||+ +.|+++||||++..+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t----~~e~l~hp~~~~~~~ 296 (372)
T cd07853 244 PHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRIS----AADALAHPYLDEGRL 296 (372)
T ss_pred CCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcC----HHHHhcCHhhCCCcc
Confidence 11111 11235778999999999999999999 999999999998654
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-45 Score=331.09 Aligned_cols=264 Identities=25% Similarity=0.372 Sum_probs=219.2
Q ss_pred CCCCccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHc-CCCCCceEEE
Q 012762 75 NNNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEML-DHPFLPTLYA 153 (457)
Q Consensus 75 ~~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~~ 153 (457)
+....++.+.+.+..||.|+.|+||+++.+. +|...|||.+.+... ....+++...++++.+. +.|+||+++|
T Consensus 85 ~r~~~dindl~~l~dlGsGtcG~V~k~~~rs----~~~iiAVK~M~rt~N--kee~kRILmDldvv~~s~dcpyIV~c~G 158 (391)
T KOG0983|consen 85 QRYQADINDLENLGDLGSGTCGQVWKMRFRS----TGHIIAVKQMRRTGN--KEENKRILMDLDVVLKSHDCPYIVQCFG 158 (391)
T ss_pred cccccChHHhhhHHhhcCCCccceEEEEEcc----cceEEEEEeecccCC--HHHHHHHHHhhhHHhhccCCCeeeeeee
Confidence 3455667788999999999999999999884 788999999976532 34456677777776655 5899999999
Q ss_pred EEEcCCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCceeecCCCCCeEEccCCCEEEecc
Q 012762 154 TLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHM-MGIIYRDLKPENVLVRSDGHIMLTDF 232 (457)
Q Consensus 154 ~~~~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~-~~iiHrDIKp~NIll~~~~~vkl~DF 232 (457)
+|..+..+++.||.| +.-+..++++.+ ++++|..+-++..-++.||.||.+ +||||||+||.|||+++.|++|||||
T Consensus 159 yFi~n~dV~IcMelM-s~C~ekLlkrik-~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDF 236 (391)
T KOG0983|consen 159 YFITNTDVFICMELM-STCAEKLLKRIK-GPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDF 236 (391)
T ss_pred EEeeCchHHHHHHHH-HHHHHHHHHHhc-CCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecc
Confidence 999999999999998 667777777653 679999999999999999999995 58999999999999999999999999
Q ss_pred CCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCc
Q 012762 233 DLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLD 312 (457)
Q Consensus 233 G~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (457)
|++..+-++....
T Consensus 237 GIsGrlvdSkAht------------------------------------------------------------------- 249 (391)
T KOG0983|consen 237 GISGRLVDSKAHT------------------------------------------------------------------- 249 (391)
T ss_pred cccceeecccccc-------------------------------------------------------------------
Confidence 9987665433221
Q ss_pred cccccccCCCCccCchhhcCC---CCCccchhhhhhHHHHHHhcCCCCCCCCC-hHHHHHHHHhcccC-CCCCCCCChHH
Q 012762 313 VRSMSFVGTHEYLAPEIISGE---GHGNAVDWWTLGIFIFELFYGTTPFKGID-HELTLANVVARALE-FPKEPSVPGPA 387 (457)
Q Consensus 313 ~~~~~~~gt~~y~aPE~l~~~---~~~~~sDiwSlG~il~elltG~~Pf~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~~ 387 (457)
.-.|.+.|||||.+.-. .|+.++||||||++++||.||++||.+.. +.+.+-.+++.... ++....+++++
T Consensus 250 ----rsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~~gFSp~F 325 (391)
T KOG0983|consen 250 ----RSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGHMGFSPDF 325 (391)
T ss_pred ----cccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCcccCcCHHH
Confidence 12499999999999644 58999999999999999999999999854 45666666664432 33344589999
Q ss_pred HHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCCC
Q 012762 388 KDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGV 421 (457)
Q Consensus 388 ~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~~ 421 (457)
++++..||..|+.+||. ..+||+|||....
T Consensus 326 ~~fv~~CL~kd~r~RP~----Y~~Ll~h~Fi~~y 355 (391)
T KOG0983|consen 326 QSFVKDCLTKDHRKRPK----YNKLLEHPFIKRY 355 (391)
T ss_pred HHHHHHHhhcCcccCcc----hHHHhcCcceeec
Confidence 99999999999999999 9999999999763
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-46 Score=368.22 Aligned_cols=249 Identities=27% Similarity=0.454 Sum_probs=221.1
Q ss_pred CCCCCccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEE
Q 012762 74 NNNNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYA 153 (457)
Q Consensus 74 ~~~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~ 153 (457)
...|++..+...-++-||+|+-|-||+|+++ ++.||||.++.- -..+++-|++|+|+||+.|.|
T Consensus 116 ~e~WeiPFe~IsELeWlGSGaQGAVF~Grl~------netVAVKKV~el----------kETdIKHLRkLkH~NII~FkG 179 (904)
T KOG4721|consen 116 EELWEIPFEEISELEWLGSGAQGAVFLGRLH------NETVAVKKVREL----------KETDIKHLRKLKHPNIITFKG 179 (904)
T ss_pred hhhccCCHHHhhhhhhhccCcccceeeeecc------CceehhHHHhhh----------hhhhHHHHHhccCcceeeEee
Confidence 4567888888888899999999999999975 678999987421 223677899999999999999
Q ss_pred EEEcCCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccC
Q 012762 154 TLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFD 233 (457)
Q Consensus 154 ~~~~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG 233 (457)
+|.....+|||||||..|-|...++.. ..++......|..+|+.|+.|||.++|||||||.-||||..+..|||+|||
T Consensus 180 VCtqsPcyCIiMEfCa~GqL~~VLka~--~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFG 257 (904)
T KOG4721|consen 180 VCTQSPCYCIIMEFCAQGQLYEVLKAG--RPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFG 257 (904)
T ss_pred eecCCceeEEeeeccccccHHHHHhcc--CccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEecccc
Confidence 999999999999999999999999875 779999999999999999999999999999999999999999999999999
Q ss_pred CCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcc
Q 012762 234 LSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDV 313 (457)
Q Consensus 234 ~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (457)
-++.+.+..
T Consensus 258 TS~e~~~~S----------------------------------------------------------------------- 266 (904)
T KOG4721|consen 258 TSKELSDKS----------------------------------------------------------------------- 266 (904)
T ss_pred chHhhhhhh-----------------------------------------------------------------------
Confidence 887665331
Q ss_pred ccccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHH
Q 012762 314 RSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQ 393 (457)
Q Consensus 314 ~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~ 393 (457)
..|.|+||..|||||+++..+.+.|+|||||||||||||||+.||.+-+...++..+-...+.+|.+..+|+.++-||+.
T Consensus 267 TkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~GfklL~Kq 346 (904)
T KOG4721|consen 267 TKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGFKLLLKQ 346 (904)
T ss_pred hhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCchHHHHHHHH
Confidence 23578999999999999999999999999999999999999999988776656555555667788888899999999999
Q ss_pred HhhhCCCCCCCCCcChHHHhcC
Q 012762 394 LLVKDPTRRMGSKMGATAIKRH 415 (457)
Q Consensus 394 ~L~~dP~~Rps~~~~~~~ll~h 415 (457)
||+-.|.+||+ +.+||.|
T Consensus 347 cw~sKpRNRPS----Frqil~H 364 (904)
T KOG4721|consen 347 CWNSKPRNRPS----FRQILLH 364 (904)
T ss_pred HHhcCCCCCcc----HHHHHHH
Confidence 99999999999 9999988
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-45 Score=377.11 Aligned_cols=264 Identities=25% Similarity=0.381 Sum_probs=220.4
Q ss_pred ccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcC
Q 012762 79 LTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCP 158 (457)
Q Consensus 79 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~ 158 (457)
...++|++.+.||+|+||+||+|++. .+++.||||++..... .......+..|+.+|..++|+||++++..+...
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~----~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~ 103 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRV----SDGEPFAVKVVDMEGM-SEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKK 103 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEc----CCCCEEEEEEEecccC-CHHHHHHHHHHHHHHhcCCCCcEEEeecceecc
Confidence 34468999999999999999999876 4788999999976543 233456677899999999999999998877543
Q ss_pred C--------cEEEEEeecCCCChHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEE
Q 012762 159 R--------WSCLLTEFCPGGDLHVLRQRQ--PDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIM 228 (457)
Q Consensus 159 ~--------~~~lV~E~~~~~sL~~~~~~~--~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vk 228 (457)
+ .+++||||+++|+|.+++... ....+++..+..++.||+.||.|||+.||+||||||+|||++.++.+|
T Consensus 104 ~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vk 183 (496)
T PTZ00283 104 DPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVK 183 (496)
T ss_pred cccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEE
Confidence 2 368999999999999888653 235689999999999999999999999999999999999999999999
Q ss_pred EeccCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccc
Q 012762 229 LTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVA 308 (457)
Q Consensus 229 l~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (457)
|+|||+++........
T Consensus 184 L~DFGls~~~~~~~~~---------------------------------------------------------------- 199 (496)
T PTZ00283 184 LGDFGFSKMYAATVSD---------------------------------------------------------------- 199 (496)
T ss_pred EEecccCeeccccccc----------------------------------------------------------------
Confidence 9999998654321100
Q ss_pred cCCccccccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHH
Q 012762 309 EPLDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAK 388 (457)
Q Consensus 309 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (457)
......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+......+..++..... +....+++++.
T Consensus 200 ----~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~ 274 (496)
T PTZ00283 200 ----DVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYD-PLPPSISPEMQ 274 (496)
T ss_pred ----cccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCC-CCCCCCCHHHH
Confidence 0011346999999999999999999999999999999999999999987777666666655433 33456889999
Q ss_pred HHHHHHhhhCCCCCCCCCcChHHHhcCCCCCC
Q 012762 389 DLIAQLLVKDPTRRMGSKMGATAIKRHQFFNG 420 (457)
Q Consensus 389 ~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~ 420 (457)
+++.+||..||.+||+ +.++++|||++.
T Consensus 275 ~li~~~L~~dP~~RPs----~~ell~~p~~~~ 302 (496)
T PTZ00283 275 EIVTALLSSDPKRRPS----SSKLLNMPICKL 302 (496)
T ss_pred HHHHHHcccChhhCcC----HHHHHhCHHHHH
Confidence 9999999999999999 999999999875
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=343.55 Aligned_cols=260 Identities=25% Similarity=0.400 Sum_probs=217.5
Q ss_pred CCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhh--hhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCC
Q 012762 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVS--RNKESRARIEREILEMLDHPFLPTLYATLDCPR 159 (457)
Q Consensus 82 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~--~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~ 159 (457)
+.|.+.+.||+|+||.||+|.+. .++..||+|++....... ......+.+|++++++++||||+++++++..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~----~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 77 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDV----DTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDE 77 (263)
T ss_pred CcccccceecCCCceEEEEEEEc----CCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCC
Confidence 46899999999999999999876 478899999987543221 223456788999999999999999999999999
Q ss_pred cEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCC
Q 012762 160 WSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGD 239 (457)
Q Consensus 160 ~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~ 239 (457)
..|+||||+++++|.+++... ..+++..++.++.|++.||.|||+.||+|+||||+||+++.++.++|+|||+++...
T Consensus 78 ~~~~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~ 155 (263)
T cd06625 78 TLSIFMEYMPGGSVKDQLKAY--GALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQ 155 (263)
T ss_pred eEEEEEEECCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence 999999999999999888765 568999999999999999999999999999999999999999999999999975432
Q ss_pred CCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcccccccc
Q 012762 240 NSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFV 319 (457)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (457)
..... ........
T Consensus 156 ~~~~~-------------------------------------------------------------------~~~~~~~~ 168 (263)
T cd06625 156 TICSS-------------------------------------------------------------------GTGMKSVT 168 (263)
T ss_pred ccccc-------------------------------------------------------------------cccccCCC
Confidence 11000 00001235
Q ss_pred CCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhhhCC
Q 012762 320 GTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDP 399 (457)
Q Consensus 320 gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP 399 (457)
|+..|+|||++.+..++.++|||||||++|||++|+.||...........+............++..+.++|.+||..||
T Consensus 169 ~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 248 (263)
T cd06625 169 GTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFLRRTFVENA 248 (263)
T ss_pred cCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCCHHHHHHHHHHhhcCc
Confidence 88899999999998899999999999999999999999987766555555554444444445688999999999999999
Q ss_pred CCCCCCCcChHHHhcCCCC
Q 012762 400 TRRMGSKMGATAIKRHQFF 418 (457)
Q Consensus 400 ~~Rps~~~~~~~ll~hp~f 418 (457)
.+||+ +.++++|+||
T Consensus 249 ~~Rpt----~~~ll~~~~~ 263 (263)
T cd06625 249 KKRPS----AEELLRHFFV 263 (263)
T ss_pred ccCCC----HHHHhhCCCC
Confidence 99999 9999999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=349.08 Aligned_cols=269 Identities=32% Similarity=0.631 Sum_probs=209.1
Q ss_pred EecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHH---cCCCCCceEEEEEEcCCcEEEEE
Q 012762 89 RLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEM---LDHPFLPTLYATLDCPRWSCLLT 165 (457)
Q Consensus 89 ~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~---l~H~nIv~l~~~~~~~~~~~lV~ 165 (457)
.||+|+||.||+|.+. .+++.||+|++.+..............|..+++. .+|+||+.+++++..++..|+||
T Consensus 1 ~lg~G~~g~Vy~~~~~----~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~ 76 (279)
T cd05633 1 IIGRGGFGEVYGCRKA----DTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFIL 76 (279)
T ss_pred CcccCCCeEEEEEEEC----CCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEE
Confidence 4899999999999876 4788999999976544333333334445544444 47999999999999999999999
Q ss_pred eecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCCCccc
Q 012762 166 EFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTA 245 (457)
Q Consensus 166 E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~~~~~ 245 (457)
||+.+++|..++..+ ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++........
T Consensus 77 e~~~~~~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~-- 152 (279)
T cd05633 77 DLMNGGDLHYHLSQH--GVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP-- 152 (279)
T ss_pred ecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccCc--
Confidence 999999998888764 5699999999999999999999999999999999999999999999999998753321100
Q ss_pred ccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCCCCcc
Q 012762 246 QLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTHEYL 325 (457)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 325 (457)
....|+..|+
T Consensus 153 ----------------------------------------------------------------------~~~~~~~~y~ 162 (279)
T cd05633 153 ----------------------------------------------------------------------HASVGTHGYM 162 (279)
T ss_pred ----------------------------------------------------------------------cCcCCCcCcc
Confidence 0124899999
Q ss_pred Cchhhc-CCCCCccchhhhhhHHHHHHhcCCCCCCCCChH--HHHHHHHhcccCCCCCCCCChHHHHHHHHHhhhCCCCC
Q 012762 326 APEIIS-GEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHE--LTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDPTRR 402 (457)
Q Consensus 326 aPE~l~-~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R 402 (457)
|||.+. +..++.++|||||||++|+|++|..||...... ....... .......+..++.++.++|.+||..||++|
T Consensus 163 aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 241 (279)
T cd05633 163 APEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT-LTVNVELPDSFSPELKSLLEGLLQRDVSKR 241 (279)
T ss_pred CHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHh-hcCCcCCccccCHHHHHHHHHHhcCCHHHh
Confidence 999986 456899999999999999999999999764321 1221111 112222234588999999999999999999
Q ss_pred CCC-CcChHHHhcCCCCCCCCchhhh--ccCCCCCCC
Q 012762 403 MGS-KMGATAIKRHQFFNGVNWALLR--CAKPPFIPR 436 (457)
Q Consensus 403 ps~-~~~~~~ll~hp~f~~~~~~~~~--~~~~~~~~~ 436 (457)
++. ...+.++++||||++.+|.... ...+|.+|.
T Consensus 242 ~~~~~~~~~~~~~h~~~~~~~~~~~~~~~~~~~~~~~ 278 (279)
T cd05633 242 LGCLGRGAQEVKEHVFFKGIDWQQVYLQKYPPPLIPP 278 (279)
T ss_pred cCCCCCCHHHHHhCccccCCCHhHHhcCCCCCCCCCC
Confidence 931 1129999999999999997653 334566654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=371.94 Aligned_cols=260 Identities=28% Similarity=0.440 Sum_probs=221.7
Q ss_pred CCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcE
Q 012762 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWS 161 (457)
Q Consensus 82 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~ 161 (457)
+.|.|+..||.|+||.||+|..+ .++...|.|++... +......+..|++||..|+||+||++++.|..++.+
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nk----et~~lAAaKvIetk---seEELEDylVEIeILa~CdHP~ivkLl~ayy~enkL 104 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNK----ETKLLAAAKVIETK---SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKL 104 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcc----cchhhhhhhhhccc---chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCce
Confidence 45889999999999999998866 47777888998543 345566778899999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCC
Q 012762 162 CLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNS 241 (457)
Q Consensus 162 ~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~ 241 (457)
+|+.|||.||-...++-.. ++.+++.++.-+|+|+|.||.|||+++|||||||..|||++.+|.++|+|||.+.....
T Consensus 105 wiliEFC~GGAVDaimlEL-~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~- 182 (1187)
T KOG0579|consen 105 WILIEFCGGGAVDAIMLEL-GRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS- 182 (1187)
T ss_pred EEEEeecCCchHhHHHHHh-ccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchh-
Confidence 9999999999987666554 47899999999999999999999999999999999999999999999999998633210
Q ss_pred CcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCC
Q 012762 242 TSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGT 321 (457)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 321 (457)
...+..+|+||
T Consensus 183 ---------------------------------------------------------------------t~qkRDsFIGT 193 (1187)
T KOG0579|consen 183 ---------------------------------------------------------------------TRQKRDSFIGT 193 (1187)
T ss_pred ---------------------------------------------------------------------HHhhhccccCC
Confidence 12234478999
Q ss_pred CCccCchhhc-----CCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccC-CCCCCCCChHHHHHHHHHh
Q 012762 322 HEYLAPEIIS-----GEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALE-FPKEPSVPGPAKDLIAQLL 395 (457)
Q Consensus 322 ~~y~aPE~l~-----~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ll~~~L 395 (457)
|+|||||+.. ..+|++++||||||++|.||.-+.+|....+....+.++.....+ +-.+..|+..+.|+|.+||
T Consensus 194 PYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws~~F~DfLk~cL 273 (1187)
T KOG0579|consen 194 PYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWSRSFSDFLKRCL 273 (1187)
T ss_pred cccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhhhHHHHHHHHHH
Confidence 9999999975 457999999999999999999999999888777777666554332 3344568899999999999
Q ss_pred hhCCCCCCCCCcChHHHhcCCCCCCCCc
Q 012762 396 VKDPTRRMGSKMGATAIKRHQFFNGVNW 423 (457)
Q Consensus 396 ~~dP~~Rps~~~~~~~ll~hp~f~~~~~ 423 (457)
..||..||+ +.+||+||||.+++-
T Consensus 274 ~Knp~~Rp~----aaqll~Hpfv~~~~S 297 (1187)
T KOG0579|consen 274 VKNPRNRPP----AAQLLKHPFVQNAPS 297 (1187)
T ss_pred hcCCccCCC----HHHHhhCcccccCCc
Confidence 999999999 999999999997643
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=362.19 Aligned_cols=256 Identities=25% Similarity=0.377 Sum_probs=204.3
Q ss_pred cCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcC-
Q 012762 80 TLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCP- 158 (457)
Q Consensus 80 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~- 158 (457)
..++|++.+.||+|+||.||+|.+. ..++.||+|++..... .......+.+|+.+++.++|+||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~----~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 89 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDA----VLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQK 89 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEec----CCCceEEEEEeCCccc-ChHHHHHHHHHHHHHHHhCCCchhceeeeeeccc
Confidence 4578999999999999999999876 4788999999865322 223445677799999999999999999988643
Q ss_pred -----CcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccC
Q 012762 159 -----RWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFD 233 (457)
Q Consensus 159 -----~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG 233 (457)
...|+||||++ ++|...+.. .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 90 ~~~~~~~~~lv~e~~~-~~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg 164 (355)
T cd07874 90 SLEEFQDVYLVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG 164 (355)
T ss_pred cccccceeEEEhhhhc-ccHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCc
Confidence 35799999995 566655543 48899999999999999999999999999999999999999999999999
Q ss_pred CCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcc
Q 012762 234 LSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDV 313 (457)
Q Consensus 234 ~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (457)
+++.......
T Consensus 165 ~~~~~~~~~~---------------------------------------------------------------------- 174 (355)
T cd07874 165 LARTAGTSFM---------------------------------------------------------------------- 174 (355)
T ss_pred ccccCCCccc----------------------------------------------------------------------
Confidence 9854321100
Q ss_pred ccccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhccc------------------
Q 012762 314 RSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARAL------------------ 375 (457)
Q Consensus 314 ~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~------------------ 375 (457)
.....||..|+|||++.+..++.++|||||||++|+|++|+.||.+.........++....
T Consensus 175 -~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (355)
T cd07874 175 -MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYV 253 (355)
T ss_pred -cCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHHHH
Confidence 0123689999999999999999999999999999999999999987664433332222100
Q ss_pred ----C-----CC-------------CCCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCC
Q 012762 376 ----E-----FP-------------KEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNG 420 (457)
Q Consensus 376 ----~-----~~-------------~~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~ 420 (457)
. ++ .....+.++++||.+||..||++||| +.|+|+||||+.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps----~~ell~hp~~~~ 316 (355)
T cd07874 254 ENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS----VDEALQHPYINV 316 (355)
T ss_pred hcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCC----HHHHhcCcchhc
Confidence 0 00 01123457899999999999999999 999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=350.05 Aligned_cols=251 Identities=16% Similarity=0.172 Sum_probs=210.0
Q ss_pred ccCCCceeE--EEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEE
Q 012762 79 LTLSDLRFV--HRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLD 156 (457)
Q Consensus 79 ~~~~~~~~~--~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~ 156 (457)
+..+++... ..||+|++|.||+|.+ +|+.||+|++++.........+.+.+|+++|++++||||+++++++.
T Consensus 15 i~~~~i~~~~~~~i~~g~~~~v~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~ 88 (283)
T PHA02988 15 IESDDIDKYTSVLIKENDQNSIYKGIF------NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFII 88 (283)
T ss_pred cCHHHcCCCCCeEEeeCCceEEEEEEE------CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEE
Confidence 344445444 6799999999999986 57899999997654333333567788999999999999999999987
Q ss_pred c----CCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCceeecCCCCCeEEccCCCEEEec
Q 012762 157 C----PRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHM-MGIIYRDLKPENVLVRSDGHIMLTD 231 (457)
Q Consensus 157 ~----~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~-~~iiHrDIKp~NIll~~~~~vkl~D 231 (457)
+ ...+++||||+++|+|.+++... ..+++.....++.|++.||.|||+ .+++||||||+|||++.++.+||+|
T Consensus 89 ~~~~~~~~~~lv~Ey~~~g~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~d 166 (283)
T PHA02988 89 DIVDDLPRLSLILEYCTRGYLREVLDKE--KDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIIC 166 (283)
T ss_pred ecccCCCceEEEEEeCCCCcHHHHHhhC--CCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcc
Confidence 6 35789999999999999998764 568899999999999999999998 4999999999999999999999999
Q ss_pred cCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCC
Q 012762 232 FDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPL 311 (457)
Q Consensus 232 FG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (457)
||+++......
T Consensus 167 fg~~~~~~~~~--------------------------------------------------------------------- 177 (283)
T PHA02988 167 HGLEKILSSPP--------------------------------------------------------------------- 177 (283)
T ss_pred cchHhhhcccc---------------------------------------------------------------------
Confidence 99975432110
Q ss_pred ccccccccCCCCccCchhhcC--CCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHH
Q 012762 312 DVRSMSFVGTHEYLAPEIISG--EGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKD 389 (457)
Q Consensus 312 ~~~~~~~~gt~~y~aPE~l~~--~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (457)
....|+..|+|||++.+ ..++.++|||||||++|||++|..||.+....+.+..++....+.+.+..++..+++
T Consensus 178 ----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~ 253 (283)
T PHA02988 178 ----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKC 253 (283)
T ss_pred ----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCcHHHHH
Confidence 01258899999999976 578999999999999999999999999887777777776666565555568899999
Q ss_pred HHHHHhhhCCCCCCCCCcChHHHhc
Q 012762 390 LIAQLLVKDPTRRMGSKMGATAIKR 414 (457)
Q Consensus 390 ll~~~L~~dP~~Rps~~~~~~~ll~ 414 (457)
|+.+||+.||++||+ +.+|++
T Consensus 254 li~~cl~~dp~~Rps----~~ell~ 274 (283)
T PHA02988 254 IVEACTSHDSIKRPN----IKEILY 274 (283)
T ss_pred HHHHHhcCCcccCcC----HHHHHH
Confidence 999999999999999 777764
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-46 Score=338.62 Aligned_cols=254 Identities=29% Similarity=0.431 Sum_probs=217.0
Q ss_pred cCCCceeE-EEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHc-CCCCCceEEEEEEc
Q 012762 80 TLSDLRFV-HRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEML-DHPFLPTLYATLDC 157 (457)
Q Consensus 80 ~~~~~~~~-~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~~~~~~ 157 (457)
..+||.+. ++||-|-.|.|-.|.++. +++.+|+|++.. ....++|+++--+. .|||||.++++|.+
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~----T~ekfALKvL~D--------s~KARrEVeLHw~~s~h~~iV~IidVyeN 126 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKR----TQEKFALKVLLD--------SPKARREVELHWMASGHPHIVSIIDVYEN 126 (400)
T ss_pred chhhheehhhhhccccCCceEEEEecc----chhhhHHHHHhc--------CHHHHhHhhhhhhhcCCCceEEeehhhhh
Confidence 34678774 689999999999999884 899999999842 23456788875554 79999999998854
Q ss_pred ----CCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEcc---CCCEEEe
Q 012762 158 ----PRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRS---DGHIMLT 230 (457)
Q Consensus 158 ----~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~---~~~vkl~ 230 (457)
...+.+|||.++||.|...++.+....|+|.++..|+.||+.|+.|||+.+|.||||||+|+|... +..+||+
T Consensus 127 s~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLt 206 (400)
T KOG0604|consen 127 SYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLT 206 (400)
T ss_pred hccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEec
Confidence 356789999999999999999988888999999999999999999999999999999999999974 4579999
Q ss_pred ccCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccC
Q 012762 231 DFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEP 310 (457)
Q Consensus 231 DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (457)
|||||+.-...
T Consensus 207 DfGFAK~t~~~--------------------------------------------------------------------- 217 (400)
T KOG0604|consen 207 DFGFAKETQEP--------------------------------------------------------------------- 217 (400)
T ss_pred ccccccccCCC---------------------------------------------------------------------
Confidence 99999754321
Q ss_pred CccccccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCCh----HHHHHHHHhcccCCCC--CCCCC
Q 012762 311 LDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDH----ELTLANVVARALEFPK--EPSVP 384 (457)
Q Consensus 311 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~----~~~~~~~~~~~~~~~~--~~~~~ 384 (457)
...++-+-|+.|.|||++....|+...|+||+||++|-|++|.+||+.... ..+-.+|..+.+.||. +..++
T Consensus 218 --~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pEWs~VS 295 (400)
T KOG0604|consen 218 --GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPEWSCVS 295 (400)
T ss_pred --ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChhHhHHH
Confidence 112234689999999999999999999999999999999999999987643 3456777788888875 45788
Q ss_pred hHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCC
Q 012762 385 GPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNG 420 (457)
Q Consensus 385 ~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~ 420 (457)
++.+|+|+++|..+|++|.+ ++++++|||..+
T Consensus 296 e~aKdlIR~LLkt~PteRlT----I~~~m~hpwi~~ 327 (400)
T KOG0604|consen 296 EAAKDLIRKLLKTEPTERLT----IEEVMDHPWINQ 327 (400)
T ss_pred HHHHHHHHHHhcCCchhhee----HHHhhcCchhcc
Confidence 99999999999999999999 999999999986
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=343.71 Aligned_cols=258 Identities=40% Similarity=0.712 Sum_probs=219.4
Q ss_pred ecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcEEEEEeecC
Q 012762 90 LGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWSCLLTEFCP 169 (457)
Q Consensus 90 LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lV~E~~~ 169 (457)
||.|+||.||+|.+. .++..||+|++.+...........+..|+++++.++|+||+++++++..+...|+||||++
T Consensus 1 lg~g~~~~v~~~~~~----~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 76 (262)
T cd05572 1 LGVGGFGRVELVKVK----SKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCL 76 (262)
T ss_pred CCCCCceEEEEEEEC----CCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCC
Confidence 699999999999986 3688999999987655544556778899999999999999999999999999999999999
Q ss_pred CCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCCCccccccc
Q 012762 170 GGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQLVS 249 (457)
Q Consensus 170 ~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~~~~~~~~~ 249 (457)
+++|.+++... ..+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 77 ~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~------- 147 (262)
T cd05572 77 GGELWTILRDR--GLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ------- 147 (262)
T ss_pred CCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-------
Confidence 99999988765 558999999999999999999999999999999999999999999999999976543211
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCCCCccCchh
Q 012762 250 DQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTHEYLAPEI 329 (457)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 329 (457)
......|+..|++||.
T Consensus 148 ----------------------------------------------------------------~~~~~~~~~~~~~PE~ 163 (262)
T cd05572 148 ----------------------------------------------------------------KTWTFCGTPEYVAPEI 163 (262)
T ss_pred ----------------------------------------------------------------ccccccCCcCccChhH
Confidence 0012358889999999
Q ss_pred hcCCCCCccchhhhhhHHHHHHhcCCCCCCCCC--hHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhhhCCCCCCCC-C
Q 012762 330 ISGEGHGNAVDWWTLGIFIFELFYGTTPFKGID--HELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDPTRRMGS-K 406 (457)
Q Consensus 330 l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rps~-~ 406 (457)
+.+..++.++|+||||+++|+|++|..||.... .......+.........+..++.++.++|.+||..||++||++ +
T Consensus 164 ~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ 243 (262)
T cd05572 164 ILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEERLGNLK 243 (262)
T ss_pred hcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCChhhCcCCcc
Confidence 988889999999999999999999999998766 4455555553333333334468899999999999999999995 3
Q ss_pred cChHHHhcCCCCCCCCch
Q 012762 407 MGATAIKRHQFFNGVNWA 424 (457)
Q Consensus 407 ~~~~~ll~hp~f~~~~~~ 424 (457)
..+.|+++||||++++|.
T Consensus 244 ~~~~~l~~~~~~~~~~~~ 261 (262)
T cd05572 244 GGIKDIKKHKWFNGFDWE 261 (262)
T ss_pred cCHHHHhcChhhhCCCCC
Confidence 468999999999999985
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-44 Score=364.89 Aligned_cols=254 Identities=24% Similarity=0.312 Sum_probs=201.6
Q ss_pred cCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCC
Q 012762 80 TLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPR 159 (457)
Q Consensus 80 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~ 159 (457)
....|.+.+.||+|+||.||+|.+. ..++.||||.... ..+.+|+++|++|+|+|||++++++..++
T Consensus 167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~----~~~~~vavK~~~~---------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~ 233 (461)
T PHA03211 167 AGLGFAIHRALTPGSEGCVFESSHP----DYPQRVVVKAGWY---------ASSVHEARLLRRLSHPAVLALLDVRVVGG 233 (461)
T ss_pred ccCCeEEEEEEccCCCeEEEEEEEC----CCCCEEEEecccc---------cCHHHHHHHHHHCCCCCCCcEEEEEEECC
Confidence 3457999999999999999999876 3678999996432 23456999999999999999999999999
Q ss_pred cEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCC
Q 012762 160 WSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGD 239 (457)
Q Consensus 160 ~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~ 239 (457)
..|||||++ .++|..++... ...+++..++.++.||+.||.|||++|||||||||+||||+.++.+||+|||+++...
T Consensus 234 ~~~lv~e~~-~~~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~ 311 (461)
T PHA03211 234 LTCLVLPKY-RSDLYTYLGAR-LRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFAR 311 (461)
T ss_pred EEEEEEEcc-CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceecc
Confidence 999999999 57887777653 2469999999999999999999999999999999999999999999999999986442
Q ss_pred CCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcccccccc
Q 012762 240 NSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFV 319 (457)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (457)
..... .....+.
T Consensus 312 ~~~~~--------------------------------------------------------------------~~~~~~~ 323 (461)
T PHA03211 312 GSWST--------------------------------------------------------------------PFHYGIA 323 (461)
T ss_pred ccccc--------------------------------------------------------------------ccccccC
Confidence 11000 0001246
Q ss_pred CCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCCh-------HHHHHHHHhc-ccC---CC----------
Q 012762 320 GTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDH-------ELTLANVVAR-ALE---FP---------- 378 (457)
Q Consensus 320 gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~-------~~~~~~~~~~-~~~---~~---------- 378 (457)
||..|+|||++.+..++.++|||||||+||||++|..|+..... ...+.+++.. ... ++
T Consensus 324 GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~ 403 (461)
T PHA03211 324 GTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQ 403 (461)
T ss_pred CCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHHHHH
Confidence 99999999999999999999999999999999998765533211 1122222221 110 00
Q ss_pred -------------------CCCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCC
Q 012762 379 -------------------KEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNG 420 (457)
Q Consensus 379 -------------------~~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~ 420 (457)
....++.++.+||.+||+.||.+||+ +.|||+||||++
T Consensus 404 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPs----a~elL~hp~f~~ 460 (461)
T PHA03211 404 YRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPS----AAELLRLPLFQS 460 (461)
T ss_pred HHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcC----HHHHhhCcccCC
Confidence 00124557899999999999999999 999999999975
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=357.09 Aligned_cols=265 Identities=21% Similarity=0.346 Sum_probs=208.0
Q ss_pred eEEEeccc--CcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcEEE
Q 012762 86 FVHRLGSG--DIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWSCL 163 (457)
Q Consensus 86 ~~~~LG~G--~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~l 163 (457)
++++||+| +||+||++.++ .+|+.||+|++..... .......+..|+++++.++||||+++++++..++..|+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~----~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~l 76 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYK----PTGEYVTVRRINLEAC-TNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 76 (327)
T ss_pred hhhhccccccceEEEEEEeec----ccCcEEEEEEechhhc-cHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEE
Confidence 56789999 78899999887 4899999999976532 22345567789999999999999999999999999999
Q ss_pred EEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCCCc
Q 012762 164 LTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTS 243 (457)
Q Consensus 164 V~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~~~ 243 (457)
||||+++++|.+++..+....+++..++.++.||+.||.|||++||+||||||+|||++.++.++++||+..........
T Consensus 77 v~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~ 156 (327)
T cd08227 77 VTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ 156 (327)
T ss_pred EEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence 99999999999998765556699999999999999999999999999999999999999999999999986532211000
Q ss_pred ccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCCCC
Q 012762 244 TAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTHE 323 (457)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 323 (457)
... ...+ ......++..
T Consensus 157 ~~~--------------------------------------------------~~~~-------------~~~~~~~~~~ 173 (327)
T cd08227 157 RLR--------------------------------------------------VVHD-------------FPKYSVKVLP 173 (327)
T ss_pred ccc--------------------------------------------------cccc-------------ccccccceec
Confidence 000 0000 0001247788
Q ss_pred ccCchhhcC--CCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCC------------------------
Q 012762 324 YLAPEIISG--EGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEF------------------------ 377 (457)
Q Consensus 324 y~aPE~l~~--~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~------------------------ 377 (457)
|+|||++.+ ..++.++|||||||++|||++|..||...................
T Consensus 174 y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (327)
T cd08227 174 WLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSG 253 (327)
T ss_pred ccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhhhcccCCcccCCcCC
Confidence 999999976 358999999999999999999999998765444333332221110
Q ss_pred --------------------CCCCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCCCC
Q 012762 378 --------------------PKEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGVN 422 (457)
Q Consensus 378 --------------------~~~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~~~ 422 (457)
+....+++.+.+||.+||+.||++||+ ++++++||||+.+.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt----~~ell~~p~f~~~~ 314 (327)
T cd08227 254 LGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPS----ASTLLNHSFFKQIK 314 (327)
T ss_pred CCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCC----HHHHhcChhhhhcc
Confidence 011134568999999999999999999 99999999998754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-44 Score=349.67 Aligned_cols=261 Identities=24% Similarity=0.374 Sum_probs=211.1
Q ss_pred cCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCC
Q 012762 80 TLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPR 159 (457)
Q Consensus 80 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~ 159 (457)
.+++|++.++||.|+||.||+|.++ .+++.||+|.+..... ......+.+|+++++.++|+||+++++++...+
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~----~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~ 77 (301)
T cd07873 4 KLETYIKLDKLGEGTYATVYKGRSK----LTDNLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEK 77 (301)
T ss_pred cccceEEeeEeccCcCEEEEEEEEc----CCCcEEEEEEEecccc--cCchhHHHHHHHHHHhcCCCCcceEEEEEecCC
Confidence 4678999999999999999999876 3778999999865422 223345667999999999999999999999999
Q ss_pred cEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCC
Q 012762 160 WSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGD 239 (457)
Q Consensus 160 ~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~ 239 (457)
..|+||||+. ++|..++... ...+++..++.++.||+.||.|||+.||+|+||||+|||++.++.++|+|||++....
T Consensus 78 ~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 155 (301)
T cd07873 78 SLTLVFEYLD-KDLKQYLDDC-GNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKS 155 (301)
T ss_pred eEEEEEeccc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccC
Confidence 9999999995 6888777654 3568999999999999999999999999999999999999999999999999975332
Q ss_pred CCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcccccccc
Q 012762 240 NSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFV 319 (457)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (457)
..... .....
T Consensus 156 ~~~~~----------------------------------------------------------------------~~~~~ 165 (301)
T cd07873 156 IPTKT----------------------------------------------------------------------YSNEV 165 (301)
T ss_pred CCCCc----------------------------------------------------------------------ccccc
Confidence 11000 00124
Q ss_pred CCCCccCchhhcCC-CCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcc-------------------cCCCC
Q 012762 320 GTHEYLAPEIISGE-GHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARA-------------------LEFPK 379 (457)
Q Consensus 320 gt~~y~aPE~l~~~-~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~-------------------~~~~~ 379 (457)
+++.|+|||++.+. .++.++|||||||++|||++|++||.+.+..+....+.... ...+.
T Consensus 166 ~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (301)
T cd07873 166 VTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNYPK 245 (301)
T ss_pred eeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccccccCc
Confidence 78899999998764 47889999999999999999999998876544433332210 01111
Q ss_pred ---------CCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCCCC
Q 012762 380 ---------EPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGVN 422 (457)
Q Consensus 380 ---------~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~~~ 422 (457)
...+++++++||.+||..||.+||| ++++++||||+.+.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t----~~eil~h~~f~~~~ 293 (301)
T cd07873 246 YRADCLHNHAPRLDSDGAELLSKLLQFEGRKRIS----AEEAMKHPYFHCLG 293 (301)
T ss_pred cccccHHhhcCCCCHHHHHHHHHHhcCCcccCcC----HHHHhcCccccccc
Confidence 1246788999999999999999999 99999999998765
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-44 Score=339.08 Aligned_cols=256 Identities=23% Similarity=0.384 Sum_probs=218.6
Q ss_pred CceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcEE
Q 012762 83 DLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWSC 162 (457)
Q Consensus 83 ~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~ 162 (457)
+|.+.+.||+|+||.||+|.++ .++..|++|.+...... ......+..|+++++.++|+||+++++++...+..|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~----~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 75 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRK----ADKRVYAMKQIDLSKMN-RREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLN 75 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEc----CCCcEEEEEEeehhhCC-HHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEE
Confidence 5889999999999999999987 47889999998765433 334566788999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCCC
Q 012762 163 LLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNST 242 (457)
Q Consensus 163 lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~~ 242 (457)
+||||+++++|.+++.......+++..+..++.||+.||.|||+.||+|+||||+||+++.++.++|+|||+++......
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~ 155 (256)
T cd08529 76 IVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT 155 (256)
T ss_pred EEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCcc
Confidence 99999999999999887655779999999999999999999999999999999999999999999999999876443211
Q ss_pred cccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCCC
Q 012762 243 STAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTH 322 (457)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 322 (457)
.. .....|+.
T Consensus 156 ~~----------------------------------------------------------------------~~~~~~~~ 165 (256)
T cd08529 156 NF----------------------------------------------------------------------ANTIVGTP 165 (256)
T ss_pred ch----------------------------------------------------------------------hhccccCc
Confidence 00 01235888
Q ss_pred CccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhhhCCCCC
Q 012762 323 EYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDPTRR 402 (457)
Q Consensus 323 ~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R 402 (457)
.|+|||++.+..++.++|||||||++|+|++|+.||...........+....... ....++.++.+++.+||+.+|++|
T Consensus 166 ~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~p~~R 244 (256)
T cd08529 166 YYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPP-VSQMYSQQLAQLIDQCLTKDYRQR 244 (256)
T ss_pred cccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC-CccccCHHHHHHHHHHccCCcccC
Confidence 9999999999889999999999999999999999998877666666655543322 222578899999999999999999
Q ss_pred CCCCcChHHHhcCCCC
Q 012762 403 MGSKMGATAIKRHQFF 418 (457)
Q Consensus 403 ps~~~~~~~ll~hp~f 418 (457)
|+ +.++++|||+
T Consensus 245 p~----~~~ll~~~~~ 256 (256)
T cd08529 245 PD----TFQLLRNPSL 256 (256)
T ss_pred cC----HHHHhhCCCC
Confidence 99 9999999985
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=360.32 Aligned_cols=255 Identities=27% Similarity=0.383 Sum_probs=206.5
Q ss_pred CCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcC--
Q 012762 81 LSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCP-- 158 (457)
Q Consensus 81 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~-- 158 (457)
.++|++++.||.|+||+||+|.+. .+++.||||++.+... .......+.+|+++|+.++|+||+++++++...
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~----~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 88 (343)
T cd07878 14 PERYQNLTPVGSGAYGSVCSAYDT----RLRQKVAVKKLSRPFQ-SLIHARRTYRELRLLKHMKHENVIGLLDVFTPATS 88 (343)
T ss_pred hhhhhhheecccCCCeEEEEEEEC----CCCCEEEEEEeCchhh-hhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccc
Confidence 368999999999999999999876 4788999999875422 222345567799999999999999999987543
Q ss_pred ----CcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCC
Q 012762 159 ----RWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDL 234 (457)
Q Consensus 159 ----~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~ 234 (457)
...|++||++ +++|..++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 89 ~~~~~~~~~~~~~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~ 164 (343)
T cd07878 89 IENFNEVYLVTNLM-GADLNNIVKC---QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGL 164 (343)
T ss_pred ccccCcEEEEeecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCcc
Confidence 3579999998 8999887754 5699999999999999999999999999999999999999999999999999
Q ss_pred CcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccc
Q 012762 235 SLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVR 314 (457)
Q Consensus 235 s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (457)
++.....
T Consensus 165 ~~~~~~~------------------------------------------------------------------------- 171 (343)
T cd07878 165 ARQADDE------------------------------------------------------------------------- 171 (343)
T ss_pred ceecCCC-------------------------------------------------------------------------
Confidence 7543211
Q ss_pred cccccCCCCccCchhhcC-CCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccC-----------------
Q 012762 315 SMSFVGTHEYLAPEIISG-EGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALE----------------- 376 (457)
Q Consensus 315 ~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~----------------- 376 (457)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+......+..+......
T Consensus 172 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (343)
T cd07878 172 MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKY 251 (343)
T ss_pred cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhHHHH
Confidence 012368999999999987 46899999999999999999999999876554444333221100
Q ss_pred ------CCC------CCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCCC
Q 012762 377 ------FPK------EPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGV 421 (457)
Q Consensus 377 ------~~~------~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~~ 421 (457)
.+. ....++.+.+||.+||..||.+||+ +.|+++||||...
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s----~~ell~hp~~~~~ 304 (343)
T cd07878 252 IQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRIS----ASEALAHPYFSQY 304 (343)
T ss_pred hhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCC----HHHHhcCcchhcc
Confidence 000 0124566899999999999999999 9999999999864
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-44 Score=348.16 Aligned_cols=265 Identities=28% Similarity=0.460 Sum_probs=218.4
Q ss_pred cCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCC
Q 012762 80 TLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPR 159 (457)
Q Consensus 80 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~ 159 (457)
..+.|+++++||.|+||.||+|++. .++..||+|++.... ......+..|+++++.++|+||+++++++..++
T Consensus 10 ~~~~y~i~~~lg~g~~g~vy~~~~~----~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 82 (292)
T cd06644 10 PNEVWEIIGELGDGAFGKVYKAKNK----ETGALAAAKVIETKS---EEELEDYMVEIEILATCNHPYIVKLLGAFYWDG 82 (292)
T ss_pred cchhhhhhheecCCCCeEEEEEEEC----CCCceEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCC
Confidence 3467999999999999999999876 478899999986542 234566778999999999999999999999999
Q ss_pred cEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCC
Q 012762 160 WSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGD 239 (457)
Q Consensus 160 ~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~ 239 (457)
..|+||||+++++|..++... ...+++..+..++.||+.+|.|||+.||+||||||+||+++.++.++|+|||++....
T Consensus 83 ~~~lv~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 161 (292)
T cd06644 83 KLWIMIEFCPGGAVDAIMLEL-DRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNV 161 (292)
T ss_pred eEEEEEecCCCCcHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceecc
Confidence 999999999999998776543 2568999999999999999999999999999999999999999999999999864322
Q ss_pred CCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcccccccc
Q 012762 240 NSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFV 319 (457)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (457)
.... ......
T Consensus 162 ~~~~----------------------------------------------------------------------~~~~~~ 171 (292)
T cd06644 162 KTLQ----------------------------------------------------------------------RRDSFI 171 (292)
T ss_pred cccc----------------------------------------------------------------------ccceec
Confidence 1100 001235
Q ss_pred CCCCccCchhhc-----CCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhccc-CCCCCCCCChHHHHHHHH
Q 012762 320 GTHEYLAPEIIS-----GEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARAL-EFPKEPSVPGPAKDLIAQ 393 (457)
Q Consensus 320 gt~~y~aPE~l~-----~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ll~~ 393 (457)
|+..|+|||++. ...++.++|||||||++|||++|..||..........++..... .......++.++.++|.+
T Consensus 172 ~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 251 (292)
T cd06644 172 GTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEFRDFLKT 251 (292)
T ss_pred CCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCCcccCHHHHHHHHH
Confidence 888999999985 34468899999999999999999999987665555544443322 222334577899999999
Q ss_pred HhhhCCCCCCCCCcChHHHhcCCCCCCCCchhh
Q 012762 394 LLVKDPTRRMGSKMGATAIKRHQFFNGVNWALL 426 (457)
Q Consensus 394 ~L~~dP~~Rps~~~~~~~ll~hp~f~~~~~~~~ 426 (457)
||..||++||+ +.++++||||..++|+..
T Consensus 252 ~l~~~p~~Rp~----~~~il~~~~~~~~~~~~~ 280 (292)
T cd06644 252 ALDKHPETRPS----AAQLLEHPFVSSVTSNRP 280 (292)
T ss_pred HhcCCcccCcC----HHHHhcCccccccccchh
Confidence 99999999999 999999999999999754
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-45 Score=362.29 Aligned_cols=260 Identities=27% Similarity=0.470 Sum_probs=234.5
Q ss_pred CCccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEE
Q 012762 77 NPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLD 156 (457)
Q Consensus 77 ~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~ 156 (457)
.......|.++..||+|.|++|.+|++. .++..||||++++.........+ +.+|++||+.|+|||||+++.+..
T Consensus 51 ~~~~vg~y~i~~tig~g~f~~V~La~~~----~t~~~VaiK~idkt~ln~~~~~k-~~rev~imk~l~HPnIvkl~~v~~ 125 (596)
T KOG0586|consen 51 DSNSVGLYVIIKTIGKGNFAKVKLARHI----LTGTEVAIKIIDKTQLNPSKRQK-LGREVDIMKSLNHPNIVKLFSVIE 125 (596)
T ss_pred ccccccceeeeeeeccceeEEEEeeEec----CCCceEEEEEehhcccChHHHHH-HHHHHHHHHhcCCcceeeeeeeee
Confidence 3445678999999999999999999987 47899999999887654443334 778999999999999999999999
Q ss_pred cCCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCc
Q 012762 157 CPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSL 236 (457)
Q Consensus 157 ~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~ 236 (457)
....+|+||||+.+|.+++++..+ +++.+..++.++.|++.|++|||+++|||||||++||||+.+.++||+|||++.
T Consensus 126 t~~~lylV~eya~~ge~~~yl~~~--gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~ 203 (596)
T KOG0586|consen 126 TEATLYLVMEYASGGELFDYLVKH--GRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFST 203 (596)
T ss_pred ecceeEEEEEeccCchhHHHHHhc--ccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccce
Confidence 999999999999999999999886 788889999999999999999999999999999999999999999999999987
Q ss_pred CCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccc
Q 012762 237 KGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSM 316 (457)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (457)
.+... ....
T Consensus 204 ~~~~~-----------------------------------------------------------------------~~lq 212 (596)
T KOG0586|consen 204 FFDYG-----------------------------------------------------------------------LMLQ 212 (596)
T ss_pred eeccc-----------------------------------------------------------------------cccc
Confidence 66421 1123
Q ss_pred cccCCCCccCchhhcCCCC-CccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHh
Q 012762 317 SFVGTHEYLAPEIISGEGH-GNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLL 395 (457)
Q Consensus 317 ~~~gt~~y~aPE~l~~~~~-~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L 395 (457)
+++|++.|.|||++.|..| ++.+|+||+|+++|-|+.|..||++..-.+.-.+.+.+.++.|.. ++.+..++|+++|
T Consensus 213 t~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~~--ms~dce~lLrk~l 290 (596)
T KOG0586|consen 213 TFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPFY--MSCDCEDLLRKFL 290 (596)
T ss_pred ccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecccce--eechhHHHHHHhh
Confidence 6789999999999999987 789999999999999999999999999888888999999999887 7888999999999
Q ss_pred hhCCCCCCCCCcChHHHhcCCCCCC
Q 012762 396 VKDPTRRMGSKMGATAIKRHQFFNG 420 (457)
Q Consensus 396 ~~dP~~Rps~~~~~~~ll~hp~f~~ 420 (457)
..+|.+|++ ++++.+|.|...
T Consensus 291 vl~Pskr~~----~dqim~~~W~n~ 311 (596)
T KOG0586|consen 291 VLNPSKRGP----CDQIMKDRWRND 311 (596)
T ss_pred ccCccccCC----HHHhhhhcccch
Confidence 999999999 999999999874
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-44 Score=345.05 Aligned_cols=255 Identities=26% Similarity=0.407 Sum_probs=210.1
Q ss_pred CCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHc-CCCCCceEEEEEEcC--
Q 012762 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEML-DHPFLPTLYATLDCP-- 158 (457)
Q Consensus 82 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~~~~~~~-- 158 (457)
+.|++.+.||+|+||.||+|.++ .+++.||+|++.... .....+..|+++++++ +|+||+++++++...
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~----~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~ 77 (272)
T cd06637 6 GIFELVELVGNGTYGQVYKGRHV----KTGQLAAIKVMDVTG----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNP 77 (272)
T ss_pred hhhhHHHheeecCCeEEEEEEEc----CCCcEEEEEEEEcCC----ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCC
Confidence 46888999999999999999886 478899999986532 2345677799999998 799999999998653
Q ss_pred ----CcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCC
Q 012762 159 ----RWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDL 234 (457)
Q Consensus 159 ----~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~ 234 (457)
..+|+||||+.+++|..++.......+++..+..++.|++.||.|||+++|+|+||||+||+++.++.++|+|||+
T Consensus 78 ~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~ 157 (272)
T cd06637 78 PGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGV 157 (272)
T ss_pred CCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCC
Confidence 4589999999999999998876556799999999999999999999999999999999999999999999999999
Q ss_pred CcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccc
Q 012762 235 SLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVR 314 (457)
Q Consensus 235 s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (457)
+........ .
T Consensus 158 ~~~~~~~~~----------------------------------------------------------------------~ 167 (272)
T cd06637 158 SAQLDRTVG----------------------------------------------------------------------R 167 (272)
T ss_pred ceecccccc----------------------------------------------------------------------c
Confidence 754321100 0
Q ss_pred cccccCCCCccCchhhc-----CCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHH
Q 012762 315 SMSFVGTHEYLAPEIIS-----GEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKD 389 (457)
Q Consensus 315 ~~~~~gt~~y~aPE~l~-----~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (457)
.....|+..|+|||++. +..++.++|||||||++|||++|..||........................++.++.+
T Consensus 168 ~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (272)
T cd06637 168 RNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKWSKKFQS 247 (272)
T ss_pred CCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCCCCCCCcCHHHHH
Confidence 11346899999999986 3357889999999999999999999998765544444333333333333457889999
Q ss_pred HHHHHhhhCCCCCCCCCcChHHHhcCCCC
Q 012762 390 LIAQLLVKDPTRRMGSKMGATAIKRHQFF 418 (457)
Q Consensus 390 ll~~~L~~dP~~Rps~~~~~~~ll~hp~f 418 (457)
|+.+||..||.+||+ +.++++||||
T Consensus 248 li~~~l~~~p~~Rpt----~~~il~~~~~ 272 (272)
T cd06637 248 FIESCLVKNHSQRPT----TEQLMKHPFI 272 (272)
T ss_pred HHHHHcCCChhhCCC----HHHHhhCCCC
Confidence 999999999999999 9999999998
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-46 Score=364.59 Aligned_cols=254 Identities=24% Similarity=0.308 Sum_probs=223.4
Q ss_pred CceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcEE
Q 012762 83 DLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWSC 162 (457)
Q Consensus 83 ~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~ 162 (457)
-|.-++.||.|+||-||.|++. .+.+.||||.+....-.+..+...+..|+..|+.|.|||++.+.|+|..+...|
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~----~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaW 102 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDV----RNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAW 102 (948)
T ss_pred HHHHHHHhcCCccceeEEeecc----CccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHH
Confidence 3777899999999999999987 488999999997665555556677888999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCCC
Q 012762 163 LLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNST 242 (457)
Q Consensus 163 lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~~ 242 (457)
|||||| -|+-.+++..++ +++.+-++..|+.+.+.||.|||+.+.||||||..|||++..|.|||+|||.+-...
T Consensus 103 LVMEYC-lGSAsDlleVhk-KplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~--- 177 (948)
T KOG0577|consen 103 LVMEYC-LGSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMA--- 177 (948)
T ss_pred HHHHHH-hccHHHHHHHHh-ccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcC---
Confidence 999999 888888888764 789999999999999999999999999999999999999999999999999864332
Q ss_pred cccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCCC
Q 012762 243 STAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTH 322 (457)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 322 (457)
...+|+|||
T Consensus 178 -----------------------------------------------------------------------PAnsFvGTP 186 (948)
T KOG0577|consen 178 -----------------------------------------------------------------------PANSFVGTP 186 (948)
T ss_pred -----------------------------------------------------------------------chhcccCCc
Confidence 123689999
Q ss_pred CccCchhhcC---CCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhhhCC
Q 012762 323 EYLAPEIISG---EGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDP 399 (457)
Q Consensus 323 ~y~aPE~l~~---~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP 399 (457)
.|||||++.. ..|+-++||||||+++.||...++|+..++....+..|....-+.-..+.|++.+++||..||+.-|
T Consensus 187 ywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~~F~~Fvd~CLqKip 266 (948)
T KOG0577|consen 187 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIP 266 (948)
T ss_pred cccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHHHHHHHHHHHHhhCc
Confidence 9999999964 4589999999999999999999999998887777776666655544566799999999999999999
Q ss_pred CCCCCCCcChHHHhcCCCCCC
Q 012762 400 TRRMGSKMGATAIKRHQFFNG 420 (457)
Q Consensus 400 ~~Rps~~~~~~~ll~hp~f~~ 420 (457)
.+||| .+++|+|+|..-
T Consensus 267 qeRpt----se~ll~H~fv~R 283 (948)
T KOG0577|consen 267 QERPT----SEELLKHRFVLR 283 (948)
T ss_pred ccCCc----HHHHhhcchhcc
Confidence 99999 999999999854
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-45 Score=377.39 Aligned_cols=264 Identities=22% Similarity=0.355 Sum_probs=227.3
Q ss_pred CCCCCccCCCceeEEEecccCcceEEEEEEeccC-CCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEE
Q 012762 74 NNNNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKS-SNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLY 152 (457)
Q Consensus 74 ~~~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~-~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~ 152 (457)
.....+...+.++.++||+|+||+||+|+..... ......||||.++.. ........|++|+++|..|+|||||+|+
T Consensus 478 ~~~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~--a~~~~~~dF~REaeLla~l~H~nIVrLl 555 (774)
T KOG1026|consen 478 LKVLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDK--AENQARQDFRREAELLAELQHPNIVRLL 555 (774)
T ss_pred cceeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhccc--ccHHHHHHHHHHHHHHHhccCCCeEEEE
Confidence 3445677789999999999999999999875433 245578999999765 3344678899999999999999999999
Q ss_pred EEEEcCCcEEEEEeecCCCChHHHHHhCC------------CCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeE
Q 012762 153 ATLDCPRWSCLLTEFCPGGDLHVLRQRQP------------DKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVL 220 (457)
Q Consensus 153 ~~~~~~~~~~lV~E~~~~~sL~~~~~~~~------------~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIl 220 (457)
|+|.+++.+|||+|||..|+|.+++.... ...++..+.+.|+.||+.|++||-++.+|||||...|+|
T Consensus 556 GVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCL 635 (774)
T KOG1026|consen 556 GVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCL 635 (774)
T ss_pred EEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhce
Confidence 99999999999999999999999987632 123888999999999999999999999999999999999
Q ss_pred EccCCCEEEeccCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCC
Q 012762 221 VRSDGHIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGN 300 (457)
Q Consensus 221 l~~~~~vkl~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (457)
|.++..|||+|||+++..-........
T Consensus 636 Vge~l~VKIsDfGLsRdiYssDYYk~~----------------------------------------------------- 662 (774)
T KOG1026|consen 636 VGENLVVKISDFGLSRDIYSSDYYKVR----------------------------------------------------- 662 (774)
T ss_pred eccceEEEecccccchhhhhhhhhccc-----------------------------------------------------
Confidence 999999999999998765422221100
Q ss_pred CCCCcccccCCccccccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHHhcccCCCC
Q 012762 301 PGTPEIVAEPLDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVVARALEFPK 379 (457)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~ 379 (457)
. .-.-..+|||||.|....|+.+||||||||+|||+++ |..||.+..+++.++.+.++.. ++.
T Consensus 663 --------------~-~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g~l-L~~ 726 (774)
T KOG1026|consen 663 --------------G-NTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAGQL-LSC 726 (774)
T ss_pred --------------C-CceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHcCCc-ccC
Confidence 0 0023678999999999999999999999999999996 9999999999999999999988 888
Q ss_pred CCCCChHHHHHHHHHhhhCCCCCCCCCcChHHH
Q 012762 380 EPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAI 412 (457)
Q Consensus 380 ~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~l 412 (457)
+..+|.++.+||..||+.+|++||+ +.||
T Consensus 727 Pe~CP~~vY~LM~~CW~~~P~~RPs----F~eI 755 (774)
T KOG1026|consen 727 PENCPTEVYSLMLECWNENPKRRPS----FKEI 755 (774)
T ss_pred CCCCCHHHHHHHHHHhhcCcccCCC----HHHH
Confidence 8889999999999999999999999 6665
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=344.68 Aligned_cols=254 Identities=33% Similarity=0.600 Sum_probs=209.3
Q ss_pred ceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcEEE
Q 012762 84 LRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWSCL 163 (457)
Q Consensus 84 ~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~l 163 (457)
|++.+.||+|+||+||+|.+. .+++.||+|++......... .....+|+.+++.++|+||+++++++......|+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~----~~~~~~~~K~~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~ 75 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNK----KNGQKVAVKIIDKSEIEEEE-REENIREIKILRRLRHPNIVQILDVFQDDNYLYI 75 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEET----TTTEEEEEEEEESTTHHHHH-HHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEEC----CCCeEEEEEEeccccccccc-cchhhhhhhccccccccccccccccccccccccc
Confidence 789999999999999999987 47889999999887543332 2233459999999999999999999999999999
Q ss_pred EEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCCCc
Q 012762 164 LTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTS 243 (457)
Q Consensus 164 V~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~~~ 243 (457)
||||+++++|..++... ..+++..+..++.||+.||.+||+.||+|+||||+||+++.++.++|+|||++.......
T Consensus 76 v~~~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~- 152 (260)
T PF00069_consen 76 VMEYCPGGSLQDYLQKN--KPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENN- 152 (260)
T ss_dssp EEEEETTEBHHHHHHHH--SSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTT-
T ss_pred ccccccccccccccccc--cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-
Confidence 99999998999998843 679999999999999999999999999999999999999999999999999975431000
Q ss_pred ccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCCCC
Q 012762 244 TAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTHE 323 (457)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 323 (457)
.......++..
T Consensus 153 ---------------------------------------------------------------------~~~~~~~~~~~ 163 (260)
T PF00069_consen 153 ---------------------------------------------------------------------ENFNPFVGTPE 163 (260)
T ss_dssp ---------------------------------------------------------------------SEBSSSSSSGG
T ss_pred ---------------------------------------------------------------------ccccccccccc
Confidence 01112358999
Q ss_pred ccCchhhc-CCCCCccchhhhhhHHHHHHhcCCCCCCCCC---hHHHHHHHHhcccCCCCC--CCCChHHHHHHHHHhhh
Q 012762 324 YLAPEIIS-GEGHGNAVDWWTLGIFIFELFYGTTPFKGID---HELTLANVVARALEFPKE--PSVPGPAKDLIAQLLVK 397 (457)
Q Consensus 324 y~aPE~l~-~~~~~~~sDiwSlG~il~elltG~~Pf~~~~---~~~~~~~~~~~~~~~~~~--~~~~~~~~~ll~~~L~~ 397 (457)
|+|||++. +..++.++||||||+++|+|++|..||.... ....+............. ...+..+.++|.+||+.
T Consensus 164 y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 243 (260)
T PF00069_consen 164 YMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDLIKKMLSK 243 (260)
T ss_dssp GSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHHHHHHSSS
T ss_pred ccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHHHHHHHccC
Confidence 99999998 7788999999999999999999999999873 223333333322222111 12237899999999999
Q ss_pred CCCCCCCCCcChHHHhcCCCC
Q 012762 398 DPTRRMGSKMGATAIKRHQFF 418 (457)
Q Consensus 398 dP~~Rps~~~~~~~ll~hp~f 418 (457)
||++||+ +.++++||||
T Consensus 244 ~p~~R~~----~~~l~~~~~~ 260 (260)
T PF00069_consen 244 DPEQRPS----AEELLKHPWF 260 (260)
T ss_dssp SGGGSTT----HHHHHTSGGG
T ss_pred ChhHCcC----HHHHhcCCCC
Confidence 9999999 9999999998
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=362.08 Aligned_cols=265 Identities=23% Similarity=0.353 Sum_probs=228.8
Q ss_pred CCCCCCCccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceE
Q 012762 72 NNNNNNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTL 151 (457)
Q Consensus 72 ~~~~~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l 151 (457)
.....|.+..++..+.++||+|+||.||+|..+..+......||+|..+...........++..|+++|++++|||||++
T Consensus 147 I~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~ 226 (474)
T KOG0194|consen 147 IPRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRF 226 (474)
T ss_pred ccccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEE
Confidence 34556788888888999999999999999999864432223389999876444566778889999999999999999999
Q ss_pred EEEEEcCCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEec
Q 012762 152 YATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTD 231 (457)
Q Consensus 152 ~~~~~~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~D 231 (457)
||+......+|||||+|.||+|.++++..+. .++..+...++.+.+.||+|||++++|||||...|+|++.++.+||+|
T Consensus 227 yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISD 305 (474)
T KOG0194|consen 227 YGVAVLEEPLMLVMELCNGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISD 305 (474)
T ss_pred EEEEcCCCccEEEEEecCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCc
Confidence 9999999999999999999999999988643 699999999999999999999999999999999999999999999999
Q ss_pred cCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCC
Q 012762 232 FDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPL 311 (457)
Q Consensus 232 FG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (457)
||+++....-.....
T Consensus 306 FGLs~~~~~~~~~~~----------------------------------------------------------------- 320 (474)
T KOG0194|consen 306 FGLSRAGSQYVMKKF----------------------------------------------------------------- 320 (474)
T ss_pred cccccCCcceeeccc-----------------------------------------------------------------
Confidence 999765431110000
Q ss_pred ccccccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHH
Q 012762 312 DVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDL 390 (457)
Q Consensus 312 ~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 390 (457)
..--...|+|||.+....|+.++|||||||++||+++ |..||.+....+...+++...++.+.+...|..+..+
T Consensus 321 -----~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~~~p~~~~~~ 395 (474)
T KOG0194|consen 321 -----LKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIPSKTPKELAKV 395 (474)
T ss_pred -----cccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCCCCCHHHHHHH
Confidence 0013568999999999999999999999999999998 8999999999999999988899998888899999999
Q ss_pred HHHHhhhCCCCCCCCCc
Q 012762 391 IAQLLVKDPTRRMGSKM 407 (457)
Q Consensus 391 l~~~L~~dP~~Rps~~~ 407 (457)
+.+||..||++||+|..
T Consensus 396 ~~~c~~~~p~~R~tm~~ 412 (474)
T KOG0194|consen 396 MKQCWKKDPEDRPTMST 412 (474)
T ss_pred HHHhccCChhhccCHHH
Confidence 99999999999999544
|
|
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=344.39 Aligned_cols=272 Identities=17% Similarity=0.256 Sum_probs=217.7
Q ss_pred CCccCCCceeEEEecccCcceEEEEEEecc-CCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEE
Q 012762 77 NPLTLSDLRFVHRLGSGDIGSVYLVQLKSK-SSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATL 155 (457)
Q Consensus 77 ~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~-~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~ 155 (457)
|.+..++|++.++||+|+||.||+|.++.. ....+..||+|.+..... ......+.+|+.+++.++|+||+++++++
T Consensus 1 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~ 78 (288)
T cd05061 1 WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESAS--LRERIEFLNEASVMKGFTCHHVVRLLGVV 78 (288)
T ss_pred CcccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCC--HHHHHHHHHHHHHHHhCCCCCeeeEEEEE
Confidence 456778999999999999999999987632 223456899999864421 22334567799999999999999999999
Q ss_pred EcCCcEEEEEeecCCCChHHHHHhCC--------CCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCE
Q 012762 156 DCPRWSCLLTEFCPGGDLHVLRQRQP--------DKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHI 227 (457)
Q Consensus 156 ~~~~~~~lV~E~~~~~sL~~~~~~~~--------~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~v 227 (457)
...+..|+||||+.+|+|.+++.... ...+....+..++.||+.||.|||+++|+||||||+|||++.++.+
T Consensus 79 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~ 158 (288)
T cd05061 79 SKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTV 158 (288)
T ss_pred cCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcE
Confidence 99999999999999999999987532 1334667888999999999999999999999999999999999999
Q ss_pred EEeccCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCccc
Q 012762 228 MLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIV 307 (457)
Q Consensus 228 kl~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (457)
+|+|||+++.........
T Consensus 159 ~L~Dfg~~~~~~~~~~~~-------------------------------------------------------------- 176 (288)
T cd05061 159 KIGDFGMTRDIYETDYYR-------------------------------------------------------------- 176 (288)
T ss_pred EECcCCcccccccccccc--------------------------------------------------------------
Confidence 999999976432111000
Q ss_pred ccCCccccccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHHhcccCCCCCCCCChH
Q 012762 308 AEPLDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVVARALEFPKEPSVPGP 386 (457)
Q Consensus 308 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 386 (457)
......++..|+|||.+.+..++.++|||||||++|||++ |..||.+....+....+..... .+....++..
T Consensus 177 ------~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 249 (288)
T cd05061 177 ------KGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGY-LDQPDNCPER 249 (288)
T ss_pred ------ccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-CCCCCCCCHH
Confidence 0001235778999999998889999999999999999998 8999988776666655554322 2223346789
Q ss_pred HHHHHHHHhhhCCCCCCCCCcChHHHhc------CCCCCCCCc
Q 012762 387 AKDLIAQLLVKDPTRRMGSKMGATAIKR------HQFFNGVNW 423 (457)
Q Consensus 387 ~~~ll~~~L~~dP~~Rps~~~~~~~ll~------hp~f~~~~~ 423 (457)
+++++.+||+.||++||+ +.++++ ||||++++|
T Consensus 250 ~~~li~~~l~~~p~~Rps----~~~ll~~l~~~~~~~~~~~~~ 288 (288)
T cd05061 250 VTDLMRMCWQFNPKMRPT----FLEIVNLLKDDLHPSFPEVSF 288 (288)
T ss_pred HHHHHHHHcCCChhHCcC----HHHHHHHHHhhcCCCCCCCCC
Confidence 999999999999999999 666654 999999998
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-44 Score=348.89 Aligned_cols=254 Identities=26% Similarity=0.409 Sum_probs=208.9
Q ss_pred CCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcE
Q 012762 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWS 161 (457)
Q Consensus 82 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~ 161 (457)
++|++.++||+|+||.||+|.+. .++..||+|.+.... .......+.+|++++++++||||+++++++..++.+
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~----~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 74 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHR----PSGLIMARKLIHLEI--KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEI 74 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEc----CCCeEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEE
Confidence 47999999999999999999876 477889999986431 223445677899999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCceeecCCCCCeEEccCCCEEEeccCCCcCCCC
Q 012762 162 CLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHM-MGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDN 240 (457)
Q Consensus 162 ~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~-~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~ 240 (457)
|+||||+++++|..++... ..+++..+..++.|++.||.|||+ .+++|+||||+|||++.++.++|+|||++.....
T Consensus 75 ~lv~ey~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 152 (308)
T cd06615 75 SICMEHMDGGSLDQVLKKA--GRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 152 (308)
T ss_pred EEEeeccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCcccccc
Confidence 9999999999999998765 678999999999999999999997 5999999999999999999999999998643321
Q ss_pred CCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccC
Q 012762 241 STSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVG 320 (457)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 320 (457)
.. ...+.|
T Consensus 153 ~~------------------------------------------------------------------------~~~~~~ 160 (308)
T cd06615 153 SM------------------------------------------------------------------------ANSFVG 160 (308)
T ss_pred cc------------------------------------------------------------------------cccCCC
Confidence 00 012468
Q ss_pred CCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccC------------------------
Q 012762 321 THEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALE------------------------ 376 (457)
Q Consensus 321 t~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~------------------------ 376 (457)
+..|+|||++.+..++.++|||||||++|+|++|+.||......... ........
T Consensus 161 ~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (308)
T cd06615 161 TRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELE-AMFGRPVSEGEAKESHRPVSGHPPDSPRPMAI 239 (308)
T ss_pred CcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHH-HhhcCccccccccCCcccccCCCCCccchhhH
Confidence 99999999998888999999999999999999999999764432221 11111000
Q ss_pred -----------CCC--CCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCC
Q 012762 377 -----------FPK--EPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNG 420 (457)
Q Consensus 377 -----------~~~--~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~ 420 (457)
.+. ...++.++++++.+||..||++||+ +.+|++||||..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt----~~~ll~~~~~~~ 292 (308)
T cd06615 240 FELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERAD----LKELTKHPFIKR 292 (308)
T ss_pred HHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcC----HHHHhcChhhhh
Confidence 000 1125678999999999999999999 999999999975
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-44 Score=343.75 Aligned_cols=253 Identities=30% Similarity=0.449 Sum_probs=207.3
Q ss_pred CCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcE
Q 012762 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWS 161 (457)
Q Consensus 82 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~ 161 (457)
++|++.+.||+|+||.||+|.+. .++..||+|++.... .......+.+|+++|++++||||+++++++...+..
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~----~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 74 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHL----LTRRILAVKVIPLDI--TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRI 74 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEc----CCCcEEEEEEEecCC--ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEE
Confidence 47899999999999999999876 478899999986542 223445678899999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCC
Q 012762 162 CLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNS 241 (457)
Q Consensus 162 ~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~ 241 (457)
++||||+++++|..+ ..+++..+..++.|++.||.|||+.||+|+||||+|||++.++.++|+|||++......
T Consensus 75 ~lv~e~~~~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~ 148 (279)
T cd06619 75 SICTEFMDGGSLDVY------RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS 148 (279)
T ss_pred EEEEecCCCCChHHh------hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc
Confidence 999999999999643 34788899999999999999999999999999999999999999999999997543211
Q ss_pred CcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCC
Q 012762 242 TSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGT 321 (457)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 321 (457)
. ....+||
T Consensus 149 ~------------------------------------------------------------------------~~~~~~~ 156 (279)
T cd06619 149 I------------------------------------------------------------------------AKTYVGT 156 (279)
T ss_pred c------------------------------------------------------------------------ccCCCCC
Confidence 0 0123689
Q ss_pred CCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChH-------HHHHHHHhcccCCCCCCCCChHHHHHHHHH
Q 012762 322 HEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHE-------LTLANVVARALEFPKEPSVPGPAKDLIAQL 394 (457)
Q Consensus 322 ~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~ 394 (457)
..|+|||++.+..++.++|||||||++|+|++|..||...... .....+.............+.++.+++.+|
T Consensus 157 ~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 236 (279)
T cd06619 157 NAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHFITQC 236 (279)
T ss_pred hhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHHHHHHHHH
Confidence 9999999999988999999999999999999999999653211 111222111111111234678899999999
Q ss_pred hhhCCCCCCCCCcChHHHhcCCCCCCCC
Q 012762 395 LVKDPTRRMGSKMGATAIKRHQFFNGVN 422 (457)
Q Consensus 395 L~~dP~~Rps~~~~~~~ll~hp~f~~~~ 422 (457)
|..||++||+ ++++++||||...+
T Consensus 237 l~~~P~~Rp~----~~eil~~~~~~~~~ 260 (279)
T cd06619 237 MRKQPKERPA----PENLMDHPFIVQYN 260 (279)
T ss_pred hhCChhhCCC----HHHHhcCccccccc
Confidence 9999999999 99999999998654
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-44 Score=361.04 Aligned_cols=266 Identities=21% Similarity=0.293 Sum_probs=214.6
Q ss_pred CCCCccCCCceeEEEecccCcceEEEEEEecc-CCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHc-CCCCCceEE
Q 012762 75 NNNPLTLSDLRFVHRLGSGDIGSVYLVQLKSK-SSNNGCFFAAKVMDKRELVSRNKESRARIEREILEML-DHPFLPTLY 152 (457)
Q Consensus 75 ~~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~-~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~ 152 (457)
..|.+..++|++.+.||+|+||.||+|.+... ...++..||+|+++.... ......+.+|+++|+.+ +|+||++++
T Consensus 31 ~~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~il~~l~~h~nIv~~~ 108 (374)
T cd05106 31 EKWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH--TDEREALMSELKILSHLGQHKNIVNLL 108 (374)
T ss_pred ccccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCC--HHHHHHHHHHHHHHHhhccCCceeeEe
Confidence 34566778899999999999999999987542 223556899999975422 22345677899999999 899999999
Q ss_pred EEEEcCCcEEEEEeecCCCChHHHHHhCC---------------------------------------------------
Q 012762 153 ATLDCPRWSCLLTEFCPGGDLHVLRQRQP--------------------------------------------------- 181 (457)
Q Consensus 153 ~~~~~~~~~~lV~E~~~~~sL~~~~~~~~--------------------------------------------------- 181 (457)
+++...+..|+|||||.+|+|.+++....
T Consensus 109 ~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (374)
T cd05106 109 GACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVS 188 (374)
T ss_pred eEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcc
Confidence 99999999999999999999998875421
Q ss_pred -----------------CCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCCCcc
Q 012762 182 -----------------DKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTST 244 (457)
Q Consensus 182 -----------------~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~~~~ 244 (457)
...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++........
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~ 268 (374)
T cd05106 189 SSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNY 268 (374)
T ss_pred ccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcce
Confidence 134788899999999999999999999999999999999999999999999997543211000
Q ss_pred cccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCCCCc
Q 012762 245 AQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTHEY 324 (457)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 324 (457)
. ......++..|
T Consensus 269 ~--------------------------------------------------------------------~~~~~~~~~~y 280 (374)
T cd05106 269 V--------------------------------------------------------------------VKGNARLPVKW 280 (374)
T ss_pred e--------------------------------------------------------------------eccCCCCccce
Confidence 0 00012356789
Q ss_pred cCchhhcCCCCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhhhCCCCCC
Q 012762 325 LAPEIISGEGHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDPTRRM 403 (457)
Q Consensus 325 ~aPE~l~~~~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rp 403 (457)
||||++.+..++.++|||||||++|||++ |..||...........++...........++.++.+++.+||+.||++||
T Consensus 281 ~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP 360 (374)
T cd05106 281 MAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSIMKMCWNLEPTERP 360 (374)
T ss_pred eCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHHHHHHHHHcCCChhhCc
Confidence 99999998889999999999999999997 99999887655555555555555544455789999999999999999999
Q ss_pred CCCcChHHHhc
Q 012762 404 GSKMGATAIKR 414 (457)
Q Consensus 404 s~~~~~~~ll~ 414 (457)
+ +.+|++
T Consensus 361 s----~~~l~~ 367 (374)
T cd05106 361 T----FSQISQ 367 (374)
T ss_pred C----HHHHHH
Confidence 9 777765
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-44 Score=355.96 Aligned_cols=251 Identities=21% Similarity=0.333 Sum_probs=198.7
Q ss_pred CCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCc
Q 012762 81 LSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRW 160 (457)
Q Consensus 81 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~ 160 (457)
..+|++++.||+|+||+||+|.+. .++..||+|+..+. ....|+.+|++++|+||+++++++...+.
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~----~~~~~valK~~~~~---------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 131 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKP----GQPDPVVLKIGQKG---------TTLIEAMLLQNVNHPSVIRMKDTLVSGAI 131 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEEC----CCCceEEEEeCCcc---------ccHHHHHHHHhCCCCCCcChhheEEeCCe
Confidence 347999999999999999999976 36788999986432 12458999999999999999999999999
Q ss_pred EEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCC
Q 012762 161 SCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDN 240 (457)
Q Consensus 161 ~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~ 240 (457)
.|+|||++ .++|..++... ...+++..++.++.||+.||.|||++|||||||||+|||++.++.+||+|||+++....
T Consensus 132 ~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 209 (357)
T PHA03209 132 TCMVLPHY-SSDLYTYLTKR-SRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVV 209 (357)
T ss_pred eEEEEEcc-CCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCcccccccc
Confidence 99999999 56887777553 35789999999999999999999999999999999999999999999999998753211
Q ss_pred CCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccC
Q 012762 241 STSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVG 320 (457)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 320 (457)
.. ......|
T Consensus 210 ~~-----------------------------------------------------------------------~~~~~~g 218 (357)
T PHA03209 210 AP-----------------------------------------------------------------------AFLGLAG 218 (357)
T ss_pred Cc-----------------------------------------------------------------------ccccccc
Confidence 00 0112458
Q ss_pred CCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCC-CCCCCCh---------HHHHHHHHhccc----CCC--------
Q 012762 321 THEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTT-PFKGIDH---------ELTLANVVARAL----EFP-------- 378 (457)
Q Consensus 321 t~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~-Pf~~~~~---------~~~~~~~~~~~~----~~~-------- 378 (457)
|..|+|||++.+..++.++|||||||++|||+++.. +|..... ...+..++.... .++
T Consensus 219 t~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 298 (357)
T PHA03209 219 TVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSRLV 298 (357)
T ss_pred cccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCccHHH
Confidence 999999999999999999999999999999998544 4443211 111111111100 011
Q ss_pred --------------------CCCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCCC
Q 012762 379 --------------------KEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGV 421 (457)
Q Consensus 379 --------------------~~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~~ 421 (457)
....++.++.+||.+||+.||.+||| +.|+|+||||+.+
T Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpt----a~e~l~hp~f~~~ 357 (357)
T PHA03209 299 RGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPS----AEEILNYPMFAQL 357 (357)
T ss_pred HHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcC----HHHHhcCchhccC
Confidence 01235667888999999999999999 9999999999863
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-44 Score=350.77 Aligned_cols=253 Identities=23% Similarity=0.334 Sum_probs=192.2
Q ss_pred EEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEc--CCcEEEE
Q 012762 87 VHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDC--PRWSCLL 164 (457)
Q Consensus 87 ~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~--~~~~~lV 164 (457)
.++||+|+||+||+|+++. ..+++.||+|.+.... ....+.+|+++|++++||||+++++++.. +..+|+|
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~--~~~~~~~aiK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv 78 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKD--GKDDRDYALKQIEGTG-----ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLL 78 (317)
T ss_pred ccccccCCCeEEEEEEEcc--CCCCceEEEEEECCCC-----CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEE
Confidence 4689999999999998753 2366789999986532 22345679999999999999999999854 4568999
Q ss_pred EeecCCCChHHHHHhC-------CCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEE----ccCCCEEEeccC
Q 012762 165 TEFCPGGDLHVLRQRQ-------PDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLV----RSDGHIMLTDFD 233 (457)
Q Consensus 165 ~E~~~~~sL~~~~~~~-------~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll----~~~~~vkl~DFG 233 (457)
|||+ +++|..++... ....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||
T Consensus 79 ~e~~-~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG 157 (317)
T cd07868 79 FDYA-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMG 157 (317)
T ss_pred Eecc-CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecC
Confidence 9999 66887776542 12358999999999999999999999999999999999999 456789999999
Q ss_pred CCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcc
Q 012762 234 LSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDV 313 (457)
Q Consensus 234 ~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (457)
+++........ ..
T Consensus 158 ~a~~~~~~~~~-------------------------------------------------------------------~~ 170 (317)
T cd07868 158 FARLFNSPLKP-------------------------------------------------------------------LA 170 (317)
T ss_pred ceeccCCCCcc-------------------------------------------------------------------cc
Confidence 98654311000 00
Q ss_pred ccccccCCCCccCchhhcCC-CCCccchhhhhhHHHHHHhcCCCCCCCCChH---------HHHHHHHhccc--------
Q 012762 314 RSMSFVGTHEYLAPEIISGE-GHGNAVDWWTLGIFIFELFYGTTPFKGIDHE---------LTLANVVARAL-------- 375 (457)
Q Consensus 314 ~~~~~~gt~~y~aPE~l~~~-~~~~~sDiwSlG~il~elltG~~Pf~~~~~~---------~~~~~~~~~~~-------- 375 (457)
.....+||+.|+|||++.+. .++.++|||||||++|||++|++||...... ..+..+.....
T Consensus 171 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (317)
T cd07868 171 DLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWE 250 (317)
T ss_pred ccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhcCCCChHHhH
Confidence 01124689999999999875 4899999999999999999999999754321 11111111000
Q ss_pred ---CCCC-------------------------CCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCC
Q 012762 376 ---EFPK-------------------------EPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFF 418 (457)
Q Consensus 376 ---~~~~-------------------------~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f 418 (457)
..+. ....+.++.+||.+||+.||.+||| ++|+|+||||
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t----~~e~l~hp~f 317 (317)
T cd07868 251 DIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRIT----SEQAMQDPYF 317 (317)
T ss_pred HHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCC----HHHHhcCCCC
Confidence 0000 0112456889999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=335.91 Aligned_cols=256 Identities=26% Similarity=0.433 Sum_probs=214.0
Q ss_pred CceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEc-CCcE
Q 012762 83 DLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDC-PRWS 161 (457)
Q Consensus 83 ~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~-~~~~ 161 (457)
+|++.+.||.|+||.||++.++ .+++.||+|.+..... .......+..|++++++++|+||+++++.+.. +..+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~----~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 75 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHR----TDGKQYVIKKLNLRNA-SRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLL 75 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEc----CCCcEEEEEEEehhhc-CHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEE
Confidence 5899999999999999999976 3678899999975433 22344567789999999999999999998864 4468
Q ss_pred EEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCC
Q 012762 162 CLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNS 241 (457)
Q Consensus 162 ~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~ 241 (457)
|+||||+++++|.+++.......+++.+++.++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++......
T Consensus 76 ~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~ 155 (257)
T cd08223 76 YIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ 155 (257)
T ss_pred EEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEeccc
Confidence 99999999999998887755567899999999999999999999999999999999999999999999999987544211
Q ss_pred CcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCC
Q 012762 242 TSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGT 321 (457)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 321 (457)
.. ......|+
T Consensus 156 ~~----------------------------------------------------------------------~~~~~~~~ 165 (257)
T cd08223 156 CD----------------------------------------------------------------------MASTLIGT 165 (257)
T ss_pred CC----------------------------------------------------------------------ccccccCC
Confidence 00 00123588
Q ss_pred CCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhhhCCCC
Q 012762 322 HEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDPTR 401 (457)
Q Consensus 322 ~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~ 401 (457)
+.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+..+... +....++..+.+++.+||..||++
T Consensus 166 ~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~ 244 (257)
T cd08223 166 PYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLP-PMPKDYSPELGELIATMLSKRPEK 244 (257)
T ss_pred cCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCC-CCccccCHHHHHHHHHHhccCccc
Confidence 9999999999988999999999999999999999999877665555555444332 223457889999999999999999
Q ss_pred CCCCCcChHHHhcCCCC
Q 012762 402 RMGSKMGATAIKRHQFF 418 (457)
Q Consensus 402 Rps~~~~~~~ll~hp~f 418 (457)
||+ +.++++||||
T Consensus 245 Rp~----~~~~l~~~~~ 257 (257)
T cd08223 245 RPS----VKSILRQPYI 257 (257)
T ss_pred CCC----HHHHhcCCCC
Confidence 999 9999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-45 Score=344.11 Aligned_cols=258 Identities=25% Similarity=0.373 Sum_probs=212.4
Q ss_pred CCccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcC-C-CC----Cce
Q 012762 77 NPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLD-H-PF----LPT 150 (457)
Q Consensus 77 ~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~-H-~n----Iv~ 150 (457)
++....+|.++..||+|.||.|..|+++. ++..||||+++.-. ...+..+.|+++|.++. + |+ +|.
T Consensus 84 gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~----~~~~vAlKIik~V~----kYreAa~iEi~vLqki~~~DP~g~~rcv~ 155 (415)
T KOG0671|consen 84 GDILTNRYEIVDLLGEGTFGKVVECWDRE----TKEHVALKIIKNVD----KYREAALIEIEVLQKINESDPNGKFRCVQ 155 (415)
T ss_pred ccccccceehhhhhcCCcccceEEEeecC----CCceehHHHHHHHH----HHhhHHHHHHHHHHHHHhcCCCCceEEEe
Confidence 34456789999999999999999999874 58899999996432 34455677999999983 2 23 788
Q ss_pred EEEEEEcCCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEcc-------
Q 012762 151 LYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRS------- 223 (457)
Q Consensus 151 l~~~~~~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~------- 223 (457)
+.++|+..++.|||+|.+ |-++++++..+...+++...++.++.|++.+++|||+.+++|.||||+|||+.+
T Consensus 156 m~~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~ 234 (415)
T KOG0671|consen 156 MRDWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTY 234 (415)
T ss_pred eehhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEe
Confidence 899999999999999999 889999999988889999999999999999999999999999999999999942
Q ss_pred -------------CCCEEEeccCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCc
Q 012762 224 -------------DGHIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHP 290 (457)
Q Consensus 224 -------------~~~vkl~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (457)
.-.|+++|||.|......
T Consensus 235 ~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~------------------------------------------------- 265 (415)
T KOG0671|consen 235 NPKKKVCFIRPLKSTAIKVIDFGSATFDHEH------------------------------------------------- 265 (415)
T ss_pred ccCCccceeccCCCcceEEEecCCcceeccC-------------------------------------------------
Confidence 224788888876543321
Q ss_pred chhccccCCCCCCCcccccCCccccccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHH
Q 012762 291 KRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANV 370 (457)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~ 370 (457)
..+++.|..|+|||++.|.+|+.++||||+||||+||++|...|+..++.+.+..+
T Consensus 266 ------------------------hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMM 321 (415)
T KOG0671|consen 266 ------------------------HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMM 321 (415)
T ss_pred ------------------------cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHHHHH
Confidence 13567899999999999999999999999999999999999999998877755443
Q ss_pred HhcccCCCCC------------------CC-------------C-------------ChHHHHHHHHHhhhCCCCCCCCC
Q 012762 371 VARALEFPKE------------------PS-------------V-------------PGPAKDLIAQLLVKDPTRRMGSK 406 (457)
Q Consensus 371 ~~~~~~~~~~------------------~~-------------~-------------~~~~~~ll~~~L~~dP~~Rps~~ 406 (457)
..-..++|.. ++ + -.++.|||++||.+||.+|+|
T Consensus 322 erIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiT-- 399 (415)
T KOG0671|consen 322 ERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRIT-- 399 (415)
T ss_pred HHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcccccc--
Confidence 3322222221 00 0 014889999999999999999
Q ss_pred cChHHHhcCCCCCC
Q 012762 407 MGATAIKRHQFFNG 420 (457)
Q Consensus 407 ~~~~~ll~hp~f~~ 420 (457)
+.|+|.||||+.
T Consensus 400 --l~EAL~HpFF~~ 411 (415)
T KOG0671|consen 400 --LREALSHPFFAR 411 (415)
T ss_pred --HHHHhcCHHhhc
Confidence 999999999985
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-44 Score=359.60 Aligned_cols=266 Identities=20% Similarity=0.298 Sum_probs=214.0
Q ss_pred CCCccCCCceeEEEecccCcceEEEEEEecc-CCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHc-CCCCCceEEE
Q 012762 76 NNPLTLSDLRFVHRLGSGDIGSVYLVQLKSK-SSNNGCFFAAKVMDKRELVSRNKESRARIEREILEML-DHPFLPTLYA 153 (457)
Q Consensus 76 ~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~-~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~~ 153 (457)
.+.+..++|++.++||+|+||+||+|.+... ...++..||||+++.... ......+.+|+++|+.+ +||||+++++
T Consensus 29 ~~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~Ei~il~~l~~HpnIv~l~~ 106 (375)
T cd05104 29 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNHINIVNLLG 106 (375)
T ss_pred ccccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC--cHHHHHHHHHHHHHHHhcCCcceeeeee
Confidence 4566677999999999999999999986422 234667899999865422 23345677899999999 8999999999
Q ss_pred EEEcCCcEEEEEeecCCCChHHHHHhCC----------------------------------------------------
Q 012762 154 TLDCPRWSCLLTEFCPGGDLHVLRQRQP---------------------------------------------------- 181 (457)
Q Consensus 154 ~~~~~~~~~lV~E~~~~~sL~~~~~~~~---------------------------------------------------- 181 (457)
++...+..|+|||||++|+|..++....
T Consensus 107 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 186 (375)
T cd05104 107 ACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKR 186 (375)
T ss_pred eeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccc
Confidence 9999999999999999999998886532
Q ss_pred ---------------------CCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCC
Q 012762 182 ---------------------DKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDN 240 (457)
Q Consensus 182 ---------------------~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~ 240 (457)
...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~ 266 (375)
T cd05104 187 RSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRN 266 (375)
T ss_pred cccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccC
Confidence 12478888999999999999999999999999999999999999999999999864431
Q ss_pred CCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccC
Q 012762 241 STSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVG 320 (457)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 320 (457)
..... ......+
T Consensus 267 ~~~~~--------------------------------------------------------------------~~~~~~~ 278 (375)
T cd05104 267 DSNYV--------------------------------------------------------------------VKGNARL 278 (375)
T ss_pred ccccc--------------------------------------------------------------------ccCCCCC
Confidence 11000 0001235
Q ss_pred CCCccCchhhcCCCCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhhhCC
Q 012762 321 THEYLAPEIISGEGHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDP 399 (457)
Q Consensus 321 t~~y~aPE~l~~~~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP 399 (457)
+..|+|||++.+..++.++|||||||++|||++ |..||..........+.+............+.++.+|+.+||..||
T Consensus 279 ~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP 358 (375)
T cd05104 279 PVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEMYDIMKSCWDADP 358 (375)
T ss_pred CcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCCCCHHHHHHHHHHccCCh
Confidence 678999999999999999999999999999997 9999987765555555555544444444578899999999999999
Q ss_pred CCCCCCCcChHHHhcC
Q 012762 400 TRRMGSKMGATAIKRH 415 (457)
Q Consensus 400 ~~Rps~~~~~~~ll~h 415 (457)
++||+ +.+|++.
T Consensus 359 ~~RPs----~~eil~~ 370 (375)
T cd05104 359 LKRPT----FKQIVQL 370 (375)
T ss_pred hHCcC----HHHHHHH
Confidence 99999 8888753
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=341.81 Aligned_cols=259 Identities=31% Similarity=0.577 Sum_probs=207.3
Q ss_pred EecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHH---HHHcCCCCCceEEEEEEcCCcEEEEE
Q 012762 89 RLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREI---LEMLDHPFLPTLYATLDCPRWSCLLT 165 (457)
Q Consensus 89 ~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~i---l~~l~H~nIv~l~~~~~~~~~~~lV~ 165 (457)
.||+|+||+||+|.+. .+++.||+|++.+...........+..|..+ ++..+|+||+.+++++...+..|+||
T Consensus 1 ~ig~g~~g~Vy~~~~~----~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 76 (278)
T cd05606 1 IIGRGGFGEVYGCRKA----DTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFIL 76 (278)
T ss_pred CcccCCCeEEEEEEEe----cCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEE
Confidence 4799999999999876 4788999999976544322323333344443 44457999999999999999999999
Q ss_pred eecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCCCccc
Q 012762 166 EFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTA 245 (457)
Q Consensus 166 E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~~~~~ 245 (457)
||+.|++|..++... ..+++..++.++.|++.||.|||+.+|+||||||+||+++.++.++|+|||++.......
T Consensus 77 e~~~g~~L~~~l~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~--- 151 (278)
T cd05606 77 DLMNGGDLHYHLSQH--GVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--- 151 (278)
T ss_pred ecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC---
Confidence 999999998888654 679999999999999999999999999999999999999999999999999875332100
Q ss_pred ccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCCCCcc
Q 012762 246 QLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTHEYL 325 (457)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 325 (457)
.....|+..|+
T Consensus 152 ---------------------------------------------------------------------~~~~~~~~~y~ 162 (278)
T cd05606 152 ---------------------------------------------------------------------PHASVGTHGYM 162 (278)
T ss_pred ---------------------------------------------------------------------CcCcCCCcCCc
Confidence 00235899999
Q ss_pred CchhhcCC-CCCccchhhhhhHHHHHHhcCCCCCCCCCh---HHHHHHHHhcccCCCCCCCCChHHHHHHHHHhhhCCCC
Q 012762 326 APEIISGE-GHGNAVDWWTLGIFIFELFYGTTPFKGIDH---ELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDPTR 401 (457)
Q Consensus 326 aPE~l~~~-~~~~~sDiwSlG~il~elltG~~Pf~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~ 401 (457)
|||++.+. .++.++||||+||++|+|++|+.||.+... ............. ....++.++.+++.+||..||.+
T Consensus 163 aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~s~~~~~li~~~l~~~p~~ 240 (278)
T cd05606 163 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE--LPDSFSPELRSLLEGLLQRDVNR 240 (278)
T ss_pred CcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCC--CCCcCCHHHHHHHHHHhhcCHHh
Confidence 99999754 589999999999999999999999987532 2222222222222 23347889999999999999999
Q ss_pred CC-----CCCcChHHHhcCCCCCCCCchhhhccCC
Q 012762 402 RM-----GSKMGATAIKRHQFFNGVNWALLRCAKP 431 (457)
Q Consensus 402 Rp-----s~~~~~~~ll~hp~f~~~~~~~~~~~~~ 431 (457)
|+ + +.++++||||+..+|+.+...+.
T Consensus 241 R~~~~~~~----~~~ll~~~~~~~~~~~~~~~~~~ 271 (278)
T cd05606 241 RLGCLGRG----AQEVKEHPFFRSLDWQMVFLQKY 271 (278)
T ss_pred ccCCCCCC----HHHHHhCccccCCCchHhhhccc
Confidence 99 7 99999999999999998754443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-44 Score=382.95 Aligned_cols=268 Identities=26% Similarity=0.392 Sum_probs=216.9
Q ss_pred CCCCccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEE
Q 012762 75 NNNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYAT 154 (457)
Q Consensus 75 ~~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~ 154 (457)
...+..+++|+++++||+|+||+||+|+++ .++..||+|++...... ......+..|+.+|+.|+|||||+++++
T Consensus 6 ~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk----~tg~~vAlKvIk~~~l~-e~~~~~~~~EI~IL~~L~HPNIVrl~d~ 80 (1021)
T PTZ00266 6 DDGESRLNEYEVIKKIGNGRFGEVFLVKHK----RTQEFFCWKAISYRGLK-EREKSQLVIEVNVMRELKHKNIVRYIDR 80 (1021)
T ss_pred cCCccccCCEEEEEEEecCCCeEEEEEEEC----CCCeEEEEEEEeccccC-HHHHHHHHHHHHHHHHcCCCCcCeEEEE
Confidence 345567789999999999999999999987 37889999999765432 2345667889999999999999999998
Q ss_pred EEc--CCcEEEEEeecCCCChHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHc-------CceeecCCCCCeEEcc
Q 012762 155 LDC--PRWSCLLTEFCPGGDLHVLRQRQ--PDKRFHESAVRFYASEVVVALEFLHMM-------GIIYRDLKPENVLVRS 223 (457)
Q Consensus 155 ~~~--~~~~~lV~E~~~~~sL~~~~~~~--~~~~~~~~~~~~i~~qi~~~L~yLH~~-------~iiHrDIKp~NIll~~ 223 (457)
|.. ...+||||||+.+++|..++... ....+++..++.|+.||+.||.|||+. +||||||||+||||+.
T Consensus 81 f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s 160 (1021)
T PTZ00266 81 FLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLST 160 (1021)
T ss_pred EEecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeec
Confidence 854 45689999999999999888653 235699999999999999999999985 4999999999999964
Q ss_pred C-----------------CCEEEeccCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCccc
Q 012762 224 D-----------------GHIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVS 286 (457)
Q Consensus 224 ~-----------------~~vkl~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (457)
+ +.+||+|||++........
T Consensus 161 ~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~------------------------------------------- 197 (1021)
T PTZ00266 161 GIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESM------------------------------------------- 197 (1021)
T ss_pred CccccccccccccccCCCCceEEccCCcccccccccc-------------------------------------------
Confidence 2 3589999999864421100
Q ss_pred ccCcchhccccCCCCCCCcccccCCccccccccCCCCccCchhhcCC--CCCccchhhhhhHHHHHHhcCCCCCCCCChH
Q 012762 287 CLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTHEYLAPEIISGE--GHGNAVDWWTLGIFIFELFYGTTPFKGIDHE 364 (457)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~~~~sDiwSlG~il~elltG~~Pf~~~~~~ 364 (457)
....+||+.|+|||++.+. .++.++||||||||||||++|..||......
T Consensus 198 ----------------------------~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~ 249 (1021)
T PTZ00266 198 ----------------------------AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNF 249 (1021)
T ss_pred ----------------------------ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcH
Confidence 0123699999999999654 4789999999999999999999999876655
Q ss_pred HHHHHHHhcccCCCCCCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCCCCc
Q 012762 365 LTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGVNW 423 (457)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~~~~ 423 (457)
..+...+.....++. ...+.++.+||..||..+|.+||+ +.|+|.|+|++.+..
T Consensus 250 ~qli~~lk~~p~lpi-~~~S~eL~dLI~~~L~~dPeeRPS----a~QlL~h~~ik~i~~ 303 (1021)
T PTZ00266 250 SQLISELKRGPDLPI-KGKSKELNILIKNLLNLSAKERPS----ALQCLGYQIIKNVGP 303 (1021)
T ss_pred HHHHHHHhcCCCCCc-CCCCHHHHHHHHHHhcCChhHCcC----HHHHhccHHHhhcCC
Confidence 544444444333332 346789999999999999999999 999999999986543
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-44 Score=370.12 Aligned_cols=270 Identities=21% Similarity=0.321 Sum_probs=199.5
Q ss_pred cCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEE--------------EeehhhhhhhhHHHHHHHHHHHHHHcCC
Q 012762 80 TLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAK--------------VMDKRELVSRNKESRARIEREILEMLDH 145 (457)
Q Consensus 80 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK--------------~~~~~~~~~~~~~~~~~~E~~il~~l~H 145 (457)
..++|+++++||+|+||+||+|.++.. .+..+++| ++.+...........+.+|+++|+.++|
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~H 222 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRAS---TEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNH 222 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEecc---chhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCC
Confidence 356899999999999999999987542 22222222 1111111122234567889999999999
Q ss_pred CCCceEEEEEEcCCcEEEEEeecCCCChHHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEc
Q 012762 146 PFLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQP---DKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVR 222 (457)
Q Consensus 146 ~nIv~l~~~~~~~~~~~lV~E~~~~~sL~~~~~~~~---~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~ 222 (457)
+||+++++++...+..|+|||++ +++|..++.... ........++.++.||+.||.|||++|||||||||+|||++
T Consensus 223 pnIv~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~ 301 (501)
T PHA03210 223 ENILKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLN 301 (501)
T ss_pred CCcCcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC
Confidence 99999999999999999999999 567766654421 12344667888999999999999999999999999999999
Q ss_pred cCCCEEEeccCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCC
Q 012762 223 SDGHIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPG 302 (457)
Q Consensus 223 ~~~~vkl~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (457)
.++.+||+|||+++.......
T Consensus 302 ~~~~vkL~DFGla~~~~~~~~----------------------------------------------------------- 322 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKERE----------------------------------------------------------- 322 (501)
T ss_pred CCCCEEEEeCCCceecCcccc-----------------------------------------------------------
Confidence 999999999999865432110
Q ss_pred CCcccccCCccccccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCC-CCCCC--hHHHHHHHHhccc----
Q 012762 303 TPEIVAEPLDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTP-FKGID--HELTLANVVARAL---- 375 (457)
Q Consensus 303 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~P-f~~~~--~~~~~~~~~~~~~---- 375 (457)
.....++||..|+|||++.+..++.++|||||||++|||++|..+ |.... ....+.+++....
T Consensus 323 ----------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 392 (501)
T PHA03210 323 ----------AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDSLSVCDE 392 (501)
T ss_pred ----------cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHHHhcccChh
Confidence 011134699999999999999999999999999999999998764 43221 1122222221100
Q ss_pred CCC--------------------------CCCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCCCCchhh
Q 012762 376 EFP--------------------------KEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGVNWALL 426 (457)
Q Consensus 376 ~~~--------------------------~~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~~~~~~~ 426 (457)
.++ ....++.++.++|.+||.+||.+||+ +.|+|.||||....+..+
T Consensus 393 ~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rps----a~elL~hp~f~~~~~~~~ 465 (501)
T PHA03210 393 EFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPG----AAELLALPLFSAEEEEEI 465 (501)
T ss_pred hcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcC----HHHHhhChhhhcCCchHH
Confidence 000 01134567888999999999999999 999999999998766443
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=345.59 Aligned_cols=262 Identities=21% Similarity=0.293 Sum_probs=206.7
Q ss_pred ccCCCceeEEEecccCcceEEEEEEeccC------------CCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCC
Q 012762 79 LTLSDLRFVHRLGSGDIGSVYLVQLKSKS------------SNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHP 146 (457)
Q Consensus 79 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~------------~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~ 146 (457)
+..++|++.++||+|+||.||+|.+.... ...+..||+|++.... .......+.+|+++|++++||
T Consensus 2 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~ 79 (304)
T cd05096 2 FPRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA--NKNARNDFLKEVKILSRLKDP 79 (304)
T ss_pred CchhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC--CHHHHHHHHHHHHHHhhcCCC
Confidence 34578999999999999999999864321 1245579999987542 223456688899999999999
Q ss_pred CCceEEEEEEcCCcEEEEEeecCCCChHHHHHhCC-----------------CCCCCHHHHHHHHHHHHHHHHHHHHcCc
Q 012762 147 FLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQP-----------------DKRFHESAVRFYASEVVVALEFLHMMGI 209 (457)
Q Consensus 147 nIv~l~~~~~~~~~~~lV~E~~~~~sL~~~~~~~~-----------------~~~~~~~~~~~i~~qi~~~L~yLH~~~i 209 (457)
||+++++++...+..||||||+.+++|.+++.... ...+++..+..++.||+.||.|||+.||
T Consensus 80 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i 159 (304)
T cd05096 80 NIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNF 159 (304)
T ss_pred CeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCc
Confidence 99999999999999999999999999998886531 1246778899999999999999999999
Q ss_pred eeecCCCCCeEEccCCCEEEeccCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccC
Q 012762 210 IYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLH 289 (457)
Q Consensus 210 iHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (457)
+||||||+|||++.++.+||+|||+++.........
T Consensus 160 vH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~-------------------------------------------- 195 (304)
T cd05096 160 VHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYR-------------------------------------------- 195 (304)
T ss_pred cccCcchhheEEcCCccEEECCCccceecccCceeE--------------------------------------------
Confidence 999999999999999999999999976442111000
Q ss_pred cchhccccCCCCCCCcccccCCccccccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhc--CCCCCCCCChHHHH
Q 012762 290 PKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFY--GTTPFKGIDHELTL 367 (457)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~ellt--G~~Pf~~~~~~~~~ 367 (457)
......++..|+|||++.+..++.++|||||||++|||++ |..||.........
T Consensus 196 ------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~ 251 (304)
T cd05096 196 ------------------------IQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTDEQVI 251 (304)
T ss_pred ------------------------ecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCCCcCCHHHHH
Confidence 0011246788999999998889999999999999999986 67888877665554
Q ss_pred HHHHhc------ccCCCCCCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhc
Q 012762 368 ANVVAR------ALEFPKEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKR 414 (457)
Q Consensus 368 ~~~~~~------~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~ 414 (457)
..+... .......+.++..+.+|+.+||..||++||+ +.+|.+
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs----~~~i~~ 300 (304)
T cd05096 252 ENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPS----FSDIHA 300 (304)
T ss_pred HHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcC----HHHHHH
Confidence 433221 1112223457889999999999999999999 888843
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=338.91 Aligned_cols=256 Identities=38% Similarity=0.717 Sum_probs=212.9
Q ss_pred EEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHH-HcCCCCCceEEEEEEcCCcEEEEEe
Q 012762 88 HRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILE-MLDHPFLPTLYATLDCPRWSCLLTE 166 (457)
Q Consensus 88 ~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~-~l~H~nIv~l~~~~~~~~~~~lV~E 166 (457)
+.||.|+||.||+|.+. .+++.||+|++.+...........+..|..++. .++|+||+++++++..++..|+|||
T Consensus 2 ~~l~~g~~~~v~~a~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e 77 (260)
T cd05611 2 KPISKGAFGSVYLAKKR----STGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVME 77 (260)
T ss_pred ccCCcCCCeeEEEEEec----CCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEe
Confidence 56899999999999876 378899999997654433333344455655544 4589999999999999999999999
Q ss_pred ecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCCCcccc
Q 012762 167 FCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQ 246 (457)
Q Consensus 167 ~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~~~~~~ 246 (457)
|+++++|..++... ..+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 78 ~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------ 149 (260)
T cd05611 78 YLNGGDCASLIKTL--GGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------ 149 (260)
T ss_pred ccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc------
Confidence 99999999998765 5689999999999999999999999999999999999999999999999998643211
Q ss_pred cccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCCCCccC
Q 012762 247 LVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTHEYLA 326 (457)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 326 (457)
.....|+..|+|
T Consensus 150 --------------------------------------------------------------------~~~~~~~~~y~~ 161 (260)
T cd05611 150 --------------------------------------------------------------------NKKFVGTPDYLA 161 (260)
T ss_pred --------------------------------------------------------------------cccCCCCcCccC
Confidence 002358889999
Q ss_pred chhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCC--CCCCChHHHHHHHHHhhhCCCCCCC
Q 012762 327 PEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPK--EPSVPGPAKDLIAQLLVKDPTRRMG 404 (457)
Q Consensus 327 PE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ll~~~L~~dP~~Rps 404 (457)
||.+.+..++.++||||||+++|+|++|..||...........+.......+. ...++.++.++|.+||+.||++||+
T Consensus 162 pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~ 241 (260)
T cd05611 162 PETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDPAKRLG 241 (260)
T ss_pred hhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccCCHHHccC
Confidence 99999888899999999999999999999999887777666666655544332 2357899999999999999999996
Q ss_pred CCcChHHHhcCCCCCCCCch
Q 012762 405 SKMGATAIKRHQFFNGVNWA 424 (457)
Q Consensus 405 ~~~~~~~ll~hp~f~~~~~~ 424 (457)
. ..++|++.||||+.++|.
T Consensus 242 ~-~~~~~~l~~~~~~~~~~~ 260 (260)
T cd05611 242 A-NGYQEIKSHPFFKSINWD 260 (260)
T ss_pred C-CcHHHHHcChHhhcCCCC
Confidence 2 116899999999999994
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=338.62 Aligned_cols=258 Identities=19% Similarity=0.270 Sum_probs=212.0
Q ss_pred ccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcC
Q 012762 79 LTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCP 158 (457)
Q Consensus 79 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~ 158 (457)
+...+|++.+.||+|+||.||+|+++.. ...+..||+|+++... .......+.+|+.++++++||||+++++++..+
T Consensus 2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~-~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 78 (266)
T cd05064 2 LDNKSIKIERILGTGRFGELCRGCLKLP-SKRELPVAIHTLRAGC--SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRG 78 (266)
T ss_pred CchHHeEEeeeecccCCCeEEEEEEecC-CCceeeEEEEecCCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecC
Confidence 4456899999999999999999987532 2356789999987542 223345678899999999999999999999999
Q ss_pred CcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCC
Q 012762 159 RWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKG 238 (457)
Q Consensus 159 ~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~ 238 (457)
+..||||||+++++|..++... ...+++..++.++.||+.||+|||++|++||||||+|||++.++.++++|||.+...
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~ 157 (266)
T cd05064 79 NTMMIVTEYMSNGALDSFLRKH-EGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQED 157 (266)
T ss_pred CCcEEEEEeCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccc
Confidence 9999999999999999888764 257899999999999999999999999999999999999999999999999975432
Q ss_pred CCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccc
Q 012762 239 DNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSF 318 (457)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (457)
...... .....
T Consensus 158 ~~~~~~---------------------------------------------------------------------~~~~~ 168 (266)
T cd05064 158 KSEAIY---------------------------------------------------------------------TTMSG 168 (266)
T ss_pred cccchh---------------------------------------------------------------------cccCC
Confidence 110000 00011
Q ss_pred cCCCCccCchhhcCCCCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhhh
Q 012762 319 VGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVK 397 (457)
Q Consensus 319 ~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~ 397 (457)
.++..|+|||++.+..++.++|||||||++|||++ |..||...........+. .....+....++..+.+++.+||+.
T Consensus 169 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~c~~~ 247 (266)
T cd05064 169 KSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVE-DGFRLPAPRNCPNLLHQLMLDCWQK 247 (266)
T ss_pred CCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHH-CCCCCCCCCCCCHHHHHHHHHHcCC
Confidence 35678999999999999999999999999999775 999999877766655544 3344555567889999999999999
Q ss_pred CCCCCCCCCcChHHHhc
Q 012762 398 DPTRRMGSKMGATAIKR 414 (457)
Q Consensus 398 dP~~Rps~~~~~~~ll~ 414 (457)
||++||+ +++|++
T Consensus 248 ~p~~RP~----~~~i~~ 260 (266)
T cd05064 248 ERGERPR----FSQIHS 260 (266)
T ss_pred CchhCCC----HHHHHH
Confidence 9999999 777764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-44 Score=339.68 Aligned_cols=265 Identities=38% Similarity=0.738 Sum_probs=221.9
Q ss_pred ecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcEEEEEeecC
Q 012762 90 LGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWSCLLTEFCP 169 (457)
Q Consensus 90 LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lV~E~~~ 169 (457)
||.|+||.||+|++. .+++.||+|++.+...........+.+|++++++++|+||+++++.+..+...|+||||+.
T Consensus 1 lg~g~~~~vy~~~~~----~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~ 76 (265)
T cd05579 1 ISKGAYGRVFLAKKK----STGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLP 76 (265)
T ss_pred CCCCCceEEEEEEEC----CCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCC
Confidence 689999999999986 3688999999987655555566778889999999999999999999999999999999999
Q ss_pred CCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCCCccccccc
Q 012762 170 GGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQLVS 249 (457)
Q Consensus 170 ~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~~~~~~~~~ 249 (457)
+++|..++... +.+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++...........
T Consensus 77 ~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~--- 151 (265)
T cd05579 77 GGDLASLLENV--GSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINL--- 151 (265)
T ss_pred CCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccc---
Confidence 99999998875 4789999999999999999999999999999999999999999999999998754321110000
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCCCCccCchh
Q 012762 250 DQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTHEYLAPEI 329 (457)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 329 (457)
...........++..|++||+
T Consensus 152 -----------------------------------------------------------~~~~~~~~~~~~~~~~~~Pe~ 172 (265)
T cd05579 152 -----------------------------------------------------------NDDEKEDKRIVGTPDYIAPEV 172 (265)
T ss_pred -----------------------------------------------------------ccccccccCcccCccccCHHH
Confidence 000001112358889999999
Q ss_pred hcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhhhCCCCCCCCCcCh
Q 012762 330 ISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDPTRRMGSKMGA 409 (457)
Q Consensus 330 l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~ 409 (457)
+.+..++.++||||||+++|+|++|..||...........+.......+....++..+.+++.+||+.+|.+||++.. +
T Consensus 173 ~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~-~ 251 (265)
T cd05579 173 ILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKS-I 251 (265)
T ss_pred hcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCccccCCHHHHHHHHHHhcCCHhhcCCCcc-H
Confidence 998889999999999999999999999998887777777776666666555445899999999999999999999111 2
Q ss_pred HHHhcCCCCCCCCc
Q 012762 410 TAIKRHQFFNGVNW 423 (457)
Q Consensus 410 ~~ll~hp~f~~~~~ 423 (457)
.++++||||+.++|
T Consensus 252 ~~~l~~~~~~~~~~ 265 (265)
T cd05579 252 EEIKNHPFFKGIDW 265 (265)
T ss_pred HHHhcCccccCCCC
Confidence 99999999999998
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=342.01 Aligned_cols=256 Identities=26% Similarity=0.366 Sum_probs=206.1
Q ss_pred CceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcEE
Q 012762 83 DLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWSC 162 (457)
Q Consensus 83 ~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~ 162 (457)
+|++.+.||+|+||.||+|+++ .++..||+|++..... .......+..|+++++.++||||+++++++..++..|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~----~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 75 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNK----KTGQIVAMKKIRLESE-EEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLY 75 (285)
T ss_pred CceEeeEecccCceEEEEEEEC----CCCcEEEEEEeccccc-cCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEE
Confidence 5899999999999999999876 3788999999865422 2233456778999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCC
Q 012762 163 LLTEFCPGGDLHVLRQRQP-DKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNS 241 (457)
Q Consensus 163 lV~E~~~~~sL~~~~~~~~-~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~ 241 (457)
+||||+. ++|..++.... ...+++..++.++.||+.||.|||+.||+|+||||+|||++.+|.++|+|||++......
T Consensus 76 ~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 154 (285)
T cd07861 76 LIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP 154 (285)
T ss_pred EEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCC
Confidence 9999996 68877776543 356899999999999999999999999999999999999999999999999997543211
Q ss_pred CcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCC
Q 012762 242 TSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGT 321 (457)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 321 (457)
... .....++
T Consensus 155 ~~~----------------------------------------------------------------------~~~~~~~ 164 (285)
T cd07861 155 VRV----------------------------------------------------------------------YTHEVVT 164 (285)
T ss_pred ccc----------------------------------------------------------------------ccCCccc
Confidence 000 0012478
Q ss_pred CCccCchhhcCC-CCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccC------------------C-----
Q 012762 322 HEYLAPEIISGE-GHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALE------------------F----- 377 (457)
Q Consensus 322 ~~y~aPE~l~~~-~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~------------------~----- 377 (457)
+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.........+...... .
T Consensus 165 ~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (285)
T cd07861 165 LWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKK 244 (285)
T ss_pred ccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhhccccCc
Confidence 899999998765 4788999999999999999999999876554333322211000 0
Q ss_pred ----CCCCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCC
Q 012762 378 ----PKEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFF 418 (457)
Q Consensus 378 ----~~~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f 418 (457)
.....++.+++++|.+||..||++||+ +.+|++||||
T Consensus 245 ~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt----~~~ll~~~~~ 285 (285)
T cd07861 245 GSLRSAVKNLDEDGLDLLEKMLIYDPAKRIS----AKKALNHPYF 285 (285)
T ss_pred chhHHhcCCCCHHHHHHHHHHhcCChhhCCC----HHHHhcCCCC
Confidence 011346788999999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=338.03 Aligned_cols=261 Identities=24% Similarity=0.358 Sum_probs=212.8
Q ss_pred CceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhh---hhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCC
Q 012762 83 DLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKREL---VSRNKESRARIEREILEMLDHPFLPTLYATLDCPR 159 (457)
Q Consensus 83 ~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~ 159 (457)
+|++.+.||.|+||+||+|... ++..+|+|.+..... ........+.+|+++|+.++|+||+++++++...+
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~-----~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 75 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTN-----QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDN 75 (265)
T ss_pred CccccceEeccCCeEEEEEEEc-----CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCC
Confidence 5888999999999999999753 678899998864321 12233456788999999999999999999999999
Q ss_pred cEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCC
Q 012762 160 WSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGD 239 (457)
Q Consensus 160 ~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~ 239 (457)
..|+||||+++++|.+++... ..+++..+..++.|++.||+|||+.||+|+||+|+||+++.++.++|+|||++....
T Consensus 76 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 153 (265)
T cd06631 76 TISIFMEFVPGGSISSILNRF--GPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLA 153 (265)
T ss_pred eEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhh
Confidence 999999999999999998765 568999999999999999999999999999999999999999999999999875432
Q ss_pred CCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcccccccc
Q 012762 240 NSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFV 319 (457)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (457)
....... .........
T Consensus 154 ~~~~~~~----------------------------------------------------------------~~~~~~~~~ 169 (265)
T cd06631 154 WVGLHGT----------------------------------------------------------------HSNMLKSMH 169 (265)
T ss_pred hcccccc----------------------------------------------------------------ccccccccC
Confidence 1100000 000011235
Q ss_pred CCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCC-CCCCCCChHHHHHHHHHhhhC
Q 012762 320 GTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEF-PKEPSVPGPAKDLIAQLLVKD 398 (457)
Q Consensus 320 gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ll~~~L~~d 398 (457)
|+..|+|||++.+..++.++|||||||++|+|++|..||...........+....... .....++.++.+++++||..|
T Consensus 170 ~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~ 249 (265)
T cd06631 170 GTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAAIDFVTSCLTRD 249 (265)
T ss_pred CCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCCHHHHHHHHHHhcCC
Confidence 8999999999999889999999999999999999999998766554444443332222 233457889999999999999
Q ss_pred CCCCCCCCcChHHHhcCCCC
Q 012762 399 PTRRMGSKMGATAIKRHQFF 418 (457)
Q Consensus 399 P~~Rps~~~~~~~ll~hp~f 418 (457)
|++||+ +.++++||||
T Consensus 250 p~~Rp~----~~~~l~~~~~ 265 (265)
T cd06631 250 QHERPS----ALQLLRHDFL 265 (265)
T ss_pred cccCCC----HHHHhcCCCC
Confidence 999999 9999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=342.72 Aligned_cols=256 Identities=27% Similarity=0.407 Sum_probs=209.5
Q ss_pred CCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHc-CCCCCceEEEEEEc--
Q 012762 81 LSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEML-DHPFLPTLYATLDC-- 157 (457)
Q Consensus 81 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~~~~~~-- 157 (457)
.+.|++.+.||.|+||+||+|.++ .+++.||+|++.... .....+..|+.+++++ +|+||+++++++..
T Consensus 15 ~~~~~~~~~lg~g~~~~v~~~~~~----~~~~~~a~K~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~ 86 (282)
T cd06636 15 AGIFELVEVVGNGTYGQVYKGRHV----KTGQLAAIKVMDVTE----DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKS 86 (282)
T ss_pred hhhhhhheeeccCCCeEEEEEEEc----CCCcEEEEEEEecCh----HHHHHHHHHHHHHHHhcCCCcEEEEeeehhccc
Confidence 357999999999999999999986 377899999986542 2335567789999888 79999999999853
Q ss_pred ----CCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccC
Q 012762 158 ----PRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFD 233 (457)
Q Consensus 158 ----~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG 233 (457)
....|+||||+.+++|..++.......+++..+..++.||+.||.|||+.||+|+||||+||+++.++.++|+|||
T Consensus 87 ~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg 166 (282)
T cd06636 87 PPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFG 166 (282)
T ss_pred ccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCc
Confidence 4578999999999999999887666678999999999999999999999999999999999999999999999999
Q ss_pred CCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcc
Q 012762 234 LSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDV 313 (457)
Q Consensus 234 ~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (457)
++........
T Consensus 167 ~~~~~~~~~~---------------------------------------------------------------------- 176 (282)
T cd06636 167 VSAQLDRTVG---------------------------------------------------------------------- 176 (282)
T ss_pred chhhhhcccc----------------------------------------------------------------------
Confidence 8754321100
Q ss_pred ccccccCCCCccCchhhc-----CCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHH
Q 012762 314 RSMSFVGTHEYLAPEIIS-----GEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAK 388 (457)
Q Consensus 314 ~~~~~~gt~~y~aPE~l~-----~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (457)
......|+..|+|||++. +..++.++|||||||++|||++|..||...........+............++.++.
T Consensus 177 ~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (282)
T cd06636 177 RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKSKKWSKKFI 256 (282)
T ss_pred CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCCCCcccccCHHHH
Confidence 011245899999999986 345788999999999999999999999876544444333332222222335788999
Q ss_pred HHHHHHhhhCCCCCCCCCcChHHHhcCCCC
Q 012762 389 DLIAQLLVKDPTRRMGSKMGATAIKRHQFF 418 (457)
Q Consensus 389 ~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f 418 (457)
++|.+||+.||.+||+ +.||++||||
T Consensus 257 ~li~~cl~~~p~~Rp~----~~ell~~~~~ 282 (282)
T cd06636 257 DFIEGCLVKNYLSRPS----TEQLLKHPFI 282 (282)
T ss_pred HHHHHHhCCChhhCcC----HHHHhcCCCC
Confidence 9999999999999999 9999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=339.97 Aligned_cols=344 Identities=22% Similarity=0.304 Sum_probs=230.2
Q ss_pred HHHHHhhhcCCCCCCCCC-ccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHH
Q 012762 61 KAIKEATSEGNNNNNNNP-LTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREI 139 (457)
Q Consensus 61 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~i 139 (457)
+...+....++.....++ +.-.+|.+.++||+|.|++||+|++. .+.+.||+||.+.... ..+....|+++
T Consensus 56 E~~~dY~kGGYHpV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDt----q~~r~VAlKVvKSAqh----YtEaAlDEIkl 127 (590)
T KOG1290|consen 56 EDPEDYRKGGYHPVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDT----QNKRYVALKVVKSAQH----YTEAALDEIKL 127 (590)
T ss_pred cChhhhhcCCCceeeccccccCceEEEEEeccccccceeEEEeec----cCCeEEEEEEEehhhH----HHHHHHHHHHH
Confidence 344455555665555444 44489999999999999999999998 4788999999986544 33445669999
Q ss_pred HHHcC-----CC---CCceEEEEEEc----CCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH-H
Q 012762 140 LEMLD-----HP---FLPTLYATLDC----PRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLH-M 206 (457)
Q Consensus 140 l~~l~-----H~---nIv~l~~~~~~----~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH-~ 206 (457)
|+++. |+ .||+|++.|.. +.++|||+|++ |.+|..+|.....++++...++.|++||+.||.||| +
T Consensus 128 L~~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~e 206 (590)
T KOG1290|consen 128 LQQVREGDPNDPGKKCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRE 206 (590)
T ss_pred HHHHHhcCCCCCCCceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHh
Confidence 99872 33 49999999964 56899999999 999999999888899999999999999999999999 5
Q ss_pred cCceeecCCCCCeEEccCCCEEEecc---CCCcCCCC-----CCccc----------c------------------cccC
Q 012762 207 MGIIYRDLKPENVLVRSDGHIMLTDF---DLSLKGDN-----STSTA----------Q------------------LVSD 250 (457)
Q Consensus 207 ~~iiHrDIKp~NIll~~~~~vkl~DF---G~s~~~~~-----~~~~~----------~------------------~~~~ 250 (457)
+||||.||||+|||+...-.--..|- |-+....+ ...+. . ....
T Consensus 207 cgIIHTDlKPENvLl~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~ 286 (590)
T KOG1290|consen 207 CGIIHTDLKPENVLLCSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEA 286 (590)
T ss_pred cCccccCCCcceeeeeccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhh
Confidence 69999999999999954310000000 00000000 00000 0 0000
Q ss_pred C--------C-CCCC------CCCCCCCCCCC---------------CCCCC-------CCcccCCCCCC----------
Q 012762 251 Q--------S-PPTG------DQQPNDCAVDQ---------------PPFGN-------SSCIIPNCIVP---------- 283 (457)
Q Consensus 251 ~--------~-~~~~------~~~~~~~~~~~---------------~~~~~-------~~~~~~~~~~~---------- 283 (457)
. . +... ......+.+.. ....+ .......+...
T Consensus 287 ~l~~~~~~~~~~~~~s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~ 366 (590)
T KOG1290|consen 287 SLAGLEGIEEEPNQESYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLS 366 (590)
T ss_pred hhcccccccccccccccccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhccccccccccccc
Confidence 0 0 0000 00000000000 00000 00000000000
Q ss_pred -------ccccc-------CcchhccccCCCCCCCcccccCCccccccccCCCCccCchhhcCCCCCccchhhhhhHHHH
Q 012762 284 -------AVSCL-------HPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIF 349 (457)
Q Consensus 284 -------~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~ 349 (457)
..+.. .+.-+.+.++.|+|.++|+..+.+.. +.|..|+|||++.|.+|+..+||||++|++|
T Consensus 367 s~~s~~~~~~n~~v~p~~~~~~~di~vKIaDlGNACW~~khFT~D----IQTRQYRapEVllGsgY~~~ADiWS~AC~~F 442 (590)
T KOG1290|consen 367 SPSSPGTIASNPLVNPDIPLPECDIRVKIADLGNACWVHKHFTED----IQTRQYRAPEVLLGSGYSTSADIWSTACMAF 442 (590)
T ss_pred CcCCccccccccccCCCCCCCccceeEEEeeccchhhhhhhhchh----hhhhhccCcceeecCCCCCchhHHHHHHHHH
Confidence 00000 23445566788999999988776654 6899999999999999999999999999999
Q ss_pred HHhcCCCCCCCCC------hHHHHHHHHhcccCCCCCC------------------------------------CCC---
Q 012762 350 ELFYGTTPFKGID------HELTLANVVARALEFPKEP------------------------------------SVP--- 384 (457)
Q Consensus 350 elltG~~Pf~~~~------~~~~~~~~~~~~~~~~~~~------------------------------------~~~--- 384 (457)
||+||.+.|...+ +++.+..|+.....+|... .++
T Consensus 443 ELaTGDyLFePhsG~~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~ 522 (590)
T KOG1290|consen 443 ELATGDYLFEPHSGENYSRDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEED 522 (590)
T ss_pred HhhcCceeecCCCCCCCCccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHH
Confidence 9999999996532 4566777666544444310 001
Q ss_pred -hHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCCC
Q 012762 385 -GPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGV 421 (457)
Q Consensus 385 -~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~~ 421 (457)
.++.+||.-||+++|++||+ |.++|+|||++.+
T Consensus 523 A~~fsdFL~PmLef~PeKR~t----A~~cl~hPwLn~~ 556 (590)
T KOG1290|consen 523 AQQFSDFLSPMLEFDPEKRPT----AAQCLKHPWLNPV 556 (590)
T ss_pred HHHHHHHHHHHHhcCcccccc----HHHHhcCccccCC
Confidence 25779999999999999999 9999999999964
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-45 Score=356.23 Aligned_cols=257 Identities=31% Similarity=0.478 Sum_probs=222.3
Q ss_pred EEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcEEEEEe
Q 012762 87 VHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWSCLLTE 166 (457)
Q Consensus 87 ~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lV~E 166 (457)
.++||+|.||+||-|.++ ++|+.||||++.|-++.. .....++.|+.||+.++||.||.+...|+..+.+++|||
T Consensus 569 devLGSGQFG~VYgg~hR----ktGrdVAvKvIdKlrFp~-kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVME 643 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHR----KTGRDVAVKVIDKLRFPT-KQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVME 643 (888)
T ss_pred HhhccCCcceeeecceec----ccCceeeeeeeecccCCC-chHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEeh
Confidence 378999999999999887 599999999999887654 456888999999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccC---CCEEEeccCCCcCCCCCCc
Q 012762 167 FCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSD---GHIMLTDFDLSLKGDNSTS 243 (457)
Q Consensus 167 ~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~---~~vkl~DFG~s~~~~~~~~ 243 (457)
.+ +|++.+++-....+++++...+.++.||+.||+|||.++|+|.||||+|||+.+. -++||||||+++...++..
T Consensus 644 Kl-~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF 722 (888)
T KOG4236|consen 644 KL-HGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF 722 (888)
T ss_pred hh-cchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhh
Confidence 99 6666666666667899999999999999999999999999999999999999754 3799999999988764332
Q ss_pred ccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCCCC
Q 012762 244 TAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTHE 323 (457)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 323 (457)
.+ +.+||+.
T Consensus 723 Rr-----------------------------------------------------------------------sVVGTPA 731 (888)
T KOG4236|consen 723 RR-----------------------------------------------------------------------SVVGTPA 731 (888)
T ss_pred hh-----------------------------------------------------------------------hhcCCcc
Confidence 21 4579999
Q ss_pred ccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCC--CCCCCChHHHHHHHHHhhhCCCC
Q 012762 324 YLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFP--KEPSVPGPAKDLIAQLLVKDPTR 401 (457)
Q Consensus 324 y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ll~~~L~~dP~~ 401 (457)
|+|||+++..+|+..-|+||.|||+|--+.|..||... +++-.+|.+..+-+| .+..++..+.|||+.+|+..-.+
T Consensus 732 YLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEd--EdIndQIQNAaFMyPp~PW~eis~~AidlIn~LLqVkm~k 809 (888)
T KOG4236|consen 732 YLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNED--EDINDQIQNAAFMYPPNPWSEISPEAIDLINNLLQVKMRK 809 (888)
T ss_pred ccCHHHHhhccccccccceeeeEEEEEEecccccCCCc--cchhHHhhccccccCCCchhhcCHHHHHHHHHHHHHHHHH
Confidence 99999999999999999999999999999999999754 345555555555554 34578999999999999999999
Q ss_pred CCCCCcChHHHhcCCCCCCC-Cchhh
Q 012762 402 RMGSKMGATAIKRHQFFNGV-NWALL 426 (457)
Q Consensus 402 Rps~~~~~~~ll~hp~f~~~-~~~~~ 426 (457)
|.+ ++..|.|||+++. -|..|
T Consensus 810 Rys----vdk~lsh~Wlq~yq~w~DL 831 (888)
T KOG4236|consen 810 RYS----VDKSLSHPWLQDYQTWLDL 831 (888)
T ss_pred hcc----hHhhccchhhhcchHHHHH
Confidence 999 9999999999984 35444
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-44 Score=342.84 Aligned_cols=261 Identities=28% Similarity=0.477 Sum_probs=217.4
Q ss_pred CCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcE
Q 012762 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWS 161 (457)
Q Consensus 82 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~ 161 (457)
++|++.++||.|+||+||+|.+. .++..||+|++... .......+..|++++++++|+||+++++++..+...
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~----~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 77 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHK----ETGLFAAAKIIQIE---SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKL 77 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEc----CCCcEEEEEEEeeC---CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeE
Confidence 57999999999999999999876 36789999998643 223456677899999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCC
Q 012762 162 CLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNS 241 (457)
Q Consensus 162 ~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~ 241 (457)
|+||||+++++|..++... ...+++..++.++.|++.||.|||++||+|+||||+||+++.++.++|+|||++......
T Consensus 78 ~lv~e~~~~~~L~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 156 (280)
T cd06611 78 WILIEFCDGGALDSIMLEL-ERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKST 156 (280)
T ss_pred EEEeeccCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhccc
Confidence 9999999999999887664 256999999999999999999999999999999999999999999999999986543211
Q ss_pred CcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCC
Q 012762 242 TSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGT 321 (457)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 321 (457)
.. ......|+
T Consensus 157 ~~----------------------------------------------------------------------~~~~~~~~ 166 (280)
T cd06611 157 LQ----------------------------------------------------------------------KRDTFIGT 166 (280)
T ss_pred cc----------------------------------------------------------------------ccceeecc
Confidence 00 01123589
Q ss_pred CCccCchhhc-----CCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhccc-CCCCCCCCChHHHHHHHHHh
Q 012762 322 HEYLAPEIIS-----GEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARAL-EFPKEPSVPGPAKDLIAQLL 395 (457)
Q Consensus 322 ~~y~aPE~l~-----~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ll~~~L 395 (457)
..|+|||++. ...++.++|||||||++|+|++|..||........+..+..... .+.....++.++.++|.+||
T Consensus 167 ~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 246 (280)
T cd06611 167 PYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFNDFLKSCL 246 (280)
T ss_pred hhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcccCCHHHHHHHHHHh
Confidence 9999999985 34467899999999999999999999988766665555554332 22233457889999999999
Q ss_pred hhCCCCCCCCCcChHHHhcCCCCCCCCch
Q 012762 396 VKDPTRRMGSKMGATAIKRHQFFNGVNWA 424 (457)
Q Consensus 396 ~~dP~~Rps~~~~~~~ll~hp~f~~~~~~ 424 (457)
..||.+||+ +.++++||||.....+
T Consensus 247 ~~~p~~Rps----~~~il~~~~~~~~~~~ 271 (280)
T cd06611 247 VKDPDDRPT----AAELLKHPFVSDQSDN 271 (280)
T ss_pred ccChhhCcC----HHHHhcChhhcccchh
Confidence 999999999 9999999999976543
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=340.33 Aligned_cols=258 Identities=28% Similarity=0.457 Sum_probs=217.1
Q ss_pred CCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcE
Q 012762 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWS 161 (457)
Q Consensus 82 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~ 161 (457)
++|++.+.||.|+||.||+|.+. .++..||+|++.... .......+..|+++++.++|+||+++++++..+...
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~----~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 74 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDK----RTNQVVAIKVIDLEE--AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKL 74 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEEC----CCCeEEEEEEeeccc--cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeE
Confidence 47899999999999999999876 378899999987542 223445677899999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCC
Q 012762 162 CLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNS 241 (457)
Q Consensus 162 ~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~ 241 (457)
|+|+||+.+++|.+++.. ..+++..++.++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++......
T Consensus 75 ~~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~ 151 (274)
T cd06609 75 WIIMEYCGGGSCLDLLKP---GKLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTST 151 (274)
T ss_pred EEEEEeeCCCcHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeeccc
Confidence 999999999999988876 37899999999999999999999999999999999999999999999999997655421
Q ss_pred CcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCC
Q 012762 242 TSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGT 321 (457)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 321 (457)
.. ......|+
T Consensus 152 ~~----------------------------------------------------------------------~~~~~~~~ 161 (274)
T cd06609 152 MS----------------------------------------------------------------------KRNTFVGT 161 (274)
T ss_pred cc----------------------------------------------------------------------ccccccCC
Confidence 10 01123588
Q ss_pred CCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhhhCCCC
Q 012762 322 HEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDPTR 401 (457)
Q Consensus 322 ~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~ 401 (457)
..|+|||++.+..++.++|||||||++|+|++|..||...........+............++.++.+++.+||..||++
T Consensus 162 ~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~p~~ 241 (274)
T cd06609 162 PFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPFKDFVSLCLNKDPKE 241 (274)
T ss_pred ccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCcccccCHHHHHHHHHHhhCChhh
Confidence 89999999998889999999999999999999999998766554444444333222222237889999999999999999
Q ss_pred CCCCCcChHHHhcCCCCCCCC
Q 012762 402 RMGSKMGATAIKRHQFFNGVN 422 (457)
Q Consensus 402 Rps~~~~~~~ll~hp~f~~~~ 422 (457)
||+ +.++++||||....
T Consensus 242 Rpt----~~~il~~~~~~~~~ 258 (274)
T cd06609 242 RPS----AKELLKHKFIKKAK 258 (274)
T ss_pred CcC----HHHHhhChhhcCCC
Confidence 999 99999999998754
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-44 Score=350.66 Aligned_cols=262 Identities=24% Similarity=0.397 Sum_probs=207.9
Q ss_pred CccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHc-CCCCCceEEEEEE
Q 012762 78 PLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEML-DHPFLPTLYATLD 156 (457)
Q Consensus 78 ~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~~~~~ 156 (457)
.+.-..|+++++||.||.+.||++... ....||+|.+... ..+.....-++.|++.|.+| +|.+|+++++|-.
T Consensus 357 ~Vkg~~Yeilk~iG~GGSSkV~kV~~s-----~~~iyalkkv~~~-~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv 430 (677)
T KOG0596|consen 357 KVKGREYEILKQIGSGGSSKVFKVLNS-----DKQIYALKKVVLL-EADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEV 430 (677)
T ss_pred EECcchhhHHHhhcCCCcceeeeeecC-----CCcchhhhHHHHh-hcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeec
Confidence 344567999999999999999998753 3345666655332 24556678899999999999 5999999999999
Q ss_pred cCCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCc
Q 012762 157 CPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSL 236 (457)
Q Consensus 157 ~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~ 236 (457)
.++++||||||- ..+|..+++... ..++.-.++.|..||++++.++|+.||||-||||.|+|+ -.|.+||+|||+|.
T Consensus 431 ~d~~lYmvmE~G-d~DL~kiL~k~~-~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLl-VkG~LKLIDFGIA~ 507 (677)
T KOG0596|consen 431 TDGYLYMVMECG-DIDLNKILKKKK-SIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLL-VKGRLKLIDFGIAN 507 (677)
T ss_pred cCceEEEEeecc-cccHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEE-EeeeEEeeeechhc
Confidence 999999999976 789998887753 334445889999999999999999999999999999999 57789999999998
Q ss_pred CCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccc
Q 012762 237 KGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSM 316 (457)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (457)
.+...+.... ..
T Consensus 508 aI~~DTTsI~--------------------------------------------------------------------kd 519 (677)
T KOG0596|consen 508 AIQPDTTSIV--------------------------------------------------------------------KD 519 (677)
T ss_pred ccCcccccee--------------------------------------------------------------------ec
Confidence 7765443321 11
Q ss_pred cccCCCCccCchhhcCCC-----------CCccchhhhhhHHHHHHhcCCCCCCCCChH-HHHHHHHhcc--cCCCCCCC
Q 012762 317 SFVGTHEYLAPEIISGEG-----------HGNAVDWWTLGIFIFELFYGTTPFKGIDHE-LTLANVVARA--LEFPKEPS 382 (457)
Q Consensus 317 ~~~gt~~y~aPE~l~~~~-----------~~~~sDiwSlG~il~elltG~~Pf~~~~~~-~~~~~~~~~~--~~~~~~~~ 382 (457)
+.+||+.||+||.+.... .+.++||||||||||+|++|++||....+. ..+..|.+.. +.+|..+.
T Consensus 520 sQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~Iefp~~~~ 599 (677)
T KOG0596|consen 520 SQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHEIEFPDIPE 599 (677)
T ss_pred cccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCccccccCCCC
Confidence 347999999999996443 357899999999999999999999876533 2334444432 24444321
Q ss_pred CChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCCC
Q 012762 383 VPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGV 421 (457)
Q Consensus 383 ~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~~ 421 (457)
..++.++|+.||.+||.+||+ +.+||+|||++.+
T Consensus 600 -~~~li~~mK~CL~rdPkkR~s----i~eLLqhpFl~~~ 633 (677)
T KOG0596|consen 600 -NDELIDVMKCCLARDPKKRWS----IPELLQHPFLQIQ 633 (677)
T ss_pred -chHHHHHHHHHHhcCcccCCC----cHHHhcCcccccc
Confidence 234999999999999999999 9999999999863
|
|
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=343.66 Aligned_cols=255 Identities=24% Similarity=0.375 Sum_probs=213.3
Q ss_pred CCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcE
Q 012762 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWS 161 (457)
Q Consensus 82 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~ 161 (457)
.+|++.+.||+|+||.||+|.+. .++..||+|.+..... .....+.+|+++++.++|+||+++++.+..+...
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~----~~~~~v~ik~~~~~~~---~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~ 92 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDV----ATGQEVAIRQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGDEL 92 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEEC----CCCcEEEEEEEecCCc---chHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEE
Confidence 58999999999999999999876 4788999999876432 2345677899999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCC
Q 012762 162 CLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNS 241 (457)
Q Consensus 162 ~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~ 241 (457)
|+||||+++++|..++.. ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.++|+|||++......
T Consensus 93 ~lv~e~~~~~~L~~~~~~---~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~ 169 (296)
T cd06654 93 WVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169 (296)
T ss_pred EEeecccCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhcccc
Confidence 999999999999998865 45889999999999999999999999999999999999999999999999987543211
Q ss_pred CcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCC
Q 012762 242 TSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGT 321 (457)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 321 (457)
.. ......|+
T Consensus 170 ~~----------------------------------------------------------------------~~~~~~~~ 179 (296)
T cd06654 170 QS----------------------------------------------------------------------KRSTMVGT 179 (296)
T ss_pred cc----------------------------------------------------------------------ccCcccCC
Confidence 00 00123588
Q ss_pred CCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhc-ccCCCCCCCCChHHHHHHHHHhhhCCC
Q 012762 322 HEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVAR-ALEFPKEPSVPGPAKDLIAQLLVKDPT 400 (457)
Q Consensus 322 ~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ll~~~L~~dP~ 400 (457)
+.|+|||.+.+..++.++|||||||++|+|++|+.||...........+... ....+....++..+.+++.+||..||+
T Consensus 180 ~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~ 259 (296)
T cd06654 180 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVE 259 (296)
T ss_pred ccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHHHHHHHHCcCCcc
Confidence 9999999999888999999999999999999999999876654333332222 222223345788899999999999999
Q ss_pred CCCCCCcChHHHhcCCCCCC
Q 012762 401 RRMGSKMGATAIKRHQFFNG 420 (457)
Q Consensus 401 ~Rps~~~~~~~ll~hp~f~~ 420 (457)
+||+ +.+|++||||..
T Consensus 260 ~Rpt----~~eil~~~~~~~ 275 (296)
T cd06654 260 KRGS----AKELLQHQFLKI 275 (296)
T ss_pred cCcC----HHHHhhChhhhc
Confidence 9999 999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=336.28 Aligned_cols=261 Identities=24% Similarity=0.391 Sum_probs=213.4
Q ss_pred CceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhh------hhHHHHHHHHHHHHHHcCCCCCceEEEEEE
Q 012762 83 DLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVS------RNKESRARIEREILEMLDHPFLPTLYATLD 156 (457)
Q Consensus 83 ~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~------~~~~~~~~~E~~il~~l~H~nIv~l~~~~~ 156 (457)
+|.+...||.|+||.||+|.+. .++..||+|.+....... ......+.+|+++++.++||||+++++++.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~----~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 76 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNA----SSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSL 76 (267)
T ss_pred CccccceeecCCCeEEEEEEec----CCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEE
Confidence 4778899999999999999876 367889999886542221 123356778999999999999999999999
Q ss_pred cCCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCc
Q 012762 157 CPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSL 236 (457)
Q Consensus 157 ~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~ 236 (457)
..++.++||||+++++|..++... +.+++..+..++.|++.||+|||+.|++||||+|+||+++.++.++|+|||+++
T Consensus 77 ~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~ 154 (267)
T cd06628 77 DADHLNIFLEYVPGGSVAALLNNY--GAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISK 154 (267)
T ss_pred eCCccEEEEEecCCCCHHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCc
Confidence 999999999999999999998775 568999999999999999999999999999999999999999999999999986
Q ss_pred CCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccc
Q 012762 237 KGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSM 316 (457)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (457)
.......... ......
T Consensus 155 ~~~~~~~~~~----------------------------------------------------------------~~~~~~ 170 (267)
T cd06628 155 KLEANSLSTK----------------------------------------------------------------TNGARP 170 (267)
T ss_pred ccccccccCC----------------------------------------------------------------cccccc
Confidence 5532110000 000011
Q ss_pred cccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhh
Q 012762 317 SFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLV 396 (457)
Q Consensus 317 ~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~ 396 (457)
.+.|+..|+|||++.+..++.++|||||||++|+|++|+.||...........+... ........++..+.++|.+||+
T Consensus 171 ~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~ 249 (267)
T cd06628 171 SLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGEN-ASPEIPSNISSEAIDFLEKTFE 249 (267)
T ss_pred ccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhcc-CCCcCCcccCHHHHHHHHHHcc
Confidence 245889999999999888999999999999999999999999886655544443332 1222234578999999999999
Q ss_pred hCCCCCCCCCcChHHHhcCCCC
Q 012762 397 KDPTRRMGSKMGATAIKRHQFF 418 (457)
Q Consensus 397 ~dP~~Rps~~~~~~~ll~hp~f 418 (457)
.||.+||+ +.+|++||||
T Consensus 250 ~~p~~Rp~----~~~il~~~~~ 267 (267)
T cd06628 250 IDHNKRPT----AAELLKHPFL 267 (267)
T ss_pred CCchhCcC----HHHHhhCCCC
Confidence 99999999 9999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=340.28 Aligned_cols=257 Identities=28% Similarity=0.449 Sum_probs=212.5
Q ss_pred CceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcEE
Q 012762 83 DLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWSC 162 (457)
Q Consensus 83 ~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~ 162 (457)
-|++.++||.|+||.||+|.+. .++..+|+|.+.... ......+.+|+++++.++|+||+++++++...+..|
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~----~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~ 78 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNK----ETGVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLW 78 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEEC----CCCeEEEEEEeCCCC---HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEE
Confidence 3688899999999999999876 377889999986542 234556778999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCCC
Q 012762 163 LLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNST 242 (457)
Q Consensus 163 lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~~ 242 (457)
+||||+++++|..++... ...+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++.......
T Consensus 79 ~v~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~ 157 (282)
T cd06643 79 ILIEFCAGGAVDAVMLEL-ERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI 157 (282)
T ss_pred EEEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEccccccccccccc
Confidence 999999999998876542 3568999999999999999999999999999999999999999999999999975432110
Q ss_pred cccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCCC
Q 012762 243 STAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTH 322 (457)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 322 (457)
. ......|+.
T Consensus 158 ~----------------------------------------------------------------------~~~~~~~~~ 167 (282)
T cd06643 158 Q----------------------------------------------------------------------RRDSFIGTP 167 (282)
T ss_pred c----------------------------------------------------------------------ccccccccc
Confidence 0 011235899
Q ss_pred CccCchhhc-----CCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhccc-CCCCCCCCChHHHHHHHHHhh
Q 012762 323 EYLAPEIIS-----GEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARAL-EFPKEPSVPGPAKDLIAQLLV 396 (457)
Q Consensus 323 ~y~aPE~l~-----~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ll~~~L~ 396 (457)
.|+|||++. +..++.++|||||||++|||++|.+||...........+..... ..+....++.++.++|.+||.
T Consensus 168 ~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 247 (282)
T cd06643 168 YWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKDFLKKCLE 247 (282)
T ss_pred cccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHHHHHHHHHHcc
Confidence 999999984 34578899999999999999999999988766555555543322 223334578899999999999
Q ss_pred hCCCCCCCCCcChHHHhcCCCCCCC
Q 012762 397 KDPTRRMGSKMGATAIKRHQFFNGV 421 (457)
Q Consensus 397 ~dP~~Rps~~~~~~~ll~hp~f~~~ 421 (457)
.||++||+ ++++++||||...
T Consensus 248 ~~p~~Rp~----~~~il~~~~~~~~ 268 (282)
T cd06643 248 KNVDARWT----TTQLLQHPFVTVN 268 (282)
T ss_pred CChhhCcC----HHHHhcCCCEecc
Confidence 99999999 9999999999853
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=337.30 Aligned_cols=254 Identities=33% Similarity=0.623 Sum_probs=215.8
Q ss_pred CceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcEE
Q 012762 83 DLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWSC 162 (457)
Q Consensus 83 ~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~ 162 (457)
+|++.+.||.|+||.||+|.+. .++..||+|++.+...........+..|++++++++||||+++++++..+...|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~----~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 76 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKR----DTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMY 76 (258)
T ss_pred CceEEEEeccCCCceEEEEEEc----cCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEE
Confidence 4899999999999999999876 378899999998766555456678888999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCCC
Q 012762 163 LLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNST 242 (457)
Q Consensus 163 lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~~ 242 (457)
+||||+.|++|..++... ..+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 77 lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 154 (258)
T cd05578 77 LVVDLLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT 154 (258)
T ss_pred EEEeCCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence 999999999999888775 579999999999999999999999999999999999999999999999999875432111
Q ss_pred cccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCCC
Q 012762 243 STAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTH 322 (457)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 322 (457)
. .....|+.
T Consensus 155 ~-----------------------------------------------------------------------~~~~~~~~ 163 (258)
T cd05578 155 L-----------------------------------------------------------------------TTSTSGTP 163 (258)
T ss_pred c-----------------------------------------------------------------------ccccCCCh
Confidence 0 01224888
Q ss_pred CccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCCh--HHHHHHHHhcccCCCCCCCCChHHHHHHHHHhhhCCC
Q 012762 323 EYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDH--ELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDPT 400 (457)
Q Consensus 323 ~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~ 400 (457)
.|+|||++.+..++.++|+||||+++|+|++|..||..... ...+...... ........++.++.++|.+||..||.
T Consensus 164 ~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~~p~ 242 (258)
T cd05578 164 GYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET-ADVLYPATWSTEAIDAINKLLERDPQ 242 (258)
T ss_pred hhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc-ccccCcccCcHHHHHHHHHHccCChh
Confidence 99999999988899999999999999999999999987663 2223332221 22233345889999999999999999
Q ss_pred CCCCCCcCh--HHHhcCCCC
Q 012762 401 RRMGSKMGA--TAIKRHQFF 418 (457)
Q Consensus 401 ~Rps~~~~~--~~ll~hp~f 418 (457)
+||+ + .|+++||||
T Consensus 243 ~R~~----~~~~~l~~~~~~ 258 (258)
T cd05578 243 KRLG----DNLKDLKNHPYF 258 (258)
T ss_pred HcCC----ccHHHHhcCCCC
Confidence 9999 7 999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-43 Score=339.41 Aligned_cols=256 Identities=27% Similarity=0.420 Sum_probs=208.7
Q ss_pred CCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcE
Q 012762 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWS 161 (457)
Q Consensus 82 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~ 161 (457)
++|++.+.||+|+||.||+|.++ .+++.||+|++..... .......+..|+++++.++|+||+++++++......
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~----~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~ 75 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNR----ETGQIVAIKKFVESED-DPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKL 75 (286)
T ss_pred CceeeeeeecccCCeEEEEEEEC----CCCcEEEEEEEeeccc-CccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEE
Confidence 47999999999999999999886 4788999999865432 122345567899999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCC
Q 012762 162 CLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNS 241 (457)
Q Consensus 162 ~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~ 241 (457)
++||||++++.|..++... ..+++..++.++.||+.||.|||+.||+|+||||+||+++.++.++|+|||++......
T Consensus 76 ~~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07847 76 HLVFEYCDHTVLNELEKNP--RGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGP 153 (286)
T ss_pred EEEEeccCccHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCC
Confidence 9999999998888776543 46899999999999999999999999999999999999999999999999997644321
Q ss_pred CcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCC
Q 012762 242 TSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGT 321 (457)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 321 (457)
.. ......++
T Consensus 154 ~~----------------------------------------------------------------------~~~~~~~~ 163 (286)
T cd07847 154 GD----------------------------------------------------------------------DYTDYVAT 163 (286)
T ss_pred cc----------------------------------------------------------------------cccCcccc
Confidence 10 00123478
Q ss_pred CCccCchhhcCC-CCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcc-------------------cCCCC--
Q 012762 322 HEYLAPEIISGE-GHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARA-------------------LEFPK-- 379 (457)
Q Consensus 322 ~~y~aPE~l~~~-~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~-------------------~~~~~-- 379 (457)
..|+|||++.+. .++.++|||||||++|+|++|..||.+....+....+.... ...+.
T Consensus 164 ~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (286)
T cd07847 164 RWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPE 243 (286)
T ss_pred cccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccccCCCcc
Confidence 899999998764 57899999999999999999999998876554443332210 00111
Q ss_pred --------CCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCC
Q 012762 380 --------EPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFF 418 (457)
Q Consensus 380 --------~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f 418 (457)
...++..+.+|+.+||..||++||+ +.|++.||||
T Consensus 244 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~----~~eil~~~~f 286 (286)
T cd07847 244 TREPLESKFPNISSPALSFLKGCLQMDPTERLS----CEELLEHPYF 286 (286)
T ss_pred cccCHHHHhccCCHHHHHHHHHHhcCCccccCC----HHHHhcCCCC
Confidence 1245778999999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=339.70 Aligned_cols=254 Identities=25% Similarity=0.410 Sum_probs=209.1
Q ss_pred CCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCc
Q 012762 81 LSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRW 160 (457)
Q Consensus 81 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~ 160 (457)
.++|.+.+.||+|+||.||+|.+. .+++.||+|+++.... .....+.+|+.+++.++||||+++++++...+.
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~----~~~~~~~ik~~~~~~~---~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~ 80 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNV----NTGELAAIKVIKLEPG---EDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDK 80 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEc----CCCcEEEEEEEecCch---hHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCE
Confidence 457999999999999999999876 4788999999865421 233456779999999999999999999999999
Q ss_pred EEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCC
Q 012762 161 SCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDN 240 (457)
Q Consensus 161 ~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~ 240 (457)
.|+||||+++++|.+++... +.+++..++.++.||+.||.|||+.||+|+||||+||+++.++.++|+|||++.....
T Consensus 81 ~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06645 81 LWICMEFCGGGSLQDIYHVT--GPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITA 158 (267)
T ss_pred EEEEEeccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccC
Confidence 99999999999999988764 5799999999999999999999999999999999999999999999999998754321
Q ss_pred CCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccC
Q 012762 241 STSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVG 320 (457)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 320 (457)
... ......|
T Consensus 159 ~~~----------------------------------------------------------------------~~~~~~~ 168 (267)
T cd06645 159 TIA----------------------------------------------------------------------KRKSFIG 168 (267)
T ss_pred ccc----------------------------------------------------------------------ccccccC
Confidence 100 0012358
Q ss_pred CCCccCchhhc---CCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCC---CCCCChHHHHHHHHH
Q 012762 321 THEYLAPEIIS---GEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPK---EPSVPGPAKDLIAQL 394 (457)
Q Consensus 321 t~~y~aPE~l~---~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~ll~~~ 394 (457)
+..|+|||++. ...++.++|||||||++|+|++|..||...................+. ...++..+.+++.+|
T Consensus 169 ~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 248 (267)
T cd06645 169 TPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHHFVKMA 248 (267)
T ss_pred cccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHHHHHHHHHH
Confidence 99999999985 445788999999999999999999999765544333333333332222 124678899999999
Q ss_pred hhhCCCCCCCCCcChHHHhcCCC
Q 012762 395 LVKDPTRRMGSKMGATAIKRHQF 417 (457)
Q Consensus 395 L~~dP~~Rps~~~~~~~ll~hp~ 417 (457)
|..||++||+ +++|++|||
T Consensus 249 l~~~P~~R~~----~~~ll~~~~ 267 (267)
T cd06645 249 LTKNPKKRPT----AEKLLQHPF 267 (267)
T ss_pred ccCCchhCcC----HHHHhcCCC
Confidence 9999999999 999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-43 Score=332.27 Aligned_cols=256 Identities=25% Similarity=0.355 Sum_probs=219.4
Q ss_pred CceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcEE
Q 012762 83 DLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWSC 162 (457)
Q Consensus 83 ~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~ 162 (457)
+|++++.||.|+||.||+++.. .++..+++|.+....... .....+.+|++++++++|+||+++++++.+.+..+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~----~~~~~~~~k~~~~~~~~~-~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~ 75 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRT----EDDSLVVWKEVNLTRLSE-KERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLL 75 (256)
T ss_pred CceEeeEecccCCceEEEEEEc----CCCcEEEEEEEeecccch-hHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEE
Confidence 5899999999999999999876 478899999986554322 34556778999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCCC
Q 012762 163 LLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNST 242 (457)
Q Consensus 163 lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~~ 242 (457)
+||||+++++|.+++.......+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++.......
T Consensus 76 ~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~ 155 (256)
T cd08221 76 IEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY 155 (256)
T ss_pred EEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence 99999999999999887655678999999999999999999999999999999999999999999999999875442211
Q ss_pred cccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCCC
Q 012762 243 STAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTH 322 (457)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 322 (457)
. ......|+.
T Consensus 156 ~----------------------------------------------------------------------~~~~~~~~~ 165 (256)
T cd08221 156 S----------------------------------------------------------------------MAETVVGTP 165 (256)
T ss_pred c----------------------------------------------------------------------cccccCCCc
Confidence 0 001235899
Q ss_pred CccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhhhCCCCC
Q 012762 323 EYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDPTRR 402 (457)
Q Consensus 323 ~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R 402 (457)
.|+|||++.+..++.++|||||||++|||++|..||......+....+..+.... ....++.++.+++.+||..||.+|
T Consensus 166 ~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~p~~R 244 (256)
T cd08221 166 YYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTP-VVSVYSSELISLVHSLLQQDPEKR 244 (256)
T ss_pred cccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCC-CccccCHHHHHHHHHHcccCcccC
Confidence 9999999998888999999999999999999999998877767676666554433 235578899999999999999999
Q ss_pred CCCCcChHHHhcCCCC
Q 012762 403 MGSKMGATAIKRHQFF 418 (457)
Q Consensus 403 ps~~~~~~~ll~hp~f 418 (457)
|+ +.++++|+|+
T Consensus 245 ~s----~~~ll~~~~l 256 (256)
T cd08221 245 PT----ADEVLDQPLL 256 (256)
T ss_pred CC----HHHHhhCcCC
Confidence 99 9999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-43 Score=332.73 Aligned_cols=256 Identities=23% Similarity=0.411 Sum_probs=218.3
Q ss_pred CceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcEE
Q 012762 83 DLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWSC 162 (457)
Q Consensus 83 ~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~ 162 (457)
+|++.+.||+|+||.||++... .+++.||+|.+...... ......+.+|+++++.++|+||+++++++...+..|
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~----~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 75 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSK----EDGKQYVIKEINISKMS-PKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLY 75 (256)
T ss_pred CceEEEEeccCCceEEEEEEEc----CCCCEEEEEEEEhHhCC-hHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEE
Confidence 5899999999999999999876 37889999999765432 234457788999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCCC
Q 012762 163 LLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNST 242 (457)
Q Consensus 163 lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~~ 242 (457)
+||||+.+++|..++.......+++..+..++.|++.||.|||++|++|+||+|+|||++.++.++|+|||++.......
T Consensus 76 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~ 155 (256)
T cd08218 76 IVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV 155 (256)
T ss_pred EEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcch
Confidence 99999999999988876555568999999999999999999999999999999999999999999999999875432110
Q ss_pred cccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCCC
Q 012762 243 STAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTH 322 (457)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 322 (457)
. ......|+.
T Consensus 156 ~----------------------------------------------------------------------~~~~~~~~~ 165 (256)
T cd08218 156 E----------------------------------------------------------------------LARTCIGTP 165 (256)
T ss_pred h----------------------------------------------------------------------hhhhccCCc
Confidence 0 000234888
Q ss_pred CccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhhhCCCCC
Q 012762 323 EYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDPTRR 402 (457)
Q Consensus 323 ~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R 402 (457)
.|+|||++.+..++.++|+|||||++|+|++|..||...........++.+... +....++.++.++|.+||..+|.+|
T Consensus 166 ~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~R 244 (256)
T cd08218 166 YYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYP-PVSSHYSYDLRNLVSQLFKRNPRDR 244 (256)
T ss_pred cccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCC-CCcccCCHHHHHHHHHHhhCChhhC
Confidence 999999999888999999999999999999999999887776666666655432 2334578899999999999999999
Q ss_pred CCCCcChHHHhcCCCC
Q 012762 403 MGSKMGATAIKRHQFF 418 (457)
Q Consensus 403 ps~~~~~~~ll~hp~f 418 (457)
|+ +.++++||||
T Consensus 245 p~----~~~vl~~~~~ 256 (256)
T cd08218 245 PS----VNSILEKNFI 256 (256)
T ss_pred cC----HHHHhhCcCC
Confidence 99 9999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-46 Score=342.37 Aligned_cols=256 Identities=23% Similarity=0.382 Sum_probs=217.5
Q ss_pred CceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcEE
Q 012762 83 DLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWSC 162 (457)
Q Consensus 83 ~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~ 162 (457)
-|.++.+||+|+||.||+|.++ .+|..+|||.+.. +...+++..|+.|+++++.++||++||.+-....++
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~----EsG~v~AIK~VPV-----~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLW 104 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHR----ESGHVLAIKKVPV-----DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLW 104 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHh----ccCcEEEEEecCc-----cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceE
Confidence 4888999999999999988876 6899999999854 356677888999999999999999999888888999
Q ss_pred EEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCCC
Q 012762 163 LLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNST 242 (457)
Q Consensus 163 lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~~ 242 (457)
+|||||..|++.+++... +..+++.++..+++..+.||+|||...-||||||..|||++.+|+.||+|||.+..+.+--
T Consensus 105 IVMEYCGAGSiSDI~R~R-~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM 183 (502)
T KOG0574|consen 105 IVMEYCGAGSISDIMRAR-RKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM 183 (502)
T ss_pred eehhhcCCCcHHHHHHHh-cCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhH
Confidence 999999999999988654 4789999999999999999999999999999999999999999999999999985543211
Q ss_pred cccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCCC
Q 012762 243 STAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTH 322 (457)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 322 (457)
.+..+.+||+
T Consensus 184 ----------------------------------------------------------------------AKRNTVIGTP 193 (502)
T KOG0574|consen 184 ----------------------------------------------------------------------AKRNTVIGTP 193 (502)
T ss_pred ----------------------------------------------------------------------HhhCccccCc
Confidence 1223568999
Q ss_pred CccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhc-ccCCCCCCCCChHHHHHHHHHhhhCCCC
Q 012762 323 EYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVAR-ALEFPKEPSVPGPAKDLIAQLLVKDPTR 401 (457)
Q Consensus 323 ~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ll~~~L~~dP~~ 401 (457)
-|||||++...+|+.++||||||++..||..|++||.+......+..|-.. ...+..+..+++++.|++++||..+|++
T Consensus 194 FWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~ 273 (502)
T KOG0574|consen 194 FWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEFNDFIRSCLIKKPEE 273 (502)
T ss_pred ccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhhhHHHHHHHHHhcCCHHH
Confidence 999999999999999999999999999999999999876543222222111 1112233458899999999999999999
Q ss_pred CCCCCcChHHHhcCCCCCCCC
Q 012762 402 RMGSKMGATAIKRHQFFNGVN 422 (457)
Q Consensus 402 Rps~~~~~~~ll~hp~f~~~~ 422 (457)
|.+ +.+|++|||.++..
T Consensus 274 R~T----A~~L~~H~FiknA~ 290 (502)
T KOG0574|consen 274 RKT----ALRLCEHTFIKNAP 290 (502)
T ss_pred HHH----HHHHhhhhhhcCCC
Confidence 999 99999999998743
|
|
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=338.05 Aligned_cols=254 Identities=24% Similarity=0.389 Sum_probs=207.8
Q ss_pred CCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCc
Q 012762 81 LSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRW 160 (457)
Q Consensus 81 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~ 160 (457)
.++|++.+.||+|+||.||+|.++ .+++.||+|++..... .....+.+|+.+++.++|+||+++++++...+.
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~----~~~~~~aik~~~~~~~---~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~ 80 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNL----HTGELAAVKIIKLEPG---DDFSLIQQEIFMVKECKHCNIVAYFGSYLSREK 80 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEEC----CCCeEEEEEEEecCcc---chHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCE
Confidence 457999999999999999999876 4788999999864321 233457789999999999999999999999999
Q ss_pred EEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCC
Q 012762 161 SCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDN 240 (457)
Q Consensus 161 ~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~ 240 (457)
.|+||||+++++|.+++... ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++.....
T Consensus 81 ~~iv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06646 81 LWICMEYCGGGSLQDIYHVT--GPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITA 158 (267)
T ss_pred EEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecc
Confidence 99999999999999888754 5789999999999999999999999999999999999999999999999999754421
Q ss_pred CCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccC
Q 012762 241 STSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVG 320 (457)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 320 (457)
... ......|
T Consensus 159 ~~~----------------------------------------------------------------------~~~~~~~ 168 (267)
T cd06646 159 TIA----------------------------------------------------------------------KRKSFIG 168 (267)
T ss_pred ccc----------------------------------------------------------------------ccCcccc
Confidence 100 0012358
Q ss_pred CCCccCchhhc---CCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCC---CCCCChHHHHHHHHH
Q 012762 321 THEYLAPEIIS---GEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPK---EPSVPGPAKDLIAQL 394 (457)
Q Consensus 321 t~~y~aPE~l~---~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~ll~~~ 394 (457)
+..|+|||.+. ...++.++|||||||++|||++|+.||...........+....+..+. ...++..+.++|++|
T Consensus 169 ~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 248 (267)
T cd06646 169 TPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHNFVKIS 248 (267)
T ss_pred CccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHHHHHHHHHH
Confidence 89999999985 334788999999999999999999999765443333332222222222 234678999999999
Q ss_pred hhhCCCCCCCCCcChHHHhcCCC
Q 012762 395 LVKDPTRRMGSKMGATAIKRHQF 417 (457)
Q Consensus 395 L~~dP~~Rps~~~~~~~ll~hp~ 417 (457)
|..||++||+ +++|++|+|
T Consensus 249 l~~~P~~Rp~----~~~il~~l~ 267 (267)
T cd06646 249 LTKNPKKRPT----AERLLTHLF 267 (267)
T ss_pred hhCChhhCcC----HHHHhcCCC
Confidence 9999999999 999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-43 Score=334.80 Aligned_cols=261 Identities=25% Similarity=0.378 Sum_probs=216.5
Q ss_pred CCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcE
Q 012762 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWS 161 (457)
Q Consensus 82 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~ 161 (457)
++|++.+.||.|+||+||+|.+. .++..+|+|++....... ....+.+|+++|+.++|+||+++++.+..++..
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~----~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 74 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICL----PNNEKVAIKRIDLEKCQT--SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDEL 74 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEc----CCCcEEEEEEeccCCcch--HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEE
Confidence 47999999999999999999876 367889999987543322 556788899999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCC
Q 012762 162 CLLTEFCPGGDLHVLRQRQPD-KRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDN 240 (457)
Q Consensus 162 ~lV~E~~~~~sL~~~~~~~~~-~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~ 240 (457)
|+|||++++++|.+++..... ..+++..++.++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++.....
T Consensus 75 ~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~ 154 (267)
T cd06610 75 WLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLAD 154 (267)
T ss_pred EEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhcc
Confidence 999999999999999876432 5689999999999999999999999999999999999999999999999999765432
Q ss_pred CCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccC
Q 012762 241 STSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVG 320 (457)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 320 (457)
..... ......+.|
T Consensus 155 ~~~~~------------------------------------------------------------------~~~~~~~~~ 168 (267)
T cd06610 155 GGDRT------------------------------------------------------------------RKVRKTFVG 168 (267)
T ss_pred Ccccc------------------------------------------------------------------ccccccccC
Confidence 11100 000113468
Q ss_pred CCCccCchhhcCC-CCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccC-CCCC---CCCChHHHHHHHHHh
Q 012762 321 THEYLAPEIISGE-GHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALE-FPKE---PSVPGPAKDLIAQLL 395 (457)
Q Consensus 321 t~~y~aPE~l~~~-~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~-~~~~---~~~~~~~~~ll~~~L 395 (457)
+..|+|||++... .++.++|+|||||++|+|++|+.||........+......... ++.. ..++..+.+++.+||
T Consensus 169 ~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 248 (267)
T cd06610 169 TPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSKSFRKMISLCL 248 (267)
T ss_pred ChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCccccccccHHHHHHHHHHc
Confidence 9999999999877 6899999999999999999999999887666555555544221 1111 256788999999999
Q ss_pred hhCCCCCCCCCcChHHHhcCCCC
Q 012762 396 VKDPTRRMGSKMGATAIKRHQFF 418 (457)
Q Consensus 396 ~~dP~~Rps~~~~~~~ll~hp~f 418 (457)
..||++||+ +.+|++||||
T Consensus 249 ~~~p~~Rp~----~~~ll~~p~~ 267 (267)
T cd06610 249 QKDPSKRPT----AEELLKHKFF 267 (267)
T ss_pred CCChhhCcC----HHHHhhCCCC
Confidence 999999999 9999999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-43 Score=341.15 Aligned_cols=256 Identities=24% Similarity=0.377 Sum_probs=215.5
Q ss_pred CCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcE
Q 012762 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWS 161 (457)
Q Consensus 82 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~ 161 (457)
.+|++.+.||.|+||+||+|.+. .+++.||+|.+..... .....+.+|+++++.++|+||+++++++...+..
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~----~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 91 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDV----ATGQEVAIKQINLQKQ---PKKELIINEILVMKELKNPNIVNFLDSFLVGDEL 91 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEc----CCCcEEEEEEEecccC---chHHHHHHHHHHHHhcCCCceeeeeeeEecCceE
Confidence 56999999999999999999876 4788999999865422 3456678899999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCC
Q 012762 162 CLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNS 241 (457)
Q Consensus 162 ~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~ 241 (457)
|+||||+.+++|..++.. ..+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++......
T Consensus 92 ~lv~e~~~~~~L~~~~~~---~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~ 168 (296)
T cd06655 92 FVVMEYLAGGSLTDVVTE---TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE 168 (296)
T ss_pred EEEEEecCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccc
Confidence 999999999999988865 45899999999999999999999999999999999999999999999999987543211
Q ss_pred CcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCC
Q 012762 242 TSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGT 321 (457)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 321 (457)
.. ......|+
T Consensus 169 ~~----------------------------------------------------------------------~~~~~~~~ 178 (296)
T cd06655 169 QS----------------------------------------------------------------------KRSTMVGT 178 (296)
T ss_pred cc----------------------------------------------------------------------cCCCcCCC
Confidence 00 00123588
Q ss_pred CCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcc-cCCCCCCCCChHHHHHHHHHhhhCCC
Q 012762 322 HEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARA-LEFPKEPSVPGPAKDLIAQLLVKDPT 400 (457)
Q Consensus 322 ~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ll~~~L~~dP~ 400 (457)
..|+|||.+.+..++.++|||||||++|+|++|..||.+.........+.... ........++..+.++|.+||..||+
T Consensus 179 ~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~ 258 (296)
T cd06655 179 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRCLEMDVE 258 (296)
T ss_pred ccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHHHHHHHhhcChh
Confidence 99999999998889999999999999999999999998876554444433322 12223345788999999999999999
Q ss_pred CCCCCCcChHHHhcCCCCCCC
Q 012762 401 RRMGSKMGATAIKRHQFFNGV 421 (457)
Q Consensus 401 ~Rps~~~~~~~ll~hp~f~~~ 421 (457)
+||+ +.+|++||||+..
T Consensus 259 ~Rpt----~~~il~~~~~~~~ 275 (296)
T cd06655 259 KRGS----AKELLQHPFLKLA 275 (296)
T ss_pred hCCC----HHHHhhChHhhhc
Confidence 9999 9999999999853
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=332.08 Aligned_cols=265 Identities=29% Similarity=0.450 Sum_probs=219.1
Q ss_pred cee-EEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHc-CCCCCceEEEEEEcCCcE
Q 012762 84 LRF-VHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEML-DHPFLPTLYATLDCPRWS 161 (457)
Q Consensus 84 ~~~-~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~~~~~~~~~~ 161 (457)
|++ .+.||+|+|+.|--|... .+|..||||++.|... ....++.+|++++..+ +|+||+.++++|+++...
T Consensus 79 YkLt~e~LGeGAyasVqtcv~i----~t~~EYAVKiidKq~g---HsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~F 151 (463)
T KOG0607|consen 79 YKLTSELLGEGAYASVQTCVSI----QTGKEYAVKIIDKQPG---HSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRF 151 (463)
T ss_pred HHhHHHHhcCccceeeeeeeee----ccchhhhhhhhhcCCc---hHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceE
Confidence 444 367999999999988765 5899999999988743 4567888899999998 699999999999999999
Q ss_pred EEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCC---CEEEeccCCCcCC
Q 012762 162 CLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDG---HIMLTDFDLSLKG 238 (457)
Q Consensus 162 ~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~---~vkl~DFG~s~~~ 238 (457)
|||||.+.||.|...++.+ ..|++.++..+..+|+.||.|||.+||.||||||+|||..... -||||||.+.--.
T Consensus 152 YLVfEKm~GGplLshI~~~--~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~ 229 (463)
T KOG0607|consen 152 YLVFEKMRGGPLLSHIQKR--KHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGI 229 (463)
T ss_pred EEEEecccCchHHHHHHHh--hhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeecccccccc
Confidence 9999999999998777765 7799999999999999999999999999999999999998665 4799999875221
Q ss_pred CCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccc
Q 012762 239 DNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSF 318 (457)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (457)
.... +|. + ..+....+-
T Consensus 230 k~~~-------------------~~s-------------p-------------------------------astP~L~tP 246 (463)
T KOG0607|consen 230 KLNN-------------------DCS-------------P-------------------------------ASTPELLTP 246 (463)
T ss_pred ccCC-------------------CCC-------------C-------------------------------CCCccccCc
Confidence 1000 000 0 001122344
Q ss_pred cCCCCccCchhhc---C--CCCCccchhhhhhHHHHHHhcCCCCCCCCC---------------hHHHHHHHHhcccCCC
Q 012762 319 VGTHEYLAPEIIS---G--EGHGNAVDWWTLGIFIFELFYGTTPFKGID---------------HELTLANVVARALEFP 378 (457)
Q Consensus 319 ~gt~~y~aPE~l~---~--~~~~~~sDiwSlG~il~elltG~~Pf~~~~---------------~~~~~~~~~~~~~~~~ 378 (457)
+|+..|||||+.. + ..|+.+.|.||||+|||-||.|.+||.+.- .+..++.|..+.+.+|
T Consensus 247 vGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEGkYeFP 326 (463)
T KOG0607|consen 247 VGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFP 326 (463)
T ss_pred ccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHhccCCcCC
Confidence 7999999999974 2 348999999999999999999999997642 3456888999999998
Q ss_pred C--CCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCCCCch
Q 012762 379 K--EPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGVNWA 424 (457)
Q Consensus 379 ~--~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~~~~~ 424 (457)
. +..++.+.++++..+|..|+.+|.+ +.++++|||++...-.
T Consensus 327 dkdWahIS~eakdlisnLlvrda~~rls----a~~vlnhPw~~~~~~e 370 (463)
T KOG0607|consen 327 DKDWAHISSEAKDLISNLLVRDAKQRLS----AAQVLNHPWVQRCAPE 370 (463)
T ss_pred hhhhHHhhHHHHHHHHHHHhccHHhhhh----hhhccCCccccccchh
Confidence 6 4578999999999999999999999 9999999999975443
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-43 Score=334.28 Aligned_cols=255 Identities=20% Similarity=0.328 Sum_probs=214.4
Q ss_pred CCccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEE
Q 012762 77 NPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLD 156 (457)
Q Consensus 77 ~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~ 156 (457)
|.+..++|++.++||+|+||.||+|.+. .+..||+|.+..... ..+.+..|++++++++|+||+++++++.
T Consensus 1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~-----~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 71 (261)
T cd05072 1 WEIPRESIKLVKKLGAGQFGEVWMGYYN-----NSTKVAVKTLKPGTM----SVQAFLEEANLMKTLQHDKLVRLYAVVT 71 (261)
T ss_pred CcCchHHeEEeeecCCcCCceEEEEEec-----CCceEEEEEccCCch----hHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence 4577789999999999999999999864 456799998865322 3456788999999999999999999999
Q ss_pred cCCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCc
Q 012762 157 CPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSL 236 (457)
Q Consensus 157 ~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~ 236 (457)
..+..++||||+.+++|.+++.......+++..++.++.||+.||+|||+.+++||||||+||+++.++.++|+|||++.
T Consensus 72 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~ 151 (261)
T cd05072 72 KEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLAR 151 (261)
T ss_pred CCCCcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccce
Confidence 99999999999999999999887666778999999999999999999999999999999999999999999999999986
Q ss_pred CCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccc
Q 012762 237 KGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSM 316 (457)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (457)
......... ..
T Consensus 152 ~~~~~~~~~---------------------------------------------------------------------~~ 162 (261)
T cd05072 152 VIEDNEYTA---------------------------------------------------------------------RE 162 (261)
T ss_pred ecCCCceec---------------------------------------------------------------------cC
Confidence 543211000 00
Q ss_pred cccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHh
Q 012762 317 SFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLL 395 (457)
Q Consensus 317 ~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L 395 (457)
...++..|+|||++.+..++.++|||||||++|+|++ |..||...........+. .....+....++.++.+++.+||
T Consensus 163 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l 241 (261)
T cd05072 163 GAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQ-RGYRMPRMENCPDELYDIMKTCW 241 (261)
T ss_pred CCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHHHHHHHHHHc
Confidence 1236778999999998889999999999999999998 999998876665555544 34455555668899999999999
Q ss_pred hhCCCCCCCCCcChHHHhc
Q 012762 396 VKDPTRRMGSKMGATAIKR 414 (457)
Q Consensus 396 ~~dP~~Rps~~~~~~~ll~ 414 (457)
..||++||+ ++++++
T Consensus 242 ~~~p~~Rp~----~~~i~~ 256 (261)
T cd05072 242 KEKAEERPT----FDYLQS 256 (261)
T ss_pred cCCcccCcC----HHHHHH
Confidence 999999999 777754
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=343.13 Aligned_cols=255 Identities=24% Similarity=0.370 Sum_probs=211.9
Q ss_pred CCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcE
Q 012762 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWS 161 (457)
Q Consensus 82 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~ 161 (457)
.+|++++.||+|+||.||+|.+. .++..||+|.+..... .....+..|+.+++.++|+||+++++++..++..
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~----~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~ 91 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDI----ATGQEVAIKQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGDEL 91 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEEC----CCCCEEEEEEEecCcc---chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEE
Confidence 68999999999999999999876 4788999999975432 2345677899999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCC
Q 012762 162 CLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNS 241 (457)
Q Consensus 162 ~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~ 241 (457)
|+||||+++++|..++.. ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.++|+|||++......
T Consensus 92 ~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~ 168 (297)
T cd06656 92 WVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 168 (297)
T ss_pred EEeecccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCC
Confidence 999999999999998865 45899999999999999999999999999999999999999999999999987543211
Q ss_pred CcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCC
Q 012762 242 TSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGT 321 (457)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 321 (457)
... .....|+
T Consensus 169 ~~~----------------------------------------------------------------------~~~~~~~ 178 (297)
T cd06656 169 QSK----------------------------------------------------------------------RSTMVGT 178 (297)
T ss_pred ccC----------------------------------------------------------------------cCcccCC
Confidence 100 0123588
Q ss_pred CCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhc-ccCCCCCCCCChHHHHHHHHHhhhCCC
Q 012762 322 HEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVAR-ALEFPKEPSVPGPAKDLIAQLLVKDPT 400 (457)
Q Consensus 322 ~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ll~~~L~~dP~ 400 (457)
+.|+|||.+.+..++.++|||||||++|+|++|..||...........+... .........++..+++|+.+||..||+
T Consensus 179 ~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 258 (297)
T cd06656 179 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNRCLEMDVD 258 (297)
T ss_pred ccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHHHHHHHHccCChh
Confidence 8999999999888999999999999999999999999775543322222211 111122345778899999999999999
Q ss_pred CCCCCCcChHHHhcCCCCCC
Q 012762 401 RRMGSKMGATAIKRHQFFNG 420 (457)
Q Consensus 401 ~Rps~~~~~~~ll~hp~f~~ 420 (457)
+||+ +.++++||||+.
T Consensus 259 ~Rps----~~~il~~~~~~~ 274 (297)
T cd06656 259 RRGS----AKELLQHPFLKL 274 (297)
T ss_pred hCcC----HHHHhcCchhcc
Confidence 9999 999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-43 Score=343.71 Aligned_cols=284 Identities=18% Similarity=0.268 Sum_probs=220.5
Q ss_pred ccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcC
Q 012762 79 LTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCP 158 (457)
Q Consensus 79 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~ 158 (457)
+...+|++.+.||+|+||+||+|.+.......+..||+|+++.. .......++..|+.+++.++|+||+++++++...
T Consensus 4 ~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~ 81 (316)
T cd05108 4 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS 81 (316)
T ss_pred cchhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC
Confidence 44568999999999999999999986533334456999998643 2233456678899999999999999999999765
Q ss_pred CcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCC
Q 012762 159 RWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKG 238 (457)
Q Consensus 159 ~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~ 238 (457)
..++|+||+.+|+|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 82 -~~~~v~e~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~ 159 (316)
T cd05108 82 -TVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (316)
T ss_pred -CceeeeecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccc
Confidence 5679999999999998887642 46888999999999999999999999999999999999999999999999998654
Q ss_pred CCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccc
Q 012762 239 DNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSF 318 (457)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (457)
....... .....
T Consensus 160 ~~~~~~~--------------------------------------------------------------------~~~~~ 171 (316)
T cd05108 160 GADEKEY--------------------------------------------------------------------HAEGG 171 (316)
T ss_pred cCCCcce--------------------------------------------------------------------eccCC
Confidence 3211100 00011
Q ss_pred cCCCCccCchhhcCCCCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhhh
Q 012762 319 VGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVK 397 (457)
Q Consensus 319 ~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~ 397 (457)
.++..|+|||++.+..++.++|||||||++|||++ |..||.+....+ +..++......+....++.++.+++.+||..
T Consensus 172 ~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~ 250 (316)
T cd05108 172 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-ISSILEKGERLPQPPICTIDVYMIMVKCWMI 250 (316)
T ss_pred ccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH-HHHHHhCCCCCCCCCCCCHHHHHHHHHHccC
Confidence 24678999999999999999999999999999997 999998766544 3445555556666667888999999999999
Q ss_pred CCCCCCCCCcChHHHhcCC--CC-CCCCchhhhccCCCCCCCCCC
Q 012762 398 DPTRRMGSKMGATAIKRHQ--FF-NGVNWALLRCAKPPFIPRPVT 439 (457)
Q Consensus 398 dP~~Rps~~~~~~~ll~hp--~f-~~~~~~~~~~~~~~~~~~~~~ 439 (457)
||++||+ +.+++.+- .. ...+|..+....+..+|.|..
T Consensus 251 ~p~~Rps----~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (316)
T cd05108 251 DADSRPK----FRELIIEFSKMARDPQRYLVIQGDERMHLPSPTD 291 (316)
T ss_pred ChhhCcC----HHHHHHHHHHHHcCCchheEecCCcccCCCCCch
Confidence 9999999 77777651 11 112333344445555555544
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-43 Score=334.35 Aligned_cols=259 Identities=25% Similarity=0.394 Sum_probs=208.6
Q ss_pred CceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhh--hhhHHHHHHHHHHHHHHcCCCCCceEEEEEEc--C
Q 012762 83 DLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELV--SRNKESRARIEREILEMLDHPFLPTLYATLDC--P 158 (457)
Q Consensus 83 ~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~--~ 158 (457)
+|++.+.||+|+||.||+|.+. .++..||+|++...... .......+.+|+++++.++|+||+++++++.. .
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~----~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 78 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDV----DTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAE 78 (266)
T ss_pred CccccceecCCCCEEEEEEEEc----CCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCC
Confidence 6899999999999999999876 37889999998654221 12234567889999999999999999999865 3
Q ss_pred CcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCC
Q 012762 159 RWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKG 238 (457)
Q Consensus 159 ~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~ 238 (457)
...+++|||+++++|..++... ..+++..++.++.||+.||.|||+++|+|+||||+||+++.++.++|+|||++...
T Consensus 79 ~~~~l~~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~ 156 (266)
T cd06651 79 KTLTIFMEYMPGGSVKDQLKAY--GALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRL 156 (266)
T ss_pred CEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCcccc
Confidence 5788999999999999888764 46899999999999999999999999999999999999999999999999997644
Q ss_pred CCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccc
Q 012762 239 DNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSF 318 (457)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (457)
....... ......
T Consensus 157 ~~~~~~~-------------------------------------------------------------------~~~~~~ 169 (266)
T cd06651 157 QTICMSG-------------------------------------------------------------------TGIRSV 169 (266)
T ss_pred ccccccC-------------------------------------------------------------------CccccC
Confidence 2110000 000123
Q ss_pred cCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhhhC
Q 012762 319 VGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKD 398 (457)
Q Consensus 319 ~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~d 398 (457)
.|+..|+|||++.+..++.++|||||||++|||++|+.||...........+............++..+.+++ +||..|
T Consensus 170 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li-~~~~~~ 248 (266)
T cd06651 170 TGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARDFL-GCIFVE 248 (266)
T ss_pred CccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCchhcCHHHHHHH-HHhcCC
Confidence 4889999999999888999999999999999999999999876655444443332222222234677888998 677789
Q ss_pred CCCCCCCCcChHHHhcCCCCC
Q 012762 399 PTRRMGSKMGATAIKRHQFFN 419 (457)
Q Consensus 399 P~~Rps~~~~~~~ll~hp~f~ 419 (457)
|++||+ +.||++||||+
T Consensus 249 p~~Rp~----~~eil~hp~~~ 265 (266)
T cd06651 249 ARHRPS----AEELLRHPFAQ 265 (266)
T ss_pred hhhCcC----HHHHhcCcccc
Confidence 999999 99999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=332.77 Aligned_cols=260 Identities=25% Similarity=0.409 Sum_probs=210.0
Q ss_pred CCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhh--hhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcC-
Q 012762 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELV--SRNKESRARIEREILEMLDHPFLPTLYATLDCP- 158 (457)
Q Consensus 82 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~- 158 (457)
.+|++.+.||+|+||.||+|.++ .++..||+|++...... .......+.+|++++++++|+||+++++++.+.
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~----~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 77 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDA----DTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPM 77 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEc----CCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCC
Confidence 47999999999999999999876 47889999998643211 122345778899999999999999999998763
Q ss_pred -CcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcC
Q 012762 159 -RWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLK 237 (457)
Q Consensus 159 -~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~ 237 (457)
..+++||||+++++|.+++... ..+++..+..++.|++.||.|||+++|+|+||||+||+++.++.++|+|||++..
T Consensus 78 ~~~~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~ 155 (265)
T cd06652 78 ERTLSIFMEHMPGGSIKDQLKSY--GALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKR 155 (265)
T ss_pred CceEEEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccc
Confidence 4678999999999999988765 5588999999999999999999999999999999999999999999999998764
Q ss_pred CCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcccccc
Q 012762 238 GDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMS 317 (457)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (457)
........ .....
T Consensus 156 ~~~~~~~~-------------------------------------------------------------------~~~~~ 168 (265)
T cd06652 156 LQTICLSG-------------------------------------------------------------------TGMKS 168 (265)
T ss_pred cccccccc-------------------------------------------------------------------ccccc
Confidence 42110000 00112
Q ss_pred ccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhhh
Q 012762 318 FVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVK 397 (457)
Q Consensus 318 ~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~ 397 (457)
..|+..|+|||++.+..++.++|||||||++|+|++|+.||...........+.........+..++..+.++|.+|| .
T Consensus 169 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l-~ 247 (265)
T cd06652 169 VTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRDFLKRIF-V 247 (265)
T ss_pred CCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchhhCHHHHHHHHHHh-c
Confidence 358899999999998889999999999999999999999998765554444433322222223356778999999999 4
Q ss_pred CCCCCCCCCcChHHHhcCCCCC
Q 012762 398 DPTRRMGSKMGATAIKRHQFFN 419 (457)
Q Consensus 398 dP~~Rps~~~~~~~ll~hp~f~ 419 (457)
+|++||+ +++|++|||++
T Consensus 248 ~p~~Rp~----~~~il~~~~~~ 265 (265)
T cd06652 248 EAKLRPS----ADELLRHTFVH 265 (265)
T ss_pred ChhhCCC----HHHHhcCcccC
Confidence 9999999 99999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-43 Score=336.79 Aligned_cols=262 Identities=21% Similarity=0.350 Sum_probs=213.8
Q ss_pred ccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcC
Q 012762 79 LTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCP 158 (457)
Q Consensus 79 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~ 158 (457)
+..++|++.++||+|+||+||+|.+...+...+..||+|.+.... .......+.+|+++++.++|+||+++++++...
T Consensus 2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 79 (283)
T cd05090 2 LPLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN--NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQE 79 (283)
T ss_pred CChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC
Confidence 456789999999999999999999765555577899999987532 223445678899999999999999999999999
Q ss_pred CcEEEEEeecCCCChHHHHHhCC---------------CCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEcc
Q 012762 159 RWSCLLTEFCPGGDLHVLRQRQP---------------DKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRS 223 (457)
Q Consensus 159 ~~~~lV~E~~~~~sL~~~~~~~~---------------~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~ 223 (457)
...|+||||+.+++|.+++.... ...+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~ 159 (283)
T cd05090 80 QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGE 159 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcC
Confidence 99999999999999998885421 134788899999999999999999999999999999999999
Q ss_pred CCCEEEeccCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCC
Q 012762 224 DGHIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGT 303 (457)
Q Consensus 224 ~~~vkl~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (457)
++.+||+|||+++.........
T Consensus 160 ~~~~kl~dfg~~~~~~~~~~~~---------------------------------------------------------- 181 (283)
T cd05090 160 QLHVKISDLGLSREIYSADYYR---------------------------------------------------------- 181 (283)
T ss_pred CCcEEeccccccccccCCccee----------------------------------------------------------
Confidence 9999999999986543211000
Q ss_pred CcccccCCccccccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHHhcccCCCCCCC
Q 012762 304 PEIVAEPLDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVVARALEFPKEPS 382 (457)
Q Consensus 304 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 382 (457)
......++..|+|||++.+..++.++|||||||++|||++ |..||.+.........+. ....++....
T Consensus 182 ----------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~ 250 (283)
T cd05090 182 ----------VQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVR-KRQLLPCSED 250 (283)
T ss_pred ----------cccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-cCCcCCCCCC
Confidence 0012246778999999998889999999999999999998 999998866544444433 3334444556
Q ss_pred CChHHHHHHHHHhhhCCCCCCCCCcChHHHhcC
Q 012762 383 VPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRH 415 (457)
Q Consensus 383 ~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~h 415 (457)
++..+.+++.+||..||++||+ +.+|+++
T Consensus 251 ~~~~~~~li~~cl~~~p~~Rp~----~~~i~~~ 279 (283)
T cd05090 251 CPPRMYSLMTECWQEGPSRRPR----FKDIHTR 279 (283)
T ss_pred CCHHHHHHHHHHcccCcccCcC----HHHHHHH
Confidence 8899999999999999999999 8888765
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-43 Score=338.36 Aligned_cols=262 Identities=23% Similarity=0.373 Sum_probs=214.4
Q ss_pred ccCCCceeEEEecccCcceEEEEEEeccC-CCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEc
Q 012762 79 LTLSDLRFVHRLGSGDIGSVYLVQLKSKS-SNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDC 157 (457)
Q Consensus 79 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~-~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~ 157 (457)
+..++|++.+.||+|+||.||+|.+.... ......||+|.+.... .......+.+|+++++.++||||+++++++..
T Consensus 2 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~ 79 (283)
T cd05048 2 IPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA--EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTK 79 (283)
T ss_pred CChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC--CHHHHHHHHHHHHHHHhcCCcccceEEEEEcC
Confidence 45678999999999999999999876432 2344689999986442 22345567889999999999999999999999
Q ss_pred CCcEEEEEeecCCCChHHHHHhCCC--------------CCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEcc
Q 012762 158 PRWSCLLTEFCPGGDLHVLRQRQPD--------------KRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRS 223 (457)
Q Consensus 158 ~~~~~lV~E~~~~~sL~~~~~~~~~--------------~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~ 223 (457)
.+..|++|||+++++|.+++..... ..+++..++.++.||+.||.|||++|++|+||||+|||++.
T Consensus 80 ~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~ 159 (283)
T cd05048 80 EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGE 159 (283)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcC
Confidence 9999999999999999998876421 45788999999999999999999999999999999999999
Q ss_pred CCCEEEeccCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCC
Q 012762 224 DGHIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGT 303 (457)
Q Consensus 224 ~~~vkl~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (457)
++.++|+|||+++.........
T Consensus 160 ~~~~~L~dfg~~~~~~~~~~~~---------------------------------------------------------- 181 (283)
T cd05048 160 GLTVKISDFGLSRDIYSADYYR---------------------------------------------------------- 181 (283)
T ss_pred CCcEEECCCcceeecccccccc----------------------------------------------------------
Confidence 9999999999975432111000
Q ss_pred CcccccCCccccccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHHhcccCCCCCCC
Q 012762 304 PEIVAEPLDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVVARALEFPKEPS 382 (457)
Q Consensus 304 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 382 (457)
......+++.|+|||++.+..++.++|||||||++|||++ |..||.+....+....+..+. ..+....
T Consensus 182 ----------~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~~~~-~~~~~~~ 250 (283)
T cd05048 182 ----------VQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQ-LLPCPED 250 (283)
T ss_pred ----------ccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC-cCCCccc
Confidence 0011246889999999998889999999999999999998 999999877766665554433 2333456
Q ss_pred CChHHHHHHHHHhhhCCCCCCCCCcChHHHhcC
Q 012762 383 VPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRH 415 (457)
Q Consensus 383 ~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~h 415 (457)
++.++.+|+.+||+.||.+||+ +.+|+++
T Consensus 251 ~~~~~~~l~~~c~~~~p~~Rp~----~~~i~~~ 279 (283)
T cd05048 251 CPARVYALMIECWNEIPARRPR----FKDIHTR 279 (283)
T ss_pred CCHHHHHHHHHHccCChhhCcC----HHHHHHH
Confidence 8899999999999999999999 8888765
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=340.54 Aligned_cols=255 Identities=24% Similarity=0.376 Sum_probs=202.4
Q ss_pred CceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcEE
Q 012762 83 DLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWSC 162 (457)
Q Consensus 83 ~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~ 162 (457)
+|++.++||+|+||.||+|.++ .+|..||+|++..... .......+..|+++++.++|+||+++++++.+....|
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~----~~g~~~~~k~~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 75 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNR----ETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLT 75 (284)
T ss_pred CceeEEEecccCCeEEEEEEEC----CCCcEEEEEEeecccc-cccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceE
Confidence 4889999999999999999986 4788999999975432 2223345667999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCCC
Q 012762 163 LLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNST 242 (457)
Q Consensus 163 lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~~ 242 (457)
+||||++ ++|..++... ...+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++.......
T Consensus 76 lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 153 (284)
T cd07839 76 LVFEYCD-QDLKKYFDSC-NGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV 153 (284)
T ss_pred EEEecCC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCC
Confidence 9999995 6787766553 3569999999999999999999999999999999999999999999999999875432110
Q ss_pred cccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCCC
Q 012762 243 STAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTH 322 (457)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 322 (457)
.. .....++.
T Consensus 154 ~~----------------------------------------------------------------------~~~~~~~~ 163 (284)
T cd07839 154 RC----------------------------------------------------------------------YSAEVVTL 163 (284)
T ss_pred CC----------------------------------------------------------------------cCCCcccc
Confidence 00 00124788
Q ss_pred CccCchhhcCCC-CCccchhhhhhHHHHHHhcCCCCCCC-CChHHHHHHHHhccc--------------C---C------
Q 012762 323 EYLAPEIISGEG-HGNAVDWWTLGIFIFELFYGTTPFKG-IDHELTLANVVARAL--------------E---F------ 377 (457)
Q Consensus 323 ~y~aPE~l~~~~-~~~~sDiwSlG~il~elltG~~Pf~~-~~~~~~~~~~~~~~~--------------~---~------ 377 (457)
.|+|||++.+.. ++.++|||||||++|+|++|..||.. .+....+..+..... . .
T Consensus 164 ~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (284)
T cd07839 164 WYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPAT 243 (284)
T ss_pred CCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccccCCCCCc
Confidence 999999987754 78999999999999999999888643 333333332221100 0 0
Q ss_pred ----CCCCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCC
Q 012762 378 ----PKEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFF 418 (457)
Q Consensus 378 ----~~~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f 418 (457)
...+.++.++.++|++||..||.+||| ++++++||||
T Consensus 244 ~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t----~~~il~h~~f 284 (284)
T cd07839 244 TSLVNVVPKLNSTGRDLLQNLLVCNPVQRIS----AEEALQHPYF 284 (284)
T ss_pred chhhhhcccCCHHHHHHHHHHhcCChhhcCC----HHHHhcCCCC
Confidence 011246788999999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-43 Score=354.31 Aligned_cols=266 Identities=21% Similarity=0.280 Sum_probs=214.9
Q ss_pred CCCCccCCCceeEEEecccCcceEEEEEEeccC-CCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcC-CCCCceEE
Q 012762 75 NNNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKS-SNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLD-HPFLPTLY 152 (457)
Q Consensus 75 ~~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~-~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~-H~nIv~l~ 152 (457)
..+.+..++|++.++||+|+||+||+|.+.... ...+..||||++.... .......+.+|+++|++++ ||||++++
T Consensus 30 ~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~~l~~l~~HpnIv~l~ 107 (400)
T cd05105 30 SRWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA--RSSEKQALMSELKIMTHLGPHLNIVNLL 107 (400)
T ss_pred CceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhcCCCCCeeeEE
Confidence 456777889999999999999999999875322 2345679999996532 2234467888999999996 99999999
Q ss_pred EEEEcCCcEEEEEeecCCCChHHHHHhCC---------------------------------------------------
Q 012762 153 ATLDCPRWSCLLTEFCPGGDLHVLRQRQP--------------------------------------------------- 181 (457)
Q Consensus 153 ~~~~~~~~~~lV~E~~~~~sL~~~~~~~~--------------------------------------------------- 181 (457)
+++...+..|||||||++|+|.+++....
T Consensus 108 ~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 187 (400)
T cd05105 108 GACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQ 187 (400)
T ss_pred EEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccc
Confidence 99999999999999999999988876431
Q ss_pred -------------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCC
Q 012762 182 -------------------------------------------DKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPEN 218 (457)
Q Consensus 182 -------------------------------------------~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~N 218 (457)
...+++..+..++.||+.||.|||+.+|+||||||+|
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~N 267 (400)
T cd05105 188 YVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARN 267 (400)
T ss_pred cchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHh
Confidence 1247888889999999999999999999999999999
Q ss_pred eEEccCCCEEEeccCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccC
Q 012762 219 VLVRSDGHIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKL 298 (457)
Q Consensus 219 Ill~~~~~vkl~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (457)
||++.++.+||+|||+++........
T Consensus 268 ill~~~~~~kL~DfGla~~~~~~~~~------------------------------------------------------ 293 (400)
T cd05105 268 VLLAQGKIVKICDFGLARDIMHDSNY------------------------------------------------------ 293 (400)
T ss_pred EEEeCCCEEEEEeCCcceeccccccc------------------------------------------------------
Confidence 99999999999999997643211000
Q ss_pred CCCCCCcccccCCccccccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHHhcccCC
Q 012762 299 GNPGTPEIVAEPLDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVVARALEF 377 (457)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~ 377 (457)
.......++..|+|||++.+..++.++|||||||++|||++ |..||............+......
T Consensus 294 --------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~~~~~~~~ 359 (400)
T cd05105 294 --------------VSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRM 359 (400)
T ss_pred --------------cccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHHHhcCCCC
Confidence 00012247788999999999889999999999999999996 999998765544444455555555
Q ss_pred CCCCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhc
Q 012762 378 PKEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKR 414 (457)
Q Consensus 378 ~~~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~ 414 (457)
+....++.++.+++.+||+.||++||+ +.+|.+
T Consensus 360 ~~~~~~~~~l~~li~~cl~~dP~~RPt----~~~l~~ 392 (400)
T cd05105 360 AKPDHATQEVYDIMVKCWNSEPEKRPS----FLHLSD 392 (400)
T ss_pred CCCccCCHHHHHHHHHHCccCHhHCcC----HHHHHH
Confidence 555678899999999999999999999 666654
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=348.58 Aligned_cols=265 Identities=18% Similarity=0.265 Sum_probs=211.7
Q ss_pred CCccCCCceeEEEecccCcceEEEEEEecc-CCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHc-CCCCCceEEEE
Q 012762 77 NPLTLSDLRFVHRLGSGDIGSVYLVQLKSK-SSNNGCFFAAKVMDKRELVSRNKESRARIEREILEML-DHPFLPTLYAT 154 (457)
Q Consensus 77 ~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~-~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~~~ 154 (457)
|.+..++|++.+.||+|+||.||+|++... +..+++.||+|+++... .......+..|+++++++ +|+||++++++
T Consensus 2 ~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~~~~l~~h~niv~~~~~ 79 (337)
T cd05054 2 WEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA--TASEYKALMTELKILIHIGHHLNVVNLLGA 79 (337)
T ss_pred cccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC--CHHHHHHHHHHHHHHHhhccCcchhheeee
Confidence 567778999999999999999999976432 22456899999986432 122345667799999999 89999999998
Q ss_pred EEc-CCcEEEEEeecCCCChHHHHHhCCC---------------------------------------------------
Q 012762 155 LDC-PRWSCLLTEFCPGGDLHVLRQRQPD--------------------------------------------------- 182 (457)
Q Consensus 155 ~~~-~~~~~lV~E~~~~~sL~~~~~~~~~--------------------------------------------------- 182 (457)
+.. +..++++|||+.+++|..++.....
T Consensus 80 ~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (337)
T cd05054 80 CTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEED 159 (337)
T ss_pred EecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccc
Confidence 764 4578999999999999988864321
Q ss_pred --------CCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCCCcccccccCCCCC
Q 012762 183 --------KRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQLVSDQSPP 254 (457)
Q Consensus 183 --------~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~~~~~~~~~~~~~~ 254 (457)
..+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++.........
T Consensus 160 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~---------- 229 (337)
T cd05054 160 EEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY---------- 229 (337)
T ss_pred hhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcch----------
Confidence 26789999999999999999999999999999999999999999999999998654211100
Q ss_pred CCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCCCCccCchhhcCCC
Q 012762 255 TGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTHEYLAPEIISGEG 334 (457)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 334 (457)
.......++..|+|||++.+..
T Consensus 230 ----------------------------------------------------------~~~~~~~~~~~y~aPE~~~~~~ 251 (337)
T cd05054 230 ----------------------------------------------------------VRKGDARLPLKWMAPESIFDKV 251 (337)
T ss_pred ----------------------------------------------------------hhccCCCCCccccCcHHhcCCC
Confidence 0011234677899999999999
Q ss_pred CCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHh
Q 012762 335 HGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIK 413 (457)
Q Consensus 335 ~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll 413 (457)
++.++|||||||++|||++ |..||.+....+.+...+...........++.++.+++.+||+.+|++||+ +.+|+
T Consensus 252 ~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPs----~~ell 327 (337)
T cd05054 252 YTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRPT----FSELV 327 (337)
T ss_pred CCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCChhhCcC----HHHHH
Confidence 9999999999999999997 999998755444444444444343334457889999999999999999999 99988
Q ss_pred cC
Q 012762 414 RH 415 (457)
Q Consensus 414 ~h 415 (457)
+|
T Consensus 328 ~~ 329 (337)
T cd05054 328 EI 329 (337)
T ss_pred HH
Confidence 75
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-44 Score=369.31 Aligned_cols=261 Identities=28% Similarity=0.381 Sum_probs=211.7
Q ss_pred ccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcC-CCCCceEEEEE-E
Q 012762 79 LTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLD-HPFLPTLYATL-D 156 (457)
Q Consensus 79 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~-H~nIv~l~~~~-~ 156 (457)
+...+++|.+.|.+|||+.||+|.+.. .|..||+|++-.. .+.....+++|+++|++|. |+|||.+++.. .
T Consensus 34 Vg~~~v~V~~vLAEGGFa~VYla~~~~----~~~~~AlKrm~~~---de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~ 106 (738)
T KOG1989|consen 34 VGSHRVTVEKVLAEGGFAQVYLAQDVK----GGKKYALKRMYVN---DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAI 106 (738)
T ss_pred ECCEEEEEEEEEccCCcEEEEEEEecC----CCceeeeeeeecC---CHHHHHHHHHHHHHHHHhcCCCceeeEeccccc
Confidence 344568899999999999999999862 4489999998543 4456677889999999995 99999999932 1
Q ss_pred c---C---CcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcC--ceeecCCCCCeEEccCCCEE
Q 012762 157 C---P---RWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMG--IIYRDLKPENVLVRSDGHIM 228 (457)
Q Consensus 157 ~---~---~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~--iiHrDIKp~NIll~~~~~vk 228 (457)
. + -.++|+||||.||.|-+++...-..+|++.+++.|+.|+|+||.+||.++ |||||||-|||||+.+|+.|
T Consensus 107 ~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~K 186 (738)
T KOG1989|consen 107 NRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYK 186 (738)
T ss_pred cccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEE
Confidence 1 1 24689999999999999988665577999999999999999999999998 99999999999999999999
Q ss_pred EeccCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccc
Q 012762 229 LTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVA 308 (457)
Q Consensus 229 l~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (457)
|||||.+...-....... +..
T Consensus 187 LCDFGSatt~~~~~~~~~--------------------------------------------------------e~~--- 207 (738)
T KOG1989|consen 187 LCDFGSATTKILSPTSAQ--------------------------------------------------------EVN--- 207 (738)
T ss_pred eCcccccccccCCCccHH--------------------------------------------------------HHH---
Confidence 999998643221110000 000
Q ss_pred cCCccccccccCCCCccCchhhc---CCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCCCCCCh
Q 012762 309 EPLDVRSMSFVGTHEYLAPEIIS---GEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPG 385 (457)
Q Consensus 309 ~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (457)
.-.......-|+.|+|||++. +.+.+.|+|||+|||+||-|++...||++.. ...|+.+.+.+|..+..++
T Consensus 208 --~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg----~laIlng~Y~~P~~p~ys~ 281 (738)
T KOG1989|consen 208 --YVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESG----KLAILNGNYSFPPFPNYSD 281 (738)
T ss_pred --HHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCc----ceeEEeccccCCCCccHHH
Confidence 001111224699999999984 6778999999999999999999999998753 3467789999999989999
Q ss_pred HHHHHHHHHhhhCCCCCCCCCcChHHHhcC
Q 012762 386 PAKDLIAQLLVKDPTRRMGSKMGATAIKRH 415 (457)
Q Consensus 386 ~~~~ll~~~L~~dP~~Rps~~~~~~~ll~h 415 (457)
.+++||+.||+.||++||+ +.|++.+
T Consensus 282 ~l~~LI~~mL~~nP~~RPn----I~Qv~~~ 307 (738)
T KOG1989|consen 282 RLKDLIRTMLQPNPDERPN----IYQVLEE 307 (738)
T ss_pred HHHHHHHHHhccCcccCCC----HHHHHHH
Confidence 9999999999999999999 7777754
|
|
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-43 Score=336.31 Aligned_cols=261 Identities=26% Similarity=0.350 Sum_probs=207.4
Q ss_pred CCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHH-HHHcCCCCCceEEEEEEcCCc
Q 012762 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREI-LEMLDHPFLPTLYATLDCPRW 160 (457)
Q Consensus 82 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~i-l~~l~H~nIv~l~~~~~~~~~ 160 (457)
++|++.+.||+|+||.||+|.++ .+|+.||+|+++..... .....+..|+++ ++.++|+||+++++++..++.
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~----~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~ 74 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHV----PTGTIMAVKRIRATVNS--QEQKRLLMDLDISMRSVDCPYTVTFYGALFREGD 74 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEc----CCCcEEEEEEEecCCCc--HHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCc
Confidence 47999999999999999999987 47899999998764221 223344456665 566799999999999999999
Q ss_pred EEEEEeecCCCChHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHc-CceeecCCCCCeEEccCCCEEEeccCCCcC
Q 012762 161 SCLLTEFCPGGDLHVLRQRQ--PDKRFHESAVRFYASEVVVALEFLHMM-GIIYRDLKPENVLVRSDGHIMLTDFDLSLK 237 (457)
Q Consensus 161 ~~lV~E~~~~~sL~~~~~~~--~~~~~~~~~~~~i~~qi~~~L~yLH~~-~iiHrDIKp~NIll~~~~~vkl~DFG~s~~ 237 (457)
.|+||||++ ++|..++... ....+++..++.++.||+.||.|||++ +++||||||+|||++.++.+||+|||++..
T Consensus 75 ~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~ 153 (283)
T cd06617 75 VWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGY 153 (283)
T ss_pred EEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccc
Confidence 999999994 7887776542 235689999999999999999999997 999999999999999999999999999754
Q ss_pred CCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcccccc
Q 012762 238 GDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMS 317 (457)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (457)
...... ...
T Consensus 154 ~~~~~~-----------------------------------------------------------------------~~~ 162 (283)
T cd06617 154 LVDSVA-----------------------------------------------------------------------KTI 162 (283)
T ss_pred cccccc-----------------------------------------------------------------------ccc
Confidence 321100 001
Q ss_pred ccCCCCccCchhhcC----CCCCccchhhhhhHHHHHHhcCCCCCCCCC-hHHHHHHHHhcccCCCCCCCCChHHHHHHH
Q 012762 318 FVGTHEYLAPEIISG----EGHGNAVDWWTLGIFIFELFYGTTPFKGID-HELTLANVVARALEFPKEPSVPGPAKDLIA 392 (457)
Q Consensus 318 ~~gt~~y~aPE~l~~----~~~~~~sDiwSlG~il~elltG~~Pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~ 392 (457)
..|+..|+|||++.+ ..++.++|+|||||++|+|++|+.||.... ..+.+..+............++.++.++|.
T Consensus 163 ~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 242 (283)
T cd06617 163 DAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKFSPEFQDFVN 242 (283)
T ss_pred ccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCccccCHHHHHHHH
Confidence 248889999999865 446889999999999999999999997543 223344433332221112347889999999
Q ss_pred HHhhhCCCCCCCCCcChHHHhcCCCCCCCCch
Q 012762 393 QLLVKDPTRRMGSKMGATAIKRHQFFNGVNWA 424 (457)
Q Consensus 393 ~~L~~dP~~Rps~~~~~~~ll~hp~f~~~~~~ 424 (457)
+||..||++||+ +.+++.||||....+.
T Consensus 243 ~~l~~~p~~Rp~----~~~il~~~~~~~~~~~ 270 (283)
T cd06617 243 KCLKKNYKERPN----YPELLQHPFFELHLSK 270 (283)
T ss_pred HHccCChhhCcC----HHHHhcCchhhhcccc
Confidence 999999999999 9999999999987665
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=331.22 Aligned_cols=255 Identities=22% Similarity=0.330 Sum_probs=212.8
Q ss_pred CccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEc
Q 012762 78 PLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDC 157 (457)
Q Consensus 78 ~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~ 157 (457)
.+...+|.+.++||+|+||.||+|.++ ..++.||+|++.... .....+.+|+++++.++|+||+++++++..
T Consensus 2 ~~~~~~~~~~~~ig~g~~~~v~~~~~~----~~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 73 (263)
T cd05052 2 EMERTDITMKHKLGGGQYGEVYEGVWK----KYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 73 (263)
T ss_pred CCchHHeEEeeecCCcccceEEEEEEe----cCCceEEEEEecCCc----hHHHHHHHHHHHHHhCCCCChhheEEEEcC
Confidence 456678999999999999999999987 368899999986532 234567789999999999999999999999
Q ss_pred CCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcC
Q 012762 158 PRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLK 237 (457)
Q Consensus 158 ~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~ 237 (457)
++..++||||+++++|.+++.......+++..++.++.|++.||.|||++|++||||||+|||++.++.+||+|||++..
T Consensus 74 ~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~ 153 (263)
T cd05052 74 EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL 153 (263)
T ss_pred CCCcEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccc
Confidence 99999999999999999998776556789999999999999999999999999999999999999999999999999765
Q ss_pred CCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcccccc
Q 012762 238 GDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMS 317 (457)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (457)
........ ...
T Consensus 154 ~~~~~~~~---------------------------------------------------------------------~~~ 164 (263)
T cd05052 154 MTGDTYTA---------------------------------------------------------------------HAG 164 (263)
T ss_pred cccceeec---------------------------------------------------------------------cCC
Confidence 43211100 001
Q ss_pred ccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhh
Q 012762 318 FVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLV 396 (457)
Q Consensus 318 ~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~ 396 (457)
..++..|+|||++.+..++.++|||||||++|||++ |..||.+....+....+. ..+.......++.++.+++.+||.
T Consensus 165 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~cl~ 243 (263)
T cd05052 165 AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KGYRMERPEGCPPKVYELMRACWQ 243 (263)
T ss_pred CCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-CCCCCCCCCCCCHHHHHHHHHHcc
Confidence 124678999999999999999999999999999998 999998876655544443 334444455688999999999999
Q ss_pred hCCCCCCCCCcChHHHhc
Q 012762 397 KDPTRRMGSKMGATAIKR 414 (457)
Q Consensus 397 ~dP~~Rps~~~~~~~ll~ 414 (457)
.||++||+ +.++++
T Consensus 244 ~~p~~Rp~----~~~l~~ 257 (263)
T cd05052 244 WNPSDRPS----FAEIHQ 257 (263)
T ss_pred CCcccCCC----HHHHHH
Confidence 99999999 777764
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=335.74 Aligned_cols=271 Identities=38% Similarity=0.713 Sum_probs=216.1
Q ss_pred CceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhh-hHHHHHHHHHHHHHHc-CCCCCceEEEEEEcCCc
Q 012762 83 DLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSR-NKESRARIEREILEML-DHPFLPTLYATLDCPRW 160 (457)
Q Consensus 83 ~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~-~~~~~~~~E~~il~~l-~H~nIv~l~~~~~~~~~ 160 (457)
+|++.+.||.|+||.||+|++... ..+|..||+|++........ .....+..|+++|+++ +|+||+++++++..+..
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~-~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~ 79 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSG-HDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTK 79 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccC-CCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCe
Confidence 488999999999999999986522 23688999999976543222 2345677899999999 69999999999999999
Q ss_pred EEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCC
Q 012762 161 SCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDN 240 (457)
Q Consensus 161 ~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~ 240 (457)
.|+||||+++++|.+++... ..+++..+..++.||+.||.|||+.|++||||||+|||++.++.++|+|||++.....
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 157 (290)
T cd05613 80 LHLILDYINGGELFTHLSQR--ERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHE 157 (290)
T ss_pred EEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceeccc
Confidence 99999999999999888764 5689999999999999999999999999999999999999999999999998754321
Q ss_pred CCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccC
Q 012762 241 STSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVG 320 (457)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 320 (457)
.... ......|
T Consensus 158 ~~~~---------------------------------------------------------------------~~~~~~~ 168 (290)
T cd05613 158 DEVE---------------------------------------------------------------------RAYSFCG 168 (290)
T ss_pred cccc---------------------------------------------------------------------ccccccC
Confidence 1000 0012358
Q ss_pred CCCccCchhhcCC--CCCccchhhhhhHHHHHHhcCCCCCCCCCh----HHHHHHHHhcccCCCCCCCCChHHHHHHHHH
Q 012762 321 THEYLAPEIISGE--GHGNAVDWWTLGIFIFELFYGTTPFKGIDH----ELTLANVVARALEFPKEPSVPGPAKDLIAQL 394 (457)
Q Consensus 321 t~~y~aPE~l~~~--~~~~~sDiwSlG~il~elltG~~Pf~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~ 394 (457)
+..|+|||.+.+. .++.++||||||+++|+|++|..||..... ......+...... ....++..+.+++.+|
T Consensus 169 ~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ll~~~ 246 (290)
T cd05613 169 TIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP--YPQEMSALAKDIIQRL 246 (290)
T ss_pred CcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCC--CCccCCHHHHHHHHHH
Confidence 8999999999753 467899999999999999999999974322 2222222222222 2344788899999999
Q ss_pred hhhCCCCCCCCC-cChHHHhcCCCCCCCCchhhh
Q 012762 395 LVKDPTRRMGSK-MGATAIKRHQFFNGVNWALLR 427 (457)
Q Consensus 395 L~~dP~~Rps~~-~~~~~ll~hp~f~~~~~~~~~ 427 (457)
|..||++|++.. ..+++++.||||+.++|..+.
T Consensus 247 l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~~~~ 280 (290)
T cd05613 247 LMKDPKKRLGCGPSDADEIKKHPFFQKINWDDLA 280 (290)
T ss_pred hcCCHHHhcCCCCCCHHHHHcCcccccCCHHHHh
Confidence 999999998321 239999999999999997763
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=329.50 Aligned_cols=255 Identities=22% Similarity=0.388 Sum_probs=215.6
Q ss_pred CceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcEE
Q 012762 83 DLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWSC 162 (457)
Q Consensus 83 ~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~ 162 (457)
+|++.+.||+|+||.||+|.+. .++..+|+|++...... ......+..|+++|++++|+||+++++.+..++..+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~----~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~ 75 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRK----ADQKLVIIKQIPVEQMT-KDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALM 75 (256)
T ss_pred CceEEEEecccCceEEEEEEEc----CCCcEEEEEEEeccccc-cHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEE
Confidence 5899999999999999999876 37889999999765432 234567888999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccC-CCEEEeccCCCcCCCCC
Q 012762 163 LLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSD-GHIMLTDFDLSLKGDNS 241 (457)
Q Consensus 163 lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~-~~vkl~DFG~s~~~~~~ 241 (457)
+||||+++++|.+++.......+++..+..++.|++.+|.|||++||+|+||||+||+++.+ +.++|+|||++......
T Consensus 76 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (256)
T cd08220 76 IVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK 155 (256)
T ss_pred EEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence 99999999999999877555668999999999999999999999999999999999999865 46899999997644311
Q ss_pred CcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCC
Q 012762 242 TSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGT 321 (457)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 321 (457)
.. .....|+
T Consensus 156 ~~-----------------------------------------------------------------------~~~~~~~ 164 (256)
T cd08220 156 SK-----------------------------------------------------------------------AYTVVGT 164 (256)
T ss_pred cc-----------------------------------------------------------------------ccccccC
Confidence 00 0023588
Q ss_pred CCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhhhCCCC
Q 012762 322 HEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDPTR 401 (457)
Q Consensus 322 ~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~ 401 (457)
..|+|||.+.+..++.++||||||+++|+|++|..||...+.......+...... +....++.++.+++.+||..||++
T Consensus 165 ~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~ 243 (256)
T cd08220 165 PCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFA-PISDRYSPDLRQLILSMLNLDPSK 243 (256)
T ss_pred CcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCC-CCCCCcCHHHHHHHHHHccCChhh
Confidence 8999999999888899999999999999999999999887666555555543322 233457889999999999999999
Q ss_pred CCCCCcChHHHhcCCCC
Q 012762 402 RMGSKMGATAIKRHQFF 418 (457)
Q Consensus 402 Rps~~~~~~~ll~hp~f 418 (457)
||+ +.|+++||||
T Consensus 244 Rpt----~~~ll~~p~~ 256 (256)
T cd08220 244 RPQ----LSQIMAQPIC 256 (256)
T ss_pred CCC----HHHHhhCCCC
Confidence 999 9999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=329.76 Aligned_cols=253 Identities=26% Similarity=0.418 Sum_probs=212.4
Q ss_pred CCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcE
Q 012762 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWS 161 (457)
Q Consensus 82 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~ 161 (457)
++|.+.+.||+|+||.||+|.++. ++..||+|.+..... ...+.+|+++++.++|+||+++++++......
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~----~~~~~~~k~~~~~~~-----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~ 73 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKE----TGQVVAIKVVPVEED-----LQEIIKEISILKQCDSPYIVKYYGSYFKNTDL 73 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcC----CCcEEEEEEeecHHH-----HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcE
Confidence 579999999999999999999863 678999999875422 56788899999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCC
Q 012762 162 CLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNS 241 (457)
Q Consensus 162 ~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~ 241 (457)
|++|||+.+++|.+++... ...+++..++.++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++......
T Consensus 74 ~l~~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~ 152 (256)
T cd06612 74 WIVMEYCGAGSVSDIMKIT-NKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDT 152 (256)
T ss_pred EEEEecCCCCcHHHHHHhC-ccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccC
Confidence 9999999999999988654 257899999999999999999999999999999999999999999999999997644321
Q ss_pred CcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCC
Q 012762 242 TSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGT 321 (457)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 321 (457)
.. ......|+
T Consensus 153 ~~----------------------------------------------------------------------~~~~~~~~ 162 (256)
T cd06612 153 MA----------------------------------------------------------------------KRNTVIGT 162 (256)
T ss_pred cc----------------------------------------------------------------------ccccccCC
Confidence 10 00123478
Q ss_pred CCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhccc-CCCCCCCCChHHHHHHHHHhhhCCC
Q 012762 322 HEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARAL-EFPKEPSVPGPAKDLIAQLLVKDPT 400 (457)
Q Consensus 322 ~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ll~~~L~~dP~ 400 (457)
..|+|||++.+..++.++|||||||++|+|++|+.||...........+..... .+.....++.++.+++.+||+.||+
T Consensus 163 ~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~ 242 (256)
T cd06612 163 PFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVKKCLVKDPE 242 (256)
T ss_pred ccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHHHHHHHHhcChh
Confidence 899999999998899999999999999999999999987655443333222111 1122234678899999999999999
Q ss_pred CCCCCCcChHHHhcCCCC
Q 012762 401 RRMGSKMGATAIKRHQFF 418 (457)
Q Consensus 401 ~Rps~~~~~~~ll~hp~f 418 (457)
+||+ +.|++.||||
T Consensus 243 ~Rps----~~~il~~~~~ 256 (256)
T cd06612 243 ERPS----AIQLLQHPFI 256 (256)
T ss_pred hCcC----HHHHhcCCCC
Confidence 9999 9999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=328.63 Aligned_cols=252 Identities=23% Similarity=0.396 Sum_probs=212.6
Q ss_pred CceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcEE
Q 012762 83 DLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWSC 162 (457)
Q Consensus 83 ~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~ 162 (457)
+|++.++||.|+||.||++.++. ++..||+|.++.... ......+..|+++++.++|+||+++++++..++.+|
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~----~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 74 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVN----SDQKYAMKEIRLPKS--SSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLY 74 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcC----CCceEEEEEEEcCcc--hHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEE
Confidence 58999999999999999998763 788999999865322 234566778999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCCC
Q 012762 163 LLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNST 242 (457)
Q Consensus 163 lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~~ 242 (457)
+||||+++++|..++.......+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++.......
T Consensus 75 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 154 (255)
T cd08219 75 IVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG 154 (255)
T ss_pred EEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeecccc
Confidence 99999999999988876555678999999999999999999999999999999999999999999999999875432110
Q ss_pred cccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCCC
Q 012762 243 STAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTH 322 (457)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 322 (457)
. ......|+.
T Consensus 155 ~----------------------------------------------------------------------~~~~~~~~~ 164 (255)
T cd08219 155 A----------------------------------------------------------------------YACTYVGTP 164 (255)
T ss_pred c----------------------------------------------------------------------ccccccCCc
Confidence 0 001235889
Q ss_pred CccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhhhCCCCC
Q 012762 323 EYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDPTRR 402 (457)
Q Consensus 323 ~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R 402 (457)
.|+|||++.+..++.++|+||||+++|+|++|..||...+.......+...... +....++..+.++|.+||..||++|
T Consensus 165 ~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R 243 (255)
T cd08219 165 YYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYK-PLPSHYSYELRSLIKQMFKRNPRSR 243 (255)
T ss_pred cccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCC-CCCcccCHHHHHHHHHHHhCCcccC
Confidence 999999999988999999999999999999999999887666555555444332 2334578899999999999999999
Q ss_pred CCCCcChHHHhcC
Q 012762 403 MGSKMGATAIKRH 415 (457)
Q Consensus 403 ps~~~~~~~ll~h 415 (457)
|+ +.+|+.-
T Consensus 244 p~----~~~il~~ 252 (255)
T cd08219 244 PS----ATTILSR 252 (255)
T ss_pred CC----HHHHhhc
Confidence 99 9998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=341.01 Aligned_cols=253 Identities=23% Similarity=0.331 Sum_probs=190.8
Q ss_pred EEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEE--cCCcEEEE
Q 012762 87 VHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLD--CPRWSCLL 164 (457)
Q Consensus 87 ~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~--~~~~~~lV 164 (457)
..+||+|+||+||+|+++. ...+..||+|.+.... ....+.+|+++|+.++||||+++++++. .+...|+|
T Consensus 6 g~~lG~G~~g~Vy~~~~~~--~~~~~~~a~k~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv 78 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKD--GKDEKEYALKQIEGTG-----ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLL 78 (317)
T ss_pred ceEeccCCCeeEEEEEecC--CCccceEEEEEecCCC-----CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEE
Confidence 3689999999999998653 2356789999986532 2234667999999999999999999885 35678999
Q ss_pred EeecCCCChHHHHHhC-------CCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEE----ccCCCEEEeccC
Q 012762 165 TEFCPGGDLHVLRQRQ-------PDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLV----RSDGHIMLTDFD 233 (457)
Q Consensus 165 ~E~~~~~sL~~~~~~~-------~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll----~~~~~vkl~DFG 233 (457)
|||+ +++|..++... ....+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||
T Consensus 79 ~e~~-~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG 157 (317)
T cd07867 79 FDYA-EHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMG 157 (317)
T ss_pred Eeee-CCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeecc
Confidence 9999 56777666432 12358899999999999999999999999999999999999 456789999999
Q ss_pred CCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcc
Q 012762 234 LSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDV 313 (457)
Q Consensus 234 ~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (457)
+++......... .
T Consensus 158 ~a~~~~~~~~~~-------------------------------------------------------------------~ 170 (317)
T cd07867 158 FARLFNSPLKPL-------------------------------------------------------------------A 170 (317)
T ss_pred ceeccCCCcccc-------------------------------------------------------------------c
Confidence 986543211000 0
Q ss_pred ccccccCCCCccCchhhcCC-CCCccchhhhhhHHHHHHhcCCCCCCCCChH---------HHHHHHHhccc--------
Q 012762 314 RSMSFVGTHEYLAPEIISGE-GHGNAVDWWTLGIFIFELFYGTTPFKGIDHE---------LTLANVVARAL-------- 375 (457)
Q Consensus 314 ~~~~~~gt~~y~aPE~l~~~-~~~~~sDiwSlG~il~elltG~~Pf~~~~~~---------~~~~~~~~~~~-------- 375 (457)
......||+.|+|||++.+. .++.++|||||||++|||++|++||...... ..+..+.....
T Consensus 171 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (317)
T cd07867 171 DLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFPADKDWE 250 (317)
T ss_pred ccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhcCCCChhhhh
Confidence 01124689999999999875 4799999999999999999999999754321 11111111000
Q ss_pred ------CC----------------------CCCCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCC
Q 012762 376 ------EF----------------------PKEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFF 418 (457)
Q Consensus 376 ------~~----------------------~~~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f 418 (457)
.+ ......+..+.+||.+||+.||.+||| +.|+|+||||
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t----~~e~l~hp~f 317 (317)
T cd07867 251 DIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRIT----SEQALQDPYF 317 (317)
T ss_pred hhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccC----HHHHhcCCCC
Confidence 00 000123456889999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-43 Score=338.78 Aligned_cols=256 Identities=29% Similarity=0.403 Sum_probs=208.7
Q ss_pred CCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcE
Q 012762 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWS 161 (457)
Q Consensus 82 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~ 161 (457)
++|++.++||+|+||.||+|.++ .+++.||+|++.+..... .....+..|+++++.++|+||+++++++..++..
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~----~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 75 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHK----ETGQIVAIKKFLESEDDK-MVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRL 75 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEEC----CCCCEEEEEeHhhccCcc-hhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeE
Confidence 46999999999999999999986 368899999986643322 3445677899999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCC
Q 012762 162 CLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNS 241 (457)
Q Consensus 162 ~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~ 241 (457)
|+||||+++++|..+.... ..+++..++.++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++......
T Consensus 76 ~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07846 76 YLVFEFVDHTVLDDLEKYP--NGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 153 (286)
T ss_pred EEEEecCCccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCC
Confidence 9999999999998776553 45899999999999999999999999999999999999999999999999987543211
Q ss_pred CcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCC
Q 012762 242 TSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGT 321 (457)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 321 (457)
.. ......|+
T Consensus 154 ~~----------------------------------------------------------------------~~~~~~~~ 163 (286)
T cd07846 154 GE----------------------------------------------------------------------VYTDYVAT 163 (286)
T ss_pred cc----------------------------------------------------------------------ccCcccce
Confidence 10 00123578
Q ss_pred CCccCchhhcCC-CCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhccc-------------------CCCC--
Q 012762 322 HEYLAPEIISGE-GHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARAL-------------------EFPK-- 379 (457)
Q Consensus 322 ~~y~aPE~l~~~-~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~-------------------~~~~-- 379 (457)
..|+|||++.+. .++.++|||||||++|||++|.+||......+....+..... ..+.
T Consensus 164 ~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (286)
T cd07846 164 RWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVK 243 (286)
T ss_pred eeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhcccccccc
Confidence 899999998764 478899999999999999999999987665443333322110 1111
Q ss_pred --------CCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCC
Q 012762 380 --------EPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFF 418 (457)
Q Consensus 380 --------~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f 418 (457)
.+.++..+.+|+.+||..||++||+ +.++++||||
T Consensus 244 ~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~----~~~il~~~~~ 286 (286)
T cd07846 244 EIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPS----SSQLLHHEFF 286 (286)
T ss_pred CcchHHHhCCCcCHHHHHHHHHHhcCCcccchh----HHHHhcCCCC
Confidence 1346788999999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=329.69 Aligned_cols=255 Identities=27% Similarity=0.429 Sum_probs=212.6
Q ss_pred CCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCc
Q 012762 81 LSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRW 160 (457)
Q Consensus 81 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~ 160 (457)
.++|++.+.||.|+||.||+|.+.. ++..+|+|++..... .....+..|+++++.++||||+++++++...+.
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~----~~~~~~ik~~~~~~~---~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~ 74 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIA----TGELVAIKVIKLEPG---DDFEIIQQEISMLKECRHPNIVAYFGSYLRRDK 74 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecC----CCCEEEEEEEEcCch---hhHHHHHHHHHHHHhCCCCChhceEEEEEeCCE
Confidence 3689999999999999999998763 677899999975432 245677889999999999999999999999999
Q ss_pred EEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCC
Q 012762 161 SCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDN 240 (457)
Q Consensus 161 ~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~ 240 (457)
+|++|||+.+++|..++... ...+++..+..++.|++.||.|||++||+|+||||+||+++.++.++|+|||++.....
T Consensus 75 ~~l~~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~ 153 (262)
T cd06613 75 LWIVMEYCGGGSLQDIYQVT-RGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTA 153 (262)
T ss_pred EEEEEeCCCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhh
Confidence 99999999999999887664 25689999999999999999999999999999999999999999999999998754321
Q ss_pred CCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccC
Q 012762 241 STSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVG 320 (457)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 320 (457)
... ......|
T Consensus 154 ~~~----------------------------------------------------------------------~~~~~~~ 163 (262)
T cd06613 154 TIA----------------------------------------------------------------------KRKSFIG 163 (262)
T ss_pred hhh----------------------------------------------------------------------ccccccC
Confidence 100 0112358
Q ss_pred CCCccCchhhcCC---CCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCC---CCCCCChHHHHHHHHH
Q 012762 321 THEYLAPEIISGE---GHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFP---KEPSVPGPAKDLIAQL 394 (457)
Q Consensus 321 t~~y~aPE~l~~~---~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~ll~~~ 394 (457)
+..|+|||.+.+. .++.++|||||||++|+|++|..||...........+....+..+ ....++.++.+++.+|
T Consensus 164 ~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 243 (262)
T cd06613 164 TPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFHDFIKKC 243 (262)
T ss_pred CccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHHHHHHHHHH
Confidence 8899999999877 788999999999999999999999988765554444433322221 1234567899999999
Q ss_pred hhhCCCCCCCCCcChHHHhcCCC
Q 012762 395 LVKDPTRRMGSKMGATAIKRHQF 417 (457)
Q Consensus 395 L~~dP~~Rps~~~~~~~ll~hp~ 417 (457)
|..||.+||+ +.+|+.|+|
T Consensus 244 l~~~p~~Rpt----~~~il~~~~ 262 (262)
T cd06613 244 LTKDPKKRPT----ATKLLQHPF 262 (262)
T ss_pred cCCChhhCCC----HHHHhcCCC
Confidence 9999999999 999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=332.60 Aligned_cols=256 Identities=27% Similarity=0.438 Sum_probs=209.5
Q ss_pred CCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHc-CCCCCceEEEEEEcCC
Q 012762 81 LSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEML-DHPFLPTLYATLDCPR 159 (457)
Q Consensus 81 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~~~~~~~~ 159 (457)
.++|++.+.||.|+||.||+|.++ .+++.||+|++..... ....+..|+++++++ +|+||+++++++....
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~----~~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~ 76 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHK----KTGQLVAIKIMDIIED----EEEEIKEEYNILRKYSNHPNIATFYGAFIKKN 76 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEEC----CCCcEEEEEEEecCch----hHHHHHHHHHHHHHhcCCCChheEEEEEEecC
Confidence 368999999999999999999986 3678999999875432 345678899999998 7999999999997644
Q ss_pred ------cEEEEEeecCCCChHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEec
Q 012762 160 ------WSCLLTEFCPGGDLHVLRQRQP--DKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTD 231 (457)
Q Consensus 160 ------~~~lV~E~~~~~sL~~~~~~~~--~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~D 231 (457)
.+|+||||+++++|.+++.... ...+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|
T Consensus 77 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d 156 (275)
T cd06608 77 PPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVD 156 (275)
T ss_pred CCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECC
Confidence 4899999999999998887543 46799999999999999999999999999999999999999999999999
Q ss_pred cCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCC
Q 012762 232 FDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPL 311 (457)
Q Consensus 232 FG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (457)
||++........
T Consensus 157 ~~~~~~~~~~~~-------------------------------------------------------------------- 168 (275)
T cd06608 157 FGVSAQLDSTLG-------------------------------------------------------------------- 168 (275)
T ss_pred Cccceecccchh--------------------------------------------------------------------
Confidence 998754321100
Q ss_pred ccccccccCCCCccCchhhcCC-----CCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccC-CCCCCCCCh
Q 012762 312 DVRSMSFVGTHEYLAPEIISGE-----GHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALE-FPKEPSVPG 385 (457)
Q Consensus 312 ~~~~~~~~gt~~y~aPE~l~~~-----~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 385 (457)
......|+..|+|||++... .++.++|||||||++|+|++|..||...........+...... ......++.
T Consensus 169 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (275)
T cd06608 169 --RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTLKSPENWSK 246 (275)
T ss_pred --hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCCCCCchhhcCH
Confidence 00123589999999998643 3678999999999999999999999876555555554443221 122233678
Q ss_pred HHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCC
Q 012762 386 PAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFF 418 (457)
Q Consensus 386 ~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f 418 (457)
++.+||.+||..||++||+ +.++++|||+
T Consensus 247 ~~~~li~~~l~~dp~~Rpt----~~~ll~~~~~ 275 (275)
T cd06608 247 KFNDFISECLIKNYEQRPF----MEELLEHPFI 275 (275)
T ss_pred HHHHHHHHHhhcChhhCcC----HHHHhcCCCC
Confidence 8999999999999999999 9999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=332.70 Aligned_cols=261 Identities=23% Similarity=0.368 Sum_probs=210.8
Q ss_pred CceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhh---hhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCC
Q 012762 83 DLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVS---RNKESRARIEREILEMLDHPFLPTLYATLDCPR 159 (457)
Q Consensus 83 ~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~---~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~ 159 (457)
+|+..+.||+|+||.||+|.+. .+++.||+|++....... ......+..|+++|++++|+||+++++++...+
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~----~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 76 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDV----KTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDS 76 (268)
T ss_pred CccccceecCcCceEEEEEEEc----CCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCC
Confidence 4788899999999999999875 478899999997543211 223567888999999999999999999999999
Q ss_pred cEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCC-CEEEeccCCCcCC
Q 012762 160 WSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDG-HIMLTDFDLSLKG 238 (457)
Q Consensus 160 ~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~-~vkl~DFG~s~~~ 238 (457)
..++||||+++++|.+++... +.+++..+..++.||+.||.|||++|++|+||||+||+++.++ .++|+|||++...
T Consensus 77 ~~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~ 154 (268)
T cd06630 77 HFNLFVEWMAGGSVSHLLSKY--GAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARL 154 (268)
T ss_pred eEEEEEeccCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence 999999999999999998764 5789999999999999999999999999999999999998776 5999999997655
Q ss_pred CCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccc
Q 012762 239 DNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSF 318 (457)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (457)
....... .......
T Consensus 155 ~~~~~~~------------------------------------------------------------------~~~~~~~ 168 (268)
T cd06630 155 AAKGTGA------------------------------------------------------------------GEFQGQL 168 (268)
T ss_pred ccccccC------------------------------------------------------------------Ccccccc
Confidence 3211000 0001123
Q ss_pred cCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHH---HhcccCCCCCCCCChHHHHHHHHHh
Q 012762 319 VGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANV---VARALEFPKEPSVPGPAKDLIAQLL 395 (457)
Q Consensus 319 ~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~ll~~~L 395 (457)
.|+..|+|||++.+..++.++|||||||++|+|++|..||...........+ ............++.++.+++.+||
T Consensus 169 ~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l 248 (268)
T cd06630 169 LGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPGLRDVTLRCL 248 (268)
T ss_pred ccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhCHHHHHHHHHHc
Confidence 5899999999998888999999999999999999999999754432222222 1122222223357788999999999
Q ss_pred hhCCCCCCCCCcChHHHhcCCCCC
Q 012762 396 VKDPTRRMGSKMGATAIKRHQFFN 419 (457)
Q Consensus 396 ~~dP~~Rps~~~~~~~ll~hp~f~ 419 (457)
..||++||+ +.++++||||+
T Consensus 249 ~~~p~~R~~----~~~ll~~~~~~ 268 (268)
T cd06630 249 ELQPEDRPP----SRELLKHPVFR 268 (268)
T ss_pred CCCcccCcC----HHHHhcCcccC
Confidence 999999999 99999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-43 Score=337.46 Aligned_cols=258 Identities=29% Similarity=0.398 Sum_probs=212.2
Q ss_pred ccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcC
Q 012762 79 LTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCP 158 (457)
Q Consensus 79 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~ 158 (457)
+..++|++++.||+|+||+||+|.+. .++..||+|++.... .......+.+|+++++.++|+||+++++++...
T Consensus 2 l~~~~~~~~~~ig~g~~g~v~~~~~~----~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 75 (284)
T cd06620 2 LRNEDLETISDLGAGNGGSVSKVKHI----PTGTVMAKKVVHIGA--KSSVRKQILRELQIMHECRSPYIVSFYGAFLNE 75 (284)
T ss_pred ccHHHHHHHHHcCCCCCeEEEEEEEc----CCCcEEEEEEEEecC--cchHHHHHHHHHHHHHHcCCCCcceEeeeEecC
Confidence 34578999999999999999999876 378899999986542 223456788899999999999999999999999
Q ss_pred CcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCceeecCCCCCeEEccCCCEEEeccCCCcC
Q 012762 159 RWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHM-MGIIYRDLKPENVLVRSDGHIMLTDFDLSLK 237 (457)
Q Consensus 159 ~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~-~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~ 237 (457)
+.+|+||||+++++|..++... +.+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++..
T Consensus 76 ~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~ 153 (284)
T cd06620 76 NNICMCMEFMDCGSLDRIYKKG--GPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGE 153 (284)
T ss_pred CEEEEEEecCCCCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccc
Confidence 9999999999999999888764 568999999999999999999997 5999999999999999999999999998643
Q ss_pred CCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcccccc
Q 012762 238 GDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMS 317 (457)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (457)
..... ...
T Consensus 154 ~~~~~------------------------------------------------------------------------~~~ 161 (284)
T cd06620 154 LINSI------------------------------------------------------------------------ADT 161 (284)
T ss_pred hhhhc------------------------------------------------------------------------cCc
Confidence 31100 002
Q ss_pred ccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChH-----------HHHHHHHhcccCCCCCCCCChH
Q 012762 318 FVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHE-----------LTLANVVARALEFPKEPSVPGP 386 (457)
Q Consensus 318 ~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~ 386 (457)
..|+..|+|||++.+..++.++|||||||++|+|++|+.||...... .....+............++.+
T Consensus 162 ~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (284)
T cd06620 162 FVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPED 241 (284)
T ss_pred cccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCchhcCHH
Confidence 35899999999998888999999999999999999999999865432 1222222221111111236788
Q ss_pred HHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCC
Q 012762 387 AKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNG 420 (457)
Q Consensus 387 ~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~ 420 (457)
+.+|+.+||..||++||+ +.++++|+||..
T Consensus 242 ~~~li~~~l~~dp~~Rpt----~~e~~~~~~~~~ 271 (284)
T cd06620 242 LRDFVDACLLKDPTERPT----PQQLCAMPPFIQ 271 (284)
T ss_pred HHHHHHHHhcCCcccCcC----HHHHhcCccccc
Confidence 999999999999999999 999999999964
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-43 Score=336.41 Aligned_cols=256 Identities=30% Similarity=0.415 Sum_probs=208.4
Q ss_pred CceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcEE
Q 012762 83 DLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWSC 162 (457)
Q Consensus 83 ~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~ 162 (457)
+|++++.||.|+||.||+|.++ .++..||||++..... .......+..|++++++++||||+++++++..++..|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~----~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 75 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNK----LTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLY 75 (284)
T ss_pred CceeeeeecCCCceEEEEEEEC----CCCCEEEEEEcccccc-ccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEE
Confidence 4889999999999999999876 3788999999865432 2223456778999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCCC
Q 012762 163 LLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNST 242 (457)
Q Consensus 163 lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~~ 242 (457)
+||||+ .++|..++.......+++..++.++.||+.||+|||+.|++|+||+|+||+++.++.+||+|||++.......
T Consensus 76 ~v~e~~-~~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~ 154 (284)
T cd07860 76 LVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 154 (284)
T ss_pred EEeecc-ccCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCc
Confidence 999999 4689888877666779999999999999999999999999999999999999999999999999875432110
Q ss_pred cccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCCC
Q 012762 243 STAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTH 322 (457)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 322 (457)
.. .....++.
T Consensus 155 ~~----------------------------------------------------------------------~~~~~~~~ 164 (284)
T cd07860 155 RT----------------------------------------------------------------------YTHEVVTL 164 (284)
T ss_pred cc----------------------------------------------------------------------cccccccc
Confidence 00 00124688
Q ss_pred CccCchhhcCCC-CCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccC------------------CCC----
Q 012762 323 EYLAPEIISGEG-HGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALE------------------FPK---- 379 (457)
Q Consensus 323 ~y~aPE~l~~~~-~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~------------------~~~---- 379 (457)
.|+|||++.+.. ++.++|||||||++|||++|+.||.+.+......++...... ++.
T Consensus 165 ~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (284)
T cd07860 165 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQ 244 (284)
T ss_pred cccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhccccccc
Confidence 999999987655 588999999999999999999999876655444333321110 000
Q ss_pred -----CCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCC
Q 012762 380 -----EPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFF 418 (457)
Q Consensus 380 -----~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f 418 (457)
.+.++.+++++|.+||+.||++||+ +.++++||||
T Consensus 245 ~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt----~~~~l~~~~f 284 (284)
T cd07860 245 DFSKVVPPLDEDGRDLLSQMLHYDPNKRIS----AKAALAHPFF 284 (284)
T ss_pred CHHHHcccCCHHHHHHHHHhcCCCcccCCC----HHHHhcCCCC
Confidence 1236778899999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=328.82 Aligned_cols=251 Identities=22% Similarity=0.317 Sum_probs=208.1
Q ss_pred cCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCC
Q 012762 80 TLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPR 159 (457)
Q Consensus 80 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~ 159 (457)
+.++|++.+.||+|+||.||++.++ .+..+|+|.+..... ....+..|+++|+.++||||+++++++...+
T Consensus 2 ~~~~~~~~~~lg~G~~~~vy~~~~~-----~~~~~a~K~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 72 (256)
T cd05114 2 NPSELTFMKELGSGQFGVVHLGKWR-----AQIKVAIKAINEGAM----SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQK 72 (256)
T ss_pred CHHHcEEeeEecCCcCceEEEEEec-----cCceEEEEecccCCc----cHHHHHHHHHHHHHCCCCCceeEEEEEccCC
Confidence 4568999999999999999999875 455799998864432 2345777999999999999999999999999
Q ss_pred cEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCC
Q 012762 160 WSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGD 239 (457)
Q Consensus 160 ~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~ 239 (457)
..|+||||+++++|.+++.... ..+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||+++...
T Consensus 73 ~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~ 151 (256)
T cd05114 73 PLYIVTEFMENGCLLNYLRQRQ-GKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVL 151 (256)
T ss_pred CEEEEEEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccC
Confidence 9999999999999998887542 468999999999999999999999999999999999999999999999999875432
Q ss_pred CCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcccccccc
Q 012762 240 NSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFV 319 (457)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (457)
...... .....
T Consensus 152 ~~~~~~---------------------------------------------------------------------~~~~~ 162 (256)
T cd05114 152 DDEYTS---------------------------------------------------------------------SSGAK 162 (256)
T ss_pred CCceec---------------------------------------------------------------------cCCCC
Confidence 111000 00113
Q ss_pred CCCCccCchhhcCCCCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhhhC
Q 012762 320 GTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKD 398 (457)
Q Consensus 320 gt~~y~aPE~l~~~~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~d 398 (457)
++..|+|||++.+..++.++||||||+++|||++ |+.||...........+.... ........+..+.+++.+||..|
T Consensus 163 ~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~~li~~c~~~~ 241 (256)
T cd05114 163 FPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGF-RLYRPKLASMTVYEVMYSCWHEK 241 (256)
T ss_pred CchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC-CCCCCCCCCHHHHHHHHHHccCC
Confidence 5678999999998889999999999999999999 999998877766666665443 22233446788999999999999
Q ss_pred CCCCCCCCcChHHHhc
Q 012762 399 PTRRMGSKMGATAIKR 414 (457)
Q Consensus 399 P~~Rps~~~~~~~ll~ 414 (457)
|++||+ +++|++
T Consensus 242 p~~Rps----~~~l~~ 253 (256)
T cd05114 242 PEGRPT----FAELLR 253 (256)
T ss_pred cccCcC----HHHHHH
Confidence 999999 888875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=334.09 Aligned_cols=257 Identities=27% Similarity=0.420 Sum_probs=208.5
Q ss_pred CCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHc-CCCCCceEEEEEEcC-
Q 012762 81 LSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEML-DHPFLPTLYATLDCP- 158 (457)
Q Consensus 81 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~~~~~~~- 158 (457)
.++|.+.+.||+|+||.||+|.++ .+++.+|+|++.... .....+..|+.+++++ +|+||+++++++...
T Consensus 21 ~~~y~~~~~l~~g~~~~vy~~~~~----~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~ 92 (291)
T cd06639 21 TDTWEIIETIGKGTYGKVYKVTNK----KDGSLAAVKILDPIS----DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKAD 92 (291)
T ss_pred CCCeEEEEEeecCCCeEEEEEEEC----CCCCEEEEEEecccc----cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEecc
Confidence 468999999999999999999876 478899999986532 2234566789999998 899999999998653
Q ss_pred ----CcEEEEEeecCCCChHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEecc
Q 012762 159 ----RWSCLLTEFCPGGDLHVLRQRQ--PDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDF 232 (457)
Q Consensus 159 ----~~~~lV~E~~~~~sL~~~~~~~--~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DF 232 (457)
+..|+||||+++++|.++++.. ....+++..++.++.|++.||.|||+.||+|+||||+||+++.++.+||+||
T Consensus 93 ~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~df 172 (291)
T cd06639 93 KLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDF 172 (291)
T ss_pred ccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeec
Confidence 3589999999999999887642 2356899999999999999999999999999999999999999999999999
Q ss_pred CCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCc
Q 012762 233 DLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLD 312 (457)
Q Consensus 233 G~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (457)
|++........
T Consensus 173 g~~~~~~~~~~--------------------------------------------------------------------- 183 (291)
T cd06639 173 GVSAQLTSTRL--------------------------------------------------------------------- 183 (291)
T ss_pred ccchhcccccc---------------------------------------------------------------------
Confidence 98754321110
Q ss_pred cccccccCCCCccCchhhcCCC-----CCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhccc-CCCCCCCCChH
Q 012762 313 VRSMSFVGTHEYLAPEIISGEG-----HGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARAL-EFPKEPSVPGP 386 (457)
Q Consensus 313 ~~~~~~~gt~~y~aPE~l~~~~-----~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 386 (457)
......|+..|+|||++.... ++.++|||||||++|||++|+.||........+..+..... .......++..
T Consensus 184 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (291)
T cd06639 184 -RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTLLHPEKWCRS 262 (291)
T ss_pred -cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCCCCCcccccCHH
Confidence 001225888999999986542 67899999999999999999999988765555554433321 12223346778
Q ss_pred HHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCC
Q 012762 387 AKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFN 419 (457)
Q Consensus 387 ~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~ 419 (457)
+.++|.+||..||++||+ +.+|++||||+
T Consensus 263 l~~li~~~l~~~p~~Rps----~~~il~~~~~~ 291 (291)
T cd06639 263 FNHFISQCLIKDFEARPS----VTHLLEHPFIK 291 (291)
T ss_pred HHHHHHHHhhcChhhCcC----HHHHhcCcccC
Confidence 999999999999999999 99999999995
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=333.08 Aligned_cols=264 Identities=17% Similarity=0.231 Sum_probs=212.4
Q ss_pred CCccCCCceeEEEecccCcceEEEEEEecc-CCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEE
Q 012762 77 NPLTLSDLRFVHRLGSGDIGSVYLVQLKSK-SSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATL 155 (457)
Q Consensus 77 ~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~-~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~ 155 (457)
|.+..++|++.++||+|+||+||+|.++.. ....+..||+|++.... .......+.+|+.+++.++|+||+++++++
T Consensus 1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~ 78 (277)
T cd05062 1 WEVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVV 78 (277)
T ss_pred CcccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEE
Confidence 345667899999999999999999987532 12356789999986432 122345677899999999999999999999
Q ss_pred EcCCcEEEEEeecCCCChHHHHHhCC--------CCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCE
Q 012762 156 DCPRWSCLLTEFCPGGDLHVLRQRQP--------DKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHI 227 (457)
Q Consensus 156 ~~~~~~~lV~E~~~~~sL~~~~~~~~--------~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~v 227 (457)
..+...++||||+.+++|.+++.... ...+++..+..++.|++.||.|||+.|++|+||||+||+++.++.+
T Consensus 79 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~ 158 (277)
T cd05062 79 SQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTV 158 (277)
T ss_pred cCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCE
Confidence 99999999999999999999886532 1235778889999999999999999999999999999999999999
Q ss_pred EEeccCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCccc
Q 012762 228 MLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIV 307 (457)
Q Consensus 228 kl~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (457)
+|+|||++...........
T Consensus 159 ~l~dfg~~~~~~~~~~~~~------------------------------------------------------------- 177 (277)
T cd05062 159 KIGDFGMTRDIYETDYYRK------------------------------------------------------------- 177 (277)
T ss_pred EECCCCCccccCCcceeec-------------------------------------------------------------
Confidence 9999999764432111000
Q ss_pred ccCCccccccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHHhcccCCCCCCCCChH
Q 012762 308 AEPLDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVVARALEFPKEPSVPGP 386 (457)
Q Consensus 308 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 386 (457)
.....++..|+|||++.+..++.++|||||||++|||++ |..||.+.........+...... +....++..
T Consensus 178 -------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 249 (277)
T cd05062 178 -------GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLL-DKPDNCPDM 249 (277)
T ss_pred -------CCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcC-CCCCCCCHH
Confidence 001136788999999998889999999999999999998 79999887776666655544332 223457889
Q ss_pred HHHHHHHHhhhCCCCCCCCCcChHHHhcC
Q 012762 387 AKDLIAQLLVKDPTRRMGSKMGATAIKRH 415 (457)
Q Consensus 387 ~~~ll~~~L~~dP~~Rps~~~~~~~ll~h 415 (457)
+.+++.+||+.||++||+ +.+++++
T Consensus 250 ~~~li~~~l~~~p~~Rps----~~e~l~~ 274 (277)
T cd05062 250 LFELMRMCWQYNPKMRPS----FLEIISS 274 (277)
T ss_pred HHHHHHHHcCCChhhCcC----HHHHHHH
Confidence 999999999999999999 8888764
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=333.99 Aligned_cols=269 Identities=39% Similarity=0.714 Sum_probs=216.3
Q ss_pred CceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhh-hhHHHHHHHHHHHHHHc-CCCCCceEEEEEEcCCc
Q 012762 83 DLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVS-RNKESRARIEREILEML-DHPFLPTLYATLDCPRW 160 (457)
Q Consensus 83 ~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~-~~~~~~~~~E~~il~~l-~H~nIv~l~~~~~~~~~ 160 (457)
+|++.+.||+|+||.||+|++... ..++..||+|++++..... ......+..|++++.++ +|+||+++++.+..+..
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~-~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~ 79 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGG-HDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTK 79 (288)
T ss_pred CceEEEEeccCCCceEEEEEEecc-ccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCE
Confidence 488999999999999999986532 2367889999997654322 22345677899999999 69999999999999999
Q ss_pred EEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCC
Q 012762 161 SCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDN 240 (457)
Q Consensus 161 ~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~ 240 (457)
.|+||||+.+++|..++... ..+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++.....
T Consensus 80 ~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 157 (288)
T cd05583 80 LHLILDYVNGGELFTHLYQR--EHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLA 157 (288)
T ss_pred EEEEEecCCCCcHHHHHhhc--CCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECcccccccc
Confidence 99999999999998887654 5689999999999999999999999999999999999999999999999998754321
Q ss_pred CCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccC
Q 012762 241 STSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVG 320 (457)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 320 (457)
... .......|
T Consensus 158 ~~~---------------------------------------------------------------------~~~~~~~~ 168 (288)
T cd05583 158 EEE---------------------------------------------------------------------ERAYSFCG 168 (288)
T ss_pred ccc---------------------------------------------------------------------cccccccC
Confidence 100 00112358
Q ss_pred CCCccCchhhcCCC--CCccchhhhhhHHHHHHhcCCCCCCCCCh----HHHHHHHHhcccCCCCCCCCChHHHHHHHHH
Q 012762 321 THEYLAPEIISGEG--HGNAVDWWTLGIFIFELFYGTTPFKGIDH----ELTLANVVARALEFPKEPSVPGPAKDLIAQL 394 (457)
Q Consensus 321 t~~y~aPE~l~~~~--~~~~sDiwSlG~il~elltG~~Pf~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~ 394 (457)
+..|+|||.+.+.. ++.++||||||+++|||++|..||..... ......+..... +....++.++.++|.+|
T Consensus 169 ~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~ 246 (288)
T cd05583 169 TIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKP--PFPKTMSAEARDFIQKL 246 (288)
T ss_pred CccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCC--CCCcccCHHHHHHHHHH
Confidence 89999999997765 78899999999999999999999964322 222333333322 33345788999999999
Q ss_pred hhhCCCCCCCCCcChHHHhcCCCCCCCCchhh
Q 012762 395 LVKDPTRRMGSKMGATAIKRHQFFNGVNWALL 426 (457)
Q Consensus 395 L~~dP~~Rps~~~~~~~ll~hp~f~~~~~~~~ 426 (457)
|+.||++||++. .+.++|+||||+.++|+.+
T Consensus 247 l~~~p~~R~t~~-~~~~~l~~~~~~~~~~~~~ 277 (288)
T cd05583 247 LEKDPKKRLGAN-GADEIKNHPFFQGIDWDDL 277 (288)
T ss_pred hcCCHhhccCcc-hHHHHhcCcccccCCHHHH
Confidence 999999999833 3678899999999999876
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=335.30 Aligned_cols=257 Identities=24% Similarity=0.388 Sum_probs=203.4
Q ss_pred cCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCC
Q 012762 80 TLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPR 159 (457)
Q Consensus 80 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~ 159 (457)
.+++|++.+.||+|+||+||+|.++ .+++.||+|.+..... ......+.+|++++++++|+||+++++++..++
T Consensus 3 ~~~~y~~~~~lg~g~~~~vy~~~~~----~~~~~~~iK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 76 (291)
T cd07844 3 KLETYKKLDKLGEGSYATVYKGRSK----LTGQLVALKEIRLEHE--EGAPFTAIREASLLKDLKHANIVTLHDIIHTKK 76 (291)
T ss_pred CccceeEEEEEeecCCeEEEEEEEc----CCCcEEEEEEEecccc--cCCchhHHHHHHHHhhCCCcceeeEEEEEecCC
Confidence 3578999999999999999999876 3678999999865421 122344567999999999999999999999999
Q ss_pred cEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCC
Q 012762 160 WSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGD 239 (457)
Q Consensus 160 ~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~ 239 (457)
..|+||||+. ++|..++.... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++...
T Consensus 77 ~~~lv~e~~~-~~L~~~~~~~~-~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 154 (291)
T cd07844 77 TLTLVFEYLD-TDLKQYMDDCG-GGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKS 154 (291)
T ss_pred eEEEEEecCC-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccC
Confidence 9999999996 58988887653 478999999999999999999999999999999999999999999999999875321
Q ss_pred CCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcccccccc
Q 012762 240 NSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFV 319 (457)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (457)
..... .....
T Consensus 155 ~~~~~----------------------------------------------------------------------~~~~~ 164 (291)
T cd07844 155 VPSKT----------------------------------------------------------------------YSNEV 164 (291)
T ss_pred CCCcc----------------------------------------------------------------------ccccc
Confidence 10000 00113
Q ss_pred CCCCccCchhhcCC-CCCccchhhhhhHHHHHHhcCCCCCCCCCh-HHHHHHHHhccc-------------------CCC
Q 012762 320 GTHEYLAPEIISGE-GHGNAVDWWTLGIFIFELFYGTTPFKGIDH-ELTLANVVARAL-------------------EFP 378 (457)
Q Consensus 320 gt~~y~aPE~l~~~-~~~~~sDiwSlG~il~elltG~~Pf~~~~~-~~~~~~~~~~~~-------------------~~~ 378 (457)
++..|+|||++.+. .++.++|||||||++|+|++|+.||.+... .+....+..... ..+
T Consensus 165 ~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (291)
T cd07844 165 VTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFP 244 (291)
T ss_pred cccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcccccccccc
Confidence 68899999998764 588999999999999999999999976552 222222211000 000
Q ss_pred ---------CCCCCC--hHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCC
Q 012762 379 ---------KEPSVP--GPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFF 418 (457)
Q Consensus 379 ---------~~~~~~--~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f 418 (457)
....++ .++.+++.+||..||++||+ +.+++.||||
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps----~~e~l~~~~f 291 (291)
T cd07844 245 FYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRIS----AAEAMKHPYF 291 (291)
T ss_pred ccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccC----HHHHhcCCCC
Confidence 001233 67889999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-43 Score=337.58 Aligned_cols=257 Identities=27% Similarity=0.394 Sum_probs=209.8
Q ss_pred CCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcE
Q 012762 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWS 161 (457)
Q Consensus 82 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~ 161 (457)
++|++++.||+|+||+||+|.+. .++..||+|.+.... .......+.+|+++|++++|+||+++++++..++..
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~----~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 74 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHR----PTGVTMAMKEIRLEL--DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAV 74 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEc----CCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeE
Confidence 47899999999999999999876 478899999986431 223346778899999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHH-cCceeecCCCCCeEEccCCCEEEeccCCCcCCC
Q 012762 162 CLLTEFCPGGDLHVLRQRQP-DKRFHESAVRFYASEVVVALEFLHM-MGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGD 239 (457)
Q Consensus 162 ~lV~E~~~~~sL~~~~~~~~-~~~~~~~~~~~i~~qi~~~L~yLH~-~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~ 239 (457)
|+||||+++++|..++.... ...+++..+..++.||+.||.|||+ .||+|+||||+||+++.++.++|+|||++....
T Consensus 75 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 154 (286)
T cd06622 75 YMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLV 154 (286)
T ss_pred EEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 99999999999988876531 2478999999999999999999996 599999999999999999999999999875432
Q ss_pred CCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcccccccc
Q 012762 240 NSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFV 319 (457)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (457)
.... ....
T Consensus 155 ~~~~------------------------------------------------------------------------~~~~ 162 (286)
T cd06622 155 ASLA------------------------------------------------------------------------KTNI 162 (286)
T ss_pred CCcc------------------------------------------------------------------------ccCC
Confidence 1100 0124
Q ss_pred CCCCccCchhhcCCC------CCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHH---HHhcccCCCCCCCCChHHHHH
Q 012762 320 GTHEYLAPEIISGEG------HGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLAN---VVARALEFPKEPSVPGPAKDL 390 (457)
Q Consensus 320 gt~~y~aPE~l~~~~------~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~l 390 (457)
|+..|+|||++.+.. ++.++|||||||++|+|++|..||........... +.... .......++.++.++
T Consensus 163 ~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l 241 (286)
T cd06622 163 GCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGD-PPTLPSGYSDDAQDF 241 (286)
T ss_pred CccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcC-CCCCCcccCHHHHHH
Confidence 788999999986543 47899999999999999999999976544333322 22221 122233488999999
Q ss_pred HHHHhhhCCCCCCCCCcChHHHhcCCCCCCC
Q 012762 391 IAQLLVKDPTRRMGSKMGATAIKRHQFFNGV 421 (457)
Q Consensus 391 l~~~L~~dP~~Rps~~~~~~~ll~hp~f~~~ 421 (457)
|.+||..||++||+ +.++++||||...
T Consensus 242 i~~~l~~~p~~Rp~----~~~l~~~~~~~~~ 268 (286)
T cd06622 242 VAKCLNKIPNRRPT----YAQLLEHPWLVKY 268 (286)
T ss_pred HHHHcccCcccCCC----HHHHhcChhhhhc
Confidence 99999999999999 9999999999753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=334.50 Aligned_cols=279 Identities=36% Similarity=0.627 Sum_probs=224.9
Q ss_pred CCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcC-CCCCceEEEEEEcCCc
Q 012762 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLD-HPFLPTLYATLDCPRW 160 (457)
Q Consensus 82 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~-H~nIv~l~~~~~~~~~ 160 (457)
++|.+.+.||.|+||.||+|.++ .++..||+|++.+...........+..|++++++++ |+||+++++++..++.
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~----~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~ 76 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEK----ETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEEN 76 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEc----CCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCce
Confidence 47999999999999999999986 378899999998765555555677888999999998 9999999999999999
Q ss_pred EEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCC
Q 012762 161 SCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDN 240 (457)
Q Consensus 161 ~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~ 240 (457)
.|+|||++++++|.+++... +.+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 77 ~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~ 154 (280)
T cd05581 77 LYFVLEYAPNGELLQYIRKY--GSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDP 154 (280)
T ss_pred EEEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence 99999999999999988775 5799999999999999999999999999999999999999999999999999865532
Q ss_pred CCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccC
Q 012762 241 STSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVG 320 (457)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 320 (457)
........ . ..+ .. .............+.|
T Consensus 155 ~~~~~~~~------~-----~~~-----------------------~~----------------~~~~~~~~~~~~~~~~ 184 (280)
T cd05581 155 NSSPESNK------G-----DAT-----------------------NI----------------DSQIEKNRRRFASFVG 184 (280)
T ss_pred ccccccCC------C-----CCc-----------------------cc----------------cccccccccccccccC
Confidence 21110000 0 000 00 0000000112234568
Q ss_pred CCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhhhCCC
Q 012762 321 THEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDPT 400 (457)
Q Consensus 321 t~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~ 400 (457)
+..|+|||++.+..++.++||||||+++|+|++|+.||........+..+......++. .++..+.++|.+||..||+
T Consensus 185 ~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~l~~~p~ 262 (280)
T cd05581 185 TAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEYSFPP--NFPPDAKDLIEKLLVLDPQ 262 (280)
T ss_pred CccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhcCCCCCC--ccCHHHHHHHHHHhcCCHh
Confidence 99999999998888999999999999999999999999988766666666655544443 4789999999999999999
Q ss_pred CCCCCCcChHHHhcCCCC
Q 012762 401 RRMGSKMGATAIKRHQFF 418 (457)
Q Consensus 401 ~Rps~~~~~~~ll~hp~f 418 (457)
+||+..+...++++||||
T Consensus 263 ~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 263 DRLGVNEGYDELKAHPFF 280 (280)
T ss_pred hCCCcccCHHHHhcCCCC
Confidence 999922222999999998
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-44 Score=355.98 Aligned_cols=252 Identities=25% Similarity=0.417 Sum_probs=210.8
Q ss_pred EEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcEEEEEee
Q 012762 88 HRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWSCLLTEF 167 (457)
Q Consensus 88 ~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lV~E~ 167 (457)
-+||+|.||+||.|+++ .+....|||-+..+. ....+-+..|+.+-+.|+|.|||+++|.+..++++-|.||-
T Consensus 581 vVLGKGTYG~VYA~RD~----~tqvrIaIKEIpekd---sr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEq 653 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDM----DTQVRIAIKEIPEKD---SREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQ 653 (1226)
T ss_pred EEeecCceeEEEeeccc----cceeEEEeeeccccc---chhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeec
Confidence 47999999999999987 488899999986543 23455677799999999999999999999999999999999
Q ss_pred cCCCChHHHHHhCCCCCC--CHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEcc-CCCEEEeccCCCcCCCCCCcc
Q 012762 168 CPGGDLHVLRQRQPDKRF--HESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRS-DGHIMLTDFDLSLKGDNSTST 244 (457)
Q Consensus 168 ~~~~sL~~~~~~~~~~~~--~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~-~~~vkl~DFG~s~~~~~~~~~ 244 (457)
++||+|..++... .+++ .|..+..+..||++||.|||++.|||||||-+|+||+. .|.+||+|||-++.+..-..
T Consensus 654 VPGGSLSsLLrsk-WGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP- 731 (1226)
T KOG4279|consen 654 VPGGSLSSLLRSK-WGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINP- 731 (1226)
T ss_pred CCCCcHHHHHHhc-cCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCc-
Confidence 9999999998764 5677 88899999999999999999999999999999999984 68999999999876642211
Q ss_pred cccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCCCCc
Q 012762 245 AQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTHEY 324 (457)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 324 (457)
-+-+|.||..|
T Consensus 732 ---------------------------------------------------------------------~TETFTGTLQY 742 (1226)
T KOG4279|consen 732 ---------------------------------------------------------------------CTETFTGTLQY 742 (1226)
T ss_pred ---------------------------------------------------------------------cccccccchhh
Confidence 12267899999
Q ss_pred cCchhhcCC--CCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHh-cccCCCCCCCCChHHHHHHHHHhhhCCCC
Q 012762 325 LAPEIISGE--GHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVA-RALEFPKEPSVPGPAKDLIAQLLVKDPTR 401 (457)
Q Consensus 325 ~aPE~l~~~--~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ll~~~L~~dP~~ 401 (457)
||||++... +|+.++|||||||++.||.||++||......+..+..+- -....|.+..++.+++.+|.+|+..||.+
T Consensus 743 MAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~FilrcFepd~~~ 822 (1226)
T KOG4279|consen 743 MAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILRCFEPDPCD 822 (1226)
T ss_pred hChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHHHHcCCCccc
Confidence 999999765 489999999999999999999999987655443222221 12223334457788999999999999999
Q ss_pred CCCCCcChHHHhcCCCCCCC
Q 012762 402 RMGSKMGATAIKRHQFFNGV 421 (457)
Q Consensus 402 Rps~~~~~~~ll~hp~f~~~ 421 (457)
||+ +.++|..||++..
T Consensus 823 R~s----A~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 823 RPS----AKDLLQDPFLQHN 838 (1226)
T ss_pred Ccc----HHHhccCcccccC
Confidence 999 9999999999875
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=333.02 Aligned_cols=257 Identities=28% Similarity=0.446 Sum_probs=211.0
Q ss_pred CceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcEE
Q 012762 83 DLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWSC 162 (457)
Q Consensus 83 ~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~ 162 (457)
+|++.+.||+|+||.||+|.+. .+|..||+|++...... ......+..|+++++.++|+||+++++++..+...|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~----~~~~~~~vK~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~ 75 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDR----ETGETVALKKVALRRLE-GGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFV 75 (286)
T ss_pred CceEEeecccCCCcEEEEEEEC----CCCceEEEEEEEccccc-chhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeE
Confidence 5899999999999999999976 36889999999765322 234566788999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCCC
Q 012762 163 LLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNST 242 (457)
Q Consensus 163 lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~~ 242 (457)
+||||+ +++|..++.... ..+++..++.++.||+.||.|||+.|++|+||||+||+++.++.++|+|||++.......
T Consensus 76 ~v~e~~-~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 153 (286)
T cd07832 76 LVMEYM-PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEE 153 (286)
T ss_pred EEeccc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCC
Confidence 999999 999998887643 669999999999999999999999999999999999999999999999999876443211
Q ss_pred cccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCCC
Q 012762 243 STAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTH 322 (457)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 322 (457)
.. ......|+.
T Consensus 154 ~~---------------------------------------------------------------------~~~~~~~~~ 164 (286)
T cd07832 154 PR---------------------------------------------------------------------LYSHQVATR 164 (286)
T ss_pred CC---------------------------------------------------------------------ccccccCcc
Confidence 00 001125899
Q ss_pred CccCchhhcCCC-CCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhccc-------------------CCCC---
Q 012762 323 EYLAPEIISGEG-HGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARAL-------------------EFPK--- 379 (457)
Q Consensus 323 ~y~aPE~l~~~~-~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~-------------------~~~~--- 379 (457)
.|+|||++.+.. ++.++|||||||++|||++|.+||.+......+..++.... .++.
T Consensus 165 ~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (286)
T cd07832 165 WYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKP 244 (286)
T ss_pred cccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcccCCCCCc
Confidence 999999987654 68999999999999999999999987666555444433211 0110
Q ss_pred ------CCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCC
Q 012762 380 ------EPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFN 419 (457)
Q Consensus 380 ------~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~ 419 (457)
....+..+.++|++||..||++||+ ++++++||||.
T Consensus 245 ~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~----~~~~l~h~~~~ 286 (286)
T cd07832 245 IPLEEIFPDASPEALDLLKGLLVYDPSKRLS----AAEALRHPYFT 286 (286)
T ss_pred chHHHhCCCccHHHHHHHHHHhccChhhCCC----HHHHhhCcCcC
Confidence 1235678999999999999999999 99999999994
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-43 Score=370.50 Aligned_cols=262 Identities=19% Similarity=0.292 Sum_probs=224.0
Q ss_pred CccCCCceeEEEecccCcceEEEEEEeccCCCC-CceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEE
Q 012762 78 PLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNN-GCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLD 156 (457)
Q Consensus 78 ~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~ 156 (457)
.+......+.+.||+|+||.||.|.....+... ...||+|.+.+. .+..+...|.+|..+|+.++|||||+++|++.
T Consensus 688 ~v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~--~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l 765 (1025)
T KOG1095|consen 688 EVPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL--SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCL 765 (1025)
T ss_pred cCChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc--CCHHHHHHHHHHHHHHhcCCCcceeeEEEeec
Confidence 355677899999999999999999987533211 345888888653 56678889999999999999999999999999
Q ss_pred cCCcEEEEEeecCCCChHHHHHhCC-----CCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEec
Q 012762 157 CPRWSCLLTEFCPGGDLHVLRQRQP-----DKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTD 231 (457)
Q Consensus 157 ~~~~~~lV~E~~~~~sL~~~~~~~~-----~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~D 231 (457)
.....+|++|||+||+|..+++... ...++......++.||++|+.||+++++|||||...|+||+....|||+|
T Consensus 766 ~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaD 845 (1025)
T KOG1095|consen 766 DSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIAD 845 (1025)
T ss_pred CCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcc
Confidence 9999999999999999999998751 35688999999999999999999999999999999999999999999999
Q ss_pred cCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCC
Q 012762 232 FDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPL 311 (457)
Q Consensus 232 FG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (457)
||+|+.+......+.-.
T Consensus 846 FGlArDiy~~~yyr~~~--------------------------------------------------------------- 862 (1025)
T KOG1095|consen 846 FGLARDIYDKDYYRKHG--------------------------------------------------------------- 862 (1025)
T ss_pred cchhHhhhhchheeccC---------------------------------------------------------------
Confidence 99998554333221100
Q ss_pred ccccccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHH
Q 012762 312 DVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDL 390 (457)
Q Consensus 312 ~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 390 (457)
+ -.-...|||||.+....++.++|||||||+|||+++ |..||....+.+++...+.+. +++.+..+|+.+.++
T Consensus 863 --~---a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg-RL~~P~~CP~~ly~l 936 (1025)
T KOG1095|consen 863 --E---AMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG-RLDPPSYCPEKLYQL 936 (1025)
T ss_pred --c---cccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC-ccCCCCCCChHHHHH
Confidence 0 012468999999999999999999999999999998 999999999999988877777 888888999999999
Q ss_pred HHHHhhhCCCCCCCCCcChHHHhc
Q 012762 391 IAQLLVKDPTRRMGSKMGATAIKR 414 (457)
Q Consensus 391 l~~~L~~dP~~Rps~~~~~~~ll~ 414 (457)
|..||+.+|++||+ +..|++
T Consensus 937 M~~CW~~~pe~RP~----F~~i~~ 956 (1025)
T KOG1095|consen 937 MLQCWKHDPEDRPS----FRTIVE 956 (1025)
T ss_pred HHHHccCChhhCcc----HHHHHh
Confidence 99999999999999 666654
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=330.71 Aligned_cols=256 Identities=21% Similarity=0.310 Sum_probs=208.6
Q ss_pred CCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcE
Q 012762 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWS 161 (457)
Q Consensus 82 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~ 161 (457)
++|++.+.||+|+||.||+|+++ .+++.||||.+.............+..|+++++.++||||+++++++...+..
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~----~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 77 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCL----LDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNEL 77 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEe----CCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeE
Confidence 58999999999999999999987 37889999998765444445556778899999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCC
Q 012762 162 CLLTEFCPGGDLHVLRQRQ--PDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGD 239 (457)
Q Consensus 162 ~lV~E~~~~~sL~~~~~~~--~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~ 239 (457)
++||||+++++|..++... ....+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++....
T Consensus 78 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~ 157 (267)
T cd08228 78 NIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceecc
Confidence 9999999999999887642 23458899999999999999999999999999999999999999999999999875443
Q ss_pred CCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcccccccc
Q 012762 240 NSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFV 319 (457)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (457)
.... ......
T Consensus 158 ~~~~----------------------------------------------------------------------~~~~~~ 167 (267)
T cd08228 158 SKTT----------------------------------------------------------------------AAHSLV 167 (267)
T ss_pred chhH----------------------------------------------------------------------HHhcCC
Confidence 1110 001235
Q ss_pred CCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCCh--HHHHHHHHhcccCCCCCCCCChHHHHHHHHHhhh
Q 012762 320 GTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDH--ELTLANVVARALEFPKEPSVPGPAKDLIAQLLVK 397 (457)
Q Consensus 320 gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~ 397 (457)
|+..|+|||++.+..++.++||||||+++|||++|..||..... ......+............++..+.++|.+||..
T Consensus 168 ~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~ 247 (267)
T cd08228 168 GTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRELVSMCIYP 247 (267)
T ss_pred CCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHHHHHHHHHHCCC
Confidence 88899999999988899999999999999999999999976432 2223332222211111234678899999999999
Q ss_pred CCCCCCCCCcChHHHhcC
Q 012762 398 DPTRRMGSKMGATAIKRH 415 (457)
Q Consensus 398 dP~~Rps~~~~~~~ll~h 415 (457)
||++||+ +.++++.
T Consensus 248 ~p~~Rp~----~~~vl~~ 261 (267)
T cd08228 248 DPDQRPD----IGYVHQI 261 (267)
T ss_pred CcccCcC----HHHHHHH
Confidence 9999999 8998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-42 Score=327.96 Aligned_cols=254 Identities=22% Similarity=0.321 Sum_probs=211.9
Q ss_pred CccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEc
Q 012762 78 PLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDC 157 (457)
Q Consensus 78 ~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~ 157 (457)
.+..++|++.+.||+|+||.||+|.+. .+..||+|.++.... ....+.+|++++++++|+||+++++++..
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~v~~~~~~-----~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 72 (261)
T cd05068 2 EIDRTSIQLLRKLGAGQFGEVWEGLWN-----NTTPVAVKTLKPGTM----DPKDFLAEAQIMKKLRHPKLIQLYAVCTL 72 (261)
T ss_pred ccchhheeeEEEecccCCccEEEEEec-----CCeEEEEEeeCCCcc----cHHHHHHHHHHHHHCCCCCccceeEEEec
Confidence 456678999999999999999999864 456799999865432 24557789999999999999999999999
Q ss_pred CCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcC
Q 012762 158 PRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLK 237 (457)
Q Consensus 158 ~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~ 237 (457)
.+..|+||||+.+++|.+++.......+++..+..++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++..
T Consensus 73 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~ 152 (261)
T cd05068 73 EEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARV 152 (261)
T ss_pred CCCeeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEE
Confidence 99999999999999999998776556789999999999999999999999999999999999999999999999999765
Q ss_pred CCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcccccc
Q 012762 238 GDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMS 317 (457)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (457)
........ ...
T Consensus 153 ~~~~~~~~---------------------------------------------------------------------~~~ 163 (261)
T cd05068 153 IKEDIYEA---------------------------------------------------------------------REG 163 (261)
T ss_pred ccCCcccc---------------------------------------------------------------------cCC
Confidence 43110000 000
Q ss_pred ccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhh
Q 012762 318 FVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLV 396 (457)
Q Consensus 318 ~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~ 396 (457)
..++..|+|||++.+..++.++|||||||++|||++ |+.||.+.........+. .....+....++..+.+++.+||.
T Consensus 164 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~ 242 (261)
T cd05068 164 AKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVD-QGYRMPCPPGCPKELYDIMLDCWK 242 (261)
T ss_pred CcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH-cCCCCCCCCcCCHHHHHHHHHHhh
Confidence 123468999999998889999999999999999998 999998877665555543 334445555688999999999999
Q ss_pred hCCCCCCCCCcChHHHhc
Q 012762 397 KDPTRRMGSKMGATAIKR 414 (457)
Q Consensus 397 ~dP~~Rps~~~~~~~ll~ 414 (457)
.||++||+ +.+|++
T Consensus 243 ~~P~~Rp~----~~~l~~ 256 (261)
T cd05068 243 EDPDDRPT----FETLQW 256 (261)
T ss_pred cCcccCCC----HHHHHH
Confidence 99999999 777754
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=337.56 Aligned_cols=260 Identities=26% Similarity=0.364 Sum_probs=209.1
Q ss_pred cCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcC-
Q 012762 80 TLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCP- 158 (457)
Q Consensus 80 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~- 158 (457)
..++|++.+.||.|+||.||+|.++ .+|..||+|++...... ........+|++++++++|+||+++++++...
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~----~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 79 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDT----TSGEIVALKKVRMDNER-DGIPISSLREITLLLNLRHPNIVELKEVVVGKH 79 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEEC----CCCcEEEEEEEEeccCC-CCCcchhhHHHHHHHhCCCCCCcceEEEEecCC
Confidence 4578999999999999999999986 47889999998654321 12233455699999999999999999998755
Q ss_pred -CcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcC
Q 012762 159 -RWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLK 237 (457)
Q Consensus 159 -~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~ 237 (457)
+.+|+||||+. ++|..++.... ..+++..++.++.||+.||.|||+.|++||||||+||+++.++.+||+|||++..
T Consensus 80 ~~~~~lv~e~~~-~~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~ 157 (309)
T cd07845 80 LDSIFLVMEYCE-QDLASLLDNMP-TPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLART 157 (309)
T ss_pred CCeEEEEEecCC-CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeee
Confidence 56899999995 58887776542 5689999999999999999999999999999999999999999999999999765
Q ss_pred CCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcccccc
Q 012762 238 GDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMS 317 (457)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (457)
....... ...
T Consensus 158 ~~~~~~~----------------------------------------------------------------------~~~ 167 (309)
T cd07845 158 YGLPAKP----------------------------------------------------------------------MTP 167 (309)
T ss_pred cCCccCC----------------------------------------------------------------------CCc
Confidence 4321100 001
Q ss_pred ccCCCCccCchhhcC-CCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhccc-------------------CC
Q 012762 318 FVGTHEYLAPEIISG-EGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARAL-------------------EF 377 (457)
Q Consensus 318 ~~gt~~y~aPE~l~~-~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~-------------------~~ 377 (457)
..++..|+|||++.+ ..++.++|||||||++|||++|+.||.+.+....+..+..... ..
T Consensus 168 ~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (309)
T cd07845 168 KVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTL 247 (309)
T ss_pred ccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccccccccc
Confidence 135788999999876 4578999999999999999999999998777666655544211 11
Q ss_pred CCC---------CCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCC
Q 012762 378 PKE---------PSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNG 420 (457)
Q Consensus 378 ~~~---------~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~ 420 (457)
+.. ...+..+.++|.+||..||++||+ +.++++||||+.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t----~~~il~h~~f~~ 295 (309)
T cd07845 248 PKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRAT----AEEALESSYFKE 295 (309)
T ss_pred cCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcC----HHHHhcChhhcc
Confidence 110 124678899999999999999999 999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=333.28 Aligned_cols=258 Identities=26% Similarity=0.407 Sum_probs=206.0
Q ss_pred ccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHc-CCCCCceEEEEEE-
Q 012762 79 LTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEML-DHPFLPTLYATLD- 156 (457)
Q Consensus 79 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~~~~~- 156 (457)
...++|++.+.||+|+||+||+|.++ .+++.||+|++.... .....+..|+.+++.+ +|+||+++++++.
T Consensus 15 ~~~~~~~~~~~lg~g~~~~vy~~~~~----~~~~~~~ik~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 15 DPSDTWEIIETIGKGTYGKVFKVLNK----KNGSKAAVKILDPIH----DIDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred CcccceeeeeeeccCCCcEEEEEEEC----CCCceeEEEeecccc----chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 34568999999999999999999876 477899999986432 2234567799999999 7999999999873
Q ss_pred ----cCCcEEEEEeecCCCChHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEe
Q 012762 157 ----CPRWSCLLTEFCPGGDLHVLRQRQ--PDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLT 230 (457)
Q Consensus 157 ----~~~~~~lV~E~~~~~sL~~~~~~~--~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~ 230 (457)
.++..|+||||+++++|..++... ....+++..+..++.|++.||.|||+.+|+||||||+||+++.++.++|+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~ 166 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLV 166 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEc
Confidence 345789999999999999887532 23568899999999999999999999999999999999999999999999
Q ss_pred ccCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccC
Q 012762 231 DFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEP 310 (457)
Q Consensus 231 DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (457)
|||+++.......
T Consensus 167 dfg~~~~~~~~~~------------------------------------------------------------------- 179 (286)
T cd06638 167 DFGVSAQLTSTRL------------------------------------------------------------------- 179 (286)
T ss_pred cCCceeecccCCC-------------------------------------------------------------------
Confidence 9999754421100
Q ss_pred CccccccccCCCCccCchhhcC-----CCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcc-cCCCCCCCCC
Q 012762 311 LDVRSMSFVGTHEYLAPEIISG-----EGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARA-LEFPKEPSVP 384 (457)
Q Consensus 311 ~~~~~~~~~gt~~y~aPE~l~~-----~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~-~~~~~~~~~~ 384 (457)
......|+..|+|||++.. ..++.++|||||||++|||++|+.||...........+.... ........++
T Consensus 180 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (286)
T cd06638 180 ---RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPTLHQPELWS 256 (286)
T ss_pred ---ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccCCCcccCCCCcC
Confidence 0012258999999999853 347889999999999999999999998765444333322221 1111223367
Q ss_pred hHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCC
Q 012762 385 GPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFF 418 (457)
Q Consensus 385 ~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f 418 (457)
..+.++|.+||+.||++||+ +.+|++|+||
T Consensus 257 ~~~~~li~~~l~~~p~~Rps----~~ell~~~~~ 286 (286)
T cd06638 257 NEFNDFIRKCLTKDYEKRPT----VSDLLQHVFI 286 (286)
T ss_pred HHHHHHHHHHccCCcccCCC----HHHHhhcccC
Confidence 78999999999999999999 9999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=331.01 Aligned_cols=263 Identities=17% Similarity=0.234 Sum_probs=213.7
Q ss_pred CCccCCCceeEEEecccCcceEEEEEEeccC-CCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEE
Q 012762 77 NPLTLSDLRFVHRLGSGDIGSVYLVQLKSKS-SNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATL 155 (457)
Q Consensus 77 ~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~-~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~ 155 (457)
+.+..++|++.+.||+|+||.||+|.++... ...+..||+|.+.... .......+.+|+++|+.++|+||+++++++
T Consensus 1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~ 78 (277)
T cd05032 1 WELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA--SMRERIEFLNEASVMKEFNCHHVVRLLGVV 78 (277)
T ss_pred CccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc--CHHHHHHHHHHHHHHHhCCCCceeEEEEEE
Confidence 3566789999999999999999999886432 2345789999986542 122345677899999999999999999999
Q ss_pred EcCCcEEEEEeecCCCChHHHHHhCC--------CCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCE
Q 012762 156 DCPRWSCLLTEFCPGGDLHVLRQRQP--------DKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHI 227 (457)
Q Consensus 156 ~~~~~~~lV~E~~~~~sL~~~~~~~~--------~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~v 227 (457)
......|+||||+.+++|..++.... ...+++..+..++.||+.||.|||+.+|+||||||+|||++.++.+
T Consensus 79 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~ 158 (277)
T cd05032 79 STGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTV 158 (277)
T ss_pred cCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCE
Confidence 99999999999999999998886532 2346888999999999999999999999999999999999999999
Q ss_pred EEeccCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCccc
Q 012762 228 MLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIV 307 (457)
Q Consensus 228 kl~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (457)
||+|||+++........
T Consensus 159 kl~dfg~~~~~~~~~~~--------------------------------------------------------------- 175 (277)
T cd05032 159 KIGDFGMTRDIYETDYY--------------------------------------------------------------- 175 (277)
T ss_pred EECCcccchhhccCccc---------------------------------------------------------------
Confidence 99999997644321100
Q ss_pred ccCCccccccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHHhcccCCCCCCCCChH
Q 012762 308 AEPLDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVVARALEFPKEPSVPGP 386 (457)
Q Consensus 308 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 386 (457)
.......++..|+|||++.+..++.++|||||||++|||++ |..||.+.........+. .......+..++..
T Consensus 176 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 249 (277)
T cd05032 176 -----RKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVI-DGGHLDLPENCPDK 249 (277)
T ss_pred -----ccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHh-cCCCCCCCCCCCHH
Confidence 00012246789999999988889999999999999999998 999998877666655555 33333334457899
Q ss_pred HHHHHHHHhhhCCCCCCCCCcChHHHhc
Q 012762 387 AKDLIAQLLVKDPTRRMGSKMGATAIKR 414 (457)
Q Consensus 387 ~~~ll~~~L~~dP~~Rps~~~~~~~ll~ 414 (457)
+.+++.+||..+|++||+ +.+|+.
T Consensus 250 ~~~li~~~l~~~p~~Rpt----~~~l~~ 273 (277)
T cd05032 250 LLELMRMCWQYNPKMRPT----FLEIVS 273 (277)
T ss_pred HHHHHHHHcCCChhhCCC----HHHHHH
Confidence 999999999999999999 888875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=334.32 Aligned_cols=255 Identities=26% Similarity=0.380 Sum_probs=200.9
Q ss_pred CCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcE
Q 012762 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWS 161 (457)
Q Consensus 82 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~ 161 (457)
.+|++.+.||+|+||.||+|.++ .++..||+|++..... ......+.+|+++++.++|+||+++++++..++..
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~----~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 78 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISR----INGQLVALKVISMKTE--EGVPFTAIREASLLKGLKHANIVLLHDIIHTKETL 78 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEc----CCCcEEEEEEecccCc--CCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeE
Confidence 57999999999999999999876 3678999999865422 22234566799999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCC
Q 012762 162 CLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNS 241 (457)
Q Consensus 162 ~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~ 241 (457)
|+||||+. ++|..++... ...+++..++.++.||+.||.|||+.||+|+||||+|||++.++.++|+|||+++.....
T Consensus 79 ~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 156 (291)
T cd07870 79 TFVFEYMH-TDLAQYMIQH-PGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIP 156 (291)
T ss_pred EEEEeccc-CCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence 99999994 6776665543 256788889999999999999999999999999999999999999999999987543211
Q ss_pred CcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCC
Q 012762 242 TSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGT 321 (457)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 321 (457)
... .....++
T Consensus 157 ~~~----------------------------------------------------------------------~~~~~~~ 166 (291)
T cd07870 157 SQT----------------------------------------------------------------------YSSEVVT 166 (291)
T ss_pred CCC----------------------------------------------------------------------CCCcccc
Confidence 000 0012478
Q ss_pred CCccCchhhcCC-CCCccchhhhhhHHHHHHhcCCCCCCCCChH-HHHHHHHhccc-----------CC-----------
Q 012762 322 HEYLAPEIISGE-GHGNAVDWWTLGIFIFELFYGTTPFKGIDHE-LTLANVVARAL-----------EF----------- 377 (457)
Q Consensus 322 ~~y~aPE~l~~~-~~~~~sDiwSlG~il~elltG~~Pf~~~~~~-~~~~~~~~~~~-----------~~----------- 377 (457)
..|+|||++.+. .++.++|||||||++|+|++|..||.+.... +.+..+..... ..
T Consensus 167 ~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (291)
T cd07870 167 LWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPC 246 (291)
T ss_pred ccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccchhcccc
Confidence 899999998764 4788999999999999999999999865432 22222211000 00
Q ss_pred -C-------CCCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCC
Q 012762 378 -P-------KEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFF 418 (457)
Q Consensus 378 -~-------~~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f 418 (457)
+ .....+.++.+++.+||..||.+||| +.|++.||||
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t----~~~~l~h~~~ 291 (291)
T cd07870 247 KPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRIS----AQDALLHPYF 291 (291)
T ss_pred CCcchhhhccccCCChHHHHHHHHHhCcCcccCcC----HHHHhcCCCC
Confidence 0 00112467899999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-42 Score=329.30 Aligned_cols=258 Identities=27% Similarity=0.458 Sum_probs=208.8
Q ss_pred CceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhh-------hhHHHHHHHHHHHHHHcCCCCCceEEEEE
Q 012762 83 DLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVS-------RNKESRARIEREILEMLDHPFLPTLYATL 155 (457)
Q Consensus 83 ~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~-------~~~~~~~~~E~~il~~l~H~nIv~l~~~~ 155 (457)
+|.+.+.||.|+||.||+|... .+++.||+|.+....... ....+.+..|+++++.++|+||+++++++
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~----~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 77 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNV----TTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFE 77 (272)
T ss_pred ceeecceecccCceEEEEEeec----CCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEe
Confidence 5888999999999999999876 478899999885422111 11234567799999999999999999999
Q ss_pred EcCCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCC
Q 012762 156 DCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235 (457)
Q Consensus 156 ~~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s 235 (457)
...+..++||||+.+++|..++... ..+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++
T Consensus 78 ~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~ 155 (272)
T cd06629 78 TTEEYLSIFLEYVPGGSIGSCLRTY--GRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGIS 155 (272)
T ss_pred ccCCceEEEEecCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccc
Confidence 9999999999999999999988775 67899999999999999999999999999999999999999999999999987
Q ss_pred cCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcccc
Q 012762 236 LKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRS 315 (457)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (457)
........ ....
T Consensus 156 ~~~~~~~~--------------------------------------------------------------------~~~~ 167 (272)
T cd06629 156 KKSDDIYD--------------------------------------------------------------------NDQN 167 (272)
T ss_pred cccccccc--------------------------------------------------------------------cccc
Confidence 54321100 0001
Q ss_pred ccccCCCCccCchhhcCCC--CCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccC--CCC--CCCCChHHHH
Q 012762 316 MSFVGTHEYLAPEIISGEG--HGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALE--FPK--EPSVPGPAKD 389 (457)
Q Consensus 316 ~~~~gt~~y~aPE~l~~~~--~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~--~~~--~~~~~~~~~~ 389 (457)
....|+..|+|||++.... ++.++|+||||+++|+|++|..||...........+...... ++. ...++..+.+
T Consensus 168 ~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (272)
T cd06629 168 MSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNLSPVALD 247 (272)
T ss_pred ccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCccccccCCHHHHH
Confidence 1235889999999998654 789999999999999999999999765554444333222211 121 1346789999
Q ss_pred HHHHHhhhCCCCCCCCCcChHHHhcCCCC
Q 012762 390 LIAQLLVKDPTRRMGSKMGATAIKRHQFF 418 (457)
Q Consensus 390 ll~~~L~~dP~~Rps~~~~~~~ll~hp~f 418 (457)
+|.+||..||++||+ +.++++||||
T Consensus 248 li~~~l~~~p~~Rps----~~~il~~~~~ 272 (272)
T cd06629 248 FLNACFTINPDNRPT----ARELLQHPFI 272 (272)
T ss_pred HHHHHhcCChhhCCC----HHHHhhCCCC
Confidence 999999999999999 9999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=328.28 Aligned_cols=252 Identities=21% Similarity=0.312 Sum_probs=208.9
Q ss_pred cCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCC
Q 012762 80 TLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPR 159 (457)
Q Consensus 80 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~ 159 (457)
+.++|++.+.||+|+||+||+|.+. .+..+|+|.+..... ....+..|++++++++||||+++++++...+
T Consensus 2 ~~~~~~~~~~lg~G~~~~vy~~~~~-----~~~~~aik~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 72 (256)
T cd05113 2 DPKDLTFLKELGTGQFGVVKYGKWR-----GQYDVAIKMIKEGSM----SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQR 72 (256)
T ss_pred ChHHeEEeeEecCcccceEEEEEec-----CCCcEEEEEcCCCcc----cHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 4568999999999999999999865 344699998865432 2356788999999999999999999999989
Q ss_pred cEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCC
Q 012762 160 WSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGD 239 (457)
Q Consensus 160 ~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~ 239 (457)
..|+||||+.+++|.+++.... ..+++..++.++.||+.||.|||+.|++|+||||+|||++.++.+||+|||+++...
T Consensus 73 ~~~lv~e~~~~~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~ 151 (256)
T cd05113 73 PIYIVTEYMSNGCLLNYLREHG-KRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVL 151 (256)
T ss_pred CcEEEEEcCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecC
Confidence 9999999999999999887643 368999999999999999999999999999999999999999999999999875432
Q ss_pred CCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcccccccc
Q 012762 240 NSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFV 319 (457)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (457)
..... ......
T Consensus 152 ~~~~~---------------------------------------------------------------------~~~~~~ 162 (256)
T cd05113 152 DDEYT---------------------------------------------------------------------SSVGSK 162 (256)
T ss_pred CCcee---------------------------------------------------------------------ecCCCc
Confidence 11000 000113
Q ss_pred CCCCccCchhhcCCCCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhhhC
Q 012762 320 GTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKD 398 (457)
Q Consensus 320 gt~~y~aPE~l~~~~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~d 398 (457)
++..|+|||++.+..++.++|||||||++|+|++ |..||...........+.... ........+..+.+++.+||..|
T Consensus 163 ~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~cl~~~ 241 (256)
T cd05113 163 FPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGL-RLYRPHLASEKVYAIMYSCWHEK 241 (256)
T ss_pred cChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCC-CCCCCCCCCHHHHHHHHHHcCCC
Confidence 6678999999998889999999999999999998 999998877666666665443 33333457789999999999999
Q ss_pred CCCCCCCCcChHHHhcC
Q 012762 399 PTRRMGSKMGATAIKRH 415 (457)
Q Consensus 399 P~~Rps~~~~~~~ll~h 415 (457)
|++||+ +.+|+.+
T Consensus 242 p~~Rp~----~~~ll~~ 254 (256)
T cd05113 242 AEERPT----FQQLLSS 254 (256)
T ss_pred cccCCC----HHHHHHh
Confidence 999999 9998864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-42 Score=325.80 Aligned_cols=255 Identities=29% Similarity=0.450 Sum_probs=212.0
Q ss_pred CceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhh--hhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCc
Q 012762 83 DLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELV--SRNKESRARIEREILEMLDHPFLPTLYATLDCPRW 160 (457)
Q Consensus 83 ~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~ 160 (457)
+|+..+.||+|+||+||+|.++ .++..||+|++...... .......+..|+++++.++|+||+++++++.....
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~----~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~ 76 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNL----DDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDN 76 (258)
T ss_pred CccccceeeecCCceEEEEEEc----CCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCe
Confidence 4778899999999999999876 37889999998654321 12344677889999999999999999999999999
Q ss_pred EEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCC
Q 012762 161 SCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDN 240 (457)
Q Consensus 161 ~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~ 240 (457)
+|+||||+++++|..++... ..+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.+||+|||++.....
T Consensus 77 ~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~ 154 (258)
T cd06632 77 LYIFLELVPGGSLAKLLKKY--GSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVE 154 (258)
T ss_pred EEEEEEecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 99999999999999998765 5689999999999999999999999999999999999999999999999998754321
Q ss_pred CCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccC
Q 012762 241 STSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVG 320 (457)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 320 (457)
.. ......|
T Consensus 155 ~~-----------------------------------------------------------------------~~~~~~~ 163 (258)
T cd06632 155 FS-----------------------------------------------------------------------FAKSFKG 163 (258)
T ss_pred cc-----------------------------------------------------------------------cccccCC
Confidence 11 0012358
Q ss_pred CCCccCchhhcCCC-CCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhhhCC
Q 012762 321 THEYLAPEIISGEG-HGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDP 399 (457)
Q Consensus 321 t~~y~aPE~l~~~~-~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP 399 (457)
+..|++||.+.... ++.++|+|||||++|+|++|+.||...........+............++.++.+++.+||..||
T Consensus 164 ~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 243 (258)
T cd06632 164 SPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILKCLQRDP 243 (258)
T ss_pred CcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHHHHHHHHhhcCc
Confidence 89999999998776 89999999999999999999999987665444444433222222234578899999999999999
Q ss_pred CCCCCCCcChHHHhcCCCC
Q 012762 400 TRRMGSKMGATAIKRHQFF 418 (457)
Q Consensus 400 ~~Rps~~~~~~~ll~hp~f 418 (457)
.+||+ +.+++.|||+
T Consensus 244 ~~Rp~----~~~~l~~~~~ 258 (258)
T cd06632 244 SLRPT----AAELLEHPFV 258 (258)
T ss_pred ccCcC----HHHHhcCCCC
Confidence 99999 9999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-42 Score=326.21 Aligned_cols=256 Identities=25% Similarity=0.466 Sum_probs=215.0
Q ss_pred CceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcEE
Q 012762 83 DLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWSC 162 (457)
Q Consensus 83 ~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~ 162 (457)
+|.+.+.||.|+||.||+|.++ .++..||+|.+....... .....+.+|+++++.++|+||+++++.+...+..|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~----~~~~~~~ik~~~~~~~~~-~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~ 75 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAK----SDSEHCVIKEIDLTKMPV-KEKEASKKEVILLAKMKHPNIVTFFASFQENGRLF 75 (257)
T ss_pred CceEEEEecCCCcceEEEEEEc----CCCceEEEEEeeHhhccc-hhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEE
Confidence 5889999999999999999987 377889999997654322 34456778999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCC-CEEEeccCCCcCCCCC
Q 012762 163 LLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDG-HIMLTDFDLSLKGDNS 241 (457)
Q Consensus 163 lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~-~vkl~DFG~s~~~~~~ 241 (457)
+||||+.+++|.+++.......+++..++.++.||+.||.|||+.+++|+||||+||+++.++ .++|+|||.+......
T Consensus 76 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (257)
T cd08225 76 IVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS 155 (257)
T ss_pred EEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence 999999999999988776555689999999999999999999999999999999999999886 4699999987544311
Q ss_pred CcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCC
Q 012762 242 TSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGT 321 (457)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 321 (457)
... .....|+
T Consensus 156 ~~~----------------------------------------------------------------------~~~~~~~ 165 (257)
T cd08225 156 MEL----------------------------------------------------------------------AYTCVGT 165 (257)
T ss_pred ccc----------------------------------------------------------------------ccccCCC
Confidence 100 0012488
Q ss_pred CCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhhhCCCC
Q 012762 322 HEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDPTR 401 (457)
Q Consensus 322 ~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~ 401 (457)
+.|+|||++.+..++.++|+|||||++|||++|..||...........+..... .+..+.++.++.++|.+||..+|++
T Consensus 166 ~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~p~~ 244 (257)
T cd08225 166 PYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYF-APISPNFSRDLRSLISQLFKVSPRD 244 (257)
T ss_pred ccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccC-CCCCCCCCHHHHHHHHHHhccChhh
Confidence 999999999888899999999999999999999999987766555555444332 2233457889999999999999999
Q ss_pred CCCCCcChHHHhcCCCC
Q 012762 402 RMGSKMGATAIKRHQFF 418 (457)
Q Consensus 402 Rps~~~~~~~ll~hp~f 418 (457)
||+ +.++++||||
T Consensus 245 Rpt----~~~ll~~~~~ 257 (257)
T cd08225 245 RPS----ITSILKRPFL 257 (257)
T ss_pred CcC----HHHHhhCCCC
Confidence 999 9999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-42 Score=327.64 Aligned_cols=259 Identities=22% Similarity=0.308 Sum_probs=213.4
Q ss_pred cCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCC
Q 012762 80 TLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPR 159 (457)
Q Consensus 80 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~ 159 (457)
..++|++.+.||+|+||+||+|.++... .....||+|+++... .......+..|+.+++.++|+||+++++++...+
T Consensus 2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~-~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 78 (266)
T cd05033 2 DPSYVTIEKVIGGGEFGEVCRGRLKLPG-KKEIDVAIKTLKAGS--SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSR 78 (266)
T ss_pred ChHHceeeeEecCCccceEEEEEEccCC-CCcceEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCC
Confidence 3568999999999999999999986431 235689999986542 2334556778999999999999999999999999
Q ss_pred cEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCC
Q 012762 160 WSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGD 239 (457)
Q Consensus 160 ~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~ 239 (457)
..|+||||+++++|.+++.... +.+++..+..++.|++.||.|||+++|+|+||||+|||++.++.++|+|||++....
T Consensus 79 ~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 157 (266)
T cd05033 79 PVMIITEYMENGSLDKFLREND-GKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLE 157 (266)
T ss_pred ceEEEEEcCCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhccc
Confidence 9999999999999999887643 478999999999999999999999999999999999999999999999999986553
Q ss_pred CCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcccccccc
Q 012762 240 NSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFV 319 (457)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (457)
....... .....
T Consensus 158 ~~~~~~~--------------------------------------------------------------------~~~~~ 169 (266)
T cd05033 158 DSEATYT--------------------------------------------------------------------TKGGK 169 (266)
T ss_pred cccccee--------------------------------------------------------------------ccCCC
Confidence 1110000 00112
Q ss_pred CCCCccCchhhcCCCCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhhhC
Q 012762 320 GTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKD 398 (457)
Q Consensus 320 gt~~y~aPE~l~~~~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~d 398 (457)
++..|+|||.+.+..++.++|||||||++|+|++ |..||...........+.. ....+....++..+.+++.+||+.|
T Consensus 170 ~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~~ 248 (266)
T cd05033 170 IPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVED-GYRLPPPMDCPSALYQLMLDCWQKD 248 (266)
T ss_pred CCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHHcCCC
Confidence 5678999999998889999999999999999997 9999988776665555543 3444555568899999999999999
Q ss_pred CCCCCCCCcChHHHhcC
Q 012762 399 PTRRMGSKMGATAIKRH 415 (457)
Q Consensus 399 P~~Rps~~~~~~~ll~h 415 (457)
|++||+ +.+|+++
T Consensus 249 p~~Rp~----~~ei~~~ 261 (266)
T cd05033 249 RNERPT----FSQIVST 261 (266)
T ss_pred cccCcC----HHHHHHH
Confidence 999999 8888764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-43 Score=332.74 Aligned_cols=256 Identities=29% Similarity=0.411 Sum_probs=211.5
Q ss_pred CCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcE
Q 012762 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWS 161 (457)
Q Consensus 82 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~ 161 (457)
++|++.+.||.|+||.||+|.++ .+++.||+|++..... ......+.+|+++++.++|+||+++++++...+..
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~----~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 74 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHR----PTGKIMAVKTIRLEIN--EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDI 74 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEc----CCCcEEEEEEEecccC--hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEE
Confidence 46888999999999999999986 4788999999876532 24456678899999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCceeecCCCCCeEEccCCCEEEeccCCCcCCCC
Q 012762 162 CLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHM-MGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDN 240 (457)
Q Consensus 162 ~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~-~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~ 240 (457)
|+||||+.+++|.+++.... ..+++..+..++.|++.||.|||+ .|++|+||||+||+++.++.++|+|||++.....
T Consensus 75 ~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~ 153 (265)
T cd06605 75 SICMEYMDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVN 153 (265)
T ss_pred EEEEEecCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHH
Confidence 99999999999999987653 678999999999999999999999 9999999999999999999999999998744321
Q ss_pred CCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccC
Q 012762 241 STSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVG 320 (457)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 320 (457)
... ....|
T Consensus 154 ~~~------------------------------------------------------------------------~~~~~ 161 (265)
T cd06605 154 SLA------------------------------------------------------------------------KTFVG 161 (265)
T ss_pred HHh------------------------------------------------------------------------hcccC
Confidence 100 01358
Q ss_pred CCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCC-----hHHHHHHHHhcccCCCCCCCCChHHHHHHHHHh
Q 012762 321 THEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGID-----HELTLANVVARALEFPKEPSVPGPAKDLIAQLL 395 (457)
Q Consensus 321 t~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L 395 (457)
+..|+|||++.+..++.++|||||||++|+|++|..||.... .......+............++.++.++|.+||
T Consensus 162 ~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 241 (265)
T cd06605 162 TSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQDFVNLCL 241 (265)
T ss_pred ChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhcCHHHHHHHHHHc
Confidence 889999999999999999999999999999999999997642 122222222221111111127888999999999
Q ss_pred hhCCCCCCCCCcChHHHhcCCCCCC
Q 012762 396 VKDPTRRMGSKMGATAIKRHQFFNG 420 (457)
Q Consensus 396 ~~dP~~Rps~~~~~~~ll~hp~f~~ 420 (457)
..||++||+ +.+++.||||+.
T Consensus 242 ~~~p~~Rpt----~~~ll~~~~~~~ 262 (265)
T cd06605 242 IKDPRERPS----YKELLEHPFIKK 262 (265)
T ss_pred CCCchhCcC----HHHHhhCchhhc
Confidence 999999999 999999999974
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-42 Score=333.87 Aligned_cols=261 Identities=24% Similarity=0.349 Sum_probs=209.2
Q ss_pred CCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcE
Q 012762 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWS 161 (457)
Q Consensus 82 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~ 161 (457)
++|++.+.||.|+||+||+|.++ .+++.||+|.+..... .......+..|+++++.++|+||+++++++......
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~----~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 76 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDR----VTNETIALKKIRLEQE-DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRL 76 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEec----CCCcEEEEEehhhccc-cccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeE
Confidence 67999999999999999999876 3788999999865432 122345677899999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEcc-CCCEEEeccCCCcCCCC
Q 012762 162 CLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRS-DGHIMLTDFDLSLKGDN 240 (457)
Q Consensus 162 ~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~-~~~vkl~DFG~s~~~~~ 240 (457)
|+||||+ +++|..++.......+++..++.++.||+.||.|||++||+|+||+|+||+++. ++.+||+|||++.....
T Consensus 77 ~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~ 155 (294)
T PLN00009 77 YLVFEYL-DLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI 155 (294)
T ss_pred EEEEecc-cccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCC
Confidence 9999999 468877776655455788999999999999999999999999999999999985 45799999999754321
Q ss_pred CCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccC
Q 012762 241 STSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVG 320 (457)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 320 (457)
.... .....|
T Consensus 156 ~~~~----------------------------------------------------------------------~~~~~~ 165 (294)
T PLN00009 156 PVRT----------------------------------------------------------------------FTHEVV 165 (294)
T ss_pred Cccc----------------------------------------------------------------------cccCce
Confidence 1000 001247
Q ss_pred CCCccCchhhcCC-CCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccC------------------CC---
Q 012762 321 THEYLAPEIISGE-GHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALE------------------FP--- 378 (457)
Q Consensus 321 t~~y~aPE~l~~~-~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~------------------~~--- 378 (457)
+..|+|||++.+. .++.++|||||||++|+|++|+.||........+.++...... .+
T Consensus 166 ~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (294)
T PLN00009 166 TLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKSAFPKWP 245 (294)
T ss_pred eecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhhhhcccCC
Confidence 8899999998764 4789999999999999999999999877655544443321000 00
Q ss_pred ------CCCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCCCC
Q 012762 379 ------KEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGVN 422 (457)
Q Consensus 379 ------~~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~~~ 422 (457)
..+.++..+.+++.+||..||++||+ +.++++||||++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps----~~~~l~~~~~~~~~ 291 (294)
T PLN00009 246 PKDLATVVPTLEPAGVDLLSKMLRLDPSKRIT----ARAALEHEYFKDLG 291 (294)
T ss_pred CCCHHHhCcCCChHHHHHHHHHccCChhhCcC----HHHHhcCchHhHHh
Confidence 01346778999999999999999999 99999999999754
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=332.17 Aligned_cols=260 Identities=20% Similarity=0.302 Sum_probs=213.3
Q ss_pred cCCCceeEEEecccCcceEEEEEEeccC-CCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcC
Q 012762 80 TLSDLRFVHRLGSGDIGSVYLVQLKSKS-SNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCP 158 (457)
Q Consensus 80 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~-~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~ 158 (457)
..++|.+.+.||+|+||.||+|.+.... ...+..||+|+++... .......+.+|+++|+.++|+||+++++++...
T Consensus 3 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 80 (280)
T cd05049 3 QRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA--SNDARKDFEREAELLTNFQHENIVKFYGVCTEG 80 (280)
T ss_pred ChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC--CHHHHHHHHHHHHHHHhcCCCCchheeeEEecC
Confidence 4567999999999999999999875321 2356789999986542 222456788899999999999999999999999
Q ss_pred CcEEEEEeecCCCChHHHHHhCC------------CCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCC
Q 012762 159 RWSCLLTEFCPGGDLHVLRQRQP------------DKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGH 226 (457)
Q Consensus 159 ~~~~lV~E~~~~~sL~~~~~~~~------------~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~ 226 (457)
...|+||||+++++|..++.... ...+++..+..++.||+.||.|||++|++||||||+||+++.++.
T Consensus 81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 81 DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCe
Confidence 99999999999999999987642 245788899999999999999999999999999999999999999
Q ss_pred EEEeccCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcc
Q 012762 227 IMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEI 306 (457)
Q Consensus 227 vkl~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (457)
++|+|||++..........
T Consensus 161 ~kl~d~g~~~~~~~~~~~~------------------------------------------------------------- 179 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYR------------------------------------------------------------- 179 (280)
T ss_pred EEECCcccceecccCccee-------------------------------------------------------------
Confidence 9999999875432110000
Q ss_pred cccCCccccccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHHhcccCCCCCCCCCh
Q 012762 307 VAEPLDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVVARALEFPKEPSVPG 385 (457)
Q Consensus 307 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (457)
......++..|+|||++.+..++.++|||||||++|||++ |..||.+.........+..+....+ ...++.
T Consensus 180 -------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 251 (280)
T cd05049 180 -------VGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGRLLQR-PRTCPS 251 (280)
T ss_pred -------cCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCcCCC-CCCCCH
Confidence 0001236788999999999999999999999999999998 9999988777776666665443332 345889
Q ss_pred HHHHHHHHHhhhCCCCCCCCCcChHHHhc
Q 012762 386 PAKDLIAQLLVKDPTRRMGSKMGATAIKR 414 (457)
Q Consensus 386 ~~~~ll~~~L~~dP~~Rps~~~~~~~ll~ 414 (457)
.+.+++.+||..||++||+ +.|+++
T Consensus 252 ~~~~li~~~l~~~p~~Rp~----~~eil~ 276 (280)
T cd05049 252 EVYDIMLGCWKRDPQQRIN----IKDIHE 276 (280)
T ss_pred HHHHHHHHHcCCCcccCCC----HHHHHH
Confidence 9999999999999999999 888875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-42 Score=334.80 Aligned_cols=265 Identities=21% Similarity=0.297 Sum_probs=216.7
Q ss_pred CCCccCCCceeEEEecccCcceEEEEEEecc-CCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHc-CCCCCceEEE
Q 012762 76 NNPLTLSDLRFVHRLGSGDIGSVYLVQLKSK-SSNNGCFFAAKVMDKRELVSRNKESRARIEREILEML-DHPFLPTLYA 153 (457)
Q Consensus 76 ~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~-~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~~ 153 (457)
.+.+..++|.+.+.||+|+||.||+|.+... ....+..||+|+++.... ......+..|+++++++ +|+||+++++
T Consensus 29 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~iv~~~~ 106 (302)
T cd05055 29 KWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAH--SSEREALMSELKIMSHLGNHENIVNLLG 106 (302)
T ss_pred cccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCC--hHHHHHHHHHHHHHHhccCCCCcceEEE
Confidence 4556677899999999999999999986421 223566899999875422 23345678899999999 7999999999
Q ss_pred EEEcCCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccC
Q 012762 154 TLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFD 233 (457)
Q Consensus 154 ~~~~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG 233 (457)
++...+..|+||||+.+++|..++.......+++.++..++.||+.||.|||+++|+|+||||+|||++.++.++|+|||
T Consensus 107 ~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg 186 (302)
T cd05055 107 ACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFG 186 (302)
T ss_pred EEecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCc
Confidence 99999999999999999999999877544558999999999999999999999999999999999999999999999999
Q ss_pred CCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcc
Q 012762 234 LSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDV 313 (457)
Q Consensus 234 ~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (457)
+++.........
T Consensus 187 ~~~~~~~~~~~~-------------------------------------------------------------------- 198 (302)
T cd05055 187 LARDIMNDSNYV-------------------------------------------------------------------- 198 (302)
T ss_pred ccccccCCCcee--------------------------------------------------------------------
Confidence 976442111000
Q ss_pred ccccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHH
Q 012762 314 RSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIA 392 (457)
Q Consensus 314 ~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~ 392 (457)
......++..|+|||++.+..++.++|||||||++|||++ |..||........+...+............+..+.+++.
T Consensus 199 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 278 (302)
T cd05055 199 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPEHAPAEIYDIMK 278 (302)
T ss_pred ecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCCCCCCCCHHHHHHHH
Confidence 0001236788999999998889999999999999999998 999998876655555555555444444567889999999
Q ss_pred HHhhhCCCCCCCCCcChHHHhc
Q 012762 393 QLLVKDPTRRMGSKMGATAIKR 414 (457)
Q Consensus 393 ~~L~~dP~~Rps~~~~~~~ll~ 414 (457)
+||..+|++||+ +.||++
T Consensus 279 ~cl~~~p~~Rpt----~~ell~ 296 (302)
T cd05055 279 TCWDADPLKRPT----FKQIVQ 296 (302)
T ss_pred HHcCCCchhCcC----HHHHHH
Confidence 999999999999 888865
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=334.84 Aligned_cols=258 Identities=27% Similarity=0.363 Sum_probs=209.1
Q ss_pred CceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhh--hhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCc
Q 012762 83 DLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVS--RNKESRARIEREILEMLDHPFLPTLYATLDCPRW 160 (457)
Q Consensus 83 ~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~--~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~ 160 (457)
+|.+.+.||+|+||.||+|.++ .+++.||+|.+....... ......+..|+++++.++|+||+++++++.+.+.
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~----~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~ 76 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDK----ETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSN 76 (298)
T ss_pred CceeeeeeeeccccEEEEEEEC----CCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCE
Confidence 4888999999999999999976 368899999997654331 2234456679999999999999999999999999
Q ss_pred EEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCC
Q 012762 161 SCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDN 240 (457)
Q Consensus 161 ~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~ 240 (457)
.|+||||+ +++|..++.... ..+++..++.++.||+.||.|||++||+|+||||+|||++.++.++|+|||++.....
T Consensus 77 ~~lv~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 154 (298)
T cd07841 77 INLVFEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGS 154 (298)
T ss_pred EEEEEccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence 99999999 999999987653 3699999999999999999999999999999999999999999999999999765432
Q ss_pred CCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccC
Q 012762 241 STSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVG 320 (457)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 320 (457)
.... .....+
T Consensus 155 ~~~~----------------------------------------------------------------------~~~~~~ 164 (298)
T cd07841 155 PNRK----------------------------------------------------------------------MTHQVV 164 (298)
T ss_pred CCcc----------------------------------------------------------------------cccccc
Confidence 1100 001236
Q ss_pred CCCccCchhhcC-CCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCC-----C----------------
Q 012762 321 THEYLAPEIISG-EGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEF-----P---------------- 378 (457)
Q Consensus 321 t~~y~aPE~l~~-~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~-----~---------------- 378 (457)
+..|+|||.+.+ ..++.++|||||||++|||++|.+||.+......+.++....... +
T Consensus 165 ~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (298)
T cd07841 165 TRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEFKPFPP 244 (298)
T ss_pred ceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccccccccCC
Confidence 788999999865 357899999999999999999988888766555444443211000 0
Q ss_pred -----CCCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCC
Q 012762 379 -----KEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNG 420 (457)
Q Consensus 379 -----~~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~ 420 (457)
.....+..+.++|.+||..||++||+ +.++++|+||++
T Consensus 245 ~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s----~~e~l~~~~~~~ 287 (298)
T cd07841 245 TPLKQIFPAASDDALDLLQRLLTLNPNKRIT----ARQALEHPYFSN 287 (298)
T ss_pred cchhhhcccccHHHHHHHHHHhcCCcccCcC----HHHHhhCccccC
Confidence 01234678899999999999999999 999999999996
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=343.34 Aligned_cols=254 Identities=26% Similarity=0.406 Sum_probs=204.3
Q ss_pred CCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcC--
Q 012762 81 LSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCP-- 158 (457)
Q Consensus 81 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~-- 158 (457)
.++|++.+.||+|+||+||+|.+. .+++.||+|++.+.. ........+.+|++++++++|+||+++++++...
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~----~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 89 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDT----VTGQNVAIKKLSRPF-QNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKS 89 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEEC----CCCCEEEEEecCccc-cChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCC
Confidence 468999999999999999999876 378899999986432 1223345566799999999999999999998643
Q ss_pred ----CcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCC
Q 012762 159 ----RWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDL 234 (457)
Q Consensus 159 ----~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~ 234 (457)
.+.|+||||+ .++|...+... +++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 90 ~~~~~~~~lv~e~~-~~~l~~~~~~~----l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~ 164 (353)
T cd07850 90 LEEFQDVYLVMELM-DANLCQVIQMD----LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGL 164 (353)
T ss_pred ccccCcEEEEEecc-CCCHHHHHhhc----CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCcc
Confidence 3579999999 56887776542 88999999999999999999999999999999999999999999999999
Q ss_pred CcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccc
Q 012762 235 SLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVR 314 (457)
Q Consensus 235 s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (457)
+........
T Consensus 165 ~~~~~~~~~----------------------------------------------------------------------- 173 (353)
T cd07850 165 ARTAGTSFM----------------------------------------------------------------------- 173 (353)
T ss_pred ceeCCCCCC-----------------------------------------------------------------------
Confidence 754321100
Q ss_pred cccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCC-----------------
Q 012762 315 SMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEF----------------- 377 (457)
Q Consensus 315 ~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~----------------- 377 (457)
.....|+..|+|||++.+..++.++|||||||++|+|++|+.||...+.......++......
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (353)
T cd07850 174 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVE 253 (353)
T ss_pred CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhHHhh
Confidence 012358899999999999999999999999999999999999998766544333332211000
Q ss_pred -------------------CC-----CCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCC
Q 012762 378 -------------------PK-----EPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFN 419 (457)
Q Consensus 378 -------------------~~-----~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~ 419 (457)
+. ....+..+.++|.+||..||++||+ +.|+|+||||+
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t----~~eiL~~~~~~ 315 (353)
T cd07850 254 NRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRIS----VDDALQHPYIN 315 (353)
T ss_pred cCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcC----HHHHhcChhHh
Confidence 00 1123556899999999999999999 99999999998
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=329.23 Aligned_cols=252 Identities=22% Similarity=0.338 Sum_probs=213.3
Q ss_pred cCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCC
Q 012762 80 TLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPR 159 (457)
Q Consensus 80 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~ 159 (457)
...+|++.++||.|+||.||+|.++ .+..+|+|++..... .....+..|+++++.++|+||+++++++...+
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~-----~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 75 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWK-----NRVRVAIKILKSDDL---LKQQDFQKEVQALKRLRHKHLISLFAVCSVGE 75 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEec-----CCCcEEEEeccccch---hhHHHHHHHHHHHhcCCCcchhheeeeEecCC
Confidence 3457999999999999999999986 377899999876432 23456778999999999999999999999999
Q ss_pred cEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCC
Q 012762 160 WSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGD 239 (457)
Q Consensus 160 ~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~ 239 (457)
..|+||||+++++|.+++.......+++..++.++.||+.||.|||++||+|+||||+||+++.++.+||+|||++....
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~ 155 (261)
T cd05148 76 PVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIK 155 (261)
T ss_pred CeEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcC
Confidence 99999999999999999987666778999999999999999999999999999999999999999999999999975442
Q ss_pred CCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcccccccc
Q 012762 240 NSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFV 319 (457)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (457)
..... .....
T Consensus 156 ~~~~~----------------------------------------------------------------------~~~~~ 165 (261)
T cd05148 156 EDVYL----------------------------------------------------------------------SSDKK 165 (261)
T ss_pred Ccccc----------------------------------------------------------------------ccCCC
Confidence 11100 00113
Q ss_pred CCCCccCchhhcCCCCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhhhC
Q 012762 320 GTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKD 398 (457)
Q Consensus 320 gt~~y~aPE~l~~~~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~d 398 (457)
++..|+|||++.+..++.++|||||||++|+|++ |+.||.+....+.+..+. .....+....++..+.+++.+||..|
T Consensus 166 ~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~l~~~ 244 (261)
T cd05148 166 IPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQIT-AGYRMPCPAKCPQEIYKIMLECWAAE 244 (261)
T ss_pred CceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHH-hCCcCCCCCCCCHHHHHHHHHHcCCC
Confidence 5778999999998889999999999999999998 899998877666666655 33455555678899999999999999
Q ss_pred CCCCCCCCcChHHHhc
Q 012762 399 PTRRMGSKMGATAIKR 414 (457)
Q Consensus 399 P~~Rps~~~~~~~ll~ 414 (457)
|++||+ +.+|++
T Consensus 245 p~~Rpt----~~~l~~ 256 (261)
T cd05148 245 PEDRPS----FKALRE 256 (261)
T ss_pred chhCcC----HHHHHH
Confidence 999999 777654
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=337.74 Aligned_cols=254 Identities=27% Similarity=0.432 Sum_probs=210.3
Q ss_pred CceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcEE
Q 012762 83 DLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWSC 162 (457)
Q Consensus 83 ~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~ 162 (457)
.|.....||+|+||.||++.+. .++..||||.+.... ......+.+|+.++++++|+||+++++.+..++..|
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~----~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~ 95 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEK----HTGKQVAVKKMDLRK---QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELW 95 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEEC----CCCCEEEEEEEecch---HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEE
Confidence 3555678999999999999875 468899999986532 234456778999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCCC
Q 012762 163 LLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNST 242 (457)
Q Consensus 163 lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~~ 242 (457)
+||||+++++|..++.. ..+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++.......
T Consensus 96 lv~e~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~ 172 (292)
T cd06658 96 VVMEFLEGGALTDIVTH---TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV 172 (292)
T ss_pred EEEeCCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhccccc
Confidence 99999999999988755 468999999999999999999999999999999999999999999999999875332110
Q ss_pred cccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCCC
Q 012762 243 STAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTH 322 (457)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 322 (457)
. ......|+.
T Consensus 173 ~----------------------------------------------------------------------~~~~~~~~~ 182 (292)
T cd06658 173 P----------------------------------------------------------------------KRKSLVGTP 182 (292)
T ss_pred c----------------------------------------------------------------------cCceeecCc
Confidence 0 001235899
Q ss_pred CccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcc-cCCCCCCCCChHHHHHHHHHhhhCCCC
Q 012762 323 EYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARA-LEFPKEPSVPGPAKDLIAQLLVKDPTR 401 (457)
Q Consensus 323 ~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ll~~~L~~dP~~ 401 (457)
.|+|||++.+..++.++|||||||++|||++|..||........+..+.... ...+....++..+.+++.+||..||.+
T Consensus 183 ~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~ 262 (292)
T cd06658 183 YWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLMLVREPSQ 262 (292)
T ss_pred cccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccCHHHHHHHHHHccCChhH
Confidence 9999999998889999999999999999999999998766555444433221 112222346788999999999999999
Q ss_pred CCCCCcChHHHhcCCCCCC
Q 012762 402 RMGSKMGATAIKRHQFFNG 420 (457)
Q Consensus 402 Rps~~~~~~~ll~hp~f~~ 420 (457)
||+ ++++++||||+.
T Consensus 263 Rpt----~~~il~~~~~~~ 277 (292)
T cd06658 263 RAT----AQELLQHPFLKL 277 (292)
T ss_pred CcC----HHHHhhChhhhc
Confidence 999 999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-42 Score=334.75 Aligned_cols=255 Identities=23% Similarity=0.305 Sum_probs=210.4
Q ss_pred CCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcE
Q 012762 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWS 161 (457)
Q Consensus 82 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~ 161 (457)
..|++.+.||+|+||+||+|.+. .++..||+|++.............+.+|+++++.++||||+++++++..++..
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~----~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~ 90 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDV----RTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTA 90 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEc----CCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeE
Confidence 56999999999999999999876 36889999998754433334456678899999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCC
Q 012762 162 CLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNS 241 (457)
Q Consensus 162 ~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~ 241 (457)
|+||||+. |+|.+++.... ..+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++......
T Consensus 91 ~lv~e~~~-g~l~~~~~~~~-~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~ 168 (307)
T cd06607 91 WLVMEYCL-GSASDILEVHK-KPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA 168 (307)
T ss_pred EEEHHhhC-CCHHHHHHHcc-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCCC
Confidence 99999995 67766665432 46899999999999999999999999999999999999999999999999987533210
Q ss_pred CcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCC
Q 012762 242 TSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGT 321 (457)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 321 (457)
....|+
T Consensus 169 --------------------------------------------------------------------------~~~~~~ 174 (307)
T cd06607 169 --------------------------------------------------------------------------NSFVGT 174 (307)
T ss_pred --------------------------------------------------------------------------CCccCC
Confidence 013478
Q ss_pred CCccCchhhc---CCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhhhC
Q 012762 322 HEYLAPEIIS---GEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKD 398 (457)
Q Consensus 322 ~~y~aPE~l~---~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~d 398 (457)
..|+|||++. ...++.++||||||+++|||++|..||...........+............++..++++|.+||..|
T Consensus 175 ~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 254 (307)
T cd06607 175 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFRNFVDSCLQKI 254 (307)
T ss_pred ccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhhCHHHHHHHHHHhcCC
Confidence 8999999985 3457889999999999999999999998776555444443332222222347788999999999999
Q ss_pred CCCCCCCCcChHHHhcCCCCCC
Q 012762 399 PTRRMGSKMGATAIKRHQFFNG 420 (457)
Q Consensus 399 P~~Rps~~~~~~~ll~hp~f~~ 420 (457)
|++||+ +.+|+.||||..
T Consensus 255 p~~Rp~----~~~il~~~~~~~ 272 (307)
T cd06607 255 PQDRPS----SEELLKHRFVLR 272 (307)
T ss_pred hhhCcC----HHHHhcChhhcc
Confidence 999999 999999999985
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-42 Score=326.23 Aligned_cols=258 Identities=28% Similarity=0.443 Sum_probs=216.6
Q ss_pred CCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcE
Q 012762 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWS 161 (457)
Q Consensus 82 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~ 161 (457)
++|++.+.||.|++|.||+|.+. .+++.||+|++...... .....+..|++++..++|+||+++++++...+..
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~----~~~~~~~vk~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 74 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHK----PTGKIYALKKIHVDGDE--EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEI 74 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEc----CCCcEEEEEEeccCcch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeE
Confidence 36899999999999999999887 37889999998765321 3456788899999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCceeecCCCCCeEEccCCCEEEeccCCCcCCCC
Q 012762 162 CLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHM-MGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDN 240 (457)
Q Consensus 162 ~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~-~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~ 240 (457)
++||||+++++|.+++... ..+++..+..++.||+.||.|||+ .|++|+||+|+||+++.++.++|+|||++.....
T Consensus 75 ~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~ 152 (264)
T cd06623 75 SIVLEYMDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLEN 152 (264)
T ss_pred EEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 9999999999999998775 679999999999999999999999 9999999999999999999999999998754431
Q ss_pred CCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccC
Q 012762 241 STSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVG 320 (457)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 320 (457)
.... .....+
T Consensus 153 ~~~~----------------------------------------------------------------------~~~~~~ 162 (264)
T cd06623 153 TLDQ----------------------------------------------------------------------CNTFVG 162 (264)
T ss_pred CCCc----------------------------------------------------------------------ccceee
Confidence 1110 012357
Q ss_pred CCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCC---hHHHHHHHHhcccCCCCCCC-CChHHHHHHHHHhh
Q 012762 321 THEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGID---HELTLANVVARALEFPKEPS-VPGPAKDLIAQLLV 396 (457)
Q Consensus 321 t~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~---~~~~~~~~~~~~~~~~~~~~-~~~~~~~ll~~~L~ 396 (457)
+..|+|||.+.+..++.++|+||||+++|+|++|..||.... .......+.. ......... ++..+.++|.+||.
T Consensus 163 ~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~ 241 (264)
T cd06623 163 TVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICD-GPPPSLPAEEFSPEFRDFISACLQ 241 (264)
T ss_pred cccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhc-CCCCCCCcccCCHHHHHHHHHHcc
Confidence 889999999998889999999999999999999999998764 2333333332 222223334 78899999999999
Q ss_pred hCCCCCCCCCcChHHHhcCCCCCCCC
Q 012762 397 KDPTRRMGSKMGATAIKRHQFFNGVN 422 (457)
Q Consensus 397 ~dP~~Rps~~~~~~~ll~hp~f~~~~ 422 (457)
.+|++||+ +.++++||||+..+
T Consensus 242 ~~p~~R~~----~~~ll~~~~~~~~~ 263 (264)
T cd06623 242 KDPKKRPS----AAELLQHPFIKKAD 263 (264)
T ss_pred CChhhCCC----HHHHHhCHHHHhcc
Confidence 99999999 99999999998653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-42 Score=335.06 Aligned_cols=255 Identities=22% Similarity=0.334 Sum_probs=206.1
Q ss_pred ccCCCceeEEEecccCcceEEEEEEeccCCCCCc--eEEEEEeehhhhhhhhHHHHHHHHHHHHHHc-CCCCCceEEEEE
Q 012762 79 LTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGC--FFAAKVMDKRELVSRNKESRARIEREILEML-DHPFLPTLYATL 155 (457)
Q Consensus 79 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~--~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~~~~ 155 (457)
+..++|++.+.||+|+||+||+|.++. ++. .+|+|.+... ........+.+|++++.++ +|+||+++++++
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~a~~~~----~~~~~~~~ik~~~~~--~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~ 77 (303)
T cd05088 4 LEWNDIKFQDVIGEGNFGQVLKARIKK----DGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGAC 77 (303)
T ss_pred cchhhceeeeeecCCCCceEEEEEEcc----CCceeeEEEEEeccc--CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEE
Confidence 456789999999999999999999763 443 4577776532 2334456778899999999 899999999999
Q ss_pred EcCCcEEEEEeecCCCChHHHHHhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEE
Q 012762 156 DCPRWSCLLTEFCPGGDLHVLRQRQP--------------DKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLV 221 (457)
Q Consensus 156 ~~~~~~~lV~E~~~~~sL~~~~~~~~--------------~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll 221 (457)
..++..|+||||+++++|..++.... ...+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 78 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili 157 (303)
T cd05088 78 EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV 157 (303)
T ss_pred CCCCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEe
Confidence 99999999999999999999887542 2357899999999999999999999999999999999999
Q ss_pred ccCCCEEEeccCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCC
Q 012762 222 RSDGHIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNP 301 (457)
Q Consensus 222 ~~~~~vkl~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (457)
+.++.+||+|||++.......
T Consensus 158 ~~~~~~kl~dfg~~~~~~~~~----------------------------------------------------------- 178 (303)
T cd05088 158 GENYVAKIADFGLSRGQEVYV----------------------------------------------------------- 178 (303)
T ss_pred cCCCcEEeCccccCcccchhh-----------------------------------------------------------
Confidence 999999999999874211000
Q ss_pred CCCcccccCCccccccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHHhcccCCCCC
Q 012762 302 GTPEIVAEPLDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVVARALEFPKE 380 (457)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~ 380 (457)
......++..|+|||++.+..++.++|||||||++|||++ |..||.+....+....+. ........
T Consensus 179 ------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~-~~~~~~~~ 245 (303)
T cd05088 179 ------------KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP-QGYRLEKP 245 (303)
T ss_pred ------------hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHh-cCCcCCCC
Confidence 0000124667999999988889999999999999999998 999998776655554443 22333333
Q ss_pred CCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcC
Q 012762 381 PSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRH 415 (457)
Q Consensus 381 ~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~h 415 (457)
..++.++.+|+.+||+.||++||+ +++++.+
T Consensus 246 ~~~~~~~~~li~~~l~~~p~~Rp~----~~~il~~ 276 (303)
T cd05088 246 LNCDDEVYDLMRQCWREKPYERPS----FAQILVS 276 (303)
T ss_pred CCCCHHHHHHHHHHcCCChhhCcC----HHHHHHH
Confidence 457889999999999999999999 8887765
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=331.75 Aligned_cols=257 Identities=25% Similarity=0.366 Sum_probs=213.4
Q ss_pred CCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcE
Q 012762 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWS 161 (457)
Q Consensus 82 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~ 161 (457)
..|+.+++||.|+||.||+|.++ .++..||+|++..... ......+.+|+++++.++|+||+++++++..+...
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~----~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 77 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDN----RTQQVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKL 77 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEc----cCCEEEEEEEEecccc--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEE
Confidence 35888899999999999999876 3678999999875422 23456778899999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCC
Q 012762 162 CLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNS 241 (457)
Q Consensus 162 ~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~ 241 (457)
|+||||+++++|.+++.. ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++......
T Consensus 78 ~lv~e~~~~~~L~~~i~~---~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06640 78 WIIMEYLGGGSALDLLRA---GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT 154 (277)
T ss_pred EEEEecCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCC
Confidence 999999999999988865 46899999999999999999999999999999999999999999999999987543211
Q ss_pred CcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCC
Q 012762 242 TSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGT 321 (457)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 321 (457)
.. ......++
T Consensus 155 ~~----------------------------------------------------------------------~~~~~~~~ 164 (277)
T cd06640 155 QI----------------------------------------------------------------------KRNTFVGT 164 (277)
T ss_pred cc----------------------------------------------------------------------ccccccCc
Confidence 00 00123478
Q ss_pred CCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhhhCCCC
Q 012762 322 HEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDPTR 401 (457)
Q Consensus 322 ~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~ 401 (457)
..|+|||++.+..++.++|+|||||++|||++|..||...........+... ........++..+.+++.+||..||++
T Consensus 165 ~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~ 243 (277)
T cd06640 165 PFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKN-NPPTLTGEFSKPFKEFIDACLNKDPSF 243 (277)
T ss_pred ccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcC-CCCCCchhhhHHHHHHHHHHcccCccc
Confidence 8999999999888999999999999999999999999876655444333222 112222346788999999999999999
Q ss_pred CCCCCcChHHHhcCCCCCCCC
Q 012762 402 RMGSKMGATAIKRHQFFNGVN 422 (457)
Q Consensus 402 Rps~~~~~~~ll~hp~f~~~~ 422 (457)
||+ +.++++|+||....
T Consensus 244 Rp~----~~~il~~~~~~~~~ 260 (277)
T cd06640 244 RPT----AKELLKHKFIVKNA 260 (277)
T ss_pred CcC----HHHHHhChHhhhcc
Confidence 999 99999999997643
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-42 Score=331.66 Aligned_cols=258 Identities=23% Similarity=0.362 Sum_probs=205.0
Q ss_pred CCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcC-CCCCceEEEEEEcCCc
Q 012762 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLD-HPFLPTLYATLDCPRW 160 (457)
Q Consensus 82 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~-H~nIv~l~~~~~~~~~ 160 (457)
++|++.+.||+|+||.||+|.+. .+++.||+|++..... .......+.+|+++++.+. |+||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~----~~~~~v~lK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~ 75 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDK----NTGKLVALKKTRLEMD-EEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEK 75 (295)
T ss_pred CCceEeeEecccCCeEEEEEEEC----CCCcEEEEEeehhhcc-ccCCchHHHHHHHHHHHccCCCCccceeeeEeecCC
Confidence 46999999999999999999986 4788999999865422 2223456777999999995 6999999999987665
Q ss_pred -----EEEEEeecCCCChHHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEcc-CCCEEEec
Q 012762 161 -----SCLLTEFCPGGDLHVLRQRQP---DKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRS-DGHIMLTD 231 (457)
Q Consensus 161 -----~~lV~E~~~~~sL~~~~~~~~---~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~-~~~vkl~D 231 (457)
.|+||||+++ +|..++.... ...+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+|
T Consensus 76 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~d 154 (295)
T cd07837 76 NGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIAD 154 (295)
T ss_pred CCCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEee
Confidence 8999999965 7877765532 246899999999999999999999999999999999999998 88999999
Q ss_pred cCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCC
Q 012762 232 FDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPL 311 (457)
Q Consensus 232 FG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (457)
||++.........
T Consensus 155 fg~~~~~~~~~~~------------------------------------------------------------------- 167 (295)
T cd07837 155 LGLGRAFSIPVKS------------------------------------------------------------------- 167 (295)
T ss_pred cccceecCCCccc-------------------------------------------------------------------
Confidence 9987543211000
Q ss_pred ccccccccCCCCccCchhhcCC-CCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccC--------------
Q 012762 312 DVRSMSFVGTHEYLAPEIISGE-GHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALE-------------- 376 (457)
Q Consensus 312 ~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~-------------- 376 (457)
.....+++.|+|||++.+. .++.++|||||||++|+|++|..||.+.+....+..+......
T Consensus 168 ---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (295)
T cd07837 168 ---YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRD 244 (295)
T ss_pred ---cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcchhhccc
Confidence 0011368889999998754 4789999999999999999999999887665554443321100
Q ss_pred ---CCC---------CCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCC
Q 012762 377 ---FPK---------EPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFN 419 (457)
Q Consensus 377 ---~~~---------~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~ 419 (457)
.+. .+.++..+.++|.+||..||.+||+ +.+++.||||+
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~----~~eil~~~~~~ 295 (295)
T cd07837 245 WHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRIS----AKAALTHPYFD 295 (295)
T ss_pred hhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCC----HHHHhcCCCcC
Confidence 000 1346788999999999999999999 99999999995
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=323.87 Aligned_cols=259 Identities=29% Similarity=0.524 Sum_probs=212.8
Q ss_pred CceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcEE
Q 012762 83 DLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWSC 162 (457)
Q Consensus 83 ~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~ 162 (457)
+|++.+.||+|+||.||+|.+. .+++.||+|++...... ......+..|+++++.++|+||+++++++...+..+
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~----~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~ 75 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNL----DTGELMAVKEIRIQDND-PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVY 75 (264)
T ss_pred CceeeeEeecCCCcEEEEEEEC----CCCcEEEEEEEECcccc-hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEE
Confidence 5889999999999999999875 36889999999766432 345677888999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCCC
Q 012762 163 LLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNST 242 (457)
Q Consensus 163 lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~~ 242 (457)
+|+||+.+++|.+++... ..+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.+||+|||++.......
T Consensus 76 lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~ 153 (264)
T cd06626 76 IFMEYCSGGTLEELLEHG--RILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNT 153 (264)
T ss_pred EEEecCCCCcHHHHHhhc--CCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCC
Confidence 999999999999988764 458899999999999999999999999999999999999999999999999976543211
Q ss_pred cccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCCC
Q 012762 243 STAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTH 322 (457)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 322 (457)
.... .......++.
T Consensus 154 ~~~~------------------------------------------------------------------~~~~~~~~~~ 167 (264)
T cd06626 154 TTMG------------------------------------------------------------------EEVQSLAGTP 167 (264)
T ss_pred Cccc------------------------------------------------------------------ccccCCcCCc
Confidence 1000 0001234788
Q ss_pred CccCchhhcCCC---CCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhc--ccCCCCCCCCChHHHHHHHHHhhh
Q 012762 323 EYLAPEIISGEG---HGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVAR--ALEFPKEPSVPGPAKDLIAQLLVK 397 (457)
Q Consensus 323 ~y~aPE~l~~~~---~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~ll~~~L~~ 397 (457)
.|+|||++.+.. ++.++||||||+++|+|++|+.||............+.. ...++....++..+.+++.+||+.
T Consensus 168 ~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 247 (264)
T cd06626 168 AYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKDFLDRCLES 247 (264)
T ss_pred CccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccccCHHHHHHHHHHccC
Confidence 999999998776 789999999999999999999999765433322222222 223344444588899999999999
Q ss_pred CCCCCCCCCcChHHHhcCCCC
Q 012762 398 DPTRRMGSKMGATAIKRHQFF 418 (457)
Q Consensus 398 dP~~Rps~~~~~~~ll~hp~f 418 (457)
||.+||+ +.+++.|||+
T Consensus 248 ~p~~R~~----~~~i~~~~~~ 264 (264)
T cd06626 248 DPKKRPT----ASELLQHPFV 264 (264)
T ss_pred CcccCCC----HHHHhcCCCC
Confidence 9999999 9999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=329.60 Aligned_cols=254 Identities=28% Similarity=0.446 Sum_probs=211.4
Q ss_pred CceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcEE
Q 012762 83 DLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWSC 162 (457)
Q Consensus 83 ~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~ 162 (457)
+|.....||+|++|.||++.++ .++..+|+|++.... ......+.+|+.+++.++|+||+++++++...++.|
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~----~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~ 92 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDK----STGRQVAVKKMDLRK---QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELW 92 (285)
T ss_pred hhhcceEeccCCCeEEEEEEEC----CCCCEEEEEEEeccc---hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEE
Confidence 4555679999999999999876 367899999986432 233455778999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCCC
Q 012762 163 LLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNST 242 (457)
Q Consensus 163 lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~~ 242 (457)
+|+||+.+++|.+++.. ..+++..+..++.||+.||+|||++||+||||+|+||+++.++.++|+|||++.......
T Consensus 93 ~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~ 169 (285)
T cd06648 93 VVMEFLEGGALTDIVTH---TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV 169 (285)
T ss_pred EEEeccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCC
Confidence 99999999999988876 568999999999999999999999999999999999999999999999999864332100
Q ss_pred cccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCCC
Q 012762 243 STAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTH 322 (457)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 322 (457)
. ......|+.
T Consensus 170 ~----------------------------------------------------------------------~~~~~~~~~ 179 (285)
T cd06648 170 P----------------------------------------------------------------------RRKSLVGTP 179 (285)
T ss_pred c----------------------------------------------------------------------ccccccCCc
Confidence 0 001235899
Q ss_pred CccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCC-CCCCCChHHHHHHHHHhhhCCCC
Q 012762 323 EYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFP-KEPSVPGPAKDLIAQLLVKDPTR 401 (457)
Q Consensus 323 ~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ll~~~L~~dP~~ 401 (457)
.|+|||++.+..++.++|||||||++|+|++|+.||...........+........ ....++..+.+++++||..||++
T Consensus 180 ~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~ 259 (285)
T cd06648 180 YWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRMLVRDPAQ 259 (285)
T ss_pred cccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHHHcccChhh
Confidence 99999999988899999999999999999999999987665555555444322221 22347789999999999999999
Q ss_pred CCCCCcChHHHhcCCCCCC
Q 012762 402 RMGSKMGATAIKRHQFFNG 420 (457)
Q Consensus 402 Rps~~~~~~~ll~hp~f~~ 420 (457)
||+ +.++++||||+.
T Consensus 260 Rpt----~~~il~~~~~~~ 274 (285)
T cd06648 260 RAT----AAELLNHPFLAK 274 (285)
T ss_pred CcC----HHHHccCccccc
Confidence 999 999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=325.70 Aligned_cols=253 Identities=23% Similarity=0.326 Sum_probs=207.8
Q ss_pred CccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEc
Q 012762 78 PLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDC 157 (457)
Q Consensus 78 ~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~ 157 (457)
.+..++|++.++||+|+||+||+|.+. ....||+|++.+... ....+.+|+++++.++|+||+++++++.
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~v~~~~~~-----~~~~valK~~~~~~~----~~~~~~~E~~~l~~l~~~~i~~~~~~~~- 71 (262)
T cd05071 2 EIPRESLRLEVKLGQGCFGEVWMGTWN-----GTTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVS- 71 (262)
T ss_pred CCChHHeeEeeecCCCCCCcEEEEEec-----CCceEEEEecccCcc----CHHHHHHHHHHHHhCCCCCcceEEEEEC-
Confidence 355678999999999999999999875 234699999975332 2356788999999999999999999875
Q ss_pred CCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcC
Q 012762 158 PRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLK 237 (457)
Q Consensus 158 ~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~ 237 (457)
....|+||||+.+++|.+++.......+++..+..++.|++.||.|||+.+|+|+||||+||+++.++.++|+|||++..
T Consensus 72 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~ 151 (262)
T cd05071 72 EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL 151 (262)
T ss_pred CCCcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceee
Confidence 45689999999999999999875556689999999999999999999999999999999999999999999999999764
Q ss_pred CCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcccccc
Q 012762 238 GDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMS 317 (457)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (457)
........ ...
T Consensus 152 ~~~~~~~~---------------------------------------------------------------------~~~ 162 (262)
T cd05071 152 IEDNEYTA---------------------------------------------------------------------RQG 162 (262)
T ss_pred cccccccc---------------------------------------------------------------------ccC
Confidence 43211000 001
Q ss_pred ccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhh
Q 012762 318 FVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLV 396 (457)
Q Consensus 318 ~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~ 396 (457)
..++..|+|||++.+..++.++|||||||++|+|++ |..||.+.........+.. ....+....++..+.+++.+||+
T Consensus 163 ~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~ 241 (262)
T cd05071 163 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER-GYRMPCPPECPESLHDLMCQCWR 241 (262)
T ss_pred CcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhc-CCCCCCccccCHHHHHHHHHHcc
Confidence 236778999999998889999999999999999999 8999988776666555443 33444455688999999999999
Q ss_pred hCCCCCCCCCcChHHHhc
Q 012762 397 KDPTRRMGSKMGATAIKR 414 (457)
Q Consensus 397 ~dP~~Rps~~~~~~~ll~ 414 (457)
.||++||+ +.+++.
T Consensus 242 ~~p~~Rp~----~~~~~~ 255 (262)
T cd05071 242 KEPEERPT----FEYLQA 255 (262)
T ss_pred CCcccCCC----HHHHHH
Confidence 99999999 777654
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=324.16 Aligned_cols=256 Identities=24% Similarity=0.396 Sum_probs=213.1
Q ss_pred CceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEc--CCc
Q 012762 83 DLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDC--PRW 160 (457)
Q Consensus 83 ~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~--~~~ 160 (457)
+|++++.||.|+||.||+|.+. .++..||+|++..... ......++..|+++++.++|+||+++++++.. ...
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~----~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 75 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRK----SDGKILVWKEIDYGNM-TEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQT 75 (265)
T ss_pred CceeeeeeccCCCeEEEEeeec----CCCCEEEEEEEecccC-CHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCE
Confidence 5889999999999999999876 3778999999876433 23345667789999999999999999998753 456
Q ss_pred EEEEEeecCCCChHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHH-----HcCceeecCCCCCeEEccCCCEEEeccC
Q 012762 161 SCLLTEFCPGGDLHVLRQRQ--PDKRFHESAVRFYASEVVVALEFLH-----MMGIIYRDLKPENVLVRSDGHIMLTDFD 233 (457)
Q Consensus 161 ~~lV~E~~~~~sL~~~~~~~--~~~~~~~~~~~~i~~qi~~~L~yLH-----~~~iiHrDIKp~NIll~~~~~vkl~DFG 233 (457)
.|++|||+++++|..++... ....+++..++.++.||+.||.||| +.+++|+||||+||+++.++.+||+|||
T Consensus 76 ~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g 155 (265)
T cd08217 76 LYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFG 155 (265)
T ss_pred EEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccc
Confidence 79999999999999888653 2467899999999999999999999 8999999999999999999999999999
Q ss_pred CCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcc
Q 012762 234 LSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDV 313 (457)
Q Consensus 234 ~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (457)
++........
T Consensus 156 ~~~~~~~~~~---------------------------------------------------------------------- 165 (265)
T cd08217 156 LAKILGHDSS---------------------------------------------------------------------- 165 (265)
T ss_pred ccccccCCcc----------------------------------------------------------------------
Confidence 9765432110
Q ss_pred ccccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHH
Q 012762 314 RSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQ 393 (457)
Q Consensus 314 ~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~ 393 (457)
......|+..|+|||++.+..++.++|+||||+++|+|++|..||...........+...... .....++.++.+++.+
T Consensus 166 ~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~~ 244 (265)
T cd08217 166 FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFR-RIPYRYSSELNEVIKS 244 (265)
T ss_pred cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCC-CCccccCHHHHHHHHH
Confidence 001235899999999999888999999999999999999999999987755555554444332 2234578899999999
Q ss_pred HhhhCCCCCCCCCcChHHHhcCCCC
Q 012762 394 LLVKDPTRRMGSKMGATAIKRHQFF 418 (457)
Q Consensus 394 ~L~~dP~~Rps~~~~~~~ll~hp~f 418 (457)
||..||++||+ +.+|++|||+
T Consensus 245 ~l~~~p~~Rp~----~~~il~~~~~ 265 (265)
T cd08217 245 MLNVDPDKRPS----TEELLQLPLI 265 (265)
T ss_pred HccCCcccCCC----HHHHhhCCCC
Confidence 99999999999 9999999995
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-42 Score=325.46 Aligned_cols=253 Identities=21% Similarity=0.348 Sum_probs=210.3
Q ss_pred CccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEc
Q 012762 78 PLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDC 157 (457)
Q Consensus 78 ~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~ 157 (457)
.+..++|+++++||+|+||.||+|..+ .++.||+|.+..... ....+.+|+++++.++|+||+++++++.
T Consensus 2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~-----~~~~~a~K~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~- 71 (260)
T cd05067 2 EVPRETLKLVKKLGAGQFGEVWMGYYN-----GHTKVAIKSLKQGSM----SPEAFLAEANLMKQLQHPRLVRLYAVVT- 71 (260)
T ss_pred ccchHHceeeeeeccCccceEEeeecC-----CCceEEEEEecCCCC----cHHHHHHHHHHHHhcCCcCeeeEEEEEc-
Confidence 456678999999999999999999864 567899999875432 2356778999999999999999999874
Q ss_pred CCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcC
Q 012762 158 PRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLK 237 (457)
Q Consensus 158 ~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~ 237 (457)
.+..|+||||+.+++|.+++.......+++..+..++.|++.||+|||+.|++|+||||+||+++.++.++|+|||++..
T Consensus 72 ~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 151 (260)
T cd05067 72 QEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARL 151 (260)
T ss_pred cCCcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceee
Confidence 45789999999999999988776667799999999999999999999999999999999999999999999999999754
Q ss_pred CCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcccccc
Q 012762 238 GDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMS 317 (457)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (457)
........ ...
T Consensus 152 ~~~~~~~~---------------------------------------------------------------------~~~ 162 (260)
T cd05067 152 IEDNEYTA---------------------------------------------------------------------REG 162 (260)
T ss_pred cCCCCccc---------------------------------------------------------------------ccC
Confidence 43110000 001
Q ss_pred ccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhh
Q 012762 318 FVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLV 396 (457)
Q Consensus 318 ~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~ 396 (457)
..++..|+|||++.+..++.++||||||+++|||++ |+.||.+.........+. .....+.....+.++.+++.+||.
T Consensus 163 ~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~ 241 (260)
T cd05067 163 AKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLE-RGYRMPRPDNCPEELYELMRLCWK 241 (260)
T ss_pred CcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHH-cCCCCCCCCCCCHHHHHHHHHHcc
Confidence 236778999999998889999999999999999998 999998877665555443 344445555688899999999999
Q ss_pred hCCCCCCCCCcChHHHhc
Q 012762 397 KDPTRRMGSKMGATAIKR 414 (457)
Q Consensus 397 ~dP~~Rps~~~~~~~ll~ 414 (457)
.||++||+ +++++.
T Consensus 242 ~~p~~Rp~----~~~l~~ 255 (260)
T cd05067 242 EKPEERPT----FEYLRS 255 (260)
T ss_pred CChhhCCC----HHHHHH
Confidence 99999999 888765
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=336.19 Aligned_cols=254 Identities=26% Similarity=0.435 Sum_probs=210.8
Q ss_pred CceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcEE
Q 012762 83 DLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWSC 162 (457)
Q Consensus 83 ~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~ 162 (457)
.|.....||+|+||.||+|.+. .++..||+|++..... .....+.+|+.+++.++||||+++++++..++..|
T Consensus 22 ~~~~~~~ig~g~~g~v~~~~~~----~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~ 94 (297)
T cd06659 22 LLENYIKIGEGSTGIVCIAREK----HSGRQVAVKMMDLRKQ---QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELW 94 (297)
T ss_pred hHHhhhhcCCCCceeEEEEEEc----CCCCEEEEEEEEeccc---chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEE
Confidence 3555668999999999999876 3688999999865432 23456778999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCCC
Q 012762 163 LLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNST 242 (457)
Q Consensus 163 lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~~ 242 (457)
+||||+++++|..++.. ..+++..++.++.||+.||.|||+.||+||||||+||+++.++.++|+|||++.......
T Consensus 95 iv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~ 171 (297)
T cd06659 95 VLMEFLQGGALTDIVSQ---TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV 171 (297)
T ss_pred EEEecCCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhccccc
Confidence 99999999999887765 568999999999999999999999999999999999999999999999999875332110
Q ss_pred cccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCCC
Q 012762 243 STAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTH 322 (457)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 322 (457)
. ......|+.
T Consensus 172 ~----------------------------------------------------------------------~~~~~~~~~ 181 (297)
T cd06659 172 P----------------------------------------------------------------------KRKSLVGTP 181 (297)
T ss_pred c----------------------------------------------------------------------cccceecCc
Confidence 0 011235899
Q ss_pred CccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccC-CCCCCCCChHHHHHHHHHhhhCCCC
Q 012762 323 EYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALE-FPKEPSVPGPAKDLIAQLLVKDPTR 401 (457)
Q Consensus 323 ~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ll~~~L~~dP~~ 401 (457)
.|+|||++.+..++.++|||||||++|||++|+.||........+..+...... ......++..+.++|.+||..||++
T Consensus 182 ~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~P~~ 261 (297)
T cd06659 182 YWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERMLTREPQE 261 (297)
T ss_pred cccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHHHHHHhcCCccc
Confidence 999999999888999999999999999999999999876655554443322211 1222357788999999999999999
Q ss_pred CCCCCcChHHHhcCCCCCC
Q 012762 402 RMGSKMGATAIKRHQFFNG 420 (457)
Q Consensus 402 Rps~~~~~~~ll~hp~f~~ 420 (457)
||+ +.++++||||..
T Consensus 262 Rps----~~~ll~~~~~~~ 276 (297)
T cd06659 262 RAT----AQELLDHPFLLQ 276 (297)
T ss_pred CcC----HHHHhhChhhcc
Confidence 999 999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=329.08 Aligned_cols=255 Identities=27% Similarity=0.434 Sum_probs=206.9
Q ss_pred eeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcEEEE
Q 012762 85 RFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWSCLL 164 (457)
Q Consensus 85 ~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lV 164 (457)
.+.+.||.|.||.||+|.++......+..|+||+++.. ......+.+..|++++++++||||+++++++...+..++|
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv 79 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS--SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLV 79 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT--SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc--cccccceeeeeccccccccccccccccccccccccccccc
Confidence 56789999999999999998444557889999999542 2233467788899999999999999999999988889999
Q ss_pred EeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCCCcc
Q 012762 165 TEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTST 244 (457)
Q Consensus 165 ~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~~~~ 244 (457)
|||+.+|+|.+++.......+++..+..++.||+.||.|||+++++|+||+++|||++.++.+||+|||++.........
T Consensus 80 ~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 80 MEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp EE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 99999999999998875678999999999999999999999999999999999999999999999999997654211110
Q ss_pred cccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCCCCc
Q 012762 245 AQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTHEY 324 (457)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 324 (457)
. ......+...|
T Consensus 160 ~--------------------------------------------------------------------~~~~~~~~~~~ 171 (259)
T PF07714_consen 160 K--------------------------------------------------------------------NDSSQQLPLRY 171 (259)
T ss_dssp E--------------------------------------------------------------------ESTTSESGGGG
T ss_pred c--------------------------------------------------------------------ccccccccccc
Confidence 0 00012367789
Q ss_pred cCchhhcCCCCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhhhCCCCCC
Q 012762 325 LAPEIISGEGHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDPTRRM 403 (457)
Q Consensus 325 ~aPE~l~~~~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rp 403 (457)
+|||++.+..++.++||||||+++|||++ |+.||...........+ ......+....++..+.++|.+||..||++||
T Consensus 172 ~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~C~~~~p~~RP 250 (259)
T PF07714_consen 172 LAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKL-KQGQRLPIPDNCPKDIYSLIQQCWSHDPEKRP 250 (259)
T ss_dssp S-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHH-HTTEETTSBTTSBHHHHHHHHHHT-SSGGGS-
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccc-cccccceeccchhHHHHHHHHHHcCCChhhCc
Confidence 99999998889999999999999999999 78999988777666666 44445555566899999999999999999999
Q ss_pred CCCcChHHHhc
Q 012762 404 GSKMGATAIKR 414 (457)
Q Consensus 404 s~~~~~~~ll~ 414 (457)
+ +.+|++
T Consensus 251 s----~~~i~~ 257 (259)
T PF07714_consen 251 S----FQEILQ 257 (259)
T ss_dssp -----HHHHHH
T ss_pred C----HHHHHh
Confidence 9 888864
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-42 Score=325.87 Aligned_cols=252 Identities=23% Similarity=0.340 Sum_probs=208.1
Q ss_pred cCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCC
Q 012762 80 TLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPR 159 (457)
Q Consensus 80 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~ 159 (457)
+..+|++.+.||+|+||.||+|.++ .+..+|+|++.+... ....+..|++++++++|+||+++++++...+
T Consensus 2 ~~~~~~~~~~lg~G~~~~v~~~~~~-----~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 72 (256)
T cd05059 2 DPSELTFLKELGSGQFGVVHLGKWR-----GKIDVAIKMIREGAM----SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQR 72 (256)
T ss_pred ChHHcchhhhhccCCCceEEEeEec-----CCccEEEEEeccCCC----CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCC
Confidence 3457999999999999999999875 456799999865432 2345677999999999999999999999999
Q ss_pred cEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCC
Q 012762 160 WSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGD 239 (457)
Q Consensus 160 ~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~ 239 (457)
..|+||||+++++|.+++.... ..+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||+++...
T Consensus 73 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~ 151 (256)
T cd05059 73 PIFIVTEYMANGCLLNYLRERK-GKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVL 151 (256)
T ss_pred ceEEEEecCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecc
Confidence 9999999999999999887643 468999999999999999999999999999999999999999999999999875432
Q ss_pred CCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcccccccc
Q 012762 240 NSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFV 319 (457)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (457)
+..... .....
T Consensus 152 ~~~~~~---------------------------------------------------------------------~~~~~ 162 (256)
T cd05059 152 DDQYTS---------------------------------------------------------------------SQGTK 162 (256)
T ss_pred cccccc---------------------------------------------------------------------cCCCC
Confidence 110000 00012
Q ss_pred CCCCccCchhhcCCCCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhhhC
Q 012762 320 GTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKD 398 (457)
Q Consensus 320 gt~~y~aPE~l~~~~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~d 398 (457)
++..|+|||.+.+..++.++|||||||++|+|++ |..||...........+. .....+....++..+.+++.+||..+
T Consensus 163 ~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~cl~~~ 241 (256)
T cd05059 163 FPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVS-AGYRLYRPKLAPTEVYTIMYSCWHEK 241 (256)
T ss_pred CCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH-cCCcCCCCCCCCHHHHHHHHHHhcCC
Confidence 4568999999998889999999999999999998 899998877666555544 33344444568899999999999999
Q ss_pred CCCCCCCCcChHHHhcC
Q 012762 399 PTRRMGSKMGATAIKRH 415 (457)
Q Consensus 399 P~~Rps~~~~~~~ll~h 415 (457)
|++||+ +.++++.
T Consensus 242 p~~Rpt----~~~~l~~ 254 (256)
T cd05059 242 PEDRPA----FKKLLSQ 254 (256)
T ss_pred hhhCcC----HHHHHHH
Confidence 999999 8888764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-42 Score=330.24 Aligned_cols=257 Identities=24% Similarity=0.423 Sum_probs=209.8
Q ss_pred CceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcC---CCCCceEEEEEEcCC
Q 012762 83 DLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLD---HPFLPTLYATLDCPR 159 (457)
Q Consensus 83 ~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~---H~nIv~l~~~~~~~~ 159 (457)
.|++.+.||.|+||.||+|.+. .++..||+|++.... .......+.+|+++++.++ |+||+++++++..+.
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~----~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~ 75 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHV----PTGRVVALKIINLDT--PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGP 75 (277)
T ss_pred hhhhhhheeccCCceEEEEEEc----CCCcEEEEEEecCCC--CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCC
Confidence 4788899999999999999976 378899999986532 2234456778999999986 999999999999999
Q ss_pred cEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCC
Q 012762 160 WSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGD 239 (457)
Q Consensus 160 ~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~ 239 (457)
..|+||||+++++|.+++.. ..+++..++.++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++....
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~---~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 152 (277)
T cd06917 76 RLWIIMEYAEGGSVRTLMKA---GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLN 152 (277)
T ss_pred EEEEEEecCCCCcHHHHHHc---cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecC
Confidence 99999999999999988765 468999999999999999999999999999999999999999999999999875443
Q ss_pred CCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcccccccc
Q 012762 240 NSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFV 319 (457)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (457)
.... ......
T Consensus 153 ~~~~----------------------------------------------------------------------~~~~~~ 162 (277)
T cd06917 153 QNSS----------------------------------------------------------------------KRSTFV 162 (277)
T ss_pred CCcc----------------------------------------------------------------------cccccc
Confidence 2110 001235
Q ss_pred CCCCccCchhhcC-CCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhhhC
Q 012762 320 GTHEYLAPEIISG-EGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKD 398 (457)
Q Consensus 320 gt~~y~aPE~l~~-~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~d 398 (457)
|+..|+|||.+.+ ..++.++|+|||||++|+|++|..||.+.........+............++.++.+++.+||..|
T Consensus 163 ~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~ 242 (277)
T cd06917 163 GTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLREFVAACLDEE 242 (277)
T ss_pred CCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCCCCCCCcccCCHHHHHHHHHHcCCC
Confidence 8899999999875 447899999999999999999999998765544333222221111111236789999999999999
Q ss_pred CCCCCCCCcChHHHhcCCCCCCCC
Q 012762 399 PTRRMGSKMGATAIKRHQFFNGVN 422 (457)
Q Consensus 399 P~~Rps~~~~~~~ll~hp~f~~~~ 422 (457)
|++||+ +.++++|+||+...
T Consensus 243 p~~R~~----~~~il~~~~~~~~~ 262 (277)
T cd06917 243 PKERLS----AEELLKSKWIKAHS 262 (277)
T ss_pred cccCcC----HHHHhhChHhhccc
Confidence 999999 99999999997643
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=334.50 Aligned_cols=258 Identities=24% Similarity=0.370 Sum_probs=212.7
Q ss_pred CCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCc
Q 012762 81 LSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRW 160 (457)
Q Consensus 81 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~ 160 (457)
.++|.+.+.||+|+||+||++.+. .++..||+|.+..... .....+..|+.+++.++||||+++++++...+.
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~----~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~ 90 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDV----ATGQEVAIKQMNLQQQ---PKKELIINEILVMRENKHPNIVNYLDSYLVGDE 90 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEc----CCCCEEEEEEeccccc---hHHHHHHHHHHHHhhcCCCCeeehhheeeeCCc
Confidence 468999999999999999999865 3677899999864322 334567889999999999999999999999999
Q ss_pred EEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCC
Q 012762 161 SCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDN 240 (457)
Q Consensus 161 ~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~ 240 (457)
.|+||||+++++|..++.. ..+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++.....
T Consensus 91 ~~lv~e~~~~~~L~~~~~~---~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~ 167 (293)
T cd06647 91 LWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 167 (293)
T ss_pred EEEEEecCCCCcHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceecccc
Confidence 9999999999999988875 4588999999999999999999999999999999999999999999999998754321
Q ss_pred CCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccC
Q 012762 241 STSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVG 320 (457)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 320 (457)
... ......|
T Consensus 168 ~~~----------------------------------------------------------------------~~~~~~~ 177 (293)
T cd06647 168 EQS----------------------------------------------------------------------KRSTMVG 177 (293)
T ss_pred ccc----------------------------------------------------------------------ccccccC
Confidence 110 0012358
Q ss_pred CCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHh-cccCCCCCCCCChHHHHHHHHHhhhCC
Q 012762 321 THEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVA-RALEFPKEPSVPGPAKDLIAQLLVKDP 399 (457)
Q Consensus 321 t~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ll~~~L~~dP 399 (457)
++.|++||.+.+..++.++|||||||++|+|++|+.||...........+.. ....++....++..+.+++.+||..||
T Consensus 178 ~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p 257 (293)
T cd06647 178 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDV 257 (293)
T ss_pred ChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHHHHHHHHccCCh
Confidence 8999999999888899999999999999999999999987654333222221 122222333467889999999999999
Q ss_pred CCCCCCCcChHHHhcCCCCCCCC
Q 012762 400 TRRMGSKMGATAIKRHQFFNGVN 422 (457)
Q Consensus 400 ~~Rps~~~~~~~ll~hp~f~~~~ 422 (457)
++||+ +.+++.|+||+..+
T Consensus 258 ~~Rp~----~~~il~h~~~~~~~ 276 (293)
T cd06647 258 EKRGS----AKELLQHPFLKIAK 276 (293)
T ss_pred hhCcC----HHHHhcCHHHhcCc
Confidence 99999 99999999998643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-42 Score=325.42 Aligned_cols=254 Identities=23% Similarity=0.341 Sum_probs=209.4
Q ss_pred CCccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEE
Q 012762 77 NPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLD 156 (457)
Q Consensus 77 ~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~ 156 (457)
|.+..++|++.++||+|+||.||+|.+. .+..+|+|.+..... ....+.+|++++++++|+||+++++++.
T Consensus 1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~-----~~~~~~~k~~~~~~~----~~~~~~~E~~~l~~l~~~~i~~~~~~~~ 71 (260)
T cd05070 1 WEIPRESLQLIKKLGNGQFGEVWMGTWN-----GNTKVAVKTLKPGTM----SPESFLEEAQIMKKLRHDKLVQLYAVVS 71 (260)
T ss_pred CCCchHHhhhhheeccccCceEEEEEec-----CCceeEEEEecCCCC----CHHHHHHHHHHHHhcCCCceEEEEeEEC
Confidence 3466778999999999999999999764 456799999876432 2345788999999999999999999885
Q ss_pred cCCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCc
Q 012762 157 CPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSL 236 (457)
Q Consensus 157 ~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~ 236 (457)
....|+||||+.+++|.+++.......+++..++.++.|++.||.|||+.||+||||||+||+++.++.++|+|||++.
T Consensus 72 -~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~ 150 (260)
T cd05070 72 -EEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLAR 150 (260)
T ss_pred -CCCcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeee
Confidence 4568999999999999999887655678999999999999999999999999999999999999999999999999975
Q ss_pred CCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccc
Q 012762 237 KGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSM 316 (457)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (457)
......... ..
T Consensus 151 ~~~~~~~~~---------------------------------------------------------------------~~ 161 (260)
T cd05070 151 LIEDNEYTA---------------------------------------------------------------------RQ 161 (260)
T ss_pred eccCccccc---------------------------------------------------------------------cc
Confidence 432111000 00
Q ss_pred cccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHh
Q 012762 317 SFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLL 395 (457)
Q Consensus 317 ~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L 395 (457)
...++..|+|||++.+..++.++||||||+++|+|++ |..||.+....+....+. .....+.....+..+.+++.+||
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l 240 (260)
T cd05070 162 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVE-RGYRMPCPQDCPISLHELMLQCW 240 (260)
T ss_pred CCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH-cCCCCCCCCcCCHHHHHHHHHHc
Confidence 1135678999999988889999999999999999999 999998877666555544 33444455568889999999999
Q ss_pred hhCCCCCCCCCcChHHHhc
Q 012762 396 VKDPTRRMGSKMGATAIKR 414 (457)
Q Consensus 396 ~~dP~~Rps~~~~~~~ll~ 414 (457)
..||++||+ +.+++.
T Consensus 241 ~~~p~~Rpt----~~~l~~ 255 (260)
T cd05070 241 KKDPEERPT----FEYLQS 255 (260)
T ss_pred ccCcccCcC----HHHHHH
Confidence 999999999 777753
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-42 Score=331.20 Aligned_cols=262 Identities=19% Similarity=0.312 Sum_probs=212.8
Q ss_pred ccCCCceeEEEecccCcceEEEEEEecc-CCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEc
Q 012762 79 LTLSDLRFVHRLGSGDIGSVYLVQLKSK-SSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDC 157 (457)
Q Consensus 79 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~-~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~ 157 (457)
+...+|++.++||+|+||+||+|.+... ....+..||+|+++... .......+..|++++..++||||+++++++..
T Consensus 2 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~ 79 (283)
T cd05091 2 INLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA--EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTK 79 (283)
T ss_pred CCHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC
Confidence 4566899999999999999999987542 12346789999997542 22234567889999999999999999999999
Q ss_pred CCcEEEEEeecCCCChHHHHHhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEcc
Q 012762 158 PRWSCLLTEFCPGGDLHVLRQRQP--------------DKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRS 223 (457)
Q Consensus 158 ~~~~~lV~E~~~~~sL~~~~~~~~--------------~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~ 223 (457)
.+..++++||+.+++|..++.... ...+++..+..++.|++.||.|||++||+||||||+|||++.
T Consensus 80 ~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~ 159 (283)
T cd05091 80 EQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFD 159 (283)
T ss_pred CCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecC
Confidence 999999999999999998875321 235788889999999999999999999999999999999999
Q ss_pred CCCEEEeccCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCC
Q 012762 224 DGHIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGT 303 (457)
Q Consensus 224 ~~~vkl~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (457)
++.+||+|||+++.........
T Consensus 160 ~~~~kl~Dfg~~~~~~~~~~~~---------------------------------------------------------- 181 (283)
T cd05091 160 KLNVKISDLGLFREVYAADYYK---------------------------------------------------------- 181 (283)
T ss_pred CCceEecccccccccccchhee----------------------------------------------------------
Confidence 9999999999976543111000
Q ss_pred CcccccCCccccccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHHhcccCCCCCCC
Q 012762 304 PEIVAEPLDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVVARALEFPKEPS 382 (457)
Q Consensus 304 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 382 (457)
......+++.|+|||++.+..++.++|||||||++|||++ |..||.+.........+..... .+....
T Consensus 182 ----------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~-~~~~~~ 250 (283)
T cd05091 182 ----------LMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQV-LPCPDD 250 (283)
T ss_pred ----------eccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCc-CCCCCC
Confidence 0001236788999999988889999999999999999998 8999988777766666665543 233456
Q ss_pred CChHHHHHHHHHhhhCCCCCCCCCcChHHHhcC
Q 012762 383 VPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRH 415 (457)
Q Consensus 383 ~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~h 415 (457)
++..+.+++.+||+.||.+||+ +.+|+..
T Consensus 251 ~~~~~~~li~~cl~~~p~~RP~----~~~i~~~ 279 (283)
T cd05091 251 CPAWVYTLMLECWNEFPSRRPR----FKDIHSR 279 (283)
T ss_pred CCHHHHHHHHHHhCCCcccCCC----HHHHHHH
Confidence 8899999999999999999999 8888753
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=329.27 Aligned_cols=260 Identities=18% Similarity=0.311 Sum_probs=211.6
Q ss_pred ccCCCceeEEEecccCcceEEEEEEeccC-CCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEc
Q 012762 79 LTLSDLRFVHRLGSGDIGSVYLVQLKSKS-SNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDC 157 (457)
Q Consensus 79 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~-~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~ 157 (457)
+...+|.+.+.||+|+||+||++.+.... ...+..+|+|.+.... ......+..|++++++++|+||+++++++..
T Consensus 2 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 78 (288)
T cd05093 2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS---DNARKDFHREAELLTNLQHEHIVKFYGVCVE 78 (288)
T ss_pred CchHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC---HHHHHHHHHHHHHHHhCCCCCcceEEEEEec
Confidence 34568999999999999999999864321 2345678999986532 2345668889999999999999999999999
Q ss_pred CCcEEEEEeecCCCChHHHHHhCC-----------CCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCC
Q 012762 158 PRWSCLLTEFCPGGDLHVLRQRQP-----------DKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGH 226 (457)
Q Consensus 158 ~~~~~lV~E~~~~~sL~~~~~~~~-----------~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~ 226 (457)
.+..|+||||+++++|.+++.... ...+++..++.++.||+.||+|||++|++||||||+|||++.++.
T Consensus 79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~ 158 (288)
T cd05093 79 GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLL 158 (288)
T ss_pred CCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCc
Confidence 999999999999999999887542 135899999999999999999999999999999999999999999
Q ss_pred EEEeccCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcc
Q 012762 227 IMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEI 306 (457)
Q Consensus 227 vkl~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (457)
++|+|||++..........
T Consensus 159 ~kl~dfg~~~~~~~~~~~~------------------------------------------------------------- 177 (288)
T cd05093 159 VKIGDFGMSRDVYSTDYYR------------------------------------------------------------- 177 (288)
T ss_pred EEeccCCccccccCCceee-------------------------------------------------------------
Confidence 9999999976432110000
Q ss_pred cccCCccccccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHHhcccCCCCCCCCCh
Q 012762 307 VAEPLDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVVARALEFPKEPSVPG 385 (457)
Q Consensus 307 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (457)
......++..|+|||++.+..++.++|||||||++|+|++ |..||...........+...... +....++.
T Consensus 178 -------~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~~~-~~~~~~~~ 249 (288)
T cd05093 178 -------VGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVL-QRPRTCPK 249 (288)
T ss_pred -------cCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCcC-CCCCCCCH
Confidence 0001236788999999998889999999999999999998 99999887776666666554432 22335788
Q ss_pred HHHHHHHHHhhhCCCCCCCCCcChHHHhc
Q 012762 386 PAKDLIAQLLVKDPTRRMGSKMGATAIKR 414 (457)
Q Consensus 386 ~~~~ll~~~L~~dP~~Rps~~~~~~~ll~ 414 (457)
++.+|+.+||+.||.+||+ +.+++.
T Consensus 250 ~l~~li~~~l~~~p~~Rpt----~~~v~~ 274 (288)
T cd05093 250 EVYDLMLGCWQREPHMRLN----IKEIHS 274 (288)
T ss_pred HHHHHHHHHccCChhhCCC----HHHHHH
Confidence 9999999999999999999 777743
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-42 Score=334.74 Aligned_cols=262 Identities=24% Similarity=0.312 Sum_probs=203.2
Q ss_pred CceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcC--Cc
Q 012762 83 DLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCP--RW 160 (457)
Q Consensus 83 ~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~--~~ 160 (457)
+|.+.++||+|+||.||+|.++.. ..+..||+|++.............+.+|+++++.++||||+++++++... ..
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~--~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNG--KDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKS 78 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCC--CCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCce
Confidence 488999999999999999998631 26789999999764322233445667799999999999999999999888 78
Q ss_pred EEEEEeecCCCChHHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEcc----CCCEEEeccC
Q 012762 161 SCLLTEFCPGGDLHVLRQRQP---DKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRS----DGHIMLTDFD 233 (457)
Q Consensus 161 ~~lV~E~~~~~sL~~~~~~~~---~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~----~~~vkl~DFG 233 (457)
+|+||||++ ++|..++.... ...+++..++.++.||+.||.|||+.+|+||||||+|||++. ++.+||+|||
T Consensus 79 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg 157 (316)
T cd07842 79 VYLLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLG 157 (316)
T ss_pred EEEEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence 999999995 56766664322 236899999999999999999999999999999999999999 8999999999
Q ss_pred CCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcc
Q 012762 234 LSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDV 313 (457)
Q Consensus 234 ~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (457)
++......... ..
T Consensus 158 ~~~~~~~~~~~-------------------------------------------------------------------~~ 170 (316)
T cd07842 158 LARLFNAPLKP-------------------------------------------------------------------LA 170 (316)
T ss_pred cccccCCCccc-------------------------------------------------------------------cc
Confidence 98654321100 00
Q ss_pred ccccccCCCCccCchhhcCC-CCCccchhhhhhHHHHHHhcCCCCCCCCChHH---------HHHHHHhc----------
Q 012762 314 RSMSFVGTHEYLAPEIISGE-GHGNAVDWWTLGIFIFELFYGTTPFKGIDHEL---------TLANVVAR---------- 373 (457)
Q Consensus 314 ~~~~~~gt~~y~aPE~l~~~-~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~---------~~~~~~~~---------- 373 (457)
......++..|+|||++.+. .++.++|||||||++|+|++|+.||.+..... .+..++..
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 250 (316)
T cd07842 171 DLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWP 250 (316)
T ss_pred ccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHHHhCCCchhHHH
Confidence 01123588999999998764 47899999999999999999999998654322 11111110
Q ss_pred -------------ccCCCCC------------CCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCC
Q 012762 374 -------------ALEFPKE------------PSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFF 418 (457)
Q Consensus 374 -------------~~~~~~~------------~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f 418 (457)
....... ...+..+.+++.+||+.||++||+ +.++++||||
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps----~~eil~~~~f 316 (316)
T cd07842 251 DIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRIT----AEEALEHPYF 316 (316)
T ss_pred HHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcC----HHHHhcCCCC
Confidence 0000000 135567899999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=329.59 Aligned_cols=265 Identities=20% Similarity=0.301 Sum_probs=214.6
Q ss_pred CCCccCCCceeEEEecccCcceEEEEEEeccC-CCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHc-CCCCCceEEE
Q 012762 76 NNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKS-SNNGCFFAAKVMDKRELVSRNKESRARIEREILEML-DHPFLPTLYA 153 (457)
Q Consensus 76 ~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~-~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~~ 153 (457)
.+.+..++|++.+.||+|+||.||++.++... ......+|+|++.... .......+.+|+++++++ +|+||+++++
T Consensus 6 ~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~ 83 (293)
T cd05053 6 EWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLG 83 (293)
T ss_pred ccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC--CHHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence 45667789999999999999999999876433 1244689999987542 122345677899999999 8999999999
Q ss_pred EEEcCCcEEEEEeecCCCChHHHHHhC--------------CCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCe
Q 012762 154 TLDCPRWSCLLTEFCPGGDLHVLRQRQ--------------PDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENV 219 (457)
Q Consensus 154 ~~~~~~~~~lV~E~~~~~sL~~~~~~~--------------~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NI 219 (457)
++..++..|+||||+.+++|..++... ....+++..++.++.||+.||.|||+.||+||||||+||
T Consensus 84 ~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Ni 163 (293)
T cd05053 84 VCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNV 163 (293)
T ss_pred EEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeE
Confidence 999999999999999999999988652 245689999999999999999999999999999999999
Q ss_pred EEccCCCEEEeccCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCC
Q 012762 220 LVRSDGHIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLG 299 (457)
Q Consensus 220 ll~~~~~vkl~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (457)
|++.++.+||+|||+++..........
T Consensus 164 l~~~~~~~kL~Dfg~~~~~~~~~~~~~----------------------------------------------------- 190 (293)
T cd05053 164 LVTEDHVMKIADFGLARDIHHIDYYRK----------------------------------------------------- 190 (293)
T ss_pred EEcCCCeEEeCccccccccccccceec-----------------------------------------------------
Confidence 999999999999999865432111000
Q ss_pred CCCCCcccccCCccccccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHHhcccCCC
Q 012762 300 NPGTPEIVAEPLDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVVARALEFP 378 (457)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~ 378 (457)
.....++..|+|||++.+..++.++|||||||++|||++ |..||.+....+....+... ....
T Consensus 191 ---------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~ 254 (293)
T cd05053 191 ---------------TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEG-YRME 254 (293)
T ss_pred ---------------cCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHHHHcC-CcCC
Confidence 001125678999999988889999999999999999997 99999887666555544433 3334
Q ss_pred CCCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcC
Q 012762 379 KEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRH 415 (457)
Q Consensus 379 ~~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~h 415 (457)
....++.++.+|+.+||..||++||+ +.+++++
T Consensus 255 ~~~~~~~~~~~li~~~l~~~p~~Rps----~~eil~~ 287 (293)
T cd05053 255 KPQNCTQELYHLMRDCWHEVPSQRPT----FKQLVED 287 (293)
T ss_pred CCCCCCHHHHHHHHHHcccCcccCcC----HHHHHHH
Confidence 44467889999999999999999999 8888764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=325.23 Aligned_cols=267 Identities=25% Similarity=0.351 Sum_probs=208.7
Q ss_pred CCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEc-CC
Q 012762 81 LSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDC-PR 159 (457)
Q Consensus 81 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~-~~ 159 (457)
+..|+++..||+|.||.||+|.-+..+....+.||||.++..+... .......+|+.+++.++|+||+.+..+|.. +.
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~t-GiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~ 101 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGT-GISMSACREIALLRELKHPNVISLVKVFLSHDK 101 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCC-CcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence 3579999999999999999996554433334589999987653221 233456679999999999999999999877 78
Q ss_pred cEEEEEeecCCCChHHHHHhC---CCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccC----CCEEEecc
Q 012762 160 WSCLLTEFCPGGDLHVLRQRQ---PDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSD----GHIMLTDF 232 (457)
Q Consensus 160 ~~~lV~E~~~~~sL~~~~~~~---~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~----~~vkl~DF 232 (457)
.++|++||. .-+|..+++.+ ..+.++...++.++.||+.|+.|||++.|+||||||.||||..+ |.|||+||
T Consensus 102 ~v~l~fdYA-EhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDl 180 (438)
T KOG0666|consen 102 KVWLLFDYA-EHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADL 180 (438)
T ss_pred eEEEEehhh-hhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecc
Confidence 899999999 55777777654 23568999999999999999999999999999999999999988 89999999
Q ss_pred CCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCc
Q 012762 233 DLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLD 312 (457)
Q Consensus 233 G~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (457)
|+++.+.++--...
T Consensus 181 GlaR~~~~plkpl~------------------------------------------------------------------ 194 (438)
T KOG0666|consen 181 GLARLFNNPLKPLA------------------------------------------------------------------ 194 (438)
T ss_pred cHHHHhhccccccc------------------------------------------------------------------
Confidence 99988764322110
Q ss_pred cccccccCCCCccCchhhcCCC-CCccchhhhhhHHHHHHhcCCCCCCCCChH---------HHHHHHHhcccCCCCCCC
Q 012762 313 VRSMSFVGTHEYLAPEIISGEG-HGNAVDWWTLGIFIFELFYGTTPFKGIDHE---------LTLANVVARALEFPKEPS 382 (457)
Q Consensus 313 ~~~~~~~gt~~y~aPE~l~~~~-~~~~sDiwSlG~il~elltG~~Pf~~~~~~---------~~~~~~~~~~~~~~~~~~ 382 (457)
.....+-|.+|+|||.+.|.. |+.+.|||++|||+.||++-++.|.+.... +.+.+|.. .+..|....
T Consensus 195 -s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf~-vLG~Pt~~~ 272 (438)
T KOG0666|consen 195 -SLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIFE-VLGTPTDKD 272 (438)
T ss_pred -cCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHHHH-HcCCCcccc
Confidence 011346799999999999986 899999999999999999999999764321 12233332 122222111
Q ss_pred C------------------------------------ChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCCC
Q 012762 383 V------------------------------------PGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGV 421 (457)
Q Consensus 383 ~------------------------------------~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~~ 421 (457)
+ ++...+|+.+||.+||-+|.+ +++.|+|+||...
T Consensus 273 Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIt----a~qAleh~yF~~d 343 (438)
T KOG0666|consen 273 WPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRIT----AEQALEHPYFTED 343 (438)
T ss_pred chhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhcc----HHHHhcccccccC
Confidence 1 234779999999999999999 9999999999864
|
|
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-42 Score=327.32 Aligned_cols=255 Identities=24% Similarity=0.354 Sum_probs=207.7
Q ss_pred CCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcE
Q 012762 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWS 161 (457)
Q Consensus 82 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~ 161 (457)
++|++.+.||.|+||.||+|.++ .++..||||.+.............+..|+++++.++|+||+++++++..++..
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~----~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~ 77 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCL----LDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNEL 77 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeec----CCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeE
Confidence 57999999999999999999976 37889999988765544444556778899999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCC
Q 012762 162 CLLTEFCPGGDLHVLRQRQ--PDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGD 239 (457)
Q Consensus 162 ~lV~E~~~~~sL~~~~~~~--~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~ 239 (457)
++||||+++++|..++... ....+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++....
T Consensus 78 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd08229 78 NIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccc
Confidence 9999999999999888642 23568999999999999999999999999999999999999999999999999875442
Q ss_pred CCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcccccccc
Q 012762 240 NSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFV 319 (457)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (457)
..... .....
T Consensus 158 ~~~~~----------------------------------------------------------------------~~~~~ 167 (267)
T cd08229 158 SKTTA----------------------------------------------------------------------AHSLV 167 (267)
T ss_pred cCCcc----------------------------------------------------------------------ccccc
Confidence 11100 01235
Q ss_pred CCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChH--HHHHHHHhcccCCCCCCCCChHHHHHHHHHhhh
Q 012762 320 GTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHE--LTLANVVARALEFPKEPSVPGPAKDLIAQLLVK 397 (457)
Q Consensus 320 gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~ 397 (457)
|+..|+|||++.+..++.++||||||+++|+|++|..||.+.... .....+............++..+.+++.+||..
T Consensus 168 ~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 247 (267)
T cd08229 168 GTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINP 247 (267)
T ss_pred CCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHHHHHHHHHhcCC
Confidence 889999999999888999999999999999999999999765432 223333322222112234778999999999999
Q ss_pred CCCCCCCCCcChHHHhc
Q 012762 398 DPTRRMGSKMGATAIKR 414 (457)
Q Consensus 398 dP~~Rps~~~~~~~ll~ 414 (457)
||++||+ +.+|++
T Consensus 248 ~p~~Rpt----~~~i~~ 260 (267)
T cd08229 248 DPEKRPD----ITYVYD 260 (267)
T ss_pred CcccCCC----HHHHHH
Confidence 9999999 776543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-42 Score=327.14 Aligned_cols=247 Identities=27% Similarity=0.466 Sum_probs=198.3
Q ss_pred CceeEEEe--cccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHc-CCCCCceEEEEEEcCC
Q 012762 83 DLRFVHRL--GSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEML-DHPFLPTLYATLDCPR 159 (457)
Q Consensus 83 ~~~~~~~L--G~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~~~~~~~~ 159 (457)
+|.+.+.+ |+|+||.||++..+ .+++.+|+|++.+..... .|+.+...+ +|+||+++++++..++
T Consensus 15 ~~~~~~~~~lg~g~~g~v~~~~~~----~~~~~~~~k~~~~~~~~~--------~e~~~~~~~~~h~~iv~~~~~~~~~~ 82 (267)
T PHA03390 15 NCEIVKKLKLIDGKFGKVSVLKHK----PTQKLFVQKIIKAKNFNA--------IEPMVHQLMKDNPNFIKLYYSVTTLK 82 (267)
T ss_pred hhccccceeecCCCceEEEEEEEc----CCCcEEEEEEEehhhcch--------hhHHHHHHhhcCCCEEEEEEEEecCC
Confidence 46666555 99999999999876 478899999987643211 123333222 7999999999999999
Q ss_pred cEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCC-CEEEeccCCCcCC
Q 012762 160 WSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDG-HIMLTDFDLSLKG 238 (457)
Q Consensus 160 ~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~-~vkl~DFG~s~~~ 238 (457)
..|+||||+++++|..++... ..+++..++.++.||+.||.|||+.|++||||||+||+++.++ .++|+|||++...
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~ 160 (267)
T PHA03390 83 GHVLIMDYIKDGDLFDLLKKE--GKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKII 160 (267)
T ss_pred eeEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceec
Confidence 999999999999999998775 4799999999999999999999999999999999999999988 9999999987533
Q ss_pred CCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccc
Q 012762 239 DNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSF 318 (457)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (457)
... ...
T Consensus 161 ~~~--------------------------------------------------------------------------~~~ 166 (267)
T PHA03390 161 GTP--------------------------------------------------------------------------SCY 166 (267)
T ss_pred CCC--------------------------------------------------------------------------ccC
Confidence 210 012
Q ss_pred cCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHH-HHHHhc-ccCCCCCCCCChHHHHHHHHHhh
Q 012762 319 VGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTL-ANVVAR-ALEFPKEPSVPGPAKDLIAQLLV 396 (457)
Q Consensus 319 ~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~-~~~~~~-~~~~~~~~~~~~~~~~ll~~~L~ 396 (457)
.|+..|+|||++.+..++.++|||||||++|+|++|..||......... ...... ....+....++..+.++|.+||+
T Consensus 167 ~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 246 (267)
T PHA03390 167 DGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSKNANDFVQSMLK 246 (267)
T ss_pred CCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcccccCHHHHHHHHHHhc
Confidence 4889999999999988999999999999999999999999865433221 111111 11222333588999999999999
Q ss_pred hCCCCCCCCCcChHHHhcCCCCCC
Q 012762 397 KDPTRRMGSKMGATAIKRHQFFNG 420 (457)
Q Consensus 397 ~dP~~Rps~~~~~~~ll~hp~f~~ 420 (457)
.||.+|++. ++++|+||||+.
T Consensus 247 ~~p~~R~~~---~~~~l~h~~~~~ 267 (267)
T PHA03390 247 YNINYRLTN---YNEIIKHPFLKI 267 (267)
T ss_pred cChhhCCch---HHHHhcCCcccC
Confidence 999999962 699999999973
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=327.76 Aligned_cols=255 Identities=19% Similarity=0.285 Sum_probs=201.4
Q ss_pred ceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcC--CcE
Q 012762 84 LRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCP--RWS 161 (457)
Q Consensus 84 ~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~--~~~ 161 (457)
|++++.||+|+||+||++........++..||+|+++... .......+.+|+++|++++||||+++++++... ..+
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC--GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGL 83 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceE
Confidence 4999999999999999987655555678899999986542 122345677899999999999999999987653 468
Q ss_pred EEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCC
Q 012762 162 CLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNS 241 (457)
Q Consensus 162 ~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~ 241 (457)
|+||||+.+++|.+++.. ..+++..++.++.|++.||.|||++||+||||||+|||++.++.++|+|||++......
T Consensus 84 ~lv~e~~~~~~l~~~~~~---~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 160 (283)
T cd05080 84 QLIMEYVPLGSLRDYLPK---HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 160 (283)
T ss_pred EEEecCCCCCCHHHHHHH---cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCCc
Confidence 999999999999998876 45999999999999999999999999999999999999999999999999997654321
Q ss_pred CcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCC
Q 012762 242 TSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGT 321 (457)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 321 (457)
...... .....++
T Consensus 161 ~~~~~~-------------------------------------------------------------------~~~~~~~ 173 (283)
T cd05080 161 HEYYRV-------------------------------------------------------------------REDGDSP 173 (283)
T ss_pred chhhcc-------------------------------------------------------------------CCCCCCC
Confidence 100000 0011256
Q ss_pred CCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChH--------------HHHHHHHhcccCCCCCCCCChHH
Q 012762 322 HEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHE--------------LTLANVVARALEFPKEPSVPGPA 387 (457)
Q Consensus 322 ~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~ 387 (457)
..|+|||++.+..++.++|||||||++|||++|..||...... ......+......+....++..+
T Consensus 174 ~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (283)
T cd05080 174 VFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMRLPCPKNCPQEV 253 (283)
T ss_pred ceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcCCCCCCCCCCCHHH
Confidence 6799999999888999999999999999999999998653321 11111222223333345678899
Q ss_pred HHHHHHHhhhCCCCCCCCCcChHHHhc
Q 012762 388 KDLIAQLLVKDPTRRMGSKMGATAIKR 414 (457)
Q Consensus 388 ~~ll~~~L~~dP~~Rps~~~~~~~ll~ 414 (457)
.+++.+||..||++||+ +++++.
T Consensus 254 ~~li~~cl~~~p~~Rps----~~~i~~ 276 (283)
T cd05080 254 YILMKNCWETEAKFRPT----FRSLIP 276 (283)
T ss_pred HHHHHHHhccChhhCCC----HHHHHH
Confidence 99999999999999999 777764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-42 Score=338.27 Aligned_cols=259 Identities=23% Similarity=0.373 Sum_probs=203.7
Q ss_pred CCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcC---
Q 012762 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCP--- 158 (457)
Q Consensus 82 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~--- 158 (457)
++|++.++||+|+||.||+|.+. .+|+.||+|++.... .......+..|++++++++|+||+++++++...
T Consensus 5 ~~y~i~~~lg~G~~g~vy~~~~~----~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 78 (336)
T cd07849 5 PRYQNLSYIGEGAYGMVCSATHK----PTGVKVAIKKISPFE--HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFE 78 (336)
T ss_pred cceEEEEEEEecCCeEEEEEEEc----CCCCeEEEEEecccc--cchhHHHHHHHHHHHHhCCCCCcCchhheeeccccc
Confidence 58999999999999999999876 478899999986421 223445677799999999999999999987544
Q ss_pred --CcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCc
Q 012762 159 --RWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSL 236 (457)
Q Consensus 159 --~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~ 236 (457)
...|+||||+ +++|..++.. ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.
T Consensus 79 ~~~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~ 154 (336)
T cd07849 79 SFNDVYIVQELM-ETDLYKLIKT---QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLAR 154 (336)
T ss_pred ccceEEEEehhc-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECccccee
Confidence 3579999999 5688777654 569999999999999999999999999999999999999999999999999976
Q ss_pred CCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccc
Q 012762 237 KGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSM 316 (457)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (457)
......... ....
T Consensus 155 ~~~~~~~~~-------------------------------------------------------------------~~~~ 167 (336)
T cd07849 155 IADPEHDHT-------------------------------------------------------------------GFLT 167 (336)
T ss_pred ecccccccc-------------------------------------------------------------------CCcC
Confidence 442110000 0001
Q ss_pred cccCCCCccCchhhcC-CCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcc---------------------
Q 012762 317 SFVGTHEYLAPEIISG-EGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARA--------------------- 374 (457)
Q Consensus 317 ~~~gt~~y~aPE~l~~-~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~--------------------- 374 (457)
...||..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.........+....
T Consensus 168 ~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (336)
T cd07849 168 EYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARNYIK 247 (336)
T ss_pred CcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhchhhhhHHh
Confidence 2368999999998765 458999999999999999999999998755433222221100
Q ss_pred -cCCC-------CCCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCCC
Q 012762 375 -LEFP-------KEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGV 421 (457)
Q Consensus 375 -~~~~-------~~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~~ 421 (457)
.... ..+..+.++.++|.+||..||++||+ +.++++||||+..
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt----~~e~l~hp~~~~~ 298 (336)
T cd07849 248 SLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRIT----VEEALAHPYLEQY 298 (336)
T ss_pred hcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcC----HHHHhcCcccccc
Confidence 0000 01235678999999999999999999 9999999999964
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=334.63 Aligned_cols=263 Identities=24% Similarity=0.330 Sum_probs=208.0
Q ss_pred CCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcC-CCCCceEEEEEEcCC
Q 012762 81 LSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLD-HPFLPTLYATLDCPR 159 (457)
Q Consensus 81 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~-H~nIv~l~~~~~~~~ 159 (457)
.++|...++||+|+||.||++.+. .+++.||+|.+.+.... .....+..|+.++.++. |+||+++++++..++
T Consensus 3 ~~~~~~~~~lg~G~~g~vy~~~~~----~~~~~~aiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~ 76 (288)
T cd06616 3 AEDLKDLGEIGRGAFGTVNKMLHK----PSGTIMAVKRIRSTVDE--KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREG 76 (288)
T ss_pred HHHhHHHHHhCCCCceEEEEEEEC----CCCCEEEEEEehhccCh--HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCC
Confidence 457888899999999999999876 47889999998754322 34556778999999985 999999999999999
Q ss_pred cEEEEEeecCCCChHHHHH---hCCCCCCCHHHHHHHHHHHHHHHHHHHHc-CceeecCCCCCeEEccCCCEEEeccCCC
Q 012762 160 WSCLLTEFCPGGDLHVLRQ---RQPDKRFHESAVRFYASEVVVALEFLHMM-GIIYRDLKPENVLVRSDGHIMLTDFDLS 235 (457)
Q Consensus 160 ~~~lV~E~~~~~sL~~~~~---~~~~~~~~~~~~~~i~~qi~~~L~yLH~~-~iiHrDIKp~NIll~~~~~vkl~DFG~s 235 (457)
..+++|||+ +++|..+.. ......+++..+..++.|++.||+|||+. +|+||||||+|||++.++.++|+|||++
T Consensus 77 ~~~~~~e~~-~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~ 155 (288)
T cd06616 77 DCWICMELM-DISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGIS 155 (288)
T ss_pred cEEEEEecc-cCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchh
Confidence 999999998 556654432 22346799999999999999999999974 9999999999999999999999999997
Q ss_pred cCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcccc
Q 012762 236 LKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRS 315 (457)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (457)
........ .
T Consensus 156 ~~~~~~~~-----------------------------------------------------------------------~ 164 (288)
T cd06616 156 GQLVDSIA-----------------------------------------------------------------------K 164 (288)
T ss_pred HHhccCCc-----------------------------------------------------------------------c
Confidence 54321100 0
Q ss_pred ccccCCCCccCchhhcCC---CCCccchhhhhhHHHHHHhcCCCCCCCCChH-HHHHHHHhccc-CCC--CCCCCChHHH
Q 012762 316 MSFVGTHEYLAPEIISGE---GHGNAVDWWTLGIFIFELFYGTTPFKGIDHE-LTLANVVARAL-EFP--KEPSVPGPAK 388 (457)
Q Consensus 316 ~~~~gt~~y~aPE~l~~~---~~~~~sDiwSlG~il~elltG~~Pf~~~~~~-~~~~~~~~~~~-~~~--~~~~~~~~~~ 388 (457)
....|+..|+|||++.+. .++.++|||||||++|+|++|+.||...... .....+..... ..+ ....++.++.
T Consensus 165 ~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 244 (288)
T cd06616 165 TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEEREFSPSFV 244 (288)
T ss_pred ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCCccCHHHH
Confidence 012488899999999876 5899999999999999999999999765421 12222222111 111 1224788999
Q ss_pred HHHHHHhhhCCCCCCCCCcChHHHhcCCCCCCCCchh
Q 012762 389 DLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGVNWAL 425 (457)
Q Consensus 389 ~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~~~~~~ 425 (457)
+|+.+||+.||++||+ +++|++||||+...|..
T Consensus 245 ~li~~~l~~~p~~Rpt----~~~i~~~~~~~~~~~~~ 277 (288)
T cd06616 245 NFINLCLIKDESKRPK----YKELLEHPFIKDYEERN 277 (288)
T ss_pred HHHHHHccCChhhCcC----HHHHhcChhhhchhhcc
Confidence 9999999999999999 99999999999876643
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=335.13 Aligned_cols=257 Identities=25% Similarity=0.362 Sum_probs=211.8
Q ss_pred CceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcEE
Q 012762 83 DLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWSC 162 (457)
Q Consensus 83 ~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~ 162 (457)
.|+..+.||+|+||.||+|.+. .++..||+|++..... ......+..|++++++++|+||+++++++..+...|
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~----~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDN----RTKEVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLW 78 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEc----CCCeEEEEEEeccccc--hHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceE
Confidence 4777889999999999999876 3678999999865422 234456788999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCCC
Q 012762 163 LLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNST 242 (457)
Q Consensus 163 lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~~ 242 (457)
+||||+++++|..++.. ..+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 79 lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06642 79 IIMEYLGGGSALDLLKP---GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ 155 (277)
T ss_pred EEEEccCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcc
Confidence 99999999999888754 568999999999999999999999999999999999999999999999999875443110
Q ss_pred cccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCCC
Q 012762 243 STAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTH 322 (457)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 322 (457)
. ......|+.
T Consensus 156 ~----------------------------------------------------------------------~~~~~~~~~ 165 (277)
T cd06642 156 I----------------------------------------------------------------------KRNTFVGTP 165 (277)
T ss_pred h----------------------------------------------------------------------hhhcccCcc
Confidence 0 001235888
Q ss_pred CccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhhhCCCCC
Q 012762 323 EYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDPTRR 402 (457)
Q Consensus 323 ~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R 402 (457)
.|+|||++.+..++.++|||||||++|||++|..||...........+... ........++.++.+++.+||..+|++|
T Consensus 166 ~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~R 244 (277)
T cd06642 166 FWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKN-SPPTLEGQYSKPFKEFVEACLNKDPRFR 244 (277)
T ss_pred cccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcC-CCCCCCcccCHHHHHHHHHHccCCcccC
Confidence 999999999888999999999999999999999999765544333332222 1111223467889999999999999999
Q ss_pred CCCCcChHHHhcCCCCCCCCc
Q 012762 403 MGSKMGATAIKRHQFFNGVNW 423 (457)
Q Consensus 403 ps~~~~~~~ll~hp~f~~~~~ 423 (457)
|+ +.++++||||....+
T Consensus 245 p~----~~~il~~~~~~~~~~ 261 (277)
T cd06642 245 PT----AKELLKHKFITRYTK 261 (277)
T ss_pred cC----HHHHHHhHHHHHHhh
Confidence 99 999999999986544
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=329.30 Aligned_cols=257 Identities=27% Similarity=0.395 Sum_probs=208.3
Q ss_pred CCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcE
Q 012762 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWS 161 (457)
Q Consensus 82 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~ 161 (457)
++|++.+.||+|+||.||+|.++ .+++.||+|+++.... .......+..|++++++++|+||+++++++..++..
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~----~~~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 75 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNK----ATGEIVAIKKFKESED-DEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRL 75 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeC----CCCcEEEEehhhhhcc-cccchhHHHHHHHHHHhcCCCCeeehhheEEECCEE
Confidence 36999999999999999999876 3688999999865432 223456778899999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCC
Q 012762 162 CLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNS 241 (457)
Q Consensus 162 ~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~ 241 (457)
|+||||++++.|..+.... ..+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.+||+|||++......
T Consensus 76 ~iv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~ 153 (288)
T cd07833 76 YLVFEYVERTLLELLEASP--GGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRAR 153 (288)
T ss_pred EEEEecCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCC
Confidence 9999999887776655443 55899999999999999999999999999999999999999999999999997554321
Q ss_pred CcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCC
Q 012762 242 TSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGT 321 (457)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 321 (457)
.. .......++
T Consensus 154 ~~---------------------------------------------------------------------~~~~~~~~~ 164 (288)
T cd07833 154 PA---------------------------------------------------------------------SPLTDYVAT 164 (288)
T ss_pred cc---------------------------------------------------------------------ccccCcccc
Confidence 10 001123578
Q ss_pred CCccCchhhcCC-CCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhccc-------------------CCC---
Q 012762 322 HEYLAPEIISGE-GHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARAL-------------------EFP--- 378 (457)
Q Consensus 322 ~~y~aPE~l~~~-~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~-------------------~~~--- 378 (457)
..|+|||++.+. .++.++||||||+++|+|++|+.||.+......+..+..... .++
T Consensus 165 ~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (288)
T cd07833 165 RWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPS 244 (288)
T ss_pred cCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccccccCCCC
Confidence 899999999888 789999999999999999999999987654433332221100 000
Q ss_pred --------CCCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCC
Q 012762 379 --------KEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFF 418 (457)
Q Consensus 379 --------~~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f 418 (457)
....++.++.+||++||..||++||+ +.++++||||
T Consensus 245 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps----~~~il~~~~f 288 (288)
T cd07833 245 QPESLERRYPGKVSSPALDFLKACLRMDPKERLT----CDELLQHPYF 288 (288)
T ss_pred CcHHHHHhcCCccchHHHHHHHHHhccCchhccc----HHHHhcCCCC
Confidence 01124788999999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=364.78 Aligned_cols=269 Identities=19% Similarity=0.267 Sum_probs=205.2
Q ss_pred CCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCc
Q 012762 81 LSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRW 160 (457)
Q Consensus 81 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~ 160 (457)
+++|++.++||+|+||+||+|.+. .+++.||+|++............++.+|+++++.++||||+++++++.+++.
T Consensus 1 igrYeIi~~LGkGgfG~VYlA~d~----~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~ 76 (932)
T PRK13184 1 MQRYDIIRLIGKGGMGEVYLAYDP----VCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDP 76 (932)
T ss_pred CCCeEEEEEEecCCCEEEEEEEEC----CCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCE
Confidence 368999999999999999999876 4788999999975433333445678889999999999999999999999999
Q ss_pred EEEEEeecCCCChHHHHHhCC---------CCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEec
Q 012762 161 SCLLTEFCPGGDLHVLRQRQP---------DKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTD 231 (457)
Q Consensus 161 ~~lV~E~~~~~sL~~~~~~~~---------~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~D 231 (457)
.|+||||++|++|.+++.... ...++...+..++.||+.||+|||++||+||||||+|||++.+|.++|+|
T Consensus 77 lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiD 156 (932)
T PRK13184 77 VYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILD 156 (932)
T ss_pred EEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEe
Confidence 999999999999998886421 12355677888999999999999999999999999999999999999999
Q ss_pred cCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCC
Q 012762 232 FDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPL 311 (457)
Q Consensus 232 FG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (457)
||+++............. ..... . ....
T Consensus 157 FGLAk~i~~~~~~~~~l~-------~~~~~------------s---------------------------------~~s~ 184 (932)
T PRK13184 157 WGAAIFKKLEEEDLLDID-------VDERN------------I---------------------------------CYSS 184 (932)
T ss_pred cCcceecccccccccccc-------ccccc------------c---------------------------------cccc
Confidence 999875521110000000 00000 0 0000
Q ss_pred ccccccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHH-HHhcccCCCCCCCCChHHHHH
Q 012762 312 DVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLAN-VVARALEFPKEPSVPGPAKDL 390 (457)
Q Consensus 312 ~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l 390 (457)
.......+||+.|||||++.+..++.++|||||||++|||++|..||........... .+...........+++.+.++
T Consensus 185 ~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~~~~~i~~P~~~~p~~~iP~~L~~L 264 (932)
T PRK13184 185 MTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKISYRDVILSPIEVAPYREIPPFLSQI 264 (932)
T ss_pred cccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhhhhhhccChhhccccccCCHHHHHH
Confidence 0011235799999999999999999999999999999999999999987544332221 111111122223578899999
Q ss_pred HHHHhhhCCCCCCCC
Q 012762 391 IAQLLVKDPTRRMGS 405 (457)
Q Consensus 391 l~~~L~~dP~~Rps~ 405 (457)
+.+||..||++|++.
T Consensus 265 I~rcL~~DP~kR~ss 279 (932)
T PRK13184 265 AMKALAVDPAERYSS 279 (932)
T ss_pred HHHHccCChhhCcCH
Confidence 999999999999883
|
|
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=324.54 Aligned_cols=259 Identities=21% Similarity=0.306 Sum_probs=210.5
Q ss_pred cCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCC
Q 012762 80 TLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPR 159 (457)
Q Consensus 80 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~ 159 (457)
..++|++.+.||+|+||.||+|.++... ..+..+|+|.++... .......+..|++++++++||||+++++++..++
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~-~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 78 (267)
T cd05066 2 DASCIKIEKVIGAGEFGEVCSGRLKLPG-KREIPVAIKTLKAGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSK 78 (267)
T ss_pred CHHHeEeeeeecccCCCceEEEEEecCC-CCceEEEEEECCCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence 3468999999999999999999876321 134579999986532 2234567788999999999999999999999999
Q ss_pred cEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCC
Q 012762 160 WSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGD 239 (457)
Q Consensus 160 ~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~ 239 (457)
..|+||||+++++|..++.... ..+++..+..++.|++.||.|||++|++||||||+|||++.++.++|+|||++....
T Consensus 79 ~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd05066 79 PVMIVTEYMENGSLDAFLRKHD-GQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 157 (267)
T ss_pred ccEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCcccccc
Confidence 9999999999999999987643 568999999999999999999999999999999999999999999999999986543
Q ss_pred CCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcccccccc
Q 012762 240 NSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFV 319 (457)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (457)
....... ......
T Consensus 158 ~~~~~~~-------------------------------------------------------------------~~~~~~ 170 (267)
T cd05066 158 DDPEAAY-------------------------------------------------------------------TTRGGK 170 (267)
T ss_pred cccceee-------------------------------------------------------------------ecCCCc
Confidence 2111000 000112
Q ss_pred CCCCccCchhhcCCCCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhhhC
Q 012762 320 GTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKD 398 (457)
Q Consensus 320 gt~~y~aPE~l~~~~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~d 398 (457)
++..|+|||++.+..++.++|+|||||++||+++ |..||...........+.. ....+....++..+.+++.+||+.+
T Consensus 171 ~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~ 249 (267)
T cd05066 171 IPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEE-GYRLPAPMDCPAALHQLMLDCWQKD 249 (267)
T ss_pred cceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhC-CCcCCCCCCCCHHHHHHHHHHcccC
Confidence 4568999999998889999999999999999886 9999988766655555443 3455655668899999999999999
Q ss_pred CCCCCCCCcChHHHhc
Q 012762 399 PTRRMGSKMGATAIKR 414 (457)
Q Consensus 399 P~~Rps~~~~~~~ll~ 414 (457)
|++||+ +.++++
T Consensus 250 p~~Rp~----~~~i~~ 261 (267)
T cd05066 250 RNERPK----FEQIVS 261 (267)
T ss_pred chhCCC----HHHHHH
Confidence 999999 777754
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-42 Score=331.80 Aligned_cols=257 Identities=25% Similarity=0.369 Sum_probs=207.7
Q ss_pred CCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcC--
Q 012762 81 LSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCP-- 158 (457)
Q Consensus 81 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~-- 158 (457)
.++|++.+.||.|+||.||+|.++ .+++.+|+|.++..... ......+.+|++++++++||||+++++++...
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~----~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 78 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDK----KTGEIVALKKLKMEKEK-EGFPITSLREINILLKLQHPNIVTVKEVVVGSNL 78 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEEC----CCCcEEEEEEEeecccc-ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCC
Confidence 357999999999999999999886 36789999999755332 23334566799999999999999999998877
Q ss_pred CcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCC
Q 012762 159 RWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKG 238 (457)
Q Consensus 159 ~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~ 238 (457)
+..|+||||+. ++|..++.... ..+++..++.++.||+.||.|||+.|++|+||||+|||++.++.++|+|||++...
T Consensus 79 ~~~~lv~e~~~-~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~ 156 (293)
T cd07843 79 DKIYMVMEYVE-HDLKSLMETMK-QPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREY 156 (293)
T ss_pred CcEEEEehhcC-cCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeec
Confidence 88999999995 59988887643 46899999999999999999999999999999999999999999999999987644
Q ss_pred CCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccc
Q 012762 239 DNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSF 318 (457)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (457)
..... .....
T Consensus 157 ~~~~~----------------------------------------------------------------------~~~~~ 166 (293)
T cd07843 157 GSPLK----------------------------------------------------------------------PYTQL 166 (293)
T ss_pred cCCcc----------------------------------------------------------------------ccccc
Confidence 32100 00012
Q ss_pred cCCCCccCchhhcCCC-CCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccC-----------CC--------
Q 012762 319 VGTHEYLAPEIISGEG-HGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALE-----------FP-------- 378 (457)
Q Consensus 319 ~gt~~y~aPE~l~~~~-~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~-----------~~-------- 378 (457)
.++..|+|||++.+.. ++.++|||||||++|+|++|..||........+.++...... ++
T Consensus 167 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (293)
T cd07843 167 VVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFT 246 (293)
T ss_pred cccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhcccccc
Confidence 4788999999997654 688999999999999999999999887665554443321100 00
Q ss_pred ---------CCCC--CChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCC
Q 012762 379 ---------KEPS--VPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFF 418 (457)
Q Consensus 379 ---------~~~~--~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f 418 (457)
..+. +++.+.++|++||+.||++||+ +.|++.||||
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t----~~ell~~~~f 293 (293)
T cd07843 247 KYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRIS----AEDALKHPYF 293 (293)
T ss_pred cccchhhhccccccCCChHHHHHHHHHhccCccccCC----HHHHhcCCCC
Confidence 0011 4778999999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=322.97 Aligned_cols=249 Identities=20% Similarity=0.346 Sum_probs=206.1
Q ss_pred CCccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEE-
Q 012762 77 NPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATL- 155 (457)
Q Consensus 77 ~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~- 155 (457)
|.+...+|++.+.||+|+||.||+|.. .+..||+|.+... ...+.+..|+.++++++|+||+++++++
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~------~~~~~~~k~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 69 (256)
T cd05082 1 WALNMKELKLLQTIGKGEFGDVMLGDY------RGNKVAVKCIKND-----ATAQAFLAEASVMTQLRHSNLVQLLGVIV 69 (256)
T ss_pred CCccHHhCeeeeeecccCCCeEEEEEE------cCCcEEEEEeCCC-----chHHHHHHHHHHHHhCCCCCeeeEEEEEE
Confidence 346677999999999999999999975 4667999998643 2345678899999999999999999975
Q ss_pred EcCCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCC
Q 012762 156 DCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235 (457)
Q Consensus 156 ~~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s 235 (457)
..++..|+||||+++++|.+++.......+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++
T Consensus 70 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~ 149 (256)
T cd05082 70 EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLT 149 (256)
T ss_pred cCCCceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccc
Confidence 45567899999999999999988765556899999999999999999999999999999999999999999999999987
Q ss_pred cCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcccc
Q 012762 236 LKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRS 315 (457)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (457)
........
T Consensus 150 ~~~~~~~~------------------------------------------------------------------------ 157 (256)
T cd05082 150 KEASSTQD------------------------------------------------------------------------ 157 (256)
T ss_pred eeccccCC------------------------------------------------------------------------
Confidence 54321100
Q ss_pred ccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHH
Q 012762 316 MSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQL 394 (457)
Q Consensus 316 ~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~ 394 (457)
...++..|+|||++.+..++.++|||||||++|||++ |+.||...........+.. .........++..+.+++.+|
T Consensus 158 -~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~ 235 (256)
T cd05082 158 -TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK-GYKMDAPDGCPPVVYDVMKQC 235 (256)
T ss_pred -CCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc-CCCCCCCCCCCHHHHHHHHHH
Confidence 1124567999999998889999999999999999997 9999987665555444432 333333456889999999999
Q ss_pred hhhCCCCCCCCCcChHHHhc
Q 012762 395 LVKDPTRRMGSKMGATAIKR 414 (457)
Q Consensus 395 L~~dP~~Rps~~~~~~~ll~ 414 (457)
|..||++||+ +.++++
T Consensus 236 l~~~p~~Rpt----~~~l~~ 251 (256)
T cd05082 236 WHLDAATRPS----FLQLRE 251 (256)
T ss_pred hcCChhhCcC----HHHHHH
Confidence 9999999999 888765
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=327.25 Aligned_cols=251 Identities=26% Similarity=0.407 Sum_probs=199.7
Q ss_pred ceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcC-CCCCceEEEEEEcC--Cc
Q 012762 84 LRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLD-HPFLPTLYATLDCP--RW 160 (457)
Q Consensus 84 ~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~-H~nIv~l~~~~~~~--~~ 160 (457)
|++.++||+|+||.||+|.++ .++..||+|++++... . ........|+.+++++. |+||+++++++.++ +.
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~----~~~~~~aik~~~~~~~-~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~ 74 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSR----KTGKYYAIKCMKKHFK-S-LEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGR 74 (282)
T ss_pred CceEeeccccccceEEEEEEc----CCCcEEEEEEehhccC-C-chhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCc
Confidence 678999999999999999876 3788999999865421 1 22223446888888884 99999999999887 88
Q ss_pred EEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCC
Q 012762 161 SCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDN 240 (457)
Q Consensus 161 ~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~ 240 (457)
.++||||++ ++|.+++.... ..+++..++.++.||+.||.|||+.|++||||||+||+++. +.+||+|||++.....
T Consensus 75 ~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~ 151 (282)
T cd07831 75 LALVFELMD-MNLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYS 151 (282)
T ss_pred EEEEEecCC-ccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEeccccccccc
Confidence 999999995 57776665532 56899999999999999999999999999999999999999 9999999999754421
Q ss_pred CCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccC
Q 012762 241 STSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVG 320 (457)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 320 (457)
... .....+
T Consensus 152 ~~~-----------------------------------------------------------------------~~~~~~ 160 (282)
T cd07831 152 KPP-----------------------------------------------------------------------YTEYIS 160 (282)
T ss_pred CCC-----------------------------------------------------------------------cCCCCC
Confidence 100 012347
Q ss_pred CCCccCchhhcC-CCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcc------------------cCCCC--
Q 012762 321 THEYLAPEIISG-EGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARA------------------LEFPK-- 379 (457)
Q Consensus 321 t~~y~aPE~l~~-~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~------------------~~~~~-- 379 (457)
+..|+|||++.. ..++.++|||||||++|||++|..||.+.+..+....+.... +.++.
T Consensus 161 ~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (282)
T cd07831 161 TRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKK 240 (282)
T ss_pred CcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccCcccc
Confidence 889999998754 446889999999999999999999998876544443332211 11111
Q ss_pred -------CCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCC
Q 012762 380 -------EPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFF 418 (457)
Q Consensus 380 -------~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f 418 (457)
...++.++.++|.+||..||++||+ ++++++||||
T Consensus 241 ~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~----~~~~l~~~~~ 282 (282)
T cd07831 241 GTGLRKLLPNASAEGLDLLKKLLAYDPDERIT----AKQALRHPYF 282 (282)
T ss_pred cccHHHHcccccHHHHHHHHHHhccCcccccC----HHHHhhCCCC
Confidence 1245788999999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=344.79 Aligned_cols=266 Identities=20% Similarity=0.269 Sum_probs=216.1
Q ss_pred CCCccCCCceeEEEecccCcceEEEEEEecc-CCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcC-CCCCceEEE
Q 012762 76 NNPLTLSDLRFVHRLGSGDIGSVYLVQLKSK-SSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLD-HPFLPTLYA 153 (457)
Q Consensus 76 ~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~-~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~-H~nIv~l~~ 153 (457)
.+.+..++|.+.++||+|+||.||+|+++.. ....+..||+|+++... .......+..|+++|.++. ||||+++++
T Consensus 31 ~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l~~H~niv~~~~ 108 (401)
T cd05107 31 AWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA--RSSEKQALMSELKIMSHLGPHLNIVNLLG 108 (401)
T ss_pred cceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC--ChhHHHHHHHHHHHHHhcCCCCCeEEEEE
Confidence 4677778899999999999999999997632 22456789999997532 2223446778999999997 999999999
Q ss_pred EEEcCCcEEEEEeecCCCChHHHHHhCCC---------------------------------------------------
Q 012762 154 TLDCPRWSCLLTEFCPGGDLHVLRQRQPD--------------------------------------------------- 182 (457)
Q Consensus 154 ~~~~~~~~~lV~E~~~~~sL~~~~~~~~~--------------------------------------------------- 182 (457)
++...+..|+|||||.+|+|.++++....
T Consensus 109 ~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (401)
T cd05107 109 ACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESAD 188 (401)
T ss_pred EEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccC
Confidence 99999999999999999999998875321
Q ss_pred ---------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCC
Q 012762 183 ---------------------------------------------KRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPE 217 (457)
Q Consensus 183 ---------------------------------------------~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~ 217 (457)
..+++..++.++.||+.||.|||+.+|+||||||+
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~ 268 (401)
T cd05107 189 YVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAAR 268 (401)
T ss_pred ccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcc
Confidence 23567778889999999999999999999999999
Q ss_pred CeEEccCCCEEEeccCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhcccc
Q 012762 218 NVLVRSDGHIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKK 297 (457)
Q Consensus 218 NIll~~~~~vkl~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (457)
|||++.++.+||+|||+++........
T Consensus 269 NiLl~~~~~~kL~DfGla~~~~~~~~~----------------------------------------------------- 295 (401)
T cd05107 269 NVLICEGKLVKICDFGLARDIMRDSNY----------------------------------------------------- 295 (401)
T ss_pred eEEEeCCCEEEEEecCcceeccccccc-----------------------------------------------------
Confidence 999999999999999997643211000
Q ss_pred CCCCCCCcccccCCccccccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHHhcccC
Q 012762 298 LGNPGTPEIVAEPLDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVVARALE 376 (457)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~ 376 (457)
.......++..|+|||++.+..++.++|||||||++|||++ |..||......+.....+.....
T Consensus 296 ---------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~~~~~~~~~ 360 (401)
T cd05107 296 ---------------ISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYR 360 (401)
T ss_pred ---------------ccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHHcCCC
Confidence 00012347889999999998889999999999999999998 89999876666666565655555
Q ss_pred CCCCCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcC
Q 012762 377 FPKEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRH 415 (457)
Q Consensus 377 ~~~~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~h 415 (457)
.+.+..++.++.+|+.+||..||++||+ +.+|++.
T Consensus 361 ~~~p~~~~~~l~~li~~cl~~~P~~RPs----~~ell~~ 395 (401)
T cd05107 361 MAKPAHASDEIYEIMQKCWEEKFEIRPD----FSQLVHL 395 (401)
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhHCcC----HHHHHHH
Confidence 5555568899999999999999999999 8887753
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=329.78 Aligned_cols=262 Identities=21% Similarity=0.329 Sum_probs=210.6
Q ss_pred ccCCCceeEEEecccCcceEEEEEEeccC------------CCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCC
Q 012762 79 LTLSDLRFVHRLGSGDIGSVYLVQLKSKS------------SNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHP 146 (457)
Q Consensus 79 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~------------~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~ 146 (457)
+..++|+++++||+|+||.||+|.+.... ...+..||+|++..... ......+.+|++++++++|+
T Consensus 2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~e~~~l~~l~~~ 79 (296)
T cd05051 2 FPRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDAS--DNAREDFLKEVKILSRLSDP 79 (296)
T ss_pred CchhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccC--HHHHHHHHHHHHHHHhcCCC
Confidence 34568999999999999999999875321 12345789999875432 23456788899999999999
Q ss_pred CCceEEEEEEcCCcEEEEEeecCCCChHHHHHhCC---------CCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCC
Q 012762 147 FLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQP---------DKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPE 217 (457)
Q Consensus 147 nIv~l~~~~~~~~~~~lV~E~~~~~sL~~~~~~~~---------~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~ 217 (457)
||+++++++..++..++||||+.+++|..++.... ...+++..++.++.|++.||.|||+.||+||||||+
T Consensus 80 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~ 159 (296)
T cd05051 80 NIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATR 159 (296)
T ss_pred CEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchh
Confidence 99999999999999999999999999999887642 126899999999999999999999999999999999
Q ss_pred CeEEccCCCEEEeccCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhcccc
Q 012762 218 NVLVRSDGHIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKK 297 (457)
Q Consensus 218 NIll~~~~~vkl~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (457)
||+++.++.++|+|||++..........
T Consensus 160 Nili~~~~~~~l~dfg~~~~~~~~~~~~---------------------------------------------------- 187 (296)
T cd05051 160 NCLVGKNYTIKIADFGMSRNLYSSDYYR---------------------------------------------------- 187 (296)
T ss_pred ceeecCCCceEEccccceeecccCccee----------------------------------------------------
Confidence 9999999999999999875432111000
Q ss_pred CCCCCCCcccccCCccccccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhc--CCCCCCCCChHHHHHHHHhc--
Q 012762 298 LGNPGTPEIVAEPLDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFY--GTTPFKGIDHELTLANVVAR-- 373 (457)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~ellt--G~~Pf~~~~~~~~~~~~~~~-- 373 (457)
......++..|+|||++.+..++.++|||||||++|||++ |..||........+......
T Consensus 188 ----------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~ 251 (296)
T cd05051 188 ----------------VQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQVIENAGHFFR 251 (296)
T ss_pred ----------------ecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHHHHHHHHhccc
Confidence 0002246788999999998889999999999999999998 78899877666665554432
Q ss_pred ----ccCCCCCCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhc
Q 012762 374 ----ALEFPKEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKR 414 (457)
Q Consensus 374 ----~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~ 414 (457)
....+....++.++.+++.+||+.||++||+ +.+|++
T Consensus 252 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt----~~el~~ 292 (296)
T cd05051 252 DDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPT----FREIHL 292 (296)
T ss_pred cccccccCCCccCCCHHHHHHHHHHhccChhcCCC----HHHHHH
Confidence 1122333456789999999999999999999 888865
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=326.72 Aligned_cols=261 Identities=19% Similarity=0.305 Sum_probs=209.4
Q ss_pred cCCCceeEEEecccCcceEEEEEEeccC-CCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcC
Q 012762 80 TLSDLRFVHRLGSGDIGSVYLVQLKSKS-SNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCP 158 (457)
Q Consensus 80 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~-~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~ 158 (457)
..++|.+.+.||+|+||.||+|.+...+ ...+..||+|.+.... .......+..|+.+++.++|+||+++++++...
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 81 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC--SEQDESDFLMEALIMSKFNHQNIVRLIGVSFER 81 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence 3467999999999999999999986321 1256789999886432 223345677899999999999999999999998
Q ss_pred CcEEEEEeecCCCChHHHHHhCCC-----CCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCC---CEEEe
Q 012762 159 RWSCLLTEFCPGGDLHVLRQRQPD-----KRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDG---HIMLT 230 (457)
Q Consensus 159 ~~~~lV~E~~~~~sL~~~~~~~~~-----~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~---~vkl~ 230 (457)
+..|+||||++|++|..++..... ..+++..++.++.||+.||.|||+++++||||||+|||++.++ .+||+
T Consensus 82 ~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 82 LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEec
Confidence 999999999999999999876532 2589999999999999999999999999999999999998654 59999
Q ss_pred ccCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccC
Q 012762 231 DFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEP 310 (457)
Q Consensus 231 DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (457)
|||+++.........
T Consensus 162 dfg~~~~~~~~~~~~----------------------------------------------------------------- 176 (277)
T cd05036 162 DFGMARDIYRASYYR----------------------------------------------------------------- 176 (277)
T ss_pred cCccccccCCcccee-----------------------------------------------------------------
Confidence 999986542111000
Q ss_pred CccccccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHH
Q 012762 311 LDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKD 389 (457)
Q Consensus 311 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (457)
......++..|+|||++.+..++.++|||||||++|||++ |..||.+.........+. ..........++..+.+
T Consensus 177 ---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 252 (277)
T cd05036 177 ---KGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVT-GGGRLDPPKGCPGPVYR 252 (277)
T ss_pred ---cCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-cCCcCCCCCCCCHHHHH
Confidence 0001124568999999998889999999999999999996 999998877665544433 33333334568899999
Q ss_pred HHHHHhhhCCCCCCCCCcChHHHhcC
Q 012762 390 LIAQLLVKDPTRRMGSKMGATAIKRH 415 (457)
Q Consensus 390 ll~~~L~~dP~~Rps~~~~~~~ll~h 415 (457)
++.+||+.||++||+ +.+|++|
T Consensus 253 ~i~~cl~~~p~~Rps----~~~vl~~ 274 (277)
T cd05036 253 IMTDCWQHTPEDRPN----FATILER 274 (277)
T ss_pred HHHHHcCCCcccCcC----HHHHHHH
Confidence 999999999999999 9999886
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=325.73 Aligned_cols=259 Identities=21% Similarity=0.293 Sum_probs=208.2
Q ss_pred ccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcC
Q 012762 79 LTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCP 158 (457)
Q Consensus 79 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~ 158 (457)
+...+|++.++||+|+||+||+|.+..........||+|++.... .......+..|+.+++.++|+||+++++++...
T Consensus 4 l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 81 (279)
T cd05109 4 LKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT--SPKANKEILDEAYVMAGVGSPYVCRLLGICLTS 81 (279)
T ss_pred cchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC--CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC
Confidence 456789999999999999999999775333334468999986542 223455677899999999999999999998754
Q ss_pred CcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCC
Q 012762 159 RWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKG 238 (457)
Q Consensus 159 ~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~ 238 (457)
..+++|||+++|+|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 82 -~~~l~~~~~~~g~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~ 159 (279)
T cd05109 82 -TVQLVTQLMPYGCLLDYVREN-KDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (279)
T ss_pred -CcEEEEEcCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeec
Confidence 578999999999999888764 256899999999999999999999999999999999999999999999999998654
Q ss_pred CCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccc
Q 012762 239 DNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSF 318 (457)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (457)
....... .....
T Consensus 160 ~~~~~~~--------------------------------------------------------------------~~~~~ 171 (279)
T cd05109 160 DIDETEY--------------------------------------------------------------------HADGG 171 (279)
T ss_pred cccccee--------------------------------------------------------------------ecCCC
Confidence 3211100 00011
Q ss_pred cCCCCccCchhhcCCCCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhhh
Q 012762 319 VGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVK 397 (457)
Q Consensus 319 ~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~ 397 (457)
.++..|+|||++.+..++.++|||||||++|||++ |..||.......... .+......+....++.++.+++.+||..
T Consensus 172 ~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~ 250 (279)
T cd05109 172 KVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPD-LLEKGERLPQPPICTIDVYMIMVKCWMI 250 (279)
T ss_pred ccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH-HHHCCCcCCCCccCCHHHHHHHHHHcCC
Confidence 25678999999998889999999999999999998 999998765544443 3444444444556889999999999999
Q ss_pred CCCCCCCCCcChHHHhc
Q 012762 398 DPTRRMGSKMGATAIKR 414 (457)
Q Consensus 398 dP~~Rps~~~~~~~ll~ 414 (457)
||++||+ +.++++
T Consensus 251 dp~~Rp~----~~~l~~ 263 (279)
T cd05109 251 DSECRPR----FRELVD 263 (279)
T ss_pred ChhhCcC----HHHHHH
Confidence 9999999 888874
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=326.78 Aligned_cols=258 Identities=30% Similarity=0.426 Sum_probs=207.9
Q ss_pred CCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcC--C
Q 012762 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCP--R 159 (457)
Q Consensus 82 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~--~ 159 (457)
++|...++||.|++|.||+|.+. .+++.||+|++..... ......+.+|++++++++|+||+++++++... +
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~----~~~~~~~~k~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 74 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLK----NTGMIFALKTITTDPN--PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSS 74 (287)
T ss_pred CceEEEEEeccCCceEEEEEEEC----CCCeEEEEEEEecCCc--hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCC
Confidence 46899999999999999999986 3788999999875422 23456678899999999999999999988653 4
Q ss_pred cEEEEEeecCCCChHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcC
Q 012762 160 WSCLLTEFCPGGDLHVLRQR--QPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLK 237 (457)
Q Consensus 160 ~~~lV~E~~~~~sL~~~~~~--~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~ 237 (457)
.+|+||||+++++|.+++.. .....+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++..
T Consensus 75 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~ 154 (287)
T cd06621 75 SIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGE 154 (287)
T ss_pred eEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccccc
Confidence 68999999999999887654 2345689999999999999999999999999999999999999999999999998743
Q ss_pred CCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcccccc
Q 012762 238 GDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMS 317 (457)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (457)
...... ..
T Consensus 155 ~~~~~~------------------------------------------------------------------------~~ 162 (287)
T cd06621 155 LVNSLA------------------------------------------------------------------------GT 162 (287)
T ss_pred cccccc------------------------------------------------------------------------cc
Confidence 321100 01
Q ss_pred ccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCC-----hHHHHHHHHhcc-cCCCCC----CCCChHH
Q 012762 318 FVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGID-----HELTLANVVARA-LEFPKE----PSVPGPA 387 (457)
Q Consensus 318 ~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~-----~~~~~~~~~~~~-~~~~~~----~~~~~~~ 387 (457)
..++..|+|||.+.+..++.++|||||||++|+|++|..||.... ..+....+.... ..++.. ..+++.+
T Consensus 163 ~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (287)
T cd06621 163 FTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKWSEEF 242 (287)
T ss_pred ccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCCCCchHHHH
Confidence 247889999999998889999999999999999999999998652 122222222211 111111 2346789
Q ss_pred HHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCCC
Q 012762 388 KDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGV 421 (457)
Q Consensus 388 ~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~~ 421 (457)
.++|.+||..||++||+ +.|+++||||+..
T Consensus 243 ~~li~~~l~~~p~~Rpt----~~eil~~~~~~~~ 272 (287)
T cd06621 243 KDFIKQCLEKDPTRRPT----PWDMLEHPWIKAQ 272 (287)
T ss_pred HHHHHHHcCCCcccCCC----HHHHHhCcccccc
Confidence 99999999999999999 9999999999764
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=322.70 Aligned_cols=255 Identities=23% Similarity=0.348 Sum_probs=209.0
Q ss_pred CCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcE
Q 012762 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWS 161 (457)
Q Consensus 82 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~ 161 (457)
++|++.+.||+|+||.||+|.+. .+|+.||+|.++............+.+|++++++++|+||+++++++...+..
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~----~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~ 77 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICL----LDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNEL 77 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEc----CCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeE
Confidence 57999999999999999999986 37889999999765544445567788899999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCC
Q 012762 162 CLLTEFCPGGDLHVLRQRQ--PDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGD 239 (457)
Q Consensus 162 ~lV~E~~~~~sL~~~~~~~--~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~ 239 (457)
++||||+++++|..++... ....+++..++.++.||+.||.|||+.||+|+||||+||+++.++.++|+|||++....
T Consensus 78 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~ 157 (267)
T cd08224 78 NIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeecc
Confidence 9999999999999888653 23558999999999999999999999999999999999999999999999999875442
Q ss_pred CCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcccccccc
Q 012762 240 NSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFV 319 (457)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (457)
..... .....
T Consensus 158 ~~~~~----------------------------------------------------------------------~~~~~ 167 (267)
T cd08224 158 SKTTA----------------------------------------------------------------------AHSLV 167 (267)
T ss_pred CCCcc----------------------------------------------------------------------cceec
Confidence 11100 01235
Q ss_pred CCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCCh--HHHHHHHHhcccCCCCCCCCChHHHHHHHHHhhh
Q 012762 320 GTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDH--ELTLANVVARALEFPKEPSVPGPAKDLIAQLLVK 397 (457)
Q Consensus 320 gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~ 397 (457)
|+..|+|||.+.+..++.++|||||||++|+|++|+.||..... ......+..+.........++..+.++|.+||..
T Consensus 168 ~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~ 247 (267)
T cd08224 168 GTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELRDLVSRCINP 247 (267)
T ss_pred CCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcCHHHHHHHHHHcCC
Confidence 88899999999988899999999999999999999999965432 2233333332222111225778999999999999
Q ss_pred CCCCCCCCCcChHHHhc
Q 012762 398 DPTRRMGSKMGATAIKR 414 (457)
Q Consensus 398 dP~~Rps~~~~~~~ll~ 414 (457)
+|++||+ +.+|++
T Consensus 248 ~p~~Rp~----~~~il~ 260 (267)
T cd08224 248 DPEKRPD----ISYVLQ 260 (267)
T ss_pred CcccCCC----HHHHHH
Confidence 9999999 877764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=322.51 Aligned_cols=255 Identities=23% Similarity=0.337 Sum_probs=213.8
Q ss_pred CCccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEE
Q 012762 77 NPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLD 156 (457)
Q Consensus 77 ~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~ 156 (457)
|++..++|++.++||+|+||+||+|.+. .+..||+|.+..... ....+..|+++++.++|+||+++++++.
T Consensus 1 ~~~~~~~~~i~~~ig~g~~~~v~~~~~~-----~~~~~~vK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 71 (261)
T cd05034 1 WEIPRESLKLERKLGAGQFGEVWMGTWN-----GTTKVAVKTLKPGTM----SPEAFLQEAQIMKKLRHDKLVQLYAVCS 71 (261)
T ss_pred CccchhheeeeeeeccCcceEEEEEEEc-----CCceEEEEEecCCcc----CHHHHHHHHHHHhhCCCCCEeeeeeeee
Confidence 3567789999999999999999999865 456799999875432 3456788999999999999999999999
Q ss_pred cCCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCc
Q 012762 157 CPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSL 236 (457)
Q Consensus 157 ~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~ 236 (457)
.....++||||+++++|.+++.......+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++.
T Consensus 72 ~~~~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~ 151 (261)
T cd05034 72 EEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLAR 151 (261)
T ss_pred cCCceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccce
Confidence 98999999999999999999887655679999999999999999999999999999999999999999999999999876
Q ss_pred CCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccc
Q 012762 237 KGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSM 316 (457)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (457)
......... ..
T Consensus 152 ~~~~~~~~~---------------------------------------------------------------------~~ 162 (261)
T cd05034 152 LIEDDEYTA---------------------------------------------------------------------RE 162 (261)
T ss_pred eccchhhhh---------------------------------------------------------------------hh
Confidence 443210000 00
Q ss_pred cccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHh
Q 012762 317 SFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLL 395 (457)
Q Consensus 317 ~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L 395 (457)
...++..|+|||.+.+..++.++|||||||++|+|++ |+.||.+......+..+. ..+..+.....+..+.+++.+||
T Consensus 163 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~l 241 (261)
T cd05034 163 GAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVE-RGYRMPRPPNCPEELYDLMLQCW 241 (261)
T ss_pred ccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHHHHHHHHHHc
Confidence 1124678999999998889999999999999999998 999998877666665554 34445555567899999999999
Q ss_pred hhCCCCCCCCCcChHHHhc
Q 012762 396 VKDPTRRMGSKMGATAIKR 414 (457)
Q Consensus 396 ~~dP~~Rps~~~~~~~ll~ 414 (457)
..||++||+ +.+++.
T Consensus 242 ~~~p~~Rp~----~~~l~~ 256 (261)
T cd05034 242 DKDPEERPT----FEYLQS 256 (261)
T ss_pred ccCcccCCC----HHHHHH
Confidence 999999999 888764
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=338.98 Aligned_cols=265 Identities=19% Similarity=0.274 Sum_probs=208.9
Q ss_pred CCccCCCceeEEEecccCcceEEEEEEeccC-CCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHc-CCCCCceEEEE
Q 012762 77 NPLTLSDLRFVHRLGSGDIGSVYLVQLKSKS-SNNGCFFAAKVMDKRELVSRNKESRARIEREILEML-DHPFLPTLYAT 154 (457)
Q Consensus 77 ~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~-~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~~~ 154 (457)
|.+..++|++.+.||.|+||+||+|.+...+ ..+++.||||+++... .......+.+|+++|..+ +|+||++++++
T Consensus 2 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~ 79 (343)
T cd05103 2 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGA 79 (343)
T ss_pred cccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC--ChHHHHHHHHHHHHHHhccCCccHhhhcce
Confidence 5677789999999999999999999865332 2467899999996532 123345677899999999 68999999998
Q ss_pred EEc-CCcEEEEEeecCCCChHHHHHhCC----------------------------------------------------
Q 012762 155 LDC-PRWSCLLTEFCPGGDLHVLRQRQP---------------------------------------------------- 181 (457)
Q Consensus 155 ~~~-~~~~~lV~E~~~~~sL~~~~~~~~---------------------------------------------------- 181 (457)
+.. +...++|||||++|+|.+++....
T Consensus 80 ~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (343)
T cd05103 80 CTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLS 159 (343)
T ss_pred eecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccc
Confidence 754 456899999999999998886531
Q ss_pred -------------CCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCCCcccccc
Q 012762 182 -------------DKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQLV 248 (457)
Q Consensus 182 -------------~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~~~~~~~~ 248 (457)
...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~---- 235 (343)
T cd05103 160 DVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY---- 235 (343)
T ss_pred cchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcch----
Confidence 123677888899999999999999999999999999999999999999999997543211000
Q ss_pred cCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCCCCccCch
Q 012762 249 SDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTHEYLAPE 328 (457)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 328 (457)
.......++..|+|||
T Consensus 236 ----------------------------------------------------------------~~~~~~~~~~~y~aPE 251 (343)
T cd05103 236 ----------------------------------------------------------------VRKGDARLPLKWMAPE 251 (343)
T ss_pred ----------------------------------------------------------------hhcCCCCCCcceECcH
Confidence 0000123567899999
Q ss_pred hhcCCCCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhhhCCCCCCCCCc
Q 012762 329 IISGEGHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDPTRRMGSKM 407 (457)
Q Consensus 329 ~l~~~~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rps~~~ 407 (457)
++.+..++.++|||||||++|+|++ |..||............+......+.....+.++.+++.+||..||++||+
T Consensus 252 ~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~~p~~Rps--- 328 (343)
T cd05103 252 TIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPT--- 328 (343)
T ss_pred HhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHHHHccCChhhCcC---
Confidence 9998889999999999999999996 999998765443344444343333333446788999999999999999999
Q ss_pred ChHHHhcC
Q 012762 408 GATAIKRH 415 (457)
Q Consensus 408 ~~~~ll~h 415 (457)
+.+|++|
T Consensus 329 -~~eil~~ 335 (343)
T cd05103 329 -FSELVEH 335 (343)
T ss_pred -HHHHHHH
Confidence 9999876
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=321.30 Aligned_cols=259 Identities=25% Similarity=0.407 Sum_probs=210.8
Q ss_pred CCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhh--hhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcC-
Q 012762 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRE--LVSRNKESRARIEREILEMLDHPFLPTLYATLDCP- 158 (457)
Q Consensus 82 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~- 158 (457)
.+|++.+.||+|+||.||+|.++ .++..||+|++.... .........+.+|++++++++|+||+++++++...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~----~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~ 77 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDA----DTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPE 77 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEc----CCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCC
Confidence 47999999999999999999876 478899999875421 11223456778899999999999999999998664
Q ss_pred -CcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcC
Q 012762 159 -RWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLK 237 (457)
Q Consensus 159 -~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~ 237 (457)
..+++||||+++++|.+++... ..+++..++.++.||+.||.|||+.|++|+||||+||+++.++.++|+|||+++.
T Consensus 78 ~~~~~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 155 (264)
T cd06653 78 EKKLSIFVEYMPGGSIKDQLKAY--GALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKR 155 (264)
T ss_pred CCEEEEEEEeCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccc
Confidence 4588999999999999888764 4588999999999999999999999999999999999999999999999999865
Q ss_pred CCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcccccc
Q 012762 238 GDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMS 317 (457)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (457)
....... ......
T Consensus 156 ~~~~~~~-------------------------------------------------------------------~~~~~~ 168 (264)
T cd06653 156 IQTICMS-------------------------------------------------------------------GTGIKS 168 (264)
T ss_pred ccccccc-------------------------------------------------------------------Cccccc
Confidence 4211000 000112
Q ss_pred ccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhhh
Q 012762 318 FVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVK 397 (457)
Q Consensus 318 ~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~ 397 (457)
+.|+..|+|||++.+..++.++|+|||||++|+|++|+.||..........++.........+..+++.+.+++.+||.
T Consensus 169 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~i~~~l~- 247 (264)
T cd06653 169 VTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACRDFLKQIFV- 247 (264)
T ss_pred cCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCcccCHHHHHHHHHHhc-
Confidence 4589999999999988899999999999999999999999987665554444443322222344578899999999999
Q ss_pred CCCCCCCCCcChHHHhcCCCC
Q 012762 398 DPTRRMGSKMGATAIKRHQFF 418 (457)
Q Consensus 398 dP~~Rps~~~~~~~ll~hp~f 418 (457)
+|..||+ +.+++.|||.
T Consensus 248 ~~~~r~~----~~~~~~~~~~ 264 (264)
T cd06653 248 EEKRRPT----AEFLLRHPFV 264 (264)
T ss_pred CcccCcc----HHHHhcCCCC
Confidence 5799999 9999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=327.48 Aligned_cols=255 Identities=24% Similarity=0.379 Sum_probs=205.9
Q ss_pred CceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcEE
Q 012762 83 DLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWSC 162 (457)
Q Consensus 83 ~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~ 162 (457)
+|++.++||.|++|+||+|++. .+|..||+|++..... ......+..|++++++++|+||+++++++...+..|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~----~~~~~~~iK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 74 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNR----TTGEIVALKEIHLDAE--EGTPSTAIREISLMKELKHENIVRLHDVIHTENKLM 74 (284)
T ss_pred CceEeeeeccCCceEEEEEEEC----CCCeEEEEEEeccccc--ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEE
Confidence 5899999999999999999986 3788999999875432 223455667999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCC
Q 012762 163 LLTEFCPGGDLHVLRQRQP-DKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNS 241 (457)
Q Consensus 163 lV~E~~~~~sL~~~~~~~~-~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~ 241 (457)
+||||+. ++|..++.... ...+++..+..++.||+.||.|||+.|++|+||||+||+++.++.++|+|||++......
T Consensus 75 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~ 153 (284)
T cd07836 75 LVFEYMD-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIP 153 (284)
T ss_pred EEEecCC-ccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCC
Confidence 9999996 58877776532 346899999999999999999999999999999999999999999999999987543211
Q ss_pred CcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCC
Q 012762 242 TSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGT 321 (457)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 321 (457)
... .....++
T Consensus 154 ~~~----------------------------------------------------------------------~~~~~~~ 163 (284)
T cd07836 154 VNT----------------------------------------------------------------------FSNEVVT 163 (284)
T ss_pred ccc----------------------------------------------------------------------ccccccc
Confidence 000 0012478
Q ss_pred CCccCchhhcCC-CCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhccc------------------CCCC---
Q 012762 322 HEYLAPEIISGE-GHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARAL------------------EFPK--- 379 (457)
Q Consensus 322 ~~y~aPE~l~~~-~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~------------------~~~~--- 379 (457)
..|++||++.+. .++.++|||||||++|+|++|+.||.+.+..+....+..... ..+.
T Consensus 164 ~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (284)
T cd07836 164 LWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFPRYPP 243 (284)
T ss_pred ccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcccccCCCh
Confidence 899999998765 478899999999999999999999988765554444332100 0000
Q ss_pred ------CCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCC
Q 012762 380 ------EPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFF 418 (457)
Q Consensus 380 ------~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f 418 (457)
.+.++..+.+++.+||+.||.+||+ +.++++||||
T Consensus 244 ~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~----~~~~l~~~~f 284 (284)
T cd07836 244 QDLQQLFPHADPLGIDLLHRLLQLNPELRIS----AHDALQHPWF 284 (284)
T ss_pred HHHHHHhhhcCcHHHHHHHHHhcCCcccCCC----HHHHhcCCCC
Confidence 1235678899999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=325.57 Aligned_cols=261 Identities=22% Similarity=0.355 Sum_probs=216.7
Q ss_pred cCCCceeEEEecccCcceEEEEEEeccC-CCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcC
Q 012762 80 TLSDLRFVHRLGSGDIGSVYLVQLKSKS-SNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCP 158 (457)
Q Consensus 80 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~-~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~ 158 (457)
..++|++++.||.|+||+||+|+++... ......||+|.+.... .......+..|+++|++++|+||+++++++...
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 80 (275)
T cd05046 3 PRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKLSHKNVVRLLGLCREA 80 (275)
T ss_pred ChHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc--chHHHHHHHHHHHHHHhcCCcceeeeEEEECCC
Confidence 4468999999999999999999976432 2345689999986542 122456788899999999999999999999998
Q ss_pred CcEEEEEeecCCCChHHHHHhCCC-------CCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEec
Q 012762 159 RWSCLLTEFCPGGDLHVLRQRQPD-------KRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTD 231 (457)
Q Consensus 159 ~~~~lV~E~~~~~sL~~~~~~~~~-------~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~D 231 (457)
+..|+||||+++++|.+++..... ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.++++|
T Consensus 81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~ 160 (275)
T cd05046 81 EPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSL 160 (275)
T ss_pred CcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEcc
Confidence 999999999999999999876531 2689999999999999999999999999999999999999999999999
Q ss_pred cCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCC
Q 012762 232 FDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPL 311 (457)
Q Consensus 232 FG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (457)
||++........
T Consensus 161 ~~~~~~~~~~~~-------------------------------------------------------------------- 172 (275)
T cd05046 161 LSLSKDVYNSEY-------------------------------------------------------------------- 172 (275)
T ss_pred cccccccCcccc--------------------------------------------------------------------
Confidence 998753321100
Q ss_pred ccccccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHH
Q 012762 312 DVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDL 390 (457)
Q Consensus 312 ~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 390 (457)
.......++..|+|||.+.+..++.++|||||||++|+|++ |..||...........+..+....+....++..+.++
T Consensus 173 -~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 251 (275)
T cd05046 173 -YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPVPEGCPSRLYKL 251 (275)
T ss_pred -cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCCCCCCCCCHHHHHH
Confidence 00011246778999999988888999999999999999998 8999988777777777666666665556788999999
Q ss_pred HHHHhhhCCCCCCCCCcChHHHhcC
Q 012762 391 IAQLLVKDPTRRMGSKMGATAIKRH 415 (457)
Q Consensus 391 l~~~L~~dP~~Rps~~~~~~~ll~h 415 (457)
+.+||+.||++||+ +.+++++
T Consensus 252 i~~~l~~~p~~Rp~----~~~~l~~ 272 (275)
T cd05046 252 MTRCWAVNPKDRPS----FSELVSA 272 (275)
T ss_pred HHHHcCCCcccCCC----HHHHHHH
Confidence 99999999999999 9998864
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=327.32 Aligned_cols=254 Identities=24% Similarity=0.377 Sum_probs=211.7
Q ss_pred CceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcEE
Q 012762 83 DLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWSC 162 (457)
Q Consensus 83 ~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~ 162 (457)
-|++.++||.|+||.||+|.+. .++..||+|++..... ......+.+|++++++++|+||+++++++..+...|
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~----~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 78 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDN----RTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLW 78 (277)
T ss_pred hhhhheeEeecCCeEEEEEEEC----CCCcEEEEEEeccccc--hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEE
Confidence 3778899999999999999876 3788999999865422 234466788999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCCC
Q 012762 163 LLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNST 242 (457)
Q Consensus 163 lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~~ 242 (457)
+||||+.+++|..++.. ..+++..+..++.|++.+|.|||+.|++|+||||+||+++.++.++|+|||++.......
T Consensus 79 lv~e~~~~~~l~~~i~~---~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06641 79 IIMEYLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 155 (277)
T ss_pred EEEEeCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccch
Confidence 99999999999988765 468999999999999999999999999999999999999999999999999875432110
Q ss_pred cccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCCC
Q 012762 243 STAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTH 322 (457)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 322 (457)
. ......|+.
T Consensus 156 ~----------------------------------------------------------------------~~~~~~~~~ 165 (277)
T cd06641 156 I----------------------------------------------------------------------KRNTFVGTP 165 (277)
T ss_pred h----------------------------------------------------------------------hhccccCCc
Confidence 0 001235788
Q ss_pred CccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhhhCCCCC
Q 012762 323 EYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDPTRR 402 (457)
Q Consensus 323 ~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R 402 (457)
.|+|||.+.+..++.++|+|||||++|+|++|..||...........+.... .......++.++.+++.+||..||++|
T Consensus 166 ~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~~p~~R 244 (277)
T cd06641 166 FWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNN-PPTLEGNYSKPLKEFVEACLNKEPSFR 244 (277)
T ss_pred cccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCC-CCCCCcccCHHHHHHHHHHccCChhhC
Confidence 9999999988888999999999999999999999998766544444433222 112223578899999999999999999
Q ss_pred CCCCcChHHHhcCCCCCC
Q 012762 403 MGSKMGATAIKRHQFFNG 420 (457)
Q Consensus 403 ps~~~~~~~ll~hp~f~~ 420 (457)
|+ +.++++||||..
T Consensus 245 p~----~~~~l~~~~~~~ 258 (277)
T cd06641 245 PT----AKELLKHKFIVR 258 (277)
T ss_pred cC----HHHHHhCHHHhh
Confidence 99 999999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=321.99 Aligned_cols=253 Identities=24% Similarity=0.316 Sum_probs=207.6
Q ss_pred CccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEc
Q 012762 78 PLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDC 157 (457)
Q Consensus 78 ~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~ 157 (457)
.+..++|.+.++||+|+||.||+|.+. .+..+|+|++.... .....+.+|++++++++|+||+++++++.
T Consensus 2 ~~~~~~~~~~~~ig~g~~~~v~~~~~~-----~~~~~~lK~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~- 71 (260)
T cd05069 2 EIPRESLRLDVKLGQGCFGEVWMGTWN-----GTTKVAIKTLKPGT----MMPEAFLQEAQIMKKLRHDKLVPLYAVVS- 71 (260)
T ss_pred cCChHHeeeeeeecCcCCCeEEEEEEc-----CCceEEEEEcccCC----ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-
Confidence 455678999999999999999999875 33469999886542 23456778999999999999999999885
Q ss_pred CCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcC
Q 012762 158 PRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLK 237 (457)
Q Consensus 158 ~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~ 237 (457)
.+..|+||||+.+++|.+++.......+++..+..++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++..
T Consensus 72 ~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~ 151 (260)
T cd05069 72 EEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARL 151 (260)
T ss_pred CCCcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceE
Confidence 45688999999999999998776555689999999999999999999999999999999999999999999999999754
Q ss_pred CCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcccccc
Q 012762 238 GDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMS 317 (457)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (457)
........ ...
T Consensus 152 ~~~~~~~~---------------------------------------------------------------------~~~ 162 (260)
T cd05069 152 IEDNEYTA---------------------------------------------------------------------RQG 162 (260)
T ss_pred ccCCcccc---------------------------------------------------------------------cCC
Confidence 42111000 001
Q ss_pred ccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhh
Q 012762 318 FVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLV 396 (457)
Q Consensus 318 ~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~ 396 (457)
..++..|+|||++.+..++.++|||||||++|||++ |..||.+.........+. .....+.....+..+.+++.+||.
T Consensus 163 ~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~ 241 (260)
T cd05069 163 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVE-RGYRMPCPQGCPESLHELMKLCWK 241 (260)
T ss_pred CccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCcccCHHHHHHHHHHcc
Confidence 136778999999998889999999999999999999 999998877666555544 334444445688899999999999
Q ss_pred hCCCCCCCCCcChHHHhc
Q 012762 397 KDPTRRMGSKMGATAIKR 414 (457)
Q Consensus 397 ~dP~~Rps~~~~~~~ll~ 414 (457)
.||++||+ ++++++
T Consensus 242 ~~p~~Rp~----~~~i~~ 255 (260)
T cd05069 242 KDPDERPT----FEYIQS 255 (260)
T ss_pred CCcccCcC----HHHHHH
Confidence 99999999 887765
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=330.23 Aligned_cols=262 Identities=27% Similarity=0.371 Sum_probs=202.7
Q ss_pred cCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCC
Q 012762 80 TLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPR 159 (457)
Q Consensus 80 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~ 159 (457)
..++|++.++||+|+||.||+|.++ .++..||+|++..... .......+.+|++++++++||||+++++++...+
T Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~----~~~~~~aik~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 84 (310)
T cd07865 10 EVSKYEKLAKIGQGTFGEVFKARHK----KTKQIVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKA 84 (310)
T ss_pred hhhheEEEEEeecCCCEEEEEEEEC----CCCcEEEEEEEeccCC-cCCchhHHHHHHHHHHhCCCCCccceEEEEeccc
Confidence 4568999999999999999999876 3788999999865422 2223345567999999999999999999986544
Q ss_pred --------cEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEec
Q 012762 160 --------WSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTD 231 (457)
Q Consensus 160 --------~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~D 231 (457)
..|+||||+ +++|..++... ...+++..++.++.||+.||.|||++|++|+||||+||+++.++.+||+|
T Consensus 85 ~~~~~~~~~~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~d 162 (310)
T cd07865 85 TPYNRYKGSFYLVFEFC-EHDLAGLLSNK-NVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLAD 162 (310)
T ss_pred ccccCCCceEEEEEcCC-CcCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECc
Confidence 459999999 56887776553 24689999999999999999999999999999999999999999999999
Q ss_pred cCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCC
Q 012762 232 FDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPL 311 (457)
Q Consensus 232 FG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (457)
||++..........
T Consensus 163 fg~~~~~~~~~~~~------------------------------------------------------------------ 176 (310)
T cd07865 163 FGLARAFSLSKNSK------------------------------------------------------------------ 176 (310)
T ss_pred CCCcccccCCcccC------------------------------------------------------------------
Confidence 99986543211000
Q ss_pred ccccccccCCCCccCchhhcCCC-CCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhccc---------------
Q 012762 312 DVRSMSFVGTHEYLAPEIISGEG-HGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARAL--------------- 375 (457)
Q Consensus 312 ~~~~~~~~gt~~y~aPE~l~~~~-~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~--------------- 375 (457)
........++..|+|||++.+.. ++.++||||||+++|||++|+.||.+.........+.....
T Consensus 177 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (310)
T cd07865 177 PNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLEL 256 (310)
T ss_pred CCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccchhh
Confidence 00001235788999999987654 78899999999999999999999987654433222221100
Q ss_pred ----CCCCC-----------CCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCC
Q 012762 376 ----EFPKE-----------PSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFF 418 (457)
Q Consensus 376 ----~~~~~-----------~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f 418 (457)
.++.. ...+..+.++|.+||..||++||+ ++++++||||
T Consensus 257 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t----~~e~l~h~~f 310 (310)
T cd07865 257 FKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRID----ADTALNHDFF 310 (310)
T ss_pred hhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccC----HHHHhcCCCC
Confidence 01100 012456789999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=330.99 Aligned_cols=265 Identities=18% Similarity=0.262 Sum_probs=211.0
Q ss_pred CCCccCCCceeEEEecccCcceEEEEEEeccCC---CCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHc-CCCCCceE
Q 012762 76 NNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSS---NNGCFFAAKVMDKRELVSRNKESRARIEREILEML-DHPFLPTL 151 (457)
Q Consensus 76 ~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~---~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l 151 (457)
.+.+..++|.+.+.||+|+||.||+|.+...+. .....+|+|++.... .......+..|+++++++ +|+||+++
T Consensus 12 ~~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~~i~~~ 89 (307)
T cd05098 12 RWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINL 89 (307)
T ss_pred cceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC--ChHHHHHHHHHHHHHHHhcCCCCEeeE
Confidence 455666899999999999999999998754322 234579999997542 122345677799999999 79999999
Q ss_pred EEEEEcCCcEEEEEeecCCCChHHHHHhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCC
Q 012762 152 YATLDCPRWSCLLTEFCPGGDLHVLRQRQP--------------DKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPE 217 (457)
Q Consensus 152 ~~~~~~~~~~~lV~E~~~~~sL~~~~~~~~--------------~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~ 217 (457)
++++...+..|+||||+.+++|.+++.... ...+++..++.++.||+.||+|||++|++||||||+
T Consensus 90 ~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~ 169 (307)
T cd05098 90 LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAAR 169 (307)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHH
Confidence 999999999999999999999999987642 134888999999999999999999999999999999
Q ss_pred CeEEccCCCEEEeccCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhcccc
Q 012762 218 NVLVRSDGHIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKK 297 (457)
Q Consensus 218 NIll~~~~~vkl~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (457)
|||++.++.+||+|||++..........
T Consensus 170 Nill~~~~~~kL~dfg~a~~~~~~~~~~---------------------------------------------------- 197 (307)
T cd05098 170 NVLVTEDNVMKIADFGLARDIHHIDYYK---------------------------------------------------- 197 (307)
T ss_pred heEEcCCCcEEECCCcccccccccchhh----------------------------------------------------
Confidence 9999999999999999875432110000
Q ss_pred CCCCCCCcccccCCccccccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHHhcccC
Q 012762 298 LGNPGTPEIVAEPLDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVVARALE 376 (457)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~ 376 (457)
......++..|+|||++.+..++.++|||||||++|||++ |..||.+....+....+. ....
T Consensus 198 ----------------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~~~ 260 (307)
T cd05098 198 ----------------KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK-EGHR 260 (307)
T ss_pred ----------------ccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHH-cCCC
Confidence 0000124568999999998889999999999999999998 899998766554444433 3333
Q ss_pred CCCCCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcC
Q 012762 377 FPKEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRH 415 (457)
Q Consensus 377 ~~~~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~h 415 (457)
......++.++.+|+.+||..+|++||+ +.+++++
T Consensus 261 ~~~~~~~~~~~~~li~~~l~~~p~~Rps----~~evl~~ 295 (307)
T cd05098 261 MDKPSNCTNELYMMMRDCWHAVPSQRPT----FKQLVED 295 (307)
T ss_pred CCCCCcCCHHHHHHHHHHcccChhhCcC----HHHHHHH
Confidence 3444567889999999999999999999 7777654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-42 Score=338.57 Aligned_cols=262 Identities=20% Similarity=0.333 Sum_probs=204.4
Q ss_pred EEeccc--CcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcEEEEE
Q 012762 88 HRLGSG--DIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWSCLLT 165 (457)
Q Consensus 88 ~~LG~G--~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lV~ 165 (457)
..||.| +||+||+|++. .+|+.||+|++....... ...+.+.+|+.+++.++||||++++++|..++..|+||
T Consensus 4 ~~ig~g~~~~~~v~~a~~~----~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~ 78 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHT----PTGTLVTVRITDLENCTE-EHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVIS 78 (328)
T ss_pred HHhCCcccCceeEEEEEEc----CCCcEEEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEE
Confidence 356666 99999999876 478999999987543322 34567888999999999999999999999999999999
Q ss_pred eecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCCCccc
Q 012762 166 EFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTA 245 (457)
Q Consensus 166 E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~~~~~ 245 (457)
||+.+++|..++.......+++..+..++.||+.||.|||++||+||||||+|||++.++.++++||+.+..........
T Consensus 79 e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~ 158 (328)
T cd08226 79 PFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA 158 (328)
T ss_pred ecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc
Confidence 99999999998887655569999999999999999999999999999999999999999999999998643221100000
Q ss_pred ccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCCCCcc
Q 012762 246 QLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTHEYL 325 (457)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 325 (457)
. .. ........++..|+
T Consensus 159 ~--------------------------------------------------~~-------------~~~~~~~~~~~~y~ 175 (328)
T cd08226 159 K--------------------------------------------------VV-------------YDFPQFSTSVLPWL 175 (328)
T ss_pred c--------------------------------------------------cc-------------ccccccccCccCcc
Confidence 0 00 00000113567899
Q ss_pred CchhhcCC--CCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccC---------------------------
Q 012762 326 APEIISGE--GHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALE--------------------------- 376 (457)
Q Consensus 326 aPE~l~~~--~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~--------------------------- 376 (457)
|||++.+. .++.++|||||||++|+|++|..||............+.....
T Consensus 176 aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (328)
T cd08226 176 SPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIG 255 (328)
T ss_pred ChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhhhccchhhhhcccc
Confidence 99999764 4789999999999999999999999876655444443322111
Q ss_pred ------------------CCCCCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCCC
Q 012762 377 ------------------FPKEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGV 421 (457)
Q Consensus 377 ------------------~~~~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~~ 421 (457)
.+....++..+.+||.+||+.||++||+ +.++++||||+.+
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt----a~e~l~~~~~~~~ 314 (328)
T cd08226 256 ESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPS----ASSLLSHAFFKQV 314 (328)
T ss_pred cchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCC----HHHHhhCHHHHHH
Confidence 1111235567899999999999999999 9999999999753
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=323.09 Aligned_cols=256 Identities=25% Similarity=0.373 Sum_probs=203.0
Q ss_pred CCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCc
Q 012762 81 LSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRW 160 (457)
Q Consensus 81 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~ 160 (457)
.+.+.....||+|+||.||+|.+. .++..||+|.+..... .....+.+|+++++.++|+||+++++++..++.
T Consensus 7 ~~~~~~~~~lg~g~~g~v~~~~~~----~~~~~v~~k~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 79 (268)
T cd06624 7 YDENGERVVLGKGTYGIVYAARDL----STQVRIAIKEIPERDS---RYVQPLHEEIALHSYLKHRNIVQYLGSDSENGF 79 (268)
T ss_pred cccCCceEEEecCCceEEEEeEec----CCCcEEEEEEecCCCH---HHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCE
Confidence 344555578999999999999876 3678899998865422 344567889999999999999999999999999
Q ss_pred EEEEEeecCCCChHHHHHhCCCCCC--CHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEcc-CCCEEEeccCCCcC
Q 012762 161 SCLLTEFCPGGDLHVLRQRQPDKRF--HESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRS-DGHIMLTDFDLSLK 237 (457)
Q Consensus 161 ~~lV~E~~~~~sL~~~~~~~~~~~~--~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~-~~~vkl~DFG~s~~ 237 (457)
.++||||+.+++|..++.... ..+ ++..+..++.||+.||.|||+.||+||||||+||+++. ++.++|+|||++..
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~ 158 (268)
T cd06624 80 FKIFMEQVPGGSLSALLRSKW-GPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKR 158 (268)
T ss_pred EEEEEecCCCCCHHHHHHHhc-ccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhhee
Confidence 999999999999998887542 334 78888999999999999999999999999999999986 67999999998754
Q ss_pred CCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcccccc
Q 012762 238 GDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMS 317 (457)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (457)
...... ....
T Consensus 159 ~~~~~~----------------------------------------------------------------------~~~~ 168 (268)
T cd06624 159 LAGINP----------------------------------------------------------------------CTET 168 (268)
T ss_pred cccCCC----------------------------------------------------------------------cccc
Confidence 321100 0001
Q ss_pred ccCCCCccCchhhcCCC--CCccchhhhhhHHHHHHhcCCCCCCCCChHHHH-HHHHhcccCCCCCCCCChHHHHHHHHH
Q 012762 318 FVGTHEYLAPEIISGEG--HGNAVDWWTLGIFIFELFYGTTPFKGIDHELTL-ANVVARALEFPKEPSVPGPAKDLIAQL 394 (457)
Q Consensus 318 ~~gt~~y~aPE~l~~~~--~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ll~~~ 394 (457)
..|+..|+|||++.+.. ++.++||||||+++|+|++|..||......... ............+..+++++.+++.+|
T Consensus 169 ~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 248 (268)
T cd06624 169 FTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNFILRC 248 (268)
T ss_pred CCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCHHHHHHHHHH
Confidence 24788999999987654 788999999999999999999999765432221 111111111122335788999999999
Q ss_pred hhhCCCCCCCCCcChHHHhcCCCC
Q 012762 395 LVKDPTRRMGSKMGATAIKRHQFF 418 (457)
Q Consensus 395 L~~dP~~Rps~~~~~~~ll~hp~f 418 (457)
|..+|.+||+ +.+++.||||
T Consensus 249 l~~~p~~Rpt----~~~ll~~~~~ 268 (268)
T cd06624 249 FEPDPDKRAS----AHDLLQDPFL 268 (268)
T ss_pred cCCCchhCCC----HHHHHhCCCC
Confidence 9999999999 9999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=329.19 Aligned_cols=266 Identities=18% Similarity=0.272 Sum_probs=214.1
Q ss_pred CCCCccCCCceeEEEecccCcceEEEEEEeccC---CCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHc-CCCCCce
Q 012762 75 NNNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKS---SNNGCFFAAKVMDKRELVSRNKESRARIEREILEML-DHPFLPT 150 (457)
Q Consensus 75 ~~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~---~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~ 150 (457)
..+.+..++|.+.+.||+|+||.||+|++...+ ...+..||+|++.... .......+..|+++++.+ +|+||++
T Consensus 8 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~ 85 (304)
T cd05101 8 PRWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIIN 85 (304)
T ss_pred CcccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc--chHHHHHHHHHHHHHHhhccCCCchh
Confidence 345677889999999999999999999864322 2345689999986432 223456678899999999 8999999
Q ss_pred EEEEEEcCCcEEEEEeecCCCChHHHHHhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCC
Q 012762 151 LYATLDCPRWSCLLTEFCPGGDLHVLRQRQP--------------DKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKP 216 (457)
Q Consensus 151 l~~~~~~~~~~~lV~E~~~~~sL~~~~~~~~--------------~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp 216 (457)
+++++......|+||||+.+++|..++.... ...++...+..++.||+.||.|||++||+||||||
T Consensus 86 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp 165 (304)
T cd05101 86 LLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAA 165 (304)
T ss_pred eeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeeccccc
Confidence 9999999999999999999999999887642 23577888999999999999999999999999999
Q ss_pred CCeEEccCCCEEEeccCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccc
Q 012762 217 ENVLVRSDGHIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKK 296 (457)
Q Consensus 217 ~NIll~~~~~vkl~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (457)
+|||++.++.+||+|||+++.........
T Consensus 166 ~Nili~~~~~~kl~D~g~~~~~~~~~~~~--------------------------------------------------- 194 (304)
T cd05101 166 RNVLVTENNVMKIADFGLARDVNNIDYYK--------------------------------------------------- 194 (304)
T ss_pred ceEEEcCCCcEEECCCccceecccccccc---------------------------------------------------
Confidence 99999999999999999986543211100
Q ss_pred cCCCCCCCcccccCCccccccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHHhccc
Q 012762 297 KLGNPGTPEIVAEPLDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVVARAL 375 (457)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~ 375 (457)
......++..|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+....+... .
T Consensus 195 -----------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-~ 256 (304)
T cd05101 195 -----------------KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEG-H 256 (304)
T ss_pred -----------------cccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcC-C
Confidence 0001135678999999998889999999999999999998 88999887766655554433 3
Q ss_pred CCCCCCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcC
Q 012762 376 EFPKEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRH 415 (457)
Q Consensus 376 ~~~~~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~h 415 (457)
.......++..+.+|+.+||..+|.+||+ +.++++.
T Consensus 257 ~~~~~~~~~~~~~~li~~cl~~~p~~Rps----~~e~l~~ 292 (304)
T cd05101 257 RMDKPANCTNELYMMMRDCWHAIPSHRPT----FKQLVED 292 (304)
T ss_pred cCCCCCCCCHHHHHHHHHHcccChhhCCC----HHHHHHH
Confidence 33344568899999999999999999999 7877764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=320.55 Aligned_cols=247 Identities=20% Similarity=0.357 Sum_probs=201.1
Q ss_pred EEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcEEEEEee
Q 012762 88 HRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWSCLLTEF 167 (457)
Q Consensus 88 ~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lV~E~ 167 (457)
+.||+|+||+||+|.++. +++.||+|.+... ........+.+|+++|++++|+||+++++++...+..|+||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~----~~~~~a~k~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 74 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRA----DNTPVAVKSCRET--LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMEL 74 (252)
T ss_pred CccCcccCccEEEEEEec----CCceEEEEecCcc--CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEee
Confidence 368999999999999873 7889999987643 2233456788899999999999999999999999999999999
Q ss_pred cCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCCCccccc
Q 012762 168 CPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQL 247 (457)
Q Consensus 168 ~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~~~~~~~ 247 (457)
+.+++|.+++... ...+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++..........
T Consensus 75 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~-- 151 (252)
T cd05084 75 VQGGDFLTFLRTE-GPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYAS-- 151 (252)
T ss_pred ccCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccc--
Confidence 9999999888654 2468999999999999999999999999999999999999999999999999975432110000
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCCCCccCc
Q 012762 248 VSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTHEYLAP 327 (457)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 327 (457)
......++..|+||
T Consensus 152 ------------------------------------------------------------------~~~~~~~~~~y~aP 165 (252)
T cd05084 152 ------------------------------------------------------------------TGGMKQIPVKWTAP 165 (252)
T ss_pred ------------------------------------------------------------------cCCCCCCceeecCc
Confidence 00001235679999
Q ss_pred hhhcCCCCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhhhCCCCCCCCC
Q 012762 328 EIISGEGHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDPTRRMGSK 406 (457)
Q Consensus 328 E~l~~~~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rps~~ 406 (457)
|.+.+..++.++|||||||++|||++ |..||...........+. .....+....++..+.+++.+||..||++||+
T Consensus 166 E~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-- 242 (252)
T cd05084 166 EALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIE-QGVRLPCPELCPDAVYRLMERCWEYDPGQRPS-- 242 (252)
T ss_pred hhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHH-cCCCCCCcccCCHHHHHHHHHHcCCChhhCcC--
Confidence 99998889999999999999999997 999998766655444433 33344444567899999999999999999999
Q ss_pred cChHHHhc
Q 012762 407 MGATAIKR 414 (457)
Q Consensus 407 ~~~~~ll~ 414 (457)
+.++++
T Consensus 243 --~~~~~~ 248 (252)
T cd05084 243 --FSTVHQ 248 (252)
T ss_pred --HHHHHH
Confidence 888764
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=336.79 Aligned_cols=255 Identities=27% Similarity=0.386 Sum_probs=207.6
Q ss_pred CCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCC-
Q 012762 81 LSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPR- 159 (457)
Q Consensus 81 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~- 159 (457)
.++|++++.||+|+||.||+|.+. .++..||+|++.+.. ........+..|+++|+.++|+||+++++++..+.
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~----~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 88 (343)
T cd07880 14 PDRYRDLKQVGSGAYGTVCSALDR----RTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLS 88 (343)
T ss_pred ccceEEEEEeeecCCeEEEEEEEC----CCCcEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcc
Confidence 467999999999999999999876 478899999986432 22233456778999999999999999999987654
Q ss_pred -----cEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCC
Q 012762 160 -----WSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDL 234 (457)
Q Consensus 160 -----~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~ 234 (457)
..|+||||+ +++|..++.. ..+++..++.++.||+.||.|||+.||+||||||+||+++.++.++|+|||+
T Consensus 89 ~~~~~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~ 164 (343)
T cd07880 89 LDRFHDFYLVMPFM-GTDLGKLMKH---EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGL 164 (343)
T ss_pred ccccceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeccc
Confidence 358999999 8899887764 5689999999999999999999999999999999999999999999999998
Q ss_pred CcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccc
Q 012762 235 SLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVR 314 (457)
Q Consensus 235 s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (457)
+......
T Consensus 165 ~~~~~~~------------------------------------------------------------------------- 171 (343)
T cd07880 165 ARQTDSE------------------------------------------------------------------------- 171 (343)
T ss_pred ccccccC-------------------------------------------------------------------------
Confidence 7543210
Q ss_pred cccccCCCCccCchhhcC-CCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCC---------------
Q 012762 315 SMSFVGTHEYLAPEIISG-EGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFP--------------- 378 (457)
Q Consensus 315 ~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~--------------- 378 (457)
.....+++.|+|||++.+ ..++.++|+|||||++|+|++|..||.+......+..++......+
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (343)
T cd07880 172 MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNY 251 (343)
T ss_pred ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhHHHH
Confidence 001247889999999976 3578999999999999999999999987665444443332211100
Q ss_pred --------------CCCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCCC
Q 012762 379 --------------KEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGV 421 (457)
Q Consensus 379 --------------~~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~~ 421 (457)
....++..+.++|.+||..||++||+ +.+++.||||+..
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t----~~~~l~~~~~~~~ 304 (343)
T cd07880 252 VKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRIT----AAEALAHPYFEEF 304 (343)
T ss_pred HHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCC----HHHHhcCccHhhh
Confidence 01346778999999999999999999 9999999999964
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=325.45 Aligned_cols=260 Identities=18% Similarity=0.321 Sum_probs=210.9
Q ss_pred ccCCCceeEEEecccCcceEEEEEEecc-CCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEc
Q 012762 79 LTLSDLRFVHRLGSGDIGSVYLVQLKSK-SSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDC 157 (457)
Q Consensus 79 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~-~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~ 157 (457)
+...+|++.++||+|+||.||+|..... ....+..+|+|.+.... ......+.+|+++++.++|+||+++++++..
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 78 (280)
T cd05092 2 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS---ESARQDFQREAELLTVLQHQHIVRFYGVCTE 78 (280)
T ss_pred CChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC---HHHHHHHHHHHHHHhcCCCCCCceEEEEEec
Confidence 3456899999999999999999975421 22356789999886532 2345678889999999999999999999999
Q ss_pred CCcEEEEEeecCCCChHHHHHhCCC-------------CCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccC
Q 012762 158 PRWSCLLTEFCPGGDLHVLRQRQPD-------------KRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSD 224 (457)
Q Consensus 158 ~~~~~lV~E~~~~~sL~~~~~~~~~-------------~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~ 224 (457)
.+..|+||||+.+++|.+++..... ..+++..++.++.||+.||+|||+.||+||||||+|||++.+
T Consensus 79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~ 158 (280)
T cd05092 79 GRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQG 158 (280)
T ss_pred CCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCC
Confidence 9999999999999999998876431 358899999999999999999999999999999999999999
Q ss_pred CCEEEeccCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCC
Q 012762 225 GHIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTP 304 (457)
Q Consensus 225 ~~vkl~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (457)
+.+||+|||++..........
T Consensus 159 ~~~kL~dfg~~~~~~~~~~~~----------------------------------------------------------- 179 (280)
T cd05092 159 LVVKIGDFGMSRDIYSTDYYR----------------------------------------------------------- 179 (280)
T ss_pred CCEEECCCCceeEcCCCceee-----------------------------------------------------------
Confidence 999999999875432110000
Q ss_pred cccccCCccccccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHHhcccCCCCCCCC
Q 012762 305 EIVAEPLDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVVARALEFPKEPSV 383 (457)
Q Consensus 305 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (457)
......+++.|+|||++.+..++.++|||||||++|||++ |..||...........+.... .......+
T Consensus 180 ---------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~ 249 (280)
T cd05092 180 ---------VGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGR-ELERPRTC 249 (280)
T ss_pred ---------cCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHcCc-cCCCCCCC
Confidence 0001235788999999999999999999999999999998 999998776666665554442 23334468
Q ss_pred ChHHHHHHHHHhhhCCCCCCCCCcChHHHhc
Q 012762 384 PGPAKDLIAQLLVKDPTRRMGSKMGATAIKR 414 (457)
Q Consensus 384 ~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~ 414 (457)
+..+.+++.+||+.||.+||+ +.+|++
T Consensus 250 ~~~~~~li~~cl~~~P~~Rp~----~~~l~~ 276 (280)
T cd05092 250 PPEVYAIMQGCWQREPQQRMV----IKDIHS 276 (280)
T ss_pred CHHHHHHHHHHccCChhhCCC----HHHHHH
Confidence 899999999999999999999 888764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=295.67 Aligned_cols=258 Identities=25% Similarity=0.385 Sum_probs=213.6
Q ss_pred CceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcEE
Q 012762 83 DLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWSC 162 (457)
Q Consensus 83 ~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~ 162 (457)
.|.-.++||+|.||+||+|+.+ ++++.||+|.++..+. .+.......+|+-+|+.|+|.|||+++++...+..+-
T Consensus 3 ~ydkmekigegtygtvfkarn~----~t~eivalkrvrlddd-degvpssalreicllkelkhknivrl~dvlhsdkklt 77 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNR----ETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLT 77 (292)
T ss_pred chHHHHhhcCCcceeeEecccC----CccceEEEEEEeccCC-CCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeE
Confidence 4666789999999999988766 5889999999976542 2234456778999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCCC
Q 012762 163 LLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNST 242 (457)
Q Consensus 163 lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~~ 242 (457)
+|+||| ..+|..+.... ++.++.+.++.++.|++.||.|+|+.+++|||+||.|+||+.+|.+|++|||+++.+.-+.
T Consensus 78 lvfe~c-dqdlkkyfdsl-ng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipv 155 (292)
T KOG0662|consen 78 LVFEFC-DQDLKKYFDSL-NGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV 155 (292)
T ss_pred EeHHHh-hHHHHHHHHhc-CCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCce
Confidence 999999 88998777664 4789999999999999999999999999999999999999999999999999987654221
Q ss_pred cccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCCC
Q 012762 243 STAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTH 322 (457)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 322 (457)
. |-+ .-+-|.
T Consensus 156 r-------------------------------cys---------------------------------------aevvtl 165 (292)
T KOG0662|consen 156 R-------------------------------CYS---------------------------------------AEVVTL 165 (292)
T ss_pred E-------------------------------eee---------------------------------------ceeeee
Confidence 0 111 125799
Q ss_pred CccCchhhcCCC-CCccchhhhhhHHHHHHh-cCCCCCCCCChHHHHHHHHhcccCCCC--C------------------
Q 012762 323 EYLAPEIISGEG-HGNAVDWWTLGIFIFELF-YGTTPFKGIDHELTLANVVARALEFPK--E------------------ 380 (457)
Q Consensus 323 ~y~aPE~l~~~~-~~~~sDiwSlG~il~ell-tG~~Pf~~~~~~~~~~~~~~~~~~~~~--~------------------ 380 (457)
.|++|.++.|.. |+...|+||.|||+.|+. .|++.|.+.+..+.+.+|........+ +
T Consensus 166 wyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp~ypat 245 (292)
T KOG0662|consen 166 WYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYPIYPAT 245 (292)
T ss_pred eccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcccCCcccc
Confidence 999999999887 899999999999999999 599999998887777777653221111 1
Q ss_pred -------CCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCCC
Q 012762 381 -------PSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGV 421 (457)
Q Consensus 381 -------~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~~ 421 (457)
+.++..-++|++++|..+|..|.+ ++..++||||...
T Consensus 246 tswsqivp~lns~grdllqkll~cnp~qris----aeaalqhpyf~d~ 289 (292)
T KOG0662|consen 246 TSWSQIVPKLNSTGRDLLQKLLKCNPAQRIS----AEAALQHPYFSDF 289 (292)
T ss_pred chHHHHhhhhcchhHHHHHHHhccCcccccC----HHHHhcCcccccc
Confidence 111224679999999999999999 9999999999853
|
|
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=329.93 Aligned_cols=265 Identities=19% Similarity=0.260 Sum_probs=212.3
Q ss_pred CCCCccCCCceeEEEecccCcceEEEEEEeccC---CCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHc-CCCCCce
Q 012762 75 NNNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKS---SNNGCFFAAKVMDKRELVSRNKESRARIEREILEML-DHPFLPT 150 (457)
Q Consensus 75 ~~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~---~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~ 150 (457)
..+.+..++|.+.++||+|+||.||+|.+.... ......||+|+++... .......+..|+++++++ +||||++
T Consensus 5 ~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~ 82 (314)
T cd05099 5 PKWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA--TDKDLADLISEMELMKLIGKHKNIIN 82 (314)
T ss_pred ccccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC--ChHHHHHHHHHHHHHHhccCCCCeee
Confidence 345677789999999999999999999864321 1245679999987532 223355677899999999 6999999
Q ss_pred EEEEEEcCCcEEEEEeecCCCChHHHHHhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCC
Q 012762 151 LYATLDCPRWSCLLTEFCPGGDLHVLRQRQP--------------DKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKP 216 (457)
Q Consensus 151 l~~~~~~~~~~~lV~E~~~~~sL~~~~~~~~--------------~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp 216 (457)
+++++...+.+|+||||+.+++|..++.... ...+++..+..++.||+.||.|||++||+||||||
T Consensus 83 ~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp 162 (314)
T cd05099 83 LLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAA 162 (314)
T ss_pred EEEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccc
Confidence 9999999999999999999999999987632 23588899999999999999999999999999999
Q ss_pred CCeEEccCCCEEEeccCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccc
Q 012762 217 ENVLVRSDGHIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKK 296 (457)
Q Consensus 217 ~NIll~~~~~vkl~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (457)
+|||++.++.+||+|||+++..........
T Consensus 163 ~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~-------------------------------------------------- 192 (314)
T cd05099 163 RNVLVTEDNVMKIADFGLARGVHDIDYYKK-------------------------------------------------- 192 (314)
T ss_pred eeEEEcCCCcEEEccccccccccccccccc--------------------------------------------------
Confidence 999999999999999999865432111000
Q ss_pred cCCCCCCCcccccCCccccccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHHhccc
Q 012762 297 KLGNPGTPEIVAEPLDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVVARAL 375 (457)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~ 375 (457)
.....++..|+|||++.+..++.++|||||||++|+|++ |..||.+.........+... .
T Consensus 193 ------------------~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-~ 253 (314)
T cd05099 193 ------------------TSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLLREG-H 253 (314)
T ss_pred ------------------cccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-C
Confidence 000124567999999998889999999999999999998 89999887766665555443 2
Q ss_pred CCCCCCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhc
Q 012762 376 EFPKEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKR 414 (457)
Q Consensus 376 ~~~~~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~ 414 (457)
.......++.++++++.+||..||++||+ +.++++
T Consensus 254 ~~~~~~~~~~~l~~li~~cl~~~p~~Rps----~~~ll~ 288 (314)
T cd05099 254 RMDKPSNCTHELYMLMRECWHAVPTQRPT----FKQLVE 288 (314)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCCcccCcC----HHHHHH
Confidence 23334467889999999999999999999 777765
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=326.49 Aligned_cols=255 Identities=27% Similarity=0.398 Sum_probs=207.2
Q ss_pred ceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcEEE
Q 012762 84 LRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWSCL 163 (457)
Q Consensus 84 ~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~l 163 (457)
|++.+.||.|++|+||+|.++ .+|..||+|++..... .......+..|+++++.++|+||+++++++..++..|+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~----~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~i 75 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDK----LTGEIVALKKIRLETE-DEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYL 75 (283)
T ss_pred CchheEecCCCCeEEEEEEEc----CCCCEEEEEEeecccc-cccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEE
Confidence 678899999999999999976 3788999999875432 22233556779999999999999999999999999999
Q ss_pred EEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCCCc
Q 012762 164 LTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTS 243 (457)
Q Consensus 164 V~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~~~ 243 (457)
||||+ +++|..++.......+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++........
T Consensus 76 v~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~ 154 (283)
T cd07835 76 VFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR 154 (283)
T ss_pred EEecc-CcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc
Confidence 99999 57899888776545799999999999999999999999999999999999999999999999999754321100
Q ss_pred ccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCCCC
Q 012762 244 TAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTHE 323 (457)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 323 (457)
. .....++..
T Consensus 155 ~----------------------------------------------------------------------~~~~~~~~~ 164 (283)
T cd07835 155 T----------------------------------------------------------------------YTHEVVTLW 164 (283)
T ss_pred c----------------------------------------------------------------------cCccccccC
Confidence 0 001136889
Q ss_pred ccCchhhcCC-CCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccC------------------CC------
Q 012762 324 YLAPEIISGE-GHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALE------------------FP------ 378 (457)
Q Consensus 324 y~aPE~l~~~-~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~------------------~~------ 378 (457)
|+|||++.+. .++.++|||||||++|+|++|+.||...+....+.++...... ++
T Consensus 165 ~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (283)
T cd07835 165 YRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQD 244 (283)
T ss_pred CCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhcccccccc
Confidence 9999998765 4788999999999999999999999877654444333321100 00
Q ss_pred ---CCCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCC
Q 012762 379 ---KEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFF 418 (457)
Q Consensus 379 ---~~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f 418 (457)
....++.++.++|.+||+.||.+||+ +.|+++||||
T Consensus 245 ~~~~~~~~~~~~~~li~~~l~~~P~~Rpt----~~~il~~~~~ 283 (283)
T cd07835 245 LSKVVPNLDEDGLDLLSKMLVYDPAKRIS----AKAALQHPYF 283 (283)
T ss_pred hhhhcCCCCHHHHHHHHHHhcCChhhCcC----HHHHhcCCCC
Confidence 12346678999999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=319.87 Aligned_cols=250 Identities=44% Similarity=0.813 Sum_probs=213.5
Q ss_pred ecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcEEEEEeecC
Q 012762 90 LGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWSCLLTEFCP 169 (457)
Q Consensus 90 LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lV~E~~~ 169 (457)
||.|+||.||+|.+. .+++.||+|++.+...........+..|+++++.++|+||+++++.+..++..|+||||+.
T Consensus 1 lg~G~~~~v~~~~~~----~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 76 (250)
T cd05123 1 LGKGSFGKVLLVRKK----DTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAP 76 (250)
T ss_pred CCCCCceEEEEEEEC----CCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCC
Confidence 699999999999876 3678999999988766555567788889999999999999999999999999999999999
Q ss_pred CCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCCCccccccc
Q 012762 170 GGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQLVS 249 (457)
Q Consensus 170 ~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~~~~~~~~~ 249 (457)
+++|.+++... ..+++..+..++.||+.||.|||+.+++|+||+|+||+++.++.++|+|||++........
T Consensus 77 ~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~------ 148 (250)
T cd05123 77 GGELFSHLSKE--GRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS------ 148 (250)
T ss_pred CCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCC------
Confidence 99999988775 4689999999999999999999999999999999999999999999999998754421100
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCCCCccCchh
Q 012762 250 DQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTHEYLAPEI 329 (457)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 329 (457)
......|+..|++||.
T Consensus 149 ----------------------------------------------------------------~~~~~~~~~~~~~Pe~ 164 (250)
T cd05123 149 ----------------------------------------------------------------RTNTFCGTPEYLAPEV 164 (250)
T ss_pred ----------------------------------------------------------------cccCCcCCccccChHH
Confidence 0112358889999999
Q ss_pred hcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhhhCCCCCCCCCcCh
Q 012762 330 ISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDPTRRMGSKMGA 409 (457)
Q Consensus 330 l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~ 409 (457)
+.+..++.++|+||||+++|+|++|..||...........+......++ ..++..+.+++++||..||++||+... +
T Consensus 165 ~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~~i~~~l~~~p~~R~~~~~-~ 241 (250)
T cd05123 165 LLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFP--EFLSPEARDLISGLLQKDPTKRLGSGG-A 241 (250)
T ss_pred hCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCC--CCCCHHHHHHHHHHhcCCHhhCCCccc-H
Confidence 9988889999999999999999999999988776666666665443333 447899999999999999999999222 2
Q ss_pred HHHhcCCCC
Q 012762 410 TAIKRHQFF 418 (457)
Q Consensus 410 ~~ll~hp~f 418 (457)
+++++||||
T Consensus 242 ~~l~~~~~f 250 (250)
T cd05123 242 EEIKAHPFF 250 (250)
T ss_pred HHHHhCCCC
Confidence 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-41 Score=318.78 Aligned_cols=249 Identities=20% Similarity=0.323 Sum_probs=209.4
Q ss_pred CccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEc
Q 012762 78 PLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDC 157 (457)
Q Consensus 78 ~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~ 157 (457)
.+..++|++.+.||.|+||.||+|.. .|+.||+|.+..... ..+++..|+.+++.++|+||+++++++..
T Consensus 2 ~~~~~~~~~~~~ig~g~~g~v~~~~~------~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 71 (256)
T cd05039 2 AINSKELKLGATIGKGEFGDVMLGDY------RGQKVAVKCLKDDST----AAQAFLAEASVMTTLRHPNLVQLLGVVLQ 71 (256)
T ss_pred ccChhhccceeeeecCCCceEEEEEe------cCcEEEEEEeccchh----HHHHHHHHHHHHHhcCCcceeeeEEEEcC
Confidence 34567899999999999999999975 467899999975432 45678889999999999999999999998
Q ss_pred CCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcC
Q 012762 158 PRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLK 237 (457)
Q Consensus 158 ~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~ 237 (457)
....|+||||+++++|.+++.......+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||+++.
T Consensus 72 ~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~ 151 (256)
T cd05039 72 GNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKE 151 (256)
T ss_pred CCCeEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcccccccc
Confidence 89999999999999999998876545799999999999999999999999999999999999999999999999998754
Q ss_pred CCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcccccc
Q 012762 238 GDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMS 317 (457)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (457)
...... .
T Consensus 152 ~~~~~~-------------------------------------------------------------------------~ 158 (256)
T cd05039 152 ASQGQD-------------------------------------------------------------------------S 158 (256)
T ss_pred cccccc-------------------------------------------------------------------------c
Confidence 421100 0
Q ss_pred ccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhh
Q 012762 318 FVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLV 396 (457)
Q Consensus 318 ~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~ 396 (457)
..++..|+|||++.+..++.++|||||||++|+|++ |..||...........+. ..........+++.+.++|.+||.
T Consensus 159 ~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~ 237 (256)
T cd05039 159 GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVE-KGYRMEAPEGCPPEVYKVMKDCWE 237 (256)
T ss_pred CCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh-cCCCCCCccCCCHHHHHHHHHHhc
Confidence 124567999999988889999999999999999997 999998776555444433 333333344578999999999999
Q ss_pred hCCCCCCCCCcChHHHhc
Q 012762 397 KDPTRRMGSKMGATAIKR 414 (457)
Q Consensus 397 ~dP~~Rps~~~~~~~ll~ 414 (457)
.+|++||+ +.++++
T Consensus 238 ~~p~~Rp~----~~~l~~ 251 (256)
T cd05039 238 LDPAKRPT----FKQLRE 251 (256)
T ss_pred cChhhCcC----HHHHHH
Confidence 99999999 888775
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-41 Score=319.68 Aligned_cols=244 Identities=20% Similarity=0.305 Sum_probs=197.0
Q ss_pred EecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcEEEEEeec
Q 012762 89 RLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWSCLLTEFC 168 (457)
Q Consensus 89 ~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lV~E~~ 168 (457)
+||+|+||.||+|.++.. .++..+|+|+++... ........+..|+++++.++|+||+++++++.. +..++||||+
T Consensus 2 ~lg~G~~g~v~~~~~~~~--~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~ 77 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMK--KSEKTVAVKILKNDN-NDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELA 77 (257)
T ss_pred cCCCcCCcceEEeEEecC--CCceEEEEEEccCCC-CcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecC
Confidence 689999999999976532 367789999986442 223345678889999999999999999998864 5678999999
Q ss_pred CCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCCCcccccc
Q 012762 169 PGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQLV 248 (457)
Q Consensus 169 ~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~~~~~~~~ 248 (457)
++++|.+++... ..+++..+..++.||+.||.|||++||+||||||.|||++.++.+||+|||++...........
T Consensus 78 ~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~-- 153 (257)
T cd05116 78 ELGPLNKFLQKN--KHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK-- 153 (257)
T ss_pred CCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeee--
Confidence 999999888764 5689999999999999999999999999999999999999999999999999865432111000
Q ss_pred cCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCCCCccCch
Q 012762 249 SDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTHEYLAPE 328 (457)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 328 (457)
......++..|+|||
T Consensus 154 -----------------------------------------------------------------~~~~~~~~~~y~aPE 168 (257)
T cd05116 154 -----------------------------------------------------------------AKTHGKWPVKWYAPE 168 (257)
T ss_pred -----------------------------------------------------------------ecCCCCCCccccCHh
Confidence 000112567899999
Q ss_pred hhcCCCCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhhhCCCCCCCCC
Q 012762 329 IISGEGHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDPTRRMGSK 406 (457)
Q Consensus 329 ~l~~~~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rps~~ 406 (457)
++.+..++.++|||||||++|||++ |..||...........+... ...+.+..++.++.++|.+||+.||++||++.
T Consensus 169 ~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~-~~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~ 246 (257)
T cd05116 169 CMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESG-ERMECPQRCPPEMYDLMKLCWTYGVDERPGFA 246 (257)
T ss_pred HhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCC-CCCCCCCCCCHHHHHHHHHHhccCchhCcCHH
Confidence 9988889999999999999999997 99999887665555554433 33444456899999999999999999999943
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-41 Score=325.71 Aligned_cols=260 Identities=18% Similarity=0.310 Sum_probs=210.3
Q ss_pred ccCCCceeEEEecccCcceEEEEEEecc-CCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEc
Q 012762 79 LTLSDLRFVHRLGSGDIGSVYLVQLKSK-SSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDC 157 (457)
Q Consensus 79 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~-~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~ 157 (457)
+...+|.+.+.||+|+||.||+|.+... ....+..+++|.+..... ...+.+.+|++++++++|+||+++++++..
T Consensus 2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 78 (291)
T cd05094 2 IKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTL---AARKDFQREAELLTNLQHEHIVKFYGVCGD 78 (291)
T ss_pred CchHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccH---HHHHHHHHHHHHHhcCCCCCcceEEEEEcc
Confidence 3456899999999999999999986432 123556789999864322 334567889999999999999999999999
Q ss_pred CCcEEEEEeecCCCChHHHHHhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEcc
Q 012762 158 PRWSCLLTEFCPGGDLHVLRQRQP--------------DKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRS 223 (457)
Q Consensus 158 ~~~~~lV~E~~~~~sL~~~~~~~~--------------~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~ 223 (457)
.+..++||||+++++|.+++..+. ...+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~ 158 (291)
T cd05094 79 GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGA 158 (291)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEcc
Confidence 999999999999999999987642 234889999999999999999999999999999999999999
Q ss_pred CCCEEEeccCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCC
Q 012762 224 DGHIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGT 303 (457)
Q Consensus 224 ~~~vkl~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (457)
++.++|+|||++.........
T Consensus 159 ~~~~~l~dfg~a~~~~~~~~~----------------------------------------------------------- 179 (291)
T cd05094 159 NLLVKIGDFGMSRDVYSTDYY----------------------------------------------------------- 179 (291)
T ss_pred CCcEEECCCCcccccCCCcee-----------------------------------------------------------
Confidence 999999999997543211000
Q ss_pred CcccccCCccccccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHHhcccCCCCCCC
Q 012762 304 PEIVAEPLDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVVARALEFPKEPS 382 (457)
Q Consensus 304 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 382 (457)
.......|+..|+|||++.+..++.++|||||||++|||++ |..||...........+...... .....
T Consensus 180 ---------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~ 249 (291)
T cd05094 180 ---------RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGRVL-ERPRV 249 (291)
T ss_pred ---------ecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhCCCCC-CCCcc
Confidence 00012247889999999999889999999999999999998 99999887766666555443322 22345
Q ss_pred CChHHHHHHHHHhhhCCCCCCCCCcChHHHhc
Q 012762 383 VPGPAKDLIAQLLVKDPTRRMGSKMGATAIKR 414 (457)
Q Consensus 383 ~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~ 414 (457)
++..+.+++.+||+.||++||+ +.++++
T Consensus 250 ~~~~~~~li~~~l~~~P~~Rpt----~~~v~~ 277 (291)
T cd05094 250 CPKEVYDIMLGCWQREPQQRLN----IKEIYK 277 (291)
T ss_pred CCHHHHHHHHHHcccChhhCcC----HHHHHH
Confidence 7889999999999999999999 777654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-41 Score=321.30 Aligned_cols=261 Identities=23% Similarity=0.332 Sum_probs=211.2
Q ss_pred cCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCC
Q 012762 80 TLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPR 159 (457)
Q Consensus 80 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~ 159 (457)
...+|++.+.||+|+||.||+|.++.... .+..||+|++.... .......+..|+++++.++||||+++++++..++
T Consensus 2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~ 78 (269)
T cd05065 2 DVSCVKIEEVIGAGEFGEVCRGRLKLPGK-REIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSR 78 (269)
T ss_pred ChHHeEEEeEecCCCCCeEEEEEEecCCC-CceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCC
Confidence 35679999999999999999999874221 34579999986532 2334567888999999999999999999999999
Q ss_pred cEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCC
Q 012762 160 WSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGD 239 (457)
Q Consensus 160 ~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~ 239 (457)
..++||||+.+++|..++... .+.+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||++....
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~ 157 (269)
T cd05065 79 PVMIITEFMENGALDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 157 (269)
T ss_pred ceEEEEecCCCCcHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccc
Confidence 999999999999999888764 3568999999999999999999999999999999999999999999999999875443
Q ss_pred CCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcccccccc
Q 012762 240 NSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFV 319 (457)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (457)
........ .......
T Consensus 158 ~~~~~~~~-----------------------------------------------------------------~~~~~~~ 172 (269)
T cd05065 158 DDTSDPTY-----------------------------------------------------------------TSSLGGK 172 (269)
T ss_pred cCcccccc-----------------------------------------------------------------ccccCCC
Confidence 21110000 0000001
Q ss_pred CCCCccCchhhcCCCCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhhhC
Q 012762 320 GTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKD 398 (457)
Q Consensus 320 gt~~y~aPE~l~~~~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~d 398 (457)
++..|+|||++.+..++.++|||||||++|||++ |..||...........+ ......+....++..+.+++.+||..+
T Consensus 173 ~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i-~~~~~~~~~~~~~~~~~~li~~~l~~~ 251 (269)
T cd05065 173 IPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAI-EQDYRLPPPMDCPTALHQLMLDCWQKD 251 (269)
T ss_pred cceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHH-HcCCcCCCcccCCHHHHHHHHHHcCCC
Confidence 2457999999998889999999999999999886 99999887766555554 344555555678899999999999999
Q ss_pred CCCCCCCCcChHHHhc
Q 012762 399 PTRRMGSKMGATAIKR 414 (457)
Q Consensus 399 P~~Rps~~~~~~~ll~ 414 (457)
|.+||+ +.+|+.
T Consensus 252 p~~Rp~----~~~i~~ 263 (269)
T cd05065 252 RNARPK----FGQIVS 263 (269)
T ss_pred hhhCcC----HHHHHH
Confidence 999999 888765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=322.81 Aligned_cols=257 Identities=20% Similarity=0.265 Sum_probs=206.3
Q ss_pred ceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCc---
Q 012762 84 LRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRW--- 160 (457)
Q Consensus 84 ~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~--- 160 (457)
|++.+.||+|+||.||+|.+... ...+..||+|++..... .......+..|+++++.++|+||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~-~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 78 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQD-DGSQLKVAVKTMKLDIH-TYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQK 78 (273)
T ss_pred CccccccCcCCCceEEEEEEecC-CCCcceEEEEEeccCcC-CHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCcccc
Confidence 57889999999999999987532 12457899999875422 23345678889999999999999999998865544
Q ss_pred ---EEEEEeecCCCChHHHHHhC----CCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccC
Q 012762 161 ---SCLLTEFCPGGDLHVLRQRQ----PDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFD 233 (457)
Q Consensus 161 ---~~lV~E~~~~~sL~~~~~~~----~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG 233 (457)
.++||||+++++|..++... ....+++..++.++.||+.||.|||+.+|+||||||+||+++.++.+||+|||
T Consensus 79 ~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg 158 (273)
T cd05035 79 IPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFG 158 (273)
T ss_pred CcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCcc
Confidence 79999999999998887543 22468999999999999999999999999999999999999999999999999
Q ss_pred CCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcc
Q 012762 234 LSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDV 313 (457)
Q Consensus 234 ~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (457)
+++.........
T Consensus 159 ~~~~~~~~~~~~-------------------------------------------------------------------- 170 (273)
T cd05035 159 LSKKIYSGDYYR-------------------------------------------------------------------- 170 (273)
T ss_pred ceeecccccccc--------------------------------------------------------------------
Confidence 976543211100
Q ss_pred ccccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHH
Q 012762 314 RSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIA 392 (457)
Q Consensus 314 ~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~ 392 (457)
......++..|+|||++.+..++.++|||||||++|||++ |..||.+....+....+... ........++..+.+++.
T Consensus 171 ~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~ 249 (273)
T cd05035 171 QGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHG-NRLKQPEDCLDELYDLMY 249 (273)
T ss_pred ccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CCCCCCcCCCHHHHHHHH
Confidence 0001125678999999988889999999999999999998 99999887776666555443 233344568899999999
Q ss_pred HHhhhCCCCCCCCCcChHHHhcC
Q 012762 393 QLLVKDPTRRMGSKMGATAIKRH 415 (457)
Q Consensus 393 ~~L~~dP~~Rps~~~~~~~ll~h 415 (457)
+||..||++||+ +.+++++
T Consensus 250 ~~l~~~p~~Rp~----~~e~~~~ 268 (273)
T cd05035 250 SCWRADPKDRPT----FTKLREV 268 (273)
T ss_pred HHcCCChhhCcC----HHHHHHH
Confidence 999999999999 8888764
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-41 Score=317.68 Aligned_cols=256 Identities=28% Similarity=0.499 Sum_probs=217.1
Q ss_pred CceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcEE
Q 012762 83 DLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWSC 162 (457)
Q Consensus 83 ~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~ 162 (457)
+|.+.+.||.|+||.||+|.+. .++..||+|++..... .......+..|+++++.++|+|++++++.+...+..+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~----~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~ 75 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRK----SDGKLYVLKEIDLSNM-SEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLC 75 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEc----CCCcEEEEEEeecccC-ChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEE
Confidence 5899999999999999999976 3688999999976432 2234556778999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCC
Q 012762 163 LLTEFCPGGDLHVLRQRQP--DKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDN 240 (457)
Q Consensus 163 lV~E~~~~~sL~~~~~~~~--~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~ 240 (457)
+||||+++++|..++.... ...+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~ 155 (258)
T cd08215 76 IVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSS 155 (258)
T ss_pred EEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeeccc
Confidence 9999999999998887643 46799999999999999999999999999999999999999999999999998754332
Q ss_pred CCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccC
Q 012762 241 STSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVG 320 (457)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 320 (457)
... ......|
T Consensus 156 ~~~----------------------------------------------------------------------~~~~~~~ 165 (258)
T cd08215 156 TVD----------------------------------------------------------------------LAKTVVG 165 (258)
T ss_pred Ccc----------------------------------------------------------------------eecceee
Confidence 110 0012358
Q ss_pred CCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhhhCCC
Q 012762 321 THEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDPT 400 (457)
Q Consensus 321 t~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~ 400 (457)
++.|+|||.+.+..++.++|+||+|+++|+|++|..||................. .+....++.++.+++.+||..||+
T Consensus 166 ~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~p~ 244 (258)
T cd08215 166 TPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQY-PPIPSQYSSELRNLVSSLLQKDPE 244 (258)
T ss_pred eecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCC-CCCCCCCCHHHHHHHHHHcCCChh
Confidence 8999999999988899999999999999999999999988776666655554432 222336889999999999999999
Q ss_pred CCCCCCcChHHHhcCCCC
Q 012762 401 RRMGSKMGATAIKRHQFF 418 (457)
Q Consensus 401 ~Rps~~~~~~~ll~hp~f 418 (457)
+||+ +.++++||||
T Consensus 245 ~Rp~----~~~ll~~~~~ 258 (258)
T cd08215 245 ERPS----IAQILQSPFI 258 (258)
T ss_pred hCcC----HHHHhcCCCC
Confidence 9999 9999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-41 Score=328.45 Aligned_cols=255 Identities=24% Similarity=0.345 Sum_probs=210.6
Q ss_pred ceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcEEE
Q 012762 84 LRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWSCL 163 (457)
Q Consensus 84 ~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~l 163 (457)
|...++||+|+||+||+|.+. .++..||+|++.............+..|+++++.++|+||+++++++......|+
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~----~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 98 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNS----HTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWL 98 (313)
T ss_pred hhcceeeccCCCeEEEEEEEC----CCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEE
Confidence 677788999999999999875 4788999999976543333444567789999999999999999999999999999
Q ss_pred EEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCCCc
Q 012762 164 LTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTS 243 (457)
Q Consensus 164 V~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~~~ 243 (457)
||||+ .++|..++... ...+++..++.++.||+.||.|||++||+|+||+|+||+++.++.++|+|||++.....
T Consensus 99 v~e~~-~~~l~~~l~~~-~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~--- 173 (313)
T cd06633 99 VMEYC-LGSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP--- 173 (313)
T ss_pred EEecC-CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccCC---
Confidence 99999 46776666553 25689999999999999999999999999999999999999999999999998632110
Q ss_pred ccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCCCC
Q 012762 244 TAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTHE 323 (457)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 323 (457)
.....|+..
T Consensus 174 -----------------------------------------------------------------------~~~~~~~~~ 182 (313)
T cd06633 174 -----------------------------------------------------------------------ANSFVGTPY 182 (313)
T ss_pred -----------------------------------------------------------------------CCCcccccc
Confidence 012358899
Q ss_pred ccCchhhc---CCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhhhCCC
Q 012762 324 YLAPEIIS---GEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDPT 400 (457)
Q Consensus 324 y~aPE~l~---~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~ 400 (457)
|+|||++. +..++.++|||||||++|+|++|..||...........+............++..+++|+.+||+.+|.
T Consensus 183 y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~ 262 (313)
T cd06633 183 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFVDYCLQKIPQ 262 (313)
T ss_pred ccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHHHHHHHHHccCChh
Confidence 99999985 345788999999999999999999999887665555555444333333345778899999999999999
Q ss_pred CCCCCCcChHHHhcCCCCCCCC
Q 012762 401 RRMGSKMGATAIKRHQFFNGVN 422 (457)
Q Consensus 401 ~Rps~~~~~~~ll~hp~f~~~~ 422 (457)
+||+ +.++++||||+..+
T Consensus 263 ~Rp~----~~~~l~~~~~~~~~ 280 (313)
T cd06633 263 ERPA----SAELLRHDFVRRDR 280 (313)
T ss_pred hCcC----HHHHhcCcccCCCc
Confidence 9999 99999999998644
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-41 Score=326.32 Aligned_cols=261 Identities=22% Similarity=0.333 Sum_probs=206.0
Q ss_pred cCCCceeEEEecccCcceEEEEEEec------------cCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCC
Q 012762 80 TLSDLRFVHRLGSGDIGSVYLVQLKS------------KSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPF 147 (457)
Q Consensus 80 ~~~~~~~~~~LG~G~fg~Vy~a~~~~------------~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~n 147 (457)
..++|++.++||+|+||+||+|.+.. ....++..||+|++.... .......+.+|+++|+.++|+|
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~E~~~l~~l~~~~ 80 (296)
T cd05095 3 PRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA--NKNARNDFLKEIKIMSRLKDPN 80 (296)
T ss_pred ChhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCC
Confidence 44679999999999999999987542 122345679999986542 2234567788999999999999
Q ss_pred CceEEEEEEcCCcEEEEEeecCCCChHHHHHhCC---------CCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCC
Q 012762 148 LPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQP---------DKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPEN 218 (457)
Q Consensus 148 Iv~l~~~~~~~~~~~lV~E~~~~~sL~~~~~~~~---------~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~N 218 (457)
|+++++++...+..|+||||+.+++|..++.... ...+++..+..++.||+.||+|||+.||+|+||||+|
T Consensus 81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~N 160 (296)
T cd05095 81 IIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRN 160 (296)
T ss_pred cceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChhe
Confidence 9999999999999999999999999998887642 1246778899999999999999999999999999999
Q ss_pred eEEccCCCEEEeccCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccC
Q 012762 219 VLVRSDGHIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKL 298 (457)
Q Consensus 219 Ill~~~~~vkl~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (457)
||++.++.++|+|||++..........
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~----------------------------------------------------- 187 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYYR----------------------------------------------------- 187 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCccee-----------------------------------------------------
Confidence 999999999999999976442110000
Q ss_pred CCCCCCcccccCCccccccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhc--CCCCCCCCChHHHHHHHHh----
Q 012762 299 GNPGTPEIVAEPLDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFY--GTTPFKGIDHELTLANVVA---- 372 (457)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~ellt--G~~Pf~~~~~~~~~~~~~~---- 372 (457)
......++..|++||+..+..++.++|||||||++|||++ |..||......+.......
T Consensus 188 ---------------~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~ 252 (296)
T cd05095 188 ---------------IQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIENTGEFFRD 252 (296)
T ss_pred ---------------ccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHHHHHHHHHHHhh
Confidence 0001235678999999988889999999999999999998 7899987665554433211
Q ss_pred --cccCCCCCCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhc
Q 012762 373 --RALEFPKEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKR 414 (457)
Q Consensus 373 --~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~ 414 (457)
.....+....++..+.+|+.+||+.||.+||+ +.+|.+
T Consensus 253 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~----~~~i~~ 292 (296)
T cd05095 253 QGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPS----FQEIHA 292 (296)
T ss_pred ccccccCCCCCCCCHHHHHHHHHHcCCCcccCCC----HHHHHH
Confidence 12223444567889999999999999999999 777653
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-42 Score=337.84 Aligned_cols=262 Identities=23% Similarity=0.349 Sum_probs=207.0
Q ss_pred CCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEc----
Q 012762 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDC---- 157 (457)
Q Consensus 82 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~---- 157 (457)
++|.+.+.||.|+||.||+|.++ .++..||+|++..... .......+..|+.+|++++|+||+++++++..
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~----~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 79 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDT----RSGKKVAIKKIPHAFD-VPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGAD 79 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEc----CCCCEEEEEEeccccc-cccchHHHHHHHHHHHhcCCCCccCHHHhccccCCC
Confidence 57999999999999999999877 4788999999875422 22344566779999999999999999998753
Q ss_pred CCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcC
Q 012762 158 PRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLK 237 (457)
Q Consensus 158 ~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~ 237 (457)
...+|+||||+ +++|..++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++..
T Consensus 80 ~~~~~lv~e~~-~~~l~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~ 156 (334)
T cd07855 80 FKDVYVVMDLM-ESDLHHIIHSD--QPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARG 156 (334)
T ss_pred CceEEEEEehh-hhhHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEeccccccee
Confidence 34689999999 56898887654 5599999999999999999999999999999999999999999999999999754
Q ss_pred CCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcccccc
Q 012762 238 GDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMS 317 (457)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (457)
........ ......
T Consensus 157 ~~~~~~~~------------------------------------------------------------------~~~~~~ 170 (334)
T cd07855 157 LSSSPTEH------------------------------------------------------------------KYFMTE 170 (334)
T ss_pred ecccCcCC------------------------------------------------------------------Cccccc
Confidence 43211000 000112
Q ss_pred ccCCCCccCchhhcC-CCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhccc--------------------C
Q 012762 318 FVGTHEYLAPEIISG-EGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARAL--------------------E 376 (457)
Q Consensus 318 ~~gt~~y~aPE~l~~-~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~--------------------~ 376 (457)
..|+..|+|||++.+ ..++.++|||||||++|||++|+.||.+.+....+..+..... .
T Consensus 171 ~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~ 250 (334)
T cd07855 171 YVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQN 250 (334)
T ss_pred ccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchhhHHHHHhh
Confidence 368999999999876 4589999999999999999999999987654332222221100 0
Q ss_pred CCC---------CCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCCC
Q 012762 377 FPK---------EPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGV 421 (457)
Q Consensus 377 ~~~---------~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~~ 421 (457)
++. .+..+.+++++|.+||+.||++||+ +.+++.||||+..
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt----~~~~l~~~~~~~~ 300 (334)
T cd07855 251 LPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERIT----VEQALQHPFLAQY 300 (334)
T ss_pred cccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcC----HHHHHhChhhhhc
Confidence 000 1346788999999999999999999 9999999999853
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=326.39 Aligned_cols=261 Identities=26% Similarity=0.412 Sum_probs=218.5
Q ss_pred CCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCc
Q 012762 81 LSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRW 160 (457)
Q Consensus 81 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~ 160 (457)
.+.|.+...||+|+||.||+|.+.. .+..||+|++..... ....+..|+++++.++|+||+++++++.....
T Consensus 18 ~~~~~~~~~l~~g~~~~v~~~~~~~----~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 89 (286)
T cd06614 18 RELYKNLEKIGEGASGEVYKATDRA----TGKEVAIKKMRLRKQ----NKELIINEILIMKDCKHPNIVDYYDSYLVGDE 89 (286)
T ss_pred cccchHhHhccCCCCeEEEEEEEcc----CCcEEEEEEEecCch----hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCE
Confidence 3568899999999999999998763 678899999975432 45567789999999999999999999999999
Q ss_pred EEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCC
Q 012762 161 SCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDN 240 (457)
Q Consensus 161 ~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~ 240 (457)
.|+||||+++++|.+++.... ..+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++.....
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 168 (286)
T cd06614 90 LWVVMEYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTK 168 (286)
T ss_pred EEEEEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhcc
Confidence 999999999999999988753 3799999999999999999999999999999999999999999999999998643321
Q ss_pred CCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccC
Q 012762 241 STSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVG 320 (457)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 320 (457)
... ......|
T Consensus 169 ~~~----------------------------------------------------------------------~~~~~~~ 178 (286)
T cd06614 169 EKS----------------------------------------------------------------------KRNSVVG 178 (286)
T ss_pred chh----------------------------------------------------------------------hhccccC
Confidence 100 0012347
Q ss_pred CCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccC-CCCCCCCChHHHHHHHHHhhhCC
Q 012762 321 THEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALE-FPKEPSVPGPAKDLIAQLLVKDP 399 (457)
Q Consensus 321 t~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ll~~~L~~dP 399 (457)
+..|+|||++.+..++.++|+|||||++|+|++|..||...........+...... ......++..+.++|.+||+.+|
T Consensus 179 ~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p 258 (286)
T cd06614 179 TPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDFLNKCLVKDP 258 (286)
T ss_pred CcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHHHHHHHHhccCh
Confidence 88999999999888999999999999999999999999877665555444433222 22223478899999999999999
Q ss_pred CCCCCCCcChHHHhcCCCCCCCCch
Q 012762 400 TRRMGSKMGATAIKRHQFFNGVNWA 424 (457)
Q Consensus 400 ~~Rps~~~~~~~ll~hp~f~~~~~~ 424 (457)
.+||+ +.+++.|+||+...|.
T Consensus 259 ~~Rpt----~~~il~~~~~~~~~~~ 279 (286)
T cd06614 259 EKRPS----AEELLQHPFLKKACPK 279 (286)
T ss_pred hhCcC----HHHHhhChHhhccCch
Confidence 99999 9999999999986553
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=318.46 Aligned_cols=254 Identities=20% Similarity=0.326 Sum_probs=209.9
Q ss_pred CCccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEE
Q 012762 77 NPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLD 156 (457)
Q Consensus 77 ~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~ 156 (457)
|.+..++|++.++||+|+||.||+|.+. .+..+|+|.+..... ....+.+|+++++.++|+||+++++++.
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~vy~~~~~-----~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 71 (260)
T cd05073 1 WEIPRESLKLEKKLGAGQFGEVWMATYN-----KHTKVAVKTMKPGSM----SVEAFLAEANVMKTLQHDKLVKLHAVVT 71 (260)
T ss_pred CcccccceeEEeEecCccceEEEEEEec-----CCccEEEEecCCChh----HHHHHHHHHHHHHhcCCCCcceEEEEEc
Confidence 4567789999999999999999999864 455699998865422 3456778999999999999999999988
Q ss_pred cCCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCc
Q 012762 157 CPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSL 236 (457)
Q Consensus 157 ~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~ 236 (457)
. ...|+||||+++++|.+++.......+++..++.++.||+.||.|||+.|++|+||||+||+++.++.+||+|||++.
T Consensus 72 ~-~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~ 150 (260)
T cd05073 72 K-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLAR 150 (260)
T ss_pred C-CCeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCccee
Confidence 7 778999999999999999987656678899999999999999999999999999999999999999999999999875
Q ss_pred CCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccc
Q 012762 237 KGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSM 316 (457)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (457)
......... ..
T Consensus 151 ~~~~~~~~~---------------------------------------------------------------------~~ 161 (260)
T cd05073 151 VIEDNEYTA---------------------------------------------------------------------RE 161 (260)
T ss_pred eccCCCccc---------------------------------------------------------------------cc
Confidence 442110000 00
Q ss_pred cccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHh
Q 012762 317 SFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLL 395 (457)
Q Consensus 317 ~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L 395 (457)
...++..|+|||++.+..++.++|+|||||++|+|++ |..||.+.+.......+ ......+.....+.++.+++.+||
T Consensus 162 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~~l 240 (260)
T cd05073 162 GAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL-ERGYRMPRPENCPEELYNIMMRCW 240 (260)
T ss_pred CCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHH-hCCCCCCCcccCCHHHHHHHHHHc
Confidence 1135678999999998889999999999999999998 99999887665555443 344444555668899999999999
Q ss_pred hhCCCCCCCCCcChHHHhc
Q 012762 396 VKDPTRRMGSKMGATAIKR 414 (457)
Q Consensus 396 ~~dP~~Rps~~~~~~~ll~ 414 (457)
..||++||+ +.+++.
T Consensus 241 ~~~p~~Rp~----~~~l~~ 255 (260)
T cd05073 241 KNRPEERPT----FEYIQS 255 (260)
T ss_pred ccCcccCcC----HHHHHH
Confidence 999999999 777754
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=319.04 Aligned_cols=252 Identities=22% Similarity=0.327 Sum_probs=207.5
Q ss_pred EEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcEEEEEee
Q 012762 88 HRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWSCLLTEF 167 (457)
Q Consensus 88 ~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lV~E~ 167 (457)
++||+|+||+||+|.+... ......||+|.+...... ...+.+..|++++++++|+||+++++++.. ...++||||
T Consensus 1 ~~ig~g~~~~v~~~~~~~~-~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~ 76 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTS-GGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTEL 76 (257)
T ss_pred CcCCccCcccEEeeeEecC-CCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEe
Confidence 4689999999999998642 123347999999775443 456778889999999999999999999988 889999999
Q ss_pred cCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCCCccccc
Q 012762 168 CPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQL 247 (457)
Q Consensus 168 ~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~~~~~~~ 247 (457)
+++++|..++.......+++..++.++.|++.||.|||++|++|+||||+||+++.++.+||+|||+++..........
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~- 155 (257)
T cd05040 77 APLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV- 155 (257)
T ss_pred cCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEecccccccccccccccee-
Confidence 9999999988775435689999999999999999999999999999999999999999999999999865432111000
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCCCCccCc
Q 012762 248 VSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTHEYLAP 327 (457)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 327 (457)
......++..|+||
T Consensus 156 ------------------------------------------------------------------~~~~~~~~~~y~~p 169 (257)
T cd05040 156 ------------------------------------------------------------------MEEHLKVPFAWCAP 169 (257)
T ss_pred ------------------------------------------------------------------cccCCCCCceecCH
Confidence 00012477889999
Q ss_pred hhhcCCCCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhhhCCCCCCCCC
Q 012762 328 EIISGEGHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDPTRRMGSK 406 (457)
Q Consensus 328 E~l~~~~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rps~~ 406 (457)
|++.+..++.++|||||||++|||++ |..||......+....+.......+....++..+.+++.+||..+|++||+
T Consensus 170 E~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-- 247 (257)
T cd05040 170 ESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVMLQCWAHNPADRPT-- 247 (257)
T ss_pred HHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHHHHHHHCCCCcccCCC--
Confidence 99998889999999999999999998 999998777666666655444444444567889999999999999999999
Q ss_pred cChHHHhc
Q 012762 407 MGATAIKR 414 (457)
Q Consensus 407 ~~~~~ll~ 414 (457)
+.++++
T Consensus 248 --~~~~~~ 253 (257)
T cd05040 248 --FAALRE 253 (257)
T ss_pred --HHHHHH
Confidence 888865
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=323.67 Aligned_cols=259 Identities=17% Similarity=0.223 Sum_probs=203.7
Q ss_pred ccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcC
Q 012762 79 LTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCP 158 (457)
Q Consensus 79 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~ 158 (457)
+..++|++++.||+|+||+||+|.+..........+++|.+... ........+..|+.+++.++||||+++++++..
T Consensus 4 ~~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~- 80 (279)
T cd05111 4 LKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR--SGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG- 80 (279)
T ss_pred CCHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc--cchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-
Confidence 45578999999999999999999986422222235778877432 122334566678888899999999999998864
Q ss_pred CcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCC
Q 012762 159 RWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKG 238 (457)
Q Consensus 159 ~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~ 238 (457)
...++||||+.+|+|.+++.... ..+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||+++..
T Consensus 81 ~~~~~i~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~ 159 (279)
T cd05111 81 ASLQLVTQLSPLGSLLDHVRQHR-DSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLL 159 (279)
T ss_pred CccEEEEEeCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceec
Confidence 45789999999999999987642 56899999999999999999999999999999999999999999999999997644
Q ss_pred CCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccc
Q 012762 239 DNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSF 318 (457)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (457)
...... ......
T Consensus 160 ~~~~~~--------------------------------------------------------------------~~~~~~ 171 (279)
T cd05111 160 YPDDKK--------------------------------------------------------------------YFYSEH 171 (279)
T ss_pred cCCCcc--------------------------------------------------------------------cccCCC
Confidence 211100 000122
Q ss_pred cCCCCccCchhhcCCCCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhhh
Q 012762 319 VGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVK 397 (457)
Q Consensus 319 ~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~ 397 (457)
.|+..|+|||++.+..++.++|||||||++|||++ |..||.+...... ..++......+....++.++.+++.+||..
T Consensus 172 ~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~c~~~ 250 (279)
T cd05111 172 KTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEV-PDLLEKGERLAQPQICTIDVYMVMVKCWMI 250 (279)
T ss_pred CCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH-HHHHHCCCcCCCCCCCCHHHHHHHHHHcCC
Confidence 47788999999998889999999999999999998 9999987655443 333333333344445778899999999999
Q ss_pred CCCCCCCCCcChHHHhc
Q 012762 398 DPTRRMGSKMGATAIKR 414 (457)
Q Consensus 398 dP~~Rps~~~~~~~ll~ 414 (457)
||++||+ +.++++
T Consensus 251 ~p~~Rps----~~el~~ 263 (279)
T cd05111 251 DENVRPT----FKELAN 263 (279)
T ss_pred CcccCcC----HHHHHH
Confidence 9999999 888766
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=335.57 Aligned_cols=258 Identities=22% Similarity=0.342 Sum_probs=205.6
Q ss_pred CCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcC---
Q 012762 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCP--- 158 (457)
Q Consensus 82 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~--- 158 (457)
.+|.+.+.||+|+||+||+|.+. .+++.||||.+..... .......+..|+++|+.++|+||+++++++...
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~----~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~ 79 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNS----ETNEKVAIKKIANAFD-NRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHRE 79 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEec----CCCCeEEEEEeccccc-ccchhHHHHHHHHHHHhcCCCCccchHHheeccccc
Confidence 47999999999999999999876 4788999999865322 222345567799999999999999999988644
Q ss_pred --CcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCc
Q 012762 159 --RWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSL 236 (457)
Q Consensus 159 --~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~ 236 (457)
...||||||+ +++|..++... +.+++..+..++.||+.||.|||+++++||||||+||+++.++.+||+|||++.
T Consensus 80 ~~~~~~lv~e~~-~~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 156 (337)
T cd07858 80 AFNDVYIVYELM-DTDLHQIIRSS--QTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 156 (337)
T ss_pred ccCcEEEEEeCC-CCCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCcccc
Confidence 3579999999 57888877654 679999999999999999999999999999999999999999999999999975
Q ss_pred CCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccc
Q 012762 237 KGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSM 316 (457)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (457)
....... ...
T Consensus 157 ~~~~~~~----------------------------------------------------------------------~~~ 166 (337)
T cd07858 157 TTSEKGD----------------------------------------------------------------------FMT 166 (337)
T ss_pred ccCCCcc----------------------------------------------------------------------ccc
Confidence 4321100 001
Q ss_pred cccCCCCccCchhhcC-CCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhc----------------------
Q 012762 317 SFVGTHEYLAPEIISG-EGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVAR---------------------- 373 (457)
Q Consensus 317 ~~~gt~~y~aPE~l~~-~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~---------------------- 373 (457)
...|+..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+...
T Consensus 167 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (337)
T cd07858 167 EYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIR 246 (337)
T ss_pred ccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhhhHHHH
Confidence 2357889999999875 45899999999999999999999999775433222221110
Q ss_pred -ccCCC------CCCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCCC
Q 012762 374 -ALEFP------KEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGV 421 (457)
Q Consensus 374 -~~~~~------~~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~~ 421 (457)
....+ ..+.++.++.++|++||..||++||+ +.++++||||..+
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps----~~ell~h~~~~~~ 297 (337)
T cd07858 247 SLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRIT----VEEALAHPYLASL 297 (337)
T ss_pred hcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccC----HHHHHcCcchhhh
Confidence 00000 12357788999999999999999999 9999999999864
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-41 Score=319.79 Aligned_cols=260 Identities=20% Similarity=0.294 Sum_probs=210.5
Q ss_pred ccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcC
Q 012762 79 LTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCP 158 (457)
Q Consensus 79 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~ 158 (457)
+..++|+..+.||+|+||.||+|.++... .....+|+|.+.... .......+..|+++++.++|+||+++++++...
T Consensus 2 i~~~~~~~~~~lg~g~~g~vy~~~~~~~~-~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 78 (268)
T cd05063 2 IHPSHITKQKVIGAGEFGEVFRGILKMPG-RKEVAVAIKTLKPGY--TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKF 78 (268)
T ss_pred CChHHceEeeEecCCCCccEEEEEEecCC-CCceEEEEEeccccC--CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccC
Confidence 34568999999999999999999986421 234579999986542 223345677899999999999999999999999
Q ss_pred CcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCC
Q 012762 159 RWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKG 238 (457)
Q Consensus 159 ~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~ 238 (457)
+..|+||||+++++|..++... .+.+++..+..++.|++.||+|||+.|++|+||||+||+++.++.+||+|||++...
T Consensus 79 ~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~ 157 (268)
T cd05063 79 KPAMIITEYMENGALDKYLRDH-DGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVL 157 (268)
T ss_pred CCcEEEEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceec
Confidence 9999999999999999888764 356899999999999999999999999999999999999999999999999997544
Q ss_pred CCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccc
Q 012762 239 DNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSF 318 (457)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (457)
....... ......
T Consensus 158 ~~~~~~~-------------------------------------------------------------------~~~~~~ 170 (268)
T cd05063 158 EDDPEGT-------------------------------------------------------------------YTTSGG 170 (268)
T ss_pred ccccccc-------------------------------------------------------------------eeccCC
Confidence 3211000 000001
Q ss_pred cCCCCccCchhhcCCCCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhhh
Q 012762 319 VGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVK 397 (457)
Q Consensus 319 ~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~ 397 (457)
..+..|+|||++.+..++.++|||||||++|||++ |..||...........+.. ....+....++.++.+++.+||+.
T Consensus 171 ~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~-~~~~~~~~~~~~~~~~li~~c~~~ 249 (268)
T cd05063 171 KIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAIND-GFRLPAPMDCPSAVYQLMLQCWQQ 249 (268)
T ss_pred CcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhc-CCCCCCCCCCCHHHHHHHHHHcCC
Confidence 23567999999998889999999999999999997 9999988776665555543 345555556889999999999999
Q ss_pred CCCCCCCCCcChHHHhc
Q 012762 398 DPTRRMGSKMGATAIKR 414 (457)
Q Consensus 398 dP~~Rps~~~~~~~ll~ 414 (457)
||++||+ +.+|++
T Consensus 250 ~p~~Rp~----~~~i~~ 262 (268)
T cd05063 250 DRARRPR----FVDIVN 262 (268)
T ss_pred CcccCcC----HHHHHH
Confidence 9999999 777764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-41 Score=329.65 Aligned_cols=254 Identities=23% Similarity=0.319 Sum_probs=212.4
Q ss_pred CceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcEE
Q 012762 83 DLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWSC 162 (457)
Q Consensus 83 ~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~ 162 (457)
.|...+.||+|+||.||+|.+. .++..||+|++.............+..|+++++.++|+||+++++++..+...|
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~----~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDV----RTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAW 101 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEc----CCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEE
Confidence 4888999999999999999876 368899999987543333344566788999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCCC
Q 012762 163 LLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNST 242 (457)
Q Consensus 163 lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~~ 242 (457)
+||||+. |+|.+++... ...+++..+..++.||+.||.|||+.||+||||+|+||+++.++.++|+|||++......
T Consensus 102 lv~e~~~-g~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~- 178 (317)
T cd06635 102 LVMEYCL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA- 178 (317)
T ss_pred EEEeCCC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCCc-
Confidence 9999995 5777666543 356899999999999999999999999999999999999999999999999986432210
Q ss_pred cccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCCC
Q 012762 243 STAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTH 322 (457)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 322 (457)
....|+.
T Consensus 179 -------------------------------------------------------------------------~~~~~~~ 185 (317)
T cd06635 179 -------------------------------------------------------------------------NSFVGTP 185 (317)
T ss_pred -------------------------------------------------------------------------ccccCCc
Confidence 0124888
Q ss_pred CccCchhhc---CCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhhhCC
Q 012762 323 EYLAPEIIS---GEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDP 399 (457)
Q Consensus 323 ~y~aPE~l~---~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP 399 (457)
.|+|||++. ...++.++|||||||++|||++|..||...........+............++..+.+++.+||+.+|
T Consensus 186 ~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p 265 (317)
T cd06635 186 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIP 265 (317)
T ss_pred cccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccHHHHHHHHHHccCCc
Confidence 999999984 34578899999999999999999999988766666666665544444444678889999999999999
Q ss_pred CCCCCCCcChHHHhcCCCCCC
Q 012762 400 TRRMGSKMGATAIKRHQFFNG 420 (457)
Q Consensus 400 ~~Rps~~~~~~~ll~hp~f~~ 420 (457)
.+||+ +.++++|+|+..
T Consensus 266 ~~Rpt----~~~il~~~~~~~ 282 (317)
T cd06635 266 QDRPT----SEELLKHMFVLR 282 (317)
T ss_pred ccCcC----HHHHHhChhhhc
Confidence 99999 999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-41 Score=325.85 Aligned_cols=254 Identities=21% Similarity=0.298 Sum_probs=204.3
Q ss_pred CCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHc-CCCCCceEEEEEEcCCc
Q 012762 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEML-DHPFLPTLYATLDCPRW 160 (457)
Q Consensus 82 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~~~~~~~~~ 160 (457)
++|++.+.||+|+||.||+|.++.. .....+++|.++.. ........+..|++++.++ +||||+++++++...+.
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~--~~~~~~~ik~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 77 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKD--GLKMNAAIKMLKEF--ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGY 77 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCC--CCcceeEEEEcccc--CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCc
Confidence 5899999999999999999987632 12235788887632 2223445678899999999 79999999999999999
Q ss_pred EEEEEeecCCCChHHHHHhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCC
Q 012762 161 SCLLTEFCPGGDLHVLRQRQP--------------DKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGH 226 (457)
Q Consensus 161 ~~lV~E~~~~~sL~~~~~~~~--------------~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~ 226 (457)
.|+||||+++++|.+++.... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~ 157 (297)
T cd05089 78 LYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLA 157 (297)
T ss_pred ceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCe
Confidence 999999999999999886532 135888999999999999999999999999999999999999999
Q ss_pred EEEeccCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcc
Q 012762 227 IMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEI 306 (457)
Q Consensus 227 vkl~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (457)
+||+|||++........
T Consensus 158 ~kl~dfg~~~~~~~~~~--------------------------------------------------------------- 174 (297)
T cd05089 158 SKIADFGLSRGEEVYVK--------------------------------------------------------------- 174 (297)
T ss_pred EEECCcCCCccccceec---------------------------------------------------------------
Confidence 99999998742210000
Q ss_pred cccCCccccccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHHhcccCCCCCCCCCh
Q 012762 307 VAEPLDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVVARALEFPKEPSVPG 385 (457)
Q Consensus 307 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (457)
......+..|+|||++.+..++.++|||||||++|||++ |..||...........+... ...+....++.
T Consensus 175 --------~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~ 245 (297)
T cd05089 175 --------KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQG-YRMEKPRNCDD 245 (297)
T ss_pred --------cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC-CCCCCCCCCCH
Confidence 000123557999999998889999999999999999997 99999887766655554433 33333445889
Q ss_pred HHHHHHHHHhhhCCCCCCCCCcChHHHhcC
Q 012762 386 PAKDLIAQLLVKDPTRRMGSKMGATAIKRH 415 (457)
Q Consensus 386 ~~~~ll~~~L~~dP~~Rps~~~~~~~ll~h 415 (457)
++.+|+.+||..||.+||+ ++++++.
T Consensus 246 ~~~~li~~~l~~~p~~Rp~----~~~i~~~ 271 (297)
T cd05089 246 EVYELMRQCWRDRPYERPP----FAQISVQ 271 (297)
T ss_pred HHHHHHHHHcCCChhhCcC----HHHHHHH
Confidence 9999999999999999999 7777654
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=314.82 Aligned_cols=254 Identities=27% Similarity=0.461 Sum_probs=215.3
Q ss_pred CceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcEE
Q 012762 83 DLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWSC 162 (457)
Q Consensus 83 ~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~ 162 (457)
+|.+.+.||+|++|.||+|.+. ..++.||+|.+...... ......+..|++++++++|+||+++++++...+..+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~----~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 75 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNL----ETGDFVAIKQISLEKIK-EEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLY 75 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEc----CCCcEEEEEEecccccC-HHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEE
Confidence 5889999999999999999876 36788999999766432 234567888999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCCC
Q 012762 163 LLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNST 242 (457)
Q Consensus 163 lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~~ 242 (457)
+||||+++++|.+++... ..+++..+..++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++.......
T Consensus 76 ~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 153 (254)
T cd06627 76 IILEYAENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVS 153 (254)
T ss_pred EEEecCCCCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCc
Confidence 999999999999988775 679999999999999999999999999999999999999999999999999976543211
Q ss_pred cccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCCC
Q 012762 243 STAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTH 322 (457)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 322 (457)
.. .....|+.
T Consensus 154 ~~----------------------------------------------------------------------~~~~~~~~ 163 (254)
T cd06627 154 KD----------------------------------------------------------------------DASVVGTP 163 (254)
T ss_pred cc----------------------------------------------------------------------ccccccch
Confidence 10 01235888
Q ss_pred CccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhhhCCCCC
Q 012762 323 EYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDPTRR 402 (457)
Q Consensus 323 ~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R 402 (457)
.|+|||.+.+..++.++|||+||+++|+|++|..||................ ..+....++..+.+++.+||..+|++|
T Consensus 164 ~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~~p~~R 242 (254)
T cd06627 164 YWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDD-HPPLPEGISPELKDFLMQCFQKDPNLR 242 (254)
T ss_pred hhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccC-CCCCCCCCCHHHHHHHHHHHhCChhhC
Confidence 9999999988888999999999999999999999998766554444443222 222334578899999999999999999
Q ss_pred CCCCcChHHHhcCCCC
Q 012762 403 MGSKMGATAIKRHQFF 418 (457)
Q Consensus 403 ps~~~~~~~ll~hp~f 418 (457)
|+ +.+++.||||
T Consensus 243 ~~----~~~~l~~~~~ 254 (254)
T cd06627 243 PT----AKQLLKHPWI 254 (254)
T ss_pred cC----HHHHhcCCCC
Confidence 99 9999999998
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-41 Score=322.44 Aligned_cols=254 Identities=27% Similarity=0.408 Sum_probs=206.2
Q ss_pred ceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHc---CCCCCceEEEEEEcCCc
Q 012762 84 LRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEML---DHPFLPTLYATLDCPRW 160 (457)
Q Consensus 84 ~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l---~H~nIv~l~~~~~~~~~ 160 (457)
|++.+.||+|+||.||+|+++ .++..||+|++..... .......+..|+++++++ +|+||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~----~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 75 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDL----NTGRFVALKKVRVPLS-EEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRT 75 (287)
T ss_pred CeEEEEecccCceEEEEEEEC----CCCCEEEEEEeccccc-cchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccC
Confidence 678999999999999999986 3688999999975432 222234455688877766 59999999999988776
Q ss_pred -----EEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCC
Q 012762 161 -----SCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235 (457)
Q Consensus 161 -----~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s 235 (457)
.+++|||+. ++|..++.......+++..++.++.||+.||.|||+.+++|+||+|+||+++.++.++|+|||++
T Consensus 76 ~~~~~~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~ 154 (287)
T cd07838 76 DRELKLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLA 154 (287)
T ss_pred CCCceeEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcc
Confidence 899999995 58988887765557999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcccc
Q 012762 236 LKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRS 315 (457)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (457)
........ .
T Consensus 155 ~~~~~~~~-----------------------------------------------------------------------~ 163 (287)
T cd07838 155 RIYSFEMA-----------------------------------------------------------------------L 163 (287)
T ss_pred eeccCCcc-----------------------------------------------------------------------c
Confidence 54321100 0
Q ss_pred ccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccC-----CC-----------C
Q 012762 316 MSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALE-----FP-----------K 379 (457)
Q Consensus 316 ~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~-----~~-----------~ 379 (457)
....++..|+|||++.+..++.++|||||||++|+|++|.+||.+....+.+.++...... ++ .
T Consensus 164 ~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (287)
T cd07838 164 TSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRSSFPS 243 (287)
T ss_pred ccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccchhhccc
Confidence 0124788999999999988999999999999999999999999987776666655542110 00 0
Q ss_pred ---------CCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCC
Q 012762 380 ---------EPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFF 418 (457)
Q Consensus 380 ---------~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f 418 (457)
...++..+.++|.+||..||.+||+ +.++++||||
T Consensus 244 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~----~~~il~~~~~ 287 (287)
T cd07838 244 YTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRIS----AFEALQHPYF 287 (287)
T ss_pred ccccchhhhhhhhhHHHHHHHHHHhccCCccCCC----HHHHhcCcCC
Confidence 0124567889999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-41 Score=323.47 Aligned_cols=259 Identities=22% Similarity=0.291 Sum_probs=205.4
Q ss_pred CceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcC--Cc
Q 012762 83 DLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCP--RW 160 (457)
Q Consensus 83 ~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~--~~ 160 (457)
-|++++.||+|+||.||+|.+......++..||+|.++... .......+.+|+++|+.++|+||+++++++... ..
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 82 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc--cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence 47899999999999999998765445678899999986432 223446788899999999999999999998775 56
Q ss_pred EEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCC
Q 012762 161 SCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDN 240 (457)
Q Consensus 161 ~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~ 240 (457)
.++||||++|++|..++.... ..+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++.....
T Consensus 83 ~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~ 161 (284)
T cd05079 83 IKLIMEFLPSGSLKEYLPRNK-NKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET 161 (284)
T ss_pred eEEEEEccCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCcccccccc
Confidence 899999999999999886642 3589999999999999999999999999999999999999999999999999765432
Q ss_pred CCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccC
Q 012762 241 STSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVG 320 (457)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 320 (457)
...... ......|
T Consensus 162 ~~~~~~-------------------------------------------------------------------~~~~~~~ 174 (284)
T cd05079 162 DKEYYT-------------------------------------------------------------------VKDDLDS 174 (284)
T ss_pred Ccccee-------------------------------------------------------------------ecCCCCC
Confidence 111000 0002347
Q ss_pred CCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCC--------------hHHHHHHHHhcccCCCCCCCCChH
Q 012762 321 THEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGID--------------HELTLANVVARALEFPKEPSVPGP 386 (457)
Q Consensus 321 t~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~ 386 (457)
+..|+|||++.+..++.++|||||||++|||+++..|+.... ........+......+....++..
T Consensus 175 ~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (284)
T cd05079 175 PVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKRLPRPPNCPEE 254 (284)
T ss_pred CccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHcCccCCCCCCCCHH
Confidence 788999999998889999999999999999999877653211 111122222333344445568899
Q ss_pred HHHHHHHHhhhCCCCCCCCCcChHHHhcC
Q 012762 387 AKDLIAQLLVKDPTRRMGSKMGATAIKRH 415 (457)
Q Consensus 387 ~~~ll~~~L~~dP~~Rps~~~~~~~ll~h 415 (457)
+.+|+.+||+.||++||+ +.+++++
T Consensus 255 ~~~li~~~l~~~p~~Rpt----~~~il~~ 279 (284)
T cd05079 255 VYQLMRKCWEFQPSKRTT----FQNLIEG 279 (284)
T ss_pred HHHHHHHHccCCcccCcC----HHHHHHH
Confidence 999999999999999999 8888764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-41 Score=325.97 Aligned_cols=262 Identities=21% Similarity=0.321 Sum_probs=205.6
Q ss_pred ccCCCceeEEEecccCcceEEEEEEeccC----------CCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCC
Q 012762 79 LTLSDLRFVHRLGSGDIGSVYLVQLKSKS----------SNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFL 148 (457)
Q Consensus 79 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~----------~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nI 148 (457)
+...+|++.++||+|+||.||+|++.... ......||+|.+.... .......+.+|+++|++++|+||
T Consensus 2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i 79 (295)
T cd05097 2 FPRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV--TKTARNDFLKEIKIMSRLKNPNI 79 (295)
T ss_pred CchHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCc
Confidence 34568999999999999999999875311 1223468999987542 23345568889999999999999
Q ss_pred ceEEEEEEcCCcEEEEEeecCCCChHHHHHhCC----------CCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCC
Q 012762 149 PTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQP----------DKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPEN 218 (457)
Q Consensus 149 v~l~~~~~~~~~~~lV~E~~~~~sL~~~~~~~~----------~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~N 218 (457)
+++++++...+..|+||||+.+++|.+++.... ...+++..+..++.|++.||.|||++|++|+||||+|
T Consensus 80 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~N 159 (295)
T cd05097 80 IRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRN 159 (295)
T ss_pred CeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhh
Confidence 999999999999999999999999998886532 1236788899999999999999999999999999999
Q ss_pred eEEccCCCEEEeccCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccC
Q 012762 219 VLVRSDGHIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKL 298 (457)
Q Consensus 219 Ill~~~~~vkl~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (457)
||++.++.+||+|||++..........
T Consensus 160 ill~~~~~~kl~dfg~~~~~~~~~~~~----------------------------------------------------- 186 (295)
T cd05097 160 CLVGNHYTIKIADFGMSRNLYSGDYYR----------------------------------------------------- 186 (295)
T ss_pred EEEcCCCcEEecccccccccccCccee-----------------------------------------------------
Confidence 999999999999999975432110000
Q ss_pred CCCCCCcccccCCccccccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhc--CCCCCCCCChHHHHHHHHh----
Q 012762 299 GNPGTPEIVAEPLDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFY--GTTPFKGIDHELTLANVVA---- 372 (457)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~ellt--G~~Pf~~~~~~~~~~~~~~---- 372 (457)
......++..|+|||++.+..++.++|||||||++|+|++ |..||...........+..
T Consensus 187 ---------------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~ 251 (295)
T cd05097 187 ---------------IQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIENTGEFFRN 251 (295)
T ss_pred ---------------ccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHHHHHHHHhhhh
Confidence 0001235778999999998889999999999999999987 7789987666555444322
Q ss_pred --cccCCCCCCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhc
Q 012762 373 --RALEFPKEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKR 414 (457)
Q Consensus 373 --~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~ 414 (457)
..........++..+.+|+.+||..||++||+ +++|++
T Consensus 252 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs----~~~i~~ 291 (295)
T cd05097 252 QGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPT----FNKIHH 291 (295)
T ss_pred ccccccCCCCCCCCHHHHHHHHHHcCCCchhCcC----HHHHHH
Confidence 11112233457889999999999999999999 777754
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=321.14 Aligned_cols=261 Identities=17% Similarity=0.220 Sum_probs=211.5
Q ss_pred ccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEc-
Q 012762 79 LTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDC- 157 (457)
Q Consensus 79 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~- 157 (457)
+..++|++.+.||+|+||.||+|.+.......+..|++|++... ........+.+|++++++++|+||+++++++..
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~ 80 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH--ASEIQVTLLLQESCLLYGLSHQNILPILHVCIED 80 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence 45678999999999999999999987533334788999998643 233445667889999999999999999998765
Q ss_pred CCcEEEEEeecCCCChHHHHHhCCC------CCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEec
Q 012762 158 PRWSCLLTEFCPGGDLHVLRQRQPD------KRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTD 231 (457)
Q Consensus 158 ~~~~~lV~E~~~~~sL~~~~~~~~~------~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~D 231 (457)
+...++++||+.+++|..++..... ..+++..+..++.||+.||+|||+.+++||||||+||+++.++.+||+|
T Consensus 81 ~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 81 GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECC
Confidence 5678999999999999988876432 4589999999999999999999999999999999999999999999999
Q ss_pred cCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCC
Q 012762 232 FDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPL 311 (457)
Q Consensus 232 FG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (457)
||+++..........
T Consensus 161 ~g~~~~~~~~~~~~~----------------------------------------------------------------- 175 (280)
T cd05043 161 NALSRDLFPMDYHCL----------------------------------------------------------------- 175 (280)
T ss_pred CCCcccccCCceEEe-----------------------------------------------------------------
Confidence 999865432111000
Q ss_pred ccccccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHH
Q 012762 312 DVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDL 390 (457)
Q Consensus 312 ~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 390 (457)
.....++..|+|||++.+..++.++|||||||++||+++ |+.||.......... .+......+....+++++.++
T Consensus 176 ---~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l 251 (280)
T cd05043 176 ---GDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAA-YLKDGYRLAQPINCPDELFAV 251 (280)
T ss_pred ---CCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHH-HHHcCCCCCCCCcCCHHHHHH
Confidence 001135778999999998889999999999999999998 999998765544443 344444555555678999999
Q ss_pred HHHHhhhCCCCCCCCCcChHHHhc
Q 012762 391 IAQLLVKDPTRRMGSKMGATAIKR 414 (457)
Q Consensus 391 l~~~L~~dP~~Rps~~~~~~~ll~ 414 (457)
+.+||..||++||+ +.++++
T Consensus 252 i~~~l~~~p~~Rps----~~~~~~ 271 (280)
T cd05043 252 MACCWALDPEERPS----FSQLVQ 271 (280)
T ss_pred HHHHcCCChhhCCC----HHHHHH
Confidence 99999999999999 777764
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-41 Score=331.42 Aligned_cols=274 Identities=24% Similarity=0.290 Sum_probs=210.0
Q ss_pred CCce-eEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhh-----------HHHHHHHHHHHHHHcCCCCCc
Q 012762 82 SDLR-FVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRN-----------KESRARIEREILEMLDHPFLP 149 (457)
Q Consensus 82 ~~~~-~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~-----------~~~~~~~E~~il~~l~H~nIv 149 (457)
++|. +.+.||.|+||+||+|.++ ..++.||+|++......... ....+.+|+++++.++|+||+
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~----~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 83 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDT----LTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIM 83 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEEC----CCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCccee
Confidence 3565 4577999999999999976 37889999998654322111 122467799999999999999
Q ss_pred eEEEEEEcCCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEE
Q 012762 150 TLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIML 229 (457)
Q Consensus 150 ~l~~~~~~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl 229 (457)
++++++..++..|+||||+. ++|..++... ..+++..+..++.||+.||.|||+.||+|+||||+||+++.++.++|
T Consensus 84 ~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl 160 (335)
T PTZ00024 84 GLVDVYVEGDFINLVMDIMA-SDLKKVVDRK--IRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKI 160 (335)
T ss_pred eeeEEEecCCcEEEEEeccc-cCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEE
Confidence 99999999999999999995 6898887654 56899999999999999999999999999999999999999999999
Q ss_pred eccCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCccccc
Q 012762 230 TDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAE 309 (457)
Q Consensus 230 ~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (457)
+|||++................. .
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~--------------------------------------------------------~ 184 (335)
T PTZ00024 161 ADFGLARRYGYPPYSDTLSKDET--------------------------------------------------------M 184 (335)
T ss_pred CCccceeeccccccccccccccc--------------------------------------------------------c
Confidence 99999865542211110000000 0
Q ss_pred CCccccccccCCCCccCchhhcCCC-CCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCC----------
Q 012762 310 PLDVRSMSFVGTHEYLAPEIISGEG-HGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFP---------- 378 (457)
Q Consensus 310 ~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~---------- 378 (457)
..........++..|+|||++.+.. ++.++|||||||++|||++|..||.+......+..+........
T Consensus 185 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 264 (335)
T PTZ00024 185 QRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFELLGTPNEDNWPQAKKL 264 (335)
T ss_pred cccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCchhhCcchhhc
Confidence 0000111224788999999997654 68999999999999999999999988776655554433111000
Q ss_pred ----------------CCCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCCCC
Q 012762 379 ----------------KEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGVN 422 (457)
Q Consensus 379 ----------------~~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~~~ 422 (457)
.....+.++.++|.+||..||++||+ ++|++.||||+...
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s----~~~~l~~~~~~~~~ 320 (335)
T PTZ00024 265 PLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERIS----AKEALKHEYFKSDP 320 (335)
T ss_pred ccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccC----HHHHhcCcccCCCC
Confidence 01234678999999999999999999 99999999999643
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=333.98 Aligned_cols=259 Identities=22% Similarity=0.320 Sum_probs=203.4
Q ss_pred CCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcC---
Q 012762 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCP--- 158 (457)
Q Consensus 82 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~--- 158 (457)
.+|.+.+.||.|+||.||+|.++ .++..||+|.+..... .....+..|++++++++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~----~~~~~v~iK~i~~~~~---~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~ 77 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDS----DCDKRVAVKKIVLTDP---QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSD 77 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEEC----CCCcEEEEEEEecCCC---chHHHHHHHHHHHHhcCCCcchhhHhhhcccccc
Confidence 58999999999999999999876 4788999999865432 3445677799999999999999999876543
Q ss_pred -----------CcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEcc-CCC
Q 012762 159 -----------RWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRS-DGH 226 (457)
Q Consensus 159 -----------~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~-~~~ 226 (457)
...|+||||+. ++|..++.. ..+++..++.++.||+.||.|||+.||+||||||+||+++. ++.
T Consensus 78 ~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~ 153 (342)
T cd07854 78 LTEDVGSLTELNSVYIVQEYME-TDLANVLEQ---GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLV 153 (342)
T ss_pred cccccccccccceEEEEeeccc-ccHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCce
Confidence 35799999995 688877754 46899999999999999999999999999999999999985 457
Q ss_pred EEEeccCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcc
Q 012762 227 IMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEI 306 (457)
Q Consensus 227 vkl~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (457)
++|+|||++...........
T Consensus 154 ~kl~dfg~~~~~~~~~~~~~------------------------------------------------------------ 173 (342)
T cd07854 154 LKIGDFGLARIVDPHYSHKG------------------------------------------------------------ 173 (342)
T ss_pred EEECCcccceecCCcccccc------------------------------------------------------------
Confidence 89999999754321110000
Q ss_pred cccCCccccccccCCCCccCchhhcC-CCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcc-----------
Q 012762 307 VAEPLDVRSMSFVGTHEYLAPEIISG-EGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARA----------- 374 (457)
Q Consensus 307 ~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~----------- 374 (457)
......|+..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.........++...
T Consensus 174 -------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (342)
T cd07854 174 -------YLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNEL 246 (342)
T ss_pred -------ccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhh
Confidence 0001247889999998765 457889999999999999999999998766544433332211
Q ss_pred -----------cCCCC------CCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCCCC
Q 012762 375 -----------LEFPK------EPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGVN 422 (457)
Q Consensus 375 -----------~~~~~------~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~~~ 422 (457)
...+. ...++.++.+||.+||..||.+||+ +.++++||||+...
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t----~~ell~h~~~~~~~ 307 (342)
T cd07854 247 LNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLT----AEEALMHPYMSCYS 307 (342)
T ss_pred hhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccC----HHHHhCCCcccccc
Confidence 00000 1246778999999999999999999 99999999998643
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=344.21 Aligned_cols=254 Identities=24% Similarity=0.396 Sum_probs=210.6
Q ss_pred ceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhh-hhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCc--
Q 012762 84 LRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELV-SRNKESRARIEREILEMLDHPFLPTLYATLDCPRW-- 160 (457)
Q Consensus 84 ~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~-- 160 (457)
.++..+||+|+|-+||+|.+. .+|..||=--++..++. +....+++..|+++|+.|+|+||+++|+++.+...
T Consensus 42 ~k~~evLGrGafKtVYka~De----~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~ 117 (632)
T KOG0584|consen 42 LKFDEVLGRGAFKTVYKAFDE----EEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKT 117 (632)
T ss_pred eehhhhcccccceeeeecccc----ccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCce
Confidence 356789999999999999875 58888874433333332 23345889999999999999999999999977655
Q ss_pred EEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcC--ceeecCCCCCeEEccC-CCEEEeccCCCcC
Q 012762 161 SCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMG--IIYRDLKPENVLVRSD-GHIMLTDFDLSLK 237 (457)
Q Consensus 161 ~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~--iiHrDIKp~NIll~~~-~~vkl~DFG~s~~ 237 (457)
+.+|+|++..|+|+.++++. +++....++.|++||+.||.|||++. |||||||.+||||+.+ |.|||+|+|||..
T Consensus 118 in~iTEL~TSGtLr~Y~kk~--~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl 195 (632)
T KOG0584|consen 118 INFITELFTSGTLREYRKKH--RRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATL 195 (632)
T ss_pred eeeeeecccCCcHHHHHHHh--ccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHH
Confidence 78999999999999999987 78999999999999999999999885 9999999999999865 8999999999976
Q ss_pred CCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcccccc
Q 012762 238 GDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMS 317 (457)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (457)
...+... .
T Consensus 196 ~r~s~ak------------------------------------------------------------------------s 203 (632)
T KOG0584|consen 196 LRKSHAK------------------------------------------------------------------------S 203 (632)
T ss_pred hhccccc------------------------------------------------------------------------e
Confidence 6533221 2
Q ss_pred ccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCCh-HHHHHHHHhcccCCCCCCCCChHHHHHHHHHhh
Q 012762 318 FVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDH-ELTLANVVARALEFPKEPSVPGPAKDLIAQLLV 396 (457)
Q Consensus 318 ~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~ 396 (457)
.+|||.|||||+.. ..|+..+||||||+.++||+|+.+||..-.+ .+++.++..+..+-.-...-.+++++||.+||.
T Consensus 204 vIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dPevr~fIekCl~ 282 (632)
T KOG0584|consen 204 VIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDPEVREFIEKCLA 282 (632)
T ss_pred eccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCHHHHHHHHHHhc
Confidence 47999999999997 6799999999999999999999999976544 456666665543322222235689999999999
Q ss_pred hCCCCCCCCCcChHHHhcCCCCCCC
Q 012762 397 KDPTRRMGSKMGATAIKRHQFFNGV 421 (457)
Q Consensus 397 ~dP~~Rps~~~~~~~ll~hp~f~~~ 421 (457)
. .++|++ +.|||+||||..-
T Consensus 283 ~-~~~R~s----a~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 283 T-KSERLS----AKELLKDPFFDED 302 (632)
T ss_pred C-chhccC----HHHHhhChhhccc
Confidence 9 999999 9999999999874
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=315.23 Aligned_cols=257 Identities=28% Similarity=0.448 Sum_probs=213.4
Q ss_pred CceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcC--Cc
Q 012762 83 DLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCP--RW 160 (457)
Q Consensus 83 ~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~--~~ 160 (457)
+|++.+.||+|++|.||+|.+. .++..|++|++...... ......+.+|++++++++|+||+++++.+... +.
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~----~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 75 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDK----DTGELMAVKSVELSGDS-EEELEALEREIRILSSLQHPNIVRYYGSERDEEKNT 75 (260)
T ss_pred CceeeeEeeecCceEEEEEEEC----CCCcEEEEEEeeccccc-hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCe
Confidence 4888999999999999999876 37889999999765432 34567788899999999999999999999988 88
Q ss_pred EEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCC
Q 012762 161 SCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDN 240 (457)
Q Consensus 161 ~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~ 240 (457)
+++||||+++++|.+++... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+.....
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 153 (260)
T cd06606 76 LNIFLEYVSGGSLSSLLKKF--GKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGD 153 (260)
T ss_pred EEEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccc
Confidence 99999999999999998875 3799999999999999999999999999999999999999999999999998765432
Q ss_pred CCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccC
Q 012762 241 STSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVG 320 (457)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 320 (457)
.... .......+
T Consensus 154 ~~~~--------------------------------------------------------------------~~~~~~~~ 165 (260)
T cd06606 154 IETG--------------------------------------------------------------------EGTGSVRG 165 (260)
T ss_pred cccc--------------------------------------------------------------------ccccCCCC
Confidence 2110 00012358
Q ss_pred CCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChH-HHHHHHHhcccCCCCCCCCChHHHHHHHHHhhhCC
Q 012762 321 THEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHE-LTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDP 399 (457)
Q Consensus 321 t~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP 399 (457)
+..|+|||.+.+..++.++||||||+++|+|++|..||...... .....+............++..+.+++.+||..||
T Consensus 166 ~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p 245 (260)
T cd06606 166 TPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLRKCLRRDP 245 (260)
T ss_pred CccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHHHHHhCcCCh
Confidence 89999999999888999999999999999999999999876522 22222222122222334568899999999999999
Q ss_pred CCCCCCCcChHHHhcCCCC
Q 012762 400 TRRMGSKMGATAIKRHQFF 418 (457)
Q Consensus 400 ~~Rps~~~~~~~ll~hp~f 418 (457)
++||+ +.++++||||
T Consensus 246 ~~Rp~----~~~ll~~~~~ 260 (260)
T cd06606 246 KKRPT----ADELLQHPFL 260 (260)
T ss_pred hhCCC----HHHHhhCCCC
Confidence 99999 9999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=334.39 Aligned_cols=257 Identities=28% Similarity=0.396 Sum_probs=205.7
Q ss_pred CCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCC--
Q 012762 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPR-- 159 (457)
Q Consensus 82 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~-- 159 (457)
++|.+.+.||+|+||.||+|.++ .+|..||+|++.+.. ........+.+|+++++.++|+||+++++++....
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~----~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 89 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDK----RTGEKVAIKKLSRPF-QSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSG 89 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeC----CCCcEEEEEEecCcc-ccccchhHHHHHHHHHHhcCCCCccchhheecccccC
Confidence 58999999999999999999876 478899999986532 22233455778999999999999999999986543
Q ss_pred ----cEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCC
Q 012762 160 ----WSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235 (457)
Q Consensus 160 ----~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s 235 (457)
.+|+||||+ ..+|..++. ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.++|+|||++
T Consensus 90 ~~~~~~~lv~e~~-~~~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~ 164 (342)
T cd07879 90 DEFQDFYLVMPYM-QTDLQKIMG----HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLA 164 (342)
T ss_pred CCCceEEEEeccc-ccCHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCC
Confidence 469999999 457765542 45899999999999999999999999999999999999999999999999997
Q ss_pred cCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcccc
Q 012762 236 LKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRS 315 (457)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (457)
+..... .
T Consensus 165 ~~~~~~-------------------------------------------------------------------------~ 171 (342)
T cd07879 165 RHADAE-------------------------------------------------------------------------M 171 (342)
T ss_pred cCCCCC-------------------------------------------------------------------------C
Confidence 533210 0
Q ss_pred ccccCCCCccCchhhcC-CCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcc--------------------
Q 012762 316 MSFVGTHEYLAPEIISG-EGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARA-------------------- 374 (457)
Q Consensus 316 ~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~-------------------- 374 (457)
....|+..|+|||++.+ ..++.++|||||||++|||++|+.||.+......+..++...
T Consensus 172 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (342)
T cd07879 172 TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYI 251 (342)
T ss_pred CCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccchHHHH
Confidence 12357889999999876 458899999999999999999999998866444443333210
Q ss_pred ---cCCCC------CCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCCCCchh
Q 012762 375 ---LEFPK------EPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGVNWAL 425 (457)
Q Consensus 375 ---~~~~~------~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~~~~~~ 425 (457)
...+. .+..+.++.+||.+||+.||++||+ +.+++.||||+.+.+..
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~----~~e~l~h~~f~~~~~~~ 307 (342)
T cd07879 252 KSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLT----ATEALEHPYFDSFRDAD 307 (342)
T ss_pred hhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcC----HHHHhcCcchhhccccc
Confidence 00000 1235678999999999999999999 99999999999887643
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=330.32 Aligned_cols=266 Identities=20% Similarity=0.279 Sum_probs=213.1
Q ss_pred CCCCccCCCceeEEEecccCcceEEEEEEeccCC---CCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHc-CCCCCce
Q 012762 75 NNNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSS---NNGCFFAAKVMDKRELVSRNKESRARIEREILEML-DHPFLPT 150 (457)
Q Consensus 75 ~~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~---~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~ 150 (457)
..+.+...+|++.+.||+|+||.||+|++...+. ..+..||+|++... ........+.+|+++++++ +|+||++
T Consensus 5 ~~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~ 82 (334)
T cd05100 5 PKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD--ATDKDLSDLVSEMEMMKMIGKHKNIIN 82 (334)
T ss_pred cccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc--cCHHHHHHHHHHHHHHHhhcCCCCeee
Confidence 4567777889999999999999999998754322 22347899988643 1223456778899999999 8999999
Q ss_pred EEEEEEcCCcEEEEEeecCCCChHHHHHhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCC
Q 012762 151 LYATLDCPRWSCLLTEFCPGGDLHVLRQRQP--------------DKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKP 216 (457)
Q Consensus 151 l~~~~~~~~~~~lV~E~~~~~sL~~~~~~~~--------------~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp 216 (457)
+++++...+..|+||||+.+++|.+++.... ...++...+..++.||+.||.|||++||+||||||
T Consensus 83 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp 162 (334)
T cd05100 83 LLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAA 162 (334)
T ss_pred eeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeecccccc
Confidence 9999999999999999999999999887532 23477888999999999999999999999999999
Q ss_pred CCeEEccCCCEEEeccCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccc
Q 012762 217 ENVLVRSDGHIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKK 296 (457)
Q Consensus 217 ~NIll~~~~~vkl~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (457)
+|||++.++.+||+|||+++.........
T Consensus 163 ~Nill~~~~~~kL~Dfg~~~~~~~~~~~~--------------------------------------------------- 191 (334)
T cd05100 163 RNVLVTEDNVMKIADFGLARDVHNIDYYK--------------------------------------------------- 191 (334)
T ss_pred ceEEEcCCCcEEECCcccceecccccccc---------------------------------------------------
Confidence 99999999999999999976443211000
Q ss_pred cCCCCCCCcccccCCccccccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHHhccc
Q 012762 297 KLGNPGTPEIVAEPLDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVVARAL 375 (457)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~ 375 (457)
......++..|+|||++.+..++.++|||||||++|||++ |..||.+....+....+... .
T Consensus 192 -----------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~-~ 253 (334)
T cd05100 192 -----------------KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEG-H 253 (334)
T ss_pred -----------------cccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC-C
Confidence 0001124568999999999889999999999999999998 89999887766655554433 3
Q ss_pred CCCCCCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcC
Q 012762 376 EFPKEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRH 415 (457)
Q Consensus 376 ~~~~~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~h 415 (457)
..+....++..+.+++.+||..+|++||+ +.+++++
T Consensus 254 ~~~~~~~~~~~l~~li~~cl~~~p~~Rps----~~ell~~ 289 (334)
T cd05100 254 RMDKPANCTHELYMIMRECWHAVPSQRPT----FKQLVED 289 (334)
T ss_pred CCCCCCCCCHHHHHHHHHHcccChhhCcC----HHHHHHH
Confidence 33344457889999999999999999999 7777765
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-41 Score=333.11 Aligned_cols=254 Identities=28% Similarity=0.398 Sum_probs=204.7
Q ss_pred CCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcC--
Q 012762 81 LSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCP-- 158 (457)
Q Consensus 81 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~-- 158 (457)
.++|.+.+.||+|+||.||+|.+. .+++.||+|++.+... .......+.+|++++++++|+||+++++++...
T Consensus 16 ~~~y~~~~~lg~G~~g~v~~~~~~----~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~ 90 (345)
T cd07877 16 PERYQNLSPVGSGAYGSVCAAFDT----KTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS 90 (345)
T ss_pred cCceEEEEEeeecCCeEEEEEEEc----CCCeEEEEEEecCcch-hhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccc
Confidence 368999999999999999999876 3788999999875322 222345677799999999999999999988543
Q ss_pred ----CcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCC
Q 012762 159 ----RWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDL 234 (457)
Q Consensus 159 ----~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~ 234 (457)
...|++++++ +++|..++.. ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+
T Consensus 91 ~~~~~~~~lv~~~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~ 166 (345)
T cd07877 91 LEEFNDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGL 166 (345)
T ss_pred ccccccEEEEehhc-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEecccc
Confidence 3478999988 8899887765 4589999999999999999999999999999999999999999999999998
Q ss_pred CcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccc
Q 012762 235 SLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVR 314 (457)
Q Consensus 235 s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (457)
+......
T Consensus 167 ~~~~~~~------------------------------------------------------------------------- 173 (345)
T cd07877 167 ARHTDDE------------------------------------------------------------------------- 173 (345)
T ss_pred ccccccc-------------------------------------------------------------------------
Confidence 7532210
Q ss_pred cccccCCCCccCchhhcC-CCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhccc------------------
Q 012762 315 SMSFVGTHEYLAPEIISG-EGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARAL------------------ 375 (457)
Q Consensus 315 ~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~------------------ 375 (457)
.....|+..|+|||++.+ ..++.++|||||||++|+|++|+.||........+..++....
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (345)
T cd07877 174 MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 253 (345)
T ss_pred ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhHHHH
Confidence 012357889999999876 4578999999999999999999999987655443333322111
Q ss_pred -----CCCC------CCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCC
Q 012762 376 -----EFPK------EPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNG 420 (457)
Q Consensus 376 -----~~~~------~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~ 420 (457)
..+. ....+.+++++|.+||..||.+||+ +.+++.||||+.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t----~~e~l~h~~f~~ 305 (345)
T cd07877 254 IQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT----AAQALAHAYFAQ 305 (345)
T ss_pred HHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCC----HHHHhcChhhhh
Confidence 0010 0135678999999999999999999 999999999985
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=322.91 Aligned_cols=257 Identities=19% Similarity=0.297 Sum_probs=206.7
Q ss_pred CceeEEEecccCcceEEEEEEeccC-CCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcE
Q 012762 83 DLRFVHRLGSGDIGSVYLVQLKSKS-SNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWS 161 (457)
Q Consensus 83 ~~~~~~~LG~G~fg~Vy~a~~~~~~-~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~ 161 (457)
+|++.+.||+|+||+||+|.+.... ......+|+|.+..... ......+..|+++++.++||||+++++.+...+..
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 78 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENAS--SSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPL 78 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCC--HHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCc
Confidence 5889999999999999999875322 22346789998865422 23346678899999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHHhCC----------------------CCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCe
Q 012762 162 CLLTEFCPGGDLHVLRQRQP----------------------DKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENV 219 (457)
Q Consensus 162 ~lV~E~~~~~sL~~~~~~~~----------------------~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NI 219 (457)
++||||+.+++|..++.... ...+++..+..++.|++.||.|||+.||+||||||+||
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~ni 158 (290)
T cd05045 79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNV 158 (290)
T ss_pred EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheE
Confidence 99999999999998876421 13578889999999999999999999999999999999
Q ss_pred EEccCCCEEEeccCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCC
Q 012762 220 LVRSDGHIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLG 299 (457)
Q Consensus 220 ll~~~~~vkl~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (457)
|++.++.+||+|||+++.........
T Consensus 159 ll~~~~~~kl~dfg~~~~~~~~~~~~------------------------------------------------------ 184 (290)
T cd05045 159 LVAEGRKMKISDFGLSRDVYEEDSYV------------------------------------------------------ 184 (290)
T ss_pred EEcCCCcEEeccccccccccCccchh------------------------------------------------------
Confidence 99999999999999976442111000
Q ss_pred CCCCCcccccCCccccccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHHhcccCCC
Q 012762 300 NPGTPEIVAEPLDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVVARALEFP 378 (457)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~ 378 (457)
......++..|+|||++.+..++.++|||||||++|||++ |..||.+........ .+......+
T Consensus 185 --------------~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~-~~~~~~~~~ 249 (290)
T cd05045 185 --------------KRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFN-LLKTGYRME 249 (290)
T ss_pred --------------cccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH-HHhCCCCCC
Confidence 0001135678999999988889999999999999999998 999998766555443 344444555
Q ss_pred CCCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhc
Q 012762 379 KEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKR 414 (457)
Q Consensus 379 ~~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~ 414 (457)
....++.++.+++.+||+.||++||+ +.++++
T Consensus 250 ~~~~~~~~~~~~i~~cl~~~P~~Rp~----~~~i~~ 281 (290)
T cd05045 250 RPENCSEEMYNLMLTCWKQEPDKRPT----FADISK 281 (290)
T ss_pred CCCCCCHHHHHHHHHHccCCcccCCC----HHHHHH
Confidence 55568899999999999999999999 777764
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=320.40 Aligned_cols=258 Identities=23% Similarity=0.358 Sum_probs=204.2
Q ss_pred CCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEc--CC
Q 012762 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDC--PR 159 (457)
Q Consensus 82 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~--~~ 159 (457)
.+|++++.||+|+||+||+|..+..+..++..||+|.+.... ......+.+|+++|+.++||||+++++++.. ..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 80 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST---AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 80 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCC
Confidence 479999999999999999998754455678899999986532 2345677889999999999999999998743 34
Q ss_pred cEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCC
Q 012762 160 WSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGD 239 (457)
Q Consensus 160 ~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~ 239 (457)
.+|+||||+++++|.+++... ...+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~ 159 (284)
T cd05081 81 NLRLVMEYLPYGSLRDYLQKH-RERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLP 159 (284)
T ss_pred ceEEEEEecCCCCHHHHHHhc-CcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCccccccc
Confidence 689999999999999988754 2458999999999999999999999999999999999999999999999999986543
Q ss_pred CCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcccccccc
Q 012762 240 NSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFV 319 (457)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (457)
........ .....
T Consensus 160 ~~~~~~~~-------------------------------------------------------------------~~~~~ 172 (284)
T cd05081 160 QDKEYYKV-------------------------------------------------------------------REPGE 172 (284)
T ss_pred CCCcceee-------------------------------------------------------------------cCCCC
Confidence 21110000 00012
Q ss_pred CCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChH---------------HHHHHHHhcccCCCCCCCCC
Q 012762 320 GTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHE---------------LTLANVVARALEFPKEPSVP 384 (457)
Q Consensus 320 gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~---------------~~~~~~~~~~~~~~~~~~~~ 384 (457)
++..|+|||++.+..++.++|||||||++|||++|..++...... ..+...+.....++....++
T Consensus 173 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (284)
T cd05081 173 SPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNGRLPAPPGCP 252 (284)
T ss_pred CceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHhcCCcCCCCCCCC
Confidence 455699999999888999999999999999999987776433211 11222333444445556688
Q ss_pred hHHHHHHHHHhhhCCCCCCCCCcChHHHhc
Q 012762 385 GPAKDLIAQLLVKDPTRRMGSKMGATAIKR 414 (457)
Q Consensus 385 ~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~ 414 (457)
.++.+|+.+||..||++||| +.+|++
T Consensus 253 ~~~~~li~~cl~~~p~~Rpt----~~ei~~ 278 (284)
T cd05081 253 AEIYAIMKECWNNDPSQRPS----FSELAL 278 (284)
T ss_pred HHHHHHHHHHccCChhhCCC----HHHHHH
Confidence 99999999999999999999 888865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=373.18 Aligned_cols=261 Identities=29% Similarity=0.471 Sum_probs=219.5
Q ss_pred CceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcEE
Q 012762 83 DLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWSC 162 (457)
Q Consensus 83 ~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~ 162 (457)
+++-...||.|.||.||-|... .+|...|+|-++.+... ......+.+|..+|..|+|||+|++||+=...+.++
T Consensus 1236 rWqrg~~Ig~G~fG~VYtavN~----~tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~ 1310 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNL----DTGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVY 1310 (1509)
T ss_pred eeccccccCCcceeeeEEeecC----CccchhhhhhhhcCccc-cccCcchHHHHHHHHhccCccccccCceeecHHHHH
Confidence 4555678999999999988866 58999999998776554 444567788999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCCC
Q 012762 163 LLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNST 242 (457)
Q Consensus 163 lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~~ 242 (457)
|.||||+||+|.++++.. +-.++...+.+..|++.||.|||+.|||||||||+||+|+.+|.+|++|||.|+...+..
T Consensus 1311 IFMEyC~~GsLa~ll~~g--ri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~ 1388 (1509)
T KOG4645|consen 1311 IFMEYCEGGSLASLLEHG--RIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNA 1388 (1509)
T ss_pred HHHHHhccCcHHHHHHhc--chhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCch
Confidence 999999999999998874 567888888999999999999999999999999999999999999999999987665432
Q ss_pred cccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCCC
Q 012762 243 STAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTH 322 (457)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 322 (457)
.+. ......+.||+
T Consensus 1389 ~~~------------------------------------------------------------------~~el~~~~GT~ 1402 (1509)
T KOG4645|consen 1389 QTM------------------------------------------------------------------PGELQSMMGTP 1402 (1509)
T ss_pred hcC------------------------------------------------------------------CHHHHhhcCCc
Confidence 111 11222467999
Q ss_pred CccCchhhcCC---CCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhhhCC
Q 012762 323 EYLAPEIISGE---GHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDP 399 (457)
Q Consensus 323 ~y~aPE~l~~~---~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP 399 (457)
.|||||++.|. +.+.+.||||||||+.||+||+.||...+++-.++..+...-..+.+..++.+.+++|.+||+.||
T Consensus 1403 ~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~ls~~g~dFle~Cl~~dP 1482 (1509)
T KOG4645|consen 1403 MYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPERLSSEGRDFLEHCLEQDP 1482 (1509)
T ss_pred hhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchhhhHhHHHHHHHHHhcCc
Confidence 99999999764 478899999999999999999999998877655544444433333344599999999999999999
Q ss_pred CCCCCCCcChHHHhcCCCCCC
Q 012762 400 TRRMGSKMGATAIKRHQFFNG 420 (457)
Q Consensus 400 ~~Rps~~~~~~~ll~hp~f~~ 420 (457)
++|.+ +.|||.|.|-+.
T Consensus 1483 ~~Rw~----~~qlle~~f~~~ 1499 (1509)
T KOG4645|consen 1483 KMRWT----ASQLLEHAFGKS 1499 (1509)
T ss_pred hhhhH----HHHHHHhhcccc
Confidence 99999 999999988663
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=317.08 Aligned_cols=246 Identities=20% Similarity=0.310 Sum_probs=204.5
Q ss_pred ccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcC
Q 012762 79 LTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCP 158 (457)
Q Consensus 79 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~ 158 (457)
+..++|++.+.||+|+||.||++.. +++.||+|++... .....+.+|++++++++|+||+++++++..+
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~------~~~~~~iK~~~~~-----~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 71 (254)
T cd05083 3 LNLQKLTLGEIIGEGEFGAVLQGEY------TGQKVAVKNIKCD-----VTAQAFLEETAVMTKLHHKNLVRLLGVILHN 71 (254)
T ss_pred ccHHHceeeeeeccCCCCceEeccc------CCCceEEEeecCc-----chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC
Confidence 4567899999999999999998863 5778999998543 2335677899999999999999999998765
Q ss_pred CcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCC
Q 012762 159 RWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKG 238 (457)
Q Consensus 159 ~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~ 238 (457)
..|+||||+.+++|.+++.......+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++...
T Consensus 72 -~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~ 150 (254)
T cd05083 72 -GLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVG 150 (254)
T ss_pred -CcEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceec
Confidence 4799999999999999988765567899999999999999999999999999999999999999999999999987532
Q ss_pred CCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccc
Q 012762 239 DNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSF 318 (457)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (457)
.... ...
T Consensus 151 ~~~~-------------------------------------------------------------------------~~~ 157 (254)
T cd05083 151 SMGV-------------------------------------------------------------------------DNS 157 (254)
T ss_pred cccC-------------------------------------------------------------------------CCC
Confidence 1100 001
Q ss_pred cCCCCccCchhhcCCCCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhhh
Q 012762 319 VGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVK 397 (457)
Q Consensus 319 ~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~ 397 (457)
..+..|+|||++.+..++.++|||||||++|||++ |..||...........+. ..........++..+.+++.+||..
T Consensus 158 ~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~ 236 (254)
T cd05083 158 KLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVE-KGYRMEPPEGCPADVYVLMTSCWET 236 (254)
T ss_pred CCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHh-CCCCCCCCCcCCHHHHHHHHHHcCC
Confidence 24567999999998889999999999999999997 999998877665554443 3344444456889999999999999
Q ss_pred CCCCCCCCCcChHHHhc
Q 012762 398 DPTRRMGSKMGATAIKR 414 (457)
Q Consensus 398 dP~~Rps~~~~~~~ll~ 414 (457)
+|++||+ +.+|+.
T Consensus 237 ~p~~Rp~----~~~l~~ 249 (254)
T cd05083 237 EPKKRPS----FHKLRE 249 (254)
T ss_pred ChhhCcC----HHHHHH
Confidence 9999999 777764
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=319.28 Aligned_cols=256 Identities=20% Similarity=0.278 Sum_probs=201.8
Q ss_pred ceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcC-----
Q 012762 84 LRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCP----- 158 (457)
Q Consensus 84 ~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~----- 158 (457)
|.+.++||+|+||.||+|.+... .....||+|.++... ........+..|+++++.++|+||+++++++...
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~--~~~~~~a~k~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 77 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQD--DSILKVAVKTMKIAI-CTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEG 77 (272)
T ss_pred CccccccCcccCceEEEeEEccC--CCeeeEEEEecccCc-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccC
Confidence 35678999999999999987631 112368999886542 2234456778899999999999999999976432
Q ss_pred -CcEEEEEeecCCCChHHHHHhC----CCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccC
Q 012762 159 -RWSCLLTEFCPGGDLHVLRQRQ----PDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFD 233 (457)
Q Consensus 159 -~~~~lV~E~~~~~sL~~~~~~~----~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG 233 (457)
...++||||+.+++|..++... ....+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||
T Consensus 78 ~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 78 YPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred CCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCC
Confidence 2468999999999998776432 22458899999999999999999999999999999999999999999999999
Q ss_pred CCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcc
Q 012762 234 LSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDV 313 (457)
Q Consensus 234 ~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (457)
+++.........
T Consensus 158 ~~~~~~~~~~~~-------------------------------------------------------------------- 169 (272)
T cd05075 158 LSKKIYNGDYYR-------------------------------------------------------------------- 169 (272)
T ss_pred cccccCccccee--------------------------------------------------------------------
Confidence 986543211000
Q ss_pred ccccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHH
Q 012762 314 RSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIA 392 (457)
Q Consensus 314 ~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~ 392 (457)
......+++.|++||++.+..++.++|||||||++|||++ |+.||.+.........+..+. ..+....++..+.+++.
T Consensus 170 ~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~ 248 (272)
T cd05075 170 QGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGN-RLKQPPDCLDGLYSLMS 248 (272)
T ss_pred cCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCCHHHHHHHH
Confidence 0001236778999999999889999999999999999999 899998877666555554432 33344568889999999
Q ss_pred HHhhhCCCCCCCCCcChHHHhcC
Q 012762 393 QLLVKDPTRRMGSKMGATAIKRH 415 (457)
Q Consensus 393 ~~L~~dP~~Rps~~~~~~~ll~h 415 (457)
+||..||++||+ +.+|+++
T Consensus 249 ~~l~~~p~~Rps----~~~l~~~ 267 (272)
T cd05075 249 SCWLLNPKDRPS----FETLRCE 267 (272)
T ss_pred HHcCCCcccCcC----HHHHHHH
Confidence 999999999999 8888764
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-41 Score=332.16 Aligned_cols=263 Identities=26% Similarity=0.330 Sum_probs=201.9
Q ss_pred CChhHHHHHHhhhcCCCCCCCCCccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHH
Q 012762 56 DDPCWKAIKEATSEGNNNNNNNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARI 135 (457)
Q Consensus 56 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~ 135 (457)
....+..+..++. +|.-...||+|+||.||+|... ++..||||.+....... ..+|..
T Consensus 63 ~~fs~~el~~AT~--------------~Fs~~~~ig~Ggfg~VYkG~l~-----~~~~vAVK~~~~~~~~~---~~eF~~ 120 (361)
T KOG1187|consen 63 RSFSYDELRKATN--------------NFSESNLIGEGGFGTVYKGVLS-----DGTVVAVKRLSSNSGQG---EREFLN 120 (361)
T ss_pred ceeeHHHHHHHHh--------------CCchhcceecCCCeEEEEEEEC-----CCCEEEEEEecCCCCcc---hhHHHH
Confidence 3455667777763 5666779999999999999985 56899999886543211 455999
Q ss_pred HHHHHHHcCCCCCceEEEEEEcCC-cEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcC---cee
Q 012762 136 EREILEMLDHPFLPTLYATLDCPR-WSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMG---IIY 211 (457)
Q Consensus 136 E~~il~~l~H~nIv~l~~~~~~~~-~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~---iiH 211 (457)
|+++|.+++|+|+|+++|||.+.+ ..+||+||+.+|+|.+.+.......++|.....|+.+++.||+|||... |||
T Consensus 121 Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiH 200 (361)
T KOG1187|consen 121 EVEILSRLRHPNLVKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIH 200 (361)
T ss_pred HHHHHhcCCCcCcccEEEEEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEec
Confidence 999999999999999999999988 4999999999999999888754338899999999999999999999754 999
Q ss_pred ecCCCCCeEEccCCCEEEeccCCCcCCCC-CCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCc
Q 012762 212 RDLKPENVLVRSDGHIMLTDFDLSLKGDN-STSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHP 290 (457)
Q Consensus 212 rDIKp~NIll~~~~~vkl~DFG~s~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (457)
||||+.|||||++...||+|||+++.... .....
T Consensus 201 rDiKssNILLD~~~~aKlsDFGLa~~~~~~~~~~~--------------------------------------------- 235 (361)
T KOG1187|consen 201 RDIKSSNILLDEDFNAKLSDFGLAKLGPEGDTSVS--------------------------------------------- 235 (361)
T ss_pred CCCCHHHeeECCCCCEEccCccCcccCCcccccee---------------------------------------------
Confidence 99999999999999999999999854432 11100
Q ss_pred chhccccCCCCCCCcccccCCccccccc-cCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCC--hHH-H
Q 012762 291 KRRRKKKLGNPGTPEIVAEPLDVRSMSF-VGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGID--HEL-T 366 (457)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~--~~~-~ 366 (457)
+. .||.+|++||++.....+.++||||||++|.||++|+.+.+... ... .
T Consensus 236 --------------------------~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l 289 (361)
T KOG1187|consen 236 --------------------------TTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSL 289 (361)
T ss_pred --------------------------eecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccH
Confidence 11 49999999999998889999999999999999999998887432 111 1
Q ss_pred HH---HHHhc-cc---CCCC-C-CCCC--h---HHHHHHHHHhhhCCCCCCCCCcChHH
Q 012762 367 LA---NVVAR-AL---EFPK-E-PSVP--G---PAKDLIAQLLVKDPTRRMGSKMGATA 411 (457)
Q Consensus 367 ~~---~~~~~-~~---~~~~-~-~~~~--~---~~~~ll~~~L~~dP~~Rps~~~~~~~ 411 (457)
.. ..+.. .+ -.+. . ...+ . .+..+...|++.+|.+||+|.+++.+
T Consensus 290 ~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~ 348 (361)
T KOG1187|consen 290 VEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKE 348 (361)
T ss_pred HHHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHH
Confidence 11 11111 00 0011 0 1222 1 25678899999999999995554333
|
|
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=315.74 Aligned_cols=252 Identities=23% Similarity=0.351 Sum_probs=209.8
Q ss_pred EEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcEEEEEee
Q 012762 88 HRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWSCLLTEF 167 (457)
Q Consensus 88 ~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lV~E~ 167 (457)
+.||+|+||.||+|.+.... ..+..||+|++....... ....+..|+++++.++|+||+++++++......++||||
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~-~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 77 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKD-GKTTEVAVKTLKEDASEE--ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEY 77 (262)
T ss_pred CccccCCceEEEEEEEecCC-CCCceEEeEeeccccchh--HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEe
Confidence 46899999999999986321 237889999997653322 466788899999999999999999999999999999999
Q ss_pred cCCCChHHHHHhCC-------CCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCC
Q 012762 168 CPGGDLHVLRQRQP-------DKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDN 240 (457)
Q Consensus 168 ~~~~sL~~~~~~~~-------~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~ 240 (457)
+++++|..++.... ...+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||.+.....
T Consensus 78 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 78 MEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred ccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEccccccccccc
Confidence 99999999987642 36789999999999999999999999999999999999999999999999999865532
Q ss_pred CCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccC
Q 012762 241 STSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVG 320 (457)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 320 (457)
.... .......+
T Consensus 158 ~~~~--------------------------------------------------------------------~~~~~~~~ 169 (262)
T cd00192 158 DDYY--------------------------------------------------------------------RKKTGGKL 169 (262)
T ss_pred cccc--------------------------------------------------------------------ccccCCCc
Confidence 1110 00012247
Q ss_pred CCCccCchhhcCCCCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhhhCC
Q 012762 321 THEYLAPEIISGEGHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDP 399 (457)
Q Consensus 321 t~~y~aPE~l~~~~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP 399 (457)
+..|+|||.+.+..++.++|||||||++|+|++ |..||...........+.. .........++.++.+++.+||..||
T Consensus 170 ~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p 248 (262)
T cd00192 170 PIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRK-GYRLPKPEYCPDELYELMLSCWQLDP 248 (262)
T ss_pred CccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc-CCCCCCCccCChHHHHHHHHHccCCc
Confidence 889999999998889999999999999999998 6999998876666555554 33444455678999999999999999
Q ss_pred CCCCCCCcChHHHhcC
Q 012762 400 TRRMGSKMGATAIKRH 415 (457)
Q Consensus 400 ~~Rps~~~~~~~ll~h 415 (457)
++||+ +.|++++
T Consensus 249 ~~Rps----~~~l~~~ 260 (262)
T cd00192 249 EDRPT----FSELVER 260 (262)
T ss_pred ccCcC----HHHHHHh
Confidence 99999 9999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-41 Score=325.73 Aligned_cols=252 Identities=27% Similarity=0.447 Sum_probs=208.4
Q ss_pred eeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcEEEE
Q 012762 85 RFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWSCLL 164 (457)
Q Consensus 85 ~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lV 164 (457)
....+||+|+||.||++..+ .++..||+|.+.... ......+.+|+.+++.++|+||+++++++..++..|+|
T Consensus 23 ~~~~~lg~g~~g~v~~~~~~----~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 95 (292)
T cd06657 23 DNFIKIGEGSTGIVCIATVK----SSGKLVAVKKMDLRK---QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVV 95 (292)
T ss_pred hhHHHcCCCCCeEEEEEEEc----CCCeEEEEEEecccc---hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEE
Confidence 33467999999999999876 478899999985432 23455678899999999999999999999999999999
Q ss_pred EeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCCCcc
Q 012762 165 TEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTST 244 (457)
Q Consensus 165 ~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~~~~ 244 (457)
|||+++++|.+++.. ..+++..++.++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++........
T Consensus 96 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~- 171 (292)
T cd06657 96 MEFLEGGALTDIVTH---TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP- 171 (292)
T ss_pred EecCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecccccc-
Confidence 999999999987754 4689999999999999999999999999999999999999999999999998643321100
Q ss_pred cccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCCCCc
Q 012762 245 AQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTHEY 324 (457)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 324 (457)
......|+..|
T Consensus 172 ---------------------------------------------------------------------~~~~~~~~~~y 182 (292)
T cd06657 172 ---------------------------------------------------------------------RRKSLVGTPYW 182 (292)
T ss_pred ---------------------------------------------------------------------cccccccCccc
Confidence 00123588999
Q ss_pred cCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhccc-CCCCCCCCChHHHHHHHHHhhhCCCCCC
Q 012762 325 LAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARAL-EFPKEPSVPGPAKDLIAQLLVKDPTRRM 403 (457)
Q Consensus 325 ~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ll~~~L~~dP~~Rp 403 (457)
+|||++.+..++.++|+||||+++|+|++|..||.+.........+..... .+.....++..+.+++.+||..||.+||
T Consensus 183 ~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~R~ 262 (292)
T cd06657 183 MAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRDPAQRA 262 (292)
T ss_pred cCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHHHHHHHHHHhCCcccCc
Confidence 999999888889999999999999999999999987665544444332221 2223345788999999999999999999
Q ss_pred CCCcChHHHhcCCCCCC
Q 012762 404 GSKMGATAIKRHQFFNG 420 (457)
Q Consensus 404 s~~~~~~~ll~hp~f~~ 420 (457)
+ +.+++.||||..
T Consensus 263 ~----~~~ll~~~~~~~ 275 (292)
T cd06657 263 T----AAELLKHPFLAK 275 (292)
T ss_pred C----HHHHhcChHHhc
Confidence 9 999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=311.96 Aligned_cols=252 Identities=29% Similarity=0.491 Sum_probs=211.9
Q ss_pred CceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcEE
Q 012762 83 DLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWSC 162 (457)
Q Consensus 83 ~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~ 162 (457)
+|.+.+.||+|++|.||+|.+. .++..|++|++..... .....+.+|+++++.++|+||+++++++..+...+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~----~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 73 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHK----RTGKEVAIKVIKLESK---EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELW 73 (253)
T ss_pred CceeeeeeccCCceEEEEEEEC----CCCcEEEEEEecccch---hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEE
Confidence 5889999999999999999976 3688999999976432 35567888999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCCC
Q 012762 163 LLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNST 242 (457)
Q Consensus 163 lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~~ 242 (457)
++|||+++++|.+++.... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 74 l~~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 152 (253)
T cd05122 74 IVMEFCSGGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTK 152 (253)
T ss_pred EEEecCCCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeeccccccccccc
Confidence 9999999999999887743 578999999999999999999999999999999999999999999999999875443211
Q ss_pred cccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCCC
Q 012762 243 STAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTH 322 (457)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 322 (457)
. .....|+.
T Consensus 153 ~-----------------------------------------------------------------------~~~~~~~~ 161 (253)
T cd05122 153 A-----------------------------------------------------------------------RNTMVGTP 161 (253)
T ss_pred c-----------------------------------------------------------------------ccceecCC
Confidence 0 11235889
Q ss_pred CccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhc-ccCCCCCCCCChHHHHHHHHHhhhCCCC
Q 012762 323 EYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVAR-ALEFPKEPSVPGPAKDLIAQLLVKDPTR 401 (457)
Q Consensus 323 ~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ll~~~L~~dP~~ 401 (457)
.|+|||.+.+..++.++||||||+++|+|++|+.||...+.......+... ....+....++..+.+++.+||..||++
T Consensus 162 ~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~ 241 (253)
T cd05122 162 YWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKKCLQKNPEK 241 (253)
T ss_pred cccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCcccccCHHHHHHHHHHccCChhh
Confidence 999999999888899999999999999999999999876544433333322 2222233334788999999999999999
Q ss_pred CCCCCcChHHHhcCCC
Q 012762 402 RMGSKMGATAIKRHQF 417 (457)
Q Consensus 402 Rps~~~~~~~ll~hp~ 417 (457)
||+ +.++++|||
T Consensus 242 R~t----~~~~l~~~~ 253 (253)
T cd05122 242 RPT----AEQLLKHPF 253 (253)
T ss_pred CCC----HHHHhcCCC
Confidence 999 999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=315.46 Aligned_cols=249 Identities=20% Similarity=0.304 Sum_probs=201.2
Q ss_pred EEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcEEEEEee
Q 012762 88 HRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWSCLLTEF 167 (457)
Q Consensus 88 ~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lV~E~ 167 (457)
++||+|+||.||+|.+...+. .+..||+|.+...... .....+..|+++++.++|+||+++++++. .+..++||||
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~-~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~ 76 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSG-KEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMEL 76 (257)
T ss_pred CccCccCceeEEEeEeeccCC-CcceEEEEecccccch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEe
Confidence 479999999999998764321 3478999999765432 34566788999999999999999999876 4568999999
Q ss_pred cCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCCCccccc
Q 012762 168 CPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQL 247 (457)
Q Consensus 168 ~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~~~~~~~ 247 (457)
+++++|.+++... ..+++..+..++.|++.||+|||..+++|+||||+|||++.++.+||+|||+++..........
T Consensus 77 ~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~- 153 (257)
T cd05060 77 APLGPLLKYLKKR--REIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR- 153 (257)
T ss_pred CCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccc-
Confidence 9999999998875 4689999999999999999999999999999999999999999999999999764421110000
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCCCCccCc
Q 012762 248 VSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTHEYLAP 327 (457)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 327 (457)
......++..|+||
T Consensus 154 ------------------------------------------------------------------~~~~~~~~~~y~aP 167 (257)
T cd05060 154 ------------------------------------------------------------------ATTAGRWPLKWYAP 167 (257)
T ss_pred ------------------------------------------------------------------cccCccccccccCH
Confidence 00001245689999
Q ss_pred hhhcCCCCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhhhCCCCCCCCC
Q 012762 328 EIISGEGHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDPTRRMGSK 406 (457)
Q Consensus 328 E~l~~~~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rps~~ 406 (457)
|++.+..++.++|||||||++|+|++ |..||......+....+. .....+....++..+++++.+||..||++||+
T Consensus 168 E~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~-- 244 (257)
T cd05060 168 ECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLE-SGERLPRPEECPQEIYSIMLSCWKYRPEDRPT-- 244 (257)
T ss_pred HHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH-cCCcCCCCCCCCHHHHHHHHHHhcCChhhCcC--
Confidence 99998889999999999999999997 999998876655544443 33344555568899999999999999999999
Q ss_pred cChHHHhc
Q 012762 407 MGATAIKR 414 (457)
Q Consensus 407 ~~~~~ll~ 414 (457)
+.++++
T Consensus 245 --~~~l~~ 250 (257)
T cd05060 245 --FSELES 250 (257)
T ss_pred --HHHHHH
Confidence 777754
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=315.68 Aligned_cols=248 Identities=21% Similarity=0.297 Sum_probs=198.1
Q ss_pred EecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcEEEEEeec
Q 012762 89 RLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWSCLLTEFC 168 (457)
Q Consensus 89 ~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lV~E~~ 168 (457)
.||+|+||.||+|.++.. ..+..||+|++.... .......+.+|++++++++|+||+++++++.. ...++||||+
T Consensus 2 ~ig~G~~g~v~~~~~~~~--~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~ 76 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMR--KKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMA 76 (257)
T ss_pred ccCCCCcccEEEEEEecC--CCceeEEEEEccccc--ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeC
Confidence 489999999999987532 245679999986542 23345678889999999999999999998864 5789999999
Q ss_pred CCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCCCcccccc
Q 012762 169 PGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQLV 248 (457)
Q Consensus 169 ~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~~~~~~~~ 248 (457)
++++|.+++... ...+++..++.++.||+.||.|||++|++||||||+|||++.++.+||+|||++...........
T Consensus 77 ~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~-- 153 (257)
T cd05115 77 SGGPLNKFLSGK-KDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYK-- 153 (257)
T ss_pred CCCCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCcccee--
Confidence 999999888653 35789999999999999999999999999999999999999999999999999764321110000
Q ss_pred cCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCCCCccCch
Q 012762 249 SDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTHEYLAPE 328 (457)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 328 (457)
....-.++..|+|||
T Consensus 154 -----------------------------------------------------------------~~~~~~~~~~y~aPE 168 (257)
T cd05115 154 -----------------------------------------------------------------ARSAGKWPLKWYAPE 168 (257)
T ss_pred -----------------------------------------------------------------ccCCCCCCcccCCHH
Confidence 000012467899999
Q ss_pred hhcCCCCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhhhCCCCCCCCCc
Q 012762 329 IISGEGHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDPTRRMGSKM 407 (457)
Q Consensus 329 ~l~~~~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rps~~~ 407 (457)
++.+..++.++|||||||++|||++ |..||...........+.. ....+....+++++.+++.+||..||++||+
T Consensus 169 ~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~c~~~~~~~Rp~--- 244 (257)
T cd05115 169 CINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQ-GKRLDCPAECPPEMYALMKDCWIYKWEDRPN--- 244 (257)
T ss_pred HHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHC-CCCCCCCCCCCHHHHHHHHHHcCCChhhCcC---
Confidence 9998889999999999999999996 9999988776665544433 3334444567899999999999999999999
Q ss_pred ChHHHhc
Q 012762 408 GATAIKR 414 (457)
Q Consensus 408 ~~~~ll~ 414 (457)
+.+|.+
T Consensus 245 -~~~i~~ 250 (257)
T cd05115 245 -FAKVEE 250 (257)
T ss_pred -HHHHHH
Confidence 666643
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-41 Score=329.02 Aligned_cols=257 Identities=21% Similarity=0.311 Sum_probs=199.2
Q ss_pred CcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcEEEEEeecCCCCh
Q 012762 94 DIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWSCLLTEFCPGGDL 173 (457)
Q Consensus 94 ~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~~sL 173 (457)
++|.||+++.+ .+++.||+|++..... .......+..|+++++.++|+||+++++++...+..|++|||+.+++|
T Consensus 12 ~~~~v~~~~~~----~~~~~~avK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l 86 (314)
T cd08216 12 DLMIVHLAKHK----PTNTLVAVKKINLDSC-SKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSC 86 (314)
T ss_pred CCceEEEEEec----CCCCEEEEEEEecccc-chhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCH
Confidence 44556666554 3788999999976532 234556788899999999999999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCCCcccccccCCCC
Q 012762 174 HVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQLVSDQSP 253 (457)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~~~~~~~~~~~~~ 253 (457)
..++.......+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||.+...........
T Consensus 87 ~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~------- 159 (314)
T cd08216 87 EDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQR------- 159 (314)
T ss_pred HHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeecccccccc-------
Confidence 9998876556799999999999999999999999999999999999999999999999998754321110000
Q ss_pred CCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCCCCccCchhhcCC
Q 012762 254 PTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTHEYLAPEIISGE 333 (457)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~ 333 (457)
..........++..|+|||++.+.
T Consensus 160 --------------------------------------------------------~~~~~~~~~~~~~~y~aPE~~~~~ 183 (314)
T cd08216 160 --------------------------------------------------------VVHDFPKSSVKNLPWLSPEVLQQN 183 (314)
T ss_pred --------------------------------------------------------ccccccccccccccccCHHHhcCC
Confidence 000001123578899999999764
Q ss_pred --CCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCC--------------------------------CC
Q 012762 334 --GHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEF--------------------------------PK 379 (457)
Q Consensus 334 --~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~--------------------------------~~ 379 (457)
.++.++|||||||++|||++|..||............+.+.... ..
T Consensus 184 ~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (314)
T cd08216 184 LQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPY 263 (314)
T ss_pred CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCcccccccccchhhhhhcch
Confidence 58899999999999999999999998765444333222211100 00
Q ss_pred CCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCCCC
Q 012762 380 EPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGVN 422 (457)
Q Consensus 380 ~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~~~ 422 (457)
...++.++.+|+.+||..||++||+ +.++|+||||+.+.
T Consensus 264 ~~~~~~~~~~li~~~l~~~P~~Rpt----~~~ll~~p~~~~~~ 302 (314)
T cd08216 264 TRTFSEHFHQFVELCLQRDPESRPS----ASQLLNHSFFKQCK 302 (314)
T ss_pred hhHHHHHHHHHHHHHhhcCCCcCcC----HHHHhcCchHhhhc
Confidence 0112356889999999999999999 99999999998653
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=325.44 Aligned_cols=256 Identities=23% Similarity=0.306 Sum_probs=210.2
Q ss_pred CCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcE
Q 012762 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWS 161 (457)
Q Consensus 82 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~ 161 (457)
..|...+.||+|+||.||+|.++ .++..+|+|.+.............+..|+++++.++|+||+++++++......
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~----~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 90 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDV----RNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTA 90 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEc----CCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCee
Confidence 35888899999999999999986 36788999998754333333445677899999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCC
Q 012762 162 CLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNS 241 (457)
Q Consensus 162 ~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~ 241 (457)
++||||+. ++|..++... ...+++..+..++.|++.||.|||+.+++||||||+|||++.++.++|+|||++......
T Consensus 91 ~lv~e~~~-~~l~~~~~~~-~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 168 (308)
T cd06634 91 WLVMEYCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (308)
T ss_pred EEEEEccC-CCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecCc
Confidence 99999995 6777666543 256899999999999999999999999999999999999999999999999986432210
Q ss_pred CcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCC
Q 012762 242 TSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGT 321 (457)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 321 (457)
....|+
T Consensus 169 --------------------------------------------------------------------------~~~~~~ 174 (308)
T cd06634 169 --------------------------------------------------------------------------NXFVGT 174 (308)
T ss_pred --------------------------------------------------------------------------ccccCC
Confidence 023588
Q ss_pred CCccCchhhcC---CCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhhhC
Q 012762 322 HEYLAPEIISG---EGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKD 398 (457)
Q Consensus 322 ~~y~aPE~l~~---~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~d 398 (457)
..|+|||++.+ ..++.++|||||||++|+|++|..||...........+............++..+.++|.+||..+
T Consensus 175 ~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~ 254 (308)
T cd06634 175 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKI 254 (308)
T ss_pred ccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccccHHHHHHHHHHhhCC
Confidence 89999999853 457889999999999999999999998766554444444443333333457888999999999999
Q ss_pred CCCCCCCCcChHHHhcCCCCCCC
Q 012762 399 PTRRMGSKMGATAIKRHQFFNGV 421 (457)
Q Consensus 399 P~~Rps~~~~~~~ll~hp~f~~~ 421 (457)
|++||+ ++++++|+|+...
T Consensus 255 P~~Rp~----~~~ll~~~~~~~~ 273 (308)
T cd06634 255 PQDRPT----SEVLLKHRFVLRE 273 (308)
T ss_pred cccCCC----HHHHhhCcccccc
Confidence 999999 9999999999863
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=321.46 Aligned_cols=261 Identities=21% Similarity=0.323 Sum_probs=209.3
Q ss_pred ccCCCceeEEEecccCcceEEEEEEecc-CCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEc
Q 012762 79 LTLSDLRFVHRLGSGDIGSVYLVQLKSK-SSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDC 157 (457)
Q Consensus 79 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~-~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~ 157 (457)
+..++|++.+.||+|+||.||+|.+... +...+..||+|++.... .......+.+|++++++++||||+++++++..
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~ 79 (288)
T cd05050 2 YPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDHPNIVKLLGVCAV 79 (288)
T ss_pred CChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc--CHHHHHHHHHHHHHHHhcCCCchheEEEEEcC
Confidence 3457899999999999999999987521 12356789999986542 22344668889999999999999999999999
Q ss_pred CCcEEEEEeecCCCChHHHHHhCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCC
Q 012762 158 PRWSCLLTEFCPGGDLHVLRQRQP--------------------DKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPE 217 (457)
Q Consensus 158 ~~~~~lV~E~~~~~sL~~~~~~~~--------------------~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~ 217 (457)
+...|+||||+.+++|.+++.... ...+++..+..++.||+.||.|||++|++||||||+
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~ 159 (288)
T cd05050 80 GKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATR 159 (288)
T ss_pred CCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHh
Confidence 999999999999999998887531 124788889999999999999999999999999999
Q ss_pred CeEEccCCCEEEeccCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhcccc
Q 012762 218 NVLVRSDGHIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKK 297 (457)
Q Consensus 218 NIll~~~~~vkl~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (457)
|||++.++.++|+|||++..........
T Consensus 160 nil~~~~~~~~l~dfg~~~~~~~~~~~~---------------------------------------------------- 187 (288)
T cd05050 160 NCLVGENMVVKIADFGLSRNIYSADYYK---------------------------------------------------- 187 (288)
T ss_pred heEecCCCceEECccccceecccCcccc----------------------------------------------------
Confidence 9999999999999999875332110000
Q ss_pred CCCCCCCcccccCCccccccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHHhcccC
Q 012762 298 LGNPGTPEIVAEPLDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVVARALE 376 (457)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~ 376 (457)
......++..|+|||++.+..++.++|||||||++|||++ |..||.+....+....+.....
T Consensus 188 ----------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~~~~~~~~~~~- 250 (288)
T cd05050 188 ----------------ASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYVRDGNV- 250 (288)
T ss_pred ----------------ccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC-
Confidence 0001124667999999998889999999999999999997 8899988776666665554432
Q ss_pred CCCCCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhc
Q 012762 377 FPKEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKR 414 (457)
Q Consensus 377 ~~~~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~ 414 (457)
.+....++.++.+|+.+||+.||++||+ +.||++
T Consensus 251 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt----~~el~~ 284 (288)
T cd05050 251 LSCPDNCPLELYNLMRLCWSKLPSDRPS----FASINR 284 (288)
T ss_pred CCCCCCCCHHHHHHHHHHcccCcccCCC----HHHHHH
Confidence 2333457889999999999999999999 777764
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=318.24 Aligned_cols=259 Identities=20% Similarity=0.265 Sum_probs=209.0
Q ss_pred ccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcC
Q 012762 79 LTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCP 158 (457)
Q Consensus 79 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~ 158 (457)
+..++|++.+.||+|+||+||+|.++.........||+|++..... ......+.+|++++++++|+||+++++++..
T Consensus 4 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~- 80 (279)
T cd05057 4 LKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS--PKANKEILDEAYVMASVDHPHVVRLLGICLS- 80 (279)
T ss_pred cCHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-
Confidence 4457899999999999999999998753333345799998865432 3345667889999999999999999999987
Q ss_pred CcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCC
Q 012762 159 RWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKG 238 (457)
Q Consensus 159 ~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~ 238 (457)
...++||||+.+++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 81 ~~~~~v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~ 159 (279)
T cd05057 81 SQVQLITQLMPLGCLLDYVRNHK-DNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (279)
T ss_pred CceEEEEecCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccc
Confidence 78899999999999999887643 45899999999999999999999999999999999999999999999999998654
Q ss_pred CCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccc
Q 012762 239 DNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSF 318 (457)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (457)
........ ....
T Consensus 160 ~~~~~~~~--------------------------------------------------------------------~~~~ 171 (279)
T cd05057 160 DVDEKEYH--------------------------------------------------------------------AEGG 171 (279)
T ss_pred cCccccee--------------------------------------------------------------------cCCC
Confidence 31111000 0001
Q ss_pred cCCCCccCchhhcCCCCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhhh
Q 012762 319 VGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVK 397 (457)
Q Consensus 319 ~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~ 397 (457)
.++..|+|||.+....++.++|+|||||++|||++ |..||.+....+....+. .....+.....+.++.+++.+||..
T Consensus 172 ~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~ 250 (279)
T cd05057 172 KVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLE-KGERLPQPPICTIDVYMVLVKCWMI 250 (279)
T ss_pred cccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh-CCCCCCCCCCCCHHHHHHHHHHcCC
Confidence 14568999999988889999999999999999998 999998876655544444 3334444455788999999999999
Q ss_pred CCCCCCCCCcChHHHhc
Q 012762 398 DPTRRMGSKMGATAIKR 414 (457)
Q Consensus 398 dP~~Rps~~~~~~~ll~ 414 (457)
||..||+ +.++++
T Consensus 251 ~p~~Rp~----~~~l~~ 263 (279)
T cd05057 251 DAESRPT----FKELIN 263 (279)
T ss_pred ChhhCCC----HHHHHH
Confidence 9999999 666654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=328.12 Aligned_cols=254 Identities=25% Similarity=0.372 Sum_probs=204.3
Q ss_pred cCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEc-C
Q 012762 80 TLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDC-P 158 (457)
Q Consensus 80 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~-~ 158 (457)
..++|++++.||.|+||.||+|.++ .+++.||+|++.+.. ........+..|+++++.++||||+++++++.. .
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~----~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 82 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQ----LTGQNVAIKKIMKPF-STPVLAKRTYRELKLLKHLRHENIISLSDIFISPL 82 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEEC----CCCCEEEEEEecccc-cccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCC
Confidence 3467999999999999999999876 478899999886532 222344566779999999999999999999865 5
Q ss_pred CcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCC
Q 012762 159 RWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKG 238 (457)
Q Consensus 159 ~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~ 238 (457)
...|+||||+ +++|..++.. ..+++..+..++.||+.||.|||+.||+||||+|.|||++.++.++|+|||++...
T Consensus 83 ~~~~lv~e~~-~~~L~~~~~~---~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~ 158 (328)
T cd07856 83 EDIYFVTELL-GTDLHRLLTS---RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQ 158 (328)
T ss_pred CcEEEEeehh-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCcccccccc
Confidence 6789999999 7789887764 46888999999999999999999999999999999999999999999999987532
Q ss_pred CCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccc
Q 012762 239 DNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSF 318 (457)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (457)
... ....
T Consensus 159 ~~~-------------------------------------------------------------------------~~~~ 165 (328)
T cd07856 159 DPQ-------------------------------------------------------------------------MTGY 165 (328)
T ss_pred CCC-------------------------------------------------------------------------cCCC
Confidence 210 0123
Q ss_pred cCCCCccCchhhcC-CCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhc------------------------
Q 012762 319 VGTHEYLAPEIISG-EGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVAR------------------------ 373 (457)
Q Consensus 319 ~gt~~y~aPE~l~~-~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~------------------------ 373 (457)
.++..|+|||++.+ ..++.++|||||||++|+|++|+.||...........+.+.
T Consensus 166 ~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (328)
T cd07856 166 VSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSL 245 (328)
T ss_pred cccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHhhc
Confidence 57889999999866 56899999999999999999999999876543222111110
Q ss_pred --ccCCCC---CCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCC
Q 012762 374 --ALEFPK---EPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFN 419 (457)
Q Consensus 374 --~~~~~~---~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~ 419 (457)
....+. .+.++..+.++|.+||+.||++||+ +++++.||||.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t----~~ell~~~~~~ 292 (328)
T cd07856 246 PKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRIS----AAEALAHPYLA 292 (328)
T ss_pred cccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCC----HHHHhcCCccc
Confidence 000010 1246788999999999999999999 99999999996
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-42 Score=306.80 Aligned_cols=266 Identities=21% Similarity=0.273 Sum_probs=211.6
Q ss_pred CccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEc
Q 012762 78 PLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDC 157 (457)
Q Consensus 78 ~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~ 157 (457)
.++-.+|++.+.||+|||+-||+++.- .++..||+|.+.-.. ....+..++|++..++++||||++++++...
T Consensus 17 ~In~~Ryri~~~LgeGGfsfv~LV~~~----s~~~~YAlKkI~c~~---~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~ 89 (302)
T KOG2345|consen 17 IINNKRYRIQRLLGEGGFSFVDLVKGL----STGHLYALKKILCHS---QEDIEEALREIDNHRKFNSPNVLRLVDHQLR 89 (302)
T ss_pred EEcCceEEEeeeecCCCceeeeeeccc----Ccccchhhheeeccc---hHHHHHHHHHHHHHHhhCCcchHHHHHHHHH
Confidence 456679999999999999999999855 378899999986543 3566778889999999999999999987644
Q ss_pred CC-----cEEEEEeecCCCChHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHcC--ceeecCCCCCeEEccCCCEE
Q 012762 158 PR-----WSCLLTEFCPGGDLHVLRQRQP--DKRFHESAVRFYASEVVVALEFLHMMG--IIYRDLKPENVLVRSDGHIM 228 (457)
Q Consensus 158 ~~-----~~~lV~E~~~~~sL~~~~~~~~--~~~~~~~~~~~i~~qi~~~L~yLH~~~--iiHrDIKp~NIll~~~~~vk 228 (457)
+. ..||+++|+..|+|.+.+++.. +..+++.++..|+.+|++||++||+.. +.||||||.|||++.++.++
T Consensus 90 ~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~v 169 (302)
T KOG2345|consen 90 EEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPV 169 (302)
T ss_pred hhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceE
Confidence 33 4899999999999988877643 346999999999999999999999998 99999999999999999999
Q ss_pred EeccCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccc
Q 012762 229 LTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVA 308 (457)
Q Consensus 229 l~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (457)
|.|||.+....-..... .+...+
T Consensus 170 l~D~GS~~~a~i~i~~~-----------------------------------------------~~a~~l---------- 192 (302)
T KOG2345|consen 170 LMDLGSATQAPIQIEGS-----------------------------------------------RQALRL---------- 192 (302)
T ss_pred EEeccCccccceEeech-----------------------------------------------HHHHHH----------
Confidence 99999875432111000 000000
Q ss_pred cCCccccccccCCCCccCchhhcCCC---CCccchhhhhhHHHHHHhcCCCCCCCCCh--HHHHHHHHhcccCCCCCCCC
Q 012762 309 EPLDVRSMSFVGTHEYLAPEIISGEG---HGNAVDWWTLGIFIFELFYGTTPFKGIDH--ELTLANVVARALEFPKEPSV 383 (457)
Q Consensus 309 ~~~~~~~~~~~gt~~y~aPE~l~~~~---~~~~sDiwSlG~il~elltG~~Pf~~~~~--~~~~~~~~~~~~~~~~~~~~ 383 (457)
+....-..|..|+|||.+.-.. .+.++|||||||+||.|+.|..||...-. ......+....+.+|....+
T Consensus 193 ----Qe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv~n~q~s~P~~~~y 268 (302)
T KOG2345|consen 193 ----QEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALAVQNAQISIPNSSRY 268 (302)
T ss_pred ----HHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEeeeccccccCCCCCc
Confidence 0001113588999999997543 58899999999999999999999964321 12233445567888888889
Q ss_pred ChHHHHHHHHHhhhCCCCCCCCCcChHHHhcC
Q 012762 384 PGPAKDLIAQLLVKDPTRRMGSKMGATAIKRH 415 (457)
Q Consensus 384 ~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~h 415 (457)
++.+.++|..||+.||.+||+ +.+++.+
T Consensus 269 se~l~~lik~mlqvdP~qRP~----i~~ll~~ 296 (302)
T KOG2345|consen 269 SEALHQLIKSMLQVDPNQRPT----IPELLSK 296 (302)
T ss_pred cHHHHHHHHHHhcCCcccCCC----HHHHHHH
Confidence 999999999999999999999 8888764
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=314.72 Aligned_cols=254 Identities=24% Similarity=0.372 Sum_probs=214.1
Q ss_pred CceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcEE
Q 012762 83 DLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWSC 162 (457)
Q Consensus 83 ~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~ 162 (457)
+|++.++||.|+||.||++.++ .++..||+|.+...... ......+..|++++++++|+||+++++++......|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~----~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 75 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRL----SDNQFYALKEVDLGSMS-QKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLC 75 (256)
T ss_pred CceEeeeecCCCceeEEEEEEC----CCCCEEEEEEEehhhcc-HHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEE
Confidence 5899999999999999999876 47889999999765433 234556677999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCC
Q 012762 163 LLTEFCPGGDLHVLRQRQ--PDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDN 240 (457)
Q Consensus 163 lV~E~~~~~sL~~~~~~~--~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~ 240 (457)
+||||+++++|..++... ....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++.....
T Consensus 76 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~ 155 (256)
T cd08530 76 IVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKK 155 (256)
T ss_pred EEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhcc
Confidence 999999999998887652 235689999999999999999999999999999999999999999999999998754432
Q ss_pred CCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccC
Q 012762 241 STSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVG 320 (457)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 320 (457)
... ....|
T Consensus 156 ~~~------------------------------------------------------------------------~~~~~ 163 (256)
T cd08530 156 NMA------------------------------------------------------------------------KTQIG 163 (256)
T ss_pred CCc------------------------------------------------------------------------ccccC
Confidence 100 01247
Q ss_pred CCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhhhCCC
Q 012762 321 THEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDPT 400 (457)
Q Consensus 321 t~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~ 400 (457)
+..|+|||.+.+..++.++|+||||+++|+|++|+.||...+.......+....+. +....++.++++++.+||..+|+
T Consensus 164 ~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~ 242 (256)
T cd08530 164 TPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYP-PIPPIYSQDLQNFIRSMLQVKPK 242 (256)
T ss_pred CccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCC-CCchhhCHHHHHHHHHHcCCCcc
Confidence 88999999999988999999999999999999999999887766555555444332 22235788999999999999999
Q ss_pred CCCCCCcChHHHhcCCCC
Q 012762 401 RRMGSKMGATAIKRHQFF 418 (457)
Q Consensus 401 ~Rps~~~~~~~ll~hp~f 418 (457)
+||+ +.++++||++
T Consensus 243 ~Rp~----~~~~l~~p~~ 256 (256)
T cd08530 243 LRPN----CDKILASPAV 256 (256)
T ss_pred cCCC----HHHHhcCCCC
Confidence 9999 9999999984
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=327.32 Aligned_cols=261 Identities=24% Similarity=0.347 Sum_probs=202.8
Q ss_pred CceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHc-CCCCCceEEEEEEc----
Q 012762 83 DLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEML-DHPFLPTLYATLDC---- 157 (457)
Q Consensus 83 ~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~~~~~~---- 157 (457)
+|++.+.||+|+||.||+|.+... ..+..||+|++.... ........+..|+++++++ +|+||+++++++..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~--~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 77 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAET--SEEETVAIKKITNVF-SKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGN 77 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCC--CcCceEEEEEecccc-ccchhHHHHHHHHHHHHHhcCCCChheeeeeeeecccc
Confidence 488999999999999999998631 127889999986431 2222345677799999999 59999999987532
Q ss_pred CCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcC
Q 012762 158 PRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLK 237 (457)
Q Consensus 158 ~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~ 237 (457)
...+|++|||+ +++|..++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||+++.
T Consensus 78 ~~~~~~~~e~~-~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~ 154 (332)
T cd07857 78 FNELYLYEELM-EADLHQIIRSG--QPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARG 154 (332)
T ss_pred CCcEEEEEecc-cCCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCcee
Confidence 24578999999 57898887654 6799999999999999999999999999999999999999999999999999865
Q ss_pred CCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcccccc
Q 012762 238 GDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMS 317 (457)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (457)
........ ......
T Consensus 155 ~~~~~~~~------------------------------------------------------------------~~~~~~ 168 (332)
T cd07857 155 FSENPGEN------------------------------------------------------------------AGFMTE 168 (332)
T ss_pred cccccccc------------------------------------------------------------------cccccC
Confidence 43211000 001113
Q ss_pred ccCCCCccCchhhcC-CCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhccc---------------------
Q 012762 318 FVGTHEYLAPEIISG-EGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARAL--------------------- 375 (457)
Q Consensus 318 ~~gt~~y~aPE~l~~-~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~--------------------- 375 (457)
..||..|+|||++.+ ..++.++|||||||++|+|++|..||........+..++....
T Consensus 169 ~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (332)
T cd07857 169 YVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRS 248 (332)
T ss_pred cccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHh
Confidence 468999999998876 4689999999999999999999999987654333332222100
Q ss_pred -------CCC-CCCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCC
Q 012762 376 -------EFP-KEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFN 419 (457)
Q Consensus 376 -------~~~-~~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~ 419 (457)
.+. ..+..+..+.+++.+||+.||++||+ +.++++||||+
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t----~~~ll~~~~~~ 296 (332)
T cd07857 249 LPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRIS----VEEALEHPYLA 296 (332)
T ss_pred ccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCC----HHHHhcChhhh
Confidence 000 11235678999999999999999999 99999999997
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=314.57 Aligned_cols=252 Identities=22% Similarity=0.326 Sum_probs=207.3
Q ss_pred cCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCC
Q 012762 80 TLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPR 159 (457)
Q Consensus 80 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~ 159 (457)
+..+|++.+.||+|+||.||+|.+. .+..+|+|++..... ....+..|+++++.++|+||+++++++....
T Consensus 2 ~~~~~~~~~~ig~g~~g~v~~~~~~-----~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 72 (256)
T cd05112 2 HPSELTLVQEIGSGQFGLVWLGYWL-----EKRKVAIKTIREGAM----SEEDFIEEAQVMMKLSHPKLVQLYGVCTERS 72 (256)
T ss_pred ChhHeEEEeeecCcccceEEEEEEe-----CCCeEEEEECCCCCC----CHHHHHHHHHHHHhCCCCCeeeEEEEEccCC
Confidence 4568999999999999999999875 466899999865432 2345778999999999999999999999999
Q ss_pred cEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCC
Q 012762 160 WSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGD 239 (457)
Q Consensus 160 ~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~ 239 (457)
..|+||||+.+++|.+++.... ..+++..++.++.|++.||.|||+.+++|+||||+||+++.++.++|+|||++....
T Consensus 73 ~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~ 151 (256)
T cd05112 73 PICLVFEFMEHGCLSDYLRAQR-GKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVL 151 (256)
T ss_pred ceEEEEEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecc
Confidence 9999999999999998887642 468899999999999999999999999999999999999999999999999875432
Q ss_pred CCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcccccccc
Q 012762 240 NSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFV 319 (457)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (457)
..... ......
T Consensus 152 ~~~~~---------------------------------------------------------------------~~~~~~ 162 (256)
T cd05112 152 DDQYT---------------------------------------------------------------------SSTGTK 162 (256)
T ss_pred cCccc---------------------------------------------------------------------ccCCCc
Confidence 11000 000113
Q ss_pred CCCCccCchhhcCCCCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhhhC
Q 012762 320 GTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKD 398 (457)
Q Consensus 320 gt~~y~aPE~l~~~~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~d 398 (457)
++..|+|||++.+..++.++|||||||++|||++ |..||...........+... .........+..+.+|+.+||..+
T Consensus 163 ~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~~~l~~~ 241 (256)
T cd05112 163 FPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAG-FRLYKPRLASQSVYELMQHCWKER 241 (256)
T ss_pred cchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCC-CCCCCCCCCCHHHHHHHHHHcccC
Confidence 5678999999998889999999999999999998 99999877766655554433 232233346889999999999999
Q ss_pred CCCCCCCCcChHHHhcC
Q 012762 399 PTRRMGSKMGATAIKRH 415 (457)
Q Consensus 399 P~~Rps~~~~~~~ll~h 415 (457)
|++||+ +.+++++
T Consensus 242 p~~Rp~----~~~~l~~ 254 (256)
T cd05112 242 PEDRPS----FSLLLHQ 254 (256)
T ss_pred hhhCCC----HHHHHHh
Confidence 999999 8888764
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=332.16 Aligned_cols=259 Identities=26% Similarity=0.357 Sum_probs=211.6
Q ss_pred CceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCC---
Q 012762 83 DLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPR--- 159 (457)
Q Consensus 83 ~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~--- 159 (457)
+|++.+.||.|+||.||+|.+. .++..||+|++.+.. ........+..|+++++.++|+||+++++++....
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~----~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 75 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDK----RTGRKVAIKKISNVF-DDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPED 75 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeC----CCCcEEEEEeecccc-ccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCccc
Confidence 5899999999999999999876 368899999987542 12334566788999999999999999999987765
Q ss_pred --cEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcC
Q 012762 160 --WSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLK 237 (457)
Q Consensus 160 --~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~ 237 (457)
.+|+||||+. ++|..++... ..+++..++.++.||+.||.|||+.||+|+||||+|||++.++.++|+|||++..
T Consensus 76 ~~~~~lv~e~~~-~~l~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~ 152 (330)
T cd07834 76 FNDVYIVTELME-TDLHKVIKSP--QPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARG 152 (330)
T ss_pred ccceEEEecchh-hhHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEe
Confidence 7899999995 6888887664 4799999999999999999999999999999999999999999999999999765
Q ss_pred CCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcccccc
Q 012762 238 GDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMS 317 (457)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (457)
....... ......
T Consensus 153 ~~~~~~~-------------------------------------------------------------------~~~~~~ 165 (330)
T cd07834 153 VDPDEDE-------------------------------------------------------------------KGFLTE 165 (330)
T ss_pred ecccccc-------------------------------------------------------------------cccccc
Confidence 4321100 000112
Q ss_pred ccCCCCccCchhhcCC-CCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCC-----------------
Q 012762 318 FVGTHEYLAPEIISGE-GHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPK----------------- 379 (457)
Q Consensus 318 ~~gt~~y~aPE~l~~~-~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~----------------- 379 (457)
..++..|+|||++.+. .++.++|||||||++|+|++|..||.+....+.+..++......+.
T Consensus 166 ~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (330)
T cd07834 166 YVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKS 245 (330)
T ss_pred cccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccchhhHHhh
Confidence 3588899999999888 7899999999999999999999999887765555544432211110
Q ss_pred ------------CCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCC
Q 012762 380 ------------EPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNG 420 (457)
Q Consensus 380 ------------~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~ 420 (457)
.+.++.++.++|.+||+.||++||+ ++++++||||+.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt----~~~ll~~~~~~~ 294 (330)
T cd07834 246 LPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRIT----ADEALAHPYLAQ 294 (330)
T ss_pred cccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCC----HHHHHhCccHHh
Confidence 1235778999999999999999999 999999999986
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=324.55 Aligned_cols=268 Identities=24% Similarity=0.334 Sum_probs=205.3
Q ss_pred CCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcC--
Q 012762 81 LSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCP-- 158 (457)
Q Consensus 81 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~-- 158 (457)
.++|++.++||+|+||.||+|.++ .+++.||+|++....... .....+.+|+++++.++|+||+++++++...
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~----~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 81 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQI----KTGRVVALKKILMHNEKD-GFPITALREIKILKKLKHPNVVPLIDMAVERPD 81 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEEC----CCCcEEEEEEEEeccCCC-CcchhHHHHHHHHHhcCCCCccchhhheecccc
Confidence 679999999999999999999976 378899999986543221 2234556799999999999999999987543
Q ss_pred ------CcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEecc
Q 012762 159 ------RWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDF 232 (457)
Q Consensus 159 ------~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DF 232 (457)
..+|+||||+. ++|...+... ...+++..++.++.||++||.|||++||+|+||||+|||++.++.++|+||
T Consensus 82 ~~~~~~~~~~lv~~~~~-~~l~~~~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~df 159 (311)
T cd07866 82 KSKRKRGSVYMVTPYMD-HDLSGLLENP-SVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADF 159 (311)
T ss_pred cccccCceEEEEEecCC-cCHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcC
Confidence 34699999994 5676665542 357999999999999999999999999999999999999999999999999
Q ss_pred CCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCc
Q 012762 233 DLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLD 312 (457)
Q Consensus 233 G~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (457)
|++............ ......
T Consensus 160 g~~~~~~~~~~~~~~-----------------------------------------------------------~~~~~~ 180 (311)
T cd07866 160 GLARPYDGPPPNPKG-----------------------------------------------------------GGGGGT 180 (311)
T ss_pred ccchhccCCCccccc-----------------------------------------------------------CCcccc
Confidence 998654321110000 000001
Q ss_pred cccccccCCCCccCchhhcCC-CCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCC-------------
Q 012762 313 VRSMSFVGTHEYLAPEIISGE-GHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFP------------- 378 (457)
Q Consensus 313 ~~~~~~~gt~~y~aPE~l~~~-~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~------------- 378 (457)
.......|++.|+|||++.+. .++.++|||||||++|||++|++||.+.........+.......+
T Consensus 181 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (311)
T cd07866 181 RKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGC 260 (311)
T ss_pred cccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhchhhhhcccc
Confidence 111234689999999998764 478999999999999999999999988766554444332211000
Q ss_pred ---------------CCCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCC
Q 012762 379 ---------------KEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFF 418 (457)
Q Consensus 379 ---------------~~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f 418 (457)
....+...+.++|.+||..||++||+ +.+++.||||
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t----~~ell~~~~f 311 (311)
T cd07866 261 EGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLT----ASDALEHPYF 311 (311)
T ss_pred cccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcC----HHHHhcCCCC
Confidence 00123467889999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=322.90 Aligned_cols=263 Identities=25% Similarity=0.393 Sum_probs=209.7
Q ss_pred CCCCccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHc-CCCCCceEEE
Q 012762 75 NNNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEML-DHPFLPTLYA 153 (457)
Q Consensus 75 ~~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~~ 153 (457)
..+.+..++|.+.+.||+|+||.||+|.+. .++..||||++++... ......+..|++++.++ +|+||+++++
T Consensus 8 ~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~----~~~~~~avK~~~~~~~--~~~~~~~~~e~~~~~~~~~~~~i~~~~~ 81 (296)
T cd06618 8 QKYPADLNDLENLGEIGSGTCGQVYKMRFK----KTGHVMAVKQMRRTGN--KEENKRILMDLDVVLKSHDCPYIVKCYG 81 (296)
T ss_pred eeccCCcchheeeeEeeccCCeEEEEEEEC----CCCeEEEEEEEeccCC--hHHHHHHHHHHHHHHhccCCCchHhhhe
Confidence 445677889999999999999999999986 3688999999975432 12334455577766666 5999999999
Q ss_pred EEEcCCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCceeecCCCCCeEEccCCCEEEecc
Q 012762 154 TLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHM-MGIIYRDLKPENVLVRSDGHIMLTDF 232 (457)
Q Consensus 154 ~~~~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~-~~iiHrDIKp~NIll~~~~~vkl~DF 232 (457)
++......|+||||+ +++|..++.... ..+++..+..++.||+.||.|||+ .||+||||+|+||+++.++.+||+||
T Consensus 82 ~~~~~~~~~~v~e~~-~~~l~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~df 159 (296)
T cd06618 82 YFITDSDVFICMELM-STCLDKLLKRIQ-GPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDF 159 (296)
T ss_pred eeecCCeEEEEeecc-CcCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECcc
Confidence 999999999999999 567877766532 478999999999999999999997 59999999999999999999999999
Q ss_pred CCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCc
Q 012762 233 DLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLD 312 (457)
Q Consensus 233 G~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (457)
|++........
T Consensus 160 g~~~~~~~~~~--------------------------------------------------------------------- 170 (296)
T cd06618 160 GISGRLVDSKA--------------------------------------------------------------------- 170 (296)
T ss_pred ccchhccCCCc---------------------------------------------------------------------
Confidence 98754321100
Q ss_pred cccccccCCCCccCchhhcCCC----CCccchhhhhhHHHHHHhcCCCCCCCCCh-HHHHHHHHhccc-CCCCCCCCChH
Q 012762 313 VRSMSFVGTHEYLAPEIISGEG----HGNAVDWWTLGIFIFELFYGTTPFKGIDH-ELTLANVVARAL-EFPKEPSVPGP 386 (457)
Q Consensus 313 ~~~~~~~gt~~y~aPE~l~~~~----~~~~sDiwSlG~il~elltG~~Pf~~~~~-~~~~~~~~~~~~-~~~~~~~~~~~ 386 (457)
.....|+..|+|||++.+.. ++.++||||||+++|+|++|+.||..... .+.+..++.... ..+....++.+
T Consensus 171 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (296)
T cd06618 171 --KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGFSPD 248 (296)
T ss_pred --ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCCCCCCCHH
Confidence 00124788999999997654 78899999999999999999999976432 334444444332 22222347889
Q ss_pred HHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCC
Q 012762 387 AKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNG 420 (457)
Q Consensus 387 ~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~ 420 (457)
+.+|+.+||..||++||+ ++++++|+||..
T Consensus 249 l~~li~~~l~~~p~~Rp~----~~~il~~~~~~~ 278 (296)
T cd06618 249 FCSFVDLCLTKDHRKRPK----YRELLQHPFIRR 278 (296)
T ss_pred HHHHHHHHccCChhhCCC----HHHHhcChhhhc
Confidence 999999999999999999 999999999984
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=331.22 Aligned_cols=254 Identities=27% Similarity=0.393 Sum_probs=207.6
Q ss_pred CCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCc
Q 012762 81 LSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRW 160 (457)
Q Consensus 81 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~ 160 (457)
.++|.+.+.||+|+||+||+|.+.. ++..||+|++..... .......+.+|+.+++.++|+||+++++++...+.
T Consensus 14 ~~~y~~~~~ig~g~~g~vy~~~~~~----~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 88 (343)
T cd07851 14 PDRYQNLSPVGSGAYGQVCSAFDTK----TGRKVAIKKLSRPFQ-SAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASS 88 (343)
T ss_pred cCceEEEEEeccCCceEEEEEEECC----CCcEEEEEecccccc-hhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccc
Confidence 4579999999999999999999863 678999999865321 22234556779999999999999999998866554
Q ss_pred ------EEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCC
Q 012762 161 ------SCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDL 234 (457)
Q Consensus 161 ------~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~ 234 (457)
.|+|+||+ +++|.+++.. ..+++..+..++.||+.||.|||+.||+||||||+||+++.++.++|+|||+
T Consensus 89 ~~~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~ 164 (343)
T cd07851 89 LEDFQDVYLVTHLM-GADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGL 164 (343)
T ss_pred ccccccEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEccccc
Confidence 89999999 7899988875 5699999999999999999999999999999999999999999999999999
Q ss_pred CcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccc
Q 012762 235 SLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVR 314 (457)
Q Consensus 235 s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (457)
+......
T Consensus 165 ~~~~~~~------------------------------------------------------------------------- 171 (343)
T cd07851 165 ARHTDDE------------------------------------------------------------------------- 171 (343)
T ss_pred ccccccc-------------------------------------------------------------------------
Confidence 7543211
Q ss_pred cccccCCCCccCchhhcCC-CCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCC---------------
Q 012762 315 SMSFVGTHEYLAPEIISGE-GHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFP--------------- 378 (457)
Q Consensus 315 ~~~~~gt~~y~aPE~l~~~-~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~--------------- 378 (457)
.....++..|+|||.+.+. .++.++|||||||++|+|++|+.||.+......+..++......+
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 251 (343)
T cd07851 172 MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARNY 251 (343)
T ss_pred ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchhHHHH
Confidence 0122478899999998653 578999999999999999999999987766555444433211000
Q ss_pred --------------CCCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCC
Q 012762 379 --------------KEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNG 420 (457)
Q Consensus 379 --------------~~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~ 420 (457)
....++..+.++|.+||..||++||+ +.+|++||||+.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt----~~ell~h~~~~~ 303 (343)
T cd07851 252 IQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRIT----AAEALAHPYLAE 303 (343)
T ss_pred HHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCC----HHHHhcCCCccc
Confidence 01235788999999999999999999 999999999994
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=322.82 Aligned_cols=260 Identities=25% Similarity=0.336 Sum_probs=206.7
Q ss_pred ccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcC
Q 012762 79 LTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCP 158 (457)
Q Consensus 79 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~ 158 (457)
...++|++.+.||+|+||+||+|.++ .+++.||+|+++.... .......+..|+++++.++||||+++++++...
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~----~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~ 78 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDK----DTGELVALKKVRLDNE-KEGFPITAIREIKILRQLNHRNIVNLKEIVTDK 78 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEEC----CCCcEEEEEEEeeccc-ccCchHHHHHHHHHHHhCCCCCeeeeeheecCc
Confidence 34578999999999999999999986 3688999999975432 222334566799999999999999999998765
Q ss_pred C----------cEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEE
Q 012762 159 R----------WSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIM 228 (457)
Q Consensus 159 ~----------~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vk 228 (457)
. .+|+||||+++ +|..++... ...+++..++.++.||+.||.|||+.||+|+||||+||+++.++.+|
T Consensus 79 ~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~k 156 (302)
T cd07864 79 QDALDFKKDKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIK 156 (302)
T ss_pred chhhhccccCCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEE
Confidence 4 78999999965 676666553 35689999999999999999999999999999999999999999999
Q ss_pred EeccCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccc
Q 012762 229 LTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVA 308 (457)
Q Consensus 229 l~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (457)
|+|||++.........
T Consensus 157 l~dfg~~~~~~~~~~~---------------------------------------------------------------- 172 (302)
T cd07864 157 LADFGLARLYNSEESR---------------------------------------------------------------- 172 (302)
T ss_pred eCcccccccccCCccc----------------------------------------------------------------
Confidence 9999987654321100
Q ss_pred cCCccccccccCCCCccCchhhcCC-CCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCC----------
Q 012762 309 EPLDVRSMSFVGTHEYLAPEIISGE-GHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEF---------- 377 (457)
Q Consensus 309 ~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~---------- 377 (457)
......++..|+|||++.+. .++.++|||||||++|||++|++||........+..+.......
T Consensus 173 -----~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (302)
T cd07864 173 -----PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDVIK 247 (302)
T ss_pred -----ccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhcccccc
Confidence 00012367789999998754 47889999999999999999999998766555444433321100
Q ss_pred ------------------CCCCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCC
Q 012762 378 ------------------PKEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFF 418 (457)
Q Consensus 378 ------------------~~~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f 418 (457)
.....++..+.++|.+||..||++||+ +.+++.||||
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~----~~~il~~~~~ 302 (302)
T cd07864 248 LPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCT----AEEALNSPWL 302 (302)
T ss_pred cccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCC----HHHHhcCCCC
Confidence 011246788999999999999999999 9999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-41 Score=329.45 Aligned_cols=260 Identities=20% Similarity=0.301 Sum_probs=216.5
Q ss_pred CCCccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEE
Q 012762 76 NNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATL 155 (457)
Q Consensus 76 ~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~ 155 (457)
..++..+...+.++||+|.||.|.+|+.. .+..||+|.++... .......|..|+++|.+|+||||++++++|
T Consensus 532 l~EfPRs~L~~~ekiGeGqFGEVhLCeve-----g~lkVAVK~Lr~~a--~~~~r~~F~kEIkiLsqLkhPNIveLvGVC 604 (807)
T KOG1094|consen 532 LVEFPRSRLRFKEKIGEGQFGEVHLCEVE-----GPLKVAVKILRPDA--TKNARNDFLKEIKILSRLKHPNIVELLGVC 604 (807)
T ss_pred hhhcchhheehhhhhcCcccceeEEEEec-----CceEEEEeecCccc--chhHHHHHHHHHHHHhccCCCCeeEEEeee
Confidence 34566678899999999999999999964 46899999997653 334567899999999999999999999999
Q ss_pred EcCCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCC
Q 012762 156 DCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235 (457)
Q Consensus 156 ~~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s 235 (457)
..++.+||||||+++|+|..++..+....+.......++.||+.||+||.+.++|||||.+.|+|++.++++||+|||++
T Consensus 605 ~~DePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgms 684 (807)
T KOG1094|consen 605 VQDDPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMS 684 (807)
T ss_pred ecCCchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccc
Confidence 99999999999999999999998874333455566779999999999999999999999999999999999999999998
Q ss_pred cCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcccc
Q 012762 236 LKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRS 315 (457)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (457)
+.+-....... -
T Consensus 685 R~lysg~yy~v--------------------------------------------------------------------q 696 (807)
T KOG1094|consen 685 RNLYSGDYYRV--------------------------------------------------------------------Q 696 (807)
T ss_pred cccccCCceee--------------------------------------------------------------------e
Confidence 75432221111 0
Q ss_pred ccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHh--cCCCCCCCCChHHHHHHHHhc------ccCCCCCCCCChHH
Q 012762 316 MSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELF--YGTTPFKGIDHELTLANVVAR------ALEFPKEPSVPGPA 387 (457)
Q Consensus 316 ~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~ell--tG~~Pf~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~ 387 (457)
...+-...|||+|.+.-..++.++|+|+||+++||++ +.+.||....+++..++.-.- ..-++.+..+|..+
T Consensus 697 gr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~~cp~~l 776 (807)
T KOG1094|consen 697 GRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPPACPQGL 776 (807)
T ss_pred cceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCCcCcHHH
Confidence 1234578999999999999999999999999999988 588999998888777664432 12233456789999
Q ss_pred HHHHHHHhhhCCCCCCCCCcChHHHhc
Q 012762 388 KDLIAQLLVKDPTRRMGSKMGATAIKR 414 (457)
Q Consensus 388 ~~ll~~~L~~dP~~Rps~~~~~~~ll~ 414 (457)
.++|.+||..|-++||+ +++|-.
T Consensus 777 yelml~Cw~~es~~RPs----Fe~lh~ 799 (807)
T KOG1094|consen 777 YELMLRCWRRESEQRPS----FEQLHL 799 (807)
T ss_pred HHHHHHHhchhhhcCCC----HHHHHH
Confidence 99999999999999999 888844
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=316.67 Aligned_cols=256 Identities=26% Similarity=0.438 Sum_probs=206.1
Q ss_pred CceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhh--hhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCc
Q 012762 83 DLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELV--SRNKESRARIEREILEMLDHPFLPTLYATLDCPRW 160 (457)
Q Consensus 83 ~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~ 160 (457)
+|.+.++||+|+||+||++.+.. .+..+++|+++..... .......+..|++++++++||||+++++++.....
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 76 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKK----AVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDA 76 (260)
T ss_pred CceeeeeecCCCCceEEEEEecC----CCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCc
Confidence 58899999999999999998763 3445666665432221 12234456678999999999999999999998899
Q ss_pred EEEEEeecCCCChHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCC
Q 012762 161 SCLLTEFCPGGDLHVLRQR--QPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKG 238 (457)
Q Consensus 161 ~~lV~E~~~~~sL~~~~~~--~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~ 238 (457)
.|+||||+.+++|..++.. .....+++..++.++.|++.||.|||+.|++|+||||+||+++. +.++|+|||++...
T Consensus 77 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~ 155 (260)
T cd08222 77 FCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLL 155 (260)
T ss_pred eEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeec
Confidence 9999999999999888764 23457899999999999999999999999999999999999964 67999999987543
Q ss_pred CCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccc
Q 012762 239 DNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSF 318 (457)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (457)
..... .....
T Consensus 156 ~~~~~----------------------------------------------------------------------~~~~~ 165 (260)
T cd08222 156 MGSCD----------------------------------------------------------------------LATTF 165 (260)
T ss_pred CCCcc----------------------------------------------------------------------cccCC
Confidence 21100 00123
Q ss_pred cCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhhhC
Q 012762 319 VGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKD 398 (457)
Q Consensus 319 ~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~d 398 (457)
.|+..|+|||.+.+..++.++|+||||+++|+|++|..||...........+...... .....++.++.++|.+||..|
T Consensus 166 ~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~ 244 (260)
T cd08222 166 TGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTP-SLPETYSRQLNSIMQSMLNKD 244 (260)
T ss_pred CCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCC-CCcchhcHHHHHHHHHHhcCC
Confidence 4788999999998888999999999999999999999999876665555555443222 123357789999999999999
Q ss_pred CCCCCCCCcChHHHhcCCCC
Q 012762 399 PTRRMGSKMGATAIKRHQFF 418 (457)
Q Consensus 399 P~~Rps~~~~~~~ll~hp~f 418 (457)
|++||+ +.++++||||
T Consensus 245 p~~Rp~----~~~il~~~~~ 260 (260)
T cd08222 245 PSLRPS----AAEILRNPFI 260 (260)
T ss_pred hhhCcC----HHHHhhCCCC
Confidence 999999 9999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=310.41 Aligned_cols=245 Identities=21% Similarity=0.353 Sum_probs=200.0
Q ss_pred EEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcEEEEEee
Q 012762 88 HRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWSCLLTEF 167 (457)
Q Consensus 88 ~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lV~E~ 167 (457)
+.||+|+||.||+|... .+..||+|++.... .......+..|+++++.++|+||+++++++...+..++||||
T Consensus 1 ~~ig~g~~g~vy~~~~~-----~~~~~a~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 73 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-----DKTPVAVKTCKEDL--PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMEL 73 (250)
T ss_pred CccCCCCCceEEEEEec-----CCcEEEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEEC
Confidence 36899999999999853 56789999986542 223344677899999999999999999999999999999999
Q ss_pred cCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCCCccccc
Q 012762 168 CPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQL 247 (457)
Q Consensus 168 ~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~~~~~~~ 247 (457)
+++++|..++.... ..+++..+..++.|++.+|.|||+.|++|+||||+||+++.++.+||+|||++..........
T Consensus 74 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~-- 150 (250)
T cd05085 74 VPGGDFLSFLRKKK-DELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSS-- 150 (250)
T ss_pred CCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceecccccccc--
Confidence 99999998886542 468899999999999999999999999999999999999999999999999875322110000
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCCCCccCc
Q 012762 248 VSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTHEYLAP 327 (457)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 327 (457)
.....++..|+||
T Consensus 151 -------------------------------------------------------------------~~~~~~~~~y~aP 163 (250)
T cd05085 151 -------------------------------------------------------------------SGLKQIPIKWTAP 163 (250)
T ss_pred -------------------------------------------------------------------CCCCCCcccccCH
Confidence 0011246679999
Q ss_pred hhhcCCCCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhhhCCCCCCCCC
Q 012762 328 EIISGEGHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDPTRRMGSK 406 (457)
Q Consensus 328 E~l~~~~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rps~~ 406 (457)
|++.+..++.++||||||+++|+|++ |..||.+.........+. ..........++.++.+++.+||..||++||+
T Consensus 164 E~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~-- 240 (250)
T cd05085 164 EALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVE-KGYRMSCPQKCPDDVYKVMQRCWDYKPENRPK-- 240 (250)
T ss_pred HHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHHHHHHHHHHcccCcccCCC--
Confidence 99998889999999999999999998 999998876655554443 33343444568899999999999999999999
Q ss_pred cChHHHhc
Q 012762 407 MGATAIKR 414 (457)
Q Consensus 407 ~~~~~ll~ 414 (457)
+.++++
T Consensus 241 --~~~l~~ 246 (250)
T cd05085 241 --FSELQK 246 (250)
T ss_pred --HHHHHH
Confidence 888765
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=317.09 Aligned_cols=260 Identities=24% Similarity=0.358 Sum_probs=209.7
Q ss_pred CCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEc--C
Q 012762 81 LSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDC--P 158 (457)
Q Consensus 81 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~--~ 158 (457)
.++|++.+.||+|+||.||+|.+...+..++..||+|++...... .....+..|+++++.++|+||+++++++.. .
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~ 80 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTLDHENIVKYKGVCEKPGG 80 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--HHHHHHHHHHHHHHhCCCCChheEEeeeecCCC
Confidence 457899999999999999999876544456889999999765332 345678889999999999999999999877 5
Q ss_pred CcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCC
Q 012762 159 RWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKG 238 (457)
Q Consensus 159 ~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~ 238 (457)
...++||||+++++|.+++.... ..+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++...
T Consensus 81 ~~~~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05038 81 RSLRLIMEYLPSGSLRDYLQRHR-DQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVL 159 (284)
T ss_pred CceEEEEecCCCCCHHHHHHhCc-cccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEccccccccc
Confidence 57899999999999999987653 35899999999999999999999999999999999999999999999999998655
Q ss_pred CCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccc
Q 012762 239 DNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSF 318 (457)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (457)
......... ....
T Consensus 160 ~~~~~~~~~-------------------------------------------------------------------~~~~ 172 (284)
T cd05038 160 PEDKDYYYV-------------------------------------------------------------------KEPG 172 (284)
T ss_pred ccCCcceec-------------------------------------------------------------------cCCC
Confidence 321110000 0011
Q ss_pred cCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChH--------------HHHHHHHhcccCCCCCCCCC
Q 012762 319 VGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHE--------------LTLANVVARALEFPKEPSVP 384 (457)
Q Consensus 319 ~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~--------------~~~~~~~~~~~~~~~~~~~~ 384 (457)
.++..|++||.+.+..++.++|||||||++|||++|..||...... ......+......+....++
T Consensus 173 ~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (284)
T cd05038 173 ESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGERLPRPPSCP 252 (284)
T ss_pred CCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHHcCCcCCCCccCC
Confidence 2566799999998888999999999999999999999998754321 12233334444555555678
Q ss_pred hHHHHHHHHHhhhCCCCCCCCCcChHHHhc
Q 012762 385 GPAKDLIAQLLVKDPTRRMGSKMGATAIKR 414 (457)
Q Consensus 385 ~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~ 414 (457)
..+.+++.+||..||++||+ +.+|++
T Consensus 253 ~~~~~li~~cl~~~p~~Rpt----~~ei~~ 278 (284)
T cd05038 253 DEVYDLMKLCWEAEPQDRPS----FADLIL 278 (284)
T ss_pred HHHHHHHHHHhccChhhCCC----HHHHHH
Confidence 89999999999999999999 777765
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-40 Score=314.23 Aligned_cols=250 Identities=21% Similarity=0.297 Sum_probs=193.9
Q ss_pred EEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcEEEEEee
Q 012762 88 HRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWSCLLTEF 167 (457)
Q Consensus 88 ~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lV~E~ 167 (457)
++||+|+||+||+|..... .....+|+|.+.... .......+.+|+++++.++|+||+++++++......|+||||
T Consensus 1 ~~lg~G~fg~v~~~~~~~~--~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~ 76 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRG--MSKARVVVKELRASA--TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEF 76 (269)
T ss_pred CcCCccCCceEEEEEEecC--CCCeEEEEeecCccC--ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEe
Confidence 3689999999999976432 245678888875432 223345677899999999999999999999999999999999
Q ss_pred cCCCChHHHHHhCCC---CCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCCCcc
Q 012762 168 CPGGDLHVLRQRQPD---KRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTST 244 (457)
Q Consensus 168 ~~~~sL~~~~~~~~~---~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~~~~ 244 (457)
+.+|+|.+++..... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 77 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~ 156 (269)
T cd05042 77 CPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYY 156 (269)
T ss_pred CCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchhe
Confidence 999999998876432 33567888999999999999999999999999999999999999999999987533211000
Q ss_pred cccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCCCCc
Q 012762 245 AQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTHEY 324 (457)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 324 (457)
. ......++..|
T Consensus 157 ~--------------------------------------------------------------------~~~~~~~~~~y 168 (269)
T cd05042 157 I--------------------------------------------------------------------TKDCHAVPLRW 168 (269)
T ss_pred e--------------------------------------------------------------------ccCCCCCcccc
Confidence 0 00012367789
Q ss_pred cCchhhcC-------CCCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHHhccc-CCCC---CCCCChHHHHHHH
Q 012762 325 LAPEIISG-------EGHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVVARAL-EFPK---EPSVPGPAKDLIA 392 (457)
Q Consensus 325 ~aPE~l~~-------~~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~-~~~~---~~~~~~~~~~ll~ 392 (457)
+|||++.. ..++.++|||||||++|||++ |..||......+.+...+.... .++. ...++..+.+++.
T Consensus 169 ~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (269)
T cd05042 169 LAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLKYSDRWYEVMQ 248 (269)
T ss_pred cCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCcccccCCHHHHHHHH
Confidence 99999753 346789999999999999998 8899988776666555544322 2222 2356788899999
Q ss_pred HHhhhCCCCCCCCCcChHHHhc
Q 012762 393 QLLVKDPTRRMGSKMGATAIKR 414 (457)
Q Consensus 393 ~~L~~dP~~Rps~~~~~~~ll~ 414 (457)
.|| .||++||+ +++|++
T Consensus 249 ~~~-~dp~~Rpt----~~~v~~ 265 (269)
T cd05042 249 FCW-LDPETRPT----AEEVHE 265 (269)
T ss_pred HHh-cCcccccC----HHHHHH
Confidence 998 59999999 888765
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-40 Score=313.54 Aligned_cols=258 Identities=23% Similarity=0.368 Sum_probs=208.1
Q ss_pred ccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcC
Q 012762 79 LTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCP 158 (457)
Q Consensus 79 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~ 158 (457)
+...+|.+.+.||+|+||.||+|.+.... .....||+|...... .....+.+..|+++++.++|+||+++++++..
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~-~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~- 78 (270)
T cd05056 3 IQREDITLGRCIGEGQFGDVYQGVYMSPE-NEKIAVAVKTCKNCT--SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE- 78 (270)
T ss_pred echhhceeeeeeCCccceeEEEEEEecCC-CCCcceEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-
Confidence 34567999999999999999999876321 234578999886542 12345677889999999999999999999875
Q ss_pred CcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCC
Q 012762 159 RWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKG 238 (457)
Q Consensus 159 ~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~ 238 (457)
+..|+||||+++++|.+++.... ..+++..++.++.||+.||.|||+.|++|+||||+|||++.++.++|+|||+++..
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~ 157 (270)
T cd05056 79 NPVWIVMELAPLGELRSYLQVNK-YSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYL 157 (270)
T ss_pred CCcEEEEEcCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeec
Confidence 45789999999999999987642 45899999999999999999999999999999999999999999999999987644
Q ss_pred CCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccc
Q 012762 239 DNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSF 318 (457)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (457)
....... ....
T Consensus 158 ~~~~~~~---------------------------------------------------------------------~~~~ 168 (270)
T cd05056 158 EDESYYK---------------------------------------------------------------------ASKG 168 (270)
T ss_pred cccccee---------------------------------------------------------------------cCCC
Confidence 3211000 0011
Q ss_pred cCCCCccCchhhcCCCCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhhh
Q 012762 319 VGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVK 397 (457)
Q Consensus 319 ~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~ 397 (457)
.++..|+|||.+.+..++.++|||||||++|||++ |..||.+....+....+.. ....+....++..+.+++.+||..
T Consensus 169 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~ 247 (270)
T cd05056 169 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIEN-GERLPMPPNCPPTLYSLMTKCWAY 247 (270)
T ss_pred CccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHc-CCcCCCCCCCCHHHHHHHHHHcCC
Confidence 24568999999988889999999999999999986 9999988776665555443 334444556889999999999999
Q ss_pred CCCCCCCCCcChHHHhcC
Q 012762 398 DPTRRMGSKMGATAIKRH 415 (457)
Q Consensus 398 dP~~Rps~~~~~~~ll~h 415 (457)
+|++||+ +.+++..
T Consensus 248 ~P~~Rpt----~~~~~~~ 261 (270)
T cd05056 248 DPSKRPR----FTELKAQ 261 (270)
T ss_pred ChhhCcC----HHHHHHH
Confidence 9999999 8887653
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=329.17 Aligned_cols=263 Identities=25% Similarity=0.381 Sum_probs=206.8
Q ss_pred CCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHc-CCCCCceEEEEEEcC-
Q 012762 81 LSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEML-DHPFLPTLYATLDCP- 158 (457)
Q Consensus 81 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~~~~~~~- 158 (457)
.++|.+.+.||+|+||.||+|.+. .++..||+|++.+.. ........+..|+++++++ +|+||+++++++...
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~----~~~~~~~vK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~ 80 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDR----RTKEVVALKKIFDAF-RNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAEN 80 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEc----CCCeEEEEEeecccc-CcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCC
Confidence 467999999999999999999876 367899999885432 1222334566799999999 999999999998654
Q ss_pred -CcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcC
Q 012762 159 -RWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLK 237 (457)
Q Consensus 159 -~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~ 237 (457)
...|+||||+. ++|..++.. ..+.+..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++..
T Consensus 81 ~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~ 156 (337)
T cd07852 81 DKDIYLVFEYME-TDLHAVIRA---NILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARS 156 (337)
T ss_pred CceEEEEecccc-cCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence 36899999995 699887765 3688899999999999999999999999999999999999999999999999765
Q ss_pred CCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcccccc
Q 012762 238 GDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMS 317 (457)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (457)
........ .......
T Consensus 157 ~~~~~~~~-----------------------------------------------------------------~~~~~~~ 171 (337)
T cd07852 157 LSELEENP-----------------------------------------------------------------ENPVLTD 171 (337)
T ss_pred cccccccc-----------------------------------------------------------------cCcchhc
Confidence 43211000 0001113
Q ss_pred ccCCCCccCchhhcC-CCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCC-------------------
Q 012762 318 FVGTHEYLAPEIISG-EGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEF------------------- 377 (457)
Q Consensus 318 ~~gt~~y~aPE~l~~-~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~------------------- 377 (457)
+.|+..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.........+.......
T Consensus 172 ~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (337)
T cd07852 172 YVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDS 251 (337)
T ss_pred ccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhh
Confidence 468999999998865 457889999999999999999999998766544433332221100
Q ss_pred ----------CCCCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCCC
Q 012762 378 ----------PKEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGV 421 (457)
Q Consensus 378 ----------~~~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~~ 421 (457)
...+.++.++.++|.+||+.||++||+ +.++++||||+.+
T Consensus 252 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps----~~~il~~~~~~~~ 301 (337)
T cd07852 252 LPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLT----AEEALEHPYVAQF 301 (337)
T ss_pred cccccccchhhhccCCCHHHHHHHHHhccCCcccccC----HHHHhhChhhhhh
Confidence 011236788999999999999999999 9999999999875
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=317.50 Aligned_cols=253 Identities=30% Similarity=0.426 Sum_probs=203.7
Q ss_pred ceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcC-CCCCceEEEEEEcCCcEE
Q 012762 84 LRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLD-HPFLPTLYATLDCPRWSC 162 (457)
Q Consensus 84 ~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~-H~nIv~l~~~~~~~~~~~ 162 (457)
|++.+.||.|+||+||+|... .+++.||+|.+...... .......+|++.+++++ |+||+++++++..++..|
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~----~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 74 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNK----ETGELVAIKKMKKKFYS--WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELY 74 (283)
T ss_pred CeeheeeccCCceEEEEEEEC----CCCcEEEEEEehhhccc--hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEE
Confidence 678899999999999999976 36789999998654221 12233456889999998 999999999999999999
Q ss_pred EEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCCC
Q 012762 163 LLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNST 242 (457)
Q Consensus 163 lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~~ 242 (457)
+||||+ +++|.+++.......+++..+..++.|++.+|.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 75 lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~ 153 (283)
T cd07830 75 FVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP 153 (283)
T ss_pred EEEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCC
Confidence 999999 8899888877644578999999999999999999999999999999999999999999999999875432110
Q ss_pred cccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCCC
Q 012762 243 STAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTH 322 (457)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 322 (457)
. .....|+.
T Consensus 154 ~-----------------------------------------------------------------------~~~~~~~~ 162 (283)
T cd07830 154 P-----------------------------------------------------------------------YTDYVSTR 162 (283)
T ss_pred C-----------------------------------------------------------------------cCCCCCcc
Confidence 0 01235888
Q ss_pred CccCchhhcC-CCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCC-------------------CC---
Q 012762 323 EYLAPEIISG-EGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEF-------------------PK--- 379 (457)
Q Consensus 323 ~y~aPE~l~~-~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~-------------------~~--- 379 (457)
.|+|||++.+ ..++.++|+||||+++|||++|+.||...........+....... +.
T Consensus 163 ~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (283)
T cd07830 163 WYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAP 242 (283)
T ss_pred cccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccccccccccc
Confidence 9999998854 447899999999999999999999998766544443332211000 00
Q ss_pred ------CCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCC
Q 012762 380 ------EPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFF 418 (457)
Q Consensus 380 ------~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f 418 (457)
....+.++.+++.+||+.||++||+ +.|++.||||
T Consensus 243 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt----~~ei~~~~~~ 283 (283)
T cd07830 243 TSLHQLIPNASPEAIDLIKDMLRWDPKKRPT----ASQALQHPYF 283 (283)
T ss_pred ccHHHHcccCCHHHHHHHHHhcccCcccCCC----HHHHhhCCCC
Confidence 0123577999999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-40 Score=310.43 Aligned_cols=255 Identities=24% Similarity=0.359 Sum_probs=210.1
Q ss_pred ceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcEEE
Q 012762 84 LRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWSCL 163 (457)
Q Consensus 84 ~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~l 163 (457)
+++.+.||.|+||.||+|.+.......+..||+|++..... ......+..|+++++.++|+||+++++++...+..|+
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 78 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDAD--EQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMI 78 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCC--hHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEE
Confidence 45788999999999999998753323458899999965422 2245678889999999999999999999999999999
Q ss_pred EEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCCCc
Q 012762 164 LTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTS 243 (457)
Q Consensus 164 V~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~~~ 243 (457)
+|||+++++|.+++.......+++..+..++.||+.||.|||+.|++|+||||+||+++.++.++|+|||++........
T Consensus 79 i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (258)
T smart00219 79 VMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY 158 (258)
T ss_pred EEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccccc
Confidence 99999999999998775433389999999999999999999999999999999999999999999999999765432210
Q ss_pred ccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCCCC
Q 012762 244 TAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTHE 323 (457)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 323 (457)
.. .....++..
T Consensus 159 ~~---------------------------------------------------------------------~~~~~~~~~ 169 (258)
T smart00219 159 YK---------------------------------------------------------------------KKGGKLPIR 169 (258)
T ss_pred cc---------------------------------------------------------------------cccCCCccc
Confidence 00 000126789
Q ss_pred ccCchhhcCCCCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhhhCCCCC
Q 012762 324 YLAPEIISGEGHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDPTRR 402 (457)
Q Consensus 324 y~aPE~l~~~~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R 402 (457)
|+|||.+.+..++.++|||||||++|+|++ |..||...........+.... ..+....++.++.+++.+||..||++|
T Consensus 170 y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~~p~~R 248 (258)
T smart00219 170 WMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGY-RLPKPENCPPEIYKLMLQCWAEDPEDR 248 (258)
T ss_pred ccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC-CCCCCCcCCHHHHHHHHHHCcCChhhC
Confidence 999999988889999999999999999998 899998876666666555443 333344588999999999999999999
Q ss_pred CCCCcChHHHhc
Q 012762 403 MGSKMGATAIKR 414 (457)
Q Consensus 403 ps~~~~~~~ll~ 414 (457)
|+ +.|+++
T Consensus 249 pt----~~~ll~ 256 (258)
T smart00219 249 PT----FSELVE 256 (258)
T ss_pred cC----HHHHHh
Confidence 99 999876
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=316.90 Aligned_cols=255 Identities=28% Similarity=0.433 Sum_probs=205.5
Q ss_pred ceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcC--CcE
Q 012762 84 LRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCP--RWS 161 (457)
Q Consensus 84 ~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~--~~~ 161 (457)
|.+.++||.|+||.||+|.+. .++..||+|++.... ........+..|++++++++|+||+++++++... +..
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~----~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 75 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNK----KTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSI 75 (287)
T ss_pred CeeeEEeccCCCeEEEEEEEC----CCCeEEEEEEEeccc-ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcE
Confidence 678999999999999999886 368899999998653 1223345677799999999999999999999888 899
Q ss_pred EEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCC
Q 012762 162 CLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNS 241 (457)
Q Consensus 162 ~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~ 241 (457)
|+||||++ ++|..++.... ..+++..++.++.||+.||.|||+.|++|+||||+||+++.++.++|+|||++......
T Consensus 76 ~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~ 153 (287)
T cd07840 76 YMVFEYMD-HDLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKR 153 (287)
T ss_pred EEEecccc-ccHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence 99999995 58888776542 57899999999999999999999999999999999999999999999999997644321
Q ss_pred CcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCC
Q 012762 242 TSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGT 321 (457)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 321 (457)
... ......++
T Consensus 154 ~~~---------------------------------------------------------------------~~~~~~~~ 164 (287)
T cd07840 154 NSA---------------------------------------------------------------------DYTNRVIT 164 (287)
T ss_pred Ccc---------------------------------------------------------------------cccccccc
Confidence 100 00012467
Q ss_pred CCccCchhhcCC-CCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCC-----CC----------------
Q 012762 322 HEYLAPEIISGE-GHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEF-----PK---------------- 379 (457)
Q Consensus 322 ~~y~aPE~l~~~-~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~-----~~---------------- 379 (457)
..|+|||.+.+. .++.++|||||||++|||++|+.||...........+....... +.
T Consensus 165 ~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (287)
T cd07840 165 LWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPY 244 (287)
T ss_pred cccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhccccccc
Confidence 889999988764 57899999999999999999999998876555444443311100 00
Q ss_pred -------CCC-CChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCC
Q 012762 380 -------EPS-VPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFF 418 (457)
Q Consensus 380 -------~~~-~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f 418 (457)
... ++..+.+++.+||..||++||+ +.+++.||||
T Consensus 245 ~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~----~~~~l~~~~~ 287 (287)
T cd07840 245 KRRLREFFKHLIDPSALDLLDKLLTLDPKKRIS----ADQALQHEYF 287 (287)
T ss_pred hhHHHHHhcccCCHHHHHHHHHHcCCChhhCcC----HHHHhhCcCC
Confidence 011 2778999999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=333.02 Aligned_cols=258 Identities=21% Similarity=0.334 Sum_probs=220.3
Q ss_pred CCCCccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEE
Q 012762 75 NNNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYAT 154 (457)
Q Consensus 75 ~~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~ 154 (457)
.+..+..+...+.+.||+|.||.||.|............||||.-++... .+..+.|..|.-||+.++||||++++|+
T Consensus 382 rnyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t--~d~tekflqEa~iMrnfdHphIikLIGv 459 (974)
T KOG4257|consen 382 RNYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCT--PDDTEKFLQEASIMRNFDHPHIIKLIGV 459 (974)
T ss_pred CcceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCC--hhhHHHHHHHHHHHHhCCCcchhheeee
Confidence 34556667788889999999999999998766555666899999876432 2346778889999999999999999999
Q ss_pred EEcCCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCC
Q 012762 155 LDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDL 234 (457)
Q Consensus 155 ~~~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~ 234 (457)
+.+ ...+||||++..|.|+.+++.++ ..++......++.||+.||.|||+.++|||||...|||+.+...|||+|||+
T Consensus 460 ~~e-~P~WivmEL~~~GELr~yLq~nk-~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGL 537 (974)
T KOG4257|consen 460 CVE-QPMWIVMELAPLGELREYLQQNK-DSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGL 537 (974)
T ss_pred eec-cceeEEEecccchhHHHHHHhcc-ccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccch
Confidence 985 47899999999999999998864 5688999999999999999999999999999999999999999999999999
Q ss_pred CcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccc
Q 012762 235 SLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVR 314 (457)
Q Consensus 235 s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (457)
++.+++.......
T Consensus 538 SR~~ed~~yYkaS------------------------------------------------------------------- 550 (974)
T KOG4257|consen 538 SRYLEDDAYYKAS------------------------------------------------------------------- 550 (974)
T ss_pred hhhccccchhhcc-------------------------------------------------------------------
Confidence 9888755432210
Q ss_pred cccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHH
Q 012762 315 SMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQ 393 (457)
Q Consensus 315 ~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~ 393 (457)
.-.-...|||||.+.-..++.++|||-|||.+||++. |..||.+-.+.+.+..+.. .-++|.++.+|+.+..|+.+
T Consensus 551 --~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEn-GeRlP~P~nCPp~LYslmsk 627 (974)
T KOG4257|consen 551 --RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIEN-GERLPCPPNCPPALYSLMSK 627 (974)
T ss_pred --ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecC-CCCCCCCCCCChHHHHHHHH
Confidence 0013567999999999999999999999999999985 9999999888877766554 45788888999999999999
Q ss_pred HhhhCCCCCCCCC
Q 012762 394 LLVKDPTRRMGSK 406 (457)
Q Consensus 394 ~L~~dP~~Rps~~ 406 (457)
||.+||.+||.+.
T Consensus 628 cWayeP~kRPrft 640 (974)
T KOG4257|consen 628 CWAYEPSKRPRFT 640 (974)
T ss_pred HhccCcccCCcHH
Confidence 9999999999954
|
|
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=315.33 Aligned_cols=242 Identities=21% Similarity=0.278 Sum_probs=191.2
Q ss_pred EecccCcceEEEEEEeccC--------------------CCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCC
Q 012762 89 RLGSGDIGSVYLVQLKSKS--------------------SNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFL 148 (457)
Q Consensus 89 ~LG~G~fg~Vy~a~~~~~~--------------------~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nI 148 (457)
.||+|+||.||+|.+.... ......||+|++..... .....+..|+++++.++||||
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~---~~~~~~~~~~~~~~~l~h~ni 78 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHR---DIALAFFETASLMSQVSHIHL 78 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHH---HHHHHHHHHHHHHhcCCCCCe
Confidence 5899999999999864211 12234689999865432 334567778999999999999
Q ss_pred ceEEEEEEcCCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCC---
Q 012762 149 PTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDG--- 225 (457)
Q Consensus 149 v~l~~~~~~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~--- 225 (457)
+++++++..+...||||||+++++|..++... .+.+++..+..++.||+.||+|||++||+||||||+|||++..+
T Consensus 79 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~ 157 (274)
T cd05076 79 AFVHGVCVRGSENIMVEEFVEHGPLDVCLRKE-KGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAE 157 (274)
T ss_pred eeEEEEEEeCCceEEEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCccc
Confidence 99999999999999999999999998887653 35789999999999999999999999999999999999997654
Q ss_pred ----CEEEeccCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCC
Q 012762 226 ----HIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNP 301 (457)
Q Consensus 226 ----~vkl~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (457)
.+|++|||++......
T Consensus 158 ~~~~~~kl~d~g~~~~~~~~------------------------------------------------------------ 177 (274)
T cd05076 158 GTSPFIKLSDPGVSFTALSR------------------------------------------------------------ 177 (274)
T ss_pred CccceeeecCCccccccccc------------------------------------------------------------
Confidence 3899999986422100
Q ss_pred CCCcccccCCccccccccCCCCccCchhhcC-CCCCccchhhhhhHHHHHHh-cCCCCCCCCChHHHHHHHHhcccCCCC
Q 012762 302 GTPEIVAEPLDVRSMSFVGTHEYLAPEIISG-EGHGNAVDWWTLGIFIFELF-YGTTPFKGIDHELTLANVVARALEFPK 379 (457)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlG~il~ell-tG~~Pf~~~~~~~~~~~~~~~~~~~~~ 379 (457)
....++..|+|||++.+ ..++.++|||||||++|||+ +|..||........ ..........+.
T Consensus 178 --------------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~-~~~~~~~~~~~~ 242 (274)
T cd05076 178 --------------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK-ERFYEKKHRLPE 242 (274)
T ss_pred --------------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH-HHHHHhccCCCC
Confidence 01247788999999876 45899999999999999995 79999987654433 223333333333
Q ss_pred CCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcC
Q 012762 380 EPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRH 415 (457)
Q Consensus 380 ~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~h 415 (457)
....++.++|.+||..||++||+ +.+|+++
T Consensus 243 --~~~~~~~~li~~cl~~~p~~Rps----~~~il~~ 272 (274)
T cd05076 243 --PSCKELATLISQCLTYEPTQRPS----FRTILRD 272 (274)
T ss_pred --CCChHHHHHHHHHcccChhhCcC----HHHHHHh
Confidence 25568999999999999999999 8998875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=315.44 Aligned_cols=243 Identities=22% Similarity=0.283 Sum_probs=191.7
Q ss_pred EEecccCcceEEEEEEeccCC---CCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcEEEE
Q 012762 88 HRLGSGDIGSVYLVQLKSKSS---NNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWSCLL 164 (457)
Q Consensus 88 ~~LG~G~fg~Vy~a~~~~~~~---~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lV 164 (457)
+.||.|+||+||+|.++.... .....||+|.+.... ....+.+..|+.+++.++||||+++++++..++..++|
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv 77 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH---RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMV 77 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh---HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEE
Confidence 368999999999998753211 123458888875432 23445677799999999999999999999998999999
Q ss_pred EeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCC--------EEEeccCCCc
Q 012762 165 TEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGH--------IMLTDFDLSL 236 (457)
Q Consensus 165 ~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~--------vkl~DFG~s~ 236 (457)
|||+.+|+|..++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++. ++++|||++.
T Consensus 78 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~ 156 (258)
T cd05078 78 QEYVKFGSLDTYLKKNK-NLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI 156 (258)
T ss_pred EecCCCCcHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEeccccccc
Confidence 99999999999887642 36899999999999999999999999999999999999987765 6899998864
Q ss_pred CCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccc
Q 012762 237 KGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSM 316 (457)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (457)
..... .
T Consensus 157 ~~~~~--------------------------------------------------------------------------~ 162 (258)
T cd05078 157 TVLPK--------------------------------------------------------------------------E 162 (258)
T ss_pred ccCCc--------------------------------------------------------------------------h
Confidence 32110 0
Q ss_pred cccCCCCccCchhhcCC-CCCccchhhhhhHHHHHHhcC-CCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHH
Q 012762 317 SFVGTHEYLAPEIISGE-GHGNAVDWWTLGIFIFELFYG-TTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQL 394 (457)
Q Consensus 317 ~~~gt~~y~aPE~l~~~-~~~~~sDiwSlG~il~elltG-~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~ 394 (457)
.+.++..|+|||++.+. .++.++|||||||++|||++| ..||........ .........++. ..+.++.+|+.+|
T Consensus 163 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~-~~~~~~~~~~~~--~~~~~~~~li~~~ 239 (258)
T cd05078 163 ILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKK-LQFYEDRHQLPA--PKWTELANLINQC 239 (258)
T ss_pred hccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHH-HHHHHccccCCC--CCcHHHHHHHHHH
Confidence 23478899999999874 479999999999999999998 566665444332 223333333333 3567899999999
Q ss_pred hhhCCCCCCCCCcChHHHhcC
Q 012762 395 LVKDPTRRMGSKMGATAIKRH 415 (457)
Q Consensus 395 L~~dP~~Rps~~~~~~~ll~h 415 (457)
|+.||++||+ +++|++.
T Consensus 240 l~~~p~~Rps----~~~il~~ 256 (258)
T cd05078 240 MDYEPDFRPS----FRAIIRD 256 (258)
T ss_pred hccChhhCCC----HHHHHHh
Confidence 9999999999 8888764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=310.27 Aligned_cols=253 Identities=16% Similarity=0.240 Sum_probs=196.1
Q ss_pred EEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEE-cCCcEEEEEe
Q 012762 88 HRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLD-CPRWSCLLTE 166 (457)
Q Consensus 88 ~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~-~~~~~~lV~E 166 (457)
+.||+|+||+||+|.+.... ..+..||+|.+.... .......+.+|+.+++.++||||+++++++. .++..|+|||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~-~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e 77 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSD-GQKIHCAVKSLNRIT--DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLP 77 (262)
T ss_pred CcccccCCceEEEEEEecCC-CceEEEEEEecCccC--CHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEe
Confidence 36899999999999875322 245689999985421 2234456778999999999999999999765 4556899999
Q ss_pred ecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCCCcccc
Q 012762 167 FCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQ 246 (457)
Q Consensus 167 ~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~~~~~~ 246 (457)
|+.+++|..++.... ....+..+..++.||+.||.|||+.+++||||||+|||++.++.+||+|||++...........
T Consensus 78 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~ 156 (262)
T cd05058 78 YMKHGDLRNFIRSET-HNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSV 156 (262)
T ss_pred cCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceee
Confidence 999999999987642 4467778889999999999999999999999999999999999999999999764432110000
Q ss_pred cccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCCCCccC
Q 012762 247 LVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTHEYLA 326 (457)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 326 (457)
.......++..|+|
T Consensus 157 ------------------------------------------------------------------~~~~~~~~~~~y~a 170 (262)
T cd05058 157 ------------------------------------------------------------------HNHTGAKLPVKWMA 170 (262)
T ss_pred ------------------------------------------------------------------cccccCcCCccccC
Confidence 00001236778999
Q ss_pred chhhcCCCCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhhhCCCCCCCC
Q 012762 327 PEIISGEGHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDPTRRMGS 405 (457)
Q Consensus 327 PE~l~~~~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rps~ 405 (457)
||++.+..++.++|||||||++|||++ |.+||...........+... ...+....+++.+.+++.+||..+|++||+
T Consensus 171 PE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~- 248 (262)
T cd05058 171 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQG-RRLLQPEYCPDPLYEVMLSCWHPKPEMRPT- 248 (262)
T ss_pred hhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC-CCCCCCCcCCHHHHHHHHHHcCCChhhCCC-
Confidence 999988889999999999999999999 56777766555544444332 233333457889999999999999999999
Q ss_pred CcChHHHhcC
Q 012762 406 KMGATAIKRH 415 (457)
Q Consensus 406 ~~~~~~ll~h 415 (457)
+.+|++.
T Consensus 249 ---~~~il~~ 255 (262)
T cd05058 249 ---FSELVSR 255 (262)
T ss_pred ---HHHHHHH
Confidence 8888753
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=312.21 Aligned_cols=250 Identities=22% Similarity=0.304 Sum_probs=193.0
Q ss_pred EEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcEEEEEee
Q 012762 88 HRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWSCLLTEF 167 (457)
Q Consensus 88 ~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lV~E~ 167 (457)
+.||+|+||.||+|.+.. ..++..+|+|.+..... ......+.+|+.++++++||||+++++++......|+||||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~--~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 76 (269)
T cd05087 1 KEIGNGWFGKVILGEVNS--GYTPAQVVVKELRVSAS--VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEF 76 (269)
T ss_pred CcccccCCceEEEEEEcC--CCCceEEEEEecCCCCC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEEC
Confidence 368999999999998652 23556799998865432 22334677799999999999999999999998999999999
Q ss_pred cCCCChHHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCCCcc
Q 012762 168 CPGGDLHVLRQRQP---DKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTST 244 (457)
Q Consensus 168 ~~~~sL~~~~~~~~---~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~~~~ 244 (457)
+++++|.+++.... ...+++..++.++.|++.||.|||+.|++||||||+||+++.++.++|+|||++.........
T Consensus 77 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~ 156 (269)
T cd05087 77 CPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYY 156 (269)
T ss_pred CCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCccee
Confidence 99999998886532 234667788899999999999999999999999999999999999999999987532211000
Q ss_pred cccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCCCCc
Q 012762 245 AQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTHEY 324 (457)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 324 (457)
.......|+..|
T Consensus 157 --------------------------------------------------------------------~~~~~~~~~~~y 168 (269)
T cd05087 157 --------------------------------------------------------------------VTPDQLWVPLRW 168 (269)
T ss_pred --------------------------------------------------------------------ecCCCcCCcccc
Confidence 000123578899
Q ss_pred cCchhhcCC-------CCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHHhc-ccCCCCC---CCCChHHHHHHH
Q 012762 325 LAPEIISGE-------GHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVVAR-ALEFPKE---PSVPGPAKDLIA 392 (457)
Q Consensus 325 ~aPE~l~~~-------~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~-~~~~~~~---~~~~~~~~~ll~ 392 (457)
+|||++.+. .++.++|||||||++|||++ |..||......+.....+.. ....+.. ...++.+.+++.
T Consensus 169 ~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 248 (269)
T cd05087 169 IAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLPLSDRWYEVMQ 248 (269)
T ss_pred cCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCCCCChHHHHHHH
Confidence 999998643 35789999999999999996 99999876655544333322 2222221 245678999999
Q ss_pred HHhhhCCCCCCCCCcChHHHhc
Q 012762 393 QLLVKDPTRRMGSKMGATAIKR 414 (457)
Q Consensus 393 ~~L~~dP~~Rps~~~~~~~ll~ 414 (457)
.|| .+|++||+ +++|++
T Consensus 249 ~c~-~~P~~Rpt----~~~l~~ 265 (269)
T cd05087 249 FCW-LQPEQRPS----AEEVHL 265 (269)
T ss_pred HHh-cCcccCCC----HHHHHH
Confidence 998 68999999 888864
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-40 Score=312.35 Aligned_cols=243 Identities=20% Similarity=0.258 Sum_probs=191.3
Q ss_pred EEecccCcceEEEEEEeccC--------CCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCC
Q 012762 88 HRLGSGDIGSVYLVQLKSKS--------SNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPR 159 (457)
Q Consensus 88 ~~LG~G~fg~Vy~a~~~~~~--------~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~ 159 (457)
+.||+|+||+||+|...... ......+|+|++.... ......+..|+.+++.++||||+++++++..+.
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~ 77 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH---RDISLAFFETASMMRQVSHKHIVLLYGVCVRDV 77 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh---hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 36899999999999854221 1234468999876542 234456777899999999999999999999999
Q ss_pred cEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCC-------EEEecc
Q 012762 160 WSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGH-------IMLTDF 232 (457)
Q Consensus 160 ~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~-------vkl~DF 232 (457)
..++||||+++++|..++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++. ++++||
T Consensus 78 ~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~ 156 (262)
T cd05077 78 ENIMVEEFVEFGPLDLFMHRK-SDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDP 156 (262)
T ss_pred CCEEEEecccCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence 999999999999998877653 356899999999999999999999999999999999999987664 899999
Q ss_pred CCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCc
Q 012762 233 DLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLD 312 (457)
Q Consensus 233 G~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (457)
|++......
T Consensus 157 g~~~~~~~~----------------------------------------------------------------------- 165 (262)
T cd05077 157 GIPITVLSR----------------------------------------------------------------------- 165 (262)
T ss_pred CCCccccCc-----------------------------------------------------------------------
Confidence 986433110
Q ss_pred cccccccCCCCccCchhhc-CCCCCccchhhhhhHHHHHHh-cCCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHH
Q 012762 313 VRSMSFVGTHEYLAPEIIS-GEGHGNAVDWWTLGIFIFELF-YGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDL 390 (457)
Q Consensus 313 ~~~~~~~gt~~y~aPE~l~-~~~~~~~sDiwSlG~il~ell-tG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 390 (457)
....|+..|+|||++. +..++.++|||||||++|||+ .|..||......+. ........... ...++++.+|
T Consensus 166 ---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~-~~~~~~~~~~~--~~~~~~~~~l 239 (262)
T cd05077 166 ---QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK-ERFYEGQCMLV--TPSCKELADL 239 (262)
T ss_pred ---ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH-HHHHhcCccCC--CCChHHHHHH
Confidence 0124788999999987 456899999999999999998 58999876543322 22222322222 2356789999
Q ss_pred HHHHhhhCCCCCCCCCcChHHHhcC
Q 012762 391 IAQLLVKDPTRRMGSKMGATAIKRH 415 (457)
Q Consensus 391 l~~~L~~dP~~Rps~~~~~~~ll~h 415 (457)
|.+||+.||.+||+ +.+|+++
T Consensus 240 i~~cl~~dp~~Rp~----~~~il~~ 260 (262)
T cd05077 240 MTHCMNYDPNQRPF----FRAIMRD 260 (262)
T ss_pred HHHHcCCChhhCcC----HHHHHHh
Confidence 99999999999999 8998875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=312.85 Aligned_cols=244 Identities=22% Similarity=0.320 Sum_probs=196.3
Q ss_pred EecccCcceEEEEEEeccCCCCC--ceEEEEEeehhhhhhhhHHHHHHHHHHHHHHc-CCCCCceEEEEEEcCCcEEEEE
Q 012762 89 RLGSGDIGSVYLVQLKSKSSNNG--CFFAAKVMDKRELVSRNKESRARIEREILEML-DHPFLPTLYATLDCPRWSCLLT 165 (457)
Q Consensus 89 ~LG~G~fg~Vy~a~~~~~~~~~~--~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~~~~~~~~~~~lV~ 165 (457)
.||+|+||.||+|.++. ++ ..+|+|.++.. ........+..|++++.++ +||||+++++++...+..|+||
T Consensus 2 ~lg~g~~g~v~~~~~~~----~~~~~~~~~k~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 75 (270)
T cd05047 2 VIGEGNFGQVLKARIKK----DGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAI 75 (270)
T ss_pred cCCCCCCceEEEEEEcC----CCCeeEEEEEEcccc--CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEE
Confidence 58999999999999863 34 35688887642 2223445677899999999 8999999999999999999999
Q ss_pred eecCCCChHHHHHhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEec
Q 012762 166 EFCPGGDLHVLRQRQP--------------DKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTD 231 (457)
Q Consensus 166 E~~~~~sL~~~~~~~~--------------~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~D 231 (457)
||+.+++|.+++.... ...+++..++.++.|++.||+|||+.|++||||||+|||++.++.+||+|
T Consensus 76 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~d 155 (270)
T cd05047 76 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIAD 155 (270)
T ss_pred EeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECC
Confidence 9999999999887532 13578999999999999999999999999999999999999999999999
Q ss_pred cCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCC
Q 012762 232 FDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPL 311 (457)
Q Consensus 232 FG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (457)
||++.......
T Consensus 156 fgl~~~~~~~~--------------------------------------------------------------------- 166 (270)
T cd05047 156 FGLSRGQEVYV--------------------------------------------------------------------- 166 (270)
T ss_pred CCCccccchhh---------------------------------------------------------------------
Confidence 99864211000
Q ss_pred ccccccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHH
Q 012762 312 DVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDL 390 (457)
Q Consensus 312 ~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 390 (457)
.......+..|+|||++.+..++.++|||||||++|||++ |..||.+.+.......+.. .........++.++.++
T Consensus 167 --~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l 243 (270)
T cd05047 167 --KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ-GYRLEKPLNCDDEVYDL 243 (270)
T ss_pred --hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhC-CCCCCCCCcCCHHHHHH
Confidence 0000124567999999988889999999999999999996 9999987766555554433 23333344578899999
Q ss_pred HHHHhhhCCCCCCCCCcChHHHhc
Q 012762 391 IAQLLVKDPTRRMGSKMGATAIKR 414 (457)
Q Consensus 391 l~~~L~~dP~~Rps~~~~~~~ll~ 414 (457)
+.+||..||.+||+ +.++++
T Consensus 244 i~~~l~~~p~~Rps----~~~il~ 263 (270)
T cd05047 244 MRQCWREKPYERPS----FAQILV 263 (270)
T ss_pred HHHHcccChhhCCC----HHHHHH
Confidence 99999999999999 777764
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=318.52 Aligned_cols=260 Identities=22% Similarity=0.317 Sum_probs=206.0
Q ss_pred ccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcC
Q 012762 79 LTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCP 158 (457)
Q Consensus 79 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~ 158 (457)
+..++|+..+.||+|+||.||+|.+..........||+|++.... .......+..|+.+++.++|+||+++++++...
T Consensus 4 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~ 81 (303)
T cd05110 4 LKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT--GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP 81 (303)
T ss_pred cchhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC
Confidence 456789999999999999999998864322223467999886532 223334677899999999999999999998754
Q ss_pred CcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCC
Q 012762 159 RWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKG 238 (457)
Q Consensus 159 ~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~ 238 (457)
..++++||+++|+|.+++... ...+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||+++..
T Consensus 82 -~~~~v~e~~~~g~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~ 159 (303)
T cd05110 82 -TIQLVTQLMPHGCLLDYVHEH-KDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (303)
T ss_pred -CceeeehhcCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccc
Confidence 467999999999999888764 246889999999999999999999999999999999999999999999999998644
Q ss_pred CCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccc
Q 012762 239 DNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSF 318 (457)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (457)
...... ......
T Consensus 160 ~~~~~~--------------------------------------------------------------------~~~~~~ 171 (303)
T cd05110 160 EGDEKE--------------------------------------------------------------------YNADGG 171 (303)
T ss_pred cCcccc--------------------------------------------------------------------cccCCC
Confidence 311100 000012
Q ss_pred cCCCCccCchhhcCCCCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhhh
Q 012762 319 VGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVK 397 (457)
Q Consensus 319 ~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~ 397 (457)
.++..|+|||++.+..++.++|||||||++|||++ |..||.+..... ...++.....++....++.++.+++.+||..
T Consensus 172 ~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~c~~~ 250 (303)
T cd05110 172 KMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE-IPDLLEKGERLPQPPICTIDVYMVMVKCWMI 250 (303)
T ss_pred ccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHHHCCCCCCCCCCCCHHHHHHHHHHcCC
Confidence 35778999999998889999999999999999997 999998765443 3344444445555556788999999999999
Q ss_pred CCCCCCCCCcChHHHhcC
Q 012762 398 DPTRRMGSKMGATAIKRH 415 (457)
Q Consensus 398 dP~~Rps~~~~~~~ll~h 415 (457)
||++||+ +.++++.
T Consensus 251 ~p~~Rp~----~~~l~~~ 264 (303)
T cd05110 251 DADSRPK----FKELAAE 264 (303)
T ss_pred ChhhCcC----HHHHHHH
Confidence 9999999 7776653
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=332.74 Aligned_cols=245 Identities=30% Similarity=0.447 Sum_probs=203.5
Q ss_pred cCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHc-CCCCCceEEEEEEcC
Q 012762 80 TLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEML-DHPFLPTLYATLDCP 158 (457)
Q Consensus 80 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~~~~~~~ 158 (457)
..++|.+...+|.|+|+.|-.|.++. +++.+++|++.+.. .....|+.++.+. +||||+++.+.+.++
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~----t~~~~~vkii~~~~-------~~~~~e~~~~~~~~~h~niv~~~~v~~~~ 388 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSP----TDQEPAVKIISKRA-------DDNQDEIPISLLVRDHPNIVKSHDVYEDG 388 (612)
T ss_pred cchhhccccccCCCCccceeeeeccc----cccchhheeccccc-------cccccccchhhhhcCCCcceeecceecCC
Confidence 35689999999999999999999874 78889999997651 1223377776665 799999999999999
Q ss_pred CcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEE-ccCCCEEEeccCCCcC
Q 012762 159 RWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLV-RSDGHIMLTDFDLSLK 237 (457)
Q Consensus 159 ~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll-~~~~~vkl~DFG~s~~ 237 (457)
.+.|+|||++.|+-|.+.+... + ....++..|+.||+.++.|||++|||||||||+|||+ +..|+++|+|||+++.
T Consensus 389 ~~~~~v~e~l~g~ell~ri~~~--~-~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~ 465 (612)
T KOG0603|consen 389 KEIYLVMELLDGGELLRRIRSK--P-EFCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSE 465 (612)
T ss_pred ceeeeeehhccccHHHHHHHhc--c-hhHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhh
Confidence 9999999999998886655443 2 3337788899999999999999999999999999999 6889999999999876
Q ss_pred CCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcccccc
Q 012762 238 GDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMS 317 (457)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (457)
.+.. .++
T Consensus 466 ~~~~-------------------------------------------------------------------------~~t 472 (612)
T KOG0603|consen 466 LERS-------------------------------------------------------------------------CDT 472 (612)
T ss_pred Cchh-------------------------------------------------------------------------hcc
Confidence 5432 112
Q ss_pred ccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhhh
Q 012762 318 FVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVK 397 (457)
Q Consensus 318 ~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~ 397 (457)
-+-|..|.|||++....|+.++||||||++||+||+|+.||........+.. +....+....+++.+++||+.||+.
T Consensus 473 p~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~---~i~~~~~s~~vS~~AKdLl~~LL~~ 549 (612)
T KOG0603|consen 473 PALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHT---RIQMPKFSECVSDEAKDLLQQLLQV 549 (612)
T ss_pred cchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHH---hhcCCccccccCHHHHHHHHHhccC
Confidence 2468899999999999999999999999999999999999988776632222 2222222256999999999999999
Q ss_pred CCCCCCCCCcChHHHhcCCCC
Q 012762 398 DPTRRMGSKMGATAIKRHQFF 418 (457)
Q Consensus 398 dP~~Rps~~~~~~~ll~hp~f 418 (457)
||.+|++ +.+++.||||
T Consensus 550 dP~~Rl~----~~~i~~h~w~ 566 (612)
T KOG0603|consen 550 DPALRLG----ADEIGAHPWF 566 (612)
T ss_pred ChhhCcC----hhhhccCcch
Confidence 9999999 9999999999
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-41 Score=335.76 Aligned_cols=260 Identities=20% Similarity=0.265 Sum_probs=220.7
Q ss_pred CCCccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEE
Q 012762 76 NNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATL 155 (457)
Q Consensus 76 ~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~ 155 (457)
..-|..++.++.++||+|.||+||+|.|+... ..-..||||+++..... .....|++|+.+|.+|+|+|+++|||+.
T Consensus 104 kclIpee~i~l~e~LG~GsFgvV~rg~Wt~ps-gk~V~VAVKclr~d~l~--~~mddflrEas~M~~L~H~hliRLyGvV 180 (1039)
T KOG0199|consen 104 KCLIPEEQIKLYELLGEGSFGVVKRGTWTQPS-GKHVNVAVKCLRDDSLN--AIMDDFLREASHMLKLQHPHLIRLYGVV 180 (1039)
T ss_pred ceeccHHHHHHHHHhcCcceeeEeeccccCCC-CcEEeEEEEeccCCccc--hhHHHHHHHHHHHHhccCcceeEEeeee
Confidence 34456678889999999999999999998632 23457899999765442 2667899999999999999999999999
Q ss_pred EcCCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCC
Q 012762 156 DCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235 (457)
Q Consensus 156 ~~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s 235 (457)
.+ ..+.||||++.+|+|.+.+.......|.......|+.||+.||.||.++++|||||...|+||-....|||+||||.
T Consensus 181 l~-qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLm 259 (1039)
T KOG0199|consen 181 LD-QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLM 259 (1039)
T ss_pred cc-chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccce
Confidence 87 77899999999999998888766678889999999999999999999999999999999999999999999999998
Q ss_pred cCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcccc
Q 012762 236 LKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRS 315 (457)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (457)
+.+.......... ..
T Consensus 260 RaLg~ned~Yvm~---------------------------------------------------------------p~-- 274 (1039)
T KOG0199|consen 260 RALGENEDMYVMA---------------------------------------------------------------PQ-- 274 (1039)
T ss_pred eccCCCCcceEec---------------------------------------------------------------CC--
Confidence 7665332211100 00
Q ss_pred ccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHH
Q 012762 316 MSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQL 394 (457)
Q Consensus 316 ~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~ 394 (457)
.--...|+|||.++...++.++|||+|||+||||++ |+.||.+-...+++.++- ..-+++....+++++.+++..|
T Consensus 275 --rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD-~~erLpRPk~csedIY~imk~c 351 (1039)
T KOG0199|consen 275 --RKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNID-AGERLPRPKYCSEDIYQIMKNC 351 (1039)
T ss_pred --CcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcc-ccccCCCCCCChHHHHHHHHHh
Confidence 013568999999999999999999999999999996 999999988888887766 6668888888999999999999
Q ss_pred hhhCCCCCCCCCc
Q 012762 395 LVKDPTRRMGSKM 407 (457)
Q Consensus 395 L~~dP~~Rps~~~ 407 (457)
|..+|.+||++..
T Consensus 352 Wah~paDRptFsa 364 (1039)
T KOG0199|consen 352 WAHNPADRPTFSA 364 (1039)
T ss_pred ccCCccccccHHH
Confidence 9999999999443
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=316.58 Aligned_cols=254 Identities=30% Similarity=0.436 Sum_probs=206.6
Q ss_pred ceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcEEE
Q 012762 84 LRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWSCL 163 (457)
Q Consensus 84 ~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~l 163 (457)
|.+.+.||.|++|.||+|.+. .+++.+|+|.+..... .......+..|+++|++++|+||+++++++..++..|+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~----~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 75 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDK----LTGEIVAIKKIKLRFE-SEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYL 75 (283)
T ss_pred CccceeeecCCCceEEEEEcC----CCCcEEEEEEeccccc-cchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEE
Confidence 677899999999999999875 4788999999875432 22344567779999999999999999999999999999
Q ss_pred EEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCCCc
Q 012762 164 LTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTS 243 (457)
Q Consensus 164 V~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~~~ 243 (457)
||||+. ++|..++.... ..+++..+..++.||+.||.|||+.||+|+||||+||+++.++.++|+|||.+........
T Consensus 76 v~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~ 153 (283)
T cd05118 76 VFEFMD-TDLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR 153 (283)
T ss_pred EEeccC-CCHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc
Confidence 999995 58877766532 5789999999999999999999999999999999999999999999999998754432110
Q ss_pred ccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCCCC
Q 012762 244 TAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTHE 323 (457)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 323 (457)
......++..
T Consensus 154 ----------------------------------------------------------------------~~~~~~~~~~ 163 (283)
T cd05118 154 ----------------------------------------------------------------------PYTHYVVTRW 163 (283)
T ss_pred ----------------------------------------------------------------------cccCccCccc
Confidence 0001247889
Q ss_pred ccCchhhcCC-CCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccC-------------------CC-----
Q 012762 324 YLAPEIISGE-GHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALE-------------------FP----- 378 (457)
Q Consensus 324 y~aPE~l~~~-~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~-------------------~~----- 378 (457)
|+|||.+.+. .++.++||||||+++|+|++|+.||...+..+.+..+...... ++
T Consensus 164 ~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (283)
T cd05118 164 YRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGM 243 (283)
T ss_pred ccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhcccccc
Confidence 9999999877 6899999999999999999999999887765544443322111 00
Q ss_pred ----CCCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCC
Q 012762 379 ----KEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFF 418 (457)
Q Consensus 379 ----~~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f 418 (457)
....++.++.++|.+||..||.+||+ +.++++||||
T Consensus 244 ~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~----~~~ll~~~~~ 283 (283)
T cd05118 244 PLPKLFPNASPQALDLLSQMLHYDPHKRIT----AEQALAHPYF 283 (283)
T ss_pred CHHHhhhhhCHHHHHHHHHHhccCcccCcC----HHHHhhCCCC
Confidence 01235678999999999999999999 9999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=315.90 Aligned_cols=254 Identities=28% Similarity=0.425 Sum_probs=207.2
Q ss_pred ceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcEEE
Q 012762 84 LRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWSCL 163 (457)
Q Consensus 84 ~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~l 163 (457)
|++.+.||+|+||.||+|... .+++.||+|++.... ........+..|++++++++|+||+++++++...+..++
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~----~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~ 75 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDK----KTGEIVALKKIRLDN-EEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYL 75 (282)
T ss_pred CeeehcccccCcceEEEeeec----CCCcEEEEEEecccc-ccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEE
Confidence 677889999999999999876 368899999997653 223344566779999999999999999999999999999
Q ss_pred EEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCCCc
Q 012762 164 LTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTS 243 (457)
Q Consensus 164 V~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~~~ 243 (457)
||||++ ++|..++.... ..+++..++.++.|++.||.|||++||+|+||+|+||+++.++.++|+|||++........
T Consensus 76 v~e~~~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 153 (282)
T cd07829 76 VFEYCD-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR 153 (282)
T ss_pred EecCcC-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc
Confidence 999996 68999887743 4699999999999999999999999999999999999999999999999998754321100
Q ss_pred ccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCCCC
Q 012762 244 TAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTHE 323 (457)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 323 (457)
......++..
T Consensus 154 ----------------------------------------------------------------------~~~~~~~~~~ 163 (282)
T cd07829 154 ----------------------------------------------------------------------TYTHEVVTLW 163 (282)
T ss_pred ----------------------------------------------------------------------ccCccccCcC
Confidence 0001236778
Q ss_pred ccCchhhcCC-CCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcc------------------cCCCC-----
Q 012762 324 YLAPEIISGE-GHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARA------------------LEFPK----- 379 (457)
Q Consensus 324 y~aPE~l~~~-~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~------------------~~~~~----- 379 (457)
|+|||.+.+. .++.++|||||||++|||++|..||........+.++.... ..++.
T Consensus 164 ~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (282)
T cd07829 164 YRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKD 243 (282)
T ss_pred cCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccccccCccc
Confidence 9999999876 68999999999999999999999998876555444433211 00010
Q ss_pred ----CCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCC
Q 012762 380 ----EPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFF 418 (457)
Q Consensus 380 ----~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f 418 (457)
.+.++.++.++|.+||..||++||+ +.+++.||||
T Consensus 244 ~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~----~~~~l~~p~~ 282 (282)
T cd07829 244 LEKVLPRLDPEGIDLLSKMLQYNPAKRIS----AKEALKHPYF 282 (282)
T ss_pred hHHhcccccHHHHHHHHHhhccCcccCCC----HHHHhhCcCC
Confidence 1234678999999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-40 Score=314.03 Aligned_cols=252 Identities=21% Similarity=0.307 Sum_probs=201.4
Q ss_pred EEecccCcceEEEEEEeccC--CCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcEEEEE
Q 012762 88 HRLGSGDIGSVYLVQLKSKS--SNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWSCLLT 165 (457)
Q Consensus 88 ~~LG~G~fg~Vy~a~~~~~~--~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lV~ 165 (457)
+.||+|+||.||+|+++... ...++.+|+|.+.+.. .......+.+|+++++.++||||+++++++...+..|+||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA--TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIM 78 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhccc--chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEE
Confidence 36899999999999876422 2344689999886532 1234556778999999999999999999999999999999
Q ss_pred eecCCCChHHHHHhC-----CCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCC-----CEEEeccCCC
Q 012762 166 EFCPGGDLHVLRQRQ-----PDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDG-----HIMLTDFDLS 235 (457)
Q Consensus 166 E~~~~~sL~~~~~~~-----~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~-----~vkl~DFG~s 235 (457)
||+++++|.+++... ....+++..+..++.||+.||.|||+.+++|+||||+||+++.++ .++|+|||++
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred eccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 999999999888653 224478899999999999999999999999999999999999877 8999999997
Q ss_pred cCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcccc
Q 012762 236 LKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRS 315 (457)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (457)
.......... ..
T Consensus 159 ~~~~~~~~~~--------------------------------------------------------------------~~ 170 (269)
T cd05044 159 RDIYKSDYYR--------------------------------------------------------------------KE 170 (269)
T ss_pred cccccccccc--------------------------------------------------------------------cC
Confidence 5442211000 00
Q ss_pred ccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHH
Q 012762 316 MSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQL 394 (457)
Q Consensus 316 ~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~ 394 (457)
....++..|+|||++.+..++.++|||||||++|||++ |..||...........+.. ...+.....++..+.+++.+|
T Consensus 171 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~ 249 (269)
T cd05044 171 GEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTA-GGRLQKPENCPDKIYQLMTNC 249 (269)
T ss_pred cccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhc-CCccCCcccchHHHHHHHHHH
Confidence 01235778999999998889999999999999999998 9999987766555544432 233334456889999999999
Q ss_pred hhhCCCCCCCCCcChHHHhc
Q 012762 395 LVKDPTRRMGSKMGATAIKR 414 (457)
Q Consensus 395 L~~dP~~Rps~~~~~~~ll~ 414 (457)
|..+|.+||+ +.++++
T Consensus 250 l~~~p~~Rp~----~~~i~~ 265 (269)
T cd05044 250 WAQDPSERPT----FDRIQE 265 (269)
T ss_pred cCCCcccCCC----HHHHHH
Confidence 9999999999 888764
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=307.43 Aligned_cols=246 Identities=24% Similarity=0.357 Sum_probs=201.6
Q ss_pred EEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcEEEEEee
Q 012762 88 HRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWSCLLTEF 167 (457)
Q Consensus 88 ~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lV~E~ 167 (457)
++||.|+||.||+|.+. .++.||+|++...... .....+..|++++++++|+||+++++++......++||||
T Consensus 1 ~~lg~g~~g~v~~~~~~-----~~~~v~~K~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 73 (251)
T cd05041 1 EKIGKGNFGDVYKGVLK-----GNTEVAVKTCRSTLPP--DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMEL 73 (251)
T ss_pred CccccCCCceEEEEEEe-----CCCcEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEc
Confidence 46899999999999875 3788999998754332 3456778899999999999999999999999999999999
Q ss_pred cCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCCCccccc
Q 012762 168 CPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQL 247 (457)
Q Consensus 168 ~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~~~~~~~ 247 (457)
+.+++|..++.... ..+++..+..++.|++.||.|||+++++||||||+|||++.++.++|+|||++..........
T Consensus 74 ~~~~~l~~~l~~~~-~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~-- 150 (251)
T cd05041 74 VPGGSLLTFLRKKK-NRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTV-- 150 (251)
T ss_pred CCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCccee--
Confidence 99999998886642 468899999999999999999999999999999999999999999999999975432110000
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCCCCccCc
Q 012762 248 VSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTHEYLAP 327 (457)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 327 (457)
......++..|+||
T Consensus 151 ------------------------------------------------------------------~~~~~~~~~~y~~P 164 (251)
T cd05041 151 ------------------------------------------------------------------SDGLKQIPIKWTAP 164 (251)
T ss_pred ------------------------------------------------------------------ccccCcceeccCCh
Confidence 00011246679999
Q ss_pred hhhcCCCCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhhhCCCCCCCCC
Q 012762 328 EIISGEGHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDPTRRMGSK 406 (457)
Q Consensus 328 E~l~~~~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rps~~ 406 (457)
|.+.+..++.++|||||||++|||++ |..||...........+. .....+....++..+.+++.+||..+|.+||+
T Consensus 165 E~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~-- 241 (251)
T cd05041 165 EALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIE-SGYRMPAPQLCPEEIYRLMLQCWAYDPENRPS-- 241 (251)
T ss_pred HhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHh-cCCCCCCCccCCHHHHHHHHHHhccChhhCcC--
Confidence 99998889999999999999999998 899998776554444433 33344444567889999999999999999999
Q ss_pred cChHHHhc
Q 012762 407 MGATAIKR 414 (457)
Q Consensus 407 ~~~~~ll~ 414 (457)
+.++++
T Consensus 242 --~~ell~ 247 (251)
T cd05041 242 --FSEIYN 247 (251)
T ss_pred --HHHHHH
Confidence 998876
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=340.14 Aligned_cols=261 Identities=21% Similarity=0.342 Sum_probs=228.2
Q ss_pred CCccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEE
Q 012762 77 NPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLD 156 (457)
Q Consensus 77 ~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~ 156 (457)
.+++.....|.++||.|.||.||.|+++... +....||||.++.. ..+.....|..|+.||-+++||||++|.|+..
T Consensus 624 kEId~s~i~Ie~VIGaGEFGEVc~GrLk~pg-kre~~VAIKTLK~G--ytekqrrdFL~EAsIMGQFdHPNIIrLEGVVT 700 (996)
T KOG0196|consen 624 KEIDPSCVKIEKVIGAGEFGEVCSGRLKLPG-KREITVAIKTLKAG--YTEKQRRDFLSEASIMGQFDHPNIIRLEGVVT 700 (996)
T ss_pred hhcChhheEEEEEEecccccceecccccCCC-CcceeEEEeeeccC--ccHHHHhhhhhhhhhcccCCCCcEEEEEEEEe
Confidence 4567778999999999999999999988533 35678999999765 44556677889999999999999999999999
Q ss_pred cCCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCc
Q 012762 157 CPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSL 236 (457)
Q Consensus 157 ~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~ 236 (457)
....++||+|||++|+|..++..+. +.|+..++..+++.|+.|+.||-+.|.|||||...|||++.+..+|++|||+++
T Consensus 701 ks~PvMIiTEyMENGsLDsFLR~~D-GqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSR 779 (996)
T KOG0196|consen 701 KSKPVMIITEYMENGSLDSFLRQND-GQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSR 779 (996)
T ss_pred cCceeEEEhhhhhCCcHHHHHhhcC-CceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEecccccee
Confidence 9999999999999999999998764 679999999999999999999999999999999999999999999999999998
Q ss_pred CCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccc
Q 012762 237 KGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSM 316 (457)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (457)
.+++...... .
T Consensus 780 vledd~~~~y---------------------------------------------------------------------t 790 (996)
T KOG0196|consen 780 VLEDDPEAAY---------------------------------------------------------------------T 790 (996)
T ss_pred ecccCCCccc---------------------------------------------------------------------c
Confidence 8764332111 0
Q ss_pred cccC--CCCccCchhhcCCCCCccchhhhhhHHHHHHh-cCCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHH
Q 012762 317 SFVG--THEYLAPEIISGEGHGNAVDWWTLGIFIFELF-YGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQ 393 (457)
Q Consensus 317 ~~~g--t~~y~aPE~l~~~~~~~~sDiwSlG~il~ell-tG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~ 393 (457)
+.-| ...|.|||.+....++.++||||+|++|||.+ +|+.||+++++++.+..+ ...+++|.+..+|..+.+||..
T Consensus 791 t~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaI-e~gyRLPpPmDCP~aL~qLMld 869 (996)
T KOG0196|consen 791 TLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAI-EQGYRLPPPMDCPAALYQLMLD 869 (996)
T ss_pred ccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHH-HhccCCCCCCCCcHHHHHHHHH
Confidence 1112 46899999999999999999999999999988 599999999998877664 5778999999999999999999
Q ss_pred HhhhCCCCCCCCCcChHHHhcC
Q 012762 394 LLVKDPTRRMGSKMGATAIKRH 415 (457)
Q Consensus 394 ~L~~dP~~Rps~~~~~~~ll~h 415 (457)
||++|-..||. +.||+.+
T Consensus 870 CWqkdR~~RP~----F~qiV~~ 887 (996)
T KOG0196|consen 870 CWQKDRNRRPK----FAQIVST 887 (996)
T ss_pred HHHHHhhcCCC----HHHHHHH
Confidence 99999999999 7887664
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=351.45 Aligned_cols=270 Identities=28% Similarity=0.376 Sum_probs=205.2
Q ss_pred CCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcC---
Q 012762 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCP--- 158 (457)
Q Consensus 82 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~--- 158 (457)
.||..++.||+||||.||+|+.+ -+|+.||||.+.... +......+.+|+.+|.+|+|||||++|..+.+.
T Consensus 479 ~DFEEL~lLGkGGFG~VvkVRNK----lDGr~YAIKKIpl~~--s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~ 552 (1351)
T KOG1035|consen 479 NDFEELELLGKGGFGSVVKVRNK----LDGREYAIKKIPLKA--SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAE 552 (1351)
T ss_pred hhhHHHHHhcCCCCceEEEEeec----ccchhhhhhhccCch--HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCc
Confidence 47888999999999999999987 489999999997764 455667788899999999999999988744210
Q ss_pred --------------------------------------------------------------------------------
Q 012762 159 -------------------------------------------------------------------------------- 158 (457)
Q Consensus 159 -------------------------------------------------------------------------------- 158 (457)
T Consensus 553 ~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~ 632 (1351)
T KOG1035|consen 553 LTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSN 632 (1351)
T ss_pred cccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccc
Confidence
Q ss_pred ------------------------------------CcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHH
Q 012762 159 ------------------------------------RWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALE 202 (457)
Q Consensus 159 ------------------------------------~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ 202 (457)
..+||-||||+...|++++.++.... .....+.+++||++||.
T Consensus 633 tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~-~~d~~wrLFreIlEGLa 711 (1351)
T KOG1035|consen 633 TSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS-QRDEAWRLFREILEGLA 711 (1351)
T ss_pred ccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch-hhHHHHHHHHHHHHHHH
Confidence 01588999999999998888753221 46788999999999999
Q ss_pred HHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCC-CCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCC
Q 012762 203 FLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDN-STSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCI 281 (457)
Q Consensus 203 yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (457)
|+|++|||||||||.||+++.++.|||+|||++..... ........ .
T Consensus 712 YIH~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~---~----------------------------- 759 (1351)
T KOG1035|consen 712 YIHDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDL---S----------------------------- 759 (1351)
T ss_pred HHHhCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhcc---C-----------------------------
Confidence 99999999999999999999999999999999865321 00000000 0
Q ss_pred CCcccccCcchhccccCCCCCCCcccccCCccccccccCCCCccCchhhcCCC---CCccchhhhhhHHHHHHhcCCCCC
Q 012762 282 VPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTHEYLAPEIISGEG---HGNAVDWWTLGIFIFELFYGTTPF 358 (457)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~---~~~~sDiwSlG~il~elltG~~Pf 358 (457)
.........+...++.+||..|+|||++.+.. |+.|+||||||+||+||+ +||
T Consensus 760 ---------------------~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~---yPF 815 (1351)
T KOG1035|consen 760 ---------------------FSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEML---YPF 815 (1351)
T ss_pred ---------------------ccccccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHh---ccC
Confidence 00000111122334668999999999998765 999999999999999999 467
Q ss_pred CCCChH-HHHHHHHhcccCCC---CCCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCC
Q 012762 359 KGIDHE-LTLANVVARALEFP---KEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFN 419 (457)
Q Consensus 359 ~~~~~~-~~~~~~~~~~~~~~---~~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~ 419 (457)
...-+. ..+.+...+.++.+ ..+.. +.-..+|+.||+.||.+||| |.|||++.||-
T Consensus 816 ~TsMERa~iL~~LR~g~iP~~~~f~~~~~-~~e~slI~~Ll~hdP~kRPt----A~eLL~s~llp 875 (1351)
T KOG1035|consen 816 GTSMERASILTNLRKGSIPEPADFFDPEH-PEEASLIRWLLSHDPSKRPT----ATELLNSELLP 875 (1351)
T ss_pred CchHHHHHHHHhcccCCCCCCcccccccc-hHHHHHHHHHhcCCCccCCC----HHHHhhccCCC
Confidence 654333 34455444444444 11222 23578999999999999999 99999999998
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=312.73 Aligned_cols=262 Identities=17% Similarity=0.186 Sum_probs=189.5
Q ss_pred ccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhH--------HHHHHHHHHHHHHcCCCCCce
Q 012762 79 LTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNK--------ESRARIEREILEMLDHPFLPT 150 (457)
Q Consensus 79 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~--------~~~~~~E~~il~~l~H~nIv~ 150 (457)
+...+|++.++||+|+||+||+|.+..... .+..+|+|+........... ......+...+..++|+||++
T Consensus 9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~-~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~ 87 (294)
T PHA02882 9 ITGKEWKIDKLIGCGGFGCVYETQCASDHC-INNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPK 87 (294)
T ss_pred cCCCceEEeeEEecCCCceEEEEEEcCCcc-cccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCc
Confidence 444689999999999999999999764211 25567778653322111000 011112233445568999999
Q ss_pred EEEEEEcCC----cEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCC
Q 012762 151 LYATLDCPR----WSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGH 226 (457)
Q Consensus 151 l~~~~~~~~----~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~ 226 (457)
+++++.... ..+++||++ ..++..++... ...++..++.++.||+.||.|||+++|+||||||+|||++.++.
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~ 164 (294)
T PHA02882 88 YYGCGSFKRCRMYYRFILLEKL-VENTKEIFKRI--KCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNR 164 (294)
T ss_pred EEEeeeEecCCceEEEEEEehh-ccCHHHHHHhh--ccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCc
Confidence 999765443 347889988 56777776653 44678889999999999999999999999999999999999999
Q ss_pred EEEeccCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcc
Q 012762 227 IMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEI 306 (457)
Q Consensus 227 vkl~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (457)
++|+|||+++...........
T Consensus 165 ~~l~DFGla~~~~~~~~~~~~----------------------------------------------------------- 185 (294)
T PHA02882 165 GYIIDYGIASHFIIHGKHIEY----------------------------------------------------------- 185 (294)
T ss_pred EEEEEcCCceeeccCCccccc-----------------------------------------------------------
Confidence 999999998655321110000
Q ss_pred cccCCccccccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHH-H--------HHHHHhcccCC
Q 012762 307 VAEPLDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHEL-T--------LANVVARALEF 377 (457)
Q Consensus 307 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~-~--------~~~~~~~~~~~ 377 (457)
.........||+.|+|||++.+..++.++|||||||++|||++|..||.+..... . ..++......
T Consensus 186 ----~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 260 (294)
T PHA02882 186 ----SKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKCDFIKRLHEGKIK- 260 (294)
T ss_pred ----ccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhHHHHHHHhhhhhhc-
Confidence 0000112359999999999999999999999999999999999999998763221 1 1222222222
Q ss_pred CCCCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhc
Q 012762 378 PKEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKR 414 (457)
Q Consensus 378 ~~~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~ 414 (457)
...++..+.++++.||..+|++||+ .++|++
T Consensus 261 --~~~~~~~~~~~~~~~~~~~~~~rp~----~~~l~~ 291 (294)
T PHA02882 261 --IKNANKFIYDFIECVTKLSYEEKPD----YDALIK 291 (294)
T ss_pred --cCCCCHHHHHHHHHHHhCCCCCCCC----HHHHHH
Confidence 2346788999999999999999999 888865
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-40 Score=307.86 Aligned_cols=233 Identities=31% Similarity=0.406 Sum_probs=189.3
Q ss_pred cCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcEEEEEeecCCCC
Q 012762 93 GDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWSCLLTEFCPGGD 172 (457)
Q Consensus 93 G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~~s 172 (457)
|.||.||+|+++ .+++.||+|++.+.. ....|...+....||||+++++++...+..|+||||++|++
T Consensus 4 g~~~~v~~~~~~----~~~~~~~~K~i~~~~--------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 71 (237)
T cd05576 4 GVIDKVLLVMDT----RTQQTFILKGLRKSS--------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGK 71 (237)
T ss_pred cccceEEEEEEc----cCCcEEEEEeecchh--------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCC
Confidence 889999999987 478899999997642 12234455555679999999999999999999999999999
Q ss_pred hHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCCCcccccccCCC
Q 012762 173 LHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQLVSDQS 252 (457)
Q Consensus 173 L~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~~~~~~~~~~~~ 252 (457)
|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.++++|||++.......
T Consensus 72 L~~~l~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~---------- 139 (237)
T cd05576 72 LWSHISKF--LNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC---------- 139 (237)
T ss_pred HHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhcccccc----------
Confidence 99888764 468999999999999999999999999999999999999999999999999764332110
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCCCCccCchhhcC
Q 012762 253 PPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTHEYLAPEIISG 332 (457)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~ 332 (457)
....++..|+|||++.+
T Consensus 140 ---------------------------------------------------------------~~~~~~~~y~aPE~~~~ 156 (237)
T cd05576 140 ---------------------------------------------------------------DGEAVENMYCAPEVGGI 156 (237)
T ss_pred ---------------------------------------------------------------ccCCcCccccCCcccCC
Confidence 01235678999999988
Q ss_pred CCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhhhCCCCCCCCC-cChHH
Q 012762 333 EGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDPTRRMGSK-MGATA 411 (457)
Q Consensus 333 ~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rps~~-~~~~~ 411 (457)
..++.++||||+||++|||++|+.||....... ........+..++..+.++|.+||+.||++|+++. ..+++
T Consensus 157 ~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~ 230 (237)
T cd05576 157 SEETEACDWWSLGAILFELLTGKTLVECHPSGI------NTHTTLNIPEWVSEEARSLLQQLLQFNPTERLGAGVAGVED 230 (237)
T ss_pred CCCCchhhHHHHHHHHHHHHHCcchhhcCchhc------ccccccCCcccCCHHHHHHHHHHccCCHHHhcCCCccchHH
Confidence 889999999999999999999999886533211 11111122234788999999999999999999943 23699
Q ss_pred HhcCCCC
Q 012762 412 IKRHQFF 418 (457)
Q Consensus 412 ll~hp~f 418 (457)
+++||||
T Consensus 231 ~~~h~~~ 237 (237)
T cd05576 231 IKSHPFF 237 (237)
T ss_pred HHcCCCC
Confidence 9999998
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=307.34 Aligned_cols=240 Identities=22% Similarity=0.262 Sum_probs=190.8
Q ss_pred EEecccCcceEEEEEEeccC------CCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcE
Q 012762 88 HRLGSGDIGSVYLVQLKSKS------SNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWS 161 (457)
Q Consensus 88 ~~LG~G~fg~Vy~a~~~~~~------~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~ 161 (457)
+.||+|+||.||+|.++... ......+++|++..... ....+.+|+++|+.++|+||+++++++.. ...
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 75 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR----DSLAFFETASLMSQLSHKHLVKLYGVCVR-DEN 75 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchh----hHHHHHHHHHHHHcCCCcchhheeeEEec-CCc
Confidence 46899999999999987432 11224678888764421 15677889999999999999999999988 778
Q ss_pred EEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCC-------CEEEeccCC
Q 012762 162 CLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDG-------HIMLTDFDL 234 (457)
Q Consensus 162 ~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~-------~vkl~DFG~ 234 (457)
++||||+.+++|..++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+
T Consensus 76 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~ 154 (259)
T cd05037 76 IMVEEYVKFGPLDVFLHREK-NNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI 154 (259)
T ss_pred EEEEEcCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCc
Confidence 99999999999999887753 2689999999999999999999999999999999999999887 799999999
Q ss_pred CcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccc
Q 012762 235 SLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVR 314 (457)
Q Consensus 235 s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (457)
+......
T Consensus 155 a~~~~~~------------------------------------------------------------------------- 161 (259)
T cd05037 155 PITVLSR------------------------------------------------------------------------- 161 (259)
T ss_pred ccccccc-------------------------------------------------------------------------
Confidence 7543210
Q ss_pred cccccCCCCccCchhhcCC--CCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHH
Q 012762 315 SMSFVGTHEYLAPEIISGE--GHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLI 391 (457)
Q Consensus 315 ~~~~~gt~~y~aPE~l~~~--~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll 391 (457)
....++..|+|||++.+. .++.++|||||||++|+|++ |..||............. .....+.. ....+.+++
T Consensus 162 -~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~-~~~~~~~~--~~~~~~~li 237 (259)
T cd05037 162 -EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ-DQHRLPMP--DCAELANLI 237 (259)
T ss_pred -cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh-cCCCCCCC--CchHHHHHH
Confidence 012467789999999877 68999999999999999999 688887764333222222 22222221 237899999
Q ss_pred HHHhhhCCCCCCCCCcChHHHhc
Q 012762 392 AQLLVKDPTRRMGSKMGATAIKR 414 (457)
Q Consensus 392 ~~~L~~dP~~Rps~~~~~~~ll~ 414 (457)
.+||..||.+||+ +.++++
T Consensus 238 ~~~l~~~p~~Rpt----~~~il~ 256 (259)
T cd05037 238 NQCWTYDPTKRPS----FRAILR 256 (259)
T ss_pred HHHhccChhhCCC----HHHHHH
Confidence 9999999999999 888875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=325.40 Aligned_cols=257 Identities=22% Similarity=0.312 Sum_probs=227.5
Q ss_pred CCCCCccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEE
Q 012762 74 NNNNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYA 153 (457)
Q Consensus 74 ~~~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~ 153 (457)
...|++...+..+.++||-|.||.||.|.|+. -...||||.++.. .....+|..|..+|+.++|||+|+++|
T Consensus 259 ~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKk----yslTvAVKtLKED----tMeveEFLkEAAvMKeikHpNLVqLLG 330 (1157)
T KOG4278|consen 259 ADKWEMERTDITMKHKLGGGQYGEVYEGVWKK----YSLTVAVKTLKED----TMEVEEFLKEAAVMKEIKHPNLVQLLG 330 (1157)
T ss_pred cchhhccchheeeeeccCCCcccceeeeeeec----cceeeehhhhhhc----chhHHHHHHHHHHHHhhcCccHHHHhh
Confidence 46788888899999999999999999999984 6678999999654 346788999999999999999999999
Q ss_pred EEEcCCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccC
Q 012762 154 TLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFD 233 (457)
Q Consensus 154 ~~~~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG 233 (457)
+|..+...|||+|||..|+|.+++.++....++.-..+.++.||..|++||..+++|||||...|+|+.++..||++|||
T Consensus 331 VCT~EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFG 410 (1157)
T KOG4278|consen 331 VCTHEPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFG 410 (1157)
T ss_pred hhccCCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccc
Confidence 99999999999999999999999999877778888888999999999999999999999999999999999999999999
Q ss_pred CCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcc
Q 012762 234 LSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDV 313 (457)
Q Consensus 234 ~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (457)
+++.+...+.++...
T Consensus 411 LsRlMtgDTYTAHAG----------------------------------------------------------------- 425 (1157)
T KOG4278|consen 411 LSRLMTGDTYTAHAG----------------------------------------------------------------- 425 (1157)
T ss_pred hhhhhcCCceecccC-----------------------------------------------------------------
Confidence 999987665543210
Q ss_pred ccccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHH
Q 012762 314 RSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIA 392 (457)
Q Consensus 314 ~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~ 392 (457)
---...|.|||.+..+.++.++|||+|||+|||+.| |-.||.+.+..+.+ ..+...+++..+..||+.+.+||+
T Consensus 426 ----AKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY-~LLEkgyRM~~PeGCPpkVYeLMr 500 (1157)
T KOG4278|consen 426 ----AKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY-GLLEKGYRMDGPEGCPPKVYELMR 500 (1157)
T ss_pred ----ccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHH-HHHhccccccCCCCCCHHHHHHHH
Confidence 002567999999999999999999999999999996 88999997766554 467788899888899999999999
Q ss_pred HHhhhCCCCCCCCCcChHHH
Q 012762 393 QLLVKDPTRRMGSKMGATAI 412 (457)
Q Consensus 393 ~~L~~dP~~Rps~~~~~~~l 412 (457)
.||+++|.+||+ +.|+
T Consensus 501 aCW~WsPsDRPs----Faei 516 (1157)
T KOG4278|consen 501 ACWNWSPSDRPS----FAEI 516 (1157)
T ss_pred HHhcCCcccCcc----HHHH
Confidence 999999999999 5555
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-41 Score=325.04 Aligned_cols=257 Identities=26% Similarity=0.409 Sum_probs=216.4
Q ss_pred ccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcC------CCCCceEE
Q 012762 79 LTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLD------HPFLPTLY 152 (457)
Q Consensus 79 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~------H~nIv~l~ 152 (457)
+.-.+|.+..-.|+|-|++|..|.+.. .|..||||+|....+ ..+.-+.|++||++|+ ..|+++++
T Consensus 429 ~LD~RY~V~~~~GkGvFs~Vvra~D~~----r~~~vAiKIIRnNE~----M~KtGl~EleiLkKL~~AD~Edk~Hclrl~ 500 (752)
T KOG0670|consen 429 LLDSRYEVQGYTGKGVFSTVVRARDQA----RGQEVAIKIIRNNEV----MHKTGLKELEILKKLNDADPEDKFHCLRLF 500 (752)
T ss_pred hhcceeEEEeccccceeeeeeeccccC----CCCeeEEEEeecchH----HhhhhhHHHHHHHHhhccCchhhhHHHHHH
Confidence 334678999999999999999998764 667999999987654 4555667999999994 46799999
Q ss_pred EEEEcCCcEEEEEeecCCCChHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccC-CCEEEe
Q 012762 153 ATLDCPRWSCLLTEFCPGGDLHVLRQRQ-PDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSD-GHIMLT 230 (457)
Q Consensus 153 ~~~~~~~~~~lV~E~~~~~sL~~~~~~~-~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~-~~vkl~ 230 (457)
..|...+++|||+|-+ ..+|.++++.. .+-++....++.|+.||..||..|-.+||+|.||||+||||++. ..+|||
T Consensus 501 r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLC 579 (752)
T KOG0670|consen 501 RHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLC 579 (752)
T ss_pred HHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeec
Confidence 9999999999999999 89999888764 34579999999999999999999999999999999999999976 578999
Q ss_pred ccCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccC
Q 012762 231 DFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEP 310 (457)
Q Consensus 231 DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (457)
|||.|-.......+
T Consensus 580 DfGSA~~~~eneit------------------------------------------------------------------ 593 (752)
T KOG0670|consen 580 DFGSASFASENEIT------------------------------------------------------------------ 593 (752)
T ss_pred cCcccccccccccc------------------------------------------------------------------
Confidence 99987544332221
Q ss_pred CccccccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCC----------
Q 012762 311 LDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKE---------- 380 (457)
Q Consensus 311 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~---------- 380 (457)
.+.-+.-|.|||++.|.+|+...|+||+||+||||+||+..|+|.++.+++...+.....+|..
T Consensus 594 ------PYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~dq 667 (752)
T KOG0670|consen 594 ------PYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQ 667 (752)
T ss_pred ------HHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchhhh
Confidence 1234567999999999999999999999999999999999999999999888877766666541
Q ss_pred -----------------------------------------CCCC-------hHHHHHHHHHhhhCCCCCCCCCcChHHH
Q 012762 381 -----------------------------------------PSVP-------GPAKDLIAQLLVKDPTRRMGSKMGATAI 412 (457)
Q Consensus 381 -----------------------------------------~~~~-------~~~~~ll~~~L~~dP~~Rps~~~~~~~l 412 (457)
+.++ ..+.+||.+||..||++|.+ +.|+
T Consensus 668 HFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit----~nqA 743 (752)
T KOG0670|consen 668 HFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRIT----VNQA 743 (752)
T ss_pred hcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCC----HHHH
Confidence 0011 14789999999999999999 9999
Q ss_pred hcCCCCCC
Q 012762 413 KRHQFFNG 420 (457)
Q Consensus 413 l~hp~f~~ 420 (457)
|+||||..
T Consensus 744 L~HpFi~~ 751 (752)
T KOG0670|consen 744 LKHPFITE 751 (752)
T ss_pred hcCCcccC
Confidence 99999974
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=308.89 Aligned_cols=255 Identities=25% Similarity=0.374 Sum_probs=207.1
Q ss_pred CceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhh-------hhhhHHHHHHHHHHHHHH-cCCCCCceEEEE
Q 012762 83 DLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKREL-------VSRNKESRARIEREILEM-LDHPFLPTLYAT 154 (457)
Q Consensus 83 ~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~-------~~~~~~~~~~~E~~il~~-l~H~nIv~l~~~ 154 (457)
+|++.+.||+|+||.||+|.++. ..++.+|+|.+..... ........+..|+.++.+ ++|+||++++++
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~---~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~ 77 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKN---NGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKT 77 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcC---CCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEee
Confidence 47889999999999999999863 2567899998864321 122234456678887765 799999999999
Q ss_pred EEcCCcEEEEEeecCCCChHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHH-cCceeecCCCCCeEEccCCCEEEec
Q 012762 155 LDCPRWSCLLTEFCPGGDLHVLRQRQ--PDKRFHESAVRFYASEVVVALEFLHM-MGIIYRDLKPENVLVRSDGHIMLTD 231 (457)
Q Consensus 155 ~~~~~~~~lV~E~~~~~sL~~~~~~~--~~~~~~~~~~~~i~~qi~~~L~yLH~-~~iiHrDIKp~NIll~~~~~vkl~D 231 (457)
+..++..|+||||+++++|.+++... ....+++..++.++.|++.||.|||+ .+++|+||+|+|||++.++.++|+|
T Consensus 78 ~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 78 FLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred EccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEec
Confidence 99999999999999999998887542 23568999999999999999999996 7899999999999999999999999
Q ss_pred cCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCC
Q 012762 232 FDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPL 311 (457)
Q Consensus 232 FG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (457)
||++.......
T Consensus 158 fg~~~~~~~~~--------------------------------------------------------------------- 168 (269)
T cd08528 158 FGLAKQKQPES--------------------------------------------------------------------- 168 (269)
T ss_pred ccceeeccccc---------------------------------------------------------------------
Confidence 99975432110
Q ss_pred ccccccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHH
Q 012762 312 DVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLI 391 (457)
Q Consensus 312 ~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll 391 (457)
......|+..|++||++.+..++.++||||||+++|+|++|+.||...........+............++..+.+++
T Consensus 169 --~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 246 (269)
T cd08528 169 --KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGMYSEDVTDVI 246 (269)
T ss_pred --ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCCcccCCHHHHHHH
Confidence 011235889999999999888999999999999999999999999877666666666555544333335788999999
Q ss_pred HHHhhhCCCCCCCCCcChHHHhcC
Q 012762 392 AQLLVKDPTRRMGSKMGATAIKRH 415 (457)
Q Consensus 392 ~~~L~~dP~~Rps~~~~~~~ll~h 415 (457)
.+||+.||++||+ +.|+..+
T Consensus 247 ~~cl~~~p~~Rp~----~~e~~~~ 266 (269)
T cd08528 247 TSCLTPDAEARPD----IIQVSAM 266 (269)
T ss_pred HHHCCCCCccCCC----HHHHHHH
Confidence 9999999999999 7777543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=304.97 Aligned_cols=266 Identities=24% Similarity=0.356 Sum_probs=214.6
Q ss_pred CCCCCCccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHH-cCCCCCceE
Q 012762 73 NNNNNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEM-LDHPFLPTL 151 (457)
Q Consensus 73 ~~~~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~-l~H~nIv~l 151 (457)
....+.+..++.+-+..||.|+||+|++-.++ ..|+..|||.++.... .....+++.|.+...+ -+.||||++
T Consensus 55 ~~~~~~F~~~~Lqdlg~iG~G~fG~V~KM~hk----~sg~~mAVKrIr~~n~--~keq~rll~e~d~~mks~~cp~IVkf 128 (361)
T KOG1006|consen 55 DAHLHTFTSDNLQDLGEIGNGAFGTVNKMLHK----PSGKLMAVKRIRSNNI--EKEQKRLLMEHDTVMKSSNCPNIVKF 128 (361)
T ss_pred cccccccccchHHHHHHhcCCcchhhhhhhcC----ccCcEEEEEEeeeccc--hHHHHHHHHHHHHHHhhcCCcHHHHH
Confidence 34456778888999999999999999987776 6899999999977644 4456777788886544 589999999
Q ss_pred EEEEEcCCcEEEEEeecCCCChHHHHHh---CCCCCCCHHHHHHHHHHHHHHHHHHH-HcCceeecCCCCCeEEccCCCE
Q 012762 152 YATLDCPRWSCLLTEFCPGGDLHVLRQR---QPDKRFHESAVRFYASEVVVALEFLH-MMGIIYRDLKPENVLVRSDGHI 227 (457)
Q Consensus 152 ~~~~~~~~~~~lV~E~~~~~sL~~~~~~---~~~~~~~~~~~~~i~~qi~~~L~yLH-~~~iiHrDIKp~NIll~~~~~v 227 (457)
||+.-.++..+|.||+| ..+|..+-++ -....++|..+-.+..-.+.||.||- ..+||||||||+||||+..|.|
T Consensus 129 yGa~F~EGdcWiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~v 207 (361)
T KOG1006|consen 129 YGALFSEGDCWICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDV 207 (361)
T ss_pred hhhhhcCCceeeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCE
Confidence 99998889999999999 7788654433 23467999999999999999999999 4689999999999999999999
Q ss_pred EEeccCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCccc
Q 012762 228 MLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIV 307 (457)
Q Consensus 228 kl~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (457)
||||||++..+.++-...
T Consensus 208 KLCDFGIcGqLv~SiAkT-------------------------------------------------------------- 225 (361)
T KOG1006|consen 208 KLCDFGICGQLVDSIAKT-------------------------------------------------------------- 225 (361)
T ss_pred eeecccchHhHHHHHHhh--------------------------------------------------------------
Confidence 999999976554321100
Q ss_pred ccCCccccccccCCCCccCchhhcC--CCCCccchhhhhhHHHHHHhcCCCCCCCCChH-HHHHHHHhcccCCCC----C
Q 012762 308 AEPLDVRSMSFVGTHEYLAPEIISG--EGHGNAVDWWTLGIFIFELFYGTTPFKGIDHE-LTLANVVARALEFPK----E 380 (457)
Q Consensus 308 ~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~-~~~~~~~~~~~~~~~----~ 380 (457)
.-+|...|||||.+.. .+|+.++||||||++|||+.||..||.+.+.. +.+..++.+..+.-. .
T Consensus 226 ---------~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~ 296 (361)
T KOG1006|consen 226 ---------VDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKEC 296 (361)
T ss_pred ---------hccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCcccc
Confidence 1158999999999964 35899999999999999999999999987653 334444444332211 1
Q ss_pred CCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCC
Q 012762 381 PSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNG 420 (457)
Q Consensus 381 ~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~ 420 (457)
...+..++.+|..||..|-++||. ..+|+++||++-
T Consensus 297 ~~~s~~~~~fintCl~Kd~~~Rpk----y~~Lk~~~fyr~ 332 (361)
T KOG1006|consen 297 VHYSFSMVRFINTCLIKDRSDRPK----YDDLKKFPFYRM 332 (361)
T ss_pred cccCHHHHHHHHHHhhcccccCcc----hhhhhcCchhhh
Confidence 346788999999999999999999 999999999975
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-39 Score=306.37 Aligned_cols=249 Identities=17% Similarity=0.267 Sum_probs=191.6
Q ss_pred EecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcEEEEEeec
Q 012762 89 RLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWSCLLTEFC 168 (457)
Q Consensus 89 ~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lV~E~~ 168 (457)
+||+|+||+||+|.+... .....+++|.+.... .......+.+|+++++.++||||+++++.+......|+||||+
T Consensus 2 ~lg~G~~g~v~~~~~~~~--~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 77 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTD--TGVARVVVKELKANA--SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYC 77 (268)
T ss_pred cCCCCcCceEEEEEEEcC--CCcceEEEEEecCCC--ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecC
Confidence 689999999999976421 123456777765432 1234567888999999999999999999999999999999999
Q ss_pred CCCChHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCCCcccc
Q 012762 169 PGGDLHVLRQRQP--DKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQ 246 (457)
Q Consensus 169 ~~~sL~~~~~~~~--~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~~~~~~ 246 (457)
++++|..++.... ...+++..++.++.||+.||+|||+.+++||||||+|||++.++.++|+|||++........
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~--- 154 (268)
T cd05086 78 ELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDY--- 154 (268)
T ss_pred CCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchh---
Confidence 9999998887642 23467778889999999999999999999999999999999999999999998643211000
Q ss_pred cccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCCCCccC
Q 012762 247 LVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTHEYLA 326 (457)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 326 (457)
........|+..|+|
T Consensus 155 -----------------------------------------------------------------~~~~~~~~~~~~y~a 169 (268)
T cd05086 155 -----------------------------------------------------------------IETEDDKCVPLRWLA 169 (268)
T ss_pred -----------------------------------------------------------------hhcccCCcCcccccC
Confidence 000012358889999
Q ss_pred chhhcC-------CCCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHHhccc-CCC---CCCCCChHHHHHHHHH
Q 012762 327 PEIISG-------EGHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVVARAL-EFP---KEPSVPGPAKDLIAQL 394 (457)
Q Consensus 327 PE~l~~-------~~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~-~~~---~~~~~~~~~~~ll~~~ 394 (457)
||++.. ..++.++|||||||++|||++ |..||........+..++.... ..+ ....+++.+.+++..|
T Consensus 170 PE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c 249 (268)
T cd05086 170 PELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPYSERWYEVLQFC 249 (268)
T ss_pred chhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCCcHHHHHHHHHH
Confidence 999853 235779999999999999996 6789987776666665544322 111 1234678899999999
Q ss_pred hhhCCCCCCCCCcChHHHhc
Q 012762 395 LVKDPTRRMGSKMGATAIKR 414 (457)
Q Consensus 395 L~~dP~~Rps~~~~~~~ll~ 414 (457)
| .+|++||+ +++|++
T Consensus 250 ~-~~P~~Rp~----~~~i~~ 264 (268)
T cd05086 250 W-LSPEKRAT----AEEVHR 264 (268)
T ss_pred h-hCcccCCC----HHHHHH
Confidence 9 68999999 888865
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=304.37 Aligned_cols=263 Identities=27% Similarity=0.361 Sum_probs=207.4
Q ss_pred CCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEc---
Q 012762 81 LSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDC--- 157 (457)
Q Consensus 81 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~--- 157 (457)
.+.|.-+.+||+|.||.||+|+.+ ++|+.||+|++-.... ....-....+|++||..|+|+|++.++..|..
T Consensus 16 ~~~yek~~kigqGtfgeVFkAr~~----n~~kkvalkkvlmene-KeGfpitalreikiL~~lkHenv~nliEic~tk~T 90 (376)
T KOG0669|consen 16 VSKYEKLAKIGQGTFGEVFKARSK----NTGKKVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKAT 90 (376)
T ss_pred chHHHHHHhcCCchHHHHHHHhhc----CccchhHHHHHHHhcc-ccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccC
Confidence 356777889999999999998876 5788899887643211 11223445679999999999999999887643
Q ss_pred -----CCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEecc
Q 012762 158 -----PRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDF 232 (457)
Q Consensus 158 -----~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DF 232 (457)
...+||||.+| ..+|..++... .-+++..++..++.+++.||.|+|...|+|||+|++|+||+.+|.+||+||
T Consensus 91 p~~r~r~t~ylVf~~c-ehDLaGlLsn~-~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADF 168 (376)
T KOG0669|consen 91 PTNRDRATFYLVFDFC-EHDLAGLLSNR-KVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADF 168 (376)
T ss_pred CcccccceeeeeHHHh-hhhHHHHhcCc-cccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeecc
Confidence 23479999999 66888777653 367999999999999999999999999999999999999999999999999
Q ss_pred CCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCc
Q 012762 233 DLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLD 312 (457)
Q Consensus 233 G~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (457)
|+++.+..+.... .
T Consensus 169 Glar~fs~~~n~~------------------------------------------------------------------k 182 (376)
T KOG0669|consen 169 GLARAFSTSKNVV------------------------------------------------------------------K 182 (376)
T ss_pred ccccceecccccC------------------------------------------------------------------C
Confidence 9987665332211 1
Q ss_pred cccccccCCCCccCchhhcCCC-CCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCC--CCCCC-------
Q 012762 313 VRSMSFVGTHEYLAPEIISGEG-HGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEF--PKEPS------- 382 (457)
Q Consensus 313 ~~~~~~~gt~~y~aPE~l~~~~-~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~--~~~~~------- 382 (457)
.+.+..+-|..|++||.+.|.. |+.+.|||..|||+.||++|.+.|.+.++...+..|..-...+ ..+++
T Consensus 183 prytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~~d~lpL~ 262 (376)
T KOG0669|consen 183 PRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNVDNLPLY 262 (376)
T ss_pred CCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCCcccchHH
Confidence 1223446799999999999875 8999999999999999999999999988776655544321111 11111
Q ss_pred ------------------------CChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCC
Q 012762 383 ------------------------VPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNG 420 (457)
Q Consensus 383 ------------------------~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~ 420 (457)
-.+++.+|+.+||..||.+|+. ++++|+|.||..
T Consensus 263 ~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~----ad~alnh~~F~k 320 (376)
T KOG0669|consen 263 QSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRID----ADQALNHDFFWK 320 (376)
T ss_pred HhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcc----hHhhhchhhhhc
Confidence 1236889999999999999999 999999999975
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=307.78 Aligned_cols=257 Identities=20% Similarity=0.294 Sum_probs=202.5
Q ss_pred ceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCC----
Q 012762 84 LRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPR---- 159 (457)
Q Consensus 84 ~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~---- 159 (457)
|++.+.||+|+||.||+|.++.. ..+++.||+|++.... ......+.+.+|+++|+.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~-~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 78 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSE-DGSFQKVAVKMLKADI-FSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGR 78 (273)
T ss_pred CcchhcccCCCCCCEEeeEeecc-CCCceEEEEEEecccc-CChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCc
Confidence 56788999999999999987642 2367899999986543 22334566788999999999999999999886532
Q ss_pred --cEEEEEeecCCCChHHHHHhCC----CCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccC
Q 012762 160 --WSCLLTEFCPGGDLHVLRQRQP----DKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFD 233 (457)
Q Consensus 160 --~~~lV~E~~~~~sL~~~~~~~~----~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG 233 (457)
..++++||+.+++|..++.... ...++...++.++.||+.||+|||+.||+||||||+||+++.++.+||+|||
T Consensus 79 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg 158 (273)
T cd05074 79 LPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFG 158 (273)
T ss_pred ccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECccc
Confidence 2478999999999987764321 2357889999999999999999999999999999999999999999999999
Q ss_pred CCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcc
Q 012762 234 LSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDV 313 (457)
Q Consensus 234 ~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (457)
+++.........
T Consensus 159 ~~~~~~~~~~~~-------------------------------------------------------------------- 170 (273)
T cd05074 159 LSKKIYSGDYYR-------------------------------------------------------------------- 170 (273)
T ss_pred ccccccCCccee--------------------------------------------------------------------
Confidence 876442111000
Q ss_pred ccccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHH
Q 012762 314 RSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIA 392 (457)
Q Consensus 314 ~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~ 392 (457)
......++..|++||.+.+..++.++|||||||++|||++ |+.||.+.........+.... ........+..+.+++.
T Consensus 171 ~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~ 249 (273)
T cd05074 171 QGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGN-RLKQPPDCLEDVYELMC 249 (273)
T ss_pred cCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCC-cCCCCCCCCHHHHHHHH
Confidence 0001235678999999998889999999999999999998 999998876665555544332 23333457789999999
Q ss_pred HHhhhCCCCCCCCCcChHHHhcC
Q 012762 393 QLLVKDPTRRMGSKMGATAIKRH 415 (457)
Q Consensus 393 ~~L~~dP~~Rps~~~~~~~ll~h 415 (457)
+||..+|++||+ +.+++++
T Consensus 250 ~~l~~~p~~Rps----~~~~~~~ 268 (273)
T cd05074 250 QCWSPEPKCRPS----FQHLRDQ 268 (273)
T ss_pred HHcCCChhhCcC----HHHHHHH
Confidence 999999999999 8887653
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=330.59 Aligned_cols=260 Identities=26% Similarity=0.424 Sum_probs=218.9
Q ss_pred ccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHc-CCCCCceEEEEEEc
Q 012762 79 LTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEML-DHPFLPTLYATLDC 157 (457)
Q Consensus 79 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~~~~~~ 157 (457)
...+-|.+.++||.|.+|.||++..+ ++++.+|+|++... .+..++++.|.+||+.+ +|||++.++++|..
T Consensus 16 dp~d~~ei~evig~Gtygkv~k~k~~----~~~~~aa~kI~~~~----~d~deEiE~eynil~~~~~hpnv~~fyg~~~k 87 (953)
T KOG0587|consen 16 DPADIFEIIEVIGNGTYGKVYKGRHV----KTGQLAAIKIMDPT----EDEEEEIELEYNMLKKYSHHPNVATFYGAFIK 87 (953)
T ss_pred CCCCccEEEEEEeeccceeEEEEeee----ecCceeeeEeecCC----ccccHHHHHHHHHHHhccCCCCcceEEEEEEE
Confidence 34456999999999999999999877 58889999998654 24556677789999887 79999999999853
Q ss_pred -----CCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEecc
Q 012762 158 -----PRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDF 232 (457)
Q Consensus 158 -----~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DF 232 (457)
++.++||||||.||+..++++...+.++.|..+.-|++.++.||.+||.+.+||||||-.|||++.+|.|||+||
T Consensus 88 ~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDF 167 (953)
T KOG0587|consen 88 KDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDF 167 (953)
T ss_pred ecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeee
Confidence 467999999999999999999988889999999999999999999999999999999999999999999999999
Q ss_pred CCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCc
Q 012762 233 DLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLD 312 (457)
Q Consensus 233 G~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (457)
|.+..+.. ..
T Consensus 168 GvSaQlds----------------------------------------------------------------------T~ 177 (953)
T KOG0587|consen 168 GVSAQLDS----------------------------------------------------------------------TV 177 (953)
T ss_pred eeeeeeec----------------------------------------------------------------------cc
Confidence 99755431 12
Q ss_pred cccccccCCCCccCchhhcCC-----CCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhc-ccCCCCCCCCChH
Q 012762 313 VRSMSFVGTHEYLAPEIISGE-----GHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVAR-ALEFPKEPSVPGP 386 (457)
Q Consensus 313 ~~~~~~~gt~~y~aPE~l~~~-----~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 386 (457)
.+..+++||+.|||||++... .|+.++|+||||++..||.-|.+|+-++.....+..|... ...+..+..++..
T Consensus 178 grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPPkLkrp~kWs~~ 257 (953)
T KOG0587|consen 178 GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKRPKKWSKK 257 (953)
T ss_pred ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCccccchhhHHHH
Confidence 334577899999999999754 3788999999999999999999999887655444433222 1122234567889
Q ss_pred HHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCC
Q 012762 387 AKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNG 420 (457)
Q Consensus 387 ~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~ 420 (457)
+.++|..||..|-++||+ ..++|+|||.+.
T Consensus 258 FndFIs~cL~Kd~e~RP~----~~~ll~hpFi~e 287 (953)
T KOG0587|consen 258 FNDFISTCLVKDYEQRPS----TEELLKHPFITE 287 (953)
T ss_pred HHHHHHHHHhhccccCcc----hhhhccCCcccc
Confidence 999999999999999999 999999999974
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-40 Score=312.14 Aligned_cols=277 Identities=27% Similarity=0.401 Sum_probs=223.1
Q ss_pred CCCCCCCCccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhh----hhhHHHHHHHHHHHHHHcCCC
Q 012762 71 NNNNNNNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELV----SRNKESRARIEREILEMLDHP 146 (457)
Q Consensus 71 ~~~~~~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~----~~~~~~~~~~E~~il~~l~H~ 146 (457)
.......+...++|-++..||.|+|+.||+|.+. ..++.||||+-...+.. ..+..+...+|.+|-+.|+||
T Consensus 452 nSQFkDHptLn~RYLlLhLLGrGGFSEVyKAFDl----~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHp 527 (775)
T KOG1151|consen 452 NSQFKDHPTLNDRYLLLHLLGRGGFSEVYKAFDL----TEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHP 527 (775)
T ss_pred hhhhccCcchHHHHHHHHHhccccHHHHHHhccc----chhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcc
Confidence 3444555666688999999999999999988765 57889999986543322 223346677899999999999
Q ss_pred CCceEEEEEE-cCCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcC--ceeecCCCCCeEEcc
Q 012762 147 FLPTLYATLD-CPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMG--IIYRDLKPENVLVRS 223 (457)
Q Consensus 147 nIv~l~~~~~-~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~--iiHrDIKp~NIll~~ 223 (457)
.||++|++|. +.+..|-|+|||+|.+|.-+++.+ +.+++.+++.|+-||+.||.||.+.. |||=||||.||||-.
T Consensus 528 RIVKlYDyfslDtdsFCTVLEYceGNDLDFYLKQh--klmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~ 605 (775)
T KOG1151|consen 528 RIVKLYDYFSLDTDSFCTVLEYCEGNDLDFYLKQH--KLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVN 605 (775)
T ss_pred eeeeeeeeeeeccccceeeeeecCCCchhHHHHhh--hhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEec
Confidence 9999999995 456789999999999999888886 77999999999999999999999774 999999999999953
Q ss_pred ---CCCEEEeccCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCC
Q 012762 224 ---DGHIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGN 300 (457)
Q Consensus 224 ---~~~vkl~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (457)
.|.+||+|||+++.+++........
T Consensus 606 GtacGeIKITDFGLSKIMdddSy~~vdG---------------------------------------------------- 633 (775)
T KOG1151|consen 606 GTACGEIKITDFGLSKIMDDDSYNSVDG---------------------------------------------------- 633 (775)
T ss_pred CcccceeEeeecchhhhccCCccCcccc----------------------------------------------------
Confidence 4789999999999887543221100
Q ss_pred CCCCcccccCCccccccccCCCCccCchhhcCC----CCCccchhhhhhHHHHHHhcCCCCCCCCChHH-HHHH---HHh
Q 012762 301 PGTPEIVAEPLDVRSMSFVGTHEYLAPEIISGE----GHGNAVDWWTLGIFIFELFYGTTPFKGIDHEL-TLAN---VVA 372 (457)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~----~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~-~~~~---~~~ 372 (457)
-.-+....||.+|++||++.-. ..+.++||||+|||+|..++|+.||...-... ++.. +..
T Consensus 634 -----------meLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIlkA 702 (775)
T KOG1151|consen 634 -----------MELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTILKA 702 (775)
T ss_pred -----------eeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchhcc
Confidence 0011234699999999998532 26889999999999999999999997643332 2211 224
Q ss_pred cccCCCCCCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCC
Q 012762 373 RALEFPKEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNG 420 (457)
Q Consensus 373 ~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~ 420 (457)
....||..+.++.+++++|++||++--++|.. +.+|-.||||..
T Consensus 703 tEVqFP~KPvVsseAkaFIRRCLaYRKeDR~D----V~qLA~dpyllP 746 (775)
T KOG1151|consen 703 TEVQFPPKPVVSSEAKAFIRRCLAYRKEDRID----VQQLACDPYLLP 746 (775)
T ss_pred eeccCCCCCccCHHHHHHHHHHHHhhhhhhhh----HHHHccCccccc
Confidence 57788888899999999999999999999999 999999999986
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=328.26 Aligned_cols=268 Identities=17% Similarity=0.208 Sum_probs=182.0
Q ss_pred CCccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEE--
Q 012762 77 NPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYAT-- 154 (457)
Q Consensus 77 ~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~-- 154 (457)
..+..++|.+.++||+|+||+||+|++.......+..||+|.+..... ......| .++...+.+++.++..
T Consensus 127 ~~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~-----~e~~~~e--~l~~~~~~~~~~~~~~~~ 199 (566)
T PLN03225 127 PSFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA-----VEIWMNE--RVRRACPNSCADFVYGFL 199 (566)
T ss_pred CCCccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch-----hHHHHHH--HHHhhchhhHHHHHHhhh
Confidence 445678999999999999999999998742222378999998754311 1111111 1222223333322221
Q ss_pred ----EEcCCcEEEEEeecCCCChHHHHHhCCCC------------------CCCHHHHHHHHHHHHHHHHHHHHcCceee
Q 012762 155 ----LDCPRWSCLLTEFCPGGDLHVLRQRQPDK------------------RFHESAVRFYASEVVVALEFLHMMGIIYR 212 (457)
Q Consensus 155 ----~~~~~~~~lV~E~~~~~sL~~~~~~~~~~------------------~~~~~~~~~i~~qi~~~L~yLH~~~iiHr 212 (457)
...+..++|||||+.+++|.+++...... ...+..+..++.||+.||.|||++||+||
T Consensus 200 ~~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHR 279 (566)
T PLN03225 200 EPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHR 279 (566)
T ss_pred cccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeC
Confidence 24556789999999999999888753211 11234567899999999999999999999
Q ss_pred cCCCCCeEEcc-CCCEEEeccCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcc
Q 012762 213 DLKPENVLVRS-DGHIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPK 291 (457)
Q Consensus 213 DIKp~NIll~~-~~~vkl~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (457)
||||+|||++. ++.+||+|||+++.......
T Consensus 280 DLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~------------------------------------------------ 311 (566)
T PLN03225 280 DVKPQNIIFSEGSGSFKIIDLGAAADLRVGIN------------------------------------------------ 311 (566)
T ss_pred cCCHHHEEEeCCCCcEEEEeCCCccccccccc------------------------------------------------
Confidence 99999999986 57999999999864421110
Q ss_pred hhccccCCCCCCCcccccCCccccccccCCCCccCchhhcCC----------------------CCCccchhhhhhHHHH
Q 012762 292 RRRKKKLGNPGTPEIVAEPLDVRSMSFVGTHEYLAPEIISGE----------------------GHGNAVDWWTLGIFIF 349 (457)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~----------------------~~~~~sDiwSlG~il~ 349 (457)
.....++||+.|||||.+... .++.++|||||||+||
T Consensus 312 ---------------------~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL~ 370 (566)
T PLN03225 312 ---------------------YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFL 370 (566)
T ss_pred ---------------------cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHHHHHH
Confidence 001134689999999976432 2345679999999999
Q ss_pred HHhcCCCCCCCCChHHHHHHHHhc-ccCC--------C-C----------CCCCChHHHHHHHHHhhhCCCCCCCCCcCh
Q 012762 350 ELFYGTTPFKGIDHELTLANVVAR-ALEF--------P-K----------EPSVPGPAKDLIAQLLVKDPTRRMGSKMGA 409 (457)
Q Consensus 350 elltG~~Pf~~~~~~~~~~~~~~~-~~~~--------~-~----------~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~ 409 (457)
||+++..++.. ....+..++.. ...+ + . ........++||.+||+.||++||+ +
T Consensus 371 el~~~~~~~~~--~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~t----a 444 (566)
T PLN03225 371 QMAFPNLRSDS--NLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRIS----A 444 (566)
T ss_pred HHHhCcCCCch--HHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccCCC----H
Confidence 99997776543 22122211111 1000 0 0 0011234568999999999999999 9
Q ss_pred HHHhcCCCCCCCCchhh
Q 012762 410 TAIKRHQFFNGVNWALL 426 (457)
Q Consensus 410 ~~ll~hp~f~~~~~~~~ 426 (457)
.++|+||||+..++..+
T Consensus 445 ~e~L~Hpff~~~~~~~~ 461 (566)
T PLN03225 445 KAALAHPYFDREGLLGL 461 (566)
T ss_pred HHHhCCcCcCCCCcccc
Confidence 99999999999888644
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=324.11 Aligned_cols=243 Identities=30% Similarity=0.473 Sum_probs=193.7
Q ss_pred ceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCC----
Q 012762 84 LRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPR---- 159 (457)
Q Consensus 84 ~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~---- 159 (457)
+...+.||+|+||.||+++++ .+|+.||||.+++.. .....++..+|++||++|+|+|||+++++-+...
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnk----etG~~vAvK~~~~~~--~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~ 88 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNK----ETGRLVAVKTFNKES--SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLV 88 (732)
T ss_pred eeehhhhcCCccceeeeeccc----ccccchhHHhhhhhc--ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcc
Confidence 555678999999999999876 599999999997753 3456678888999999999999999999865443
Q ss_pred --cEEEEEeecCCCChHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEc--cCC--CEEEecc
Q 012762 160 --WSCLLTEFCPGGDLHVLRQRQ-PDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVR--SDG--HIMLTDF 232 (457)
Q Consensus 160 --~~~lV~E~~~~~sL~~~~~~~-~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~--~~~--~vkl~DF 232 (457)
.-.+|||||.||+|+..+.+- +..++++.+++.++..++.||.|||++|||||||||.||++- .+| .-||+||
T Consensus 89 ~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDf 168 (732)
T KOG4250|consen 89 TRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDF 168 (732)
T ss_pred cccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecc
Confidence 457999999999999888763 346899999999999999999999999999999999999985 334 4699999
Q ss_pred CCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCc
Q 012762 233 DLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLD 312 (457)
Q Consensus 233 G~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (457)
|.|+..++..
T Consensus 169 G~Arel~d~s---------------------------------------------------------------------- 178 (732)
T KOG4250|consen 169 GAARELDDNS---------------------------------------------------------------------- 178 (732)
T ss_pred cccccCCCCC----------------------------------------------------------------------
Confidence 9998776432
Q ss_pred cccccccCCCCccCchhhcC-CCCCccchhhhhhHHHHHHhcCCCCCCCCC----hHHHHHHHHhccc------------
Q 012762 313 VRSMSFVGTHEYLAPEIISG-EGHGNAVDWWTLGIFIFELFYGTTPFKGID----HELTLANVVARAL------------ 375 (457)
Q Consensus 313 ~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlG~il~elltG~~Pf~~~~----~~~~~~~~~~~~~------------ 375 (457)
...+++||..|.+||.+.. ..|+..+|.|||||++|+++||..||.... +.++...+..+..
T Consensus 179 -~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~~~~~eN 257 (732)
T KOG4250|consen 179 -LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIGAQEEEN 257 (732)
T ss_pred -eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeEeeecccC
Confidence 2236789999999999985 778999999999999999999999995432 2334444433211
Q ss_pred -------CCCCCCCCCh----HHHHHHHHHhhhCCCCCC
Q 012762 376 -------EFPKEPSVPG----PAKDLIAQLLVKDPTRRM 403 (457)
Q Consensus 376 -------~~~~~~~~~~----~~~~ll~~~L~~dP~~Rp 403 (457)
.+|.+..++. .+-..+..||..||.+|.
T Consensus 258 gpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~ 296 (732)
T KOG4250|consen 258 GPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG 296 (732)
T ss_pred CceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence 1111112222 345788999999999998
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=313.43 Aligned_cols=270 Identities=17% Similarity=0.231 Sum_probs=193.7
Q ss_pred CCccCCCceeEEEecccCcceEEEEEEecc------------CCCCCceEEEEEeehhhhhh-----------hhHHHHH
Q 012762 77 NPLTLSDLRFVHRLGSGDIGSVYLVQLKSK------------SSNNGCFFAAKVMDKRELVS-----------RNKESRA 133 (457)
Q Consensus 77 ~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~------------~~~~~~~vAvK~~~~~~~~~-----------~~~~~~~ 133 (457)
.....++|.+.++||+|+||+||+|.+... ....++.||||.+....... .......
T Consensus 140 ~r~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~ 219 (507)
T PLN03224 140 SRWSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETG 219 (507)
T ss_pred CCccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchh
Confidence 345678999999999999999999975321 22356789999986432110 0111223
Q ss_pred HHHHHHHHHcCCCCC-----ceEEEEEEc--------CCcEEEEEeecCCCChHHHHHhCC-------------------
Q 012762 134 RIEREILEMLDHPFL-----PTLYATLDC--------PRWSCLLTEFCPGGDLHVLRQRQP------------------- 181 (457)
Q Consensus 134 ~~E~~il~~l~H~nI-----v~l~~~~~~--------~~~~~lV~E~~~~~sL~~~~~~~~------------------- 181 (457)
..|+.++.+++|.++ ++++++|.. .+..+|||||+.+++|.++++...
T Consensus 220 ~vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~ 299 (507)
T PLN03224 220 MVEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPD 299 (507)
T ss_pred HHHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhh
Confidence 446777777776654 667777643 346799999999999998886421
Q ss_pred ---CCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCCCcccccccCCCCCCCCC
Q 012762 182 ---DKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQ 258 (457)
Q Consensus 182 ---~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~~~~~~~~~~~~~~~~~~ 258 (457)
...+++..++.++.|++.+|.|||+.+|+||||||+|||++.++.+||+|||++..........
T Consensus 300 ~~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~------------- 366 (507)
T PLN03224 300 NMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFN------------- 366 (507)
T ss_pred hcccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccC-------------
Confidence 1124567788999999999999999999999999999999999999999999975432110000
Q ss_pred CCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCCCCccCchhhcCCC----
Q 012762 259 QPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTHEYLAPEIISGEG---- 334 (457)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~---- 334 (457)
...-.+|+.|+|||.+....
T Consensus 367 --------------------------------------------------------~~~g~~tp~Y~aPE~l~~~~~~~~ 390 (507)
T PLN03224 367 --------------------------------------------------------PLYGMLDPRYSPPEELVMPQSCPR 390 (507)
T ss_pred --------------------------------------------------------ccccCCCcceeChhhhcCCCCCCc
Confidence 00113588999999986432
Q ss_pred ----------------CC--ccchhhhhhHHHHHHhcCCC-CCCCCChH-----------HHHHHHHhcccCCCCCCCCC
Q 012762 335 ----------------HG--NAVDWWTLGIFIFELFYGTT-PFKGIDHE-----------LTLANVVARALEFPKEPSVP 384 (457)
Q Consensus 335 ----------------~~--~~sDiwSlG~il~elltG~~-Pf~~~~~~-----------~~~~~~~~~~~~~~~~~~~~ 384 (457)
|+ .+.||||+||++|+|++|.. ||...... .....+....+.++.....+
T Consensus 391 ~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~~~~~~d~~s 470 (507)
T PLN03224 391 APAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKYDFSLLDRNK 470 (507)
T ss_pred cchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCCCcccccccC
Confidence 11 24799999999999999985 77542211 11112222344555556678
Q ss_pred hHHHHHHHHHhhhCC---CCCCCCCcChHHHhcCCCCC
Q 012762 385 GPAKDLIAQLLVKDP---TRRMGSKMGATAIKRHQFFN 419 (457)
Q Consensus 385 ~~~~~ll~~~L~~dP---~~Rps~~~~~~~ll~hp~f~ 419 (457)
+..++|+.+||..+| .+|+| ++|+|+||||.
T Consensus 471 ~~~~dLi~~LL~~~~~~~~~RlS----a~eaL~Hp~f~ 504 (507)
T PLN03224 471 EAGWDLACKLITKRDQANRGRLS----VGQALSHRFFL 504 (507)
T ss_pred hHHHHHHHHHhccCCCCcccCCC----HHHHhCCCCcC
Confidence 899999999999876 68999 99999999996
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=276.88 Aligned_cols=254 Identities=24% Similarity=0.395 Sum_probs=204.8
Q ss_pred cCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcC-CCCCceEEEEEEcC
Q 012762 80 TLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLD-HPFLPTLYATLDCP 158 (457)
Q Consensus 80 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~-H~nIv~l~~~~~~~ 158 (457)
..++|++.+++|+|.|+.||.|... .+++.++||+++. -+.+.+.+|+.||+.|. ||||++++++..+.
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~----~~~eK~ViKiLKP------VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp 105 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINI----TNNEKCVIKILKP------VKKKKIKREIKILQNLRGGPNIIKLLDIVKDP 105 (338)
T ss_pred ccchHHHHHHHcCccHhhHhccccc----CCCceEEEeeech------HHHHHHHHHHHHHHhccCCCCeeehhhhhcCc
Confidence 5679999999999999999998865 4788899999965 35567888999999995 99999999998765
Q ss_pred --CcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccC-CCEEEeccCCC
Q 012762 159 --RWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSD-GHIMLTDFDLS 235 (457)
Q Consensus 159 --~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~-~~vkl~DFG~s 235 (457)
....||+||+++.+...+.. .++...++.++.|++.||.|+|++||+|||+||.|++|+.. ..++|+|+|+|
T Consensus 106 ~SktpaLiFE~v~n~Dfk~ly~-----tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLA 180 (338)
T KOG0668|consen 106 ESKTPSLIFEYVNNTDFKQLYP-----TLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLA 180 (338)
T ss_pred cccCchhHhhhhccccHHHHhh-----hhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchH
Confidence 45689999999988876643 48888999999999999999999999999999999999965 57999999999
Q ss_pred cCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcccc
Q 012762 236 LKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRS 315 (457)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (457)
....+....
T Consensus 181 EFYHp~~eY----------------------------------------------------------------------- 189 (338)
T KOG0668|consen 181 EFYHPGKEY----------------------------------------------------------------------- 189 (338)
T ss_pred hhcCCCcee-----------------------------------------------------------------------
Confidence 776543322
Q ss_pred ccccCCCCccCchhhcCCC-CCccchhhhhhHHHHHHhcCCCCCC-CCChHHHHHHHHhc-------------ccCCCC-
Q 012762 316 MSFVGTHEYLAPEIISGEG-HGNAVDWWTLGIFIFELFYGTTPFK-GIDHELTLANVVAR-------------ALEFPK- 379 (457)
Q Consensus 316 ~~~~gt~~y~aPE~l~~~~-~~~~sDiwSlG~il~elltG~~Pf~-~~~~~~~~~~~~~~-------------~~~~~~- 379 (457)
...+.+..|--||.+...+ |+..-|+|||||+|..|+..+.||. |.++.+.+.+|..- .+.++.
T Consensus 190 nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~ 269 (338)
T KOG0668|consen 190 NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQ 269 (338)
T ss_pred eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChh
Confidence 1235677889999998765 8999999999999999999888874 54544443333210 111110
Q ss_pred --------------------C-CCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCCCCc
Q 012762 380 --------------------E-PSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGVNW 423 (457)
Q Consensus 380 --------------------~-~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~~~~ 423 (457)
. .-+++++.||+.++|..|-.+|+| +.|++.||||..+.-
T Consensus 270 ~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlT----akEam~HpyF~~~~~ 330 (338)
T KOG0668|consen 270 FEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLT----AKEAMAHPYFAPVRE 330 (338)
T ss_pred HhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccc----hHHHhcCchHHHHHH
Confidence 0 123578999999999999999999 999999999987543
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=282.76 Aligned_cols=242 Identities=41% Similarity=0.699 Sum_probs=200.6
Q ss_pred CcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcEEEEEeecCCCCh
Q 012762 94 DIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWSCLLTEFCPGGDL 173 (457)
Q Consensus 94 ~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~~sL 173 (457)
+||.||+|.+. .+++.+|+|++........ ...+..|++++++++|+||+++++++......+++|||+.+++|
T Consensus 1 ~~g~v~~~~~~----~~~~~~~~k~~~~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L 74 (244)
T smart00220 1 SFGKVYLARDK----KTGKLVAIKVIKKEKIKKK--RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDL 74 (244)
T ss_pred CceEEEEEEEC----CCCcEEEEEEecccccccH--HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCH
Confidence 58999999986 3688999999976533221 56788899999999999999999999998999999999999999
Q ss_pred HHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCCCcccccccCCCC
Q 012762 174 HVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQLVSDQSP 253 (457)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~~~~~~~~~~~~~ 253 (457)
..++... ..+++..+..++.+++.+|.|||+.+++|+||+|.||+++.++.++|+|||++.......
T Consensus 75 ~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~----------- 141 (244)
T smart00220 75 FDLLKKR--GRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG----------- 141 (244)
T ss_pred HHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc-----------
Confidence 9988775 338999999999999999999999999999999999999999999999999976543211
Q ss_pred CCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCCCCccCchhhcCC
Q 012762 254 PTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTHEYLAPEIISGE 333 (457)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~ 333 (457)
......|+..|++||.+.+.
T Consensus 142 ------------------------------------------------------------~~~~~~~~~~~~~pE~~~~~ 161 (244)
T smart00220 142 ------------------------------------------------------------LLTTFVGTPEYMAPEVLLGK 161 (244)
T ss_pred ------------------------------------------------------------ccccccCCcCCCCHHHHccC
Confidence 00123588899999999988
Q ss_pred CCCccchhhhhhHHHHHHhcCCCCCCCCC-hHHHHHHHHhcccCCCCCCC-CChHHHHHHHHHhhhCCCCCCCCCcChHH
Q 012762 334 GHGNAVDWWTLGIFIFELFYGTTPFKGID-HELTLANVVARALEFPKEPS-VPGPAKDLIAQLLVKDPTRRMGSKMGATA 411 (457)
Q Consensus 334 ~~~~~sDiwSlG~il~elltG~~Pf~~~~-~~~~~~~~~~~~~~~~~~~~-~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ 411 (457)
.++.++|||+||+++|+|++|..||.... .................... ++.++.+++.+||..||++||+ +.+
T Consensus 162 ~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~----~~~ 237 (244)
T smart00220 162 GYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLT----AEE 237 (244)
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhccC----HHH
Confidence 88999999999999999999999998733 33333333333322222222 7889999999999999999999 999
Q ss_pred HhcCCCC
Q 012762 412 IKRHQFF 418 (457)
Q Consensus 412 ll~hp~f 418 (457)
+++||||
T Consensus 238 ~~~~~~~ 244 (244)
T smart00220 238 ALQHPFF 244 (244)
T ss_pred HhhCCCC
Confidence 9999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=318.80 Aligned_cols=260 Identities=22% Similarity=0.317 Sum_probs=217.4
Q ss_pred CCCccCCCceeEEEecccCcceEEEEEEeccCCC---CCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHc-CCCCCceE
Q 012762 76 NNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSN---NGCFFAAKVMDKRELVSRNKESRARIEREILEML-DHPFLPTL 151 (457)
Q Consensus 76 ~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~---~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l 151 (457)
.+.+..++..+.+.||+|.||.||+|..+..... ....||||.++.... ....+.+..|+++|+.+ .|+||+.+
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~--~~~~~~~~~El~~m~~~g~H~niv~l 367 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENAS--SSEKKDLMSELNVLKELGKHPNIVNL 367 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccC--cHHHHHHHHHHHHHHHhcCCcchhhh
Confidence 5677777788888999999999999987654433 267899999876533 35677888899999998 59999999
Q ss_pred EEEEEcCCcEEEEEeecCCCChHHHHHhCC------C--------CCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCC
Q 012762 152 YATLDCPRWSCLLTEFCPGGDLHVLRQRQP------D--------KRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPE 217 (457)
Q Consensus 152 ~~~~~~~~~~~lV~E~~~~~sL~~~~~~~~------~--------~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~ 217 (457)
++++...+.+++|+||+..|+|..++.... . ..++..+...++.||+.|++||++.++|||||...
T Consensus 368 lG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaR 447 (609)
T KOG0200|consen 368 LGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAAR 447 (609)
T ss_pred eeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhh
Confidence 999999999999999999999999988753 0 13888999999999999999999999999999999
Q ss_pred CeEEccCCCEEEeccCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhcccc
Q 012762 218 NVLVRSDGHIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKK 297 (457)
Q Consensus 218 NIll~~~~~vkl~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (457)
|||+..+..+||+|||+++...+.......
T Consensus 448 NVLi~~~~~~kIaDFGlar~~~~~~~y~~~-------------------------------------------------- 477 (609)
T KOG0200|consen 448 NVLITKNKVIKIADFGLARDHYNKDYYRTK-------------------------------------------------- 477 (609)
T ss_pred hEEecCCCEEEEccccceeccCCCCceEec--------------------------------------------------
Confidence 999999999999999999865433222100
Q ss_pred CCCCCCCcccccCCccccccccC--CCCccCchhhcCCCCCccchhhhhhHHHHHHhc-CCCCCCCCC-hHHHHHHHHhc
Q 012762 298 LGNPGTPEIVAEPLDVRSMSFVG--THEYLAPEIISGEGHGNAVDWWTLGIFIFELFY-GTTPFKGID-HELTLANVVAR 373 (457)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~g--t~~y~aPE~l~~~~~~~~sDiwSlG~il~ellt-G~~Pf~~~~-~~~~~~~~~~~ 373 (457)
.-.| ...|||||.+....|+.++||||||++|||+++ |..||.+.. ..+. ...+..
T Consensus 478 -------------------~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l-~~~l~~ 537 (609)
T KOG0200|consen 478 -------------------SSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEEL-LEFLKE 537 (609)
T ss_pred -------------------CCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHH-HHHHhc
Confidence 0012 335999999999889999999999999999997 999999865 4444 447777
Q ss_pred ccCCCCCCCCChHHHHHHHHHhhhCCCCCCCCCc
Q 012762 374 ALEFPKEPSVPGPAKDLIAQLLVKDPTRRMGSKM 407 (457)
Q Consensus 374 ~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rps~~~ 407 (457)
..++..+..+++++.++|+.||..+|++||++.+
T Consensus 538 G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~ 571 (609)
T KOG0200|consen 538 GNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSE 571 (609)
T ss_pred CCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHH
Confidence 7888888889999999999999999999999443
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=285.62 Aligned_cols=255 Identities=27% Similarity=0.423 Sum_probs=205.8
Q ss_pred CCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCC-
Q 012762 81 LSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPR- 159 (457)
Q Consensus 81 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~- 159 (457)
..+|.-+..+|.|.- .|..|-+. -.++.||+|.+... ........+..+|..++..++|+||++++.+|.-..
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~----v~~~~v~ikk~~~p-f~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~ 89 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQ----VLGRPVAIKKLSRP-FQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKT 89 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchh----hccCceehhhhcCc-cccCccchhhhhhhhhhhhhcccceeeeeeccCcccc
Confidence 457888889999988 66655544 47888999988654 444556678888999999999999999999995443
Q ss_pred -----cEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCC
Q 012762 160 -----WSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDL 234 (457)
Q Consensus 160 -----~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~ 234 (457)
..|+|||++ ..+|...+.. .++-..+..++.|++.|++|||+.||+||||||+||++..++.+||.|||+
T Consensus 90 l~~~~e~y~v~e~m-~~nl~~vi~~----elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ 164 (369)
T KOG0665|consen 90 LEEFQEVYLVMELM-DANLCQVILM----ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGL 164 (369)
T ss_pred HHHHHhHHHHHHhh-hhHHHHHHHH----hcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchh
Confidence 579999999 8899887774 377888999999999999999999999999999999999999999999999
Q ss_pred CcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccc
Q 012762 235 SLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVR 314 (457)
Q Consensus 235 s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (457)
++.... +.+
T Consensus 165 ar~e~~-----------------------------------------------------------------------~~~ 173 (369)
T KOG0665|consen 165 ARTEDT-----------------------------------------------------------------------DFM 173 (369)
T ss_pred hcccCc-----------------------------------------------------------------------ccc
Confidence 864321 123
Q ss_pred cccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccC------------------
Q 012762 315 SMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALE------------------ 376 (457)
Q Consensus 315 ~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~------------------ 376 (457)
.+.++.|..|+|||++.+..|...+||||+||++.||++|...|.|.+..+...+++.....
T Consensus 174 mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~ 253 (369)
T KOG0665|consen 174 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVE 253 (369)
T ss_pred cCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhh
Confidence 44578999999999999999999999999999999999999999886654444333321110
Q ss_pred -------------CCCC---------CCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCCCCc
Q 012762 377 -------------FPKE---------PSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGVNW 423 (457)
Q Consensus 377 -------------~~~~---------~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~~~~ 423 (457)
+|.. ..-...+++++.+||..||++|.+ ++++|+||||+ -|
T Consensus 254 ~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Ris----v~daL~HPY~~--vw 316 (369)
T KOG0665|consen 254 NRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRIS----VDDALRHPYIK--VW 316 (369)
T ss_pred cChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhccc----HHHHhcCCeee--ee
Confidence 0000 011235789999999999999999 99999999999 45
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=287.39 Aligned_cols=248 Identities=24% Similarity=0.342 Sum_probs=192.4
Q ss_pred CCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHH--HcCCCCCceEEEEEEcCC
Q 012762 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILE--MLDHPFLPTLYATLDCPR 159 (457)
Q Consensus 82 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~--~l~H~nIv~l~~~~~~~~ 159 (457)
.+.++.+.||+|.||.||+|.|+ |+.||||++... .+..+.+|.+|.+ +|+|+||+.+++.-..+.
T Consensus 211 rqI~L~e~IGkGRyGEVwrG~wr------Ge~VAVKiF~sr------dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~ 278 (513)
T KOG2052|consen 211 RQIVLQEIIGKGRFGEVWRGRWR------GEDVAVKIFSSR------DERSWFRETEIYQTVMLRHENILGFIAADNKDN 278 (513)
T ss_pred heeEEEEEecCccccceeecccc------CCceEEEEeccc------chhhhhhHHHHHHHHHhccchhhhhhhccccCC
Confidence 57899999999999999999985 788999999653 4566777999875 469999999999765443
Q ss_pred ----cEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHc--------CceeecCCCCCeEEccCCCE
Q 012762 160 ----WSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMM--------GIIYRDLKPENVLVRSDGHI 227 (457)
Q Consensus 160 ----~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~--------~iiHrDIKp~NIll~~~~~v 227 (457)
.++||++|.+.|||++++.+ ..++.+....++.-++.||++||.. .|.|||||..|||+.++|.+
T Consensus 279 gs~TQLwLvTdYHe~GSL~DyL~r---~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C 355 (513)
T KOG2052|consen 279 GSWTQLWLVTDYHEHGSLYDYLNR---NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTC 355 (513)
T ss_pred CceEEEEEeeecccCCcHHHHHhh---ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcE
Confidence 47999999999999999998 5789999999999999999999942 39999999999999999999
Q ss_pred EEeccCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCccc
Q 012762 228 MLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIV 307 (457)
Q Consensus 228 kl~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (457)
-|+|+|||......+...
T Consensus 356 ~IADLGLAv~h~~~t~~i-------------------------------------------------------------- 373 (513)
T KOG2052|consen 356 CIADLGLAVRHDSDTDTI-------------------------------------------------------------- 373 (513)
T ss_pred EEeeceeeEEecccCCcc--------------------------------------------------------------
Confidence 999999987665433221
Q ss_pred ccCCccccccccCCCCccCchhhcCCCC------CccchhhhhhHHHHHHhc----------CCCCCCCCChH-----HH
Q 012762 308 AEPLDVRSMSFVGTHEYLAPEIISGEGH------GNAVDWWTLGIFIFELFY----------GTTPFKGIDHE-----LT 366 (457)
Q Consensus 308 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~------~~~sDiwSlG~il~ellt----------G~~Pf~~~~~~-----~~ 366 (457)
+...+..+||..|||||++...-. -..+||||||.|+||++. -++||++.... ++
T Consensus 374 ----di~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~eeM 449 (513)
T KOG2052|consen 374 ----DIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSFEEM 449 (513)
T ss_pred ----cCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCHHHH
Confidence 222335589999999999975421 237999999999999983 25788764322 22
Q ss_pred HHHHHhcccCCCCCCCCC-----hHHHHHHHHHhhhCCCCCCCCCcChHHHhc
Q 012762 367 LANVVARALEFPKEPSVP-----GPAKDLIAQLLVKDPTRRMGSKMGATAIKR 414 (457)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~-----~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~ 414 (457)
..-+....++...+..+. ..+-.||+.||..||.-|.+ +-.|.+
T Consensus 450 rkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRlt----ALriKK 498 (513)
T KOG2052|consen 450 RKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLT----ALRIKK 498 (513)
T ss_pred hcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhH----HHHHHH
Confidence 222222333433333332 24668899999999999999 666654
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=311.02 Aligned_cols=249 Identities=27% Similarity=0.364 Sum_probs=199.1
Q ss_pred eEEEecccCcce-EEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHc-CCCCCceEEEEEEcCCcEEE
Q 012762 86 FVHRLGSGDIGS-VYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEML-DHPFLPTLYATLDCPRWSCL 163 (457)
Q Consensus 86 ~~~~LG~G~fg~-Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~~~~~~~~~~~l 163 (457)
-.+.+|.|+-|+ ||+|.. .|+.||||.+-. .......+|+..|+.- +|||||++|+.=.+.+..||
T Consensus 513 ~~eilG~Gs~Gt~Vf~G~y------e~R~VAVKrll~------e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YI 580 (903)
T KOG1027|consen 513 PKEILGYGSNGTVVFRGVY------EGREVAVKRLLE------EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYI 580 (903)
T ss_pred cHHHcccCCCCcEEEEEee------CCceehHHHHhh------HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEE
Confidence 346789999986 899986 678999999843 3456678899999887 69999999999999999999
Q ss_pred EEeecCCCChHHHHHhC-CCCC-CCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEcc---CC--CEEEeccCCCc
Q 012762 164 LTEFCPGGDLHVLRQRQ-PDKR-FHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRS---DG--HIMLTDFDLSL 236 (457)
Q Consensus 164 V~E~~~~~sL~~~~~~~-~~~~-~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~---~~--~vkl~DFG~s~ 236 (457)
..|+| ..+|.++++.. .... ......+.++.|++.||++||+.+||||||||.||||.. ++ .++|+|||+++
T Consensus 581 alELC-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsK 659 (903)
T KOG1027|consen 581 ALELC-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSK 659 (903)
T ss_pred EehHh-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEeccccccc
Confidence 99999 89999999873 1111 111445778899999999999999999999999999986 34 68999999998
Q ss_pred CCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccc
Q 012762 237 KGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSM 316 (457)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (457)
.+......-. +..
T Consensus 660 kl~~~~sS~~-------------------------------------------------------------------r~s 672 (903)
T KOG1027|consen 660 KLAGGKSSFS-------------------------------------------------------------------RLS 672 (903)
T ss_pred ccCCCcchhh-------------------------------------------------------------------ccc
Confidence 8764332211 011
Q ss_pred cccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcC-CCCCCCCChHHHHHHHHhcccCCCCCCCC-ChHHHHHHHHH
Q 012762 317 SFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYG-TTPFKGIDHELTLANVVARALEFPKEPSV-PGPAKDLIAQL 394 (457)
Q Consensus 317 ~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG-~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ll~~~ 394 (457)
+..||-+|+|||++....-..++|||||||++|+.++| .-||.. ..+...+|+.+.+.+..-... ..++.+||.+|
T Consensus 673 ~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd--~~~R~~NIl~~~~~L~~L~~~~d~eA~dLI~~m 750 (903)
T KOG1027|consen 673 GGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGD--SLERQANILTGNYTLVHLEPLPDCEAKDLISRM 750 (903)
T ss_pred CCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCc--hHHhhhhhhcCccceeeeccCchHHHHHHHHHh
Confidence 33599999999999988888899999999999999986 899975 344556777766554432111 12789999999
Q ss_pred hhhCCCCCCCCCcChHHHhcCCCCCC
Q 012762 395 LVKDPTRRMGSKMGATAIKRHQFFNG 420 (457)
Q Consensus 395 L~~dP~~Rps~~~~~~~ll~hp~f~~ 420 (457)
|.+||..||+ |.++|.||||=+
T Consensus 751 l~~dP~~RPs----a~~VL~HPlFW~ 772 (903)
T KOG1027|consen 751 LNPDPQLRPS----ATDVLNHPLFWD 772 (903)
T ss_pred cCCCcccCCC----HHHHhCCCccCC
Confidence 9999999999 999999999953
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=277.62 Aligned_cols=261 Identities=25% Similarity=0.357 Sum_probs=204.8
Q ss_pred CCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCC--
Q 012762 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPR-- 159 (457)
Q Consensus 82 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~-- 159 (457)
.|.+--+.||.|+||+||.+++. .+|+.||+|.+..- ...-...+++.+|+++|.-++|.|++..++..+-..
T Consensus 53 ~Di~PDRPIGYGAFGVVWsVTDP----RdgrrvalkK~pnv-fq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~d 127 (449)
T KOG0664|consen 53 QDIQPDRPIGYGAFGVVWSVTDP----RSGKRVALKKMPNV-FQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPS 127 (449)
T ss_pred ccCCCCCcccccceeEEEeccCC----CCccchhHhhcchH-HHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCch
Confidence 45566689999999999988765 48999999998543 233345677888999999999999999988775442
Q ss_pred ---cEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCc
Q 012762 160 ---WSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSL 236 (457)
Q Consensus 160 ---~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~ 236 (457)
.+|+|+|++ -.+|..++-.- ..++...++-++.||+.||.|||+.||+||||||.|+|++++..+||||||+++
T Consensus 128 fFqEiYV~TELm-QSDLHKIIVSP--Q~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLAR 204 (449)
T KOG0664|consen 128 FFQELYVLTELM-QSDLHKIIVSP--QALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLAR 204 (449)
T ss_pred HHHHHHHHHHHH-HhhhhheeccC--CCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEeccccccc
Confidence 468899998 67787666542 568888999999999999999999999999999999999999999999999998
Q ss_pred CCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccc
Q 012762 237 KGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSM 316 (457)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (457)
..+..... ..+
T Consensus 205 vee~d~~~---------------------------------------------------------------------hMT 215 (449)
T KOG0664|consen 205 TWDQRDRL---------------------------------------------------------------------NMT 215 (449)
T ss_pred ccchhhhh---------------------------------------------------------------------hhH
Confidence 76532211 011
Q ss_pred cccCCCCccCchhhcCCC-CCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHh-----------------------
Q 012762 317 SFVGTHEYLAPEIISGEG-HGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVA----------------------- 372 (457)
Q Consensus 317 ~~~gt~~y~aPE~l~~~~-~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~----------------------- 372 (457)
.-+-|..|+|||++.|.. |+.++||||.|||+.||+..+..|......+.+..|.+
T Consensus 216 qEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~LR 295 (449)
T KOG0664|consen 216 HEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHVLR 295 (449)
T ss_pred HHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhhc
Confidence 225688999999999876 89999999999999999999999987665444433332
Q ss_pred cccCCCCC---------CCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCCCCc
Q 012762 373 RALEFPKE---------PSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGVNW 423 (457)
Q Consensus 373 ~~~~~~~~---------~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~~~~ 423 (457)
+..+.|.. ..-..+..+++.+||.+||.+|.+ .++.+.|+|...-+.
T Consensus 296 ~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris----~~~A~~~~~~~e~R~ 351 (449)
T KOG0664|consen 296 AGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRIS----VEEALQHRYLEEGRL 351 (449)
T ss_pred cCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCccccc----Hhhhcccccccccce
Confidence 11111211 111235789999999999999999 999999999977543
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=286.79 Aligned_cols=302 Identities=21% Similarity=0.286 Sum_probs=211.4
Q ss_pred CCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHc-CCCCCceEEEEEEcCC
Q 012762 81 LSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEML-DHPFLPTLYATLDCPR 159 (457)
Q Consensus 81 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~~~~~~~~ 159 (457)
...|.++.+||+|.|++||+|.+... ...++.||+|.+... ....++..|+++|..+ .+.||+++.+++..++
T Consensus 35 ~~~~~~v~kigeGsFssv~~a~~~~~-~~~~~~valk~i~~t-----s~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 35 SNAYKVVNKIGEGSFSSVYKATDIEQ-DTKRRYVALKAIYRT-----SSPSRILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhhccccccchhhhhhhhHhhh-ccccceEeeeecccc-----cCchHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 35799999999999999999987642 236789999998543 4556788899999998 6999999999999999
Q ss_pred cEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccC-CCEEEeccCCCcCC
Q 012762 160 WSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSD-GHIMLTDFDLSLKG 238 (457)
Q Consensus 160 ~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~-~~vkl~DFG~s~~~ 238 (457)
.+++||||+++....++... ++..+++.+++.++.||.++|.+|||||||||.|+|.+.. +.-.|+|||++...
T Consensus 109 ~v~ivlp~~~H~~f~~l~~~-----l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~ 183 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYRS-----LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRY 183 (418)
T ss_pred eeEEEecccCccCHHHHHhc-----CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHH
Confidence 99999999999999887754 6788999999999999999999999999999999999854 77899999998742
Q ss_pred CCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccc
Q 012762 239 DNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSF 318 (457)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (457)
........-.. .+.+ ... .+...... ..+....-...|................
T Consensus 184 d~~~~~~~s~~-------~~~~--~~~-~~~g~~~~----------------~~~~~~~~~p~g~~~~~~~~r~~~~anr 237 (418)
T KOG1167|consen 184 DGYQQTEHSRS-------YSGR--HAT-PAMGKDVH----------------CQSVATASKPAGYYRRCNDGRPSERANR 237 (418)
T ss_pred Hhhhhhhhhhh-------hhcc--cCC-ccccCccc----------------ccccccccCCCCceeccCCCccceeccc
Confidence 21110000000 0000 000 00000000 0000000001111111123334445567
Q ss_pred cCCCCccCchhhcCCC-CCccchhhhhhHHHHHHhcCCCCCCCCChH-HHHHHHH--------------hcc--cCC---
Q 012762 319 VGTHEYLAPEIISGEG-HGNAVDWWTLGIFIFELFYGTTPFKGIDHE-LTLANVV--------------ARA--LEF--- 377 (457)
Q Consensus 319 ~gt~~y~aPE~l~~~~-~~~~sDiwSlG~il~elltG~~Pf~~~~~~-~~~~~~~--------------~~~--~~~--- 377 (457)
.||++|+|||++.+.+ .+.++||||.|+|+..+++++.||....+. ..+..+. .+. +..
T Consensus 238 AGT~GfRaPEvL~k~~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn 317 (418)
T KOG1167|consen 238 AGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSN 317 (418)
T ss_pred CCCCCCCchHHHhhccCcCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeecccc
Confidence 8999999999998765 688999999999999999999999653311 1111111 000 000
Q ss_pred -------------C-----------------CCCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCCCCc
Q 012762 378 -------------P-----------------KEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGVNW 423 (457)
Q Consensus 378 -------------~-----------------~~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~~~~ 423 (457)
. .....+..+.+|+.+||+.||.+|.+ ++++|+||||...+.
T Consensus 318 ~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRit----AEeALkHpFF~~~~~ 389 (418)
T KOG1167|consen 318 IPTIPELRVNFETLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRIT----AEDALKHPFFDEADR 389 (418)
T ss_pred ccccHHHHhchhccChhhcccccccceeeccccccccHHHHHHHHHHccCChhhccc----HHHHhcCcCCcchhh
Confidence 0 00112336889999999999999999 999999999997544
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=259.33 Aligned_cols=220 Identities=28% Similarity=0.390 Sum_probs=180.0
Q ss_pred CCCccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHc-CCCCCceEEEE
Q 012762 76 NNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEML-DHPFLPTLYAT 154 (457)
Q Consensus 76 ~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~~~ 154 (457)
+..+..+++.-+..||+|++|.|-+-++. .+|...|+|.+... ......++..+|+.+..+. .+|.+|++||.
T Consensus 40 ~~eV~ad~L~~i~elGrGayG~vekmrh~----~sg~imAvKri~~t--vn~q~q~r~L~dldi~~r~~~CPf~V~FyGa 113 (282)
T KOG0984|consen 40 NFEVPADDLVGIEELGRGAYGVVEKMRHI----QSGTIMAVKRIRAT--VNSQEQKRLLMDLDIIMRTVDCPFTVHFYGA 113 (282)
T ss_pred ccccchhhhhhhhhhcCCccchhhheeec----cCCeEEEEeeehhh--cChHHHHHHHHhhhhhccCCCCCeEEEeehh
Confidence 35677788888999999999999877776 69999999999654 2344566677788886664 79999999999
Q ss_pred EEcCCcEEEEEeecCCCChHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHHHHc-CceeecCCCCCeEEccCCCEEEec
Q 012762 155 LDCPRWSCLLTEFCPGGDLHVLRQR--QPDKRFHESAVRFYASEVVVALEFLHMM-GIIYRDLKPENVLVRSDGHIMLTD 231 (457)
Q Consensus 155 ~~~~~~~~lV~E~~~~~sL~~~~~~--~~~~~~~~~~~~~i~~qi~~~L~yLH~~-~iiHrDIKp~NIll~~~~~vkl~D 231 (457)
...+..+++.||.| ..+|..+... ..++.++|..+-+++..++.||.|||++ .+||||+||.||||+.+|+||+||
T Consensus 114 ~~regdvwIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCD 192 (282)
T KOG0984|consen 114 LFREGDVWICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICD 192 (282)
T ss_pred hhccccEEEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcc
Confidence 98899999999999 8888766543 3457899999999999999999999965 899999999999999999999999
Q ss_pred cCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCC
Q 012762 232 FDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPL 311 (457)
Q Consensus 232 FG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (457)
||++-.+.++-...
T Consensus 193 FGIsG~L~dSiAkt------------------------------------------------------------------ 206 (282)
T KOG0984|consen 193 FGISGYLVDSIAKT------------------------------------------------------------------ 206 (282)
T ss_pred cccceeehhhhHHH------------------------------------------------------------------
Confidence 99986654332110
Q ss_pred ccccccccCCCCccCchhhcC----CCCCccchhhhhhHHHHHHhcCCCCCCCCC-hHHHHHHHHhc
Q 012762 312 DVRSMSFVGTHEYLAPEIISG----EGHGNAVDWWTLGIFIFELFYGTTPFKGID-HELTLANVVAR 373 (457)
Q Consensus 312 ~~~~~~~~gt~~y~aPE~l~~----~~~~~~sDiwSlG~il~elltG~~Pf~~~~-~~~~~~~~~~~ 373 (457)
--.|...|||||.+.. ..|+.++||||||+++.||.+++.||.... ..+.+.+++..
T Consensus 207 -----~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVee 268 (282)
T KOG0984|consen 207 -----MDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEE 268 (282)
T ss_pred -----HhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcC
Confidence 0148889999999864 368999999999999999999999998654 44555555543
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=294.76 Aligned_cols=205 Identities=30% Similarity=0.456 Sum_probs=178.1
Q ss_pred CccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHH-----HHHHHHHHHHHHcC---CCCCc
Q 012762 78 PLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKE-----SRARIEREILEMLD---HPFLP 149 (457)
Q Consensus 78 ~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~-----~~~~~E~~il~~l~---H~nIv 149 (457)
.-...+|..++.||+|+||.|++|.++. +...|+||.+.|.++..+... .-+-.|++||..|+ |+||+
T Consensus 557 ~~k~s~yttlq~lG~GAyGkV~lai~K~----n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIl 632 (772)
T KOG1152|consen 557 YKKFSDYTTLQPLGEGAYGKVNLAIHKE----NNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENIL 632 (772)
T ss_pred ecccccceeeeeccccccceEEEeeecc----cceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchh
Confidence 3455789999999999999999999984 677899999988876544332 23445999999997 99999
Q ss_pred eEEEEEEcCCcEEEEEeec-CCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEE
Q 012762 150 TLYATLDCPRWSCLLTEFC-PGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIM 228 (457)
Q Consensus 150 ~l~~~~~~~~~~~lV~E~~-~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vk 228 (457)
+++++|++++++||+||-- +|.+|++++..+ ..++|.+++.|++|++.|+++||++||||||||-+|+.++.+|.+|
T Consensus 633 KlLdfFEddd~yyl~te~hg~gIDLFd~IE~k--p~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~k 710 (772)
T KOG1152|consen 633 KLLDFFEDDDYYYLETEVHGEGIDLFDFIEFK--PRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVK 710 (772)
T ss_pred hhhheeecCCeeEEEecCCCCCcchhhhhhcc--CccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEE
Confidence 9999999999999999975 567889999887 6799999999999999999999999999999999999999999999
Q ss_pred EeccCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccc
Q 012762 229 LTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVA 308 (457)
Q Consensus 229 l~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (457)
|+|||.+....
T Consensus 711 lidfgsaa~~k--------------------------------------------------------------------- 721 (772)
T KOG1152|consen 711 LIDFGSAAYTK--------------------------------------------------------------------- 721 (772)
T ss_pred Eeeccchhhhc---------------------------------------------------------------------
Confidence 99999763221
Q ss_pred cCCccccccccCCCCccCchhhcCCCC-CccchhhhhhHHHHHHhcCCCCCCC
Q 012762 309 EPLDVRSMSFVGTHEYLAPEIISGEGH-GNAVDWWTLGIFIFELFYGTTPFKG 360 (457)
Q Consensus 309 ~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~sDiwSlG~il~elltG~~Pf~~ 360 (457)
......|+||..|.|||++.|..| +..-|||+||++||-+++.+.||+.
T Consensus 722 ---sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 722 ---SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred ---CCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 111225789999999999999997 8889999999999999999999974
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=287.23 Aligned_cols=245 Identities=24% Similarity=0.351 Sum_probs=189.7
Q ss_pred ccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHH--cCCCCCceEEEEEE
Q 012762 79 LTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEM--LDHPFLPTLYATLD 156 (457)
Q Consensus 79 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~--l~H~nIv~l~~~~~ 156 (457)
+.....++++.||+|.||.||+|.. .++.||||++..+ ....+..|.+|... ++|+||++++++-+
T Consensus 207 ~~l~pl~l~eli~~Grfg~V~KaqL------~~~~VAVKifp~~------~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ek 274 (534)
T KOG3653|consen 207 LELDPLQLLELIGRGRFGCVWKAQL------DNRLVAVKIFPEQ------EKQSFQNEKNIYSLPGMKHENILQFIGAEK 274 (534)
T ss_pred ccCCchhhHHHhhcCccceeehhhc------cCceeEEEecCHH------HHHHHHhHHHHHhccCccchhHHHhhchhc
Confidence 3456788999999999999999987 4689999999653 56678889998776 58999999999875
Q ss_pred cCC----cEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHc---------CceeecCCCCCeEEcc
Q 012762 157 CPR----WSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMM---------GIIYRDLKPENVLVRS 223 (457)
Q Consensus 157 ~~~----~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~---------~iiHrDIKp~NIll~~ 223 (457)
... .++||+||.+.|+|.++++. ..+++.....++.-|++||+|||+- .|+|||||..||||..
T Consensus 275 r~t~~~~eywLVt~fh~kGsL~dyL~~---ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~ 351 (534)
T KOG3653|consen 275 RGTADRMEYWLVTEFHPKGSLCDYLKA---NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKN 351 (534)
T ss_pred cCCccccceeEEeeeccCCcHHHHHHh---ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEcc
Confidence 544 78999999999999999998 5799999999999999999999953 4999999999999999
Q ss_pred CCCEEEeccCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCC
Q 012762 224 DGHIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGT 303 (457)
Q Consensus 224 ~~~vkl~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (457)
|+++.|+|||+|..+.......
T Consensus 352 DlTccIaDFGLAl~~~p~~~~~---------------------------------------------------------- 373 (534)
T KOG3653|consen 352 DLTCCIADFGLALRLEPGKPQG---------------------------------------------------------- 373 (534)
T ss_pred CCcEEeeccceeEEecCCCCCc----------------------------------------------------------
Confidence 9999999999997765221100
Q ss_pred CcccccCCccccccccCCCCccCchhhcCCCC-C-----ccchhhhhhHHHHHHhcCCC------------CCCC-----
Q 012762 304 PEIVAEPLDVRSMSFVGTHEYLAPEIISGEGH-G-----NAVDWWTLGIFIFELFYGTT------------PFKG----- 360 (457)
Q Consensus 304 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~-----~~sDiwSlG~il~elltG~~------------Pf~~----- 360 (457)
....-+||.+|||||++.|..- . .+.||||+|.|||||++... ||..
T Consensus 374 ----------d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~h 443 (534)
T KOG3653|consen 374 ----------DTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNH 443 (534)
T ss_pred ----------chhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCC
Confidence 0112379999999999987642 2 37899999999999996432 3331
Q ss_pred CChHHHHHHHHhcccCCCCCCC-----CChHHHHHHHHHhhhCCCCCCCCC
Q 012762 361 IDHELTLANVVARALEFPKEPS-----VPGPAKDLIAQLLVKDPTRRMGSK 406 (457)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~ll~~~L~~dP~~Rps~~ 406 (457)
..-+++...++....+...+.. -...+++.+..||..|++-|.|..
T Consensus 444 Pt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~ 494 (534)
T KOG3653|consen 444 PTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAG 494 (534)
T ss_pred CCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhH
Confidence 1223334444444333221111 123588999999999999999944
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=300.87 Aligned_cols=253 Identities=23% Similarity=0.267 Sum_probs=211.7
Q ss_pred CceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcEE
Q 012762 83 DLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWSC 162 (457)
Q Consensus 83 ~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~ 162 (457)
..+..++||.|+||+||+|.|......-+..||+|++... .......++..|+-+|.+|+|||++++++++.... +.
T Consensus 697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~--t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~q 773 (1177)
T KOG1025|consen 697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEF--TSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQ 773 (1177)
T ss_pred hhhhhceeccccceeEEeeeEecCCceecceeEEEEeecc--CCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HH
Confidence 3555678999999999999987654455678999998654 33445677888999999999999999999998765 78
Q ss_pred EEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCCC
Q 012762 163 LLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNST 242 (457)
Q Consensus 163 lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~~ 242 (457)
||++|+++|.|.++++.++ ..+-....+.|+.||++||.|||++++|||||...||||.+...|||.|||+++.+....
T Consensus 774 lvtq~mP~G~LlDyvr~hr-~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~ 852 (1177)
T KOG1025|consen 774 LVTQLMPLGCLLDYVREHR-DNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE 852 (1177)
T ss_pred HHHHhcccchHHHHHHHhh-ccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCccc
Confidence 9999999999999988764 568888899999999999999999999999999999999999999999999998765322
Q ss_pred cccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCCC
Q 012762 243 STAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTH 322 (457)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 322 (457)
...... .---.+
T Consensus 853 ~ey~~~--------------------------------------------------------------------~gK~pi 864 (1177)
T KOG1025|consen 853 KEYSAP--------------------------------------------------------------------GGKVPI 864 (1177)
T ss_pred cccccc--------------------------------------------------------------------ccccCc
Confidence 111000 001356
Q ss_pred CccCchhhcCCCCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhhhCCCC
Q 012762 323 EYLAPEIISGEGHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDPTR 401 (457)
Q Consensus 323 ~y~aPE~l~~~~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~ 401 (457)
.|||-|.+....|+.++|||||||++||++| |..||.+....+ +.+.+...-+++.++.++-++..+|.+||..|+..
T Consensus 865 kwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~e-I~dlle~geRLsqPpiCtiDVy~~mvkCwmid~~~ 943 (1177)
T KOG1025|consen 865 KWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEE-IPDLLEKGERLSQPPICTIDVYMVMVKCWMIDADS 943 (1177)
T ss_pred HHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHH-hhHHHhccccCCCCCCccHHHHHHHHHHhccCccc
Confidence 7999999999999999999999999999997 999999987654 44556666678888999999999999999999999
Q ss_pred CCCCCcC
Q 012762 402 RMGSKMG 408 (457)
Q Consensus 402 Rps~~~~ 408 (457)
||+++..
T Consensus 944 rp~fkel 950 (1177)
T KOG1025|consen 944 RPTFKEL 950 (1177)
T ss_pred CccHHHH
Confidence 9995443
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=327.46 Aligned_cols=238 Identities=19% Similarity=0.235 Sum_probs=182.1
Q ss_pred CceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcEE
Q 012762 83 DLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWSC 162 (457)
Q Consensus 83 ~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~ 162 (457)
.+.....||+|+||.||+|+++ .++..||+|.+..... ....|++++++++|||||++++++...+..|
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~----~~~~~vavK~~~~~~~-------~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~ 759 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSI----KNGMQFVVKEINDVNS-------IPSSEIADMGKLQHPNIVKLIGLCRSEKGAY 759 (968)
T ss_pred hCCcccEEccCCCeeEEEEEEC----CCCcEEEEEEccCCcc-------ccHHHHHHHhhCCCCCcceEEEEEEcCCCCE
Confidence 4566778999999999999876 3788999999864321 1123688899999999999999999999999
Q ss_pred EEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HcCceeecCCCCCeEEccCCCEEEeccCCCcCCC
Q 012762 163 LLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLH---MMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGD 239 (457)
Q Consensus 163 lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH---~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~ 239 (457)
+||||+++|+|.++++. +++..+..++.||+.||+||| +.+|+||||||+||+++.++..++. ||......
T Consensus 760 lv~Ey~~~g~L~~~l~~-----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~ 833 (968)
T PLN00113 760 LIHEYIEGKNLSEVLRN-----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLC 833 (968)
T ss_pred EEEeCCCCCcHHHHHhc-----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccc
Confidence 99999999999998853 788999999999999999999 6699999999999999988887765 55432110
Q ss_pred CCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcccccccc
Q 012762 240 NSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFV 319 (457)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (457)
. .....
T Consensus 834 ~--------------------------------------------------------------------------~~~~~ 839 (968)
T PLN00113 834 T--------------------------------------------------------------------------DTKCF 839 (968)
T ss_pred c--------------------------------------------------------------------------CCCcc
Confidence 0 00124
Q ss_pred CCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChH-HHHHHHHh-------------cccCCC--CCCCC
Q 012762 320 GTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHE-LTLANVVA-------------RALEFP--KEPSV 383 (457)
Q Consensus 320 gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~-~~~~~~~~-------------~~~~~~--~~~~~ 383 (457)
||..|||||++.+..++.++|||||||++|||++|+.||...... ........ ...... .....
T Consensus 840 ~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (968)
T PLN00113 840 ISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNE 919 (968)
T ss_pred ccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCccHHH
Confidence 889999999999999999999999999999999999999543211 00111000 000000 00011
Q ss_pred ChHHHHHHHHHhhhCCCCCCCCCcChHHHhcC
Q 012762 384 PGPAKDLIAQLLVKDPTRRMGSKMGATAIKRH 415 (457)
Q Consensus 384 ~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~h 415 (457)
..++.+++.+||+.||++||+ +.|+++.
T Consensus 920 ~~~~~~l~~~Cl~~~P~~RPt----~~evl~~ 947 (968)
T PLN00113 920 IVEVMNLALHCTATDPTARPC----ANDVLKT 947 (968)
T ss_pred HHHHHHHHHhhCcCCchhCcC----HHHHHHH
Confidence 124678999999999999999 7777654
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=296.28 Aligned_cols=258 Identities=25% Similarity=0.397 Sum_probs=218.0
Q ss_pred cCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCC
Q 012762 80 TLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPR 159 (457)
Q Consensus 80 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~ 159 (457)
..++|.++.++|.|+||.||+|+++ .+++..|+|+++... .....-+..|+-+++-++|+|||.+++.+...+
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~----~s~elaavkvVkLep---~dd~~~iqqei~~~~dc~h~nivay~gsylr~d 85 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDK----RSGELAAVKVVKLEP---GDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRD 85 (829)
T ss_pred CccchhheeeecCCcccchhhhccc----ccCchhhheeeeccC---CccccccccceeeeecCCCcChHHHHhhhhhhc
Confidence 3468999999999999999999887 488899999997653 244555667888999999999999999999999
Q ss_pred cEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCC
Q 012762 160 WSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGD 239 (457)
Q Consensus 160 ~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~ 239 (457)
.+++.||||.||+|.+.-+.. +.+++.++..+++..++||+|||++|-+|||||-.|||++..|.||+.|||.+..+.
T Consensus 86 klwicMEycgggslQdiy~~T--gplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqit 163 (829)
T KOG0576|consen 86 KLWICMEYCGGGSLQDIYHVT--GPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQIT 163 (829)
T ss_pred CcEEEEEecCCCcccceeeec--ccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhh
Confidence 999999999999998876654 889999999999999999999999999999999999999999999999999874432
Q ss_pred CCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcccccccc
Q 012762 240 NSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFV 319 (457)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (457)
. +. .+..+|+
T Consensus 164 a-----------------------------------------------ti-----------------------~Krksfi 173 (829)
T KOG0576|consen 164 A-----------------------------------------------TI-----------------------AKRKSFI 173 (829)
T ss_pred h-----------------------------------------------hh-----------------------hhhhccc
Confidence 1 01 1122578
Q ss_pred CCCCccCchhh---cCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCC---CCCCChHHHHHHHH
Q 012762 320 GTHEYLAPEII---SGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPK---EPSVPGPAKDLIAQ 393 (457)
Q Consensus 320 gt~~y~aPE~l---~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~ll~~ 393 (457)
||+.|||||+. +...|+..+|||++|+...|+---++|.........+..+-.-.+..|. ...+++.+.+|++.
T Consensus 174 GtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~fh~fvK~ 253 (829)
T KOG0576|consen 174 GTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEFFHNFVKG 253 (829)
T ss_pred CCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchHHHHHHHHH
Confidence 99999999997 3456999999999999999999988887766555555554444444443 34678899999999
Q ss_pred HhhhCCCCCCCCCcChHHHhcCCCCCC
Q 012762 394 LLVKDPTRRMGSKMGATAIKRHQFFNG 420 (457)
Q Consensus 394 ~L~~dP~~Rps~~~~~~~ll~hp~f~~ 420 (457)
+|..+|.+||+ ++.+|.|||...
T Consensus 254 altknpKkRpt----aeklL~h~fvs~ 276 (829)
T KOG0576|consen 254 ALTKNPKKRPT----AEKLLQHPFVSQ 276 (829)
T ss_pred HhcCCCccCCC----hhhheeceeecc
Confidence 99999999999 999999999876
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=258.85 Aligned_cols=262 Identities=18% Similarity=0.221 Sum_probs=212.8
Q ss_pred CccCCCceeEEEecccCcceEEEEEEeccCCCCC-ceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEE
Q 012762 78 PLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNG-CFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLD 156 (457)
Q Consensus 78 ~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~-~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~ 156 (457)
.+...++++...+-+|.||.||.|.|+..+..++ +.|-+|.++.. .+......+..|.-+|..+.|||+..+.++..
T Consensus 280 ~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~--AS~iQv~~~L~es~lly~~sH~nll~V~~V~i 357 (563)
T KOG1024|consen 280 TVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH--ASQIQVNLLLQESMLLYGASHPNLLSVLGVSI 357 (563)
T ss_pred hhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc--ccHHHHHHHHHHHHHHhcCcCCCccceeEEEe
Confidence 4555678899999999999999998886655444 34556666443 44556677778888888889999999999886
Q ss_pred cC-CcEEEEEeecCCCChHHHHHhCC------CCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEE
Q 012762 157 CP-RWSCLLTEFCPGGDLHVLRQRQP------DKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIML 229 (457)
Q Consensus 157 ~~-~~~~lV~E~~~~~sL~~~~~~~~------~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl 229 (457)
++ ...++++.+..-|+|..++...+ ...++..+...++.|++.|++|||+.||||.||...|++|++.-+|||
T Consensus 358 e~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkl 437 (563)
T KOG1024|consen 358 EDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKL 437 (563)
T ss_pred eccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEe
Confidence 54 56788999999999999988432 234677788889999999999999999999999999999999999999
Q ss_pred eccCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCccccc
Q 012762 230 TDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAE 309 (457)
Q Consensus 230 ~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (457)
+|-.+++.+-+...... +|
T Consensus 438 tDsaLSRDLFP~DYhcL----------------------------------------------------GD--------- 456 (563)
T KOG1024|consen 438 TDSALSRDLFPGDYHCL----------------------------------------------------GD--------- 456 (563)
T ss_pred ccchhccccCccccccc----------------------------------------------------CC---------
Confidence 99999876654332210 00
Q ss_pred CCccccccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHH
Q 012762 310 PLDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVVARALEFPKEPSVPGPAK 388 (457)
Q Consensus 310 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (457)
.-.....||+||.+....|+.++|+||||++||||+| |+.||-..+..++. .++...+++..+.++|+++.
T Consensus 457 -------nEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~-~ylkdGyRlaQP~NCPDeLf 528 (563)
T KOG1024|consen 457 -------NENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEME-HYLKDGYRLAQPFNCPDELF 528 (563)
T ss_pred -------CCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHH-HHHhccceecCCCCCcHHHH
Confidence 0014668999999999999999999999999999997 99999887766554 45667788888889999999
Q ss_pred HHHHHHhhhCCCCCCCCCcChHHHhc
Q 012762 389 DLIAQLLVKDPTRRMGSKMGATAIKR 414 (457)
Q Consensus 389 ~ll~~~L~~dP~~Rps~~~~~~~ll~ 414 (457)
.+|..||..+|++||+ .+|+..
T Consensus 529 ~vMacCWallpeeRPs----f~Qlv~ 550 (563)
T KOG1024|consen 529 TVMACCWALLPEERPS----FSQLVI 550 (563)
T ss_pred HHHHHHHhcCcccCCC----HHHHHH
Confidence 9999999999999999 777643
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=237.10 Aligned_cols=213 Identities=37% Similarity=0.595 Sum_probs=182.9
Q ss_pred ecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcEEEEEeecC
Q 012762 90 LGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWSCLLTEFCP 169 (457)
Q Consensus 90 LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lV~E~~~ 169 (457)
||+|.+|.||++... .+++.+++|++....... ....+.+|+++++.+.|++|+++++++......+++||++.
T Consensus 1 l~~g~~~~v~~~~~~----~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~ 74 (215)
T cd00180 1 LGEGGFGTVYLARDK----KTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCE 74 (215)
T ss_pred CCcCCceEEEEEEec----CCCcEEEEEEeccccchh--HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCC
Confidence 689999999999875 258899999997653221 34678889999999999999999999999899999999999
Q ss_pred CCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEcc-CCCEEEeccCCCcCCCCCCcccccc
Q 012762 170 GGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRS-DGHIMLTDFDLSLKGDNSTSTAQLV 248 (457)
Q Consensus 170 ~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~-~~~vkl~DFG~s~~~~~~~~~~~~~ 248 (457)
+++|..++.... ..++...+..++.+++.+|.+||+.|++|+||+|.||+++. ++.++|+|||.+........
T Consensus 75 ~~~l~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~----- 148 (215)
T cd00180 75 GGSLKDLLKENE-GKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS----- 148 (215)
T ss_pred CCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-----
Confidence 899999887642 46899999999999999999999999999999999999998 89999999998754432110
Q ss_pred cCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCCCCccCch
Q 012762 249 SDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTHEYLAPE 328 (457)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 328 (457)
......+...|++||
T Consensus 149 -----------------------------------------------------------------~~~~~~~~~~~~~pe 163 (215)
T cd00180 149 -----------------------------------------------------------------LLKTIVGTPAYMAPE 163 (215)
T ss_pred -----------------------------------------------------------------hhhcccCCCCccChh
Confidence 001124788999999
Q ss_pred hhcCC-CCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhhhCCCCCCCCCc
Q 012762 329 IISGE-GHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDPTRRMGSKM 407 (457)
Q Consensus 329 ~l~~~-~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rps~~~ 407 (457)
.+... .++.+.|+|++|+++++| ..+.+++.+||..||++||+
T Consensus 164 ~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------~~~~~~l~~~l~~~p~~R~~--- 207 (215)
T cd00180 164 VLLGKGYYSEKSDIWSLGVILYEL---------------------------------PELKDLIRKMLQKDPEKRPS--- 207 (215)
T ss_pred HhcccCCCCchhhhHHHHHHHHHH---------------------------------HHHHHHHHHHhhCCcccCcC---
Confidence 99887 788999999999999999 56899999999999999999
Q ss_pred ChHHHhcCC
Q 012762 408 GATAIKRHQ 416 (457)
Q Consensus 408 ~~~~ll~hp 416 (457)
+.++++|+
T Consensus 208 -~~~l~~~~ 215 (215)
T cd00180 208 -AKEILEHL 215 (215)
T ss_pred -HHHHhhCC
Confidence 99999874
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=294.07 Aligned_cols=236 Identities=16% Similarity=0.200 Sum_probs=159.0
Q ss_pred HcCC-CCCceEEEEE-------EcCCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeec
Q 012762 142 MLDH-PFLPTLYATL-------DCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRD 213 (457)
Q Consensus 142 ~l~H-~nIv~l~~~~-------~~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrD 213 (457)
.+.| +||+.++++| ...+.++++||++ +++|..++... ...+++..++.++.||+.||.|||++||||||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrD 105 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP-DRSVDAFECFHVFRQIVEIVNAAHSQGIVVHN 105 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc-cccccHHHHHHHHHHHHHHHHHHHhCCeeecc
Confidence 3455 5777888877 2234567889988 78999998653 35699999999999999999999999999999
Q ss_pred CCCCCeEEccCCCEEEeccCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchh
Q 012762 214 LKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRR 293 (457)
Q Consensus 214 IKp~NIll~~~~~vkl~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (457)
|||+||||+..|.+|++|||++........ ..+...+||......... ...
T Consensus 106 lKP~NiLl~~~~~~k~~d~~~~~~~~~~~~-------------------~~~ki~DfG~a~~~~~~~-------~~~--- 156 (793)
T PLN00181 106 VRPSCFVMSSFNHVSFIESASCSDSGSDED-------------------ATTKSREIGSSRREEILS-------ERR--- 156 (793)
T ss_pred CCchhEEEcccCcEEEeeccccCccccccc-------------------Cccccccccccccccccc-------ccc---
Confidence 999999999999999999998754321100 011122222221100000 000
Q ss_pred ccccCCCCCCCcccccCCccccccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhc
Q 012762 294 RKKKLGNPGTPEIVAEPLDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVAR 373 (457)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~ 373 (457)
...... ....+........+||+.|||||++.+..|+.++|||||||+||||++|.+|+..... .+..+...
T Consensus 157 ----~~~~~~--~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~--~~~~~~~~ 228 (793)
T PLN00181 157 ----IEKLEE--VKKQPFPMKQILAMEMSWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR--TMSSLRHR 228 (793)
T ss_pred ----hhhhhc--cccCCCcccccccCCCcceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH--HHHHHHHh
Confidence 000000 0000011112234699999999999999999999999999999999999998764221 22222111
Q ss_pred ccCCCCCCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCCC
Q 012762 374 ALEFPKEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGV 421 (457)
Q Consensus 374 ~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~~ 421 (457)
.. .+..........+++.+||..||.+||+ +.||++||||...
T Consensus 229 ~~-~~~~~~~~~~~~~~~~~~L~~~P~~Rps----~~eil~h~~~~~~ 271 (793)
T PLN00181 229 VL-PPQILLNWPKEASFCLWLLHPEPSCRPS----MSELLQSEFINEP 271 (793)
T ss_pred hc-ChhhhhcCHHHHHHHHHhCCCChhhCcC----hHHHhhchhhhhh
Confidence 11 1111112345678999999999999999 9999999999763
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-30 Score=238.03 Aligned_cols=211 Identities=36% Similarity=0.640 Sum_probs=175.3
Q ss_pred ceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcEEE
Q 012762 84 LRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWSCL 163 (457)
Q Consensus 84 ~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~l 163 (457)
|.+.+.||.|++|+||+|.+. .++..+|+|.+...... .....+..|++.++.++|+|++++++++......++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~----~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~ 74 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDK----GTGELVAVKVLKKEKTE--KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYL 74 (225)
T ss_pred CceeeEeecCCCeEEEEEEEc----CCCcEEEEEeeccccch--HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEE
Confidence 567899999999999999876 35789999999765332 245678889999999999999999999999899999
Q ss_pred EEeecCCCChHHHHHhCCCCC-CCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCCC
Q 012762 164 LTEFCPGGDLHVLRQRQPDKR-FHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNST 242 (457)
Q Consensus 164 V~E~~~~~sL~~~~~~~~~~~-~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~~ 242 (457)
++|++.+++|..++... .. +++..+..++.|++.+|.|||+.+++|+||+|.||+++.++.++|+|||++.......
T Consensus 75 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~ 152 (225)
T smart00221 75 VMEYCEGGDLFDYLRKK--GGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDL 152 (225)
T ss_pred EEeccCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcc
Confidence 99999999999998875 33 8899999999999999999999999999999999999999999999999876543211
Q ss_pred cccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCCC
Q 012762 243 STAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTH 322 (457)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 322 (457)
.. ......++.
T Consensus 153 ~~---------------------------------------------------------------------~~~~~~~~~ 163 (225)
T smart00221 153 AA---------------------------------------------------------------------LLKTVKGTP 163 (225)
T ss_pred cc---------------------------------------------------------------------cccceeccC
Confidence 00 001235788
Q ss_pred CccCchhh-cCCCCCccchhhhhhHHHHHHhcCCCCCCC-CChH-HHHHHHH
Q 012762 323 EYLAPEII-SGEGHGNAVDWWTLGIFIFELFYGTTPFKG-IDHE-LTLANVV 371 (457)
Q Consensus 323 ~y~aPE~l-~~~~~~~~sDiwSlG~il~elltG~~Pf~~-~~~~-~~~~~~~ 371 (457)
.|++||.+ ....++.++|+|+||+++++|++|+.||.. .... .+...+.
T Consensus 164 ~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~ 215 (225)
T smart00221 164 FYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWS 215 (225)
T ss_pred CcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHh
Confidence 99999999 666678899999999999999999999977 4444 3444433
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-32 Score=275.57 Aligned_cols=274 Identities=40% Similarity=0.720 Sum_probs=232.4
Q ss_pred EecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcC-CCCCceEEEEEEcCCcEEEEEee
Q 012762 89 RLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLD-HPFLPTLYATLDCPRWSCLLTEF 167 (457)
Q Consensus 89 ~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~-H~nIv~l~~~~~~~~~~~lV~E~ 167 (457)
++|+|+||.|++++ +......+..||+|+.++......... ....|..++..++ ||.+|++.-.|+.+...+++++|
T Consensus 1 vlg~g~~gkvfLvr-k~~g~da~~~yamkvl~k~t~~~~~~~-~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~ 78 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVR-KAGGADAGHLYAMKVLKKATLKVRDRT-HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDF 78 (612)
T ss_pred CCCcCCCcchHHHH-Hhccccccchhhhhccccccccccccc-ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhh
Confidence 37999999999987 334456788999999988766555444 5566888999986 99999999999999999999999
Q ss_pred cCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCCCccccc
Q 012762 168 CPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQL 247 (457)
Q Consensus 168 ~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~~~~~~~ 247 (457)
..||.|...+.. ...+.+...+.+...++.+++++|+.+|+|||+|++||+++.+|++++.|||+++..-..+
T Consensus 79 ~rgg~lft~l~~--~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~----- 151 (612)
T KOG0603|consen 79 LRGGDLFTRLSK--EVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK----- 151 (612)
T ss_pred cccchhhhcccc--CCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhh-----
Confidence 999999765544 3668888899999999999999999999999999999999999999999999976543111
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCCCCccCc
Q 012762 248 VSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTHEYLAP 327 (457)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 327 (457)
..|||..||||
T Consensus 152 ---------------------------------------------------------------------~~cgt~eymAp 162 (612)
T KOG0603|consen 152 ---------------------------------------------------------------------IACGTYEYRAP 162 (612)
T ss_pred ---------------------------------------------------------------------hcccchhhhhh
Confidence 11699999999
Q ss_pred hhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhhhCCCCCCCCC-
Q 012762 328 EIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDPTRRMGSK- 406 (457)
Q Consensus 328 E~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rps~~- 406 (457)
|+++ .+...+|.||||++++||++|..||.+ +....|+......|.. +...+++++..++..+|.+|....
T Consensus 163 EI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~p~~--l~~~a~~~~~~l~~r~p~nrLg~~~ 234 (612)
T KOG0603|consen 163 EIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEMPRE--LSAEARSLFRQLFKRNPENRLGAGP 234 (612)
T ss_pred Hhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCCchh--hhHHHHHHHHHHHhhCHHHHhccCc
Confidence 9998 678899999999999999999999988 6667777666666655 788899999999999999999864
Q ss_pred cChHHHhcCCCCCCCCchhh--hccCCCCCCCCCCccccccccC
Q 012762 407 MGATAIKRHQFFNGVNWALL--RCAKPPFIPRPVTCRDLTTTNS 448 (457)
Q Consensus 407 ~~~~~ll~hp~f~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 448 (457)
..+.++++|+||..++|+.+ +..+|||.|...+.++..+.+.
T Consensus 235 ~~~~eik~h~f~~~i~~~~l~~r~~~~~fkp~~~~e~~~~~fd~ 278 (612)
T KOG0603|consen 235 DGVDEIKQHEFFQSIDWNELEARSRPPPFKPGSITERDVAQFDP 278 (612)
T ss_pred chhHHHhccchheeeeHhhHhhcCCCCCCCCcccchhhhhhcCc
Confidence 57899999999999999955 6788899988877777665544
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=231.65 Aligned_cols=284 Identities=18% Similarity=0.287 Sum_probs=226.2
Q ss_pred CCccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcC-CCCCceEEEEE
Q 012762 77 NPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLD-HPFLPTLYATL 155 (457)
Q Consensus 77 ~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~-H~nIv~l~~~~ 155 (457)
..+..+.|+++++||+|+||.+|+|... .+|..||||+-+.. .....+..|..+.+.|+ ...|..+..++
T Consensus 10 ~~iv~gky~lvrkiGsGSFGdIy~~~~i----~~ge~VAiK~Es~~-----a~hpqL~yEskvY~iL~~g~GiP~i~~y~ 80 (341)
T KOG1163|consen 10 ELIVGGKYKLVRKIGSGSFGDIYLGISI----TSGEEVAIKLESSK-----AKHPQLLYESKVYRILQGGVGIPHIRHYG 80 (341)
T ss_pred hheeccceEEEEeecCCchhheeeeeec----cCCceEEEEeeccc-----CCCcchhHHHHHHHHhccCCCCchhhhhc
Confidence 4466788999999999999999999876 58999999998654 45556777999999996 57899999999
Q ss_pred EcCCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccC---CCEEEecc
Q 012762 156 DCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSD---GHIMLTDF 232 (457)
Q Consensus 156 ~~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~---~~vkl~DF 232 (457)
.+..+-.|||+++ |.+|++++.-+ .+.++..+++-++-||+.-++|+|.+++|||||||+|+|+.-+ ..+.|+||
T Consensus 81 ~e~~ynvlVMdLL-GPsLEdLfnfC-~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDF 158 (341)
T KOG1163|consen 81 TEKDYNVLVMDLL-GPSLEDLFNFC-SRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDF 158 (341)
T ss_pred cccccceeeeecc-CccHHHHHHHH-hhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEec
Confidence 9999999999999 99999998775 4779999999999999999999999999999999999999744 57899999
Q ss_pred CCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCc
Q 012762 233 DLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLD 312 (457)
Q Consensus 233 G~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (457)
|+++...+..+....+-
T Consensus 159 GLaKky~d~~t~~HIpy--------------------------------------------------------------- 175 (341)
T KOG1163|consen 159 GLAKKYRDIRTRQHIPY--------------------------------------------------------------- 175 (341)
T ss_pred cchhhhccccccccCcc---------------------------------------------------------------
Confidence 99988765543322110
Q ss_pred cccccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCC---hHHHHHHHHhcccCCCCC---CCCChH
Q 012762 313 VRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGID---HELTLANVVARALEFPKE---PSVPGP 386 (457)
Q Consensus 313 ~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~---~~~~~~~~~~~~~~~~~~---~~~~~~ 386 (457)
.....+.||..|.+-....+...+.+.|+-|+|.+|..+..|..||++.. ..+.+++|.......+.. ..+|.+
T Consensus 176 re~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~ie~LC~G~P~E 255 (341)
T KOG1163|consen 176 REDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPIEVLCKGFPAE 255 (341)
T ss_pred ccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCHHHHhCCCcHH
Confidence 01114579999999988888888999999999999999999999999864 445677777777666543 467888
Q ss_pred HHHHHHHHhhhCCCCCCCCCcChHHH-------hcCCCCCCCCchhhhccCCCCCC
Q 012762 387 AKDLIAQLLVKDPTRRMGSKMGATAI-------KRHQFFNGVNWALLRCAKPPFIP 435 (457)
Q Consensus 387 ~~~ll~~~L~~dP~~Rps~~~~~~~l-------l~hp~f~~~~~~~~~~~~~~~~~ 435 (457)
+...+.-|-..--++-|..-. +.++ |+|.+---.||..+++....--+
T Consensus 256 F~myl~Y~R~L~F~E~Pdy~y-lrqlFriLfr~ln~~~d~iyDW~~lkqk~~q~~~ 310 (341)
T KOG1163|consen 256 FAMYLNYCRGLGFEEKPDYMY-LRQLFRILFRTLNHQYDYIYDWTMLKQKSQQSGR 310 (341)
T ss_pred HHHHHHHHhhcCCCCCCcHHH-HHHHHHHHHhhccccCCeEeeHHHHHHHhhcccC
Confidence 999999987766666666321 2222 45555455799999765554443
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-30 Score=235.12 Aligned_cols=239 Identities=21% Similarity=0.309 Sum_probs=181.2
Q ss_pred CCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHc-CCCCCceEEE-EEEcCC
Q 012762 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEML-DHPFLPTLYA-TLDCPR 159 (457)
Q Consensus 82 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~~-~~~~~~ 159 (457)
+.|.|.+.||+|.||.+-+|+++ .++..+|+|.+.+... ....|.+|...--.| .|.||+.-|+ .|+..+
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr----~s~t~ivlKavp~p~t----t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d 95 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHR----QSKTRIVLKAVPRPQT----TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSD 95 (378)
T ss_pred hhhhHHHHhcccceeeEEeeecc----CCceEEEeeccCcchh----hHHHHHHHhccceeeccchhhhHHHHHHhhcCc
Confidence 56999999999999999999988 4788999999876543 344455565543334 5889988776 577888
Q ss_pred cEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEcc--CCCEEEeccCCCcC
Q 012762 160 WSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRS--DGHIMLTDFDLSLK 237 (457)
Q Consensus 160 ~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~--~~~vkl~DFG~s~~ 237 (457)
.++++|||++.|+|..-+.. .++.|...+.++.|+++||.|||++++||||||.+||||-. .-.|||||||+.+.
T Consensus 96 ~YvF~qE~aP~gdL~snv~~---~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k 172 (378)
T KOG1345|consen 96 AYVFVQEFAPRGDLRSNVEA---AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRK 172 (378)
T ss_pred eEEEeeccCccchhhhhcCc---ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccc
Confidence 88999999999999765544 67999999999999999999999999999999999999953 24899999998753
Q ss_pred CCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcccccc
Q 012762 238 GDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMS 317 (457)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (457)
...-.. .
T Consensus 173 ~g~tV~-------------------------------------------------------------------------~ 179 (378)
T KOG1345|consen 173 VGTTVK-------------------------------------------------------------------------Y 179 (378)
T ss_pred cCceeh-------------------------------------------------------------------------h
Confidence 321000 1
Q ss_pred ccCCCCccCchhhcCC---C--CCccchhhhhhHHHHHHhcCCCCCCCCChH-H---HHHHHHhc-ccCCCC-CCCCChH
Q 012762 318 FVGTHEYLAPEIISGE---G--HGNAVDWWTLGIFIFELFYGTTPFKGIDHE-L---TLANVVAR-ALEFPK-EPSVPGP 386 (457)
Q Consensus 318 ~~gt~~y~aPE~l~~~---~--~~~~sDiwSlG~il~elltG~~Pf~~~~~~-~---~~~~~~~~-~~~~~~-~~~~~~~ 386 (457)
+--+..|.+||.+... . ..+.+|||.||+++|.+++|.+||+..... . .+.+...+ ....|. ...+++.
T Consensus 180 ~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~F~~fs~~ 259 (378)
T KOG1345|consen 180 LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKKFNPFSEK 259 (378)
T ss_pred hhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCchhhcccCHH
Confidence 1246679999987533 2 367899999999999999999999854321 1 12222222 223332 2357788
Q ss_pred HHHHHHHHhhhCCCCCCC
Q 012762 387 AKDLIAQLLVKDPTRRMG 404 (457)
Q Consensus 387 ~~~ll~~~L~~dP~~Rps 404 (457)
+..+.++-|..++++|-.
T Consensus 260 a~r~Fkk~lt~~~~drck 277 (378)
T KOG1345|consen 260 ALRLFKKSLTPRFKDRCK 277 (378)
T ss_pred HHHHHHHhcCCcccccch
Confidence 999999999999999955
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8e-28 Score=236.87 Aligned_cols=256 Identities=25% Similarity=0.326 Sum_probs=194.9
Q ss_pred CceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCC----CCCceEEEEE-Ec
Q 012762 83 DLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDH----PFLPTLYATL-DC 157 (457)
Q Consensus 83 ~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H----~nIv~l~~~~-~~ 157 (457)
+|++.++||+|+||.||+|.+.... ...+|+|+....... ....+..|..+|..+.. .++..+++.+ ..
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~---~~~~a~K~e~~~~~~---~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~ 92 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEK---NKEYAKKLEKKELGS---KPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRST 92 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCC---CeeEEEEEEEecccC---CCccchhHHHHHHHHhhhcCCCCCCEEEEeccCC
Confidence 7999999999999999999976421 468999998764221 11256779999988863 6899999999 57
Q ss_pred CCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccC-----CCEEEecc
Q 012762 158 PRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSD-----GHIMLTDF 232 (457)
Q Consensus 158 ~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~-----~~vkl~DF 232 (457)
+.+.||||+++ |.+|.++....+.+.++...+..++.|++.+|++||+.|+|||||||+|+++... ..+.|.||
T Consensus 93 ~~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDf 171 (322)
T KOG1164|consen 93 EDFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDF 171 (322)
T ss_pred CceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEec
Confidence 88899999999 9999999988777899999999999999999999999999999999999999865 36999999
Q ss_pred CCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCc
Q 012762 233 DLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLD 312 (457)
Q Consensus 233 G~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (457)
|+++.......... . ..+..
T Consensus 172 Glar~~~~~~~~~~---------------------------------------------------------~---~~~~r 191 (322)
T KOG1164|consen 172 GLARRFKYVGDSGG---------------------------------------------------------N---LRPPR 191 (322)
T ss_pred CCCccccccCCCCc---------------------------------------------------------c---cccCC
Confidence 99973321110000 0 00000
Q ss_pred cccccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHH---hcccCCCCCCCCChHHHH
Q 012762 313 VRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVV---ARALEFPKEPSVPGPAKD 389 (457)
Q Consensus 313 ~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~ 389 (457)
.....+.||..|+++.+..+...+.+.|+||++.++.||+.|..||.+.........+. ............+..+..
T Consensus 192 ~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (322)
T KOG1164|consen 192 PQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPRKLLTDRFGDLKPEEFAK 271 (322)
T ss_pred CCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhhhhccccccCCChHHHHH
Confidence 10124569999999999999999999999999999999999999997765332222221 111111112235567888
Q ss_pred HHHHHhhhCCCCCCCC
Q 012762 390 LIAQLLVKDPTRRMGS 405 (457)
Q Consensus 390 ll~~~L~~dP~~Rps~ 405 (457)
++..+-..+...+|..
T Consensus 272 ~~~~~~~~~~~~~Pdy 287 (322)
T KOG1164|consen 272 ILEYIDSLDYEDKPDY 287 (322)
T ss_pred HHHHhhccCCcCCCCH
Confidence 8888878899999994
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-27 Score=221.28 Aligned_cols=248 Identities=20% Similarity=0.332 Sum_probs=197.6
Q ss_pred CceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHc-CCCCCceEEEEEEcCCcE
Q 012762 83 DLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEML-DHPFLPTLYATLDCPRWS 161 (457)
Q Consensus 83 ~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~~~~~~~~~~ 161 (457)
.|++.++||+|.||++++|... .+++.||||.-..+ ...-+++.|.+..+.| ..++|..+|-+..++.+-
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl----~nne~VAIKfEPrk-----S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~N 99 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNL----YNNEPVAIKFEPRK-----SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYN 99 (449)
T ss_pred cceeccccccCcceeeeccccc----ccCceEEEEecccc-----CCcchHHHHHHHHHHHcCCCCCCceeeeccccchh
Confidence 6999999999999999999865 58999999987543 3445567788888888 579999999999999999
Q ss_pred EEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCC-----CEEEeccCCCc
Q 012762 162 CLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDG-----HIMLTDFDLSL 236 (457)
Q Consensus 162 ~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~-----~vkl~DFG~s~ 236 (457)
.||||++ |.+|+++..-+ +++|+...+..++.||+.-++|+|++.+|.|||||+|+||...+ .+.|+|||+++
T Consensus 100 iLVidLL-GPSLEDLFD~C-gR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK 177 (449)
T KOG1165|consen 100 ILVIDLL-GPSLEDLFDLC-GRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAK 177 (449)
T ss_pred hhhhhhh-CcCHHHHHHHh-cCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchh
Confidence 9999999 99999998876 57899999999999999999999999999999999999997544 58999999999
Q ss_pred CCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccc
Q 012762 237 KGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSM 316 (457)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (457)
...++.+...++- . ...
T Consensus 178 ~YrDp~TkqHIPY--------------------------------------------------------------r-E~K 194 (449)
T KOG1165|consen 178 EYRDPKTKQHIPY--------------------------------------------------------------R-EHK 194 (449)
T ss_pred hhcCccccccCcc--------------------------------------------------------------c-ccc
Confidence 8887665443211 0 112
Q ss_pred cccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCC---ChHHHHHHHHhcccCCCCC---CCCChHHHHH
Q 012762 317 SFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGI---DHELTLANVVARALEFPKE---PSVPGPAKDL 390 (457)
Q Consensus 317 ~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~---~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l 390 (457)
++.||..||+-....|...+.+.|+-|||-+++..|.|..||.+. ++++.+++|-+..-..+.. ..+|.++..-
T Consensus 195 SLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~i~~Lc~g~P~efa~Y 274 (449)
T KOG1165|consen 195 SLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTPIEVLCEGFPEEFATY 274 (449)
T ss_pred ccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCCHHHHHhcCHHHHHHH
Confidence 457999999999999999999999999999999999999999875 4556666655443333321 2355555554
Q ss_pred HHHHhhhCCCCCCC
Q 012762 391 IAQLLVKDPTRRMG 404 (457)
Q Consensus 391 l~~~L~~dP~~Rps 404 (457)
|.-.-..+-++-|.
T Consensus 275 l~yvR~L~F~E~PD 288 (449)
T KOG1165|consen 275 LRYVRRLDFFETPD 288 (449)
T ss_pred HHHHHhcCcccCCC
Confidence 44444444444444
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-28 Score=219.34 Aligned_cols=161 Identities=20% Similarity=0.192 Sum_probs=128.1
Q ss_pred CChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCCCcccccccC
Q 012762 171 GDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQLVSD 250 (457)
Q Consensus 171 ~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~~~~~~~~~~ 250 (457)
|+|.+++... ...+++..++.++.||+.||.|||+.+ ||+|||++.++.+|+ ||++......
T Consensus 1 GsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~--------- 62 (176)
T smart00750 1 VSLADILEVR-GRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE--------- 62 (176)
T ss_pred CcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc---------
Confidence 6888888764 356999999999999999999999998 999999999999999 9987543210
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCCCCccCchhh
Q 012762 251 QSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTHEYLAPEII 330 (457)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l 330 (457)
...||+.|||||++
T Consensus 63 ------------------------------------------------------------------~~~g~~~y~aPE~~ 76 (176)
T smart00750 63 ------------------------------------------------------------------QSRVDPYFMAPEVI 76 (176)
T ss_pred ------------------------------------------------------------------cCCCcccccChHHh
Confidence 01488999999999
Q ss_pred cCCCCCccchhhhhhHHHHHHhcCCCCCCCCChH-HHHHHHHhcccCCC-----CCCCCCh--HHHHHHHHHhhhCCCCC
Q 012762 331 SGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHE-LTLANVVARALEFP-----KEPSVPG--PAKDLIAQLLVKDPTRR 402 (457)
Q Consensus 331 ~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~-~~~~~~~~~~~~~~-----~~~~~~~--~~~~ll~~~L~~dP~~R 402 (457)
.+..++.++|||||||++|||++|+.||...... ..+..+........ ....++. .+.++|.+||..||.+|
T Consensus 77 ~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~R 156 (176)
T smart00750 77 QGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFMRVCASRLPQRR 156 (176)
T ss_pred cCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHHHHHhcccccc
Confidence 9999999999999999999999999999765432 23333333222211 1112333 58999999999999999
Q ss_pred CCCCcChHHHhcCCCCC
Q 012762 403 MGSKMGATAIKRHQFFN 419 (457)
Q Consensus 403 ps~~~~~~~ll~hp~f~ 419 (457)
|+ +.++++|+|+.
T Consensus 157 p~----~~~ll~~~~~~ 169 (176)
T smart00750 157 EA----ANHYLAHCRAL 169 (176)
T ss_pred cC----HHHHHHHHHHH
Confidence 99 99999999864
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.3e-28 Score=256.12 Aligned_cols=265 Identities=38% Similarity=0.675 Sum_probs=203.2
Q ss_pred CCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCc
Q 012762 81 LSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRW 160 (457)
Q Consensus 81 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~ 160 (457)
-.+|..++.|-.|+||-||+++++ .+.+.||+|+ +++.+.-++ ||...+.|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~----~trqrfa~ki-Nkq~lilRn----------ilt~a~npfvv----------- 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHK----ETRQRFAMKI-NKQNLILRN----------ILTFAGNPFVV----------- 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeecc----ccccchhhcc-cccchhhhc----------cccccCCccee-----------
Confidence 368999999999999999999987 4778899954 444331111 44444555555
Q ss_pred EEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCC
Q 012762 161 SCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDN 240 (457)
Q Consensus 161 ~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~ 240 (457)
|+=..+++.. +.++. +++.+++|||+-||+|||+||+|.+|+.-|++|++|||+++....
T Consensus 136 ----------gDc~tllk~~--g~lPv--------dmvla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLm 195 (1205)
T KOG0606|consen 136 ----------GDCATLLKNI--GPLPV--------DMVLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLM 195 (1205)
T ss_pred ----------chhhhhcccC--CCCcc--------hhhHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhh
Confidence 3333334432 33442 348899999999999999999999999999999999999876543
Q ss_pred CCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccC
Q 012762 241 STSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVG 320 (457)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 320 (457)
...+ .+.... +............+|
T Consensus 196 s~at-nl~eg~------------------------------------------------------I~k~t~Ef~dKqvcg 220 (1205)
T KOG0606|consen 196 SLAT-NLKEGH------------------------------------------------------IEKDTHEFQDKQVCG 220 (1205)
T ss_pred hccc-hhhhcc------------------------------------------------------hHHHHHHhhhccccC
Confidence 3222 111000 000011112234689
Q ss_pred CCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCC-CCCChHHHHHHHHHhhhCC
Q 012762 321 THEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKE-PSVPGPAKDLIAQLLVKDP 399 (457)
Q Consensus 321 t~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ll~~~L~~dP 399 (457)
|+.|+|||++...+|+..+|+|++|+|+||.+.|..||.+...++.+...+...+.+++. ..++.++++++.++|..+|
T Consensus 221 TPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~dea~p~Ea~dli~~LL~qnp 300 (1205)
T KOG0606|consen 221 TPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEEDEALPPEAQDLIEQLLRQNP 300 (1205)
T ss_pred CccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccccCcCCCHHHHHHHHHHHHhCh
Confidence 999999999999999999999999999999999999999999999999999888877764 4678899999999999999
Q ss_pred CCCCCCCcChHHHhcCCCCCCCCchhhhccCCCCCCCCCCcccccccc
Q 012762 400 TRRMGSKMGATAIKRHQFFNGVNWALLRCAKPPFIPRPVTCRDLTTTN 447 (457)
Q Consensus 400 ~~Rps~~~~~~~ll~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 447 (457)
..|.... .+-++.+|+||+..||.-|-.++.+|+|......|...-.
T Consensus 301 ~~Rlgt~-ga~evk~h~ff~~LDw~~llRqkaefvpql~~eddtsyfd 347 (1205)
T KOG0606|consen 301 LCRLGTG-GALEVKQHGFFQLLDWKSLLRQKAEFVPQLESEDDTSYFD 347 (1205)
T ss_pred Hhhcccc-hhhhhhhccceeecccchhhhhhccccccccccccchhhc
Confidence 9997654 6889999999999999977778899999887777655433
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.9e-26 Score=219.93 Aligned_cols=262 Identities=32% Similarity=0.517 Sum_probs=205.6
Q ss_pred ceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCC-CCceEEEEEEcCCcEE
Q 012762 84 LRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHP-FLPTLYATLDCPRWSC 162 (457)
Q Consensus 84 ~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~-nIv~l~~~~~~~~~~~ 162 (457)
|.+.+.||.|+||.||++.+. ..+|+|.+.............+.+|+.+++.+.|+ +|+++++++......+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~-------~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~ 74 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR-------KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLY 74 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec-------cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEE
Confidence 788999999999999999864 67899999877554443577788899999999988 7999999998777789
Q ss_pred EEEeecCCCChHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCC-CEEEeccCCCcCCCC
Q 012762 163 LLTEFCPGGDLHVLRQRQPD-KRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDG-HIMLTDFDLSLKGDN 240 (457)
Q Consensus 163 lV~E~~~~~sL~~~~~~~~~-~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~-~vkl~DFG~s~~~~~ 240 (457)
++++++.+++|..++..... ..+.......++.|++.++.|+|+.+++||||||+||+++..+ .++++|||++.....
T Consensus 75 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~ 154 (384)
T COG0515 75 LVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPD 154 (384)
T ss_pred EEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCC
Confidence 99999999999966665421 2689999999999999999999999999999999999999988 799999999863332
Q ss_pred CCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccC
Q 012762 241 STSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVG 320 (457)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 320 (457)
....... .......+|
T Consensus 155 ~~~~~~~----------------------------------------------------------------~~~~~~~~~ 170 (384)
T COG0515 155 PGSTSSI----------------------------------------------------------------PALPSTSVG 170 (384)
T ss_pred CCccccc----------------------------------------------------------------ccccccccc
Confidence 1111000 001224579
Q ss_pred CCCccCchhhcC---CCCCccchhhhhhHHHHHHhcCCCCCCCCCh----HHHHHHHHhcccC-CCCCC--CC----ChH
Q 012762 321 THEYLAPEIISG---EGHGNAVDWWTLGIFIFELFYGTTPFKGIDH----ELTLANVVARALE-FPKEP--SV----PGP 386 (457)
Q Consensus 321 t~~y~aPE~l~~---~~~~~~sDiwSlG~il~elltG~~Pf~~~~~----~~~~~~~~~~~~~-~~~~~--~~----~~~ 386 (457)
|..|++||.+.+ ..+....|+||+|++++++++|..||..... ......+...... ..... .. ...
T Consensus 171 t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (384)
T COG0515 171 TPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSPSNPELISKA 250 (384)
T ss_pred ccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccccccCccccchhhHH
Confidence 999999999988 5688999999999999999999999887663 3333333333322 22111 11 146
Q ss_pred HHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCC
Q 012762 387 AKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNG 420 (457)
Q Consensus 387 ~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~ 420 (457)
+.+++.+++..+|..|.+ ..+...++|...
T Consensus 251 ~~~~~~~~~~~~~~~r~~----~~~~~~~~~~~~ 280 (384)
T COG0515 251 ASDLLKKLLAKDPKNRLS----SSSDLSHDLLAH 280 (384)
T ss_pred HHHHHHHHHhcCchhcCC----HHHHhhchHhhC
Confidence 899999999999999999 777777755554
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-28 Score=257.28 Aligned_cols=263 Identities=24% Similarity=0.322 Sum_probs=193.5
Q ss_pred eeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehh---hhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcE
Q 012762 85 RFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKR---ELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWS 161 (457)
Q Consensus 85 ~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~ 161 (457)
...+.+|.|++|.|+.+.... ....++.|.+... ..........+..|.-+-..|.|+|++..+..+.+....
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~----~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~ 396 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRS----DLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGI 396 (601)
T ss_pred CccceeeecccCceEEEEecC----CCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccc
Confidence 467889999999888776542 3334444443311 111111112244455566678999998877766655555
Q ss_pred EEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCC
Q 012762 162 CLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNS 241 (457)
Q Consensus 162 ~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~ 241 (457)
.-+||||++ +|+.++... +.++..++..++.|++.||+|||+.||.|||||++|+++..+|.+||+|||.+....-.
T Consensus 397 ~~~mE~~~~-Dlf~~~~~~--~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~ 473 (601)
T KOG0590|consen 397 LQSMEYCPY-DLFSLVMSN--GKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYP 473 (601)
T ss_pred hhhhhcccH-HHHHHHhcc--cccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccC
Confidence 555999999 999988874 57899999999999999999999999999999999999999999999999987544321
Q ss_pred CcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCC
Q 012762 242 TSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGT 321 (457)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 321 (457)
-.. .......++|+
T Consensus 474 ~e~------------------------------------------------------------------~~~~~~g~~gS 487 (601)
T KOG0590|consen 474 WEK------------------------------------------------------------------NIHESSGIVGS 487 (601)
T ss_pred cch------------------------------------------------------------------hhhhhcCcccC
Confidence 110 01122356899
Q ss_pred CCccCchhhcCCCCCc-cchhhhhhHHHHHHhcCCCCCCCCChHHHHH-HHH-hcccC-----CCCCCCCChHHHHHHHH
Q 012762 322 HEYLAPEIISGEGHGN-AVDWWTLGIFIFELFYGTTPFKGIDHELTLA-NVV-ARALE-----FPKEPSVPGPAKDLIAQ 393 (457)
Q Consensus 322 ~~y~aPE~l~~~~~~~-~sDiwSlG~il~elltG~~Pf~~~~~~~~~~-~~~-~~~~~-----~~~~~~~~~~~~~ll~~ 393 (457)
..|+|||++.+..|+. ..||||.|+++..|.+|+.||......+... ... ..... ......++...+.+|.+
T Consensus 488 ~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~lp~~~~~~~~~ 567 (601)
T KOG0590|consen 488 DPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSLLPRETRIIIYR 567 (601)
T ss_pred CcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHHhchhhHHHHHHH
Confidence 9999999999999965 7899999999999999999997655443321 110 00000 01123467788999999
Q ss_pred HhhhCCCCCCCCCcChHHHhcCCCCCCCCch
Q 012762 394 LLVKDPTRRMGSKMGATAIKRHQFFNGVNWA 424 (457)
Q Consensus 394 ~L~~dP~~Rps~~~~~~~ll~hp~f~~~~~~ 424 (457)
||+.||.+|.+ +++|++.+||+.++=+
T Consensus 568 ~l~~~P~~R~t----i~~i~~d~W~~~i~~c 594 (601)
T KOG0590|consen 568 MLQLDPTKRIT----IEQILNDEWIRSIECC 594 (601)
T ss_pred HccCChhheec----HHHHhhChHhhhcceE
Confidence 99999999999 9999999999987644
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-26 Score=228.98 Aligned_cols=145 Identities=22% Similarity=0.146 Sum_probs=115.3
Q ss_pred ccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhh--hhhhHHHHHHHHHHHHHHcCCCCCce-EEEEE
Q 012762 79 LTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKREL--VSRNKESRARIEREILEMLDHPFLPT-LYATL 155 (457)
Q Consensus 79 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~~~~E~~il~~l~H~nIv~-l~~~~ 155 (457)
.-.++|.+.++||+|+||+||+|+++. .+++.||||++..... ........+.+|+++|+.++|+||+. ++++
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~---~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~- 90 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAG---DPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT- 90 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcC---CCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc-
Confidence 345689999999999999999998763 2567789998753211 12233566889999999999999985 5442
Q ss_pred EcCCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecC-CCCCeEEccCCCEEEeccCC
Q 012762 156 DCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDL-KPENVLVRSDGHIMLTDFDL 234 (457)
Q Consensus 156 ~~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDI-Kp~NIll~~~~~vkl~DFG~ 234 (457)
+..||||||++|++|... . . .. ...++.|++.+|.|||+.||+|||| ||+|||++.++.+||+|||+
T Consensus 91 ---~~~~LVmE~~~G~~L~~~-~--~---~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGl 158 (365)
T PRK09188 91 ---GKDGLVRGWTEGVPLHLA-R--P---HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQL 158 (365)
T ss_pred ---CCcEEEEEccCCCCHHHh-C--c---cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECcc
Confidence 457999999999999632 1 1 11 1467899999999999999999999 99999999999999999999
Q ss_pred CcCCC
Q 012762 235 SLKGD 239 (457)
Q Consensus 235 s~~~~ 239 (457)
++...
T Consensus 159 A~~~~ 163 (365)
T PRK09188 159 ASVFR 163 (365)
T ss_pred ceecc
Confidence 87664
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-25 Score=204.14 Aligned_cols=266 Identities=20% Similarity=0.334 Sum_probs=213.0
Q ss_pred ChhHHHHHHhhhcCCCCCCCCCccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHH
Q 012762 57 DPCWKAIKEATSEGNNNNNNNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIE 136 (457)
Q Consensus 57 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E 136 (457)
+..|+..+... ..........++..++.++.+|.+...|..|+|+|. |..+++|+++.+....+. ...|..|
T Consensus 166 dt~wkgtktr~-rdatlsr~~gid~~~lnl~tkl~e~hsgelwrgrwq------gndivakil~vr~~t~ri-srdfnee 237 (448)
T KOG0195|consen 166 DTTWKGTKTRT-RDATLSRYTGIDVSSLNLITKLAESHSGELWRGRWQ------GNDIVAKILNVREVTARI-SRDFNEE 237 (448)
T ss_pred ccccccccccc-cccccccccCcchhhhhhhhhhccCCCccccccccc------Ccchhhhhhhhhhcchhh-cchhhhh
Confidence 44455533222 222333455677788889999999999999999985 445777998877665443 3446668
Q ss_pred HHHHHHcCCCCCceEEEEEEcCCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcC--ceeecC
Q 012762 137 REILEMLDHPFLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMG--IIYRDL 214 (457)
Q Consensus 137 ~~il~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~--iiHrDI 214 (457)
.-.|+.+.||||+.+++.+....++.++..|++.|+|+.+++...+-..+..++..++.+|+.|+.|||+.. |.---|
T Consensus 238 fp~lrifshpnilpvlgacnsppnlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~l 317 (448)
T KOG0195|consen 238 FPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYL 317 (448)
T ss_pred CcceeeecCCchhhhhhhccCCCCceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhc
Confidence 888888999999999999999999999999999999999999987777888999999999999999999875 444568
Q ss_pred CCCCeEEccCCCEEE--eccCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcch
Q 012762 215 KPENVLVRSDGHIML--TDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKR 292 (457)
Q Consensus 215 Kp~NIll~~~~~vkl--~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (457)
....++|+++.+.+| +|--++...
T Consensus 318 ns~hvmidedltarismad~kfsfqe------------------------------------------------------ 343 (448)
T KOG0195|consen 318 NSKHVMIDEDLTARISMADTKFSFQE------------------------------------------------------ 343 (448)
T ss_pred ccceEEecchhhhheecccceeeeec------------------------------------------------------
Confidence 888999998876554 343332111
Q ss_pred hccccCCCCCCCcccccCCccccccccCCCCccCchhhcCCCC---CccchhhhhhHHHHHHhcCCCCCCCCChHHHHHH
Q 012762 293 RRKKKLGNPGTPEIVAEPLDVRSMSFVGTHEYLAPEIISGEGH---GNAVDWWTLGIFIFELFYGTTPFKGIDHELTLAN 369 (457)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~---~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~ 369 (457)
......+.||+||.++..+- -.++|+|||++++|||.|.+.||...+..+.-.+
T Consensus 344 -----------------------~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmk 400 (448)
T KOG0195|consen 344 -----------------------VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMK 400 (448)
T ss_pred -----------------------cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhh
Confidence 01235789999999988764 3479999999999999999999999998888888
Q ss_pred HHhcccCCCCCCCCChHHHHHHHHHhhhCCCCCCCCCc
Q 012762 370 VVARALEFPKEPSVPGPAKDLIAQLLVKDPTRRMGSKM 407 (457)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rps~~~ 407 (457)
+....++...++.++..+..|+.-|+..||-+||.+-+
T Consensus 401 ialeglrv~ippgis~hm~klm~icmnedpgkrpkfdm 438 (448)
T KOG0195|consen 401 IALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDM 438 (448)
T ss_pred hhhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcce
Confidence 88888888888889999999999999999999999544
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.6e-26 Score=238.02 Aligned_cols=248 Identities=21% Similarity=0.264 Sum_probs=180.8
Q ss_pred CceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhh-hhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcE
Q 012762 83 DLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKREL-VSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWS 161 (457)
Q Consensus 83 ~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~ 161 (457)
+|...+.||.+.|=+|.+|.++ .|. |+|||+-++.. .+-....+...|++ ...++|||++.+.-+...++..
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~-----eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAA 96 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDR-----EGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAA 96 (1431)
T ss_pred ceeeecccCchhhhhhhhccCC-----Cce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHH
Confidence 6888999999999999998864 555 99999977652 22222333333555 6667999999999998888889
Q ss_pred EEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCC
Q 012762 162 CLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNS 241 (457)
Q Consensus 162 ~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~ 241 (457)
|||-+|+ ..+|++.+..+ .-+...+.+.|+.||+.||.-+|..||+|+|||.+||||++-+.+.|+||.--+-.
T Consensus 97 ylvRqyv-khnLyDRlSTR--PFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPt--- 170 (1431)
T KOG1240|consen 97 YLVRQYV-KHNLYDRLSTR--PFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPT--- 170 (1431)
T ss_pred HHHHHHH-hhhhhhhhccc--hHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCc---
Confidence 9999999 78998888764 44677888999999999999999999999999999999999999999999632110
Q ss_pred CcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCC
Q 012762 242 TSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGT 321 (457)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 321 (457)
-.|+.+ +++..++-+.. ..-
T Consensus 171 ----------------------------------YLPeDN-------------------Padf~fFFDTS-------rRR 190 (1431)
T KOG1240|consen 171 ----------------------------------YLPEDN-------------------PADFTFFFDTS-------RRR 190 (1431)
T ss_pred ----------------------------------cCCCCC-------------------cccceEEEecC-------Cce
Confidence 001111 12211111111 123
Q ss_pred CCccCchhhcCC----------C-CCccchhhhhhHHHHHHhc-CCCCCCCCC-------hHHHHHHHHhcccCCCCCCC
Q 012762 322 HEYLAPEIISGE----------G-HGNAVDWWTLGIFIFELFY-GTTPFKGID-------HELTLANVVARALEFPKEPS 382 (457)
Q Consensus 322 ~~y~aPE~l~~~----------~-~~~~sDiwSlG~il~ellt-G~~Pf~~~~-------~~~~~~~~~~~~~~~~~~~~ 382 (457)
.+|.|||.+... + .+++.||||+||+++||++ |++||.-.. +....+..+++.
T Consensus 191 tCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~~e~~Le~I-------- 262 (1431)
T KOG1240|consen 191 TCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNADDPEQLLEKI-------- 262 (1431)
T ss_pred eeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCccCHHHHHHhC--------
Confidence 489999998642 2 4678999999999999997 799985311 011111111111
Q ss_pred CChHHHHHHHHHhhhCCCCCCCCCcChHHHhcC
Q 012762 383 VPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRH 415 (457)
Q Consensus 383 ~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~h 415 (457)
-+..+++||..|++.||++|.+ +++.|+-
T Consensus 263 ed~~~Rnlil~Mi~rdPs~RlS----AedyL~~ 291 (1431)
T KOG1240|consen 263 EDVSLRNLILSMIQRDPSKRLS----AEDYLQK 291 (1431)
T ss_pred cCccHHHHHHHHHccCchhccC----HHHHHHh
Confidence 2236899999999999999999 9999986
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.2e-24 Score=198.52 Aligned_cols=140 Identities=15% Similarity=0.126 Sum_probs=113.0
Q ss_pred CCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHH------HHHHHHHHHHcCCCCCceEEEE
Q 012762 81 LSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESR------ARIEREILEMLDHPFLPTLYAT 154 (457)
Q Consensus 81 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~------~~~E~~il~~l~H~nIv~l~~~ 154 (457)
.++|++++.||.|+||.||++.. ++..+|+|++.......+..... +.+|++.+.+|.|++|..+.++
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~------~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~ 103 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDT------DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDF 103 (232)
T ss_pred hCceEEEEEecCCCceEEEEEec------CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEe
Confidence 46899999999999999998653 35579999997654333333333 5788889999999999999988
Q ss_pred EEcC--------CcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCC
Q 012762 155 LDCP--------RWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGH 226 (457)
Q Consensus 155 ~~~~--------~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~ 226 (457)
+... +..+|||||++|.+|.++.. +++ ....+++.+|..||+.|++||||||.||+++.+|
T Consensus 104 ~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~------~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g- 172 (232)
T PRK10359 104 YLLAERKTLRYAHTYIMLIEYIEGVELNDMPE------ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG- 172 (232)
T ss_pred eeecccccccccCCeEEEEEEECCccHHHhhh------ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-
Confidence 6543 35789999999999977632 333 2456999999999999999999999999999988
Q ss_pred EEEeccCCCcC
Q 012762 227 IMLTDFDLSLK 237 (457)
Q Consensus 227 vkl~DFG~s~~ 237 (457)
++|+|||....
T Consensus 173 i~liDfg~~~~ 183 (232)
T PRK10359 173 LRIIDLSGKRC 183 (232)
T ss_pred EEEEECCCccc
Confidence 99999998643
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.8e-24 Score=195.02 Aligned_cols=144 Identities=24% Similarity=0.260 Sum_probs=110.1
Q ss_pred EEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhH-----------------------HHHHHHHHHHHHHc
Q 012762 87 VHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNK-----------------------ESRARIEREILEML 143 (457)
Q Consensus 87 ~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~-----------------------~~~~~~E~~il~~l 143 (457)
...||+|+||+||+|.+. +|+.||||+++......... ......|.++|.++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-----~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 76 (190)
T cd05147 2 NGCISTGKEANVYHATTA-----NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRL 76 (190)
T ss_pred CCccccccceEEEEEECC-----CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHH
Confidence 468999999999999864 68899999997653211110 12234599999999
Q ss_pred CCCCCceEEEEEEcCCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHH-HHcCceeecCCCCCeEEc
Q 012762 144 DHPFLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFL-HMMGIIYRDLKPENVLVR 222 (457)
Q Consensus 144 ~H~nIv~l~~~~~~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yL-H~~~iiHrDIKp~NIll~ 222 (457)
.+++|.....+.. . ..+|||||++|++|...+.. ...+++..+..++.|++.+|.|| |+.||+||||||+|||++
T Consensus 77 ~~~~v~~p~~~~~-~-~~~iVmE~i~g~~l~~~~~~--~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~ 152 (190)
T cd05147 77 VTAGIPCPEPILL-K-SHVLVMEFIGDDGWAAPRLK--DAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH 152 (190)
T ss_pred HHCCCCCCcEEEe-c-CCEEEEEEeCCCCCcchhhh--cCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE
Confidence 8887644333222 2 23899999988877544322 25789999999999999999999 699999999999999998
Q ss_pred cCCCEEEeccCCCcCCCC
Q 012762 223 SDGHIMLTDFDLSLKGDN 240 (457)
Q Consensus 223 ~~~~vkl~DFG~s~~~~~ 240 (457)
++.++|+|||++.....
T Consensus 153 -~~~v~LiDFG~a~~~~~ 169 (190)
T cd05147 153 -DGKLYIIDVSQSVEHDH 169 (190)
T ss_pred -CCcEEEEEccccccCCC
Confidence 57899999999875543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.9e-24 Score=205.51 Aligned_cols=277 Identities=23% Similarity=0.295 Sum_probs=184.3
Q ss_pred CCCccCCCceeEEEecccCcceEEEEEEeccCC------C------------------CC-------ceEEEEEeehhhh
Q 012762 76 NNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSS------N------------------NG-------CFFAAKVMDKREL 124 (457)
Q Consensus 76 ~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~------~------------------~~-------~~vAvK~~~~~~~ 124 (457)
...+.+++|.+.+.||+|..+.||.|+...... . .. -..|||.+-.-+.
T Consensus 151 dskFtiddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~ 230 (598)
T KOG4158|consen 151 DSKFTIDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEH 230 (598)
T ss_pred hcccchhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhccccc
Confidence 345778999999999999999999988654110 0 00 1235555432211
Q ss_pred hhhh--HHHHHHHHH------HHH--------HH-------c-CCCCCceEEEEEEcC----------------------
Q 012762 125 VSRN--KESRARIER------EIL--------EM-------L-DHPFLPTLYATLDCP---------------------- 158 (457)
Q Consensus 125 ~~~~--~~~~~~~E~------~il--------~~-------l-~H~nIv~l~~~~~~~---------------------- 158 (457)
.+.+ ..+..-+|. ..+ +. | +|||||+++++|.+.
T Consensus 231 ~s~~~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~ 310 (598)
T KOG4158|consen 231 DSGDAHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPS 310 (598)
T ss_pred CCchHHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceeccc
Confidence 1110 111111121 011 11 1 599999999987542
Q ss_pred -----CcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEcc--CC--CEEE
Q 012762 159 -----RWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRS--DG--HIML 229 (457)
Q Consensus 159 -----~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~--~~--~vkl 229 (457)
..+|+||.-+ ..+|++++-. ...+....+-++.|+++|+.|||.+||.|||+|.+||||.- |+ .+.|
T Consensus 311 g~g~~~tlylvMkrY-~~tLr~yl~~---~~~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVv 386 (598)
T KOG4158|consen 311 GAGEPKTLYLVMKRY-RQTLREYLWT---RHRSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVV 386 (598)
T ss_pred ccCCCceEEEehhcc-hhhHHHHHhc---CCCchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEE
Confidence 2469999988 7899888866 34566677788899999999999999999999999999963 33 5789
Q ss_pred eccCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCccccc
Q 012762 230 TDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAE 309 (457)
Q Consensus 230 ~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (457)
+|||++...+.........+
T Consensus 387 aDFGCcLAd~~hGlqlpy~S------------------------------------------------------------ 406 (598)
T KOG4158|consen 387 ADFGCCLADDNHGLQLPYES------------------------------------------------------------ 406 (598)
T ss_pred cccceeeecccccccccccc------------------------------------------------------------
Confidence 99998754332111111110
Q ss_pred CCccccccccCCCCccCchhhcCCC------CCccchhhhhhHHHHHHhcCCCCCCCCChHHH-HHHHHhcccCCC-CCC
Q 012762 310 PLDVRSMSFVGTHEYLAPEIISGEG------HGNAVDWWTLGIFIFELFYGTTPFKGIDHELT-LANVVARALEFP-KEP 381 (457)
Q Consensus 310 ~~~~~~~~~~gt~~y~aPE~l~~~~------~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~-~~~~~~~~~~~~-~~~ 381 (457)
.....-|....||||+....+ --.++|.|+.|.+.||++....||++..+... .....+. .+| -+.
T Consensus 407 ----~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~--qLPalp~ 480 (598)
T KOG4158|consen 407 ----DEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQES--QLPALPS 480 (598)
T ss_pred ----ccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhh--hCCCCcc
Confidence 111234788899999986543 13489999999999999999999988433211 1111111 222 234
Q ss_pred CCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCCCCc
Q 012762 382 SVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGVNW 423 (457)
Q Consensus 382 ~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~~~~ 423 (457)
.+++.+++++..+|+.||++|++. .++..+++.-.+..-+|
T Consensus 481 ~vpp~~rqlV~~lL~r~pskRvsp-~iAANvl~LsLw~~~~~ 521 (598)
T KOG4158|consen 481 RVPPVARQLVFDLLKRDPSKRVSP-NIAANVLNLSLWRMGED 521 (598)
T ss_pred cCChHHHHHHHHHhcCCccccCCc-cHHHhHHHHHHhcCchH
Confidence 589999999999999999999984 44666777655555555
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.2e-24 Score=200.46 Aligned_cols=236 Identities=25% Similarity=0.319 Sum_probs=150.7
Q ss_pred CceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcC----------CCCCceEE
Q 012762 83 DLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLD----------HPFLPTLY 152 (457)
Q Consensus 83 ~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~----------H~nIv~l~ 152 (457)
.+...+.||.|+|+.||.+++. .+|+.+|+|++...........+.+++|.-....+. |-.++--+
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~----~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~ 88 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDV----ETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPL 88 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEET----TTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---S
T ss_pred EEEEccccccCCceEEEEEEEc----cCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeee
Confidence 3677889999999999999987 589999999987665555555666665553333321 21222222
Q ss_pred EEE---------EcC---C-----cEEEEEeecCCCChHHHHHh---CCCC--CCCHHHHHHHHHHHHHHHHHHHHcCce
Q 012762 153 ATL---------DCP---R-----WSCLLTEFCPGGDLHVLRQR---QPDK--RFHESAVRFYASEVVVALEFLHMMGII 210 (457)
Q Consensus 153 ~~~---------~~~---~-----~~~lV~E~~~~~sL~~~~~~---~~~~--~~~~~~~~~i~~qi~~~L~yLH~~~ii 210 (457)
+.. ... . ..+++|+-+ -++|..++.. .... .+.......+..|+++.+++||..|+|
T Consensus 89 d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlV 167 (288)
T PF14531_consen 89 DLLRIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLV 167 (288)
T ss_dssp EEEEETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred EEEEEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceE
Confidence 221 111 1 247888888 7888766543 2111 122223344558999999999999999
Q ss_pred eecCCCCCeEEccCCCEEEeccCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCc
Q 012762 211 YRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHP 290 (457)
Q Consensus 211 HrDIKp~NIll~~~~~vkl~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (457)
|+||||+|+|++.+|.++|+||+..........
T Consensus 168 Hgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~----------------------------------------------- 200 (288)
T PF14531_consen 168 HGDIKPENFLLDQDGGVFLGDFSSLVRAGTRYR----------------------------------------------- 200 (288)
T ss_dssp EST-SGGGEEE-TTS-EEE--GGGEEETTEEEE-----------------------------------------------
T ss_pred ecccceeeEEEcCCCCEEEcChHHHeecCceee-----------------------------------------------
Confidence 999999999999999999999987543321100
Q ss_pred chhccccCCCCCCCcccccCCccccccccCCCCccCchhhcCC--------CCCccchhhhhhHHHHHHhcCCCCCCCCC
Q 012762 291 KRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTHEYLAPEIISGE--------GHGNAVDWWTLGIFIFELFYGTTPFKGID 362 (457)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~--------~~~~~sDiwSlG~il~elltG~~Pf~~~~ 362 (457)
....+..|.|||..... .++.+.|.|+||+++|.|++|..||....
T Consensus 201 --------------------------~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~ 254 (288)
T PF14531_consen 201 --------------------------CSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSS 254 (288)
T ss_dssp --------------------------GGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCG
T ss_pred --------------------------ccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCCCC
Confidence 01245779999987442 46889999999999999999999998754
Q ss_pred hHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhhhCCCCC
Q 012762 363 HELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDPTRR 402 (457)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R 402 (457)
....... .+.....+|+.++.||..+|.+||++|
T Consensus 255 ~~~~~~~------~f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 255 PEADPEW------DFSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp GGSTSGG------GGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred ccccccc------cchhcCCcCHHHHHHHHHHccCCcccC
Confidence 3322111 233333689999999999999999988
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.2e-23 Score=186.62 Aligned_cols=143 Identities=20% Similarity=0.177 Sum_probs=111.8
Q ss_pred EEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhh-----------------------hHHHHHHHHHHHHHHc
Q 012762 87 VHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSR-----------------------NKESRARIEREILEML 143 (457)
Q Consensus 87 ~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~-----------------------~~~~~~~~E~~il~~l 143 (457)
.+.||+|+||+||+|.+. +|+.||||+++....... ........|.+.+.++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-----~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 76 (190)
T cd05145 2 NGCISTGKEANVYHARTG-----DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRL 76 (190)
T ss_pred CceeecCCCcEEEEEEcC-----CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHH
Confidence 568999999999999864 689999999986522100 0122345789999999
Q ss_pred CCCCCceEEEEEEcCCcEEEEEeecCCCChHHH-HHhCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCceeecCCCCCeEE
Q 012762 144 DHPFLPTLYATLDCPRWSCLLTEFCPGGDLHVL-RQRQPDKRFHESAVRFYASEVVVALEFLHM-MGIIYRDLKPENVLV 221 (457)
Q Consensus 144 ~H~nIv~l~~~~~~~~~~~lV~E~~~~~sL~~~-~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~-~~iiHrDIKp~NIll 221 (457)
.|++|.....+... ..||||||++|+++... +.. ..+++..+..++.|++.+|.+||+ .||+||||||+|||+
T Consensus 77 ~~~~i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~---~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll 151 (190)
T cd05145 77 YEAGVPVPEPILLK--KNVLVMEFIGDDGSPAPRLKD---VPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILY 151 (190)
T ss_pred HhCCCCCceEEEec--CCEEEEEEecCCCchhhhhhh---ccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEE
Confidence 99987544443332 24899999988765332 332 567888999999999999999999 999999999999999
Q ss_pred ccCCCEEEeccCCCcCCCC
Q 012762 222 RSDGHIMLTDFDLSLKGDN 240 (457)
Q Consensus 222 ~~~~~vkl~DFG~s~~~~~ 240 (457)
+ ++.++|+|||++.....
T Consensus 152 ~-~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 152 H-DGKPYIIDVSQAVELDH 169 (190)
T ss_pred E-CCCEEEEEcccceecCC
Confidence 8 88999999999877653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.9e-22 Score=179.96 Aligned_cols=201 Identities=21% Similarity=0.190 Sum_probs=141.8
Q ss_pred eeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhh-hHHHHHHHHHHHHHHcC-CCCCceEEEEEEcCCcEE
Q 012762 85 RFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSR-NKESRARIEREILEMLD-HPFLPTLYATLDCPRWSC 162 (457)
Q Consensus 85 ~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~-~~~~~~~~E~~il~~l~-H~nIv~l~~~~~~~~~~~ 162 (457)
.+...|+.|+||+||++.. .+..++.+.+........ .....+.+|+++|++|+ |++|++++++ +..|
T Consensus 5 ~~~~~l~~~~f~~v~~~~~------~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~ 74 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG------GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRH 74 (218)
T ss_pred ccceeecCCCcceEEEeec------CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEE
Confidence 4567899999999997653 566777777654433211 12235788999999995 5889999986 3469
Q ss_pred EEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecC-CCCCeEEccCCCEEEeccCCCcCCCCC
Q 012762 163 LLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDL-KPENVLVRSDGHIMLTDFDLSLKGDNS 241 (457)
Q Consensus 163 lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDI-Kp~NIll~~~~~vkl~DFG~s~~~~~~ 241 (457)
++|||+.|.+|...+.. . ...++.|++.+|.++|++||+|||| ||+|||++.+|.++|+|||++......
T Consensus 75 lvmeyI~G~~L~~~~~~--------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~ 145 (218)
T PRK12274 75 LDRSYLAGAAMYQRPPR--------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPR 145 (218)
T ss_pred EEEeeecCccHHhhhhh--------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCc
Confidence 99999999998643221 1 1347789999999999999999999 799999999999999999998754322
Q ss_pred Ccccc-cccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccC
Q 012762 242 TSTAQ-LVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVG 320 (457)
Q Consensus 242 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 320 (457)
..... +...+ ...+. + .-..+
T Consensus 146 ~~~~r~L~~rD---------------------------------l~~ll-k------------------------~~~~y 167 (218)
T PRK12274 146 ARWMRLLARED---------------------------------LRHLL-K------------------------HKRMY 167 (218)
T ss_pred chHHHHHHHHH---------------------------------HHHHH-H------------------------HHHhc
Confidence 11000 00000 00000 0 00126
Q ss_pred CCCccCchhhcCC-CCC-ccchhhhhhHHHHHHhcCCCCCCCCC
Q 012762 321 THEYLAPEIISGE-GHG-NAVDWWTLGIFIFELFYGTTPFKGID 362 (457)
Q Consensus 321 t~~y~aPE~l~~~-~~~-~~sDiwSlG~il~elltG~~Pf~~~~ 362 (457)
++.|+.|+...-. ..+ .+.+.++.|+-+|.++|+..++.+..
T Consensus 168 ~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 168 CPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred CCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 8888999876543 233 57788999999999999999987644
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.5e-21 Score=176.57 Aligned_cols=134 Identities=20% Similarity=0.267 Sum_probs=104.5
Q ss_pred EEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHc-----CCCCCceEEEEEEcCC--
Q 012762 87 VHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEML-----DHPFLPTLYATLDCPR-- 159 (457)
Q Consensus 87 ~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l-----~H~nIv~l~~~~~~~~-- 159 (457)
.+.||+|+||.||. +. .++.. +||++..... .....+.+|+++++.+ +||||+++++++.++.
T Consensus 7 ~~~LG~G~~~~Vy~--hp----~~~~k-~IKv~~~~~~---~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~ 76 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HP----EDAQR-CIKIVYHRGD---GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGT 76 (210)
T ss_pred cceecCCCceEEEE--CC----CCcCe-EEEEEecccc---chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCC
Confidence 46899999999994 33 24444 6898865422 2345688899999999 6799999999998873
Q ss_pred -cEE-EEEee--cCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHH-HHHHHcCceeecCCCCCeEEccC----CCEEEe
Q 012762 160 -WSC-LLTEF--CPGGDLHVLRQRQPDKRFHESAVRFYASEVVVAL-EFLHMMGIIYRDLKPENVLVRSD----GHIMLT 230 (457)
Q Consensus 160 -~~~-lV~E~--~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L-~yLH~~~iiHrDIKp~NIll~~~----~~vkl~ 230 (457)
.++ +|||| +.+++|.++++. ..+++. ..++.|++.++ +|||+++||||||||+|||++.. +.++|+
T Consensus 77 g~v~~~I~e~~G~~~~tL~~~l~~---~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~Li 151 (210)
T PRK10345 77 GYVYDVIADFDGKPSITLTEFAEQ---CRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVC 151 (210)
T ss_pred eEEEEEEecCCCCcchhHHHHHHc---ccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEE
Confidence 444 78999 557999999976 346665 35678888888 99999999999999999999742 379999
Q ss_pred ccCCC
Q 012762 231 DFDLS 235 (457)
Q Consensus 231 DFG~s 235 (457)
||+-+
T Consensus 152 Dg~G~ 156 (210)
T PRK10345 152 DNIGE 156 (210)
T ss_pred ECCCC
Confidence 95443
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.4e-21 Score=209.39 Aligned_cols=199 Identities=25% Similarity=0.352 Sum_probs=159.8
Q ss_pred CCccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcC---CCCCceEEE
Q 012762 77 NPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLD---HPFLPTLYA 153 (457)
Q Consensus 77 ~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~---H~nIv~l~~ 153 (457)
..+....|.|.+.||+|+||+||+|... +|+.||+|+-+... ..++..-.+++.+|+ -+.|+++..
T Consensus 693 ~~~~~~~~~I~~e~G~g~y~~vy~a~~~-----~~~~~alK~e~P~~------~WEfYI~~q~~~RLk~~~~~~~~~~~~ 761 (974)
T KOG1166|consen 693 FEVGGEKFCISKEIGEGSYGSVYVATHS-----NGKLVALKVEKPPN------PWEFYICLQVMERLKPQMLPSIMHISS 761 (974)
T ss_pred eeecceeEEEEeeeccccceEEEEeecC-----CCcEEEEEeecCCC------ceeeeehHHHHHhhchhhhcchHHHHH
Confidence 3445568999999999999999999865 49999999976532 222333344555554 345677777
Q ss_pred EEEcCCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEcc-------CCC
Q 012762 154 TLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRS-------DGH 226 (457)
Q Consensus 154 ~~~~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~-------~~~ 226 (457)
++...+..+||+||.+.|+|-+++.. .+.+++..+..+..||+.-|+.||..+|||+||||+|+||.. ..-
T Consensus 762 a~~~~~~S~lv~ey~~~Gtlld~~N~--~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~ 839 (974)
T KOG1166|consen 762 AHVFQNASVLVSEYSPYGTLLDLINT--NKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKG 839 (974)
T ss_pred HHccCCcceeeeeccccccHHHhhcc--CCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccc
Confidence 77777788999999999999999884 588999999999999999999999999999999999999953 225
Q ss_pred EEEeccCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcc
Q 012762 227 IMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEI 306 (457)
Q Consensus 227 vkl~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (457)
++|+|||.+..+.--..
T Consensus 840 l~lIDfG~siDm~lfp~--------------------------------------------------------------- 856 (974)
T KOG1166|consen 840 LYLIDFGRSIDMKLFPD--------------------------------------------------------------- 856 (974)
T ss_pred eEEEecccceeeeEcCC---------------------------------------------------------------
Confidence 89999999865531110
Q ss_pred cccCCccccccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCC
Q 012762 307 VAEPLDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTT 356 (457)
Q Consensus 307 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~ 356 (457)
..+....++|-.+-++|+..|.+|++.+|.|.|+.+++-||.|++
T Consensus 857 -----~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 857 -----GTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred -----CcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 122334578999999999999999999999999999999999875
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.4e-21 Score=205.55 Aligned_cols=317 Identities=31% Similarity=0.485 Sum_probs=236.7
Q ss_pred cCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCC
Q 012762 80 TLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPR 159 (457)
Q Consensus 80 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~ 159 (457)
..+++.+.+-+-+|.|+.++.+.-. ..|-..++|+..+............+.+..++-...||.++...-.+....
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa----~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rs 877 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPA----GSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRS 877 (1205)
T ss_pred CCccceecccccCCCCcccccCCcc----ccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCC
Confidence 3456777778888999999977644 245556777766554444444555555666655567788887777777888
Q ss_pred cEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCC
Q 012762 160 WSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGD 239 (457)
Q Consensus 160 ~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~ 239 (457)
..+|||+|+.+++|...++.- +..+++.++.++..+.++++|||...++|||++|.|+|+..+|..++.|||......
T Consensus 878 P~~L~~~~~~~~~~~Skl~~~--~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg 955 (1205)
T KOG0606|consen 878 PLPLVGHYLNGGDLPSKLHNS--GCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVG 955 (1205)
T ss_pred CcchhhHHhccCCchhhhhcC--CCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccc
Confidence 899999999999998888764 567888889999999999999999999999999999999999999999999543322
Q ss_pred CCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcccccccc
Q 012762 240 NSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFV 319 (457)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (457)
-......+. |.++...+.- +....++.. .......+.....
T Consensus 956 ~~~p~~~~s----------------------g~~~~~~~~~-------~~~~~~~~~----------l~~~~~~~~~~~~ 996 (1205)
T KOG0606|consen 956 LIPPTTDLS----------------------GPSSSGTPRR-------LSRSERRPQ----------LSADEARRKHAVV 996 (1205)
T ss_pred cccCcCCcc----------------------cccccCcccc-------ccccccccc----------cccchhhcccccc
Confidence 111110000 0000000000 000000000 0000112233567
Q ss_pred CCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCCC-CCChHHHHHHHHHhhhC
Q 012762 320 GTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEP-SVPGPAKDLIAQLLVKD 398 (457)
Q Consensus 320 gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ll~~~L~~d 398 (457)
||+.|.+||.+.+...+..+|+|++|++++|.++|.+||.....+..+.++..+...++.-+ ..+..+++++...|..+
T Consensus 997 ~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~ 1076 (1205)
T KOG0606|consen 997 GTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEE 1076 (1205)
T ss_pred CCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcchhhhhhccccCCCCCCCCccccChhhhhhhhhhhccC
Confidence 99999999999999999999999999999999999999999999999999999888877643 46788999999999999
Q ss_pred CCCCCCCCcChHHHhcCCCCCCCCchhhhccCCCCCCCCCCccc
Q 012762 399 PTRRMGSKMGATAIKRHQFFNGVNWALLRCAKPPFIPRPVTCRD 442 (457)
Q Consensus 399 P~~Rps~~~~~~~ll~hp~f~~~~~~~~~~~~~~~~~~~~~~~~ 442 (457)
|.+|..+ .++.++..|+||+.++|..+....-+|+|++-+..|
T Consensus 1077 ~~qr~~a-~~~~e~k~~~~~~~~~~~~l~~q~~~~~p~~~s~~d 1119 (1205)
T KOG0606|consen 1077 PTQRLGA-KGAAEVKGHPFFQDVDWENLALQKAEFVPQPESTQD 1119 (1205)
T ss_pred chhccCc-ccccccccCCccCCCCccccccccCccCCCCCCCCc
Confidence 9999982 234589999999999999999999999999976444
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.84 E-value=9.3e-21 Score=177.79 Aligned_cols=149 Identities=21% Similarity=0.201 Sum_probs=114.5
Q ss_pred CceeEEEecccCcceEEEEE-EeccCCCCCceEEEEEeehhhhhhh---------------------hHHHHHHHHHHHH
Q 012762 83 DLRFVHRLGSGDIGSVYLVQ-LKSKSSNNGCFFAAKVMDKRELVSR---------------------NKESRARIEREIL 140 (457)
Q Consensus 83 ~~~~~~~LG~G~fg~Vy~a~-~~~~~~~~~~~vAvK~~~~~~~~~~---------------------~~~~~~~~E~~il 140 (457)
.|.+.+.||+|+||.||+|. +. .+|+.||+|++........ .....+.+|.+++
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~----~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L 104 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFD----GSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNL 104 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecC----CCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHH
Confidence 48889999999999999998 33 3789999999975431100 0123456799999
Q ss_pred HHcCCCC--CceEEEEEEcCCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcC-ceeecCCCC
Q 012762 141 EMLDHPF--LPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMG-IIYRDLKPE 217 (457)
Q Consensus 141 ~~l~H~n--Iv~l~~~~~~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~-iiHrDIKp~ 217 (457)
+++.+.+ +.+++++ . ..+|||||++|++|..+.... ..+....+..++.||+.+|.+||+.| |+||||||+
T Consensus 105 ~~L~~~~i~~p~~~~~---~-~~~lV~E~~~g~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~ 178 (237)
T smart00090 105 QRLYEAGVPVPKPIAW---R-RNVLVMEFIGGDGLPAPRLKD--VEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEY 178 (237)
T ss_pred HHHHhcCCCCCeeeEe---c-CceEEEEEecCCccccccccc--CCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChh
Confidence 9997533 4445543 2 358999999988886544222 44666677899999999999999999 999999999
Q ss_pred CeEEccCCCEEEeccCCCcCCCCCC
Q 012762 218 NVLVRSDGHIMLTDFDLSLKGDNST 242 (457)
Q Consensus 218 NIll~~~~~vkl~DFG~s~~~~~~~ 242 (457)
||+++ ++.++|+|||++.....+.
T Consensus 179 NIli~-~~~i~LiDFg~a~~~~~~~ 202 (237)
T smart00090 179 NILVH-DGKVVIIDVSQSVELDHPM 202 (237)
T ss_pred hEEEE-CCCEEEEEChhhhccCCcc
Confidence 99998 8899999999987665544
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.82 E-value=5.1e-21 Score=189.18 Aligned_cols=185 Identities=25% Similarity=0.388 Sum_probs=137.1
Q ss_pred CcEEEEEeecCCCChHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcC
Q 012762 159 RWSCLLTEFCPGGDLHVLRQRQ-PDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLK 237 (457)
Q Consensus 159 ~~~~lV~E~~~~~sL~~~~~~~-~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~ 237 (457)
.++|+.|++|.-.+|.+++.+. .....+......++.|+..|++| +|.+|||+||.||+...+..+||+|||+...
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts 405 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTS 405 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheee
Confidence 3689999999999999999743 34456778889999999999999 9999999999999999999999999999754
Q ss_pred CCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcccccc
Q 012762 238 GDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMS 317 (457)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (457)
...... ..+...+...
T Consensus 406 ~~~~~~----------------------------------------------------------------~~~~~a~~t~ 421 (516)
T KOG1033|consen 406 QDKDET----------------------------------------------------------------VAPAAASHTQ 421 (516)
T ss_pred cccCCc----------------------------------------------------------------ccchhhhhhh
Confidence 432110 0001122234
Q ss_pred ccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhh
Q 012762 318 FVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLV 396 (457)
Q Consensus 318 ~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~ 396 (457)
.+||..||+||.+.+..|+.++||||||+||+||+. -...|.. ...+..+.++.++....... +.-..|+++||.
T Consensus 422 ~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er---~~t~~d~r~g~ip~~~~~d~-p~e~~ll~~lls 497 (516)
T KOG1033|consen 422 QVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFER---IATLTDIRDGIIPPEFLQDY-PEEYTLLQQLLS 497 (516)
T ss_pred cccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHH---HHhhhhhhcCCCChHHhhcC-cHHHHHHHHhcC
Confidence 579999999999999999999999999999999996 2333321 12233333333221111122 234689999999
Q ss_pred hCCCCCCCCCcChHHHhcCCCC
Q 012762 397 KDPTRRMGSKMGATAIKRHQFF 418 (457)
Q Consensus 397 ~dP~~Rps~~~~~~~ll~hp~f 418 (457)
..|.+||+ +.+.-.|+|.
T Consensus 498 ~~p~~RP~----~~~~~~~~~~ 515 (516)
T KOG1033|consen 498 PSPEERPS----AIEVALHEFL 515 (516)
T ss_pred CCcccCch----HHHHhhhhhc
Confidence 99999998 7777777764
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.9e-19 Score=166.23 Aligned_cols=138 Identities=22% Similarity=0.215 Sum_probs=113.1
Q ss_pred EEecccCcceEEEEEEeccCCCCCceEEEEEeehhhh-----hhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcEE
Q 012762 88 HRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKREL-----VSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWSC 162 (457)
Q Consensus 88 ~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~-----~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~ 162 (457)
+.||+|++|.||+|.+ .|..+++|+...... .......++.+|++++..+.|++|.....++...+..+
T Consensus 2 ~~l~~G~~~~vy~~~~------~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~ 75 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF------LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFI 75 (211)
T ss_pred cccccCceEEEEEEee------CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCE
Confidence 5789999999999985 466789998653221 11122345778999999999999887777776777889
Q ss_pred EEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCC
Q 012762 163 LLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKG 238 (457)
Q Consensus 163 lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~ 238 (457)
+||||++|++|.+++.... . ....++.+++.+|.+||+.|++|+|++|.|||++ ++.++|+|||++...
T Consensus 76 lv~e~~~G~~L~~~~~~~~-----~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~~ 144 (211)
T PRK14879 76 IVMEYIEGEPLKDLINSNG-----M-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEFS 144 (211)
T ss_pred EEEEEeCCcCHHHHHHhcc-----H-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccCC
Confidence 9999999999998886531 2 7788999999999999999999999999999998 789999999998653
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.81 E-value=3.3e-19 Score=163.15 Aligned_cols=134 Identities=22% Similarity=0.231 Sum_probs=106.5
Q ss_pred EecccCcceEEEEEEeccCCCCCceEEEEEeehhhhh-----hhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcEEE
Q 012762 89 RLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELV-----SRNKESRARIEREILEMLDHPFLPTLYATLDCPRWSCL 163 (457)
Q Consensus 89 ~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~-----~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~l 163 (457)
.||+|+||+||+|.+ .+..+++|+....... ......++.+|++++..+.|+++.....++......++
T Consensus 1 ~ig~G~~~~vy~~~~------~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~l 74 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF------LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTI 74 (199)
T ss_pred CCCCCceEEEEEeec------CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEE
Confidence 379999999999984 4567999986533211 12234667789999999998876555555555667789
Q ss_pred EEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCC
Q 012762 164 LTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKG 238 (457)
Q Consensus 164 V~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~ 238 (457)
||||++|++|.+++.... . .++.|++.+|.+||+.|++|+|++|.||+++ ++.++++|||++...
T Consensus 75 v~e~~~g~~l~~~~~~~~---~------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 75 VMEYIEGKPLKDVIEEGN---D------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred EEEEECCccHHHHHhhcH---H------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 999999999988765521 1 7889999999999999999999999999998 889999999998654
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.9e-21 Score=204.07 Aligned_cols=263 Identities=22% Similarity=0.348 Sum_probs=204.8
Q ss_pred CceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcC-CCCCceEEEEEEcCCcE
Q 012762 83 DLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLD-HPFLPTLYATLDCPRWS 161 (457)
Q Consensus 83 ~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~-H~nIv~l~~~~~~~~~~ 161 (457)
.|.+.+.||+|+|+.|-++.... .....+|.|.+.... ...........|..+-+.+. |.|++++++.....+..
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~~---~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~ 96 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNSR---DPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSY 96 (601)
T ss_pred cccccccccccccchhhhhhhcC---CCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCccc
Confidence 57788889999999998876532 345567777765443 23344555566888888886 99999999999999999
Q ss_pred EEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH-HcCceeecCCCCCeEEccCC-CEEEeccCCCcCCC
Q 012762 162 CLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLH-MMGIIYRDLKPENVLVRSDG-HIMLTDFDLSLKGD 239 (457)
Q Consensus 162 ~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH-~~~iiHrDIKp~NIll~~~~-~vkl~DFG~s~~~~ 239 (457)
+++++|..|+++...+........+...+..++.|+..+|.|+| ..++.||||||+|.+++..+ .+++.|||+|....
T Consensus 97 ~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~ 176 (601)
T KOG0590|consen 97 LLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYR 176 (601)
T ss_pred ccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhcccc
Confidence 99999999999987763222226777888899999999999999 99999999999999999999 99999999986654
Q ss_pred CCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcccccccc
Q 012762 240 NSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFV 319 (457)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (457)
...... ......+
T Consensus 177 ~~~g~~-------------------------------------------------------------------~~~~~~~ 189 (601)
T KOG0590|consen 177 NKNGAE-------------------------------------------------------------------RSLKDRC 189 (601)
T ss_pred ccCCcc-------------------------------------------------------------------eeeeccc
Confidence 311100 0111236
Q ss_pred C-CCCccCchhhcCCC-CCccchhhhhhHHHHHHhcCCCCCCCCChHHH-HHHHHhc--ccCCCCCCCCChHHHHHHHHH
Q 012762 320 G-THEYLAPEIISGEG-HGNAVDWWTLGIFIFELFYGTTPFKGIDHELT-LANVVAR--ALEFPKEPSVPGPAKDLIAQL 394 (457)
Q Consensus 320 g-t~~y~aPE~l~~~~-~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~-~~~~~~~--~~~~~~~~~~~~~~~~ll~~~ 394 (457)
| ++.|+|||...+.. .....|+||.|+++.-+++|..|+........ +...... ......+..++....+++.++
T Consensus 190 g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~k~ 269 (601)
T KOG0590|consen 190 GSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWNSISDQAHDLLHKI 269 (601)
T ss_pred CCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCccccCChhhhhccccc
Confidence 7 99999999999864 47899999999999999999999976554331 1111111 112334456788899999999
Q ss_pred hhhCCCCCCCCCcChHHHhcCCCCCC
Q 012762 395 LVKDPTRRMGSKMGATAIKRHQFFNG 420 (457)
Q Consensus 395 L~~dP~~Rps~~~~~~~ll~hp~f~~ 420 (457)
|..+|+.|.+ +.++..++|+..
T Consensus 270 l~~~~~~r~s----~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 270 LKENPSNRLS----IEELKLDNWLSS 291 (601)
T ss_pred ccCCchhccc----cccccccccccc
Confidence 9999999999 999999999987
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=2e-19 Score=164.60 Aligned_cols=140 Identities=22% Similarity=0.202 Sum_probs=108.9
Q ss_pred ceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhh-------------------hHHHHHHHHHHHHHHcC
Q 012762 84 LRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSR-------------------NKESRARIEREILEMLD 144 (457)
Q Consensus 84 ~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~-------------------~~~~~~~~E~~il~~l~ 144 (457)
|.+.+.||+|+||.||+|.+. +|+.||||++........ ........|..++..+.
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 91 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDP-----DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALY 91 (198)
T ss_pred hhcCCccccCcceEEEEEEcC-----CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHH
Confidence 778899999999999999864 688999999765321000 01123567888899998
Q ss_pred CCC--CceEEEEEEcCCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEc
Q 012762 145 HPF--LPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVR 222 (457)
Q Consensus 145 H~n--Iv~l~~~~~~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~ 222 (457)
|.+ ++.+++. ...++||||++|++|..+... .....++.+|+.++.++|+.||+|+||||+||+++
T Consensus 92 ~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~ 159 (198)
T cd05144 92 EEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVD 159 (198)
T ss_pred HcCCCCCceeec----CCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEc
Confidence 774 5555542 345899999999999765321 34567889999999999999999999999999999
Q ss_pred cCCCEEEeccCCCcCCCC
Q 012762 223 SDGHIMLTDFDLSLKGDN 240 (457)
Q Consensus 223 ~~~~vkl~DFG~s~~~~~ 240 (457)
.++.++|+|||++.....
T Consensus 160 ~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 160 DDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred CCCcEEEEECCccccCCC
Confidence 999999999999866554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.80 E-value=5.6e-19 Score=185.57 Aligned_cols=140 Identities=24% Similarity=0.223 Sum_probs=111.6
Q ss_pred CceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhh-----hhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEc
Q 012762 83 DLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRE-----LVSRNKESRARIEREILEMLDHPFLPTLYATLDC 157 (457)
Q Consensus 83 ~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~-----~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~ 157 (457)
.|...+.||+|+||+||+|.+. +..+++|+..... ........++.+|+++++.++|++|+....++..
T Consensus 334 ~~~~~~~iG~G~~g~Vy~~~~~------~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~ 407 (535)
T PRK09605 334 RKIPDHLIGKGAEADIKKGEYL------GRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVD 407 (535)
T ss_pred ccCccceeccCCcEEEEEEeec------CccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEe
Confidence 3466889999999999999864 2234444322211 1112234567889999999999999988877777
Q ss_pred CCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcC
Q 012762 158 PRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLK 237 (457)
Q Consensus 158 ~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~ 237 (457)
....++||||++|++|.+++. ....++.|++.+|.|||+.||+||||||+|||+ .++.++|+|||+++.
T Consensus 408 ~~~~~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 408 PEEKTIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred CCCCEEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 778899999999999988765 346788999999999999999999999999999 678899999999876
Q ss_pred CC
Q 012762 238 GD 239 (457)
Q Consensus 238 ~~ 239 (457)
..
T Consensus 477 ~~ 478 (535)
T PRK09605 477 SD 478 (535)
T ss_pred CC
Confidence 54
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.76 E-value=4.1e-18 Score=154.32 Aligned_cols=140 Identities=21% Similarity=0.251 Sum_probs=100.5
Q ss_pred EEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHH---------------------HHHHHHHHHHHcCC
Q 012762 87 VHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKES---------------------RARIEREILEMLDH 145 (457)
Q Consensus 87 ~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~---------------------~~~~E~~il~~l~H 145 (457)
.+.||+|+||+||+|.+. +++.||||++............ ....|.+.+..+.+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-----~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~ 76 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-----DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYE 76 (187)
T ss_pred CcccccccceeEEEEECC-----CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHH
Confidence 467999999999999864 6789999998754322111111 11346666666654
Q ss_pred C--CCceEEEEEEcCCcEEEEEeecCCCChHH-HHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCceeecCCCCCeEE
Q 012762 146 P--FLPTLYATLDCPRWSCLLTEFCPGGDLHV-LRQRQPDKRFHESAVRFYASEVVVALEFLHM-MGIIYRDLKPENVLV 221 (457)
Q Consensus 146 ~--nIv~l~~~~~~~~~~~lV~E~~~~~sL~~-~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~-~~iiHrDIKp~NIll 221 (457)
. .+.+.+++ ...++||||++++.+.. .+... ... ..++.++.+++.++.++|. .||+|+||||+||++
T Consensus 77 ~~~~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~---~~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili 148 (187)
T cd05119 77 AGVPVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDV---RLL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILV 148 (187)
T ss_pred cCCCCCceEec----CCCEEEEEEeCCCCccChhhhhh---hhc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEE
Confidence 3 35555554 23589999998854421 11111 011 5678899999999999999 999999999999999
Q ss_pred ccCCCEEEeccCCCcCCCC
Q 012762 222 RSDGHIMLTDFDLSLKGDN 240 (457)
Q Consensus 222 ~~~~~vkl~DFG~s~~~~~ 240 (457)
+ ++.++|+|||.+.....
T Consensus 149 ~-~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 149 D-DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred E-CCcEEEEECcccccccC
Confidence 9 89999999999876654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=4.3e-18 Score=171.41 Aligned_cols=200 Identities=22% Similarity=0.290 Sum_probs=151.9
Q ss_pred HHHcCCCCCceEEEEEEcCCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCc-eeecCCCCC
Q 012762 140 LEMLDHPFLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGI-IYRDLKPEN 218 (457)
Q Consensus 140 l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~i-iHrDIKp~N 218 (457)
|+.+.|.|+.+++|.+.++...++|.+||..|+|.+.+... .-.++......++++|+.||.|||.--| .|+.++..|
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~-~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~n 79 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE-DIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSN 79 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc-ccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeecccc
Confidence 45689999999999999999999999999999999998873 4668888899999999999999997655 999999999
Q ss_pred eEEccCCCEEEeccCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccC
Q 012762 219 VLVRSDGHIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKL 298 (457)
Q Consensus 219 Ill~~~~~vkl~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (457)
++++....+||+|||+..........
T Consensus 80 Clvd~~w~lklt~~Gl~~~~~~~~~~------------------------------------------------------ 105 (484)
T KOG1023|consen 80 CLVDSRWVLKLTDFGLNSLLEETAEP------------------------------------------------------ 105 (484)
T ss_pred ceeeeeEEEEechhhhcccccccccc------------------------------------------------------
Confidence 99999999999999996544320000
Q ss_pred CCCCCCcccccCCccccccccCCCCccCchhhcCCC-------CCccchhhhhhHHHHHHhcCCCCCCCCCh----HHHH
Q 012762 299 GNPGTPEIVAEPLDVRSMSFVGTHEYLAPEIISGEG-------HGNAVDWWTLGIFIFELFYGTTPFKGIDH----ELTL 367 (457)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-------~~~~sDiwSlG~il~elltG~~Pf~~~~~----~~~~ 367 (457)
... ....-...|.|||.+.+.. .+.+.||||||++++|+++..-||..... .+..
T Consensus 106 --------~~~------~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~~~~~~~~~eii 171 (484)
T KOG1023|consen 106 --------EAH------HPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDLRNLVEDPDEII 171 (484)
T ss_pred --------ccc------chhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCccccccccCChHHHH
Confidence 000 0011345799999998742 35679999999999999999999976322 1233
Q ss_pred HHHHhcccC--CCC---CCCCChHHHHHHHHHhhhCCCCCCCCCcChHHH
Q 012762 368 ANVVARALE--FPK---EPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAI 412 (457)
Q Consensus 368 ~~~~~~~~~--~~~---~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~l 412 (457)
..+...... .|. ...+++++..+++.||..+|++||+ ++++
T Consensus 172 ~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs----~~~i 217 (484)
T KOG1023|consen 172 LRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPS----IEQI 217 (484)
T ss_pred HHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCcc----HHHH
Confidence 332221111 111 1145567999999999999999999 6655
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.75 E-value=2.1e-17 Score=155.37 Aligned_cols=139 Identities=24% Similarity=0.300 Sum_probs=106.1
Q ss_pred EEec-ccCcceEEEEEEeccCCCCCceEEEEEeehhhhh----------hhhHHHHHHHHHHHHHHcCCCCC--ceEEEE
Q 012762 88 HRLG-SGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELV----------SRNKESRARIEREILEMLDHPFL--PTLYAT 154 (457)
Q Consensus 88 ~~LG-~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~----------~~~~~~~~~~E~~il~~l~H~nI--v~l~~~ 154 (457)
..|| .|+.|+||.+.. .+..+|||.+...... ......++.+|.+++..|.|++| +..+++
T Consensus 37 ~~lg~~~g~gtv~~v~~------~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~ 110 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQT------PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAA 110 (239)
T ss_pred ceeecCCCCccEEEEEe------CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEee
Confidence 4577 788889988874 4678999988643221 11234567889999999998775 677776
Q ss_pred EEcCC-c---EEEEEeecCC-CChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEE
Q 012762 155 LDCPR-W---SCLLTEFCPG-GDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIML 229 (457)
Q Consensus 155 ~~~~~-~---~~lV~E~~~~-~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl 229 (457)
..... . .+||||+++| .+|.+++.. ..+++.. +.||+.+|.+||+.||+||||||+|||++.++.++|
T Consensus 111 ~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~---~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~L 183 (239)
T PRK01723 111 RVVRHGLFYRADILIERIEGARDLVALLQE---APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWL 183 (239)
T ss_pred eeeecCcceeeeEEEEecCCCCCHHHHHhc---CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEE
Confidence 54322 2 3599999987 689888765 3455543 578999999999999999999999999998899999
Q ss_pred eccCCCcCCC
Q 012762 230 TDFDLSLKGD 239 (457)
Q Consensus 230 ~DFG~s~~~~ 239 (457)
+|||.+....
T Consensus 184 IDfg~~~~~~ 193 (239)
T PRK01723 184 IDFDRGELRT 193 (239)
T ss_pred EECCCcccCC
Confidence 9999986643
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.1e-16 Score=138.51 Aligned_cols=134 Identities=26% Similarity=0.343 Sum_probs=112.0
Q ss_pred eEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCC--CCCceEEEEEEcCCcEEE
Q 012762 86 FVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDH--PFLPTLYATLDCPRWSCL 163 (457)
Q Consensus 86 ~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H--~nIv~l~~~~~~~~~~~l 163 (457)
+++.||.|.++.||++... +..+++|+...... ...+..|..+++.+.| .++++++.++...+..++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~------~~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~ 70 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK------DEDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYL 70 (155)
T ss_pred cceecccccccceEEEEec------CCeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEE
Confidence 4578999999999999863 36799999865421 4567789999999976 589999999988888999
Q ss_pred EEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHc---CceeecCCCCCeEEccCCCEEEeccCCCcCCC
Q 012762 164 LTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMM---GIIYRDLKPENVLVRSDGHIMLTDFDLSLKGD 239 (457)
Q Consensus 164 V~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~---~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~ 239 (457)
+|||+.|+.+..+ +......++.+++.+|.+||.. +++|+||+|+||+++..+.++++|||.+....
T Consensus 71 v~e~~~g~~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~~ 140 (155)
T cd05120 71 LMEWIEGETLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYGP 140 (155)
T ss_pred EEEecCCeecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCCC
Confidence 9999988877543 4556677889999999999985 79999999999999988999999999986543
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.66 E-value=1.4e-16 Score=160.67 Aligned_cols=264 Identities=22% Similarity=0.206 Sum_probs=193.1
Q ss_pred cCCCceeEEEecc--cCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHc-CCCCCceEEEEEE
Q 012762 80 TLSDLRFVHRLGS--GDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEML-DHPFLPTLYATLD 156 (457)
Q Consensus 80 ~~~~~~~~~~LG~--G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~~~~~ 156 (457)
....+.+...+|. |.+|.||.+...+ ...+..+|+|.-+. .........+-.+|..-.+++ .|+|.++.+..+.
T Consensus 112 ~~~~~~~~~~~g~~~g~~~s~~~~~~~~--~~s~~~~a~k~s~~-p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e 188 (524)
T KOG0601|consen 112 FDQRFPISSRTGSLPGSKGSVFKSRCTN--SESPHKFAVKKSKI-PFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWE 188 (524)
T ss_pred hhhhcccccccccCCCCCceeecccCCc--ccCCcccccccccC-CCCCccccccccchhhcccccCccccccccCcccc
Confidence 3345778889999 9999999887632 24777899887432 122223333444566666666 4999999999999
Q ss_pred cCCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHH----HHHHHHHcCceeecCCCCCeEEccC-CCEEEec
Q 012762 157 CPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVV----ALEFLHMMGIIYRDLKPENVLVRSD-GHIMLTD 231 (457)
Q Consensus 157 ~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~----~L~yLH~~~iiHrDIKp~NIll~~~-~~vkl~D 231 (457)
..+..|+-+|+| +.+|..+.... ..-++...++..+.++.. ||..+|+.+++|-|+||+||++..+ ..++++|
T Consensus 189 ~~~~lfiqtE~~-~~sl~~~~~~~-~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~d 266 (524)
T KOG0601|consen 189 GSGILFIQTELC-GESLQSYCHTP-CNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTD 266 (524)
T ss_pred cCCcceeeeccc-cchhHHhhhcc-cccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCC
Confidence 999999999999 78887776653 345888999999999999 9999999999999999999999999 8899999
Q ss_pred cCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCC
Q 012762 232 FDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPL 311 (457)
Q Consensus 232 FG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (457)
||+...+.+........
T Consensus 267 f~~v~~i~~~~~~~~~~--------------------------------------------------------------- 283 (524)
T KOG0601|consen 267 FGLVSKISDGNFSSVFK--------------------------------------------------------------- 283 (524)
T ss_pred cceeEEccCCcccccee---------------------------------------------------------------
Confidence 99987665433211100
Q ss_pred ccccccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCC--ChHHHHHHHHhcccCCCCCCCCChHHHH
Q 012762 312 DVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGI--DHELTLANVVARALEFPKEPSVPGPAKD 389 (457)
Q Consensus 312 ~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (457)
....--|...|++||.+++. ++...|||++|.++.+..+|..+.... ..-..+.+ ..+........+.++..
T Consensus 284 --~~~r~~~~~~Y~~ke~~~~l-~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~---~~ip~e~~~~~s~~l~~ 357 (524)
T KOG0601|consen 284 --VSKRPEGDCIYAAKELLNGL-ATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ---GYIPLEFCEGGSSSLRS 357 (524)
T ss_pred --eeecCCCCceEeChhhhccc-cchHhhhcchhhhhHhhHhhcccccCCCCCCcccccc---ccCchhhhcCcchhhhh
Confidence 00011377789999999866 788999999999999999877655332 11111111 01111112234456667
Q ss_pred HHHHHhhhCCCCCCCCCcChHHHhcCCCCCCC
Q 012762 390 LIAQLLVKDPTRRMGSKMGATAIKRHQFFNGV 421 (457)
Q Consensus 390 ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~~ 421 (457)
.+..|+..+|-.|++ ++.+++|++....
T Consensus 358 ~~~~~~d~~~~~~~~----~q~~~~l~~i~s~ 385 (524)
T KOG0601|consen 358 VTSQMLDEDPRLRLT----AQILTALNVIHSK 385 (524)
T ss_pred HHHHhcCcchhhhhH----HHHHhccccccch
Confidence 999999999999999 9999999998764
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.1e-14 Score=148.53 Aligned_cols=144 Identities=21% Similarity=0.173 Sum_probs=98.2
Q ss_pred EEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhh---hh----------------------------------HH
Q 012762 88 HRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVS---RN----------------------------------KE 130 (457)
Q Consensus 88 ~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~---~~----------------------------------~~ 130 (457)
+.||.|++|+||+|+.+ +|+.||||+.+..-... +. .+
T Consensus 123 ~plasaSigQVh~A~l~-----~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~E 197 (437)
T TIGR01982 123 KPLAAASIAQVHRARLV-----DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRE 197 (437)
T ss_pred cceeeeehhheEEEEec-----CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHH
Confidence 57999999999999975 78999999986531100 00 00
Q ss_pred HHHHHHHHHHHHc----CCCCCceEEEEE-EcCCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHH-HHHHH
Q 012762 131 SRARIEREILEML----DHPFLPTLYATL-DCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVV-ALEFL 204 (457)
Q Consensus 131 ~~~~~E~~il~~l----~H~nIv~l~~~~-~~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~-~L~yL 204 (457)
-.+.+|.+.+.++ .|.+-+.+-.++ ......+|||||++|++|.++..... .... ...++.+++. .+..+
T Consensus 198 ldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~-~~~~---~~~ia~~~~~~~l~ql 273 (437)
T TIGR01982 198 LDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDE-AGLD---RKALAENLARSFLNQV 273 (437)
T ss_pred HCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHh-cCCC---HHHHHHHHHHHHHHHH
Confidence 1233455555444 233333333332 22345689999999999987765421 1222 2345555555 47889
Q ss_pred HHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCC
Q 012762 205 HMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDN 240 (457)
Q Consensus 205 H~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~ 240 (457)
|..|++|+|+||.||+++.+|.++++|||++....+
T Consensus 274 ~~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 274 LRDGFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred HhCCceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 999999999999999999999999999999877653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.53 E-value=1.4e-13 Score=140.52 Aligned_cols=118 Identities=19% Similarity=0.214 Sum_probs=96.8
Q ss_pred CCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcEEEEEeecCCCChHHHHHhCCCCCCCHH
Q 012762 109 NNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHES 188 (457)
Q Consensus 109 ~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~ 188 (457)
..+..|.|.+.+...- .......+-++-|+.|+||||+++++.++.++..|||+|-+ ..|...+++ +...
T Consensus 35 ~~~~~vsVF~~~~~~~---~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~-----l~~~ 104 (690)
T KOG1243|consen 35 ADGGPVSVFVYKRSNG---EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKE-----LGKE 104 (690)
T ss_pred ccCCceEEEEEeCCCc---hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHH-----hHHH
Confidence 3677788887765422 23444566777899999999999999999999999999998 466666666 3366
Q ss_pred HHHHHHHHHHHHHHHHH-HcCceeecCCCCCeEEccCCCEEEeccCCCc
Q 012762 189 AVRFYASEVVVALEFLH-MMGIIYRDLKPENVLVRSDGHIMLTDFDLSL 236 (457)
Q Consensus 189 ~~~~i~~qi~~~L~yLH-~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~ 236 (457)
.+..-+.||+.||.||| +.+++|++|.-+-|+|+..|..||++|.++.
T Consensus 105 ~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~ 153 (690)
T KOG1243|consen 105 EVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVS 153 (690)
T ss_pred HHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEe
Confidence 67777899999999998 6789999999999999999999999998764
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.53 E-value=9.8e-15 Score=150.79 Aligned_cols=147 Identities=19% Similarity=0.181 Sum_probs=97.1
Q ss_pred CCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhh-------------------------------hhHH
Q 012762 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVS-------------------------------RNKE 130 (457)
Q Consensus 82 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~-------------------------------~~~~ 130 (457)
.+|.. +.||+|++|+||+|+++. +|+.||||+.++.-... +...
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~----~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~ 194 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKD----NGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFE 194 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECC----CCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHH
Confidence 45665 789999999999999872 58999999997542100 0111
Q ss_pred HH------HHHHHHHHHHc----CCCCCceEEEEEE-cCCcEEEEEeecCCCChHHHHHhCCCC----CCCHHHHHHHHH
Q 012762 131 SR------ARIEREILEML----DHPFLPTLYATLD-CPRWSCLLTEFCPGGDLHVLRQRQPDK----RFHESAVRFYAS 195 (457)
Q Consensus 131 ~~------~~~E~~il~~l----~H~nIv~l~~~~~-~~~~~~lV~E~~~~~sL~~~~~~~~~~----~~~~~~~~~i~~ 195 (457)
.. +.+|...+.++ .+.+.+.+-.++. .....+|||||++|+.|.++......+ .+.+..+..++.
T Consensus 195 ~~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~ 274 (537)
T PRK04750 195 KTLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFT 274 (537)
T ss_pred HHHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHH
Confidence 11 23344333333 2444444444442 245678999999999997643221112 244444455555
Q ss_pred HHHHHHHHHHHcCceeecCCCCCeEEccCC----CEEEeccCCCcCCCC
Q 012762 196 EVVVALEFLHMMGIIYRDLKPENVLVRSDG----HIMLTDFDLSLKGDN 240 (457)
Q Consensus 196 qi~~~L~yLH~~~iiHrDIKp~NIll~~~~----~vkl~DFG~s~~~~~ 240 (457)
|++ ..|++|+|+||.||+++.+| .++++|||++..+..
T Consensus 275 Qif-------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 275 QVF-------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HHH-------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 554 58999999999999999888 999999999876654
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.50 E-value=2.1e-14 Score=144.99 Aligned_cols=252 Identities=20% Similarity=0.250 Sum_probs=183.5
Q ss_pred cCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHc-CCCCCceEEEEEEcC
Q 012762 80 TLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEML-DHPFLPTLYATLDCP 158 (457)
Q Consensus 80 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~~~~~~~ 158 (457)
...+|.++..||.|.|+.|+.+..+. .++..|++|-..+......... .-..|+-+...+ .|.+++.++..+...
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~---~~~~~Y~~ke~~~~l~~~~~di-~sl~ev~l~~~l~~~~~~~g~~~~W~~~ 338 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRP---EGDCIYAAKELLNGLATFASDI-FSLGEVILEAILGSHLPSVGKNSSWSQL 338 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecC---CCCceEeChhhhccccchHhhh-cchhhhhHhhHhhcccccCCCCCCcccc
Confidence 44678999999999999999877332 4788999998866544333322 233466666666 599999999988888
Q ss_pred CcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccC-CCEEEeccCCCcC
Q 012762 159 RWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSD-GHIMLTDFDLSLK 237 (457)
Q Consensus 159 ~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~-~~vkl~DFG~s~~ 237 (457)
+..|+-.|||+++++...+.. ...+.+...+.+..|++.++.++|+..++|+|+||+||++..+ +..+++|||+...
T Consensus 339 r~~~ip~e~~~~~s~~l~~~~--~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~ 416 (524)
T KOG0601|consen 339 RQGYIPLEFCEGGSSSLRSVT--SQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTR 416 (524)
T ss_pred ccccCchhhhcCcchhhhhHH--HHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccc
Confidence 888999999999998654422 2457788889999999999999999999999999999999886 7889999998632
Q ss_pred CCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcccccc
Q 012762 238 GDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMS 317 (457)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (457)
+. ...+.
T Consensus 417 ~~-------------------------------------------------------------------------~~~~~ 423 (524)
T KOG0601|consen 417 LA-------------------------------------------------------------------------FSSGV 423 (524)
T ss_pred cc-------------------------------------------------------------------------eeccc
Confidence 11 01112
Q ss_pred ccCCCCcc--CchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHh
Q 012762 318 FVGTHEYL--APEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLL 395 (457)
Q Consensus 318 ~~gt~~y~--aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L 395 (457)
+.+...++ +++.+....+..+.|++|||..+.+.++|...-.... ....+..+ ..+..+....++..+.+.++
T Consensus 424 ~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~---~~~~i~~~--~~p~~~~~~~~~q~~~kv~~ 498 (524)
T KOG0601|consen 424 FHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV---QSLTIRSG--DTPNLPGLKLQLQVLLKVMI 498 (524)
T ss_pred ccccccccccchhhccccccccccccccccccccccccCcccCcccc---cceeeecc--cccCCCchHHhhhhhhhhhc
Confidence 23444455 4444455668899999999999999999876433221 11222222 23333344578899999999
Q ss_pred hhCCCCCCCCCcChHHHhcCCCCC
Q 012762 396 VKDPTRRMGSKMGATAIKRHQFFN 419 (457)
Q Consensus 396 ~~dP~~Rps~~~~~~~ll~hp~f~ 419 (457)
..|+..|+. +.++..|.=|.
T Consensus 499 ~~~~~~~~l----~~~l~~~~~~~ 518 (524)
T KOG0601|consen 499 NPDRKRRPS----AVELSLHSEFY 518 (524)
T ss_pred CCccccchh----hhhhcccchhh
Confidence 999999999 88887775443
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.49 E-value=1.5e-13 Score=122.13 Aligned_cols=130 Identities=22% Similarity=0.253 Sum_probs=96.9
Q ss_pred EEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCC-ceEEEEEEcCCcEEEEE
Q 012762 87 VHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFL-PTLYATLDCPRWSCLLT 165 (457)
Q Consensus 87 ~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nI-v~l~~~~~~~~~~~lV~ 165 (457)
++.|+.|.++.||+++. .+..|++|+...... ....+..|.++++.+.+.++ .+++.+.. ...++||
T Consensus 3 ~~~l~~G~~~~vy~~~~------~~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~ 70 (170)
T cd05151 3 ISPLKGGMTNKNYRVEV------ANKKYVVRIPGNGTE----LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLIT 70 (170)
T ss_pred eeecCCcccCceEEEEE------CCeEEEEEeCCCCcc----cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEE
Confidence 46789999999999875 366899999754321 12235679999998865554 45555543 3357999
Q ss_pred eecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCc-----eeecCCCCCeEEccCCCEEEeccCCCcCCC
Q 012762 166 EFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGI-----IYRDLKPENVLVRSDGHIMLTDFDLSLKGD 239 (457)
Q Consensus 166 E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~i-----iHrDIKp~NIll~~~~~vkl~DFG~s~~~~ 239 (457)
||++|.++... ......++.+++.+|..||..++ +|+|++|.||+++ ++.++++|||.+....
T Consensus 71 e~i~G~~l~~~----------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~~~ 138 (170)
T cd05151 71 EFIEGSELLTE----------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGMND 138 (170)
T ss_pred EecCCCccccc----------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccCCC
Confidence 99999888532 01123456799999999999885 9999999999998 6789999999976543
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.48 E-value=8e-13 Score=119.35 Aligned_cols=146 Identities=16% Similarity=0.131 Sum_probs=103.5
Q ss_pred EEEecccCcceEEEEEEecc--CCCCCceEEEEEeehhhhh-------------------hhhHHHHHH----HHHHHHH
Q 012762 87 VHRLGSGDIGSVYLVQLKSK--SSNNGCFFAAKVMDKRELV-------------------SRNKESRAR----IEREILE 141 (457)
Q Consensus 87 ~~~LG~G~fg~Vy~a~~~~~--~~~~~~~vAvK~~~~~~~~-------------------~~~~~~~~~----~E~~il~ 141 (457)
...||.|-=+.||.|..... ....+..+|||+.+..... ..+....+. +|.+.|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 35789999999999974310 0113578999998432110 011122333 7899999
Q ss_pred HcC--CCCCceEEEEEEcCCcEEEEEeecCCCChH-HHHHhCCCCCCCHHHHHHHHHHHHHHHHHH-HHcCceeecCCCC
Q 012762 142 MLD--HPFLPTLYATLDCPRWSCLLTEFCPGGDLH-VLRQRQPDKRFHESAVRFYASEVVVALEFL-HMMGIIYRDLKPE 217 (457)
Q Consensus 142 ~l~--H~nIv~l~~~~~~~~~~~lV~E~~~~~sL~-~~~~~~~~~~~~~~~~~~i~~qi~~~L~yL-H~~~iiHrDIKp~ 217 (457)
+|. .-++...+++ ...+|||||+.++.+. ..++. ..+++..+..+..|++.+|..| |..||||+||++.
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd---~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~ 154 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD---AKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEY 154 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc---cccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHH
Confidence 984 4677788875 3567999999665442 12222 3456667778889999999999 8999999999999
Q ss_pred CeEEccCCCEEEeccCCCcCCCC
Q 012762 218 NVLVRSDGHIMLTDFDLSLKGDN 240 (457)
Q Consensus 218 NIll~~~~~vkl~DFG~s~~~~~ 240 (457)
|||+. ++.+.|+|||.+.....
T Consensus 155 NIL~~-~~~v~iIDF~qav~~~h 176 (197)
T cd05146 155 NMLWH-DGKVWFIDVSQSVEPTH 176 (197)
T ss_pred HEEEE-CCcEEEEECCCceeCCC
Confidence 99996 57899999999876653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.47 E-value=6.5e-14 Score=131.24 Aligned_cols=207 Identities=18% Similarity=0.251 Sum_probs=144.6
Q ss_pred HHHcCCCCCceEEEEEEcCC-----cEEEEEeecCCCChHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHcC--ce
Q 012762 140 LEMLDHPFLPTLYATLDCPR-----WSCLLTEFCPGGDLHVLRQRQP--DKRFHESAVRFYASEVVVALEFLHMMG--II 210 (457)
Q Consensus 140 l~~l~H~nIv~l~~~~~~~~-----~~~lV~E~~~~~sL~~~~~~~~--~~~~~~~~~~~i~~qi~~~L~yLH~~~--ii 210 (457)
|-.+.|-|||+++.|+.+.+ ...++.||+.-|+|..++++.+ ...+.....++|+.||+.||.|||+.. |+
T Consensus 121 llqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppii 200 (458)
T KOG1266|consen 121 LLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPII 200 (458)
T ss_pred HHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccc
Confidence 44567999999999986544 4688999999999999888742 356888899999999999999999885 99
Q ss_pred eecCCCCCeEEccCCCEEEeccCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCc
Q 012762 211 YRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHP 290 (457)
Q Consensus 211 HrDIKp~NIll~~~~~vkl~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (457)
|+++..+-|++..+|-+|++--...... +
T Consensus 201 hgnlTc~tifiq~ngLIkig~~ap~s~h---------------------------------------------------~ 229 (458)
T KOG1266|consen 201 HGNLTCDTIFIQHNGLIKIGSVAPDSTH---------------------------------------------------P 229 (458)
T ss_pred cCCcchhheeecCCceEEecccCccccc---------------------------------------------------h
Confidence 9999999999998888887532211000 0
Q ss_pred chhccccCCCCCCCcccccCCccccccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCC-CCCChHHHHHH
Q 012762 291 KRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPF-KGIDHELTLAN 369 (457)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf-~~~~~~~~~~~ 369 (457)
..+... ......-.|-++|.+||.=.-...+-++|||+||....||..|..-- .+.+.......
T Consensus 230 s~~~~~---------------~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ 294 (458)
T KOG1266|consen 230 SVNSTR---------------EAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEEN 294 (458)
T ss_pred hhhhhh---------------HhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHheeccCCCcceeehhhh
Confidence 000000 00000113677899998765555677999999999999999887542 22222222222
Q ss_pred HHhcccCCCCCCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCCC
Q 012762 370 VVARALEFPKEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGV 421 (457)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~~ 421 (457)
+....+.+.. +--++++.+||+-.|..||+ +.+++.||.+=.+
T Consensus 295 ia~~i~~len-----~lqr~~i~kcl~~eP~~rp~----ar~llfHpllfeV 337 (458)
T KOG1266|consen 295 IANVIIGLEN-----GLQRGSITKCLEGEPNGRPD----ARLLLFHPLLFEV 337 (458)
T ss_pred hhhheeeccC-----ccccCcCcccccCCCCCCcc----hhhhhcCceeeec
Confidence 2222221111 12357899999999999999 9999999986554
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.36 E-value=1.5e-11 Score=107.13 Aligned_cols=145 Identities=21% Similarity=0.177 Sum_probs=107.5
Q ss_pred eEEEecccCcceEEEEEEeccCCCCCceEEEEEeehh-----hhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCc
Q 012762 86 FVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKR-----ELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRW 160 (457)
Q Consensus 86 ~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~-----~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~ 160 (457)
.+..|-+|+=+.|+++.+ .|+...||.--.+ .+...-...+..+|+++|.++.--.|.--.-+|.+...
T Consensus 11 ~l~likQGAEArv~~~~~------~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~ 84 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF------SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYG 84 (229)
T ss_pred cceeeeccceeeEeeecc------CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCC
Confidence 567888999999999886 5677666643222 22222334667789999999865565444445555566
Q ss_pred EEEEEeecCC-CChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCC---CEEEeccCCCc
Q 012762 161 SCLLTEFCPG-GDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDG---HIMLTDFDLSL 236 (457)
Q Consensus 161 ~~lV~E~~~~-~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~---~vkl~DFG~s~ 236 (457)
-+|+|||++| .++.+++...............++.+|-+.|.-||..+|||+||..+||+|..+| .+.++|||++.
T Consensus 85 ~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~ 164 (229)
T KOG3087|consen 85 GQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSS 164 (229)
T ss_pred CeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchh
Confidence 7899999966 3677777665444455555578999999999999999999999999999998776 35899999974
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.34 E-value=1.5e-11 Score=107.72 Aligned_cols=134 Identities=21% Similarity=0.205 Sum_probs=97.2
Q ss_pred EecccCcceEEEEEEeccCCCCCceEEEEEeehhhhh-----hhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcEEE
Q 012762 89 RLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELV-----SRNKESRARIEREILEMLDHPFLPTLYATLDCPRWSCL 163 (457)
Q Consensus 89 ~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~-----~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~l 163 (457)
.+++|+=+.||++.+. |..+++|.-.++... ..-...+-.+|.++|.++.--.|.--+=++.+.....|
T Consensus 3 ~i~~GAEa~i~~~~~~------g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I 76 (204)
T COG3642 3 LIKQGAEAIIYLTDFL------GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLI 76 (204)
T ss_pred hhhCCcceeEEeeecc------CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEE
Confidence 5788999999988764 334666654333222 22234556779999998865454433334445566779
Q ss_pred EEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCC
Q 012762 164 LTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKG 238 (457)
Q Consensus 164 V~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~ 238 (457)
+|||++|..|.+++... ...+++.+-.-+.-||..||||+||.+.||++..++ +.++|||++..-
T Consensus 77 ~me~I~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~s 141 (204)
T COG3642 77 VMEYIEGELLKDALEEA---------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEFS 141 (204)
T ss_pred EEEEeCChhHHHHHHhc---------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCccccc
Confidence 99999999998888763 145667777888889999999999999999997665 999999998643
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.29 E-value=2e-11 Score=113.18 Aligned_cols=142 Identities=21% Similarity=0.250 Sum_probs=105.4
Q ss_pred EEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCC--CCCceEEEEEEcC---CcEE
Q 012762 88 HRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDH--PFLPTLYATLDCP---RWSC 162 (457)
Q Consensus 88 ~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H--~nIv~l~~~~~~~---~~~~ 162 (457)
+.||.|.++.||+++.. +|..|++|+....... .....+..|.++++.+.+ .++.+++.+.... +..+
T Consensus 4 ~~l~~G~~n~~~~v~~~-----~g~~~ilK~~~~~~~~--~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~ 76 (223)
T cd05154 4 RQLSGGQSNLTYLLTAG-----GGRRLVLRRPPPGALL--PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPF 76 (223)
T ss_pred eecCCCccceEEEEEec-----CCcceEEEeCCCcccC--cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCce
Confidence 57899999999999863 3578999998654321 124457789999999965 4467788877654 3678
Q ss_pred EEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH------------------------------------
Q 012762 163 LLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHM------------------------------------ 206 (457)
Q Consensus 163 lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~------------------------------------ 206 (457)
+||||++|.+|...+.. ..+++.....++.+++..|..||+
T Consensus 77 ~v~e~i~G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (223)
T cd05154 77 YVMERVDGRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDE 153 (223)
T ss_pred EEEEEeCCEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccc
Confidence 99999999988654321 235666666777777777777773
Q ss_pred --------------------cCceeecCCCCCeEEcc--CCCEEEeccCCCcCCC
Q 012762 207 --------------------MGIIYRDLKPENVLVRS--DGHIMLTDFDLSLKGD 239 (457)
Q Consensus 207 --------------------~~iiHrDIKp~NIll~~--~~~vkl~DFG~s~~~~ 239 (457)
..++|+|+++.||+++. ++.+.|+||+.+....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~g~ 208 (223)
T cd05154 154 PPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATLGD 208 (223)
T ss_pred cHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccccCC
Confidence 24699999999999988 5678999999876543
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.28 E-value=8e-12 Score=128.19 Aligned_cols=167 Identities=22% Similarity=0.354 Sum_probs=120.0
Q ss_pred HHHHHHHHHH-HcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCC
Q 012762 196 EVVVALEFLH-MMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSS 274 (457)
Q Consensus 196 qi~~~L~yLH-~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (457)
++..||.|+| +.++||++|.|++|+++..|..||+.|+++....+....
T Consensus 107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~------------------------------ 156 (700)
T KOG2137|consen 107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEY------------------------------ 156 (700)
T ss_pred cccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCcc------------------------------
Confidence 4459999999 558999999999999999999999999987544322110
Q ss_pred cccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccc-cccCCCCccCchhhcCCCCCccchhhhhhHHHHHHh-
Q 012762 275 CIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSM-SFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELF- 352 (457)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~ell- 352 (457)
....-+.+.. ...-...|.|||++.+...+.++|+||+||++|.+.
T Consensus 157 --------------------------------p~~~yd~~lp~~~~~~~~f~apE~~~~~~~~~~sd~fSlG~li~~i~~ 204 (700)
T KOG2137|consen 157 --------------------------------PFSEYDPPLPLLLQPHLNFLAPEYLLGTTNTPASDVFSLGVLIYTIYN 204 (700)
T ss_pred --------------------------------ccccCCCCCChhhccCcccccchhhccccccccccceeeeeEEEEEec
Confidence 0000000000 112456899999999988899999999999999999
Q ss_pred cCCCCCCCCChHHHH--HHHHhcccCCCCCCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCCCCchhhhc
Q 012762 353 YGTTPFKGIDHELTL--ANVVARALEFPKEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGVNWALLRC 428 (457)
Q Consensus 353 tG~~Pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~~~~~~~~~ 428 (457)
.|+..+........+ .........+-....+|.++++-|.++|..|+..||+ +.+++..+||.+..-..|+.
T Consensus 205 ~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~----~~~l~~~~ff~D~~~~aLrf 278 (700)
T KOG2137|consen 205 GGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPT----LDLLLSIPFFSDPGLKALRF 278 (700)
T ss_pred CCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcc----hhhhhcccccCCchhhhhhh
Confidence 566666544322222 1222222223334679999999999999999999999 99999999999866555543
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.18 E-value=8e-10 Score=105.28 Aligned_cols=128 Identities=17% Similarity=0.013 Sum_probs=93.0
Q ss_pred CCceEEEEEeehhhhhh---h-----hHHHHHHHHHHHHHHcC--CCCCceEEEEEEc-----CCcEEEEEeecCCC-Ch
Q 012762 110 NGCFFAAKVMDKRELVS---R-----NKESRARIEREILEMLD--HPFLPTLYATLDC-----PRWSCLLTEFCPGG-DL 173 (457)
Q Consensus 110 ~~~~vAvK~~~~~~~~~---~-----~~~~~~~~E~~il~~l~--H~nIv~l~~~~~~-----~~~~~lV~E~~~~~-sL 173 (457)
.|+.|.||......... . .....+.+|.+.+.+|. .-.++..++++.. ....+||||++++. +|
T Consensus 44 ~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL 123 (268)
T PRK15123 44 AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISL 123 (268)
T ss_pred CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccH
Confidence 56678888764332110 0 11123677888888884 3344556666643 23468999999775 79
Q ss_pred HHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEcc-------CCCEEEeccCCCcC
Q 012762 174 HVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRS-------DGHIMLTDFDLSLK 237 (457)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~-------~~~vkl~DFG~s~~ 237 (457)
.+++...............++.+++..+.-||..||+|+|+++.|||++. ++.+.|+||+.+..
T Consensus 124 ~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 124 EDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred HHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence 88876433345667788899999999999999999999999999999975 46899999998754
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.18 E-value=1.9e-10 Score=103.51 Aligned_cols=129 Identities=21% Similarity=0.245 Sum_probs=85.1
Q ss_pred eEEEEEEeccCCCCCceEEEEEeehhhhh-----------------------hhhHHHHHHHHHHHHHHcCCC--CCceE
Q 012762 97 SVYLVQLKSKSSNNGCFFAAKVMDKRELV-----------------------SRNKESRARIEREILEMLDHP--FLPTL 151 (457)
Q Consensus 97 ~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~-----------------------~~~~~~~~~~E~~il~~l~H~--nIv~l 151 (457)
.||.|... .|..+|+|+.+..... ........++|.+.|.++..- ++.+.
T Consensus 1 ~Vy~~~~~-----~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p 75 (188)
T PF01163_consen 1 DVYHAIDP-----DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKP 75 (188)
T ss_dssp EEEEEEEC-----TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--E
T ss_pred CEEEEECC-----CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcE
Confidence 48888764 6789999997432111 111235567799999999755 56777
Q ss_pred EEEEEcCCcEEEEEeecC--CCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHH-HHHcCceeecCCCCCeEEccCCCEE
Q 012762 152 YATLDCPRWSCLLTEFCP--GGDLHVLRQRQPDKRFHESAVRFYASEVVVALEF-LHMMGIIYRDLKPENVLVRSDGHIM 228 (457)
Q Consensus 152 ~~~~~~~~~~~lV~E~~~--~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~y-LH~~~iiHrDIKp~NIll~~~~~vk 228 (457)
+++. ..+|||||++ |..+..+.... +.......++.+++..+.. +|..||||+||.+.|||++.+ .+.
T Consensus 76 ~~~~----~~~ivME~I~~~G~~~~~l~~~~----~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~ 146 (188)
T PF01163_consen 76 YDYN----RNVIVMEYIGEDGVPLPRLKDVD----LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVY 146 (188)
T ss_dssp EEEE----TTEEEEE--EETTEEGGCHHHCG----GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEE
T ss_pred EEEe----CCEEEEEecCCCccchhhHHhcc----ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEE
Confidence 7653 3469999998 66665544432 2244566777888886665 579999999999999999876 899
Q ss_pred EeccCCCcCCC
Q 012762 229 LTDFDLSLKGD 239 (457)
Q Consensus 229 l~DFG~s~~~~ 239 (457)
|+|||.+....
T Consensus 147 iIDf~qav~~~ 157 (188)
T PF01163_consen 147 IIDFGQAVDSS 157 (188)
T ss_dssp E--GTTEEETT
T ss_pred EEecCcceecC
Confidence 99999986654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.07 E-value=5.7e-09 Score=104.06 Aligned_cols=134 Identities=18% Similarity=0.172 Sum_probs=103.7
Q ss_pred cceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEc----CCcEEEEEeecCC
Q 012762 95 IGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDC----PRWSCLLTEFCPG 170 (457)
Q Consensus 95 fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~----~~~~~lV~E~~~~ 170 (457)
-.+.|+|+.. .+|..|++|++...+.....+ ...-+++++++.|.|||++.++|.. +..+++|++|+++
T Consensus 289 ~~Ttyk~~s~----~DG~~YvLkRlhg~r~~~~nk---~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~ 361 (655)
T KOG3741|consen 289 SITTYKATSN----VDGNAYVLKRLHGDRDQSTNK---DTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPS 361 (655)
T ss_pred cceeEeeeec----cCCceeeeeeeccccccCccc---chHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCC
Confidence 4578888866 488899999995433322221 2235788999999999999998863 3467999999865
Q ss_pred -CChHHHHHhC-------------CCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCC
Q 012762 171 -GDLHVLRQRQ-------------PDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235 (457)
Q Consensus 171 -~sL~~~~~~~-------------~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s 235 (457)
++|.++.-.. .+...+|..++.++.|+..||.++|+.|+.-+-|-|.+||++.+..++|..-|+.
T Consensus 362 s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~ 440 (655)
T KOG3741|consen 362 SPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIM 440 (655)
T ss_pred CchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccce
Confidence 5666543221 1345789999999999999999999999999999999999998878888877764
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.95 E-value=7.1e-09 Score=96.27 Aligned_cols=140 Identities=21% Similarity=0.200 Sum_probs=103.0
Q ss_pred ceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhh-------------------hhHHHHHHHHHHHHHHcC
Q 012762 84 LRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVS-------------------RNKESRARIEREILEMLD 144 (457)
Q Consensus 84 ~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~-------------------~~~~~~~~~E~~il~~l~ 144 (457)
+.+..+||.|.=+.||.|.+. .|..+|||.=+.....- .......++|.++|.+|.
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~-----~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~ 167 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP-----KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLY 167 (304)
T ss_pred HhhccccccCccceEEEEECC-----CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhh
Confidence 345678999999999999864 68899999643221110 011244567888999986
Q ss_pred CC--CCceEEEEEEcCCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEc
Q 012762 145 HP--FLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVR 222 (457)
Q Consensus 145 H~--nIv~l~~~~~~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~ 222 (457)
-. .|.+.+++ +..++||||++|-.|..+. +..+....++..|++-+.-+-..||||+|+.+-|||++
T Consensus 168 ~~G~~VP~P~~~----nRHaVvMe~ieG~eL~~~r-------~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~ 236 (304)
T COG0478 168 PEGVKVPKPIAW----NRHAVVMEYIEGVELYRLR-------LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVT 236 (304)
T ss_pred hcCCCCCCcccc----ccceeeeehcccceeeccc-------CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEe
Confidence 44 67777765 3457999999998875432 23444556667777777777799999999999999999
Q ss_pred cCCCEEEeccCCCcCCC
Q 012762 223 SDGHIMLTDFDLSLKGD 239 (457)
Q Consensus 223 ~~~~vkl~DFG~s~~~~ 239 (457)
.||.+.++||-.+....
T Consensus 237 ~dg~~~vIDwPQ~v~~~ 253 (304)
T COG0478 237 EDGDIVVIDWPQAVPIS 253 (304)
T ss_pred cCCCEEEEeCcccccCC
Confidence 99999999998775544
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.95 E-value=1.8e-08 Score=92.63 Aligned_cols=128 Identities=29% Similarity=0.254 Sum_probs=94.4
Q ss_pred CCceEEEEEeehhh----hhhhhHHHHHHHHHHHHHHcC--CCCCceEEEEEEcCC----cEEEEEeecCC-CChHHHHH
Q 012762 110 NGCFFAAKVMDKRE----LVSRNKESRARIEREILEMLD--HPFLPTLYATLDCPR----WSCLLTEFCPG-GDLHVLRQ 178 (457)
Q Consensus 110 ~~~~vAvK~~~~~~----~~~~~~~~~~~~E~~il~~l~--H~nIv~l~~~~~~~~----~~~lV~E~~~~-~sL~~~~~ 178 (457)
.++.|-+|.....- ....-...+..+|.+.+..|. .-.++..+++..... ..+||+|++++ .+|.+++.
T Consensus 31 ~~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~ 110 (206)
T PF06293_consen 31 VGRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQ 110 (206)
T ss_pred cceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHH
Confidence 45566666543221 111123456777888888874 344567777765532 35899999987 47988887
Q ss_pred hCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCC---CEEEeccCCCcCCC
Q 012762 179 RQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDG---HIMLTDFDLSLKGD 239 (457)
Q Consensus 179 ~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~---~vkl~DFG~s~~~~ 239 (457)
... ..+......++.++...+.-||+.||+|+|+++.|||++.++ .+.++||+-++...
T Consensus 111 ~~~--~~~~~~~~~ll~~l~~~i~~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~~ 172 (206)
T PF06293_consen 111 QWE--QLDPSQRRELLRALARLIAKLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFRP 172 (206)
T ss_pred hhc--ccchhhHHHHHHHHHHHHHHHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeCC
Confidence 642 266777888999999999999999999999999999999887 89999999876544
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.86 E-value=7.8e-08 Score=87.28 Aligned_cols=141 Identities=14% Similarity=0.108 Sum_probs=100.9
Q ss_pred cccCcceEEEEEEeccCCCCCceEEEEEeehhhhhh---hhHHHHHHHHHHHHHHcC--CCCCceEEEEEEc--C--CcE
Q 012762 91 GSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVS---RNKESRARIEREILEMLD--HPFLPTLYATLDC--P--RWS 161 (457)
Q Consensus 91 G~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~---~~~~~~~~~E~~il~~l~--H~nIv~l~~~~~~--~--~~~ 161 (457)
|.||.+-|+.... .|..|-+|.-...-..+ +.....+.+|...|..|. .-.+.++..+... + -..
T Consensus 27 ~rgG~SgV~r~~~------~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA 100 (216)
T PRK09902 27 RRNGMSGVQCVER------NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRA 100 (216)
T ss_pred CCCCcceEEEEEe------CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEE
Confidence 5688888887664 34457777654211111 234566888999988884 3335555522211 1 135
Q ss_pred EEEEeecC-CCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCC--EEEeccCCCcC
Q 012762 162 CLLTEFCP-GGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGH--IMLTDFDLSLK 237 (457)
Q Consensus 162 ~lV~E~~~-~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~--vkl~DFG~s~~ 237 (457)
+||+|-+. ..+|.+++........++.....++.+|+..|.-||+.|+.|+|+-+.||+++.+|. ++++||.-++.
T Consensus 101 ~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 101 LLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 89999773 278888877654456788888899999999999999999999999999999987777 99999987643
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.76 E-value=1.5e-07 Score=86.72 Aligned_cols=142 Identities=23% Similarity=0.236 Sum_probs=97.4
Q ss_pred EEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhH---------------------HHHHHHHHHHHHHcC-
Q 012762 87 VHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNK---------------------ESRARIEREILEMLD- 144 (457)
Q Consensus 87 ~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~---------------------~~~~~~E~~il~~l~- 144 (457)
...|.+|.-+.||+|... .+..+|+|+++......... ..-.+.|..-|+++.
T Consensus 53 ~g~istGKEA~Vy~a~~~-----~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~e 127 (268)
T COG1718 53 VGCISTGKEANVYLAETG-----DGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYE 127 (268)
T ss_pred EeeecCCcceEEEeeccC-----CCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHH
Confidence 347788888899998753 67899999996543322211 011233555666663
Q ss_pred -CCCCceEEEEEEcCCcEEEEEeecCCCCh-HHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCceeecCCCCCeEE
Q 012762 145 -HPFLPTLYATLDCPRWSCLLTEFCPGGDL-HVLRQRQPDKRFHESAVRFYASEVVVALEFLHM-MGIIYRDLKPENVLV 221 (457)
Q Consensus 145 -H~nIv~l~~~~~~~~~~~lV~E~~~~~sL-~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~-~~iiHrDIKp~NIll 221 (457)
+-.+.+-+++.. ..|||||+....+ .-.++ .-.+...++..+..++++.+.-|-. .++||+||..-|||+
T Consensus 128 AGVrvP~Pi~~~~----nVLvMEfIg~~g~pAP~Lk---Dv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~ 200 (268)
T COG1718 128 AGVRVPEPIAFRN----NVLVMEFIGDDGLPAPRLK---DVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILV 200 (268)
T ss_pred cCCCCCCceeecC----CeEEEEeccCCCCCCCCcc---cCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEE
Confidence 455566666543 3699999943311 11111 1234444677888899999998887 899999999999999
Q ss_pred ccCCCEEEeccCCCcCCCCC
Q 012762 222 RSDGHIMLTDFDLSLKGDNS 241 (457)
Q Consensus 222 ~~~~~vkl~DFG~s~~~~~~ 241 (457)
. ++.+.|+|||.+.....+
T Consensus 201 ~-~~~p~iID~~QaV~~~hp 219 (268)
T COG1718 201 H-DGEPYIIDVSQAVTIDHP 219 (268)
T ss_pred E-CCeEEEEECccccccCCC
Confidence 8 889999999998766543
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.72 E-value=3.6e-07 Score=83.29 Aligned_cols=138 Identities=17% Similarity=0.198 Sum_probs=90.8
Q ss_pred CCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHH------HHHHHHHHHHc---CCCCCceEE
Q 012762 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESR------ARIEREILEML---DHPFLPTLY 152 (457)
Q Consensus 82 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~------~~~E~~il~~l---~H~nIv~l~ 152 (457)
.+|.+++++-.....-|-+-.. +|..+++|..+...-........ ..+++..+..+ +-..+..++
T Consensus 31 ~~~~~~kv~k~~~r~~ValIei------~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~y 104 (229)
T PF06176_consen 31 NNYKIIKVFKNTKRNYVALIEI------DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPY 104 (229)
T ss_pred CCceEEEeecCCCccEEEEEEE------CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccce
Confidence 5788899998888888877663 67889999987643222211111 11223333333 233333333
Q ss_pred EEEE-----cCCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCE
Q 012762 153 ATLD-----CPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHI 227 (457)
Q Consensus 153 ~~~~-----~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~v 227 (457)
.+.. .....+|||||++|..|.++.. +++ .+...|.+++.-||+.|++|+|.+|.|++++.+ .+
T Consensus 105 l~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~------i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~-~i 173 (229)
T PF06176_consen 105 LAAEKKIFRYTSSYVLLMEYIEGVELNDIED------IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN-GI 173 (229)
T ss_pred eeeeeeeccceeEEEEEEEEecCeecccchh------cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECC-cE
Confidence 3322 1234568999999999865432 232 244567788999999999999999999999855 49
Q ss_pred EEeccCCCc
Q 012762 228 MLTDFDLSL 236 (457)
Q Consensus 228 kl~DFG~s~ 236 (457)
+++||+..+
T Consensus 174 ~iID~~~k~ 182 (229)
T PF06176_consen 174 RIIDTQGKR 182 (229)
T ss_pred EEEECcccc
Confidence 999998753
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.70 E-value=2.8e-07 Score=90.05 Aligned_cols=238 Identities=22% Similarity=0.243 Sum_probs=146.8
Q ss_pred eeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHc-CCCCCceEEEE------EEc
Q 012762 85 RFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEML-DHPFLPTLYAT------LDC 157 (457)
Q Consensus 85 ~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~~~------~~~ 157 (457)
...+.||+|+-+.+|-.-- -+. -+.|++.+-...... ..++.|... .||-+-.=+.+ ..+
T Consensus 14 ~~gr~LgqGgea~ly~l~e------~~d-~VAKIYh~Pppa~~a------qk~a~la~~p~~p~~~~rvaWPqa~L~G~~ 80 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGE------VRD-QVAKIYHAPPPAAQA------QKVAELAATPDAPLLNYRVAWPQATLHGGR 80 (637)
T ss_pred CCCccccCCccceeeecch------hhc-hhheeecCCCchHHH------HHHHHhccCCCCcchhhhhcccHHHhhCCC
Confidence 3467899999999994421 122 344887653221111 123334433 45544331111 112
Q ss_pred CC-cEEEEEeecCCCCh-HHHH----HhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEec
Q 012762 158 PR-WSCLLTEFCPGGDL-HVLR----QRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTD 231 (457)
Q Consensus 158 ~~-~~~lV~E~~~~~sL-~~~~----~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~D 231 (457)
.+ .+-+.|+.+.|..= ..+. .++......+.....+++.|+.+..-||..|.+-+|+.++|+|++.++.|.|.|
T Consensus 81 ~~~~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVd 160 (637)
T COG4248 81 RGKVIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVD 160 (637)
T ss_pred ccceeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEc
Confidence 22 25678888766422 1111 112233467888899999999999999999999999999999999999999998
Q ss_pred cCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCC
Q 012762 232 FDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPL 311 (457)
Q Consensus 232 FG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (457)
-..-....+.
T Consensus 161 sDsfqi~~ng---------------------------------------------------------------------- 170 (637)
T COG4248 161 SDSFQINANG---------------------------------------------------------------------- 170 (637)
T ss_pred ccceeeccCC----------------------------------------------------------------------
Confidence 5321111100
Q ss_pred ccccccccCCCCccCchhhc-----CCCCCccchhhhhhHHHHHHhcC-CCCCCCCChH----HHHH-HHHhcc------
Q 012762 312 DVRSMSFVGTHEYLAPEIIS-----GEGHGNAVDWWTLGIFIFELFYG-TTPFKGIDHE----LTLA-NVVARA------ 374 (457)
Q Consensus 312 ~~~~~~~~gt~~y~aPE~l~-----~~~~~~~sDiwSlG~il~elltG-~~Pf~~~~~~----~~~~-~~~~~~------ 374 (457)
.....-+|...|.+||... +..-+...|.|.||+++++|+.| +-||.+.... --++ .|-.+.
T Consensus 171 -~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~ya~~ 249 (637)
T COG4248 171 -TLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFAYASD 249 (637)
T ss_pred -ceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceeeechh
Confidence 0001126899999999875 33346789999999999999986 9999764211 0011 111111
Q ss_pred ---cCCCC-----CCCCChHHHHHHHHHhhh--CCCCCCCCC
Q 012762 375 ---LEFPK-----EPSVPGPAKDLIAQLLVK--DPTRRMGSK 406 (457)
Q Consensus 375 ---~~~~~-----~~~~~~~~~~ll~~~L~~--dP~~Rps~~ 406 (457)
...+. ...+++++..|..+|+.. ++.-||+.+
T Consensus 250 ~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~ 291 (637)
T COG4248 250 QRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAK 291 (637)
T ss_pred ccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHH
Confidence 11111 124568899999999875 467899954
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.67 E-value=1.6e-07 Score=96.95 Aligned_cols=145 Identities=24% Similarity=0.228 Sum_probs=91.2
Q ss_pred EEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhh---h----------------------------hHHHH----
Q 012762 88 HRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVS---R----------------------------NKESR---- 132 (457)
Q Consensus 88 ~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~---~----------------------------~~~~~---- 132 (457)
..|+.++-|+||.|+++ +|+.|||||....-... + ...+.
T Consensus 131 ~PiAsASIaQVH~A~L~-----sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~E 205 (517)
T COG0661 131 EPIASASIAQVHRAVLK-----SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREE 205 (517)
T ss_pred CchhhhhHhhheeEEec-----CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHH
Confidence 57899999999999997 69999999974421100 0 00011
Q ss_pred --HHHHHHHHHHc----C-CCCCceEEEEE-EcCCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHH
Q 012762 133 --ARIEREILEML----D-HPFLPTLYATL-DCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFL 204 (457)
Q Consensus 133 --~~~E~~il~~l----~-H~nIv~l~~~~-~~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yL 204 (457)
+.+|..-+.++ + .++ +++=.++ +......|+|||++|..+.++..... .+++...+.....++. +.-+
T Consensus 206 lDy~~EA~n~~~~~~nf~~~~~-v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f--~~q~ 281 (517)
T COG0661 206 LDYRREAANAERFRENFKDDPD-VYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRAF--LRQL 281 (517)
T ss_pred hCHHHHHHHHHHHHHHcCCCCC-eEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHH--HHHH
Confidence 12233333333 2 232 2222222 33455679999999999987743322 4455444333322221 2223
Q ss_pred HHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCC
Q 012762 205 HMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNS 241 (457)
Q Consensus 205 H~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~ 241 (457)
-..|++|.|.+|.||+++.+|.+.+.|||+.....+.
T Consensus 282 ~~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~ 318 (517)
T COG0661 282 LRDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK 318 (517)
T ss_pred HhcCccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence 3489999999999999999999999999998766543
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.65 E-value=3.2e-09 Score=108.21 Aligned_cols=243 Identities=16% Similarity=0.181 Sum_probs=160.8
Q ss_pred CceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCC-CceEEEEEEcCCcE
Q 012762 83 DLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPF-LPTLYATLDCPRWS 161 (457)
Q Consensus 83 ~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~n-Iv~l~~~~~~~~~~ 161 (457)
.+...+-+++|+++++++.+..+ .. ....+.+.. ......++++|.+++||| .+..++-++.+.+.
T Consensus 243 ws~~fh~fvK~altknpKkRpta----ek-lL~h~fvs~--------~l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~ 309 (829)
T KOG0576|consen 243 WSEFFHNFVKGALTKNPKKRPTA----EK-LLQHPFVSQ--------TLSRRLAIELLDKVNNPNPVVRYLEDYDGEDYL 309 (829)
T ss_pred chHHHHHHHHHHhcCCCccCCCh----hh-heeceeecc--------chhhHHHHHHHHHccCCCCcccccccCCccccc
Confidence 46666778999999999766432 22 223555532 244556899999999999 77778888888899
Q ss_pred EEEEeecCCC-ChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCC
Q 012762 162 CLLTEFCPGG-DLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDN 240 (457)
Q Consensus 162 ~lV~E~~~~~-sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~ 240 (457)
+++|+++.++ +-...+.. ..-.+.+-+...+++.-..+|+++|+.--+|+| ||+..+ +..+..||+....+..
T Consensus 310 ~i~~~i~s~~rs~~~~~~~-se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~ 383 (829)
T KOG0576|consen 310 WIPMRICSTGRSSALEMTV-SEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTR 383 (829)
T ss_pred chhhhhhcCCccccccCCh-hhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccCc
Confidence 9999999776 22111110 011233444555667778899999988778998 777754 6789999987644332
Q ss_pred CCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccC
Q 012762 241 STSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVG 320 (457)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 320 (457)
.- ...++.+
T Consensus 384 ~~-----------------------------------------------------------------------~~~t~~~ 392 (829)
T KOG0576|consen 384 TM-----------------------------------------------------------------------KPRTAIG 392 (829)
T ss_pred cc-----------------------------------------------------------------------ccccCCC
Confidence 10 1124579
Q ss_pred CCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcc--cCCCCCCCCChHHH-HHHHHHhhh
Q 012762 321 THEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARA--LEFPKEPSVPGPAK-DLIAQLLVK 397 (457)
Q Consensus 321 t~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~-~ll~~~L~~ 397 (457)
|+.++|||+..+..+....|+|++|+-..+|.-|.+|-........ .+-.+. ..+.....++.... ++...|+.-
T Consensus 393 ~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~P~~~~~--~~g~~p~s~~L~~~~aw~~~~~~~~~~~~~~g 470 (829)
T KOG0576|consen 393 TPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSSPPAVLP--MIGNGPNSPMLTDKSAWSPVFHRDFPAPCLNG 470 (829)
T ss_pred CCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCCCccccC--CCCCCCCccccchhhhcCcccccCCcccccCC
Confidence 9999999999999999999999999988888878777543111000 000000 00000001111122 477788888
Q ss_pred CCCCCCCCCcChHHHhcCCCCCCC
Q 012762 398 DPTRRMGSKMGATAIKRHQFFNGV 421 (457)
Q Consensus 398 dP~~Rps~~~~~~~ll~hp~f~~~ 421 (457)
.|..|+. ...++.|.+|++-
T Consensus 471 ~P~~pkv----~mgacfsKvfngC 490 (829)
T KOG0576|consen 471 LPPTPKV----HMGACFSKVFNGC 490 (829)
T ss_pred CCCCCcc----hhhHHHHHHhccC
Confidence 8999988 8889999998873
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.61 E-value=7.8e-07 Score=82.97 Aligned_cols=138 Identities=12% Similarity=0.065 Sum_probs=85.5
Q ss_pred EEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCC--CceEEEEEEcCCcEEEEE
Q 012762 88 HRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPF--LPTLYATLDCPRWSCLLT 165 (457)
Q Consensus 88 ~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~n--Iv~l~~~~~~~~~~~lV~ 165 (457)
..||.|..+.||+. .+..+++|+..... ......+|.++++.+..-+ +.+++++....+...+||
T Consensus 7 ~~i~~G~t~~~y~~--------~~~~~VlR~~~~~~-----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~ 73 (226)
T TIGR02172 7 TQTGEGGNGESYTH--------KTGKWMLKLYNPGF-----DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIY 73 (226)
T ss_pred eeecCCCCcceeEe--------cCCCEEEEeCCCCC-----CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeee
Confidence 57899999999963 23357889875421 2334577999999986433 578888888888888999
Q ss_pred eecCCCC-hH--------------HHH-------HhCCCCCCCHHHH-HHHHHH----------HHH-HHHHHH----Hc
Q 012762 166 EFCPGGD-LH--------------VLR-------QRQPDKRFHESAV-RFYASE----------VVV-ALEFLH----MM 207 (457)
Q Consensus 166 E~~~~~s-L~--------------~~~-------~~~~~~~~~~~~~-~~i~~q----------i~~-~L~yLH----~~ 207 (457)
|+++|.. +. ..+ +..+......... ..+..+ +.. ...+|. ..
T Consensus 74 e~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~ 153 (226)
T TIGR02172 74 ELIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTS 153 (226)
T ss_pred eecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCC
Confidence 9998864 11 101 1110011111110 111000 111 122222 12
Q ss_pred CceeecCCCCCeEEccCCCEEEeccCCCcCCC
Q 012762 208 GIIYRDLKPENVLVRSDGHIMLTDFDLSLKGD 239 (457)
Q Consensus 208 ~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~ 239 (457)
.++|+|+.|.||+++.++ +.++||+.+....
T Consensus 154 ~~~HgD~~~~Nii~~~~~-~~iIDwe~a~~Gd 184 (226)
T TIGR02172 154 TCLHGDFQIGNLITSGKG-TYWIDLGDFGYGN 184 (226)
T ss_pred ceEecCCCCCcEEEcCCC-cEEEechhcCcCC
Confidence 478999999999999888 9999999875443
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.57 E-value=3.3e-07 Score=79.98 Aligned_cols=131 Identities=24% Similarity=0.273 Sum_probs=96.4
Q ss_pred ceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCC-ceEEEEEEcCCcEE
Q 012762 84 LRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFL-PTLYATLDCPRWSC 162 (457)
Q Consensus 84 ~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nI-v~l~~~~~~~~~~~ 162 (457)
.++.+.||+|.+|.||+|.++ |..+|+|+-.. +.....+..|+++|..+...++ .++|.|..+ +
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~~------~~~~a~Kvrr~-----ds~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~ 88 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEWR------GGEVALKVRRR-----DSPRRNLEKEAKILEILAGEGVTPEVYFYGED----F 88 (201)
T ss_pred hhhhhhhhcccccEEEEeecc------CceEEEEEecC-----CcchhhHHHHHHHHHHhhhcCCCceEEEechh----h
Confidence 456788999999999999985 55899998743 3566778889999999987776 456666543 3
Q ss_pred EEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCC-CCCeEEccCCCEEEeccCCCcCC
Q 012762 163 LLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLK-PENVLVRSDGHIMLTDFDLSLKG 238 (457)
Q Consensus 163 lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIK-p~NIll~~~~~vkl~DFG~s~~~ 238 (457)
+.|||++|-.|..+-.. .+... +..+++.-.-|-..||-|..|. |..++|-.++.+.|+||.-|..-
T Consensus 89 i~me~i~G~~L~~~~~~-----~~rk~----l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k 156 (201)
T COG2112 89 IRMEYIDGRPLGKLEIG-----GDRKH----LLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATFK 156 (201)
T ss_pred hhhhhhcCcchhhhhhc-----ccHHH----HHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhhc
Confidence 56999999888654322 12223 3445555555667899999997 77777777779999999987643
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.49 E-value=1.2e-06 Score=95.41 Aligned_cols=202 Identities=19% Similarity=0.232 Sum_probs=138.0
Q ss_pred HHHHHHHHHHcCCCCCceEEEEEEcCCcE----EEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcC
Q 012762 133 ARIEREILEMLDHPFLPTLYATLDCPRWS----CLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMG 208 (457)
Q Consensus 133 ~~~E~~il~~l~H~nIv~l~~~~~~~~~~----~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~ 208 (457)
...|.+.+.+..|+|++.++.|....... .+..|+|...++...++.- ...+....+.+..++++||.|+|+..
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v--~~i~~~~~r~~~~~~~~GL~~~h~~~ 306 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSV--GSIPLETLRILHQKLLEGLAYLHSLS 306 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhc--cccCHHHHHHHHHHHhhhHHHHHHhc
Confidence 34466678888999999999998654332 3456788888988887765 67889999999999999999999986
Q ss_pred ceeecCCCC---CeEEccCCCEEEe--ccCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCC
Q 012762 209 IIYRDLKPE---NVLVRSDGHIMLT--DFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVP 283 (457)
Q Consensus 209 iiHrDIKp~---NIll~~~~~vkl~--DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (457)
..|.-+-.. +--.+.++.+.++ ||+.++...+.....
T Consensus 307 l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~-------------------------------------- 348 (1351)
T KOG1035|consen 307 LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSF-------------------------------------- 348 (1351)
T ss_pred cceeEEecccccccccCccceeecchhhhcccccCCCcccch--------------------------------------
Confidence 555544443 3333445555655 777654443221110
Q ss_pred cccccCcchhccccCCCCCCCcccccCCccccccccCCCCccCchhhcCCCCCc--cchhhhhhHHHHHHhcCCCCCCCC
Q 012762 284 AVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTHEYLAPEIISGEGHGN--AVDWWTLGIFIFELFYGTTPFKGI 361 (457)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~--~sDiwSlG~il~elltG~~Pf~~~ 361 (457)
...-+..+.++|......+.. ..|+|.+|..+..+..|..+-...
T Consensus 349 ---------------------------------~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~~~~i~~~~ 395 (1351)
T KOG1035|consen 349 ---------------------------------SDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLSQGEDISEKS 395 (1351)
T ss_pred ---------------------------------hhcCccccccccccccccchhhhhhHHHHHHHHHhhhhhcCcccccc
Confidence 112455677888777665544 479999999999999877543211
Q ss_pred ChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCCCC
Q 012762 362 DHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGVN 422 (457)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~~~ 422 (457)
. .....+.. .......+++.+|+..+.++|++ +.+++.|+|.+.-.
T Consensus 396 ~---~~~~~l~~--------~~~~~~~d~~~~~~~~~~~~Rl~----~~~ll~~~f~~~~~ 441 (1351)
T KOG1035|consen 396 A---VPVSLLDV--------LSTSELLDALPKCLDEDSEERLS----ALELLTHPFLRFPT 441 (1351)
T ss_pred c---chhhhhcc--------ccchhhhhhhhhhcchhhhhccc----hhhhhhchhccccc
Confidence 1 11111100 11225788999999999999999 99999999987643
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.46 E-value=3.8e-06 Score=78.07 Aligned_cols=139 Identities=27% Similarity=0.339 Sum_probs=82.0
Q ss_pred EEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCC--CCceEEEEEE---cCCcE
Q 012762 87 VHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHP--FLPTLYATLD---CPRWS 161 (457)
Q Consensus 87 ~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~--nIv~l~~~~~---~~~~~ 161 (457)
++.|+.|..+.||++... + ..+++|+.... .....+..|.++++.|... .+.+++.+.. .....
T Consensus 2 i~~l~~G~~n~~~~v~~~-----~-~~~vlK~~~~~-----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~ 70 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTD-----D-GRYVLKFYRPP-----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFP 70 (239)
T ss_dssp EEEEEESSSSEEEEEEET-----T-SEEEEEEESSH-----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEE
T ss_pred CccCCCCCeeeEEEEEEC-----C-cEEEEEEeCCC-----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccc
Confidence 578999999999998853 3 58999997543 2445566788898888533 3567776442 23357
Q ss_pred EEEEeecCCCChHH----------------HHH---hC--CCCCCCHHH------HHHH---------------HHHHHH
Q 012762 162 CLLTEFCPGGDLHV----------------LRQ---RQ--PDKRFHESA------VRFY---------------ASEVVV 199 (457)
Q Consensus 162 ~lV~E~~~~~sL~~----------------~~~---~~--~~~~~~~~~------~~~i---------------~~qi~~ 199 (457)
+++|++++|..+.. ++. .. ....+.... .... ...+..
T Consensus 71 ~~~~~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 150 (239)
T PF01636_consen 71 YLLMEYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEE 150 (239)
T ss_dssp EEEEEEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHH
T ss_pred eEEEEEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHH
Confidence 89999999988866 111 11 111111100 0000 111222
Q ss_pred -HHHHHHH-------cCceeecCCCCCeEEc-cCCCEEEeccCCCc
Q 012762 200 -ALEFLHM-------MGIIYRDLKPENVLVR-SDGHIMLTDFDLSL 236 (457)
Q Consensus 200 -~L~yLH~-------~~iiHrDIKp~NIll~-~~~~vkl~DFG~s~ 236 (457)
.+..+++ ..++|+|+.|.|||++ .++.+.|+||+.+.
T Consensus 151 ~~~~~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 151 RLLQELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHHHHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred HHHHHHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 3333332 3599999999999999 56666899998864
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.45 E-value=2.6e-06 Score=80.39 Aligned_cols=139 Identities=20% Similarity=0.133 Sum_probs=85.4
Q ss_pred EecccCc-ceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcC-CCCCceEEEEEEcCCcEEEEEe
Q 012762 89 RLGSGDI-GSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLD-HPFLPTLYATLDCPRWSCLLTE 166 (457)
Q Consensus 89 ~LG~G~f-g~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~-H~nIv~l~~~~~~~~~~~lV~E 166 (457)
.|-.|.+ +.||+... .+..+.+|+..... ......|+++++.+. +--+.+++++...++..++|||
T Consensus 5 ~~~~g~~~~~v~~~~~------~~~~~~vk~~~~~~------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e 72 (244)
T cd05150 5 RVTEGQSGATVYRLDG------KNPGLYLKIAPSGP------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTS 72 (244)
T ss_pred ecCCCCCcCeEEEEcC------CCCcEEEEecCCCc------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEE
Confidence 4455655 78998753 23568888875432 234566999988883 4557788888877777899999
Q ss_pred ecCCCChHHHHH-------------------hCC--CCCCCHH--HHHHH-----------------------HHHHHHH
Q 012762 167 FCPGGDLHVLRQ-------------------RQP--DKRFHES--AVRFY-----------------------ASEVVVA 200 (457)
Q Consensus 167 ~~~~~sL~~~~~-------------------~~~--~~~~~~~--~~~~i-----------------------~~qi~~~ 200 (457)
+++|.+|..... ..+ ...+... ..... ..+++..
T Consensus 73 ~i~G~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 152 (244)
T cd05150 73 AVPGVPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAE 152 (244)
T ss_pred eeCCccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHH
Confidence 999988753310 011 0111100 00000 1111111
Q ss_pred HHHH----HHcCceeecCCCCCeEEccCCCEEEeccCCCcCCC
Q 012762 201 LEFL----HMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGD 239 (457)
Q Consensus 201 L~yL----H~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~ 239 (457)
|... ....++|+|+.|.|||++.++.+.|+||+.+....
T Consensus 153 l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~gd 195 (244)
T cd05150 153 LEATRPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGVAD 195 (244)
T ss_pred HHhhCCCcCceEEECCCCCCccEEEeCCcEEEEEEcccccccc
Confidence 1111 12349999999999999988778899999875443
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.41 E-value=4.2e-06 Score=75.49 Aligned_cols=128 Identities=24% Similarity=0.350 Sum_probs=90.8
Q ss_pred CCceeEEEecccCc-ceEEEEEEeccCCCCCceEEEEEeehhhhhhh------------------hHHHHHHHHHHHHHH
Q 012762 82 SDLRFVHRLGSGDI-GSVYLVQLKSKSSNNGCFFAAKVMDKRELVSR------------------NKESRARIEREILEM 142 (457)
Q Consensus 82 ~~~~~~~~LG~G~f-g~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~------------------~~~~~~~~E~~il~~ 142 (457)
.+++.++.||.|.- |.||+++. .|..||+|++..-..... ....-|..|-+...+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I------~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgR 110 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI------DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGR 110 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE------CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHH
Confidence 78999999999999 99999986 677999999422111100 112345667776665
Q ss_pred c---CCCCC--ceEEEEEEcC------------------CcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHH
Q 012762 143 L---DHPFL--PTLYATLDCP------------------RWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVV 199 (457)
Q Consensus 143 l---~H~nI--v~l~~~~~~~------------------~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~ 199 (457)
| ++.++ |+++||..-. ....||.||+.... .+. ..-+.+|+.
T Consensus 111 Lke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------~~~----~~~~~~~~~ 175 (207)
T PF13095_consen 111 LKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------PLQ----IRDIPQMLR 175 (207)
T ss_pred HHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------ccc----hhHHHHHHH
Confidence 5 46667 9999987322 12367888875433 122 223467888
Q ss_pred HHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCC
Q 012762 200 ALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235 (457)
Q Consensus 200 ~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s 235 (457)
-|..+|..||+-+|+|+.|.. + -+|+|||.+
T Consensus 176 dl~~~~k~gI~~~Dv~~~ny~---~--G~lvDfs~~ 206 (207)
T PF13095_consen 176 DLKILHKLGIVPRDVKPRNYR---G--GKLVDFSSS 206 (207)
T ss_pred HHHHHHHCCeeeccCcccccc---C--CEEEecccC
Confidence 899999999999999999986 3 489999864
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.39 E-value=2.6e-06 Score=87.87 Aligned_cols=145 Identities=21% Similarity=0.210 Sum_probs=91.1
Q ss_pred EEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhh----------------------------hhHHHH------
Q 012762 87 VHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVS----------------------------RNKESR------ 132 (457)
Q Consensus 87 ~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~----------------------------~~~~~~------ 132 (457)
.+.||.-+.|+||+|+.+ +|+.|||||-+..--.. +...+.
T Consensus 166 ~~piaaASlaQVhrA~L~-----~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELD 240 (538)
T KOG1235|consen 166 EEPIAAASLAQVHRARLK-----NGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELD 240 (538)
T ss_pred cchhhhcchhheEEEEec-----CCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcc
Confidence 367999999999999987 69999999964321000 000011
Q ss_pred HHHHHH----HHHHcCCCC------CceEEEEEEcCCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHH
Q 012762 133 ARIERE----ILEMLDHPF------LPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALE 202 (457)
Q Consensus 133 ~~~E~~----il~~l~H~n------Iv~l~~~~~~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ 202 (457)
|.+|.+ +.+.+.|-+ |.++|..+ .....|+||||+|..+.++..... .+++...+..-+.++.. +
T Consensus 241 F~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i~~-~gi~~~~i~~~l~~~~~--~ 315 (538)
T KOG1235|consen 241 FTKEAKNAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAIDK-RGISPHDILNKLVEAYL--E 315 (538)
T ss_pred hHHHHHhHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHHHH-cCCCHHHHHHHHHHHHH--H
Confidence 122322 233345655 44444433 345789999999988865543322 44665544433333222 1
Q ss_pred HHHHcCceeecCCCCCeEEcc----CCCEEEeccCCCcCCCCC
Q 012762 203 FLHMMGIIYRDLKPENVLVRS----DGHIMLTDFDLSLKGDNS 241 (457)
Q Consensus 203 yLH~~~iiHrDIKp~NIll~~----~~~vkl~DFG~s~~~~~~ 241 (457)
-|-..|++|.|=+|.||+++. ++.+.+.|||+.......
T Consensus 316 qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~ 358 (538)
T KOG1235|consen 316 QIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK 358 (538)
T ss_pred HHHhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence 222568999999999999984 568999999998766543
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.29 E-value=1.2e-05 Score=89.11 Aligned_cols=152 Identities=16% Similarity=0.296 Sum_probs=92.5
Q ss_pred eEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcC-CCCC--ceEEEEEEcC---C
Q 012762 86 FVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLD-HPFL--PTLYATLDCP---R 159 (457)
Q Consensus 86 ~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~-H~nI--v~l~~~~~~~---~ 159 (457)
-++.|+.|.+..+|+...... .....+++|+....... .....+.+|.++|+.+. |.+| .+++.++.+. +
T Consensus 42 ~v~~l~gG~sn~ty~l~~~~~--~~~~~~VLR~~p~~~~~--~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G 117 (822)
T PLN02876 42 KVSQFGHGQSNPTFLLEVGNG--GSVKRYVLRKKPPGKLL--QSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIG 117 (822)
T ss_pred eEEEeCCCCcCceEEEEECCC--CcceeEEEEeCCCCccC--ccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCC
Confidence 367889999999999875421 11135777776443211 12345678999999995 6664 7888887654 4
Q ss_pred cEEEEEeecCCCChHH--------------------HHH---hCCCC--C---------CCHHHHHHHHHH---------
Q 012762 160 WSCLLTEFCPGGDLHV--------------------LRQ---RQPDK--R---------FHESAVRFYASE--------- 196 (457)
Q Consensus 160 ~~~lV~E~~~~~sL~~--------------------~~~---~~~~~--~---------~~~~~~~~i~~q--------- 196 (457)
..|+||||++|..+.+ .+. ..... . +...++..|..+
T Consensus 118 ~~flVME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~ 197 (822)
T PLN02876 118 TAFYIMEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGK 197 (822)
T ss_pred CceEEEEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccC
Confidence 6789999998765321 111 10000 0 111223222121
Q ss_pred ------HHHHHHHHHH-----------cCceeecCCCCCeEEccC-CC-EEEeccCCCcCCCCC
Q 012762 197 ------VVVALEFLHM-----------MGIIYRDLKPENVLVRSD-GH-IMLTDFDLSLKGDNS 241 (457)
Q Consensus 197 ------i~~~L~yLH~-----------~~iiHrDIKp~NIll~~~-~~-vkl~DFG~s~~~~~~ 241 (457)
+...+++|.. ..+||+|+++.|||++.+ +. +-|.||+++....+.
T Consensus 198 ~~~~~~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~GdPl 261 (822)
T PLN02876 198 PPRNPKMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLGNQM 261 (822)
T ss_pred CCCChhHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccCChH
Confidence 2233556642 249999999999999853 33 579999987665543
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.23 E-value=1e-05 Score=75.91 Aligned_cols=72 Identities=14% Similarity=0.202 Sum_probs=46.7
Q ss_pred EEecccCcc-eEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCC---CCceEEEEEEcC---Cc
Q 012762 88 HRLGSGDIG-SVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHP---FLPTLYATLDCP---RW 160 (457)
Q Consensus 88 ~~LG~G~fg-~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~---nIv~l~~~~~~~---~~ 160 (457)
+.|+.|+.. .||+. +..+++|+.... .....+.+|.++|+.|... .+..+++..... ..
T Consensus 3 ~~~~~gG~~n~vy~~---------~~~~VlR~~~~~-----~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~ 68 (235)
T cd05155 3 EPVDSGGTDNATFRL---------GDDMSVRLPSAA-----GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPW 68 (235)
T ss_pred eeccCCCcccceEEc---------CCceEEEcCCcc-----chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCc
Confidence 567777776 49854 224778876542 1234677899999888532 355556554432 24
Q ss_pred EEEEEeecCCCCh
Q 012762 161 SCLLTEFCPGGDL 173 (457)
Q Consensus 161 ~~lV~E~~~~~sL 173 (457)
.|+||++++|.++
T Consensus 69 ~~~l~~~i~G~~l 81 (235)
T cd05155 69 PWSVYRWLEGETA 81 (235)
T ss_pred ceEEEEeecCCCC
Confidence 5899999999776
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.19 E-value=4.5e-05 Score=69.32 Aligned_cols=133 Identities=20% Similarity=0.275 Sum_probs=93.9
Q ss_pred EEecccCcceEEEEEEeccCCCCCceEEEEEeehhh-------------hhhhhHHHHHHHHHHHHHHcC------CCCC
Q 012762 88 HRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRE-------------LVSRNKESRARIEREILEMLD------HPFL 148 (457)
Q Consensus 88 ~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~-------------~~~~~~~~~~~~E~~il~~l~------H~nI 148 (457)
..||+|+.-.||.- ......+||++.... ........+.++|+.-...+. +.+|
T Consensus 7 ~~i~~G~~R~cy~H-------P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i 79 (199)
T PF10707_consen 7 DLIAQGGERDCYQH-------PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHI 79 (199)
T ss_pred cccccCCCceEEEC-------CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCccccc
Confidence 46899999999941 345568899997765 001122455566766655554 7889
Q ss_pred ceEEEEEEcCCcEEEEEeecCC------CChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEc
Q 012762 149 PTLYATLDCPRWSCLLTEFCPG------GDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVR 222 (457)
Q Consensus 149 v~l~~~~~~~~~~~lV~E~~~~------~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~ 222 (457)
.+++|+.+++.-.-+|+|.+.+ .+|.+++.. ..+++ . +...+-+-.+||-+.+|+.+||+|.||++.
T Consensus 80 ~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~---~~~~~-~---~~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~ 152 (199)
T PF10707_consen 80 PRFYGFVETNLGLGLVVELIRDADGNISPTLEDYLKE---GGLTE-E---LRQALDEFKRYLLDHHIVIRDLNPHNIVVQ 152 (199)
T ss_pred ccEeEEEecCCceEEEEEEEECCCCCcCccHHHHHHc---CCccH-H---HHHHHHHHHHHHHHcCCeecCCCcccEEEE
Confidence 9999999999888999998633 356777755 45665 2 233344556788899999999999999997
Q ss_pred cC--C--CEEEec-cCC
Q 012762 223 SD--G--HIMLTD-FDL 234 (457)
Q Consensus 223 ~~--~--~vkl~D-FG~ 234 (457)
.. + .+.|+| ||-
T Consensus 153 ~~~~~~~~lvlIDG~G~ 169 (199)
T PF10707_consen 153 RRDSGEFRLVLIDGLGE 169 (199)
T ss_pred ecCCCceEEEEEeCCCC
Confidence 43 2 578888 553
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.97 E-value=0.00014 Score=70.85 Aligned_cols=79 Identities=19% Similarity=0.151 Sum_probs=56.6
Q ss_pred ceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCC---CCCceEEEEEEcC--
Q 012762 84 LRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDH---PFLPTLYATLDCP-- 158 (457)
Q Consensus 84 ~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H---~nIv~l~~~~~~~-- 158 (457)
..-.+.||.|..+.||..... .+ .+.+|..+.. .....+..|.+.|+.|.. -.|.++++++..+
T Consensus 16 ~~~~~~i~~G~~~~vy~~~~~-----~~-~~~~k~~~~~-----~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~ 84 (297)
T PRK10593 16 LSRVECISEQPYAALWALYDS-----QG-NPMPLMARSF-----STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQS 84 (297)
T ss_pred hheeeecCCccceeEEEEEcC-----CC-CEEEEEeccc-----ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCc
Confidence 344678999999999987642 23 4677775321 123467789999999853 4688899887543
Q ss_pred -CcEEEEEeecCCCCh
Q 012762 159 -RWSCLLTEFCPGGDL 173 (457)
Q Consensus 159 -~~~~lV~E~~~~~sL 173 (457)
+..+||||+++|.++
T Consensus 85 ~g~~~LVmE~i~G~~~ 100 (297)
T PRK10593 85 PGPDVLLLERLRGVSV 100 (297)
T ss_pred CCCeEEEEeccCCEec
Confidence 668999999988764
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.91 E-value=0.0002 Score=70.04 Aligned_cols=143 Identities=21% Similarity=0.243 Sum_probs=83.5
Q ss_pred CceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCC--CCceEEEEE-----
Q 012762 83 DLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHP--FLPTLYATL----- 155 (457)
Q Consensus 83 ~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~--nIv~l~~~~----- 155 (457)
...-++.++.|....+|++... +| .+++|+..... ....+..|.+++..|... .+.+++...
T Consensus 23 ~~~~i~~~~~G~~n~~y~v~t~-----~~-~~vLK~~~~~~-----~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~ 91 (307)
T TIGR00938 23 ELLSLKGIAEGVENSNYLLTTD-----VG-RYILTLYEKRV-----KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQL 91 (307)
T ss_pred CceeccccCCccccceEEEEeC-----CC-cEEEEEecCCC-----CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCee
Confidence 4455777888888899987531 33 57889875421 123345577888877422 244554421
Q ss_pred -EcCCcEEEEEeecCCCChH-----------HHH---HhC-CCCC------CCHHH-----HH----------HHHHHHH
Q 012762 156 -DCPRWSCLLTEFCPGGDLH-----------VLR---QRQ-PDKR------FHESA-----VR----------FYASEVV 198 (457)
Q Consensus 156 -~~~~~~~lV~E~~~~~sL~-----------~~~---~~~-~~~~------~~~~~-----~~----------~i~~qi~ 198 (457)
...+..++||||++|..+. ..+ +.. .... ..... .. .....+.
T Consensus 92 ~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~ 171 (307)
T TIGR00938 92 STLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELD 171 (307)
T ss_pred hhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHH
Confidence 2245678999999886541 111 110 0000 00000 00 0011233
Q ss_pred HHHHHHHH-------cCceeecCCCCCeEEccCCCEEEeccCCCc
Q 012762 199 VALEFLHM-------MGIIYRDLKPENVLVRSDGHIMLTDFDLSL 236 (457)
Q Consensus 199 ~~L~yLH~-------~~iiHrDIKp~NIll~~~~~vkl~DFG~s~ 236 (457)
..++++.. .++||+|+++.||+++.++.+.|+||+.+.
T Consensus 172 ~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 172 KELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred HHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 34555542 589999999999999988877899999864
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.88 E-value=3.9e-06 Score=93.38 Aligned_cols=229 Identities=13% Similarity=0.046 Sum_probs=150.6
Q ss_pred eEEEEEeehhhhhh--hhHHHHHHHHHHHHHHcCCCCCceEEEEEEc--CCcEEEEEeecCCCChHHHHHhC--CCCCCC
Q 012762 113 FFAAKVMDKRELVS--RNKESRARIEREILEMLDHPFLPTLYATLDC--PRWSCLLTEFCPGGDLHVLRQRQ--PDKRFH 186 (457)
Q Consensus 113 ~vAvK~~~~~~~~~--~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~--~~~~~lV~E~~~~~sL~~~~~~~--~~~~~~ 186 (457)
.+.+|+.+..+... +...+....|+.-++...|+++...+.=... ....+.+++|+.+|.+...+-.. ....+.
T Consensus 1254 ~Fk~~I~ke~d~e~LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld 1333 (2724)
T KOG1826|consen 1254 WFKFSIYKEYDFENLSEPLKEMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLD 1333 (2724)
T ss_pred eeEEEeehhhhHHHHhhHHHHhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcch
Confidence 35666665443321 2223334445666667789998877665533 33568999999999998777542 122344
Q ss_pred HHHHHHHHHHHHHHHHHHHHc-----CceeecCCCCCeEEccCCCEEEeccCCCcCCCCCCcccccccCCCCCCCCCCCC
Q 012762 187 ESAVRFYASEVVVALEFLHMM-----GIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPN 261 (457)
Q Consensus 187 ~~~~~~i~~qi~~~L~yLH~~-----~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (457)
+..+.....+.+.+..-+|++ -.+|+++|+-|.+|..+-.+|++++|+.+...+...
T Consensus 1334 ~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~s------------------ 1395 (2724)
T KOG1826|consen 1334 RSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLS------------------ 1395 (2724)
T ss_pred hchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCcccccccccccccCchHh------------------
Confidence 444444444447777777754 289999999999999999999999999873322111
Q ss_pred CCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCCCCccCchhhcCCCCCccchh
Q 012762 262 DCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTHEYLAPEIISGEGHGNAVDW 341 (457)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDi 341 (457)
.....++++.|+.|++.....++.++|+
T Consensus 1396 ----------------------------------------------------f~Gl~l~sp~~v~qli~N~ik~t~rsdi 1423 (2724)
T KOG1826|consen 1396 ----------------------------------------------------FFGLELCSPIYVLQLIKNEIKFTKRSDI 1423 (2724)
T ss_pred ----------------------------------------------------hhhhhhCCHHHHHHHHHHHHhhhhHHHH
Confidence 1113468889999999998889999999
Q ss_pred hhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCC----CCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCC
Q 012762 342 WTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPK----EPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQF 417 (457)
Q Consensus 342 wSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~ 417 (457)
|..|+.+|++..|..+|-. ....++++..+-.. +...|++.-.....+|-+.-..||. -...+.-+.
T Consensus 1424 lr~s~~ly~rs~~n~~fi~-----flq~~Lkgiidn~tf~sIe~l~pgdaNve~~~~Ll~K~~~rp~----q~isls~d~ 1494 (2724)
T KOG1826|consen 1424 LRRSLSLYLRSDGNAYFIF-----FLQPALKGIIDNHTFFSIEKLKPGDANVEALHRLLWKYMERPG----QYISLSRDH 1494 (2724)
T ss_pred HHHHHHHHHHhcccHHHHH-----HHHHHHcCcccccccccccccCCCcccHHHHHHHHHHhhhcch----hhhhccccc
Confidence 9999999999999888743 23333333332222 2223455555556666666678888 666776666
Q ss_pred CCC
Q 012762 418 FNG 420 (457)
Q Consensus 418 f~~ 420 (457)
|..
T Consensus 1495 ~a~ 1497 (2724)
T KOG1826|consen 1495 FAV 1497 (2724)
T ss_pred ccc
Confidence 643
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.87 E-value=2e-05 Score=75.36 Aligned_cols=135 Identities=20% Similarity=0.255 Sum_probs=96.4
Q ss_pred ceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhH-------------------HHHHHHHHHHHHHcC
Q 012762 84 LRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNK-------------------ESRARIEREILEMLD 144 (457)
Q Consensus 84 ~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~-------------------~~~~~~E~~il~~l~ 144 (457)
+.+..+||-|.=+.||.+.+. .|..+++|+=+......++. .....+|...|+.|.
T Consensus 94 ~svGnqIGVGKESDIY~v~d~-----~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~ 168 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADE-----EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALY 168 (465)
T ss_pred hhhccccccccccceEEEecC-----CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHH
Confidence 456788999999999999874 68888988643332221111 122345777888874
Q ss_pred -C-CCCceEEEEEEcCCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEc
Q 012762 145 -H-PFLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVR 222 (457)
Q Consensus 145 -H-~nIv~l~~~~~~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~ 222 (457)
| --|.+.+++ +..|+|||++.|..|....+.. .+..+...+..-+.-|...|+||+|..-=||++.
T Consensus 169 e~gfpVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v~--------d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~ 236 (465)
T KOG2268|consen 169 ERGFPVPKPIDH----NRHCVVMELVDGYPLRQVRHVE--------DPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVK 236 (465)
T ss_pred HcCCCCCCcccc----cceeeHHHhhcccceeeeeecC--------ChHHHHHHHHHHHHHHHHcCceecccchheeEEe
Confidence 3 335555554 3568999999999986544321 2334555666677788899999999999999999
Q ss_pred cCCCEEEeccCCC
Q 012762 223 SDGHIMLTDFDLS 235 (457)
Q Consensus 223 ~~~~vkl~DFG~s 235 (457)
.++.++++||-..
T Consensus 237 dd~~i~vIDFPQm 249 (465)
T KOG2268|consen 237 DDDKIVVIDFPQM 249 (465)
T ss_pred cCCCEEEeechHh
Confidence 9999999999754
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.82 E-value=0.00012 Score=71.32 Aligned_cols=144 Identities=22% Similarity=0.261 Sum_probs=95.5
Q ss_pred eEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhh-------------------H----HHHHHHHHHHHHH
Q 012762 86 FVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRN-------------------K----ESRARIEREILEM 142 (457)
Q Consensus 86 ~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~-------------------~----~~~~~~E~~il~~ 142 (457)
+-..|..|-=+.||.|.-. +|..+|||+++..-+...+ . .--...|.+-|++
T Consensus 148 inGCiSTGKEANVYHat~~-----dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkR 222 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATEE-----DGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKR 222 (520)
T ss_pred cccccccCccceeEeeecC-----CCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHH
Confidence 3456788999999998754 7888999998543221111 0 1112336666777
Q ss_pred cCCCCCceEEEEEEcCCcEEEEEeecCCCCh-HHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH-HcCceeecCCCCCeE
Q 012762 143 LDHPFLPTLYATLDCPRWSCLLTEFCPGGDL-HVLRQRQPDKRFHESAVRFYASEVVVALEFLH-MMGIIYRDLKPENVL 220 (457)
Q Consensus 143 l~H~nIv~l~~~~~~~~~~~lV~E~~~~~sL-~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH-~~~iiHrDIKp~NIl 220 (457)
|+...|..---.. - ....|||+|+.+... .-.++ +..++...+..+-.|++.-+.-|- .+++||.||.-=|+|
T Consensus 223 l~~aGIP~PePIl-L-k~hVLVM~FlGrdgw~aPkLK---d~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~L 297 (520)
T KOG2270|consen 223 LNNAGIPCPEPIL-L-KNHVLVMEFLGRDGWAAPKLK---DASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLL 297 (520)
T ss_pred HHhcCCCCCCcee-e-ecceEeeeeccCCCCcCcccc---cccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhhe
Confidence 7655543211111 1 124699999943222 11222 356777788888888888888776 679999999999999
Q ss_pred EccCCCEEEeccCCCcCCCC
Q 012762 221 VRSDGHIMLTDFDLSLKGDN 240 (457)
Q Consensus 221 l~~~~~vkl~DFG~s~~~~~ 240 (457)
+ .+|.+.|+|.+.+.....
T Consensus 298 y-hdG~lyiIDVSQSVE~DH 316 (520)
T KOG2270|consen 298 Y-HDGKLYIIDVSQSVEHDH 316 (520)
T ss_pred E-ECCEEEEEEccccccCCC
Confidence 8 578899999998876653
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.81 E-value=8.5e-05 Score=67.12 Aligned_cols=98 Identities=21% Similarity=0.201 Sum_probs=77.1
Q ss_pred HHHHHHHHcCC-CCCceEEEEEEcCCcEEEEEeecCCCChHHHHH-hCCCCCCCHHHHHHHHHHHHHHHHHHHH---cCc
Q 012762 135 IEREILEMLDH-PFLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQ-RQPDKRFHESAVRFYASEVVVALEFLHM---MGI 209 (457)
Q Consensus 135 ~E~~il~~l~H-~nIv~l~~~~~~~~~~~lV~E~~~~~sL~~~~~-~~~~~~~~~~~~~~i~~qi~~~L~yLH~---~~i 209 (457)
.|.-+|+.+.+ +++++++|+|-. ++|.||...+++..... .......++.....++.++++.+.+|+. ..+
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~ 83 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFF 83 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcE
Confidence 37778888865 699999999843 57999997776642100 0011346899999999999999999997 358
Q ss_pred eeecCCCCCeEEccCCCEEEeccCCCc
Q 012762 210 IYRDLKPENVLVRSDGHIMLTDFDLSL 236 (457)
Q Consensus 210 iHrDIKp~NIll~~~~~vkl~DFG~s~ 236 (457)
.-.|++++|+-++.+|.+|++|...+.
T Consensus 84 ~lcDv~~~nfgv~~~~~lk~iDld~v~ 110 (188)
T PF12260_consen 84 YLCDVSPDNFGVNDDGRLKLIDLDDVF 110 (188)
T ss_pred EEeecchHHeEEeCCCcEEEEechhcc
Confidence 888999999999999999999998654
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.81 E-value=0.00071 Score=68.10 Aligned_cols=79 Identities=20% Similarity=0.195 Sum_probs=55.3
Q ss_pred EEEecccCcceEEEEEEeccCCCCC-ceEEEEEeehhhh----hhhhHHHHHHHHHHHHHHcC---CCCCceEEEEEEcC
Q 012762 87 VHRLGSGDIGSVYLVQLKSKSSNNG-CFFAAKVMDKREL----VSRNKESRARIEREILEMLD---HPFLPTLYATLDCP 158 (457)
Q Consensus 87 ~~~LG~G~fg~Vy~a~~~~~~~~~~-~~vAvK~~~~~~~----~~~~~~~~~~~E~~il~~l~---H~nIv~l~~~~~~~ 158 (457)
.+.||.|.+..||++... .| +.|+||.-....- .......+...|.+.|+.+. -.++++++.+. .
T Consensus 31 ~~elggGn~N~VyrV~~~-----~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D--~ 103 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDT-----EGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD--E 103 (401)
T ss_pred eeEcCCCceEEEEEEEeC-----CCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC--C
Confidence 578999999999999864 34 5799998542210 01234567788999988863 34678888873 3
Q ss_pred CcEEEEEeecCCCC
Q 012762 159 RWSCLLTEFCPGGD 172 (457)
Q Consensus 159 ~~~~lV~E~~~~~s 172 (457)
+..++|||++++..
T Consensus 104 ~~~~lVME~L~~~~ 117 (401)
T PRK09550 104 ELAVTVMEDLSDHK 117 (401)
T ss_pred CCCEEEEecCCCcc
Confidence 55789999997644
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.80 E-value=0.00016 Score=70.15 Aligned_cols=140 Identities=19% Similarity=0.160 Sum_probs=83.7
Q ss_pred eeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCC--CCceEEEE------EE
Q 012762 85 RFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHP--FLPTLYAT------LD 156 (457)
Q Consensus 85 ~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~--nIv~l~~~------~~ 156 (457)
.-++.|..|....+|+... .+..+++|+... ........|++++..|.+. .+.+++.. ..
T Consensus 17 ~~i~~i~~G~~n~~y~v~~------~~~~~vLr~~~~------~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~ 84 (296)
T cd05153 17 LSFEGISAGIENTNYFVTT------DSGRYVLTLFEK------VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSE 84 (296)
T ss_pred hheecccCccccceEEEEe------CCCcEEEEEcCC------CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeee
Confidence 3366788888899998763 234688998753 1234456688888888433 24555442 23
Q ss_pred cCCcEEEEEeecCCCChHH----HHH----------hC----CCC----CC-CHHHH--H--------HHHHHHHHHHHH
Q 012762 157 CPRWSCLLTEFCPGGDLHV----LRQ----------RQ----PDK----RF-HESAV--R--------FYASEVVVALEF 203 (457)
Q Consensus 157 ~~~~~~lV~E~~~~~sL~~----~~~----------~~----~~~----~~-~~~~~--~--------~i~~qi~~~L~y 203 (457)
.++..++||++++|..+.. ... .. ... .. .+... . .....+...+.+
T Consensus 85 ~~~~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 164 (296)
T cd05153 85 LAGKPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELAR 164 (296)
T ss_pred eCCceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHH
Confidence 3456789999999877521 000 00 000 00 00000 0 011112333444
Q ss_pred HHH-------cCceeecCCCCCeEEccCCCEEEeccCCCc
Q 012762 204 LHM-------MGIIYRDLKPENVLVRSDGHIMLTDFDLSL 236 (457)
Q Consensus 204 LH~-------~~iiHrDIKp~NIll~~~~~vkl~DFG~s~ 236 (457)
+.. .+++|+|+.|.|||++.++.+.|+||+.+.
T Consensus 165 l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 165 QDAFDPSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred HHhhhhhcCCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 443 479999999999999987777899998864
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.79 E-value=0.00021 Score=66.92 Aligned_cols=76 Identities=26% Similarity=0.301 Sum_probs=48.7
Q ss_pred EEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCC-CceEEEEEEcCCcEEEEE
Q 012762 87 VHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPF-LPTLYATLDCPRWSCLLT 165 (457)
Q Consensus 87 ~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~n-Iv~l~~~~~~~~~~~lV~ 165 (457)
++.|..|-...+|++.... ..+..|++|+...... ......+|..+++.+...+ ++++++.+.. .+||
T Consensus 3 i~~l~gG~tN~~~~v~~~~---~~~~~~vlR~~~~~~~----~~~d~~~E~~~~~~l~~~gl~P~v~~~~~~----~~l~ 71 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKE---DNQDAVLVRVYGNKTE----LIIDRERELRIHKLLSKHGLAPKLYATFQN----GLIY 71 (235)
T ss_pred EEEcCCcccceEEEEEcCC---CCCCeEEEEEccCCcc----ceecHHHHHHHHHHHHhCCCCCeEEEEeCC----cEEE
Confidence 4678889999999886421 0246788998754311 1112245888888885333 4556554432 3899
Q ss_pred eecCCCCh
Q 012762 166 EFCPGGDL 173 (457)
Q Consensus 166 E~~~~~sL 173 (457)
||++|.++
T Consensus 72 e~i~G~~l 79 (235)
T cd05157 72 EFIPGRTL 79 (235)
T ss_pred EeeCCCcC
Confidence 99998776
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.66 E-value=0.00058 Score=64.89 Aligned_cols=137 Identities=19% Similarity=0.260 Sum_probs=78.7
Q ss_pred EecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCC-ceEEEEEEcCCcEEEEEee
Q 012762 89 RLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFL-PTLYATLDCPRWSCLLTEF 167 (457)
Q Consensus 89 ~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nI-v~l~~~~~~~~~~~lV~E~ 167 (457)
.+..|-.+.+|+... ++..+++|+...... ........|.++|+.+...++ .+++.... .++||||
T Consensus 3 ~~~~G~tn~~y~~~~------~~~~~vlR~~~~~~~---~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~ 69 (256)
T TIGR02721 3 TLSGGLTNRSWRIEH------PGISFVWRPQSPVCK---ALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEW 69 (256)
T ss_pred cCCCcCcCCeEEEEe------CCccEEEeeCCcccc---cccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEe
Confidence 345688889998762 456788898654311 110123568889998864433 44554432 3689999
Q ss_pred cCCCChHH--------------HHHh---CC--CCCCCH-HHHHHHHHHH---------HHHHHHHHH--------cCce
Q 012762 168 CPGGDLHV--------------LRQR---QP--DKRFHE-SAVRFYASEV---------VVALEFLHM--------MGII 210 (457)
Q Consensus 168 ~~~~sL~~--------------~~~~---~~--~~~~~~-~~~~~i~~qi---------~~~L~yLH~--------~~ii 210 (457)
++|..+.. ++.+ .+ ...+.. ..+..+..++ ...+..+-. ..++
T Consensus 70 i~G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 149 (256)
T TIGR02721 70 LEGEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPL 149 (256)
T ss_pred ccCcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeee
Confidence 99876531 1111 11 111121 1122222121 111222211 2589
Q ss_pred eecCCCCCeEEccCCCEEEeccCCCcCCC
Q 012762 211 YRDLKPENVLVRSDGHIMLTDFDLSLKGD 239 (457)
Q Consensus 211 HrDIKp~NIll~~~~~vkl~DFG~s~~~~ 239 (457)
|+|+.|.||+++.++ +.|+||+.+....
T Consensus 150 H~Dl~~~Nil~~~~~-~~lIDwE~a~~gd 177 (256)
T TIGR02721 150 HMDVHAYNLVVTPQG-LKLIDWEYASDGD 177 (256)
T ss_pred cCCCCcCcEEEeCCC-CEEEeccccCcCC
Confidence 999999999999877 7899999875544
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.63 E-value=0.00053 Score=67.37 Aligned_cols=138 Identities=17% Similarity=0.198 Sum_probs=76.0
Q ss_pred EEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCC--CCCceEEEE------EEcC
Q 012762 87 VHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDH--PFLPTLYAT------LDCP 158 (457)
Q Consensus 87 ~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H--~nIv~l~~~------~~~~ 158 (457)
++.|+.|....+|+.... .| .+++|++. . ........|.++++.|.. -.+.+++.. ....
T Consensus 27 ~~~l~~G~~n~~y~v~t~-----~g-~~vLK~~~-~-----~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~ 94 (319)
T PRK05231 27 LKGIAEGIENSNFFLTTT-----QG-EYVLTLFE-R-----LTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELA 94 (319)
T ss_pred cchhccccccceEEEEeC-----CC-cEEEEEec-c-----CChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeC
Confidence 456778888899987632 33 68899875 1 112233446667766632 224444431 2234
Q ss_pred CcEEEEEeecCCCChH-----------HHHHh---C-CC--------CCCCH--HHHHH-----------HHHH-HHHHH
Q 012762 159 RWSCLLTEFCPGGDLH-----------VLRQR---Q-PD--------KRFHE--SAVRF-----------YASE-VVVAL 201 (457)
Q Consensus 159 ~~~~lV~E~~~~~sL~-----------~~~~~---~-~~--------~~~~~--~~~~~-----------i~~q-i~~~L 201 (457)
+..+++|||++|..+. ..+.+ . .. ..+.. ..... .+.+ +-..+
T Consensus 95 g~~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 174 (319)
T PRK05231 95 GKPAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQL 174 (319)
T ss_pred CEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHH
Confidence 5678999999887541 11111 0 00 00000 00000 1111 11112
Q ss_pred HHHH-------HcCceeecCCCCCeEEccCCCEEEeccCCCc
Q 012762 202 EFLH-------MMGIIYRDLKPENVLVRSDGHIMLTDFDLSL 236 (457)
Q Consensus 202 ~yLH-------~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~ 236 (457)
..+. ..++||+|+++.|||++.+....|+||+.+.
T Consensus 175 ~~~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 175 AFLASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred HhhhccccccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 2222 2379999999999999866556899999874
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.41 E-value=0.0013 Score=64.14 Aligned_cols=80 Identities=21% Similarity=0.245 Sum_probs=50.1
Q ss_pred EEEecccCcceEEEEEEecc--CCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCC-CceEEEEEEcCCcEEE
Q 012762 87 VHRLGSGDIGSVYLVQLKSK--SSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPF-LPTLYATLDCPRWSCL 163 (457)
Q Consensus 87 ~~~LG~G~fg~Vy~a~~~~~--~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~n-Iv~l~~~~~~~~~~~l 163 (457)
++.|..|-...||++..... ....++.|++|+..... .......+|.++++.+...+ ..++++++.. .+
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~----~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~ 74 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV----ELLIDRERELVVFARLSERNLGPKLYGIFPN----GR 74 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC----cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cc
Confidence 45677788889998874310 11235789999975431 11223456888888885333 4566666542 26
Q ss_pred EEeecCCCChH
Q 012762 164 LTEFCPGGDLH 174 (457)
Q Consensus 164 V~E~~~~~sL~ 174 (457)
||||++|..+.
T Consensus 75 v~e~i~G~~l~ 85 (302)
T cd05156 75 IEEFIPSRTLT 85 (302)
T ss_pred hhheeCCCcCC
Confidence 89999887763
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.33 E-value=0.0019 Score=64.28 Aligned_cols=145 Identities=16% Similarity=0.171 Sum_probs=84.8
Q ss_pred eeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCC-ceEEEEEEcCCcEEE
Q 012762 85 RFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFL-PTLYATLDCPRWSCL 163 (457)
Q Consensus 85 ~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nI-v~l~~~~~~~~~~~l 163 (457)
.-+..|-.|-...+|++.........++.|++|+..... ....++ ..|.++++.+..-++ .++++.+..+ .
T Consensus 39 ~~i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t---~~~idR-~~E~~~~~~l~~~gl~P~~~~~~~~g----~ 110 (344)
T PLN02236 39 LQVIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV---ELFFDR-DDEIRTFECMSRHGQGPRLLGRFPNG----R 110 (344)
T ss_pred EEEEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC---Ceeech-HHHHHHHHHHHHcCCCCceEEEECCc----e
Confidence 334456558899999987542222245689999986532 222333 558889988854444 4666766432 5
Q ss_pred EEeecCCCChHHH-------H-------H---hCC--CC--CCCHHHHHHHHHHH-----------------HHHHHHH-
Q 012762 164 LTEFCPGGDLHVL-------R-------Q---RQP--DK--RFHESAVRFYASEV-----------------VVALEFL- 204 (457)
Q Consensus 164 V~E~~~~~sL~~~-------~-------~---~~~--~~--~~~~~~~~~i~~qi-----------------~~~L~yL- 204 (457)
|+||+++.+|... . . ... .. ......+..+..++ ...+..|
T Consensus 111 v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~ 190 (344)
T PLN02236 111 VEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLE 190 (344)
T ss_pred EEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHH
Confidence 8999988776311 1 0 000 01 11122232332221 1111122
Q ss_pred ---H----HcCceeecCCCCCeEEcc-CCCEEEeccCCCcC
Q 012762 205 ---H----MMGIIYRDLKPENVLVRS-DGHIMLTDFDLSLK 237 (457)
Q Consensus 205 ---H----~~~iiHrDIKp~NIll~~-~~~vkl~DFG~s~~ 237 (457)
. ...++|+|+++.|||++. ++.+.++||..+..
T Consensus 191 ~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 191 KELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred HHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 1 235899999999999986 46899999998753
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=97.28 E-value=0.0041 Score=62.56 Aligned_cols=77 Identities=17% Similarity=0.188 Sum_probs=53.7
Q ss_pred eEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhh-hh---hhHHHHHHHHHHHHHHcC---CCCCceEEEEEEcC
Q 012762 86 FVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKREL-VS---RNKESRARIEREILEMLD---HPFLPTLYATLDCP 158 (457)
Q Consensus 86 ~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~-~~---~~~~~~~~~E~~il~~l~---H~nIv~l~~~~~~~ 158 (457)
..+.||.|....||+.... +..|+||.-..... .. .....+...|.+.|+.+. ..++.+++.++.
T Consensus 36 ~~~eiggGn~N~VyrV~~~------~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de-- 107 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSS------SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR-- 107 (418)
T ss_pred eEEEcCCCceeeEEEEEcC------CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--
Confidence 4778999999999997742 34588888653221 11 124566667888887764 357888998877
Q ss_pred CcEEEEEeecCC
Q 012762 159 RWSCLLTEFCPG 170 (457)
Q Consensus 159 ~~~~lV~E~~~~ 170 (457)
+..+++||++++
T Consensus 108 d~~vlvME~L~~ 119 (418)
T PLN02756 108 TMALIGMRYLEP 119 (418)
T ss_pred CCCEEEEeecCC
Confidence 346789999966
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.27 E-value=0.0025 Score=61.36 Aligned_cols=32 Identities=28% Similarity=0.480 Sum_probs=26.6
Q ss_pred CceeecCCCCCeEEccCCC-EEEeccCCCcCCC
Q 012762 208 GIIYRDLKPENVLVRSDGH-IMLTDFDLSLKGD 239 (457)
Q Consensus 208 ~iiHrDIKp~NIll~~~~~-vkl~DFG~s~~~~ 239 (457)
.++|+|+++.|||++.++. .-|+||+.+....
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iGD 218 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKVGD 218 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhcccCC
Confidence 4899999999999987555 5699999886654
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.16 E-value=0.0048 Score=61.02 Aligned_cols=76 Identities=18% Similarity=0.139 Sum_probs=50.0
Q ss_pred EecccCcceEEEEEEeccCCCCCceEEEEEeehhhh----hhhhHHHHHHHHHHHHHHcC--CC-CCceEEEEEEcCCcE
Q 012762 89 RLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKREL----VSRNKESRARIEREILEMLD--HP-FLPTLYATLDCPRWS 161 (457)
Q Consensus 89 ~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~----~~~~~~~~~~~E~~il~~l~--H~-nIv~l~~~~~~~~~~ 161 (457)
.||.|....||++... ..++.|+||.-...-- .......+...|.++|+... -| .++++|.+ +.+..
T Consensus 2 EigdGnlN~VfrV~~~----~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~ 75 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQ----EGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMA 75 (370)
T ss_pred cCCCCceEEEEEEEcC----CCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccc
Confidence 5799999999999853 2235788887643221 12445677778999998763 24 45556555 33445
Q ss_pred EEEEeecCC
Q 012762 162 CLLTEFCPG 170 (457)
Q Consensus 162 ~lV~E~~~~ 170 (457)
.+|||+++.
T Consensus 76 ~~vMEdL~~ 84 (370)
T TIGR01767 76 VTVMEDLSH 84 (370)
T ss_pred eehHhhCcc
Confidence 699999854
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.06 E-value=0.0011 Score=67.26 Aligned_cols=80 Identities=20% Similarity=0.250 Sum_probs=57.4
Q ss_pred ccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCC-----------CCCChHHHHHHHHHhhhCCCCCCCC
Q 012762 337 NAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKE-----------PSVPGPAKDLIAQLLVKDPTRRMGS 405 (457)
Q Consensus 337 ~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~ll~~~L~~dP~~Rps~ 405 (457)
+++|||++|.++.|+.-|...+....+.+....+..- +..+.. ..++.-..+++.+|+-..|..||.
T Consensus 110 pKsdVwsl~~i~~el~L~~~l~~~~~~s~~l~~i~k~-~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l- 187 (725)
T KOG1093|consen 110 PKSDVWSLGFIILELYLGISLEAELTESEYLEILLKY-YTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPL- 187 (725)
T ss_pred cchhhhhHHHHHHHHHHhhHHHHHHHHHHHHHHHHHh-ccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccc-
Confidence 3999999999999999998877665444443333321 111111 124455778999999999999998
Q ss_pred CcChHHHhcCCCCCCC
Q 012762 406 KMGATAIKRHQFFNGV 421 (457)
Q Consensus 406 ~~~~~~ll~hp~f~~~ 421 (457)
..++.+++-|..+
T Consensus 188 ---~~~~~k~~i~~ev 200 (725)
T KOG1093|consen 188 ---PMELSKRCSFTEV 200 (725)
T ss_pred ---hhHHhcCccHHHH
Confidence 8899999888764
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.05 E-value=0.0046 Score=61.86 Aligned_cols=78 Identities=19% Similarity=0.324 Sum_probs=53.0
Q ss_pred EEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhh---hhhhHHHHHHHHHHHHHHcC--CC-CCceEEEEEEcCCc
Q 012762 87 VHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKREL---VSRNKESRARIEREILEMLD--HP-FLPTLYATLDCPRW 160 (457)
Q Consensus 87 ~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~~~~~E~~il~~l~--H~-nIv~l~~~~~~~~~ 160 (457)
.+.||.|.-.-||++.+.. .+..|+||--...-- .......+...|.++|+.+. -| .+++++.+- ...
T Consensus 34 ~~eigdGnlN~VfrV~~~~----~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~D--~e~ 107 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQ----KNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLFD--SVM 107 (409)
T ss_pred eeEcCCCceEEEEEEeeCC----CCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEEC--cHH
Confidence 7789999999999998631 245688886533211 22445678888999998873 34 466666653 334
Q ss_pred EEEEEeecCC
Q 012762 161 SCLLTEFCPG 170 (457)
Q Consensus 161 ~~lV~E~~~~ 170 (457)
..+|||+++.
T Consensus 108 ~~~vMEdL~~ 117 (409)
T PRK12396 108 NCCVMEDLSD 117 (409)
T ss_pred hhHHHHhCcc
Confidence 5689998854
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.94 E-value=0.0079 Score=59.46 Aligned_cols=146 Identities=13% Similarity=0.184 Sum_probs=82.7
Q ss_pred CCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCC-ceEEEEEEcCCc
Q 012762 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFL-PTLYATLDCPRW 160 (457)
Q Consensus 82 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nI-v~l~~~~~~~~~ 160 (457)
+++.+.. |..|-...+|++...... .++..|++|+..... ....+ ..+|..+++.+..-++ .++++++.. +
T Consensus 15 ~~i~i~~-l~gGlTN~~~~v~~~~~~-~~~~~~v~Ri~g~~t---~~~Id-R~~E~~il~~l~~~gl~P~~l~~~~~-G- 86 (330)
T PLN02421 15 SDFSVER-ISGGITNLLLKVSVKEEN-GNEVSVTVRLFGPNT---DYVID-RERELQAIKYLSAAGFGAKLLGVFGN-G- 86 (330)
T ss_pred CceEEEE-eCCcccceEEEEEecCCC-CCCceEEEEEecCCc---CeEec-hHHHHHHHHHHHhcCCCCceeEEeCC-c-
Confidence 3455544 444888899988754211 123478899886531 11222 2458889988865555 466766632 2
Q ss_pred EEEEEeecCCCChHH-------HH-------Hh-CC----CC-CC-CHHHHHHHHHHH----------------------
Q 012762 161 SCLLTEFCPGGDLHV-------LR-------QR-QP----DK-RF-HESAVRFYASEV---------------------- 197 (457)
Q Consensus 161 ~~lV~E~~~~~sL~~-------~~-------~~-~~----~~-~~-~~~~~~~i~~qi---------------------- 197 (457)
+|.+|++|..|.. .+ ++ +. .. .. ....+..+..++
T Consensus 87 --~i~~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l 164 (330)
T PLN02421 87 --MIQSFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEEL 164 (330)
T ss_pred --EeehhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHH
Confidence 5899998876521 01 11 11 00 01 122233332221
Q ss_pred HHHHHHHH----Hc----CceeecCCCCCeEEcc-CCCEEEeccCCCcC
Q 012762 198 VVALEFLH----MM----GIIYRDLKPENVLVRS-DGHIMLTDFDLSLK 237 (457)
Q Consensus 198 ~~~L~yLH----~~----~iiHrDIKp~NIll~~-~~~vkl~DFG~s~~ 237 (457)
..-+..+. .. -++|+|+.+.|||++. ++.++++||+.+..
T Consensus 165 ~~~~~~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 165 RDEIVELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred HHHHHHHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 11122222 11 2899999999999974 57899999998743
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.93 E-value=0.022 Score=55.62 Aligned_cols=29 Identities=24% Similarity=0.480 Sum_probs=25.3
Q ss_pred cCceeecCCCCCeEEccCCCEEEeccCCCc
Q 012762 207 MGIIYRDLKPENVLVRSDGHIMLTDFDLSL 236 (457)
Q Consensus 207 ~~iiHrDIKp~NIll~~~~~vkl~DFG~s~ 236 (457)
.+++|+|+.+.||+++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 47899999999999987 678999999654
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.89 E-value=0.013 Score=57.19 Aligned_cols=151 Identities=12% Similarity=0.168 Sum_probs=83.6
Q ss_pred ceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCC--CCCceEEEEEEcCC--
Q 012762 84 LRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDH--PFLPTLYATLDCPR-- 159 (457)
Q Consensus 84 ~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H--~nIv~l~~~~~~~~-- 159 (457)
..+++.+-.|..-.+|.... +++.+++. ... ............+|.++++.+.- --+...++.+..+.
T Consensus 27 ~~~v~~~~~G~sn~t~~~~~------~~~~~vlR-~P~-~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g 98 (321)
T COG3173 27 LLIVEEISGGWSNDTFRLGD------TGQKYVLR-KPP-RGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLG 98 (321)
T ss_pred CceeeeccCCcccceEEEec------CCceEEEe-cCC-ccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCC
Confidence 34445554444444554442 36677777 321 11112233445568888887743 33455566665554
Q ss_pred cEEEEEeecCCCCh---------H-HHHH--------h-C--C------C---CCCCHHHHHHHHHH-------------
Q 012762 160 WSCLLTEFCPGGDL---------H-VLRQ--------R-Q--P------D---KRFHESAVRFYASE------------- 196 (457)
Q Consensus 160 ~~~lV~E~~~~~sL---------~-~~~~--------~-~--~------~---~~~~~~~~~~i~~q------------- 196 (457)
..|.||+|++|..+ . .+.. . + . . ..+....+..+..+
T Consensus 99 ~pf~v~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p 178 (321)
T COG3173 99 TPFYVMEWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIP 178 (321)
T ss_pred CceEEEEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCc
Confidence 66999999988432 1 1111 0 0 0 0 00111111111111
Q ss_pred -HHHHHHHHHHc--------CceeecCCCCCeEEccCCCEEEeccCCCcCCCCCC
Q 012762 197 -VVVALEFLHMM--------GIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNST 242 (457)
Q Consensus 197 -i~~~L~yLH~~--------~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~~ 242 (457)
+..-..+|+.+ .++|+|+++.||+++.++-+-++||+++...++..
T Consensus 179 ~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP~~ 233 (321)
T COG3173 179 LADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGDPLE 233 (321)
T ss_pred hHHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCCcHH
Confidence 12234555543 48999999999999988889999999987766543
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.78 E-value=0.0033 Score=57.85 Aligned_cols=30 Identities=33% Similarity=0.624 Sum_probs=21.2
Q ss_pred cCceeecCCCCCeEE-ccCCCEEEeccCCCc
Q 012762 207 MGIIYRDLKPENVLV-RSDGHIMLTDFDLSL 236 (457)
Q Consensus 207 ~~iiHrDIKp~NIll-~~~~~vkl~DFG~s~ 236 (457)
..++|+|+.+.|||+ ..++.++|+||..+.
T Consensus 143 ~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~ 173 (211)
T PF01633_consen 143 LVFCHNDLNPGNILINNKDGEVKLIDFEYAG 173 (211)
T ss_dssp EEEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred ceEeeccCccccEEeccCCCeEEEecHHHHh
Confidence 359999999999999 788999999998764
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.48 E-value=0.019 Score=57.75 Aligned_cols=84 Identities=12% Similarity=0.122 Sum_probs=48.5
Q ss_pred CCceeEEEecccCcceEEEEEEeccC--CCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCC-CceEEEEEEcC
Q 012762 82 SDLRFVHRLGSGDIGSVYLVQLKSKS--SNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPF-LPTLYATLDCP 158 (457)
Q Consensus 82 ~~~~~~~~LG~G~fg~Vy~a~~~~~~--~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~n-Iv~l~~~~~~~ 158 (457)
+++.+. .|..|-...+|++.....+ ....+.|.+++.... .....+ -.+|.++++.+...+ -.++++.+..
T Consensus 51 ~~i~i~-~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~---~~l~Id-R~~E~~i~~~Ls~~glgP~l~~~f~~- 124 (383)
T PTZ00384 51 EFIEIK-KMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTY---NSLVID-NDLQYNIAKLLGDNNFGPKIIGRFGD- 124 (383)
T ss_pred ccEEEE-EeCCcccceEEEEEecCCCCCccccceEEEEeccCC---CceEec-cHHHHHHHHHHHhCCCCCeEEEecCC-
Confidence 344444 5555999999999754211 001122444443211 111122 244889999996544 4667777753
Q ss_pred CcEEEEEeecCCCChH
Q 012762 159 RWSCLLTEFCPGGDLH 174 (457)
Q Consensus 159 ~~~~lV~E~~~~~sL~ 174 (457)
++|.||++|..|.
T Consensus 125 ---g~l~efIeGr~l~ 137 (383)
T PTZ00384 125 ---FTIQEWVEGNTMG 137 (383)
T ss_pred ---EEEEEEeccccCC
Confidence 5999999998773
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.46 E-value=0.0079 Score=58.85 Aligned_cols=74 Identities=20% Similarity=0.274 Sum_probs=56.9
Q ss_pred EcCCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHc-CceeecCCCCCeEEccCCCEEEeccCC
Q 012762 156 DCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMM-GIIYRDLKPENVLVRSDGHIMLTDFDL 234 (457)
Q Consensus 156 ~~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~-~iiHrDIKp~NIll~~~~~vkl~DFG~ 234 (457)
.+..+.|++|++- |+.|... + .-..+++..++++.+.-++-+... ..=|||+..+||||+ +|+|.|+||-+
T Consensus 296 de~~y~yl~~kdh-gt~is~i-k-----~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfkl 367 (488)
T COG5072 296 DETLYLYLHFKDH-GTPISII-K-----ADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKL 367 (488)
T ss_pred CCceEEEEEEecC-Cceeeee-e-----cccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeee
Confidence 3445778999987 7777422 2 234567778888877777666643 689999999999999 99999999999
Q ss_pred CcC
Q 012762 235 SLK 237 (457)
Q Consensus 235 s~~ 237 (457)
++.
T Consensus 368 sRl 370 (488)
T COG5072 368 SRL 370 (488)
T ss_pred eec
Confidence 873
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.25 E-value=0.015 Score=57.69 Aligned_cols=61 Identities=26% Similarity=0.238 Sum_probs=45.8
Q ss_pred EEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH-HcCceeecCCCCCeEEccC
Q 012762 161 SCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLH-MMGIIYRDLKPENVLVRSD 224 (457)
Q Consensus 161 ~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH-~~~iiHrDIKp~NIll~~~ 224 (457)
..|+-+|..|.++..+++. ...++...+.++.-...||.-|- -.+++|.|++|.||++...
T Consensus 320 ~vl~E~~~~Gl~v~~~v~~---~~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf~ 381 (565)
T KOG1236|consen 320 LVLVETYERGLSVLRFVKW---KSQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRFN 381 (565)
T ss_pred ceeeeeccccccHHhhhhc---ccChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEec
Confidence 3567778888898888776 44666677777776677765544 4589999999999999643
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.18 E-value=0.13 Score=50.36 Aligned_cols=30 Identities=10% Similarity=0.067 Sum_probs=27.4
Q ss_pred CceeecCCCCCeEEccCCCEEEeccCCCcC
Q 012762 208 GIIYRDLKPENVLVRSDGHIMLTDFDLSLK 237 (457)
Q Consensus 208 ~iiHrDIKp~NIll~~~~~vkl~DFG~s~~ 237 (457)
++||+|+.+.|||++.++.+.++||..+..
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 799999999999999999999999987654
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.17 E-value=0.075 Score=51.34 Aligned_cols=76 Identities=24% Similarity=0.259 Sum_probs=48.2
Q ss_pred ceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcC---CCCCceEEEEEEcCCc
Q 012762 84 LRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLD---HPFLPTLYATLDCPRW 160 (457)
Q Consensus 84 ~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~---H~nIv~l~~~~~~~~~ 160 (457)
.+-.+.|+.|....+|... ..+..|.||+-.. .....+..|.+-|+.|. --.+++++++....+.
T Consensus 19 i~~~~~v~GG~i~~a~~~~------~~~~~~FvK~~~~------~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~ 86 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLD------TDGGSYFVKVNSE------SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDD 86 (288)
T ss_dssp --EEEEE--SSSSEEEEEE------TTS-EEEEEEEEG------GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSC
T ss_pred eeeeEecCCCChhheEEEE------CCCccEEEEecCh------hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCC
Confidence 4456788999999999876 2667888998752 23345677888888883 4457899999988878
Q ss_pred EEEEEeecCCC
Q 012762 161 SCLLTEFCPGG 171 (457)
Q Consensus 161 ~~lV~E~~~~~ 171 (457)
.||||||++.+
T Consensus 87 ~fLlle~l~~~ 97 (288)
T PF03881_consen 87 AFLLLEFLEMG 97 (288)
T ss_dssp CEEEEE-----
T ss_pred ceEEEEeecCC
Confidence 89999999776
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.02 E-value=0.074 Score=60.46 Aligned_cols=139 Identities=20% Similarity=0.260 Sum_probs=77.3
Q ss_pred EEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcC--CCC--CceEEE--------E
Q 012762 87 VHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLD--HPF--LPTLYA--------T 154 (457)
Q Consensus 87 ~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~--H~n--Iv~l~~--------~ 154 (457)
++.|+ |..-.+|+.... +|..|++|+.+... .......|.++|..|. ++. +.+++- .
T Consensus 30 ~~~L~-s~~d~nf~v~~~-----~g~~yVLKi~~~~~-----~~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~ 98 (1013)
T PRK06148 30 ATPLD-GERDLNFRLTTD-----DGADYILKIVNPSE-----PRVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLAS 98 (1013)
T ss_pred EeecC-CcCCceEEEEeC-----CCCeEEEEEcCCcc-----chhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEE
Confidence 35675 456788887642 56789999997542 2233344666776662 223 333322 1
Q ss_pred EEc-CC--cEEEEEeecCCCChHHH-------HHh--------------C--C--CCCCCH-----------------HH
Q 012762 155 LDC-PR--WSCLLTEFCPGGDLHVL-------RQR--------------Q--P--DKRFHE-----------------SA 189 (457)
Q Consensus 155 ~~~-~~--~~~lV~E~~~~~sL~~~-------~~~--------------~--~--~~~~~~-----------------~~ 189 (457)
... ++ +.+.+|+|++|..|... +.. . + ...+.+ ..
T Consensus 99 v~~~~G~~~~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~ 178 (1013)
T PRK06148 99 AQDPDGEPRLLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPE 178 (1013)
T ss_pred eecCCCceEEEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHH
Confidence 111 22 46778999999877541 110 0 0 011111 11
Q ss_pred HHHHHHHHHHHHHH-----HH--HcCceeecCCCCCeEEccCC--CE-EEeccCCCc
Q 012762 190 VRFYASEVVVALEF-----LH--MMGIIYRDLKPENVLVRSDG--HI-MLTDFDLSL 236 (457)
Q Consensus 190 ~~~i~~qi~~~L~y-----LH--~~~iiHrDIKp~NIll~~~~--~v-kl~DFG~s~ 236 (457)
.+.++.+++..+.- +. ..++||+|+.+.|||++.++ .+ -|+|||-+.
T Consensus 179 ~r~~l~~~~~~~~~~v~p~l~~Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~ 235 (1013)
T PRK06148 179 DRALVERFLARFERNVAPRLAALPAQVIHNDANDYNILVDADDGERISGLIDFGDAV 235 (1013)
T ss_pred HHHHHHHHHHHHHHHHHHHHhcCCcceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence 22233334333321 21 24799999999999999775 45 499999764
|
|
| >PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function | Back alignment and domain information |
|---|
Probab=95.94 E-value=0.11 Score=50.27 Aligned_cols=78 Identities=18% Similarity=0.155 Sum_probs=48.0
Q ss_pred cccCcceEEEEEEec----cCCCCCceEEEEEeehhhhhhh--hHHHHHHHHHHHHHHc-------C--C----CCCceE
Q 012762 91 GSGDIGSVYLVQLKS----KSSNNGCFFAAKVMDKRELVSR--NKESRARIEREILEML-------D--H----PFLPTL 151 (457)
Q Consensus 91 G~G~fg~Vy~a~~~~----~~~~~~~~vAvK~~~~~~~~~~--~~~~~~~~E~~il~~l-------~--H----~nIv~l 151 (457)
|.|-.|.+|++.... ........++||.......... .....+.+|+.+.+.+ . + ..+.++
T Consensus 2 Gd~y~s~~~rv~v~~~~~~~~~~~~~s~ivK~~p~~~~~~~~~~~~~~f~~E~~fY~~~~p~l~~~~~~~~~~~~~~P~~ 81 (294)
T PF02958_consen 2 GDNYLSDMYRVTVTYELKGDGKNEPLSLIVKSPPTNPSRREFLREMGSFRREIFFYRELLPELEELQKEAGDPFKFFPKC 81 (294)
T ss_pred CCcceeEEEEEEEEEEEccCCCceEEEEEEEeCCCchhhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHhccccceeeceE
Confidence 788889999987754 2233445788998862222111 2345677787765543 1 1 235666
Q ss_pred EEEEEcCCcEEEEEeec
Q 012762 152 YATLDCPRWSCLLTEFC 168 (457)
Q Consensus 152 ~~~~~~~~~~~lV~E~~ 168 (457)
+....+....+||||-+
T Consensus 82 ~~~~~~~~~~~lvlEDL 98 (294)
T PF02958_consen 82 YYADEDPGDEVLVLEDL 98 (294)
T ss_pred EEeccCCCceeeehhhh
Confidence 66665555678999855
|
All known members of this group are proteins from drosophila and Caenorhabditis elegans. |
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.86 E-value=0.22 Score=49.05 Aligned_cols=71 Identities=13% Similarity=0.015 Sum_probs=41.6
Q ss_pred cCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCC--CCCceEE---E--EEEcCCcEEEEE
Q 012762 93 GDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDH--PFLPTLY---A--TLDCPRWSCLLT 165 (457)
Q Consensus 93 G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H--~nIv~l~---~--~~~~~~~~~lV~ 165 (457)
+.-..||+.... ++..+++|+...... ....+..|.+.+..|.. -.|+... + ....++..+.|+
T Consensus 36 s~eN~vy~v~~~-----~~~~~vlKv~r~~~~----~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~ 106 (325)
T PRK11768 36 SYENRVYQFGDE-----DGRRVVAKFYRPERW----SDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALF 106 (325)
T ss_pred cccceEEEEecC-----CCCEEEEEEcCcccC----CHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEE
Confidence 334678877642 566799999854321 23445567887777632 1122211 1 223345678899
Q ss_pred eecCCCC
Q 012762 166 EFCPGGD 172 (457)
Q Consensus 166 E~~~~~s 172 (457)
++++|..
T Consensus 107 ~~~~G~~ 113 (325)
T PRK11768 107 PRRGGRA 113 (325)
T ss_pred eeeCCCC
Confidence 9998764
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.74 E-value=0.15 Score=52.50 Aligned_cols=84 Identities=19% Similarity=0.212 Sum_probs=52.2
Q ss_pred CCCceeEEEecccCcceEEEEEEeccCC----CCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCC-ceEEEEE
Q 012762 81 LSDLRFVHRLGSGDIGSVYLVQLKSKSS----NNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFL-PTLYATL 155 (457)
Q Consensus 81 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~----~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nI-v~l~~~~ 155 (457)
.++. -++.|..|-.-.+|++....... ..++.|.+++..... ..... ...|..+++.+...+| .++++.+
T Consensus 105 ~~~I-~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~t---e~lId-R~~E~~v~~~ls~~gi~P~l~~~f 179 (442)
T PTZ00296 105 EDDV-RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDV---DELYN-PISEFEVYKTMSKYRIAPQLLNTF 179 (442)
T ss_pred cccE-EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCc---cceeC-HHHHHHHHHHHHHCCCCCceEEEe
Confidence 3455 56677778889999997542111 124679999986532 11222 2448888888755454 3566665
Q ss_pred EcCCcEEEEEeecCCCCh
Q 012762 156 DCPRWSCLLTEFCPGGDL 173 (457)
Q Consensus 156 ~~~~~~~lV~E~~~~~sL 173 (457)
. ...|.||++|..|
T Consensus 180 ~----gg~I~efi~g~~l 193 (442)
T PTZ00296 180 S----GGRIEEWLYGDPL 193 (442)
T ss_pred C----CCEEEEeeCCccC
Confidence 3 2468999988755
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=95.08 E-value=0.055 Score=49.57 Aligned_cols=85 Identities=13% Similarity=0.077 Sum_probs=58.6
Q ss_pred HHHHHHHHHHHHcCCCCCceEEEEEEcCCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH--cC
Q 012762 131 SRARIEREILEMLDHPFLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHM--MG 208 (457)
Q Consensus 131 ~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~--~~ 208 (457)
..+..+.++++++. .|+++..- ++-.+-++.|+|..... .+.. ++.-=+.+|.-.|+ .+
T Consensus 103 ~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i-----------~~~N----~i~agi~~L~~fH~~~~~ 163 (308)
T PF07387_consen 103 ALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI-----------NFSN----FITAGIKDLMDFHSENQH 163 (308)
T ss_pred hhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc-----------chhH----HHHHhHHHHHHhhccCCC
Confidence 44567888888775 57777732 33345689999932111 1111 11112567888893 47
Q ss_pred ceeecCCCCCeEEccCCCEEEeccCC
Q 012762 209 IIYRDLKPENVLVRSDGHIMLTDFDL 234 (457)
Q Consensus 209 iiHrDIKp~NIll~~~~~vkl~DFG~ 234 (457)
.+|+|-.|+||+.++.|.+||.|=+.
T Consensus 164 ~lHGD~np~NiM~D~~G~lKlVDP~~ 189 (308)
T PF07387_consen 164 CLHGDCNPDNIMCDKFGYLKLVDPVC 189 (308)
T ss_pred eecCCCChhheeecCCCCEEecChhh
Confidence 99999999999999999999999875
|
The function of this family is unknown. |
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 457 | ||||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-36 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 7e-32 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 7e-32 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 9e-32 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-31 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 4e-31 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 4e-25 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 6e-15 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 5e-25 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 6e-18 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-24 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-24 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-24 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-24 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-24 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-21 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-23 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 3e-19 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-23 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 3e-19 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-23 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 4e-19 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-23 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 3e-19 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-23 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 5e-19 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-23 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 4e-19 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-23 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 4e-19 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 4e-23 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-15 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 6e-23 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-15 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 7e-23 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-15 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 7e-23 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-15 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 9e-23 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 6e-15 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-22 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-15 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-22 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 6e-15 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-22 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-14 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-22 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 6e-15 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-22 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 6e-15 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-22 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 6e-15 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-22 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 6e-15 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-22 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 4e-15 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-22 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 6e-15 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-22 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 4e-15 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-22 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 4e-15 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-22 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 4e-15 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-22 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-15 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-22 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-19 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-22 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-19 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-22 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 8e-16 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-22 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-19 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-22 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-19 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-22 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-19 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-22 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 6e-15 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 7e-22 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 6e-15 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 8e-22 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 4e-19 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 8e-22 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 7e-19 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-21 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-16 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-21 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 7e-17 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-21 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-16 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 3e-21 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 5e-17 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 3e-21 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 8e-17 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 3e-21 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 6e-17 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-21 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 8e-17 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-21 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 8e-17 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 3e-21 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 3e-16 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 4e-21 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 5e-17 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-21 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 7e-17 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-21 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-17 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 5e-21 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 8e-17 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 5e-21 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 7e-17 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 5e-21 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 8e-17 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 5e-21 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 8e-17 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 5e-21 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-16 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-21 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 8e-17 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-21 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 9e-17 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-21 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 8e-17 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 7e-21 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 8e-17 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 7e-21 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 8e-17 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 7e-21 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 7e-17 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 7e-21 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 3e-16 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 7e-21 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 8e-17 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 7e-21 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 8e-17 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 9e-21 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 8e-17 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 9e-21 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 8e-17 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-20 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 6e-18 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-20 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 7e-17 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-20 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 8e-17 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-20 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 5e-17 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-20 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 9e-16 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-20 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 4e-16 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-20 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 5e-16 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-20 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 5e-16 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-20 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 7e-17 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-20 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 7e-17 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-20 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 9e-17 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-20 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 8e-17 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-20 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 8e-17 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-20 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-16 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-20 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 8e-17 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-20 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 5e-17 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-20 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 7e-17 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-20 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 8e-17 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-20 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 7e-18 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-20 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 7e-17 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 3e-20 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 8e-17 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 3e-20 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 8e-17 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 3e-20 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-16 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 4e-20 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 7e-17 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 4e-20 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 8e-17 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 8e-20 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 8e-17 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-19 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-19 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 3e-19 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 3e-19 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-15 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 3e-19 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-15 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 3e-19 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 3e-19 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-15 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 4e-19 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 4e-19 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 4e-19 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 4e-19 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 4e-19 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 4e-19 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 4e-19 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 5e-17 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 4e-19 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 5e-19 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 5e-19 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 7e-19 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 5e-14 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-18 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-18 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 7e-07 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 3e-18 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-15 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-17 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-11 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-17 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-11 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-17 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-11 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-17 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-11 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 1e-17 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 2e-15 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-17 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-17 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 4e-16 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-17 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-17 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 4e-17 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 3e-17 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 8e-17 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 3e-17 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-17 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 3e-17 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 4e-17 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 7e-17 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 9e-17 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-16 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-16 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-15 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-16 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-15 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-16 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-16 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 6e-16 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 7e-16 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 9e-10 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 9e-16 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-15 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-15 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-15 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-15 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 3e-15 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-09 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-15 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 4e-15 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 4e-15 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 4e-15 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 4e-15 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 4e-15 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 4e-15 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 4e-15 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 4e-15 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 4e-15 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-15 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 5e-15 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 5e-15 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 9e-10 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 5e-15 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-09 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-15 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 5e-15 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 5e-15 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 5e-15 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 6e-15 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 6e-15 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 7e-15 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-11 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-15 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-11 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-15 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-11 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-15 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 8e-15 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 4e-11 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 8e-15 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-09 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-14 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-14 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-14 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-14 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-14 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-14 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-14 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-14 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-13 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-13 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-07 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-13 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 3e-13 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 4e-13 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 4e-13 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 6e-13 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 4e-06 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 6e-13 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 4e-06 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 6e-13 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 3e-06 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 7e-13 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-06 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 9e-13 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 9e-13 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 9e-13 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-12 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 8e-06 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-12 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-12 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 4e-08 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 2e-12 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 2e-12 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-12 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 4e-12 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 9e-12 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 3e-04 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 9e-12 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 3e-04 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-12 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-04 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-11 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-04 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-11 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 3e-04 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-11 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-11 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-11 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-11 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-04 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-11 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-04 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-11 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 5e-04 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-11 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 4e-04 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-11 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 4e-04 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 3e-11 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 3e-11 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 3e-11 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 4e-11 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-04 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 4e-11 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 4e-11 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 6e-11 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 6e-11 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 4e-04 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-10 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-10 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-10 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-10 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-10 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-10 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-10 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-06 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-10 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 3e-10 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 4e-10 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 5e-10 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 5e-10 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 5e-10 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 5e-10 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 6e-10 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-04 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 8e-10 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 8e-10 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 8e-10 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 8e-10 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 9e-10 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 9e-10 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 9e-06 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-09 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-09 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-09 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-09 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-09 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-09 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-09 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-09 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 3e-09 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 3e-09 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 3e-09 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 4e-09 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 6e-09 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 6e-09 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 7e-09 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 8e-09 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 6e-08 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-09 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 9e-09 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 9e-09 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 9e-09 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 9e-09 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-09 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-08 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-08 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-08 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-08 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-08 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-08 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-08 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 4e-04 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-08 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 3e-04 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-08 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-08 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-08 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-08 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-08 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-08 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-08 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-08 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-06 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-08 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-08 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-05 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-08 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 3e-06 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-08 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-08 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-08 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-08 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 5e-07 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-08 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-06 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-08 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-06 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-08 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-06 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 4e-08 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 7e-04 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 4e-08 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 4e-08 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 4e-07 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 5e-08 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 5e-08 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 8e-07 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 5e-08 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 4e-07 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 6e-08 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 9e-07 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 6e-08 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 6e-08 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 8e-07 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 6e-08 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-04 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 6e-08 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 8e-07 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 8e-08 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 6e-05 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 8e-08 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 8e-08 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 6e-05 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 9e-08 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 9e-08 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 9e-08 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 9e-08 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 9e-08 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 9e-08 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 9e-08 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-07 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-07 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-07 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-07 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-07 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-07 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-07 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-07 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-07 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-07 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 3e-05 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-07 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 3e-05 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 1e-07 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 4e-05 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-07 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-07 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 8e-06 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-07 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 4e-05 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-07 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 8e-06 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-07 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-07 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-07 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-07 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-07 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 3e-07 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 7e-06 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-07 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-07 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 3e-07 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 3e-07 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 3e-07 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 7e-05 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 3e-07 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 5e-04 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 3e-07 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-04 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 3e-07 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-04 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 3e-07 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 7e-05 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 3e-07 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 8e-05 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 4e-07 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 4e-07 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 4e-07 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 3e-05 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 4e-07 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 7e-07 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-07 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 6e-07 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 6e-07 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 6e-07 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 6e-07 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-07 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 6e-07 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 7e-07 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 7e-07 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 7e-07 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 7e-07 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 7e-07 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 7e-07 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 8e-07 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 8e-07 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 8e-07 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 9e-07 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 9e-07 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 9e-07 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-06 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-06 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-06 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-06 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-06 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-06 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-06 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-06 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-06 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-06 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-06 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-06 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-06 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 1e-06 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-06 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-06 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-06 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-06 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-06 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-06 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-06 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-06 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-06 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-06 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-06 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-06 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-06 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-06 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-06 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-06 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-06 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-06 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 3e-06 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 3e-06 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 3e-06 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 3e-06 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 3e-06 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 4e-06 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 4e-06 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 4e-06 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-06 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-06 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-06 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 4e-06 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-06 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-06 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 4e-06 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 5e-06 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-06 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 5e-06 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 5e-06 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 5e-06 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 6e-06 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 6e-06 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 6e-06 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 6e-06 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 7e-06 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 7e-06 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 8e-06 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 8e-06 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 8e-06 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 9e-04 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 8e-06 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 9e-06 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 9e-06 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 9e-06 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 9e-06 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 7e-04 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-05 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-05 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 8e-04 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-05 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-05 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 1e-05 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-05 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-05 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-05 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-05 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-05 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-05 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-05 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-05 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-05 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-05 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-05 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 2e-05 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-05 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-05 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-05 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-05 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-05 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-05 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-05 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-05 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-05 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-05 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-05 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-05 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-05 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-05 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-05 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-05 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 3e-05 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 3e-05 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-05 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-05 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 3e-05 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 3e-05 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 3e-05 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 3e-05 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 3e-05 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 3e-05 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 3e-05 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 4e-05 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 4e-05 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 3e-04 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 4e-05 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 4e-04 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 4e-05 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 3e-04 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 4e-05 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 4e-05 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 4e-04 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 4e-05 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 5e-05 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 5e-05 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 4e-04 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 5e-05 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 5e-05 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 4e-04 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 5e-05 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 5e-05 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 5e-05 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 6e-05 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 6e-05 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 7e-05 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-05 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 7e-05 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-05 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 8e-05 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 8e-05 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 8e-05 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 8e-05 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 8e-05 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-04 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 8e-05 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-05 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-04 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 8e-05 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 9e-05 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 9e-05 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 9e-05 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 9e-05 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 9e-05 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 9e-05 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 9e-05 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 9e-05 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 9e-05 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-05 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 1e-04 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-04 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-04 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-04 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-04 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 1e-04 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-04 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 1e-04 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-04 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 4e-04 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-04 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-04 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-04 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-04 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-04 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-04 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-04 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-04 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-04 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-04 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-04 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-04 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-04 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-04 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 1e-04 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 7e-04 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-04 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-04 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-04 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-04 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-04 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-04 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-04 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-04 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-04 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-04 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 2e-04 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-04 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 2e-04 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-04 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 2e-04 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 2e-04 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 2e-04 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 2e-04 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-04 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 2e-04 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-04 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 3e-04 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-04 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 2e-04 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 2e-04 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-04 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-04 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 2e-04 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 2e-04 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-04 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 2e-04 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-04 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-04 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-04 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-04 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 2e-04 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 2e-04 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-04 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-04 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 2e-04 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 3e-04 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 3e-04 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-04 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-04 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 3e-04 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 3e-04 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 3e-04 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 3e-04 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 3e-04 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-04 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 3e-04 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 3e-04 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-04 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-04 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 3e-04 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-04 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-04 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-04 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-04 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 3e-04 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 3e-04 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 4e-04 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 4e-04 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 4e-04 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 4e-04 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-04 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 4e-04 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 4e-04 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 4e-04 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 4e-04 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-04 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 4e-04 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-04 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 4e-04 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 4e-04 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 4e-04 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 4e-04 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 4e-04 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 4e-04 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 4e-04 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 4e-04 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 4e-04 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 4e-04 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-04 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 5e-04 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 5e-04 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-04 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 5e-04 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 5e-04 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 5e-04 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 5e-04 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 5e-04 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 5e-04 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 5e-04 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 5e-04 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 5e-04 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 5e-04 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 5e-04 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 5e-04 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 6e-04 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 6e-04 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 6e-04 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 6e-04 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 6e-04 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 6e-04 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 6e-04 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 6e-04 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 6e-04 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 6e-04 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 6e-04 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 6e-04 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 6e-04 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 6e-04 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 6e-04 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 6e-04 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 6e-04 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 6e-04 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 6e-04 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 6e-04 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 6e-04 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 6e-04 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 6e-04 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 6e-04 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 6e-04 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 6e-04 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 6e-04 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 6e-04 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 6e-04 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 6e-04 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 6e-04 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 6e-04 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 6e-04 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 6e-04 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 6e-04 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 7e-04 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 7e-04 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 7e-04 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 7e-04 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 7e-04 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 7e-04 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 7e-04 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 7e-04 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 7e-04 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 7e-04 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 7e-04 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 7e-04 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 8e-04 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 7e-04 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 8e-04 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 7e-04 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 7e-04 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 7e-04 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 7e-04 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 7e-04 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 7e-04 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 8e-04 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 7e-04 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 7e-04 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 7e-04 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 7e-04 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 7e-04 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 8e-04 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 8e-04 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 8e-04 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 8e-04 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 8e-04 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-04 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 8e-04 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 8e-04 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 8e-04 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 8e-04 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 8e-04 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 8e-04 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 9e-04 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 9e-04 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 9e-04 |
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 457 | |||
| 1uu3_A | 310 | HPDK1, 3-phosphoinositide dependent protein kinase | 1e-100 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 9e-93 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 1e-89 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 3e-86 | |
| 3pvu_A | 695 | Beta-adrenergic receptor kinase 1; transferase, se | 3e-81 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 7e-66 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 5e-65 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 3e-55 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 7e-54 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 6e-53 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 9e-42 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 5e-51 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 2e-42 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 1e-50 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 1e-40 | |
| 3g51_A | 325 | Ribosomal protein S6 kinase alpha-3; N-terminal ki | 2e-50 | |
| 3g51_A | 325 | Ribosomal protein S6 kinase alpha-3; N-terminal ki | 2e-41 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 2e-49 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 3e-37 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 8e-49 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 9e-39 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 2e-48 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 3e-35 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 2e-48 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 4e-39 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 3e-48 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 1e-34 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 3e-48 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 1e-38 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 6e-48 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 1e-38 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 6e-48 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 9e-36 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 2e-47 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 3e-47 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 4e-37 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 5e-47 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 6e-39 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 1e-46 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 2e-41 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 3e-46 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 1e-45 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 3e-38 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 4e-45 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 4e-45 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 4e-45 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 3e-44 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 7e-36 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 8e-44 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 2e-43 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 8e-43 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 1e-42 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 4e-42 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 7e-42 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 1e-41 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 2e-41 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 5e-41 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 2e-40 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 2e-40 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 4e-40 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 2e-39 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 1e-38 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 1e-38 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 3e-36 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 4e-36 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 1e-35 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 3e-35 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 1e-16 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 3e-34 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 1e-33 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 6e-33 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 1e-32 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 3e-32 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 4e-31 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 7e-15 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 9e-31 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 4e-29 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 7e-29 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 9e-29 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 1e-28 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 1e-28 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 1e-15 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 1e-28 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 4e-13 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 2e-28 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 5e-14 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 2e-28 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 2e-18 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 4e-28 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 1e-19 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 6e-28 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 7e-28 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 2e-19 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 7e-28 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 4e-19 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 8e-28 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 4e-22 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 5e-27 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 6e-27 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 5e-16 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 1e-26 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 3e-26 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 1e-15 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 4e-26 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 5e-18 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 6e-26 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 2e-14 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 1e-25 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 1e-25 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 4e-13 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 2e-25 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 4e-15 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 2e-25 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 1e-14 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 3e-25 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 7e-16 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 5e-25 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 6e-25 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 3e-17 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 7e-25 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 9e-25 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 1e-24 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 1e-15 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 3e-24 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 5e-20 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 4e-24 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 8e-18 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 5e-24 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 3e-13 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 9e-24 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 5e-17 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 1e-23 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 1e-13 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 3e-23 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 5e-23 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 4e-15 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 5e-23 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 6e-17 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 4e-22 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 9e-22 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 8e-16 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 1e-21 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 1e-14 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 1e-21 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 7e-11 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 1e-21 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 2e-21 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 6e-14 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 2e-21 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 2e-06 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 2e-21 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 2e-21 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 2e-07 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 4e-21 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 9e-16 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 4e-21 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 5e-09 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 4e-21 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 4e-21 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 1e-08 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 7e-21 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 1e-07 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 9e-21 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 1e-09 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 1e-20 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 6e-09 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 2e-20 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 2e-20 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 4e-13 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 2e-20 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 3e-20 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 3e-11 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 3e-20 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 2e-13 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 4e-20 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 1e-12 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 4e-20 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 7e-20 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 2e-19 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 4e-16 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 3e-19 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 9e-19 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 6e-06 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 1e-18 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 1e-05 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 6e-18 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 4e-06 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 1e-17 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 9e-09 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 3e-17 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 3e-06 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 4e-17 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 1e-16 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 2e-08 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 1e-16 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 3e-13 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 1e-16 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 1e-16 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 2e-16 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 1e-13 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 3e-16 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 3e-16 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 6e-16 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 2e-15 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 1e-14 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 4e-09 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 1e-14 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 6e-08 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 3e-14 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 3e-14 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 1e-08 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 1e-13 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 1e-13 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 1e-13 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 2e-06 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 2e-13 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 2e-13 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 5e-08 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 3e-13 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 3e-13 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 5e-13 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 5e-13 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 7e-13 | |
| 3zzw_A | 289 | Tyrosine-protein kinase transmembrane receptor RO; | 8e-13 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 9e-13 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 1e-12 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 1e-12 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 1e-12 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 2e-12 | |
| 3v5q_A | 297 | NT-3 growth factor receptor; kinase domain, kinase | 2e-12 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 3e-12 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 4e-12 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 4e-12 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 6e-12 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 7e-12 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 7e-12 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 9e-12 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 1e-11 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 1e-11 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 1e-11 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 1e-11 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 1e-11 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 2e-11 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 2e-11 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 2e-11 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 3e-11 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 3e-11 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 3e-11 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 4e-11 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 4e-11 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 6e-11 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 6e-11 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 6e-11 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 7e-11 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 7e-11 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 7e-11 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 8e-11 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 1e-10 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 1e-10 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 2e-10 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 2e-10 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 2e-10 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 2e-10 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 2e-10 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 2e-10 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 2e-10 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 2e-10 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 3e-10 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 3e-10 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 3e-10 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 4e-10 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 4e-10 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 4e-10 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 6e-10 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 8e-10 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 1e-09 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 1e-09 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 4e-04 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 1e-09 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 1e-09 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 1e-09 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 2e-09 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 4e-04 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 2e-09 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 2e-09 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 2e-09 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 2e-09 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 3e-04 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 3e-09 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 3e-09 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 3e-09 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 7e-04 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 3e-09 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 8e-05 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 4e-09 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 4e-09 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 6e-09 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 4e-04 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 9e-09 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 1e-08 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 3e-04 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 1e-08 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 2e-08 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 2e-08 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 3e-08 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 5e-04 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 3e-08 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 4e-04 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 2e-07 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 2e-07 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 3e-06 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 3e-06 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 3e-04 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 4e-06 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 2e-05 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 6e-05 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 1e-04 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 5e-04 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 5e-04 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 6e-04 |
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 302 bits (775), Expect = e-100
Identities = 96/375 (25%), Positives = 149/375 (39%), Gaps = 82/375 (21%)
Query: 65 EATSEGNNNNNNNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKREL 124
+ D +F LG G +V L + + +A K+++KR +
Sbjct: 13 GSLQHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELA----TSREYAIKILEKRHI 68
Query: 125 VSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKR 184
+ NK ER+++ LDHPF LY T + G+L L+ +
Sbjct: 69 IKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGEL--LKYIRKIGS 126
Query: 185 FHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS--LKGDNST 242
F E+ RFY +E+V ALE+LH GII+RDLKPEN+L+ D HI +TDF + L ++
Sbjct: 127 FDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 186
Query: 243 STAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPG 302
+ A NS G
Sbjct: 187 ARA--------------------------NSFV--------------------------G 194
Query: 303 TPEIVAEPLDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGID 362
T + Y++PE+++ + + D W LG I++L G PF+ +
Sbjct: 195 TAQ------------------YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN 236
Query: 363 HELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDPTRRMGSKM--GATAIKRHQFFNG 420
L ++ +FP A+DL+ +LLV D T+R+G + G +K H FF
Sbjct: 237 EYLIFQKIIKLEYDFP--EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 294
Query: 421 VNWALLRCAKPPFIP 435
V W L PP +
Sbjct: 295 VTWENLHQQTPPKLT 309
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 285 bits (732), Expect = 9e-93
Identities = 94/374 (25%), Positives = 156/374 (41%), Gaps = 88/374 (23%)
Query: 72 NNNNNNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKES 131
N + + D V +G G G V LV+ K + +A K++ K E++ R+ +
Sbjct: 59 NKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHK----STRKVYAMKLLSKFEMIKRSDSA 114
Query: 132 RARIEREILEMLDHPFLPTLYATLDCPRWSCLLTEFCPGGDL-HVLRQRQPDKRFHESAV 190
ER+I+ + P++ L+ R+ ++ E+ PGGDL +++ E
Sbjct: 115 FFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNY----DVPEKWA 170
Query: 191 RFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQLVSD 250
RFY +EVV+AL+ +H MG I+RD+KP+N+L+ GH+ L DF +K +
Sbjct: 171 RFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRC---- 226
Query: 251 QSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEP 310
+++ GTP+
Sbjct: 227 ---------------------DTAV--------------------------GTPD----- 234
Query: 311 LDVRSMSFVGTHEYLAPEIISGEG----HGNAVDWWTLGIFIFELFYGTTPFKGIDHELT 366
Y++PE++ +G +G DWW++G+F++E+ G TPF T
Sbjct: 235 -------------YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT 281
Query: 367 LANVVA--RALEFPKEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGVNWA 424
+ ++ +L FP + + AK+LI L D R+G G IKRH FF WA
Sbjct: 282 YSKIMNHKNSLTFPDDNDISKEAKNLICAFL-TDREVRLGRN-GVEEIKRHLFFKNDQWA 339
Query: 425 LL--RCAKPPFIPR 436
R P +P
Sbjct: 340 WETLRDTVAPVVPD 353
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 277 bits (711), Expect = 1e-89
Identities = 100/382 (26%), Positives = 153/382 (40%), Gaps = 86/382 (22%)
Query: 65 EATSEGNNNNNNNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKREL 124
+ L D + +G G V +V++K G +A K+M+K ++
Sbjct: 44 QWAEPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQ----TGQVYAMKIMNKWDM 99
Query: 125 VSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKR 184
+ R + S R ER++L D ++ L+ + L+ E+ GGDL L + +R
Sbjct: 100 LKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKF-GER 158
Query: 185 FHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTST 244
RFY +E+V+A++ +H +G ++RD+KP+N+L+ GHI L DF LK +
Sbjct: 159 IPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTV 218
Query: 245 AQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTP 304
+ GTP
Sbjct: 219 RS-------------------------LVAV--------------------------GTP 227
Query: 305 EIVAEPLDVRSMSFVGTHEYLAPEIISGEG-------HGNAVDWWTLGIFIFELFYGTTP 357
+ YL+PEI+ G +G DWW LG+F +E+FYG TP
Sbjct: 228 D------------------YLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269
Query: 358 FKGIDHELTLANVVAR--ALEFPKEPS-VPGPAKDLIAQLLVKDPTRRMGSKMGATAIKR 414
F T +V L P VP A+D I +LL P R+G GA +
Sbjct: 270 FYADSTAETYGKIVHYKEHLSLPLVDEGVPEEARDFIQRLL-CPPETRLGRG-GAGDFRT 327
Query: 415 HQFFNGVNWALLRCAKPPFIPR 436
H FF G++W LR + PPF P
Sbjct: 328 HPFFFGLDWDGLRDSVPPFTPD 349
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 266 bits (683), Expect = 3e-86
Identities = 113/418 (27%), Positives = 174/418 (41%), Gaps = 95/418 (22%)
Query: 35 SNPSSSTPSAAKTHHAPPRCNDDPCWKAIKEATSEGNNNNNNNPLTLSDLRFVHRLGSGD 94
+ S + + +K N + + + + + LG+G
Sbjct: 7 HHEEEGGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIENFELLKVLGTGA 66
Query: 95 IGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKE-SRARIEREILEMLDH-PFLPTLY 152
G V+LV+ K + G +A KV+ K +V + K R ER++LE + PFL TL+
Sbjct: 67 YGKVFLVR-KISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLH 125
Query: 153 ATLDCPRWSCLLTEFCPGGDL--HVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGII 210
L+ ++ GG+L H+ ++ RF E V+ Y E+V+ALE LH +GII
Sbjct: 126 YAFQTETKLHLILDYINGGELFTHLSQRE----RFTEHEVQIYVGEIVLALEHLHKLGII 181
Query: 211 YRDLKPENVLVRSDGHIMLTDFDLS---LKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQ 267
YRD+K EN+L+ S+GH++LTDF LS + + +
Sbjct: 182 YRDIKLENILLDSNGHVVLTDFGLSKEFVADETERA------------------------ 217
Query: 268 PPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTHEYLAP 327
C GT E Y+AP
Sbjct: 218 ----YDFC--------------------------GTIE------------------YMAP 229
Query: 328 EIISGE--GHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLA----NVVARALEFPKEP 381
+I+ G GH AVDWW+LG+ ++EL G +PF + + A ++ +P
Sbjct: 230 DIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP--Q 287
Query: 382 SVPGPAKDLIAQLLVKDPTRRMGS-KMGATAIKRHQFFNGVNWALL--RCAKPPFIPR 436
+ AKDLI +LL+KDP +R+G A IK H FF +NW L + PF P
Sbjct: 288 EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVPAPFKPV 345
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 264 bits (676), Expect = 3e-81
Identities = 91/377 (24%), Positives = 150/377 (39%), Gaps = 90/377 (23%)
Query: 71 NNNNNNNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKE 130
N N LT++D +G G G VY + + G +A K +DK+ + + E
Sbjct: 178 KNVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKA----DTGKMYAMKCLDKKRIKMKQGE 233
Query: 131 SRARIEREILEML---DHPFLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHE 187
+ A ER +L ++ D PF+ + P + + GGDLH + F E
Sbjct: 234 TLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH--GVFSE 291
Query: 188 SAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQL 247
+ +RFYA+E+++ LE +H ++YRDLKP N+L+ GH+ ++D L+
Sbjct: 292 ADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP---- 347
Query: 248 VSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIV 307
++S GT
Sbjct: 348 ------------------------HASV--------------------------GTHG-- 355
Query: 308 AEPLDVRSMSFVGTHEYLAPEIIS-GEGHGNAVDWWTLGIFIFELFYGTTPF---KGIDH 363
Y+APE++ G + ++ DW++LG +F+L G +PF K D
Sbjct: 356 ----------------YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK 399
Query: 364 ELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDPTRRMGS-KMGATAIKRHQFFNGVN 422
+ A+E P S + L+ LL +D RR+G GA +K FF ++
Sbjct: 400 HEIDRMTLTMAVELP--DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLD 457
Query: 423 WALL--RCAKPPFIPRP 437
W ++ + PP IP
Sbjct: 458 WQMVFLQKYPPPLIPPR 474
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 212 bits (541), Expect = 7e-66
Identities = 84/355 (23%), Positives = 126/355 (35%), Gaps = 84/355 (23%)
Query: 74 NNNNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRA 133
+ L D LG G G+VYL + K + A KV+ K +L E +
Sbjct: 1 SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQ----SKFILALKVLFKAQLEKAGVEHQL 56
Query: 134 RIEREILEMLDHPFLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFY 193
R E EI L HP + LY L+ E+ P G ++ Q+ +F E Y
Sbjct: 57 RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SKFDEQRTATY 114
Query: 194 ASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQLVSDQSP 253
+E+ AL + H +I+RD+KPEN+ L LK ++D
Sbjct: 115 ITELANALSYCHSKRVIHRDIKPENL---------LLGSAGELK----------IAD--- 152
Query: 254 PTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDV 313
FG S
Sbjct: 153 ----------------FGWS----------------------------------VHAPSS 162
Query: 314 RSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVAR 373
R GT +YL PE+I G H VD W+LG+ +E G PF+ ++ T +
Sbjct: 163 RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV 222
Query: 374 ALEFPKEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGVNWALLRC 428
FP V A+DLI++LL +P++R + + H + + C
Sbjct: 223 EFTFP--DFVTEGARDLISRLLKHNPSQRPMLR----EVLEHPWITANSSKPSNC 271
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 210 bits (536), Expect = 5e-65
Identities = 93/358 (25%), Positives = 133/358 (37%), Gaps = 88/358 (24%)
Query: 78 PLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIER 137
T+ D LG G G+VYL + K N A KV+ K +L E + R E
Sbjct: 10 KFTIDDFDIGRPLGKGKFGNVYLAREKQ----NKFIMALKVLFKSQLEKEGVEHQLRREI 65
Query: 138 EILEMLDHPFLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEV 197
EI L HP + +Y + L+ EF P G+L+ Q+ RF E + E+
Sbjct: 66 EIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKH--GRFDEQRSATFMEEL 123
Query: 198 VVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGD 257
AL + H +I+RD+KPEN+ L + LK ++D
Sbjct: 124 ADALHYCHERKVIHRDIKPENL---------LMGYKGELK----------IAD------- 157
Query: 258 QQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMS 317
FG S P RR+ +
Sbjct: 158 ------------FG-------------WSVHAPSLRRR---------------------T 171
Query: 318 FVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEF 377
GT +YL PE+I G+ H VD W G+ +E G PF H T +V L+F
Sbjct: 172 MCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKF 231
Query: 378 PKEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGVNWALLRCAKPPFIP 435
P P + +KDLI++LL P +R + + H + A R PP
Sbjct: 232 P--PFLSDGSKDLISKLLRYHPPQR----LPLKGVMEHPWVK----ANSRRVLPPVYQ 279
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 184 bits (470), Expect = 3e-55
Identities = 73/355 (20%), Positives = 122/355 (34%), Gaps = 87/355 (24%)
Query: 81 LSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREIL 140
SD + LG G G V + + ++A K + E K S E +L
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNAL----DSRYYAIKKIRHTE----EKLSTILSEVMLL 56
Query: 141 EMLDHPFLPTLYATLDCPRWS-------------CLLTEFCPGGDLHVLRQRQPDKRFHE 187
L+H ++ YA R + E+C G L+ L +
Sbjct: 57 ASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSEN-LNQQR 115
Query: 188 SAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQL 247
+++ AL ++H GII+RDLKP N+ + ++ + DF L+ S +L
Sbjct: 116 DEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKL 175
Query: 248 VSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIV 307
S P + D S+ GT
Sbjct: 176 DSQNLPGSSD------------NLTSAI--------------------------GTA--- 194
Query: 308 AEPLDVRSMSFVGTHEYLAPEIISGEGH-GNAVDWWTLGIFIFELFYGTTPFKGIDHELT 366
Y+A E++ G GH +D ++LGI FE+ Y G++
Sbjct: 195 ---------------MYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP--FSTGMERVNI 237
Query: 367 LANVVARALEFPKE--PSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFN 419
L + + ++EFP + + K +I L+ DP +R GA + +
Sbjct: 238 LKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKR----PGARTLLNSGWLP 288
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 7e-54
Identities = 65/398 (16%), Positives = 124/398 (31%), Gaps = 123/398 (30%)
Query: 71 NNNNNNNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELV----- 125
N ++D R + L G + L + + F+A K +K L
Sbjct: 20 NKYVKEKDKYINDYRIIRTLNQGKFNKIILCE------KDNKFYALKKYEKSLLEKKRDF 73
Query: 126 ---------SRNKESRARIEREILEMLDHPFLPTLYATLDCPRWSCLLTEFCPGGDL--- 173
++K + E +I+ + + + T + ++ E+ +
Sbjct: 74 TKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKF 133
Query: 174 ---HVLRQRQPDKRFHESAVRFYASEVVVALEFLHM-MGIIYRDLKPENVLVRSDGHIML 229
+ + ++ V+ + ++H I +RD+KP N+L+
Sbjct: 134 DEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILM-------- 185
Query: 230 TDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLH 289
D + +K +SD FG S
Sbjct: 186 -DKNGRVK----------LSD-------------------FG-------------ESEYM 202
Query: 290 PKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTHEYLAPEIISGEG--HGNAVDWWTLGIF 347
++ K GT+E++ PE S E +G VD W+LGI
Sbjct: 203 VDKKIK---------------------GSRGTYEFMPPEFFSNESSYNGAKVDIWSLGIC 241
Query: 348 IFELFYGTTPFKG-IDHELTLANVVARALEFPKE-----------------PSVPGPAKD 389
++ +FY PF I N+ + +E+P + + D
Sbjct: 242 LYVMFYNVVPFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDID 301
Query: 390 LIAQLLVKDPTRRMGSKMGATAIKRHQFFNGVNWALLR 427
+ L K+P R+ S+ +H++ N LR
Sbjct: 302 FLKLFLRKNPAERITSE----DALKHEWLADTNIEDLR 335
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 6e-53
Identities = 60/203 (29%), Positives = 100/203 (49%), Gaps = 8/203 (3%)
Query: 43 SAAKTHHAPPRCNDDPCWKAIKEATSEGNNNNNNNPLTLSDLRFVHRLGSGDIGSVYLVQ 102
+AA + + KE + + N L + LG+G G V LV+
Sbjct: 2 NAAAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVK 61
Query: 103 LKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWSC 162
K +G +A K++DK+++V + E+ IL+ ++ PFL L +
Sbjct: 62 HK----ESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLY 117
Query: 163 LLTEFCPGGDL-HVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLV 221
++ E+ GG++ LR+ RF E RFYA+++V+ E+LH + +IYRDLKPEN+L+
Sbjct: 118 MVMEYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI 174
Query: 222 RSDGHIMLTDFDLSLKGDNSTST 244
G+I +TDF + + T T
Sbjct: 175 DQQGYIQVTDFGFAKRVKGRTWT 197
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 9e-42
Identities = 47/126 (37%), Positives = 66/126 (52%), Gaps = 5/126 (3%)
Query: 314 RSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVAR 373
R+ + GT E LAPEII +G+ AVDWW LG+ I+E+ G PF +V+
Sbjct: 194 RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG 253
Query: 374 ALEFPKEPSVPGPAKDLIAQLLVKDPTRRMGS-KMGATAIKRHQFFNGVNWALL--RCAK 430
+ FP KDL+ LL D T+R G+ K G IK H++F +W + R +
Sbjct: 254 KVRFP--SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVE 311
Query: 431 PPFIPR 436
PFIP+
Sbjct: 312 APFIPK 317
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 5e-51
Identities = 57/166 (34%), Positives = 95/166 (57%), Gaps = 6/166 (3%)
Query: 79 LTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIERE 138
+L D + + LG+G G V+L++ + NG ++A KV+ K +V + ER
Sbjct: 3 YSLQDFQILRTLGTGSFGRVHLIRSRH----NGRYYAMKVLKKEIVVRLKQVEHTNDERL 58
Query: 139 ILEMLDHPFLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVV 198
+L ++ HPF+ ++ T + ++ ++ GG+L L ++ +RF +FYA+EV
Sbjct: 59 MLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKS--QRFPNPVAKFYAAEVC 116
Query: 199 VALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTST 244
+ALE+LH IIYRDLKPEN+L+ +GHI +TDF + + T T
Sbjct: 117 LALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYT 162
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 151 bits (385), Expect = 2e-42
Identities = 42/137 (30%), Positives = 74/137 (54%), Gaps = 6/137 (4%)
Query: 314 RSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVAR 373
+ + GT +Y+APE++S + + ++DWW+ GI I+E+ G TPF + T ++
Sbjct: 159 VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA 218
Query: 374 ALEFPKEPSVPGPAKDLIAQLLVKDPTRRMGS-KMGATAIKRHQFFNGVNWALL--RCAK 430
L FP P KDL+++L+ +D ++R+G+ + G +K H +F V W L R +
Sbjct: 219 ELRFP--PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIE 276
Query: 431 PPFIPRPVTCRDLTTTN 447
P+ P P+ T+
Sbjct: 277 TPYEP-PIQQGQGDTSQ 292
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 173 bits (442), Expect = 1e-50
Identities = 63/184 (34%), Positives = 90/184 (48%), Gaps = 11/184 (5%)
Query: 67 TSEGNNNNNNNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVS 126
+SE + N + + LG G G V+ V+ K +N G FA KV+ K +V
Sbjct: 2 SSETSVNRGPEKIRPECFELLRVLGKGGYGKVFQVR-KVTGANTGKIFAMKVLKKAMIVR 60
Query: 127 RNKE-SRARIEREILEMLDHPFLPTLYATLDCPRWSCLLTEFCPGGDL--HVLRQRQPDK 183
K+ + + ER ILE + HPF+ L L+ E+ GG+L + R+
Sbjct: 61 NAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREG---- 116
Query: 184 RFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS---LKGDN 240
F E FY +E+ +AL LH GIIYRDLKPEN+++ GH+ LTDF L +
Sbjct: 117 IFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT 176
Query: 241 STST 244
T T
Sbjct: 177 VTHT 180
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 146 bits (372), Expect = 1e-40
Identities = 45/128 (35%), Positives = 71/128 (55%), Gaps = 5/128 (3%)
Query: 312 DVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVV 371
+ +F GT EY+APEI+ GH AVDWW+LG ++++ G PF G + + T+ ++
Sbjct: 175 GTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKIL 234
Query: 372 ARALEFPKEPSVPGPAKDLIAQLLVKDPTRRMGS-KMGATAIKRHQFFNGVNWALL--RC 428
L P P + A+DL+ +LL ++ R+G+ A ++ H FF +NW L R
Sbjct: 235 KCKLNLP--PYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEELLARK 292
Query: 429 AKPPFIPR 436
+PPF P
Sbjct: 293 VEPPFKPL 300
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 2e-50
Identities = 65/187 (34%), Positives = 99/187 (52%), Gaps = 11/187 (5%)
Query: 63 IKEATSEGNNNNNNNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKR 122
IKE + + S + LG G G V+LV+ K S+ +A KV+ K
Sbjct: 5 IKEIAITHHVKEGHEKADPSQFELLKVLGQGSFGKVFLVK-KISGSDARQLYAMKVLKKA 63
Query: 123 ELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWSCLLTEFCPGGDL--HVLRQRQ 180
L R++ R ++ER+IL ++HPF+ L+ L+ +F GGDL + ++
Sbjct: 64 TLKVRDRV-RTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEV- 121
Query: 181 PDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS---LK 237
F E V+FY +E+ +AL+ LH +GIIYRDLKPEN+L+ +GHI LTDF LS +
Sbjct: 122 ---MFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESID 178
Query: 238 GDNSTST 244
+ +
Sbjct: 179 HEKKAYS 185
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 2e-41
Identities = 46/128 (35%), Positives = 73/128 (57%), Gaps = 5/128 (3%)
Query: 312 DVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVV 371
+ ++ SF GT EY+APE+++ GH + DWW+ G+ +FE+ GT PF+G D + T+ ++
Sbjct: 180 EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMIL 239
Query: 372 ARALEFPKEPSVPGPAKDLIAQLLVKDPTRRMGS-KMGATAIKRHQFFNGVNWALL--RC 428
L P + A+ L+ L ++P R+G+ G IKRH FF+ ++W L R
Sbjct: 240 KAKLGMP--QFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWNKLYRRE 297
Query: 429 AKPPFIPR 436
PPF P
Sbjct: 298 IHPPFKPA 305
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 2e-49
Identities = 53/178 (29%), Positives = 81/178 (45%), Gaps = 9/178 (5%)
Query: 72 NNNNNNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKES 131
P+ LG G G V+ Q+K G +A K ++K+ L R
Sbjct: 175 KWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMK----ATGKLYACKKLNKKRLKKRKGYQ 230
Query: 132 RARIEREILEMLDHPFLPTLYATLDCPRWSCLLTEFCPGGDL--HVLRQRQPDKRFHESA 189
A +E++IL + F+ +L + CL+ GGD+ H+ + + F E
Sbjct: 231 GAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPR 290
Query: 190 VRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS---LKGDNSTST 244
FY +++V LE LH IIYRDLKPENVL+ DG++ ++D L+ G T
Sbjct: 291 AIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKG 348
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 3e-37
Identities = 35/140 (25%), Positives = 68/140 (48%), Gaps = 11/140 (7%)
Query: 312 DVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLA--- 368
++ + GT ++APE++ GE + +VD++ LG+ ++E+ PF+ ++
Sbjct: 343 QTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELK 402
Query: 369 -NVVARALEFPKEPSVPGPAKDLIAQLLVKDPTRRMGSK-MGATAIKRHQFFNGVNWALL 426
V+ +A+ +P +KD LL KDP +R+G + ++ H F ++W L
Sbjct: 403 QRVLEQAVTYP--DKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQL 460
Query: 427 --RCAKPPFIPRP--VTCRD 442
PPF+P V ++
Sbjct: 461 EAGMLTPPFVPDSRTVYAKN 480
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 8e-49
Identities = 57/186 (30%), Positives = 91/186 (48%), Gaps = 14/186 (7%)
Query: 65 EATSEGNNNNNNNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKREL 124
S+ +NN N + + L+D F+ LG G G V L + K +A K++ K +
Sbjct: 3 NTVSKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERK----GTDELYAVKILKKDVV 58
Query: 125 VSRNKESRARIEREILEMLD-HPFLPTLYATLDCPRWSCLLTEFCPGGDL--HVLRQRQP 181
+ + +E+ +L + PFL L++ + E+ GGDL H+ +
Sbjct: 59 IQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVG-- 116
Query: 182 DKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS---LKG 238
RF E FYA+E+ + L FL GIIYRDLK +NV++ S+GHI + DF + +
Sbjct: 117 --RFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD 174
Query: 239 DNSTST 244
+T T
Sbjct: 175 GVTTKT 180
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 9e-39
Identities = 42/135 (31%), Positives = 73/135 (54%), Gaps = 6/135 (4%)
Query: 312 DVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVV 371
V + +F GT +Y+APEII+ + +G +VDWW G+ ++E+ G PF+G D + +++
Sbjct: 175 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM 234
Query: 372 ARALEFPKEPSVPGPAKDLIAQLLVKDPTRRMGS-KMGATAIKRHQFFNGVNWALL--RC 428
+ +P S+ A + L+ K P +R+G G IK H FF ++W L +
Sbjct: 235 EHNVAYP--KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKE 292
Query: 429 AKPPFIPRPVTCRDL 443
+PP+ P+ R+
Sbjct: 293 IQPPYKPK-ACGRNA 306
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 2e-48
Identities = 50/174 (28%), Positives = 88/174 (50%), Gaps = 8/174 (4%)
Query: 73 NNNNNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESR 132
+ N + + +G G G V +VQ +A K M+K++ V RN+
Sbjct: 6 FDENEDVNFDHFEILRAIGKGSFGKVCIVQKND----TKKMYAMKYMNKQKCVERNEVRN 61
Query: 133 ARIEREILEMLDHPFLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRF 192
E +I++ L+HPFL L+ + ++ + GGDL Q+ F E V+
Sbjct: 62 VFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQN--VHFKEETVKL 119
Query: 193 YASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS--LKGDNSTST 244
+ E+V+AL++L II+RD+KP+N+L+ GH+ +TDF+++ L + +T
Sbjct: 120 FICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT 173
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 3e-35
Identities = 33/132 (25%), Positives = 59/132 (44%), Gaps = 13/132 (9%)
Query: 312 DVRSMSFVGTHEYLAPEIIS---GEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELT-- 366
+ + + GT Y+APE+ S G G+ AVDWW+LG+ +EL G P+ +
Sbjct: 168 ETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKE 227
Query: 367 -LANVVARALEFPKEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGVNWAL 425
+ + +P + L+ +LL +P +R + ++ + N +NW
Sbjct: 228 IVHTFETTVVTYP--SAWSQEMVSLLKKLLEPNPDQRFS---QLSDVQNFPYMNDINWDA 282
Query: 426 L--RCAKPPFIP 435
+ + P FIP
Sbjct: 283 VFQKRLIPGFIP 294
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 2e-48
Identities = 56/171 (32%), Positives = 92/171 (53%), Gaps = 13/171 (7%)
Query: 79 LTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIERE 138
+T++D ++ LG G G V LV+ K G ++A K++ K ++++++ + E
Sbjct: 2 VTMNDFDYLKLLGKGTFGKVILVREK----ATGRYYAMKILRKEVIIAKDEVAHTVTESR 57
Query: 139 ILEMLDHPFLPTLYATLDCPRWSCLLTEFCPGGDL--HVLRQRQPDKRFHESAVRFYASE 196
+L+ HPFL L C + E+ GG+L H+ R+R F E RFY +E
Sbjct: 58 VLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER----VFTEERARFYGAE 113
Query: 197 VVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS---LKGDNSTST 244
+V ALE+LH ++YRD+K EN+++ DGHI +TDF L + + T
Sbjct: 114 IVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT 164
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 4e-39
Identities = 47/128 (36%), Positives = 69/128 (53%), Gaps = 5/128 (3%)
Query: 312 DVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVV 371
+F GT EYLAPE++ +G AVDWW LG+ ++E+ G PF DHE ++
Sbjct: 159 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL 218
Query: 372 ARALEFPKEPSVPGPAKDLIAQLLVKDPTRRMGS-KMGATAIKRHQFFNGVNWALL--RC 428
+ FP ++ AK L+A LL KDP +R+G A + H+FF +NW + +
Sbjct: 219 MEEIRFP--RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKK 276
Query: 429 AKPPFIPR 436
PPF P+
Sbjct: 277 LLPPFKPQ 284
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 3e-48
Identities = 63/187 (33%), Positives = 97/187 (51%), Gaps = 14/187 (7%)
Query: 64 KEATSEGNNNNNNNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRE 123
KEA + + ++ L L D + +G G V LV+LK +A +V+ K
Sbjct: 34 KEAMNTRESGKASSSLGLQDFDLLRVIGRGSYAKVLLVRLK----KTDRIYAMRVVKKEL 89
Query: 124 LVSRNKESRARIEREILEM-LDHPFLPTLYATLDCPRWSCLLTEFCPGGDL--HVLRQRQ 180
+ + E+ + E +HPFL L++ + E+ GGDL H+ RQR
Sbjct: 90 VNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQR- 148
Query: 181 PDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS---LK 237
+ E RFY++E+ +AL +LH GIIYRDLK +NVL+ S+GHI LTD+ + L+
Sbjct: 149 ---KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 205
Query: 238 GDNSTST 244
++TST
Sbjct: 206 PGDTTST 212
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 1e-34
Identities = 42/138 (30%), Positives = 67/138 (48%), Gaps = 15/138 (10%)
Query: 312 DVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPF---------KGID 362
+ +F GT Y+APEI+ GE +G +VDWW LG+ +FE+ G +PF
Sbjct: 207 GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNT 266
Query: 363 HELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDPTRRMGS--KMGATAIKRHQFFNG 420
+ ++ + + P S+ A ++ L KDP R+G + G I+ H FF
Sbjct: 267 EDYLFQVILEKQIRIP--RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 324
Query: 421 VNWALL--RCAKPPFIPR 436
V+W ++ + PPF P
Sbjct: 325 VDWDMMEQKQVVPPFKPN 342
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 3e-48
Identities = 55/185 (29%), Positives = 93/185 (50%), Gaps = 9/185 (4%)
Query: 65 EATSEGNNNNNNNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKREL 124
E + L D + +G G G V +V+LK+ FA K+++K E+
Sbjct: 57 EWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKN----ADKVFAMKILNKWEM 112
Query: 125 VSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKR 184
+ R + + R ER++L D ++ TL+ L+ ++ GGDL L + + R
Sbjct: 113 LKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKF-EDR 171
Query: 185 FHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLK----GDN 240
E RFY +E+V+A++ +H + ++RD+KP+N+L+ +GHI L DF LK G
Sbjct: 172 LPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV 231
Query: 241 STSTA 245
+S A
Sbjct: 232 QSSVA 236
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 1e-38
Identities = 43/133 (32%), Positives = 67/133 (50%), Gaps = 10/133 (7%)
Query: 312 DVRSMSFVGTHEYLAPEIISGE-----GHGNAVDWWTLGIFIFELFYGTTPFKGIDHELT 366
V+S VGT +Y++PEI+ +G DWW+LG+ ++E+ YG TPF T
Sbjct: 230 TVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET 289
Query: 367 LANVVARALEFP---KEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGVNW 423
++ F + V AKDLI +L+ R+G G K+H FF+G++W
Sbjct: 290 YGKIMNHKERFQFPTQVTDVSENAKDLIRRLI-CSREHRLGQN-GIEDFKKHPFFSGIDW 347
Query: 424 ALLRCAKPPFIPR 436
+R + P+IP
Sbjct: 348 DNIRNCEAPYIPE 360
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 6e-48
Identities = 65/187 (34%), Positives = 95/187 (50%), Gaps = 14/187 (7%)
Query: 64 KEATSEGNNNNNNNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRE 123
G N++N L + + F+ LG G G V L ++K G +A KV+ K
Sbjct: 5 SSKEGNGIGVNSSNRLGIDNFEFIRVLGKGSFGKVMLARVK----ETGDLYAVKVLKKDV 60
Query: 124 LVSRNKESRARIEREILEM-LDHPFLPTLYATLDCPRWSCLLTEFCPGGDL--HVLRQRQ 180
++ + E+ IL + +HPFL L+ P + EF GGDL H+ + R
Sbjct: 61 ILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSR- 119
Query: 181 PDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS---LK 237
RF E+ RFYA+E++ AL FLH GIIYRDLK +NVL+ +GH L DF + +
Sbjct: 120 ---RFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC 176
Query: 238 GDNSTST 244
+T+T
Sbjct: 177 NGVTTAT 183
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 1e-38
Identities = 44/129 (34%), Positives = 71/129 (55%), Gaps = 6/129 (4%)
Query: 312 DVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVV 371
V + +F GT +Y+APEI+ +G AVDWW +G+ ++E+ G PF+ + + ++
Sbjct: 178 GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAIL 237
Query: 372 ARALEFPKEPSVPGPAKDLIAQLLVKDPTRRMGSKM--GATAIKRHQFFNGVNWALL--R 427
+ +P + A ++ + K+PT R+GS G AI RH FF ++WA L R
Sbjct: 238 NDEVVYP--TWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWAQLNHR 295
Query: 428 CAKPPFIPR 436
+PPF PR
Sbjct: 296 QIEPPFRPR 304
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 6e-48
Identities = 62/176 (35%), Positives = 92/176 (52%), Gaps = 14/176 (7%)
Query: 75 NNNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRAR 134
+PL L D + +G G V LV+LK +A KV+ K + +
Sbjct: 2 AMDPLGLQDFDLLRVIGRGSYAKVLLVRLK----KTDRIYAMKVVKKELVNDDEDIDWVQ 57
Query: 135 IEREILEM-LDHPFLPTLYATLDCPRWSCLLTEFCPGGDL--HVLRQRQPDKRFHESAVR 191
E+ + E +HPFL L++ + E+ GGDL H+ RQR + E R
Sbjct: 58 TEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQR----KLPEEHAR 113
Query: 192 FYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS---LKGDNSTST 244
FY++E+ +AL +LH GIIYRDLK +NVL+ S+GHI LTD+ + L+ ++TST
Sbjct: 114 FYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST 169
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 9e-36
Identities = 42/138 (30%), Positives = 67/138 (48%), Gaps = 15/138 (10%)
Query: 312 DVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPF---------KGID 362
+ +F GT Y+APEI+ GE +G +VDWW LG+ +FE+ G +PF
Sbjct: 164 GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNT 223
Query: 363 HELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDPTRRMGS--KMGATAIKRHQFFNG 420
+ ++ + + P S+ A ++ L KDP R+G + G I+ H FF
Sbjct: 224 EDYLFQVILEKQIRIP--RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 281
Query: 421 VNWALL--RCAKPPFIPR 436
V+W ++ + PPF P
Sbjct: 282 VDWDMMEQKQVVPPFKPN 299
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 2e-47
Identities = 78/387 (20%), Positives = 134/387 (34%), Gaps = 92/387 (23%)
Query: 34 GSNPSSSTPSAAKTHHAPPRCNDDPCWKAIKEATSEGNNNNNNNPLTLSDLRFVHRLGSG 93
G P+ + AP P K I E + P + LG G
Sbjct: 1 GPAPADPGKAGVPGVAAPGAPAAAPPAKEIPEVLVD--------PRSRRRYVRGRFLGKG 52
Query: 94 DIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYA 153
+ + ++ FA K++ K L+ ++ + +E I L H + +
Sbjct: 53 GFAKCFEI----SDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 154 TLDCPRWSCLLTEFCPGGDL-HVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYR 212
+ + ++ E C L + ++R K E R+Y ++V+ ++LH +I+R
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLELHKRR---KALTEPEARYYLRQIVLGCQYLHRNRVIHR 165
Query: 213 DLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGN 272
DLK N+ + + DL +K + D FG
Sbjct: 166 DLKLGNLFL---------NEDLEVK----------IGD-------------------FGL 187
Query: 273 SSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTHEYLAPEIISG 332
++ + RKK L GTP Y+APE++S
Sbjct: 188 ATKV------------EYDGERKKVLC--GTPN------------------YIAPEVLSK 215
Query: 333 EGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIA 392
+GH VD W++G ++ L G PF+ + T + P + A LI
Sbjct: 216 KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIP--KHINPVAASLIQ 273
Query: 393 QLLVKDPTRRMGSKMGATAIKRHQFFN 419
++L DPT R + +FF
Sbjct: 274 KMLQTDPTAR----PTINELLNDEFFT 296
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 3e-47
Identities = 56/181 (30%), Positives = 87/181 (48%), Gaps = 10/181 (5%)
Query: 68 SEGNNNNNNNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSR 127
+ L + D LG G G V+L + K FFA K + K ++
Sbjct: 3 LNKERPSLQIKLKIEDFILHKMLGKGSFGKVFLAEFK----KTNQFFAIKALKKDVVLMD 58
Query: 128 NKESRARIEREILEM-LDHPFLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFH 186
+ +E+ +L + +HPFL ++ T + E+ GGDL Q +F
Sbjct: 59 DDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSC--HKFD 116
Query: 187 ESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS---LKGDNSTS 243
S FYA+E+++ L+FLH GI+YRDLK +N+L+ DGHI + DF + + GD T+
Sbjct: 117 LSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTN 176
Query: 244 T 244
T
Sbjct: 177 T 177
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 4e-37
Identities = 42/127 (33%), Positives = 73/127 (57%), Gaps = 7/127 (5%)
Query: 312 DVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVV 371
D ++ +F GT +Y+APEI+ G+ + ++VDWW+ G+ ++E+ G +PF G D E ++
Sbjct: 172 DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIR 231
Query: 372 ARALEFPKEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGVNWALL--RCA 429
+P + AKDL+ +L V++P +R+G I++H F +NW L +
Sbjct: 232 MDNPFYP--RWLEKEAKDLLVKLFVREPEKRLGV---RGDIRQHPLFREINWEELERKEI 286
Query: 430 KPPFIPR 436
PPF P+
Sbjct: 287 DPPFRPK 293
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 5e-47
Identities = 53/175 (30%), Positives = 82/175 (46%), Gaps = 6/175 (3%)
Query: 72 NNNNNNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKES 131
P+T + R LG G G V Q++ G +A K ++K+ + R E+
Sbjct: 174 KWLERQPVTKNTFRQYRVLGKGGFGEVCACQVR----ATGKMYACKKLEKKRIKKRKGEA 229
Query: 132 RARIEREILEMLDHPFLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVR 191
A E++ILE ++ F+ +L + CL+ GGDL F E+
Sbjct: 230 MALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAV 289
Query: 192 FYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS--LKGDNSTST 244
FYA+E+ LE LH I+YRDLKPEN+L+ GHI ++D L+ + +
Sbjct: 290 FYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKG 344
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 6e-39
Identities = 44/138 (31%), Positives = 67/138 (48%), Gaps = 7/138 (5%)
Query: 312 DVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVV 371
VGT Y+APE++ E + + DWW LG ++E+ G +PF+ ++ V
Sbjct: 339 GQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE 398
Query: 372 ARALEFPKE--PSVPGPAKDLIAQLLVKDPTRRMGSK-MGATAIKRHQFFNGVNWALL-- 426
E P+E A+ L +QLL KDP R+G + A +K H F +N+ L
Sbjct: 399 RLVKEVPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFKRLGA 458
Query: 427 RCAKPPFIPRP--VTCRD 442
+PPF P P + C+D
Sbjct: 459 GMLEPPFKPDPQAIYCKD 476
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 1e-46
Identities = 63/177 (35%), Positives = 98/177 (55%), Gaps = 14/177 (7%)
Query: 74 NNNNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRA 133
++N SD F+ +G G G V L + K F+A KV+ K+ ++ + +E
Sbjct: 30 SSNPHAKPSDFHFLKVIGKGSFGKVLLARHK----AEEVFYAVKVLQKKAILKKKEEKHI 85
Query: 134 RIEREILEM-LDHPFLPTLYATLDCPRWSCLLTEFCPGGDL--HVLRQRQPDKRFHESAV 190
ER +L + HPFL L+ + + ++ GG+L H+ R+R F E
Sbjct: 86 MSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRER----CFLEPRA 141
Query: 191 RFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS---LKGDNSTST 244
RFYA+E+ AL +LH + I+YRDLKPEN+L+ S GHI+LTDF L ++ +++TST
Sbjct: 142 RFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTST 198
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 2e-41
Identities = 45/127 (35%), Positives = 70/127 (55%), Gaps = 4/127 (3%)
Query: 312 DVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVV 371
+ + +F GT EYLAPE++ + + VDWW LG ++E+ YG PF + N++
Sbjct: 193 NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNIL 252
Query: 372 ARALEFPKEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGVNWALL--RCA 429
+ L+ P++ A+ L+ LL KD T+R+G+K IK H FF+ +NW L +
Sbjct: 253 NKPLQLK--PNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINWDDLINKKI 310
Query: 430 KPPFIPR 436
PPF P
Sbjct: 311 TPPFNPN 317
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 3e-46
Identities = 70/344 (20%), Positives = 124/344 (36%), Gaps = 84/344 (24%)
Query: 77 NPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIE 136
+P + LG G + + ++ FA K++ K L+ ++ + +E
Sbjct: 10 DPRSRRRYVRGRFLGKGGFAKCFEI----SDADTKEVFAGKIVPKSLLLKPHQREKMSME 65
Query: 137 REILEMLDHPFLPTLYATLDCPRWSCLLTEFCPGGDL-HVLRQRQPDKRFHESAVRFYAS 195
I L H + + + + ++ E C L + ++R K E R+Y
Sbjct: 66 ISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRR---KALTEPEARYYLR 122
Query: 196 EVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQLVSDQSPPT 255
++V+ ++LH +I+RDLK N+ + + DL +K + D
Sbjct: 123 QIVLGCQYLHRNRVIHRDLKLGNLFL---------NEDLEVK----------IGD----- 158
Query: 256 GDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRS 315
FG ++ + RKK L GTP
Sbjct: 159 --------------FGLATKV------------EYDGERKKVLC--GTPN---------- 180
Query: 316 MSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARAL 375
Y+APE++S +GH VD W++G ++ L G PF+ + T +
Sbjct: 181 --------YIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY 232
Query: 376 EFPKEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFN 419
P + A LI ++L DPT R + +FF
Sbjct: 233 SIP--KHINPVAASLIQKMLQTDPTAR----PTINELLNDEFFT 270
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 1e-45
Identities = 65/234 (27%), Positives = 108/234 (46%), Gaps = 19/234 (8%)
Query: 17 FTSTTTNSGSETTWTTSGSNPSSSTPSAAKTHHAPPRCNDDPCWKAIKEATSEGNNNNNN 76
F T E T +AA+ +D+ E +
Sbjct: 88 FHVETPEEREEWTTAIQTVADGLKKQAAAEMDFRSGSPSDNS-----GAEEMEVSLAKPK 142
Query: 77 NPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIE 136
+ +T+++ ++ LG G G V LV+ K G ++A K++ K +V++++ + E
Sbjct: 143 HRVTMNEFEYLKLLGKGTFGKVILVKEK----ATGRYYAMKILKKEVIVAKDEVAHTLTE 198
Query: 137 REILEMLDHPFLPTLYATLDCPRWSCLLTEFCPGGDL--HVLRQRQPDKRFHESAVRFYA 194
+L+ HPFL L + C + E+ GG+L H+ R+R F E RFY
Sbjct: 199 NRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRER----VFSEDRARFYG 254
Query: 195 SEVVVALEFLHM-MGIIYRDLKPENVLVRSDGHIMLTDFDLS---LKGDNSTST 244
+E+V AL++LH ++YRDLK EN+++ DGHI +TDF L +K + T
Sbjct: 255 AEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT 308
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 3e-38
Identities = 47/128 (36%), Positives = 70/128 (54%), Gaps = 5/128 (3%)
Query: 312 DVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVV 371
+F GT EYLAPE++ +G AVDWW LG+ ++E+ G PF DHE ++
Sbjct: 303 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL 362
Query: 372 ARALEFPKEPSVPGPAKDLIAQLLVKDPTRRMGS-KMGATAIKRHQFFNGVNWALL--RC 428
+ FP ++ AK L++ LL KDP +R+G A I +H+FF G+ W + +
Sbjct: 363 MEEIRFP--RTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKK 420
Query: 429 AKPPFIPR 436
PPF P+
Sbjct: 421 LSPPFKPQ 428
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 4e-45
Identities = 81/324 (25%), Positives = 124/324 (38%), Gaps = 88/324 (27%)
Query: 90 LGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVS-RNKESRARIERE--ILEMLDHP 146
LGSG V + KS G +AAK + KR+ + R R IERE IL + HP
Sbjct: 20 LGSGQFAIVKKCREKS----TGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHP 75
Query: 147 FLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQR-QPDKRFHESAVRFYASEVVVALEFLH 205
+ TL+ + L+ E GG+L + E + +++ + +LH
Sbjct: 76 NIITLHDVYENRTDVVLILELVSGGELF---DFLAQKESLSEEEATSFIKQILDGVNYLH 132
Query: 206 MMGIIYRDLKPENVLVRS----DGHIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPN 261
I + DLKPEN+++ HI L DF L+ + ++ +
Sbjct: 133 TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF------------- 179
Query: 262 DCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGT 321
GTPE VA
Sbjct: 180 ----------------------------------------GTPEFVA------------- 186
Query: 322 HEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEP 381
PEI++ E G D W++G+ + L G +PF G + TLAN+ A + +F +E
Sbjct: 187 -----PEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEF 241
Query: 382 --SVPGPAKDLIAQLLVKDPTRRM 403
AKD I +LLVK+ +R+
Sbjct: 242 FSQTSELAKDFIRKLLVKETRKRL 265
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 4e-45
Identities = 71/320 (22%), Positives = 116/320 (36%), Gaps = 78/320 (24%)
Query: 90 LGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIERE--ILEMLDHPF 147
+G G V + G FA K++D + S S ++RE I ML HP
Sbjct: 32 IGKGPFSVVRRCINRE----TGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPH 87
Query: 148 LPTLYATLDCPRWSCLLTEFCPGGDL--HVLRQRQPDKRFHESAVRFYASEVVVALEFLH 205
+ L T ++ EF G DL ++++ + E+ Y +++ AL + H
Sbjct: 88 IVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH 147
Query: 206 MMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAV 265
II+RD+KP VL+ S + +K +
Sbjct: 148 DNNIIHRDVKPHCVLLASK------ENSAPVK----------LGG--------------- 176
Query: 266 DQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTHEYL 325
FG + +LG G + VGT ++
Sbjct: 177 ----FGVA----------------------IQLGESGL----------VAGGRVGTPHFM 200
Query: 326 APEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEP--SV 383
APE++ E +G VD W G+ +F L G PF G L ++ + +
Sbjct: 201 APEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERL-FEGIIKGKYKMNPRQWSHI 259
Query: 384 PGPAKDLIAQLLVKDPTRRM 403
AKDL+ ++L+ DP R+
Sbjct: 260 SESAKDLVRRMLMLDPAERI 279
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 4e-45
Identities = 77/378 (20%), Positives = 123/378 (32%), Gaps = 92/378 (24%)
Query: 34 GSNPSSSTPSAAKTHHAPPRCNDDPCWKAIKEATSEGNNNNNNNPLTLSDLRFVHRLGSG 93
+ + P + D ++ I + + + LGSG
Sbjct: 4 SHHHHHHGSKVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVY-DYYDILEELGSG 62
Query: 94 DIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIERE--ILEMLDHPFLPTL 151
G V+ K+ G F AK ++ + ++ E I+ L HP L L
Sbjct: 63 AFGVVHRCVEKA----TGRVFVAKFINTPYP-----LDKYTVKNEISIMNQLHHPKLINL 113
Query: 152 YATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFH--ESAVRFYASEVVVALEFLHMMGI 209
+ + L+ EF GG+L R + + E+ V Y + L+ +H I
Sbjct: 114 HDAFEDKYEMVLILEFLSGGELF---DRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSI 170
Query: 210 IYRDLKPENVLVRS--DGHIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQ 267
++ D+KPEN++ + + + DF L+ K +
Sbjct: 171 VHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT------------------- 211
Query: 268 PPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTHEYLAP 327
T E A P
Sbjct: 212 ----------------------------------ATAEFAA------------------P 219
Query: 328 EIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKE--PSVPG 385
EI+ E G D W +G+ + L G +PF G D TL NV EF ++ SV
Sbjct: 220 EIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSP 279
Query: 386 PAKDLIAQLLVKDPTRRM 403
AKD I LL K+P +R+
Sbjct: 280 EAKDFIKNLLQKEPRKRL 297
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 163 bits (413), Expect = 3e-44
Identities = 61/250 (24%), Positives = 102/250 (40%), Gaps = 14/250 (5%)
Query: 1 MQPSAEDTAEDPDNLSFTSTTTNSGSETTWTTSGSNPSSSTPSAAKTHHAPPRCNDDPCW 60
+ + + + F + G + K A
Sbjct: 260 LSFGISELQKAGVDGWFKLLSQEEGEYFNVPVPPEGSEGNEELRQKFERAKIGQGTKAPE 319
Query: 61 KAIKEATSEGNNNNNNNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMD 120
+ S+ +NN N + + L+D F+ LG G G V L + K +A K++
Sbjct: 320 EKTANTISKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERK----GTDELYAVKILK 375
Query: 121 KRELVSRNKESRARIEREILEM-LDHPFLPTLYATLDCPRWSCLLTEFCPGGDL--HVLR 177
K ++ + +E+ +L + PFL L++ + E+ GGDL H+ +
Sbjct: 376 KDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQ 435
Query: 178 QRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS-- 235
RF E FYA+E+ + L FL GIIYRDLK +NV++ S+GHI + DF +
Sbjct: 436 VG----RFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKE 491
Query: 236 -LKGDNSTST 244
+ +T T
Sbjct: 492 NIWDGVTTKT 501
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 7e-36
Identities = 42/135 (31%), Positives = 74/135 (54%), Gaps = 6/135 (4%)
Query: 312 DVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVV 371
V + +F GT +Y+APEII+ + +G +VDWW G+ ++E+ G PF+G D + +++
Sbjct: 496 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM 555
Query: 372 ARALEFPKEPSVPGPAKDLIAQLLVKDPTRRMGS-KMGATAIKRHQFFNGVNWALL--RC 428
+ +P S+ A + L+ K P +R+G G IK H FF ++W L +
Sbjct: 556 EHNVAYP--KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKE 613
Query: 429 AKPPFIPRPVTCRDL 443
+PP+ P+ + R+
Sbjct: 614 IQPPYKPK-ASGRNA 627
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 8e-44
Identities = 76/322 (23%), Positives = 124/322 (38%), Gaps = 86/322 (26%)
Query: 90 LGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIERE--ILEMLDH-P 146
LG G V KS G +AAK + KR ++ RA I E +LE+ P
Sbjct: 37 LGRGKFAVVRQCISKS----TGQEYAAKFLKKRRR---GQDCRAEILHEIAVLELAKSCP 89
Query: 147 FLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHM 206
+ L+ + L+ E+ GG++ L + + E+ V +++ + +LH
Sbjct: 90 RVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQ 149
Query: 207 MGIIYRDLKPENVLVRS---DGHIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDC 263
I++ DLKP+N+L+ S G I + DF +S K
Sbjct: 150 NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRK-------------------------- 183
Query: 264 AVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTHE 323
+ ++ +G TPE +A
Sbjct: 184 ------------------------IGHACELREIMG---TPEYLA--------------- 201
Query: 324 YLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEP-- 381
PEI++ + A D W +GI + L T+PF G D++ T N+ +++ +E
Sbjct: 202 ---PEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFS 258
Query: 382 SVPGPAKDLIAQLLVKDPTRRM 403
SV A D I LLVK+P +R
Sbjct: 259 SVSQLATDFIQSLLVKNPEKRP 280
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 156 bits (395), Expect = 2e-43
Identities = 78/410 (19%), Positives = 141/410 (34%), Gaps = 108/410 (26%)
Query: 19 STTTNSGSETTWTTSGSNPSSSTPSAAKTHHAPPRCNDDP-CWKAIKEATSEGNNNNNNN 77
S+ + G+E + S N + N D +K + +
Sbjct: 9 SSGVDLGTENLYFQSMKNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPA 68
Query: 78 PLTLSDLRFVHR----------------LGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDK 121
P D R V LG G G V+ + + G AAK++
Sbjct: 69 PPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETA----TGLKLAAKIIKT 124
Query: 122 RELVSRNKESRARIERE--ILEMLDHPFLPTLYATLDCPRWSCLLTEFCPGGDL--HVLR 177
R + + + ++ E ++ LDH L LY + L+ E+ GG+L ++
Sbjct: 125 RGM-----KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIID 179
Query: 178 QRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRS--DGHIMLTDFDLS 235
+ E + ++ + +H M I++ DLKPEN+L + I + DF L+
Sbjct: 180 E---SYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLA 236
Query: 236 LKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRK 295
+ P+ + K
Sbjct: 237 RR--------------------------------------------------YKPREKLK 246
Query: 296 KKLGNPGTPEIVAEPLDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGT 355
G TPE +A PE+++ + D W++G+ + L G
Sbjct: 247 VNFG---TPEFLA------------------PEVVNYDFVSFPTDMWSVGVIAYMLLSGL 285
Query: 356 TPFKGIDHELTLANVVARALEFPKE--PSVPGPAKDLIAQLLVKDPTRRM 403
+PF G + TL N++A + E + AK+ I++LL+K+ + R+
Sbjct: 286 SPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFISKLLIKEKSWRI 335
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 8e-43
Identities = 69/354 (19%), Positives = 119/354 (33%), Gaps = 90/354 (25%)
Query: 81 LSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIERE-- 138
L+D + LG G G V+ + K + C +A K + + +R ++ RE
Sbjct: 4 LTDFEPIQCLGRGGFGVVFEAKNKV----DDCNYAIKRIRL----PNRELAREKVMREVK 55
Query: 139 ILEMLDHPFLPTLY---ATLDCPRWS---------CLLTEFCPGGDL-HVLRQRQPDKRF 185
L L+HP + + + + + C +L + R +
Sbjct: 56 ALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEER 115
Query: 186 HESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTA 245
S ++ A+EFLH G+++RDLKP N+ D + + DF L D
Sbjct: 116 ERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQ 175
Query: 246 QLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPE 305
+++ P + G GT
Sbjct: 176 TVLT----------------------------------------PMPAYARHTGQVGTK- 194
Query: 306 IVAEPLDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHEL 365
Y++PE I G + + VD ++LG+ +FEL Y ++
Sbjct: 195 -----------------LYMSPEQIHGNSYSHKVDIFSLGLILFELLY--PFSTQMERVR 235
Query: 366 TLANVVARALEFPKEPS-VPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFF 418
TL +V R L+FP + ++ +L P R A I + F
Sbjct: 236 TLTDV--RNLKFPPLFTQKYPCEYVMVQDMLSPSPMER----PEAINIIENAVF 283
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 1e-42
Identities = 71/375 (18%), Positives = 123/375 (32%), Gaps = 118/375 (31%)
Query: 90 LGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIERE--ILEMLDHPF 147
+G G G V + A K+M+K ++ N + RI+ E +++ L HP
Sbjct: 34 IGQGSYGVVRVAIENQ----TRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPN 89
Query: 148 LPTLYATLDCPRWSCLLTEFCPGGDL---------------------------------- 173
+ LY + ++ CL+ E C GG L
Sbjct: 90 IARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEA 149
Query: 174 ----HVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIML 229
+ D E + ++ AL +LH GI +RD+KPEN L ++
Sbjct: 150 INGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNK---- 205
Query: 230 TDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLH 289
+K + D FG S
Sbjct: 206 ---SFEIK----------LVD-------------------FGLSKEFYKL---------- 223
Query: 290 PKRRRKKKLGNPGTPEIVAEPLDVRSMS-FVGTHEYLAPEIISGEGH--GNAVDWWTLGI 346
+ M+ GT ++APE+++ G D W+ G+
Sbjct: 224 -------------------NNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGV 264
Query: 347 FIFELFYGTTPFKGIDHELTLANVVARALEFPKEP--SVPGPAKDLIAQLLVKDPTRRMG 404
+ L G PF G++ T++ V+ + L F + A+DL++ LL ++ R
Sbjct: 265 LLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDER-- 322
Query: 405 SKMGATAIKRHQFFN 419
A +H + +
Sbjct: 323 --FDAMRALQHPWIS 335
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 156 bits (395), Expect = 4e-42
Identities = 76/393 (19%), Positives = 127/393 (32%), Gaps = 107/393 (27%)
Query: 35 SNPSSSTPSAAKTHHAPPRCNDDPCWKAIKEATSEGNNNNNNNPLTLSDLR--------- 85
P++ + D K ++ + +N +N
Sbjct: 94 CEPTAPVLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHD 153
Query: 86 -------FVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIERE 138
LG+G G V+ V ++ G FAAK + ++ + + +E
Sbjct: 154 HVLDHYDIHEELGTGAFGVVHRVTERA----TGNNFAAKFVMTP-----HESDKETVRKE 204
Query: 139 --ILEMLDHPFLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFH--ESAVRFYA 194
+ +L HP L L+ + ++ EF GG+L ++ D+ E Y
Sbjct: 205 IQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELF---EKVADEHNKMSEDEAVEYM 261
Query: 195 SEVVVALEFLHMMGIIYRDLKPENVLV--RSDGHIMLTDFDLSLKGDNSTSTAQLVSDQS 252
+V L +H ++ DLKPEN++ + + L DF L+
Sbjct: 262 RQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAH--------------- 306
Query: 253 PPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLD 312
L PK+ K G T E A
Sbjct: 307 -----------------------------------LDPKQSVKVTTG---TAEFAA---- 324
Query: 313 VRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVA 372
PE+ G+ G D W++G+ + L G +PF G + + TL NV +
Sbjct: 325 --------------PEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKS 370
Query: 373 RALEFPKE--PSVPGPAKDLIAQLLVKDPTRRM 403
+ KD I +LL+ DP RM
Sbjct: 371 CDWNMDDSAFSGISEDGKDFIRKLLLADPNTRM 403
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 7e-42
Identities = 75/322 (23%), Positives = 122/322 (37%), Gaps = 79/322 (24%)
Query: 85 RFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLD 144
+ LG G G V L + K G A KV+ KR++ + + E ++L+ LD
Sbjct: 29 KGQRVLGKGSFGEVILCKDKI----TGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 145 HPFLPTLYATLDCPRWSCLLTEFCPGGDL-HVLRQRQPDKRFHESAVRFYASEVVVALEF 203
HP + LY + + L+ E GG+L + R KRF E +V+ + +
Sbjct: 85 HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISR---KRFSEVDAARIIRQVLSGITY 141
Query: 204 LHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDC 263
+H I++RDLKPEN+L+ S D +++
Sbjct: 142 MHKNKIVHRDLKPENLLLESK------SKDANIR-------------------------- 169
Query: 264 AVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTHE 323
+D FG S+ + + + +GT
Sbjct: 170 IID---FGLSTHFEAS-----------------------------KKMK----DKIGTAY 193
Query: 324 YLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEP-- 381
Y+APE++ G + D W+ G+ ++ L G PF G + L V F
Sbjct: 194 YIAPEVLHGT-YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWK 252
Query: 382 SVPGPAKDLIAQLLVKDPTRRM 403
V AKDLI ++L P+ R+
Sbjct: 253 KVSESAKDLIRKMLTYVPSMRI 274
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 1e-41
Identities = 63/367 (17%), Positives = 120/367 (32%), Gaps = 92/367 (25%)
Query: 66 ATSEGNNNNNNNPLTLSDLRFV--HRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRE 123
G N +++ + ++GSG V+ V + +A K ++ E
Sbjct: 10 GVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVL-----NEKKQIYAIKYVNLEE 64
Query: 124 LVSRNKESRARIEREI--LEMLDHPFLP--TLYATLDCPRWSCLLTEFCPGGDLH-VLRQ 178
+ ++ EI L L LY ++ ++ E C DL+ L++
Sbjct: 65 A---DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKK 120
Query: 179 RQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKG 238
+ K + Y ++ A+ +H GI++ DLKP N L+ DG + L DF ++ +
Sbjct: 121 K---KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQM 176
Query: 239 DNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKL 298
T++ +S
Sbjct: 177 QPDTTSVVK------------------------DSQV----------------------- 189
Query: 299 GNPGT-----PEIVAEPLDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFY 353
GT PE + + S D W+LG ++ + Y
Sbjct: 190 ---GTVNYMPPEAIKD------------MSSSRENGKSKSKISPKSDVWSLGCILYYMTY 234
Query: 354 GTTPFKGIDHEL-TLANVVARALEFPKEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAI 412
G TPF+ I +++ L ++ E +D++ L +DP +R + +
Sbjct: 235 GKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQR----ISIPEL 290
Query: 413 KRHQFFN 419
H +
Sbjct: 291 LAHPYVQ 297
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 2e-41
Identities = 81/361 (22%), Positives = 132/361 (36%), Gaps = 84/361 (23%)
Query: 48 HHAPPRCNDDPCWKAIKEATSEGNNNNNNNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKS 107
HH + + + G + + V +LGSG G V L + K
Sbjct: 3 HHHHHSSGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKV-- 60
Query: 108 SNNGCFFAAKVMDKRELVSRNKESRARIERE--ILEMLDHPFLPTLYATLDCPRWSCLLT 165
A K++ K + + + ++ E +L++LDHP + LY + R L+
Sbjct: 61 --THVERAIKIIRKTSVSTSSNS---KLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115
Query: 166 EFCPGGDL-HVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSD 224
E GG+L + R +F+E +V+ + +LH I++RDLKPEN+L+ S
Sbjct: 116 ECYKGGELFDEIIHR---MKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESK 172
Query: 225 GHIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPA 284
+ D +K VD FG S+
Sbjct: 173 ------EKDALIK--------------------------IVD---FGLSAVFENQ----- 192
Query: 285 VSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTL 344
+ + +GT Y+APE++ + + D W++
Sbjct: 193 ------------------------KKMK----ERLGTAYYIAPEVLRKK-YDEKCDVWSI 223
Query: 345 GIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEP--SVPGPAKDLIAQLLVKDPTRR 402
G+ +F L G PF G + L V F +V AKDLI Q+L D RR
Sbjct: 224 GVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRR 283
Query: 403 M 403
+
Sbjct: 284 I 284
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 5e-41
Identities = 67/402 (16%), Positives = 132/402 (32%), Gaps = 95/402 (23%)
Query: 31 TTSGSNPSSSTPSAAKTHHAPPRCNDDPCWKAIKEATSEGNNNNNNNPLTLSDLRF--VH 88
+SG P S + D P + + +++ N +++ + +
Sbjct: 6 HSSGLVPRGSGMKETAAAKFERQHMDSP---DLGTDDDDKASSSANECISVKGRIYSILK 62
Query: 89 RLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREI--LEMLDHP 146
++GSG V+ V + +A K ++ E + ++ EI L L
Sbjct: 63 QIGSGGSSKVFQVL-----NEKKQIYAIKYVNLEEA---DNQTLDSYRNEIAYLNKLQQH 114
Query: 147 FLP--TLYATLDCPRWSCLLTEFCPGGDLH-VLRQRQPDKRFHESAVRFYASEVVVALEF 203
LY ++ ++ E C DL+ L+++ K + Y ++ A+
Sbjct: 115 SDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHT 170
Query: 204 LHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDC 263
+H GI++ DLKP N L+ DG + L DF ++ + T++
Sbjct: 171 IHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVK---------------- 213
Query: 264 AVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGT-----PEIVAEPLDVRSMSF 318
+S G PE + +
Sbjct: 214 --------DSQV--------------------------GAVNYMPPEAIKD--------- 230
Query: 319 VGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHEL-TLANVVARALEF 377
S D W+LG ++ + YG TPF+ I +++ L ++ E
Sbjct: 231 ---MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI 287
Query: 378 PKEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFN 419
+D++ L +DP +R + + H +
Sbjct: 288 EFPDIPEKDLQDVLKCCLKRDPKQR----ISIPELLAHPYVQ 325
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 2e-40
Identities = 75/319 (23%), Positives = 122/319 (38%), Gaps = 84/319 (26%)
Query: 90 LGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIERE--ILEMLDHPF 147
LG G G V + + +A KV++K +++ I RE +L+ LDHP
Sbjct: 30 LGKGSFGEVLKCKDRI----TQQEYAVKVINKASAKNKDTS---TILREVELLKKLDHPN 82
Query: 148 LPTLYATLDCPRWSCLLTEFCPGGDL-HVLRQRQPDKRFHESAVRFYASEVVVALEFLHM 206
+ L+ L+ ++ E GG+L + +R KRF E +V + ++H
Sbjct: 83 IMKLFEILEDSSSFYIVGELYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYMHK 139
Query: 207 MGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVD 266
I++RDLKPEN+L+ S + D +K +D
Sbjct: 140 HNIVHRDLKPENILLESK------EKDCDIK--------------------------IID 167
Query: 267 QPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTHEYLA 326
FG S+C N + +GT Y+A
Sbjct: 168 ---FGLSTCFQQN-----------------------------TKMK----DRIGTAYYIA 191
Query: 327 PEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEP--SVP 384
PE++ G + D W+ G+ ++ L GT PF G + L V F ++
Sbjct: 192 PEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTIS 250
Query: 385 GPAKDLIAQLLVKDPTRRM 403
AKDLI ++L P+ R+
Sbjct: 251 DDAKDLIRKMLTFHPSLRI 269
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 2e-40
Identities = 61/341 (17%), Positives = 113/341 (33%), Gaps = 90/341 (26%)
Query: 90 LGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREI--LEMLDHPF 147
+GSG V+ V + +A K ++ E + ++ EI L L
Sbjct: 17 IGSGGSSKVFQVL-----NEKKQIYAIKYVNLEEA---DNQTLDSYRNEIAYLNKLQQHS 68
Query: 148 LP--TLYATLDCPRWSCLLTEFCPGGDLH-VLRQRQPDKRFHESAVRFYASEVVVALEFL 204
LY ++ ++ E C DL+ L+++ K + Y ++ A+ +
Sbjct: 69 DKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTI 124
Query: 205 HMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCA 264
H GI++ DLKP N L+ DG + L DF ++ + T++
Sbjct: 125 HQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVK----------------- 166
Query: 265 VDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGT-----PEIVAEPLDVRSMSFV 319
+S GT PE + +
Sbjct: 167 -------DSQV--------------------------GTVNYMPPEAIKDMS-------- 185
Query: 320 GTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHEL-TLANVVARALEFP 378
S D W+LG ++ + YG TPF+ I +++ L ++ E
Sbjct: 186 ----SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIE 241
Query: 379 KEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFN 419
+D++ L +DP +R + + H +
Sbjct: 242 FPDIPEKDLQDVLKCCLKRDPKQR----ISIPELLAHPYVQ 278
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 4e-40
Identities = 69/354 (19%), Positives = 116/354 (32%), Gaps = 84/354 (23%)
Query: 64 KEATSEGNNNNNNNPLTLS----DLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVM 119
S G N + F+ +LG G V LV+ +G F+A K +
Sbjct: 7 HHHHSSGRENLYFQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLH----DGHFYALKRI 62
Query: 120 DKRELVSRNKESRARIEREILEMLDHPFLPTLY-ATLDCPRWS---CLLTEFCPGGDL-- 173
E R + A+ E ++ + +HP + L L LL F G L
Sbjct: 63 LCHEQQDREE---AQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWN 119
Query: 174 HVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFD 233
+ R + E + + + LE +H G +RDLKP N I+L D +
Sbjct: 120 EIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTN--------ILLGD-E 170
Query: 234 LSLK-GDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKR 292
D G+ + +C+H +
Sbjct: 171 GQPVLMD------------------------------LGSMN----------QACIHVEG 190
Query: 293 RRKKKLGNPGTPEIVAEPLDVRSMSFVGTHEYLAPEIISGEGH---GNAVDWWTLGIFIF 349
R + + + T Y APE+ S + H D W+LG ++
Sbjct: 191 SR----------QALTLQDWA---AQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLY 237
Query: 350 ELFYGTTPFKGID-HELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDPTRR 402
+ +G P+ + ++A V L P+ P L+ ++ DP +R
Sbjct: 238 AMMFGEGPYDMVFQKGDSVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQR 291
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 2e-39
Identities = 77/369 (20%), Positives = 130/369 (35%), Gaps = 89/369 (24%)
Query: 48 HHAPPRCNDDPCWKAIKEATSEGNNNNNNNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKS 107
HH + A + G V +LGSG G V L + K+
Sbjct: 2 HHHHHHSSGRENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKN-- 59
Query: 108 SNNGCFFAAKVMDKRELVSR--------NKESRARIERE--ILEMLDHPFLPTLYATLDC 157
A KV+ K + ++ I E +L+ LDHP + L+ +
Sbjct: 60 --GHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFED 117
Query: 158 PRWSCLLTEFCPGGDL-HVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKP 216
++ L+TEF GG+L + R +F E +++ + +LH I++RD+KP
Sbjct: 118 KKYFYLVTEFYEGGELFEQIINR---HKFDECDAANIMKQILSGICYLHKHNIVHRDIKP 174
Query: 217 ENVLVRSDGHIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCI 276
EN+L+ + + L++K VD FG SS
Sbjct: 175 ENILLENK------NSLLNIK--------------------------IVD---FGLSSFF 199
Query: 277 IPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTHEYLAPEIISGEGHG 336
D + +GT Y+APE++ + +
Sbjct: 200 SK---------------------------------DYKLRDRLGTAYYIAPEVLKKK-YN 225
Query: 337 NAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEP--SVPGPAKDLIAQL 394
D W+ G+ ++ L G PF G + + + V F ++ AK+LI +
Sbjct: 226 EKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNISDEAKELIKLM 285
Query: 395 LVKDPTRRM 403
L D +R
Sbjct: 286 LTYDYNKRC 294
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 1e-38
Identities = 53/346 (15%), Positives = 97/346 (28%), Gaps = 76/346 (21%)
Query: 78 PLTLSDLRFVHRLGSGDIGSVYLVQLK-SKSSNNGCFFAAKVMDKRELVSRNKESRARIE 136
L + H LG G VY + N F KV + +
Sbjct: 61 QLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQL 117
Query: 137 REILEMLDHPFLPTLYATLDCPRWSCLLTEFCPGGDLH---VLRQRQPDKRFHESAVRFY 193
E L+ Y+ S L+ E G L L + P+K + V +
Sbjct: 118 MERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISF 177
Query: 194 ASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQLVSDQSP 253
A ++ +E +H II+ D+KP+N ++ + +
Sbjct: 178 AMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFL------------------------EQD 213
Query: 254 PTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDV 313
D +D G S ++ P
Sbjct: 214 DEDDLSAGLALID---LGQSI------------------------------DMKLFPKGT 240
Query: 314 RSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPF-KGIDHELTLANVVA 372
+ T + E++S + +D++ + ++ + +GT K E +
Sbjct: 241 IFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFR 300
Query: 373 RALEFP-----------KEPSVPGPAKDLIAQLLVKDPTRRMGSKM 407
R P+ DL+ Q L K + +K+
Sbjct: 301 RLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKI 346
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 144 bits (363), Expect = 1e-38
Identities = 53/392 (13%), Positives = 92/392 (23%), Gaps = 119/392 (30%)
Query: 84 LRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREIL--- 140
L LG D + G F V E N + + E L
Sbjct: 80 LVRGTVLGQEDPYAYLEA----TDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLL 135
Query: 141 -------------------EMLDHPFLPTLYATLDCPRWSCLLTEF----CPGGDLHVL- 176
+++ P + R +L+ F +L
Sbjct: 136 RGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFG 195
Query: 177 ----RQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDF 232
K A +V+ L LH G+++ L+P ++++ G + LT F
Sbjct: 196 EVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGF 255
Query: 233 DLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKR 292
+ ++ S + P G F
Sbjct: 256 EHLVRDGASAVS---------PIG-----------RGFA--------------------- 274
Query: 293 RRKKKLGNPGTPEIVAEPLDVRSMSFVGTHEYLAPEIISGEGHGN-----AVDWWTLGIF 347
PE A ++ H A D WTLG+
Sbjct: 275 ----------PPETTA------------------ERMLPFGQHHPTLMTFAFDTWTLGLA 306
Query: 348 IFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDPTRRMGSKM 407
I+ ++ P + F ++P P + L+ L R +
Sbjct: 307 IYWIWCADLPNTDDAALGGSEWI------FRSCKNIPQPVRALLEGFLRYPKEDR----L 356
Query: 408 GATAIKRHQFFNGVNWALLRCAKPPFIPRPVT 439
+ + L T
Sbjct: 357 LPLQAMETPEYEQLRTELSAALPLYQTDGEPT 388
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 3e-36
Identities = 84/378 (22%), Positives = 145/378 (38%), Gaps = 109/378 (28%)
Query: 70 GNNNNNNNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNK 129
G++ ++ + + L+ +G G G V L + N+ ++A KV+ K++L+ +
Sbjct: 1 GSSGSSGDCVQLNQYTLKDEIGKGSYGVVKLA----YNENDNTYYAMKVLSKKKLIRQAG 56
Query: 130 ESR---------------------ARIEREI--LEMLDHPFLPTLYATLDCPRWS--CLL 164
R ++ +EI L+ LDHP + L LD P ++
Sbjct: 57 FPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMV 116
Query: 165 TEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSD 224
E G + + K E RFY +++ +E+LH II+RD+KP N+LV
Sbjct: 117 FELVNQGPVMEVPTL---KPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLV--- 170
Query: 225 GHIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPA 284
D +K ++D FG S N +
Sbjct: 171 ------GEDGHIK----------IAD-------------------FGVS-----NEFKGS 190
Query: 285 VSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTHEYLAPEIISGEG---HGNAVDW 341
+ L + VGT ++APE +S G A+D
Sbjct: 191 DALLS---------------------------NTVGTPAFMAPESLSETRKIFSGKALDV 223
Query: 342 WTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDPTR 401
W +G+ ++ +G PF + + ++ALEFP +P + KDLI ++L K+P
Sbjct: 224 WAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPES 283
Query: 402 RMGSKMGATAIKRHQFFN 419
R+ + IK H +
Sbjct: 284 RI--VV--PEIKLHPWVT 297
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 4e-36
Identities = 57/349 (16%), Positives = 112/349 (32%), Gaps = 88/349 (25%)
Query: 81 LSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREIL 140
++ + ++GSG+ GSV+ +GC +A K K S ++++ R
Sbjct: 10 TTEFHELEKIGSGEFGSVFKC----VKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHA 65
Query: 141 EMLDHPFLPTLYATLDCPRWS-----CLLTEFCPGGDLHVL--RQRQPDKRFHESAVRFY 193
+ H + ++ W+ + E+C GG L + F E+ ++
Sbjct: 66 VLGQHSHVVRYFSA-----WAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDL 120
Query: 194 ASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTS-TAQLVSDQS 252
+V L ++H M +++ D+KP N+ + + S ++
Sbjct: 121 LLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKI----- 175
Query: 253 PPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLD 312
GD G+ ++ +P
Sbjct: 176 ---GD------------LGHV----------------------TRISSP----------- 187
Query: 313 VRSMSFVGTHEYLAPEIISGE-GHGNAVDWWTLGIFIFELFYGTTPFKGID--HELTLAN 369
G +LA E++ H D + L + + + D HE+
Sbjct: 188 ---QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEI---- 240
Query: 370 VVARALEFPKEPSV-PGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQF 417
R P+ P V +L+ ++ DP RR A A+ +H
Sbjct: 241 ---RQGRLPRIPQVLSQEFTELLKVMIHPDPERR----PSAMALVKHSV 282
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 1e-35
Identities = 67/385 (17%), Positives = 114/385 (29%), Gaps = 128/385 (33%)
Query: 85 RFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLD 144
LG G +V+ + K G FA KV + E E+L+ L+
Sbjct: 12 LLSDILGQGATANVFRGRHKK----TGDLFAIKVFNNISF--LRPVDVQMREFEVLKKLN 65
Query: 145 HPFLPTLYATLDCP--RWSCLLTEFCPGGDL-HVLRQRQPDKRFHESAVRFYASEVVVAL 201
H + L+A + R L+ EFCP G L VL + ES +VV +
Sbjct: 66 HKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGM 125
Query: 202 EFLHMMGIIYRDLKPENVLVRS----DGHIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGD 257
L GI++R++KP N++ LTDF + + ++
Sbjct: 126 NHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE--------------- 170
Query: 258 QQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMS 317
S GT E +
Sbjct: 171 ------------QFVSLY--------------------------GTEEYLH--------- 183
Query: 318 FVGTHEYLAPEIISG--------EGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLAN 369
P++ + +G VD W++G+ + G+ PF+ +
Sbjct: 184 ---------PDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKE 234
Query: 370 VVARAL-----------------------EFPKEPSVPGPAKD----LIAQLLVKDPTRR 402
V+ + + + P S+ + ++A +L D +
Sbjct: 235 VMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKC 294
Query: 403 MGSKMGATAIKRHQFFNGVNWALLR 427
G QFF + L R
Sbjct: 295 WGFD---------QFFAETSDILHR 310
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 3e-35
Identities = 49/215 (22%), Positives = 78/215 (36%), Gaps = 11/215 (5%)
Query: 33 SGSNPSSSTPSAAKTHHAPPRCNDDPCWKAIKEATSEGNNNNNNNPLTLSDLRFVHRLGS 92
SG + + H PR +A + S G + + + + RLG
Sbjct: 9 SGVDLGTENLYFQSMHQLQPRRVSFRG-EASETLQSPGYDPSRPESFFQQSFQRLSRLGH 67
Query: 93 GDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEML-DHPFLPTL 151
G G V+ V +S +G +A K +++ R E E + HP L
Sbjct: 68 GSYGEVFKV----RSKEDGRLYAVKRSMSPFRGPKDRA-RKLAEVGSHEKVGQHPCCVRL 122
Query: 152 YATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIY 211
+ L TE C G L + E+ V Y + ++AL LH G+++
Sbjct: 123 EQAWEEGGILYLQTELC-GPSLQQHCEAWG-ASLPEAQVWGYLRDTLLALAHLHSQGLVH 180
Query: 212 RDLKPENVLVRSDGHIMLTDFDLS--LKGDNSTST 244
D+KP N+ + G L DF L L +
Sbjct: 181 LDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEV 215
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 1e-16
Identities = 24/106 (22%), Positives = 40/106 (37%), Gaps = 16/106 (15%)
Query: 317 SFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGID--HELTLANVVARA 374
G Y+APE++ G +G A D ++LG+ I E+ G + +L R
Sbjct: 215 VQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGWQQL-------RQ 266
Query: 375 LEFPKE--PSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFF 418
P E + + ++ +L DP R A A+
Sbjct: 267 GYLPPEFTAGLSSELRSVLVMMLEPDPKLR----ATAEALLALPVL 308
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 3e-34
Identities = 65/372 (17%), Positives = 111/372 (29%), Gaps = 118/372 (31%)
Query: 85 RFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIERE--ILEM 142
LG G +V+ + K G FA KV + RE +L+
Sbjct: 12 LLSDILGQGATANVFRGRHKK----TGDLFAIKVFNNISF----LRPVDVQMREFEVLKK 63
Query: 143 LDHPFLPTLYATLDCP--RWSCLLTEFCPGGDL-HVLRQRQPDKRFHESAVRFYASEVVV 199
L+H + L+A + R L+ EFCP G L VL + ES +VV
Sbjct: 64 LNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVG 123
Query: 200 ALEFLHMMGIIYRDLKPENVLVRS----DGHIMLTDFDLSLKGDNSTSTAQLVSDQSPPT 255
+ L GI++R++KP N++ LTDF + + ++
Sbjct: 124 GMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE------------- 170
Query: 256 GDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVA-EPLDVR 314
S GT E + + +
Sbjct: 171 --------------QFVSLY--------------------------GTEEYLHPDMYERA 190
Query: 315 SMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVAR- 373
+ +Y G VD W++G+ + G+ PF+ + V+ +
Sbjct: 191 VLRKDHQKKY-----------GATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI 239
Query: 374 ----------------------ALEFPKEPSVPGPAKD----LIAQLLVKDPTRRMGSKM 407
+ + P S+ + ++A +L D + G
Sbjct: 240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFD- 298
Query: 408 GATAIKRHQFFN 419
QFF
Sbjct: 299 --------QFFA 302
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 1e-33
Identities = 69/341 (20%), Positives = 119/341 (34%), Gaps = 90/341 (26%)
Query: 85 RFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREI--LEM 142
V LG G G V L + A K++D + V + I++EI +M
Sbjct: 10 DLVQTLGEGAYGEVQLA----VNRVTEEAVAVKIVDMKRAV----DCPENIKKEICINKM 61
Query: 143 LDHPFLPTLYATLDCPRWSCLLTEFCPGGDL--HVLRQRQPDKRFHESAVRFYASEVVVA 200
L+H + Y L E+C GG+L + PD E + + +++
Sbjct: 62 LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE----PDIGMPEPDAQRFFHQLMAG 117
Query: 201 LEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQP 260
+ +LH +GI +RD+KPEN+L+ D +LK +SD
Sbjct: 118 VVYLHGIGITHRDIKPENLLL---------DERDNLK----------ISD---------- 148
Query: 261 NDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVG 320
FG L L+ G
Sbjct: 149 ---------FG--------------------------LATVFRYNNRERLLN----KMCG 169
Query: 321 THEYLAPEIISGEG-HGNAVDWWTLGIFIFELFYGTTPFKGIDHEL-TLANVVARALEFP 378
T Y+APE++ H VD W+ GI + + G P+ ++ +
Sbjct: 170 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLN 229
Query: 379 KEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFN 419
+ L+ ++LV++P+ R+ IK+ +++N
Sbjct: 230 PWKKIDSAPLALLHKILVENPSARITIP----DIKKDRWYN 266
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 6e-33
Identities = 72/379 (18%), Positives = 131/379 (34%), Gaps = 95/379 (25%)
Query: 85 RFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREI--LEM 142
V LG G G V L + A K++D + V + I++EI +M
Sbjct: 10 DLVQTLGEGAYGEVQLA----VNRVTEEAVAVKIVDMKRAV----DCPENIKKEICINKM 61
Query: 143 LDHPFLPTLYATLDCPRWSCLLTEFCPGGDL--HVLRQRQPDKRFHESAVRFYASEVVVA 200
L+H + Y L E+C GG+L + PD E + + +++
Sbjct: 62 LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE----PDIGMPEPDAQRFFHQLMAG 117
Query: 201 LEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQP 260
+ +LH +GI +RD+KPEN+L+ D +LK +SD
Sbjct: 118 VVYLHGIGITHRDIKPENLLL---------DERDNLK----------ISD---------- 148
Query: 261 NDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVG 320
FG L L+ G
Sbjct: 149 ---------FG--------------------------LATVFRYNNRERLLN----KMCG 169
Query: 321 THEYLAPEIISGEG-HGNAVDWWTLGIFIFELFYGTTPFKGIDHEL-TLANVVARALEFP 378
T Y+APE++ H VD W+ GI + + G P+ ++ +
Sbjct: 170 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLN 229
Query: 379 KEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFN-GVNWALLRCAKPPFIPRP 437
+ L+ ++LV++P+ R+ IK+ +++N + K P +
Sbjct: 230 PWKKIDSAPLALLHKILVENPSARITIP----DIKKDRWYNKPLKKGA----KRPRVTSG 281
Query: 438 VTCRDLTTTNSSIDNSIEY 456
+ + I +++++
Sbjct: 282 GVSESPSGFSKHIQSNLDF 300
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-32
Identities = 77/335 (22%), Positives = 132/335 (39%), Gaps = 92/335 (27%)
Query: 90 LGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREI--LEMLDHPF 147
LG G G V + + G A K+++++++ S + + I+REI L++ HP
Sbjct: 19 LGVGTFGKVKI----GEHQLTGHKVAVKILNRQKIRSLDVVGK--IKREIQNLKLFRHPH 72
Query: 148 LPTLYATLDCPRWSCLLTEFCPGGDL--HVLRQRQPDKRFHESAVRFYASEVVVALEFLH 205
+ LY + P ++ E+ GG+L ++ + R E R +++ A+++ H
Sbjct: 73 IIKLYQVISTPTDFFMVMEYVSGGELFDYICKH----GRVEEMEARRLFQQILSAVDYCH 128
Query: 206 MMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAV 265
+++RDLKPENVL+ D ++ K ++D
Sbjct: 129 RHMVVHRDLKPENVLL---------DAHMNAK----------IAD--------------- 154
Query: 266 DQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTHEYL 325
FG S+ + + SC G+P Y
Sbjct: 155 ----FGLSNMMSDGEFL-RTSC--------------GSPN------------------YA 177
Query: 326 APEIISGEG-HGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVP 384
APE+ISG G VD W+ G+ ++ L GT PF +H TL + F +
Sbjct: 178 APEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDD-EHVPTLFKKIRGG-VFYIPEYLN 235
Query: 385 GPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFN 419
L+ +L DP +R K I+ H++F
Sbjct: 236 RSVATLLMHMLQVDPLKRATIK----DIREHEWFK 266
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 3e-32
Identities = 75/342 (21%), Positives = 117/342 (34%), Gaps = 102/342 (29%)
Query: 90 LGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEML----DH 145
LG G V +A K+++K+ R+R+ RE+ EML H
Sbjct: 21 LGEGAHARVQTCINLI----TSQEYAVKIIEKQPG-----HIRSRVFREV-EMLYQCQGH 70
Query: 146 PFLPTLYATLDCPRWSCLLTEFCPGGDL--HVLRQRQPDKRFHESAVRFYASEVVVALEF 203
+ L + L+ E GG + H+ ++ + F+E +V AL+F
Sbjct: 71 RNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKR----RHFNELEASVVVQDVASALDF 126
Query: 204 LHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDC 263
LH GI +RDLKPEN+L +K + D
Sbjct: 127 LHNKGIAHRDLKPENILCEHPNQ------VSPVK----------ICD------------- 157
Query: 264 AVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTHE 323
F S I N I L ++ G+ E
Sbjct: 158 ------FDLGSGIKLN---------------------GDCSPISTPEL----LTPCGSAE 186
Query: 324 YLAPEIISG-----EGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARA---- 374
Y+APE++ + D W+LG+ ++ L G PF G +
Sbjct: 187 YMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQ 246
Query: 375 -----------LEFPKEP--SVPGPAKDLIAQLLVKDPTRRM 403
EFP + + AKDLI++LLV+D +R+
Sbjct: 247 NMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRL 288
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 4e-31
Identities = 37/175 (21%), Positives = 80/175 (45%), Gaps = 5/175 (2%)
Query: 72 NNNNNNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKES 131
N ++ + ++G G G LV+ +G + K ++ + S+ +E
Sbjct: 14 GTENLYFQSMEKYVRLQKIGEGSFGKAILVKSTE----DGRQYVIKEINISRMSSKEREE 69
Query: 132 RARIEREILEMLDHPFLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVR 191
+R E +L + HP + + + ++ ++C GGDL Q F E +
Sbjct: 70 -SRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQIL 128
Query: 192 FYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQ 246
+ ++ +AL+ +H I++RD+K +N+ + DG + L DF ++ +++ A+
Sbjct: 129 DWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELAR 183
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 7e-15
Identities = 24/103 (23%), Positives = 43/103 (41%), Gaps = 7/103 (6%)
Query: 317 SFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALE 376
+ +GT YL+PEI + + N D W LG ++EL F+ + + +++
Sbjct: 184 ACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISG--S 241
Query: 377 FPKEPS-VPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFF 418
FP + L++QL ++P R +I F
Sbjct: 242 FPPVSLHYSYDLRSLVSQLFKRNPRDR----PSVNSILEKGFI 280
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 4e-29
Identities = 80/335 (23%), Positives = 135/335 (40%), Gaps = 93/335 (27%)
Query: 90 LGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREI--LEMLDHPF 147
LG G G V L + A K + ++ L + R +EREI L++L HP
Sbjct: 17 LGEGSFGKVKL----ATHYKTQQKVALKFISRQLLKKSDMHMR--VEREISYLKLLRHPH 70
Query: 148 LPTLYATLDCPRWSCLLTEFCPGGDL--HVLRQRQPDKRFHESAVRFYASEVVVALEFLH 205
+ LY + P ++ E+ GG+L +++ + KR E R + +++ A+E+ H
Sbjct: 71 IIKLYDVITTPTDIVMVIEYA-GGELFDYIVEK----KRMTEDEGRRFFQQIICAIEYCH 125
Query: 206 MMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAV 265
I++RDLKPEN+ L D +L++K ++D
Sbjct: 126 RHKIVHRDLKPENL---------LLDDNLNVK----------IAD--------------- 151
Query: 266 DQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTHEYL 325
FG S+ + + SC G+P Y
Sbjct: 152 ----FGLSNIMTDGNFL-KTSC--------------GSPN------------------YA 174
Query: 326 APEIISGEG-HGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVP 384
APE+I+G+ G VD W+ GI ++ + G PF + L V + +
Sbjct: 175 APEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDD-EFIPNLFKKVNSC-VYVMPDFLS 232
Query: 385 GPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFN 419
A+ LI +++V DP +R+ + I+R +FN
Sbjct: 233 PGAQSLIRRMIVADPMQRITIQ----EIRRDPWFN 263
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 7e-29
Identities = 66/356 (18%), Positives = 116/356 (32%), Gaps = 87/356 (24%)
Query: 71 NNNNNNNPLTLSDLRFV--HRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRN 128
+ + + + + + F LG G G++ + + A K +
Sbjct: 11 DGDEETSVVIVGKISFCPKDVLGHGAEGTIVY-----RGMFDNRDVAVKRILPE------ 59
Query: 129 KESRARIEREILEMLD-HPFLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHE 187
S A E ++L D HP + + T ++ + E C L + Q D
Sbjct: 60 CFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC-AATLQEYVE-QKDFAHLG 117
Query: 188 SAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQL 247
+ L LH + I++RDLKP N+L+ + A +
Sbjct: 118 LEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISM-------------PNAHGKIKA-M 163
Query: 248 VSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIV 307
+SD FG KKL
Sbjct: 164 ISD-------------------FGLC----------------------KKLAVG------ 176
Query: 308 AEPLDVRSMSFVGTHEYLAPEIISGEGHGN---AVDWWTLG-IFIFELFYGTTPFKGIDH 363
R GT ++APE++S + N VD ++ G +F + + G+ PF
Sbjct: 177 -RHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQ 235
Query: 364 ELTLANVVARALEFPKEPSVPGP-AKDLIAQLLVKDPTRRMGSKMGATAIKRHQFF 418
+ A +L+ A++LI +++ DP +R A + +H FF
Sbjct: 236 RQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKR----PSAKHVLKHPFF 287
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 9e-29
Identities = 65/399 (16%), Positives = 120/399 (30%), Gaps = 91/399 (22%)
Query: 22 TNSGSETTWTTSGSNPSSSTPSAAKTHHAPPRCNDDPCWKAIKEATSEGNNNNNNNPLTL 81
+ S S + S + + +AK P D+ T + + +
Sbjct: 2 SGSVSSGQAHSLASLAKTWSSGSAKLQRLGPETEDN----EGVLLTEKLKPVDYEYREEV 57
Query: 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILE 141
+ R+G G G V+ + K G A K + E
Sbjct: 58 HWMTHQPRVGRGSFGEVH----RMKDKQTGFQCAVKKVRLEVFRVE--------ELVACA 105
Query: 142 MLDHPFLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVAL 201
L P + LY + W + E GG L L ++ E +Y + + L
Sbjct: 106 GLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQM--GCLPEDRALYYLGQALEGL 163
Query: 202 EFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPN 261
E+LH I++ D+K +N ++L+ + D
Sbjct: 164 EYLHTRRILHGDVKADN--------VLLSSDGSRAA----------LCD----------- 194
Query: 262 DCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGT 321
FG++ C+ P+ + ++ GT
Sbjct: 195 --------FGHALCLQPDGLGKSLL---------------------------TGDYIPGT 219
Query: 322 HEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEP 381
++APE++ G+ VD W+ + + G P+ + + + P
Sbjct: 220 ETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIP 279
Query: 382 SVPGP-AKDLIAQLLVKDPTRRMGSKMGATAIK--RHQF 417
P I + L K+P R A+A++ R
Sbjct: 280 PSCAPLTAQAIQEGLRKEPVHR------ASAMELRRKVG 312
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 1e-28
Identities = 75/336 (22%), Positives = 119/336 (35%), Gaps = 92/336 (27%)
Query: 90 LGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREI--LEMLDHPF 147
LG G G VY + +N A K + +R + + EI + L H
Sbjct: 30 LGKGTYGIVY----AGRDLSNQVRIAIKEIPER-----DSRYSQPLHEEIALHKHLKHKN 80
Query: 148 LPTLYATLDCPRWSCLLTEFCPGGDLH-VLRQRQPDKRFHESAVRFYASEVVVALEFLHM 206
+ + + + E PGG L +LR + + +E + FY +++ L++LH
Sbjct: 81 IVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHD 140
Query: 207 MGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVD 266
I++RD+K +N +++ + LK +SD
Sbjct: 141 NQIVHRDIKGDN--------VLINTYSGVLK----------ISD---------------- 166
Query: 267 QPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTHEYLA 326
FG S K+L + +F GT +Y+A
Sbjct: 167 ---FGTS----------------------KRLAGINP----------CTETFTGTLQYMA 191
Query: 327 PEII--SGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEP-SV 383
PEII G+G A D W+LG I E+ G PF + V P+ P S+
Sbjct: 192 PEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESM 251
Query: 384 PGPAKDLIAQLLVKDPTRRMGSKMGATAIK--RHQF 417
AK I + DP +R A A +F
Sbjct: 252 SAEAKAFILKCFEPDPDKR------ACANDLLVDEF 281
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-28
Identities = 35/186 (18%), Positives = 68/186 (36%), Gaps = 29/186 (15%)
Query: 77 NPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIE 136
+ D + + +GSG G V+ + + +G + K + +A E
Sbjct: 6 DKRFGMDFKEIELIGSGGFGQVFKAKHRI----DGKTYVIKRVKY-------NNEKAERE 54
Query: 137 REILEMLDHP--------FLPTLYATLDCPRWS--------CLLTEFCPGGDLHVLRQRQ 180
+ L LDH + Y + S + EFC G L +++
Sbjct: 55 VKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR 114
Query: 181 PDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS--LKG 238
++ + ++ ++++H +I RDLKP N+ + + + DF L LK
Sbjct: 115 RGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKN 174
Query: 239 DNSTST 244
D +
Sbjct: 175 DGKRTR 180
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 1e-15
Identities = 24/107 (22%), Positives = 37/107 (34%), Gaps = 10/107 (9%)
Query: 312 DVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVV 371
D + GT Y++PE IS + +G VD + LG+ + EL +
Sbjct: 175 DGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS------KFF 228
Query: 372 ARALEFPKEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFF 418
+ K L+ +LL K P R + I R
Sbjct: 229 TDLRDGIISDIFDKKEKTLLQKLLSKKPEDR----PNTSEILRTLTV 271
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 1e-28
Identities = 41/187 (21%), Positives = 78/187 (41%), Gaps = 6/187 (3%)
Query: 62 AIKEATSEGNNNNNNNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDK 121
+ + + + TL++ R ++G G VY +G A K +
Sbjct: 12 PVPQFQPQKALRPDMGYNTLANFRIEKKIGRGQFSEVYRA----ACLLDGVPVALKKVQI 67
Query: 122 RELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWSCLLTEFCPGGDLHVL--RQR 179
+L+ + E ++L+ L+HP + YA+ ++ E GDL + +
Sbjct: 68 FDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFK 127
Query: 180 QPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGD 239
+ + E V Y ++ ALE +H +++RD+KP NV + + G + L D L
Sbjct: 128 KQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS 187
Query: 240 NSTSTAQ 246
+ T+ A
Sbjct: 188 SKTTAAH 194
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 4e-13
Identities = 25/90 (27%), Positives = 44/90 (48%), Gaps = 6/90 (6%)
Query: 317 SFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARAL- 375
S VGT Y++PE I G+ D W+LG ++E+ +PF G ++ L ++ +
Sbjct: 195 SLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG--DKMNLYSLCKKIEQ 252
Query: 376 -EFPKEPS--VPGPAKDLIAQLLVKDPTRR 402
++P PS + L+ + DP +R
Sbjct: 253 CDYPPLPSDHYSEELRQLVNMCINPDPEKR 282
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-28
Identities = 42/178 (23%), Positives = 78/178 (43%), Gaps = 14/178 (7%)
Query: 78 PLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIER 137
P D ++ +G+G G ++ KS +G K +D + K+ E
Sbjct: 2 PSRAEDYEVLYTIGTGSYGRCQKIRRKS----DGKILVWKELDYGSMTEAEKQM-LVSEV 56
Query: 138 EILEMLDHPFLPTLYATLDCPRWS--CLLTEFCPGGDLHVL--RQRQPDKRFHESAVRFY 193
+L L HP + Y + + ++ E+C GGDL + + + + E V
Sbjct: 57 NLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRV 116
Query: 194 ASEVVVALEFLH-----MMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQ 246
+++ +AL+ H +++RDLKP NV + ++ L DF L+ ++ TS A+
Sbjct: 117 MTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAK 174
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 5e-14
Identities = 27/107 (25%), Positives = 46/107 (42%), Gaps = 4/107 (3%)
Query: 297 KLGNPGTPEIVAEPLDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTT 356
KLG+ G I+ +FVGT Y++PE ++ + D W+LG ++EL
Sbjct: 156 KLGDFGLARILNHDTSFAK-TFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMP 214
Query: 357 PFKGIDHELTLANVVARALEFPKEPSV-PGPAKDLIAQLLVKDPTRR 402
PF + LA + +F + P ++I ++L R
Sbjct: 215 PFTAFSQK-ELAGKIREG-KFRRIPYRYSDELNEIITRMLNLKDYHR 259
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-28
Identities = 34/154 (22%), Positives = 67/154 (43%), Gaps = 19/154 (12%)
Query: 90 LGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIERE--ILEMLDHPF 147
LG G+ G V+ S + + AK + + + +++E IL + H
Sbjct: 13 LGRGEFGIVHRCVETS----SKKTYMAKFVKVK------GTDQVLVKKEISILNIARHRN 62
Query: 148 LPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFH--ESAVRFYASEVVVALEFLH 205
+ L+ + + ++ EF G D+ +R F E + Y +V AL+FLH
Sbjct: 63 ILHLHESFESMEELVMIFEFISGLDIF---ERINTSAFELNEREIVSYVHQVCEALQFLH 119
Query: 206 MMGIIYRDLKPENVLVRS--DGHIMLTDFDLSLK 237
I + D++PEN++ ++ I + +F + +
Sbjct: 120 SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQ 153
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 2e-18
Identities = 25/87 (28%), Positives = 40/87 (45%), Gaps = 2/87 (2%)
Query: 319 VGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFP 378
EY APE+ + A D W+LG ++ L G PF ++ + N++ F
Sbjct: 164 FTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFD 223
Query: 379 KEP--SVPGPAKDLIAQLLVKDPTRRM 403
+E + A D + +LLVK+ RM
Sbjct: 224 EEAFKEISIEAMDFVDRLLVKERKSRM 250
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 4e-28
Identities = 46/154 (29%), Positives = 69/154 (44%), Gaps = 15/154 (9%)
Query: 90 LGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVS-RNKESRARIERE--ILEMLDHP 146
LGSG V + K G +AAK + KR L S R SR IERE IL + HP
Sbjct: 13 LGSGQFAIVRKCRQKG----TGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHP 68
Query: 147 FLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQR-QPDKRFHESAVRFYASEVVVALEFLH 205
+ TL+ + L+ E GG+L + E + +++ + +LH
Sbjct: 69 NIITLHDIFENKTDVVLILELVSGGELF---DFLAEKESLTEDEATQFLKQILDGVHYLH 125
Query: 206 MMGIIYRDLKPENVLVRS----DGHIMLTDFDLS 235
I + DLKPEN+++ + I L DF ++
Sbjct: 126 SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA 159
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 87.6 bits (218), Expect = 1e-19
Identities = 36/88 (40%), Positives = 51/88 (57%), Gaps = 2/88 (2%)
Query: 318 FVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEF 377
GT E++APEI++ E G D W++G+ + L G +PF G + TL N+ A +F
Sbjct: 171 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDF 230
Query: 378 PKEP--SVPGPAKDLIAQLLVKDPTRRM 403
+E + AKD I +LLVKDP RRM
Sbjct: 231 DEEYFSNTSELAKDFIRRLLVKDPKRRM 258
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 6e-28
Identities = 75/367 (20%), Positives = 127/367 (34%), Gaps = 91/367 (24%)
Query: 72 NNNNNNPLTLSDLRFVHR-LGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKE 130
N N +L +L + LG G G+V + S G A K M
Sbjct: 4 ANIPNFEQSLKNLVVSEKILGYGSSGTVVF-----QGSFQGRPVAVKRMLID------FC 52
Query: 131 SRARIEREIL-EMLDHPFLPTLYATLDCPRWSCLLTEFCPGGDLHVL-----RQRQPDKR 184
A +E ++L E DHP + Y + R+ + E C +L L + K
Sbjct: 53 DIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKL 111
Query: 185 FHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTST 244
E ++ + LH + II+RDLKP+N+LV + + + + + +
Sbjct: 112 QKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVST------SSRFTADQQTGAENL 165
Query: 245 AQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTP 304
L+SD FG KKL + +
Sbjct: 166 RILISD-------------------FGLC----------------------KKLDSGQSS 184
Query: 305 EIVAEPLDVRSMSFVGTHEYLAPEIISGEGH-------GNAVDWWTLG-IFIFELFYGTT 356
+ GT + APE++ + ++D +++G +F + L G
Sbjct: 185 ------FRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH 238
Query: 357 PFKGIDHELTLANVVARALEFPKEPSVPGP-----AKDLIAQLLVKDPTRRMGSKMGATA 411
PF D +N++ + + A DLI+Q++ DP +R A
Sbjct: 239 PFG--DKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKR----PTAMK 292
Query: 412 IKRHQFF 418
+ RH F
Sbjct: 293 VLRHPLF 299
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 7e-28
Identities = 47/154 (30%), Positives = 69/154 (44%), Gaps = 15/154 (9%)
Query: 90 LGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELV-SRNKESRARIERE--ILEMLDHP 146
LGSG V + KS G +AAK + KR+ SR SR IERE IL + H
Sbjct: 20 LGSGQFAIVKKCREKS----TGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHH 75
Query: 147 FLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQR-QPDKRFHESAVRFYASEVVVALEFLH 205
+ TL+ + L+ E GG+L + E + +++ + +LH
Sbjct: 76 NVITLHDVYENRTDVVLILELVSGGELF---DFLAQKESLSEEEATSFIKQILDGVNYLH 132
Query: 206 MMGIIYRDLKPENVLVRS----DGHIMLTDFDLS 235
I + DLKPEN+++ HI L DF L+
Sbjct: 133 TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 2e-19
Identities = 32/88 (36%), Positives = 51/88 (57%), Gaps = 2/88 (2%)
Query: 318 FVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEF 377
GT E++APEI++ E G D W++G+ + L G +PF G + TLAN+ + + +F
Sbjct: 178 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDF 237
Query: 378 PKEP--SVPGPAKDLIAQLLVKDPTRRM 403
+E AKD I +LLVK+ +R+
Sbjct: 238 DEEFFSHTSELAKDFIRKLLVKETRKRL 265
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 7e-28
Identities = 47/156 (30%), Positives = 71/156 (45%), Gaps = 15/156 (9%)
Query: 90 LGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELV-SRNKESRARIERE--ILEMLDHP 146
LGSG V + KS G +AAK + KR SR SR IERE IL+ + HP
Sbjct: 19 LGSGQFAVVKKCREKS----TGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHP 74
Query: 147 FLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQR-QPDKRFHESAVRFYASEVVVALEFLH 205
+ TL+ + L+ E GG+L + E + +++ + +LH
Sbjct: 75 NVITLHEVYENKTDVILILELVAGGELF---DFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 206 MMGIIYRDLKPENVLVRS----DGHIMLTDFDLSLK 237
+ I + DLKPEN+++ I + DF L+ K
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 167
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 4e-19
Identities = 38/88 (43%), Positives = 51/88 (57%), Gaps = 2/88 (2%)
Query: 318 FVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEF 377
GT E++APEI++ E G D W++G+ + L G +PF G + TLANV A EF
Sbjct: 177 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEF 236
Query: 378 PKEP--SVPGPAKDLIAQLLVKDPTRRM 403
E + AKD I +LLVKDP +RM
Sbjct: 237 EDEYFSNTSALAKDFIRRLLVKDPKKRM 264
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 8e-28
Identities = 43/157 (27%), Positives = 76/157 (48%), Gaps = 7/157 (4%)
Query: 80 TLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREI 139
+ D + + LG G VY +S + G A K++DK+ + R + E +I
Sbjct: 9 KIEDFKVGNLLGKGSFAGVYRA----ESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKI 64
Query: 140 LEMLDHPFLPTLYATLDCPRWSCLLTEFCPGGDL-HVLRQRQPDKRFHESAVRFYASEVV 198
L HP + LY + + L+ E C G++ L+ R K F E+ R + +++
Sbjct: 65 HCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRV--KPFSENEARHFMHQII 122
Query: 199 VALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235
+ +LH GI++RDL N+L+ + +I + DF L+
Sbjct: 123 TGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLA 159
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 94.9 bits (237), Expect = 4e-22
Identities = 34/100 (34%), Positives = 48/100 (48%), Gaps = 6/100 (6%)
Query: 320 GTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPK 379
GT Y++PEI + HG D W+LG + L G PF + TL VV E P
Sbjct: 174 GTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMP- 232
Query: 380 EPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFN 419
+ AKDLI QLL ++P R + +++ H F +
Sbjct: 233 -SFLSIEAKDLIHQLLRRNPADR----LSLSSVLDHPFMS 267
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 5e-27
Identities = 62/331 (18%), Positives = 107/331 (32%), Gaps = 98/331 (29%)
Query: 81 LSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIERE-- 138
++ +G G G V K+ A K + ++ R E
Sbjct: 7 YKEIEVEEVVGRGAFGVVC------KAKWRAKDVAIKQI-------ESESERKAFIVELR 53
Query: 139 ILEMLDHPFLPTLYATLDCPRWSCLLTEFCPGGDLH-VLRQRQPDKRFHESAVRFYASEV 197
L ++HP + LY C CL+ E+ GG L+ VL +P + + + +
Sbjct: 54 QLSRVNHPNIVKLYGA--CLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQC 111
Query: 198 VVALEFLHMM---GIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQLVSDQSPP 254
+ +LH M +I+RDLKP N ++L LK + D
Sbjct: 112 SQGVAYLHSMQPKALIHRDLKPPN--------LLLVAGGTVLK----------ICD---- 149
Query: 255 TGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVR 314
FG ++C I
Sbjct: 150 ---------------FG-TACDIQT----------------------------------H 159
Query: 315 SMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARA 374
+ G+ ++APE+ G + D ++ GI ++E+ PF I
Sbjct: 160 MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHN 219
Query: 375 ---LEFPKEPSVPGPAKDLIAQLLVKDPTRR 402
K ++P P + L+ + KDP++R
Sbjct: 220 GTRPPLIK--NLPKPIESLMTRCWSKDPSQR 248
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 6e-27
Identities = 43/153 (28%), Positives = 76/153 (49%), Gaps = 15/153 (9%)
Query: 90 LGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIERE--ILEMLDHPF 147
LGSG G V+LV+ +S +G K ++K R++ +IE E +L+ LDHP
Sbjct: 30 LGSGAFGDVHLVEERS----SGLERVIKTINKD----RSQVPMEQIEAEIEVLKSLDHPN 81
Query: 148 LPTLYATLDCPRWSCLLTEFCPGGDL--HVLRQRQPDKRFHESAVRFYASEVVVALEFLH 205
+ ++ + ++ E C GG+L ++ + K E V +++ AL + H
Sbjct: 82 IIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH 141
Query: 206 MMGIIYRDLKPENVLVRS---DGHIMLTDFDLS 235
++++DLKPEN+L + I + DF L+
Sbjct: 142 SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLA 174
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 5e-16
Identities = 26/88 (29%), Positives = 39/88 (44%), Gaps = 2/88 (2%)
Query: 317 SFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALE 376
+ GT Y+APE+ + D W+ G+ ++ L G PF G E +
Sbjct: 185 NAAGTALYMAPEVFKRD-VTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPN 243
Query: 377 FPKEP-SVPGPAKDLIAQLLVKDPTRRM 403
+ E + A DL+ Q+L KDP RR
Sbjct: 244 YAVECRPLTPQAVDLLKQMLTKDPERRP 271
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-26
Identities = 62/329 (18%), Positives = 117/329 (35%), Gaps = 88/329 (26%)
Query: 81 LSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREIL 140
DL ++G+G G+V+ ++ +G A K++ +++ + R E I+
Sbjct: 36 WCDLNIKEKIGAGSFGTVH------RAEWHGSDVAVKILMEQDFHAERVNEFLR-EVAIM 88
Query: 141 EMLDHPFLPTLY-ATLDCPRWSCLLTEFCPGGDLH-VLRQRQPDKRFHESAVRFYASEVV 198
+ L HP + A P ++TE+ G L+ +L + ++ E A +V
Sbjct: 89 KRLRHPNIVLFMGAVTQPPNL-SIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVA 147
Query: 199 VALEFLHMMG--IIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQLVSDQSPPTG 256
+ +LH I++R+LK N+ L D ++K V D
Sbjct: 148 KGMNYLHNRNPPIVHRNLKSPNL---------LVDKKYTVK----------VCD------ 182
Query: 257 DQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSM 316
FG +S L + S
Sbjct: 183 -------------FG-------------LSRLKAST-------------------FLSSK 197
Query: 317 SFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARA-- 374
S GT E++APE++ E D ++ G+ ++EL P+ ++ + V
Sbjct: 198 SAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNP-AQVVAAVGFKCK 256
Query: 375 -LEFPKEPSVPGPAKDLIAQLLVKDPTRR 402
LE P+ ++ +I +P +R
Sbjct: 257 RLEIPR--NLNPQVAAIIEGCWTNEPWKR 283
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 3e-26
Identities = 48/170 (28%), Positives = 77/170 (45%), Gaps = 16/170 (9%)
Query: 85 RFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIERE--ILEM 142
V LG G G V + + +A KV++K +++ I RE +L+
Sbjct: 25 NIVCMLGKGSFGEVLKCKDRI----TQQEYAVKVINKASAKNKDTS---TILREVELLKK 77
Query: 143 LDHPFLPTLYATLDCPRWSCLLTEFCPGGDL-HVLRQRQPDKRFHESAVRFYASEVVVAL 201
LDHP + L+ L+ ++ E GG+L + +R KRF E +V +
Sbjct: 78 LDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGI 134
Query: 202 EFLHMMGIIYRDLKPENVLVRS---DGHIMLTDFDLSLKGDNSTSTAQLV 248
++H I++RDLKPEN+L+ S D I + DF LS +T +
Sbjct: 135 TYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI 184
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 1e-15
Identities = 27/89 (30%), Positives = 43/89 (48%), Gaps = 3/89 (3%)
Query: 317 SFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALE 376
+GT Y+APE++ G + D W+ G+ ++ L GT PF G + L V
Sbjct: 182 DRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYA 240
Query: 377 FPKEP--SVPGPAKDLIAQLLVKDPTRRM 403
F ++ AKDLI ++L P+ R+
Sbjct: 241 FDLPQWRTISDDAKDLIRKMLTFHPSLRI 269
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 4e-26
Identities = 41/152 (26%), Positives = 77/152 (50%), Gaps = 16/152 (10%)
Query: 90 LGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIERE--ILEMLDHPF 147
LG G V K+ G FAAK+++ ++L +R+ + ++ERE I L HP
Sbjct: 14 LGKGAFSVVRRCVHKT----TGLEFAAKIINTKKLSARDFQ---KLEREARICRKLQHPN 66
Query: 148 LPTLYATLDCPRWSCLLTEFCPGGDL-HVLRQRQPDKRFHESAVRFYASEVVVALEFLHM 206
+ L+ ++ + L+ + GG+L + R + + E+ +++ ++ + H
Sbjct: 67 IVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR---EFYSEADASHCIQQILESIAYCHS 123
Query: 207 MGIIYRDLKPENVLVRS---DGHIMLTDFDLS 235
GI++R+LKPEN+L+ S + L DF L+
Sbjct: 124 NGIVHRNLKPENLLLASKAKGAAVKLADFGLA 155
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 5e-18
Identities = 28/88 (31%), Positives = 44/88 (50%), Gaps = 2/88 (2%)
Query: 318 FVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEF 377
F GT YL+PE++ + + VD W G+ ++ L G PF D A + A A ++
Sbjct: 167 FAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDY 226
Query: 378 PKEP--SVPGPAKDLIAQLLVKDPTRRM 403
P +V AK LI +L +P +R+
Sbjct: 227 PSPEWDTVTPEAKSLIDSMLTVNPKKRI 254
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 6e-26
Identities = 52/239 (21%), Positives = 82/239 (34%), Gaps = 18/239 (7%)
Query: 8 TAEDPDNLSFTSTTTNSGSETTWTTSGSNPSSSTPSAAKTHHAPPRCNDDPCWKAIKEAT 67
E N E S + SA A + P
Sbjct: 16 NKERRRARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQ 75
Query: 68 SEGNNNNNNNPLTLSDLR----FVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRE 123
S G + + + +G G V ++ G FA K+M+
Sbjct: 76 SMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRA----TGHEFAVKIMEVTA 131
Query: 124 LVSRN---KESRARIERE--ILEML-DHPFLPTLYATLDCPRWSCLLTEFCPGGDL-HVL 176
+E R RE IL + HP + TL + + + L+ + G+L L
Sbjct: 132 ERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYL 191
Query: 177 RQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235
++ E R ++ A+ FLH I++RDLKPEN+L+ + I L+DF S
Sbjct: 192 TEK---VALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFS 247
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 2e-14
Identities = 31/94 (32%), Positives = 42/94 (44%), Gaps = 8/94 (8%)
Query: 318 FVGTHEYLAPEIISG------EGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVV 371
GT YLAPEI+ G+G VD W G+ +F L G+ PF L L ++
Sbjct: 259 LCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIM 318
Query: 372 ARALEFPKEP--SVPGPAKDLIAQLLVKDPTRRM 403
+F KDLI++LL DP R+
Sbjct: 319 EGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARL 352
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-25
Identities = 75/370 (20%), Positives = 128/370 (34%), Gaps = 104/370 (28%)
Query: 71 NNNNNNNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKE 130
+++ + D +GSG V + + A K ++ + + +
Sbjct: 4 DSSALPWSINRDDYELQEVIGSGATAVVQ----AAYCAPKKEKVAIKRIN----LEKCQT 55
Query: 131 SRARIEREILEM--LDHPFLPTLYAT--LDCPRWSCLLTEFCPGGDL-HVLRQRQPD--- 182
S + +EI M HP + + Y + + W L+ + GG + +++
Sbjct: 56 SMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELW--LVMKLLSGGSVLDIIKHIVAKGEH 113
Query: 183 --KRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDN 240
ES + EV+ LE+LH G I+RD+K N+L+ DG + + D
Sbjct: 114 KSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIAD--------- 164
Query: 241 STSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGN 300
FG S+ + + R + +K
Sbjct: 165 -----------------------------FGVSAFL--------ATGGDITRNKVRK--- 184
Query: 301 PGTPEIVAEPLDVRSMSFVGTHEYLAPEIIS-GEGHGNAVDWWTLGIFIFELFYGTTPFK 359
+FVGT ++APE++ G+ D W+ GI EL G P+
Sbjct: 185 ----------------TFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYH 228
Query: 360 GIDH----ELTLANVVARALEFPKEPSVPG-----PAKDLIAQLLVKDPTRRMGSKMGAT 410
LTL N LE + + +I+ L KDP +R T
Sbjct: 229 KYPPMKVLMLTLQNDPPS-LETGVQDKEMLKKYGKSFRKMISLCLQKDPEKR------PT 281
Query: 411 AIK--RHQFF 418
A + RH+FF
Sbjct: 282 AAELLRHKFF 291
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 109 bits (272), Expect = 1e-25
Identities = 43/163 (26%), Positives = 67/163 (41%), Gaps = 20/163 (12%)
Query: 85 RFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIERE--ILEM 142
RLG+G G V + G A K + + ++R R E I++
Sbjct: 17 EMKERLGTGGFGYVLRWIHQD----TGEQVAIKQCRQE----LSPKNRERWCLEIQIMKK 68
Query: 143 LDHPFLPTLYATLDCP------RWSCLLTEFCPGGDL-HVLRQRQPDKRFHESAVRFYAS 195
L+HP + + D L E+C GGDL L Q + E +R S
Sbjct: 69 LNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLS 128
Query: 196 EVVVALEFLHMMGIIYRDLKPENVLVRSDGH---IMLTDFDLS 235
++ AL +LH II+RDLKPEN++++ + D +
Sbjct: 129 DISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYA 171
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 70.5 bits (172), Expect = 4e-13
Identities = 25/128 (19%), Positives = 42/128 (32%), Gaps = 26/128 (20%)
Query: 317 SFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVAR--- 373
FVGT +YLAPE++ + + VD+W+ G FE G PF + V
Sbjct: 182 EFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSN 241
Query: 374 -----------ALEFPKEPSVPGP--------AKDLIAQLLVKDPTRRMGSKMGATAIKR 414
A++F P + + +L+ +R
Sbjct: 242 EHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDP----QNPN 297
Query: 415 HQFFNGVN 422
F ++
Sbjct: 298 VGCFQALD 305
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 53/175 (30%), Positives = 85/175 (48%), Gaps = 20/175 (11%)
Query: 72 NNNNNNPLTLSDL-RFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELV---SR 127
++ + P L D LGSG G V L + A +++ KR+ +R
Sbjct: 124 DDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERK----TCKKVAIRIISKRKFAIGSAR 179
Query: 128 NKESRARIERE--ILEMLDHPFLPTLYATLDCPRWSCLLTEFCPGGDL--HVLRQRQPDK 183
+ +E E IL+ L+HP + + D + ++ E GG+L V+ K
Sbjct: 180 EADPALNVETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGN----K 234
Query: 184 RFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRS---DGHIMLTDFDLS 235
R E+ + Y ++++A+++LH GII+RDLKPENVL+ S D I +TDF S
Sbjct: 235 RLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS 289
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 4e-15
Identities = 31/92 (33%), Positives = 44/92 (47%), Gaps = 6/92 (6%)
Query: 318 FVGTHEYLAPEIISG---EGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARA 374
GT YLAPE++ G+ AVD W+LG+ +F G PF +++L + +
Sbjct: 301 LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSG 360
Query: 375 -LEFPKEP--SVPGPAKDLIAQLLVKDPTRRM 403
F E V A DL+ +LLV DP R
Sbjct: 361 KYNFIPEVWAEVSEKALDLVKKLLVVDPKARF 392
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-25
Identities = 49/160 (30%), Positives = 77/160 (48%), Gaps = 17/160 (10%)
Query: 85 RFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVS---RNKESRARIERE--I 139
LGSG G V L + A K++ KR+ R + +E E I
Sbjct: 13 IMSKTLGSGACGEVKLAFERK----TCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68
Query: 140 LEMLDHPFLPTLYATLDCPRWSCLLTEFCPGGDL-HVLRQRQPDKRFHESAVRFYASEVV 198
L+ L+HP + + D + ++ E GG+L + + R E+ + Y +++
Sbjct: 69 LKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNK---RLKEATCKLYFYQML 124
Query: 199 VALEFLHMMGIIYRDLKPENVLVRS---DGHIMLTDFDLS 235
+A+++LH GII+RDLKPENVL+ S D I +TDF S
Sbjct: 125 LAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS 164
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 1e-14
Identities = 31/92 (33%), Positives = 44/92 (47%), Gaps = 6/92 (6%)
Query: 318 FVGTHEYLAPEIISG---EGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARA 374
GT YLAPE++ G+ AVD W+LG+ +F G PF +++L + +
Sbjct: 176 LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSG 235
Query: 375 -LEFPKEP--SVPGPAKDLIAQLLVKDPTRRM 403
F E V A DL+ +LLV DP R
Sbjct: 236 KYNFIPEVWAEVSEKALDLVKKLLVVDPKARF 267
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 3e-25
Identities = 43/166 (25%), Positives = 67/166 (40%), Gaps = 17/166 (10%)
Query: 90 LGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRN----KESRARIERE--ILEML 143
LG G V K +A K++D S + +E R +E IL +
Sbjct: 25 LGRGVSSVVRRCIHKP----TCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKV 80
Query: 144 D-HPFLPTLYATLDCPRWSCLLTEFCPGGDL-HVLRQRQPDKRFHESAVRFYASEVVVAL 201
HP + L T + + L+ + G+L L ++ E R ++ +
Sbjct: 81 SGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK---VTLSEKETRKIMRALLEVI 137
Query: 202 EFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS--LKGDNSTSTA 245
LH + I++RDLKPEN+L+ D +I LTDF S L
Sbjct: 138 CALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREV 183
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 7e-16
Identities = 35/120 (29%), Positives = 50/120 (41%), Gaps = 16/120 (13%)
Query: 318 FVGTHEYLAPEIISG------EGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVV 371
GT YLAPEII G+G VD W+ G+ ++ L G+ PF L L ++
Sbjct: 183 VCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIM 242
Query: 372 ARALEFPKEP--SVPGPAKDLIAQLLVKDPTRRMGSKMGATA--IKRHQFFNGVNWALLR 427
+ +F KDL+++ LV P +R TA H FF +R
Sbjct: 243 SGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRY------TAEEALAHPFFQQYVVEEVR 296
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 105 bits (262), Expect = 5e-25
Identities = 49/363 (13%), Positives = 91/363 (25%), Gaps = 94/363 (25%)
Query: 83 DLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEM 142
L+ V L GD V+LV+ FA KV SR++ R
Sbjct: 63 KLKLVEPLRVGDRSVVFLVRDVE----RLEDFALKVFTMGAENSRSELERLHEATFAAAR 118
Query: 143 LDHPFLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALE 202
L D ++ + P + + + ++ +
Sbjct: 119 LLGESPEEARDRR----------RLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMP 168
Query: 203 FLHMMGIIYRDLKPENVLVRSDGHIMLTDFD--LSLKGDNSTSTAQLVSDQSPPTGDQQP 260
D ++ + D +GD +++ Q
Sbjct: 169 -----------------AASVDLELLFSTLDFVYVFRGDEGILALHILTAQ--------- 202
Query: 261 NDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKR---RRKK------------KLGNPGTPE 305
++ + L K LG+
Sbjct: 203 --------------------LIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSA-- 240
Query: 306 IVAEPLDVRSMSFVGTHEYLAPEIISGEG--HGNAVDWWTLGIFIFELFYGTTPFKGID- 362
+ R + Y E ++ +A++ W LG+ I+ ++ PF +
Sbjct: 241 --LWKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTP 298
Query: 363 ------HELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQ 416
+L +L F +P K LI + L D RR +
Sbjct: 299 GIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRR----LLPLEAMETP 354
Query: 417 FFN 419
F
Sbjct: 355 EFL 357
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 6e-25
Identities = 41/152 (26%), Positives = 77/152 (50%), Gaps = 16/152 (10%)
Query: 90 LGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIERE--ILEMLDHPF 147
LG G V K+ G FAAK+++ ++L +R+ + ++ERE I L HP
Sbjct: 37 LGKGAFSVVRRCVHKT----TGLEFAAKIINTKKLSARDFQ---KLEREARICRKLQHPN 89
Query: 148 LPTLYATLDCPRWSCLLTEFCPGGDL-HVLRQRQPDKRFHESAVRFYASEVVVALEFLHM 206
+ L+ ++ + L+ + GG+L + R + + E+ +++ ++ + H
Sbjct: 90 IVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR---EFYSEADASHCIQQILESIAYCHS 146
Query: 207 MGIIYRDLKPENVLVRS---DGHIMLTDFDLS 235
GI++R+LKPEN+L+ S + L DF L+
Sbjct: 147 NGIVHRNLKPENLLLASKAKGAAVKLADFGLA 178
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 3e-17
Identities = 28/88 (31%), Positives = 44/88 (50%), Gaps = 2/88 (2%)
Query: 318 FVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEF 377
F GT YL+PE++ + + VD W G+ ++ L G PF D A + A A ++
Sbjct: 190 FAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDY 249
Query: 378 PKEP--SVPGPAKDLIAQLLVKDPTRRM 403
P +V AK LI +L +P +R+
Sbjct: 250 PSPEWDTVTPEAKSLIDSMLTVNPKKRI 277
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 7e-25
Identities = 63/325 (19%), Positives = 117/325 (36%), Gaps = 71/325 (21%)
Query: 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIERE--I 139
SDL LG G G V + +VM +EL+ ++E++ +E +
Sbjct: 10 SDLIHGEVLGKGCFGQAIKVTHRETG---------EVMVMKELIRFDEETQRTFLKEVKV 60
Query: 140 LEMLDHPFLPTLYATLDCPRWSCLLTEFCPGGDLH-VLRQRQPDKRFHESAVRFYASEVV 198
+ L+HP + L + +TE+ GG L +++ D ++ S +A ++
Sbjct: 61 MRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKS--MDSQYPWSQRVSFAKDIA 118
Query: 199 VALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQ 258
+ +LH M II+RDL N LVR + ++++ DF L
Sbjct: 119 SGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGL------------------------ 154
Query: 259 QPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSF 318
+ ++ + K+ +KK +
Sbjct: 155 ---------------ARLMVDEKTQPEGLRSLKKPDRKK-----------------RYTV 182
Query: 319 VGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGID-HELTLANVVARALEF 377
VG ++APE+I+G + VD ++ GI + E+ + V L+
Sbjct: 183 VGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDR 242
Query: 378 PKEPSVPGPAKDLIAQLLVKDPTRR 402
P+ P + + DP +R
Sbjct: 243 YCPPNCPPSFFPITVRCCDLDPEKR 267
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 9e-25
Identities = 70/329 (21%), Positives = 112/329 (34%), Gaps = 83/329 (25%)
Query: 81 LSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIERE-- 138
++L +G G G VY ++ G A K + + ++ + +E
Sbjct: 6 FAELTLEEIIGIGGFGKVY------RAFWIGDEVAVKAA-RHDPDEDISQTIENVRQEAK 58
Query: 139 ILEMLDHPFLPTLY-ATLDCPRWSCLLTEFCPGGDLH-VLRQRQPDKRFHESAVRFYASE 196
+ ML HP + L L P CL+ EF GG L+ VL ++ + V + A +
Sbjct: 59 LFAMLKHPNIIALRGVCLKEPNL-CLVMEFARGGPLNRVLSGKRIP---PDILVNW-AVQ 113
Query: 197 VVVALEFLHMMG---IIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQLVSDQSP 253
+ + +LH II+RDLK N+L+ + LK ++D
Sbjct: 114 IARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLS-NKILK----------ITD--- 159
Query: 254 PTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDV 313
FG ++ R K+ G
Sbjct: 160 ----------------FG-------------LARE---WHRTTKMSAAGAY--------- 178
Query: 314 RSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVAR 373
++APE+I D W+ G+ ++EL G PF+GID V
Sbjct: 179 ---------AWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMN 229
Query: 374 ALEFPKEPSVPGPAKDLIAQLLVKDPTRR 402
L P + P P L+ DP R
Sbjct: 230 KLALPIPSTCPEPFAKLMEDCWNPDPHSR 258
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 1e-24
Identities = 45/152 (29%), Positives = 70/152 (46%), Gaps = 18/152 (11%)
Query: 90 LGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIERE--ILEMLDHPF 147
+G G G V + K AAK + K + E R ++E I++ LDHP
Sbjct: 17 IGRGSWGEVKIAVQKG----TRIRRAAKKIPKYFV-----EDVDRFKQEIEIMKSLDHPN 67
Query: 148 LPTLYATLDCPRWSCLLTEFCPGGDL-HVLRQRQPDKRFHESAVRFYASEVVVALEFLHM 206
+ LY T + L+ E C GG+L + + + F ES +V+ A+ + H
Sbjct: 68 IIRLYETFEDNTDIYLVMELCTGGELFERVVHK---RVFRESDAARIMKDVLSAVAYCHK 124
Query: 207 MGIIYRDLKPENVLVRS---DGHIMLTDFDLS 235
+ + +RDLKPEN L + D + L DF L+
Sbjct: 125 LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLA 156
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 1e-15
Identities = 25/89 (28%), Positives = 45/89 (50%), Gaps = 3/89 (3%)
Query: 317 SFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALE 376
+ VGT Y++P+++ G +G D W+ G+ ++ L G PF + +
Sbjct: 167 TKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFT 225
Query: 377 FPKEP--SVPGPAKDLIAQLLVKDPTRRM 403
FP++ +V A+ LI +LL K P +R+
Sbjct: 226 FPEKDWLNVSPQAESLIRRLLTKSPKQRI 254
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 30/193 (15%), Positives = 54/193 (27%), Gaps = 35/193 (18%)
Query: 83 DLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEM 142
L LG D + + G F V E N + + E L +
Sbjct: 74 TLVRGTVLGQEDPYAYLEATDQE----TGESFEVHVPYFTERPPSNAIKQMKEEVLRLRL 129
Query: 143 L----------------------DHPFLPTLYATLDCPRWSCLLTEF----CPGGDLHVL 176
L P + R +L+ F +L
Sbjct: 130 LRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTF 189
Query: 177 -----RQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTD 231
K A +V+ L LH G+++ L+P ++++ G + LT
Sbjct: 190 GEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTG 249
Query: 232 FDLSLKGDNSTST 244
F+ ++ +
Sbjct: 250 FEHLVRDGARVVS 262
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 90.5 bits (224), Expect = 5e-20
Identities = 16/133 (12%), Positives = 35/133 (26%), Gaps = 26/133 (19%)
Query: 314 RSMSFVGTHEYLAPEIISGEG-----------HGNAVDWWTLGIFIFELFYGTTPFKGID 362
+ + + PE+ + + D W LG+ I+ ++ P
Sbjct: 258 ARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDA 317
Query: 363 HELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGVN 422
+ F ++P P + L+ L R + + +
Sbjct: 318 ALGGSEWI------FRSCKNIPQPVRALLEGFLRYPKEDR----LLPLQAMETPEYEQLR 367
Query: 423 WALLRCAKPPFIP 435
L +P
Sbjct: 368 TEL-----SAALP 375
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 4e-24
Identities = 46/160 (28%), Positives = 74/160 (46%), Gaps = 20/160 (12%)
Query: 90 LGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIERE--ILEMLDHPF 147
LGSG V+LV+ + G FA K + K + +E E +L+ + H
Sbjct: 17 LGSGAFSEVFLVKQRL----TGKLFALKCIKKSPAFRDS-----SLENEIAVLKKIKHEN 67
Query: 148 LPTLYATLDCPRWSCLLTEFCPGGDL--HVLRQRQPDKRFHESAVRFYASEVVVALEFLH 205
+ TL + L+ + GG+L +L + + E +V+ A+++LH
Sbjct: 68 IVTLEDIYESTTHYYLVMQLVSGGELFDRILER----GVYTEKDASLVIQQVLSAVKYLH 123
Query: 206 MMGIIYRDLKPENVLVRS---DGHIMLTDFDLSLKGDNST 242
GI++RDLKPEN+L + + IM+TDF LS N
Sbjct: 124 ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI 163
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 8e-18
Identities = 27/90 (30%), Positives = 40/90 (44%), Gaps = 2/90 (2%)
Query: 316 MSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARAL 375
+ GT Y+APE+++ + + AVD W++G+ + L G PF +
Sbjct: 165 STACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYY 224
Query: 376 EFPKEP--SVPGPAKDLIAQLLVKDPTRRM 403
EF + AKD I LL KDP R
Sbjct: 225 EFESPFWDDISESAKDFICHLLEKDPNERY 254
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 5e-24
Identities = 38/162 (23%), Positives = 62/162 (38%), Gaps = 22/162 (13%)
Query: 84 LRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREI---L 140
LR L G VY + +G +A K + +E I +E+
Sbjct: 30 LRVRRVLAEGGFAFVYEA----QDVGSGREYALKRLLSN-----EEEKNRAIIQEVCFMK 80
Query: 141 EMLDHPFLPTLYATLDCPRWS--------CLLTEFCPGGDLHVLRQRQPDKRFHESAVRF 192
++ HP + + + LLTE C G + L++ + V
Sbjct: 81 KLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLK 140
Query: 193 YASEVVVALEFLHMMG--IIYRDLKPENVLVRSDGHIMLTDF 232
+ A++ +H II+RDLK EN+L+ + G I L DF
Sbjct: 141 IFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDF 182
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 69.8 bits (171), Expect = 3e-13
Identities = 23/90 (25%), Positives = 33/90 (36%), Gaps = 7/90 (7%)
Query: 316 MSFVGTHEYLAPEII---SGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVA 372
++ T Y PEII S G D W LG ++ L + PF + L +V
Sbjct: 208 ITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPF---EDGAKLR-IVN 263
Query: 373 RALEFPKEPSVPGPAKDLIAQLLVKDPTRR 402
P + LI +L +P R
Sbjct: 264 GKYSIPPHDTQYTVFHSLIRAMLQVNPEER 293
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 9e-24
Identities = 39/152 (25%), Positives = 74/152 (48%), Gaps = 16/152 (10%)
Query: 90 LGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIERE--ILEMLDHPF 147
LG G V G +AA +++ ++L +R+ + ++ERE I +L HP
Sbjct: 19 LGKGAFSVVRRCVKVL----AGQEYAAMIINTKKLSARDHQ---KLEREARICRLLKHPN 71
Query: 148 LPTLYATLDCPRWSCLLTEFCPGGDL-HVLRQRQPDKRFHESAVRFYASEVVVALEFLHM 206
+ L+ ++ L+ + GG+L + R + + E+ +++ A+ H
Sbjct: 72 IVRLHDSISEEGHHYLIFDLVTGGELFEDIVAR---EYYSEADASHCIQQILEAVLHCHQ 128
Query: 207 MGIIYRDLKPENVLVRS---DGHIMLTDFDLS 235
MG+++R+LKPEN+L+ S + L DF L+
Sbjct: 129 MGVVHRNLKPENLLLASKLKGAAVKLADFGLA 160
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 5e-17
Identities = 30/88 (34%), Positives = 47/88 (53%), Gaps = 2/88 (2%)
Query: 318 FVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEF 377
F GT YL+PE++ + +G VD W G+ ++ L G PF D + A A +F
Sbjct: 173 FAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDF 232
Query: 378 PKEP--SVPGPAKDLIAQLLVKDPTRRM 403
P +V AKDLI ++L +P++R+
Sbjct: 233 PSPEWDTVTPEAKDLINKMLTINPSKRI 260
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 1e-23
Identities = 42/150 (28%), Positives = 72/150 (48%), Gaps = 10/150 (6%)
Query: 90 LGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREI--LEMLDHPF 147
LG G G V V S C A K++ K++L R A +++EI L L H
Sbjct: 13 LGEGSYGKVKEV----LDSETLCRRAVKILKKKKL-RRIPNGEANVKKEIQLLRRLRHKN 67
Query: 148 LPTLYATLDC--PRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLH 205
+ L L + ++ E+C G +L P+KRF Y +++ LE+LH
Sbjct: 68 VIQLVDVLYNEEKQKMYMVMEYCVCGMQEML-DSVPEKRFPVCQAHGYFCQLIDGLEYLH 126
Query: 206 MMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235
GI+++D+KP N+L+ + G + ++ ++
Sbjct: 127 SQGIVHKDIKPGNLLLTTGGTLKISALGVA 156
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 1e-13
Identities = 30/128 (23%), Positives = 51/128 (39%), Gaps = 9/128 (7%)
Query: 320 GTHEYLAPEIISGEG--HGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEF 377
G+ + PEI +G G VD W+ G+ ++ + G PF+G + N+ +
Sbjct: 173 GSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAI 232
Query: 378 PKEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFN-GVNWALLRCAKPPFIPR 436
P P DL+ +L +P +R + I++H +F A PP
Sbjct: 233 P--GDCGPPLSDLLKGMLEYEPAKRFSIR----QIRQHSWFRKKHPPAEAPVPIPPSPDT 286
Query: 437 PVTCRDLT 444
R +T
Sbjct: 287 KDRWRSMT 294
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 99 bits (249), Expect = 3e-23
Identities = 57/389 (14%), Positives = 110/389 (28%), Gaps = 128/389 (32%)
Query: 82 SDLRFVHRLGSG--DIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREI 139
+ +G G D+ +V ++ G + + ++ L + + E ++ E+
Sbjct: 25 GCYELLTVIGKGFEDLMTVN----LARYKPTGEYVTVRRIN---LEACSNEMVTFLQGEL 77
Query: 140 LEM--LDHPFLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEV 197
+HP + AT ++T F G L +E A+ + V
Sbjct: 78 HVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGV 137
Query: 198 VVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGD 257
+ AL+++H MG ++R +K ++L+ DG + L+ + ++S
Sbjct: 138 LKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSN---------LSMISHGQ----- 183
Query: 258 QQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMS 317
R++ P
Sbjct: 184 -----------------------------------RQRVVHDFPKY-------------- 194
Query: 318 FVGTHEYLAPEII--SGEGHGNAVDWWTLGIFIFELFYGTTPF----------------- 358
V +L+PE++ + +G+ D +++GI EL G PF
Sbjct: 195 SVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTV 254
Query: 359 ---------------------KGIDHELTLANVVARALEFPKEPSVPGPA------KDLI 391
PS P +
Sbjct: 255 PCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFV 314
Query: 392 AQLLVKDPTRRMGSKMGATAIK--RHQFF 418
Q L ++P R +A H FF
Sbjct: 315 EQCLQRNPDAR------PSASTLLNHSFF 337
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 5e-23
Identities = 38/152 (25%), Positives = 68/152 (44%), Gaps = 20/152 (13%)
Query: 90 LGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLD-HPFL 148
LG G K + FA K++ KR E+ + E L++ + HP +
Sbjct: 19 LGEGSFSICRKCVHKK----SNQAFAVKIISKR------MEANTQKEITALKLCEGHPNI 68
Query: 149 PTLYATLDCPRWSCLLTEFCPGGDL--HVLRQRQPDKRFHESAVRFYASEVVVALEFLHM 206
L+ + L+ E GG+L + ++ K F E+ + ++V A+ +H
Sbjct: 69 VKLHEVFHDQLHTFLVMELLNGGELFERIKKK----KHFSETEASYIMRKLVSAVSHMHD 124
Query: 207 MGIIYRDLKPENVLVRS---DGHIMLTDFDLS 235
+G+++RDLKPEN+L + I + DF +
Sbjct: 125 VGVVHRDLKPENLLFTDENDNLEIKIIDFGFA 156
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 4e-15
Identities = 29/97 (29%), Positives = 46/97 (47%), Gaps = 9/97 (9%)
Query: 316 MSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELT-------LA 368
+ T Y APE+++ G+ + D W+LG+ ++ + G PF+ D LT +
Sbjct: 167 KTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMK 226
Query: 369 NVVARALEFPKEP--SVPGPAKDLIAQLLVKDPTRRM 403
+ F E +V AKDLI LL DP +R+
Sbjct: 227 KIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRL 263
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 5e-23
Identities = 48/206 (23%), Positives = 79/206 (38%), Gaps = 19/206 (9%)
Query: 36 NPSSSTPSAAKTHHAPPRCNDDPCWKAIKEATSEGNNNNNNNPLTLSDL-RFVHRLGSGD 94
+ SS + + + + + +N LSD LG G
Sbjct: 6 HHSSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGA 65
Query: 95 IGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYAT 154
VY + K +A KV+ K + R E +L L HP + L
Sbjct: 66 TSIVYRCKQKG----TQKPYALKVLKKTV-----DKKIVRTEIGVLLRLSHPNIIKLKEI 116
Query: 155 LDCPRWSCLLTEFCPGGDL--HVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYR 212
+ P L+ E GG+L ++ + + E +++ A+ +LH GI++R
Sbjct: 117 FETPTEISLVLELVTGGELFDRIVEK----GYYSERDAADAVKQILEAVAYLHENGIVHR 172
Query: 213 DLKPENVLVRS---DGHIMLTDFDLS 235
DLKPEN+L + D + + DF LS
Sbjct: 173 DLKPENLLYATPAPDAPLKIADFGLS 198
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 6e-17
Identities = 29/90 (32%), Positives = 43/90 (47%), Gaps = 3/90 (3%)
Query: 317 SFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARA-L 375
+ GT Y APEI+ G +G VD W++GI + L G PF + + +
Sbjct: 209 TVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEY 268
Query: 376 EFPKEP--SVPGPAKDLIAQLLVKDPTRRM 403
F V AKDL+ +L+V DP +R+
Sbjct: 269 YFISPWWDEVSLNAKDLVRKLIVLDPKKRL 298
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 96.9 bits (241), Expect = 4e-22
Identities = 55/295 (18%), Positives = 101/295 (34%), Gaps = 54/295 (18%)
Query: 87 VHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESR-ARIEREILEML-- 143
+ +LG G +V+L F A KV + S + A E +L+ +
Sbjct: 42 IRKLGWGHFSTVWLS----WDIQGKKFVAMKV-----VKSAEHYTETALDEIRLLKSVRN 92
Query: 144 ---DHP---FLPTLYATLDC-----PRWS--CLLTEFCPGGDLHVLRQRQPDKRFHESAV 190
+ P + L LD + C++ E G L + + V
Sbjct: 93 SDPNDPNREMVVQL---LDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCV 148
Query: 191 RFYASEVVVALEFLHM-MGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQLVS 249
+ +V+ L++LH II+ D+KPEN+L+ + + +
Sbjct: 149 KKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVN--------------EQYIRRLAAEA 194
Query: 250 DQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAE 309
+ +G P+ AV P + ++ + + +KL A
Sbjct: 195 TEWQRSGAPPPSGSAVSTAPATAGNFLVNPL----------EPKNAEKLKVKIADLGNAC 244
Query: 310 PLDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHE 364
+ + T +Y + E++ G G+ D W+ FEL G F+ E
Sbjct: 245 WVHKHFTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGE 299
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 9e-22
Identities = 37/154 (24%), Positives = 58/154 (37%), Gaps = 20/154 (12%)
Query: 90 LGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEML-DHPFL 148
LG G G V + G A K++ + E + P +
Sbjct: 37 LGLGVNGKVLECFHRR----TGQKCALKLLYDSPKARQ--------EVDHHWQASGGPHI 84
Query: 149 PTLYAT----LDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFL 204
+ R ++ E GG+L Q + D+ F E ++ A++FL
Sbjct: 85 VCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFL 144
Query: 205 HMMGIIYRDLKPENVLVRS---DGHIMLTDFDLS 235
H I +RD+KPEN+L S D + LTDF +
Sbjct: 145 HSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFA 178
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 8e-16
Identities = 28/94 (29%), Positives = 41/94 (43%), Gaps = 6/94 (6%)
Query: 316 MSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVAR-- 373
+ T Y+APE++ E + + D W+LG+ ++ L G PF + + R
Sbjct: 187 QTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIR 246
Query: 374 --ALEFPKEP--SVPGPAKDLIAQLLVKDPTRRM 403
FP V AK LI LL DPT R+
Sbjct: 247 LGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERL 280
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 1e-21
Identities = 47/233 (20%), Positives = 80/233 (34%), Gaps = 29/233 (12%)
Query: 30 WTTSGSNPSSSTPSAAKTHHAPPRCNDDPCWKAIKEATSEGNNNNNNNPLTLSDLRFVHR 89
+ G +P P+ A P P + + + + L + +
Sbjct: 3 SNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDD 62
Query: 90 -------LGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEM 142
LG G G V + K FA K++ R E E+
Sbjct: 63 YKVTSQVLGLGINGKVLQIFNKR----TQEKFALKMLQDCPKARR--------EVELHWR 110
Query: 143 L-DHPFLPTLYAT----LDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEV 197
P + + + ++ E GG+L Q + D+ F E +
Sbjct: 111 ASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSI 170
Query: 198 VVALEFLHMMGIIYRDLKPENVLVRS---DGHIMLTDFDLS--LKGDNSTSTA 245
A+++LH + I +RD+KPEN+L S + + LTDF + NS +T
Sbjct: 171 GEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTP 223
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 1e-14
Identities = 27/94 (28%), Positives = 40/94 (42%), Gaps = 6/94 (6%)
Query: 316 MSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELT----LANVV 371
+ T Y+APE++ E + + D W+LG+ ++ L G PF +
Sbjct: 221 TTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR 280
Query: 372 ARALEFPKEP--SVPGPAKDLIAQLLVKDPTRRM 403
EFP V K LI LL +PT+RM
Sbjct: 281 MGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRM 314
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 1e-21
Identities = 43/169 (25%), Positives = 71/169 (42%), Gaps = 18/169 (10%)
Query: 84 LRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREI--LE 141
L+F +G G +VY K + A + R+L K R R + E L+
Sbjct: 28 LKFDIEIGRGSFKTVY----KGLDTETTVEVAWCELQDRKL---TKSERQRFKEEAEMLK 80
Query: 142 MLDHP----FLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEV 197
L HP F + +T+ + L+TE G L +R K +R + ++
Sbjct: 81 GLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQI 138
Query: 198 VVALEFLHMMG--IIYRDLKPENVLV-RSDGHIMLTDFDLSLKGDNSTS 243
+ L+FLH II+RDLK +N+ + G + + D L+ S +
Sbjct: 139 LKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA 187
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 7e-11
Identities = 21/105 (20%), Positives = 43/105 (40%), Gaps = 10/105 (9%)
Query: 317 SFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALE 376
+ +GT E++APE+ E + +VD + G+ + E+ P+ + + V ++
Sbjct: 189 AVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK 247
Query: 377 FPKEPSVPGP-AKDLIAQLLVKDPTRRMGSKMGATAIK--RHQFF 418
V P K++I + ++ R + H FF
Sbjct: 248 PASFDKVAIPEVKEIIEGCIRQNKDER------YSIKDLLNHAFF 286
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 1e-21
Identities = 59/329 (17%), Positives = 105/329 (31%), Gaps = 87/329 (26%)
Query: 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILE 141
+ R+GSG G+VY + A K+++ + ++ E +L
Sbjct: 24 GQITVGQRIGSGSFGTVYKGKWHGD-------VAVKMLNVTAPTPQQLQAFKN-EVGVLR 75
Query: 142 MLDHPFLPTLYATLDCPRWSCLLTEFCPGGDL-HVLRQRQPDKRFHESAVRFYASEVVVA 200
H + P+ ++T++C G L H L + +F + A +
Sbjct: 76 KTRHVNILLFMGYSTAPQL-AIVTQWCEGSSLYHHLHAS--ETKFEMKKLIDIARQTARG 132
Query: 201 LEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQP 260
+++LH II+RDLK N+ D ++K + D
Sbjct: 133 MDYLHAKSIIHRDLKSNNI---------FLHEDNTVK----------IGD---------- 163
Query: 261 NDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVG 320
FG + K + G
Sbjct: 164 ---------FGLA-------------------TEKSRWSGSHQ-----------FEQLSG 184
Query: 321 THEYLAPEIISGEGHG---NAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEF 377
+ ++APE+I + D + GI ++EL G P+ I++ + +V R
Sbjct: 185 SILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLS 244
Query: 378 PKEPSVPG----PAKDLIAQLLVKDPTRR 402
P V K L+A+ L K R
Sbjct: 245 PDLSKVRSNCPKRMKRLMAECLKKKRDER 273
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 2e-21
Identities = 41/150 (27%), Positives = 79/150 (52%), Gaps = 15/150 (10%)
Query: 90 LGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREI--LEMLDHPF 147
+G G+ V L ++ G A K++DK +L N S ++ RE+ +++L+HP
Sbjct: 23 IGKGNFAKVKL----ARHILTGREVAIKIIDKTQL---NPTSLQKLFREVRIMKILNHPN 75
Query: 148 LPTLYATLDCPRWSCLLTEFCPGGDL--HVLRQRQPDKRFHESAVRFYASEVVVALEFLH 205
+ L+ ++ + L+ E+ GG++ +++ R E R ++V A+++ H
Sbjct: 76 IVKLFEVIETEKTLYLIMEYASGGEVFDYLVAH----GRMKEKEARSKFRQIVSAVQYCH 131
Query: 206 MMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235
I++RDLK EN+L+ +D +I + DF S
Sbjct: 132 QKRIVHRDLKAENLLLDADMNIKIADFGFS 161
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 6e-14
Identities = 27/103 (26%), Positives = 48/103 (46%), Gaps = 7/103 (6%)
Query: 318 FVGTHEYLAPEIISGEG-HGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALE 376
F G Y APE+ G+ G VD W+LG+ ++ L G+ PF G + + V+
Sbjct: 173 FCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYR 232
Query: 377 FPKEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFN 419
P + ++L+ + LV +P +R + I + ++ N
Sbjct: 233 IP--FYMSTDCENLLKRFLVLNPIKRGTLEQ----IMKDRWIN 269
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 2e-21
Identities = 35/169 (20%), Positives = 61/169 (36%), Gaps = 13/169 (7%)
Query: 81 LSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREIL 140
L F+ +L G ++ K G KV+ R+ +R E L
Sbjct: 9 FKQLNFLTKLNENHSGELW------KGRWQGNDIVVKVLKVRDWSTRKSRDFNE-ECPRL 61
Query: 141 EMLDHPFLPTLY-ATLDCPRWS-CLLTEFCPGGDL-HVLRQRQPDKRFHESAVRFYASEV 197
+ HP + + A P L+T + P G L +VL + AV+F A ++
Sbjct: 62 RIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKF-ALDM 120
Query: 198 VVALEFLHMMG--IIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTST 244
+ FLH + I L +V++ D ++ D+ +
Sbjct: 121 ARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGRM 169
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 2e-06
Identities = 17/91 (18%), Positives = 34/91 (37%), Gaps = 3/91 (3%)
Query: 315 SMSFVGTHEYLAPEIISGEGHGN---AVDWWTLGIFIFELFYGTTPFKGIDHELTLANVV 371
S + ++APE + + + D W+ + ++EL PF + + V
Sbjct: 165 SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVA 224
Query: 372 ARALEFPKEPSVPGPAKDLIAQLLVKDPTRR 402
L P + L+ + +DP +R
Sbjct: 225 LEGLRPTIPPGISPHVSKLMKICMNEDPAKR 255
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 94.1 bits (234), Expect = 2e-21
Identities = 41/185 (22%), Positives = 68/185 (36%), Gaps = 33/185 (17%)
Query: 81 LSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREI- 139
+ +G G G V+ + + G A K+ RE E E EI
Sbjct: 41 ARTIVLQESIGKGRFGEVWRGKWR------GEEVAVKIFSSRE------ERSWFREAEIY 88
Query: 140 -LEMLDHPFLPTLYA-----TLDCPRWSCLLTEFCPGGDLH-VLRQRQPDKRFHESAVRF 192
ML H + A + L++++ G L L + E ++
Sbjct: 89 QTVMLRHENILGFIAADNKDNGTWTQL-WLVSDYHEHGSLFDYLNRYTVT---VEGMIKL 144
Query: 193 YASEVVVALEFLHM--------MGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTST 244
A L LHM I +RDLK +N+LV+ +G + D L+++ D++T T
Sbjct: 145 -ALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDT 203
Query: 245 AQLVS 249
+
Sbjct: 204 IDIAP 208
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 2e-21
Identities = 40/171 (23%), Positives = 69/171 (40%), Gaps = 22/171 (12%)
Query: 72 NNNNNNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKES 131
+ + T DL+ + +G G GSV + K +G A K + + +++
Sbjct: 12 SPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKP----SGQIMAVKRIR----STVDEKE 63
Query: 132 RARIEREI---LEMLDHPFLPTLYATL----DCPRWSCLLTEFCPGGDLHVLRQ--RQPD 182
+ ++ ++ + D P++ Y L DC W C+ E + D
Sbjct: 64 QKQLLMDLDVVMRSSDCPYIVQFYGALFREGDC--WICM--ELMSTSFDKFYKYVYSVLD 119
Query: 183 KRFHESAVRFYASEVVVALEFLH-MMGIIYRDLKPENVLVRSDGHIMLTDF 232
E + V AL L + II+RD+KP N+L+ G+I L DF
Sbjct: 120 DVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDF 170
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 2e-07
Identities = 24/101 (23%), Positives = 38/101 (37%), Gaps = 11/101 (10%)
Query: 313 VRSMS---FVGTHEYLAPEIISGEGHGNA----VDWWTLGIFIFELFYGTTPFKGIDHEL 365
V S++ G Y+APE I D W+LGI ++EL G P+ +
Sbjct: 177 VDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF 236
Query: 366 TLANVVARA----LEFPKEPSVPGPAKDLIAQLLVKDPTRR 402
V + L +E + + L KD ++R
Sbjct: 237 DQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKR 277
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 4e-21
Identities = 44/162 (27%), Positives = 68/162 (41%), Gaps = 24/162 (14%)
Query: 90 LGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEML-DHPFL 148
+G G K+ FA K++DK + E EIL HP +
Sbjct: 30 IGVGSYSVCKRCIHKA----TNMEFAVKIIDKSKR-------DPTEEIEILLRYGQHPNI 78
Query: 149 PTLYATLDCPRWSCLLTEFCPGGDL--HVLRQRQPDKRFHESAVRFYASEVVVALEFLHM 206
TL D ++ ++TE GG+L +LRQ K F E + +E+LH
Sbjct: 79 ITLKDVYDDGKYVYVVTELMKGGELLDKILRQ----KFFSEREASAVLFTITKTVEYLHA 134
Query: 207 MGIIYRDLKPENVLVRSDGH----IMLTDFDLS--LKGDNST 242
G+++RDLKP N+L + I + DF + L+ +N
Sbjct: 135 QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGL 176
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 9e-16
Identities = 28/94 (29%), Positives = 49/94 (52%), Gaps = 7/94 (7%)
Query: 316 MSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKG----IDHELTLANVV 371
M+ T ++APE++ +G+ A D W+LG+ ++ + G TPF E+ LA +
Sbjct: 178 MTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEI-LARIG 236
Query: 372 ARALEFPKEP--SVPGPAKDLIAQLLVKDPTRRM 403
+ SV AKDL++++L DP +R+
Sbjct: 237 SGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRL 270
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 4e-21
Identities = 42/168 (25%), Positives = 69/168 (41%), Gaps = 22/168 (13%)
Query: 73 NNNNNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESR 132
++DL + +GSG G V+ ++ + G A K M S NKE
Sbjct: 16 GGQRYQAEINDLENLGEMGSGTCGQVWKMRFRK----TGHVIAVKQMR----RSGNKEEN 67
Query: 133 ARIEREI---LEMLDHPFLPTLYATL----DCPRWSCLLTEFCPGGDLHVLRQRQPDKRF 185
RI ++ L+ D P++ + T D + + E + ++ Q
Sbjct: 68 KRILMDLDVVLKSHDCPYIVQCFGTFITNTDV--FIAM--ELMGTCAEKLKKRMQ--GPI 121
Query: 186 HESAVRFYASEVVVALEFLH-MMGIIYRDLKPENVLVRSDGHIMLTDF 232
E + +V AL +L G+I+RD+KP N+L+ G I L DF
Sbjct: 122 PERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDF 169
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 1e-08
Identities = 24/100 (24%), Positives = 37/100 (37%), Gaps = 10/100 (10%)
Query: 313 VRSMS---FVGTHEYLAPEII-----SGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHE 364
V + G Y+APE I + + D W+LGI + EL G P+K +
Sbjct: 176 VDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD 235
Query: 365 LTLANVVAR--ALEFPKEPSVPGPAKDLIAQLLVKDPTRR 402
+ V + P G + + L KD +R
Sbjct: 236 FEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKR 275
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 7e-21
Identities = 35/178 (19%), Positives = 71/178 (39%), Gaps = 21/178 (11%)
Query: 81 LSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIE--RE 138
+++ + ++G G G V+ +L + A K + + + E RE
Sbjct: 18 DNEIEYEKQIGKGGFGLVHKGRLVK----DKSVVAIKSLILGDSEGETEMIEKFQEFQRE 73
Query: 139 --ILEMLDHPFLPTLY-ATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYAS 195
I+ L+HP + LY + P ++ EF P GDL+ + +R
Sbjct: 74 VFIMSNLNHPNIVKLYGLMHNPP---RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRL-ML 129
Query: 196 EVVVALEFLHMMG--IIYRDLKPENVLVRSDG-----HIMLTDFDLS-LKGDNSTSTA 245
++ + +E++ I++RDL+ N+ ++S + DF LS + +
Sbjct: 130 DIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVSGLL 187
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 1e-07
Identities = 17/94 (18%), Positives = 38/94 (40%), Gaps = 8/94 (8%)
Query: 315 SMSFVGTHEYLAPEIISGEG--HGNAVDWWTLGIFIFELFYGTTPFKGIDH-ELTLANVV 371
+G +++APE I E + D ++ + ++ + G PF + ++ N++
Sbjct: 183 VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMI 242
Query: 372 ARA---LEFPKEPSVPGPAKDLIAQLLVKDPTRR 402
P+ P +++I DP +R
Sbjct: 243 REEGLRPTIPE--DCPPRLRNVIELCWSGDPKKR 274
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 9e-21
Identities = 42/166 (25%), Positives = 70/166 (42%), Gaps = 21/166 (12%)
Query: 76 NNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARI 135
+ + DL + LG G G V ++ +G A K + + N + + R+
Sbjct: 1 SMEVKADDLEPIMELGRGAYGVVEKMRHVP----SGQIMAVKRIR----ATVNSQEQKRL 52
Query: 136 EREI---LEMLDHPFLPTLYATL----DCPRWSCLLTEFCPGGDLHVLRQ-RQPDKRFHE 187
++ + +D PF T Y L D W C+ E +Q + E
Sbjct: 53 LMDLDISMRTVDCPFTVTFYGALFREGDV--WICM--ELMDTSLDKFYKQVIDKGQTIPE 108
Query: 188 SAVRFYASEVVVALEFLHM-MGIIYRDLKPENVLVRSDGHIMLTDF 232
+ A +V ALE LH + +I+RD+KP NVL+ + G + + DF
Sbjct: 109 DILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDF 154
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 1e-09
Identities = 24/99 (24%), Positives = 35/99 (35%), Gaps = 10/99 (10%)
Query: 313 VRSM---SFVGTHEYLAPEIISGEGHGNA----VDWWTLGIFIFELFYGTTPFKGIDHEL 365
V + G Y+APE I+ E + D W+LGI + EL P+
Sbjct: 161 VDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPF 220
Query: 366 TLANVVARALEFPKEPS--VPGPAKDLIAQLLVKDPTRR 402
V P+ P+ D +Q L K+ R
Sbjct: 221 QQLKQVVEE-PSPQLPADKFSAEFVDFTSQCLKKNSKER 258
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 92.2 bits (229), Expect = 1e-20
Identities = 47/186 (25%), Positives = 77/186 (41%), Gaps = 17/186 (9%)
Query: 61 KAIKEATSEGNNNNNNNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMD 120
+ K + L D + LG+G+ G V+ V K +G A K++
Sbjct: 12 QQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKP----SGLVMARKLIH 67
Query: 121 KRELVSRNKESRARIERE--ILEMLDHPFLPTLYATL--DCPRWSCLLTEFCPGGDLHVL 176
+ R +I RE +L + P++ Y D C+ E GG L +
Sbjct: 68 ----LEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM--EHMDGGSLDQV 121
Query: 177 RQRQPDKRFHESAVRFYASEVVVALEFLHMMG-IIYRDLKPENVLVRSDGHIMLTDFDLS 235
++ R E + + V+ L +L I++RD+KP N+LV S G I L DF +S
Sbjct: 122 LKKA--GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVS 179
Query: 236 LKGDNS 241
+ +S
Sbjct: 180 GQLIDS 185
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 56.4 bits (136), Expect = 6e-09
Identities = 21/94 (22%), Positives = 33/94 (35%), Gaps = 2/94 (2%)
Query: 313 VRSM--SFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANV 370
+ SM SFVGT Y++PE + G + D W++G+ + E+ G P D +
Sbjct: 183 IDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMF 242
Query: 371 VARALEFPKEPSVPGPAKDLIAQLLVKDPTRRMG 404
+ E D M
Sbjct: 243 GCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMA 276
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 2e-20
Identities = 81/416 (19%), Positives = 142/416 (34%), Gaps = 135/416 (32%)
Query: 35 SNPSSSTPSAAKTHHAPPRCNDDPCWKAIKEATSEGNNNNNNNPLTLSDLRFVHRLGSGD 94
+ S + + A++ +G+ P L L ++G G
Sbjct: 6 HHSSGVDLGTENLYFQSGVVTHEQFKAALRMVVDQGD------PRLL--LDSYVKIGEGS 57
Query: 95 IGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEM--LDHPFLPTLY 152
G V ++ ++G A K+MD R+ ++ R + E++ M H + +Y
Sbjct: 58 TGIVC----LAREKHSGRQVAVKMMDLRK-----QQRRELLFNEVVIMRDYQHFNVVEMY 108
Query: 153 AT--LDCPRWSCLLTEFCPGGDLH-VLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGI 209
+ + W +L EF GG L ++ Q R +E + V+ AL +LH G+
Sbjct: 109 KSYLVGEELW--VLMEFLQGGALTDIVSQ----VRLNEEQIATVCEAVLQALAYLHAQGV 162
Query: 210 IYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPP 269
I+RD+K +++L+ DG + L+DF AQ+ D
Sbjct: 163 IHRDIKSDSILLTLDGRVKLSDFGFC---------AQISKDVP----------------- 196
Query: 270 FGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPG--TPEIVAEPLDVRSMSFVGTHEYLAP 327
+RK +G P PE+++
Sbjct: 197 -----------------------KRKSLVGTPYWMAPEVISR------------------ 215
Query: 328 EIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEF-PKE--PSVP 384
+ VD W+LGI + E+ G P+ + +A++ P +
Sbjct: 216 -----SLYATEVDIWSLGIMVIEMVDGEPPYFSD-SPV-------QAMKRLRDSPPPKLK 262
Query: 385 GPAK------DLIAQLLVKDPTRRMGSKMGATAIK--RHQFFNGVNWALLRCAKPP 432
K D + ++LV+DP R ATA + H F L P
Sbjct: 263 NSHKVSPVLRDFLERMLVRDPQER------ATAQELLDHPF--------LLQTGLP 304
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 2e-20
Identities = 35/154 (22%), Positives = 63/154 (40%), Gaps = 16/154 (10%)
Query: 90 LGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSR---NKESRARIEREI--LEMLD 144
LGSG G V+ + K + K +++ ++ EI L ++
Sbjct: 32 LGSGAFGFVWT----AVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVE 87
Query: 145 HPFLPTLYATLDCPRWSCLLTEF-CPGGDL--HVLRQRQPDKRFHESAVRFYASEVVVAL 201
H + + + + L+ E G DL + R R E + ++V A+
Sbjct: 88 HANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRH----PRLDEPLASYIFRQLVSAV 143
Query: 202 EFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235
+L + II+RD+K EN+++ D I L DF +
Sbjct: 144 GYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSA 177
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 4e-13
Identities = 26/103 (25%), Positives = 43/103 (41%), Gaps = 13/103 (12%)
Query: 318 FVGTHEYLAPEIISGEG-HGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALE 376
F GT EY APE++ G G ++ W+LG+ ++ L + PF ++ V A+
Sbjct: 189 FCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELE------ETVEAAIH 242
Query: 377 FPKEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFN 419
P S L++ LL P RR + + +
Sbjct: 243 PPYLVS--KELMSLVSGLLQPVPERRTTLEK----LVTDPWVT 279
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 2e-20
Identities = 42/185 (22%), Positives = 74/185 (40%), Gaps = 33/185 (17%)
Query: 81 LSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREI- 139
++ V ++G G G V++ + + G A KV E S +E EI
Sbjct: 36 AKQIQMVKQIGKGRYGEVWMGKWR------GEKVAVKVFFTTEEASWFRE------TEIY 83
Query: 140 -LEMLDHPFLPTLYA-----TLDCPRWSCLLTEFCPGGDLH-VLRQRQPDKRFHESAVRF 192
++ H + A T + L+T++ G L+ L+ D +S ++
Sbjct: 84 QTVLMRHENILGFIAADIKGTGSWTQL-YLITDYHENGSLYDYLKSTTLD---AKSMLKL 139
Query: 193 YASEVVVALEFLHM--------MGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTST 244
A V L LH I +RDLK +N+LV+ +G + D L++K + T+
Sbjct: 140 -AYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNE 198
Query: 245 AQLVS 249
+
Sbjct: 199 VDIPP 203
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 3e-20
Identities = 37/153 (24%), Positives = 59/153 (38%), Gaps = 20/153 (13%)
Query: 90 LGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREIL-EMLDHPFL 148
LG G G V + K FA K++ R E E+ P +
Sbjct: 26 LGLGINGKVLQIFNKR----TQEKFALKMLQDCPKARR--------EVELHWRASQCPHI 73
Query: 149 PTLYA----TLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFL 204
+ + ++ E GG+L Q + D+ F E + A+++L
Sbjct: 74 VRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 133
Query: 205 HMMGIIYRDLKPENVLVRS---DGHIMLTDFDL 234
H + I +RD+KPEN+L S + + LTDF
Sbjct: 134 HSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 166
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 3e-11
Identities = 25/85 (29%), Positives = 34/85 (40%), Gaps = 7/85 (8%)
Query: 325 LAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELT----LANVVARALEFPKE 380
A E GE + + D W+LG+ ++ L G PF + EFP
Sbjct: 166 FAKETT-GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNP 224
Query: 381 P--SVPGPAKDLIAQLLVKDPTRRM 403
V K LI LL +PT+RM
Sbjct: 225 EWSEVSEEVKMLIRNLLKTEPTQRM 249
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 3e-20
Identities = 37/152 (24%), Positives = 64/152 (42%), Gaps = 20/152 (13%)
Query: 90 LGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREI--LEMLDHPF 147
+GSG+ G L+ + A K +++ + N ++REI L HP
Sbjct: 28 IGSGNFGVARLM----RDKLTKELVAVKYIERGAAIDEN------VQREIINHRSLRHPN 77
Query: 148 LPTLYATLDCPRWSCLLTEFCPGGDL--HVLRQRQPDKRFHESAVRFYASEVVVALEFLH 205
+ + P ++ E+ GG+L + RF E RF+ +++ + + H
Sbjct: 78 IVRFKEVILTPTHLAIIMEYASGGELYERICNA----GRFSEDEARFFFQQLLSGVSYCH 133
Query: 206 MMGIIYRDLKPENVLV--RSDGHIMLTDFDLS 235
M I +RDLK EN L+ + + DF S
Sbjct: 134 SMQICHRDLKLENTLLDGSPAPRLKICDFGYS 165
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 2e-13
Identities = 28/108 (25%), Positives = 47/108 (43%), Gaps = 9/108 (8%)
Query: 317 SFVGTHEYLAPEIISGEG-HGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARAL 375
S VGT Y+APE++ + G D W+ G+ ++ + G PF+ + + R L
Sbjct: 176 STVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRIL 235
Query: 376 ----EFPKEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFN 419
P + + LI+++ V DP R+ IK H +F
Sbjct: 236 SVKYSIPDDIRISPECCHLISRIFVADPATRISIP----EIKTHSWFL 279
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 91.8 bits (228), Expect = 4e-20
Identities = 41/150 (27%), Positives = 75/150 (50%), Gaps = 14/150 (9%)
Query: 90 LGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREI--LEMLDHPF 147
LG G G V + K G A K+++++++ S + + I REI L++ HP
Sbjct: 24 LGVGTFGKVKV----GKHELTGHKVAVKILNRQKIRSLDVVGK--IRREIQNLKLFRHPH 77
Query: 148 LPTLYATLDCPRWSCLLTEFCPGGDL--HVLRQRQPDKRFHESAVRFYASEVVVALEFLH 205
+ LY + P ++ E+ GG+L ++ + R E R +++ +++ H
Sbjct: 78 IIKLYQVISTPSDIFMVMEYVSGGELFDYICKN----GRLDEKESRRLFQQILSGVDYCH 133
Query: 206 MMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235
+++RDLKPENVL+ + + + DF LS
Sbjct: 134 RHMVVHRDLKPENVLLDAHMNAKIADFGLS 163
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 68.3 bits (167), Expect = 1e-12
Identities = 36/138 (26%), Positives = 58/138 (42%), Gaps = 19/138 (13%)
Query: 318 FVGTHEYLAPEIISGEG-HGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALE 376
G+ Y APE+ISG G VD W+ G+ ++ L GT PF DH TL +
Sbjct: 175 SCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDD-DHVPTLFKKICDG-I 232
Query: 377 FPKEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGVNWALLRCAKPPFIPR 436
F + L+ +L DP +R K I+ H++F +P+
Sbjct: 233 FYTPQYLNPSVISLLKHMLQVDPMKRATIK----DIREHEWFK------------QDLPK 276
Query: 437 PVTCRDLTTTNSSIDNSI 454
+ D + +++ ID+
Sbjct: 277 YLFPEDPSYSSTMIDDEA 294
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 4e-20
Identities = 40/183 (21%), Positives = 67/183 (36%), Gaps = 33/183 (18%)
Query: 83 DLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREI--L 140
D+ + +G G G V+ G A K+ R+ S E E+
Sbjct: 9 DITLLECVGKGRYGEVWRGSW------QGENVAVKIFSSRDEKS------WFRETELYNT 56
Query: 141 EMLDHPFLPTLYA-----TLDCPRWSCLLTEFCPGGDLH-VLRQRQPDKRFHESAVRFYA 194
ML H + A + L+T + G L+ L+ D S +R
Sbjct: 57 VMLRHENILGFIASDMTSRHSSTQL-WLITHYHEMGSLYDYLQLTTLD---TVSCLRI-V 111
Query: 195 SEVVVALEFLHM--------MGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQ 246
+ L LH+ I +RDLK +N+LV+ +G + D L++ ST+
Sbjct: 112 LSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLD 171
Query: 247 LVS 249
+ +
Sbjct: 172 VGN 174
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 87.6 bits (217), Expect = 2e-19
Identities = 30/206 (14%), Positives = 60/206 (29%), Gaps = 7/206 (3%)
Query: 53 RCNDDPCWKAIKEATSEGNNNNNNNPL----TLSDLRFVHRLGSGDIGSVYLVQLKSKSS 108
+ D C AIK + L+ L H + +
Sbjct: 26 KNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE--HPGIVRYFNAWLETPPEKWQE 83
Query: 109 NNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWSCLLTEFC 168
+ L S + ++ ++ + + + C
Sbjct: 84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLC 143
Query: 169 PGGDLH-VLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHI 227
+L + +R + ++ A+EFLH G+++RDLKP N+ D +
Sbjct: 144 RKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVV 203
Query: 228 MLTDFDLSLKGDNSTSTAQLVSDQSP 253
+ DF L D +++
Sbjct: 204 KVGDFGLVTAMDQDEEEQTVLTPMPA 229
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 78.4 bits (193), Expect = 4e-16
Identities = 30/103 (29%), Positives = 45/103 (43%), Gaps = 9/103 (8%)
Query: 317 SFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALE 376
VGT Y++PE I G + + VD ++LG+ +FEL Y + E R L+
Sbjct: 235 GQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQ----MERVRIITDVRNLK 290
Query: 377 FPKEPSVPGP-AKDLIAQLLVKDPTRRMGSKMGATAIKRHQFF 418
FP + P ++ +L PT R AT I + F
Sbjct: 291 FPLLFTQKYPQEHMMVQDMLSPSPTER----PEATDIIENAIF 329
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 3e-19
Identities = 79/376 (21%), Positives = 127/376 (33%), Gaps = 127/376 (33%)
Query: 74 NNNNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRA 133
+ +P ++G G G+VY + G A + M+ ++ + +
Sbjct: 14 SVGDPKKK--YTRFEKIGQGASGTVY----TAMDVATGQEVAIRQMNLQQ-----QPKKE 62
Query: 134 RIEREILEM--LDHPFLPTLYAT--LDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESA 189
I EIL M +P + + + W ++ E+ GG L + E
Sbjct: 63 LIINEILVMRENKNPNIVNYLDSYLVGDELW--VVMEYLAGGSLTDVVTETC---MDEGQ 117
Query: 190 VRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQLVS 249
+ E + ALEFLH +I+RD+K +N+L+ DG + LTDF AQ+
Sbjct: 118 IAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFC---------AQITP 168
Query: 250 DQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPG--TPEIV 307
+QS +R +G P PE+V
Sbjct: 169 EQS----------------------------------------KRSTMVGTPYWMAPEVV 188
Query: 308 AEPLDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTL 367
+ +G VD W+LGI E+ G P+ + L
Sbjct: 189 TR-----------------------KAYGPKVDIWSLGIMAIEMIEGEPPYLNE-NPL-- 222
Query: 368 ANVVARALEF-PKE--PSVPGPAK------DLIAQLLVKDPTRRMGSKMGATAIK--RHQ 416
RAL P + P K D + + L D +R +A + +HQ
Sbjct: 223 -----RALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKR------GSAKELLQHQ 271
Query: 417 FFNGVNWALLRCAKPP 432
F L+ AKP
Sbjct: 272 F--------LKIAKPL 279
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 9e-19
Identities = 50/175 (28%), Positives = 83/175 (47%), Gaps = 18/175 (10%)
Query: 62 AIKEATSEGNNNNNNNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDK 121
+++++ + + +P + ++ V LG G G VY K+K+ G AAKV++
Sbjct: 1 SMRKSREYEHVRRDLDPNEVWEI--VGELGDGAFGKVY----KAKNKETGALAAAKVIET 54
Query: 122 RELVSRNKESRARIEREILEM--LDHPFLPTLYAT--LDCPRWSCLLTEFCPGGDLHVLR 177
+ +E EI + DHP++ L D W ++ EFCPGG + +
Sbjct: 55 KS-----EEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLW--IMIEFCPGGAVDAIM 107
Query: 178 QRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDF 232
+ E ++ +++ AL FLH II+RDLK NVL+ +G I L DF
Sbjct: 108 LELD-RGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADF 161
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 6e-06
Identities = 28/119 (23%), Positives = 48/119 (40%), Gaps = 32/119 (26%)
Query: 317 SFVGTHEYLAPEIISGE-----GHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVV 371
SF+GT ++APE++ E + D W+LGI + E+ P + + +
Sbjct: 176 SFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL-NPM------ 228
Query: 372 ARALEF--PKE--PSVPGPA------KDLIAQLLVKDPTRRMGSKMGATAIK--RHQFF 418
R L K P++ P+ +D + L K+P R +A + H F
Sbjct: 229 -RVL-LKIAKSDPPTLLTPSKWSVEFRDFLKIALDKNPETR------PSAAQLLEHPFV 279
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 1e-18
Identities = 43/160 (26%), Positives = 67/160 (41%), Gaps = 23/160 (14%)
Query: 87 VHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREIL---EML 143
V +G+G G VY K + G A KVMD + I++EI +
Sbjct: 29 VELVGNGTYGQVY----KGRHVKTGQLAAIKVMDVTG------DEEEEIKQEINMLKKYS 78
Query: 144 DHPFLPTLY--------ATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYAS 195
H + T Y +D W L+ EFC G + L + E + +
Sbjct: 79 HHRNIATYYGAFIKKNPPGMDDQLW--LVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICR 136
Query: 196 EVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235
E++ L LH +I+RD+K +NVL+ + + L DF +S
Sbjct: 137 EILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVS 176
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 1e-05
Identities = 30/117 (25%), Positives = 50/117 (42%), Gaps = 29/117 (24%)
Query: 317 SFVGTHEYLAPEIISGE-----GHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVV 371
+F+GT ++APE+I+ + + D W+LGI E+ G P + H +
Sbjct: 188 TFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM-HPM------ 240
Query: 372 ARALEF--PKEPSVPG--------PAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFF 418
RAL F P+ P+ P + I LVK+ ++R + +H F
Sbjct: 241 -RAL-FLIPRNPA-PRLKSKKWSKKFQSFIESCLVKNHSQR----PATEQLMKHPFI 290
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 6e-18
Identities = 37/157 (23%), Positives = 63/157 (40%), Gaps = 14/157 (8%)
Query: 81 LSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREIL 140
L +G G G VY + + A +++D ++ R E
Sbjct: 32 FEQLEIGELIGKGRFGQVYHGRWHGE-------VAIRLIDIERDNEDQLKAFKR-EVMAY 83
Query: 141 EMLDHPFLPTLY-ATLDCPRWSCLLTEFCPGGDLH-VLRQRQPDKRFHESAVRFYASEVV 198
H + A + P ++T C G L+ V+R + R A E+V
Sbjct: 84 RQTRHENVVLFMGACMSPPHL-AIITSLCKGRTLYSVVRDA--KIVLDVNKTRQIAQEIV 140
Query: 199 VALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235
+ +LH GI+++DLK +NV +G +++TDF L
Sbjct: 141 KGMGYLHAKGILHKDLKSKNVFY-DNGKVVITDFGLF 176
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 4e-06
Identities = 18/96 (18%), Positives = 28/96 (29%), Gaps = 9/96 (9%)
Query: 316 MSFVGTHEYLAPEIISGEGHGN---------AVDWWTLGIFIFELFYGTTPFKGIDHELT 366
G +LAPEII D + LG +EL PFK E
Sbjct: 192 RIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAI 251
Query: 367 LANVVARALEFPKEPSVPGPAKDLIAQLLVKDPTRR 402
+ + + + D++ + R
Sbjct: 252 IWQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEER 287
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 1e-17
Identities = 41/172 (23%), Positives = 74/172 (43%), Gaps = 19/172 (11%)
Query: 65 EATSEGNNNNNNNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKREL 124
++ G N +P L + ++G G G V+ K + A K++D
Sbjct: 7 QSGLPGMQNLKADPEELFTK--LEKIGKGSFGEVF----KGIDNRTQKVVAIKIID---- 56
Query: 125 VSRNKESRARIEREILEM--LDHPFLPTLYATL--DCPRWSCLLTEFCPGGDLHVLRQRQ 180
+ ++ I++EI + D P++ Y + D W ++ E+ GG L +
Sbjct: 57 LEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLW--IIMEYLGGGSALDLLEPG 114
Query: 181 PDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDF 232
P E+ + E++ L++LH I+RD+K NVL+ G + L DF
Sbjct: 115 P---LDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADF 163
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 9e-09
Identities = 33/111 (29%), Positives = 52/111 (46%), Gaps = 23/111 (20%)
Query: 317 SFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALE 376
+FVGT ++APE+I + + D W+LGI EL G P + H + + L
Sbjct: 178 TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSEL-HPM-------KVLF 229
Query: 377 F-PKE--PSVPG----PAKDLIAQLLVKDPTRRMGSKMGATAIK--RHQFF 418
PK P++ G P K+ + L K+P+ R TA + +H+F
Sbjct: 230 LIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFR------PTAKELLKHKFI 274
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 3e-17
Identities = 38/163 (23%), Positives = 64/163 (39%), Gaps = 16/163 (9%)
Query: 74 NNNNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRA 133
++P L + +G G G+VY ++ N A K M ++ E
Sbjct: 48 FKDDPEKLFSD--LREIGHGSFGAVY----FARDVRNSEVVAIKKMSYSG--KQSNEKWQ 99
Query: 134 RIEREILEM--LDHPFLPTLYAT--LDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESA 189
I +E+ + L HP + W L+ E+C G +L + K E
Sbjct: 100 DIIKEVRFLQKLRHPNTIQYRGCYLREHTAW--LVMEYCLGSASDLLEVHK--KPLQEVE 155
Query: 190 VRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDF 232
+ + L +LH +I+RD+K N+L+ G + L DF
Sbjct: 156 IAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDF 198
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 3e-06
Identities = 28/116 (24%), Positives = 46/116 (39%), Gaps = 29/116 (25%)
Query: 317 SFVGTHEYLAPEIISGE---GHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVAR 373
SFVGT ++APE+I + VD W+LGI EL P + + +
Sbjct: 209 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM-NAM-------S 260
Query: 374 ALEF--PKE--PSVPGPA-----KDLIAQLLVKDPTRRMGSKMGATAIK--RHQFF 418
AL + + P++ ++ + L K P R T+ +H+F
Sbjct: 261 AL-YHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDR------PTSEVLLKHRFV 309
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 81.0 bits (200), Expect = 4e-17
Identities = 44/189 (23%), Positives = 73/189 (38%), Gaps = 31/189 (16%)
Query: 81 LSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREI- 139
L +L+ + +G G G+VY L + A KV N+++ E+ I
Sbjct: 12 LDNLKLLELIGRGRYGAVYKGSL------DERPVAVKVFS-----FANRQNFIN-EKNIY 59
Query: 140 -LEMLDHPFLPTLYA-----TLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFY 193
+ +++H + T D L+ E+ P G L S+ R
Sbjct: 60 RVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSD--WVSSCRL- 116
Query: 194 ASEVVVALEFLHMM---------GIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTST 244
A V L +LH I +RDL NVLV++DG +++DF LS++ +
Sbjct: 117 AHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLV 176
Query: 245 AQLVSDQSP 253
D +
Sbjct: 177 RPGEEDNAA 185
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 1e-16
Identities = 43/166 (25%), Positives = 72/166 (43%), Gaps = 20/166 (12%)
Query: 71 NNNNNNNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKE 130
++ P + + +LG G GSVY K+ G A K + + S +E
Sbjct: 20 EDSLTKQPEEV--FDVLEKLGEGSYGSVY----KAIHKETGQIVAIKQVP---VESDLQE 70
Query: 131 SRARIEREILEM--LDHPFLPTLYAT--LDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFH 186
I +EI M D P + Y + + W ++ E+C G + + + + K
Sbjct: 71 ----IIKEISIMQQCDSPHVVKYYGSYFKNTDLW--IVMEYCGAGSVSDIIRLRN-KTLT 123
Query: 187 ESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDF 232
E + + LE+LH M I+RD+K N+L+ ++GH L DF
Sbjct: 124 EDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADF 169
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 2e-08
Identities = 34/113 (30%), Positives = 50/113 (44%), Gaps = 25/113 (22%)
Query: 317 SFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALE 376
+ +GT ++APE+I G+ D W+LGI E+ G P+ I H + RA+
Sbjct: 184 TVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADI-HPM-------RAIF 235
Query: 377 F-PKE--PSVPGPA------KDLIAQLLVKDPTRRMGSKMGATAIK--RHQFF 418
P P+ P D + Q LVK P +R ATA + +H F
Sbjct: 236 MIPTNPPPTFRKPELWSDNFTDFVKQCLVKSPEQR------ATATQLLQHPFV 282
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 1e-16
Identities = 43/202 (21%), Positives = 73/202 (36%), Gaps = 17/202 (8%)
Query: 43 SAAKTHHAPPRCNDDPCWKAIKEATSEGNNNNNNNPLTLSDLRFVHRLGSGDIGSVYLVQ 102
S HH+ + + S + LGSG GSVY
Sbjct: 4 SHHHHHHSSGLVPRGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYS-- 61
Query: 103 LKSKSSNNGCFFAAKVMDKRELVSRNKESR-ARIEREI--LEMLDHPFLP---TLYATLD 156
++ A K ++K + + R+ E+ L+ + F L +
Sbjct: 62 --GIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF-SGVIRLLDWFE 118
Query: 157 CPRWSCLLTEFC-PGGDL-HVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDL 214
P L+ E P DL + +R E R + +V+ A+ H G+++RD+
Sbjct: 119 RPDSFVLILERPEPVQDLFDFITERG---ALQEELARSFFWQVLEAVRHCHNCGVLHRDI 175
Query: 215 KPENVLV-RSDGHIMLTDFDLS 235
K EN+L+ + G + L DF
Sbjct: 176 KDENILIDLNRGELKLIDFGSG 197
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 3e-13
Identities = 27/108 (25%), Positives = 43/108 (39%), Gaps = 17/108 (15%)
Query: 318 FVGTHEYLAPEIISGEG-HGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALE 376
F GT Y PE I HG + W+LGI ++++ G PF+ + ++ +
Sbjct: 208 FDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVF 261
Query: 377 FPKEPSVPGPAKDLIAQLLVKDPTRRMGSKMGAT--AIKRHQFFNGVN 422
F + S + LI L P+ R T I+ H + V
Sbjct: 262 FRQRVSS--ECQHLIRWCLALRPSDR------PTFEEIQNHPWMQDVL 301
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 1e-16
Identities = 41/163 (25%), Positives = 68/163 (41%), Gaps = 20/163 (12%)
Query: 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVM------DKRELVSRNKESRARI 135
L+F+ +LG G+ GSV + + N G A K + R+
Sbjct: 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFER--------- 91
Query: 136 EREILEMLDHPFLPTLYA--TLDCPRWSCLLTEFCPGGDLHV-LRQRQPDKRFHESAVRF 192
E EIL+ L H + R L+ E+ P G L L++ + R +
Sbjct: 92 EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE--RIDHIKLLQ 149
Query: 193 YASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235
Y S++ +E+L I+RDL N+LV ++ + + DF L+
Sbjct: 150 YTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT 192
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 1e-16
Identities = 41/164 (25%), Positives = 63/164 (38%), Gaps = 21/164 (12%)
Query: 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKV-------MDKRELVSRNKESRAR 134
L+ + LG G G V L + + N G A K +L
Sbjct: 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKK-------- 72
Query: 135 IEREILEMLDHPFLPTLYA--TLDCPRWSCLLTEFCPGGDLHV-LRQRQPDKRFHESAVR 191
E EIL L H + T D L+ EF P G L L + + + +
Sbjct: 73 -EIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKN--KINLKQQL 129
Query: 192 FYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235
YA ++ +++L ++RDL NVLV S+ + + DF L+
Sbjct: 130 KYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLT 173
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 2e-16
Identities = 34/156 (21%), Positives = 60/156 (38%), Gaps = 17/156 (10%)
Query: 90 LGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNK-ESRARIEREILEM------ 142
LG G G+V+ + A KV+ + ++ + E+ +
Sbjct: 39 LGKGGFGTVFA----GHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAG 94
Query: 143 LDHPFLPTLYATLDCPRWSCLLTEF-CPGGDL-HVLRQRQPDKRFHESAVRFYASEVVVA 200
HP + L + L+ E P DL + ++ E R + +VV A
Sbjct: 95 GGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKG---PLGEGPSRCFFGQVVAA 151
Query: 201 LEFLHMMGIIYRDLKPENVLVRSD-GHIMLTDFDLS 235
++ H G+++RD+K EN+L+ G L DF
Sbjct: 152 IQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSG 187
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 1e-13
Identities = 29/120 (24%), Positives = 41/120 (34%), Gaps = 14/120 (11%)
Query: 318 FVGTHEYLAPEIISGEG-HGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALE 376
F GT Y PE IS H W+LGI ++++ G PF+ ++ L
Sbjct: 198 FDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------EILEAELH 251
Query: 377 FPKEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFN-GVNWALLRCAKPPFIP 435
FP V LI + L P+ R I + L +K P
Sbjct: 252 FP--AHVSPDCCALIRRCLAPKPSSR----PSLEEILLDPWMQTPAEDVPLNPSKGGPAP 305
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 3e-16
Identities = 36/181 (19%), Positives = 62/181 (34%), Gaps = 33/181 (18%)
Query: 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREI-- 139
L+ + G G V+ K+ + A K+ ++ K+S E E+
Sbjct: 24 MPLQLLEVKARGRFGCVW------KAQLLNEYVAVKIFPIQD-----KQSWQN-EYEVYS 71
Query: 140 LEMLDHPFLPTLYATLDCPRWS----CLLTEFCPGGDLH-VLRQRQPDKRFHESAVRFYA 194
L + H + L+T F G L L+ A
Sbjct: 72 LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVVS---WNELCHI-A 127
Query: 195 SEVVVALEFLHMM----------GIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTST 244
+ L +LH I +RD+K +NVL++++ + DF L+LK + S
Sbjct: 128 ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSA 187
Query: 245 A 245
Sbjct: 188 G 188
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 3e-16
Identities = 41/163 (25%), Positives = 68/163 (41%), Gaps = 20/163 (12%)
Query: 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVM------DKRELVSRNKESRARI 135
L+F+ +LG G+ GSV + + N G A K + R+
Sbjct: 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFER--------- 60
Query: 136 EREILEMLDHPFLPTLYA--TLDCPRWSCLLTEFCPGGDLHV-LRQRQPDKRFHESAVRF 192
E EIL+ L H + R L+ E+ P G L L++ + R +
Sbjct: 61 EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE--RIDHIKLLQ 118
Query: 193 YASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235
Y S++ +E+L I+RDL N+LV ++ + + DF L+
Sbjct: 119 YTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT 161
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 6e-16
Identities = 35/164 (21%), Positives = 57/164 (34%), Gaps = 23/164 (14%)
Query: 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKV-------MDKRELVSRNKESRAR 134
L+ + LG G G V L + G A K +
Sbjct: 31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQ-------- 82
Query: 135 IEREILEMLDHPFLPTLYA--TLDCPRWSCLLTEFCPGGDLHV-LRQRQPDKRFHESAVR 191
E +IL L H + L+ E+ P G L L + + +
Sbjct: 83 -EIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH----SIGLAQLL 137
Query: 192 FYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235
+A ++ + +LH I+RDL NVL+ +D + + DF L+
Sbjct: 138 LFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLA 181
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 2e-15
Identities = 41/163 (25%), Positives = 71/163 (43%), Gaps = 20/163 (12%)
Query: 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKV------MDKRELVSRNKESRARI 135
L+++ +LG G+ GSV L + N G A K +R+
Sbjct: 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQR--------- 73
Query: 136 EREILEMLDHPFLPTLYA--TLDCPRWSCLLTEFCPGGDLHV-LRQRQPDKRFHESAVRF 192
E +IL+ L F+ + L+ E+ P G L L++ + R S +
Sbjct: 74 EIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRA--RLDASRLLL 131
Query: 193 YASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235
Y+S++ +E+L ++RDL N+LV S+ H+ + DF L+
Sbjct: 132 YSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLA 174
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 75.3 bits (185), Expect = 1e-14
Identities = 36/159 (22%), Positives = 65/159 (40%), Gaps = 27/159 (16%)
Query: 85 RFVHRLGSGDIGSVYL---VQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIERE--I 139
+ G +G +YL + NG K + + S + E++A E
Sbjct: 83 EVKGCIAHGGLGWIYLALDRNV------NGRPVVLKGL----VHSGDAEAQAMAMAERQF 132
Query: 140 LEMLDHPFLPTLY-----ATLDCPRWSCLLTEFCPGGDL-HVLRQRQPDKRFHESAVRFY 193
L + HP + ++ ++ E+ G L Q+ P A+ Y
Sbjct: 133 LAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKLPVAE----AIA-Y 187
Query: 194 ASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDF 232
E++ AL +LH +G++Y DLKPEN+++ + + L D
Sbjct: 188 LLEILPALSYLHSIGLVYNDLKPENIMLTEEQ-LKLIDL 225
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 57.9 bits (140), Expect = 4e-09
Identities = 20/97 (20%), Positives = 32/97 (32%), Gaps = 13/97 (13%)
Query: 313 VRSM----SFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLA 368
V + GT + APEI+ G A D +T+G + L G + L
Sbjct: 228 VSRINSFGYLYGTPGFQAPEIVRT-GPTVATDIYTVGRTLAALTLDLPTRNG-RYVDGLP 285
Query: 369 NVVARALEFPKEPSVPGPAKDLIAQLLVKDPTRRMGS 405
E L+ + + DP +R +
Sbjct: 286 -------EDDPVLKTYDSYGRLLRRAIDPDPRQRFTT 315
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 1e-14
Identities = 35/167 (20%), Positives = 70/167 (41%), Gaps = 18/167 (10%)
Query: 85 RFVHRLGSGDIGSVYL---VQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILE 141
+ V +LG G + +VYL L A K + +E+ R ERE+
Sbjct: 14 KIVDKLGGGGMSTVYLAEDTIL-------NIKVAIKAI--FIPPREKEETLKRFEREVHN 64
Query: 142 M--LDHPFLPTLYATLDCPRWSCLLTEFCPGGDL-HVLRQRQPDKRFHESAVRFYASEVV 198
L H + ++ + L+ E+ G L + P + ++++
Sbjct: 65 SSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGP---LSVDTAINFTNQIL 121
Query: 199 VALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTA 245
++ H M I++RD+KP+N+L+ S+ + + DF ++ ++ T
Sbjct: 122 DGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQ 168
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 6e-08
Identities = 23/96 (23%), Positives = 39/96 (40%), Gaps = 17/96 (17%)
Query: 317 SFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARAL- 375
+GT +Y +PE GE D +++GI ++E+ G PF G V+ A+
Sbjct: 171 HVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNG-------ETAVSIAIK 223
Query: 376 ----EFPKEPS-----VPGPAKDLIAQLLVKDPTRR 402
P + +P ++I + KD R
Sbjct: 224 HIQDSVPNVTTDVRKDIPQSLSNVILRATEKDKANR 259
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 3e-14
Identities = 36/176 (20%), Positives = 71/176 (40%), Gaps = 24/176 (13%)
Query: 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVM-------DKRELVSRNKESRAR 134
++ + + LGSG G+VY + A K + +E++
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD-------- 66
Query: 135 IEREILEMLDHPFLPTLYAT-LDCPRWSCLLTEFCPGGDLHV-LRQRQPDKRFHESAVRF 192
E ++ +D+P + L L L+T+ P G L +R+ +
Sbjct: 67 -EAYVMASVDNPHVCRLLGICLTSTVQ--LITQLMPFGCLLDYVREH--KDNIGSQYLLN 121
Query: 193 YASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS--LKGDNSTSTAQ 246
+ ++ + +L +++RDL NVLV++ H+ +TDF L+ L + A+
Sbjct: 122 WCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 177
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 3e-14
Identities = 41/166 (24%), Positives = 69/166 (41%), Gaps = 16/166 (9%)
Query: 85 RFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIERE--ILEM 142
R +G G +G VY + + A K+M E +S + R R++RE
Sbjct: 37 RLRRLVGRGGMGDVYEAEDTVR----ERIVALKLM--SETLSSDPVFRTRMQREARTAGR 90
Query: 143 LDHPFLPTLYAT--LDCPRWSCLLTEFCPGGDL-HVLRQRQPDKRFHESAVRFYASEVVV 199
L P + ++ +D + + G DL +LR++ P ++
Sbjct: 91 LQEPHVVPIHDFGEIDGQLY--VDMRLINGVDLAAMLRRQGP---LAPPRAVAIVRQIGS 145
Query: 200 ALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTA 245
AL+ H G +RD+KPEN+LV +D L DF ++ + T
Sbjct: 146 ALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQ 191
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 55.3 bits (134), Expect = 1e-08
Identities = 25/94 (26%), Positives = 42/94 (44%), Gaps = 9/94 (9%)
Query: 317 SFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALE 376
+ VGT Y+APE S D + L ++E G+ P++G D L+ + A +
Sbjct: 194 NTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQG-D---QLSVMGAHINQ 249
Query: 377 FPKEPS-----VPGPAKDLIAQLLVKDPTRRMGS 405
PS +P +IA+ + K+P R +
Sbjct: 250 AIPRPSTVRPGIPVAFDAVIARGMAKNPEDRYVT 283
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 1e-13
Identities = 33/176 (18%), Positives = 66/176 (37%), Gaps = 24/176 (13%)
Query: 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKV-------MDKRELVSRNKESRAR 134
++LR + LGSG G+V+ + + KV + +
Sbjct: 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTD-------- 64
Query: 135 IEREILEMLDHPFLPTLYAT-LDCPRWSCLLTEFCPGGDLHV-LRQRQPDKRFHESAVRF 192
+ LDH + L L+T++ P G L +RQ + +
Sbjct: 65 -HMLAIGSLDHAHIVRLLGLCPGSSLQ--LVTQYLPLGSLLDHVRQHRG--ALGPQLLLN 119
Query: 193 YASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS--LKGDNSTSTAQ 246
+ ++ + +L G+++R+L NVL++S + + DF ++ L D+
Sbjct: 120 WGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYS 175
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 1e-13
Identities = 42/193 (21%), Positives = 77/193 (39%), Gaps = 19/193 (9%)
Query: 46 KTHHAPPRCNDDPCWKAIKEATSEGNNNNNNNPLTLSDLRFVHRLGSGDIGSVYLVQLKS 105
+ + DP +A+ + T+E + S + +G+G+ G VY LK+
Sbjct: 18 ENLYFQGAMGSDPN-QAVLKFTTE---------IHPSCVTRQKVIGAGEFGEVYKGMLKT 67
Query: 106 KSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYA--TLDCPRWSCL 163
S A K + + + + E I+ H + L + P +
Sbjct: 68 SSGKKEVPVAIKTL--KAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM--I 123
Query: 164 LTEFCPGGDLHV-LRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVR 222
+TE+ G L LR++ D F + + +++L M ++RDL N+LV
Sbjct: 124 ITEYMENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVN 181
Query: 223 SDGHIMLTDFDLS 235
S+ ++DF LS
Sbjct: 182 SNLVCKVSDFGLS 194
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 69.8 bits (171), Expect = 1e-13
Identities = 24/159 (15%), Positives = 43/159 (27%), Gaps = 30/159 (18%)
Query: 85 RFVHRLGSGDIGSVYL---------VQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARI 135
R + G + V A +D + +
Sbjct: 34 RLLIFHGGVPPLQFWQALDTALDRQV-------------ALTFVDPQ--GVLPDDVLQET 78
Query: 136 ERE--ILEMLDHPFLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFY 193
L +D P + + + ++ E+ GG L + P A+R
Sbjct: 79 LSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADTSPS---PVGAIR-A 134
Query: 194 ASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDF 232
+ A + H G+ P V V DG ++L
Sbjct: 135 MQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYP 173
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 2e-06
Identities = 13/89 (14%), Positives = 23/89 (25%), Gaps = 12/89 (13%)
Query: 319 VGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFP 378
+ + D +G ++ L P LA P
Sbjct: 170 LAYPATMPDA-------NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQP 222
Query: 379 KEPS-----VPGPAKDLIAQLLVKDPTRR 402
EP+ +P + A+ + D R
Sbjct: 223 IEPADIDRDIPFQISAVAARSVQGDGGIR 251
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 2e-13
Identities = 52/284 (18%), Positives = 94/284 (33%), Gaps = 78/284 (27%)
Query: 90 LGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKES---RARIEREILEML--- 143
+G G G V L + +N ++A KV+ RN + A+IE +IL+ +
Sbjct: 43 MGDGTFGRV----LLCQHIDNKKYYAVKVV-------RNIKKYTRSAKIEADILKKIQND 91
Query: 144 ---DHPFLPTLYATLDCPRWSCLLTEFCPGGDLH-VLRQRQPDKRFHESAVRFYASEVVV 199
++ + + CL+ E G L+ ++ + FH ++ Y E++
Sbjct: 92 DINNNNIV-KYHGKFMYYDHMCLIFEPL-GPSLYEIITRNN-YNGFHIEDIKLYCIEILK 148
Query: 200 ALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQ 259
AL +L M + + DLKPEN+L+ +
Sbjct: 149 ALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRR-------------VTDGKKIQIYR 195
Query: 260 PNDCAV---DQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSM 316
+ D FG + + ++
Sbjct: 196 TKSTGIKLID---FG-CATFKSDYHGSIINTRQ--------------------------- 224
Query: 317 SFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKG 360
Y APE+I G + D W+ G + EL+ G+ F+
Sbjct: 225 -------YRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRT 261
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 2e-13
Identities = 37/170 (21%), Positives = 69/170 (40%), Gaps = 22/170 (12%)
Query: 85 RFVHRLGSGDIGSVYL---VQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREIL- 140
LG G + V+L ++ A KV+ + +L +R+ R RE
Sbjct: 15 ELGEILGFGGMSEVHLARDLRD-------HRDVAVKVL-RADL-ARDPSFYLRFRREAQN 65
Query: 141 -EMLDHPFLPTLY----ATLDCPRWSCLLTEFCPGGDLH-VLRQRQPDKRFHESAVRFYA 194
L+HP + +Y A ++ E+ G L ++ P
Sbjct: 66 AAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVI 122
Query: 195 SEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTST 244
++ AL F H GII+RD+KP N+++ + + + DF ++ +S ++
Sbjct: 123 ADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNS 172
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 5e-08
Identities = 25/91 (27%), Positives = 43/91 (47%), Gaps = 8/91 (8%)
Query: 317 SFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALE 376
+ +GT +YL+PE G+ D ++LG ++E+ G PF G D +++A E
Sbjct: 178 AVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTG-DSPVSVA--YQHVRE 234
Query: 377 FPKEPS-----VPGPAKDLIAQLLVKDPTRR 402
P PS + ++ + L K+P R
Sbjct: 235 DPIPPSARHEGLSADLDAVVLKALAKNPENR 265
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 3e-13
Identities = 43/162 (26%), Positives = 69/162 (42%), Gaps = 24/162 (14%)
Query: 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKV-----MDKRELVSRNKESRARIE 136
+D+ H+LG G G VY K S A K M+ E + E
Sbjct: 13 TDITMKHKLGGGQYGEVYEGVWKKYSLT----VAVKTLKEDTMEVEEFLK---------E 59
Query: 137 REILEMLDHPFLPTLYA--TLDCPRWSCLLTEFCPGGDLHV-LRQRQPDKRFHESAVRFY 193
+++ + HP L L T + P + ++TEF G+L LR+ + +
Sbjct: 60 AAVMKEIKHPNLVQLLGVCTREPPFY--IITEFMTYGNLLDYLRECNRQEVSAVVLLYM- 116
Query: 194 ASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235
A+++ A+E+L I+RDL N LV + + + DF LS
Sbjct: 117 ATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLS 158
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 3e-13
Identities = 47/170 (27%), Positives = 73/170 (42%), Gaps = 11/170 (6%)
Query: 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARI-EREIL 140
DLR + +LG G G V + + S A K + K +++S+ + I E +
Sbjct: 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSV-AVKCL-KPDVLSQPEAMDDFIREVNAM 75
Query: 141 EMLDHPFLPTLYA-TLDCPRWSCLLTEFCPGGDLHV-LRQRQPDKRFHESAVRFYASEVV 198
LDH L LY L P ++TE P G L LR+ Q F + YA +V
Sbjct: 76 HSLDHRNLIRLYGVVLTPPMK--MVTELAPLGSLLDRLRKHQG--HFLLGTLSRYAVQVA 131
Query: 199 VALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS--LKGDNSTSTAQ 246
+ +L I+RDL N+L+ + + + DF L L ++ Q
Sbjct: 132 EGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQ 181
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 5e-13
Identities = 35/169 (20%), Positives = 70/169 (41%), Gaps = 10/169 (5%)
Query: 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILE 141
++ + + LGSG G+VY + A K + + + + E ++
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILD-EAYVMA 72
Query: 142 MLDHPFLPTLYAT-LDCPRWSCLLTEFCPGGDLHV-LRQRQPDKRFHESAVRFYASEVVV 199
+D+P + L L L+T+ P G L +R+ + + ++
Sbjct: 73 SVDNPHVCRLLGICLTSTVQ--LITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAK 128
Query: 200 ALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS--LKGDNSTSTAQ 246
+ +L +++RDL NVLV++ H+ +TDF L+ L + A+
Sbjct: 129 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 177
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 5e-13
Identities = 39/157 (24%), Positives = 69/157 (43%), Gaps = 15/157 (9%)
Query: 85 RFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLD 144
R ++GSG G +YL G +V K E V + K + IE +I +M+
Sbjct: 12 RLGRKIGSGSFGDIYLG----TDIAAG----EEVAIKLECV-KTKHPQLHIESKIYKMMQ 62
Query: 145 H-PFLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEF 203
+PT+ ++ ++ E G L L ++F V A +++ +E+
Sbjct: 63 GGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEY 120
Query: 204 LHMMGIIYRDLKPENVLVRSDGH---IMLTDFDLSLK 237
+H I+RD+KP+N L+ + + DF L+ K
Sbjct: 121 IHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 157
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 7e-13
Identities = 46/186 (24%), Positives = 76/186 (40%), Gaps = 24/186 (12%)
Query: 58 PCWKAIKEATSEGNNNNNNNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAK 117
P K K + N + + +D+ H+LG G G VY K S A K
Sbjct: 196 PAPKRNKPTIYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTV----AVK 251
Query: 118 V-----MDKRELVSRNKESRARIEREILEMLDHPFLPTLYA--TLDCPRWSCLLTEFCPG 170
M+ E + E +++ + HP L L T + P + ++TEF
Sbjct: 252 TLKEDTMEVEEFLK---------EAAVMKEIKHPNLVQLLGVCTREPPFY--IITEFMTY 300
Query: 171 GDLHV-LRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIML 229
G+L LR+ + + A+++ A+E+L I+R+L N LV + + +
Sbjct: 301 GNLLDYLRECNRQEVSAVVLLYM-ATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKV 359
Query: 230 TDFDLS 235
DF LS
Sbjct: 360 ADFGLS 365
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 8e-13
Identities = 38/178 (21%), Positives = 61/178 (34%), Gaps = 35/178 (19%)
Query: 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAA-KVM-------DKRELVSRNKESRA 133
S +RF+ LG G VY L + A K + + E
Sbjct: 9 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRH------- 61
Query: 134 RIEREILEMLDHPFLPTLYA--TLDCPRWSCLLTEFCPGGDLH-VLRQRQPDKRFHESAV 190
E + L HP + L T D P ++ +C GDLH L R P +
Sbjct: 62 --EAMLRARLQHPNVVCLLGVVTKDQPL--SMIFSYCSHGDLHEFLVMRSPHSDVGSTDD 117
Query: 191 RFYASEVVVALEFLHM-------------MGIIYRDLKPENVLVRSDGHIMLTDFDLS 235
+ +F+H+ ++++DL NVLV ++ ++D L
Sbjct: 118 DRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLF 175
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 9e-13
Identities = 37/159 (23%), Positives = 65/159 (40%), Gaps = 17/159 (10%)
Query: 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILE 141
DL ++G G+ G V+ +L++ ++ A K RE + + +A+ +E
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTL----VAVKSC--RETLP--PDLKAKFLQEARI 165
Query: 142 M--LDHPFLPTLYA--TLDCPRWSCLLTEFCPGGDL-HVLRQRQPDKRFHESAVRFYASE 196
+ HP + L T P + ++ E GGD LR R + +
Sbjct: 166 LKQYSHPNIVRLIGVCTQKQPIY--IVMELVQGGDFLTFLRTEGA--RLRVKTLLQMVGD 221
Query: 197 VVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235
+E+L I+RDL N LV + ++DF +S
Sbjct: 222 AAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMS 260
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 1e-12
Identities = 42/157 (26%), Positives = 64/157 (40%), Gaps = 10/157 (6%)
Query: 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILE 141
S + +GSGD G V +L+ + A K + K R + E I+
Sbjct: 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRD-VPVAIKAL-KAGYTERQRRDFLS-EASIMG 105
Query: 142 MLDHPFLPTLYA--TLDCPRWSCLLTEFCPGGDLHV-LRQRQPDKRFHESAVRFYASEVV 198
DHP + L T ++TE+ G L LR D +F + V
Sbjct: 106 QFDHPNIIRLEGVVTRGRLAM--IVTEYMENGSLDTFLRTH--DGQFTIMQLVGMLRGVG 161
Query: 199 VALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235
+ +L +G ++RDL NVLV S+ ++DF LS
Sbjct: 162 AGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLS 198
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 1e-12
Identities = 43/154 (27%), Positives = 69/154 (44%), Gaps = 23/154 (14%)
Query: 87 VHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREI--LEML- 143
V +LG G V+ ++ + N K++ + +I+REI LE L
Sbjct: 41 VRKLGRGKYSEVF----EAINITNNEKVVVKIL--------KPVKKKKIKREIKILENLR 88
Query: 144 DHPFLPTLYATL--DCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVAL 201
P + TL + R L+ E D L Q D + +RFY E++ AL
Sbjct: 89 GGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTD--YD---IRFYMYEILKAL 143
Query: 202 EFLHMMGIIYRDLKPENVLV-RSDGHIMLTDFDL 234
++ H MGI++RD+KP NV++ + L D+ L
Sbjct: 144 DYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGL 177
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 1e-12
Identities = 55/282 (19%), Positives = 92/282 (32%), Gaps = 78/282 (27%)
Query: 90 LGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKES---RARIEREILEML--- 143
LG G G V ++ A K++ RN AR+E +L+ +
Sbjct: 27 LGEGTFGKVVECLDHAR---GKSQVALKII-------RNVGKYREAARLEINVLKKIKEK 76
Query: 144 ----DHPFLPTLYATLDCPRWSCLLTEFCPGGDLH-VLRQRQPDKRFHESAVRFYASEVV 198
+ + + C+ E G + L++ + + VR A ++
Sbjct: 77 DKENKFLCV-LMSDWFNFHGHMCIAFELL-GKNTFEFLKENN-FQPYPLPHVRHMAYQLC 133
Query: 199 VALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQ 258
AL FLH + + DLKPEN+L + L + S + + +T+ V+D
Sbjct: 134 HALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVAD-------- 185
Query: 259 QPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSF 318
FG S+ V+ H
Sbjct: 186 -----------FG-SATFDHEHHTTIVATRH----------------------------- 204
Query: 319 VGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKG 360
Y PE+I G D W++G +FE + G T F+
Sbjct: 205 -----YRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQT 241
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 2e-12
Identities = 57/284 (20%), Positives = 87/284 (30%), Gaps = 100/284 (35%)
Query: 90 LGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKES---RARIEREILEML--- 143
+G G G V +K+ A K++ RN++ +A E ILE L
Sbjct: 105 IGKGSFGQV----VKAYDHKVHQHVALKMV-------RNEKRFHRQAAEEIRILEHLRKQ 153
Query: 144 ----DHPFLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVV 199
+ + C+ E +L+ L ++ + F VR +A ++
Sbjct: 154 DKDNTMNVI-HMLENFTFRNHICMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQ 211
Query: 200 ALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQ 259
L+ LH II+ DLKPEN I+L
Sbjct: 212 CLDALHKNRIIHCDLKPEN--------ILLKQ---------------------------- 235
Query: 260 PNDCAV---DQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSM 316
+ D FG SSC + +
Sbjct: 236 QGRSGIKVID---FG-SSCYEHQRVYTYIQSRF--------------------------- 264
Query: 317 SFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKG 360
Y APE+I G +G +D W+LG + EL G G
Sbjct: 265 -------YRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPG 301
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 2e-12
Identities = 37/177 (20%), Positives = 61/177 (34%), Gaps = 34/177 (19%)
Query: 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAA-KVM------DKRELVSRNKESRAR 134
D+ LG G G V+L + + S A K + +++
Sbjct: 15 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQR-------- 66
Query: 135 IEREILEMLDHPFLPTLYA--TLDCPRWSCLLTEFCPGGDLH-VLRQRQPDKRFHESAVR 191
E E+L L H + Y P ++ E+ GDL+ LR PD
Sbjct: 67 -EAELLTNLQHEHIVKFYGVCGDGDPL--IMVFEYMKHGDLNKFLRAHGPDAMILVDGQP 123
Query: 192 FYASEVVVALEFLHM-------------MGIIYRDLKPENVLVRSDGHIMLTDFDLS 235
A + + LH+ ++RDL N LV ++ + + DF +S
Sbjct: 124 RQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMS 180
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 3e-12
Identities = 32/159 (20%), Positives = 62/159 (38%), Gaps = 17/159 (10%)
Query: 85 RFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLD 144
+ R+G G G ++ + N +V K E R+ + R E ++L
Sbjct: 13 KVGRRIGEGSFGVIFEG----TNLLNN----QQVAIKFEPR-RSDAPQLRDEYRTYKLLA 63
Query: 145 H-PFLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEF 203
+P +Y + L+ + G L L ++F V A +++ ++
Sbjct: 64 GCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQS 121
Query: 204 LHMMGIIYRDLKPENVLVRSDGH-----IMLTDFDLSLK 237
+H ++YRD+KP+N L+ I + DF +
Sbjct: 122 IHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 160
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 4e-12
Identities = 31/172 (18%), Positives = 59/172 (34%), Gaps = 29/172 (16%)
Query: 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAA-KVM-------DKRELVSRNKESRA 133
+ LG G G VY K + A K + ++ E ++
Sbjct: 25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN------- 77
Query: 134 RIEREILEMLDHPFLPTLYA--TLDCPRWSCLLTEFCPGGDLH-VLRQRQPDKRFHESAV 190
E +++ + + L + P ++ E GDL LR +P +
Sbjct: 78 --EASVMKEFNCHHVVRLLGVVSQGQPT--LVIMELMTRGDLKSYLRSLRPAMANNPVLA 133
Query: 191 RF-------YASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235
A E+ + +L+ ++RDL N +V D + + DF ++
Sbjct: 134 PPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMT 185
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 4e-12
Identities = 39/169 (23%), Positives = 74/169 (43%), Gaps = 11/169 (6%)
Query: 82 SDLRFVHR-LGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREIL 140
L + LGSG+ G+V + K A K++ K E + E ++
Sbjct: 16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTV--AVKIL-KNEANDPALKDELLAEANVM 72
Query: 141 EMLDHPFLPTLYATLDCPRWSCLLTEFCPGGDLHV-LRQRQPDKRFHESAVRFYASEVVV 199
+ LD+P++ + + W L+ E G L+ L+Q + + + +V +
Sbjct: 73 QQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQN---RHVKDKNIIELVHQVSM 128
Query: 200 ALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS--LKGDNSTSTAQ 246
+++L ++RDL NVL+ + + ++DF LS L+ D + AQ
Sbjct: 129 GMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 177
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 64.9 bits (159), Expect = 6e-12
Identities = 44/162 (27%), Positives = 66/162 (40%), Gaps = 26/162 (16%)
Query: 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKV-----MDKRELVSRNKESRARIE 136
S+L FV +GSG G V+L +K A K M + + + E
Sbjct: 8 SELTFVQEIGSGQFGLVHLGYWLNKDK-----VAIKTIREGAMSEEDFIE---------E 53
Query: 137 REILEMLDHPFLPTLYA--TLDCPRWSCLLTEFCPGGDLHV-LRQRQPDKRFHESAVRFY 193
E++ L HP L LY P L+TEF G L LR + F +
Sbjct: 54 AEVMMKLSHPKLVQLYGVCLEQAPIC--LVTEFMEHGCLSDYLRTQ--RGLFAAETLLGM 109
Query: 194 ASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235
+V + +L +I+RDL N LV + I ++DF ++
Sbjct: 110 CLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMT 151
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 7e-12
Identities = 38/157 (24%), Positives = 67/157 (42%), Gaps = 10/157 (6%)
Query: 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILE 141
+++ +G+G+ G V +LK S A K + K + + E I+
Sbjct: 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKE-ISVAIKTL-KVGYTEKQRRDFLG-EASIMG 101
Query: 142 MLDHPFLPTLYA--TLDCPRWSCLLTEFCPGGDLHV-LRQRQPDKRFHESAVRFYASEVV 198
DHP + L T P ++TE+ G L LR+ D +F + +
Sbjct: 102 QFDHPNIIRLEGVVTKSKPVM--IVTEYMENGSLDSFLRKH--DAQFTVIQLVGMLRGIA 157
Query: 199 VALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235
+++L MG ++RDL N+L+ S+ ++DF L
Sbjct: 158 SGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLG 194
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 7e-12
Identities = 38/176 (21%), Positives = 63/176 (35%), Gaps = 33/176 (18%)
Query: 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAA-KVM------DKRELVSRNKESRAR 134
D+ LG G G V+L + + A K + +++
Sbjct: 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQR-------- 92
Query: 135 IEREILEMLDHPFLPTLYA--TLDCPRWSCLLTEFCPGGDLH-VLRQRQPDKRFHESAVR 191
E E+L ML H + + T P ++ E+ GDL+ LR PD +
Sbjct: 93 -EAELLTMLQHQHIVRFFGVCTEGRPL--LMVFEYMRHGDLNRFLRSHGPDAKLLAGGED 149
Query: 192 F------------YASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235
AS+V + +L + ++RDL N LV + + DF +S
Sbjct: 150 VAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMS 205
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 9e-12
Identities = 52/282 (18%), Positives = 85/282 (30%), Gaps = 78/282 (27%)
Query: 90 LGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKES---RARIEREILEML--- 143
LG G G V G A K++ +N + AR E ++LE L
Sbjct: 22 LGEGAFGKVVECI---DHKAGGRHVAVKIV-------KNVDRYCEAARSEIQVLEHLNTT 71
Query: 144 ----DHPFLPTLYATLDCPRWSCLLTEFCPGGDLH-VLRQRQPDKRFHESAVRFYASEVV 198
+ + + C++ E G + +++ F +R A ++
Sbjct: 72 DPNSTFRCV-QMLEWFEHHGHICIVFELL-GLSTYDFIKENG-FLPFRLDHIRKMAYQIC 128
Query: 199 VALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQ 258
++ FLH + + DLKPEN+L + + + + V D
Sbjct: 129 KSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVD-------- 180
Query: 259 QPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSF 318
FG S+ VS H
Sbjct: 181 -----------FG-SATYDDEHHSTLVSTRH----------------------------- 199
Query: 319 VGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKG 360
Y APE+I G D W++G + E + G T F
Sbjct: 200 -----YRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPT 236
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 1e-11
Identities = 38/173 (21%), Positives = 70/173 (40%), Gaps = 24/173 (13%)
Query: 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVM----DKRELVSRNKESRARIER 137
+L+ + +G G+ G V L + A K + + ++ E
Sbjct: 193 KELKLLQTIGKGEFGDVMLGDYRGNK------VAVKCIKNDATAQAFLA---------EA 237
Query: 138 EILEMLDHPFLPTLYA--TLDCPRWSCLLTEFCPGGDLHV-LRQRQPDKRFHESAVRFYA 194
++ L H L L + ++TE+ G L LR R + ++F +
Sbjct: 238 SVMTQLRHSNLVQLLGVIVEEKGGL-YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKF-S 295
Query: 195 SEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQL 247
+V A+E+L ++RDL NVLV D ++DF L+ + ++ T +L
Sbjct: 296 LDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL 348
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 64.1 bits (157), Expect = 1e-11
Identities = 40/163 (24%), Positives = 63/163 (38%), Gaps = 28/163 (17%)
Query: 82 SDLRFVHRLGSGDIGSVYLVQLKS------KSSNNGCFFAAKVMDKRELVSRNKESRARI 135
++ + LGSG G V L + K K G M + E
Sbjct: 8 EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS------MSEDEFFQ--------- 52
Query: 136 EREILEMLDHPFLPTLYA--TLDCPRWSCLLTEFCPGGDL-HVLRQRQPDKRFHESAVRF 192
E + + L HP L Y + + P + ++TE+ G L + LR K S +
Sbjct: 53 EAQTMMKLSHPKLVKFYGVCSKEYPIY--IVTEYISNGCLLNYLRSH--GKGLEPSQLLE 108
Query: 193 YASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235
+V + FL I+RDL N LV D + ++DF ++
Sbjct: 109 MCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMT 151
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 1e-11
Identities = 40/156 (25%), Positives = 64/156 (41%), Gaps = 9/156 (5%)
Query: 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILE 141
+ +G G G V+ S N A K K +E + E +
Sbjct: 15 ERIELGRCIGEGQFGDVHQGIYMSPE-NPALAVAIKTC-KNCTSDSVREKFLQ-EALTMR 71
Query: 142 MLDHPFLPTLYA-TLDCPRWSCLLTEFCPGGDLHV-LRQRQPDKRFHESAVRFYASEVVV 199
DHP + L + P W ++ E C G+L L+ R+ +++ YA ++
Sbjct: 72 QFDHPHIVKLIGVITENPVW--IIMELCTLGELRSFLQVRKY--SLDLASLILYAYQLST 127
Query: 200 ALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235
AL +L ++RD+ NVLV S+ + L DF LS
Sbjct: 128 ALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLS 163
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 65.7 bits (160), Expect = 1e-11
Identities = 43/161 (26%), Positives = 72/161 (44%), Gaps = 10/161 (6%)
Query: 89 RLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFL 148
LG G+ GSV + + A KV+ K+ + E R E +I+ LD+P++
Sbjct: 343 ELGCGNFGSVRQGVYRMR--KKQIDVAIKVL-KQGTEKADTEEMMR-EAQIMHQLDNPYI 398
Query: 149 PTLYATLDCPRWSCLLTEFCPGGDLH-VLRQRQPDKRFHESAVRFYASEVVVALEFLHMM 207
L L+ E GG LH L + + S V +V + +++L
Sbjct: 399 VRLIGVCQAEAL-MLVMEMAGGGPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEEK 455
Query: 208 GIIYRDLKPENVLVRSDGHIMLTDFDLS--LKGDNSTSTAQ 246
++R+L NVL+ + + ++DF LS L D+S TA+
Sbjct: 456 NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR 496
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 1e-11
Identities = 36/161 (22%), Positives = 64/161 (39%), Gaps = 24/161 (14%)
Query: 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVM----DKRELVSRNKESRARIER 137
+L+ + +G G+ G V L + A K + + ++ E
Sbjct: 21 KELKLLQTIGKGEFGDVMLGDYRGNK------VAVKCIKNDATAQAFLA---------EA 65
Query: 138 EILEMLDHPFLPTLYA--TLDCPRWSCLLTEFCPGGDLHV-LRQRQPDKRFHESAVRFYA 194
++ L H L L + ++TE+ G L LR R + ++F +
Sbjct: 66 SVMTQLRHSNLVQLLGVIVEEKGGL-YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKF-S 123
Query: 195 SEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235
+V A+E+L ++RDL NVLV D ++DF L+
Sbjct: 124 LDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLT 164
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 2e-11
Identities = 40/182 (21%), Positives = 65/182 (35%), Gaps = 37/182 (20%)
Query: 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVM-------DKRELVSRNKESRAR 134
+D++F +G G+ G V ++K A K M D R+
Sbjct: 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDA--AIKRMKEYASKDDHRDFAG-------- 74
Query: 135 IEREILEML-DHPFLPTLYA--TLDCPRWSCLLTEFCPGGDLH-VLRQRQPDKRFHESAV 190
E E+L L HP + L L E+ P G+L LR+ + + A+
Sbjct: 75 -ELEVLCKLGHHPNIINLLGACEHRGYL--YLAIEYAPHGNLLDFLRKSRVLETDPAFAI 131
Query: 191 RFYASEVVVALEFLHM-------------MGIIYRDLKPENVLVRSDGHIMLTDFDLSLK 237
+ + + + LH I+RDL N+LV + + DF LS
Sbjct: 132 ANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRG 191
Query: 238 GD 239
+
Sbjct: 192 QE 193
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 65.3 bits (159), Expect = 2e-11
Identities = 46/205 (22%), Positives = 79/205 (38%), Gaps = 10/205 (4%)
Query: 33 SGSNPSSSTPSAAKTHHAPPRCNDDPCWKAIKEATSEGNNNNNNNPLTLSDLRFVHRLGS 92
S +++ ++H DD +E T + + + + +G
Sbjct: 342 SIPKLANNEKQGVRSHTVSVSETDDYAEIIDEEDTYTMPSTRDYE-IQRERIELGRCIGE 400
Query: 93 GDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLY 152
G G V+ S N A K K +E + E + DHP + L
Sbjct: 401 GQFGDVHQGIYMSPE-NPAMAVAIKTC-KNCTSDSVREKFLQ-EALTMRQFDHPHIVKLI 457
Query: 153 A-TLDCPRWSCLLTEFCPGGDLHV-LRQRQPDKRFHESAVRFYASEVVVALEFLHMMGII 210
+ P W ++ E C G+L L+ R+ +++ YA ++ AL +L +
Sbjct: 458 GVITENPVW--IIMELCTLGELRSFLQVRKF--SLDLASLILYAYQLSTALAYLESKRFV 513
Query: 211 YRDLKPENVLVRSDGHIMLTDFDLS 235
+RD+ NVLV S+ + L DF LS
Sbjct: 514 HRDIAARNVLVSSNDCVKLGDFGLS 538
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 2e-11
Identities = 35/164 (21%), Positives = 65/164 (39%), Gaps = 12/164 (7%)
Query: 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILE 141
LG G+ GSV QLK + + A K++ K ++++ + E ++
Sbjct: 23 QQFTLGRMLGKGEFGSVREAQLKQEDGSF-VKVAVKML-KADIIASSDIEEFLREAACMK 80
Query: 142 MLDHPFLPTLYA--TLDCPRWS----CLLTEFCPGGDLH-VLRQRQPDKRFHESAVR--- 191
DHP + L + ++ F GDLH L + + ++
Sbjct: 81 EFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLV 140
Query: 192 FYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235
+ ++ +E+L I+RDL N ++ D + + DF LS
Sbjct: 141 RFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLS 184
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 3e-11
Identities = 41/187 (21%), Positives = 74/187 (39%), Gaps = 45/187 (24%)
Query: 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAA-KVM-------DKRELVSRNKESRA 133
+L LG G+ G V G A K++ + R+L+S
Sbjct: 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLS------- 75
Query: 134 RIEREILEMLDHPFLPTLYA--TLDCPRWSCLLTEFCPGGDLH-VLRQRQPDKRFHESAV 190
E +L+ ++HP + LY + D P L+ E+ G L LR+ + + +
Sbjct: 76 --EFNVLKQVNHPHVIKLYGACSQDGPL--LLIVEYAKYGSLRGFLRESRKVGPGYLGSG 131
Query: 191 RF---------------------YASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIM- 228
+A ++ +++L M +++RDL N+LV ++G M
Sbjct: 132 GSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILV-AEGRKMK 190
Query: 229 LTDFDLS 235
++DF LS
Sbjct: 191 ISDFGLS 197
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 3e-11
Identities = 45/170 (26%), Positives = 74/170 (43%), Gaps = 13/170 (7%)
Query: 82 SDLRFV-HRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREIL 140
+L LG G+ GSV + + A KV+ K+ + E R E +I+
Sbjct: 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDV--AIKVL-KQGTEKADTEEMMR-EAQIM 64
Query: 141 EMLDHPFLPTLYA-TLDCPRWSCLLTEFCPGGDLHV-LRQRQPDKRFHESAVRFYASEVV 198
LD+P++ L L+ E GG LH L + + S V +V
Sbjct: 65 HQLDNPYIVRLIGVCQAEALM--LVMEMAGGGPLHKFLVGK--REEIPVSNVAELLHQVS 120
Query: 199 VALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS--LKGDNSTSTAQ 246
+ +++L ++RDL NVL+ + + ++DF LS L D+S TA+
Sbjct: 121 MGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR 170
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 3e-11
Identities = 36/186 (19%), Positives = 62/186 (33%), Gaps = 43/186 (23%)
Query: 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAA-KVM-------DKRELVSRNKESRA 133
+++ +V +G G G V+ + A K++ + +
Sbjct: 47 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQR------- 99
Query: 134 RIEREILEMLDHPFLPTLYA--TLDCPRWSCLLTEFCPGGDLH-VLRQRQPDKRFHESAV 190
E ++ D+P + L + P CLL E+ GDL+ LR P S
Sbjct: 100 --EAALMAEFDNPNIVKLLGVCAVGKPM--CLLFEYMAYGDLNEFLRSMSPHTVCSLSHS 155
Query: 191 RF---------------------YASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIML 229
A +V + +L ++RDL N LV + + +
Sbjct: 156 DLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKI 215
Query: 230 TDFDLS 235
DF LS
Sbjct: 216 ADFGLS 221
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 4e-11
Identities = 34/161 (21%), Positives = 65/161 (40%), Gaps = 24/161 (14%)
Query: 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKV-----MDKRELVSRNKESRARIE 136
L+ +LG+G G V++ + A K M ++ E
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTK-----VAVKTMKPGSMSVEAFLA---------E 233
Query: 137 REILEMLDHPFLPTLYATLDCPRWS-CLLTEFCPGGDL-HVLRQRQPDKRFHESAVRFYA 194
+++ L H L L+A + ++TEF G L L+ + K+ + F +
Sbjct: 234 ANVMKTLQHDKLVKLHAV--VTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDF-S 290
Query: 195 SEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235
+++ + F+ I+RDL+ N+LV + + DF L+
Sbjct: 291 AQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLA 331
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 4e-11
Identities = 35/161 (21%), Positives = 63/161 (39%), Gaps = 24/161 (14%)
Query: 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKV-----MDKRELVSRNKESRARIE 136
LR +LG G G V++ + A K M + E
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTR-----VAIKTLKPGTMSPEAFLQ---------E 229
Query: 137 REILEMLDHPFLPTLYA-TLDCPRWSCLLTEFCPGGDL-HVLRQRQPDKRFHESAVRFYA 194
++++ L H L LYA + P + ++TE+ G L L+ V A
Sbjct: 230 AQVMKKLRHEKLVQLYAVVSEEPIY--IVTEYMSKGSLLDFLKGETGKYLRLPQLVDM-A 286
Query: 195 SEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235
+++ + ++ M ++RDL+ N+LV + + DF L+
Sbjct: 287 AQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLA 327
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 63.3 bits (154), Expect = 6e-11
Identities = 42/218 (19%), Positives = 72/218 (33%), Gaps = 25/218 (11%)
Query: 26 SETTWTTSGSNPSSSTPSAAKTHHAPPRCNDDPCWKAIKEATSEGNNNNNNNPLTLSDLR 85
S N + + R K S +++
Sbjct: 3 SHEAAAAQQHNSGTQHTVSGSQQEGQQRKQHHS----SKPTASMPRPHSDWQ--IPDRYE 56
Query: 86 FVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREI--LEML 143
H +G+G G V ++ A K K V + RI REI L L
Sbjct: 57 IRHLIGTGSYGHVC----EAYDKLEKRVVAIK---KILRVFEDLIDCKRILREIAILNRL 109
Query: 144 DHPFLPTLYATLDCPRWSC-----LLTEFCPGGDLH-VLRQRQPDKRFHESAVRFYASEV 197
+H + + + ++ E D + R H ++ +
Sbjct: 110 NHDHVVKVLDIVIPKDVEKFDELYVVLEIA-DSDFKKLFRTPVYLTELH---IKTLLYNL 165
Query: 198 VVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235
+V ++++H GI++RDLKP N LV D + + DF L+
Sbjct: 166 LVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLA 203
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 61.8 bits (151), Expect = 6e-11
Identities = 37/163 (22%), Positives = 63/163 (38%), Gaps = 28/163 (17%)
Query: 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKV-----MDKRELVSRNKESRARIE 136
L+ V RLG+G G V++ + A K M ++ E
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTK-----VAVKSLKQGSMSPDAFLA---------E 58
Query: 137 REILEMLDHPFLPTLYATLDC---PRWSCLLTEFCPGGDL-HVLRQRQPDKRFHESAVRF 192
+++ L H L LYA P + ++TE+ G L L+ K +
Sbjct: 59 ANLMKQLQHQRLVRLYAV--VTQEPIY--IITEYMENGSLVDFLKTPSGIKLTINKLLDM 114
Query: 193 YASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235
A+++ + F+ I+RDL+ N+LV + DF L+
Sbjct: 115 -AAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLA 156
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 62.2 bits (152), Expect = 6e-11
Identities = 41/162 (25%), Positives = 68/162 (41%), Gaps = 32/162 (19%)
Query: 87 VHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIE---------- 136
V ++G G G VY K+++ G A K + R++
Sbjct: 8 VEKIGEGTYGVVY----KARNKLTGEVVALK--------------KIRLDTETEGVPSTA 49
Query: 137 -REI--LEMLDHPFLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFY 193
REI L+ L+HP + L + L+ EF DL ++ Y
Sbjct: 50 IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSY 108
Query: 194 ASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235
+++ L F H +++RDLKP+N+L+ ++G I L DF L+
Sbjct: 109 LFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLA 150
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 7e-11
Identities = 43/162 (26%), Positives = 70/162 (43%), Gaps = 26/162 (16%)
Query: 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKV-----MDKRELVSRNKESRARIE 136
DL F+ LG+G G V + + + A K+ M + E + E
Sbjct: 24 KDLTFLKELGTGQFGVVKYGKWRGQYD-----VAIKMIKEGSMSEDEFIE---------E 69
Query: 137 REILEMLDHPFLPTLYA--TLDCPRWSCLLTEFCPGGDL-HVLRQRQPDKRFHESAVRFY 193
+++ L H L LY T P + ++TE+ G L + LR+ + RF +
Sbjct: 70 AKVMMNLSHEKLVQLYGVCTKQRPIF--IITEYMANGCLLNYLREMRH--RFQTQQLLEM 125
Query: 194 ASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235
+V A+E+L ++RDL N LV G + ++DF LS
Sbjct: 126 CKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLS 167
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 7e-11
Identities = 59/286 (20%), Positives = 100/286 (34%), Gaps = 96/286 (33%)
Query: 90 LGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKES---RARIEREILEML--- 143
+G G G V +K+ + A K++ +NK++ +A+IE +LE++
Sbjct: 62 IGKGSFGQV----VKAYDRVEQEWVAIKII-------KNKKAFLNQAQIEVRLLELMNKH 110
Query: 144 ---DHPFLPTLYATLDCPRWSCLLTEFCPGGDLH-VLRQRQPDKRFHESAVRFYASEVVV 199
++ L CL+ E +L+ +LR + + R +A ++
Sbjct: 111 DTEMKYYIVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNTN-FRGVSLNLTRKFAQQMCT 168
Query: 200 ALEFLHM--MGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGD 257
AL FL + II+ DLKPEN I+L N +A + D
Sbjct: 169 ALLFLATPELSIIHCDLKPEN--------ILLC---------NPKRSAIKIVD------- 204
Query: 258 QQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMS 317
FG SSC + I +
Sbjct: 205 ------------FG-SSCQLGQRIYQYIQSRF---------------------------- 223
Query: 318 FVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDH 363
Y +PE++ G + A+D W+LG + E+ G F G +
Sbjct: 224 ------YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANE 263
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 7e-11
Identities = 43/214 (20%), Positives = 76/214 (35%), Gaps = 55/214 (25%)
Query: 66 ATSEGNNNNNNNPLTLS-----------------DLRFVHRLGSGDIGSVY---LVQLKS 105
+S +++++ +P+ L LG G G V V +
Sbjct: 2 GSSHHHHHHSQDPMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDK 61
Query: 106 KSSNNGCFFAAKVM-------DKRELVSRNKESRARIEREILEML-DHPFLPTLYA--TL 155
A K++ D +LVS E E+++M+ H + L T
Sbjct: 62 DKPKEAVTVAVKMLKDDATEKDLSDLVS---------EMEMMKMIGKHKNIINLLGACTQ 112
Query: 156 DCPRWSCLLTEFCPGGDLH-VLRQRQPDKRFHESAVRF-------------YASEVVVAL 201
D P ++ E+ G+L LR R+P + + ++ +
Sbjct: 113 DGPL--YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGM 170
Query: 202 EFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235
E+L I+RDL NVLV + + + DF L+
Sbjct: 171 EYLASQKCIHRDLAARNVLVTENNVMKIADFGLA 204
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 8e-11
Identities = 28/165 (16%), Positives = 53/165 (32%), Gaps = 15/165 (9%)
Query: 85 RFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRE------LVSRNKESRARIERE 138
+ + G +Y S + + K K + +N RA +
Sbjct: 45 KLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQ 104
Query: 139 I-----LEMLDHPFLPTLYAT-LDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRF 192
+ L +PT + ++ L+ G L P E +V
Sbjct: 105 VNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQ 163
Query: 193 YASEVVVALEFLHMMGIIYRDLKPENVLV--RSDGHIMLTDFDLS 235
A ++ ALEFLH ++ ++ EN+ V + L + +
Sbjct: 164 VACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFA 208
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 1e-10
Identities = 42/156 (26%), Positives = 67/156 (42%), Gaps = 9/156 (5%)
Query: 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILE 141
D+ LG G G VY + A K K++ NKE E I++
Sbjct: 12 EDVVLNRILGEGFFGEVYEGVYTNHK-GEKINVAVKTC-KKDCTLDNKEKFMS-EAVIMK 68
Query: 142 MLDHPFLPTLYA-TLDCPRWSCLLTEFCPGGDL-HVLRQRQPDKRFHESAVRFYASEVVV 199
LDHP + L + P W ++ E P G+L H L + + + Y+ ++
Sbjct: 69 NLDHPHIVKLIGIIEEEPTW--IIMELYPYGELGHYLERNKN--SLKVLTLVLYSLQICK 124
Query: 200 ALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235
A+ +L + ++RD+ N+LV S + L DF LS
Sbjct: 125 AMAYLESINCVHRDIAVRNILVASPECVKLGDFGLS 160
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 1e-10
Identities = 50/210 (23%), Positives = 85/210 (40%), Gaps = 48/210 (22%)
Query: 60 WKAIKEATSEGNNNNNNNPLTL----------SDLRFVHRLGSGDIGSVYLVQLKSKSSN 109
WK I+ + EGN+ +P L ++L+F LG+G G V
Sbjct: 16 WKIIE--SYEGNSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKE 73
Query: 110 NGCFFAA-KVM-------DKRELVSRNKESRARIEREILEMLD-HPFLPTLYA--TLDCP 158
+ A K++ +K L+S E +I+ L H + L T P
Sbjct: 74 DAVLKVAVKMLKSTAHADEKEALMS---------ELKIMSHLGQHENIVNLLGACTHGGP 124
Query: 159 RWSCLLTEFCPGGDL-HVLRQRQPDKRFHESAVRF-----------YASEVVVALEFLHM 206
++TE+C GDL + LR++ + ++S+V + FL
Sbjct: 125 V--LVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS 182
Query: 207 MGIIYRDLKPENVLVRSDGHIM-LTDFDLS 235
I+RD+ NVL+ ++GH+ + DF L+
Sbjct: 183 KNCIHRDVAARNVLL-TNGHVAKIGDFGLA 211
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 2e-10
Identities = 43/157 (27%), Positives = 70/157 (44%), Gaps = 19/157 (12%)
Query: 87 VHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKV--MDKRELVSRNKESRARIEREI--LEM 142
+ +LG+G +VY K + G + A K +D E S A I REI ++
Sbjct: 10 LEKLGNGTYATVY----KGLNKTTGVYVALKEVKLDSEEGTP----STA-I-REISLMKE 59
Query: 143 LDHPFLPTLYATLDCPRWSCLLTEFCPGGDLHVL----RQRQPDKRFHESAVRFYASEVV 198
L H + LY + L+ EF DL + + V+++ +++
Sbjct: 60 LKHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLL 118
Query: 199 VALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235
L F H I++RDLKP+N+L+ G + L DF L+
Sbjct: 119 QGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLA 155
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 2e-10
Identities = 34/173 (19%), Positives = 62/173 (35%), Gaps = 31/173 (17%)
Query: 82 SDLRFVHRLGSGDIGSVYLVQLKS----------KSSNNGCFFAAKVMDKRELVSRNKES 131
+ L LG G+ GSV LK K+ + + E +S
Sbjct: 34 NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDN---SSQREIEEFLS----- 85
Query: 132 RARIEREILEMLDHPFLPTLYA--TLDCPRWSC---LLTEFCPGGDLH-VLRQRQPDKRF 185
E ++ HP + L + ++ F GDLH L + +
Sbjct: 86 ----EAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGP 141
Query: 186 HESAVR---FYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235
++ + ++ + +E+L ++RDL N ++R D + + DF LS
Sbjct: 142 KHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLS 194
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 2e-10
Identities = 41/181 (22%), Positives = 66/181 (36%), Gaps = 38/181 (20%)
Query: 82 SDLRFVHRLGSGDIGSVY---LVQLKSKSSNNGCFFAAKVM-------DKRELVSRNKES 131
L LG G G V V + A K++ D +LVS
Sbjct: 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVS----- 135
Query: 132 RARIEREILEML-DHPFLPTLYA--TLDCPRWSCLLTEFCPGGDLH-VLRQRQPDKRFHE 187
E E+++M+ H + L T D P ++ E+ G+L LR R+P +
Sbjct: 136 ----EMEMMKMIGKHKNIINLLGACTQDGPL--YVIVEYASKGNLREYLRARRPPGMEYS 189
Query: 188 SAVRF-------------YASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDL 234
+ ++ +E+L I+RDL NVLV + + + DF L
Sbjct: 190 YDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGL 249
Query: 235 S 235
+
Sbjct: 250 A 250
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 2e-10
Identities = 34/172 (19%), Positives = 61/172 (35%), Gaps = 29/172 (16%)
Query: 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAA-KVM-------DKRELVSRNKESRA 133
++ + LG G G VY Q+ ++ A K + D+ + +
Sbjct: 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM------- 123
Query: 134 RIEREILEMLDHPFLPTLYA--TLDCPRWSCLLTEFCPGGDLH-VLRQRQPD----KRFH 186
E I+ +H + PR +L E GGDL LR+ +P
Sbjct: 124 --EALIISKFNHQNIVRCIGVSLQSLPR--FILLELMAGGDLKSFLRETRPRPSQPSSLA 179
Query: 187 ESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIML---TDFDLS 235
+ A ++ ++L I+RD+ N L+ G + DF ++
Sbjct: 180 MLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA 231
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 2e-10
Identities = 34/172 (19%), Positives = 61/172 (35%), Gaps = 29/172 (16%)
Query: 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAA-KVM-------DKRELVSRNKESRA 133
++ + LG G G VY Q+ ++ A K + D+ + +
Sbjct: 30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM------- 82
Query: 134 RIEREILEMLDHPFLPTLYA--TLDCPRWSCLLTEFCPGGDLH-VLRQRQP----DKRFH 186
E I+ +H + PR +L E GGDL LR+ +P
Sbjct: 83 --EALIISKFNHQNIVRCIGVSLQSLPR--FILMELMAGGDLKSFLRETRPRPSQPSSLA 138
Query: 187 ESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIML---TDFDLS 235
+ A ++ ++L I+RD+ N L+ G + DF ++
Sbjct: 139 MLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA 190
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 2e-10
Identities = 27/165 (16%), Positives = 56/165 (33%), Gaps = 25/165 (15%)
Query: 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAK-------VMDKRELVSRNKESRAR 134
+ F +G G G VY L A K + + + ++
Sbjct: 25 LIVHFNEVIGRGHFGCVYHGTLLDND-GKKIHCAVKSLNRITDIGEVSQFLT-------- 75
Query: 135 IEREILEMLDHPFLPTLYA---TLDCPRWSCLLTEFCPGGDLH-VLRQRQPDKRFHESAV 190
E I++ HP + +L + ++ + GDL +R +
Sbjct: 76 -EGIIMKDFSHPNVLSLLGICLRSEGSPL--VVLPYMKHGDLRNFIRNETH--NPTVKDL 130
Query: 191 RFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235
+ +V +++L ++RDL N ++ + + DF L+
Sbjct: 131 IGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLA 175
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 2e-10
Identities = 48/213 (22%), Positives = 89/213 (41%), Gaps = 29/213 (13%)
Query: 31 TTSGSNPSSSTPSAAKTHHAPPRCNDDPCWKAIKEATSEGNNNNNNNPLTLSDLRFVHRL 90
TTS + + D K + G + ++ +D + +
Sbjct: 7 TTSFAESCKPV-QQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVI--- 62
Query: 91 GSGDIGSVYLVQLKSKSSNNGCFFAAK--VMDKRELVSRNKESRARIEREILEMLDHPFL 148
G+G G VY ++K ++G A K + DKR ++R E +I+ LDH +
Sbjct: 63 GNGSFGVVY----QAKLCDSGELVAIKKVLQDKRF------KNR---ELQIMRKLDHCNI 109
Query: 149 PTL----YATLDCPRWSCL--LTEFCPGGDLH-VLRQRQPDK-RFHESAVRFYASEVVVA 200
L Y++ + L + ++ P ++ V R K V+ Y ++ +
Sbjct: 110 VRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 168
Query: 201 LEFLHMMGIIYRDLKPENVLVRSDGHIM-LTDF 232
L ++H GI +RD+KP+N+L+ D ++ L DF
Sbjct: 169 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDF 201
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 60.3 bits (147), Expect = 2e-10
Identities = 45/162 (27%), Positives = 67/162 (41%), Gaps = 23/162 (14%)
Query: 87 VHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIE----REI--- 139
V +G G G+VY K++ ++G F A K V + RE+
Sbjct: 14 VAEIGVGAYGTVY----KARDPHSGHFVALK----SVRVPNGGGGGGGLPISTVREVALL 65
Query: 140 --LEMLDHPFLPTLY-----ATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRF 192
LE +HP + L + D L+ E DL + P ++
Sbjct: 66 RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKD 124
Query: 193 YASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDL 234
+ + L+FLH I++RDLKPEN+LV S G + L DF L
Sbjct: 125 LMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGL 166
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 3e-10
Identities = 32/168 (19%), Positives = 56/168 (33%), Gaps = 21/168 (12%)
Query: 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFF---AAKVMDKRELVSRNKESRARIERE 138
DL F LG G ++ + KV+DK RN
Sbjct: 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDK---AHRNYSESFFEAAS 64
Query: 139 ILEMLDHPFLPTLYA--TLDCPRWSCLLTEFCPGGDLHV-LRQRQPDKRFHESAVRFYAS 195
++ L H L Y L+ EF G L L++ + + A
Sbjct: 65 MMSKLSHKHLVLNYGVCVCGDENI--LVQEFVKFGSLDTYLKKNKN--CINILWKLEVAK 120
Query: 196 EVVVALEFLHMMGIIYRDLKPENVLVRSDGHIM--------LTDFDLS 235
++ A+ FL +I+ ++ +N+L+ + L+D +S
Sbjct: 121 QLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGIS 168
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 61.0 bits (148), Expect = 3e-10
Identities = 35/161 (21%), Positives = 63/161 (39%), Gaps = 24/161 (14%)
Query: 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKV-----MDKRELVSRNKESRARIE 136
LR +LG G G V++ + A K M + E
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTR-----VAIKTLKPGTMSPEAFLQ---------E 312
Query: 137 REILEMLDHPFLPTLYA-TLDCPRWSCLLTEFCPGGDL-HVLRQRQPDKRFHESAVRFYA 194
++++ L H L LYA + P + ++TE+ G L L+ V A
Sbjct: 313 AQVMKKLRHEKLVQLYAVVSEEPIY--IVTEYMSKGSLLDFLKGETGKYLRLPQLVDM-A 369
Query: 195 SEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235
+++ + ++ M ++RDL+ N+LV + + DF L+
Sbjct: 370 AQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLA 410
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 3e-10
Identities = 34/235 (14%), Positives = 72/235 (30%), Gaps = 34/235 (14%)
Query: 12 PDNLSFTSTTTNSGSETTWTTSGSNPSSSTPSAAKTHHAPPRCNDDPCWKAIKEATSEGN 71
P + +T + + A T H + +A++ +
Sbjct: 28 PRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDLSALNPELVQAVQHVVIGPS 87
Query: 72 NNNNNNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAK-------VMDKREL 124
+ + F +G G G VY L A K + + +
Sbjct: 88 S---------LIVHFNEVIGRGHFGCVYHGTLLDND-GKKIHCAVKSLNRITDIGEVSQF 137
Query: 125 VSRNKESRARIEREILEMLDHPFLPTLYA---TLDCPRWSCLLTEFCPGGDLH-VLRQRQ 180
++ E I++ HP + +L + ++ + GDL +R
Sbjct: 138 LT---------EGIIMKDFSHPNVLSLLGICLRSEGSPL--VVLPYMKHGDLRNFIRNET 186
Query: 181 PDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235
+ + +V ++FL ++RDL N ++ + + DF L+
Sbjct: 187 H--NPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLA 239
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 60.8 bits (147), Expect = 4e-10
Identities = 35/157 (22%), Positives = 65/157 (41%), Gaps = 15/157 (9%)
Query: 85 RFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEML- 143
R ++GSG G +YL + +V K E V + K + E +I +L
Sbjct: 10 RLGRKIGSGSFGEIYLG----TNIQTN----EEVAIKLENV-KTKHPQLLYESKIYRILQ 60
Query: 144 DHPFLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEF 203
+P + ++ L+ + G L L ++ V A +++ +EF
Sbjct: 61 GGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEF 118
Query: 204 LHMMGIIYRDLKPENVLVRSDGH---IMLTDFDLSLK 237
+H ++RD+KP+N L+ + + DF L+ K
Sbjct: 119 VHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 4e-10
Identities = 39/182 (21%), Positives = 72/182 (39%), Gaps = 40/182 (21%)
Query: 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAA--------KVMDKRELVSRNKESRA 133
+ L F LG+G G V ++ A + ++ L+S
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMS------- 75
Query: 134 RIEREILEML-DHPFLPTLYA--TLDCPRWSCLLTEFCPGGDL-HVLRQRQPDKRFHESA 189
E ++L L +H + L T+ P ++TE+C GDL + LR+++ +++
Sbjct: 76 --ELKVLSYLGNHMNIVNLLGACTIGGPT--LVITEYCCYGDLLNFLRRKRDSFICSKTS 131
Query: 190 VRF---------------YASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIM-LTDFD 233
++ +V + FL I+RDL N+L+ + G I + DF
Sbjct: 132 PAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL-THGRITKICDFG 190
Query: 234 LS 235
L+
Sbjct: 191 LA 192
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 4e-10
Identities = 42/181 (23%), Positives = 67/181 (37%), Gaps = 38/181 (20%)
Query: 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFF---AAKVM-------DKRELVSRNKES 131
L LG G G V L + + A K++ D +L+S
Sbjct: 69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLIS----- 123
Query: 132 RARIEREILEML-DHPFLPTLYA--TLDCPRWSCLLTEFCPGGDLHV-LRQRQPDKRFHE 187
E E+++M+ H + L T D P ++ E+ G+L L+ R+P +
Sbjct: 124 ----EMEMMKMIGKHKNIINLLGACTQDGPL--YVIVEYASKGNLREYLQARRPPGLEYS 177
Query: 188 SAVRF-------------YASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDL 234
A +V +E+L I+RDL NVLV D + + DF L
Sbjct: 178 YNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGL 237
Query: 235 S 235
+
Sbjct: 238 A 238
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 59.8 bits (145), Expect = 6e-10
Identities = 29/166 (17%), Positives = 63/166 (37%), Gaps = 17/166 (10%)
Query: 85 RFVHRLGSGDIGSVYLVQLKS-KSSNNGCFFAAKVMDKR--------ELVSRNKESRARI 135
+ +G G G +YL + S +S + KV + R +
Sbjct: 38 KVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQ 97
Query: 136 EREILEMLDHPFLPTLYA----TLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVR 191
+ L + +P + + + ++ + G DL + + KRF V
Sbjct: 98 KWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN-AKRFSRKTVL 155
Query: 192 FYASEVVVALEFLHMMGIIYRDLKPENVLV--RSDGHIMLTDFDLS 235
+ ++ LE++H ++ D+K N+L+ ++ + L D+ L+
Sbjct: 156 QLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLA 201
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 59.1 bits (144), Expect = 8e-10
Identities = 41/151 (27%), Positives = 62/151 (41%), Gaps = 17/151 (11%)
Query: 89 RLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREI--LEMLDHP 146
++G G G V+ K ++ + G A K K + + REI L+ L HP
Sbjct: 10 KIGEGSYGVVF----KCRNRDTGQIVAIK---KFLESEDDPVIKKIALREIRMLKQLKHP 62
Query: 147 FLPTLYATLDCPRWSCLLT---EFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEF 203
L L L+ R L E+C + R + E V+ + + A+ F
Sbjct: 63 NLVNL---LEVFRRKRRLHLVFEYCDH-TVLHELDRYQ-RGVPEHLVKSITWQTLQAVNF 117
Query: 204 LHMMGIIYRDLKPENVLVRSDGHIMLTDFDL 234
H I+RD+KPEN+L+ I L DF
Sbjct: 118 CHKHNCIHRDVKPENILITKHSVIKLCDFGF 148
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 1e-09
Identities = 30/165 (18%), Positives = 57/165 (34%), Gaps = 25/165 (15%)
Query: 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAK-------VMDKRELVSRNKESRAR 134
+G G G VY + ++ N A K + +
Sbjct: 21 VVTHSDRVIGKGHFGVVYHGEYIDQA-QNRIQCAIKSLSRITEMQQVEAFLR-------- 71
Query: 135 IEREILEMLDHPFLPTLYA---TLDCPRWSCLLTEFCPGGDLH-VLRQRQPDKRFHESAV 190
E ++ L+HP + L + +L + GDL +R Q + + +
Sbjct: 72 -EGLLMRGLNHPNVLALIGIMLPPEGLPH--VLLPYMCHGDLLQFIRSPQRNPTVKD-LI 127
Query: 191 RFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235
F +V +E+L ++RDL N ++ + + DF L+
Sbjct: 128 SF-GLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLA 171
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 1e-09
Identities = 38/159 (23%), Positives = 64/159 (40%), Gaps = 22/159 (13%)
Query: 94 DIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRA--------RIEREI--LEML 143
++ +VY S G +A V+ K R R RE+ L+ +
Sbjct: 22 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM 81
Query: 144 DHPFLPTLYATLDCPRWSC-------LLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASE 196
H + L + P + L+ F G DL L + + ++F +
Sbjct: 82 RHENVIGLL-DVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHEKLGEDR---IQFLVYQ 136
Query: 197 VVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235
++ L ++H GII+RDLKP N+ V D + + DF L+
Sbjct: 137 MLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA 175
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 4e-04
Identities = 30/116 (25%), Positives = 49/116 (42%), Gaps = 30/116 (25%)
Query: 318 FVGTHEYLAPEII-SGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDH--------ELT-- 366
+V T Y APE+I + + VD W++G + E+ G T FKG DH ++T
Sbjct: 185 YVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGT 244
Query: 367 --------LANVVARA--LEFPKEPSVP--------GP-AKDLIAQLLVKDPTRRM 403
L + A+ P+ P A +L+ ++LV D +R+
Sbjct: 245 PPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRV 300
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 1e-09
Identities = 68/364 (18%), Positives = 110/364 (30%), Gaps = 126/364 (34%)
Query: 80 TLSDLRF--VHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKES---RAR 134
D R+ V +LG G +V+L + N A K++ R + A
Sbjct: 15 PYKDARYILVRKLGWGHFSTVWLAK----DMVNNTHVAMKIV-------RGDKVYTEAAE 63
Query: 135 IEREILEML--------DHPFLPTLYATLDC-----PRWS--CLLTEFCPGGDLHVLRQR 179
E ++L+ + D + LD P ++ E G +L L ++
Sbjct: 64 DEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKK 122
Query: 180 QPDKRFHESAVRFYASEVVVALEFLH-MMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKG 238
+ V+ + ++++ L+++H GII H TD +K
Sbjct: 123 YEHRGIPLIYVKQISKQLLLGLDYMHRRCGII---------------H---TD----IKP 160
Query: 239 DNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKL 298
+N L+ P Q D G ++C
Sbjct: 161 ENV-----LMEIVDSPENLIQIKIA--D---LG-NACWYDEHY----------------- 192
Query: 299 GNPGTPEIVAEPLDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPF 358
T I T EY +PE++ G G D W+ IFEL G F
Sbjct: 193 ----TNSIQ-------------TREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLF 235
Query: 359 KGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQ---LLVKDPTRRMGSKMGATAIKRH 415
+ + + D IAQ LL + P S +
Sbjct: 236 EPDEGHSYTKD------------------DDHIAQIIELLGELP-----SYLLRNGKYTR 272
Query: 416 QFFN 419
FFN
Sbjct: 273 TFFN 276
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 1e-09
Identities = 37/157 (23%), Positives = 70/157 (44%), Gaps = 17/157 (10%)
Query: 85 RFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLD 144
R ++G G+ G + L K+ + A K+ + ++ + +E + L
Sbjct: 12 RVGKKIGCGNFGELRLG----KNLYTNEYVAIKLEPMK-----SRAPQLHLEYRFYKQLG 62
Query: 145 H-PFLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEF 203
+P +Y C +++ ++ E G L L D+ F V A +++ +E+
Sbjct: 63 SGDGIPQVYYFGPCGKYNAMVLELL-GPSLEDLFDLC-DRTFSLKTVLMIAIQLISRMEY 120
Query: 204 LHMMGIIYRDLKPENVLVRSDGH-----IMLTDFDLS 235
+H +IYRD+KPEN L+ G+ I + DF L+
Sbjct: 121 VHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALA 157
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 1e-09
Identities = 46/219 (21%), Positives = 73/219 (33%), Gaps = 55/219 (25%)
Query: 60 WKAIKEATSEGNNNNNNNPLTL----------SDLRFVHRLGSGDIGSVYLVQLKSKSSN 109
+ ++ S N + +L F LGSG G V S
Sbjct: 13 LQMVQVTGSSDNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKT 72
Query: 110 NGCFFAA--------KVMDKRELVSRNKESRARIEREILEML-DHPFLPTLYA--TLDCP 158
A ++ L+S E +++ L H + L TL P
Sbjct: 73 GVSIQVAVKMLKEKADSSEREALMS---------ELKMMTQLGSHENIVNLLGACTLSGP 123
Query: 159 RWSCLLTEFCPGGDL-HVLRQRQPDKRFHESAVRF--------------------YASEV 197
L+ E+C GDL + LR ++ E +A +V
Sbjct: 124 I--YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQV 181
Query: 198 VVALEFLHMMGIIYRDLKPENVLVRSDGHIM-LTDFDLS 235
+EFL ++RDL NVLV + G ++ + DF L+
Sbjct: 182 AKGMEFLEFKSCVHRDLAARNVLV-THGKVVKICDFGLA 219
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 2e-09
Identities = 41/159 (25%), Positives = 65/159 (40%), Gaps = 22/159 (13%)
Query: 94 DIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRA--------RIEREI--LEML 143
++ Y S G AA V+ K SR R RE+ L+ +
Sbjct: 26 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 85
Query: 144 DHPFLPTLYATLDCPRWSC-------LLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASE 196
H + L + P S L+T G DL+ + + Q H V+F +
Sbjct: 86 KHENVIGLL-DVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDH---VQFLIYQ 140
Query: 197 VVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235
++ L+++H II+RDLKP N+ V D + + DF L+
Sbjct: 141 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA 179
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 4e-04
Identities = 31/116 (26%), Positives = 48/116 (41%), Gaps = 30/116 (25%)
Query: 318 FVGTHEYLAPEII-SGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDH--------ELT-- 366
+V T Y APEI+ + + VD W++G + EL G T F G DH L
Sbjct: 189 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 248
Query: 367 --------LANVVARA--LEFPKEPSVP--------GP-AKDLIAQLLVKDPTRRM 403
+++ AR + P + P A DL+ ++LV D +R+
Sbjct: 249 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRI 304
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 2e-09
Identities = 39/153 (25%), Positives = 67/153 (43%), Gaps = 16/153 (10%)
Query: 87 VHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKV--MDKRELVSRNKESRARIEREI--LEM 142
+ +LG G +VY K KS A K ++ E A I RE+ L+
Sbjct: 7 LDKLGEGTYATVY----KGKSKLTDNLVALKEIRLEHEEGAP----CTA-I-REVSLLKD 56
Query: 143 LDHPFLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALE 202
L H + TL+ + + L+ E+ DL + V+ + +++ L
Sbjct: 57 LKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQY-LDDCGNIINMHNVKLFLFQLLRGLA 114
Query: 203 FLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235
+ H +++RDLKP+N+L+ G + L DF L+
Sbjct: 115 YCHRQKVLHRDLKPQNLLINERGELKLADFGLA 147
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 57.5 bits (140), Expect = 2e-09
Identities = 25/101 (24%), Positives = 47/101 (46%), Gaps = 4/101 (3%)
Query: 137 REI--LEMLDHPFLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYA 194
REI L+ L H + LY + + L+ E DL L + +
Sbjct: 49 REISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCE-GGLESVTAKSFL 106
Query: 195 SEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235
+++ + + H +++RDLKP+N+L+ +G + + DF L+
Sbjct: 107 LQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLA 147
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 2e-09
Identities = 40/180 (22%), Positives = 65/180 (36%), Gaps = 37/180 (20%)
Query: 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAA-KVM-------DKRELVSRNKESRA 133
L+ LG G G V C A K++ + R L+S
Sbjct: 27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMS------- 79
Query: 134 RIEREILEMLD-HPFLPTLYA---TLDCPRWSCLLTEFCPGGDLH-VLRQRQPDKRFHES 188
E +IL + H + L P ++ EFC G+L LR ++ + ++
Sbjct: 80 --ELKILIHIGHHLNVVNLLGACTKPGGPL--MVIVEFCKFGNLSTYLRSKRNEFVPYKV 135
Query: 189 AVRF-------------YASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235
A Y+ +V +EFL I+RDL N+L+ + + DF L+
Sbjct: 136 APEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA 195
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 57.9 bits (140), Expect = 2e-09
Identities = 35/143 (24%), Positives = 65/143 (45%), Gaps = 25/143 (17%)
Query: 111 GCFFAAKVMDKRELVSRNKESRA--------RIEREI--LEMLDHPFLPTLYATLDCPRW 160
G AA V+ K SR R RE+ ++ ++H + +L + P+
Sbjct: 76 GIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL-NVFTPQK 134
Query: 161 SC-------LLTEFCPGGDLH-VLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYR 212
+ L+ E +L V++ +R + + +++ ++ LH GII+R
Sbjct: 135 TLEEFQDVYLVMELM-DANLCQVIQMELDHER-----MSYLLYQMLCGIKHLHSAGIIHR 188
Query: 213 DLKPENVLVRSDGHIMLTDFDLS 235
DLKP N++V+SD + + DF L+
Sbjct: 189 DLKPSNIVVKSDCTLKILDFGLA 211
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 42.1 bits (99), Expect = 3e-04
Identities = 27/126 (21%), Positives = 46/126 (36%), Gaps = 40/126 (31%)
Query: 318 FVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDH-------------- 363
+V T Y APE+I G G+ VD W++G + E+ F G D+
Sbjct: 223 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP 282
Query: 364 -ELTLANVVARALEF----PKEPSVP---------------------GPAKDLIAQLLVK 397
+ + + PK + A+DL++++LV
Sbjct: 283 CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVI 342
Query: 398 DPTRRM 403
DP +R+
Sbjct: 343 DPAKRI 348
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 3e-09
Identities = 51/275 (18%), Positives = 83/275 (30%), Gaps = 71/275 (25%)
Query: 134 RIEREI--LEMLDHPFLPTLYATLDCPRWSC-----LLTEFCPGGDLH-VLRQRQPDKRF 185
RI REI L L ++ LY + ++ E DL + +
Sbjct: 71 RILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIA-DSDLKKLFKTPIFLTEE 129
Query: 186 HESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTA 245
H ++ +++ F+H GII+RDLKP N L+ D + + DF L A
Sbjct: 130 H---IKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGL----------A 176
Query: 246 QLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPE 305
+ ++ + + P N + +
Sbjct: 177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTS-------------------------- 210
Query: 306 IVAEPLDVRSMSFVGTHEYLAPEIISGEGH-GNAVDWWTLGIFIF-ELFYGTTPFKGIDH 363
V T Y APE+I + + ++D W+ G IF EL
Sbjct: 211 ------------HVVTRWYRAPELILLQENYTKSIDIWSTGC-IFAELLNMLQSHINDPT 257
Query: 364 ELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKD 398
L FP P ++ K
Sbjct: 258 N-------RFPL-FPGSSCFPLSPDRNSKKVHEKS 284
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 57.2 bits (139), Expect = 3e-09
Identities = 32/101 (31%), Positives = 52/101 (51%), Gaps = 4/101 (3%)
Query: 137 REI--LEMLDHPFLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYA 194
REI L+ L HP + +L + R L+ EF DL + +S ++ Y
Sbjct: 68 REISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENK-TGLQDSQIKIYL 125
Query: 195 SEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235
+++ + H I++RDLKP+N+L+ SDG + L DF L+
Sbjct: 126 YQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLA 166
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 57.2 bits (139), Expect = 3e-09
Identities = 40/152 (26%), Positives = 61/152 (40%), Gaps = 17/152 (11%)
Query: 89 RLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREI--LEMLDHP 146
+G G G V K ++ + G A K K +K + REI L+ L H
Sbjct: 32 LVGEGSYGMVM----KCRNKDTGRIVAIK---KFLESDDDKMVKKIAMREIKLLKQLRHE 84
Query: 147 FLPTLYATLDCPRWSCLLT---EFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEF 203
L L L+ + EF + + P V+ Y +++ + F
Sbjct: 85 NLVNL---LEVCKKKKRWYLVFEFVDH-TILDDLELFP-NGLDYQVVQKYLFQIINGIGF 139
Query: 204 LHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235
H II+RD+KPEN+LV G + L DF +
Sbjct: 140 CHSHNIIHRDIKPENILVSQSGVVKLCDFGFA 171
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 40.7 bits (96), Expect = 7e-04
Identities = 33/136 (24%), Positives = 46/136 (33%), Gaps = 43/136 (31%)
Query: 321 THE-----YLAPEIISGEGH-GNAVDWWTLG-IFIFELFYGTTPFKG---IDHELTL--- 367
E Y APE++ G+ G AVD W +G + E+F G F G ID +L
Sbjct: 182 DDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVT-EMFMGEPLFPGDSDID-QLYHIMM 239
Query: 368 --------------ANVVARALEFPKE----------PSVPGPAKDLIAQLLVKDPTRRM 403
N V + P+ P + DL + L DP +R
Sbjct: 240 CLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKR- 298
Query: 404 GSKMGATAIKRHQFFN 419
+ H FF
Sbjct: 299 ---PFCAELLHHDFFQ 311
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 3e-09
Identities = 37/160 (23%), Positives = 67/160 (41%), Gaps = 25/160 (15%)
Query: 94 DIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRA--------RIEREI--LEML 143
+ Y S G AA V+ K SR R RE+ ++ +
Sbjct: 22 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCV 81
Query: 144 DHPFLPTLYATLDCPRWSC-------LLTEFCPGGDLH-VLRQRQPDKRFHESAVRFYAS 195
+H + L + P+ S ++ E +L V++ +R + +
Sbjct: 82 NHKNIIGLL-NVFTPQKSLEEFQDVYIVMELM-DANLCQVIQMELDHER-----MSYLLY 134
Query: 196 EVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235
+++ ++ LH GII+RDLKP N++V+SD + + DF L+
Sbjct: 135 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 174
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 8e-05
Identities = 28/126 (22%), Positives = 46/126 (36%), Gaps = 40/126 (31%)
Query: 318 FVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDH-------------- 363
+V T Y APE+I G G+ VD W++G + E+ G F G DH
Sbjct: 186 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTP 245
Query: 364 -ELTLANVVARALEF----PKEPSVP---------------------GPAKDLIAQLLVK 397
+ + + PK A+DL++++LV
Sbjct: 246 CPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVI 305
Query: 398 DPTRRM 403
D ++R+
Sbjct: 306 DASKRI 311
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 56.8 bits (138), Expect = 4e-09
Identities = 39/162 (24%), Positives = 68/162 (41%), Gaps = 33/162 (20%)
Query: 87 VHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIE---------- 136
+ ++G G G+V+ K+K+ A K R R++
Sbjct: 7 LEKIGEGTYGTVF----KAKNRETHEIVALK--------------RVRLDDDDEGVPSSA 48
Query: 137 -REI--LEMLDHPFLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFY 193
REI L+ L H + L+ L + L+ EFC DL V+ +
Sbjct: 49 LREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCN-GDLDPEIVKSF 106
Query: 194 ASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235
+++ L F H +++RDLKP+N+L+ +G + L +F L+
Sbjct: 107 LFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLA 148
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 4e-09
Identities = 42/246 (17%), Positives = 84/246 (34%), Gaps = 79/246 (32%)
Query: 134 RIEREIL---EMLDHP--------FLPT----LYATLDCPRWSCLLTEFCPGGDLHVLRQ 178
R REI+ E+ H +Y L+ ++ DLH + +
Sbjct: 54 RTFREIMILTELSGHENIVNLLNVLRADNDRDVY----------LVFDYM-ETDLHAVIR 102
Query: 179 RQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKG 238
+ H ++ +++ +++LH G+++RD+KP N+L+ ++ H+ + DF L
Sbjct: 103 ANILEPVH---KQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGL---- 155
Query: 239 DNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKL 298
++ + T + + + + +
Sbjct: 156 ------SRSFVNIRRVTNNIPLSINENTENFDDDQPIL---------------------- 187
Query: 299 GNPGTPEIVAEPLDVRSMSFVGTHEYLAPEII-SGEGHGNAVDWWTLGIFIFELFYGTTP 357
T +V T Y APEI+ + +D W+LG + E+ G
Sbjct: 188 ----TD-------------YVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPI 230
Query: 358 FKGIDH 363
F G
Sbjct: 231 FPGSST 236
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 6e-09
Identities = 35/160 (21%), Positives = 68/160 (42%), Gaps = 25/160 (15%)
Query: 94 DIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRA--------RIEREI--LEML 143
++ Y+ S G +A E V+ K SR R RE+ L+ +
Sbjct: 21 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHM 80
Query: 144 DHPFLPTLYATLDCPRWSC-------LLTEFCPGGDLH-VLRQRQPDKRFHESAVRFYAS 195
H + L + P S L+ F DL ++ + +++ +++
Sbjct: 81 QHENVIGLL-DVFTPASSLRNFYDFYLVMPFM-QTDLQKIMGLKFSEEK-----IQYLVY 133
Query: 196 EVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235
+++ L+++H G+++RDLKP N+ V D + + DF L+
Sbjct: 134 QMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLA 173
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 4e-04
Identities = 31/116 (26%), Positives = 50/116 (43%), Gaps = 30/116 (25%)
Query: 318 FVGTHEYLAPEII-SGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDH--------ELT-- 366
+V T Y APE+I S + VD W++G + E+ G T FKG D+ ++T
Sbjct: 183 YVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGV 242
Query: 367 --------LANVVARAL--EFPKEPSVP--------GP-AKDLIAQLLVKDPTRRM 403
L + A++ P+ P P A DL+ ++L D +R+
Sbjct: 243 PGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRL 298
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 56.0 bits (136), Expect = 9e-09
Identities = 32/100 (32%), Positives = 48/100 (48%), Gaps = 4/100 (4%)
Query: 137 REI--LEMLDHPFLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYA 194
REI L+ L HP + L L+ +F DL V+ + S ++ Y
Sbjct: 61 REIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVI-IKDNSLVLTPSHIKAYM 118
Query: 195 SEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDL 234
+ LE+LH I++RDLKP N+L+ +G + L DF L
Sbjct: 119 LMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGL 158
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 55.3 bits (134), Expect = 1e-08
Identities = 32/108 (29%), Positives = 50/108 (46%), Gaps = 11/108 (10%)
Query: 137 REI-----LEMLDHPFLPTLYATLDCPRWSC-----LLTEFCPGGDLHVLRQRQPDKRFH 186
RE+ LE +HP + L+ R L+ E DL + P+
Sbjct: 60 REVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVP 118
Query: 187 ESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDL 234
++ +++ L+FLH +++RDLKP+N+LV S G I L DF L
Sbjct: 119 TETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGL 166
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 41.8 bits (99), Expect = 3e-04
Identities = 29/160 (18%), Positives = 53/160 (33%), Gaps = 44/160 (27%)
Query: 321 THE-----YLAPEIISGEGHGNAVDWWTLG-IFIFELFYGTTPFKGIDHELTLANVVARA 374
T Y APE++ + VD W++G IF E+F F+G ++ +
Sbjct: 177 TSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIF-AEMFRRKPLFRG-SSDVDQLGKILDV 234
Query: 375 L-----------------EFPKEPSVP---------GPAKDLIAQLLVKDPTRRMGSKMG 408
+ F + + P KDL+ + L +P +R+
Sbjct: 235 IGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRI----- 289
Query: 409 ATAIK--RHQFFNGVNWALLRCAKPPFIPRPVTCRDLTTT 446
+A H +F + + +P +L T
Sbjct: 290 -SAYSALSHPYFQDLE--RCKENLDSHLPPSQNTSELNTA 326
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 1e-08
Identities = 31/165 (18%), Positives = 62/165 (37%), Gaps = 18/165 (10%)
Query: 85 RFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKR--------ELVSRNKESRARIE 136
++GSG G +YL + KV + + R + +
Sbjct: 40 VLGKKIGSGGFGLIYLAF-PTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKK 98
Query: 137 REILEMLDHPFLPTLY----ATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRF 192
+ LD+ +P Y + ++ E G DL + + + F +S V
Sbjct: 99 WIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQ--NGTFKKSTVLQ 155
Query: 193 YASEVVVALEFLHMMGIIYRDLKPENVLV--RSDGHIMLTDFDLS 235
++ LE++H ++ D+K N+L+ ++ + L D+ LS
Sbjct: 156 LGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLS 200
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 54.9 bits (133), Expect = 2e-08
Identities = 40/169 (23%), Positives = 65/169 (38%), Gaps = 41/169 (24%)
Query: 87 VHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIE---------- 136
+ ++G G G V+ K++ G A K + +E
Sbjct: 22 LAKIGQGTFGEVF----KARHRKTGQKVALK--------------KVLMENEKEGFPITA 63
Query: 137 -REI--LEMLDHPFLPTLY-----ATLDCPRWSC---LLTEFCPGGDLHVLRQRQPDKRF 185
REI L++L H + L R L+ +FC DL L +F
Sbjct: 64 LREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGL-LSNVLVKF 121
Query: 186 HESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDL 234
S ++ ++ L ++H I++RD+K NVL+ DG + L DF L
Sbjct: 122 TLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGL 170
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 2e-08
Identities = 46/208 (22%), Positives = 92/208 (44%), Gaps = 31/208 (14%)
Query: 34 GSNPSSSTPSAAKTHHAPPRCNDDPCWKAIKEATSEGNNNNNNNPLTLSDLRFVHRLGSG 93
GS S+ P + DDP K IK S+G + ++ + +G+G
Sbjct: 1 GSFTMSNAPLNGVKLNP----LDDPN-KVIKVLASDGKTGEQR-EIAYTNCK---VIGNG 51
Query: 94 DIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTL-- 151
G V+ ++K + +V K+ L + ++R E +I+ ++ HP + L
Sbjct: 52 SFGVVF----QAKLVESD-----EVAIKKVLQDKRFKNR---ELQIMRIVKHPNVVDLKA 99
Query: 152 --YATLDCPRWSC--LLTEFCPGGDLH-VLRQR-QPDKRFHESAVRFYASEVVVALEFLH 205
Y+ D L+ E+ P ++ R + + ++ Y +++ +L ++H
Sbjct: 100 FFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH 158
Query: 206 MMGIIYRDLKPENVLVRSDGHIM-LTDF 232
+GI +RD+KP+N+L+ ++ L DF
Sbjct: 159 SIGICHRDIKPQNLLLDPPSGVLKLIDF 186
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 3e-08
Identities = 31/127 (24%), Positives = 57/127 (44%), Gaps = 11/127 (8%)
Query: 134 RIEREI--LEMLDHPFLPTLYATLDCPRWSC-----LLTEFCPGGDLHVLRQRQPDKRFH 186
R REI L+ H + T++ + ++ E DLH + Q H
Sbjct: 55 RTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELM-QTDLHRVISTQMLSDDH 113
Query: 187 ESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQ 246
++++ + + A++ LH +I+RDLKP N+L+ S+ + + DF L+ D S +
Sbjct: 114 ---IQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNS 170
Query: 247 LVSDQSP 253
+ Q
Sbjct: 171 EPTGQQS 177
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 5e-04
Identities = 31/116 (26%), Positives = 48/116 (41%), Gaps = 31/116 (26%)
Query: 319 VGTHEYLAPEII-SGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDH-------------- 363
V T Y APE++ + + A+D W+ G + ELF F G D+
Sbjct: 183 VATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTP 242
Query: 364 --ELTLANVV-ARALEF----PKEPSVP--------GP-AKDLIAQLLVKDPTRRM 403
+ L + RA E+ P P+ P P DL+ ++LV DP +R+
Sbjct: 243 HSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRI 298
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 3e-08
Identities = 29/111 (26%), Positives = 51/111 (45%), Gaps = 13/111 (11%)
Query: 134 RIEREI--LEMLDHPFLPTLYATLDCPRWSC-----LLTEFCPGGDLH-VLRQRQPD-KR 184
R+ REI L HP + L L+TE DL V+ ++
Sbjct: 75 RVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIVISP 133
Query: 185 FHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235
H ++++ +++ L LH G+++RDL P N+L+ + I + DF+L+
Sbjct: 134 QH---IQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLA 181
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 4e-04
Identities = 28/117 (23%), Positives = 44/117 (37%), Gaps = 31/117 (26%)
Query: 318 FVGTHEYLAPEII-SGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDH--------ELT-- 366
+V Y APE++ +G VD W+ G + E+F F+G E+
Sbjct: 193 YVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGT 252
Query: 367 --------LANVVARALEFPKEPSVPGP------------AKDLIAQLLVKDPTRRM 403
++ AR +VP A DLIA++L +P RR+
Sbjct: 253 PKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRI 309
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 2e-07
Identities = 31/171 (18%), Positives = 66/171 (38%), Gaps = 18/171 (10%)
Query: 94 DIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVS-------RNKESRARIEREI--LEMLD 144
D+G Y G +A + V+ ++ R REI L
Sbjct: 24 DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR 83
Query: 145 HPFLPTLYATLDCPRWSC-----LLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVV 199
H + + + P ++ + DL+ L + Q H + ++ +++
Sbjct: 84 HENIIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDH---ICYFLYQILR 139
Query: 200 ALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQLVSD 250
L+++H +++RDLKP N+L+ + + + DF L+ D +++
Sbjct: 140 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTE 190
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 2e-07
Identities = 36/166 (21%), Positives = 63/166 (37%), Gaps = 39/166 (23%)
Query: 87 VHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIE---------- 136
+ +LG G G VY K+ + A K R R+E
Sbjct: 39 ITKLGEGTYGEVY----KAIDTVTNETVAIK--------------RIRLEHEEEGVPGTA 80
Query: 137 -REI--LEMLDHPFLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFY 193
RE+ L+ L H + L + + L+ E+ DL + PD ++ +
Sbjct: 81 IREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPD--VSMRVIKSF 137
Query: 194 ASEVVVALEFLHMMGIIYRDLKPENVLV-----RSDGHIMLTDFDL 234
+++ + F H ++RDLKP+N+L+ + + DF L
Sbjct: 138 LYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGL 183
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 3e-06
Identities = 35/159 (22%), Positives = 64/159 (40%), Gaps = 21/159 (13%)
Query: 89 RLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFL 148
++G G G VY K K + +A K + + +S S R E +L L HP +
Sbjct: 28 KVGRGTYGHVYKA--KRKDGKDDKDYALKQI-EGTGISM---SACR-EIALLRELKHPNV 80
Query: 149 PTLYATLDCPRWSC--LLTEFCPGGDLHVL-------RQRQPDKRFHESAVRFYASEVVV 199
+L LL ++ DL + + + + V+ +++
Sbjct: 81 ISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILD 139
Query: 200 ALEFLHMMGIIYRDLKPENVLVRSD----GHIMLTDFDL 234
+ +LH +++RDLKP N+LV + G + + D
Sbjct: 140 GIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF 178
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 3e-06
Identities = 29/134 (21%), Positives = 55/134 (41%), Gaps = 21/134 (15%)
Query: 134 RIEREI--LEMLDHP--------FLPTLYATLDCPRWSC------LLTEFCPGGDLHVLR 177
REI + LDH P+ D ++ E+ DL +
Sbjct: 54 HALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-ETDLANVL 112
Query: 178 QRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRS-DGHIMLTDFDLSL 236
++ P H R + +++ L+++H +++RDLKP N+ + + D + + DF L+
Sbjct: 113 EQGPLLEEH---ARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLAR 169
Query: 237 KGDNSTSTAQLVSD 250
D S +S+
Sbjct: 170 IMDPHYSHKGHLSE 183
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 3e-04
Identities = 23/114 (20%), Positives = 37/114 (32%), Gaps = 29/114 (25%)
Query: 319 VGTHEYLAPEII-SGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDH-------------- 363
+ T Y +P ++ S + A+D W G E+ G T F G
Sbjct: 185 LVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVV 244
Query: 364 -ELTLANVVARALEF----PKEPSVP--------GP-AKDLIAQLLVKDPTRRM 403
E +++ + EP P A D + Q+L P R+
Sbjct: 245 HEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRL 298
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 47.6 bits (114), Expect = 4e-06
Identities = 53/229 (23%), Positives = 81/229 (35%), Gaps = 53/229 (23%)
Query: 34 GSNPSSSTPSAAKTHHAPPRCNDDPCW---KAIKEATSEGNNNNNNNPLTLSDLRFVHRL 90
GS S +T S + + ++EAT NN ++ +
Sbjct: 2 GSKYSKATNSINDALSSSYLVPFESYRVPLVDLEEAT---NNFDHKF-----------LI 47
Query: 91 GSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSR--NKESRARIEREILEMLDHPFL 148
G G G VY L +G A K S +E E E L HP L
Sbjct: 48 GHGVFGKVYKGVL-----RDGAKVALKRRTPE---SSQGIEEFET--EIETLSFCRHPHL 97
Query: 149 PTL--YATLDCPRWSCLLTEFCPGGDL--HVLRQRQP------DKRFH---ESAVRFYAS 195
+L + L+ ++ G+L H+ P ++R +A R
Sbjct: 98 VSLIGFCDERNEM--ILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAA-R---- 150
Query: 196 EVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTST 244
L +LH II+RD+K N+L+ + +TDF +S KG T
Sbjct: 151 ----GLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQT 195
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 2e-05
Identities = 30/144 (20%), Positives = 58/144 (40%), Gaps = 26/144 (18%)
Query: 111 GCFFAAKVMDKRELVS-----RNKESRARIEREI--LEMLDHPFLPTLYATLDCPRWS-- 161
G K V+ ++ R R + + L +L HP + L +
Sbjct: 37 GTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDR 96
Query: 162 -----CLLTEFCPGGDLH-VLR----QRQPDKRFHESAVRFYASEVVVALEFLHM--MGI 209
++ E+ P LH R ++ ++ + +++ ++ LH+ + +
Sbjct: 97 RDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPIL---IKVFLFQLIRSIGCLHLPSVNV 152
Query: 210 IYRDLKPENVLV-RSDGHIMLTDF 232
+RD+KP NVLV +DG + L DF
Sbjct: 153 CHRDIKPHNVLVNEADGTLKLCDF 176
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 44.0 bits (104), Expect = 6e-05
Identities = 23/90 (25%), Positives = 43/90 (47%), Gaps = 13/90 (14%)
Query: 163 LLTEFCPGGDLH-----VLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPE 217
++ E+ P LH +R + + Y ++ A+ F+H +GI +RD+KP+
Sbjct: 115 VIMEYVPD-TLHKVLKSFIRSGRSIPMNL---ISIYIYQLFRAVGFIHSLGICHRDIKPQ 170
Query: 218 NVLV-RSDGHIMLTDFDLS---LKGDNSTS 243
N+LV D + L DF + + + S +
Sbjct: 171 NLLVNSKDNTLKLCDFGSAKKLIPSEPSVA 200
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 44.1 bits (103), Expect = 1e-04
Identities = 65/421 (15%), Positives = 130/421 (30%), Gaps = 123/421 (29%)
Query: 88 HRLGSGDIGSVYLVQLKSKSSNNGCF----FAAKVMDKRE----LVSRNKESRAR----- 134
H+ DI SV+ N C ++ K E ++S++ S
Sbjct: 14 HQYQYKDILSVFEDAFVD---NFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGTLRLFWT 70
Query: 135 --------IEREILEML--DHPFLPTLYATLDCPRWSCLLTEFC-----------PGGDL 173
+++ + E+L ++ FL + T + + S + +
Sbjct: 71 LLSKQEEMVQKFVEEVLRINYKFLMSPIKT-EQRQPSMMTRMYIEQRDRLYNDNQVFAKY 129
Query: 174 HVLRQRQPDKRFHESAVRFYASEVVVALEFLH-MMGI--------IYRDLKPENVLVRSD 224
+V R QP + ++ + ++ V+ + ++G + K V + D
Sbjct: 130 NVSRL-QPYLKLRQALLELRPAKNVL----IDGVLGSGKTWVALDVCLSYK---VQCKMD 181
Query: 225 GHIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPA 284
I F L+LK N S ++ + P + + S N +
Sbjct: 182 FKI----FWLNLK--NCNSPETVL--------EMLQKLLYQIDPNWTSRSDHSSNIKLRI 227
Query: 285 VSCLHPKRRRKKKLGNPGTPE--IVAEPLD-VRSMSFVGTHEYLAPEIISGEGHGNAVDW 341
S + ++ L + +V L V++ + NA +
Sbjct: 228 HSI---QAELRRLLKSKPYENCLLV---LLNVQN-----------AKAW------NAFN- 263
Query: 342 WTLG--IFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDP 399
L I + TT FK + L+ A +L+ P K L+ + L P
Sbjct: 264 --LSCKILL------TTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRP 315
Query: 400 TRRMGSKMGATAIKRHQFFNGVNWALLRCAKPPFIPRP-----VTCRDLTTTNSSIDNSI 454
+ + + + +R + V C LTT I++S+
Sbjct: 316 -----QDLPREVLTTNPRRLSIIAESIR----DGLATWDNWKHVNCDKLTTI---IESSL 363
Query: 455 E 455
Sbjct: 364 N 364
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 41.1 bits (96), Expect = 5e-04
Identities = 30/145 (20%), Positives = 46/145 (31%), Gaps = 11/145 (7%)
Query: 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILE 141
L+ LG G G V C A M K + E +IL
Sbjct: 22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA-LMSELKILI 80
Query: 142 MLD-HPFLPTLY-ATLDCPRWSCLLTEFCPGGDLHV-LRQRQPDKRFHESAVRFYASEVV 198
+ H + L A ++ EFC G+L LR ++ + Y ++
Sbjct: 81 HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNE-------FVPYKTKGA 133
Query: 199 VALEFLHMMGIIYRDLKPENVLVRS 223
+ +G I DLK + S
Sbjct: 134 RFRQGKDYVGAIPVDLKRRLDSITS 158
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 41.0 bits (95), Expect = 5e-04
Identities = 27/208 (12%), Positives = 57/208 (27%), Gaps = 56/208 (26%)
Query: 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVM---DKRELVSRNKESRARIERE 138
L+ ++G G G V+ ++ + A K++ + ++++ I E
Sbjct: 20 EKLQRCEKIGEGVFGEVF------QTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPE 73
Query: 139 IL-----------EMLDHPFLPTLYA----TLDCPRWSC--------------------- 162
I+ L + P
Sbjct: 74 IIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFK 133
Query: 163 -----LLTEFCPGG-DLHVLRQRQPDKRFHESAVRFYASEVVVALEFLH-MMGIIYRDLK 215
++ EF GG DL +R + + + ++ +L + +RDL
Sbjct: 134 DDQLFIVLEFEFGGIDLEQMRTKLSS----LATAKSILHQLTASLAVAEASLRFEHRDLH 189
Query: 216 PENVLVRSDGHIMLTDFDLSLKGDNSTS 243
NVL++ L +
Sbjct: 190 WGNVLLKKTSLKKLHYTLNGKSSTIPSC 217
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 40.6 bits (96), Expect = 6e-04
Identities = 39/186 (20%), Positives = 68/186 (36%), Gaps = 40/186 (21%)
Query: 63 IKEATSEGNNNNNNNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKR 122
+K T NN + P+++ +++G G G VY K N A K +
Sbjct: 20 LKNVT----NNFDERPISVGG----NKMGEGGFGVVY------KGYVNNTTVAVKKLAAM 65
Query: 123 ELVSR---NKESRARIEREILEMLDHPFLPTL--YATLDCPRWSCLLTEFCPGGD----L 173
++ ++ E +++ H L L +++ CL+ + P G L
Sbjct: 66 VDITTEELKQQFDQ--EIKVMAKCQHENLVELLGFSSDGDDL--CLVYVYMPNGSLLDRL 121
Query: 174 HVLRQRQP---DKRFH--ESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIM 228
L P R + A + FLH I+RD+K N+L+
Sbjct: 122 SCLDGTPPLSWHMRCKIAQGAAN--------GINFLHENHHIHRDIKSANILLDEAFTAK 173
Query: 229 LTDFDL 234
++DF L
Sbjct: 174 ISDFGL 179
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 457 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.95 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.93 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.87 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.8 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.48 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.36 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.28 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.09 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.96 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.77 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.74 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.64 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.49 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.41 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.4 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.39 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 98.08 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.95 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.73 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.69 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.68 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.67 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.58 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.42 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.38 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.38 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.29 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.25 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.16 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 97.02 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.39 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.99 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 83.49 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 81.13 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 80.35 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-70 Score=526.44 Aligned_cols=278 Identities=35% Similarity=0.618 Sum_probs=249.0
Q ss_pred CCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCc
Q 012762 81 LSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRW 160 (457)
Q Consensus 81 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~ 160 (457)
.++|+++++||+|+||+||+|+++ .+|+.||||++.+...........+.+|+++|++|+|||||+++++|.+++.
T Consensus 31 ~~dy~i~~~lG~G~fg~V~~a~~~----~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~ 106 (311)
T 4aw0_A 31 PEDFKFGKILGEGSFSTVVLAREL----ATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEK 106 (311)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET----TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred ccccEEEEEEecccCeEEEEEEEC----CCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCE
Confidence 468999999999999999999987 4889999999998877777778889999999999999999999999999999
Q ss_pred EEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCC
Q 012762 161 SCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDN 240 (457)
Q Consensus 161 ~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~ 240 (457)
+|||||||+||+|.+++... +.+++..++.++.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+....
T Consensus 107 ~yivmEy~~gG~L~~~i~~~--~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~ 184 (311)
T 4aw0_A 107 LYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 184 (311)
T ss_dssp EEEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCC
Confidence 99999999999999999875 6799999999999999999999999999999999999999999999999999976542
Q ss_pred CCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccC
Q 012762 241 STSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVG 320 (457)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 320 (457)
... .....+++|
T Consensus 185 ~~~--------------------------------------------------------------------~~~~~~~~G 196 (311)
T 4aw0_A 185 ESK--------------------------------------------------------------------QARANSFVG 196 (311)
T ss_dssp TTT--------------------------------------------------------------------CCCBCCCCS
T ss_pred CCC--------------------------------------------------------------------cccccCccc
Confidence 111 112235689
Q ss_pred CCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhhhCCC
Q 012762 321 THEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDPT 400 (457)
Q Consensus 321 t~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~ 400 (457)
|+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..+.+.+++...+.+|. .+++++++||.+||+.||+
T Consensus 197 Tp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p~--~~s~~~~dli~~lL~~dp~ 274 (311)
T 4aw0_A 197 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPE--KFFPKARDLVEKLLVLDAT 274 (311)
T ss_dssp CGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT--TCCHHHHHHHHHHSCSSGG
T ss_pred CcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc--ccCHHHHHHHHHHccCCHh
Confidence 99999999999999999999999999999999999999999988999999998887775 4899999999999999999
Q ss_pred CCCCCCc--ChHHHhcCCCCCCCCchhhhccCCCCC
Q 012762 401 RRMGSKM--GATAIKRHQFFNGVNWALLRCAKPPFI 434 (457)
Q Consensus 401 ~Rps~~~--~~~~ll~hp~f~~~~~~~~~~~~~~~~ 434 (457)
+||+..+ ...+|++||||++++|..+....||.+
T Consensus 275 ~R~t~~e~~~~~~i~~Hp~F~~idw~~l~~~~pP~l 310 (311)
T 4aw0_A 275 KRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKL 310 (311)
T ss_dssp GSTTSGGGTCHHHHHTSGGGTTCCCTTGGGSCCCCC
T ss_pred HCcChHHHcCCHHHHCCCCcCCCCHHHhcCCCCCCC
Confidence 9999322 123479999999999999988877754
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-68 Score=514.96 Aligned_cols=283 Identities=38% Similarity=0.731 Sum_probs=241.4
Q ss_pred CCccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEE
Q 012762 77 NPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLD 156 (457)
Q Consensus 77 ~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~ 156 (457)
..++.++|++++.||+|+||+||+|++.. +..+++.||||++++...... ...++.+|+++|++|+|||||++++++.
T Consensus 19 ~~~~p~~Y~i~~~lG~G~fg~Vy~a~~~~-~~~~~~~vAiK~i~~~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~~~~~ 96 (304)
T 3ubd_A 19 EKADPSQFELLKVLGQGSFGKVFLVKKIS-GSDARQLYAMKVLKKATLKVR-DRVRTKMERDILVEVNHPFIVKLHYAFQ 96 (304)
T ss_dssp CCCCGGGEEEEEEEECGGGCEEEEEEECS-STTTTCEEEEEEEESEEEEEE-ECC------CCCCCCCCTTEECEEEEEE
T ss_pred ccCCccccEEEEEEecCCCeEEEEEEEcc-CCCCCEEEEEEEEehHHcChH-HHHHHHHHHHHHHHCCCCCCCeEEEEEE
Confidence 34556799999999999999999998653 334788999999987644322 2346778999999999999999999999
Q ss_pred cCCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCc
Q 012762 157 CPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSL 236 (457)
Q Consensus 157 ~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~ 236 (457)
+++.+|||||||+||+|.+++... +.+++..++.++.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+
T Consensus 97 ~~~~~~ivmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~ 174 (304)
T 3ubd_A 97 TEGKLYLILDFLRGGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSK 174 (304)
T ss_dssp ETTEEEEEECCCTTCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEE
T ss_pred ECCEEEEEEEcCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccce
Confidence 999999999999999999999875 679999999999999999999999999999999999999999999999999986
Q ss_pred CCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccc
Q 012762 237 KGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSM 316 (457)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (457)
...... ....
T Consensus 175 ~~~~~~----------------------------------------------------------------------~~~~ 184 (304)
T 3ubd_A 175 ESIDHE----------------------------------------------------------------------KKAY 184 (304)
T ss_dssp C---------------------------------------------------------------------------CCCC
T ss_pred eccCCC----------------------------------------------------------------------cccc
Confidence 543211 1122
Q ss_pred cccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhh
Q 012762 317 SFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLV 396 (457)
Q Consensus 317 ~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~ 396 (457)
+++||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..+.+.+++...+.+|. .+++++++||.+||+
T Consensus 185 ~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~--~~s~~~~~li~~~L~ 262 (304)
T 3ubd_A 185 SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQ--FLSPEAQSLLRMLFK 262 (304)
T ss_dssp SCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT--TSCHHHHHHHHHHTC
T ss_pred ccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCC--cCCHHHHHHHHHHcc
Confidence 467999999999999999999999999999999999999999999988889999888777665 489999999999999
Q ss_pred hCCCCCCCCC-cChHHHhcCCCCCCCCchhh--hccCCCCCC
Q 012762 397 KDPTRRMGSK-MGATAIKRHQFFNGVNWALL--RCAKPPFIP 435 (457)
Q Consensus 397 ~dP~~Rps~~-~~~~~ll~hp~f~~~~~~~~--~~~~~~~~~ 435 (457)
.||++||+.. ..++||++||||+++||..+ +...|||+|
T Consensus 263 ~dP~~R~ta~~~~~~eil~Hp~f~~idw~~l~~~~~~pP~~P 304 (304)
T 3ubd_A 263 RNPANRLGAGPDGVEEIKRHSFFSTIDWNKLYRREIHPPFKP 304 (304)
T ss_dssp SSGGGSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSSCC
T ss_pred cCHHHCCCCCcCCHHHHHcCccccCCCHHHHHhCCCCcCcCC
Confidence 9999999953 24689999999999999987 467799987
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-65 Score=500.14 Aligned_cols=256 Identities=27% Similarity=0.433 Sum_probs=226.2
Q ss_pred CCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCc
Q 012762 81 LSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRW 160 (457)
Q Consensus 81 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~ 160 (457)
.++|+++++||+|+||+||+|+++ .+|+.||||++.+... ...+.+.+|+++|+.|+|||||+++++|.+++.
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~----~tg~~vAiK~i~~~~~---~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~ 145 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVR----SSGKLVAVKKMDLRKQ---QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDE 145 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEET----TTCCEEEEEEEEGGGC---SSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred hHhcEEeEEeecCcCeEEEEEEEC----CCCCEEEEEEEecCch---hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 357999999999999999999987 4899999999986543 334557789999999999999999999999999
Q ss_pred EEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCC
Q 012762 161 SCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDN 240 (457)
Q Consensus 161 ~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~ 240 (457)
+|||||||+||+|.+++.. +.+++..++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+....
T Consensus 146 ~~ivmEy~~gg~L~~~l~~---~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 222 (346)
T 4fih_A 146 LWVVMEFLEGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK 222 (346)
T ss_dssp EEEEECCCTTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EEEEEeCCCCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCC
Confidence 9999999999999999876 5699999999999999999999999999999999999999999999999999875532
Q ss_pred CCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccC
Q 012762 241 STSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVG 320 (457)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 320 (457)
.. ....+++|
T Consensus 223 ~~----------------------------------------------------------------------~~~~~~~G 232 (346)
T 4fih_A 223 EV----------------------------------------------------------------------PRRKSLVG 232 (346)
T ss_dssp SS----------------------------------------------------------------------CCBCCCCS
T ss_pred CC----------------------------------------------------------------------Cccccccc
Confidence 11 11225689
Q ss_pred CCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhccc-CCCCCCCCChHHHHHHHHHhhhCC
Q 012762 321 THEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARAL-EFPKEPSVPGPAKDLIAQLLVKDP 399 (457)
Q Consensus 321 t~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ll~~~L~~dP 399 (457)
|+.|||||++.+..|+.++|||||||++|||++|++||.+.+..+.+..+..... .++....+++++++||.+||+.||
T Consensus 233 Tp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~L~~dP 312 (346)
T 4fih_A 233 TPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDP 312 (346)
T ss_dssp CGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGGSCHHHHHHHHHHSCSST
T ss_pred CcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccccCCHHHHHHHHHHcCCCh
Confidence 9999999999999999999999999999999999999999887777777765532 233445689999999999999999
Q ss_pred CCCCCCCcChHHHhcCCCCCC
Q 012762 400 TRRMGSKMGATAIKRHQFFNG 420 (457)
Q Consensus 400 ~~Rps~~~~~~~ll~hp~f~~ 420 (457)
++||| ++|||+||||+.
T Consensus 313 ~~R~t----a~e~l~Hp~~~~ 329 (346)
T 4fih_A 313 AQRAT----AAELLKHPFLAK 329 (346)
T ss_dssp TTSCC----HHHHTTCGGGGG
T ss_pred hHCcC----HHHHhcCHhhcC
Confidence 99999 999999999984
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-65 Score=501.43 Aligned_cols=261 Identities=21% Similarity=0.402 Sum_probs=227.6
Q ss_pred cCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCC
Q 012762 80 TLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPR 159 (457)
Q Consensus 80 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~ 159 (457)
.+++|+++++||+|+||+||+|+++ .+|+.||||++.+.... ......+.+|+++|++|+|||||+++++|.+++
T Consensus 22 sme~Y~~~~~lG~G~fg~V~~a~~~----~~~~~vAiK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~ 96 (350)
T 4b9d_A 22 SMEKYVRLQKIGEGSFGKAILVKST----EDGRQYVIKEINISRMS-SKEREESRREVAVLANMKHPNIVQYRESFEENG 96 (350)
T ss_dssp CCCCEEEEEEC------CEEEEEET----TTCCEEEEEEEECTTSC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred cccceEEeEEEecCCCeEEEEEEEC----CCCCEEEEEEEehHHCC-HHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECC
Confidence 4689999999999999999999987 48899999999876543 334677889999999999999999999999999
Q ss_pred cEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCC
Q 012762 160 WSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGD 239 (457)
Q Consensus 160 ~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~ 239 (457)
.+|||||||+||+|.+++.......+++..++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+...
T Consensus 97 ~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 176 (350)
T 4b9d_A 97 SLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLN 176 (350)
T ss_dssp EEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCC
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeec
Confidence 99999999999999999987766778999999999999999999999999999999999999999999999999987553
Q ss_pred CCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcccccccc
Q 012762 240 NSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFV 319 (457)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (457)
... ....+++
T Consensus 177 ~~~----------------------------------------------------------------------~~~~~~~ 186 (350)
T 4b9d_A 177 STV----------------------------------------------------------------------ELARACI 186 (350)
T ss_dssp HHH----------------------------------------------------------------------HHHHHHH
T ss_pred CCc----------------------------------------------------------------------ccccccC
Confidence 210 0112457
Q ss_pred CCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhhhCC
Q 012762 320 GTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDP 399 (457)
Q Consensus 320 gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP 399 (457)
||+.|||||++.+..|+.++|||||||+||||++|+.||.+.+..+.+.+++...+. +.+..+++++++||.+||+.||
T Consensus 187 GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~-~~~~~~s~~~~~li~~~L~~dP 265 (350)
T 4b9d_A 187 GTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFP-PVSLHYSYDLRSLVSQLFKRNP 265 (350)
T ss_dssp SCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC-CCCTTSCHHHHHHHHHHTCSSG
T ss_pred CCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCC-CCCccCCHHHHHHHHHHccCCh
Confidence 999999999999999999999999999999999999999999888888888877653 3345689999999999999999
Q ss_pred CCCCCCCcChHHHhcCCCCCC
Q 012762 400 TRRMGSKMGATAIKRHQFFNG 420 (457)
Q Consensus 400 ~~Rps~~~~~~~ll~hp~f~~ 420 (457)
++||+ ++|||+||||+.
T Consensus 266 ~~R~s----~~e~l~hp~~~~ 282 (350)
T 4b9d_A 266 RDRPS----VNSILEKGFIAK 282 (350)
T ss_dssp GGSCC----HHHHHTSHHHHT
T ss_pred hHCcC----HHHHhcCHHhhc
Confidence 99999 999999999975
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-64 Score=507.16 Aligned_cols=256 Identities=27% Similarity=0.433 Sum_probs=226.8
Q ss_pred CCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCc
Q 012762 81 LSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRW 160 (457)
Q Consensus 81 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~ 160 (457)
.++|+++++||+|+||+||+|+++ .+|+.||||++.+... ...+.+.+|+++|+.|+|||||+++++|.+++.
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~----~tg~~vAiK~i~~~~~---~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~ 222 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVR----SSGKLVAVKKMDLRKQ---QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDE 222 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEET----TTCCEEEEEEEESTTC---SSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred hHhcEeeeEeccCcCcEEEEEEEC----CCCCEEEEEEEeccch---hHHHHHHHHHHHHHhCCCCCCCceEEEEEECCE
Confidence 457999999999999999999987 4899999999976533 334567889999999999999999999999999
Q ss_pred EEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCC
Q 012762 161 SCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDN 240 (457)
Q Consensus 161 ~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~ 240 (457)
+|||||||+||+|.++++. +.+++..++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+....
T Consensus 223 ~~iVmEy~~gG~L~~~i~~---~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~ 299 (423)
T 4fie_A 223 LWVVMEFLEGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK 299 (423)
T ss_dssp EEEEEECCTTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCS
T ss_pred EEEEEeCCCCCcHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCC
Confidence 9999999999999999876 5699999999999999999999999999999999999999999999999999875532
Q ss_pred CCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccC
Q 012762 241 STSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVG 320 (457)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 320 (457)
.. ....+++|
T Consensus 300 ~~----------------------------------------------------------------------~~~~~~~G 309 (423)
T 4fie_A 300 EV----------------------------------------------------------------------PRRKSLVG 309 (423)
T ss_dssp SC----------------------------------------------------------------------CCBCCCEE
T ss_pred CC----------------------------------------------------------------------cccccccc
Confidence 11 11225689
Q ss_pred CCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhccc-CCCCCCCCChHHHHHHHHHhhhCC
Q 012762 321 THEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARAL-EFPKEPSVPGPAKDLIAQLLVKDP 399 (457)
Q Consensus 321 t~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ll~~~L~~dP 399 (457)
|+.|||||++.+..|+.++|||||||++|||++|++||.+.+....+..+..... .++....+++++++||.+||..||
T Consensus 310 Tp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~L~~dP 389 (423)
T 4fie_A 310 TPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDP 389 (423)
T ss_dssp CTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCHHHHHHHHHHSCSST
T ss_pred CcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccCCHHHHHHHHHHcCCCh
Confidence 9999999999999999999999999999999999999999888777777766532 334445789999999999999999
Q ss_pred CCCCCCCcChHHHhcCCCCCC
Q 012762 400 TRRMGSKMGATAIKRHQFFNG 420 (457)
Q Consensus 400 ~~Rps~~~~~~~ll~hp~f~~ 420 (457)
++||+ ++|||+||||+.
T Consensus 390 ~~R~t----a~ell~Hp~~~~ 406 (423)
T 4fie_A 390 AQRAT----AAELLKHPFLAK 406 (423)
T ss_dssp TTSCC----HHHHTTCGGGGG
T ss_pred hHCcC----HHHHhcCHHhcC
Confidence 99999 999999999985
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-64 Score=480.89 Aligned_cols=256 Identities=26% Similarity=0.472 Sum_probs=215.7
Q ss_pred CCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCc
Q 012762 81 LSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRW 160 (457)
Q Consensus 81 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~ 160 (457)
+++|++++.||+|+||+||+|+++ .+|+.||||++.+..........++.+|+++|+.++|||||++++++.+++.
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~----~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~ 87 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHT----TTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDE 87 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECT----TTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred eeCeEEEEEEecCcCeEEEEEEEC----CCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCE
Confidence 478999999999999999999876 4889999999988766655667788999999999999999999999999999
Q ss_pred EEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCC
Q 012762 161 SCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDN 240 (457)
Q Consensus 161 ~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~ 240 (457)
+||||||| +|+|.+++... +.+++..++.++.||+.||+|||++||+||||||+||||+.+|.+||+|||+|+....
T Consensus 88 ~~ivmEy~-~g~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 164 (275)
T 3hyh_A 88 IIMVIEYA-GNELFDYIVQR--DKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD 164 (275)
T ss_dssp EEEEEECC-CEEHHHHHHHS--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC-----
T ss_pred EEEEEeCC-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCC
Confidence 99999999 78998888775 6799999999999999999999999999999999999999999999999999865432
Q ss_pred CCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccC
Q 012762 241 STSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVG 320 (457)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 320 (457)
.. ...+.+|
T Consensus 165 ~~-----------------------------------------------------------------------~~~~~~G 173 (275)
T 3hyh_A 165 GN-----------------------------------------------------------------------FLKTSCG 173 (275)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred CC-----------------------------------------------------------------------ccCCeeE
Confidence 11 1124579
Q ss_pred CCCccCchhhcCCCC-CccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhhhCC
Q 012762 321 THEYLAPEIISGEGH-GNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDP 399 (457)
Q Consensus 321 t~~y~aPE~l~~~~~-~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP 399 (457)
|+.|||||++.+..| +.++|||||||++|||++|+.||.+.+....+..+....+.+|. .+++++++||.+||+.||
T Consensus 174 T~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~p~--~~s~~~~~li~~~L~~dP 251 (275)
T 3hyh_A 174 SPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPK--FLSPGAAGLIKRMLIVNP 251 (275)
T ss_dssp -CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT--TSCHHHHHHHHHHSCSSG
T ss_pred CcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCC--CCCHHHHHHHHHHccCCh
Confidence 999999999999886 68999999999999999999999998888888888888777765 489999999999999999
Q ss_pred CCCCCCCcChHHHhcCCCCCC
Q 012762 400 TRRMGSKMGATAIKRHQFFNG 420 (457)
Q Consensus 400 ~~Rps~~~~~~~ll~hp~f~~ 420 (457)
++||| ++|+++||||+.
T Consensus 252 ~~R~s----~~eil~hpw~k~ 268 (275)
T 3hyh_A 252 LNRIS----IHEIMQDDWFKV 268 (275)
T ss_dssp GGSCC----HHHHHHCHHHHT
T ss_pred hHCcC----HHHHHcCccccc
Confidence 99999 999999999973
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-62 Score=511.36 Aligned_cols=286 Identities=31% Similarity=0.594 Sum_probs=244.6
Q ss_pred CCCccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHH---HHHHcCCCCCceEE
Q 012762 76 NNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIERE---ILEMLDHPFLPTLY 152 (457)
Q Consensus 76 ~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~---il~~l~H~nIv~l~ 152 (457)
+..+.+++|+++++||+|+||+||+|+++ .+|+.||||++.+..+...........|.. +++.++|||||+++
T Consensus 183 ~~~~slddf~i~k~LG~G~fG~V~la~~~----~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~ 258 (689)
T 3v5w_A 183 NIHLTMNDFSVHRIIGRGGFGEVYGCRKA----DTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMS 258 (689)
T ss_dssp TCCCCGGGEEEEEEEEECSSEEEEEEEET----TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEE
T ss_pred CCCCchHHeEEEEEEecccCeEEEEEEEC----CCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEE
Confidence 45678899999999999999999999987 489999999999887766555555555654 44556899999999
Q ss_pred EEEEcCCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEecc
Q 012762 153 ATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDF 232 (457)
Q Consensus 153 ~~~~~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DF 232 (457)
++|.+.+.+|||||||+||+|..++... +.+++..++.|+.||+.||+|||++|||||||||+||||+.+|.+||+||
T Consensus 259 ~~f~~~~~lylVmEy~~GGdL~~~l~~~--~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DF 336 (689)
T 3v5w_A 259 YAFHTPDKLSFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDL 336 (689)
T ss_dssp EEEECSSEEEEEECCCCSCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCC
T ss_pred EEEEECCEEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEeccc
Confidence 9999999999999999999999999875 67999999999999999999999999999999999999999999999999
Q ss_pred CCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCc
Q 012762 233 DLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLD 312 (457)
Q Consensus 233 G~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (457)
|+|+.....
T Consensus 337 GlA~~~~~~----------------------------------------------------------------------- 345 (689)
T 3v5w_A 337 GLACDFSKK----------------------------------------------------------------------- 345 (689)
T ss_dssp TTCEECSSC-----------------------------------------------------------------------
T ss_pred ceeeecCCC-----------------------------------------------------------------------
Confidence 998654321
Q ss_pred cccccccCCCCccCchhhc-CCCCCccchhhhhhHHHHHHhcCCCCCCCCC---hHHHHHHHHhcccCCCCCCCCChHHH
Q 012762 313 VRSMSFVGTHEYLAPEIIS-GEGHGNAVDWWTLGIFIFELFYGTTPFKGID---HELTLANVVARALEFPKEPSVPGPAK 388 (457)
Q Consensus 313 ~~~~~~~gt~~y~aPE~l~-~~~~~~~sDiwSlG~il~elltG~~Pf~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (457)
...+++||+.|||||++. +..|+.++|||||||+||||++|++||.+.. ...+...+......+|. .++++++
T Consensus 346 -~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~p~--~~S~~a~ 422 (689)
T 3v5w_A 346 -KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPD--SFSPELR 422 (689)
T ss_dssp -CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCCCT--TSCHHHH
T ss_pred -CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCCCc--cCCHHHH
Confidence 112468999999999996 4679999999999999999999999997643 23445556666666654 4999999
Q ss_pred HHHHHHhhhCCCCCCCC-CcChHHHhcCCCCCCCCchhh--hccCCCCCCCCCCcc
Q 012762 389 DLIAQLLVKDPTRRMGS-KMGATAIKRHQFFNGVNWALL--RCAKPPFIPRPVTCR 441 (457)
Q Consensus 389 ~ll~~~L~~dP~~Rps~-~~~~~~ll~hp~f~~~~~~~~--~~~~~~~~~~~~~~~ 441 (457)
+||.+||+.||.+|++. ...++||++||||+++||..+ +...|||+|......
T Consensus 423 dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW~~l~~~~~~pP~~P~~~~~~ 478 (689)
T 3v5w_A 423 SLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPRGEVN 478 (689)
T ss_dssp HHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCHHHHHTTCSCCSCCCCTTCSS
T ss_pred HHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCCHHHHHcCCCCcCccCCCCCCC
Confidence 99999999999999985 245799999999999999987 567899999765443
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-61 Score=466.90 Aligned_cols=253 Identities=23% Similarity=0.396 Sum_probs=214.0
Q ss_pred ceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEc----CC
Q 012762 84 LRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDC----PR 159 (457)
Q Consensus 84 ~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~----~~ 159 (457)
|++.++||+|+||+||+|.++ .+++.||+|++.+.... .....++.+|+++|++|+|||||+++++|.+ ++
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~----~~~~~vAiK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~ 102 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDT----ETTVEVAWCELQDRKLT-KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKK 102 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEET----TTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEE
T ss_pred EEeeeEEecCcCcEEEEEEEC----CCCeEEEEEEEchhhCC-HHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCc
Confidence 478889999999999999987 47899999999876543 3345778899999999999999999999865 35
Q ss_pred cEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcC--ceeecCCCCCeEEcc-CCCEEEeccCCCc
Q 012762 160 WSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMG--IIYRDLKPENVLVRS-DGHIMLTDFDLSL 236 (457)
Q Consensus 160 ~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~--iiHrDIKp~NIll~~-~~~vkl~DFG~s~ 236 (457)
.+|||||||+||+|.+++... +.+++..++.|+.||+.||+|||++| ||||||||+||||+. +|.+||+|||+|+
T Consensus 103 ~~~lvmEy~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~ 180 (290)
T 3fpq_A 103 CIVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp EEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred EEEEEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCE
Confidence 689999999999999999875 67999999999999999999999998 999999999999984 7899999999986
Q ss_pred CCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccc
Q 012762 237 KGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSM 316 (457)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (457)
..... ...
T Consensus 181 ~~~~~------------------------------------------------------------------------~~~ 188 (290)
T 3fpq_A 181 LKRAS------------------------------------------------------------------------FAK 188 (290)
T ss_dssp GCCTT------------------------------------------------------------------------SBE
T ss_pred eCCCC------------------------------------------------------------------------ccC
Confidence 43211 112
Q ss_pred cccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccC-CCCCCCCChHHHHHHHHHh
Q 012762 317 SFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALE-FPKEPSVPGPAKDLIAQLL 395 (457)
Q Consensus 317 ~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ll~~~L 395 (457)
+++||+.|||||++.+ .|+.++|||||||+||||++|+.||.+......+...+..... ...+..+++++++||.+||
T Consensus 189 ~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L 267 (290)
T 3fpq_A 189 AVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCI 267 (290)
T ss_dssp ESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHS
T ss_pred CcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccCCHHHHHHHHHHc
Confidence 4579999999999976 5999999999999999999999999876655444444433322 2233457889999999999
Q ss_pred hhCCCCCCCCCcChHHHhcCCCCCC
Q 012762 396 VKDPTRRMGSKMGATAIKRHQFFNG 420 (457)
Q Consensus 396 ~~dP~~Rps~~~~~~~ll~hp~f~~ 420 (457)
+.||++||| ++|||+||||+.
T Consensus 268 ~~dP~~R~s----~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 268 RQNKDERYS----IKDLLNHAFFQE 288 (290)
T ss_dssp CSSGGGSCC----HHHHHTSGGGC-
T ss_pred cCChhHCcC----HHHHhcCccccC
Confidence 999999999 999999999984
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-61 Score=475.18 Aligned_cols=259 Identities=22% Similarity=0.319 Sum_probs=220.6
Q ss_pred cCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCC
Q 012762 80 TLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPR 159 (457)
Q Consensus 80 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~ 159 (457)
..++|++.++||+|+||+||+|+++ .+|+.||||++++... ..+|+++|+.|+|||||++++++.+++
T Consensus 56 ~~~~~~~~~~lG~G~fG~Vy~a~~~----~~g~~vAiK~i~~~~~--------~~~E~~il~~l~HpnIV~l~~~~~~~~ 123 (336)
T 4g3f_A 56 EVHWMTHQPRVGRGSFGEVHRMKDK----QTGFQCAVKKVRLEVF--------RVEELVACAGLSSPRIVPLYGAVREGP 123 (336)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEET----TTCCEEEEEEEETTTC--------CTHHHHTTTTCCCTTBCCEEEEEEETT
T ss_pred chhheEeCcEeccCCCeEEEEEEEC----CCCCEEEEEEECHHHh--------HHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 4568999999999999999999987 4899999999976532 235999999999999999999999999
Q ss_pred cEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCC-CEEEeccCCCcCC
Q 012762 160 WSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDG-HIMLTDFDLSLKG 238 (457)
Q Consensus 160 ~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~-~vkl~DFG~s~~~ 238 (457)
.+|||||||+||+|.++++.. +.+++..++.++.||+.||+|||++|||||||||+||||+.+| .+||+|||+|+..
T Consensus 124 ~~~ivmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~ 201 (336)
T 4g3f_A 124 WVNIFMELLEGGSLGQLIKQM--GCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCL 201 (336)
T ss_dssp EEEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC
T ss_pred EEEEEEeccCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEc
Confidence 999999999999999999875 6799999999999999999999999999999999999999988 6999999999765
Q ss_pred CCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccc
Q 012762 239 DNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSF 318 (457)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (457)
........ ......+
T Consensus 202 ~~~~~~~~-----------------------------------------------------------------~~~~~~~ 216 (336)
T 4g3f_A 202 QPDGLGKS-----------------------------------------------------------------LLTGDYI 216 (336)
T ss_dssp -----------------------------------------------------------------------------CCC
T ss_pred cCCCcccc-----------------------------------------------------------------eecCCcc
Confidence 43211100 0011245
Q ss_pred cCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCC-CCCCCChHHHHHHHHHhhh
Q 012762 319 VGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFP-KEPSVPGPAKDLIAQLLVK 397 (457)
Q Consensus 319 ~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ll~~~L~~ 397 (457)
+||+.|||||++.+..|+.++|||||||++|||++|+.||.+......+.++......+. .++.+++++.+||.+||+.
T Consensus 217 ~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~li~~~L~~ 296 (336)
T 4g3f_A 217 PGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAIQEGLRK 296 (336)
T ss_dssp CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSCTTSCHHHHHHHHHHTCS
T ss_pred ccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcCccCCHHHHHHHHHHccC
Confidence 799999999999999999999999999999999999999998877777777777654432 3456899999999999999
Q ss_pred CCCCCCCCCcChHHH-------------hcCCCCCCC
Q 012762 398 DPTRRMGSKMGATAI-------------KRHQFFNGV 421 (457)
Q Consensus 398 dP~~Rps~~~~~~~l-------------l~hp~f~~~ 421 (457)
||.+||| +.|| |+|||+...
T Consensus 297 dP~~R~s----a~el~~~l~~~l~~~~~l~hPw~~~~ 329 (336)
T 4g3f_A 297 EPVHRAS----AMELRRKVGKALQEVGGLKSPWKGEY 329 (336)
T ss_dssp SGGGSCC----HHHHHHHHHHHHHHTTSSCSCSSSSC
T ss_pred CHhHCcC----HHHHHHHHHHHHhhhhhccCCCcCCC
Confidence 9999999 8887 568887653
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-59 Score=471.76 Aligned_cols=264 Identities=22% Similarity=0.310 Sum_probs=221.1
Q ss_pred CCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEc----
Q 012762 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDC---- 157 (457)
Q Consensus 82 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~---- 157 (457)
++|+++++||+|+||+||+|+++ .+|+.||||++++... ......++.+|+++|+.|+|||||++++++..
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~----~t~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 128 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRR----LTGQQVAIKKIPNAFD-VVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPY 128 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEET----TTCCEEEEEEETTTTS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCT
T ss_pred CCeEEEEEEecccCeEEEEEEEC----CCCCEEEEEEECcccc-chHHHHHHHHHHHHHHhcCCCCcceEeeeeeccccc
Confidence 57999999999999999999987 4899999999976532 23345677889999999999999999998754
Q ss_pred --CCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCC
Q 012762 158 --PRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235 (457)
Q Consensus 158 --~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s 235 (457)
.+.+|||||||+ |+|..++... +.+++..++.++.||+.||.|||++|||||||||+|||++.+|.+||+|||++
T Consensus 129 ~~~~~~~ivmE~~~-g~L~~~i~~~--~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla 205 (398)
T 4b99_A 129 GEFKSVYVVLDLME-SDLHQIIHSS--QPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMA 205 (398)
T ss_dssp TTCCCEEEEEECCS-EEHHHHHTSS--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred ccCCEEEEEEeCCC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeeccee
Confidence 367899999994 7798888764 78999999999999999999999999999999999999999999999999998
Q ss_pred cCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcccc
Q 012762 236 LKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRS 315 (457)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (457)
+........ .....
T Consensus 206 ~~~~~~~~~------------------------------------------------------------------~~~~~ 219 (398)
T 4b99_A 206 RGLCTSPAE------------------------------------------------------------------HQYFM 219 (398)
T ss_dssp BCC-------------------------------------------------------------------------CCCC
T ss_pred eecccCccc------------------------------------------------------------------ccccc
Confidence 765321110 01122
Q ss_pred ccccCCCCccCchhhcCCC-CCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCC---------------
Q 012762 316 MSFVGTHEYLAPEIISGEG-HGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPK--------------- 379 (457)
Q Consensus 316 ~~~~gt~~y~aPE~l~~~~-~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~--------------- 379 (457)
.+++||+.|||||++.+.. |+.++||||+||++|||++|++||.+.+..+.+..++......+.
T Consensus 220 ~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~ 299 (398)
T 4b99_A 220 TEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYI 299 (398)
T ss_dssp CSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-----CHHHHH
T ss_pred ccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhh
Confidence 3568999999999998864 699999999999999999999999998888887777654332221
Q ss_pred --------------CCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCCCCc
Q 012762 380 --------------EPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGVNW 423 (457)
Q Consensus 380 --------------~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~~~~ 423 (457)
.+.+++++++||.+||..||++||| ++|+|+||||+....
T Consensus 300 ~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t----a~e~L~Hp~f~~~~~ 353 (398)
T 4b99_A 300 QSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARIS----AAAALRHPFLAKYHD 353 (398)
T ss_dssp HSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCC----HHHHTTSGGGTTTCC
T ss_pred hcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcC----HHHHhcCHhhCcCCC
Confidence 1246789999999999999999999 999999999997654
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-60 Score=459.68 Aligned_cols=270 Identities=25% Similarity=0.410 Sum_probs=201.0
Q ss_pred CCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCC--
Q 012762 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPR-- 159 (457)
Q Consensus 82 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~-- 159 (457)
++|++++.||+|+||+||+|+++ .+|+.||||+++... .....+.+.+|+++|++|+|||||+++++|.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~----~~~~~vAiK~i~~~~--~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~ 78 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNK----VDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTT 78 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEET----TTCCEEEEEEEEECS--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--
T ss_pred hhCEEeeEEecCCCeEEEEEEEC----CCCCEEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcc
Confidence 47999999999999999999987 478999999997542 2334567889999999999999999999987544
Q ss_pred ----------cEEEEEeecCCCChHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEE
Q 012762 160 ----------WSCLLTEFCPGGDLHVLRQRQPD-KRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIM 228 (457)
Q Consensus 160 ----------~~~lV~E~~~~~sL~~~~~~~~~-~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vk 228 (457)
++|||||||+||+|.+++..... ....+..++.++.||+.||+|||++|||||||||+||||+.+|.+|
T Consensus 79 ~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vK 158 (299)
T 4g31_A 79 EKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVK 158 (299)
T ss_dssp --------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEE
T ss_pred ccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEE
Confidence 47999999999999999976422 2345677899999999999999999999999999999999999999
Q ss_pred EeccCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccc
Q 012762 229 LTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVA 308 (457)
Q Consensus 229 l~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (457)
|+|||+|+............ ..
T Consensus 159 l~DFGla~~~~~~~~~~~~~----------------------------------------------------------~~ 180 (299)
T 4g31_A 159 VGDFGLVTAMDQDEEEQTVL----------------------------------------------------------TP 180 (299)
T ss_dssp ECCCCCC-------------------------------------------------------------------------
T ss_pred EccCccceecCCCccccccc----------------------------------------------------------cc
Confidence 99999997765322111000 00
Q ss_pred cCCccccccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHH-HHHHHHhcccCCCC-CCCCChH
Q 012762 309 EPLDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHEL-TLANVVARALEFPK-EPSVPGP 386 (457)
Q Consensus 309 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~-~~~~~~~~~~~~~~-~~~~~~~ 386 (457)
.+...+..+.+||+.|||||++.+..|+.++|||||||++|||++ ||.+..+.. .+..+.. ..+|. ....++.
T Consensus 181 ~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~~~~~~--~~~p~~~~~~~~~ 255 (299)
T 4g31_A 181 MPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLTDVRN--LKFPPLFTQKYPC 255 (299)
T ss_dssp -----------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHHHT--TCCCHHHHHHCHH
T ss_pred cccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHHHHHhc--CCCCCCCcccCHH
Confidence 001122335689999999999999999999999999999999996 886533222 2222222 22221 1224566
Q ss_pred HHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCCCCch
Q 012762 387 AKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGVNWA 424 (457)
Q Consensus 387 ~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~~~~~ 424 (457)
+.+||.+||+.||++||+ +.|||+||||++++|.
T Consensus 256 ~~~li~~~L~~dP~~Rps----~~eil~h~~~~~~~~p 289 (299)
T 4g31_A 256 EYVMVQDMLSPSPMERPE----AINIIENAVFEDLDFP 289 (299)
T ss_dssp HHHHHHHHTCSSGGGSCC----HHHHHTSGGGCCC---
T ss_pred HHHHHHHHcCCChhHCcC----HHHHhcCHhhCCCCCC
Confidence 889999999999999999 9999999999999984
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-59 Score=455.44 Aligned_cols=263 Identities=18% Similarity=0.306 Sum_probs=218.0
Q ss_pred CCccCCCceeEEEecccCcceEEEEEEecc-CCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEE
Q 012762 77 NPLTLSDLRFVHRLGSGDIGSVYLVQLKSK-SSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATL 155 (457)
Q Consensus 77 ~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~-~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~ 155 (457)
..+..++|.+.++||+|+||+||+|+++.. +..+++.||||+++.. .....+.+.+|+++|++|+|||||++++++
T Consensus 36 ~~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~~ 112 (329)
T 4aoj_A 36 HHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTMLQHQHIVRFFGVC 112 (329)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC---SHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred cccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC---CHHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence 456678999999999999999999998642 3346889999999753 234557789999999999999999999999
Q ss_pred EcCCcEEEEEeecCCCChHHHHHhCC-------------CCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEc
Q 012762 156 DCPRWSCLLTEFCPGGDLHVLRQRQP-------------DKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVR 222 (457)
Q Consensus 156 ~~~~~~~lV~E~~~~~sL~~~~~~~~-------------~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~ 222 (457)
.+++.+|||||||++|+|.++++... .+.+++.+++.|+.||+.||.|||+++||||||||+||||+
T Consensus 113 ~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~ 192 (329)
T 4aoj_A 113 TEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVG 192 (329)
T ss_dssp CSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE
T ss_pred EECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEEC
Confidence 99999999999999999999987642 24699999999999999999999999999999999999999
Q ss_pred cCCCEEEeccCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCC
Q 012762 223 SDGHIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPG 302 (457)
Q Consensus 223 ~~~~vkl~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (457)
.++.+||+|||+++.........
T Consensus 193 ~~~~~Ki~DFGla~~~~~~~~~~--------------------------------------------------------- 215 (329)
T 4aoj_A 193 QGLVVKIGDFGMSRDIYSTDYYR--------------------------------------------------------- 215 (329)
T ss_dssp TTTEEEECCCC---------------------------------------------------------------------
T ss_pred CCCcEEEcccccceeccCCCcce---------------------------------------------------------
Confidence 99999999999987553211100
Q ss_pred CCcccccCCccccccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHHhcccCCCCCC
Q 012762 303 TPEIVAEPLDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVVARALEFPKEP 381 (457)
Q Consensus 303 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 381 (457)
.....+||+.|||||++.+..|+.++|||||||+||||+| |+.||.+.+..+.+..+..+ .+++.+.
T Consensus 216 -----------~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~g-~~~~~p~ 283 (329)
T 4aoj_A 216 -----------VGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQG-RELERPR 283 (329)
T ss_dssp ---------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHHT-CCCCCCT
T ss_pred -----------ecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC-CCCCCcc
Confidence 0113469999999999999999999999999999999998 99999998887777776654 3455556
Q ss_pred CCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcC
Q 012762 382 SVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRH 415 (457)
Q Consensus 382 ~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~h 415 (457)
.+++++.+||.+||+.||++||+ +.||+++
T Consensus 284 ~~~~~~~~li~~cl~~dP~~RPs----~~ei~~~ 313 (329)
T 4aoj_A 284 ACPPEVYAIMRGCWQREPQQRHS----IKDVHAR 313 (329)
T ss_dssp TCCHHHHHHHHHHCCSSTTTSCC----HHHHHHH
T ss_pred cccHHHHHHHHHHcCcChhHCcC----HHHHHHH
Confidence 79999999999999999999999 8888764
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-59 Score=450.11 Aligned_cols=265 Identities=18% Similarity=0.319 Sum_probs=221.4
Q ss_pred CCccCCCceeEEEecccCcceEEEEEEecc-CCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEE
Q 012762 77 NPLTLSDLRFVHRLGSGDIGSVYLVQLKSK-SSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATL 155 (457)
Q Consensus 77 ~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~-~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~ 155 (457)
..+..++|.+.++||+|+||+||+|+++.. ...+++.||||+++.. .....+.+.+|+++|++|+|||||++++++
T Consensus 8 ~~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~~ 84 (299)
T 4asz_A 8 QHIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQHEHIVKFYGVC 84 (299)
T ss_dssp CBCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred cccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC---ChHHHHHHHHHHHHHHhCCCCCCccEEEEE
Confidence 346678999999999999999999997632 2346789999999753 234567789999999999999999999999
Q ss_pred EcCCcEEEEEeecCCCChHHHHHhC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccC
Q 012762 156 DCPRWSCLLTEFCPGGDLHVLRQRQ-----------PDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSD 224 (457)
Q Consensus 156 ~~~~~~~lV~E~~~~~sL~~~~~~~-----------~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~ 224 (457)
.+++.+|||||||++|+|.++++.. ....+++..++.++.||+.||.|||+++||||||||+||||+.+
T Consensus 85 ~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~ 164 (299)
T 4asz_A 85 VEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGEN 164 (299)
T ss_dssp CSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG
T ss_pred eeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCC
Confidence 9999999999999999999999763 23579999999999999999999999999999999999999999
Q ss_pred CCEEEeccCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCC
Q 012762 225 GHIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTP 304 (457)
Q Consensus 225 ~~vkl~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (457)
+.+||+|||+|+........
T Consensus 165 ~~~Ki~DFGla~~~~~~~~~------------------------------------------------------------ 184 (299)
T 4asz_A 165 LLVKIGDFGMSRDVYSTDYY------------------------------------------------------------ 184 (299)
T ss_dssp GCEEECCCSCHHHHTGGGCE------------------------------------------------------------
T ss_pred CcEEECCcccceecCCCCce------------------------------------------------------------
Confidence 99999999998654321110
Q ss_pred cccccCCccccccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHHhcccCCCCCCCC
Q 012762 305 EIVAEPLDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVVARALEFPKEPSV 383 (457)
Q Consensus 305 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (457)
.......||+.|||||++.+..|+.++|||||||+||||+| |+.||.+.+..+.+..+..+. ..+.+..+
T Consensus 185 --------~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~~-~~~~p~~~ 255 (299)
T 4asz_A 185 --------RVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGR-VLQRPRTC 255 (299)
T ss_dssp --------EETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHTC-CCCCCTTC
T ss_pred --------eecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC-CCCCCccc
Confidence 00112469999999999999999999999999999999998 999999988888777776654 34445569
Q ss_pred ChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCC
Q 012762 384 PGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFN 419 (457)
Q Consensus 384 ~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~ 419 (457)
|+++.+||.+||+.||++||+ +.+|. +|++
T Consensus 256 ~~~~~~li~~cl~~dP~~RPs----~~~i~--~~L~ 285 (299)
T 4asz_A 256 PQEVYELMLGCWQREPHMRKN----IKGIH--TLLQ 285 (299)
T ss_dssp CHHHHHHHHHHTCSSGGGSCC----HHHHH--HHHH
T ss_pred hHHHHHHHHHHcCCChhHCcC----HHHHH--HHHH
Confidence 999999999999999999999 88884 3444
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-58 Score=445.68 Aligned_cols=257 Identities=21% Similarity=0.314 Sum_probs=213.2
Q ss_pred CCCCccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEE
Q 012762 75 NNNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYAT 154 (457)
Q Consensus 75 ~~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~ 154 (457)
..|++..+++++.++||+|+||+||+|+++ ..||||+++.... .....+.+.+|+++|++++|||||+++++
T Consensus 29 ~~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~-------~~vAvK~~~~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~ 100 (307)
T 3omv_A 29 YYWEIEASEVMLSTRIGSGSFGTVYKGKWH-------GDVAVKILKVVDP-TPEQFQAFRNEVAVLRKTRHVNILLFMGY 100 (307)
T ss_dssp CCCBCCTTSCCEEEECCCCSSSEEEEEESS-------SEEEEEECCCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred cCcEEcHHHeEEeeEEeeCCCcEEEEEEEC-------CcEEEEEEEecCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 457899999999999999999999999864 2599999875432 23456778999999999999999999998
Q ss_pred EEcCCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCC
Q 012762 155 LDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDL 234 (457)
Q Consensus 155 ~~~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~ 234 (457)
+.. +.+|||||||+||+|.+++... ...+++..+..++.||+.||+|||+++||||||||+||||+.++.+||+|||+
T Consensus 101 ~~~-~~~~iVmEy~~gGsL~~~l~~~-~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGl 178 (307)
T 3omv_A 101 MTK-DNLAIVTQWCEGSSLYKHLHVQ-ETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGL 178 (307)
T ss_dssp ECS-SSCEEEEECCSSCBHHHHHHTS-CCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSS
T ss_pred EEC-CeEEEEEEcCCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccC
Confidence 865 5689999999999999998764 35799999999999999999999999999999999999999999999999999
Q ss_pred CcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccc
Q 012762 235 SLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVR 314 (457)
Q Consensus 235 s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (457)
|+........ ..
T Consensus 179 a~~~~~~~~~--------------------------------------------------------------------~~ 190 (307)
T 3omv_A 179 ATVKSRWSGS--------------------------------------------------------------------QQ 190 (307)
T ss_dssp CBC-----------------------------------------------------------------------------
T ss_pred ceecccCCcc--------------------------------------------------------------------ee
Confidence 8755321110 11
Q ss_pred cccccCCCCccCchhhcCC---CCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCC----CCCCChHH
Q 012762 315 SMSFVGTHEYLAPEIISGE---GHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPK----EPSVPGPA 387 (457)
Q Consensus 315 ~~~~~gt~~y~aPE~l~~~---~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~ 387 (457)
..+.+||+.|||||++.+. .|+.++|||||||+||||+||+.||.+......+..++......|. ...+++++
T Consensus 191 ~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l 270 (307)
T 3omv_A 191 VEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAM 270 (307)
T ss_dssp ---CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTTSCHHH
T ss_pred ecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccccchHHH
Confidence 1245799999999999753 5899999999999999999999999988777666666666554442 34578999
Q ss_pred HHHHHHHhhhCCCCCCCCCcChHHHh
Q 012762 388 KDLIAQLLVKDPTRRMGSKMGATAIK 413 (457)
Q Consensus 388 ~~ll~~~L~~dP~~Rps~~~~~~~ll 413 (457)
.+||.+||+.||++||| +.||+
T Consensus 271 ~~li~~cl~~dP~~RPs----~~ei~ 292 (307)
T 3omv_A 271 KRLVADCVKKVKEERPL----FPQIL 292 (307)
T ss_dssp HHHHHHHTCSSSTTSCC----HHHHH
T ss_pred HHHHHHHcCCCHhHCcC----HHHHH
Confidence 99999999999999999 66654
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-58 Score=456.39 Aligned_cols=284 Identities=20% Similarity=0.294 Sum_probs=212.8
Q ss_pred CCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHc-CCCCCceEEEEEEcCCc
Q 012762 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEML-DHPFLPTLYATLDCPRW 160 (457)
Q Consensus 82 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~~~~~~~~~ 160 (457)
++|++.++||+|+||+||+|+++. +..+++.||+|++.+. ....++.+|+++|+.+ +|||||+++++|.+.++
T Consensus 21 ~~Y~i~~~lG~G~fg~Vy~a~~~~-~~~~~~~vAiK~i~~~-----~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~ 94 (361)
T 4f9c_A 21 NVFKIEDKIGEGTFSSVYLATAQL-QVGPEEKIALKHLIPT-----SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDH 94 (361)
T ss_dssp GTCEEEEEEEECSSEEEEEEEEEB-TTSCEEEEEEEEECTT-----SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTE
T ss_pred CcEEEEEEEecccCcEEEEEEEcc-cCCCCCEEEEEEEccc-----cCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCE
Confidence 579999999999999999998763 2346789999998654 2345677899999998 69999999999999999
Q ss_pred EEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccC-CCEEEeccCCCcCCC
Q 012762 161 SCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSD-GHIMLTDFDLSLKGD 239 (457)
Q Consensus 161 ~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~-~~vkl~DFG~s~~~~ 239 (457)
+|||||||+||+|.++++ .+++.+++.++.||+.||+|||++|||||||||+|||++.+ +.+||+|||+|+...
T Consensus 95 ~~lvmE~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~ 169 (361)
T 4f9c_A 95 VVIAMPYLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTH 169 (361)
T ss_dssp EEEEEECCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECT
T ss_pred EEEEEeCCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccC
Confidence 999999999999998873 48999999999999999999999999999999999999877 899999999997665
Q ss_pred CCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcccccccc
Q 012762 240 NSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFV 319 (457)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (457)
+............. ....+.. ..............+.+
T Consensus 170 ~~~~~~~~~~~~~~-----------------~~~~~~~-------------------------~~~~~~~~~~~~~~~~~ 207 (361)
T 4f9c_A 170 DTKIELLKFVQSEA-----------------QQERCSQ-------------------------NKCSICLSRRQQVAPRA 207 (361)
T ss_dssp TCSCGGGGGC--------------------------------------------------------------------CC
T ss_pred Cccccccccccccc-----------------ccccccc-------------------------ccccccccccccccccc
Confidence 43221110000000 0000000 00000001122334568
Q ss_pred CCCCccCchhhcCCC-CCccchhhhhhHHHHHHhcCCCCCCCCCh-HHHHHHHHhcc-----------------------
Q 012762 320 GTHEYLAPEIISGEG-HGNAVDWWTLGIFIFELFYGTTPFKGIDH-ELTLANVVARA----------------------- 374 (457)
Q Consensus 320 gt~~y~aPE~l~~~~-~~~~sDiwSlG~il~elltG~~Pf~~~~~-~~~~~~~~~~~----------------------- 374 (457)
||+.|||||++.+.. |+.++||||+||++|||++|+.||....+ .+.+..+....
T Consensus 208 GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p 287 (361)
T 4f9c_A 208 GTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVP 287 (361)
T ss_dssp CCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCC
T ss_pred cCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCc
Confidence 999999999998864 89999999999999999999999965543 33333332100
Q ss_pred -----------------------------cCCCCCCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCCCC
Q 012762 375 -----------------------------LEFPKEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGVN 422 (457)
Q Consensus 375 -----------------------------~~~~~~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~~~ 422 (457)
........++++++|||.+||+.||++|+| ++|+|+||||++++
T Consensus 288 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DLl~~lL~~dP~~R~t----a~eaL~Hp~f~~i~ 360 (361)
T 4f9c_A 288 AQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLLDKLLDLNPASRIT----AEEALLHPFFKDMS 360 (361)
T ss_dssp CCCHHHHHHHHC----------------------CTTCCHHHHHHHHHHTCSCTTTSCC----HHHHHTSGGGTTC-
T ss_pred chhhhHHHHhhccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcC----HHHHhcCcccCCCC
Confidence 011123457889999999999999999999 99999999999865
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-58 Score=448.26 Aligned_cols=265 Identities=20% Similarity=0.304 Sum_probs=221.5
Q ss_pred CCCccCCCceeEEEecccCcceEEEEEEecc-CCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEE
Q 012762 76 NNPLTLSDLRFVHRLGSGDIGSVYLVQLKSK-SSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYAT 154 (457)
Q Consensus 76 ~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~-~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~ 154 (457)
..++..++++++++||+|+||+||+|++... +..+++.||||+++... .....+.+.+|+++|++|+|||||+++++
T Consensus 20 ~~ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~--~~~~~~~f~~E~~il~~l~HpNIV~l~g~ 97 (308)
T 4gt4_A 20 LKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA--EGPLREEFRHEAMLRARLQHPNVVCLLGV 97 (308)
T ss_dssp CCBCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C--CC-CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc--ChHHHHHHHHHHHHHHhCCCCCCCCcceE
Confidence 3467788999999999999999999997532 23467899999997542 23345778999999999999999999999
Q ss_pred EEcCCcEEEEEeecCCCChHHHHHhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeE
Q 012762 155 LDCPRWSCLLTEFCPGGDLHVLRQRQP--------------DKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVL 220 (457)
Q Consensus 155 ~~~~~~~~lV~E~~~~~sL~~~~~~~~--------------~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIl 220 (457)
+..++.+|||||||++|+|.+++.... ...+++..+..++.||+.||+|||+++||||||||+|||
T Consensus 98 ~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NIL 177 (308)
T 4gt4_A 98 VTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVL 177 (308)
T ss_dssp ECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred EEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceE
Confidence 999999999999999999999986532 245899999999999999999999999999999999999
Q ss_pred EccCCCEEEeccCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCC
Q 012762 221 VRSDGHIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGN 300 (457)
Q Consensus 221 l~~~~~vkl~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (457)
|+.++.+||+|||+++........
T Consensus 178 l~~~~~~Ki~DFGlar~~~~~~~~-------------------------------------------------------- 201 (308)
T 4gt4_A 178 VYDKLNVKISDLGLFREVYAADYY-------------------------------------------------------- 201 (308)
T ss_dssp ECGGGCEEECCSCCBCGGGGGGCB--------------------------------------------------------
T ss_pred ECCCCCEEECCcccceeccCCCce--------------------------------------------------------
Confidence 999999999999998654311100
Q ss_pred CCCCcccccCCccccccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHHhcccCCCC
Q 012762 301 PGTPEIVAEPLDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVVARALEFPK 379 (457)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~ 379 (457)
......+||+.|||||++.+..|+.++|||||||+||||+| |..||.+.+..+....+..+ ...+.
T Consensus 202 ------------~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i~~~-~~~~~ 268 (308)
T 4gt4_A 202 ------------KLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNR-QVLPC 268 (308)
T ss_dssp ------------CSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHHHTT-CCCCC
T ss_pred ------------eEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CCCCC
Confidence 01113469999999999999999999999999999999998 89999998887777766554 44555
Q ss_pred CCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcC
Q 012762 380 EPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRH 415 (457)
Q Consensus 380 ~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~h 415 (457)
+..+|.++.+||.+||+.||++||+ +.||+++
T Consensus 269 p~~~~~~~~~li~~C~~~dP~~RPs----~~ei~~~ 300 (308)
T 4gt4_A 269 PDDCPAWVYALMIECWNEFPSRRPR----FKDIHSR 300 (308)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred cccchHHHHHHHHHHcCCChhHCcC----HHHHHHH
Confidence 6679999999999999999999999 8888764
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-57 Score=453.27 Aligned_cols=290 Identities=37% Similarity=0.721 Sum_probs=249.7
Q ss_pred CCccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHc-CCCCCceEEEEE
Q 012762 77 NPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEML-DHPFLPTLYATL 155 (457)
Q Consensus 77 ~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~~~~ 155 (457)
..+..++|++++.||+|+||+||+|+++ .+++.||+|++.+...........+..|+++|+.+ +||||+++++++
T Consensus 18 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~----~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~ 93 (353)
T 3txo_A 18 NRLGIDNFEFIRVLGKGSFGKVMLARVK----ETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCF 93 (353)
T ss_dssp -----CCEEEEEEEEEETTEEEEEEEET----TTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred CCCchhheEEEEEEeeCCCEEEEEEEEc----CCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEE
Confidence 4567789999999999999999999987 47899999999987666666777888899999988 799999999999
Q ss_pred EcCCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCC
Q 012762 156 DCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235 (457)
Q Consensus 156 ~~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s 235 (457)
.+.+.+|||||||+||+|..++... +.+++..++.++.||+.||+|||++||+||||||+||||+.+|.+||+|||++
T Consensus 94 ~~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a 171 (353)
T 3txo_A 94 QTPDRLFFVMEFVNGGDLMFHIQKS--RRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMC 171 (353)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred EeCCEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccce
Confidence 9999999999999999999888775 67999999999999999999999999999999999999999999999999998
Q ss_pred cCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcccc
Q 012762 236 LKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRS 315 (457)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (457)
+..... ....
T Consensus 172 ~~~~~~----------------------------------------------------------------------~~~~ 181 (353)
T 3txo_A 172 KEGICN----------------------------------------------------------------------GVTT 181 (353)
T ss_dssp BCSCC---------------------------------------------------------------------------
T ss_pred eecccC----------------------------------------------------------------------Cccc
Confidence 643211 0112
Q ss_pred ccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHh
Q 012762 316 MSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLL 395 (457)
Q Consensus 316 ~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L 395 (457)
.+++||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..+.+..++.....+|.. ++.++.+||.+||
T Consensus 182 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~--~~~~~~~li~~lL 259 (353)
T 3txo_A 182 ATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTW--LHEDATGILKSFM 259 (353)
T ss_dssp ----CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTT--SCHHHHHHHHHHT
T ss_pred cccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCC--CCHHHHHHHHHHh
Confidence 24579999999999999899999999999999999999999999999889999999888777754 8999999999999
Q ss_pred hhCCCCCCCC--CcChHHHhcCCCCCCCCchhh--hccCCCCCCCCCCccccc
Q 012762 396 VKDPTRRMGS--KMGATAIKRHQFFNGVNWALL--RCAKPPFIPRPVTCRDLT 444 (457)
Q Consensus 396 ~~dP~~Rps~--~~~~~~ll~hp~f~~~~~~~~--~~~~~~~~~~~~~~~~~~ 444 (457)
..||++||+. ...+++|++||||++++|..+ +...|||+|+.....|.+
T Consensus 260 ~~dP~~R~~~~~~~~~~~il~hp~f~~~~w~~l~~~~~~~p~~p~~~~~~~~~ 312 (353)
T 3txo_A 260 TKNPTMRLGSLTQGGEHAILRHPFFKEIDWAQLNHRQIEPPFRPRIKSREDVS 312 (353)
T ss_dssp CSSGGGSTTSGGGTCTHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCCSTTCCT
T ss_pred hhCHHHccCCcccCCHHHHhhCCcccCCCHHHHhcCcCCCCccCCCCCccccc
Confidence 9999999993 122389999999999999877 567899999877666554
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-57 Score=445.05 Aligned_cols=288 Identities=35% Similarity=0.704 Sum_probs=251.7
Q ss_pred ccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcC
Q 012762 79 LTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCP 158 (457)
Q Consensus 79 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~ 158 (457)
+..++|++++.||+|+||+||+|+++ .+|+.||+|++.+...........+..|+++|+.++||||+++++++...
T Consensus 2 ~~~~~y~~~~~lG~G~fg~V~~~~~~----~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~ 77 (337)
T 1o6l_A 2 VTMNDFDYLKLLGKGTFGKVILVREK----ATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTH 77 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEET----TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECS
T ss_pred CChHHeEEEEEEecCCCeEEEEEEEC----CCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeC
Confidence 45679999999999999999999986 47899999999887665666677888899999999999999999999999
Q ss_pred CcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCC
Q 012762 159 RWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKG 238 (457)
Q Consensus 159 ~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~ 238 (457)
+.+|+||||++||+|..++... +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++..
T Consensus 78 ~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 155 (337)
T 1o6l_A 78 DRLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEG 155 (337)
T ss_dssp SEEEEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred CEEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhc
Confidence 9999999999999999888765 67999999999999999999999999999999999999999999999999998643
Q ss_pred CCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccc
Q 012762 239 DNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSF 318 (457)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (457)
.... ....++
T Consensus 156 ~~~~----------------------------------------------------------------------~~~~~~ 165 (337)
T 1o6l_A 156 ISDG----------------------------------------------------------------------ATMKTF 165 (337)
T ss_dssp CCTT----------------------------------------------------------------------CCBCCC
T ss_pred ccCC----------------------------------------------------------------------Cccccc
Confidence 2110 011245
Q ss_pred cCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhhhC
Q 012762 319 VGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKD 398 (457)
Q Consensus 319 ~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~d 398 (457)
+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+.......+......+|. .+++++++||.+||+.|
T Consensus 166 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~--~~s~~~~~li~~lL~~d 243 (337)
T 1o6l_A 166 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR--TLSPEAKSLLAGLLKKD 243 (337)
T ss_dssp EECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT--TSCHHHHHHHHHHTCSS
T ss_pred ccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCC--CCCHHHHHHHHHHhhcC
Confidence 7999999999999999999999999999999999999999998888888888887777765 48999999999999999
Q ss_pred CCCCCCCC-cChHHHhcCCCCCCCCchhh--hccCCCCCCCCCCccccc
Q 012762 399 PTRRMGSK-MGATAIKRHQFFNGVNWALL--RCAKPPFIPRPVTCRDLT 444 (457)
Q Consensus 399 P~~Rps~~-~~~~~ll~hp~f~~~~~~~~--~~~~~~~~~~~~~~~~~~ 444 (457)
|++||+.. ..++||++||||++++|..+ +...|||+|......|.+
T Consensus 244 P~~R~g~~~~~~~ei~~h~~f~~~~~~~~~~~~~~pp~~p~~~~~~d~~ 292 (337)
T 1o6l_A 244 PKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEVDTR 292 (337)
T ss_dssp TTTSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCSSTTCCT
T ss_pred HHHhcCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCCCCCCCCcchhh
Confidence 99999211 11999999999999999877 457799999876665543
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-57 Score=478.36 Aligned_cols=263 Identities=27% Similarity=0.420 Sum_probs=233.6
Q ss_pred cCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCC
Q 012762 80 TLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPR 159 (457)
Q Consensus 80 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~ 159 (457)
.+++|+++++||+|+||+||+|+++ .+|+.||+|++.+... .....+.+|+++|+.|+|||||+++++|.+++
T Consensus 155 il~~Y~i~~~lG~G~fg~V~~~~~~----~tg~~~AiK~i~~~~~---~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 227 (573)
T 3uto_A 155 VLDHYDIHEELGTGAFGVVHRVTER----ATGNNFAAKFVMTPHE---SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDN 227 (573)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEET----TTCCEEEEEEEECCSH---HHHHHHHHHHHHHHHTCCTTBCCEEEEEECSS
T ss_pred CccccEEEEEEeeccCeEEEEEEEC----CCCCEEEEEEEeccch---hhHHHHHHHHHHHHhCCCCCCCeEEEEEEECC
Confidence 4578999999999999999999987 4899999999976532 34566788999999999999999999999999
Q ss_pred cEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccC--CCEEEeccCCCcC
Q 012762 160 WSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSD--GHIMLTDFDLSLK 237 (457)
Q Consensus 160 ~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~--~~vkl~DFG~s~~ 237 (457)
.+|||||||+||+|.+++... .+.+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++.
T Consensus 228 ~~~iv~E~~~gg~L~~~i~~~-~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~ 306 (573)
T 3uto_A 228 EMVMIYEFMSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAH 306 (573)
T ss_dssp EEEEEEECCCCCBHHHHHTCT-TSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEE
T ss_pred EEEEEEeecCCCcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeE
Confidence 999999999999999888643 3579999999999999999999999999999999999999854 8999999999876
Q ss_pred CCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcccccc
Q 012762 238 GDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMS 317 (457)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (457)
...... ..+
T Consensus 307 ~~~~~~-----------------------------------------------------------------------~~~ 315 (573)
T 3uto_A 307 LDPKQS-----------------------------------------------------------------------VKV 315 (573)
T ss_dssp CCTTSE-----------------------------------------------------------------------EEE
T ss_pred ccCCCc-----------------------------------------------------------------------eee
Confidence 542211 124
Q ss_pred ccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCC--CCCCChHHHHHHHHHh
Q 012762 318 FVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPK--EPSVPGPAKDLIAQLL 395 (457)
Q Consensus 318 ~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ll~~~L 395 (457)
.+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..+.+.++....+.++. ...+++++++||.+||
T Consensus 316 ~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~~L 395 (573)
T 3uto_A 316 TTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLL 395 (573)
T ss_dssp ECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHHHHHHHTTS
T ss_pred eEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHc
Confidence 57999999999999999999999999999999999999999999988888888887776654 3568999999999999
Q ss_pred hhCCCCCCCCCcChHHHhcCCCCCCCCchh
Q 012762 396 VKDPTRRMGSKMGATAIKRHQFFNGVNWAL 425 (457)
Q Consensus 396 ~~dP~~Rps~~~~~~~ll~hp~f~~~~~~~ 425 (457)
+.||++||+ +.|+|+||||+..+|..
T Consensus 396 ~~dp~~R~t----~~e~l~Hpw~~~~~~~~ 421 (573)
T 3uto_A 396 LADPNTRMT----IHQALEHPWLTPGNAPG 421 (573)
T ss_dssp CSSGGGSCC----HHHHHHSTTTSCCCCTT
T ss_pred cCChhHCcC----HHHHhcCcCcCCCCCCC
Confidence 999999999 99999999999988753
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-57 Score=449.00 Aligned_cols=266 Identities=18% Similarity=0.269 Sum_probs=225.2
Q ss_pred CCCccCCCceeEEEecccCcceEEEEEEeccC-CCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCC-CCCceEEE
Q 012762 76 NNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKS-SNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDH-PFLPTLYA 153 (457)
Q Consensus 76 ~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~-~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H-~nIv~l~~ 153 (457)
.|++..++|++.++||+|+||+||+|.++..+ ...++.||||++.... .......+.+|+++|++++| ||||++++
T Consensus 58 ~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~--~~~~~~~~~~E~~il~~l~hhpnIV~l~g 135 (353)
T 4ase_A 58 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLG 135 (353)
T ss_dssp HHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--ChHHHHHHHHHHHHHHHcCCCCcEEEEEE
Confidence 46788899999999999999999999987543 3355789999997643 23345678899999999965 89999999
Q ss_pred EEEc-CCcEEEEEeecCCCChHHHHHhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCC
Q 012762 154 TLDC-PRWSCLLTEFCPGGDLHVLRQRQP--------------DKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPEN 218 (457)
Q Consensus 154 ~~~~-~~~~~lV~E~~~~~sL~~~~~~~~--------------~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~N 218 (457)
+|.. ++.+|||||||++|+|.++++... ...+++..+..++.||+.||+|||+++||||||||+|
T Consensus 136 ~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~N 215 (353)
T 4ase_A 136 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARN 215 (353)
T ss_dssp EECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred EEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccc
Confidence 9865 457899999999999999997632 2458999999999999999999999999999999999
Q ss_pred eEEccCCCEEEeccCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccC
Q 012762 219 VLVRSDGHIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKL 298 (457)
Q Consensus 219 Ill~~~~~vkl~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (457)
|||+.++.+||+|||+|+........
T Consensus 216 ILl~~~~~vKi~DFGlar~~~~~~~~------------------------------------------------------ 241 (353)
T 4ase_A 216 ILLSEKNVVKICDFGLARDIYKDPDY------------------------------------------------------ 241 (353)
T ss_dssp EEECGGGCEEECCCGGGSCTTTCTTS------------------------------------------------------
T ss_pred eeeCCCCCEEECcchhhhhcccCCCc------------------------------------------------------
Confidence 99999999999999999765322110
Q ss_pred CCCCCCcccccCCccccccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHHhcccCC
Q 012762 299 GNPGTPEIVAEPLDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVVARALEF 377 (457)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~ 377 (457)
....+.+||+.|||||++.+..|+.++|||||||+||||+| |+.||.+......+..++....++
T Consensus 242 --------------~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~~i~~g~~~ 307 (353)
T 4ase_A 242 --------------VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM 307 (353)
T ss_dssp --------------EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCC
T ss_pred --------------eeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHHcCCCC
Confidence 11123579999999999999999999999999999999998 999999877666666666666666
Q ss_pred CCCCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcC
Q 012762 378 PKEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRH 415 (457)
Q Consensus 378 ~~~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~h 415 (457)
+.+..+++++.+||.+||+.||++||| +.||++|
T Consensus 308 ~~p~~~~~~~~~li~~c~~~dP~~RPt----~~eil~~ 341 (353)
T 4ase_A 308 RAPDYTTPEMYQTMLDCWHGEPSQRPT----FSELVEH 341 (353)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred CCCccCCHHHHHHHHHHcCcChhHCcC----HHHHHHH
Confidence 666779999999999999999999999 9999887
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-56 Score=450.67 Aligned_cols=292 Identities=34% Similarity=0.659 Sum_probs=245.5
Q ss_pred CCccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHc-CCCCCceEEEEE
Q 012762 77 NPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEML-DHPFLPTLYATL 155 (457)
Q Consensus 77 ~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~~~~ 155 (457)
..+..++|+++++||+|+||+||+|+++ .+++.||+|++++...........+..|+.+|+++ +||||+++++++
T Consensus 47 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~----~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~ 122 (396)
T 4dc2_A 47 SSLGLQDFDLLRVIGRGSYAKVLLVRLK----KTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF 122 (396)
T ss_dssp --CCGGGEEEEEEEEECSSEEEEEEEET----TTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred cCCChhHcEEEEEEeeCCCeEEEEEEEC----CCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEE
Confidence 3466789999999999999999999987 47899999999887655555556678899999887 899999999999
Q ss_pred EcCCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCC
Q 012762 156 DCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235 (457)
Q Consensus 156 ~~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s 235 (457)
...+.+|||||||+||+|..++... +.+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||++
T Consensus 123 ~~~~~~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla 200 (396)
T 4dc2_A 123 QTESRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMC 200 (396)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred EECCEEEEEEEcCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeeccee
Confidence 9999999999999999999888775 67999999999999999999999999999999999999999999999999998
Q ss_pred cCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcccc
Q 012762 236 LKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRS 315 (457)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (457)
+..... ....
T Consensus 201 ~~~~~~----------------------------------------------------------------------~~~~ 210 (396)
T 4dc2_A 201 KEGLRP----------------------------------------------------------------------GDTT 210 (396)
T ss_dssp BCCCCT----------------------------------------------------------------------TCCB
T ss_pred eecccC----------------------------------------------------------------------CCcc
Confidence 642211 0112
Q ss_pred ccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCC---------ChHHHHHHHHhcccCCCCCCCCChH
Q 012762 316 MSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGI---------DHELTLANVVARALEFPKEPSVPGP 386 (457)
Q Consensus 316 ~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~ 386 (457)
.+++||+.|+|||++.+..|+.++|||||||++|||++|+.||... ........+......+|.. ++.+
T Consensus 211 ~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~--~s~~ 288 (396)
T 4dc2_A 211 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS--LSVK 288 (396)
T ss_dssp CCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCCTT--SCHH
T ss_pred ccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCCCc--CCHH
Confidence 2457999999999999999999999999999999999999999643 2233556666666666654 8999
Q ss_pred HHHHHHHHhhhCCCCCCCCC--cChHHHhcCCCCCCCCchhh--hccCCCCCCCCCCccccccc
Q 012762 387 AKDLIAQLLVKDPTRRMGSK--MGATAIKRHQFFNGVNWALL--RCAKPPFIPRPVTCRDLTTT 446 (457)
Q Consensus 387 ~~~ll~~~L~~dP~~Rps~~--~~~~~ll~hp~f~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 446 (457)
+++||.+||+.||.+||+.. ..++||++||||++++|..+ +...|||+|......|.+.-
T Consensus 289 ~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w~~l~~~~~~pp~~p~~~~~~d~~~f 352 (396)
T 4dc2_A 289 AASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVPPFKPNISGEFGLDNF 352 (396)
T ss_dssp HHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCCHHHHHTTCSCCSCCCCCCSSTTGGGS
T ss_pred HHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCCHHHHHcCCCCCCCcCCCCCccchhhc
Confidence 99999999999999999942 22589999999999999987 45779999988776665443
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-56 Score=443.80 Aligned_cols=287 Identities=32% Similarity=0.652 Sum_probs=249.9
Q ss_pred CCCccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHc-CCCCCceEEEE
Q 012762 76 NNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEML-DHPFLPTLYAT 154 (457)
Q Consensus 76 ~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~~~ 154 (457)
...+..++|++++.||+|+||+||+|+++ .+++.||+|++++...........+..|+++|..+ +||||++++++
T Consensus 14 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~----~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~ 89 (353)
T 2i0e_A 14 RDRMKLTDFNFLMVLGKGSFGKVMLSERK----GTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSC 89 (353)
T ss_dssp -----CTTEEEEEEEEEETTEEEEEEEET----TEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEE
T ss_pred cCCCchHHcEEEEEEeeCCCEEEEEEEEC----CCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEE
Confidence 34567889999999999999999999986 47889999999987665666677788899999887 89999999999
Q ss_pred EEcCCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCC
Q 012762 155 LDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDL 234 (457)
Q Consensus 155 ~~~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~ 234 (457)
+...+.+||||||++||+|..++... +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+
T Consensus 90 ~~~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~ 167 (353)
T 2i0e_A 90 FQTMDRLYFVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGM 167 (353)
T ss_dssp EECSSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred EEcCCEEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCc
Confidence 99999999999999999999988765 5699999999999999999999999999999999999999999999999999
Q ss_pred CcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccc
Q 012762 235 SLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVR 314 (457)
Q Consensus 235 s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (457)
++...... ..
T Consensus 168 a~~~~~~~----------------------------------------------------------------------~~ 177 (353)
T 2i0e_A 168 CKENIWDG----------------------------------------------------------------------VT 177 (353)
T ss_dssp CBCCCCTT----------------------------------------------------------------------CC
T ss_pred ccccccCC----------------------------------------------------------------------cc
Confidence 86432110 01
Q ss_pred cccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHH
Q 012762 315 SMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQL 394 (457)
Q Consensus 315 ~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~ 394 (457)
..+++||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+....+..++.....+|. .++.++++||.+|
T Consensus 178 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~--~~s~~~~~li~~l 255 (353)
T 2i0e_A 178 TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK--SMSKEAVAICKGL 255 (353)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT--TSCHHHHHHHHHH
T ss_pred cccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCC--CCCHHHHHHHHHH
Confidence 12457999999999999999999999999999999999999999998888888888888777765 4899999999999
Q ss_pred hhhCCCCCCCCC-cChHHHhcCCCCCCCCchhh--hccCCCCCCCCCCc
Q 012762 395 LVKDPTRRMGSK-MGATAIKRHQFFNGVNWALL--RCAKPPFIPRPVTC 440 (457)
Q Consensus 395 L~~dP~~Rps~~-~~~~~ll~hp~f~~~~~~~~--~~~~~~~~~~~~~~ 440 (457)
|..||.+||+.. ..+++|++||||++++|..+ +...|||+|.....
T Consensus 256 L~~dP~~R~~~~~~~~~~i~~h~~f~~~~w~~l~~~~~~~p~~p~~~~~ 304 (353)
T 2i0e_A 256 MTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPPYKPKACGR 304 (353)
T ss_dssp TCSCTTSCTTCSTTHHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCCCC
T ss_pred hhcCHHHcCCCCCCCHHHHhcCccccCCCHHHHHhCCCCCCcCCCCCCc
Confidence 999999999742 23799999999999999987 56789999987554
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-56 Score=435.63 Aligned_cols=279 Identities=34% Similarity=0.690 Sum_probs=247.1
Q ss_pred ccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcC
Q 012762 79 LTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCP 158 (457)
Q Consensus 79 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~ 158 (457)
+.+++|++++.||+|+||+||+|+++ .+|+.||+|++.+...........+..|+.+|+.++||||+++++++.+.
T Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~~~~~----~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~ 78 (318)
T 1fot_A 3 YSLQDFQILRTLGTGSFGRVHLIRSR----HNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDA 78 (318)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEET----TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECS
T ss_pred CChHHcEEEEEEeeCCCEEEEEEEEC----CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeC
Confidence 45679999999999999999999986 47899999999887665555667788899999999999999999999999
Q ss_pred CcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCC
Q 012762 159 RWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKG 238 (457)
Q Consensus 159 ~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~ 238 (457)
+.+|+||||++||+|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++..
T Consensus 79 ~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~ 156 (318)
T 1fot_A 79 QQIFMIMDYIEGGELFSLLRKS--QRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYV 156 (318)
T ss_dssp SEEEEEECCCCSCBHHHHHHHT--SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEEC
T ss_pred CEEEEEEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceec
Confidence 9999999999999999999875 67999999999999999999999999999999999999999999999999998643
Q ss_pred CCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccc
Q 012762 239 DNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSF 318 (457)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (457)
... ..+.
T Consensus 157 ~~~-------------------------------------------------------------------------~~~~ 163 (318)
T 1fot_A 157 PDV-------------------------------------------------------------------------TYTL 163 (318)
T ss_dssp SSC-------------------------------------------------------------------------BCCC
T ss_pred CCc-------------------------------------------------------------------------cccc
Confidence 211 1134
Q ss_pred cCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhhhC
Q 012762 319 VGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKD 398 (457)
Q Consensus 319 ~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~d 398 (457)
+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+....+..++.....+|. .++.++++||.+||..|
T Consensus 164 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~--~~~~~~~~li~~lL~~d 241 (318)
T 1fot_A 164 CGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPP--FFNEDVKDLLSRLITRD 241 (318)
T ss_dssp CSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCT--TSCHHHHHHHHHHTCSC
T ss_pred cCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC--CCCHHHHHHHHHHhccC
Confidence 6999999999999999999999999999999999999999998888888888888777664 48999999999999999
Q ss_pred CCCCCCCCc-ChHHHhcCCCCCCCCchhh--hccCCCCCCCCC
Q 012762 399 PTRRMGSKM-GATAIKRHQFFNGVNWALL--RCAKPPFIPRPV 438 (457)
Q Consensus 399 P~~Rps~~~-~~~~ll~hp~f~~~~~~~~--~~~~~~~~~~~~ 438 (457)
|++|++... .+++|++||||++++|..+ +...|||.|...
T Consensus 242 p~~R~~~~~~~~~~i~~hp~f~~~~~~~~~~~~~~~p~~p~~~ 284 (318)
T 1fot_A 242 LSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETPYEPPIQ 284 (318)
T ss_dssp TTTCTTSSTTTTHHHHTSGGGSSCCHHHHHTTCSCCSCCCCC-
T ss_pred HHHcCCCcCCCHHHHhcCccccCCCHHHHHhCCCCCCCCCCcC
Confidence 999993211 2999999999999999877 456789998765
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-56 Score=441.61 Aligned_cols=283 Identities=33% Similarity=0.695 Sum_probs=240.1
Q ss_pred CccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHc-CCCCCceEEEEEE
Q 012762 78 PLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEML-DHPFLPTLYATLD 156 (457)
Q Consensus 78 ~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~~~~~ 156 (457)
.+..++|++.+.||+|+||+||+|+++ .+|+.||+|++++...........+..|+++|+.+ +||||+++++++.
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~----~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~ 88 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFK----KTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQ 88 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEET----TTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEEC----CCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEE
Confidence 466789999999999999999999987 47899999999987665556667788899999887 9999999999999
Q ss_pred cCCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCc
Q 012762 157 CPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSL 236 (457)
Q Consensus 157 ~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~ 236 (457)
+.+.+|+||||++||+|..++... +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++
T Consensus 89 ~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~ 166 (345)
T 1xjd_A 89 TKENLFFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCK 166 (345)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred eCCEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhh
Confidence 999999999999999999988775 579999999999999999999999999999999999999999999999999986
Q ss_pred CCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccc
Q 012762 237 KGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSM 316 (457)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (457)
...... ....
T Consensus 167 ~~~~~~----------------------------------------------------------------------~~~~ 176 (345)
T 1xjd_A 167 ENMLGD----------------------------------------------------------------------AKTN 176 (345)
T ss_dssp CCCCTT----------------------------------------------------------------------CCBC
T ss_pred hcccCC----------------------------------------------------------------------Cccc
Confidence 432110 0112
Q ss_pred cccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhh
Q 012762 317 SFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLV 396 (457)
Q Consensus 317 ~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~ 396 (457)
+++||+.|+|||++.+..|+.++|||||||++|||++|..||.+.+....+..+......++. .++.++++||.+||.
T Consensus 177 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~--~~s~~~~~li~~lL~ 254 (345)
T 1xjd_A 177 TFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPR--WLEKEAKDLLVKLFV 254 (345)
T ss_dssp CCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT--TSCHHHHHHHHHHSC
T ss_pred CCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCCCc--ccCHHHHHHHHHHhc
Confidence 457999999999999999999999999999999999999999998888888888877766664 489999999999999
Q ss_pred hCCCCCCCCCcChH-HHhcCCCCCCCCchhh--hccCCCCCCCCCCccc
Q 012762 397 KDPTRRMGSKMGAT-AIKRHQFFNGVNWALL--RCAKPPFIPRPVTCRD 442 (457)
Q Consensus 397 ~dP~~Rps~~~~~~-~ll~hp~f~~~~~~~~--~~~~~~~~~~~~~~~~ 442 (457)
.||++||+ +. +|++||||++++|..+ +...|||.|......|
T Consensus 255 ~dp~~R~~----~~~~i~~hp~f~~~~w~~l~~~~~~~p~~p~~~~~~d 299 (345)
T 1xjd_A 255 REPEKRLG----VRGDIRQHPLFREINWEELERKEIDPPFRPKVKSPFD 299 (345)
T ss_dssp SSGGGSBT----TBSCGGGSGGGTTCCHHHHHTTCSCC-----------
T ss_pred CCHhHcCC----ChHHHHcCccccCCCHHHHhhCCCCCCcCCCCCCcch
Confidence 99999999 76 9999999999999887 4578999987655444
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-56 Score=446.78 Aligned_cols=288 Identities=36% Similarity=0.674 Sum_probs=240.7
Q ss_pred CccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHH-HHHcCCCCCceEEEEEE
Q 012762 78 PLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREI-LEMLDHPFLPTLYATLD 156 (457)
Q Consensus 78 ~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~i-l~~l~H~nIv~l~~~~~ 156 (457)
.+..++|++++.||+|+||+||+|+++ .+++.||+|++.+...........+..|..+ ++.++||||+++++++.
T Consensus 34 ~~~~~~y~~~~~lG~G~fg~V~~~~~~----~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~ 109 (373)
T 2r5t_A 34 HAKPSDFHFLKVIGKGSFGKVLLARHK----AEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQ 109 (373)
T ss_dssp TCCGGGEEEEEEEECCTTCEEEEEEET----TTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEE
T ss_pred CCChhheEEEEEEeeCCCeEEEEEEEc----CCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEE
Confidence 456689999999999999999999987 4788999999988766555556666777777 46789999999999999
Q ss_pred cCCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCc
Q 012762 157 CPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSL 236 (457)
Q Consensus 157 ~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~ 236 (457)
..+.+||||||++||+|..++... +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++
T Consensus 110 ~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~ 187 (373)
T 2r5t_A 110 TADKLYFVLDYINGGELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCK 187 (373)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCG
T ss_pred eCCEEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCcccc
Confidence 999999999999999999888775 679999999999999999999999999999999999999999999999999986
Q ss_pred CCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccc
Q 012762 237 KGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSM 316 (457)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (457)
..... .....
T Consensus 188 ~~~~~----------------------------------------------------------------------~~~~~ 197 (373)
T 2r5t_A 188 ENIEH----------------------------------------------------------------------NSTTS 197 (373)
T ss_dssp GGBCC----------------------------------------------------------------------CCCCC
T ss_pred ccccC----------------------------------------------------------------------CCccc
Confidence 42110 00112
Q ss_pred cccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhh
Q 012762 317 SFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLV 396 (457)
Q Consensus 317 ~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~ 396 (457)
+++||+.|+|||++.+..|+.++|||||||++|||++|..||.+.+..+.+..++.....++. .++.++++||.+||+
T Consensus 198 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~--~~~~~~~~li~~lL~ 275 (373)
T 2r5t_A 198 TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKP--NITNSARHLLEGLLQ 275 (373)
T ss_dssp SBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCCCS--SSCHHHHHHHHHHTC
T ss_pred cccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCCCC--CCCHHHHHHHHHHcc
Confidence 457999999999999999999999999999999999999999998888888888888766664 489999999999999
Q ss_pred hCCCCCCCCCcChHHHhcCCCCCCCCchhh--hccCCCCCCCCCCcccc
Q 012762 397 KDPTRRMGSKMGATAIKRHQFFNGVNWALL--RCAKPPFIPRPVTCRDL 443 (457)
Q Consensus 397 ~dP~~Rps~~~~~~~ll~hp~f~~~~~~~~--~~~~~~~~~~~~~~~~~ 443 (457)
.||.+||+....+.+|++||||++++|..+ +...|||+|......|.
T Consensus 276 ~dp~~R~~~~~~~~~i~~h~~f~~~~w~~l~~~~~~pp~~p~~~~~~d~ 324 (373)
T 2r5t_A 276 KDRTKRLGAKDDFMEIKSHVFFSLINWDDLINKKITPPFNPNVSGPNDL 324 (373)
T ss_dssp SSGGGSTTTTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCSCCC----
T ss_pred cCHHhCCCCCCCHHHHhCCccccCCCHHHHHhCCCCCCCCCCCCCcchh
Confidence 999999997777899999999999999887 56789999987655443
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-56 Score=450.67 Aligned_cols=289 Identities=34% Similarity=0.629 Sum_probs=251.8
Q ss_pred CccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEc
Q 012762 78 PLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDC 157 (457)
Q Consensus 78 ~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~ 157 (457)
.+..++|+++++||+|+||+||+|+++ .+++.||+|++.+...........+..|+++|+.++||||+++++++.+
T Consensus 65 ~~~~~~y~~~~~LG~G~fG~V~~~~~~----~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 140 (410)
T 3v8s_A 65 RMKAEDYEVVKVIGRGAFGEVQLVRHK----STRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 140 (410)
T ss_dssp SCCGGGEEEEEEEEECSSEEEEEEEET----TTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred ccCccccEEEEEEEcCCCEEEEEEEEC----CCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence 456679999999999999999999987 4788999999988766555555667889999999999999999999999
Q ss_pred CCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcC
Q 012762 158 PRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLK 237 (457)
Q Consensus 158 ~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~ 237 (457)
.+.+|||||||+||+|..++.. ..+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+++.
T Consensus 141 ~~~~~lV~E~~~gg~L~~~l~~---~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~ 217 (410)
T 3v8s_A 141 DRYLYMVMEYMPGGDLVNLMSN---YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMK 217 (410)
T ss_dssp SSEEEEEECCCTTEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred CCEEEEEEeCCCCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEe
Confidence 9999999999999999999876 4699999999999999999999999999999999999999999999999999865
Q ss_pred CCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcccccc
Q 012762 238 GDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMS 317 (457)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (457)
...... ....+
T Consensus 218 ~~~~~~---------------------------------------------------------------------~~~~~ 228 (410)
T 3v8s_A 218 MNKEGM---------------------------------------------------------------------VRCDT 228 (410)
T ss_dssp CCTTSE---------------------------------------------------------------------EECCS
T ss_pred eccCCc---------------------------------------------------------------------ccccC
Confidence 432110 01124
Q ss_pred ccCCCCccCchhhcCCC----CCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcc--cCCCCCCCCChHHHHHH
Q 012762 318 FVGTHEYLAPEIISGEG----HGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARA--LEFPKEPSVPGPAKDLI 391 (457)
Q Consensus 318 ~~gt~~y~aPE~l~~~~----~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~ll 391 (457)
.+||+.|+|||++.+.. |+.++|||||||++|||++|+.||.+.+....+.+++... +.+|....++.++++||
T Consensus 229 ~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li 308 (410)
T 3v8s_A 229 AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLI 308 (410)
T ss_dssp CCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTTCCCCHHHHHHH
T ss_pred CcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCcccccHHHHHHH
Confidence 57999999999998765 7899999999999999999999999988888888887654 56666667999999999
Q ss_pred HHHhhhCCCC--CCCCCcChHHHhcCCCCCCCCchh--hhccCCCCCCCCCCccccccc
Q 012762 392 AQLLVKDPTR--RMGSKMGATAIKRHQFFNGVNWAL--LRCAKPPFIPRPVTCRDLTTT 446 (457)
Q Consensus 392 ~~~L~~dP~~--Rps~~~~~~~ll~hp~f~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 446 (457)
.+||..+|.+ |++ ++||++||||++++|.. ++...|||+|......|.+.-
T Consensus 309 ~~lL~~~~~rlgR~~----~~ei~~Hp~f~~~~w~~~~~~~~~~p~~p~~~~~~d~~~f 363 (410)
T 3v8s_A 309 CAFLTDREVRLGRNG----VEEIKRHLFFKNDQWAWETLRDTVAPVVPDLSSDIDTSNF 363 (410)
T ss_dssp HHHSSCGGGCTTSSC----HHHHHTSGGGCCSSCCSTTGGGSCCSCCCCCSSTTCCTTS
T ss_pred HHHccChhhhCCCCC----HHHHhcCccccCCCHHHHhhcccCCCCCCcCCCccchhhc
Confidence 9999988888 999 99999999999999864 477889999988776665443
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-55 Score=436.82 Aligned_cols=289 Identities=34% Similarity=0.630 Sum_probs=255.7
Q ss_pred CCCccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEE
Q 012762 76 NNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATL 155 (457)
Q Consensus 76 ~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~ 155 (457)
......++|++++.||+|+||+||+|+++ .+|+.||+|++.+...........+.+|+++|+.++||||+++++++
T Consensus 35 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~----~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 110 (350)
T 1rdq_E 35 QNTAQLDQFDRIKTLGTGSFGRVMLVKHK----ESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF 110 (350)
T ss_dssp CCCCCGGGEEEEEEEEECSSCEEEEEEET----TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred ccCCCHHHCEEEEEeecCcCcEEEEEEEC----CCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 34567789999999999999999999986 47889999999887766656677888899999999999999999999
Q ss_pred EcCCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCC
Q 012762 156 DCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235 (457)
Q Consensus 156 ~~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s 235 (457)
.+.+.+||||||++|++|..++... +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++
T Consensus 111 ~~~~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a 188 (350)
T 1rdq_E 111 KDNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188 (350)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred EcCCEEEEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccc
Confidence 9999999999999999999998875 56999999999999999999999999999999999999999999999999998
Q ss_pred cCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcccc
Q 012762 236 LKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRS 315 (457)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (457)
+..... .
T Consensus 189 ~~~~~~-------------------------------------------------------------------------~ 195 (350)
T 1rdq_E 189 KRVKGR-------------------------------------------------------------------------T 195 (350)
T ss_dssp EECSSC-------------------------------------------------------------------------B
T ss_pred eeccCC-------------------------------------------------------------------------c
Confidence 644211 1
Q ss_pred ccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHh
Q 012762 316 MSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLL 395 (457)
Q Consensus 316 ~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L 395 (457)
.+.+||+.|+|||++.+..++.++|||||||++|||++|..||.+......+..+......+|. .++.++.+||.+||
T Consensus 196 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~--~~~~~~~~li~~lL 273 (350)
T 1rdq_E 196 WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS--HFSSDLKDLLRNLL 273 (350)
T ss_dssp CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT--TCCHHHHHHHHHHS
T ss_pred ccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCCCC--CCCHHHHHHHHHHh
Confidence 1347999999999999999999999999999999999999999998888888888888777665 48999999999999
Q ss_pred hhCCCCCCCCC-cChHHHhcCCCCCCCCchhh--hccCCCCCCCCCCcccccc
Q 012762 396 VKDPTRRMGSK-MGATAIKRHQFFNGVNWALL--RCAKPPFIPRPVTCRDLTT 445 (457)
Q Consensus 396 ~~dP~~Rps~~-~~~~~ll~hp~f~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 445 (457)
+.||.+||+.. ..+++|++||||++++|..+ +...|||+|......|.+.
T Consensus 274 ~~dp~~R~~~~~~~~~ei~~h~~f~~~~w~~~~~~~~~~p~~p~~~~~~~~~~ 326 (350)
T 1rdq_E 274 QVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSN 326 (350)
T ss_dssp CSCTTTCTTSSTTTTHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCCSTTCCTT
T ss_pred hcCHHhccCCccCCHHHHHhCcCcCCCCHHHHhhccCCCCCCCCCCCcccccc
Confidence 99999999842 45899999999999999877 4678999998765555443
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-55 Score=435.85 Aligned_cols=289 Identities=35% Similarity=0.679 Sum_probs=245.8
Q ss_pred CCccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHc-CCCCCceEEEEE
Q 012762 77 NPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEML-DHPFLPTLYATL 155 (457)
Q Consensus 77 ~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~~~~ 155 (457)
..+..++|++++.||+|+||+||+|+++ .+++.||+|++.+...........+.+|+++|+++ +||||+++++++
T Consensus 4 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~----~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~ 79 (345)
T 3a8x_A 4 DPLGLQDFDLLRVIGRGSYAKVLLVRLK----KTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF 79 (345)
T ss_dssp CCCCGGGEEEEEEEEECSSEEEEEEEET----TTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred CCCchhheEEEEEEEecCCeEEEEEEEC----CCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEE
Confidence 3466789999999999999999999987 47899999999887665556667788899999987 899999999999
Q ss_pred EcCCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCC
Q 012762 156 DCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235 (457)
Q Consensus 156 ~~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s 235 (457)
...+.+||||||++||+|..++... +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++
T Consensus 80 ~~~~~~~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a 157 (345)
T 3a8x_A 80 QTESRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMC 157 (345)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGC
T ss_pred EeCCEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEecccc
Confidence 9999999999999999999888765 57999999999999999999999999999999999999999999999999998
Q ss_pred cCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcccc
Q 012762 236 LKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRS 315 (457)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (457)
+...... ...
T Consensus 158 ~~~~~~~----------------------------------------------------------------------~~~ 167 (345)
T 3a8x_A 158 KEGLRPG----------------------------------------------------------------------DTT 167 (345)
T ss_dssp BCSCCTT----------------------------------------------------------------------CCB
T ss_pred ccccCCC----------------------------------------------------------------------Ccc
Confidence 6432110 011
Q ss_pred ccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCC---------ChHHHHHHHHhcccCCCCCCCCChH
Q 012762 316 MSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGI---------DHELTLANVVARALEFPKEPSVPGP 386 (457)
Q Consensus 316 ~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~ 386 (457)
.+++||+.|+|||++.+..++.++|||||||++|||++|+.||... ........+......+|. .++.+
T Consensus 168 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~--~~s~~ 245 (345)
T 3a8x_A 168 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR--SLSVK 245 (345)
T ss_dssp CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCCT--TSCHH
T ss_pred cccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCCC--CCCHH
Confidence 2457999999999999999999999999999999999999999752 233445566666666654 48999
Q ss_pred HHHHHHHHhhhCCCCCCCCC--cChHHHhcCCCCCCCCchhh--hccCCCCCCCCCCcccc
Q 012762 387 AKDLIAQLLVKDPTRRMGSK--MGATAIKRHQFFNGVNWALL--RCAKPPFIPRPVTCRDL 443 (457)
Q Consensus 387 ~~~ll~~~L~~dP~~Rps~~--~~~~~ll~hp~f~~~~~~~~--~~~~~~~~~~~~~~~~~ 443 (457)
+++||.+||..||.+||+.. ..++|+++||||++++|..+ +...|||.|......|.
T Consensus 246 ~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~w~~~~~~~~~~p~~p~~~~~~~~ 306 (345)
T 3a8x_A 246 AASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVPPFKPNISGEFGL 306 (345)
T ss_dssp HHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCCTTTCG
T ss_pred HHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCCHHHHHhCCCCCCcCCCCCCcchh
Confidence 99999999999999999942 12489999999999999877 45778999987654443
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-56 Score=451.34 Aligned_cols=290 Identities=33% Similarity=0.619 Sum_probs=250.6
Q ss_pred CccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEc
Q 012762 78 PLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDC 157 (457)
Q Consensus 78 ~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~ 157 (457)
.+..++|+++++||+|+||+||+|+++ .+++.||+|++.+...........+..|+++|..++||||++++++|.+
T Consensus 70 ~~~~~~y~~~~~LG~G~fG~V~~~~~~----~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 145 (437)
T 4aw2_A 70 RLHREDFEILKVIGRGAFGEVAVVKLK----NADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD 145 (437)
T ss_dssp SCCGGGEEEEEEEEECSSEEEEEEEET----TTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred cCChhheEEEEEEEeCCCEEEEEEEEc----CCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence 345679999999999999999999987 4788999999988765555555568889999999999999999999999
Q ss_pred CCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcC
Q 012762 158 PRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLK 237 (457)
Q Consensus 158 ~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~ 237 (457)
.+.+|||||||+||+|..++... ...+++..++.++.||+.||.|||++|||||||||+||||+.+|.+||+|||+++.
T Consensus 146 ~~~~~lV~Ey~~gg~L~~~l~~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~ 224 (437)
T 4aw2_A 146 DNNLYLVMDYYVGGDLLTLLSKF-EDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLK 224 (437)
T ss_dssp SSEEEEEECCCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred CCEEEEEEecCCCCcHHHHHHHc-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhh
Confidence 99999999999999999998763 36799999999999999999999999999999999999999999999999999865
Q ss_pred CCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcccccc
Q 012762 238 GDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMS 317 (457)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (457)
...... .....
T Consensus 225 ~~~~~~---------------------------------------------------------------------~~~~~ 235 (437)
T 4aw2_A 225 LMEDGT---------------------------------------------------------------------VQSSV 235 (437)
T ss_dssp CCTTSC---------------------------------------------------------------------EECCS
T ss_pred cccCCC---------------------------------------------------------------------ccccc
Confidence 432111 01113
Q ss_pred ccCCCCccCchhhc-----CCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcc--cCCCCC-CCCChHHHH
Q 012762 318 FVGTHEYLAPEIIS-----GEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARA--LEFPKE-PSVPGPAKD 389 (457)
Q Consensus 318 ~~gt~~y~aPE~l~-----~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~--~~~~~~-~~~~~~~~~ 389 (457)
.+||+.|+|||++. +..|+.++|||||||++|||++|+.||.+.+..+.+.+++... +.+|.. ..+++++++
T Consensus 236 ~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~d 315 (437)
T 4aw2_A 236 AVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSENAKD 315 (437)
T ss_dssp CCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCSSCCCSCHHHHH
T ss_pred ccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCcccccCCHHHHH
Confidence 47999999999997 4568999999999999999999999999988888888887643 444443 458999999
Q ss_pred HHHHHhhhCCCC--CCCCCcChHHHhcCCCCCCCCchhhhccCCCCCCCCCCcccccc
Q 012762 390 LIAQLLVKDPTR--RMGSKMGATAIKRHQFFNGVNWALLRCAKPPFIPRPVTCRDLTT 445 (457)
Q Consensus 390 ll~~~L~~dP~~--Rps~~~~~~~ll~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 445 (457)
||.+||..+|++ |++ ++|+++||||++++|..++...|||+|......|.+.
T Consensus 316 Li~~lL~~~~~r~~r~~----~~eil~Hpff~~i~w~~l~~~~~p~~P~~~~~~d~~~ 369 (437)
T 4aw2_A 316 LIRRLICSREHRLGQNG----IEDFKKHPFFSGIDWDNIRNCEAPYIPEVSSPTDTSN 369 (437)
T ss_dssp HHHTTSSCGGGCTTTTT----THHHHTSGGGTTCCTTTGGGSCCSCCCCCSSTTCCTT
T ss_pred HHHHHhcccccccCCCC----HHHHhCCCccCCCCHHHHhhCCCCCCCcCCCccchhh
Confidence 999999988888 999 9999999999999999999999999998776666544
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-55 Score=446.16 Aligned_cols=286 Identities=36% Similarity=0.655 Sum_probs=243.2
Q ss_pred CccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEc
Q 012762 78 PLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDC 157 (457)
Q Consensus 78 ~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~ 157 (457)
.+..++|++++.||+|+||+||+|+++ .+|+.||+|++.+...........+..|+++|..++||||+++++++.+
T Consensus 57 ~~~~~~f~~~~~lG~G~fG~V~~~~~~----~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 132 (412)
T 2vd5_A 57 RLQRDDFEILKVIGRGAFSEVAVVKMK----QTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD 132 (412)
T ss_dssp SCCGGGEEEEEEEEECSSCEEEEEEET----TTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred cCChhhEEEEEEEeeCCCeEEEEEEEC----CCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence 356689999999999999999999987 4789999999988765555555668889999999999999999999999
Q ss_pred CCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcC
Q 012762 158 PRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLK 237 (457)
Q Consensus 158 ~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~ 237 (457)
.+.+||||||++||+|..++... ...+++..++.++.||+.||+|||++|||||||||+||||+.+|.+||+|||+++.
T Consensus 133 ~~~~~lVmE~~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~ 211 (412)
T 2vd5_A 133 ENYLYLVMEYYVGGDLLTLLSKF-GERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLK 211 (412)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHH-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred CCEEEEEEcCCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhhee
Confidence 99999999999999999998764 24799999999999999999999999999999999999999999999999999865
Q ss_pred CCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcccccc
Q 012762 238 GDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMS 317 (457)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (457)
...... .....
T Consensus 212 ~~~~~~---------------------------------------------------------------------~~~~~ 222 (412)
T 2vd5_A 212 LRADGT---------------------------------------------------------------------VRSLV 222 (412)
T ss_dssp CCTTSC---------------------------------------------------------------------EECSS
T ss_pred ccCCCc---------------------------------------------------------------------cccce
Confidence 432111 01123
Q ss_pred ccCCCCccCchhhc-------CCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcc--cCCCC-CCCCChHH
Q 012762 318 FVGTHEYLAPEIIS-------GEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARA--LEFPK-EPSVPGPA 387 (457)
Q Consensus 318 ~~gt~~y~aPE~l~-------~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~--~~~~~-~~~~~~~~ 387 (457)
.+||+.|+|||++. +..|+.++|||||||++|||++|+.||.+.+..+.+.+++... +.+|. ...++.++
T Consensus 223 ~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~ 302 (412)
T 2vd5_A 223 AVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGVPEEA 302 (412)
T ss_dssp CCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC----CCCHHH
T ss_pred eccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCCccccCCCHHH
Confidence 57999999999997 3468999999999999999999999999988888888877643 34443 24689999
Q ss_pred HHHHHHHhhhCCCCCC---CCCcChHHHhcCCCCCCCCchhhhccCCCCCCCCCCccc
Q 012762 388 KDLIAQLLVKDPTRRM---GSKMGATAIKRHQFFNGVNWALLRCAKPPFIPRPVTCRD 442 (457)
Q Consensus 388 ~~ll~~~L~~dP~~Rp---s~~~~~~~ll~hp~f~~~~~~~~~~~~~~~~~~~~~~~~ 442 (457)
++||.+||. +|.+|+ + ++||++||||++++|..++...|||+|......|
T Consensus 303 ~dli~~lL~-~p~~Rlgr~~----~~ei~~Hpff~~i~w~~l~~~~~p~~p~~~~~~d 355 (412)
T 2vd5_A 303 RDFIQRLLC-PPETRLGRGG----AGDFRTHPFFFGLDWDGLRDSVPPFTPDFEGATD 355 (412)
T ss_dssp HHHHHTTSS-CGGGCTTTTT----HHHHHTSGGGTTCCSTTSTTSCCSCCCC-----C
T ss_pred HHHHHHHcC-ChhhcCCCCC----HHHHhcCCCcCCCCHHHHhhcCCCCCCcCCCccc
Confidence 999999999 999985 6 9999999999999999999999999998765444
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-54 Score=435.11 Aligned_cols=281 Identities=29% Similarity=0.578 Sum_probs=243.3
Q ss_pred CCCCccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEE
Q 012762 75 NNNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYAT 154 (457)
Q Consensus 75 ~~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~ 154 (457)
....+..++|++++.||+|+||+||+|+++ .+++.||+|++.+...........+.+|+++|+.++|||||+++++
T Consensus 8 ~~~~v~~~~y~i~~~LG~G~fG~V~~~~~~----~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~ 83 (384)
T 4fr4_A 8 ENEDVNFDHFEILRAIGKGSFGKVCIVQKN----DTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYS 83 (384)
T ss_dssp CCCCCCGGGEEEEEEEECCTTCCEEEEEET----TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred CCCCCChHHeEEEEEEeeCCCeEEEEEEEC----CCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence 345678899999999999999999999987 4788999999998876666677888899999999999999999999
Q ss_pred EEcCCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCC
Q 012762 155 LDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDL 234 (457)
Q Consensus 155 ~~~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~ 234 (457)
+.+.+.+|+||||+.||+|..++... ..+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+
T Consensus 84 ~~~~~~~~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~ 161 (384)
T 4fr4_A 84 FQDEEDMFMVVDLLLGGDLRYHLQQN--VHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNI 161 (384)
T ss_dssp EECSSEEEEEECCCTTEEHHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred EEeCCEEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccce
Confidence 99999999999999999999988764 6799999999999999999999999999999999999999999999999999
Q ss_pred CcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccc
Q 012762 235 SLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVR 314 (457)
Q Consensus 235 s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (457)
++...... .
T Consensus 162 a~~~~~~~-----------------------------------------------------------------------~ 170 (384)
T 4fr4_A 162 AAMLPRET-----------------------------------------------------------------------Q 170 (384)
T ss_dssp CEECCTTC-----------------------------------------------------------------------C
T ss_pred eeeccCCC-----------------------------------------------------------------------c
Confidence 86543211 1
Q ss_pred cccccCCCCccCchhhcC---CCCCccchhhhhhHHHHHHhcCCCCCCCCC---hHHHHHHHHhcccCCCCCCCCChHHH
Q 012762 315 SMSFVGTHEYLAPEIISG---EGHGNAVDWWTLGIFIFELFYGTTPFKGID---HELTLANVVARALEFPKEPSVPGPAK 388 (457)
Q Consensus 315 ~~~~~gt~~y~aPE~l~~---~~~~~~sDiwSlG~il~elltG~~Pf~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (457)
..+++||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.... .......+......++. .++.++.
T Consensus 171 ~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~p~--~~s~~~~ 248 (384)
T 4fr4_A 171 ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPS--AWSQEMV 248 (384)
T ss_dssp BCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCCCT--TSCHHHH
T ss_pred eeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCCCC--cCCHHHH
Confidence 124579999999999974 458999999999999999999999997543 33444455555555554 4899999
Q ss_pred HHHHHHhhhCCCCCCCCCcChHHHhcCCCCCCCCchhh--hccCCCCCCCC
Q 012762 389 DLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGVNWALL--RCAKPPFIPRP 437 (457)
Q Consensus 389 ~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~~~~~~~--~~~~~~~~~~~ 437 (457)
+||.+||..||.+||+. +++|++||||++++|..+ +...|||+|..
T Consensus 249 ~li~~lL~~dP~~R~s~---~~~l~~hp~f~~~~w~~~~~~~~~p~~~p~~ 296 (384)
T 4fr4_A 249 SLLKKLLEPNPDQRFSQ---LSDVQNFPYMNDINWDAVFQKRLIPGFIPNK 296 (384)
T ss_dssp HHHHHHSCSSGGGSCCS---HHHHHTSGGGTTCCHHHHHTTCSCCCCCCSC
T ss_pred HHHHHHhcCCHhHhccc---HHHHHcChhhhcCCHHHHHhCCCCCCCCCCC
Confidence 99999999999999985 899999999999999877 46779999875
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-55 Score=447.32 Aligned_cols=288 Identities=35% Similarity=0.703 Sum_probs=242.6
Q ss_pred CCccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEE
Q 012762 77 NPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLD 156 (457)
Q Consensus 77 ~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~ 156 (457)
..+..++|+++++||+|+||+||+|.++ .+|+.||||++.+...........+.+|+++|+.++||||+++++++.
T Consensus 143 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~----~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~ 218 (446)
T 4ejn_A 143 HRVTMNEFEYLKLLGKGTFGKVILVKEK----ATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQ 218 (446)
T ss_dssp -CCCGGGEEEEEEEEEETTEEEEEEEET----TTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEE
T ss_pred cCCChHHcEEeEEEeeCcCEEEEEEEEc----CCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEe
Confidence 4456789999999999999999999986 478999999998776555556667788999999999999999999999
Q ss_pred cCCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCceeecCCCCCeEEccCCCEEEeccCCC
Q 012762 157 CPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHM-MGIIYRDLKPENVLVRSDGHIMLTDFDLS 235 (457)
Q Consensus 157 ~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~-~~iiHrDIKp~NIll~~~~~vkl~DFG~s 235 (457)
..+.+||||||+++++|..++... ..+++..++.++.||+.||+|||+ .||+||||||+||||+.++.+||+|||++
T Consensus 219 ~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a 296 (446)
T 4ejn_A 219 THDRLCFVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLC 296 (446)
T ss_dssp ETTEEEEEECCCSSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCC
T ss_pred eCCEEEEEEeeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCc
Confidence 999999999999999999888775 679999999999999999999998 99999999999999999999999999998
Q ss_pred cCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcccc
Q 012762 236 LKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRS 315 (457)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (457)
+...... ...
T Consensus 297 ~~~~~~~----------------------------------------------------------------------~~~ 306 (446)
T 4ejn_A 297 KEGIKDG----------------------------------------------------------------------ATM 306 (446)
T ss_dssp CTTCC---------------------------------------------------------------------------
T ss_pred eeccCCC----------------------------------------------------------------------ccc
Confidence 6432111 011
Q ss_pred ccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHh
Q 012762 316 MSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLL 395 (457)
Q Consensus 316 ~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L 395 (457)
...+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.........+......++.. +++++.+||.+||
T Consensus 307 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~--~~~~~~~li~~~L 384 (446)
T 4ejn_A 307 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRT--LGPEAKSLLSGLL 384 (446)
T ss_dssp CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTT--SCHHHHHHHHHHT
T ss_pred ccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCcc--CCHHHHHHHHHHc
Confidence 23579999999999999999999999999999999999999999988888888888887776654 8999999999999
Q ss_pred hhCCCCCC-----CCCcChHHHhcCCCCCCCCchhh--hccCCCCCCCCCCccccccc
Q 012762 396 VKDPTRRM-----GSKMGATAIKRHQFFNGVNWALL--RCAKPPFIPRPVTCRDLTTT 446 (457)
Q Consensus 396 ~~dP~~Rp-----s~~~~~~~ll~hp~f~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 446 (457)
..||.+|| + ++|+++||||++++|..+ +...|||.|......|.+.-
T Consensus 385 ~~dP~~R~~~~~~t----~~ell~hp~f~~~~~~~~~~~~~~pp~~p~~~~~~~~~~~ 438 (446)
T 4ejn_A 385 KKDPKQRLGGGSED----AKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYF 438 (446)
T ss_dssp CSSTTTSTTCSTTT----HHHHHTSGGGTTCCHHHHHTTCSCCSCCCSCSSTTCCTTC
T ss_pred ccCHHHhCCCCCCC----HHHHHhCccccCCCHHHHhhCcCCCCccCCCCCccchhhc
Confidence 99999999 7 999999999999999876 56789999988776665443
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-54 Score=462.97 Aligned_cols=287 Identities=32% Similarity=0.656 Sum_probs=250.3
Q ss_pred CCCCccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHc-CCCCCceEEE
Q 012762 75 NNNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEML-DHPFLPTLYA 153 (457)
Q Consensus 75 ~~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~~ 153 (457)
....+.+++|+++++||+|+||+||+|+++ .+++.||||++++...........+..|+++|..+ +||||+.+++
T Consensus 334 ~~~~~~~~~f~~~~~LG~G~fG~V~~~~~~----~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~ 409 (674)
T 3pfq_A 334 NRDRMKLTDFNFLMVLGKGSFGKVMLSERK----GTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHS 409 (674)
T ss_dssp ------CTTEEEEEESSBTTTBCEEEEEES----SSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEE
T ss_pred ccccccccceEEEEEEccCCCEEEEEEEEC----CCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEE
Confidence 345577889999999999999999999987 47889999999987666666677788899999987 7999999999
Q ss_pred EEEcCCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccC
Q 012762 154 TLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFD 233 (457)
Q Consensus 154 ~~~~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG 233 (457)
++.+.+.+||||||++||+|..++... +.+++..++.++.||+.||+|||++|||||||||+||||+.+|.+||+|||
T Consensus 410 ~~~~~~~~~lV~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFG 487 (674)
T 3pfq_A 410 CFQTMDRLYFVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFG 487 (674)
T ss_dssp ECBCSSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCT
T ss_pred EEEeCCEEEEEEeCcCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecc
Confidence 999999999999999999999998875 679999999999999999999999999999999999999999999999999
Q ss_pred CCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcc
Q 012762 234 LSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDV 313 (457)
Q Consensus 234 ~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (457)
+++...... .
T Consensus 488 la~~~~~~~----------------------------------------------------------------------~ 497 (674)
T 3pfq_A 488 MCKENIWDG----------------------------------------------------------------------V 497 (674)
T ss_dssp TCEECCCTT----------------------------------------------------------------------C
T ss_pred eeeccccCC----------------------------------------------------------------------c
Confidence 986432110 1
Q ss_pred ccccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHH
Q 012762 314 RSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQ 393 (457)
Q Consensus 314 ~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~ 393 (457)
...+++||+.|+|||++.+..|+.++|||||||+||||++|+.||.+.+..+.+..++.....+|.. ++.++++||.+
T Consensus 498 ~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~--~s~~~~~li~~ 575 (674)
T 3pfq_A 498 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKS--MSKEAVAICKG 575 (674)
T ss_dssp CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCCTT--SCHHHHHHHHH
T ss_pred ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCcc--CCHHHHHHHHH
Confidence 1224579999999999999999999999999999999999999999999989999999888777754 99999999999
Q ss_pred HhhhCCCCCCCCC-cChHHHhcCCCCCCCCchhh--hccCCCCCCCCCC
Q 012762 394 LLVKDPTRRMGSK-MGATAIKRHQFFNGVNWALL--RCAKPPFIPRPVT 439 (457)
Q Consensus 394 ~L~~dP~~Rps~~-~~~~~ll~hp~f~~~~~~~~--~~~~~~~~~~~~~ 439 (457)
||+.||++|++.. ..++||++||||++++|..+ +...|||+|+...
T Consensus 576 lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~w~~l~~~~~~pp~~p~~~~ 624 (674)
T 3pfq_A 576 LMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPPYKPKASG 624 (674)
T ss_dssp HSCSSSTTCTTCSTTHHHHHHSSGGGSSCCHHHHTTTCSCCSCCCBCCG
T ss_pred HccCCHHHCCCCCCCcHHHHhcCccccCCCHHHHHhCCCCCCCCCcCCC
Confidence 9999999999931 22499999999999999987 5678999998754
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-54 Score=423.56 Aligned_cols=295 Identities=34% Similarity=0.652 Sum_probs=235.1
Q ss_pred CCccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhh-hhHHHHHHHHHHHHHHcCCCCCceEEEEE
Q 012762 77 NPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVS-RNKESRARIEREILEMLDHPFLPTLYATL 155 (457)
Q Consensus 77 ~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~-~~~~~~~~~E~~il~~l~H~nIv~l~~~~ 155 (457)
..+..++|++.+.||+|+||+||+|++.. +..+++.||+|++++..... ......+.+|+++|+.++||||+++++++
T Consensus 12 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~-~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 90 (327)
T 3a62_A 12 EKIRPECFELLRVLGKGGYGKVFQVRKVT-GANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAF 90 (327)
T ss_dssp -CCCGGGEEEEEEEEEETTEEEEEEEECS-STTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEE
T ss_pred CCCCHHHeEEEEEEEeCCCEEEEEEEEec-cCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEE
Confidence 34667899999999999999999998742 22478999999998654322 22345577899999999999999999999
Q ss_pred EcCCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCC
Q 012762 156 DCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235 (457)
Q Consensus 156 ~~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s 235 (457)
...+.+|+||||++|++|..++... +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++
T Consensus 91 ~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~ 168 (327)
T 3a62_A 91 QTGGKLYLILEYLSGGELFMQLERE--GIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLC 168 (327)
T ss_dssp ECSSCEEEEEECCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC
T ss_pred EcCCEEEEEEeCCCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCcc
Confidence 9999999999999999999988765 56999999999999999999999999999999999999999999999999997
Q ss_pred cCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcccc
Q 012762 236 LKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRS 315 (457)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (457)
+...... ...
T Consensus 169 ~~~~~~~----------------------------------------------------------------------~~~ 178 (327)
T 3a62_A 169 KESIHDG----------------------------------------------------------------------TVT 178 (327)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred cccccCC----------------------------------------------------------------------ccc
Confidence 5432110 001
Q ss_pred ccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHh
Q 012762 316 MSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLL 395 (457)
Q Consensus 316 ~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L 395 (457)
...+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+......+..+......++. .++.++.+||.+||
T Consensus 179 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p~--~~~~~~~~li~~~L 256 (327)
T 3a62_A 179 HTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPP--YLTQEARDLLKKLL 256 (327)
T ss_dssp CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCT--TSCHHHHHHHHHHS
T ss_pred cccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCC--CCCHHHHHHHHHHH
Confidence 1346999999999999999999999999999999999999999998888888888877766664 48999999999999
Q ss_pred hhCCCCCCCCC-cChHHHhcCCCCCCCCchhh--hccCCCCCCCCCCccccccc
Q 012762 396 VKDPTRRMGSK-MGATAIKRHQFFNGVNWALL--RCAKPPFIPRPVTCRDLTTT 446 (457)
Q Consensus 396 ~~dP~~Rps~~-~~~~~ll~hp~f~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 446 (457)
..||++||+.. ..+.++++||||++++|..+ +...|||.|......|....
T Consensus 257 ~~dp~~R~~~~~~~~~e~l~hp~f~~~~~~~~~~~~~~~p~~p~~~~~~~~~~~ 310 (327)
T 3a62_A 257 KRNAASRLGAGPGDAGEVQAHPFFRHINWEELLARKVEPPFKPLLQSEEDVSQF 310 (327)
T ss_dssp CSCGGGSTTSSTTTHHHHHHSGGGSSCCHHHHHTTCSCCSCCCC----------
T ss_pred hcCHhhccCCCCCCHHHHHcCCcccCCCHHHHhhccCCCCCCCCcCChhhhhhc
Confidence 99999999432 13999999999999999866 45678999988766665443
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-53 Score=445.60 Aligned_cols=287 Identities=30% Similarity=0.578 Sum_probs=248.1
Q ss_pred CCccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEE
Q 012762 77 NPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLD 156 (457)
Q Consensus 77 ~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~ 156 (457)
..+..++|.+++.||+|+||+||+|+++ .+|+.||+|++.+...........+..|+++|+.++||||+++++++.
T Consensus 180 ~~~~~~~f~~~~~LG~G~fG~Vy~a~~~----~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~ 255 (543)
T 3c4z_A 180 QPMGEDWFLDFRVLGRGGFGEVFACQMK----ATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFE 255 (543)
T ss_dssp SCCCGGGEEEEEEEEECSSSEEEEEEET----TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred ccCChhheEEEEEEeeCCCeEEEEEEEC----CCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEe
Confidence 3466789999999999999999999986 478999999998877665566678888999999999999999999999
Q ss_pred cCCcEEEEEeecCCCChHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCC
Q 012762 157 CPRWSCLLTEFCPGGDLHVLRQRQP--DKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDL 234 (457)
Q Consensus 157 ~~~~~~lV~E~~~~~sL~~~~~~~~--~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~ 234 (457)
..+.+||||||++||+|..++.... ...+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+
T Consensus 256 ~~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGl 335 (543)
T 3c4z_A 256 TKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGL 335 (543)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTT
T ss_pred eCCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecce
Confidence 9999999999999999998887643 35799999999999999999999999999999999999999999999999999
Q ss_pred CcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccc
Q 012762 235 SLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVR 314 (457)
Q Consensus 235 s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (457)
++....... .
T Consensus 336 a~~~~~~~~----------------------------------------------------------------------~ 345 (543)
T 3c4z_A 336 AVELKAGQT----------------------------------------------------------------------K 345 (543)
T ss_dssp CEECCTTCC----------------------------------------------------------------------C
T ss_pred eeeccCCCc----------------------------------------------------------------------c
Confidence 865432110 0
Q ss_pred cccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCC----hHHHHHHHHhcccCCCCCCCCChHHHHH
Q 012762 315 SMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGID----HELTLANVVARALEFPKEPSVPGPAKDL 390 (457)
Q Consensus 315 ~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~l 390 (457)
...++||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.. .......+......+|. .++.++++|
T Consensus 346 ~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p~--~~s~~~~~l 423 (543)
T 3c4z_A 346 TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPD--KFSPASKDF 423 (543)
T ss_dssp BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCCT--TSCHHHHHH
T ss_pred cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCCc--ccCHHHHHH
Confidence 113479999999999999999999999999999999999999998753 34556666666655553 589999999
Q ss_pred HHHHhhhCCCCCCCCCc-ChHHHhcCCCCCCCCchhhh--ccCCCCCCCCCC
Q 012762 391 IAQLLVKDPTRRMGSKM-GATAIKRHQFFNGVNWALLR--CAKPPFIPRPVT 439 (457)
Q Consensus 391 l~~~L~~dP~~Rps~~~-~~~~ll~hp~f~~~~~~~~~--~~~~~~~~~~~~ 439 (457)
|.+||..||++||+... .+++|++||||++++|..+. ...|||+|.+..
T Consensus 424 i~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~w~~l~~~~~~pp~~P~~~~ 475 (543)
T 3c4z_A 424 CEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQLEAGMLTPPFVPDSRT 475 (543)
T ss_dssp HHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCCHHHHHTTCSCCSCCCCSSS
T ss_pred HHHhccCCHhHCCCCcccCHHHHHcCccccCCCHHHHHcCCCCCCCCCCccc
Confidence 99999999999998543 47999999999999999875 568999998754
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-54 Score=447.67 Aligned_cols=286 Identities=33% Similarity=0.572 Sum_probs=245.1
Q ss_pred CCccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEE
Q 012762 77 NPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLD 156 (457)
Q Consensus 77 ~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~ 156 (457)
..+..++|++.+.||+|+||+||+|+++ .+|+.||+|++.+...........+.+|+++|+.++||||+++++++.
T Consensus 179 ~~~~~~~f~~~~~LG~G~fG~Vy~a~~~----~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~ 254 (576)
T 2acx_A 179 QPVTKNTFRQYRVLGKGGFGEVCACQVR----ATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYE 254 (576)
T ss_dssp SCCCGGGEEEEEEEEEETTEEEEEEEET----TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred cCccccceEEEEEEeeCCCEEEEEEEEC----CCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEe
Confidence 3467789999999999999999999986 478999999999877666666777888999999999999999999999
Q ss_pred cCCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCc
Q 012762 157 CPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSL 236 (457)
Q Consensus 157 ~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~ 236 (457)
+.+.+||||||++||+|..++.......+++..++.++.||+.||.|||++|||||||||+||||+.+|.+||+|||+++
T Consensus 255 ~~~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~ 334 (576)
T 2acx_A 255 TKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAV 334 (576)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred eCCEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccce
Confidence 99999999999999999998887655669999999999999999999999999999999999999999999999999986
Q ss_pred CCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccc
Q 012762 237 KGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSM 316 (457)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (457)
...... ...
T Consensus 335 ~~~~~~-----------------------------------------------------------------------~~~ 343 (576)
T 2acx_A 335 HVPEGQ-----------------------------------------------------------------------TIK 343 (576)
T ss_dssp ECCTTC-----------------------------------------------------------------------CEE
T ss_pred ecccCc-----------------------------------------------------------------------ccc
Confidence 543211 011
Q ss_pred cccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCCh----HHHHHHHHhcccCCCCCCCCChHHHHHHH
Q 012762 317 SFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDH----ELTLANVVARALEFPKEPSVPGPAKDLIA 392 (457)
Q Consensus 317 ~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~ll~ 392 (457)
..+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+... ......+......++ ..++.++++||.
T Consensus 344 ~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p--~~~s~~~~dLI~ 421 (576)
T 2acx_A 344 GRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYS--ERFSPQARSLCS 421 (576)
T ss_dssp CCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCC--TTSCHHHHHHHH
T ss_pred ccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCC--ccCCHHHHHHHH
Confidence 34699999999999998999999999999999999999999987542 334444444444444 458999999999
Q ss_pred HHhhhCCCCCCCCCc-ChHHHhcCCCCCCCCchhhh--ccCCCCCCCCCC
Q 012762 393 QLLVKDPTRRMGSKM-GATAIKRHQFFNGVNWALLR--CAKPPFIPRPVT 439 (457)
Q Consensus 393 ~~L~~dP~~Rps~~~-~~~~ll~hp~f~~~~~~~~~--~~~~~~~~~~~~ 439 (457)
+||..||.+||+... .++||++||||++++|..+. ...|||+|.+..
T Consensus 422 ~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~w~~l~~~~~~pp~~p~~~~ 471 (576)
T 2acx_A 422 QLLCKDPAERLGCRGGSAREVKEHPLFKKLNFKRLGAGMLEPPFKPDPQA 471 (576)
T ss_dssp HHTCSSGGGSTTCSSSHHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCCC
T ss_pred HhccCCHHHcCCCCCCCHHHHHhChhhccCCHHHHhcCCCCCCCCCCccc
Confidence 999999999994221 28999999999999998875 567999998753
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-52 Score=413.52 Aligned_cols=262 Identities=25% Similarity=0.445 Sum_probs=231.2
Q ss_pred CccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEc
Q 012762 78 PLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDC 157 (457)
Q Consensus 78 ~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~ 157 (457)
....++|++++.||+|+||+||+|.+. .+|+.||||++.+... .......+.+|+++|+.++||||+++++++..
T Consensus 11 ~~~~~~y~~~~~lG~G~~g~V~~a~~~----~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 85 (328)
T 3fe3_A 11 QPHIGNYRLLKTIGKGNFAKVKLARHI----LTGREVAIKIIDKTQL-NPTSLQKLFREVRIMKILNHPNIVKLFEVIET 85 (328)
T ss_dssp CCEETTEEEEEEEEECSSEEEEEEEET----TTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred CCccCCEEEEEEEeeCCCEEEEEEEEC----CCCCEEEEEEEEhhcC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE
Confidence 345678999999999999999999986 4789999999987543 23445677889999999999999999999999
Q ss_pred CCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcC
Q 012762 158 PRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLK 237 (457)
Q Consensus 158 ~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~ 237 (457)
.+.+|+||||+++++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 86 ~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 163 (328)
T 3fe3_A 86 EKTLYLIMEYASGGEVFDYLVAH--GRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNE 163 (328)
T ss_dssp SSEEEEEECCCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGG
T ss_pred CCEEEEEEECCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCcee
Confidence 99999999999999999988765 6799999999999999999999999999999999999999999999999999754
Q ss_pred CCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcccccc
Q 012762 238 GDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMS 317 (457)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (457)
..... ....
T Consensus 164 ~~~~~-----------------------------------------------------------------------~~~~ 172 (328)
T 3fe3_A 164 FTVGG-----------------------------------------------------------------------KLDA 172 (328)
T ss_dssp GSSSC-----------------------------------------------------------------------GGGT
T ss_pred cCCCC-----------------------------------------------------------------------cccc
Confidence 32110 1123
Q ss_pred ccCCCCccCchhhcCCCCC-ccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhh
Q 012762 318 FVGTHEYLAPEIISGEGHG-NAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLV 396 (457)
Q Consensus 318 ~~gt~~y~aPE~l~~~~~~-~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~ 396 (457)
.+||+.|+|||++.+..+. .++|||||||++|+|++|+.||.+.+.......+..+.+..|.. ++.++.+||.+||.
T Consensus 173 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~--~s~~~~~li~~~L~ 250 (328)
T 3fe3_A 173 FCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFY--MSTDCENLLKRFLV 250 (328)
T ss_dssp TSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTT--SCHHHHHHHHHHCC
T ss_pred ccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCC--CCHHHHHHHHHHCC
Confidence 5799999999999988874 79999999999999999999999998888888888887777654 89999999999999
Q ss_pred hCCCCCCCCCcChHHHhcCCCCCCCCc
Q 012762 397 KDPTRRMGSKMGATAIKRHQFFNGVNW 423 (457)
Q Consensus 397 ~dP~~Rps~~~~~~~ll~hp~f~~~~~ 423 (457)
.||.+||| ++|+++||||+...+
T Consensus 251 ~dP~~R~t----~~eil~h~~~~~~~~ 273 (328)
T 3fe3_A 251 LNPIKRGT----LEQIMKDRWINAGHE 273 (328)
T ss_dssp SSTTTSCC----HHHHTTCTTTTTTCT
T ss_pred CChhHCcC----HHHHhcCHhhcCCCc
Confidence 99999999 999999999987543
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-53 Score=419.44 Aligned_cols=264 Identities=28% Similarity=0.431 Sum_probs=231.6
Q ss_pred CCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhh---hHHHHHHHHHHHHHHcCCCCCceEEEEEEc
Q 012762 81 LSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSR---NKESRARIEREILEMLDHPFLPTLYATLDC 157 (457)
Q Consensus 81 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~---~~~~~~~~E~~il~~l~H~nIv~l~~~~~~ 157 (457)
.++|++.+.||+|+||+||+|.++ .+|+.||+|++.+...... .....+.+|+++|+.++||||+++++++.+
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~----~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~ 86 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREK----STGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYEN 86 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEET----TTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred hhceEEeeEEeeCcCEEEEEEEEC----CCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEe
Confidence 357999999999999999999987 4789999999987543221 134678889999999999999999999999
Q ss_pred CCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCC----CEEEeccC
Q 012762 158 PRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDG----HIMLTDFD 233 (457)
Q Consensus 158 ~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~----~vkl~DFG 233 (457)
.+.+|+||||++|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||
T Consensus 87 ~~~~~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG 164 (361)
T 2yab_A 87 RTDVVLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (361)
T ss_dssp SSEEEEEEECCCSCBHHHHHTTC--SCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCS
T ss_pred CCEEEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecC
Confidence 99999999999999999988764 6799999999999999999999999999999999999998776 79999999
Q ss_pred CCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcc
Q 012762 234 LSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDV 313 (457)
Q Consensus 234 ~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (457)
++.......
T Consensus 165 ~a~~~~~~~----------------------------------------------------------------------- 173 (361)
T 2yab_A 165 LAHEIEDGV----------------------------------------------------------------------- 173 (361)
T ss_dssp SCEECCTTC-----------------------------------------------------------------------
T ss_pred CceEcCCCC-----------------------------------------------------------------------
Confidence 986543211
Q ss_pred ccccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCC--CCCCChHHHHHH
Q 012762 314 RSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPK--EPSVPGPAKDLI 391 (457)
Q Consensus 314 ~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ll 391 (457)
.....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+....+.+..+....+.++. ...++.++++||
T Consensus 174 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 253 (361)
T 2yab_A 174 EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSELAKDFI 253 (361)
T ss_dssp CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCHHHHHHH
T ss_pred ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhccCCCHHHHHHH
Confidence 011346999999999999999999999999999999999999999998888888888877766653 246889999999
Q ss_pred HHHhhhCCCCCCCCCcChHHHhcCCCCCCCCchh
Q 012762 392 AQLLVKDPTRRMGSKMGATAIKRHQFFNGVNWAL 425 (457)
Q Consensus 392 ~~~L~~dP~~Rps~~~~~~~ll~hp~f~~~~~~~ 425 (457)
.+||..||++||+ +.|+++||||+.++|..
T Consensus 254 ~~~L~~dP~~R~t----~~e~l~hp~~~~~~~~~ 283 (361)
T 2yab_A 254 RKLLVKETRKRLT----IQEALRHPWITPVDTQQ 283 (361)
T ss_dssp HHHSCSSTTTSCC----HHHHHTSTTTSCSSHHH
T ss_pred HHHCCCChhHCcC----HHHHhcCcCcCCCchhh
Confidence 9999999999999 99999999999998854
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-53 Score=414.84 Aligned_cols=251 Identities=22% Similarity=0.273 Sum_probs=191.2
Q ss_pred CCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCC--
Q 012762 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPR-- 159 (457)
Q Consensus 82 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~-- 159 (457)
.+|.+.++||+|+||+||+|++ +|+.||||+++.... .....+.|+.++.+++|||||++++++..++
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~------~g~~VAvK~l~~~~~----~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~ 72 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW------RGEEVAVKIFSSREE----RSWFREAEIYQTVMLRHENILGFIAADNKDNGT 72 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE------TTEEEEEEEECGGGH----HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSS
T ss_pred cEEEEEEEEeeCCCeEEEEEEE------CCEEEEEEEECccch----hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCC
Confidence 4689999999999999999986 478999999976421 2222334555566789999999999997654
Q ss_pred --cEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHc--------CceeecCCCCCeEEccCCCEEE
Q 012762 160 --WSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMM--------GIIYRDLKPENVLVRSDGHIML 229 (457)
Q Consensus 160 --~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~--------~iiHrDIKp~NIll~~~~~vkl 229 (457)
.+|||||||++|+|.++++. ..+++..+..++.|++.||+|||++ +||||||||+||||+.++.+||
T Consensus 73 ~~~~~lV~Ey~~~gsL~~~l~~---~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki 149 (303)
T 3hmm_A 73 WTQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI 149 (303)
T ss_dssp SEEEEEEEECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEE
T ss_pred ceEEEEEecCCCCCcHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEE
Confidence 57999999999999999987 5699999999999999999999987 9999999999999999999999
Q ss_pred eccCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCccccc
Q 012762 230 TDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAE 309 (457)
Q Consensus 230 ~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (457)
+|||+++.........
T Consensus 150 ~DFGla~~~~~~~~~~---------------------------------------------------------------- 165 (303)
T 3hmm_A 150 ADLGLAVRHDSATDTI---------------------------------------------------------------- 165 (303)
T ss_dssp CCCTTCEEEETTTTEE----------------------------------------------------------------
T ss_pred EeCCCCccccCCCCce----------------------------------------------------------------
Confidence 9999987543221110
Q ss_pred CCccccccccCCCCccCchhhcCC------CCCccchhhhhhHHHHHHhcCCCCCCCCC---------------hHHHHH
Q 012762 310 PLDVRSMSFVGTHEYLAPEIISGE------GHGNAVDWWTLGIFIFELFYGTTPFKGID---------------HELTLA 368 (457)
Q Consensus 310 ~~~~~~~~~~gt~~y~aPE~l~~~------~~~~~sDiwSlG~il~elltG~~Pf~~~~---------------~~~~~~ 368 (457)
.......+||+.|||||++.+. .|+.++|||||||+||||+||..||.... ......
T Consensus 166 --~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~ 243 (303)
T 3hmm_A 166 --DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRK 243 (303)
T ss_dssp --SCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHH
T ss_pred --eeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHHHHHH
Confidence 0111235799999999999765 35779999999999999999977653211 122233
Q ss_pred HHHhcccCCCCCC-----CCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcC
Q 012762 369 NVVARALEFPKEP-----SVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRH 415 (457)
Q Consensus 369 ~~~~~~~~~~~~~-----~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~h 415 (457)
.+.....+.+.+. ..+..+.+|+.+||+.||++||| +.||++.
T Consensus 244 ~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt----~~ei~~~ 291 (303)
T 3hmm_A 244 VVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLT----ALRIKKT 291 (303)
T ss_dssp HHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCC----HHHHHHH
T ss_pred HHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcC----HHHHHHH
Confidence 3333333322211 12246889999999999999999 8887653
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-52 Score=401.38 Aligned_cols=258 Identities=24% Similarity=0.371 Sum_probs=222.7
Q ss_pred cCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCC
Q 012762 80 TLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPR 159 (457)
Q Consensus 80 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~ 159 (457)
..++|++.++||+|+||+||+|.+. .+++.||+|++..... .....+.+|+.+++.++||||+++++++..++
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~----~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 90 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDV----ATGQEVAIRQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGD 90 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBT----TTCCEEEEEEEEGGGC---SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred hhhceeeeeeeccCCCeEEEEEEEC----CCCcEEEEEEeecccc---cHHHHHHHHHHHHhcCCCCCCCeEeEEEEECC
Confidence 3468999999999999999999876 4788999999976532 34566788999999999999999999999999
Q ss_pred cEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCC
Q 012762 160 WSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGD 239 (457)
Q Consensus 160 ~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~ 239 (457)
..|+||||++|++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 91 ~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 167 (297)
T 3fxz_A 91 ELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 167 (297)
T ss_dssp EEEEEEECCTTCBHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEEEECCCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecC
Confidence 99999999999999999887 469999999999999999999999999999999999999999999999999976543
Q ss_pred CCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcccccccc
Q 012762 240 NSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFV 319 (457)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (457)
.... .....+
T Consensus 168 ~~~~----------------------------------------------------------------------~~~~~~ 177 (297)
T 3fxz_A 168 PEQS----------------------------------------------------------------------KRSTMV 177 (297)
T ss_dssp STTC----------------------------------------------------------------------CBCCCC
T ss_pred Cccc----------------------------------------------------------------------ccCCcc
Confidence 2111 111346
Q ss_pred CCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhccc-CCCCCCCCChHHHHHHHHHhhhC
Q 012762 320 GTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARAL-EFPKEPSVPGPAKDLIAQLLVKD 398 (457)
Q Consensus 320 gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ll~~~L~~d 398 (457)
||+.|+|||++.+..++.++|||||||++|||++|..||.+.........+..... .......++..+.+||.+||+.|
T Consensus 178 gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d 257 (297)
T 3fxz_A 178 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMD 257 (297)
T ss_dssp SCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHHHHHHHHSCSS
T ss_pred CCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHHHHHHHHccCC
Confidence 99999999999999999999999999999999999999998776665555544332 33344568899999999999999
Q ss_pred CCCCCCCCcChHHHhcCCCCCCC
Q 012762 399 PTRRMGSKMGATAIKRHQFFNGV 421 (457)
Q Consensus 399 P~~Rps~~~~~~~ll~hp~f~~~ 421 (457)
|++||+ +.|+++||||+..
T Consensus 258 p~~Rps----~~ell~h~~~~~~ 276 (297)
T 3fxz_A 258 VEKRGS----AKELLQHQFLKIA 276 (297)
T ss_dssp TTTSCC----HHHHTTCGGGGGC
T ss_pred hhHCcC----HHHHhhChhhccc
Confidence 999999 9999999999853
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-51 Score=398.81 Aligned_cols=264 Identities=25% Similarity=0.389 Sum_probs=217.2
Q ss_pred ccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcC
Q 012762 79 LTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCP 158 (457)
Q Consensus 79 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~ 158 (457)
--.++|+++++||+|+||+||+|++. +++.||+|++..... .......+.+|+++|+.++||||+++++++..+
T Consensus 18 ~l~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 91 (311)
T 3niz_A 18 GLMEKYQKLEKVGEGTYGVVYKAKDS-----QGRIVALKRIRLDAE-DEGIPSTAIREISLLKELHHPNIVSLIDVIHSE 91 (311)
T ss_dssp CSSCEEEEEEEEEECSSCEEEEEEET-----TSCEEEEEEEC-------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCS
T ss_pred chHhhhHhhhhccCCCCeEEEEEEEC-----CCCEEEEEEEecccc-cchhhHHHHHHHHHHHHcCCCCEeeeeeEEccC
Confidence 34578999999999999999999874 588999999975432 233456778899999999999999999999999
Q ss_pred CcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCC
Q 012762 159 RWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKG 238 (457)
Q Consensus 159 ~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~ 238 (457)
+..|+||||++ ++|..++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 92 ~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~ 169 (311)
T 3niz_A 92 RCLTLVFEFME-KDLKKVLDEN-KTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAF 169 (311)
T ss_dssp SCEEEEEECCS-EEHHHHHHTC-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEET
T ss_pred CEEEEEEcCCC-CCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceec
Confidence 99999999996 5787777654 356999999999999999999999999999999999999999999999999998654
Q ss_pred CCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccc
Q 012762 239 DNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSF 318 (457)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (457)
...... ....
T Consensus 170 ~~~~~~----------------------------------------------------------------------~~~~ 179 (311)
T 3niz_A 170 GIPVRS----------------------------------------------------------------------YTHE 179 (311)
T ss_dssp TSCCC-------------------------------------------------------------------------CC
T ss_pred CCCccc----------------------------------------------------------------------ccCC
Confidence 321100 1123
Q ss_pred cCCCCccCchhhcC-CCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCC------------------
Q 012762 319 VGTHEYLAPEIISG-EGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPK------------------ 379 (457)
Q Consensus 319 ~gt~~y~aPE~l~~-~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~------------------ 379 (457)
+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+......+..+.........
T Consensus 180 ~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (311)
T 3niz_A 180 VVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQ 259 (311)
T ss_dssp CCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHSCCCC
T ss_pred cccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhhcccc
Confidence 58999999999987 45899999999999999999999999987776666665542211110
Q ss_pred ----------CCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCCCCch
Q 012762 380 ----------EPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGVNWA 424 (457)
Q Consensus 380 ----------~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~~~~~ 424 (457)
.+.++.++.+||.+||+.||++||| +.|+|+||||++++++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt----~~ell~hp~f~~~~~~ 310 (311)
T 3niz_A 260 VFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRIS----ARDAMNHPYFKDLDPQ 310 (311)
T ss_dssp CCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCC----HHHHHTSGGGTTSCTT
T ss_pred cccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCC----HHHHhcCcccccCCcc
Confidence 1235678999999999999999999 9999999999998875
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-51 Score=416.87 Aligned_cols=258 Identities=26% Similarity=0.475 Sum_probs=225.9
Q ss_pred CCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcE
Q 012762 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWS 161 (457)
Q Consensus 82 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~ 161 (457)
++|++.++||+|+||+||+|.++ .+|+.||+|++.+.... ......+.+|+++|+.++||||+++++++.+++..
T Consensus 11 ~~Y~i~~~LG~G~fg~V~~~~~~----~~~~~~a~K~i~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 85 (444)
T 3soa_A 11 EEYQLFEELGKGAFSVVRRCVKV----LAGQEYAAMIINTKKLS-ARDHQKLEREARICRLLKHPNIVRLHDSISEEGHH 85 (444)
T ss_dssp HHEEEEEEEEEC--CEEEEEEET----TTTEEEEEEEEESCSCH-HHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEE
T ss_pred CCeEEEEEeccCCCeEEEEEEEC----CCCcEEEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEE
Confidence 57999999999999999999877 48899999999876443 23456788899999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEc---cCCCEEEeccCCCcCC
Q 012762 162 CLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVR---SDGHIMLTDFDLSLKG 238 (457)
Q Consensus 162 ~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~---~~~~vkl~DFG~s~~~ 238 (457)
|+|||||.||+|.+.+... ..+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||++...
T Consensus 86 ~lv~E~~~gg~L~~~i~~~--~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~ 163 (444)
T 3soa_A 86 YLIFDLVTGGELFEDIVAR--EYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEV 163 (444)
T ss_dssp EEEECCCBCCBHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCC
T ss_pred EEEEEeCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEe
Confidence 9999999999999888775 6799999999999999999999999999999999999998 4578999999998654
Q ss_pred CCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccc
Q 012762 239 DNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSF 318 (457)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (457)
..... .....
T Consensus 164 ~~~~~----------------------------------------------------------------------~~~~~ 173 (444)
T 3soa_A 164 EGEQQ----------------------------------------------------------------------AWFGF 173 (444)
T ss_dssp CTTCC----------------------------------------------------------------------BCCCS
T ss_pred cCCCc----------------------------------------------------------------------eeecc
Confidence 32111 01134
Q ss_pred cCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCC--CCCChHHHHHHHHHhh
Q 012762 319 VGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKE--PSVPGPAKDLIAQLLV 396 (457)
Q Consensus 319 ~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ll~~~L~ 396 (457)
+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.........+..+.+.++.. ..+++++++||.+||+
T Consensus 174 ~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~ 253 (444)
T 3soa_A 174 AGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLT 253 (444)
T ss_dssp CSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSC
T ss_pred cCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCHHHHHHHHHHcC
Confidence 69999999999999999999999999999999999999999988888888888887766543 5789999999999999
Q ss_pred hCCCCCCCCCcChHHHhcCCCCCC
Q 012762 397 KDPTRRMGSKMGATAIKRHQFFNG 420 (457)
Q Consensus 397 ~dP~~Rps~~~~~~~ll~hp~f~~ 420 (457)
.||++||+ +.|+|+||||+.
T Consensus 254 ~dP~~Rpt----a~e~L~hp~~~~ 273 (444)
T 3soa_A 254 INPSKRIT----AAEALKHPWISH 273 (444)
T ss_dssp SSTTTSCC----HHHHHHSCTTHH
T ss_pred CChhHCCC----HHHHhcCccccC
Confidence 99999999 999999999964
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-51 Score=402.86 Aligned_cols=264 Identities=30% Similarity=0.442 Sum_probs=229.0
Q ss_pred CCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhh---hHHHHHHHHHHHHHHcCCCCCceEEEEEEcC
Q 012762 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSR---NKESRARIEREILEMLDHPFLPTLYATLDCP 158 (457)
Q Consensus 82 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~---~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~ 158 (457)
++|++.+.||+|+||+||+|.++ .+++.||+|++.+...... .....+.+|+++|+.++||||+++++++...
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~----~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 86 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREK----STGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENK 86 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEET----TTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred cceEeceEEeeCCCeEEEEEEEC----CCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence 56999999999999999999986 4788999999976543221 1356788899999999999999999999999
Q ss_pred CcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCC----CEEEeccCC
Q 012762 159 RWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDG----HIMLTDFDL 234 (457)
Q Consensus 159 ~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~----~vkl~DFG~ 234 (457)
+..|+||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+
T Consensus 87 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~ 164 (326)
T 2y0a_A 87 TDVILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164 (326)
T ss_dssp SEEEEEEECCCSCBHHHHHTTS--SCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTT
T ss_pred CEEEEEEEcCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCC
Confidence 9999999999999999998764 6799999999999999999999999999999999999999887 899999999
Q ss_pred CcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccc
Q 012762 235 SLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVR 314 (457)
Q Consensus 235 s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (457)
+........
T Consensus 165 a~~~~~~~~----------------------------------------------------------------------- 173 (326)
T 2y0a_A 165 AHKIDFGNE----------------------------------------------------------------------- 173 (326)
T ss_dssp CEECCTTSC-----------------------------------------------------------------------
T ss_pred CeECCCCCc-----------------------------------------------------------------------
Confidence 865431110
Q ss_pred cccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCC--CCCChHHHHHHH
Q 012762 315 SMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKE--PSVPGPAKDLIA 392 (457)
Q Consensus 315 ~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ll~ 392 (457)
....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+......+..+......++.. ..++..+.+||.
T Consensus 174 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 253 (326)
T 2y0a_A 174 FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIR 253 (326)
T ss_dssp CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHH
T ss_pred cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccccCCHHHHHHHH
Confidence 012369999999999999999999999999999999999999999988877777777665555432 457899999999
Q ss_pred HHhhhCCCCCCCCCcChHHHhcCCCCCCCCchhh
Q 012762 393 QLLVKDPTRRMGSKMGATAIKRHQFFNGVNWALL 426 (457)
Q Consensus 393 ~~L~~dP~~Rps~~~~~~~ll~hp~f~~~~~~~~ 426 (457)
+||..||++||+ +.|+|+||||+..+|...
T Consensus 254 ~~L~~dP~~Rpt----~~e~l~hp~~~~~~~~~~ 283 (326)
T 2y0a_A 254 RLLVKDPKKRMT----IQDSLQHPWIKPKDTQQA 283 (326)
T ss_dssp HHSCSSGGGSCC----HHHHHHSTTTSCCSHHHH
T ss_pred HHccCChhhCCC----HHHHhcCCCccCCcchhh
Confidence 999999999999 999999999999888543
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-51 Score=399.97 Aligned_cols=261 Identities=31% Similarity=0.532 Sum_probs=218.8
Q ss_pred CccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhh-----------------------hHHHHHH
Q 012762 78 PLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSR-----------------------NKESRAR 134 (457)
Q Consensus 78 ~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~-----------------------~~~~~~~ 134 (457)
.+..++|++.+.||+|+||+||+|+++ .+++.||||++.+...... .....+.
T Consensus 9 ~~~~~~y~~~~~lG~G~~g~Vy~a~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 84 (298)
T 2zv2_A 9 CVQLNQYTLKDEIGKGSYGVVKLAYNE----NDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVY 84 (298)
T ss_dssp -CEETTEEEEEEEEC--CCEEEEEEET----TTTEEEEEEEEECC-------------------------------CHHH
T ss_pred ceeecceEEEeEEeecCCEEEEEEEEC----CCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHH
Confidence 356689999999999999999999876 4789999999976543211 1235678
Q ss_pred HHHHHHHHcCCCCCceEEEEEEc--CCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceee
Q 012762 135 IEREILEMLDHPFLPTLYATLDC--PRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYR 212 (457)
Q Consensus 135 ~E~~il~~l~H~nIv~l~~~~~~--~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHr 212 (457)
+|+++|+.++||||+++++++.. .+.+||||||+++++|.+++. ...+++..++.++.||+.||.|||++||+||
T Consensus 85 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~ 161 (298)
T 2zv2_A 85 QEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT---LKPLSEDQARFYFQDLIKGIEYLHYQKIIHR 161 (298)
T ss_dssp HHHHHHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC---SSCCCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred HHHHHHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHCCeecc
Confidence 89999999999999999999986 568899999999999977543 3579999999999999999999999999999
Q ss_pred cCCCCCeEEccCCCEEEeccCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcch
Q 012762 213 DLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKR 292 (457)
Q Consensus 213 DIKp~NIll~~~~~vkl~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (457)
||||+|||++.++.+||+|||++........
T Consensus 162 Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~------------------------------------------------- 192 (298)
T 2zv2_A 162 DIKPSNLLVGEDGHIKIADFGVSNEFKGSDA------------------------------------------------- 192 (298)
T ss_dssp CCCGGGEEECTTSCEEECCCTTCEECSSSSC-------------------------------------------------
T ss_pred CCCHHHEEECCCCCEEEecCCCccccccccc-------------------------------------------------
Confidence 9999999999999999999999865432110
Q ss_pred hccccCCCCCCCcccccCCccccccccCCCCccCchhhcCCC---CCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHH
Q 012762 293 RRKKKLGNPGTPEIVAEPLDVRSMSFVGTHEYLAPEIISGEG---HGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLAN 369 (457)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~---~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~ 369 (457)
......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.........
T Consensus 193 ---------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~ 251 (298)
T 2zv2_A 193 ---------------------LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSK 251 (298)
T ss_dssp ---------------------EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred ---------------------cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHHHHHH
Confidence 011236999999999998765 37889999999999999999999998877777777
Q ss_pred HHhcccCCCCCCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCC
Q 012762 370 VVARALEFPKEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFN 419 (457)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~ 419 (457)
+......++....+++++.+||.+||..||++||+ +.||++||||+
T Consensus 252 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s----~~e~l~hp~~~ 297 (298)
T 2zv2_A 252 IKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIV----VPEIKLHPWVT 297 (298)
T ss_dssp HHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCC----HHHHTTCHHHH
T ss_pred HhcccCCCCCccccCHHHHHHHHHHhhcChhhCCC----HHHHhcCcccc
Confidence 77777777777789999999999999999999999 99999999985
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-51 Score=412.55 Aligned_cols=277 Identities=20% Similarity=0.311 Sum_probs=223.1
Q ss_pred CCccCCCceeEEEeccc--CcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEE
Q 012762 77 NPLTLSDLRFVHRLGSG--DIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYAT 154 (457)
Q Consensus 77 ~~~~~~~~~~~~~LG~G--~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~ 154 (457)
.....++|+++++||+| +||+||+|+++ .+++.||||++..... .......+.+|+++|+.++|||||+++++
T Consensus 20 ~~~~~~~y~~~~~lG~G~~~~g~V~~~~~~----~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 94 (389)
T 3gni_B 20 FLPEGGCYELLTVIGKGFEDLMTVNLARYK----PTGEYVTVRRINLEAC-SNEMVTFLQGELHVSKLFNHPNIVPYRAT 94 (389)
T ss_dssp CCCCGGGEEEEEEEEEETTTTEEEEEEEET----TTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccCCCCcEEEEecccCCcCCceEEEEEEEc----CCCCEEEEEEeccccc-ChHHHHHHHHHHHHHHhCCCCCCCcEeEE
Confidence 34466789999999999 99999999987 4789999999987643 23456678889999999999999999999
Q ss_pred EEcCCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCC
Q 012762 155 LDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDL 234 (457)
Q Consensus 155 ~~~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~ 234 (457)
+..++.+|+|||||++++|.+++.......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+
T Consensus 95 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~ 174 (389)
T 3gni_B 95 FIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRS 174 (389)
T ss_dssp EEETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGG
T ss_pred EEECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEccccc
Confidence 99999999999999999999999887667799999999999999999999999999999999999999999999999998
Q ss_pred CcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccc
Q 012762 235 SLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVR 314 (457)
Q Consensus 235 s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (457)
+............ ....
T Consensus 175 ~~~~~~~~~~~~~---------------------------------------------------------------~~~~ 191 (389)
T 3gni_B 175 NLSMISHGQRQRV---------------------------------------------------------------VHDF 191 (389)
T ss_dssp CEECEETTEECSC---------------------------------------------------------------BCCC
T ss_pred ceeeccccccccc---------------------------------------------------------------cccc
Confidence 7544211110000 0000
Q ss_pred cccccCCCCccCchhhcC--CCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccC----------------
Q 012762 315 SMSFVGTHEYLAPEIISG--EGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALE---------------- 376 (457)
Q Consensus 315 ~~~~~gt~~y~aPE~l~~--~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~---------------- 376 (457)
....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+......+..++.....
T Consensus 192 ~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (389)
T 3gni_B 192 PKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMS 271 (389)
T ss_dssp CTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC----------------------
T ss_pred cccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcccccccccccccccc
Confidence 112369999999999988 57899999999999999999999999886655544443322211
Q ss_pred ----------------------------CCCCCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCCCCchh
Q 012762 377 ----------------------------FPKEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGVNWAL 425 (457)
Q Consensus 377 ----------------------------~~~~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~~~~~~ 425 (457)
.+....+++++.+||.+||+.||++||+ +.|+|+||||+.+.|..
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt----a~ell~hp~f~~~~~~~ 344 (389)
T 3gni_B 272 PSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPS----ASTLLNHSFFKQIKRRA 344 (389)
T ss_dssp ----------------------------------CCHHHHHHHHHHTCSCTTTSCC----HHHHTTSGGGGGC---C
T ss_pred ccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCC----HHHHhcCHHHHHHhhcc
Confidence 0122346788999999999999999999 99999999999988743
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-51 Score=408.19 Aligned_cols=257 Identities=26% Similarity=0.464 Sum_probs=225.4
Q ss_pred CCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcE
Q 012762 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWS 161 (457)
Q Consensus 82 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~ 161 (457)
++|++.+.||+|+||+||+|.++ .+++.||+|++...... ......+.+|+++|+.++||||+++++++.+.+..
T Consensus 29 ~~y~~~~~lG~G~~g~V~~~~~~----~~~~~~avK~~~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~ 103 (362)
T 2bdw_A 29 DNYDVKEELGKGAFSVVRRCVHK----TTGLEFAAKIINTKKLS-ARDFQKLEREARICRKLQHPNIVRLHDSIQEESFH 103 (362)
T ss_dssp HHEEEEEEEEEETTEEEEEEEET----TTCCEEEEEEEETTTCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred cCeEEeeEEecCCCeEEEEEEEC----CCCCEEEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEE
Confidence 57999999999999999999986 47889999999865432 23456788899999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccC---CCEEEeccCCCcCC
Q 012762 162 CLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSD---GHIMLTDFDLSLKG 238 (457)
Q Consensus 162 ~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~---~~vkl~DFG~s~~~ 238 (457)
|+||||+.|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++...
T Consensus 104 ~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~ 181 (362)
T 2bdw_A 104 YLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 181 (362)
T ss_dssp EEEECCCCSCBHHHHHTTC--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCC
T ss_pred EEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEe
Confidence 9999999999998887664 679999999999999999999999999999999999999865 45999999998654
Q ss_pred CCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccc
Q 012762 239 DNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSF 318 (457)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (457)
..... ....
T Consensus 182 ~~~~~-----------------------------------------------------------------------~~~~ 190 (362)
T 2bdw_A 182 NDSEA-----------------------------------------------------------------------WHGF 190 (362)
T ss_dssp TTCCS-----------------------------------------------------------------------CCCS
T ss_pred cCCcc-----------------------------------------------------------------------cccC
Confidence 32110 1134
Q ss_pred cCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCC--CCCChHHHHHHHHHhh
Q 012762 319 VGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKE--PSVPGPAKDLIAQLLV 396 (457)
Q Consensus 319 ~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ll~~~L~ 396 (457)
+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.+.......+..+.+.++.. ..+++++++||.+||.
T Consensus 191 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~ 270 (362)
T 2bdw_A 191 AGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLT 270 (362)
T ss_dssp CSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHHHHHHHHHHSC
T ss_pred CCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHcC
Confidence 69999999999999999999999999999999999999999988888888888877766543 4678999999999999
Q ss_pred hCCCCCCCCCcChHHHhcCCCCCC
Q 012762 397 KDPTRRMGSKMGATAIKRHQFFNG 420 (457)
Q Consensus 397 ~dP~~Rps~~~~~~~ll~hp~f~~ 420 (457)
.||++||+ +.++|+||||..
T Consensus 271 ~dP~~R~t----~~e~l~hp~~~~ 290 (362)
T 2bdw_A 271 VNPKKRIT----ADQALKVPWICN 290 (362)
T ss_dssp SSGGGSCC----HHHHTTSHHHHT
T ss_pred CChhhCcC----HHHHhcCcccCC
Confidence 99999999 999999999975
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-52 Score=410.05 Aligned_cols=258 Identities=28% Similarity=0.451 Sum_probs=221.2
Q ss_pred ccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcC
Q 012762 79 LTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCP 158 (457)
Q Consensus 79 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~ 158 (457)
...++|++.+.||+|+||+||+|.+. .+++.||+|++.+...........+.+|+++|+.++||||+++++++...
T Consensus 6 ~~i~~Y~i~~~lG~G~~g~V~~a~~~----~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 81 (336)
T 3h4j_B 6 RHIGPYIIRETLGEGSFGKVKLATHY----KTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTP 81 (336)
T ss_dssp SEETTEEEEEEEEEETTEEEEEEEET----TTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccCCEEEEEEEecCCCeEEEEEEEC----CCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC
Confidence 34578999999999999999999986 47889999999877655545556788899999999999999999999999
Q ss_pred CcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCC
Q 012762 159 RWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKG 238 (457)
Q Consensus 159 ~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~ 238 (457)
+..|+||||+ +|+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 82 ~~~~lv~E~~-~g~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~ 158 (336)
T 3h4j_B 82 TDIVMVIEYA-GGELFDYIVEK--KRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIM 158 (336)
T ss_dssp SEEEEEECCC-CEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTT
T ss_pred CEEEEEEECC-CCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceec
Confidence 9999999999 78888877664 67999999999999999999999999999999999999999999999999998654
Q ss_pred CCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccc
Q 012762 239 DNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSF 318 (457)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (457)
..... ....
T Consensus 159 ~~~~~-----------------------------------------------------------------------~~~~ 167 (336)
T 3h4j_B 159 TDGNF-----------------------------------------------------------------------LKTS 167 (336)
T ss_dssp TTSBT-----------------------------------------------------------------------TCCC
T ss_pred cCCcc-----------------------------------------------------------------------cccc
Confidence 32110 1134
Q ss_pred cCCCCccCchhhcCCCC-CccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhhh
Q 012762 319 VGTHEYLAPEIISGEGH-GNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVK 397 (457)
Q Consensus 319 ~gt~~y~aPE~l~~~~~-~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~ 397 (457)
+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.........+.......| ..+++++.+||.+||..
T Consensus 168 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p--~~~s~~~~~li~~~L~~ 245 (336)
T 3h4j_B 168 CGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMP--DFLSPGAQSLIRRMIVA 245 (336)
T ss_dssp TTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSSCCCCC--TTSCHHHHHHHHTTSCS
T ss_pred cCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCc--ccCCHHHHHHHHHHcCC
Confidence 69999999999998876 7899999999999999999999987655444433333333333 34889999999999999
Q ss_pred CCCCCCCCCcChHHHhcCCCCCC
Q 012762 398 DPTRRMGSKMGATAIKRHQFFNG 420 (457)
Q Consensus 398 dP~~Rps~~~~~~~ll~hp~f~~ 420 (457)
||.+||| ++||++||||+.
T Consensus 246 dP~~Rpt----~~eil~hp~~~~ 264 (336)
T 3h4j_B 246 DPMQRIT----IQEIRRDPWFNV 264 (336)
T ss_dssp SGGGSCC----HHHHTTCHHHHT
T ss_pred ChhHCcC----HHHHHhChhhcc
Confidence 9999999 999999999985
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-51 Score=407.10 Aligned_cols=293 Identities=37% Similarity=0.680 Sum_probs=233.0
Q ss_pred CCccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhh-hhHHHHHHHHHHHHHHc-CCCCCceEEEE
Q 012762 77 NPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVS-RNKESRARIEREILEML-DHPFLPTLYAT 154 (457)
Q Consensus 77 ~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~-~~~~~~~~~E~~il~~l-~H~nIv~l~~~ 154 (457)
..+..++|++++.||+|+||+||+|++.. ...+++.||||++++..... ......+.+|+++|+++ +||||++++++
T Consensus 49 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 127 (355)
T 1vzo_A 49 EKVGIENFELLKVLGTGAYGKVFLVRKIS-GHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYA 127 (355)
T ss_dssp CCCCGGGEEEEEEEEETTTEEEEEEEECS-STTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEE
T ss_pred ccccccceEEEEEeccCCCEEEEEEEEcc-cCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEE
Confidence 34566799999999999999999999753 23478999999997543211 12234456799999999 79999999999
Q ss_pred EEcCCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCC
Q 012762 155 LDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDL 234 (457)
Q Consensus 155 ~~~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~ 234 (457)
+...+.+||||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+
T Consensus 128 ~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 205 (355)
T 1vzo_A 128 FQTETKLHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGL 205 (355)
T ss_dssp EEETTEEEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred EeeCceEEEEeecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCC
Confidence 99999999999999999999998775 5699999999999999999999999999999999999999999999999999
Q ss_pred CcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccc
Q 012762 235 SLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVR 314 (457)
Q Consensus 235 s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (457)
++...... ...
T Consensus 206 a~~~~~~~---------------------------------------------------------------------~~~ 216 (355)
T 1vzo_A 206 SKEFVADE---------------------------------------------------------------------TER 216 (355)
T ss_dssp EEECCGGG---------------------------------------------------------------------GGG
T ss_pred CeecccCC---------------------------------------------------------------------CCc
Confidence 86443111 011
Q ss_pred cccccCCCCccCchhhcCC--CCCccchhhhhhHHHHHHhcCCCCCCCCCh----HHHHHHHHhcccCCCCCCCCChHHH
Q 012762 315 SMSFVGTHEYLAPEIISGE--GHGNAVDWWTLGIFIFELFYGTTPFKGIDH----ELTLANVVARALEFPKEPSVPGPAK 388 (457)
Q Consensus 315 ~~~~~gt~~y~aPE~l~~~--~~~~~sDiwSlG~il~elltG~~Pf~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (457)
...++||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ......+......++ ..++..+.
T Consensus 217 ~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 294 (355)
T 1vzo_A 217 AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP--QEMSALAK 294 (355)
T ss_dssp GCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCC--TTSCHHHH
T ss_pred ccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCCCC--cccCHHHH
Confidence 1235799999999999863 478999999999999999999999975432 233334443333333 45889999
Q ss_pred HHHHHHhhhCCCCCCCCC-cChHHHhcCCCCCCCCchhhh--ccCCCCCCCCCCcccc
Q 012762 389 DLIAQLLVKDPTRRMGSK-MGATAIKRHQFFNGVNWALLR--CAKPPFIPRPVTCRDL 443 (457)
Q Consensus 389 ~ll~~~L~~dP~~Rps~~-~~~~~ll~hp~f~~~~~~~~~--~~~~~~~~~~~~~~~~ 443 (457)
+||.+||..||.+||+.. ..++++++||||+.++|..+. ...+||.|......|.
T Consensus 295 ~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~~~~l~~~~~~~p~~p~~~~~~d~ 352 (355)
T 1vzo_A 295 DLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVPAPFKPVIRDELDV 352 (355)
T ss_dssp HHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCCC-CCC
T ss_pred HHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCChhHhhhccCCCCCCCcccccccc
Confidence 999999999999999211 019999999999999998774 4557888876555443
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=391.75 Aligned_cols=259 Identities=23% Similarity=0.353 Sum_probs=211.8
Q ss_pred CCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCc
Q 012762 81 LSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRW 160 (457)
Q Consensus 81 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~ 160 (457)
+++|+++++||+|+||+||+|+++ .+++.||+|++..... .......+.+|+++++.++||||+++++++.+++.
T Consensus 1 l~~y~~~~~lg~G~~g~V~~~~~~----~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 75 (292)
T 3o0g_A 1 MQKYEKLEKIGEGTYGTVFKAKNR----ETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKK 75 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEET----TTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTE
T ss_pred CCCceeeeEecCCCCeEEEEEEEC----CCCceEEEEeeeccCC-cCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCE
Confidence 368999999999999999999987 4788999999976542 33345677889999999999999999999999999
Q ss_pred EEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCC
Q 012762 161 SCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDN 240 (457)
Q Consensus 161 ~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~ 240 (457)
.|+||||+++ +|...+... .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 76 ~~lv~e~~~~-~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 153 (292)
T 3o0g_A 76 LTLVFEFCDQ-DLKKYFDSC-NGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGI 153 (292)
T ss_dssp EEEEEECCSE-EHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCS
T ss_pred EEEEEecCCC-CHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCC
Confidence 9999999965 555554442 36799999999999999999999999999999999999999999999999999865431
Q ss_pred CCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccC
Q 012762 241 STSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVG 320 (457)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 320 (457)
... ......|
T Consensus 154 ~~~----------------------------------------------------------------------~~~~~~~ 163 (292)
T 3o0g_A 154 PVR----------------------------------------------------------------------CYSAEVV 163 (292)
T ss_dssp CCS----------------------------------------------------------------------CCCSCCS
T ss_pred ccc----------------------------------------------------------------------cccCCcc
Confidence 110 0112368
Q ss_pred CCCccCchhhcCCC-CCccchhhhhhHHHHHHhcCCCCC-CCCChHHHHHHHHhcccCCC--------------------
Q 012762 321 THEYLAPEIISGEG-HGNAVDWWTLGIFIFELFYGTTPF-KGIDHELTLANVVARALEFP-------------------- 378 (457)
Q Consensus 321 t~~y~aPE~l~~~~-~~~~sDiwSlG~il~elltG~~Pf-~~~~~~~~~~~~~~~~~~~~-------------------- 378 (457)
|+.|+|||++.+.. ++.++|||||||++|+|++|..|| .+......+..+........
T Consensus 164 t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (292)
T 3o0g_A 164 TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYP 243 (292)
T ss_dssp CGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCC
T ss_pred ccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccccccccccccc
Confidence 99999999998776 799999999999999999887774 55555555555543211111
Q ss_pred -------CCCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCC
Q 012762 379 -------KEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNG 420 (457)
Q Consensus 379 -------~~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~ 420 (457)
..+.++.++++||.+||+.||++||| ++|+++||||++
T Consensus 244 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t----~~e~l~hp~f~~ 288 (292)
T 3o0g_A 244 ATTSLVNVVPKLNATGRDLLQNLLKCNPVQRIS----AEEALQHPYFSD 288 (292)
T ss_dssp TTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCC----HHHHHTSGGGTT
T ss_pred CCcchhhcccccChHHHHHHHHHhccChhhCCC----HHHHhcCccccc
Confidence 11246788999999999999999999 999999999985
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-51 Score=405.28 Aligned_cols=263 Identities=25% Similarity=0.418 Sum_probs=221.9
Q ss_pred CCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhh--hHHHHHHHHHHHHHHcCCCCCceEEEEEEcCC
Q 012762 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSR--NKESRARIEREILEMLDHPFLPTLYATLDCPR 159 (457)
Q Consensus 82 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~--~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~ 159 (457)
++|++.+.||+|+||+||+|.++ .+++.||||++........ .....+.+|+++|+.++||||+++++++..++
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 99 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINR----ETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDG 99 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEET----TTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred cceEEeeEEeeCCCEEEEEEEEC----CCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence 57999999999999999999886 4789999999987654322 13567888999999999999999999999999
Q ss_pred cEEEEEeecCCCChHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCC---EEEeccCC
Q 012762 160 WSCLLTEFCPGGDLHVLRQRQ--PDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGH---IMLTDFDL 234 (457)
Q Consensus 160 ~~~lV~E~~~~~sL~~~~~~~--~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~---vkl~DFG~ 234 (457)
.+|||||||+|++|..++... ....+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+
T Consensus 100 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 100 MLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 999999999999997766542 2346899999999999999999999999999999999999987654 99999999
Q ss_pred CcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccc
Q 012762 235 SLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVR 314 (457)
Q Consensus 235 s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (457)
+........ .
T Consensus 180 a~~~~~~~~----------------------------------------------------------------------~ 189 (351)
T 3c0i_A 180 AIQLGESGL----------------------------------------------------------------------V 189 (351)
T ss_dssp CEECCTTSC----------------------------------------------------------------------B
T ss_pred eeEecCCCe----------------------------------------------------------------------e
Confidence 865432110 0
Q ss_pred cccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCC--CCCCChHHHHHHH
Q 012762 315 SMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPK--EPSVPGPAKDLIA 392 (457)
Q Consensus 315 ~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ll~ 392 (457)
....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+. .......+....+..+. ...++.++++||.
T Consensus 190 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~-~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 268 (351)
T 3c0i_A 190 AGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT-KERLFEGIIKGKYKMNPRQWSHISESAKDLVR 268 (351)
T ss_dssp CCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSS-HHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHH
T ss_pred ecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCc-HHHHHHHHHcCCCCCCccccccCCHHHHHHHH
Confidence 11346999999999999999999999999999999999999999874 44556666666554432 2458899999999
Q ss_pred HHhhhCCCCCCCCCcChHHHhcCCCCCCCCc
Q 012762 393 QLLVKDPTRRMGSKMGATAIKRHQFFNGVNW 423 (457)
Q Consensus 393 ~~L~~dP~~Rps~~~~~~~ll~hp~f~~~~~ 423 (457)
+||..||++||+ +.++++||||+..++
T Consensus 269 ~~L~~dP~~R~s----~~e~l~hp~~~~~~~ 295 (351)
T 3c0i_A 269 RMLMLDPAERIT----VYEALNHPWLKERDR 295 (351)
T ss_dssp HHTCSSTTTSCC----HHHHHTSHHHHTHHH
T ss_pred HHCCCChhHCcC----HHHHhcChhhcCCcc
Confidence 999999999999 999999999987543
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-51 Score=419.04 Aligned_cols=263 Identities=25% Similarity=0.446 Sum_probs=232.8
Q ss_pred CCCCccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEE
Q 012762 75 NNNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYAT 154 (457)
Q Consensus 75 ~~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~ 154 (457)
....+..++|.+.+.||+|+||+||+|+++ .+|+.||||++.+...........+.+|+++|+.++||||++++++
T Consensus 9 ~~~~~~~~~Y~l~~~LG~G~fg~V~~a~~~----~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~ 84 (476)
T 2y94_A 9 HDGRVKIGHYILGDTLGVGTFGKVKVGKHE----LTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQV 84 (476)
T ss_dssp CCSCCEETTEEEEEEEECCSSSCEEEEEET----TTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred cCCCceecCEEEEEEEeeCCCeEEEEEEEC----CCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence 345677889999999999999999999986 4789999999988766555566788899999999999999999999
Q ss_pred EEcCCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCC
Q 012762 155 LDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDL 234 (457)
Q Consensus 155 ~~~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~ 234 (457)
+...+.+||||||++|++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 85 ~~~~~~~~lv~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~ 162 (476)
T 2y94_A 85 ISTPSDIFMVMEYVSGGELFDYICKN--GRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGL 162 (476)
T ss_dssp EECSSEEEEEEECCSSEEHHHHTTSS--SSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSS
T ss_pred EEECCEEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccc
Confidence 99999999999999999999988654 6799999999999999999999999999999999999999999999999999
Q ss_pred CcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccc
Q 012762 235 SLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVR 314 (457)
Q Consensus 235 s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (457)
+........
T Consensus 163 a~~~~~~~~----------------------------------------------------------------------- 171 (476)
T 2y94_A 163 SNMMSDGEF----------------------------------------------------------------------- 171 (476)
T ss_dssp CEECCTTCC-----------------------------------------------------------------------
T ss_pred hhhcccccc-----------------------------------------------------------------------
Confidence 865432110
Q ss_pred cccccCCCCccCchhhcCCCC-CccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHH
Q 012762 315 SMSFVGTHEYLAPEIISGEGH-GNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQ 393 (457)
Q Consensus 315 ~~~~~gt~~y~aPE~l~~~~~-~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~ 393 (457)
..+.+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.........+..+.+..+. .+++++.+||.+
T Consensus 172 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~--~~s~~~~~Li~~ 249 (476)
T 2y94_A 172 LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQ--YLNPSVISLLKH 249 (476)
T ss_dssp BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCCCT--TCCHHHHHHHHH
T ss_pred ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCCCc--cCCHHHHHHHHH
Confidence 113469999999999998876 78999999999999999999999998888888888777666554 488999999999
Q ss_pred HhhhCCCCCCCCCcChHHHhcCCCCCC
Q 012762 394 LLVKDPTRRMGSKMGATAIKRHQFFNG 420 (457)
Q Consensus 394 ~L~~dP~~Rps~~~~~~~ll~hp~f~~ 420 (457)
||..||.+||+ +.||++||||+.
T Consensus 250 ~L~~dP~~Rpt----~~eil~hp~~~~ 272 (476)
T 2y94_A 250 MLQVDPMKRAT----IKDIREHEWFKQ 272 (476)
T ss_dssp HTCSSTTTSCC----HHHHHTCHHHHT
T ss_pred HcCCCchhCcC----HHHHHhCHHhhh
Confidence 99999999999 999999999985
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-51 Score=401.39 Aligned_cols=257 Identities=22% Similarity=0.353 Sum_probs=226.0
Q ss_pred CCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCc
Q 012762 81 LSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRW 160 (457)
Q Consensus 81 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~ 160 (457)
.++|++.+.||+|+||+||+|.++ .+++.||+|++.... .....+.+|+++|+.++||||+++++++.+.+.
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~----~~~~~~a~K~~~~~~----~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 75 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVET----SSKKTYMAKFVKVKG----TDQVLVKKEISILNIARHRNILHLHESFESMEE 75 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEET----TTTEEEEEEEECCCT----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTE
T ss_pred hhceEeeeEEecCCCeEEEEEEEC----CCCcEEEEEEEecCc----ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCE
Confidence 468999999999999999999986 478999999986432 344567889999999999999999999999999
Q ss_pred EEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEcc--CCCEEEeccCCCcCC
Q 012762 161 SCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRS--DGHIMLTDFDLSLKG 238 (457)
Q Consensus 161 ~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~--~~~vkl~DFG~s~~~ 238 (457)
+|+|||||+|++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++...
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~ 154 (321)
T 1tki_A 76 LVMIFEFISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL 154 (321)
T ss_dssp EEEEECCCCCCBHHHHHTSS-SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred EEEEEEeCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeEC
Confidence 99999999999999888653 346999999999999999999999999999999999999987 789999999998654
Q ss_pred CCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccc
Q 012762 239 DNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSF 318 (457)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (457)
..... ....
T Consensus 155 ~~~~~-----------------------------------------------------------------------~~~~ 163 (321)
T 1tki_A 155 KPGDN-----------------------------------------------------------------------FRLL 163 (321)
T ss_dssp CTTCE-----------------------------------------------------------------------EEEE
T ss_pred CCCCc-----------------------------------------------------------------------cccc
Confidence 32111 1134
Q ss_pred cCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCC--CCCCChHHHHHHHHHhh
Q 012762 319 VGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPK--EPSVPGPAKDLIAQLLV 396 (457)
Q Consensus 319 ~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ll~~~L~ 396 (457)
.||+.|+|||++.+..++.++|||||||++|+|++|..||.+......+..+....+.++. ...++.++.+||.+||.
T Consensus 164 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~ 243 (321)
T 1tki_A 164 FTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLV 243 (321)
T ss_dssp ESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSC
T ss_pred cCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHHHHHHHHHcC
Confidence 6999999999999988999999999999999999999999998888888888887766653 24689999999999999
Q ss_pred hCCCCCCCCCcChHHHhcCCCCCCC
Q 012762 397 KDPTRRMGSKMGATAIKRHQFFNGV 421 (457)
Q Consensus 397 ~dP~~Rps~~~~~~~ll~hp~f~~~ 421 (457)
.||.+||+ +.|+|+||||+..
T Consensus 244 ~dp~~Rpt----~~e~l~hp~~~~~ 264 (321)
T 1tki_A 244 KERKSRMT----ASEALQHPWLKQK 264 (321)
T ss_dssp SSGGGSCC----HHHHHHSHHHHSC
T ss_pred CChhHCcC----HHHHhcChhhccC
Confidence 99999999 9999999999864
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-50 Score=389.70 Aligned_cols=260 Identities=32% Similarity=0.532 Sum_probs=229.0
Q ss_pred CCccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEE
Q 012762 77 NPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLD 156 (457)
Q Consensus 77 ~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~ 156 (457)
..+..++|++.+.||+|+||+||+|.++ .++..||+|++.+...........+.+|+++++.++||||+++++++.
T Consensus 4 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 79 (279)
T 3fdn_A 4 RQWALEDFEIGRPLGKGKFGNVYLAREK----QSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH 79 (279)
T ss_dssp CCCCGGGEEEEEEEEECSSEEEEEEEET----TTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred ceeecccEEEeeEEecCCCeEEEEEEEc----cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEe
Confidence 3566789999999999999999999886 478899999998876655556778889999999999999999999999
Q ss_pred cCCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCc
Q 012762 157 CPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSL 236 (457)
Q Consensus 157 ~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~ 236 (457)
+.+..|+||||+++++|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 80 ~~~~~~lv~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~ 157 (279)
T 3fdn_A 80 DATRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV 157 (279)
T ss_dssp CSSEEEEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEES
T ss_pred cCCEEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccc
Confidence 999999999999999999888765 569999999999999999999999999999999999999999999999999874
Q ss_pred CCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccc
Q 012762 237 KGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSM 316 (457)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (457)
...... ..
T Consensus 158 ~~~~~~------------------------------------------------------------------------~~ 165 (279)
T 3fdn_A 158 HAPSSR------------------------------------------------------------------------RT 165 (279)
T ss_dssp CC------------------------------------------------------------------------------
T ss_pred cCCccc------------------------------------------------------------------------cc
Confidence 332110 11
Q ss_pred cccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhh
Q 012762 317 SFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLV 396 (457)
Q Consensus 317 ~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~ 396 (457)
...||+.|+|||++.+..++.++|||||||++|+|++|..||...........+......++. .++.++.+||.+||.
T Consensus 166 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~l~ 243 (279)
T 3fdn_A 166 DLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD--FVTEGARDLISRLLK 243 (279)
T ss_dssp --CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCT--TSCHHHHHHHHHHCC
T ss_pred ccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCCC--cCCHHHHHHHHHHhc
Confidence 236899999999999999999999999999999999999999998887777777766665554 488999999999999
Q ss_pred hCCCCCCCCCcChHHHhcCCCCCC
Q 012762 397 KDPTRRMGSKMGATAIKRHQFFNG 420 (457)
Q Consensus 397 ~dP~~Rps~~~~~~~ll~hp~f~~ 420 (457)
.||.+||+ +.||++||||+.
T Consensus 244 ~~p~~Rps----~~e~l~h~~~~~ 263 (279)
T 3fdn_A 244 HNPSQRPM----LREVLEHPWITA 263 (279)
T ss_dssp SSGGGSCC----HHHHHHCHHHHH
T ss_pred cChhhCCC----HHHHhhCccccC
Confidence 99999999 999999999985
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-50 Score=388.77 Aligned_cols=272 Identities=32% Similarity=0.539 Sum_probs=233.3
Q ss_pred CCccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEE
Q 012762 77 NPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLD 156 (457)
Q Consensus 77 ~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~ 156 (457)
..+..++|++.+.||+|+||+||+|.+. .+++.||+|++.+...........+.+|+++++.++||||+++++++.
T Consensus 9 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~----~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 84 (284)
T 2vgo_A 9 RKFTIDDFDIGRPLGKGKFGNVYLAREK----QNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFH 84 (284)
T ss_dssp -CCCGGGEEEEEEEEECSSEEEEEEEET----TTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred cchhhhhceeeheecCCCCeEEEEEEEc----CCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEE
Confidence 4566789999999999999999999976 478899999998776555555677889999999999999999999999
Q ss_pred cCCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCc
Q 012762 157 CPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSL 236 (457)
Q Consensus 157 ~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~ 236 (457)
..+..|+||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.
T Consensus 85 ~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~ 162 (284)
T 2vgo_A 85 DRKRIYLMLEFAPRGELYKELQKH--GRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSV 162 (284)
T ss_dssp CSSEEEEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred cCCEEEEEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccc
Confidence 999999999999999999888775 569999999999999999999999999999999999999999999999999875
Q ss_pred CCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccc
Q 012762 237 KGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSM 316 (457)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (457)
...... ..
T Consensus 163 ~~~~~~------------------------------------------------------------------------~~ 170 (284)
T 2vgo_A 163 HAPSLR------------------------------------------------------------------------RR 170 (284)
T ss_dssp ECSSSC------------------------------------------------------------------------BC
T ss_pred cCcccc------------------------------------------------------------------------cc
Confidence 432110 01
Q ss_pred cccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhh
Q 012762 317 SFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLV 396 (457)
Q Consensus 317 ~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~ 396 (457)
...|++.|+|||++.+..++.++|||||||++|+|++|..||...........+......++. .++.++.++|.+||.
T Consensus 171 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~l~ 248 (284)
T 2vgo_A 171 TMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPP--FLSDGSKDLISKLLR 248 (284)
T ss_dssp CCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCT--TSCHHHHHHHHHHSC
T ss_pred cccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccCCCC--cCCHHHHHHHHHHhh
Confidence 235899999999999999999999999999999999999999988877777777766655553 488999999999999
Q ss_pred hCCCCCCCCCcChHHHhcCCCCCCCCchhhhccCCCCCCC
Q 012762 397 KDPTRRMGSKMGATAIKRHQFFNGVNWALLRCAKPPFIPR 436 (457)
Q Consensus 397 ~dP~~Rps~~~~~~~ll~hp~f~~~~~~~~~~~~~~~~~~ 436 (457)
.||.+||+ +.++++||||+... +...||..+.
T Consensus 249 ~~p~~Rps----~~~ll~h~~~~~~~----~~~~p~~~~~ 280 (284)
T 2vgo_A 249 YHPPQRLP----LKGVMEHPWVKANS----RRVLPPVYQS 280 (284)
T ss_dssp SSGGGSCC----HHHHHTCHHHHHHC----CCCCCCCC--
T ss_pred cCHhhCCC----HHHHhhCHHHHhhc----cccCCCcccc
Confidence 99999999 99999999998432 2334554443
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-51 Score=400.01 Aligned_cols=261 Identities=23% Similarity=0.392 Sum_probs=217.4
Q ss_pred CCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCc
Q 012762 81 LSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRW 160 (457)
Q Consensus 81 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~ 160 (457)
.++|++++.||+|+||+||+|.++ .+++.||+|++..... ......+.+|+++++.++||||+++++++..++.
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~----~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 79 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNR----VTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGNI 79 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEET----TTCCEEEEEEEECC---------CHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhhceeeeEEecCCCEEEEEEEEC----CCCcEEEEEEEEcccc--cchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCe
Confidence 478999999999999999999886 4788999999965432 1233567789999999999999999999999999
Q ss_pred EEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCC
Q 012762 161 SCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDN 240 (457)
Q Consensus 161 ~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~ 240 (457)
.|+|||||++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 157 (323)
T 3tki_A 80 QYLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRY 157 (323)
T ss_dssp EEEEEECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEE
T ss_pred EEEEEEcCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceecc
Confidence 99999999999998887654 5799999999999999999999999999999999999999999999999999864421
Q ss_pred CCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccC
Q 012762 241 STSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVG 320 (457)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 320 (457)
.... ......+|
T Consensus 158 ~~~~--------------------------------------------------------------------~~~~~~~g 169 (323)
T 3tki_A 158 NNRE--------------------------------------------------------------------RLLNKMCG 169 (323)
T ss_dssp TTEE--------------------------------------------------------------------CCBCSCCS
T ss_pred CCcc--------------------------------------------------------------------cccCCCcc
Confidence 1100 01113469
Q ss_pred CCCccCchhhcCCCC-CccchhhhhhHHHHHHhcCCCCCCCCChH-HHHHHHHhcccCCCCCCCCChHHHHHHHHHhhhC
Q 012762 321 THEYLAPEIISGEGH-GNAVDWWTLGIFIFELFYGTTPFKGIDHE-LTLANVVARALEFPKEPSVPGPAKDLIAQLLVKD 398 (457)
Q Consensus 321 t~~y~aPE~l~~~~~-~~~sDiwSlG~il~elltG~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~d 398 (457)
|+.|+|||++.+..+ +.++|||||||++|+|++|+.||...... .............+....++..+.+||.+||..|
T Consensus 170 t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 249 (323)
T 3tki_A 170 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVEN 249 (323)
T ss_dssp CGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSS
T ss_pred CcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHHHHHHHHHHccCC
Confidence 999999999988775 78999999999999999999999876554 3334444444444444568899999999999999
Q ss_pred CCCCCCCCcChHHHhcCCCCCCC
Q 012762 399 PTRRMGSKMGATAIKRHQFFNGV 421 (457)
Q Consensus 399 P~~Rps~~~~~~~ll~hp~f~~~ 421 (457)
|++||+ +.|+++||||+..
T Consensus 250 P~~R~t----~~eil~h~~~~~~ 268 (323)
T 3tki_A 250 PSARIT----IPDIKKDRWYNKP 268 (323)
T ss_dssp TTTSCC----HHHHTTCTTTTCC
T ss_pred hhhCcC----HHHHhhChhhccc
Confidence 999999 9999999999864
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-50 Score=390.95 Aligned_cols=263 Identities=25% Similarity=0.356 Sum_probs=213.5
Q ss_pred ccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhh--hhHHHHHHHHHHHHHHc---CCCCCceEEE
Q 012762 79 LTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVS--RNKESRARIEREILEML---DHPFLPTLYA 153 (457)
Q Consensus 79 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~--~~~~~~~~~E~~il~~l---~H~nIv~l~~ 153 (457)
+..++|+++++||+|+||+||+|+++ .+++.||+|++....... ......+.+|+++++.+ +||||+++++
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~ 81 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDP----HSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMD 81 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECT----TTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEEC----CCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeee
Confidence 44578999999999999999999876 478999999997532111 11123455677777666 5999999999
Q ss_pred EEEcCC-----cEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEE
Q 012762 154 TLDCPR-----WSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIM 228 (457)
Q Consensus 154 ~~~~~~-----~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vk 228 (457)
++.... ..++||||+. ++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.++.+|
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~k 160 (308)
T 3g33_A 82 VCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVK 160 (308)
T ss_dssp EEEECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEE
T ss_pred eeeccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEE
Confidence 997765 5799999995 6999999887666699999999999999999999999999999999999999999999
Q ss_pred EeccCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccc
Q 012762 229 LTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVA 308 (457)
Q Consensus 229 l~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (457)
|+|||+++.......
T Consensus 161 l~Dfg~a~~~~~~~~----------------------------------------------------------------- 175 (308)
T 3g33_A 161 LADFGLARIYSYQMA----------------------------------------------------------------- 175 (308)
T ss_dssp ECSCSCTTTSTTCCC-----------------------------------------------------------------
T ss_pred EeeCccccccCCCcc-----------------------------------------------------------------
Confidence 999999865432111
Q ss_pred cCCccccccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCC---------
Q 012762 309 EPLDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPK--------- 379 (457)
Q Consensus 309 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~--------- 379 (457)
....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+......+..+.......+.
T Consensus 176 ------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 249 (308)
T 3g33_A 176 ------LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSL 249 (308)
T ss_dssp ------SGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSCSSCSS
T ss_pred ------cCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccchhhc
Confidence 11346999999999999999999999999999999999999999998887777776653222111
Q ss_pred ----------------CCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCCC
Q 012762 380 ----------------EPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGV 421 (457)
Q Consensus 380 ----------------~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~~ 421 (457)
.+.+++++.+||.+||+.||++||| +.|+|+||||+..
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t----~~e~l~h~~~~~~ 303 (308)
T 3g33_A 250 PRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRIS----AFRALQHSYLHKD 303 (308)
T ss_dssp CGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCC----HHHHHTSTTC---
T ss_pred cccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCC----HHHHhcCccccCC
Confidence 1246788999999999999999999 9999999999863
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-50 Score=413.62 Aligned_cols=293 Identities=24% Similarity=0.296 Sum_probs=204.3
Q ss_pred CCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEc---
Q 012762 81 LSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDC--- 157 (457)
Q Consensus 81 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~--- 157 (457)
.++|++++.||+|+||+||+|+++ .+++.||||++.+. ........++.+|+++|+.++||||+++++++..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~----~~~~~vaiK~i~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 126 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDK----LEKRVVAIKKILRV-FEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDV 126 (458)
T ss_dssp CTTEEECCC-------CEEEEEEC----C--CEEEEEEECST-TSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCT
T ss_pred CCCeEEeeEeeecCCeEEEEEEEC----CCCcEEEEEEechh-hcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCc
Confidence 368999999999999999999987 47889999999653 2233455778889999999999999999999943
Q ss_pred --CCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCC
Q 012762 158 --PRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235 (457)
Q Consensus 158 --~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s 235 (457)
...+||||||+ +++|..++... ..+++..++.++.||+.||.|||++|||||||||+||||+.++.+||+|||++
T Consensus 127 ~~~~~~~lv~e~~-~~~L~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla 203 (458)
T 3rp9_A 127 EKFDELYVVLEIA-DSDFKKLFRTP--VYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLA 203 (458)
T ss_dssp TTCCCEEEEECCC-SEEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred ccCceEEEEEecc-ccchhhhcccC--CCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccc
Confidence 35789999998 78998888764 67999999999999999999999999999999999999999999999999999
Q ss_pred cCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcccc
Q 012762 236 LKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRS 315 (457)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (457)
+............... . ... ...+.+++ .........
T Consensus 204 ~~~~~~~~~~~~~~~~--------~------------------------------~~~-~~~~~~~~----~~~~~~~~~ 240 (458)
T 3rp9_A 204 RTVDYPENGNSQLPIS--------P------------------------------RED-DMNLVTFP----HTKNLKRQL 240 (458)
T ss_dssp BCTTSCTTCCCCCC------------------------------------------------------------------
T ss_pred hhccCccccccccccC--------c------------------------------ccc-cccccccc----ccccccccc
Confidence 7664322111000000 0 000 00000000 000011223
Q ss_pred ccccCCCCccCchhh-cCCCCCccchhhhhhHHHHHHhc-----------CCCCCCCCCh--------------------
Q 012762 316 MSFVGTHEYLAPEII-SGEGHGNAVDWWTLGIFIFELFY-----------GTTPFKGIDH-------------------- 363 (457)
Q Consensus 316 ~~~~gt~~y~aPE~l-~~~~~~~~sDiwSlG~il~ellt-----------G~~Pf~~~~~-------------------- 363 (457)
...+||+.|+|||++ .+..|+.++|||||||+||||++ |+++|.+...
T Consensus 241 ~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~ 320 (458)
T 3rp9_A 241 TGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGN 320 (458)
T ss_dssp ----CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGGGCCCSCC--------------------CHHH
T ss_pred cCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccccccccccCCCCccccccccccccccccccccCC
Confidence 356899999999987 45669999999999999999998 7777766431
Q ss_pred HHHHHHHHhccc--------------------CCC---------CCCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhc
Q 012762 364 ELTLANVVARAL--------------------EFP---------KEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKR 414 (457)
Q Consensus 364 ~~~~~~~~~~~~--------------------~~~---------~~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~ 414 (457)
...+..+..... .++ ..+.++.++.+||.+||..||++||| ++|+|+
T Consensus 321 ~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t----~~e~L~ 396 (458)
T 3rp9_A 321 RDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRIT----INECLA 396 (458)
T ss_dssp HHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCC----HHHHHH
T ss_pred HHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCCCHHHHHHHHHHhccCccccCC----HHHHhc
Confidence 111222211100 000 12346889999999999999999999 999999
Q ss_pred CCCCCCCCchhhhc
Q 012762 415 HQFFNGVNWALLRC 428 (457)
Q Consensus 415 hp~f~~~~~~~~~~ 428 (457)
||||+.++|.....
T Consensus 397 Hp~f~~~~~~~~e~ 410 (458)
T 3rp9_A 397 HPFFKEVRIAEVET 410 (458)
T ss_dssp SGGGTTTCCGGGCC
T ss_pred CHhhhhcCCCccCC
Confidence 99999999976643
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-50 Score=390.00 Aligned_cols=260 Identities=23% Similarity=0.354 Sum_probs=213.2
Q ss_pred CCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCc
Q 012762 81 LSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRW 160 (457)
Q Consensus 81 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~ 160 (457)
+++|++++.||+|+||+||+|++. +++.||+|++..... .......+.+|+++|+.++||||+++++++...+.
T Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 74 (288)
T 1ob3_A 1 MEKYHGLEKIGEGTYGVVYKAQNN-----YGETFALKKIRLEKE-DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKR 74 (288)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEET-----TSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSC
T ss_pred CccchhhhhcccCCCEEEEEEEcC-----CCCEEEEEEEecccc-ccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCe
Confidence 368999999999999999999873 688999999965432 22234567789999999999999999999999999
Q ss_pred EEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCC
Q 012762 161 SCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDN 240 (457)
Q Consensus 161 ~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~ 240 (457)
.|+||||++ ++|..++... .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 75 ~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 152 (288)
T 1ob3_A 75 LVLVFEHLD-QDLKKLLDVC-EGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGI 152 (288)
T ss_dssp EEEEEECCS-EEHHHHHHTS-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC
T ss_pred EEEEEEecC-CCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCc
Confidence 999999995 5898888764 36799999999999999999999999999999999999999999999999999754321
Q ss_pred CCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccC
Q 012762 241 STSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVG 320 (457)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 320 (457)
... ......|
T Consensus 153 ~~~----------------------------------------------------------------------~~~~~~~ 162 (288)
T 1ob3_A 153 PVR----------------------------------------------------------------------KYTHEIV 162 (288)
T ss_dssp -------------------------------------------------------------------------------C
T ss_pred ccc----------------------------------------------------------------------ccccccc
Confidence 100 0112358
Q ss_pred CCCccCchhhcCC-CCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCC---------------------
Q 012762 321 THEYLAPEIISGE-GHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFP--------------------- 378 (457)
Q Consensus 321 t~~y~aPE~l~~~-~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~--------------------- 378 (457)
|+.|+|||++.+. .++.++|||||||++|||++|..||.+......+..+.......+
T Consensus 163 t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (288)
T 1ob3_A 163 TLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYE 242 (288)
T ss_dssp CCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCC
T ss_pred cccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccccccccccccc
Confidence 9999999999875 489999999999999999999999999887766666554211100
Q ss_pred ------CCCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCCCC
Q 012762 379 ------KEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGVN 422 (457)
Q Consensus 379 ------~~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~~~ 422 (457)
....++.++.+||.+||+.||++||+ +.|+++||||+..+
T Consensus 243 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt----~~e~l~hp~f~~~n 288 (288)
T 1ob3_A 243 PLPWESFLKGLDESGIDLLSKMLKLDPNQRIT----AKQALEHAYFKENN 288 (288)
T ss_dssp CCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCC----HHHHHTSGGGGC--
T ss_pred CccHHHHhhhcCHHHHHHHHHHcCCCcccCCC----HHHHhcCcchhhcC
Confidence 01246788999999999999999999 99999999998653
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-50 Score=399.91 Aligned_cols=258 Identities=28% Similarity=0.418 Sum_probs=209.2
Q ss_pred cCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCC
Q 012762 80 TLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPR 159 (457)
Q Consensus 80 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~ 159 (457)
..++|++.+.||+|+||+||+|+++ .+++.||||++.... ....+.+|+++|++++||||+++++++...+
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~----~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 121 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQK----GTQKPYALKVLKKTV-----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPT 121 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEET----TTCCEEEEEEEEC---------------CHHHHHCCCTTBCCEEEEEECSS
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEEC----CCCcEEEEEEeccch-----hHHHHHHHHHHHHhCCCCCCcceeeeEecCC
Confidence 3467999999999999999999986 378899999997542 3456778999999999999999999999999
Q ss_pred cEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEcc---CCCEEEeccCCCc
Q 012762 160 WSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRS---DGHIMLTDFDLSL 236 (457)
Q Consensus 160 ~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~---~~~vkl~DFG~s~ 236 (457)
..|+||||+++++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++
T Consensus 122 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~ 199 (349)
T 2w4o_A 122 EISLVLELVTGGELFDRIVEK--GYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSK 199 (349)
T ss_dssp EEEEEECCCCSCBHHHHHTTC--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC---
T ss_pred eEEEEEEeCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCcccc
Confidence 999999999999999888764 66999999999999999999999999999999999999975 7899999999986
Q ss_pred CCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccc
Q 012762 237 KGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSM 316 (457)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (457)
....... ..
T Consensus 200 ~~~~~~~-----------------------------------------------------------------------~~ 208 (349)
T 2w4o_A 200 IVEHQVL-----------------------------------------------------------------------MK 208 (349)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred ccCcccc-----------------------------------------------------------------------cc
Confidence 4431100 11
Q ss_pred cccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHH-HHHHHHhcccCCCC--CCCCChHHHHHHHH
Q 012762 317 SFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHEL-TLANVVARALEFPK--EPSVPGPAKDLIAQ 393 (457)
Q Consensus 317 ~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~-~~~~~~~~~~~~~~--~~~~~~~~~~ll~~ 393 (457)
..+||+.|+|||++.+..++.++|||||||++|||++|..||.+..... .+..+......++. ...++.++.+||.+
T Consensus 209 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~ 288 (349)
T 2w4o_A 209 TVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVRK 288 (349)
T ss_dssp ----CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHT
T ss_pred cccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCHHHHHHHHH
Confidence 2469999999999999999999999999999999999999998766544 55556655544432 35688999999999
Q ss_pred HhhhCCCCCCCCCcChHHHhcCCCCCCCCc
Q 012762 394 LLVKDPTRRMGSKMGATAIKRHQFFNGVNW 423 (457)
Q Consensus 394 ~L~~dP~~Rps~~~~~~~ll~hp~f~~~~~ 423 (457)
||..||++||+ +.|+++||||++..+
T Consensus 289 ~L~~dP~~Rpt----~~e~l~hp~~~~~~~ 314 (349)
T 2w4o_A 289 LIVLDPKKRLT----TFQALQHPWVTGKAA 314 (349)
T ss_dssp TSCSSGGGSCC----HHHHHHSTTTTSTTC
T ss_pred HccCChhhCcC----HHHHhcCcccCCCcc
Confidence 99999999999 999999999997654
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=383.06 Aligned_cols=265 Identities=26% Similarity=0.445 Sum_probs=230.2
Q ss_pred CCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCc
Q 012762 81 LSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRW 160 (457)
Q Consensus 81 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~ 160 (457)
.++|++.+.||+|+||+||+|.++ .+++.||+|++..... .......+.+|++++++++||||+++++++...+.
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~----~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 79 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHK----TTGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQEESF 79 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEET----TTCCEEEEEEEEGGGC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEc----CCCceEEEEEeecccC-CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCE
Confidence 368999999999999999999987 4788999999976643 23345677889999999999999999999999999
Q ss_pred EEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCC---EEEeccCCCcC
Q 012762 161 SCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGH---IMLTDFDLSLK 237 (457)
Q Consensus 161 ~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~---vkl~DFG~s~~ 237 (457)
.|+||||+++++|...+... ..+++..+..++.||+.||.|||++||+||||||+|||++.++. +||+|||++..
T Consensus 80 ~~~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~ 157 (284)
T 3kk8_A 80 HYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE 157 (284)
T ss_dssp EEEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred EEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEE
Confidence 99999999999998877765 66999999999999999999999999999999999999986655 99999999854
Q ss_pred CCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcccccc
Q 012762 238 GDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMS 317 (457)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (457)
...... ...
T Consensus 158 ~~~~~~-----------------------------------------------------------------------~~~ 166 (284)
T 3kk8_A 158 VNDSEA-----------------------------------------------------------------------WHG 166 (284)
T ss_dssp CCSSCB-----------------------------------------------------------------------CCC
T ss_pred cccCcc-----------------------------------------------------------------------ccC
Confidence 432111 112
Q ss_pred ccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCC--CCCChHHHHHHHHHh
Q 012762 318 FVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKE--PSVPGPAKDLIAQLL 395 (457)
Q Consensus 318 ~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ll~~~L 395 (457)
..||+.|+|||++.+..++.++|||||||++|+|++|..||.+.........+.......+.. ..+++++.+||.+||
T Consensus 167 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 246 (284)
T 3kk8_A 167 FAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSML 246 (284)
T ss_dssp SCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHS
T ss_pred CCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHHHHHHHHHHc
Confidence 469999999999999999999999999999999999999999988888888877776665543 468899999999999
Q ss_pred hhCCCCCCCCCcChHHHhcCCCCCCCCchhhh
Q 012762 396 VKDPTRRMGSKMGATAIKRHQFFNGVNWALLR 427 (457)
Q Consensus 396 ~~dP~~Rps~~~~~~~ll~hp~f~~~~~~~~~ 427 (457)
+.||++||+ +.|+++||||+..++....
T Consensus 247 ~~dp~~Rps----~~~~l~h~~~~~~~~~~~~ 274 (284)
T 3kk8_A 247 TVNPKKRIT----ADQALKVPWICNRERVASA 274 (284)
T ss_dssp CSSTTTSCC----HHHHTTSHHHHSCCCGGGS
T ss_pred ccChhhCCC----HHHHhcCccccCChhHHhH
Confidence 999999999 9999999999987776543
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-51 Score=412.40 Aligned_cols=255 Identities=27% Similarity=0.387 Sum_probs=208.3
Q ss_pred ccCCCceeE-EEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHH-cCCCCCceEEEEEE
Q 012762 79 LTLSDLRFV-HRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEM-LDHPFLPTLYATLD 156 (457)
Q Consensus 79 ~~~~~~~~~-~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~-l~H~nIv~l~~~~~ 156 (457)
...++|.+. +.||+|+||+||+|.++ .+++.||||++... ..+.+|++++.+ ++||||+++++++.
T Consensus 58 ~~~~~y~~~~~~LG~G~~g~V~~~~~~----~~~~~vAiK~~~~~--------~~~~~E~~~~~~~~~hp~iv~l~~~~~ 125 (400)
T 1nxk_A 58 AIIDDYKVTSQVLGLGINGKVLQIFNK----RTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYE 125 (400)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEET----TTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred cccccceeccceeeeccCeEEEEEEEC----CCCCEEEEEEeCcc--------hhHHHHHHHHHHhcCCCCcceEeEEEe
Confidence 345678887 78999999999999986 47899999999642 245668888744 58999999999987
Q ss_pred c----CCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEcc---CCCEEE
Q 012762 157 C----PRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRS---DGHIML 229 (457)
Q Consensus 157 ~----~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~---~~~vkl 229 (457)
. .+++|||||||+||+|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||
T Consensus 126 ~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl 205 (400)
T 1nxk_A 126 NLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKL 205 (400)
T ss_dssp EEETTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEE
T ss_pred ecccCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEE
Confidence 5 567899999999999999998765567999999999999999999999999999999999999997 789999
Q ss_pred eccCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCccccc
Q 012762 230 TDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAE 309 (457)
Q Consensus 230 ~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (457)
+|||+++......
T Consensus 206 ~DFG~a~~~~~~~------------------------------------------------------------------- 218 (400)
T 1nxk_A 206 TDFGFAKETTSHN------------------------------------------------------------------- 218 (400)
T ss_dssp CCCTTCEECC----------------------------------------------------------------------
T ss_pred EecccccccCCCC-------------------------------------------------------------------
Confidence 9999986443110
Q ss_pred CCccccccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHH----HHHHHHhcccCCCC--CCCC
Q 012762 310 PLDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHEL----TLANVVARALEFPK--EPSV 383 (457)
Q Consensus 310 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~----~~~~~~~~~~~~~~--~~~~ 383 (457)
...+.+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+..... ....+..+.+.++. ...+
T Consensus 219 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 294 (400)
T 1nxk_A 219 ----SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 294 (400)
T ss_dssp ------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTTTTTTS
T ss_pred ----ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCcccccC
Confidence 0113469999999999999999999999999999999999999998754322 44555555555543 3568
Q ss_pred ChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCC
Q 012762 384 PGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNG 420 (457)
Q Consensus 384 ~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~ 420 (457)
+.++.+||.+||..||++||+ +.||++||||..
T Consensus 295 s~~~~~li~~~L~~dP~~Rpt----~~eil~hp~~~~ 327 (400)
T 1nxk_A 295 SEEVKMLIRNLLKTEPTQRMT----ITEFMNHPWIMQ 327 (400)
T ss_dssp CHHHHHHHHTTSCSSGGGSCC----HHHHHHSHHHHT
T ss_pred CHHHHHHHHHHCCCChhHCcC----HHHHhcCccccC
Confidence 999999999999999999999 999999999975
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-50 Score=395.90 Aligned_cols=264 Identities=24% Similarity=0.364 Sum_probs=205.0
Q ss_pred CCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCc
Q 012762 81 LSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRW 160 (457)
Q Consensus 81 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~ 160 (457)
.++|+++++||+|+||+||+|.++ .+|+.||+|++.... .......+.+|+++|+.++||||+++++++..++.
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~----~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 77 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNK----TTGVYVALKEVKLDS--EEGTPSTAIREISLMKELKHENIVRLYDVIHTENK 77 (317)
T ss_dssp ---------------CEEEEEECS----SSCCEEEEEEEECCS--TTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTE
T ss_pred ccceeEeeEECCCCCEEEEEEEEC----CCCcEEEEEEeeccc--ccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCe
Confidence 468999999999999999999876 478999999997543 22234567789999999999999999999999999
Q ss_pred EEEEEeecCCCChHHHHHhCC----CCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCc
Q 012762 161 SCLLTEFCPGGDLHVLRQRQP----DKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSL 236 (457)
Q Consensus 161 ~~lV~E~~~~~sL~~~~~~~~----~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~ 236 (457)
.|+||||++ ++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++
T Consensus 78 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~ 156 (317)
T 2pmi_A 78 LTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLAR 156 (317)
T ss_dssp EEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCE
T ss_pred EEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccce
Confidence 999999996 69988876532 2458999999999999999999999999999999999999999999999999986
Q ss_pred CCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccc
Q 012762 237 KGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSM 316 (457)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (457)
....... ...
T Consensus 157 ~~~~~~~----------------------------------------------------------------------~~~ 166 (317)
T 2pmi_A 157 AFGIPVN----------------------------------------------------------------------TFS 166 (317)
T ss_dssp ETTSCCC----------------------------------------------------------------------CCC
T ss_pred ecCCCcc----------------------------------------------------------------------cCC
Confidence 5431110 001
Q ss_pred cccCCCCccCchhhcCC-CCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCC-----------------
Q 012762 317 SFVGTHEYLAPEIISGE-GHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFP----------------- 378 (457)
Q Consensus 317 ~~~gt~~y~aPE~l~~~-~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~----------------- 378 (457)
..+||+.|+|||++.+. .++.++|||||||++|||++|+.||.+......+..+.......+
T Consensus 167 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (317)
T 2pmi_A 167 SEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNI 246 (317)
T ss_dssp CCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTTCCTTC
T ss_pred CCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhhhccccc
Confidence 23589999999999874 589999999999999999999999999887776666654221110
Q ss_pred ---------------CCCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCCCCchh
Q 012762 379 ---------------KEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGVNWAL 425 (457)
Q Consensus 379 ---------------~~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~~~~~~ 425 (457)
....++.++.+||.+||+.||++||+ +.|+|+||||+...|..
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt----~~e~l~hp~f~~~~~~~ 304 (317)
T 2pmi_A 247 QQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLS----AKQALHHPWFAEYYHHA 304 (317)
T ss_dssp CCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCC----HHHHTTSGGGGGGCC--
T ss_pred ccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCC----HHHHhCChhhhcccchh
Confidence 01246788999999999999999999 99999999999877753
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-50 Score=393.61 Aligned_cols=265 Identities=28% Similarity=0.427 Sum_probs=229.6
Q ss_pred CCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhh---hHHHHHHHHHHHHHHcCCCCCceEEEEEEc
Q 012762 81 LSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSR---NKESRARIEREILEMLDHPFLPTLYATLDC 157 (457)
Q Consensus 81 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~---~~~~~~~~E~~il~~l~H~nIv~l~~~~~~ 157 (457)
.++|++.+.||+|+||+||+|+++ .+|+.||+|++.+...... .....+.+|+++|+.++||||+++++++..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 86 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREK----STGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYEN 86 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEET----TTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hccEEEeeEeeecCCEEEEEEEEC----CCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEec
Confidence 357999999999999999999986 4788999999976533221 135678889999999999999999999999
Q ss_pred CCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCC----CEEEeccC
Q 012762 158 PRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDG----HIMLTDFD 233 (457)
Q Consensus 158 ~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~----~vkl~DFG 233 (457)
.+..|+||||+++++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++ .+||+|||
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg 164 (321)
T 2a2a_A 87 RTDVVLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (321)
T ss_dssp SSEEEEEECCCCSCBHHHHHHTC--SCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred CCEEEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCc
Confidence 99999999999999999998764 6799999999999999999999999999999999999999887 79999999
Q ss_pred CCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcc
Q 012762 234 LSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDV 313 (457)
Q Consensus 234 ~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (457)
++........
T Consensus 165 ~~~~~~~~~~---------------------------------------------------------------------- 174 (321)
T 2a2a_A 165 LAHEIEDGVE---------------------------------------------------------------------- 174 (321)
T ss_dssp TCEECCTTCC----------------------------------------------------------------------
T ss_pred cceecCcccc----------------------------------------------------------------------
Confidence 9865432110
Q ss_pred ccccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCC--CCCChHHHHHH
Q 012762 314 RSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKE--PSVPGPAKDLI 391 (457)
Q Consensus 314 ~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ll 391 (457)
.....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.........+......++.. ..++..+.+||
T Consensus 175 -~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li 253 (321)
T 2a2a_A 175 -FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSELAKDFI 253 (321)
T ss_dssp -CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTCCHHHHHHH
T ss_pred -ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhcccCHHHHHHH
Confidence 012359999999999999999999999999999999999999999988887777777665554421 45788999999
Q ss_pred HHHhhhCCCCCCCCCcChHHHhcCCCCCCCCchhh
Q 012762 392 AQLLVKDPTRRMGSKMGATAIKRHQFFNGVNWALL 426 (457)
Q Consensus 392 ~~~L~~dP~~Rps~~~~~~~ll~hp~f~~~~~~~~ 426 (457)
.+||..||++||+ +.|+++||||+.++|...
T Consensus 254 ~~~l~~dp~~Rps----~~e~l~hp~~~~~~~~~~ 284 (321)
T 2a2a_A 254 RKLLVKETRKRLT----IQEALRHPWITPVDNQQA 284 (321)
T ss_dssp HTTSCSSTTTSCC----HHHHHHSTTTSCSSHHHH
T ss_pred HHHcCCChhhCcC----HHHHhcCccccCCCcccc
Confidence 9999999999999 999999999999988654
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-50 Score=400.77 Aligned_cols=257 Identities=25% Similarity=0.430 Sum_probs=212.3
Q ss_pred ccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcC
Q 012762 79 LTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCP 158 (457)
Q Consensus 79 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~ 158 (457)
...++|+++++||+|+||+||+|+++ .+++.||||++.+... ....+.+|+.+++.++||||+++++++...
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~~----~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 88 (361)
T 3uc3_A 17 HDSDRYDFVKDIGSGNFGVARLMRDK----LTKELVAVKYIERGAA----IDENVQREIINHRSLRHPNIVRFKEVILTP 88 (361)
T ss_dssp CCTTTEEEEEEESSSTTSSEEEEEET----TTCCEEEEEEEESSTT----SCHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEEC----CCCcEEEEEEEecCcc----ccHHHHHHHHHHHhCCCCCCCcEEEEEeeC
Confidence 34578999999999999999999987 4788999999976432 234577899999999999999999999999
Q ss_pred CcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCC--EEEeccCCCc
Q 012762 159 RWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGH--IMLTDFDLSL 236 (457)
Q Consensus 159 ~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~--vkl~DFG~s~ 236 (457)
+.+|+||||+++++|..++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++
T Consensus 89 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~ 166 (361)
T 3uc3_A 89 THLAIIMEYASGGELYERICNA--GRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSK 166 (361)
T ss_dssp SEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC-
T ss_pred CEEEEEEEeCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccc
Confidence 9999999999999999888764 57999999999999999999999999999999999999987765 9999999975
Q ss_pred CCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccc
Q 012762 237 KGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSM 316 (457)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (457)
...... ...
T Consensus 167 ~~~~~~-----------------------------------------------------------------------~~~ 175 (361)
T 3uc3_A 167 SSVLHS-----------------------------------------------------------------------QPK 175 (361)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred cccccC-----------------------------------------------------------------------CCC
Confidence 322110 011
Q ss_pred cccCCCCccCchhhcCCCCCcc-chhhhhhHHHHHHhcCCCCCCCCCh----HHHHHHHHhcccCCCCCCCCChHHHHHH
Q 012762 317 SFVGTHEYLAPEIISGEGHGNA-VDWWTLGIFIFELFYGTTPFKGIDH----ELTLANVVARALEFPKEPSVPGPAKDLI 391 (457)
Q Consensus 317 ~~~gt~~y~aPE~l~~~~~~~~-sDiwSlG~il~elltG~~Pf~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~ll 391 (457)
..+||+.|+|||++.+..+..+ +|||||||++|+|++|+.||.+... ...+..+......++....++.++++||
T Consensus 176 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li 255 (361)
T 3uc3_A 176 STVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCHLI 255 (361)
T ss_dssp -----CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCCHHHHHHH
T ss_pred CCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCCHHHHHHH
Confidence 3469999999999998887655 8999999999999999999987543 3445555666667777667899999999
Q ss_pred HHHhhhCCCCCCCCCcChHHHhcCCCCCC
Q 012762 392 AQLLVKDPTRRMGSKMGATAIKRHQFFNG 420 (457)
Q Consensus 392 ~~~L~~dP~~Rps~~~~~~~ll~hp~f~~ 420 (457)
.+||+.||++||+ +.||++||||..
T Consensus 256 ~~~L~~dP~~Rps----~~ell~hp~f~~ 280 (361)
T 3uc3_A 256 SRIFVADPATRIS----IPEIKTHSWFLK 280 (361)
T ss_dssp HHHSCSCTTTSCC----HHHHHTSHHHHT
T ss_pred HHHccCChhHCcC----HHHHHhCcchhc
Confidence 9999999999999 999999999954
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-50 Score=398.72 Aligned_cols=263 Identities=21% Similarity=0.283 Sum_probs=212.9
Q ss_pred cCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCC
Q 012762 80 TLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPR 159 (457)
Q Consensus 80 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~ 159 (457)
..++|+++++||+|+||+||+|+++ .+++.||||++..... .......+.+|+++|+.++||||+++++++..++
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~----~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 106 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDT----VTNETVAIKRIRLEHE-EEGVPGTAIREVSLLKELQHRNIIELKSVIHHNH 106 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEET----TTTEEEEEEECCCCC---------CHHHHHHGGGCCCTTBCCEEEEEEETT
T ss_pred chhhEEEEEEEEecCCeEEEEEEEC----CCCceEEEEEEccccc-ccccchhHHHHHHHHHHcCCCCcceEEEEEecCC
Confidence 3568999999999999999999876 4789999999975432 2233455678999999999999999999999999
Q ss_pred cEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEc-----cCCCEEEeccCC
Q 012762 160 WSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVR-----SDGHIMLTDFDL 234 (457)
Q Consensus 160 ~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~-----~~~~vkl~DFG~ 234 (457)
..||||||++ ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+
T Consensus 107 ~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~ 183 (329)
T 3gbz_A 107 RLHLIFEYAE-NDLKKYMDKN--PDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGL 183 (329)
T ss_dssp EEEEEEECCS-EEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTH
T ss_pred EEEEEEecCC-CCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCC
Confidence 9999999996 5999988875 5699999999999999999999999999999999999995 445599999999
Q ss_pred CcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccc
Q 012762 235 SLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVR 314 (457)
Q Consensus 235 s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (457)
++....... .
T Consensus 184 a~~~~~~~~----------------------------------------------------------------------~ 193 (329)
T 3gbz_A 184 ARAFGIPIR----------------------------------------------------------------------Q 193 (329)
T ss_dssp HHHHC---------------------------------------------------------------------------
T ss_pred ccccCCccc----------------------------------------------------------------------c
Confidence 864421110 0
Q ss_pred cccccCCCCccCchhhcCCC-CCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCC-------------
Q 012762 315 SMSFVGTHEYLAPEIISGEG-HGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKE------------- 380 (457)
Q Consensus 315 ~~~~~gt~~y~aPE~l~~~~-~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~------------- 380 (457)
....+||+.|+|||++.+.. ++.++|||||||++|||++|..||.+......+..+.......+..
T Consensus 194 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (329)
T 3gbz_A 194 FTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQ 273 (329)
T ss_dssp ------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred cCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhhhhhhh
Confidence 11235899999999998754 8999999999999999999999999988777776665532211110
Q ss_pred ---------------CCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCCCCch
Q 012762 381 ---------------PSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGVNWA 424 (457)
Q Consensus 381 ---------------~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~~~~~ 424 (457)
..+++++.+||.+||+.||++||+ +.|+|+||||++.+|.
T Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t----~~e~l~hp~f~~~~~~ 328 (329)
T 3gbz_A 274 SFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRIS----AKNALEHPYFSHNDFD 328 (329)
T ss_dssp TCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCC----HHHHHTSGGGSSSCSC
T ss_pred hhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCC----HHHHhCCcccCCCCCC
Confidence 015688999999999999999999 9999999999999995
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-50 Score=402.04 Aligned_cols=279 Identities=24% Similarity=0.364 Sum_probs=209.8
Q ss_pred CCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcC-CCCCceEEEEEEcCC
Q 012762 81 LSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLD-HPFLPTLYATLDCPR 159 (457)
Q Consensus 81 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~-H~nIv~l~~~~~~~~ 159 (457)
.++|++++.||+|+||+||+|.++ .+|+.||||++.+.. .......++.+|+.+|+.+. ||||+++++++...+
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~----~~~~~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~ 82 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDR----RTGEVVAVKKIFDAF-QNSTDAQRTFREIMILTELSGHENIVNLLNVLRADN 82 (388)
T ss_dssp HTTEEEEEC-------CEEEEEET----TTCCEEEEEEECC---CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTT
T ss_pred cCceEEEEEeeeCCCeEEEEEEEC----CCCCEEEEEEecccc-cChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCC
Confidence 468999999999999999999987 478999999986542 23345566778999999997 999999999997544
Q ss_pred --cEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcC
Q 012762 160 --WSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLK 237 (457)
Q Consensus 160 --~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~ 237 (457)
.+|||||||+ ++|..++.. ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.
T Consensus 83 ~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 158 (388)
T 3oz6_A 83 DRDVYLVFDYME-TDLHAVIRA---NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRS 158 (388)
T ss_dssp SSCEEEEEECCS-EEHHHHHHH---TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred CCEEEEEecccC-cCHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCccccc
Confidence 7899999995 689888876 5699999999999999999999999999999999999999999999999999876
Q ss_pred CCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcccccc
Q 012762 238 GDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMS 317 (457)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (457)
.............. .................
T Consensus 159 ~~~~~~~~~~~~~~-------------------------------------------------~~~~~~~~~~~~~~~~~ 189 (388)
T 3oz6_A 159 FVNIRRVTNNIPLS-------------------------------------------------INENTENFDDDQPILTD 189 (388)
T ss_dssp SSSCCCCCCCGGGC-------------------------------------------------CC---------------
T ss_pred cccccccccccccc-------------------------------------------------ccccccccccccccccC
Confidence 54321110000000 00000000001112234
Q ss_pred ccCCCCccCchhhcC-CCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCC-----------------
Q 012762 318 FVGTHEYLAPEIISG-EGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPK----------------- 379 (457)
Q Consensus 318 ~~gt~~y~aPE~l~~-~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~----------------- 379 (457)
++||+.|+|||++.+ ..|+.++|||||||++|||++|++||.+.+....+..++... ..|.
T Consensus 190 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~-~~p~~~~~~~~~~~~~~~~~~ 268 (388)
T 3oz6_A 190 YVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVI-DFPSNEDVESIQSPFAKTMIE 268 (388)
T ss_dssp CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH-CCCCHHHHHTSCCSSHHHHHH
T ss_pred CcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc-CCCCHHHHHhccCHHHHHHHH
Confidence 689999999999987 568999999999999999999999999988777766665321 1111
Q ss_pred -----------------------------CCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCCCC
Q 012762 380 -----------------------------EPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGVN 422 (457)
Q Consensus 380 -----------------------------~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~~~ 422 (457)
...+++++.+||.+||..||++||| ++|+|+||||+.+.
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t----~~e~l~Hp~~~~~~ 336 (388)
T 3oz6_A 269 SLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRIS----ANDALKHPFVSIFH 336 (388)
T ss_dssp HHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCC----HHHHTTSTTTTTTC
T ss_pred hCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCC----HHHHhCCHHHHHhc
Confidence 1257889999999999999999999 99999999998753
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-50 Score=402.31 Aligned_cols=260 Identities=29% Similarity=0.424 Sum_probs=225.0
Q ss_pred CCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCc
Q 012762 81 LSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRW 160 (457)
Q Consensus 81 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~ 160 (457)
.++|++++.||+|+||+||+|.++ .+++.||+|++..... .....+.+|+++|+.++||||+++++++.+.+.
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~----~~~~~~a~K~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~ 122 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEK----ATGRVFVAKFINTPYP---LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYE 122 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEET----TTCCEEEEEEEECCSH---HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSE
T ss_pred ccceEEEEEEecCCCEEEEEEEEC----CCCCEEEEEEecccch---hhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCE
Confidence 468999999999999999999986 4788999999975422 234567889999999999999999999999999
Q ss_pred EEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEcc--CCCEEEeccCCCcCC
Q 012762 161 SCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRS--DGHIMLTDFDLSLKG 238 (457)
Q Consensus 161 ~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~--~~~vkl~DFG~s~~~ 238 (457)
+||||||+.|++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++..
T Consensus 123 ~~lv~E~~~gg~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~ 201 (387)
T 1kob_A 123 MVLILEFLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKL 201 (387)
T ss_dssp EEEEEECCCCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEEC
T ss_pred EEEEEEcCCCCcHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceec
Confidence 99999999999999887653 356999999999999999999999999999999999999974 478999999998654
Q ss_pred CCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccc
Q 012762 239 DNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSF 318 (457)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (457)
..... ....
T Consensus 202 ~~~~~-----------------------------------------------------------------------~~~~ 210 (387)
T 1kob_A 202 NPDEI-----------------------------------------------------------------------VKVT 210 (387)
T ss_dssp CTTSC-----------------------------------------------------------------------EEEE
T ss_pred CCCcc-----------------------------------------------------------------------eeee
Confidence 32111 1123
Q ss_pred cCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCC--CCCCChHHHHHHHHHhh
Q 012762 319 VGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPK--EPSVPGPAKDLIAQLLV 396 (457)
Q Consensus 319 ~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ll~~~L~ 396 (457)
.||+.|+|||++.+..++.++|||||||++|||++|..||.+......+..+....+.++. ...++.++.+||.+||.
T Consensus 211 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~ 290 (387)
T 1kob_A 211 TATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQ 290 (387)
T ss_dssp CSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSC
T ss_pred ccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHHHHHHHHHHcC
Confidence 6999999999999999999999999999999999999999998887777777776655443 34688999999999999
Q ss_pred hCCCCCCCCCcChHHHhcCCCCCCCCc
Q 012762 397 KDPTRRMGSKMGATAIKRHQFFNGVNW 423 (457)
Q Consensus 397 ~dP~~Rps~~~~~~~ll~hp~f~~~~~ 423 (457)
.||++||+ +.|+|+||||++..+
T Consensus 291 ~dP~~Rpt----~~ell~hp~~~~~~~ 313 (387)
T 1kob_A 291 KEPRKRLT----VHDALEHPWLKGDHS 313 (387)
T ss_dssp SSGGGSCC----HHHHHTSTTTSSCCT
T ss_pred CChhHCcC----HHHHhhCccccCCcc
Confidence 99999999 999999999997544
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-49 Score=392.83 Aligned_cols=260 Identities=25% Similarity=0.441 Sum_probs=228.4
Q ss_pred cCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCC
Q 012762 80 TLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPR 159 (457)
Q Consensus 80 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~ 159 (457)
..++|++.+.||+|+||+||+|.+. .+++.||+|++.+...........+.+|+++++.++|+||+++++++.+.+
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~----~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 114 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDA----DTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDND 114 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEET----TTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred cCCceEEEEEEeeCCCeEEEEEEEC----CCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence 3468999999999999999999986 478899999998765545556677888999999999999999999999999
Q ss_pred cEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCC
Q 012762 160 WSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGD 239 (457)
Q Consensus 160 ~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~ 239 (457)
..|+||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 115 ~~~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 192 (335)
T 2owb_A 115 FVFVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 192 (335)
T ss_dssp EEEEEECCCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred eEEEEEecCCCCCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecc
Confidence 999999999999999988765 679999999999999999999999999999999999999999999999999986543
Q ss_pred CCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcccccccc
Q 012762 240 NSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFV 319 (457)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (457)
.... ......
T Consensus 193 ~~~~----------------------------------------------------------------------~~~~~~ 202 (335)
T 2owb_A 193 YDGE----------------------------------------------------------------------RKKVLC 202 (335)
T ss_dssp STTC----------------------------------------------------------------------CBCCCC
T ss_pred cCcc----------------------------------------------------------------------cccccC
Confidence 1110 011246
Q ss_pred CCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhhhCC
Q 012762 320 GTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDP 399 (457)
Q Consensus 320 gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP 399 (457)
||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+......++. .++..+.+||.+||..||
T Consensus 203 gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~l~~dp 280 (335)
T 2owb_A 203 GTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPK--HINPVAASLIQKMLQTDP 280 (335)
T ss_dssp SCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCT--TSCHHHHHHHHHHTCSSG
T ss_pred CCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCCCc--cCCHHHHHHHHHHccCCh
Confidence 999999999999999999999999999999999999999988877777777766665554 488999999999999999
Q ss_pred CCCCCCCcChHHHhcCCCCCCC
Q 012762 400 TRRMGSKMGATAIKRHQFFNGV 421 (457)
Q Consensus 400 ~~Rps~~~~~~~ll~hp~f~~~ 421 (457)
++||+ +.|+++||||...
T Consensus 281 ~~Rps----~~ell~~~~~~~~ 298 (335)
T 2owb_A 281 TARPT----INELLNDEFFTSG 298 (335)
T ss_dssp GGSCC----GGGGGGSHHHHTS
T ss_pred hHCcC----HHHHhcCccccCC
Confidence 99999 9999999999863
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-50 Score=397.42 Aligned_cols=262 Identities=26% Similarity=0.405 Sum_probs=220.7
Q ss_pred CCCCCCCccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcC-----CC
Q 012762 72 NNNNNNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLD-----HP 146 (457)
Q Consensus 72 ~~~~~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~-----H~ 146 (457)
.....+.+..++|+++++||+|+||+||+|++. .+++.||||++.... .....+..|+++|+.+. ||
T Consensus 25 ~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~----~~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~h~ 96 (360)
T 3llt_A 25 FSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHI----DNKKYYAVKVVRNIK----KYTRSAKIEADILKKIQNDDINNN 96 (360)
T ss_dssp CCCCTTCEETTTEEEEEEEEECSSEEEEEEEET----TTCCEEEEEEECSCH----HHHHHHHHHHHHHHHTCCCSTTGG
T ss_pred eeeecceEecCEEEEEEEEcccCCeEEEEEEEC----CCCeEEEEEEeccch----hhhhhhHHHHHHHHHhcccCCCCC
Confidence 344556667789999999999999999999986 478899999996432 33455677999999986 99
Q ss_pred CCceEEEEEEcCCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEcc---
Q 012762 147 FLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRS--- 223 (457)
Q Consensus 147 nIv~l~~~~~~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~--- 223 (457)
||+++++++...+..||||||+ +++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 97 ~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~ 175 (360)
T 3llt_A 97 NIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYF 175 (360)
T ss_dssp GBCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTC
T ss_pred CeecccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccc
Confidence 9999999999999999999999 999999998876677999999999999999999999999999999999999975
Q ss_pred ----------------------CCCEEEeccCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCC
Q 012762 224 ----------------------DGHIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCI 281 (457)
Q Consensus 224 ----------------------~~~vkl~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (457)
++.+||+|||++......
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~---------------------------------------- 215 (360)
T 3llt_A 176 EKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY---------------------------------------- 215 (360)
T ss_dssp CEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC----------------------------------------
T ss_pred cccccchhcccccccccccccCCCCEEEEeccCceecCCC----------------------------------------
Confidence 789999999998543211
Q ss_pred CCcccccCcchhccccCCCCCCCcccccCCccccccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCC
Q 012762 282 VPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGI 361 (457)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~ 361 (457)
....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.
T Consensus 216 ---------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 262 (360)
T 3llt_A 216 ---------------------------------HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTH 262 (360)
T ss_dssp ---------------------------------CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ---------------------------------CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCC
Confidence 01246999999999999999999999999999999999999999988
Q ss_pred ChHHHHHHHHhcccCCCC--------------------------C------------------CCCChHHHHHHHHHhhh
Q 012762 362 DHELTLANVVARALEFPK--------------------------E------------------PSVPGPAKDLIAQLLVK 397 (457)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~--------------------------~------------------~~~~~~~~~ll~~~L~~ 397 (457)
.....+..+.......+. . ...++.+.+||.+||+.
T Consensus 263 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 342 (360)
T 3llt_A 263 EHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQI 342 (360)
T ss_dssp SHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCS
T ss_pred cHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcC
Confidence 776666655543322221 0 01135678999999999
Q ss_pred CCCCCCCCCcChHHHhcCCCCC
Q 012762 398 DPTRRMGSKMGATAIKRHQFFN 419 (457)
Q Consensus 398 dP~~Rps~~~~~~~ll~hp~f~ 419 (457)
||++||+ +.|+|+||||+
T Consensus 343 dP~~Rpt----a~elL~hp~f~ 360 (360)
T 3llt_A 343 DPTLRPS----PAELLKHKFLE 360 (360)
T ss_dssp SGGGSCC----HHHHTTSGGGC
T ss_pred ChhhCCC----HHHHhcCcccC
Confidence 9999999 99999999996
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-50 Score=395.88 Aligned_cols=266 Identities=28% Similarity=0.410 Sum_probs=226.9
Q ss_pred CCceeE-EEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHc-CCCCCceEEEEEEcCC
Q 012762 82 SDLRFV-HRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEML-DHPFLPTLYATLDCPR 159 (457)
Q Consensus 82 ~~~~~~-~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~~~~~~~~ 159 (457)
++|.+. +.||+|+||+||+|.++ .+++.||+|++.+.... ......+.+|+++++.+ +||||+++++++...+
T Consensus 28 ~~y~~~~~~lG~G~~g~V~~~~~~----~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~ 102 (327)
T 3lm5_A 28 NFYILTSKELGRGKFAVVRQCISK----STGQEYAAKFLKKRRRG-QDCRAEILHEIAVLELAKSCPRVINLHEVYENTS 102 (327)
T ss_dssp HHEEEEEEEEEEETTEEEEEEEET----TTCCEEEEEEEESEETT-EECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred hEEeeccceeCCCCCeEEEEEEEC----CCCCEEEEEEEehhhcc-hHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCC
Confidence 457777 89999999999999986 47899999999765432 23456778899999999 5699999999999999
Q ss_pred cEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEcc---CCCEEEeccCCCc
Q 012762 160 WSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRS---DGHIMLTDFDLSL 236 (457)
Q Consensus 160 ~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~---~~~vkl~DFG~s~ 236 (457)
..|+||||+.+++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++
T Consensus 103 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~ 182 (327)
T 3lm5_A 103 EIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSR 182 (327)
T ss_dssp EEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCE
T ss_pred eEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCcccc
Confidence 9999999999999998886655678999999999999999999999999999999999999987 7899999999986
Q ss_pred CCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccc
Q 012762 237 KGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSM 316 (457)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (457)
....... ..
T Consensus 183 ~~~~~~~-----------------------------------------------------------------------~~ 191 (327)
T 3lm5_A 183 KIGHACE-----------------------------------------------------------------------LR 191 (327)
T ss_dssp EC------------------------------------------------------------------------------
T ss_pred ccCCccc-----------------------------------------------------------------------cc
Confidence 5432110 11
Q ss_pred cccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCC--CCCCChHHHHHHHHH
Q 012762 317 SFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPK--EPSVPGPAKDLIAQL 394 (457)
Q Consensus 317 ~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ll~~~ 394 (457)
...||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.........+.......+. ...++..+.+||.+|
T Consensus 192 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~ 271 (327)
T 3lm5_A 192 EIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLATDFIQSL 271 (327)
T ss_dssp --CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHH
T ss_pred cccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhhcccCHHHHHHHHHH
Confidence 246999999999999999999999999999999999999999998888777777766555443 346889999999999
Q ss_pred hhhCCCCCCCCCcChHHHhcCCCCCCCCchhhh
Q 012762 395 LVKDPTRRMGSKMGATAIKRHQFFNGVNWALLR 427 (457)
Q Consensus 395 L~~dP~~Rps~~~~~~~ll~hp~f~~~~~~~~~ 427 (457)
|..||++||+ ++++|+||||+..+|..+.
T Consensus 272 L~~dP~~Rpt----~~~ll~h~~~~~~~~~~~~ 300 (327)
T 3lm5_A 272 LVKNPEKRPT----AEICLSHSWLQQWDFENLF 300 (327)
T ss_dssp SCSSGGGSCC----HHHHTTCGGGCCCCTTCC-
T ss_pred cCCChhhCcC----HHHHhCCHhhccccccccc
Confidence 9999999999 9999999999999997653
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-50 Score=389.50 Aligned_cols=263 Identities=26% Similarity=0.377 Sum_probs=215.6
Q ss_pred CCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCc
Q 012762 81 LSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRW 160 (457)
Q Consensus 81 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~ 160 (457)
.++|+++++||+|+||+||+|.++ .+|+.||+|++..... .......+.+|++++++++||||+++++++...+.
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~----~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 76 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNR----DTGQIVAIKKFLESED-DPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRR 76 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEET----TTCCEEEEEEECCCCC--HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred cccceEeeEEeecCCeEEEEEEeC----CCCcEEEEEEeecccc-chHHHHHHHHHHHHHHhCCCCCccchhheeecCCe
Confidence 468999999999999999999986 4788999999865432 23345667789999999999999999999999999
Q ss_pred EEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCC
Q 012762 161 SCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDN 240 (457)
Q Consensus 161 ~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~ 240 (457)
.|+||||+++++|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 77 ~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 154 (311)
T 4agu_A 77 LHLVFEYCDHTVLHELDRYQ--RGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTG 154 (311)
T ss_dssp EEEEEECCSEEHHHHHHHTS--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred EEEEEEeCCCchHHHHHhhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccC
Confidence 99999999999998887764 6699999999999999999999999999999999999999999999999999865432
Q ss_pred CCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccC
Q 012762 241 STSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVG 320 (457)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 320 (457)
.... ....+|
T Consensus 155 ~~~~----------------------------------------------------------------------~~~~~~ 164 (311)
T 4agu_A 155 PSDY----------------------------------------------------------------------YDDEVA 164 (311)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred cccc----------------------------------------------------------------------cCCCcC
Confidence 1110 012358
Q ss_pred CCCccCchhhcC-CCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhccc-------------------CCCC-
Q 012762 321 THEYLAPEIISG-EGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARAL-------------------EFPK- 379 (457)
Q Consensus 321 t~~y~aPE~l~~-~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~-------------------~~~~- 379 (457)
|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+..... ..+.
T Consensus 165 ~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (311)
T 4agu_A 165 TRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDP 244 (311)
T ss_dssp -GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCCCCCC
T ss_pred CccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccCcCCCc
Confidence 999999999987 5689999999999999999999999998877665554443211 1111
Q ss_pred ---------CCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCCCCch
Q 012762 380 ---------EPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGVNWA 424 (457)
Q Consensus 380 ---------~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~~~~~ 424 (457)
.+.++.++.+||.+||..||++||+ ++|+++||||+++.|.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt----~~ell~hp~f~~~~~~ 294 (311)
T 4agu_A 245 EDMEPLELKFPNISYPALGLLKGCLHMDPTERLT----CEQLLHHPYFENIREI 294 (311)
T ss_dssp SSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCC----HHHHHTSGGGTTCC--
T ss_pred cccchhhhhcccccHHHHHHHHHHccCChhhcCC----HHHHhcChHHHhccCH
Confidence 1357788999999999999999999 9999999999998774
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-50 Score=399.15 Aligned_cols=257 Identities=29% Similarity=0.446 Sum_probs=217.4
Q ss_pred CCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHc-CCCCCceEEEEEEcCC
Q 012762 81 LSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEML-DHPFLPTLYATLDCPR 159 (457)
Q Consensus 81 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~~~~~~~~ 159 (457)
.++|++.+.||+|+||+||+|.++ .+++.||||++.+... ...+|+++|.++ +||||+++++++.+++
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~----~~~~~~avK~~~~~~~-------~~~~E~~~l~~~~~hp~iv~~~~~~~~~~ 89 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHK----ATNMEFAVKIIDKSKR-------DPTEEIEILLRYGQHPNIITLKDVYDDGK 89 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEET----TTTEEEEEEEEETTTC-------CCHHHHHHHHHHTTSTTBCCEEEEEECSS
T ss_pred cccEEEEEEEeeCCCEEEEEEEEC----CCCCEEEEEEEEcccC-------ChHHHHHHHHHhcCCCCcCeEEEEEEcCC
Confidence 357999999999999999999987 4789999999976532 134588888887 7999999999999999
Q ss_pred cEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccC----CCEEEeccCCC
Q 012762 160 WSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSD----GHIMLTDFDLS 235 (457)
Q Consensus 160 ~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~----~~vkl~DFG~s 235 (457)
.+|+|||||+||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||+..+ +.+||+|||++
T Consensus 90 ~~~lv~E~~~gg~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a 167 (342)
T 2qr7_A 90 YVYVVTELMKGGELLDKILRQ--KFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFA 167 (342)
T ss_dssp EEEEEECCCCSCBHHHHHHTC--TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTC
T ss_pred EEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCc
Confidence 999999999999999888765 679999999999999999999999999999999999998543 35999999998
Q ss_pred cCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcccc
Q 012762 236 LKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRS 315 (457)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (457)
+....... ..
T Consensus 168 ~~~~~~~~----------------------------------------------------------------------~~ 177 (342)
T 2qr7_A 168 KQLRAENG----------------------------------------------------------------------LL 177 (342)
T ss_dssp EECBCTTC----------------------------------------------------------------------CB
T ss_pred ccCcCCCC----------------------------------------------------------------------ce
Confidence 65432110 11
Q ss_pred ccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCC---ChHHHHHHHHhcccCCCC--CCCCChHHHHH
Q 012762 316 MSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGI---DHELTLANVVARALEFPK--EPSVPGPAKDL 390 (457)
Q Consensus 316 ~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~---~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l 390 (457)
.+.+||+.|+|||++.+..|+.++|||||||++|||++|..||.+. ...+.+..+..+.+.++. +..+++++++|
T Consensus 178 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 257 (342)
T 2qr7_A 178 MTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTAKDL 257 (342)
T ss_dssp CCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTTSCHHHHHH
T ss_pred eccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccccCCHHHHHH
Confidence 1346999999999999888999999999999999999999999863 345566666666665543 35689999999
Q ss_pred HHHHhhhCCCCCCCCCcChHHHhcCCCCCCCCchhh
Q 012762 391 IAQLLVKDPTRRMGSKMGATAIKRHQFFNGVNWALL 426 (457)
Q Consensus 391 l~~~L~~dP~~Rps~~~~~~~ll~hp~f~~~~~~~~ 426 (457)
|.+||..||++||+ +.++++||||. +|..+
T Consensus 258 i~~~L~~dP~~R~t----~~~il~hp~~~--~~~~~ 287 (342)
T 2qr7_A 258 VSKMLHVDPHQRLT----AALVLRHPWIV--HWDQL 287 (342)
T ss_dssp HHHHTCSSTTTSCC----HHHHTTSHHHH--TGGGS
T ss_pred HHHHCCCChhHCcC----HHHHhcCCeec--Ccccc
Confidence 99999999999999 99999999995 57554
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-50 Score=395.55 Aligned_cols=265 Identities=23% Similarity=0.326 Sum_probs=213.6
Q ss_pred CCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCc
Q 012762 81 LSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRW 160 (457)
Q Consensus 81 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~ 160 (457)
+++|+++++||+|+||+||+|.++ .+++.||+|++..... ......+.+|+++|+.++||||+++++++...+.
T Consensus 1 l~~y~~~~~lG~G~~g~V~~~~~~----~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 74 (324)
T 3mtl_A 1 METYIKLDKLGEGTYATVYKGKSK----LTDNLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKS 74 (324)
T ss_dssp CCSEEEEEEEEECSSEEEEEEEET----TTCCEEEEEEECC--------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSC
T ss_pred CCceEEEEEEcCCCCEEEEEEEEC----CCCcEEEEEEEecccc--cccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCE
Confidence 368999999999999999999986 4788999999965432 1111234469999999999999999999999999
Q ss_pred EEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCC
Q 012762 161 SCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDN 240 (457)
Q Consensus 161 ~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~ 240 (457)
.|+||||++ ++|..++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 75 ~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 152 (324)
T 3mtl_A 75 LTLVFEYLD-KDLKQYLDDC-GNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSI 152 (324)
T ss_dssp EEEEEECCS-EEHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC--
T ss_pred EEEEecccc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccC
Confidence 999999995 6888887764 35699999999999999999999999999999999999999999999999999864431
Q ss_pred CCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccC
Q 012762 241 STSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVG 320 (457)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 320 (457)
... .....+|
T Consensus 153 ~~~----------------------------------------------------------------------~~~~~~~ 162 (324)
T 3mtl_A 153 PTK----------------------------------------------------------------------TYDNEVV 162 (324)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred Ccc----------------------------------------------------------------------ccccccC
Confidence 110 0112358
Q ss_pred CCCccCchhhcC-CCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCC--------------------
Q 012762 321 THEYLAPEIISG-EGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPK-------------------- 379 (457)
Q Consensus 321 t~~y~aPE~l~~-~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~-------------------- 379 (457)
|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+....+....+.......+.
T Consensus 163 t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (324)
T 3mtl_A 163 TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYPKY 242 (324)
T ss_dssp CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTCCCCC
T ss_pred cccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhcccccccc
Confidence 999999999987 56899999999999999999999999998877766665543221111
Q ss_pred --------CCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCCCCchhhh
Q 012762 380 --------EPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGVNWALLR 427 (457)
Q Consensus 380 --------~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~~~~~~~~ 427 (457)
...++.++.+||.+||+.||++||+ +.|+|+||||..+.+...+
T Consensus 243 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t----~~e~l~hp~f~~~~~~~~~ 294 (324)
T 3mtl_A 243 RAEALLSHAPRLDSDGADLLTKLLQFEGRNRIS----AEDAMKHPFFLSLGERIHK 294 (324)
T ss_dssp CCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCC----HHHHTTSGGGGGGCSTTSS
T ss_pred cchhhhhhcCCCCHHHHHHHHHHcCcCcccCCC----HHHHhcChhhhhccccccc
Confidence 1246788999999999999999999 9999999999987665433
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-50 Score=382.93 Aligned_cols=261 Identities=28% Similarity=0.510 Sum_probs=201.0
Q ss_pred CCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCc
Q 012762 81 LSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRW 160 (457)
Q Consensus 81 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~ 160 (457)
.++|++.+.||+|+||+||+|++. .+++.||+|++.+...........+.+|+++++.++||||+++++++...+.
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 85 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESI----HTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNY 85 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET----TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSE
T ss_pred cccceeeeeecCCCceEEEEEEEc----cCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCe
Confidence 468999999999999999999876 4788999999987665555556778899999999999999999999999999
Q ss_pred EEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCC
Q 012762 161 SCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDN 240 (457)
Q Consensus 161 ~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~ 240 (457)
.|+||||+++++|..++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 164 (278)
T 3cok_A 86 VYLVLEMCHNGEMNRYLKNR-VKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKM 164 (278)
T ss_dssp EEEEEECCTTEEHHHHHHTC-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred EEEEEecCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence 99999999999999988764 35689999999999999999999999999999999999999999999999999765431
Q ss_pred CCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccC
Q 012762 241 STSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVG 320 (457)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 320 (457)
... ......|
T Consensus 165 ~~~----------------------------------------------------------------------~~~~~~~ 174 (278)
T 3cok_A 165 PHE----------------------------------------------------------------------KHYTLCG 174 (278)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred CCC----------------------------------------------------------------------cceeccC
Confidence 110 0112368
Q ss_pred CCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhhhCCC
Q 012762 321 THEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDPT 400 (457)
Q Consensus 321 t~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~ 400 (457)
|+.|+|||++.+..++.++|||||||++|+|++|+.||...........+.......+ ..++.++.+||.+||..||+
T Consensus 175 ~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~dp~ 252 (278)
T 3cok_A 175 TPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMP--SFLSIEAKDLIHQLLRRNPA 252 (278)
T ss_dssp -----------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSCCCCC--TTSCHHHHHHHHHHSCSSGG
T ss_pred CCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcccCCc--cccCHHHHHHHHHHcccCHh
Confidence 9999999999998899999999999999999999999988765555554444443333 34889999999999999999
Q ss_pred CCCCCCcChHHHhcCCCCCCCC
Q 012762 401 RRMGSKMGATAIKRHQFFNGVN 422 (457)
Q Consensus 401 ~Rps~~~~~~~ll~hp~f~~~~ 422 (457)
+||+ +.++++||||....
T Consensus 253 ~Rps----~~~~l~h~~~~~~~ 270 (278)
T 3cok_A 253 DRLS----LSSVLDHPFMSRNS 270 (278)
T ss_dssp GSCC----HHHHTTSTTTC---
T ss_pred hCCC----HHHHhcCccccCCC
Confidence 9999 99999999998643
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-49 Score=382.09 Aligned_cols=260 Identities=25% Similarity=0.441 Sum_probs=227.7
Q ss_pred cCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCC
Q 012762 80 TLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPR 159 (457)
Q Consensus 80 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~ 159 (457)
..++|++.+.||+|+||+||+|.++ .+++.||+|++.+...........+.+|+++++.++|+||+++++++...+
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~----~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 88 (294)
T 2rku_A 13 SRRRYVRGRFLGKGGFAKCFEISDA----DTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDND 88 (294)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEET----TTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred cccceEEEEEEeecCCEEEEEEEEC----CCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCC
Confidence 4468999999999999999999986 478899999998765545556677888999999999999999999999999
Q ss_pred cEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCC
Q 012762 160 WSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGD 239 (457)
Q Consensus 160 ~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~ 239 (457)
..|+||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 89 ~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 166 (294)
T 2rku_A 89 FVFVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 166 (294)
T ss_dssp EEEEEEECCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecc
Confidence 999999999999999988775 579999999999999999999999999999999999999999999999999976543
Q ss_pred CCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcccccccc
Q 012762 240 NSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFV 319 (457)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (457)
.... ......
T Consensus 167 ~~~~----------------------------------------------------------------------~~~~~~ 176 (294)
T 2rku_A 167 YDGE----------------------------------------------------------------------RKKVLC 176 (294)
T ss_dssp STTC----------------------------------------------------------------------CBCCCC
T ss_pred cCcc----------------------------------------------------------------------cccccc
Confidence 1100 011235
Q ss_pred CCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhhhCC
Q 012762 320 GTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDP 399 (457)
Q Consensus 320 gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP 399 (457)
||+.|+|||++.+..++.++|||||||++|+|++|+.||......+....+.......+. .++..+.++|.+||..||
T Consensus 177 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~l~~~p 254 (294)
T 2rku_A 177 GTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPK--HINPVAASLIQKMLQTDP 254 (294)
T ss_dssp SCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCT--TSCHHHHHHHHHHTCSSG
T ss_pred CCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCCCcc--ccCHHHHHHHHHHcccCh
Confidence 899999999999988999999999999999999999999988877777777666555554 588999999999999999
Q ss_pred CCCCCCCcChHHHhcCCCCCCC
Q 012762 400 TRRMGSKMGATAIKRHQFFNGV 421 (457)
Q Consensus 400 ~~Rps~~~~~~~ll~hp~f~~~ 421 (457)
++||+ +.|+++||||...
T Consensus 255 ~~Rps----~~~ll~~~~~~~~ 272 (294)
T 2rku_A 255 TARPT----INELLNDEFFTSG 272 (294)
T ss_dssp GGSCC----GGGGGGSHHHHTS
T ss_pred hhCcC----HHHHhhChheecC
Confidence 99999 9999999999853
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-50 Score=395.74 Aligned_cols=269 Identities=26% Similarity=0.435 Sum_probs=223.6
Q ss_pred CCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhh--hhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCC
Q 012762 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELV--SRNKESRARIEREILEMLDHPFLPTLYATLDCPR 159 (457)
Q Consensus 82 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~ 159 (457)
++|++.+.||+|+||+||+|.++ .+++.||+|++.+.... .......+.+|+++|+.++||||+++++++.+.+
T Consensus 26 ~~y~~~~~lG~G~~g~V~~~~~~----~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 101 (345)
T 3hko_A 26 KKYHLKGAIGQGSYGVVRVAIEN----QTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQ 101 (345)
T ss_dssp HHEEEEEEEEECSSCEEEEEEET----TTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hheeecceeeecCCeEEEEEEEC----CCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCC
Confidence 47999999999999999999876 47889999999876542 2345677888999999999999999999999999
Q ss_pred cEEEEEeecCCCChHHHHHhC--------------------------------------CCCCCCHHHHHHHHHHHHHHH
Q 012762 160 WSCLLTEFCPGGDLHVLRQRQ--------------------------------------PDKRFHESAVRFYASEVVVAL 201 (457)
Q Consensus 160 ~~~lV~E~~~~~sL~~~~~~~--------------------------------------~~~~~~~~~~~~i~~qi~~~L 201 (457)
..|+|||||+|++|.+++... ....+++..++.++.||+.||
T Consensus 102 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l 181 (345)
T 3hko_A 102 YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSAL 181 (345)
T ss_dssp EEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHH
T ss_pred eEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHH
Confidence 999999999999999887521 012246788899999999999
Q ss_pred HHHHHcCceeecCCCCCeEEccCC--CEEEeccCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCC
Q 012762 202 EFLHMMGIIYRDLKPENVLVRSDG--HIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPN 279 (457)
Q Consensus 202 ~yLH~~~iiHrDIKp~NIll~~~~--~vkl~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (457)
.|||++||+||||||+|||++.++ .+||+|||++..........
T Consensus 182 ~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~---------------------------------- 227 (345)
T 3hko_A 182 HYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGE---------------------------------- 227 (345)
T ss_dssp HHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC-----------------------------------
T ss_pred HHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccc----------------------------------
Confidence 999999999999999999998776 89999999986432111000
Q ss_pred CCCCcccccCcchhccccCCCCCCCcccccCCccccccccCCCCccCchhhcC--CCCCccchhhhhhHHHHHHhcCCCC
Q 012762 280 CIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTHEYLAPEIISG--EGHGNAVDWWTLGIFIFELFYGTTP 357 (457)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~sDiwSlG~il~elltG~~P 357 (457)
........||+.|+|||++.+ ..++.++|||||||++|||++|+.|
T Consensus 228 --------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~p 275 (345)
T 3hko_A 228 --------------------------------YYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVP 275 (345)
T ss_dssp ---------------------------------------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred --------------------------------cccccccCCCccccCchhhccCCCCCCcHHHHHHHHHHHHHHHHCCCC
Confidence 001113469999999999976 5689999999999999999999999
Q ss_pred CCCCChHHHHHHHHhcccCCCCC--CCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCCCCch
Q 012762 358 FKGIDHELTLANVVARALEFPKE--PSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGVNWA 424 (457)
Q Consensus 358 f~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~~~~~ 424 (457)
|.+....+....++.....++.. ..++.++.+||.+||..||.+||+ +.++++||||+.+.|.
T Consensus 276 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps----~~~~l~hp~~~~~~~~ 340 (345)
T 3hko_A 276 FPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFD----AMRALQHPWISQFSDK 340 (345)
T ss_dssp SCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCC----HHHHHHSHHHHTTSSC
T ss_pred CCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCC----HHHHhcChhhccChHh
Confidence 99988888888888776655543 347899999999999999999999 9999999999987764
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-49 Score=378.93 Aligned_cols=262 Identities=25% Similarity=0.451 Sum_probs=221.4
Q ss_pred CCCccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEE
Q 012762 76 NNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATL 155 (457)
Q Consensus 76 ~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~ 155 (457)
...+..++|++.+.||+|+||.||+|.++ .+++.||||++.............+.+|+++++.++||||+++++++
T Consensus 5 ~g~~~~~~y~i~~~lg~G~~g~V~~~~~~----~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 80 (276)
T 2h6d_A 5 DGRVKIGHYVLGDTLGVGTFGKVKIGEHQ----LTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVI 80 (276)
T ss_dssp --CCEETTEEEEEEEEECSSEEEEEEEET----TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred cCcceeccEEEEeeecCCCCeEEEEEEEC----CCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEE
Confidence 34567789999999999999999999986 37889999999877655555667888999999999999999999999
Q ss_pred EcCCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCC
Q 012762 156 DCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235 (457)
Q Consensus 156 ~~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s 235 (457)
...+..|+||||+++++|.+++... ..+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++
T Consensus 81 ~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~ 158 (276)
T 2h6d_A 81 STPTDFFMVMEYVSGGELFDYICKH--GRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLS 158 (276)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGG
T ss_pred ecCCeEEEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccc
Confidence 9999999999999999999998775 56999999999999999999999999999999999999999999999999997
Q ss_pred cCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcccc
Q 012762 236 LKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRS 315 (457)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (457)
........ .
T Consensus 159 ~~~~~~~~-----------------------------------------------------------------------~ 167 (276)
T 2h6d_A 159 NMMSDGEF-----------------------------------------------------------------------L 167 (276)
T ss_dssp GCCCC---------------------------------------------------------------------------
T ss_pred cccCCCcc-----------------------------------------------------------------------e
Confidence 65432110 0
Q ss_pred ccccCCCCccCchhhcCCCC-CccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHH
Q 012762 316 MSFVGTHEYLAPEIISGEGH-GNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQL 394 (457)
Q Consensus 316 ~~~~gt~~y~aPE~l~~~~~-~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~ 394 (457)
....||+.|+|||++.+..+ +.++||||||+++|+|++|..||...........+.......+. .++..+.++|.+|
T Consensus 168 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~~ 245 (276)
T 2h6d_A 168 RTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPE--YLNRSVATLLMHM 245 (276)
T ss_dssp ---------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT--TSCHHHHHHHHHH
T ss_pred ecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccCch--hcCHHHHHHHHHH
Confidence 12358999999999988775 68999999999999999999999988777777776666555543 4889999999999
Q ss_pred hhhCCCCCCCCCcChHHHhcCCCCCC
Q 012762 395 LVKDPTRRMGSKMGATAIKRHQFFNG 420 (457)
Q Consensus 395 L~~dP~~Rps~~~~~~~ll~hp~f~~ 420 (457)
|+.||.+||+ +.++++||||+.
T Consensus 246 l~~~p~~Rps----~~~~l~h~~~~~ 267 (276)
T 2h6d_A 246 LQVDPLKRAT----IKDIREHEWFKQ 267 (276)
T ss_dssp TCSSGGGSCC----HHHHHHSHHHHT
T ss_pred ccCChhhCCC----HHHHHhChhhcc
Confidence 9999999999 999999999975
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-49 Score=393.03 Aligned_cols=266 Identities=18% Similarity=0.267 Sum_probs=221.5
Q ss_pred CCCCccCCCceeEEEecccCcceEEEEEEeccC---CCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHc-CCCCCce
Q 012762 75 NNNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKS---SNNGCFFAAKVMDKRELVSRNKESRARIEREILEML-DHPFLPT 150 (457)
Q Consensus 75 ~~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~---~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~ 150 (457)
..+.+..++|++.+.||+|+||+||+|++...+ ...+..||||+++... .......+.+|+++|+++ +||||++
T Consensus 74 ~~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~ 151 (370)
T 2psq_A 74 PKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIIN 151 (370)
T ss_dssp TTTBCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC--BHHHHHHHHHHHHHHHHSCCCTTBCC
T ss_pred ccccccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc--CHHHHHHHHHHHHHHHHhcCCCCEee
Confidence 345677889999999999999999999976422 2456789999997642 334456788899999999 8999999
Q ss_pred EEEEEEcCCcEEEEEeecCCCChHHHHHhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCC
Q 012762 151 LYATLDCPRWSCLLTEFCPGGDLHVLRQRQP--------------DKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKP 216 (457)
Q Consensus 151 l~~~~~~~~~~~lV~E~~~~~sL~~~~~~~~--------------~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp 216 (457)
+++++...+.+|+||||+++|+|.+++.... ...+++..++.++.||+.||.|||++||+||||||
T Consensus 152 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp 231 (370)
T 2psq_A 152 LLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAA 231 (370)
T ss_dssp EEEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCG
T ss_pred EEEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccch
Confidence 9999999999999999999999999988753 23589999999999999999999999999999999
Q ss_pred CCeEEccCCCEEEeccCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccc
Q 012762 217 ENVLVRSDGHIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKK 296 (457)
Q Consensus 217 ~NIll~~~~~vkl~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (457)
+||||+.++.+||+|||+++.........
T Consensus 232 ~NIll~~~~~~kl~DFG~a~~~~~~~~~~--------------------------------------------------- 260 (370)
T 2psq_A 232 RNVLVTENNVMKIADFGLARDINNIDYYK--------------------------------------------------- 260 (370)
T ss_dssp GGEEECTTCCEEECCCSSCEETTCCCTTC---------------------------------------------------
T ss_pred hhEEECCCCCEEEccccCCcccCccccee---------------------------------------------------
Confidence 99999999999999999986543211100
Q ss_pred cCCCCCCCcccccCCccccccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHHhccc
Q 012762 297 KLGNPGTPEIVAEPLDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVVARAL 375 (457)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~ 375 (457)
......||+.|+|||++.+..++.++|||||||++|||++ |..||.+....+....+... .
T Consensus 261 -----------------~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~~~~~~-~ 322 (370)
T 2psq_A 261 -----------------KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEG-H 322 (370)
T ss_dssp -----------------TTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT-C
T ss_pred -----------------cccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC-C
Confidence 0012247889999999999999999999999999999999 99999987776666554433 3
Q ss_pred CCCCCCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcC
Q 012762 376 EFPKEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRH 415 (457)
Q Consensus 376 ~~~~~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~h 415 (457)
.......++.++.+||.+||..||++||+ +.|++++
T Consensus 323 ~~~~~~~~~~~l~~li~~~l~~dP~~Rpt----~~ell~~ 358 (370)
T 2psq_A 323 RMDKPANCTNELYMMMRDCWHAVPSQRPT----FKQLVED 358 (370)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHcCCChhhCcC----HHHHHHH
Confidence 44445568999999999999999999999 8888764
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-49 Score=386.86 Aligned_cols=256 Identities=27% Similarity=0.431 Sum_probs=219.6
Q ss_pred CceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcEE
Q 012762 83 DLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWSC 162 (457)
Q Consensus 83 ~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~ 162 (457)
.|...++||+|+||+||+|+++ .+|+.||||++.... ......+.+|+++++.++||||+++++++...+..|
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~----~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 118 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREK----HSGRQVAVKMMDLRK---QQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELW 118 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEET----TTCCEEEEEEEETTT---CCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred hhhccEEeccCCCeEEEEEEEC----CCCcEEEEEEEeccc---hhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEE
Confidence 4888899999999999999976 478999999997543 234566788999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCCC
Q 012762 163 LLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNST 242 (457)
Q Consensus 163 lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~~ 242 (457)
+||||+++++|.+++.. ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus 119 lv~e~~~~~~L~~~l~~---~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 195 (321)
T 2c30_A 119 VLMEFLQGGALTDIVSQ---VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV 195 (321)
T ss_dssp EEECCCCSCBHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS
T ss_pred EEEecCCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCc
Confidence 99999999999998865 569999999999999999999999999999999999999999999999999976543211
Q ss_pred cccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCCC
Q 012762 243 STAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTH 322 (457)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 322 (457)
. ......||+
T Consensus 196 ~----------------------------------------------------------------------~~~~~~gt~ 205 (321)
T 2c30_A 196 P----------------------------------------------------------------------KRKSLVGTP 205 (321)
T ss_dssp C----------------------------------------------------------------------CBCCCCSCG
T ss_pred c----------------------------------------------------------------------ccccccCCc
Confidence 0 011346999
Q ss_pred CccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccC-CCCCCCCChHHHHHHHHHhhhCCCC
Q 012762 323 EYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALE-FPKEPSVPGPAKDLIAQLLVKDPTR 401 (457)
Q Consensus 323 ~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ll~~~L~~dP~~ 401 (457)
.|+|||++.+..++.++|||||||++|||++|+.||.+.........+...... ......++..+.++|.+||..||++
T Consensus 206 ~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~ 285 (321)
T 2c30_A 206 YWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERMLVRDPQE 285 (321)
T ss_dssp GGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCTTGGGSCHHHHHHHHHHSCSSTTT
T ss_pred cccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcCccccCCHHHHHHHHHHccCChhh
Confidence 999999999999999999999999999999999999987776666665544322 2223357889999999999999999
Q ss_pred CCCCCcChHHHhcCCCCCCCC
Q 012762 402 RMGSKMGATAIKRHQFFNGVN 422 (457)
Q Consensus 402 Rps~~~~~~~ll~hp~f~~~~ 422 (457)
||+ +.++++||||....
T Consensus 286 Rps----~~ell~hp~~~~~~ 302 (321)
T 2c30_A 286 RAT----AQELLDHPFLLQTG 302 (321)
T ss_dssp SCC----HHHHHTSGGGGGCC
T ss_pred CcC----HHHHhcChhhccCC
Confidence 999 99999999998643
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-49 Score=402.51 Aligned_cols=288 Identities=24% Similarity=0.300 Sum_probs=212.9
Q ss_pred cCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcC-
Q 012762 80 TLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCP- 158 (457)
Q Consensus 80 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~- 158 (457)
..++|++++.||+|+||+||+|+++ .+++.||||++.+. ........++.+|+++|+.++|+||+++++++...
T Consensus 24 i~~~y~~~~~lG~G~~g~V~~a~~~----~~~~~vAiK~~~~~-~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 98 (432)
T 3n9x_A 24 VPDNYIIKHLIGRGSYGYVYLAYDK----NTEKNVAIKKVNRM-FEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDD 98 (432)
T ss_dssp CCTTEEEEEEEEEETTEEEEEEEET----TTTEEEEEEEECST-TTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSC
T ss_pred ecCCEEEEEEEeecCCEEEEEEEEC----CCCcEEEEEEeCch-hcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCC
Confidence 3468999999999999999999987 47899999999753 22334557788899999999999999999999766
Q ss_pred ----CcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCC
Q 012762 159 ----RWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDL 234 (457)
Q Consensus 159 ----~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~ 234 (457)
+.+||||||+ +++|..++... ..+++..++.++.||+.||.|||+.||+||||||+||||+.++.+||+|||+
T Consensus 99 ~~~~~~~~lv~e~~-~~~L~~~~~~~--~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGl 175 (432)
T 3n9x_A 99 LLKFDELYIVLEIA-DSDLKKLFKTP--IFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGL 175 (432)
T ss_dssp TTTCCCEEEEEECC-SEEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred CCcCCeEEEEEecC-CcCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCC
Confidence 5789999999 56999888764 6799999999999999999999999999999999999999999999999999
Q ss_pred CcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccc
Q 012762 235 SLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVR 314 (457)
Q Consensus 235 s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (457)
++............... ...............
T Consensus 176 a~~~~~~~~~~~~~~~~------------------------------------------------~~~~~~~~~~~~~~~ 207 (432)
T 3n9x_A 176 ARTINSEKDTNIVNDLE------------------------------------------------ENEEPGPHNKNLKKQ 207 (432)
T ss_dssp CEEC----------------------------------------------------------------------------
T ss_pred ccccccccccccccccc------------------------------------------------ccccccccccchhcc
Confidence 87664322111000000 000000000000112
Q ss_pred cccccCCCCccCchhh-cCCCCCccchhhhhhHHHHHHhcC-----------CCCCCCCCh-----------------HH
Q 012762 315 SMSFVGTHEYLAPEII-SGEGHGNAVDWWTLGIFIFELFYG-----------TTPFKGIDH-----------------EL 365 (457)
Q Consensus 315 ~~~~~gt~~y~aPE~l-~~~~~~~~sDiwSlG~il~elltG-----------~~Pf~~~~~-----------------~~ 365 (457)
....+||+.|+|||++ .+..|+.++|||||||++|||++| .++|.+... ..
T Consensus 208 ~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ 287 (432)
T 3n9x_A 208 LTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRD 287 (432)
T ss_dssp ---CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCCSCCCSCSCC----------CHHHHHH
T ss_pred ccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccccccccCCCccccccCcccccccccccchHH
Confidence 3356899999999996 455699999999999999999984 444444320 11
Q ss_pred HHHHHHhccc------------------------CCCC-----CCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCC
Q 012762 366 TLANVVARAL------------------------EFPK-----EPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQ 416 (457)
Q Consensus 366 ~~~~~~~~~~------------------------~~~~-----~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp 416 (457)
.+..++.... ..+. .+.+++++.+||.+||..||++||+ ++|+|+||
T Consensus 288 ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t----a~e~L~Hp 363 (432)
T 3n9x_A 288 QLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRIT----IDQALDHP 363 (432)
T ss_dssp HHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSTTTSCC----HHHHHTCG
T ss_pred HHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHhcCCcccCCC----HHHHhcCh
Confidence 1111111100 0000 1357899999999999999999999 99999999
Q ss_pred CCCCCCchhhh
Q 012762 417 FFNGVNWALLR 427 (457)
Q Consensus 417 ~f~~~~~~~~~ 427 (457)
||+.++|....
T Consensus 364 ~f~~~~~~~~e 374 (432)
T 3n9x_A 364 YLKDVRKKKLE 374 (432)
T ss_dssp GGTTTCCTTTC
T ss_pred hhhhccCcccC
Confidence 99999997654
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-49 Score=394.25 Aligned_cols=259 Identities=27% Similarity=0.374 Sum_probs=211.9
Q ss_pred CCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCC-
Q 012762 81 LSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPR- 159 (457)
Q Consensus 81 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~- 159 (457)
.++|++++.||+|+||+||+|.++ .+|+.||||++.... .......++.+|+++|+.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~----~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 98 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDG----RTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDET 98 (367)
T ss_dssp BSSEEEEEEC------CEEEEEET----TTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSS
T ss_pred cceEEEeEEeeecCCeEEEEEEEC----CCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCc
Confidence 468999999999999999999986 478999999986532 23345567888999999999999999999997653
Q ss_pred -----cEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCC
Q 012762 160 -----WSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDL 234 (457)
Q Consensus 160 -----~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~ 234 (457)
.+|+||||+ +++|..++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 99 ~~~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 174 (367)
T 1cm8_A 99 LDDFTDFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGL 174 (367)
T ss_dssp TTTCCCCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred cccCceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeec
Confidence 469999999 8999999877 5699999999999999999999999999999999999999999999999999
Q ss_pred CcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccc
Q 012762 235 SLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVR 314 (457)
Q Consensus 235 s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (457)
++.....
T Consensus 175 a~~~~~~------------------------------------------------------------------------- 181 (367)
T 1cm8_A 175 ARQADSE------------------------------------------------------------------------- 181 (367)
T ss_dssp CEECCSS-------------------------------------------------------------------------
T ss_pred ccccccc-------------------------------------------------------------------------
Confidence 8643211
Q ss_pred cccccCCCCccCchhhcC-CCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCC---------------
Q 012762 315 SMSFVGTHEYLAPEIISG-EGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFP--------------- 378 (457)
Q Consensus 315 ~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~--------------- 378 (457)
....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+....+..++......+
T Consensus 182 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~ 261 (367)
T 1cm8_A 182 MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNY 261 (367)
T ss_dssp CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHH
T ss_pred cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHHHHH
Confidence 112468999999999987 6799999999999999999999999999887666666554322111
Q ss_pred --------------CCCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCCCCchh
Q 012762 379 --------------KEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGVNWAL 425 (457)
Q Consensus 379 --------------~~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~~~~~~ 425 (457)
....+++++.+||.+||..||.+||| ++|+|+||||+...+..
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t----~~e~l~hp~f~~~~~~~ 318 (367)
T 1cm8_A 262 MKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVT----AGEALAHPYFESLHDTE 318 (367)
T ss_dssp HHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCC----HHHHHHSGGGTTTC---
T ss_pred HHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCC----HHHHhcChHHHhhcCCc
Confidence 11346789999999999999999999 99999999999876643
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-49 Score=379.39 Aligned_cols=254 Identities=28% Similarity=0.470 Sum_probs=222.6
Q ss_pred CCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcE
Q 012762 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWS 161 (457)
Q Consensus 82 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~ 161 (457)
++|++.+.||+|+||+||+|.++ .++..||+|++.+... .....+.+|+++++.++||||+++++++...+..
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~----~~~~~~a~k~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (277)
T 3f3z_A 9 QYYTLENTIGRGSWGEVKIAVQK----GTRIRRAAKKIPKYFV---EDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDI 81 (277)
T ss_dssp HHEEEEEEEEEETTEEEEEEEET----TTCCEEEEEEEEGGGC---SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred hhEEeeeEEeecCCEEEEEEEeC----CCCcEEEEEeehhhcc---chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeE
Confidence 47999999999999999999986 4788999999976432 3456788899999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEE---ccCCCEEEeccCCCcCC
Q 012762 162 CLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLV---RSDGHIMLTDFDLSLKG 238 (457)
Q Consensus 162 ~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll---~~~~~vkl~DFG~s~~~ 238 (457)
|+||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++...
T Consensus 82 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~ 159 (277)
T 3f3z_A 82 YLVMELCTGGELFERVVHK--RVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF 159 (277)
T ss_dssp EEEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred EEEEeccCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceec
Confidence 9999999999998888765 669999999999999999999999999999999999999 77889999999998654
Q ss_pred CCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccc
Q 012762 239 DNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSF 318 (457)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (457)
..... ....
T Consensus 160 ~~~~~-----------------------------------------------------------------------~~~~ 168 (277)
T 3f3z_A 160 KPGKM-----------------------------------------------------------------------MRTK 168 (277)
T ss_dssp CTTSC-----------------------------------------------------------------------BCCC
T ss_pred cCccc-----------------------------------------------------------------------hhcc
Confidence 32111 1123
Q ss_pred cCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCC--CCCChHHHHHHHHHhh
Q 012762 319 VGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKE--PSVPGPAKDLIAQLLV 396 (457)
Q Consensus 319 ~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ll~~~L~ 396 (457)
.||+.|+|||++.+. ++.++|||||||++|+|++|+.||...........+......++.. ..+++.+.+||.+||+
T Consensus 169 ~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 247 (277)
T 3f3z_A 169 VGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAESLIRRLLT 247 (277)
T ss_dssp CSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTC
T ss_pred CCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHHHHHHHHHHcc
Confidence 599999999999765 8999999999999999999999999988888888887776666542 3588999999999999
Q ss_pred hCCCCCCCCCcChHHHhcCCCCCC
Q 012762 397 KDPTRRMGSKMGATAIKRHQFFNG 420 (457)
Q Consensus 397 ~dP~~Rps~~~~~~~ll~hp~f~~ 420 (457)
.||++||+ +.++++||||+.
T Consensus 248 ~dp~~R~s----~~~~l~h~~~~~ 267 (277)
T 3f3z_A 248 KSPKQRIT----SLQALEHEWFEK 267 (277)
T ss_dssp SSTTTSCC----HHHHTTSHHHHH
T ss_pred CChhhCcC----HHHHhcCHHHhc
Confidence 99999999 999999999975
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-50 Score=400.37 Aligned_cols=259 Identities=25% Similarity=0.430 Sum_probs=218.9
Q ss_pred Ccee--EEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCc
Q 012762 83 DLRF--VHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRW 160 (457)
Q Consensus 83 ~~~~--~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~ 160 (457)
.|.+ .+.||+|+||+||+|.++ .+|+.||+|++..... .....+.+|+++|++++||||+++++++...+.
T Consensus 88 ~~~~~~~~~lG~G~~g~Vy~a~~~----~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 160 (373)
T 2x4f_A 88 FYTVSKTEILGGGRFGQVHKCEET----ATGLKLAAKIIKTRGM---KDKEEVKNEISVMNQLDHANLIQLYDAFESKND 160 (373)
T ss_dssp TEEEEEEEECC-----CEEEEEET----TTCCEEEEEEEECCSH---HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred ceeeecceEEecCcCEEEEEEEEc----CCCcEEEEEEEccccc---ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCE
Confidence 3554 678999999999999876 4789999999976432 345678889999999999999999999999999
Q ss_pred EEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEE--ccCCCEEEeccCCCcCC
Q 012762 161 SCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLV--RSDGHIMLTDFDLSLKG 238 (457)
Q Consensus 161 ~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll--~~~~~vkl~DFG~s~~~ 238 (457)
+||||||+++++|.+++... ...+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||+++..
T Consensus 161 ~~lv~E~~~~~~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~ 239 (373)
T 2x4f_A 161 IVLVMEYVDGGELFDRIIDE-SYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRY 239 (373)
T ss_dssp EEEEEECCTTCEEHHHHHHT-GGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEEC
T ss_pred EEEEEeCCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceec
Confidence 99999999999998887653 2468999999999999999999999999999999999999 45678999999998654
Q ss_pred CCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccc
Q 012762 239 DNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSF 318 (457)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (457)
..... ....
T Consensus 240 ~~~~~-----------------------------------------------------------------------~~~~ 248 (373)
T 2x4f_A 240 KPREK-----------------------------------------------------------------------LKVN 248 (373)
T ss_dssp CTTCB-----------------------------------------------------------------------CCCC
T ss_pred CCccc-----------------------------------------------------------------------cccc
Confidence 32110 1123
Q ss_pred cCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCC--CCCCChHHHHHHHHHhh
Q 012762 319 VGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPK--EPSVPGPAKDLIAQLLV 396 (457)
Q Consensus 319 ~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ll~~~L~ 396 (457)
+||+.|+|||++.+..++.++|||||||++|||++|..||.+......+..++...+.++. ...+++++++||.+||.
T Consensus 249 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~ 328 (373)
T 2x4f_A 249 FGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFISKLLI 328 (373)
T ss_dssp CSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHHHHHHTTSC
T ss_pred cCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHHHHHHHHHcC
Confidence 5999999999999888999999999999999999999999998888888888877665543 24688999999999999
Q ss_pred hCCCCCCCCCcChHHHhcCCCCCCCCch
Q 012762 397 KDPTRRMGSKMGATAIKRHQFFNGVNWA 424 (457)
Q Consensus 397 ~dP~~Rps~~~~~~~ll~hp~f~~~~~~ 424 (457)
.||.+||+ +.|+|+||||+..+|.
T Consensus 329 ~dp~~Rps----~~e~l~hp~~~~~~~~ 352 (373)
T 2x4f_A 329 KEKSWRIS----ASEALKHPWLSDHKLH 352 (373)
T ss_dssp SSGGGSCC----HHHHHHSHHHHCHHHH
T ss_pred CChhhCCC----HHHHhcCcCcCCCchh
Confidence 99999999 9999999999987764
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-49 Score=408.74 Aligned_cols=256 Identities=25% Similarity=0.351 Sum_probs=208.3
Q ss_pred cCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcC-
Q 012762 80 TLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCP- 158 (457)
Q Consensus 80 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~- 158 (457)
..++|+++++||+|+||+||+|+++ .+++.||||++.+.. .......++.+|+++|+.++||||+++++++...
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~----~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 134 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDA----VLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQK 134 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEET----TTTEEEEEEEEESGG-GSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCC
T ss_pred ecCCeEEEEEeecCCCeEEEEEEEC----CCCCEEEEEEECccc-cChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCC
Confidence 3578999999999999999999987 478999999997642 2334566788899999999999999999999655
Q ss_pred -----CcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccC
Q 012762 159 -----RWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFD 233 (457)
Q Consensus 159 -----~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG 233 (457)
..+||||||+++ +|...+. ..+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||
T Consensus 135 ~~~~~~~~~lv~E~~~~-~l~~~~~----~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG 209 (464)
T 3ttj_A 135 TLEEFQDVYLVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG 209 (464)
T ss_dssp STTTCCEEEEEEECCSE-EHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCC
T ss_pred ccccCCeEEEEEeCCCC-CHHHHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEE
Confidence 357999999965 5655553 348999999999999999999999999999999999999999999999999
Q ss_pred CCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcc
Q 012762 234 LSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDV 313 (457)
Q Consensus 234 ~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (457)
+++......
T Consensus 210 ~a~~~~~~~----------------------------------------------------------------------- 218 (464)
T 3ttj_A 210 LARTAGTSF----------------------------------------------------------------------- 218 (464)
T ss_dssp CC-----CC-----------------------------------------------------------------------
T ss_pred eeeecCCCc-----------------------------------------------------------------------
Confidence 986443210
Q ss_pred ccccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCC---------------
Q 012762 314 RSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFP--------------- 378 (457)
Q Consensus 314 ~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~--------------- 378 (457)
.....+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..+.+..++.......
T Consensus 219 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~~~ 298 (464)
T 3ttj_A 219 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYV 298 (464)
T ss_dssp CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHHHHH
T ss_pred ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhhhHh
Confidence 11135799999999999999999999999999999999999999999887776666654322110
Q ss_pred ----CCCC---------------------CChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCC
Q 012762 379 ----KEPS---------------------VPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNG 420 (457)
Q Consensus 379 ----~~~~---------------------~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~ 420 (457)
.... .+.++++||.+||..||++||| ++|+|+||||+.
T Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t----a~e~L~Hp~~~~ 361 (464)
T 3ttj_A 299 ENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS----VDDALQHPYINV 361 (464)
T ss_dssp TTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCC----HHHHHTSTTTGG
T ss_pred hcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCC----HHHHhcChhhhh
Confidence 0000 0356899999999999999999 999999999984
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-50 Score=416.28 Aligned_cols=263 Identities=29% Similarity=0.443 Sum_probs=229.6
Q ss_pred cCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCC
Q 012762 80 TLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPR 159 (457)
Q Consensus 80 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~ 159 (457)
-.++|++.++||+|+||+||+|+++ .+++.||||++.+...........+.+|+++|++++||||+++++++...+
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~----~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 99 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDK----ITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKG 99 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEET----TTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ccCceEEeeEEecCCCEEEEEEEEC----CCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence 3467999999999999999999986 478899999998765554556778889999999999999999999999999
Q ss_pred cEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEE---ccCCCEEEeccCCCc
Q 012762 160 WSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLV---RSDGHIMLTDFDLSL 236 (457)
Q Consensus 160 ~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll---~~~~~vkl~DFG~s~ 236 (457)
..|+|||||.+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.
T Consensus 100 ~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 177 (484)
T 3nyv_A 100 YFYLVGEVYTGGELFDEIISR--KRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLST 177 (484)
T ss_dssp EEEEEECCCCSCBHHHHHHTC--SCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHH
T ss_pred EEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeE
Confidence 999999999999999888764 679999999999999999999999999999999999999 467899999999986
Q ss_pred CCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccc
Q 012762 237 KGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSM 316 (457)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (457)
....... ..
T Consensus 178 ~~~~~~~-----------------------------------------------------------------------~~ 186 (484)
T 3nyv_A 178 HFEASKK-----------------------------------------------------------------------MK 186 (484)
T ss_dssp HBCCCCS-----------------------------------------------------------------------HH
T ss_pred Ecccccc-----------------------------------------------------------------------cc
Confidence 4432111 11
Q ss_pred cccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCC--CCCCChHHHHHHHHH
Q 012762 317 SFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPK--EPSVPGPAKDLIAQL 394 (457)
Q Consensus 317 ~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ll~~~ 394 (457)
..+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+......+..+....+.++. +..+++++++||.+|
T Consensus 187 ~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~ 265 (484)
T 3nyv_A 187 DKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKM 265 (484)
T ss_dssp HHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHHHHHHHHHH
T ss_pred cCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHHHHHHHHHH
Confidence 3469999999999987 5999999999999999999999999999888888888887665543 356889999999999
Q ss_pred hhhCCCCCCCCCcChHHHhcCCCCCCCCch
Q 012762 395 LVKDPTRRMGSKMGATAIKRHQFFNGVNWA 424 (457)
Q Consensus 395 L~~dP~~Rps~~~~~~~ll~hp~f~~~~~~ 424 (457)
|+.||.+||+ +.|+|+||||+...+.
T Consensus 266 L~~dp~~R~s----~~e~l~h~~~~~~~~~ 291 (484)
T 3nyv_A 266 LTYVPSMRIS----ARDALDHEWIQTYTKE 291 (484)
T ss_dssp TCSSGGGSCC----HHHHHTSHHHHHHTC-
T ss_pred CCCChhHCcC----HHHHhhChhhcccccc
Confidence 9999999999 9999999999865543
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-49 Score=381.51 Aligned_cols=265 Identities=24% Similarity=0.419 Sum_probs=222.2
Q ss_pred CCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhh-hhHHHHHHHHHHHHHHcCCCCCceEEEEEE--c
Q 012762 81 LSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVS-RNKESRARIEREILEMLDHPFLPTLYATLD--C 157 (457)
Q Consensus 81 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~-~~~~~~~~~E~~il~~l~H~nIv~l~~~~~--~ 157 (457)
.++|++.+.||+|+||.||+|.+. .+++.||+|++.+..... ......+.+|+++++.++||||+++++++. .
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~----~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 79 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDS----ETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEE 79 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBT----TTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC-
T ss_pred ccceeEeeEEecCCCeEEEEEEEC----CCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCC
Confidence 468999999999999999999876 478899999998765432 345677888999999999999999999984 4
Q ss_pred CCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcC
Q 012762 158 PRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLK 237 (457)
Q Consensus 158 ~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~ 237 (457)
.+..|+||||++++ |.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 80 ~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~ 158 (305)
T 2wtk_C 80 KQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEA 158 (305)
T ss_dssp --CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred CCeEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccc
Confidence 56889999999766 77777776667899999999999999999999999999999999999999999999999999865
Q ss_pred CCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcccccc
Q 012762 238 GDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMS 317 (457)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (457)
....... .....
T Consensus 159 ~~~~~~~--------------------------------------------------------------------~~~~~ 170 (305)
T 2wtk_C 159 LHPFAAD--------------------------------------------------------------------DTCRT 170 (305)
T ss_dssp CCTTCSS--------------------------------------------------------------------CEECC
T ss_pred cCccccc--------------------------------------------------------------------ccccc
Confidence 4321100 00112
Q ss_pred ccCCCCccCchhhcCCCC--CccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHh
Q 012762 318 FVGTHEYLAPEIISGEGH--GNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLL 395 (457)
Q Consensus 318 ~~gt~~y~aPE~l~~~~~--~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L 395 (457)
..||+.|+|||++.+... +.++|||||||++|+|++|..||.+.........+......++. .++..+.+||.+||
T Consensus 171 ~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~--~~~~~l~~li~~~l 248 (305)
T 2wtk_C 171 SQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPG--DCGPPLSDLLKGML 248 (305)
T ss_dssp CCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCCS--SSCHHHHHHHHHHT
T ss_pred CCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCCCCC--ccCHHHHHHHHHHc
Confidence 358999999999987543 78999999999999999999999998877777777766555543 58899999999999
Q ss_pred hhCCCCCCCCCcChHHHhcCCCCCCCCch
Q 012762 396 VKDPTRRMGSKMGATAIKRHQFFNGVNWA 424 (457)
Q Consensus 396 ~~dP~~Rps~~~~~~~ll~hp~f~~~~~~ 424 (457)
..||.+||+ +.|+++||||+.....
T Consensus 249 ~~dp~~Rps----~~~ll~~~~~~~~~~~ 273 (305)
T 2wtk_C 249 EYEPAKRFS----IRQIRQHSWFRKKHPP 273 (305)
T ss_dssp CSSTTTSCC----HHHHHHSHHHHSCCCC
T ss_pred cCChhhCCC----HHHHhcCcccccCCCC
Confidence 999999999 9999999999976554
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-49 Score=378.76 Aligned_cols=257 Identities=28% Similarity=0.450 Sum_probs=216.2
Q ss_pred CCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcE
Q 012762 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWS 161 (457)
Q Consensus 82 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~ 161 (457)
++|++.++||+|+||+||+|.++ .++..||+|++.... .......+.+|+++|+.++||||+++++++...+..
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~----~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 95 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEER----SSGLERVIKTINKDR--SQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNM 95 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEET----TTCCEEEEEEEEGGG--CCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred hheeecceeccCCCeEEEEEEEc----cCCceEEEEEeeccc--cchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeE
Confidence 57999999999999999999976 478899999997653 233456788899999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEE---ccCCCEEEeccCCCc
Q 012762 162 CLLTEFCPGGDLHVLRQRQ--PDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLV---RSDGHIMLTDFDLSL 236 (457)
Q Consensus 162 ~lV~E~~~~~sL~~~~~~~--~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll---~~~~~vkl~DFG~s~ 236 (457)
|+||||+++++|.+++... ....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.
T Consensus 96 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~ 175 (285)
T 3is5_A 96 YIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAE 175 (285)
T ss_dssp EEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCC
T ss_pred EEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecce
Confidence 9999999999998877542 23679999999999999999999999999999999999999 456789999999986
Q ss_pred CCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccc
Q 012762 237 KGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSM 316 (457)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (457)
....... ..
T Consensus 176 ~~~~~~~-----------------------------------------------------------------------~~ 184 (285)
T 3is5_A 176 LFKSDEH-----------------------------------------------------------------------ST 184 (285)
T ss_dssp C-------------------------------------------------------------------------------
T ss_pred ecCCccc-----------------------------------------------------------------------Cc
Confidence 5432110 11
Q ss_pred cccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCC-CCCChHHHHHHHHHh
Q 012762 317 SFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKE-PSVPGPAKDLIAQLL 395 (457)
Q Consensus 317 ~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ll~~~L 395 (457)
...||+.|+|||++. ..++.++|||||||++|+|++|+.||.+.........+.......... ..+++++.+||.+||
T Consensus 185 ~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 263 (285)
T 3is5_A 185 NAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQAVDLLKQML 263 (285)
T ss_dssp --CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--CCCCHHHHHHHHHHT
T ss_pred CcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccccCcCCHHHHHHHHHHc
Confidence 235899999999986 458999999999999999999999999988777666665554444322 347899999999999
Q ss_pred hhCCCCCCCCCcChHHHhcCCCCCC
Q 012762 396 VKDPTRRMGSKMGATAIKRHQFFNG 420 (457)
Q Consensus 396 ~~dP~~Rps~~~~~~~ll~hp~f~~ 420 (457)
+.||++||+ +.|+++||||+.
T Consensus 264 ~~dP~~Rps----~~e~l~hp~f~~ 284 (285)
T 3is5_A 264 TKDPERRPS----AAQVLHHEWFKQ 284 (285)
T ss_dssp CSCTTTSCC----HHHHHTSGGGGC
T ss_pred cCChhhCcC----HHHHhcCHHhhc
Confidence 999999999 999999999985
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-49 Score=387.28 Aligned_cols=267 Identities=27% Similarity=0.412 Sum_probs=211.9
Q ss_pred CCceeE-EEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHc-CCCCCceEEEEEEcCC
Q 012762 82 SDLRFV-HRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEML-DHPFLPTLYATLDCPR 159 (457)
Q Consensus 82 ~~~~~~-~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~~~~~~~~ 159 (457)
++|++. +.||+|+||+||+|.++ .+++.||||++.+.. ......+.+|+++|+++ +||||+++++++...+
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~----~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~ 84 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINL----ITSQEYAVKIIEKQP---GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEED 84 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECS----SSCCEEEEEEEECCS---SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred eeEEecCceecCCceEEEEEEEEc----CCCcEEEEEEEeeCc---chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCC
Confidence 578885 78999999999999876 478899999997642 23456778899999885 7999999999999999
Q ss_pred cEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCC---EEEeccCCCc
Q 012762 160 WSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGH---IMLTDFDLSL 236 (457)
Q Consensus 160 ~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~---vkl~DFG~s~ 236 (457)
..|+||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++.
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~ 162 (316)
T 2ac3_A 85 RFYLVFEKMRGGSILSHIHKR--RHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGS 162 (316)
T ss_dssp EEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC
T ss_pred EEEEEEEcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCcc
Confidence 999999999999999998775 57999999999999999999999999999999999999998775 9999999976
Q ss_pred CCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccc
Q 012762 237 KGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSM 316 (457)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (457)
.......... .......
T Consensus 163 ~~~~~~~~~~---------------------------------------------------------------~~~~~~~ 179 (316)
T 2ac3_A 163 GIKLNGDCSP---------------------------------------------------------------ISTPELL 179 (316)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred ccccCCcccc---------------------------------------------------------------ccccccc
Confidence 5431110000 0000111
Q ss_pred cccCCCCccCchhhcC-----CCCCccchhhhhhHHHHHHhcCCCCCCCCCh---------------HHHHHHHHhcccC
Q 012762 317 SFVGTHEYLAPEIISG-----EGHGNAVDWWTLGIFIFELFYGTTPFKGIDH---------------ELTLANVVARALE 376 (457)
Q Consensus 317 ~~~gt~~y~aPE~l~~-----~~~~~~sDiwSlG~il~elltG~~Pf~~~~~---------------~~~~~~~~~~~~~ 376 (457)
..+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+... ......+......
T Consensus 180 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~ 259 (316)
T 2ac3_A 180 TPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYE 259 (316)
T ss_dssp --CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHHHHHHHCCCC
T ss_pred cccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHHHHHhccCcc
Confidence 3469999999999975 4578999999999999999999999987542 2345555555555
Q ss_pred CCCC--CCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCCCCch
Q 012762 377 FPKE--PSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGVNWA 424 (457)
Q Consensus 377 ~~~~--~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~~~~~ 424 (457)
++.. ..++.++++||.+||..||.+||+ +.|+++||||++..|.
T Consensus 260 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rps----~~e~l~hp~~~~~~~~ 305 (316)
T 2ac3_A 260 FPDKDWAHISCAAKDLISKLLVRDAKQRLS----AAQVLQHPWVQGCAPE 305 (316)
T ss_dssp CCHHHHTTSCHHHHHHHHHHSCSSTTTSCC----HHHHHHSTTCC-----
T ss_pred cCchhcccCCHHHHHHHHHHhhCChhhCCC----HHHHhcChhhcCCCCc
Confidence 5432 458899999999999999999999 9999999999987664
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=378.69 Aligned_cols=266 Identities=27% Similarity=0.396 Sum_probs=225.0
Q ss_pred CCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhh------hhhhHHHHHHHHHHHHHHcC-CCCCceEEE
Q 012762 81 LSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKREL------VSRNKESRARIEREILEMLD-HPFLPTLYA 153 (457)
Q Consensus 81 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~------~~~~~~~~~~~E~~il~~l~-H~nIv~l~~ 153 (457)
.++|++.+.||+|+||+||+|.++ .+++.||||++..... ........+.+|+++|+++. ||||+++++
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~ 91 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHK----PTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKD 91 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEET----TTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred hhccceeeeecCCCceEEEEEEEc----CcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeee
Confidence 468999999999999999999986 4789999999975421 11233456778999999995 999999999
Q ss_pred EEEcCCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccC
Q 012762 154 TLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFD 233 (457)
Q Consensus 154 ~~~~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG 233 (457)
++...+..|+||||+++++|.+++... ..+++..++.++.||+.||.|||++||+|+||||+||+++.++.+||+|||
T Consensus 92 ~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg 169 (298)
T 1phk_A 92 TYETNTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFG 169 (298)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCT
T ss_pred eeccCCeEEEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEeccc
Confidence 999999999999999999999998774 579999999999999999999999999999999999999999999999999
Q ss_pred CCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcc
Q 012762 234 LSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDV 313 (457)
Q Consensus 234 ~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (457)
++........
T Consensus 170 ~~~~~~~~~~---------------------------------------------------------------------- 179 (298)
T 1phk_A 170 FSCQLDPGEK---------------------------------------------------------------------- 179 (298)
T ss_dssp TCEECCTTCC----------------------------------------------------------------------
T ss_pred chhhcCCCcc----------------------------------------------------------------------
Confidence 9765432110
Q ss_pred ccccccCCCCccCchhhc------CCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCC--CCCCh
Q 012762 314 RSMSFVGTHEYLAPEIIS------GEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKE--PSVPG 385 (457)
Q Consensus 314 ~~~~~~gt~~y~aPE~l~------~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~ 385 (457)
.....||+.|+|||++. ...++.++|||||||++|+|++|..||...........+......++.. ..++.
T Consensus 180 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (298)
T 1phk_A 180 -LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSD 258 (298)
T ss_dssp -BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTGGGSCH
T ss_pred -cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCcccccccCH
Confidence 11235899999999985 4457899999999999999999999999888777777777776655433 45789
Q ss_pred HHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCCCCchhhh
Q 012762 386 PAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGVNWALLR 427 (457)
Q Consensus 386 ~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~~~~~~~~ 427 (457)
.+.+||.+||..||++||+ +.++++||||+...|..++
T Consensus 259 ~l~~li~~~l~~dp~~Rps----~~~ll~h~~~~~~~~~~~~ 296 (298)
T 1phk_A 259 TVKDLVSRFLVVQPQKRYT----AEEALAHPFFQQYVVEEVR 296 (298)
T ss_dssp HHHHHHHHHCCSSGGGSCC----HHHHTTSGGGCTTC-----
T ss_pred HHHHHHHHHccCCcccCCC----HHHHHhChHhhhccchhhc
Confidence 9999999999999999999 9999999999998886654
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-50 Score=390.84 Aligned_cols=263 Identities=22% Similarity=0.317 Sum_probs=217.6
Q ss_pred cCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCC
Q 012762 80 TLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPR 159 (457)
Q Consensus 80 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~ 159 (457)
-.++|++.+.||+|+||+||+|++. .+++.||||++.............+.+|+++++.++||||+++++++....
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 85 (311)
T 3ork_A 10 LSDRYELGEILGFGGMSEVHLARDL----RDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET 85 (311)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEET----TTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEE
T ss_pred ecCcEEEEEEEccCCCEEEEEEEEC----CCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccC
Confidence 3468999999999999999999986 478999999998765545555677888999999999999999999987654
Q ss_pred c----EEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCC
Q 012762 160 W----SCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235 (457)
Q Consensus 160 ~----~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s 235 (457)
. .|+||||++|++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 86 ~~~~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a 163 (311)
T 3ork_A 86 PAGPLPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIA 163 (311)
T ss_dssp TTEEEEEEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC
T ss_pred CCCcccEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCc
Confidence 3 49999999999999998775 57999999999999999999999999999999999999999999999999998
Q ss_pred cCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcccc
Q 012762 236 LKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRS 315 (457)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (457)
.......... ...
T Consensus 164 ~~~~~~~~~~-------------------------------------------------------------------~~~ 176 (311)
T 3ork_A 164 RAIADSGNSV-------------------------------------------------------------------TQT 176 (311)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred cccccccccc-------------------------------------------------------------------ccc
Confidence 6543221100 011
Q ss_pred ccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCC--CCCCChHHHHHHHH
Q 012762 316 MSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPK--EPSVPGPAKDLIAQ 393 (457)
Q Consensus 316 ~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ll~~ 393 (457)
...+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.........+.......+. ...++.++.++|.+
T Consensus 177 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 256 (311)
T 3ork_A 177 AAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLK 256 (311)
T ss_dssp -----CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHSTTCCHHHHHHHHH
T ss_pred cccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccCCCCHHHHHHHHH
Confidence 1346999999999999999999999999999999999999999988877766666655433321 24588999999999
Q ss_pred HhhhCCCCCCCCCcChHHHhcCCCCC
Q 012762 394 LLVKDPTRRMGSKMGATAIKRHQFFN 419 (457)
Q Consensus 394 ~L~~dP~~Rps~~~~~~~ll~hp~f~ 419 (457)
||+.||++||+ ..+++.|+|++
T Consensus 257 ~l~~dP~~R~~----~~~~l~~~l~~ 278 (311)
T 3ork_A 257 ALAKNPENRYQ----TAAEMRADLVR 278 (311)
T ss_dssp HTCSSGGGSCS----SHHHHHHHHHH
T ss_pred HHhcCHhhChh----hHHHHHHHHHH
Confidence 99999999999 99999998876
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-49 Score=389.41 Aligned_cols=252 Identities=26% Similarity=0.468 Sum_probs=196.1
Q ss_pred CceeE---EEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcC-CCCCceEEEEEEcC
Q 012762 83 DLRFV---HRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLD-HPFLPTLYATLDCP 158 (457)
Q Consensus 83 ~~~~~---~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~-H~nIv~l~~~~~~~ 158 (457)
+|.+. +.||+|+||+||+|.++ .+++.||||++.+. ....+.+|+++|+.+. ||||+++++++.+.
T Consensus 9 ~y~~~~~~~~lG~G~~g~V~~~~~~----~~~~~vavK~~~~~------~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~ 78 (325)
T 3kn6_A 9 HYDLDLKDKPLGEGSFSICRKCVHK----KSNQAFAVKIISKR------MEANTQKEITALKLCEGHPNIVKLHEVFHDQ 78 (325)
T ss_dssp HEEECTTSCCSEEETTEEEEEEEET----TTCCEEEEEEEEGG------GHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred ccccccCCCccccCCCeEEEEEEEC----CCCCEEEEEEEChh------hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcC
Confidence 45554 78999999999999987 47889999999754 3345677999999996 99999999999999
Q ss_pred CcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCC---CEEEeccCCC
Q 012762 159 RWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDG---HIMLTDFDLS 235 (457)
Q Consensus 159 ~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~---~vkl~DFG~s 235 (457)
+..||||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a 156 (325)
T 3kn6_A 79 LHTFLVMELLNGGELFERIKKK--KHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFA 156 (325)
T ss_dssp SEEEEEECCCCSCBHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTC
T ss_pred CEEEEEEEccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccc
Confidence 9999999999999999998875 6799999999999999999999999999999999999998766 7999999998
Q ss_pred cCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcccc
Q 012762 236 LKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRS 315 (457)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (457)
+....... ..
T Consensus 157 ~~~~~~~~----------------------------------------------------------------------~~ 166 (325)
T 3kn6_A 157 RLKPPDNQ----------------------------------------------------------------------PL 166 (325)
T ss_dssp EECCC---------------------------------------------------------------------------
T ss_pred eecCCCCC----------------------------------------------------------------------cc
Confidence 64432110 01
Q ss_pred ccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCCh-------HHHHHHHHhcccCCCCC--CCCChH
Q 012762 316 MSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDH-------ELTLANVVARALEFPKE--PSVPGP 386 (457)
Q Consensus 316 ~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~-------~~~~~~~~~~~~~~~~~--~~~~~~ 386 (457)
...+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+... .+....+..+.+.++.. ..++++
T Consensus 167 ~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 246 (325)
T 3kn6_A 167 KTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQE 246 (325)
T ss_dssp -----------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHHHHTSCHH
T ss_pred cccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcccccCCCHH
Confidence 133689999999999999999999999999999999999999986432 34555555555444432 357899
Q ss_pred HHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCC
Q 012762 387 AKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNG 420 (457)
Q Consensus 387 ~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~ 420 (457)
+++||.+||..||++||+ +.|+++||||+.
T Consensus 247 ~~~li~~~L~~dP~~Rpt----~~ell~h~w~~~ 276 (325)
T 3kn6_A 247 AKDLIQGLLTVDPNKRLK----MSGLRYNEWLQD 276 (325)
T ss_dssp HHHHHHHHHCCCTTTCCC----TTTSTTCGGGCT
T ss_pred HHHHHHHHCCCChhHCCC----HHHHhcChhhcc
Confidence 999999999999999999 999999999985
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-49 Score=389.54 Aligned_cols=267 Identities=24% Similarity=0.309 Sum_probs=214.0
Q ss_pred cCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhh--hHHHHHHHHHHHHHHcCCCCCceEEEEEEc
Q 012762 80 TLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSR--NKESRARIEREILEMLDHPFLPTLYATLDC 157 (457)
Q Consensus 80 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~--~~~~~~~~E~~il~~l~H~nIv~l~~~~~~ 157 (457)
..++|++++.||+|+||+||+|.++ .+|+.||||++........ .....+.+|+++++.++||||+++++++..
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 83 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDK----NTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH 83 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECS----SCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred HhcccEEEeEEeecCCEEEEEEEEC----CCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEee
Confidence 3468999999999999999999876 4788999999975432211 112456789999999999999999999999
Q ss_pred CCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcC
Q 012762 158 PRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLK 237 (457)
Q Consensus 158 ~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~ 237 (457)
.+..|+||||+++ +|..++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 84 ~~~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (346)
T 1ua2_A 84 KSNISLVFDFMET-DLEVIIKDN-SLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKS 161 (346)
T ss_dssp TTCCEEEEECCSE-EHHHHHTTC-CSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGST
T ss_pred CCceEEEEEcCCC-CHHHHHHhc-CcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEeccccee
Confidence 9999999999965 888777653 35689999999999999999999999999999999999999999999999999865
Q ss_pred CCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcccccc
Q 012762 238 GDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMS 317 (457)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (457)
...... ....
T Consensus 162 ~~~~~~----------------------------------------------------------------------~~~~ 171 (346)
T 1ua2_A 162 FGSPNR----------------------------------------------------------------------AYTH 171 (346)
T ss_dssp TTSCCC----------------------------------------------------------------------CCCC
T ss_pred ccCCcc----------------------------------------------------------------------cCCc
Confidence 432110 0112
Q ss_pred ccCCCCccCchhhcCC-CCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCC-----------------
Q 012762 318 FVGTHEYLAPEIISGE-GHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPK----------------- 379 (457)
Q Consensus 318 ~~gt~~y~aPE~l~~~-~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~----------------- 379 (457)
.+||+.|+|||++.+. .++.++|||||||++|||++|.+||.+......+..+.........
T Consensus 172 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (346)
T 1ua2_A 172 QVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKS 251 (346)
T ss_dssp SCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCC
T ss_pred ccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCcccccccc
Confidence 3689999999999765 4899999999999999999999999998887777776653221110
Q ss_pred ---------CCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCCCCchhh
Q 012762 380 ---------EPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGVNWALL 426 (457)
Q Consensus 380 ---------~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~~~~~~~ 426 (457)
...++.++.+||.+||..||++||+ +.|+++||||+...|...
T Consensus 252 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt----~~ell~h~~f~~~~~~~~ 303 (346)
T 1ua2_A 252 FPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARIT----ATQALKMKYFSNRPGPTP 303 (346)
T ss_dssp CCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCC----HHHHHTSGGGTSSSCCCC
T ss_pred cCCCChHHhhccCCHHHHHHHHHHhccChhhCCC----HHHHhcChhhhcCCCCCC
Confidence 0345688999999999999999999 999999999998776543
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-49 Score=392.16 Aligned_cols=276 Identities=25% Similarity=0.346 Sum_probs=217.1
Q ss_pred cCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCC
Q 012762 80 TLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPR 159 (457)
Q Consensus 80 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~ 159 (457)
..++|++++.||+|+||+||+|.+. .+++.||||++.... ........+.+|+++++.++||||+++++++...+
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~~~~~----~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 97 (371)
T 2xrw_A 23 VLKRYQNLKPIGSGAQGIVCAAYDA----ILERNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQK 97 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEET----TTTEEEEEEEEECTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCC
T ss_pred hhhheeEeeeeEecCCEEEEEEEEC----CCCceEEEEEecccc-CChHHHHHHHHHHHHHHhcCCCCccceEEeecccc
Confidence 3578999999999999999999876 478899999997542 23344567788999999999999999999997665
Q ss_pred ------cEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccC
Q 012762 160 ------WSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFD 233 (457)
Q Consensus 160 ------~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG 233 (457)
..|+||||++ ++|..++. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 98 ~~~~~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg 172 (371)
T 2xrw_A 98 SLEEFQDVYIVMELMD-ANLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG 172 (371)
T ss_dssp STTTCCEEEEEEECCS-EEHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCC
T ss_pred ccccccceEEEEEcCC-CCHHHHHh----hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEee
Confidence 7899999995 57877775 348999999999999999999999999999999999999999999999999
Q ss_pred CCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcc
Q 012762 234 LSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDV 313 (457)
Q Consensus 234 ~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (457)
+++......
T Consensus 173 ~a~~~~~~~----------------------------------------------------------------------- 181 (371)
T 2xrw_A 173 LARTAGTSF----------------------------------------------------------------------- 181 (371)
T ss_dssp C-------------------------------------------------------------------------------
T ss_pred ccccccccc-----------------------------------------------------------------------
Confidence 986442110
Q ss_pred ccccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCC----------------
Q 012762 314 RSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEF---------------- 377 (457)
Q Consensus 314 ~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~---------------- 377 (457)
.....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+....+..++......
T Consensus 182 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 261 (371)
T 2xrw_A 182 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYV 261 (371)
T ss_dssp --------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHHHHH
T ss_pred ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHH
Confidence 0112469999999999999999999999999999999999999999988776666655432111
Q ss_pred ---CCCC---------------------CCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCCCCchhhhccCCCC
Q 012762 378 ---PKEP---------------------SVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGVNWALLRCAKPPF 433 (457)
Q Consensus 378 ---~~~~---------------------~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~~~~~~~~~~~~~~ 433 (457)
+... ..+.++++||.+||..||++||| ++|+|+||||+...........||.
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t----~~e~l~hp~~~~~~~~~~~~~~~~~ 337 (371)
T 2xrw_A 262 ENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRIS----VDEALQHPYINVWYDPSEAEAPPPK 337 (371)
T ss_dssp HSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCC----HHHHHHSHHHHTTCCHHHHTCCCCC
T ss_pred hhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCC----HHHHhCCcchhhhcCccccCCCCCC
Confidence 0000 01457899999999999999999 9999999999864444445566777
Q ss_pred CCCCCCc
Q 012762 434 IPRPVTC 440 (457)
Q Consensus 434 ~~~~~~~ 440 (457)
+|.....
T Consensus 338 ~~~~~~~ 344 (371)
T 2xrw_A 338 IPDKQLD 344 (371)
T ss_dssp CCTTTTC
T ss_pred CCChhhc
Confidence 7765443
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-49 Score=384.48 Aligned_cols=255 Identities=24% Similarity=0.332 Sum_probs=205.1
Q ss_pred cCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHc-CCCCCceEEEEEEcC
Q 012762 80 TLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEML-DHPFLPTLYATLDCP 158 (457)
Q Consensus 80 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~~~~~~~ 158 (457)
..++|+++++||+|+||+||+|+++ .+++.||||++....... ........|+..+..+ +|+||+++++++.++
T Consensus 55 ~~~~y~~~~~LG~G~~g~Vy~~~~~----~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~ 129 (311)
T 3p1a_A 55 FQQSFQRLSRLGHGSYGEVFKVRSK----EDGRLYAVKRSMSPFRGP-KDRARKLAEVGSHEKVGQHPCCVRLEQAWEEG 129 (311)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEET----TTSCEEEEEEESSSCCSH-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred hhhheeeeheeccCCCeEEEEEEEC----CCCeEEEEEEecccccCh-HHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeC
Confidence 3467999999999999999999987 478999999986543222 2233344455555554 999999999999999
Q ss_pred CcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCC
Q 012762 159 RWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKG 238 (457)
Q Consensus 159 ~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~ 238 (457)
+.+||||||+ +++|..++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 130 ~~~~lv~e~~-~~~L~~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~ 207 (311)
T 3p1a_A 130 GILYLQTELC-GPSLQQHCEAW-GASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVEL 207 (311)
T ss_dssp TEEEEEEECC-CCBHHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEEC
T ss_pred CEEEEEEecc-CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeec
Confidence 9999999999 78998877664 356999999999999999999999999999999999999999999999999997654
Q ss_pred CCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccc
Q 012762 239 DNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSF 318 (457)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (457)
..... ....
T Consensus 208 ~~~~~-----------------------------------------------------------------------~~~~ 216 (311)
T 3p1a_A 208 GTAGA-----------------------------------------------------------------------GEVQ 216 (311)
T ss_dssp C-----------------------------------------------------------------------------CC
T ss_pred ccCCC-----------------------------------------------------------------------Cccc
Confidence 32111 0123
Q ss_pred cCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhhhC
Q 012762 319 VGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKD 398 (457)
Q Consensus 319 ~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~d 398 (457)
.||+.|+|||++.+ .++.++|||||||++|||++|..||.+.. ....+............++.++.+||.+||+.|
T Consensus 217 ~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d 292 (311)
T 3p1a_A 217 EGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE---GWQQLRQGYLPPEFTAGLSSELRSVLVMMLEPD 292 (311)
T ss_dssp CCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH---HHHHHTTTCCCHHHHTTSCHHHHHHHHHHSCSS
T ss_pred CCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc---HHHHHhccCCCcccccCCCHHHHHHHHHHcCCC
Confidence 59999999999987 69999999999999999999977765532 233333332222223458899999999999999
Q ss_pred CCCCCCCCcChHHHhcCCCCCC
Q 012762 399 PTRRMGSKMGATAIKRHQFFNG 420 (457)
Q Consensus 399 P~~Rps~~~~~~~ll~hp~f~~ 420 (457)
|++||+ +.||++||||+.
T Consensus 293 P~~Rpt----~~ell~hp~~~~ 310 (311)
T 3p1a_A 293 PKLRAT----AEALLALPVLRQ 310 (311)
T ss_dssp TTTSCC----HHHHHTSGGGSC
T ss_pred hhhCcC----HHHHHhCccccC
Confidence 999999 999999999985
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-49 Score=410.32 Aligned_cols=258 Identities=31% Similarity=0.453 Sum_probs=219.0
Q ss_pred CCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcE
Q 012762 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWS 161 (457)
Q Consensus 82 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~ 161 (457)
++|+++++||+|+||+||+|+++ .++..||+|++.+..... .....+.+|+++|+.++||||+++++++...+.+
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~----~~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 111 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDK----VTHVERAIKIIRKTSVST-SSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNY 111 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEET----TTCCEEEEEEEEC------CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred cCeEEeeEEecCCCEEEEEEEEC----CCCcEEEEEEEeccccCc-hHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEE
Confidence 46999999999999999999987 478899999998764332 2356678899999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccC---CCEEEeccCCCcCC
Q 012762 162 CLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSD---GHIMLTDFDLSLKG 238 (457)
Q Consensus 162 ~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~---~~vkl~DFG~s~~~ 238 (457)
|+|||||.+|+|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++.. +.+||+|||++...
T Consensus 112 ~lv~e~~~~g~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~ 189 (494)
T 3lij_A 112 YLVMECYKGGELFDEIIHR--MKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVF 189 (494)
T ss_dssp EEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred EEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeEC
Confidence 9999999999998877665 679999999999999999999999999999999999999764 55999999998654
Q ss_pred CCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccc
Q 012762 239 DNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSF 318 (457)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (457)
..... ....
T Consensus 190 ~~~~~-----------------------------------------------------------------------~~~~ 198 (494)
T 3lij_A 190 ENQKK-----------------------------------------------------------------------MKER 198 (494)
T ss_dssp BTTBC-----------------------------------------------------------------------BCCC
T ss_pred CCCcc-----------------------------------------------------------------------cccc
Confidence 32110 1134
Q ss_pred cCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCC--CCCCChHHHHHHHHHhh
Q 012762 319 VGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPK--EPSVPGPAKDLIAQLLV 396 (457)
Q Consensus 319 ~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ll~~~L~ 396 (457)
+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+....+.+..+....+.++. ...++..+++||.+||+
T Consensus 199 ~gt~~y~aPE~l~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~ 277 (494)
T 3lij_A 199 LGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQ 277 (494)
T ss_dssp CSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHHHHHHHHHHTC
T ss_pred CCCcCeeCHHHHcc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHHHHHHHHHHCC
Confidence 69999999999874 5999999999999999999999999999888888888887766543 35689999999999999
Q ss_pred hCCCCCCCCCcChHHHhcCCCCCCCC
Q 012762 397 KDPTRRMGSKMGATAIKRHQFFNGVN 422 (457)
Q Consensus 397 ~dP~~Rps~~~~~~~ll~hp~f~~~~ 422 (457)
.||.+||| +.|+|+||||+...
T Consensus 278 ~dp~~R~s----~~e~l~hp~~~~~~ 299 (494)
T 3lij_A 278 FDSQRRIS----AQQALEHPWIKEMC 299 (494)
T ss_dssp SSTTTSCC----HHHHHTCHHHHHHH
T ss_pred CChhhCcc----HHHHhcCcccccCc
Confidence 99999999 99999999998643
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-49 Score=389.15 Aligned_cols=256 Identities=24% Similarity=0.306 Sum_probs=220.6
Q ss_pred CCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcE
Q 012762 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWS 161 (457)
Q Consensus 82 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~ 161 (457)
+.|.+++.||+|+||+||+|++. .+++.||||++.............+.+|+++|++++||||+++++++..++..
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~----~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 129 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDV----RNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTA 129 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEET----TTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred hheeeeeEEccCCCEEEEEEEEc----cCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeE
Confidence 45999999999999999999976 47899999999765444444556788899999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCC
Q 012762 162 CLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNS 241 (457)
Q Consensus 162 ~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~ 241 (457)
||||||+. |+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 130 ~lv~e~~~-g~l~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~ 207 (348)
T 1u5q_A 130 WLVMEYCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 207 (348)
T ss_dssp EEEEECCS-EEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred EEEEecCC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC
Confidence 99999995 6787777543 267999999999999999999999999999999999999999999999999997543210
Q ss_pred CcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCC
Q 012762 242 TSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGT 321 (457)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 321 (457)
...+||
T Consensus 208 --------------------------------------------------------------------------~~~~gt 213 (348)
T 1u5q_A 208 --------------------------------------------------------------------------NSFVGT 213 (348)
T ss_dssp --------------------------------------------------------------------------CCCCSC
T ss_pred --------------------------------------------------------------------------CcccCC
Confidence 123699
Q ss_pred CCccCchhhc---CCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhhhC
Q 012762 322 HEYLAPEIIS---GEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKD 398 (457)
Q Consensus 322 ~~y~aPE~l~---~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~d 398 (457)
+.|+|||++. +..++.++|||||||++|||++|+.||.+......+..+............+++.+.+||.+||+.|
T Consensus 214 ~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 293 (348)
T 1u5q_A 214 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKI 293 (348)
T ss_dssp GGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSS
T ss_pred cceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccC
Confidence 9999999985 4568999999999999999999999999887777666666665544445568999999999999999
Q ss_pred CCCCCCCCcChHHHhcCCCCCCC
Q 012762 399 PTRRMGSKMGATAIKRHQFFNGV 421 (457)
Q Consensus 399 P~~Rps~~~~~~~ll~hp~f~~~ 421 (457)
|++||+ +++|++||||...
T Consensus 294 P~~Rps----~~~ll~h~~~~~~ 312 (348)
T 1u5q_A 294 PQDRPT----SEVLLKHRFVLRE 312 (348)
T ss_dssp GGGSCC----HHHHTTCHHHHSC
T ss_pred hhhCcC----HHHHhhChhhhcc
Confidence 999999 9999999999753
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-49 Score=407.63 Aligned_cols=258 Identities=29% Similarity=0.457 Sum_probs=223.8
Q ss_pred CCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcE
Q 012762 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWS 161 (457)
Q Consensus 82 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~ 161 (457)
++|+++++||+|+||+||+|.++ .+++.||||++.+.... ......+.+|+++|++++||||+++++++...+.+
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~----~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 96 (486)
T 3mwu_A 22 ERYNIVCMLGKGSFGEVLKCKDR----ITQQEYAVKVINKASAK-NKDTSTILREVELLKKLDHPNIMKLFEILEDSSSF 96 (486)
T ss_dssp HHEEEEEEEECCSSSEEEEEEET----TTCCEEEEEEEEHHHHB-CSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred cceEEeEEEeecCCEEEEEEEEC----CCCCEEEEEEEeccccc-chHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEE
Confidence 57999999999999999999986 47889999999875432 23456788899999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEc---cCCCEEEeccCCCcCC
Q 012762 162 CLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVR---SDGHIMLTDFDLSLKG 238 (457)
Q Consensus 162 ~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~---~~~~vkl~DFG~s~~~ 238 (457)
|+|||||.+++|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++...
T Consensus 97 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 174 (486)
T 3mwu_A 97 YIVGELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174 (486)
T ss_dssp EEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTB
T ss_pred EEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeEC
Confidence 9999999999998887665 6799999999999999999999999999999999999995 4567999999998644
Q ss_pred CCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccc
Q 012762 239 DNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSF 318 (457)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (457)
.... .....
T Consensus 175 ~~~~-----------------------------------------------------------------------~~~~~ 183 (486)
T 3mwu_A 175 QQNT-----------------------------------------------------------------------KMKDR 183 (486)
T ss_dssp CCC---------------------------------------------------------------------------CC
T ss_pred CCCC-----------------------------------------------------------------------ccCCC
Confidence 3211 01123
Q ss_pred cCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCC--CCCCCChHHHHHHHHHhh
Q 012762 319 VGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFP--KEPSVPGPAKDLIAQLLV 396 (457)
Q Consensus 319 ~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ll~~~L~ 396 (457)
+||+.|+|||++.+. |+.++|||||||++|+|++|..||.+....+.+..+....+.++ .+..+++++++||.+||.
T Consensus 184 ~gt~~y~aPE~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~ 262 (486)
T 3mwu_A 184 IGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLT 262 (486)
T ss_dssp TTGGGGCCGGGGGSC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHHHHHHHHHHTC
T ss_pred cCCCCCCCHHHhCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHHHHHHHHHHcC
Confidence 699999999999874 99999999999999999999999999888888888887766544 335688999999999999
Q ss_pred hCCCCCCCCCcChHHHhcCCCCCCCC
Q 012762 397 KDPTRRMGSKMGATAIKRHQFFNGVN 422 (457)
Q Consensus 397 ~dP~~Rps~~~~~~~ll~hp~f~~~~ 422 (457)
.||.+||+ +.++|+||||+...
T Consensus 263 ~dp~~R~t----~~~~l~hp~~~~~~ 284 (486)
T 3mwu_A 263 FHPSLRIT----ATQCLEHPWIQKYS 284 (486)
T ss_dssp SSTTTSCC----HHHHHHCHHHHHTC
T ss_pred CChhhCcC----HHHHhcCHhhccCc
Confidence 99999999 99999999998643
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-49 Score=380.99 Aligned_cols=255 Identities=29% Similarity=0.487 Sum_probs=220.5
Q ss_pred CCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcE
Q 012762 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWS 161 (457)
Q Consensus 82 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~ 161 (457)
++|++.+.||+|+||+||+|+++ .+|+.||+|++..... .....+.+|+++++.++||||+++++++...+..
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~----~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (304)
T 2jam_A 9 KTFIFMEVLGSGAFSEVFLVKQR----LTGKLFALKCIKKSPA---FRDSSLENEIAVLKKIKHENIVTLEDIYESTTHY 81 (304)
T ss_dssp HHEEEEEEEEECSSEEEEEEEET----TTCCEEEEEEEECC---------HHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceeeeeccCCCCceEEEEEEC----CCCCEEEEEEEecccc---cchHHHHHHHHHHHhCCCCCeeehhhhcccCCEE
Confidence 57999999999999999999976 4788999999975432 2345677899999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEE---ccCCCEEEeccCCCcCC
Q 012762 162 CLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLV---RSDGHIMLTDFDLSLKG 238 (457)
Q Consensus 162 ~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll---~~~~~vkl~DFG~s~~~ 238 (457)
|+||||+++++|.+++... +.+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||++...
T Consensus 82 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~ 159 (304)
T 2jam_A 82 YLVMQLVSGGELFDRILER--GVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKME 159 (304)
T ss_dssp EEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCC
T ss_pred EEEEEcCCCccHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceec
Confidence 9999999999999888764 569999999999999999999999999999999999999 67889999999997533
Q ss_pred CCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccc
Q 012762 239 DNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSF 318 (457)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (457)
.... ....
T Consensus 160 ~~~~------------------------------------------------------------------------~~~~ 167 (304)
T 2jam_A 160 QNGI------------------------------------------------------------------------MSTA 167 (304)
T ss_dssp CCBT------------------------------------------------------------------------THHH
T ss_pred CCCc------------------------------------------------------------------------cccc
Confidence 2110 1123
Q ss_pred cCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCC--CCCCChHHHHHHHHHhh
Q 012762 319 VGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPK--EPSVPGPAKDLIAQLLV 396 (457)
Q Consensus 319 ~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ll~~~L~ 396 (457)
.||+.|+|||++.+..++.++|||||||++|+|++|..||.+.........+......++. ...++.++.+||.+||.
T Consensus 168 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~ 247 (304)
T 2jam_A 168 CGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDFICHLLE 247 (304)
T ss_dssp HSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHHHHHHHHHHC
T ss_pred cCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHHHHHHHHHHcC
Confidence 5999999999999999999999999999999999999999998887777777777655443 35688999999999999
Q ss_pred hCCCCCCCCCcChHHHhcCCCCCCC
Q 012762 397 KDPTRRMGSKMGATAIKRHQFFNGV 421 (457)
Q Consensus 397 ~dP~~Rps~~~~~~~ll~hp~f~~~ 421 (457)
.||++||+ +.++++||||++.
T Consensus 248 ~dp~~Rps----~~~~l~h~~~~~~ 268 (304)
T 2jam_A 248 KDPNERYT----CEKALSHPWIDGN 268 (304)
T ss_dssp SSTTTSCC----HHHHHTSHHHHSS
T ss_pred CChhHCcC----HHHHhcCccccCC
Confidence 99999999 9999999999863
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-48 Score=396.78 Aligned_cols=256 Identities=25% Similarity=0.326 Sum_probs=215.7
Q ss_pred ccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHc------CCCCCceEE
Q 012762 79 LTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEML------DHPFLPTLY 152 (457)
Q Consensus 79 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l------~H~nIv~l~ 152 (457)
....+|+++++||+|+||+||+|.++ .+++.||||++.... .....+..|+++++.+ +|+||++++
T Consensus 94 ~~~~ry~~~~~LG~G~fg~V~~a~~~----~~~~~vAvK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~ 165 (429)
T 3kvw_A 94 HVAYRYEVLKVIGKGSFGQVVKAYDH----KVHQHVALKMVRNEK----RFHRQAAEEIRILEHLRKQDKDNTMNVIHML 165 (429)
T ss_dssp EETTTEEEEEEEEESSSEEEEEEEET----TTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEE
T ss_pred cccCcEEEEEEcccCccEEEEEEEEC----CCCcEEEEEEECCcc----chHHHHHHHHHHHHHHhhccccCCcCEEEEE
Confidence 44568999999999999999999876 478999999997542 2345667788888877 577999999
Q ss_pred EEEEcCCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCC--EEEe
Q 012762 153 ATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGH--IMLT 230 (457)
Q Consensus 153 ~~~~~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~--vkl~ 230 (457)
+++...+.+||||||+ +++|.+++.......+++..++.++.||+.||.|||++|||||||||+||||+.++. +||+
T Consensus 166 ~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~ 244 (429)
T 3kvw_A 166 ENFTFRNHICMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVI 244 (429)
T ss_dssp EEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEEC
T ss_pred eecccCCeEEEEEecc-CCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEe
Confidence 9999999999999999 579999988876677999999999999999999999999999999999999999887 9999
Q ss_pred ccCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccC
Q 012762 231 DFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEP 310 (457)
Q Consensus 231 DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (457)
|||++......
T Consensus 245 DFG~a~~~~~~--------------------------------------------------------------------- 255 (429)
T 3kvw_A 245 DFGSSCYEHQR--------------------------------------------------------------------- 255 (429)
T ss_dssp CCTTCEETTCC---------------------------------------------------------------------
T ss_pred ecccceecCCc---------------------------------------------------------------------
Confidence 99997543211
Q ss_pred CccccccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCC-----------
Q 012762 311 LDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPK----------- 379 (457)
Q Consensus 311 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~----------- 379 (457)
..+.+||+.|+|||++.+..++.++|||||||++|||++|..||.+....+.+..++......+.
T Consensus 256 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~ 331 (429)
T 3kvw_A 256 ----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKN 331 (429)
T ss_dssp ----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBTTHHH
T ss_pred ----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhhhhhh
Confidence 11346999999999999999999999999999999999999999998877766665542111000
Q ss_pred ----------------------------------------------CCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHh
Q 012762 380 ----------------------------------------------EPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIK 413 (457)
Q Consensus 380 ----------------------------------------------~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll 413 (457)
....++++.+||.+||+.||++||| +.|+|
T Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpt----a~e~L 407 (429)
T 3kvw_A 332 FVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMT----PGQAL 407 (429)
T ss_dssp HBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCC----HHHHH
T ss_pred ccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCC----HHHHh
Confidence 0123677899999999999999999 99999
Q ss_pred cCCCCCC
Q 012762 414 RHQFFNG 420 (457)
Q Consensus 414 ~hp~f~~ 420 (457)
+||||+.
T Consensus 408 ~Hpw~~~ 414 (429)
T 3kvw_A 408 RHPWLRR 414 (429)
T ss_dssp TSTTTC-
T ss_pred CChhhcc
Confidence 9999985
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-49 Score=408.42 Aligned_cols=259 Identities=27% Similarity=0.407 Sum_probs=221.4
Q ss_pred CCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhh----------hHHHHHHHHHHHHHHcCCCCCce
Q 012762 81 LSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSR----------NKESRARIEREILEMLDHPFLPT 150 (457)
Q Consensus 81 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~----------~~~~~~~~E~~il~~l~H~nIv~ 150 (457)
.++|+++++||+|+||+||+|.++ .+++.||+|++.+...... .....+.+|+++|+.++||||++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~----~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~ 110 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEK----NGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIK 110 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEET----TTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCC
T ss_pred ccceEEEeEecccCCeEEEEEEEC----CCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCe
Confidence 468999999999999999999987 4788999999987543221 34567888999999999999999
Q ss_pred EEEEEEcCCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCC---CE
Q 012762 151 LYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDG---HI 227 (457)
Q Consensus 151 l~~~~~~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~---~v 227 (457)
+++++.+.+.+|||||||+||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+
T Consensus 111 ~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~ 188 (504)
T 3q5i_A 111 LFDVFEDKKYFYLVTEFYEGGELFEQIINR--HKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNI 188 (504)
T ss_dssp EEEEEECSSEEEEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSE
T ss_pred EEEEEEcCCEEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccE
Confidence 999999999999999999999998888765 6799999999999999999999999999999999999998776 69
Q ss_pred EEeccCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCccc
Q 012762 228 MLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIV 307 (457)
Q Consensus 228 kl~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (457)
||+|||++........
T Consensus 189 kl~Dfg~a~~~~~~~~---------------------------------------------------------------- 204 (504)
T 3q5i_A 189 KIVDFGLSSFFSKDYK---------------------------------------------------------------- 204 (504)
T ss_dssp EECCCTTCEECCTTSC----------------------------------------------------------------
T ss_pred EEEECCCCEEcCCCCc----------------------------------------------------------------
Confidence 9999999865432110
Q ss_pred ccCCccccccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCC--CCCCCh
Q 012762 308 AEPLDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPK--EPSVPG 385 (457)
Q Consensus 308 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~ 385 (457)
....+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+......+..+..+.+.++. ...+++
T Consensus 205 -------~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 276 (504)
T 3q5i_A 205 -------LRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNISD 276 (504)
T ss_dssp -------BCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCH
T ss_pred -------cccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccCCCCH
Confidence 113469999999999875 5899999999999999999999999999888888888887765542 256899
Q ss_pred HHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCCC
Q 012762 386 PAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGV 421 (457)
Q Consensus 386 ~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~~ 421 (457)
++++||.+||..||.+||+ +.|+|+||||+..
T Consensus 277 ~~~~li~~~L~~dp~~R~t----~~e~l~h~~~~~~ 308 (504)
T 3q5i_A 277 EAKELIKLMLTYDYNKRCT----AEEALNSRWIKKY 308 (504)
T ss_dssp HHHHHHHHHTCSSTTTSCC----HHHHHTSHHHHHT
T ss_pred HHHHHHHHHcCCChhHCCC----HHHHhcCHhhhhc
Confidence 9999999999999999999 9999999999753
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-49 Score=394.46 Aligned_cols=267 Identities=24% Similarity=0.360 Sum_probs=222.1
Q ss_pred CCCccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEE
Q 012762 76 NNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATL 155 (457)
Q Consensus 76 ~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~ 155 (457)
...+..++|++++.||+|+||+||+|.++ .++..||+|++.... .......+.+|+++|+.++||||+++++++
T Consensus 27 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~----~~~~~va~K~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 100 (360)
T 3eqc_A 27 VGELKDDDFEKISELGAGNGGVVFKVSHK----PSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAF 100 (360)
T ss_dssp CCCCCGGGEEEEEEEEECSSCEEEEEEET----TTCCEEEEEEEECCC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEE
T ss_pred ccccccccceeeeeecCCCCeEEEEEEEC----CCCcEEEEEEecccc--CHHHHHHHHHHHHHHHHCCCCCEEEEeEEE
Confidence 34567789999999999999999999986 478899999997642 234456788899999999999999999999
Q ss_pred EcCCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHc-CceeecCCCCCeEEccCCCEEEeccCC
Q 012762 156 DCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMM-GIIYRDLKPENVLVRSDGHIMLTDFDL 234 (457)
Q Consensus 156 ~~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~-~iiHrDIKp~NIll~~~~~vkl~DFG~ 234 (457)
..++..|+||||+++++|.+++... +.+++..+..++.||+.||.|||+. ||+||||||+|||++.++.+||+|||+
T Consensus 101 ~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 178 (360)
T 3eqc_A 101 YSDGEISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGV 178 (360)
T ss_dssp EETTEEEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCC
T ss_pred EECCEEEEEEECCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCC
Confidence 9999999999999999999998875 5699999999999999999999986 999999999999999999999999998
Q ss_pred CcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccc
Q 012762 235 SLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVR 314 (457)
Q Consensus 235 s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (457)
+...... .
T Consensus 179 ~~~~~~~------------------------------------------------------------------------~ 186 (360)
T 3eqc_A 179 SGQLIDS------------------------------------------------------------------------M 186 (360)
T ss_dssp CHHHHHH------------------------------------------------------------------------C
T ss_pred Ccccccc------------------------------------------------------------------------c
Confidence 7432110 0
Q ss_pred cccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHH--------------------------
Q 012762 315 SMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLA-------------------------- 368 (457)
Q Consensus 315 ~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~-------------------------- 368 (457)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||..........
T Consensus 187 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (360)
T 3eqc_A 187 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNK 266 (360)
T ss_dssp ----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-----------------------
T ss_pred ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcccc
Confidence 112469999999999999999999999999999999999999998765443221
Q ss_pred ----------------HHHhcccCCCCCCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCCCCchhh
Q 012762 369 ----------------NVVARALEFPKEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGVNWALL 426 (457)
Q Consensus 369 ----------------~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~~~~~~~ 426 (457)
.+............++.++.+||.+||..||++||+ +.|+++||||+..+|..+
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt----~~ell~hp~~~~~~~~~~ 336 (360)
T 3eqc_A 267 FGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERAD----LKQLMVHAFIKRSDAEEV 336 (360)
T ss_dssp -------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCC----HHHHHTSHHHHHHHHSCC
T ss_pred cccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCC----HHHHhhChHhhcchHhhh
Confidence 112222222222347889999999999999999999 999999999988666433
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-48 Score=389.36 Aligned_cols=257 Identities=29% Similarity=0.450 Sum_probs=220.6
Q ss_pred CCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhh-----hhhhHHHHHHHHHHHHHHc-CCCCCceEEEEE
Q 012762 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKREL-----VSRNKESRARIEREILEML-DHPFLPTLYATL 155 (457)
Q Consensus 82 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~-----~~~~~~~~~~~E~~il~~l-~H~nIv~l~~~~ 155 (457)
++|++.+.||+|+||+||+|.++ .+|+.||||++..... ........+.+|+++++.+ +||||+++++++
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~----~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 169 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHR----ATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY 169 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEET----TTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred hhcccceEEecCCCEEEEEEEEC----CCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEE
Confidence 46999999999999999999986 3789999999975431 1122345678899999999 899999999999
Q ss_pred EcCCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCC
Q 012762 156 DCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235 (457)
Q Consensus 156 ~~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s 235 (457)
...+..||||||++|++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.+|.+||+|||++
T Consensus 170 ~~~~~~~lv~e~~~g~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~ 247 (365)
T 2y7j_A 170 ESSSFMFLVFDLMRKGELFDYLTEK--VALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFS 247 (365)
T ss_dssp EBSSEEEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred eeCCEEEEEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcc
Confidence 9999999999999999999988764 57999999999999999999999999999999999999999999999999997
Q ss_pred cCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcccc
Q 012762 236 LKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRS 315 (457)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (457)
........ .
T Consensus 248 ~~~~~~~~-----------------------------------------------------------------------~ 256 (365)
T 2y7j_A 248 CHLEPGEK-----------------------------------------------------------------------L 256 (365)
T ss_dssp EECCTTCC-----------------------------------------------------------------------B
T ss_pred cccCCCcc-----------------------------------------------------------------------c
Confidence 65432110 1
Q ss_pred ccccCCCCccCchhhcCC------CCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCC--CCCCChHH
Q 012762 316 MSFVGTHEYLAPEIISGE------GHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPK--EPSVPGPA 387 (457)
Q Consensus 316 ~~~~gt~~y~aPE~l~~~------~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 387 (457)
...+||+.|+|||++.+. .++.++|||||||++|+|++|..||........+..+....+.++. ...++..+
T Consensus 257 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 336 (365)
T 2y7j_A 257 RELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDRSSTV 336 (365)
T ss_dssp CCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHHHSSSCHHH
T ss_pred ccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCcccccCCHHH
Confidence 124699999999999643 5788999999999999999999999988877777777766655442 24678899
Q ss_pred HHHHHHHhhhCCCCCCCCCcChHHHhcCCCCC
Q 012762 388 KDLIAQLLVKDPTRRMGSKMGATAIKRHQFFN 419 (457)
Q Consensus 388 ~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~ 419 (457)
.+||.+||..||++||+ +.++++||||+
T Consensus 337 ~~li~~~L~~dP~~Rps----~~ell~hp~f~ 364 (365)
T 2y7j_A 337 KDLISRLLQVDPEARLT----AEQALQHPFFE 364 (365)
T ss_dssp HHHHHHHSCSSTTTSCC----HHHHHHSGGGC
T ss_pred HHHHHHHcCCChhHCcC----HHHHhcCcccC
Confidence 99999999999999999 99999999997
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=387.17 Aligned_cols=260 Identities=24% Similarity=0.356 Sum_probs=213.2
Q ss_pred ccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCC--CCCceEEEEEE
Q 012762 79 LTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDH--PFLPTLYATLD 156 (457)
Q Consensus 79 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H--~nIv~l~~~~~ 156 (457)
+..++|++++.||+|+||+||+|.+. +++.||||++..... .......+.+|+++|+.++| +||+++++++.
T Consensus 6 ~~~~~y~i~~~lG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~ 79 (343)
T 3dbq_A 6 VKGRIYSILKQIGSGGSSKVFQVLNE-----KKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI 79 (343)
T ss_dssp SSSCEEEEEEEESCCSSEEEEEEECT-----TSCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred eecCEEEEEEEEecCCCeEEEEEEeC-----CCCEEEEEEeecccc-chHHHHHHHHHHHHHHhhhhcCCceEEEeeeEe
Confidence 45568999999999999999999863 688999999976532 23345678889999999976 99999999999
Q ss_pred cCCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCc
Q 012762 157 CPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSL 236 (457)
Q Consensus 157 ~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~ 236 (457)
.++.+|||||+ .+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++
T Consensus 80 ~~~~~~lv~e~-~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~ 155 (343)
T 3dbq_A 80 TDQYIYMVMEC-GNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIAN 155 (343)
T ss_dssp CSSEEEEEECC-CSEEHHHHHHHS--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSC
T ss_pred eCCEEEEEEeC-CCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeeccccc
Confidence 99999999995 489999999875 6799999999999999999999999999999999999996 6889999999986
Q ss_pred CCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccc
Q 012762 237 KGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSM 316 (457)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (457)
........ ....
T Consensus 156 ~~~~~~~~--------------------------------------------------------------------~~~~ 167 (343)
T 3dbq_A 156 QMQPDTTS--------------------------------------------------------------------VVKD 167 (343)
T ss_dssp CC------------------------------------------------------------------------------
T ss_pred ccCccccc--------------------------------------------------------------------ccCC
Confidence 55321110 0011
Q ss_pred cccCCCCccCchhhcC-----------CCCCccchhhhhhHHHHHHhcCCCCCCCCChH-HHHHHHHhcccCCCCCCCCC
Q 012762 317 SFVGTHEYLAPEIISG-----------EGHGNAVDWWTLGIFIFELFYGTTPFKGIDHE-LTLANVVARALEFPKEPSVP 384 (457)
Q Consensus 317 ~~~gt~~y~aPE~l~~-----------~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~ 384 (457)
..+||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... ..+..++............+
T Consensus 168 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (343)
T 3dbq_A 168 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPE 247 (343)
T ss_dssp --CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCCCCCSC
T ss_pred CCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCcccCCcccCC
Confidence 3469999999999975 56889999999999999999999999875443 34445554444444445577
Q ss_pred hHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCC
Q 012762 385 GPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNG 420 (457)
Q Consensus 385 ~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~ 420 (457)
.++.+||.+||+.||.+||+ +.|+++||||+.
T Consensus 248 ~~l~~li~~~L~~dp~~Rpt----~~e~l~hp~~~~ 279 (343)
T 3dbq_A 248 KDLQDVLKCCLKRDPKQRIS----IPELLAHPYVQI 279 (343)
T ss_dssp HHHHHHHHHHTCSSTTTSCC----HHHHHTSHHHHS
T ss_pred HHHHHHHHHHcCCChhHCCC----HHHHHhCccccc
Confidence 89999999999999999999 999999999974
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-49 Score=387.91 Aligned_cols=267 Identities=26% Similarity=0.343 Sum_probs=220.4
Q ss_pred CCccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEE
Q 012762 77 NPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLD 156 (457)
Q Consensus 77 ~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~ 156 (457)
.....++|++++.||+|+||+||+|+++ .+++.||+|++..... .......+.+|+++++.++||||+++++++.
T Consensus 20 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~----~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 94 (331)
T 4aaa_A 20 YFQSMEKYENLGLVGEGSYGMVMKCRNK----DTGRIVAIKKFLESDD-DKMVKKIAMREIKLLKQLRHENLVNLLEVCK 94 (331)
T ss_dssp CCBCGGGEEEEEEGGGGTTSSEEEEEET----TTCCEEEEEEEESCSS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hhhhhhhheeeeEEeecCCEEEEEEEEC----CCCceEEEEEEecCCC-chHHHHHHHHHHHHHhhCCCCCEeeEEEEee
Confidence 4456789999999999999999999986 4788999999865432 2334566778999999999999999999999
Q ss_pred cCCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCc
Q 012762 157 CPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSL 236 (457)
Q Consensus 157 ~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~ 236 (457)
..+..|+||||+++++|..++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.
T Consensus 95 ~~~~~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 172 (331)
T 4aaa_A 95 KKKRWYLVFEFVDHTILDDLELFP--NGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFAR 172 (331)
T ss_dssp ETTEEEEEEECCSEEHHHHHHHST--TCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC-
T ss_pred cCCEEEEEEecCCcchHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCce
Confidence 999999999999999998876654 569999999999999999999999999999999999999999999999999986
Q ss_pred CCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccc
Q 012762 237 KGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSM 316 (457)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (457)
....... ...
T Consensus 173 ~~~~~~~----------------------------------------------------------------------~~~ 182 (331)
T 4aaa_A 173 TLAAPGE----------------------------------------------------------------------VYD 182 (331)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred eecCCcc----------------------------------------------------------------------ccC
Confidence 5432110 001
Q ss_pred cccCCCCccCchhhcCC-CCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccC-------------------
Q 012762 317 SFVGTHEYLAPEIISGE-GHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALE------------------- 376 (457)
Q Consensus 317 ~~~gt~~y~aPE~l~~~-~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~------------------- 376 (457)
...||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.........++.....
T Consensus 183 ~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (331)
T 4aaa_A 183 DEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVR 262 (331)
T ss_dssp -CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTCC
T ss_pred CCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcccccccc
Confidence 23589999999999876 6899999999999999999999999988876666555432111
Q ss_pred CCC----------CCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCCCCch
Q 012762 377 FPK----------EPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGVNWA 424 (457)
Q Consensus 377 ~~~----------~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~~~~~ 424 (457)
.+. .+.+++.+.+||.+||+.||++||+ +.|+|+||||+..+|.
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt----~~ell~hp~f~~~~~~ 316 (331)
T 4aaa_A 263 LPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPF----CAELLHHDFFQMDGFA 316 (331)
T ss_dssp CCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCC----GGGGGGSHHHHGGGHH
T ss_pred CccccccchhhhcccchhHHHHHHHHHHhccCcccCCC----HHHHhcCchhccCChh
Confidence 111 1246889999999999999999999 9999999999987664
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-49 Score=391.23 Aligned_cols=256 Identities=25% Similarity=0.414 Sum_probs=215.3
Q ss_pred CCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhh-----hHHHHHHHHHHHHHHcCCCCCceEEEEEE
Q 012762 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSR-----NKESRARIEREILEMLDHPFLPTLYATLD 156 (457)
Q Consensus 82 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~-----~~~~~~~~E~~il~~l~H~nIv~l~~~~~ 156 (457)
++|++.+.||+|+||+||+|+++ .+++.||||++.+...... .....+.+|+++|+.++||||+++++++.
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~a~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~ 99 (335)
T 3dls_A 24 QKYSTMSPLGSGAFGFVWTAVDK----EKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFE 99 (335)
T ss_dssp HHEEEEEECSSSSSCSEEEEEET----TTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEE
T ss_pred cceEEEeEEEecCCEEEEEEEEC----CCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 47999999999999999999976 4789999999987643221 13345667999999999999999999999
Q ss_pred cCCcEEEEEeecCCC-ChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCC
Q 012762 157 CPRWSCLLTEFCPGG-DLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235 (457)
Q Consensus 157 ~~~~~~lV~E~~~~~-sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s 235 (457)
..+..++||||+.+| +|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 100 ~~~~~~lv~e~~~~g~~l~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a 177 (335)
T 3dls_A 100 NQGFFQLVMEKHGSGLDLFAFIDRH--PRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSA 177 (335)
T ss_dssp CSSEEEEEEECCTTSCBHHHHHHTC--CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred eCCEEEEEEEeCCCCccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccc
Confidence 999999999998666 999888775 57999999999999999999999999999999999999999999999999998
Q ss_pred cCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcccc
Q 012762 236 LKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRS 315 (457)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (457)
........ .
T Consensus 178 ~~~~~~~~-----------------------------------------------------------------------~ 186 (335)
T 3dls_A 178 AYLERGKL-----------------------------------------------------------------------F 186 (335)
T ss_dssp EECCTTCC-----------------------------------------------------------------------B
T ss_pred eECCCCCc-----------------------------------------------------------------------e
Confidence 65432111 1
Q ss_pred ccccCCCCccCchhhcCCCC-CccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHH
Q 012762 316 MSFVGTHEYLAPEIISGEGH-GNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQL 394 (457)
Q Consensus 316 ~~~~gt~~y~aPE~l~~~~~-~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~ 394 (457)
...+||+.|+|||++.+..+ +.++|||||||++|+|++|..||..... ....... ....++.++.+||.+|
T Consensus 187 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~~~~--~~~~~~~~l~~li~~~ 258 (335)
T 3dls_A 187 YTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE------TVEAAIH--PPYLVSKELMSLVSGL 258 (335)
T ss_dssp CEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG------GTTTCCC--CSSCCCHHHHHHHHHH
T ss_pred eccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH------HHhhccC--CCcccCHHHHHHHHHH
Confidence 13469999999999998886 8899999999999999999999976322 1122222 2334889999999999
Q ss_pred hhhCCCCCCCCCcChHHHhcCCCCCC------CCchhh
Q 012762 395 LVKDPTRRMGSKMGATAIKRHQFFNG------VNWALL 426 (457)
Q Consensus 395 L~~dP~~Rps~~~~~~~ll~hp~f~~------~~~~~~ 426 (457)
|..||++||+ +.+|++||||+. .+|..+
T Consensus 259 L~~dP~~Rps----~~ell~hp~~~~~~~~~~~~~~~~ 292 (335)
T 3dls_A 259 LQPVPERRTT----LEKLVTDPWVTQPVNLADYTWEEV 292 (335)
T ss_dssp TCSSGGGSCC----HHHHHHCTTTTCCCCGGGCCHHHH
T ss_pred ccCChhhCcC----HHHHhcCccccCCccccccCHHHH
Confidence 9999999999 999999999976 456544
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-49 Score=400.01 Aligned_cols=263 Identities=30% Similarity=0.467 Sum_probs=210.3
Q ss_pred CCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhh-----hHHHHHHHHHHHHHHcCCCCCceEEEEE
Q 012762 81 LSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSR-----NKESRARIEREILEMLDHPFLPTLYATL 155 (457)
Q Consensus 81 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~-----~~~~~~~~E~~il~~l~H~nIv~l~~~~ 155 (457)
.++|++.+.||+|+||+||+|.++ .+++.||||++.+...... .....+.+|+++|++++||||+++++++
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~ 209 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFER----KTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF 209 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEET----TTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEE
T ss_pred hccEEEEeEEeeCCCeEEEEEEEC----CCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 368999999999999999999987 4788999999987653321 2223477899999999999999999998
Q ss_pred EcCCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCC---CEEEecc
Q 012762 156 DCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDG---HIMLTDF 232 (457)
Q Consensus 156 ~~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~---~vkl~DF 232 (457)
.. +..|+||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+||
T Consensus 210 ~~-~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DF 286 (419)
T 3i6u_A 210 DA-EDYYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDF 286 (419)
T ss_dssp ES-SEEEEEEECCTTCBGGGGTSSS--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCS
T ss_pred ec-CceEEEEEcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeec
Confidence 65 4579999999999998877654 6799999999999999999999999999999999999997544 5999999
Q ss_pred CCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCc
Q 012762 233 DLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLD 312 (457)
Q Consensus 233 G~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (457)
|+++.......
T Consensus 287 G~a~~~~~~~~--------------------------------------------------------------------- 297 (419)
T 3i6u_A 287 GHSKILGETSL--------------------------------------------------------------------- 297 (419)
T ss_dssp STTTSCC-------------------------------------------------------------------------
T ss_pred ccceecCCCcc---------------------------------------------------------------------
Confidence 99865432110
Q ss_pred cccccccCCCCccCchhhcC---CCCCccchhhhhhHHHHHHhcCCCCCCCCChHHH-HHHHHhcccCCCC--CCCCChH
Q 012762 313 VRSMSFVGTHEYLAPEIISG---EGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELT-LANVVARALEFPK--EPSVPGP 386 (457)
Q Consensus 313 ~~~~~~~gt~~y~aPE~l~~---~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~-~~~~~~~~~~~~~--~~~~~~~ 386 (457)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||........ ...+......+.. ...+++.
T Consensus 298 --~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 375 (419)
T 3i6u_A 298 --MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEK 375 (419)
T ss_dssp ---------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHHHTTSCHH
T ss_pred --ccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchhhcccCHH
Confidence 113469999999999864 5678899999999999999999999987654433 3333334333321 2457899
Q ss_pred HHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCCCCchh
Q 012762 387 AKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGVNWAL 425 (457)
Q Consensus 387 ~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~~~~~~ 425 (457)
+.+||.+||+.||++||+ ++|+|+||||+..+|..
T Consensus 376 ~~~li~~~L~~dP~~Rps----~~e~l~hp~~~~~~~~~ 410 (419)
T 3i6u_A 376 ALDLVKKLLVVDPKARFT----TEEALRHPWLQDEDMKR 410 (419)
T ss_dssp HHHHHHHHSCSSTTTSCC----HHHHHHSGGGCCHHHHH
T ss_pred HHHHHHHHccCChhHCcC----HHHHhCCcccCChhHHH
Confidence 999999999999999999 99999999999877743
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-48 Score=379.15 Aligned_cols=260 Identities=22% Similarity=0.344 Sum_probs=214.4
Q ss_pred CCCCCccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEE
Q 012762 74 NNNNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYA 153 (457)
Q Consensus 74 ~~~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~ 153 (457)
.....+..++|++.++||+|+||+||+|++ .+..||||++..... .......+.+|+++|++++||||+++++
T Consensus 29 ~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~------~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~ 101 (309)
T 3p86_A 29 GDDMDIPWCDLNIKEKIGAGSFGTVHRAEW------HGSDVAVKILMEQDF-HAERVNEFLREVAIMKRLRHPNIVLFMG 101 (309)
T ss_dssp ---CBCCGGGEEEEEEEEECSSEEEEEEEE------TTEEEEEEEECCCCC-SHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccccCChhHceeeeEeecCCCeEEEEEEE------CCCcEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEE
Confidence 345567778999999999999999999975 577899999976543 2334567888999999999999999999
Q ss_pred EEEcCCcEEEEEeecCCCChHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHcC--ceeecCCCCCeEEccCCCEEEe
Q 012762 154 TLDCPRWSCLLTEFCPGGDLHVLRQRQPD-KRFHESAVRFYASEVVVALEFLHMMG--IIYRDLKPENVLVRSDGHIMLT 230 (457)
Q Consensus 154 ~~~~~~~~~lV~E~~~~~sL~~~~~~~~~-~~~~~~~~~~i~~qi~~~L~yLH~~~--iiHrDIKp~NIll~~~~~vkl~ 230 (457)
++...+..|+||||+++++|.+++..... ..+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+
T Consensus 102 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~ 181 (309)
T 3p86_A 102 AVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVC 181 (309)
T ss_dssp EECSTTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEEC
T ss_pred EEEECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEEC
Confidence 99999999999999999999999876421 23899999999999999999999999 9999999999999999999999
Q ss_pred ccCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccC
Q 012762 231 DFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEP 310 (457)
Q Consensus 231 DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (457)
|||+++.......
T Consensus 182 Dfg~a~~~~~~~~------------------------------------------------------------------- 194 (309)
T 3p86_A 182 DFGLSRLKASTFL------------------------------------------------------------------- 194 (309)
T ss_dssp CCC-----------------------------------------------------------------------------
T ss_pred CCCCCcccccccc-------------------------------------------------------------------
Confidence 9999864321100
Q ss_pred CccccccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHH
Q 012762 311 LDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDL 390 (457)
Q Consensus 311 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 390 (457)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.........+............++.++.+|
T Consensus 195 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 271 (309)
T 3p86_A 195 ---SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAI 271 (309)
T ss_dssp ----------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHHH
T ss_pred ---ccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHHH
Confidence 01124699999999999999999999999999999999999999999887777776655555555556799999999
Q ss_pred HHHHhhhCCCCCCCCCcChHHHhc
Q 012762 391 IAQLLVKDPTRRMGSKMGATAIKR 414 (457)
Q Consensus 391 l~~~L~~dP~~Rps~~~~~~~ll~ 414 (457)
|.+||..||.+||+ +.+|++
T Consensus 272 i~~~l~~dP~~Rps----~~~ll~ 291 (309)
T 3p86_A 272 IEGCWTNEPWKRPS----FATIMD 291 (309)
T ss_dssp HHHHTCSSGGGSCC----HHHHHH
T ss_pred HHHHccCChhhCcC----HHHHHH
Confidence 99999999999999 888876
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-49 Score=386.51 Aligned_cols=256 Identities=25% Similarity=0.376 Sum_probs=209.1
Q ss_pred ccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcC-CCCCceEEEEEEc
Q 012762 79 LTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLD-HPFLPTLYATLDC 157 (457)
Q Consensus 79 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~-H~nIv~l~~~~~~ 157 (457)
...++|++++.||+|+||+||+|++. .+++.||||++... ....+.+|+++|+.+. ||||+++++++..
T Consensus 33 ~~~~~y~~~~~lg~G~~g~V~~~~~~----~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~ 102 (330)
T 3nsz_A 33 GNQDDYQLVRKLGRGKYSEVFEAINI----TNNEKVVVKILKPV------KKKKIKREIKILENLRGGPNIITLADIVKD 102 (330)
T ss_dssp EEGGGEEEEEEEEECSSEEEEEEEET----TTCCEEEEEEECSC------CHHHHHHHHHHHHHHTTSTTBCCEEEEEEC
T ss_pred cCCCceEEEEEecccCCeEEEEEEEC----CCCcEEEEEEeccc------chHHHHHHHHHHHHcCCCCCEEEeeeeecc
Confidence 44578999999999999999999876 47889999999643 3456788999999997 9999999999987
Q ss_pred --CCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCC-CEEEeccCC
Q 012762 158 --PRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDG-HIMLTDFDL 234 (457)
Q Consensus 158 --~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~-~vkl~DFG~ 234 (457)
....++||||+++++|..++.. +++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+
T Consensus 103 ~~~~~~~lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~ 177 (330)
T 3nsz_A 103 PVSRTPALVFEHVNNTDFKQLYQT-----LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGL 177 (330)
T ss_dssp TTTCCEEEEEECCCCCCHHHHGGG-----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTT
T ss_pred CCCCceEEEEeccCchhHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCC
Confidence 6678999999999999887743 89999999999999999999999999999999999999777 899999999
Q ss_pred CcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccc
Q 012762 235 SLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVR 314 (457)
Q Consensus 235 s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (457)
++.......
T Consensus 178 a~~~~~~~~----------------------------------------------------------------------- 186 (330)
T 3nsz_A 178 AEFYHPGQE----------------------------------------------------------------------- 186 (330)
T ss_dssp CEECCTTCC-----------------------------------------------------------------------
T ss_pred ceEcCCCCc-----------------------------------------------------------------------
Confidence 865432111
Q ss_pred cccccCCCCccCchhhcC-CCCCccchhhhhhHHHHHHhcCCCCCCCCC-hHHHHHHHHh-------------cccCC--
Q 012762 315 SMSFVGTHEYLAPEIISG-EGHGNAVDWWTLGIFIFELFYGTTPFKGID-HELTLANVVA-------------RALEF-- 377 (457)
Q Consensus 315 ~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlG~il~elltG~~Pf~~~~-~~~~~~~~~~-------------~~~~~-- 377 (457)
.....||..|+|||++.+ ..++.++|||||||++|+|++|..||.... ....+..+.. .....
T Consensus 187 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (330)
T 3nsz_A 187 YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDP 266 (330)
T ss_dssp CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCT
T ss_pred cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhcccccc
Confidence 112358999999999987 568999999999999999999999995543 2222222111 00000
Q ss_pred --------------------CCCCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCCCCch
Q 012762 378 --------------------PKEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGVNWA 424 (457)
Q Consensus 378 --------------------~~~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~~~~~ 424 (457)
.....++.++.+||.+||..||++||| ++|+|+||||+++.|+
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt----a~e~l~hp~f~~~~~~ 329 (330)
T 3nsz_A 267 RFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLT----AREAMEHPYFYTVVKD 329 (330)
T ss_dssp HHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCC----HHHHHTSGGGTTCC--
T ss_pred chhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCC----HHHHhcCccHhhhccC
Confidence 011226889999999999999999999 9999999999998775
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-49 Score=379.07 Aligned_cols=263 Identities=29% Similarity=0.461 Sum_probs=224.4
Q ss_pred CCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhh---hHHHHHHHHHHHHHHcCCCCCceEEEEEEcC
Q 012762 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSR---NKESRARIEREILEMLDHPFLPTLYATLDCP 158 (457)
Q Consensus 82 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~---~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~ 158 (457)
++|++.+.||+|+||+||+|+++ .+++.||+|++........ .....+.+|+++|++++||||+++++++...
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~----~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 80 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQK----GTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENK 80 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEET----TTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhHHhhcccCceEEEEEEEc----CCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCC
Confidence 47999999999999999999986 3788999999976543221 1356788899999999999999999999999
Q ss_pred CcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCC----CEEEeccCC
Q 012762 159 RWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDG----HIMLTDFDL 234 (457)
Q Consensus 159 ~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~----~vkl~DFG~ 234 (457)
+..|+||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++.++ .+||+|||+
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~ 158 (283)
T 3bhy_A 81 TDVVLILELVSGGELFDFLAEK--ESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGI 158 (283)
T ss_dssp SEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred CeEEEEEeecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEeccc
Confidence 9999999999999999998764 5799999999999999999999999999999999999998877 899999999
Q ss_pred CcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccc
Q 012762 235 SLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVR 314 (457)
Q Consensus 235 s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (457)
+........
T Consensus 159 ~~~~~~~~~----------------------------------------------------------------------- 167 (283)
T 3bhy_A 159 AHKIEAGNE----------------------------------------------------------------------- 167 (283)
T ss_dssp CEECC---------------------------------------------------------------------------
T ss_pred ceeccCCCc-----------------------------------------------------------------------
Confidence 764432110
Q ss_pred cccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCC--CCCCChHHHHHHH
Q 012762 315 SMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPK--EPSVPGPAKDLIA 392 (457)
Q Consensus 315 ~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ll~ 392 (457)
.....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.........+......++. ...++..+.+||.
T Consensus 168 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 247 (283)
T 3bhy_A 168 FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAKDFIR 247 (283)
T ss_dssp ----CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTCCHHHHHHHH
T ss_pred ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccCCHHHHHHHH
Confidence 01235899999999999999999999999999999999999999998877777776665544432 2457889999999
Q ss_pred HHhhhCCCCCCCCCcChHHHhcCCCCCCCCchh
Q 012762 393 QLLVKDPTRRMGSKMGATAIKRHQFFNGVNWAL 425 (457)
Q Consensus 393 ~~L~~dP~~Rps~~~~~~~ll~hp~f~~~~~~~ 425 (457)
+||..||++||+ +.++++||||+.++|..
T Consensus 248 ~~l~~dp~~Rps----~~~~l~h~~~~~~~~~~ 276 (283)
T 3bhy_A 248 RLLVKDPKRRMT----IAQSLEHSWIKAIRRRN 276 (283)
T ss_dssp TTSCSSGGGSCC----HHHHHHCHHHHHHHHCC
T ss_pred HHccCCHhHCcC----HHHHHhCHHHHHHHHHh
Confidence 999999999999 99999999999766543
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=373.34 Aligned_cols=260 Identities=23% Similarity=0.391 Sum_probs=217.8
Q ss_pred CCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcE
Q 012762 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWS 161 (457)
Q Consensus 82 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~ 161 (457)
++|++.+.||+|+||+||+|.++ .+++.||+|++..... ......+.+|+++++.++||||+++++++...+..
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~----~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNR----VTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQ 80 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEET----TTCCEEEEEEEEGGGC--TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred cceEEEEEeecCCCcEEEEEEEC----CCCcEEEEEEeeeccc--hhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEE
Confidence 57999999999999999999976 4788999999976532 23456788899999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCC
Q 012762 162 CLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNS 241 (457)
Q Consensus 162 ~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~ 241 (457)
|+||||+++++|.+++... ..+++..++.++.||+.||.|||++||+|+||||+||+++.++.+||+|||++......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 158 (276)
T 2yex_A 81 YLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (276)
T ss_dssp EEEEECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred EEEEEecCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCC
Confidence 9999999999998887653 57999999999999999999999999999999999999999999999999997544211
Q ss_pred CcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCC
Q 012762 242 TSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGT 321 (457)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 321 (457)
... .......||
T Consensus 159 ~~~--------------------------------------------------------------------~~~~~~~~~ 170 (276)
T 2yex_A 159 NRE--------------------------------------------------------------------RLLNKMCGT 170 (276)
T ss_dssp TEE--------------------------------------------------------------------CCBCCCCSC
T ss_pred cch--------------------------------------------------------------------hcccCCccc
Confidence 100 001134689
Q ss_pred CCccCchhhcCCCC-CccchhhhhhHHHHHHhcCCCCCCCCChH-HHHHHHHhcccCCCCCCCCChHHHHHHHHHhhhCC
Q 012762 322 HEYLAPEIISGEGH-GNAVDWWTLGIFIFELFYGTTPFKGIDHE-LTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDP 399 (457)
Q Consensus 322 ~~y~aPE~l~~~~~-~~~sDiwSlG~il~elltG~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP 399 (457)
+.|+|||++.+..+ +.++|||||||++|+|++|..||...... .....+.......+....++..+.+||.+||+.||
T Consensus 171 ~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 250 (276)
T 2yex_A 171 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENP 250 (276)
T ss_dssp GGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSST
T ss_pred cCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHHHHHHHHCCCCc
Confidence 99999999988775 78999999999999999999999876543 23333443333334445688999999999999999
Q ss_pred CCCCCCCcChHHHhcCCCCCCC
Q 012762 400 TRRMGSKMGATAIKRHQFFNGV 421 (457)
Q Consensus 400 ~~Rps~~~~~~~ll~hp~f~~~ 421 (457)
++||+ +.||++||||+..
T Consensus 251 ~~Rps----~~~il~~~~~~~~ 268 (276)
T 2yex_A 251 SARIT----IPDIKKDRWYNKP 268 (276)
T ss_dssp TTSCC----HHHHTTCTTTTCC
T ss_pred hhCCC----HHHHhcCccccCh
Confidence 99999 9999999999864
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-49 Score=385.35 Aligned_cols=268 Identities=23% Similarity=0.380 Sum_probs=206.5
Q ss_pred CCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCC--
Q 012762 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPR-- 159 (457)
Q Consensus 82 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~-- 159 (457)
++|++++.||+|+||+||+|+++ .+|+.||||++.... .......+.+|+++|++++||||+++++++.+..
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~----~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 79 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNK----VDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPE 79 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEET----TTCCEEEEEEEECCS--TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSC
T ss_pred hcCceeeEecCCCCeEEEEEEEc----CCCcEEEEEEeecCC--chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccc
Confidence 57999999999999999999986 478899999997543 2345577889999999999999999999986543
Q ss_pred -------------------------------------------------------cEEEEEeecCCCChHHHHHhCCC-C
Q 012762 160 -------------------------------------------------------WSCLLTEFCPGGDLHVLRQRQPD-K 183 (457)
Q Consensus 160 -------------------------------------------------------~~~lV~E~~~~~sL~~~~~~~~~-~ 183 (457)
+.|+|||||++++|.+++..... .
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~ 159 (332)
T 3qd2_B 80 KWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLE 159 (332)
T ss_dssp HHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGG
T ss_pred hhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCcc
Confidence 37999999999999999887532 2
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCCCcccccccCCCCCCCCCCCCCC
Q 012762 184 RFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDC 263 (457)
Q Consensus 184 ~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (457)
...+..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.............
T Consensus 160 ~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~-------------- 225 (332)
T 3qd2_B 160 DREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLT-------------- 225 (332)
T ss_dssp GSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC----------------------
T ss_pred chhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccc--------------
Confidence 356667899999999999999999999999999999999999999999999876643221110000
Q ss_pred CCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCCCCccCchhhcCCCCCccchhhh
Q 012762 264 AVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWT 343 (457)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwS 343 (457)
..+........+||+.|+|||++.+..++.++||||
T Consensus 226 --------------------------------------------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s 261 (332)
T 3qd2_B 226 --------------------------------------------PMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFS 261 (332)
T ss_dssp --------------------------------------------------CCCSCC-CGGGSCHHHHHCCCCCTHHHHHH
T ss_pred --------------------------------------------cccccccccccCCCcCccChHHhcCCCCcchhhHHH
Confidence 000001112346999999999999999999999999
Q ss_pred hhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCC-CCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCCC
Q 012762 344 LGIFIFELFYGTTPFKGIDHELTLANVVARALEFPK-EPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGV 421 (457)
Q Consensus 344 lG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~~ 421 (457)
|||++|||++|..|+.. .......+... ..+. ....++++.+||.+||+.||++||+ +.|+++||||+++
T Consensus 262 lG~il~el~~~~~~~~~--~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rps----~~~~l~~~~f~~~ 332 (332)
T 3qd2_B 262 LGLILFELLYSFSTQME--RVRIITDVRNL--KFPLLFTQKYPQEHMMVQDMLSPSPTERPE----ATDIIENAIFENL 332 (332)
T ss_dssp HHHHHHHHHSCCCCHHH--HHHHHHHHHTT--CCCHHHHHHCHHHHHHHHHHHCSSGGGSCC----HHHHHHSTTCCCC
T ss_pred HHHHHHHHHHcCCChhH--HHHHHHHhhcc--CCCcccccCChhHHHHHHHHccCCCCcCCC----HHHHhhchhhhcC
Confidence 99999999998876532 11122222211 1221 1234577899999999999999999 9999999999864
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-49 Score=389.72 Aligned_cols=269 Identities=21% Similarity=0.371 Sum_probs=229.6
Q ss_pred CCccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhH--------------HHHHHHHHHHHHH
Q 012762 77 NPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNK--------------ESRARIEREILEM 142 (457)
Q Consensus 77 ~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~--------------~~~~~~E~~il~~ 142 (457)
.....++|++.+.||+|+||+||+|.+ +++.||+|++.......... ...+.+|+++++.
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~V~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 99 (348)
T 2pml_X 26 KDKYINDYRIIRTLNQGKFNKIILCEK------DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITD 99 (348)
T ss_dssp SCEEETTEEEEEEEECCSSCCEEEEEE------TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTT
T ss_pred cccccCceEEEEEEcCCCCeEEEEEEc------CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHh
Confidence 445668999999999999999999986 68899999998765432221 1678889999999
Q ss_pred cCCCCCceEEEEEEcCCcEEEEEeecCCCChHHH------HHhCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCceeecCC
Q 012762 143 LDHPFLPTLYATLDCPRWSCLLTEFCPGGDLHVL------RQRQPDKRFHESAVRFYASEVVVALEFLHM-MGIIYRDLK 215 (457)
Q Consensus 143 l~H~nIv~l~~~~~~~~~~~lV~E~~~~~sL~~~------~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~-~~iiHrDIK 215 (457)
++||||+++++++...+..|+||||+++++|.++ +.......+++..++.++.||+.||.|||+ .||+|||||
T Consensus 100 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~ 179 (348)
T 2pml_X 100 IKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVK 179 (348)
T ss_dssp CCCTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCC
T ss_pred CCCCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCC
Confidence 9999999999999999999999999999999887 555445789999999999999999999999 999999999
Q ss_pred CCCeEEccCCCEEEeccCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhcc
Q 012762 216 PENVLVRSDGHIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRK 295 (457)
Q Consensus 216 p~NIll~~~~~vkl~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (457)
|+|||++.++.+||+|||++......
T Consensus 180 p~Nil~~~~~~~kl~dfg~~~~~~~~------------------------------------------------------ 205 (348)
T 2pml_X 180 PSNILMDKNGRVKLSDFGESEYMVDK------------------------------------------------------ 205 (348)
T ss_dssp GGGEEECTTSCEEECCCTTCEECBTT------------------------------------------------------
T ss_pred hHhEEEcCCCcEEEeccccccccccc------------------------------------------------------
Confidence 99999999999999999997644211
Q ss_pred ccCCCCCCCcccccCCccccccccCCCCccCchhhcCC-CCCc-cchhhhhhHHHHHHhcCCCCCCCCCh-HHHHHHHHh
Q 012762 296 KKLGNPGTPEIVAEPLDVRSMSFVGTHEYLAPEIISGE-GHGN-AVDWWTLGIFIFELFYGTTPFKGIDH-ELTLANVVA 372 (457)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~-~sDiwSlG~il~elltG~~Pf~~~~~-~~~~~~~~~ 372 (457)
......||..|+|||++.+. .++. ++|||||||++|||++|..||..... ......+..
T Consensus 206 ------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~i~~ 267 (348)
T 2pml_X 206 ------------------KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRT 267 (348)
T ss_dssp ------------------EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHHHTS
T ss_pred ------------------cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhc
Confidence 01123589999999999987 5666 99999999999999999999998776 566666666
Q ss_pred cccCCCCC-----------------CCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCCCCchhhh
Q 012762 373 RALEFPKE-----------------PSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGVNWALLR 427 (457)
Q Consensus 373 ~~~~~~~~-----------------~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~~~~~~~~ 427 (457)
....++.. ..++.++.+||.+||+.||.+||+ +.|+++||||+..+|..+.
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps----~~e~l~hp~f~~~~~~~~~ 335 (348)
T 2pml_X 268 KNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERIT----SEDALKHEWLADTNIEDLR 335 (348)
T ss_dssp CCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCC----HHHHHTSGGGTTCCHHHHH
T ss_pred cCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCC----HHHHhcCccccCCCHHHHH
Confidence 65555532 458899999999999999999999 9999999999999997654
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-48 Score=386.66 Aligned_cols=259 Identities=20% Similarity=0.327 Sum_probs=214.9
Q ss_pred CCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcC---
Q 012762 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCP--- 158 (457)
Q Consensus 82 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~--- 158 (457)
++|++++.||+|+||+||+|.+. .+++.||||++.... .......+.+|+++|++++||||+++++++...
T Consensus 27 ~~y~~~~~lG~G~~g~V~~~~~~----~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 100 (364)
T 3qyz_A 27 PRYTNLSYIGEGAYGMVCSAYDN----LNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIE 100 (364)
T ss_dssp TTEEEEEEEEECSSEEEEEEEET----TTTEEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTT
T ss_pred ccEEEEEEeecCCCeEEEEEEEC----CCCeEEEEEEecccc--CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCcc
Confidence 58999999999999999999876 478899999997532 233456788899999999999999999999655
Q ss_pred --CcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCc
Q 012762 159 --RWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSL 236 (457)
Q Consensus 159 --~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~ 236 (457)
...|+||||++ ++|..++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 101 ~~~~~~iv~e~~~-~~L~~~l~~---~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~ 176 (364)
T 3qyz_A 101 QMKDVYIVQDLME-TDLYKLLKT---QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLAR 176 (364)
T ss_dssp TCCCEEEEEECCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred ccceEEEEEcccC-cCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceE
Confidence 46899999995 699988876 569999999999999999999999999999999999999999999999999986
Q ss_pred CCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccc
Q 012762 237 KGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSM 316 (457)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (457)
........ .....
T Consensus 177 ~~~~~~~~-------------------------------------------------------------------~~~~~ 189 (364)
T 3qyz_A 177 VADPDHDH-------------------------------------------------------------------TGFLT 189 (364)
T ss_dssp ECCGGGCB-------------------------------------------------------------------CCTTC
T ss_pred ecCCCCCc-------------------------------------------------------------------ccccc
Confidence 54321110 00011
Q ss_pred cccCCCCccCchhhcC-CCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCC-----------------
Q 012762 317 SFVGTHEYLAPEIISG-EGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFP----------------- 378 (457)
Q Consensus 317 ~~~gt~~y~aPE~l~~-~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~----------------- 378 (457)
..+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+......+..++......+
T Consensus 190 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (364)
T 3qyz_A 190 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLL 269 (364)
T ss_dssp CCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHHHHHHHH
T ss_pred ccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHH
Confidence 3469999999998765 4589999999999999999999999998877666666553211111
Q ss_pred ---C---------CCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCCC
Q 012762 379 ---K---------EPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGV 421 (457)
Q Consensus 379 ---~---------~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~~ 421 (457)
. ...++.++.+||.+||..||++||+ +.|+|+||||+..
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t----~~e~l~hp~~~~~ 320 (364)
T 3qyz_A 270 SLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIE----VEQALAHPYLEQY 320 (364)
T ss_dssp TSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCC----HHHHHTSGGGTTT
T ss_pred hcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCC----HHHHhcCcchhhc
Confidence 0 1346789999999999999999999 9999999999975
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=393.08 Aligned_cols=261 Identities=24% Similarity=0.365 Sum_probs=214.6
Q ss_pred ccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcC--CCCCceEEEEEE
Q 012762 79 LTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLD--HPFLPTLYATLD 156 (457)
Q Consensus 79 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~--H~nIv~l~~~~~ 156 (457)
+...+|++++.||+|+||+||+|.+. .++.||||++..... .......+.+|+++|++++ |+||+++++++.
T Consensus 53 ~~~~~y~~~~~LG~G~fg~Vy~~~~~-----~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~ 126 (390)
T 2zmd_A 53 VKGRIYSILKQIGSGGSSKVFQVLNE-----KKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI 126 (390)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEECT-----TCCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred ccCCceEEEEEEccCCCeEEEEEEcC-----CCCEEEEEEEecccc-cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEe
Confidence 34456999999999999999999864 478999999976543 2345567888999999996 599999999999
Q ss_pred cCCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCc
Q 012762 157 CPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSL 236 (457)
Q Consensus 157 ~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~ 236 (457)
.++.+||||| +.+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++
T Consensus 127 ~~~~~~lv~E-~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~ 202 (390)
T 2zmd_A 127 TDQYIYMVME-CGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIAN 202 (390)
T ss_dssp CSSEEEEEEE-CCSEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSC
T ss_pred cCCEEEEEEe-cCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccc
Confidence 9999999999 5589999998875 5789999999999999999999999999999999999995 6899999999986
Q ss_pred CCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccc
Q 012762 237 KGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSM 316 (457)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (457)
........ ....
T Consensus 203 ~~~~~~~~--------------------------------------------------------------------~~~~ 214 (390)
T 2zmd_A 203 QMQPDTTS--------------------------------------------------------------------VVKD 214 (390)
T ss_dssp CC-----------------------------------------------------------------------------C
T ss_pred cccCCCcc--------------------------------------------------------------------ccCC
Confidence 55321110 0011
Q ss_pred cccCCCCccCchhhcC-----------CCCCccchhhhhhHHHHHHhcCCCCCCCCChH-HHHHHHHhcccCCCCCCCCC
Q 012762 317 SFVGTHEYLAPEIISG-----------EGHGNAVDWWTLGIFIFELFYGTTPFKGIDHE-LTLANVVARALEFPKEPSVP 384 (457)
Q Consensus 317 ~~~gt~~y~aPE~l~~-----------~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~ 384 (457)
..+||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... ..+..++......+.....+
T Consensus 215 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (390)
T 2zmd_A 215 SQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPE 294 (390)
T ss_dssp CSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCCCCCCCSC
T ss_pred CCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccCCCCccch
Confidence 3469999999999976 35889999999999999999999999876443 45555555555554445568
Q ss_pred hHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCCC
Q 012762 385 GPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGV 421 (457)
Q Consensus 385 ~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~~ 421 (457)
.++.+||.+||..||.+||+ +.|+++||||+..
T Consensus 295 ~~~~~li~~~L~~dP~~Rps----~~ell~hp~~~~~ 327 (390)
T 2zmd_A 295 KDLQDVLKCCLKRDPKQRIS----IPELLAHPYVQIQ 327 (390)
T ss_dssp HHHHHHHHHHTCSSTTTSCC----HHHHHTSHHHHSC
T ss_pred HHHHHHHHHHcccChhhCCC----HHHHhhCcCcccc
Confidence 89999999999999999999 9999999999754
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=390.98 Aligned_cols=258 Identities=27% Similarity=0.370 Sum_probs=201.8
Q ss_pred CCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcC--
Q 012762 81 LSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCP-- 158 (457)
Q Consensus 81 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~-- 158 (457)
.++|++++.||+|+||+||+|.+. .+|+.||||++.... .......++.+|+++|+.++||||+++++++...
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~----~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 102 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDT----KTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS 102 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEET----TTTEEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSS
T ss_pred CCceEEeeEEeecCCeEEEEEEEC----CCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCc
Confidence 368999999999999999999876 488999999996532 2334556778899999999999999999999654
Q ss_pred ----CcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCC
Q 012762 159 ----RWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDL 234 (457)
Q Consensus 159 ----~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~ 234 (457)
...|+|||++ +++|..++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 103 ~~~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~ 178 (367)
T 2fst_X 103 LEEFNDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGL 178 (367)
T ss_dssp GGGCCCCEEEEECC-CEECC--------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC---
T ss_pred cccCCeEEEEeccc-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeeccc
Confidence 5679999999 8999888765 5699999999999999999999999999999999999999999999999999
Q ss_pred CcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccc
Q 012762 235 SLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVR 314 (457)
Q Consensus 235 s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (457)
++.....
T Consensus 179 a~~~~~~------------------------------------------------------------------------- 185 (367)
T 2fst_X 179 ARHTADE------------------------------------------------------------------------- 185 (367)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred ccccccc-------------------------------------------------------------------------
Confidence 8543211
Q ss_pred cccccCCCCccCchhhcC-CCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCC----------------
Q 012762 315 SMSFVGTHEYLAPEIISG-EGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEF---------------- 377 (457)
Q Consensus 315 ~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~---------------- 377 (457)
....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+....+..++......
T Consensus 186 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~ 265 (367)
T 2fst_X 186 MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 265 (367)
T ss_dssp -----CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHHHHH
T ss_pred CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHH
Confidence 112469999999999987 568999999999999999999999999988766665554421111
Q ss_pred -------CC------CCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCCCCch
Q 012762 378 -------PK------EPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGVNWA 424 (457)
Q Consensus 378 -------~~------~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~~~~~ 424 (457)
+. ....++++.+||.+||..||.+||+ +.|+|+||||+.....
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t----~~e~L~hp~~~~~~~~ 321 (367)
T 2fst_X 266 IQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT----AAQALAHAYFAQYHDP 321 (367)
T ss_dssp HHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCC----HHHHHTSGGGTTTCCG
T ss_pred HhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcC----HHHHhcChhhhhccCC
Confidence 10 1245788999999999999999999 9999999999976554
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-48 Score=386.14 Aligned_cols=267 Identities=26% Similarity=0.346 Sum_probs=216.1
Q ss_pred cCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEc--
Q 012762 80 TLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDC-- 157 (457)
Q Consensus 80 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~-- 157 (457)
..++|+++++||+|+||+||+|+++ .+|+.||+|++..... .......+.+|+++|+.++||||+++++++..
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~----~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 89 (351)
T 3mi9_A 15 EVSKYEKLAKIGQGTFGEVFKARHR----KTGQKVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKA 89 (351)
T ss_dssp BGGGEEEEEECSSCSTTSEEEEEET----TTCCEEEEEECCCSSC-SSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-
T ss_pred cccceeEEEEEecCCCcEEEEEEEC----CCCCEEEEEEEecccc-cccchHHHHHHHHHHHhccCCCcccHhheeeccc
Confidence 4578999999999999999999986 4788999999865532 22234556789999999999999999999876
Q ss_pred ------CCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEec
Q 012762 158 ------PRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTD 231 (457)
Q Consensus 158 ------~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~D 231 (457)
.+.+|+||||++ ++|...+... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|
T Consensus 90 ~~~~~~~~~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~D 167 (351)
T 3mi9_A 90 SPYNRCKGSIYLVFDFCE-HDLAGLLSNV-LVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLAD 167 (351)
T ss_dssp -------CEEEEEEECCS-EEHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECC
T ss_pred cccccCCceEEEEEeccC-CCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEcc
Confidence 446899999996 5776666543 35699999999999999999999999999999999999999999999999
Q ss_pred cCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCC
Q 012762 232 FDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPL 311 (457)
Q Consensus 232 FG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (457)
||+++.........
T Consensus 168 fg~a~~~~~~~~~~------------------------------------------------------------------ 181 (351)
T 3mi9_A 168 FGLARAFSLAKNSQ------------------------------------------------------------------ 181 (351)
T ss_dssp CTTCEECCCCSSSS------------------------------------------------------------------
T ss_pred chhccccccccccc------------------------------------------------------------------
Confidence 99986553211110
Q ss_pred ccccccccCCCCccCchhhcCC-CCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCC--CC------
Q 012762 312 DVRSMSFVGTHEYLAPEIISGE-GHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKE--PS------ 382 (457)
Q Consensus 312 ~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~--~~------ 382 (457)
.......+||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.........+.......+.. +.
T Consensus 182 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 261 (351)
T 3mi9_A 182 PNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYEL 261 (351)
T ss_dssp CCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCGG
T ss_pred ccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccccccchh
Confidence 0111234689999999999874 58999999999999999999999999988777766665543333221 11
Q ss_pred ----------------------CChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCCCCc
Q 012762 383 ----------------------VPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGVNW 423 (457)
Q Consensus 383 ----------------------~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~~~~ 423 (457)
.++.+.+||.+||+.||++||+ ++|+|+||||+...+
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t----~~e~l~hp~f~~~~~ 320 (351)
T 3mi9_A 262 YEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRID----SDDALNHDFFWSDPM 320 (351)
T ss_dssp GTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCC----HHHHHTSGGGGSSSC
T ss_pred hcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCC----HHHHhCCCCcCCCCC
Confidence 1567899999999999999999 999999999987544
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-48 Score=391.71 Aligned_cols=263 Identities=25% Similarity=0.394 Sum_probs=209.8
Q ss_pred ccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcC
Q 012762 79 LTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCP 158 (457)
Q Consensus 79 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~ 158 (457)
....+|++.+.||+|+||+||+|++.. ++ .||+|.+..... ...+|+++|+.++||||+++++++...
T Consensus 37 ~~~~~Y~~~~~lG~G~~g~V~~a~~~~----~~-~~aikk~~~~~~-------~~~~E~~il~~l~h~niv~l~~~~~~~ 104 (394)
T 4e7w_A 37 QREIAYTNCKVIGNGSFGVVFQAKLVE----SD-EVAIKKVLQDKR-------FKNRELQIMRIVKHPNVVDLKAFFYSN 104 (394)
T ss_dssp EEEEEEEEEEEEEEETTEEEEEEEETT----TE-EEEEEEEECCTT-------SCCHHHHHHHTCCCTTBCCEEEEEEEE
T ss_pred cccceEEEeEEEeeCCCeEEEEEEECC----CC-eEEEEEEecCcc-------hHHHHHHHHHhCCCCCcceEEEEEEec
Confidence 344679999999999999999999762 34 488887754321 123599999999999999999999554
Q ss_pred C------cEEEEEeecCCCChHHHHHh-CCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEc-cCCCEEEe
Q 012762 159 R------WSCLLTEFCPGGDLHVLRQR-QPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVR-SDGHIMLT 230 (457)
Q Consensus 159 ~------~~~lV~E~~~~~sL~~~~~~-~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~-~~~~vkl~ 230 (457)
+ ++|+||||++++.+..+... .....+++..++.++.||+.||.|||++||+||||||+||||+ .++.+||+
T Consensus 105 ~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~ 184 (394)
T 4e7w_A 105 GDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLI 184 (394)
T ss_dssp SSSSSCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEEC
T ss_pred CCCCCceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEe
Confidence 3 38899999966544433321 2246799999999999999999999999999999999999999 78999999
Q ss_pred ccCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccC
Q 012762 231 DFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEP 310 (457)
Q Consensus 231 DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (457)
|||+++.......
T Consensus 185 DFG~a~~~~~~~~------------------------------------------------------------------- 197 (394)
T 4e7w_A 185 DFGSAKILIAGEP------------------------------------------------------------------- 197 (394)
T ss_dssp CCTTCEECCTTCC-------------------------------------------------------------------
T ss_pred eCCCcccccCCCC-------------------------------------------------------------------
Confidence 9999865432110
Q ss_pred CccccccccCCCCccCchhhcCC-CCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcc---------------
Q 012762 311 LDVRSMSFVGTHEYLAPEIISGE-GHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARA--------------- 374 (457)
Q Consensus 311 ~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~--------------- 374 (457)
....+||+.|+|||++.+. .|+.++|||||||++|||++|+.||.+.+....+..++...
T Consensus 198 ----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~ 273 (394)
T 4e7w_A 198 ----NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNY 273 (394)
T ss_dssp ----CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGG
T ss_pred ----CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhh
Confidence 1134689999999999876 48999999999999999999999999988776666655421
Q ss_pred --cCCCC----------CCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCCCCchhhhc
Q 012762 375 --LEFPK----------EPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGVNWALLRC 428 (457)
Q Consensus 375 --~~~~~----------~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~~~~~~~~~ 428 (457)
..++. ...+++++.+||.+||+.||.+||+ +.|+++||||+.++|.....
T Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t----~~e~l~hp~f~~~~~~~~~~ 335 (394)
T 4e7w_A 274 MEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLT----AIEALCHPFFDELRTGEARM 335 (394)
T ss_dssp SSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCC----HHHHHTSGGGSTTTSSCCCC
T ss_pred hhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCC----HHHHhcChhhhhhccccccC
Confidence 11111 1237789999999999999999999 99999999999988865443
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-48 Score=376.66 Aligned_cols=252 Identities=20% Similarity=0.323 Sum_probs=211.5
Q ss_pred CccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEc
Q 012762 78 PLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDC 157 (457)
Q Consensus 78 ~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~ 157 (457)
.+..++|++++.||+|+||+||+|++. .+++.||+|++.............+.+|+++++.++||||+++++++..
T Consensus 7 ~~~~~~y~i~~~lg~G~~g~V~~~~~~----~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~ 82 (294)
T 4eqm_A 7 KIINERYKIVDKLGGGGMSTVYLAEDT----ILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEE 82 (294)
T ss_dssp SCEETTEEEEEEEEEETTEEEEEEEET----TTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEEC
T ss_pred hHhhccEEEEEEEccCCCEEEEEEEEC----CCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeee
Confidence 445578999999999999999999876 4788999999866544444556788899999999999999999999999
Q ss_pred CCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcC
Q 012762 158 PRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLK 237 (457)
Q Consensus 158 ~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~ 237 (457)
++..|+||||++|++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 83 ~~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~ 160 (294)
T 4eqm_A 83 DDCYYLVMEYIEGPTLSEYIESH--GPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKA 160 (294)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTT
T ss_pred CCeEEEEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCccc
Confidence 99999999999999999998875 5799999999999999999999999999999999999999999999999999865
Q ss_pred CCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcccccc
Q 012762 238 GDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMS 317 (457)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (457)
....... ....
T Consensus 161 ~~~~~~~---------------------------------------------------------------------~~~~ 171 (294)
T 4eqm_A 161 LSETSLT---------------------------------------------------------------------QTNH 171 (294)
T ss_dssp C-------------------------------------------------------------------------------
T ss_pred ccccccc---------------------------------------------------------------------ccCc
Confidence 4321110 1113
Q ss_pred ccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCC---CCCCCChHHHHHHHHH
Q 012762 318 FVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFP---KEPSVPGPAKDLIAQL 394 (457)
Q Consensus 318 ~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~ll~~~ 394 (457)
..||+.|+|||++.+..++.++|||||||++|+|++|+.||.+..........+....... ....+++.+.++|.+|
T Consensus 172 ~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 251 (294)
T 4eqm_A 172 VLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSNVILRA 251 (294)
T ss_dssp ---CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHHHHHHHHHH
T ss_pred cccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCHHHHHHHHHH
Confidence 4699999999999999999999999999999999999999998877666555554433221 2346889999999999
Q ss_pred hhhCCCCCCC
Q 012762 395 LVKDPTRRMG 404 (457)
Q Consensus 395 L~~dP~~Rps 404 (457)
|..||.+||+
T Consensus 252 l~~dp~~R~~ 261 (294)
T 4eqm_A 252 TEKDKANRYK 261 (294)
T ss_dssp SCSSGGGSCS
T ss_pred hcCCHhHccc
Confidence 9999999996
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-48 Score=395.18 Aligned_cols=258 Identities=24% Similarity=0.402 Sum_probs=208.8
Q ss_pred CCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcC--
Q 012762 81 LSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCP-- 158 (457)
Q Consensus 81 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~-- 158 (457)
..+|++.+.||+|+||+||+|+++ .+|+.||||++..... ...+|+++|+.++|+||+++++++...
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~----~~~~~vaiK~~~~~~~-------~~~~E~~il~~l~hpniv~l~~~~~~~~~ 121 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLC----DSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGE 121 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEET----TTCCEEEEEEEECCTT-------SCCHHHHHHHTCCCTTBCCEEEEEEEEET
T ss_pred cceEEeeeEEeeCCCEEEEEEEEC----CCCcEEEEEEecccch-------hHHHHHHHHHHcCCCCccceeeEEeccCC
Confidence 447999999999999999999986 4788999999865321 223599999999999999999988432
Q ss_pred ----CcEEEEEeecCCCChHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccC-CCEEEec
Q 012762 159 ----RWSCLLTEFCPGGDLHVLRQR--QPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSD-GHIMLTD 231 (457)
Q Consensus 159 ----~~~~lV~E~~~~~sL~~~~~~--~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~-~~vkl~D 231 (457)
.++++||||+++ +|..++.. .....+++..++.++.||+.||.|||++||+||||||+||||+.+ +.+||+|
T Consensus 122 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~D 200 (420)
T 1j1b_A 122 KKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCD 200 (420)
T ss_dssp TTTEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECC
T ss_pred CCcceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEecc
Confidence 246899999954 66555442 234679999999999999999999999999999999999999965 5689999
Q ss_pred cCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCC
Q 012762 232 FDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPL 311 (457)
Q Consensus 232 FG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (457)
||+++......
T Consensus 201 FG~a~~~~~~~--------------------------------------------------------------------- 211 (420)
T 1j1b_A 201 FGSAKQLVRGE--------------------------------------------------------------------- 211 (420)
T ss_dssp CTTCEECCTTC---------------------------------------------------------------------
T ss_pred chhhhhcccCC---------------------------------------------------------------------
Confidence 99986543111
Q ss_pred ccccccccCCCCccCchhhcCC-CCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhc-----------------
Q 012762 312 DVRSMSFVGTHEYLAPEIISGE-GHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVAR----------------- 373 (457)
Q Consensus 312 ~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~----------------- 373 (457)
.....+||+.|+|||++.+. .|+.++|||||||++|||++|+.||.+....+.+..++..
T Consensus 212 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~~ 289 (420)
T 1j1b_A 212 --PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYT 289 (420)
T ss_dssp --CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSCCC
T ss_pred --CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhh
Confidence 01134689999999999875 6899999999999999999999999998877666665542
Q ss_pred ccCCCC----------CCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCCCCchh
Q 012762 374 ALEFPK----------EPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGVNWAL 425 (457)
Q Consensus 374 ~~~~~~----------~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~~~~~~ 425 (457)
.+.++. ...++.++.+||.+||..||.+||+ +.|+++||||+.+.+..
T Consensus 290 ~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t----~~e~l~hp~f~~~~~~~ 347 (420)
T 1j1b_A 290 EFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLT----PLEACAHSFFDELRDPN 347 (420)
T ss_dssp CCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCC----HHHHHTSGGGGGGGCTT
T ss_pred hhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCC----HHHHhCCHhhccccccc
Confidence 112221 1346789999999999999999999 99999999998876643
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-48 Score=379.92 Aligned_cols=264 Identities=25% Similarity=0.381 Sum_probs=219.0
Q ss_pred ccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHc-CCCCCceEEEEEEc
Q 012762 79 LTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEML-DHPFLPTLYATLDC 157 (457)
Q Consensus 79 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~~~~~~ 157 (457)
...++|++.+.||+|+||+||+|++. .+++.||||++.... .....+.+|+++++++ +||||+++++++..
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~----~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 92 (326)
T 2x7f_A 21 DPAGIFELVELVGNGTYGQVYKGRHV----KTGQLAAIKVMDVTG----DEEEEIKQEINMLKKYSHHRNIATYYGAFIK 92 (326)
T ss_dssp CCTTTEEEEEEEEEETTEEEEEEEET----TTCCEEEEEEEECCS----STTHHHHHHHHHHHHHCCSTTBCCEEEEEEE
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEEC----CCCCeEEEEEEecCc----ccHHHHHHHHHHHHhccCCCCeeeeeeEEee
Confidence 34578999999999999999999986 478899999996532 2345677899999999 89999999999976
Q ss_pred ------CCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEec
Q 012762 158 ------PRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTD 231 (457)
Q Consensus 158 ------~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~D 231 (457)
.+..|+||||+++++|.+++.......+++..++.++.||+.||.|||+.||+|+||||+|||++.++.+||+|
T Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~D 172 (326)
T 2x7f_A 93 KNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVD 172 (326)
T ss_dssp CC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECC
T ss_pred ccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEee
Confidence 46789999999999999999876556799999999999999999999999999999999999999999999999
Q ss_pred cCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCC
Q 012762 232 FDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPL 311 (457)
Q Consensus 232 FG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (457)
||++........
T Consensus 173 fg~~~~~~~~~~-------------------------------------------------------------------- 184 (326)
T 2x7f_A 173 FGVSAQLDRTVG-------------------------------------------------------------------- 184 (326)
T ss_dssp CTTTC---------------------------------------------------------------------------
T ss_pred CcCceecCcCcc--------------------------------------------------------------------
Confidence 999764431100
Q ss_pred ccccccccCCCCccCchhhc-----CCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCCCCCChH
Q 012762 312 DVRSMSFVGTHEYLAPEIIS-----GEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGP 386 (457)
Q Consensus 312 ~~~~~~~~gt~~y~aPE~l~-----~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 386 (457)
......||+.|+|||++. +..++.++|||||||++|+|++|..||.+.........+............++..
T Consensus 185 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (326)
T 2x7f_A 185 --RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKWSKK 262 (326)
T ss_dssp --------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCSCSCHH
T ss_pred --ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccccCCccccCHH
Confidence 011246999999999997 4568999999999999999999999998877766666555554444444568899
Q ss_pred HHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCCCCch
Q 012762 387 AKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGVNWA 424 (457)
Q Consensus 387 ~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~~~~~ 424 (457)
+.+||.+||..||.+||+ +.++++||||+...+.
T Consensus 263 l~~li~~~l~~dp~~Rps----~~~ll~hp~~~~~~~~ 296 (326)
T 2x7f_A 263 FQSFIESCLVKNHSQRPA----TEQLMKHPFIRDQPNE 296 (326)
T ss_dssp HHHHHHHHCCSSGGGSCC----HHHHHTSHHHHCCTTH
T ss_pred HHHHHHHHhccChhhCCC----HHHHhhChHHhhCccc
Confidence 999999999999999999 9999999999987664
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-48 Score=372.26 Aligned_cols=257 Identities=23% Similarity=0.381 Sum_probs=214.0
Q ss_pred cCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEc--
Q 012762 80 TLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDC-- 157 (457)
Q Consensus 80 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~-- 157 (457)
....|++.+.||+|+||+||+|.+. .++..||+|++..... .......+.+|+++|+.++||||+++++++..
T Consensus 24 ~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~~va~k~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 98 (290)
T 1t4h_A 24 DGRFLKFDIEIGRGSFKTVYKGLDT----ETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV 98 (290)
T ss_dssp TSCEEEEEEEEEECSSEEEEEEEET----TTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES
T ss_pred CceeEEeeeeccCCCCeEEEEeEec----CCceEEEEEEecchhh-CHHHHHHHHHHHHHHHhCCCCCeeeeeeeecccc
Confidence 3446999999999999999999876 4788999999976543 23456778889999999999999999999865
Q ss_pred --CCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcC--ceeecCCCCCeEEc-cCCCEEEecc
Q 012762 158 --PRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMG--IIYRDLKPENVLVR-SDGHIMLTDF 232 (457)
Q Consensus 158 --~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~--iiHrDIKp~NIll~-~~~~vkl~DF 232 (457)
...+|+||||+++++|.+++... ..+++..++.++.||+.||.|||+.| |+||||||+|||++ .++.+||+||
T Consensus 99 ~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Df 176 (290)
T 1t4h_A 99 KGKKCIVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDL 176 (290)
T ss_dssp SSCEEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCT
T ss_pred CCCceEEEEEEecCCCCHHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeC
Confidence 35689999999999999999875 66999999999999999999999999 99999999999998 7899999999
Q ss_pred CCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCc
Q 012762 233 DLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLD 312 (457)
Q Consensus 233 G~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (457)
|++.......
T Consensus 177 g~~~~~~~~~---------------------------------------------------------------------- 186 (290)
T 1t4h_A 177 GLATLKRASF---------------------------------------------------------------------- 186 (290)
T ss_dssp TGGGGCCTTS----------------------------------------------------------------------
T ss_pred CCcccccccc----------------------------------------------------------------------
Confidence 9975432111
Q ss_pred cccccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccC-CCCCCCCChHHHHHH
Q 012762 313 VRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALE-FPKEPSVPGPAKDLI 391 (457)
Q Consensus 313 ~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ll 391 (457)
.....||+.|+|||++.+ .++.++|||||||++|+|++|+.||............+..... .......++++.+||
T Consensus 187 --~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 263 (290)
T 1t4h_A 187 --AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEII 263 (290)
T ss_dssp --BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHH
T ss_pred --cccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCCCCHHHHHHH
Confidence 112359999999999875 4899999999999999999999999886655444444333322 222345678999999
Q ss_pred HHHhhhCCCCCCCCCcChHHHhcCCCCCC
Q 012762 392 AQLLVKDPTRRMGSKMGATAIKRHQFFNG 420 (457)
Q Consensus 392 ~~~L~~dP~~Rps~~~~~~~ll~hp~f~~ 420 (457)
.+||..||.+||+ +.++++||||+.
T Consensus 264 ~~~l~~dp~~Rps----~~ell~h~~f~~ 288 (290)
T 1t4h_A 264 EGCIRQNKDERYS----IKDLLNHAFFQE 288 (290)
T ss_dssp HHHSCSSGGGSCC----HHHHHTSGGGC-
T ss_pred HHHccCChhhCCC----HHHHhhCccccc
Confidence 9999999999999 999999999985
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-48 Score=373.46 Aligned_cols=262 Identities=25% Similarity=0.303 Sum_probs=204.6
Q ss_pred CccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEc
Q 012762 78 PLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDC 157 (457)
Q Consensus 78 ~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~ 157 (457)
.+..++|++++.||+|+||+||+|.+. .+++.||+|++..... .......+..+..+++.++||||+++++++..
T Consensus 3 ~i~~~~y~~~~~lg~G~~g~V~~~~~~----~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~ 77 (290)
T 3fme_A 3 EVKADDLEPIMELGRGAYGVVEKMRHV----PSGQIMAVKRIRATVN-SQEQKRLLMDLDISMRTVDCPFTVTFYGALFR 77 (290)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEET----TTTEEEEEEEEC---C-HHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred cccHHhhhhHHhcCCCCCeEEEEEEec----CCCeEEEEEEeecccC-cHHHHHHHHHHHHHHHhCCCCeEEEEeeeeec
Confidence 466789999999999999999999986 4789999999976432 22223334444555777899999999999999
Q ss_pred CCcEEEEEeecCCCChHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHHHHc-CceeecCCCCCeEEccCCCEEEeccCC
Q 012762 158 PRWSCLLTEFCPGGDLHVLRQR--QPDKRFHESAVRFYASEVVVALEFLHMM-GIIYRDLKPENVLVRSDGHIMLTDFDL 234 (457)
Q Consensus 158 ~~~~~lV~E~~~~~sL~~~~~~--~~~~~~~~~~~~~i~~qi~~~L~yLH~~-~iiHrDIKp~NIll~~~~~vkl~DFG~ 234 (457)
++..|+||||++ ++|.+++.. .....+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+
T Consensus 78 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T 3fme_A 78 EGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGI 156 (290)
T ss_dssp SSSEEEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC--
T ss_pred cCCEEEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCC
Confidence 999999999995 588776654 2346799999999999999999999998 999999999999999999999999999
Q ss_pred CcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccc
Q 012762 235 SLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVR 314 (457)
Q Consensus 235 s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (457)
+........
T Consensus 157 ~~~~~~~~~----------------------------------------------------------------------- 165 (290)
T 3fme_A 157 SGYLVDDVA----------------------------------------------------------------------- 165 (290)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred ccccccccc-----------------------------------------------------------------------
Confidence 865432111
Q ss_pred cccccCCCCccCchhh----cCCCCCccchhhhhhHHHHHHhcCCCCCCCCC-hHHHHHHHHhcccCCCCCCCCChHHHH
Q 012762 315 SMSFVGTHEYLAPEII----SGEGHGNAVDWWTLGIFIFELFYGTTPFKGID-HELTLANVVARALEFPKEPSVPGPAKD 389 (457)
Q Consensus 315 ~~~~~gt~~y~aPE~l----~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (457)
.....||+.|+|||++ .+..++.++|||||||++|+|++|+.||.... ........+...........++.++.+
T Consensus 166 ~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (290)
T 3fme_A 166 KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVD 245 (290)
T ss_dssp ----CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCTTTSCHHHHH
T ss_pred ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCcccccCCHHHHH
Confidence 0122589999999996 45568999999999999999999999998643 334444444444443344568999999
Q ss_pred HHHHHhhhCCCCCCCCCcChHHHhcCCCCCC
Q 012762 390 LIAQLLVKDPTRRMGSKMGATAIKRHQFFNG 420 (457)
Q Consensus 390 ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~ 420 (457)
||.+||+.||++||+ +.|+++||||+.
T Consensus 246 li~~~l~~~p~~Rpt----~~e~l~hp~f~~ 272 (290)
T 3fme_A 246 FTSQCLKKNSKERPT----YPELMQHPFFTL 272 (290)
T ss_dssp HHHHHTCSSGGGSCC----HHHHTTSHHHHH
T ss_pred HHHHHhhcChhhCcC----HHHHHhCccccc
Confidence 999999999999999 999999999974
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-48 Score=381.40 Aligned_cols=273 Identities=25% Similarity=0.331 Sum_probs=217.4
Q ss_pred CCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcC--
Q 012762 81 LSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCP-- 158 (457)
Q Consensus 81 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~-- 158 (457)
.++|++.+.||+|+||+||+|.++ .+|+.||||++... ........+.+|+++|+.++||||+++++++...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~----~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 83 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHK----PTGEIVAIKKIEPF--DKPLFALRTLREIKILKHFKHENIITIFNIQRPDSF 83 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEET----TTTEEEEEEEECCC--SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCS
T ss_pred ccceEEeeEEcCCCCeEEEEEEEC----CCCcEEEEEeeccc--ccchHHHHHHHHHHHHHhCcCCCcCCeeeeeccccc
Confidence 468999999999999999999976 47899999999643 2233455677899999999999999999988654
Q ss_pred ---CcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCC
Q 012762 159 ---RWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235 (457)
Q Consensus 159 ---~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s 235 (457)
...|+||||+. ++|..++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 84 ~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a 159 (353)
T 2b9h_A 84 ENFNEVYIIQELMQ-TDLHRVIST---QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLA 159 (353)
T ss_dssp TTCCCEEEEECCCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTC
T ss_pred CccceEEEEEeccC-ccHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccc
Confidence 67899999995 699888876 56999999999999999999999999999999999999999999999999998
Q ss_pred cCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcccc
Q 012762 236 LKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRS 315 (457)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (457)
............. .......
T Consensus 160 ~~~~~~~~~~~~~------------------------------------------------------------~~~~~~~ 179 (353)
T 2b9h_A 160 RIIDESAADNSEP------------------------------------------------------------TGQQSGM 179 (353)
T ss_dssp EECC----------------------------------------------------------------------------
T ss_pred cccccccccccCc------------------------------------------------------------cccccch
Confidence 7654321110000 0000111
Q ss_pred ccccCCCCccCchhhcC-CCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCC-----------------
Q 012762 316 MSFVGTHEYLAPEIISG-EGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEF----------------- 377 (457)
Q Consensus 316 ~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~----------------- 377 (457)
..++||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+......+..+.......
T Consensus 180 ~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (353)
T 2b9h_A 180 VEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREY 259 (353)
T ss_dssp CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTTTTTTCCCHHHHHH
T ss_pred hhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhccccccccchhhHH
Confidence 23579999999999865 668999999999999999999999999877665554443211110
Q ss_pred -------CC------CCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCCCCchhhh
Q 012762 378 -------PK------EPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGVNWALLR 427 (457)
Q Consensus 378 -------~~------~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~~~~~~~~ 427 (457)
+. ...++.++.+||.+||..||++||+ +.|+++||||+...|....
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt----~~ell~hp~~~~~~~~~~~ 318 (353)
T 2b9h_A 260 IKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRIT----AKEALEHPYLQTYHDPNDE 318 (353)
T ss_dssp HHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCC----HHHHHTSGGGTTTCCTTSS
T ss_pred hhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCC----HHHHhcCccccccCCcccc
Confidence 00 1357889999999999999999999 9999999999998876543
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-48 Score=391.07 Aligned_cols=258 Identities=26% Similarity=0.410 Sum_probs=210.1
Q ss_pred ccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEc-
Q 012762 79 LTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDC- 157 (457)
Q Consensus 79 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~- 157 (457)
...++|++.+.||+|+||+||+|++. .+|+.||||++..... ...+|+++|+.++||||+++++++..
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~----~~~~~vAiK~~~~~~~-------~~~~E~~il~~l~hpnIv~l~~~~~~~ 72 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDI----ESGKRFALKKVLQDPR-------YKNRELDIMKVLDHVNIIKLVDYFYTT 72 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEET----TTCCEEEEEEEECCTT-------SCCHHHHHHTTCCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEEEeccCEEEEEEEEC----CCCCEEEEEEEecCcc-------hHHHHHHHHHHcCCCCccchhheeeec
Confidence 34568999999999999999999986 4789999999865421 12359999999999999999999843
Q ss_pred -------------------------------------CCcEEEEEeecCCCChHHHHHh--CCCCCCCHHHHHHHHHHHH
Q 012762 158 -------------------------------------PRWSCLLTEFCPGGDLHVLRQR--QPDKRFHESAVRFYASEVV 198 (457)
Q Consensus 158 -------------------------------------~~~~~lV~E~~~~~sL~~~~~~--~~~~~~~~~~~~~i~~qi~ 198 (457)
..++++||||++ ++|...+.. .....+++..++.++.||+
T Consensus 73 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~ 151 (383)
T 3eb0_A 73 GDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLF 151 (383)
T ss_dssp -------------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHH
T ss_pred CcccccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHH
Confidence 345899999996 687766653 2346799999999999999
Q ss_pred HHHHHHHHcCceeecCCCCCeEEc-cCCCEEEeccCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCccc
Q 012762 199 VALEFLHMMGIIYRDLKPENVLVR-SDGHIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCII 277 (457)
Q Consensus 199 ~~L~yLH~~~iiHrDIKp~NIll~-~~~~vkl~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (457)
.||.|||++||+||||||+|||++ .++.+||+|||+++.......
T Consensus 152 ~aL~~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---------------------------------- 197 (383)
T 3eb0_A 152 RAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP---------------------------------- 197 (383)
T ss_dssp HHHHHHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC----------------------------------
T ss_pred HHHHHHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC----------------------------------
Confidence 999999999999999999999998 678999999999865432111
Q ss_pred CCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCCCCccCchhhcCCC-CCccchhhhhhHHHHHHhcCCC
Q 012762 278 PNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTHEYLAPEIISGEG-HGNAVDWWTLGIFIFELFYGTT 356 (457)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~sDiwSlG~il~elltG~~ 356 (457)
.....||+.|+|||++.+.. ++.++|||||||++|||++|+.
T Consensus 198 -------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~ 240 (383)
T 3eb0_A 198 -------------------------------------SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKP 240 (383)
T ss_dssp -------------------------------------CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSC
T ss_pred -------------------------------------CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCC
Confidence 11236899999999998765 8999999999999999999999
Q ss_pred CCCCCChHHHHHHHHhccc-----------------CCC----------CCCCCChHHHHHHHHHhhhCCCCCCCCCcCh
Q 012762 357 PFKGIDHELTLANVVARAL-----------------EFP----------KEPSVPGPAKDLIAQLLVKDPTRRMGSKMGA 409 (457)
Q Consensus 357 Pf~~~~~~~~~~~~~~~~~-----------------~~~----------~~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~ 409 (457)
||.+....+.+..++.... .++ ....++.++.+||.+||+.||++||+ +
T Consensus 241 pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t----~ 316 (383)
T 3eb0_A 241 LFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRIN----P 316 (383)
T ss_dssp SSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCC----H
T ss_pred CCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCC----H
Confidence 9999887777766654211 111 12347788999999999999999999 9
Q ss_pred HHHhcCCCCCCCCc
Q 012762 410 TAIKRHQFFNGVNW 423 (457)
Q Consensus 410 ~~ll~hp~f~~~~~ 423 (457)
.|+++||||+.+.+
T Consensus 317 ~e~l~hp~f~~~~~ 330 (383)
T 3eb0_A 317 YEAMAHPFFDHLRN 330 (383)
T ss_dssp HHHHTSGGGHHHHH
T ss_pred HHHhcCHHHHHHHh
Confidence 99999999987544
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-48 Score=378.05 Aligned_cols=274 Identities=23% Similarity=0.319 Sum_probs=200.5
Q ss_pred CCCccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEE
Q 012762 76 NNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATL 155 (457)
Q Consensus 76 ~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~ 155 (457)
.+.+..++|++.+.||+|+||+||+|.+. .+++.||||++..... ......+.+|+++++.++||||+++++++
T Consensus 9 p~~i~~~~y~~~~~lg~G~~g~V~~~~~~----~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 82 (303)
T 2vwi_A 9 PWSINRDDYELQEVIGSGATAVVQAAYCA----PKKEKVAIKRINLEKC--QTSMDELLKEIQAMSQCHHPNIVSYYTSF 82 (303)
T ss_dssp ----CCCCCEEEEECC---CCCEEEEEC--------CEEEEECCC------------------CCCCCCCTTBCCEEEEE
T ss_pred ccccchhhhhhhheeccccceEEEEEEEC----CCCcEEEEEEEEhhhc--chhHHHHHHHHHHHhhcCCCCEeeEEEEE
Confidence 35567789999999999999999999876 3788999999975432 23345677899999999999999999999
Q ss_pred EcCCcEEEEEeecCCCChHHHHHh------CCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEE
Q 012762 156 DCPRWSCLLTEFCPGGDLHVLRQR------QPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIML 229 (457)
Q Consensus 156 ~~~~~~~lV~E~~~~~sL~~~~~~------~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl 229 (457)
...+..|+||||+++++|.+++.. .....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||
T Consensus 83 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl 162 (303)
T 2vwi_A 83 VVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQI 162 (303)
T ss_dssp ESSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEE
T ss_pred eecCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEE
Confidence 999999999999999999988874 13456999999999999999999999999999999999999999999999
Q ss_pred eccCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCccccc
Q 012762 230 TDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAE 309 (457)
Q Consensus 230 ~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (457)
+|||++...........
T Consensus 163 ~dfg~~~~~~~~~~~~~--------------------------------------------------------------- 179 (303)
T 2vwi_A 163 ADFGVSAFLATGGDITR--------------------------------------------------------------- 179 (303)
T ss_dssp CCCHHHHHCC----------------------------------------------------------------------
T ss_pred EeccchheeccCCCccc---------------------------------------------------------------
Confidence 99999765432110000
Q ss_pred CCccccccccCCCCccCchhhcC-CCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCC--------CC
Q 012762 310 PLDVRSMSFVGTHEYLAPEIISG-EGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFP--------KE 380 (457)
Q Consensus 310 ~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~--------~~ 380 (457)
........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.................... ..
T Consensus 180 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (303)
T 2vwi_A 180 --NKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDKEML 257 (303)
T ss_dssp ----------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTTC-----CCC
T ss_pred --hhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCccccccccchhh
Confidence 000113469999999999976 5689999999999999999999999998776655554443322111 12
Q ss_pred CCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCCCCch
Q 012762 381 PSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGVNWA 424 (457)
Q Consensus 381 ~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~~~~~ 424 (457)
..++.++.+||.+||..||.+||+ +.++++||||+...+.
T Consensus 258 ~~~~~~~~~li~~~l~~dp~~Rps----~~~ll~h~~~~~~~~~ 297 (303)
T 2vwi_A 258 KKYGKSFRKMISLCLQKDPEKRPT----AAELLRHKFFQKAKNK 297 (303)
T ss_dssp CCCCHHHHHHHHHHCCSSGGGSCC----HHHHHTSTTC------
T ss_pred hhhhHHHHHHHHHHccCChhhCcC----HHHHhhChhhhcCCCC
Confidence 357789999999999999999999 9999999999987664
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=384.52 Aligned_cols=258 Identities=27% Similarity=0.361 Sum_probs=214.4
Q ss_pred CCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcE
Q 012762 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWS 161 (457)
Q Consensus 82 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~ 161 (457)
++|++.+.||+|+||+||+|.++ .+|+.||||++.... ........+.+|+++++.++||||+++++++...+..
T Consensus 42 ~~y~~~~~lG~G~~g~Vy~~~~~----~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 116 (371)
T 4exu_A 42 KTYVSPTHVGSGAYGSVCSAIDK----RSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSL 116 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEET----TTTEEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSS
T ss_pred ccEEEEeEEecCCCeEEEEEEEC----CCCCEEEEEEecccc-cchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCc
Confidence 68999999999999999999987 478999999997543 2334456778899999999999999999999877654
Q ss_pred ------EEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCC
Q 012762 162 ------CLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235 (457)
Q Consensus 162 ------~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s 235 (457)
|+||||+. ++|..++. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 117 ~~~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a 191 (371)
T 4exu_A 117 RNFYDFYLVMPFMQ-TDLQKIMG----MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLA 191 (371)
T ss_dssp TTCCCCEEEEECCC-EEHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC
T ss_pred ccceeEEEEEcccc-ccHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCcc
Confidence 99999995 78876653 45999999999999999999999999999999999999999999999999998
Q ss_pred cCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcccc
Q 012762 236 LKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRS 315 (457)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (457)
+..... .
T Consensus 192 ~~~~~~-------------------------------------------------------------------------~ 198 (371)
T 4exu_A 192 RHADAE-------------------------------------------------------------------------M 198 (371)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred cccccC-------------------------------------------------------------------------c
Confidence 543211 1
Q ss_pred ccccCCCCccCchhhcC-CCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCC-----------------
Q 012762 316 MSFVGTHEYLAPEIISG-EGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEF----------------- 377 (457)
Q Consensus 316 ~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~----------------- 377 (457)
...+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+....+.+..++......
T Consensus 199 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 278 (371)
T 4exu_A 199 TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYI 278 (371)
T ss_dssp -CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHHHHHH
T ss_pred CCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhhhhhh
Confidence 12468999999999987 678999999999999999999999999887776666655422111
Q ss_pred ------CC------CCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCCCCchhh
Q 012762 378 ------PK------EPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGVNWALL 426 (457)
Q Consensus 378 ------~~------~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~~~~~~~ 426 (457)
+. ...+++++.+||.+||+.||++||+ +.|+|+||||+......-
T Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt----~~ell~hp~f~~~~~~~~ 335 (371)
T 4exu_A 279 QSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLT----AAQALTHPFFEPFRDPEE 335 (371)
T ss_dssp HHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCC----HHHHHTSGGGTTTCCGGG
T ss_pred hccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCC----HHHHhcCcccccCCCccc
Confidence 00 1346889999999999999999999 999999999998766543
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-48 Score=378.47 Aligned_cols=263 Identities=22% Similarity=0.323 Sum_probs=219.6
Q ss_pred CCCccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEE
Q 012762 76 NNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATL 155 (457)
Q Consensus 76 ~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~ 155 (457)
...+..++|++.+.||+|+||+||+|+++... ..+..||||++.... .......+.+|+++|+.++||||+++++++
T Consensus 43 ~~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 119 (325)
T 3kul_A 43 TREIEASRIHIEKIIGSGDSGEVCYGRLRVPG-QRDVPVAIKALKAGY--TERQRRDFLSEASIMGQFDHPNIIRLEGVV 119 (325)
T ss_dssp CCBCCGGGEEEEEEEEETTTEEEEEEEECCTT-SCCEEEEEEEECTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred ccccChhHeEEeeEEEeCCCcEEEEEEEecCC-CCCceEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence 45677789999999999999999999986422 245679999997542 234456788899999999999999999999
Q ss_pred EcCCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCC
Q 012762 156 DCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235 (457)
Q Consensus 156 ~~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s 235 (457)
..++..||||||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 120 ~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 198 (325)
T 3kul_A 120 TRGRLAMIVTEYMENGSLDTFLRTH-DGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLS 198 (325)
T ss_dssp CGGGCCEEEEECCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSC
T ss_pred EeCCccEEEeeCCCCCcHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcc
Confidence 9999999999999999999998654 357999999999999999999999999999999999999999999999999998
Q ss_pred cCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcccc
Q 012762 236 LKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRS 315 (457)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (457)
+.......... ..
T Consensus 199 ~~~~~~~~~~~-------------------------------------------------------------------~~ 211 (325)
T 3kul_A 199 RVLEDDPDAAY-------------------------------------------------------------------TT 211 (325)
T ss_dssp EECC----CCE-------------------------------------------------------------------EC
T ss_pred cccccCcccee-------------------------------------------------------------------ec
Confidence 76542211100 00
Q ss_pred ccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHH
Q 012762 316 MSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQL 394 (457)
Q Consensus 316 ~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~ 394 (457)
....||+.|+|||++.+..++.++|||||||++|||++ |..||.+.........+... ...+....++..+.+||.+|
T Consensus 212 ~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~ 290 (325)
T 3kul_A 212 TGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEG-YRLPAPMGCPHALHQLMLDC 290 (325)
T ss_dssp C---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTT-CCCCCCTTCCHHHHHHHHHH
T ss_pred cCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcC-CCCCCCCCcCHHHHHHHHHH
Confidence 11246889999999998899999999999999999998 99999988877766665544 45556667999999999999
Q ss_pred hhhCCCCCCCCCcChHHHhc
Q 012762 395 LVKDPTRRMGSKMGATAIKR 414 (457)
Q Consensus 395 L~~dP~~Rps~~~~~~~ll~ 414 (457)
|..||++||+ +.+|++
T Consensus 291 l~~dp~~Rps----~~eil~ 306 (325)
T 3kul_A 291 WHKDRAQRPR----FSQIVS 306 (325)
T ss_dssp TCSSGGGSCC----HHHHHH
T ss_pred ccCChhhCcC----HHHHHH
Confidence 9999999999 887765
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=376.46 Aligned_cols=265 Identities=25% Similarity=0.351 Sum_probs=218.9
Q ss_pred CCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHc---CCCCCceEEEEEE-
Q 012762 81 LSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEML---DHPFLPTLYATLD- 156 (457)
Q Consensus 81 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l---~H~nIv~l~~~~~- 156 (457)
.++|++.+.||+|+||+||+|++.. .+++.||+|++....... .....+.+|+++++.+ +||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~ 85 (326)
T 1blx_A 10 DQQYECVAEIGEGAYGKVFKARDLK---NGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTV 85 (326)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETT---TTTEEEEEEEEEEEBCTT-SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEE
T ss_pred hhceeeeeeecccccEEEEEEEecC---CCCEEEEEEEeccCcccc-cCCchhhHHHHHHHhhhccCCCCeEeeeeeeee
Confidence 3689999999999999999999742 367899999997543211 1223455677777766 8999999999987
Q ss_pred ----cCCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEecc
Q 012762 157 ----CPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDF 232 (457)
Q Consensus 157 ----~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DF 232 (457)
.....++||||+. ++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Df 164 (326)
T 1blx_A 86 SRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADF 164 (326)
T ss_dssp EECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSC
T ss_pred cccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecC
Confidence 5567899999996 69999998876667999999999999999999999999999999999999999999999999
Q ss_pred CCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCc
Q 012762 233 DLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLD 312 (457)
Q Consensus 233 G~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (457)
|++.......
T Consensus 165 g~~~~~~~~~---------------------------------------------------------------------- 174 (326)
T 1blx_A 165 GLARIYSFQM---------------------------------------------------------------------- 174 (326)
T ss_dssp CSCCCCCGGG----------------------------------------------------------------------
T ss_pred cccccccCCC----------------------------------------------------------------------
Confidence 9986443110
Q ss_pred cccccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCC-----C---------
Q 012762 313 VRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEF-----P--------- 378 (457)
Q Consensus 313 ~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~-----~--------- 378 (457)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+......+..++...... +
T Consensus 175 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 253 (326)
T 1blx_A 175 -ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQA 253 (326)
T ss_dssp -GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGG
T ss_pred -CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCccccccchhh
Confidence 0112368999999999999999999999999999999999999999988777776665421100 0
Q ss_pred -----------CCCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCCCCchh
Q 012762 379 -----------KEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGVNWAL 425 (457)
Q Consensus 379 -----------~~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~~~~~~ 425 (457)
....++..+.+||.+||..||++||+ +.++++||||+.++|..
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt----~~e~l~hp~~~~~~~~~ 307 (326)
T 1blx_A 254 FHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRIS----AYSALSHPYFQDLERCK 307 (326)
T ss_dssp SCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCC----HHHHHTSGGGTTCCCCC
T ss_pred hcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCC----HHHHhcCccccccchhh
Confidence 11347888999999999999999999 99999999999988753
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-48 Score=374.78 Aligned_cols=265 Identities=28% Similarity=0.433 Sum_probs=219.4
Q ss_pred ccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcC
Q 012762 79 LTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCP 158 (457)
Q Consensus 79 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~ 158 (457)
...++|++++.||+|+||+||+|.++ .+++.||+|++.... ......+.+|+++++.++||||+++++++...
T Consensus 16 ~~~~~y~i~~~lg~G~~g~V~~~~~~----~~~~~~aiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 88 (302)
T 2j7t_A 16 DPNEVWEIVGELGDGAFGKVYKAKNK----ETGALAAAKVIETKS---EEELEDYIVEIEILATCDHPYIVKLLGAYYHD 88 (302)
T ss_dssp CGGGTEEEEEEEECSTTCCEEEEEET----TTCCEEEEEEEC-------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC
T ss_pred CCccceeecceeccCCCeEEEEEEEc----CCCcEEEEEEecCCC---HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeC
Confidence 34568999999999999999999986 478899999987542 23456778899999999999999999999999
Q ss_pred CcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCC
Q 012762 159 RWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKG 238 (457)
Q Consensus 159 ~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~ 238 (457)
+..|+||||+++++|..++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 89 ~~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 167 (302)
T 2j7t_A 89 GKLWIMIEFCPGGAVDAIMLEL-DRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKN 167 (302)
T ss_dssp -CEEEEEECCTTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHH
T ss_pred CeEEEEEEeCCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCccc
Confidence 9999999999999999887653 256999999999999999999999999999999999999999999999999986321
Q ss_pred CCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccc
Q 012762 239 DNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSF 318 (457)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (457)
... .......
T Consensus 168 ~~~----------------------------------------------------------------------~~~~~~~ 177 (302)
T 2j7t_A 168 LKT----------------------------------------------------------------------LQKRDSF 177 (302)
T ss_dssp HHH----------------------------------------------------------------------HHC----
T ss_pred ccc----------------------------------------------------------------------ccccccc
Confidence 100 0001124
Q ss_pred cCCCCccCchhhc-----CCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccC-CCCCCCCChHHHHHHH
Q 012762 319 VGTHEYLAPEIIS-----GEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALE-FPKEPSVPGPAKDLIA 392 (457)
Q Consensus 319 ~gt~~y~aPE~l~-----~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ll~ 392 (457)
.||+.|+|||++. +..++.++|||||||++|+|++|..||...........+...... ......++..+.++|.
T Consensus 178 ~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 257 (302)
T 2j7t_A 178 IGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEFRDFLK 257 (302)
T ss_dssp -CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHHHHH
T ss_pred cCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCCccccCHHHHHHHH
Confidence 6999999999983 667899999999999999999999999988776666665554332 2233457889999999
Q ss_pred HHhhhCCCCCCCCCcChHHHhcCCCCCCCCchh
Q 012762 393 QLLVKDPTRRMGSKMGATAIKRHQFFNGVNWAL 425 (457)
Q Consensus 393 ~~L~~dP~~Rps~~~~~~~ll~hp~f~~~~~~~ 425 (457)
+||..||++||+ +.+|++||||+.+.|..
T Consensus 258 ~~l~~dp~~Rps----~~~ll~h~~~~~~~~~~ 286 (302)
T 2j7t_A 258 IALDKNPETRPS----AAQLLEHPFVSSITSNK 286 (302)
T ss_dssp HHSCSCTTTSCC----HHHHTTSTTTTTCCCCH
T ss_pred HHcccChhhCCC----HHHHhcChHHhhhccch
Confidence 999999999999 99999999999988854
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-48 Score=383.64 Aligned_cols=266 Identities=19% Similarity=0.282 Sum_probs=221.3
Q ss_pred CCCccCCCceeEEEecccCcceEEEEEEecc-CCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHc-CCCCCceEEE
Q 012762 76 NNPLTLSDLRFVHRLGSGDIGSVYLVQLKSK-SSNNGCFFAAKVMDKRELVSRNKESRARIEREILEML-DHPFLPTLYA 153 (457)
Q Consensus 76 ~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~-~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~~ 153 (457)
.+.+..++|++.+.||+|+||+||+|++... +..+++.||||++.... .......+.+|+++|+++ +||||+++++
T Consensus 16 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpniv~~~~ 93 (359)
T 3vhe_A 16 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLG 93 (359)
T ss_dssp HHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC--CHHHHHHHHHHHHHHHhhcCCcceeeeee
Confidence 3456778999999999999999999986532 23577899999997542 233456788899999999 7999999999
Q ss_pred EEEcCC-cEEEEEeecCCCChHHHHHhCCC--------------------------------------------------
Q 012762 154 TLDCPR-WSCLLTEFCPGGDLHVLRQRQPD-------------------------------------------------- 182 (457)
Q Consensus 154 ~~~~~~-~~~lV~E~~~~~sL~~~~~~~~~-------------------------------------------------- 182 (457)
++...+ ..|+|||||++|+|.+++.....
T Consensus 94 ~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (359)
T 3vhe_A 94 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSL 173 (359)
T ss_dssp EECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------------
T ss_pred eeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccccc
Confidence 998755 48999999999999999876532
Q ss_pred --------------CCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCCCcccccc
Q 012762 183 --------------KRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQLV 248 (457)
Q Consensus 183 --------------~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~~~~~~~~ 248 (457)
..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++........
T Consensus 174 ~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~---- 249 (359)
T 3vhe_A 174 SDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY---- 249 (359)
T ss_dssp ----------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTC----
T ss_pred chhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccc----
Confidence 12899999999999999999999999999999999999999999999999998654321110
Q ss_pred cCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCCCCccCch
Q 012762 249 SDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTHEYLAPE 328 (457)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 328 (457)
.......||+.|+|||
T Consensus 250 ----------------------------------------------------------------~~~~~~~~t~~y~aPE 265 (359)
T 3vhe_A 250 ----------------------------------------------------------------VRKGDARLPLKWMAPE 265 (359)
T ss_dssp ----------------------------------------------------------------EEC--CEECGGGCCHH
T ss_pred ----------------------------------------------------------------hhccccCCCceeEChh
Confidence 0111335899999999
Q ss_pred hhcCCCCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhhhCCCCCCCCCc
Q 012762 329 IISGEGHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDPTRRMGSKM 407 (457)
Q Consensus 329 ~l~~~~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rps~~~ 407 (457)
++.+..++.++|||||||++|||++ |..||.+..........+......+....+++++.++|.+||..||.+||+
T Consensus 266 ~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps--- 342 (359)
T 3vhe_A 266 TIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPT--- 342 (359)
T ss_dssp HHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCC---
T ss_pred hhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCCC---
Confidence 9999999999999999999999998 999999877666666666555555555678999999999999999999999
Q ss_pred ChHHHhcC
Q 012762 408 GATAIKRH 415 (457)
Q Consensus 408 ~~~~ll~h 415 (457)
+.||++|
T Consensus 343 -~~ell~~ 349 (359)
T 3vhe_A 343 -FSELVEH 349 (359)
T ss_dssp -HHHHHHH
T ss_pred -HHHHHHH
Confidence 9999876
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-48 Score=378.84 Aligned_cols=262 Identities=25% Similarity=0.359 Sum_probs=216.4
Q ss_pred CCCccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCC------CCc
Q 012762 76 NNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHP------FLP 149 (457)
Q Consensus 76 ~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~------nIv 149 (457)
.+.+..++|++.+.||+|+||+||+|.+.. .+++.||||++.... .....+.+|+++++.++|+ +|+
T Consensus 8 ~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~ 80 (339)
T 1z57_A 8 SGDVLSARYEIVDTLGEGAFGKVVECIDHK---AGGRHVAVKIVKNVD----RYCEAARSEIQVLEHLNTTDPNSTFRCV 80 (339)
T ss_dssp TTCEETTTEEEEEEEEEETTEEEEEEEETT---TTTEEEEEEEECSSH----HHHHHHHHHHHHHHHHHHHCTTCTTCBC
T ss_pred cCCCccCceEEEEEEecCCCeEEEEEEecC---CCCcEEEEEEEecCC----chhHHHHHHHHHHHHhhhcCCCCceeeE
Confidence 344556799999999999999999998732 368899999997532 3456677899999988655 499
Q ss_pred eEEEEEEcCCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEcc------
Q 012762 150 TLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRS------ 223 (457)
Q Consensus 150 ~l~~~~~~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~------ 223 (457)
++++++...+..|+||||+ +++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 81 ~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~ 159 (339)
T 1z57_A 81 QMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEA 159 (339)
T ss_dssp CEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEE
T ss_pred eeecccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccc
Confidence 9999999999999999999 999999998876567999999999999999999999999999999999999987
Q ss_pred -------------CCCEEEeccCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCc
Q 012762 224 -------------DGHIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHP 290 (457)
Q Consensus 224 -------------~~~vkl~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (457)
++.+||+|||++......
T Consensus 160 ~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~------------------------------------------------- 190 (339)
T 1z57_A 160 YNPKIKRDERTLINPDIKVVDFGSATYDDEH------------------------------------------------- 190 (339)
T ss_dssp EC----CEEEEESCCCEEECCCSSCEETTSC-------------------------------------------------
T ss_pred cCCccccccccccCCCceEeeCcccccCccc-------------------------------------------------
Confidence 668999999997543211
Q ss_pred chhccccCCCCCCCcccccCCccccccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHH
Q 012762 291 KRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANV 370 (457)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~ 370 (457)
.....||+.|+|||++.+..++.++|||||||++|||++|..||...+..+....+
T Consensus 191 ------------------------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 246 (339)
T 1z57_A 191 ------------------------HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMM 246 (339)
T ss_dssp ------------------------CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHHH
T ss_pred ------------------------cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 01236999999999999999999999999999999999999999987766555444
Q ss_pred HhcccCCCC------------------------------------------CCCCChHHHHHHHHHhhhCCCCCCCCCcC
Q 012762 371 VARALEFPK------------------------------------------EPSVPGPAKDLIAQLLVKDPTRRMGSKMG 408 (457)
Q Consensus 371 ~~~~~~~~~------------------------------------------~~~~~~~~~~ll~~~L~~dP~~Rps~~~~ 408 (457)
.......+. ....++++.+||.+||..||.+||+
T Consensus 247 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt---- 322 (339)
T 1z57_A 247 ERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRIT---- 322 (339)
T ss_dssp HHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCC----
T ss_pred HHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccC----
Confidence 332221111 1112456889999999999999999
Q ss_pred hHHHhcCCCCCCCC
Q 012762 409 ATAIKRHQFFNGVN 422 (457)
Q Consensus 409 ~~~ll~hp~f~~~~ 422 (457)
+.|+++||||+.++
T Consensus 323 ~~ell~hp~f~~~~ 336 (339)
T 1z57_A 323 LREALKHPFFDLLK 336 (339)
T ss_dssp HHHHTTSGGGGGGG
T ss_pred HHHHhcCHHHHHHh
Confidence 99999999998654
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-48 Score=391.43 Aligned_cols=261 Identities=21% Similarity=0.294 Sum_probs=209.0
Q ss_pred CCCCCccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcC--------C
Q 012762 74 NNNNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLD--------H 145 (457)
Q Consensus 74 ~~~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~--------H 145 (457)
...+.+..++|+++++||+|+||+||+|++. .+++.||||++.... .....+.+|+++|+.+. |
T Consensus 29 ~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~----~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~ 100 (397)
T 1wak_A 29 VKIGDLFNGRYHVIRKLGWGHFSTVWLSWDI----QGKKFVAMKVVKSAE----HYTETALDEIRLLKSVRNSDPNDPNR 100 (397)
T ss_dssp SCTTCEETTTEEEEEEEEECSSEEEEEEEET----TTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHSCTTCGGG
T ss_pred EehhhhcCCeEEEEEEeeecCCeeEEEEEec----CCCeEEEEEEEecCC----cchHHHHHHHHHHHHHhhcCCCCCCc
Confidence 3344555688999999999999999999876 478999999997542 34566778999999985 7
Q ss_pred CCCceEEEEEE----cCCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHc-CceeecCCCCCeE
Q 012762 146 PFLPTLYATLD----CPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMM-GIIYRDLKPENVL 220 (457)
Q Consensus 146 ~nIv~l~~~~~----~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~-~iiHrDIKp~NIl 220 (457)
+||+++++++. ....+||||||+ +++|...+.......+++..++.++.||+.||.|||++ ||+||||||+|||
T Consensus 101 ~~iv~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIl 179 (397)
T 1wak_A 101 EMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENIL 179 (397)
T ss_dssp GGBCCEEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEE
T ss_pred ceeeeeecceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHee
Confidence 88999999997 566899999999 67776666665556799999999999999999999998 9999999999999
Q ss_pred EccCC-------------------------------------------------CEEEeccCCCcCCCCCCcccccccCC
Q 012762 221 VRSDG-------------------------------------------------HIMLTDFDLSLKGDNSTSTAQLVSDQ 251 (457)
Q Consensus 221 l~~~~-------------------------------------------------~vkl~DFG~s~~~~~~~~~~~~~~~~ 251 (457)
|+.++ .+||+|||++......
T Consensus 180 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~---------- 249 (397)
T 1wak_A 180 LSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH---------- 249 (397)
T ss_dssp ECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----------
T ss_pred EeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----------
Confidence 98775 7999999997544211
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCCCCccCchhhc
Q 012762 252 SPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTHEYLAPEIIS 331 (457)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~ 331 (457)
....+||+.|+|||++.
T Consensus 250 ---------------------------------------------------------------~~~~~gt~~y~aPE~~~ 266 (397)
T 1wak_A 250 ---------------------------------------------------------------FTEDIQTRQYRSLEVLI 266 (397)
T ss_dssp ---------------------------------------------------------------SCSCCSCGGGCCHHHHH
T ss_pred ---------------------------------------------------------------CccCCCCCcccCChhhc
Confidence 01235999999999999
Q ss_pred CCCCCccchhhhhhHHHHHHhcCCCCCCCCCh------HHHHHHHHhcccCCC---------------------------
Q 012762 332 GEGHGNAVDWWTLGIFIFELFYGTTPFKGIDH------ELTLANVVARALEFP--------------------------- 378 (457)
Q Consensus 332 ~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~------~~~~~~~~~~~~~~~--------------------------- 378 (457)
+..++.++|||||||++|||++|+.||.+... ...+..+.......+
T Consensus 267 ~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (397)
T 1wak_A 267 GSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLK 346 (397)
T ss_dssp TSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCC
T ss_pred CCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccC
Confidence 99999999999999999999999999986542 222222222111111
Q ss_pred -------------CCCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCC
Q 012762 379 -------------KEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNG 420 (457)
Q Consensus 379 -------------~~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~ 420 (457)
.....+..+.+||.+||+.||++||+ +.|||+||||++
T Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt----~~e~l~hp~~~~ 397 (397)
T 1wak_A 347 PWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRAT----AAECLRHPWLNS 397 (397)
T ss_dssp CCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCC----HHHHHTSGGGGC
T ss_pred CcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCC----HHHHhhCccccC
Confidence 00112356889999999999999999 999999999974
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-49 Score=398.14 Aligned_cols=263 Identities=20% Similarity=0.209 Sum_probs=201.0
Q ss_pred CCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHc--CCCCCceEE------
Q 012762 81 LSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEML--DHPFLPTLY------ 152 (457)
Q Consensus 81 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l--~H~nIv~l~------ 152 (457)
..+|++.+.||+|+||+||+|+++ .+++.||||++.............++.|+++++.| +||||++++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p 136 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDV----ERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLP 136 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEET----TTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCC
T ss_pred ceeeeeeeeccCCCCEEEEEEEEC----CCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEee
Confidence 345999999999999999999986 47899999999886554555666778886666555 599988755
Q ss_pred -EEEEcC-----------------CcEEEEEeecCCCChHHHHHhCCCCCCCHHHH------HHHHHHHHHHHHHHHHcC
Q 012762 153 -ATLDCP-----------------RWSCLLTEFCPGGDLHVLRQRQPDKRFHESAV------RFYASEVVVALEFLHMMG 208 (457)
Q Consensus 153 -~~~~~~-----------------~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~------~~i~~qi~~~L~yLH~~~ 208 (457)
+++... ..+|||||||+ ++|.+++.... ..+.+... ..++.||+.||.|||++|
T Consensus 137 ~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ 214 (371)
T 3q60_A 137 SDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD-FVYVFRGDEGILALHILTAQLIRLAANLQSKG 214 (371)
T ss_dssp CEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH-HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred ehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc-cccchhhhhhhhhHHHHHHHHHHHHHHHHHCC
Confidence 455433 23799999997 89999987642 23444444 567799999999999999
Q ss_pred ceeecCCCCCeEEccCCCEEEeccCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCccccc
Q 012762 209 IIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCL 288 (457)
Q Consensus 209 iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (457)
|+||||||+||||+.+|.+||+|||+++......
T Consensus 215 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~---------------------------------------------- 248 (371)
T 3q60_A 215 LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG---------------------------------------------- 248 (371)
T ss_dssp EEETTCSGGGEEECTTSCEEECCGGGEEETTCEE----------------------------------------------
T ss_pred CccCcCCHHHEEECCCCCEEEEecceeeecCCCc----------------------------------------------
Confidence 9999999999999999999999999986443111
Q ss_pred CcchhccccCCCCCCCcccccCCccccccccCCCCccCchhhcC--CCCCccchhhhhhHHHHHHhcCCCCCCCCChHHH
Q 012762 289 HPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTHEYLAPEIISG--EGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELT 366 (457)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~ 366 (457)
....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+......
T Consensus 249 ---------------------------~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~ 301 (371)
T 3q60_A 249 ---------------------------PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIK 301 (371)
T ss_dssp ---------------------------EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTCT
T ss_pred ---------------------------cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCcccc
Confidence 02247799999999987 6799999999999999999999999987632211
Q ss_pred --H-----HHHHhcccCCCCCCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCCCCchhh
Q 012762 367 --L-----ANVVARALEFPKEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGVNWALL 426 (457)
Q Consensus 367 --~-----~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~~~~~~~ 426 (457)
. .......+.++....+++.+.+||.+||+.||++||+ +.++++||||+.++|...
T Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt----~~e~l~hp~f~~~~~~~~ 364 (371)
T 3q60_A 302 GSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLL----PLEAMETPEFLQLQNEIS 364 (371)
T ss_dssp TCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCC----HHHHTTSHHHHHHHHHHH
T ss_pred cchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCC----HHHHhcCHHHHHHHHHHh
Confidence 0 1111123344444578999999999999999999999 999999999999888654
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=390.10 Aligned_cols=275 Identities=17% Similarity=0.266 Sum_probs=224.1
Q ss_pred CCccCCCceeEEEecccCcceEEEEEEecc-CCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEE
Q 012762 77 NPLTLSDLRFVHRLGSGDIGSVYLVQLKSK-SSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATL 155 (457)
Q Consensus 77 ~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~-~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~ 155 (457)
..+..++|+++++||+|+||+||+|.+... +..+++.||||++... ........+.+|+.+|++++||||+++++++
T Consensus 66 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~ 143 (367)
T 3l9p_A 66 KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV--CSEQDELDFLMEALIISKFNHQNIVRCIGVS 143 (367)
T ss_dssp CBCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSS--CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred hhcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccc--cChhhHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 456678999999999999999999996532 2346789999999643 2234455678899999999999999999999
Q ss_pred EcCCcEEEEEeecCCCChHHHHHhCC-----CCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCC---CE
Q 012762 156 DCPRWSCLLTEFCPGGDLHVLRQRQP-----DKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDG---HI 227 (457)
Q Consensus 156 ~~~~~~~lV~E~~~~~sL~~~~~~~~-----~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~---~v 227 (457)
...+..|+|||||++|+|.+++.... ...+++..++.++.||+.||.|||++||+||||||+||||+.+| .+
T Consensus 144 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~ 223 (367)
T 3l9p_A 144 LQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVA 223 (367)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCE
T ss_pred ecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceE
Confidence 99999999999999999999987743 24589999999999999999999999999999999999999655 59
Q ss_pred EEeccCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCccc
Q 012762 228 MLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIV 307 (457)
Q Consensus 228 kl~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (457)
||+|||+++.......
T Consensus 224 kL~DFG~a~~~~~~~~---------------------------------------------------------------- 239 (367)
T 3l9p_A 224 KIGDFGMARDIYRAGY---------------------------------------------------------------- 239 (367)
T ss_dssp EECCCHHHHHHHHHSS----------------------------------------------------------------
T ss_pred EECCCccccccccccc----------------------------------------------------------------
Confidence 9999999753311000
Q ss_pred ccCCccccccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHHhcccCCCCCCCCChH
Q 012762 308 AEPLDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVVARALEFPKEPSVPGP 386 (457)
Q Consensus 308 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 386 (457)
........||+.|+|||++.+..++.++|||||||++|||++ |..||.+.........+.... .......++..
T Consensus 240 ----~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~ 314 (367)
T 3l9p_A 240 ----YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG-RMDPPKNCPGP 314 (367)
T ss_dssp ----CTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC-CCCCCTTCCHH
T ss_pred ----cccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-CCCCCccCCHH
Confidence 001113458999999999999999999999999999999998 999999988777766665543 33444568999
Q ss_pred HHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCCCCchhh
Q 012762 387 AKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGVNWALL 426 (457)
Q Consensus 387 ~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~~~~~~~ 426 (457)
+.+||.+||+.||++||+ +.+|++|.++-..+...+
T Consensus 315 l~~li~~~l~~dP~~Rps----~~eil~~l~~~~~~~~~~ 350 (367)
T 3l9p_A 315 VYRIMTQCWQHQPEDRPN----FAIILERIEYCTQDPDVI 350 (367)
T ss_dssp HHHHHHHHTCSSGGGSCC----HHHHHHHHHHHHHCHHHH
T ss_pred HHHHHHHHcCCCHhHCcC----HHHHHHHHHHHhhChhhc
Confidence 999999999999999999 999999977654444433
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=368.05 Aligned_cols=253 Identities=19% Similarity=0.288 Sum_probs=207.6
Q ss_pred CCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHc-CCCCCceEEEEEEcCCc
Q 012762 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEML-DHPFLPTLYATLDCPRW 160 (457)
Q Consensus 82 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~~~~~~~~~ 160 (457)
++|++++.||+|+||+||+|.++ .+++.||+|++...... ......+.+|+.++..+ +||||+++++++...+.
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~----~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~ 85 (289)
T 1x8b_A 11 TEFHELEKIGSGEFGSVFKCVKR----LDGCIYAIKRSKKPLAG-SVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDH 85 (289)
T ss_dssp HHEEEEEEEEEETTEEEEEEEET----TTCCEEEEEEEECCCTT-SHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTE
T ss_pred chhhhhhhhcCCCceEEEEEEEc----CCCceEEEEEecccccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCe
Confidence 57999999999999999999986 47889999999764322 23456677799999998 99999999999999999
Q ss_pred EEEEEeecCCCChHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccC--------------
Q 012762 161 SCLLTEFCPGGDLHVLRQRQP--DKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSD-------------- 224 (457)
Q Consensus 161 ~~lV~E~~~~~sL~~~~~~~~--~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~-------------- 224 (457)
.|+||||+++++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 86 MLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC----------------
T ss_pred EEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCccccccccccc
Confidence 999999999999999887642 2568999999999999999999999999999999999999844
Q ss_pred -----CCEEEeccCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCC
Q 012762 225 -----GHIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLG 299 (457)
Q Consensus 225 -----~~vkl~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (457)
..+||+|||++.......
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~~--------------------------------------------------------- 188 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSPQ--------------------------------------------------------- 188 (289)
T ss_dssp ----CCCEEECCCTTCEETTCSC---------------------------------------------------------
T ss_pred ccCCceEEEEcccccccccCCcc---------------------------------------------------------
Confidence 479999999875443110
Q ss_pred CCCCCcccccCCccccccccCCCCccCchhhcCC-CCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCC
Q 012762 300 NPGTPEIVAEPLDVRSMSFVGTHEYLAPEIISGE-GHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFP 378 (457)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~ 378 (457)
...||+.|+|||++.+. .++.++|||||||++|+|++|.+++.... ....+..... ..
T Consensus 189 -----------------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~---~~~~~~~~~~-~~ 247 (289)
T 1x8b_A 189 -----------------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD---QWHEIRQGRL-PR 247 (289)
T ss_dssp -----------------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH---HHHHHHTTCC-CC
T ss_pred -----------------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh---HHHHHHcCCC-CC
Confidence 12489999999999876 56789999999999999999998875532 2333333322 22
Q ss_pred CCCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCCC
Q 012762 379 KEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGV 421 (457)
Q Consensus 379 ~~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~~ 421 (457)
....+++++.+||.+||..||++||+ +.++++||||+..
T Consensus 248 ~~~~~~~~~~~li~~~l~~dp~~Rps----~~~ll~h~~~~~~ 286 (289)
T 1x8b_A 248 IPQVLSQEFTELLKVMIHPDPERRPS----AMALVKHSVLLSA 286 (289)
T ss_dssp CSSCCCHHHHHHHHHHTCSSGGGSCC----HHHHHTCTTC---
T ss_pred CCcccCHHHHHHHHHHhCCCcccCCC----HHHHhhChHhhhh
Confidence 23458899999999999999999999 9999999999863
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=366.00 Aligned_cols=257 Identities=23% Similarity=0.305 Sum_probs=218.6
Q ss_pred CCCCccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEE
Q 012762 75 NNNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYAT 154 (457)
Q Consensus 75 ~~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~ 154 (457)
..+.+..++|++.+.||+|+||+||+|.+. ++..||+|++..... ....+.+|++++++++||||++++++
T Consensus 3 ~~~~i~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~ 73 (269)
T 4hcu_A 3 GKWVIDPSELTFVQEIGSGQFGLVHLGYWL-----NKDKVAIKTIREGAM----SEEDFIEEAEVMMKLSHPKLVQLYGV 73 (269)
T ss_dssp --CBCCGGGEEEEEEEEECSSCEEEEEEET-----TTEEEEEEEECTTSB----CHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccEEeChhhceeeheecCCCccEEEEEEec-----CCCeEEEEEeccccc----CHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 346678889999999999999999999875 567899999976432 34567889999999999999999999
Q ss_pred EEcCCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCC
Q 012762 155 LDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDL 234 (457)
Q Consensus 155 ~~~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~ 234 (457)
+.+.+..|+||||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 74 ~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~ 152 (269)
T 4hcu_A 74 CLEQAPICLVFEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGM 152 (269)
T ss_dssp ECSSSSEEEEEECCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTG
T ss_pred EecCCceEEEEEeCCCCcHHHHHHhc-CcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccc
Confidence 99999999999999999999998764 35699999999999999999999999999999999999999999999999999
Q ss_pred CcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccc
Q 012762 235 SLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVR 314 (457)
Q Consensus 235 s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (457)
+......... .
T Consensus 153 ~~~~~~~~~~---------------------------------------------------------------------~ 163 (269)
T 4hcu_A 153 TRFVLDDQYT---------------------------------------------------------------------S 163 (269)
T ss_dssp GGGBCCHHHH---------------------------------------------------------------------S
T ss_pred cccccccccc---------------------------------------------------------------------c
Confidence 8644321100 0
Q ss_pred cccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHH
Q 012762 315 SMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQ 393 (457)
Q Consensus 315 ~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~ 393 (457)
.....||+.|+|||++.+..++.++|||||||++|+|++ |..||...........+... ........++.++.+++.+
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~ 242 (269)
T 4hcu_A 164 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG-FRLYKPRLASTHVYQIMNH 242 (269)
T ss_dssp TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT-CCCCCCTTSCHHHHHHHHH
T ss_pred ccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcC-ccCCCCCcCCHHHHHHHHH
Confidence 112247889999999999999999999999999999999 99999988877776666544 3344445688999999999
Q ss_pred HhhhCCCCCCCCCcChHHHhcC
Q 012762 394 LLVKDPTRRMGSKMGATAIKRH 415 (457)
Q Consensus 394 ~L~~dP~~Rps~~~~~~~ll~h 415 (457)
||..||++||+ +.++++|
T Consensus 243 ~l~~~p~~Rps----~~~ll~~ 260 (269)
T 4hcu_A 243 CWRERPEDRPA----FSRLLRQ 260 (269)
T ss_dssp HTCSSGGGSCC----HHHHHHH
T ss_pred HccCCcccCcC----HHHHHHH
Confidence 99999999999 9998876
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-48 Score=379.81 Aligned_cols=261 Identities=30% Similarity=0.483 Sum_probs=210.9
Q ss_pred CCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhh-----hhhHHHHHHHHHHHHHHcCCCCCceEEEEEE
Q 012762 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELV-----SRNKESRARIEREILEMLDHPFLPTLYATLD 156 (457)
Q Consensus 82 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~-----~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~ 156 (457)
++|++.+.||+|+||.||+|.++ .+++.||||++.+.... .......+.+|+++|+.++||||+++++++.
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 85 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFER----KTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD 85 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEET----TTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hceeEeeEEecCCCEEEEEEEEc----CCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEc
Confidence 47999999999999999999986 47899999999765432 1122345778999999999999999999997
Q ss_pred cCCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCC---EEEeccC
Q 012762 157 CPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGH---IMLTDFD 233 (457)
Q Consensus 157 ~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~---vkl~DFG 233 (457)
.+. .|+||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||
T Consensus 86 ~~~-~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg 162 (322)
T 2ycf_A 86 AED-YYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFG 162 (322)
T ss_dssp SSS-EEEEEECCTTEETHHHHSTT--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCT
T ss_pred CCc-eEEEEecCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCc
Confidence 665 89999999999999887654 67999999999999999999999999999999999999987664 9999999
Q ss_pred CCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcc
Q 012762 234 LSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDV 313 (457)
Q Consensus 234 ~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (457)
++........
T Consensus 163 ~~~~~~~~~~---------------------------------------------------------------------- 172 (322)
T 2ycf_A 163 HSKILGETSL---------------------------------------------------------------------- 172 (322)
T ss_dssp TCEECCCCHH----------------------------------------------------------------------
T ss_pred cceecccccc----------------------------------------------------------------------
Confidence 9865432110
Q ss_pred ccccccCCCCccCchhhc---CCCCCccchhhhhhHHHHHHhcCCCCCCCCChHH-HHHHHHhcccCCCC--CCCCChHH
Q 012762 314 RSMSFVGTHEYLAPEIIS---GEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHEL-TLANVVARALEFPK--EPSVPGPA 387 (457)
Q Consensus 314 ~~~~~~gt~~y~aPE~l~---~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~-~~~~~~~~~~~~~~--~~~~~~~~ 387 (457)
.....||+.|+|||++. +..++.++|||||||++|+|++|..||....... ....+......+.. ...++.++
T Consensus 173 -~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (322)
T 2ycf_A 173 -MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKA 251 (322)
T ss_dssp -HHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHHHTTSCHHH
T ss_pred -cccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchhhhhcCHHH
Confidence 11246999999999974 4568999999999999999999999998755432 33333333333221 24578999
Q ss_pred HHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCCCCch
Q 012762 388 KDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGVNWA 424 (457)
Q Consensus 388 ~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~~~~~ 424 (457)
.+||.+||..||++||+ +.++++||||+..+|.
T Consensus 252 ~~li~~~l~~dP~~Rps----~~~~l~h~~~~~~~~~ 284 (322)
T 2ycf_A 252 LDLVKKLLVVDPKARFT----TEEALRHPWLQDEDMK 284 (322)
T ss_dssp HHHHHHHSCSSTTTSCC----HHHHHTSGGGCCHHHH
T ss_pred HHHHHHHcccCHhhCCC----HHHHhhCcCcCCHHHH
Confidence 99999999999999999 9999999999987763
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=379.57 Aligned_cols=266 Identities=23% Similarity=0.314 Sum_probs=217.5
Q ss_pred CCCccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCC------Cc
Q 012762 76 NNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPF------LP 149 (457)
Q Consensus 76 ~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~n------Iv 149 (457)
.+..-.++|++.+.||+|+||+||+|.++. ..++.||+|++.... .....+.+|+++++.++|++ |+
T Consensus 13 ~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~~~ 85 (355)
T 2eu9_A 13 IGDWLQERYEIVGNLGEGTFGKVVECLDHA---RGKSQVALKIIRNVG----KYREAARLEINVLKKIKEKDKENKFLCV 85 (355)
T ss_dssp TTCEETTTEEEEEEEEEETTEEEEEEEETT---TTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHHCTTSCSCBC
T ss_pred cCceecccEEEEEEeeccCCeEEEEEEecC---CCceEEEEEEEcccc----cchhHHHHHHHHHHHHhhcCCCCceeEE
Confidence 344556899999999999999999999763 234789999997532 34456778999999987655 89
Q ss_pred eEEEEEEcCCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEE--------
Q 012762 150 TLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLV-------- 221 (457)
Q Consensus 150 ~l~~~~~~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll-------- 221 (457)
.+++++...+..||||||+ +++|..++.......+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 86 ~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~ 164 (355)
T 2eu9_A 86 LMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETL 164 (355)
T ss_dssp CEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEE
T ss_pred EeeeeeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccc
Confidence 9999999999999999999 7777777776655679999999999999999999999999999999999999
Q ss_pred -----------ccCCCEEEeccCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCc
Q 012762 222 -----------RSDGHIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHP 290 (457)
Q Consensus 222 -----------~~~~~vkl~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (457)
+.++.+||+|||+++.....
T Consensus 165 ~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~------------------------------------------------- 195 (355)
T 2eu9_A 165 YNEHKSCEEKSVKNTSIRVADFGSATFDHEH------------------------------------------------- 195 (355)
T ss_dssp ECCC-CCCEEEESCCCEEECCCTTCEETTSC-------------------------------------------------
T ss_pred ccccccccccccCCCcEEEeecCcccccccc-------------------------------------------------
Confidence 56789999999997543211
Q ss_pred chhccccCCCCCCCcccccCCccccccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHH
Q 012762 291 KRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANV 370 (457)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~ 370 (457)
....+||+.|+|||++.+..++.++|||||||++|||++|..||.+.........+
T Consensus 196 ------------------------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 251 (355)
T 2eu9_A 196 ------------------------HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMM 251 (355)
T ss_dssp ------------------------CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred ------------------------ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 01236999999999999999999999999999999999999999987766555444
Q ss_pred HhcccCCCC------------------------------------------CCCCChHHHHHHHHHhhhCCCCCCCCCcC
Q 012762 371 VARALEFPK------------------------------------------EPSVPGPAKDLIAQLLVKDPTRRMGSKMG 408 (457)
Q Consensus 371 ~~~~~~~~~------------------------------------------~~~~~~~~~~ll~~~L~~dP~~Rps~~~~ 408 (457)
.......|. ....+.++.+||.+||..||++||+
T Consensus 252 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt---- 327 (355)
T 2eu9_A 252 EKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRIT---- 327 (355)
T ss_dssp HHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCC----
T ss_pred HHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcC----
Confidence 332222111 0111347889999999999999999
Q ss_pred hHHHhcCCCCCCCCchhh
Q 012762 409 ATAIKRHQFFNGVNWALL 426 (457)
Q Consensus 409 ~~~ll~hp~f~~~~~~~~ 426 (457)
+.|+++||||++++|...
T Consensus 328 ~~e~l~hp~f~~~~~~~~ 345 (355)
T 2eu9_A 328 LAEALLHPFFAGLTPEER 345 (355)
T ss_dssp HHHHTTSGGGGGCCHHHH
T ss_pred HHHHhcChhhcCCChhhc
Confidence 999999999999988643
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=372.80 Aligned_cols=261 Identities=25% Similarity=0.405 Sum_probs=215.7
Q ss_pred cCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCC
Q 012762 80 TLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPR 159 (457)
Q Consensus 80 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~ 159 (457)
..++|++.+.||+|+||+||+|.++ .+|+.||+|++.... ....+.+|+++++.++||||+++++++...+
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~----~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 97 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHK----ETGQIVAIKQVPVES-----DLQEIIKEISIMQQCDSPHVVKYYGSYFKNT 97 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEET----TTCCEEEEEEEETTS-----CCHHHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred chhhhhhheeeccCCCeEEEEEEEC----CCCCEEEEEecCchH-----HHHHHHHHHHHHHhCCCCCCccEEEEEEeCC
Confidence 4568999999999999999999876 478899999997542 3456778999999999999999999999999
Q ss_pred cEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCC
Q 012762 160 WSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGD 239 (457)
Q Consensus 160 ~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~ 239 (457)
..|+||||+++++|.+++... ...+++..++.++.||+.||.|||+.||+|+||||+||+++.++.+||+|||++....
T Consensus 98 ~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 176 (314)
T 3com_A 98 DLWIVMEYCGAGSVSDIIRLR-NKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLT 176 (314)
T ss_dssp EEEEEEECCTTEEHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECB
T ss_pred EEEEEeecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhh
Confidence 999999999999999988743 3679999999999999999999999999999999999999999999999999975443
Q ss_pred CCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcccccccc
Q 012762 240 NSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFV 319 (457)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (457)
.... ......
T Consensus 177 ~~~~----------------------------------------------------------------------~~~~~~ 186 (314)
T 3com_A 177 DTMA----------------------------------------------------------------------KRNTVI 186 (314)
T ss_dssp TTBS----------------------------------------------------------------------CBCCCC
T ss_pred hhcc----------------------------------------------------------------------ccCccC
Confidence 1110 011235
Q ss_pred CCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhccc-CCCCCCCCChHHHHHHHHHhhhC
Q 012762 320 GTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARAL-EFPKEPSVPGPAKDLIAQLLVKD 398 (457)
Q Consensus 320 gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ll~~~L~~d 398 (457)
||+.|+|||++.+..++.++|||||||++|+|++|..||...........+..... .+.....++..+.+||.+||..|
T Consensus 187 ~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 266 (314)
T 3com_A 187 GTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDFVKQCLVKS 266 (314)
T ss_dssp SCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHHHHHHHTCSC
T ss_pred CCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccCCHHHHHHHHHHccCC
Confidence 89999999999999999999999999999999999999988766555444433321 22223457889999999999999
Q ss_pred CCCCCCCCcChHHHhcCCCCCCCCch
Q 012762 399 PTRRMGSKMGATAIKRHQFFNGVNWA 424 (457)
Q Consensus 399 P~~Rps~~~~~~~ll~hp~f~~~~~~ 424 (457)
|.+||+ +.++++||||+...+.
T Consensus 267 p~~Rpt----~~~ll~~~~~~~~~~~ 288 (314)
T 3com_A 267 PEQRAT----ATQLLQHPFVRSAKGV 288 (314)
T ss_dssp TTTSCC----HHHHTTSHHHHTCCCG
T ss_pred hhhCcC----HHHHHhCHHHhcCCcc
Confidence 999999 9999999999987664
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=364.53 Aligned_cols=253 Identities=28% Similarity=0.440 Sum_probs=209.9
Q ss_pred CccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhh-hhHHHHHHHHHHHHHHcCCCCCceEEEEEE
Q 012762 78 PLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVS-RNKESRARIEREILEMLDHPFLPTLYATLD 156 (457)
Q Consensus 78 ~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~-~~~~~~~~~E~~il~~l~H~nIv~l~~~~~ 156 (457)
.+..++|++.+.||+|+||+||+|.+ .+..||+|++....... ......+.+|+++++.++||||+++++++.
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~V~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 76 (271)
T 3dtc_A 3 EIDFAELTLEEIIGIGGFGKVYRAFW------IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCL 76 (271)
T ss_dssp BCCTTSEEEEEEEEEETTEEEEEEEE------TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccchhheeeeeeeccCCCeEEEEEEE------cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe
Confidence 35678999999999999999999986 47789999987643322 223467888999999999999999999999
Q ss_pred cCCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcC---ceeecCCCCCeEEcc--------CC
Q 012762 157 CPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMG---IIYRDLKPENVLVRS--------DG 225 (457)
Q Consensus 157 ~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~---iiHrDIKp~NIll~~--------~~ 225 (457)
.++..|+||||+++++|..++.. ..+++..++.++.||+.||.|||++| |+||||||+|||++. ++
T Consensus 77 ~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~ 153 (271)
T 3dtc_A 77 KEPNLCLVMEFARGGPLNRVLSG---KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNK 153 (271)
T ss_dssp CC--CEEEEECCTTEEHHHHHTS---SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSC
T ss_pred cCCceEEEEEcCCCCCHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCc
Confidence 99999999999999999988854 57999999999999999999999999 999999999999986 67
Q ss_pred CEEEeccCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCc
Q 012762 226 HIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPE 305 (457)
Q Consensus 226 ~vkl~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (457)
.+||+|||++........
T Consensus 154 ~~kl~Dfg~~~~~~~~~~-------------------------------------------------------------- 171 (271)
T 3dtc_A 154 ILKITDFGLAREWHRTTK-------------------------------------------------------------- 171 (271)
T ss_dssp CEEECCCCC-----------------------------------------------------------------------
T ss_pred ceEEccCCcccccccccc--------------------------------------------------------------
Confidence 899999999864431110
Q ss_pred ccccCCccccccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCCCCCCh
Q 012762 306 IVAEPLDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPG 385 (457)
Q Consensus 306 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (457)
....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.........+.......+....+++
T Consensus 172 ----------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (271)
T 3dtc_A 172 ----------MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTCPE 241 (271)
T ss_dssp --------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCCCTTCCH
T ss_pred ----------cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCCCcccCH
Confidence 1235899999999999999999999999999999999999999998887777777777766676677999
Q ss_pred HHHHHHHHHhhhCCCCCCCCCcChHHHhcC
Q 012762 386 PAKDLIAQLLVKDPTRRMGSKMGATAIKRH 415 (457)
Q Consensus 386 ~~~~ll~~~L~~dP~~Rps~~~~~~~ll~h 415 (457)
.+.++|.+||..||.+||+ +.|+++|
T Consensus 242 ~~~~li~~~l~~~p~~Rps----~~e~l~~ 267 (271)
T 3dtc_A 242 PFAKLMEDCWNPDPHSRPS----FTNILDQ 267 (271)
T ss_dssp HHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred HHHHHHHHHhcCCcccCcC----HHHHHHH
Confidence 9999999999999999999 9998875
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-47 Score=379.82 Aligned_cols=266 Identities=20% Similarity=0.274 Sum_probs=222.3
Q ss_pred CCCCccCCCceeEEEecccCcceEEEEEEeccCC---CCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHc-CCCCCce
Q 012762 75 NNNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSS---NNGCFFAAKVMDKRELVSRNKESRARIEREILEML-DHPFLPT 150 (457)
Q Consensus 75 ~~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~---~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~ 150 (457)
..+.+..++|++.++||+|+||+||+|++...+. ..+..||+|++... ........+.+|+++++++ +||||++
T Consensus 62 ~~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~hpnIv~ 139 (382)
T 3tt0_A 62 PRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD--ATEKDLSDLISEMEMMKMIGKHKNIIN 139 (382)
T ss_dssp TTTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT--CCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred cccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc--cCHHHHHHHHHHHHHHHHhcCCchhhh
Confidence 4456777899999999999999999999764322 34568999999764 2334456788899999999 9999999
Q ss_pred EEEEEEcCCcEEEEEeecCCCChHHHHHhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCC
Q 012762 151 LYATLDCPRWSCLLTEFCPGGDLHVLRQRQP--------------DKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKP 216 (457)
Q Consensus 151 l~~~~~~~~~~~lV~E~~~~~sL~~~~~~~~--------------~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp 216 (457)
+++++..++..|+||||+++++|.+++.... ...+++..++.++.||+.||.|||++||+||||||
T Consensus 140 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp 219 (382)
T 3tt0_A 140 LLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAA 219 (382)
T ss_dssp EEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG
T ss_pred heeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCc
Confidence 9999999999999999999999999998753 24599999999999999999999999999999999
Q ss_pred CCeEEccCCCEEEeccCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccc
Q 012762 217 ENVLVRSDGHIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKK 296 (457)
Q Consensus 217 ~NIll~~~~~vkl~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (457)
+||||+.++.+||+|||+++.........
T Consensus 220 ~NIll~~~~~~kL~DFG~a~~~~~~~~~~--------------------------------------------------- 248 (382)
T 3tt0_A 220 RNVLVTEDNVMKIADFGLARDIHHIDYYK--------------------------------------------------- 248 (382)
T ss_dssp GGEEECTTCCEEECSCSCCCCSSCCCTTC---------------------------------------------------
T ss_pred ceEEEcCCCcEEEcccCcccccccccccc---------------------------------------------------
Confidence 99999999999999999986543211100
Q ss_pred cCCCCCCCcccccCCccccccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHHhccc
Q 012762 297 KLGNPGTPEIVAEPLDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVVARAL 375 (457)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~ 375 (457)
......||+.|+|||++.+..++.++|||||||++|+|++ |..||.+....+....+.. ..
T Consensus 249 -----------------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~~~~~~-~~ 310 (382)
T 3tt0_A 249 -----------------KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKE-GH 310 (382)
T ss_dssp -----------------CCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHT-TC
T ss_pred -----------------cccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-CC
Confidence 0012247889999999999999999999999999999999 9999998877666555443 33
Q ss_pred CCCCCCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcC
Q 012762 376 EFPKEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRH 415 (457)
Q Consensus 376 ~~~~~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~h 415 (457)
.......++.++.+||.+||+.||++||+ +.||+++
T Consensus 311 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps----~~ell~~ 346 (382)
T 3tt0_A 311 RMDKPSNCTNELYMMMRDCWHAVPSQRPT----FKQLVED 346 (382)
T ss_dssp CCCCCSSCCHHHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred CCCCCccCCHHHHHHHHHHcCCChhhCcC----HHHHHHH
Confidence 44445568999999999999999999999 8888875
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-47 Score=369.62 Aligned_cols=255 Identities=24% Similarity=0.376 Sum_probs=219.4
Q ss_pred CCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcE
Q 012762 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWS 161 (457)
Q Consensus 82 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~ 161 (457)
+.|++++.||+|+||+||+|.+. .+++.||+|++..... ......+.+|+++++.++||||+++++++...+..
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~----~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 95 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDN----RTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKL 95 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEET----TTCCEEEEEEEETTTC--STTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred HHHHHhhhhcccCCeEEEEEEEC----CCCcEEEEEEeccccc--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeE
Confidence 56999999999999999999876 4788999999976532 23456788899999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCC
Q 012762 162 CLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNS 241 (457)
Q Consensus 162 ~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~ 241 (457)
|+||||+++++|.+++.. ..+++..++.++.||+.||.|||+.||+|+||||+|||++.++.+||+|||++......
T Consensus 96 ~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 172 (303)
T 3a7i_A 96 WIIMEYLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 172 (303)
T ss_dssp EEEEECCTTEEHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTT
T ss_pred EEEEEeCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCcc
Confidence 999999999999998865 57999999999999999999999999999999999999999999999999998554321
Q ss_pred CcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCC
Q 012762 242 TSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGT 321 (457)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 321 (457)
.. ......||
T Consensus 173 ~~----------------------------------------------------------------------~~~~~~~~ 182 (303)
T 3a7i_A 173 QI----------------------------------------------------------------------KRNTFVGT 182 (303)
T ss_dssp BC----------------------------------------------------------------------CBCCCCSC
T ss_pred cc----------------------------------------------------------------------ccCccCCC
Confidence 10 01134699
Q ss_pred CCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhhhCCCC
Q 012762 322 HEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDPTR 401 (457)
Q Consensus 322 ~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~ 401 (457)
+.|+|||++.+..++.++|||||||++|+|++|..||...........+.... .......++..+.+||.+||..||++
T Consensus 183 ~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~ 261 (303)
T 3a7i_A 183 PFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNN-PPTLEGNYSKPLKEFVEACLNKEPSF 261 (303)
T ss_dssp GGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC-CCCCCSSCCHHHHHHHHHHCCSSGGG
T ss_pred cCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCC-CCCCccccCHHHHHHHHHHcCCChhh
Confidence 99999999999999999999999999999999999998877666555544332 22233468899999999999999999
Q ss_pred CCCCCcChHHHhcCCCCCC
Q 012762 402 RMGSKMGATAIKRHQFFNG 420 (457)
Q Consensus 402 Rps~~~~~~~ll~hp~f~~ 420 (457)
||+ +.+|++||||..
T Consensus 262 Rps----~~~ll~~~~~~~ 276 (303)
T 3a7i_A 262 RPT----AKELLKHKFILR 276 (303)
T ss_dssp SCC----HHHHTTCHHHHH
T ss_pred CcC----HHHHhhChhhhc
Confidence 999 999999999964
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-47 Score=376.03 Aligned_cols=259 Identities=27% Similarity=0.355 Sum_probs=213.2
Q ss_pred CCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCc
Q 012762 81 LSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRW 160 (457)
Q Consensus 81 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~ 160 (457)
.++|.+.+.||+|+||+||+|.++ .+|+.||||++.... ........+.+|+.+|+.++||||+++++++...+.
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~----~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 97 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDK----RSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASS 97 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEET----TTTEEEEEEEESSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSS
T ss_pred CceEEEeeeEecCCCeEEEEEEEC----CCCCEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCcccHhheEecccc
Confidence 368999999999999999999986 478999999997542 233445677889999999999999999999987654
Q ss_pred ------EEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCC
Q 012762 161 ------SCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDL 234 (457)
Q Consensus 161 ------~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~ 234 (457)
.|+||||+. ++|..++. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 98 ~~~~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~ 172 (353)
T 3coi_A 98 LRNFYDFYLVMPFMQ-TDLQKIMG----LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGL 172 (353)
T ss_dssp GGGCCCCEEEEECCS-EEGGGTTT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTC
T ss_pred cccceeEEEEecccc-CCHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeeccc
Confidence 499999995 68876653 3599999999999999999999999999999999999999999999999999
Q ss_pred CcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccc
Q 012762 235 SLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVR 314 (457)
Q Consensus 235 s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (457)
+......
T Consensus 173 ~~~~~~~------------------------------------------------------------------------- 179 (353)
T 3coi_A 173 ARHADAE------------------------------------------------------------------------- 179 (353)
T ss_dssp TTC-----------------------------------------------------------------------------
T ss_pred ccCCCCC-------------------------------------------------------------------------
Confidence 7543211
Q ss_pred cccccCCCCccCchhhcC-CCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccC-----------------
Q 012762 315 SMSFVGTHEYLAPEIISG-EGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALE----------------- 376 (457)
Q Consensus 315 ~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~----------------- 376 (457)
.....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+......+..++.....
T Consensus 180 ~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 259 (353)
T 3coi_A 180 MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSY 259 (353)
T ss_dssp ----CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHHHHH
T ss_pred ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHHHHH
Confidence 012358999999999987 56899999999999999999999999987766655554432110
Q ss_pred -----------C-CCCCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCCCCchhh
Q 012762 377 -----------F-PKEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGVNWALL 426 (457)
Q Consensus 377 -----------~-~~~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~~~~~~~ 426 (457)
+ .....++.++.+||.+||..||++||+ +.++++||||+.+.....
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt----~~e~l~hp~f~~~~~~~~ 317 (353)
T 3coi_A 260 IQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLT----AAQALTHPFFEPFRDPEE 317 (353)
T ss_dssp HHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCC----HHHHHTSGGGTTTCCGGG
T ss_pred HHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCC----HHHHhcCcchhhccCccc
Confidence 0 112356889999999999999999999 999999999998766543
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-47 Score=373.69 Aligned_cols=266 Identities=20% Similarity=0.335 Sum_probs=213.7
Q ss_pred cCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHc-CCCCCceEEEEEEcC
Q 012762 80 TLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEML-DHPFLPTLYATLDCP 158 (457)
Q Consensus 80 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~~~~~~~ 158 (457)
..++|++.+.||+|+||+||+|.+. .+++.||||++.... ....+.+|+++++.+ +|+||+++++++..+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~----~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 77 (330)
T 2izr_A 7 VGPNFRVGKKIGCGNFGELRLGKNL----YTNEYVAIKLEPMKS-----RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCG 77 (330)
T ss_dssp ETTTEEEEEECCC-CTTSEEEEEET----TTTEEEEEEEEETTC-----SSCCHHHHHHHHHHHCSCTTSCCEEEEEEET
T ss_pred EcCCeEEEEEeeccCCceEEEEEEC----CCCcEEEEEEecccc-----chHHHHHHHHHHHHhhCCCCCCEEEEEEecC
Confidence 3468999999999999999999976 478999999987542 223577899999999 999999999999999
Q ss_pred CcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCC-----EEEeccC
Q 012762 159 RWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGH-----IMLTDFD 233 (457)
Q Consensus 159 ~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~-----vkl~DFG 233 (457)
+..||||||+ +++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||
T Consensus 78 ~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg 155 (330)
T 2izr_A 78 KYNAMVLELL-GPSLEDLFDLC-DRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFA 155 (330)
T ss_dssp TEEEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCT
T ss_pred CccEEEEEeC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcc
Confidence 9999999999 99999998875 367999999999999999999999999999999999999998887 9999999
Q ss_pred CCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcc
Q 012762 234 LSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDV 313 (457)
Q Consensus 234 ~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (457)
+++........... ...
T Consensus 156 ~a~~~~~~~~~~~~---------------------------------------------------------------~~~ 172 (330)
T 2izr_A 156 LAKEYIDPETKKHI---------------------------------------------------------------PYR 172 (330)
T ss_dssp TCEESBCTTTCCBC---------------------------------------------------------------CCC
T ss_pred cceeeecCCCCccc---------------------------------------------------------------ccc
Confidence 98755322111000 000
Q ss_pred ccccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCCh---HHHHHHHHhcccCCCC---CCCCChHH
Q 012762 314 RSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDH---ELTLANVVARALEFPK---EPSVPGPA 387 (457)
Q Consensus 314 ~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~---~~~~~~~~~~~~~~~~---~~~~~~~~ 387 (457)
.....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+... ...+..+.......+. ...+| ++
T Consensus 173 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~p-~~ 251 (330)
T 2izr_A 173 EHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPIEVLCENFP-EM 251 (330)
T ss_dssp CCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCHHHHTTTCH-HH
T ss_pred ccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCHHHHhccCh-HH
Confidence 11245799999999999999999999999999999999999999987533 3334444333333321 12345 89
Q ss_pred HHHHHHHhhhCCCCCCCCCcChHHHhc----------CCCCCCCCch
Q 012762 388 KDLIAQLLVKDPTRRMGSKMGATAIKR----------HQFFNGVNWA 424 (457)
Q Consensus 388 ~~ll~~~L~~dP~~Rps~~~~~~~ll~----------hp~f~~~~~~ 424 (457)
.++|..||..||.+||+ +++|++ ..+...++|.
T Consensus 252 ~~li~~~l~~~p~~RP~----~~~l~~~l~~~~~~~~~~~~~~~dw~ 294 (330)
T 2izr_A 252 ATYLRYVRRLDFFEKPD----YDYLRKLFTDLFDRKGYMFDYEYDWI 294 (330)
T ss_dssp HHHHHHHHHCCTTCCCC----HHHHHHHHHHHHHHTTCCCSCCCTTT
T ss_pred HHHHHHHHhCCCCCCCC----HHHHHHHHHHHHHHcCCCCCCCccCC
Confidence 99999999999999999 666654 4455568887
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-49 Score=398.24 Aligned_cols=251 Identities=17% Similarity=0.181 Sum_probs=202.5
Q ss_pred cCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHH---HHHcCCCCCceEE----
Q 012762 80 TLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREI---LEMLDHPFLPTLY---- 152 (457)
Q Consensus 80 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~i---l~~l~H~nIv~l~---- 152 (457)
..++|++.+.||+|+||+||+|+++ .+|+.||||++.+...........+.+|+++ |+.++|||||+++
T Consensus 71 ~~~~y~~~~~lG~G~~g~V~~a~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~ 146 (377)
T 3byv_A 71 RPRTLVRGTVLGQEDPYAYLEATDQ----ETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFI 146 (377)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEC-----CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBC
T ss_pred CCceEEEcceeecCCCEEEEEEEEC----CCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhh
Confidence 3578999999999999999999976 4788999999986544455566788889955 4555899999998
Q ss_pred ---EEEEcCCc-----------------EEEEEeecCCCChHHHHHhCCCCCCC-------HHHHHHHHHHHHHHHHHHH
Q 012762 153 ---ATLDCPRW-----------------SCLLTEFCPGGDLHVLRQRQPDKRFH-------ESAVRFYASEVVVALEFLH 205 (457)
Q Consensus 153 ---~~~~~~~~-----------------~~lV~E~~~~~sL~~~~~~~~~~~~~-------~~~~~~i~~qi~~~L~yLH 205 (457)
+++...+. .||||||+ +|+|.+++... +.++ +..++.++.||+.||.|||
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~--~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH 223 (377)
T 3byv_A 147 FPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVL--LSHSSTHKSLVHHARLQLTLQVIRLLASLH 223 (377)
T ss_dssp CCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHH--HHTTTTTHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred hhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhc--cccccccccccHHHHHHHHHHHHHHHHHHH
Confidence 77665542 79999999 78999998764 2244 4788889999999999999
Q ss_pred HcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcc
Q 012762 206 MMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAV 285 (457)
Q Consensus 206 ~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (457)
++||+||||||+||||+.++.+||+|||+++....
T Consensus 224 ~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~--------------------------------------------- 258 (377)
T 3byv_A 224 HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA--------------------------------------------- 258 (377)
T ss_dssp HTTEECSCCCGGGEEECTTCCEEECCGGGCEETTC---------------------------------------------
T ss_pred hCCeecCCCCHHHEEEcCCCCEEEEechhheecCC---------------------------------------------
Confidence 99999999999999999999999999999864321
Q ss_pred cccCcchhccccCCCCCCCcccccCCccccccccCCCCccCchhhcCC-----------CCCccchhhhhhHHHHHHhcC
Q 012762 286 SCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTHEYLAPEIISGE-----------GHGNAVDWWTLGIFIFELFYG 354 (457)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-----------~~~~~sDiwSlG~il~elltG 354 (457)
.....+| +.|+|||++.+. .++.++|||||||++|||++|
T Consensus 259 ----------------------------~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg 309 (377)
T 3byv_A 259 ----------------------------RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCA 309 (377)
T ss_dssp ----------------------------EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHS
T ss_pred ----------------------------cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHC
Confidence 1113458 999999999987 799999999999999999999
Q ss_pred CCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCCC
Q 012762 355 TTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGV 421 (457)
Q Consensus 355 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~~ 421 (457)
+.||.+.........+. .....+++++.+||.+||..||++||+ +.|+++||||+.+
T Consensus 310 ~~Pf~~~~~~~~~~~~~------~~~~~~~~~~~~li~~~L~~dp~~Rpt----~~e~l~hp~f~~~ 366 (377)
T 3byv_A 310 DLPITKDAALGGSEWIF------RSCKNIPQPVRALLEGFLRYPKEDRLL----PLQAMETPEYEQL 366 (377)
T ss_dssp SCCC------CCSGGGG------SSCCCCCHHHHHHHHHHTCSSGGGCCC----HHHHHTSHHHHHH
T ss_pred CCCCcccccccchhhhh------hhccCCCHHHHHHHHHHcCCCchhCCC----HHHHhhChHHHHH
Confidence 99998755433322221 122468899999999999999999999 9999999999864
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-47 Score=372.50 Aligned_cols=256 Identities=23% Similarity=0.383 Sum_probs=208.0
Q ss_pred cCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCC
Q 012762 80 TLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPR 159 (457)
Q Consensus 80 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~ 159 (457)
..++|++.+.||+|+||+||+|+++ .+++.||||++..... ......+.+|+++|++++||||+++++++....
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~----~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 80 (319)
T 4euu_A 7 SNHLWLLSDILGQGATANVFRGRHK----KTGDLFAIKVFNNISF--LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETT 80 (319)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEET----TTCCEEEEEEECGGGG--GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTT
T ss_pred CCCCEEEEEEecCCCCeEEEEEEEC----CCCcEEEEEEeccccc--cchHHHHHHHHHHHHhcCCCCcceEEEEeecCC
Confidence 3468999999999999999999987 3788999999976533 233566778999999999999999999998765
Q ss_pred --cEEEEEeecCCCChHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEE----ccCCCEEEecc
Q 012762 160 --WSCLLTEFCPGGDLHVLRQRQP-DKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLV----RSDGHIMLTDF 232 (457)
Q Consensus 160 --~~~lV~E~~~~~sL~~~~~~~~-~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll----~~~~~vkl~DF 232 (457)
..||||||+++++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+||
T Consensus 81 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Df 160 (319)
T 4euu_A 81 TRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDF 160 (319)
T ss_dssp TCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCC
T ss_pred CceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccC
Confidence 7899999999999999987643 2349999999999999999999999999999999999999 77778999999
Q ss_pred CCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCc
Q 012762 233 DLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLD 312 (457)
Q Consensus 233 G~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (457)
|+++.......
T Consensus 161 g~a~~~~~~~~--------------------------------------------------------------------- 171 (319)
T 4euu_A 161 GAARELEDDEQ--------------------------------------------------------------------- 171 (319)
T ss_dssp TTCEECCTTCC---------------------------------------------------------------------
T ss_pred CCceecCCCCc---------------------------------------------------------------------
Confidence 99865432111
Q ss_pred cccccccCCCCccCchhhc--------CCCCCccchhhhhhHHHHHHhcCCCCCCCCCh----HHHHHHHHhccc-----
Q 012762 313 VRSMSFVGTHEYLAPEIIS--------GEGHGNAVDWWTLGIFIFELFYGTTPFKGIDH----ELTLANVVARAL----- 375 (457)
Q Consensus 313 ~~~~~~~gt~~y~aPE~l~--------~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~----~~~~~~~~~~~~----- 375 (457)
.....||+.|+|||++. +..++.++|||||||++|||++|+.||..... ...+..++....
T Consensus 172 --~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~~ 249 (319)
T 4euu_A 172 --FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAIS 249 (319)
T ss_dssp --BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCTTCCE
T ss_pred --eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCCcccch
Confidence 11246999999999986 46789999999999999999999999975432 334444444322
Q ss_pred --------------CCCCCCC----CChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCC
Q 012762 376 --------------EFPKEPS----VPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQ 416 (457)
Q Consensus 376 --------------~~~~~~~----~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp 416 (457)
.++.... ++..+.+||.+||+.||++||+ ++|+|+||
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s----~~ell~h~ 304 (319)
T 4euu_A 250 GVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWG----FDQFFAET 304 (319)
T ss_dssp EEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCC----HHHHHHHH
T ss_pred hhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhcc----HHHhhhcc
Confidence 1111111 2346889999999999999999 99999986
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=388.54 Aligned_cols=264 Identities=21% Similarity=0.290 Sum_probs=195.0
Q ss_pred Ccee-EEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEE--cCC
Q 012762 83 DLRF-VHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLD--CPR 159 (457)
Q Consensus 83 ~~~~-~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~--~~~ 159 (457)
.|.+ .++||+|+||+||+|+++. ..+++.||||++.... ....+.+|+++|+.++||||+++++++. ...
T Consensus 21 ~y~~~g~~lG~G~~g~Vy~~~~~~--~~~~~~vaiK~~~~~~-----~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 93 (405)
T 3rgf_A 21 LFEYEGCKVGRGTYGHVYKAKRKD--GKDDKDYALKQIEGTG-----ISMSACREIALLRELKHPNVISLQKVFLSHADR 93 (405)
T ss_dssp HEECSSCCCC-----EEEEEEESS--SSCCCCEEEEECSSSS-----CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTT
T ss_pred hhhhcCcEeeecCCeEEEEEEEcc--CCCCeEEEEEEECCCC-----CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCC
Confidence 4666 4589999999999998753 2367899999996542 2235678999999999999999999995 467
Q ss_pred cEEEEEeecCCCChHHHHHhC-------CCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEE----ccCCCEE
Q 012762 160 WSCLLTEFCPGGDLHVLRQRQ-------PDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLV----RSDGHIM 228 (457)
Q Consensus 160 ~~~lV~E~~~~~sL~~~~~~~-------~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll----~~~~~vk 228 (457)
.+||||||+. ++|..++... ....+++..++.++.||+.||.|||++||+||||||+|||| +.++.+|
T Consensus 94 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~k 172 (405)
T 3rgf_A 94 KVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVK 172 (405)
T ss_dssp EEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEE
T ss_pred eEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEE
Confidence 8999999994 6787766532 12359999999999999999999999999999999999999 6778999
Q ss_pred EeccCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccc
Q 012762 229 LTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVA 308 (457)
Q Consensus 229 l~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (457)
|+|||+++........
T Consensus 173 l~Dfg~a~~~~~~~~~---------------------------------------------------------------- 188 (405)
T 3rgf_A 173 IADMGFARLFNSPLKP---------------------------------------------------------------- 188 (405)
T ss_dssp ECCTTCCC------------------------------------------------------------------------
T ss_pred EEECCCceecCCCCcc----------------------------------------------------------------
Confidence 9999998655321100
Q ss_pred cCCccccccccCCCCccCchhhcCCC-CCccchhhhhhHHHHHHhcCCCCCCCCChH---------HHHHHHHhcccCCC
Q 012762 309 EPLDVRSMSFVGTHEYLAPEIISGEG-HGNAVDWWTLGIFIFELFYGTTPFKGIDHE---------LTLANVVARALEFP 378 (457)
Q Consensus 309 ~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~sDiwSlG~il~elltG~~Pf~~~~~~---------~~~~~~~~~~~~~~ 378 (457)
.......+||+.|+|||++.+.. ++.++|||||||++|||++|+.||.+.... ..+..++......+
T Consensus 189 ---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~~g~p~ 265 (405)
T 3rgf_A 189 ---LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPA 265 (405)
T ss_dssp -----------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHHHHHCCCC
T ss_pred ---cccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHHHhhCCCC
Confidence 00112347999999999998854 899999999999999999999999765432 33333332211111
Q ss_pred C------------------------------------CCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCCCC
Q 012762 379 K------------------------------------EPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGVN 422 (457)
Q Consensus 379 ~------------------------------------~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~~~ 422 (457)
. ....+..+.+||.+||..||.+||| ++|+|+||||+...
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~t----a~e~L~hp~f~~~~ 341 (405)
T 3rgf_A 266 DKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRIT----SEQAMQDPYFLEDP 341 (405)
T ss_dssp TTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCC----HHHHHTSGGGTSSS
T ss_pred hhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCC----HHHHhcChhhccCC
Confidence 0 0112677899999999999999999 99999999999877
Q ss_pred chh
Q 012762 423 WAL 425 (457)
Q Consensus 423 ~~~ 425 (457)
|..
T Consensus 342 ~~~ 344 (405)
T 3rgf_A 342 LPT 344 (405)
T ss_dssp CCC
T ss_pred CCc
Confidence 654
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=369.74 Aligned_cols=259 Identities=29% Similarity=0.445 Sum_probs=221.7
Q ss_pred CCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcE
Q 012762 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWS 161 (457)
Q Consensus 82 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~ 161 (457)
++|++++.||+|+||+||+|+++ .+++.||+|++...... ......+.+|++++++++||||+++++++...+..
T Consensus 22 ~~y~i~~~lg~G~~g~V~~~~~~----~~~~~valK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 96 (287)
T 2wei_A 22 ERYNIVCMLGKGSFGEVLKCKDR----ITQQEYAVKVINKASAK-NKDTSTILREVELLKKLDHPNIMKLFEILEDSSSF 96 (287)
T ss_dssp HHEEEEEEEEEETTEEEEEEEET----TTCCEEEEEEEEGGGBS-SSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred hcceeeEEEcCCCCEEEEEEEEc----CCCcEEEEEEecccccc-hHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeE
Confidence 47999999999999999999986 37889999999765432 23456788899999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccC---CCEEEeccCCCcCC
Q 012762 162 CLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSD---GHIMLTDFDLSLKG 238 (457)
Q Consensus 162 ~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~---~~vkl~DFG~s~~~ 238 (457)
|+||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++...
T Consensus 97 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~ 174 (287)
T 2wei_A 97 YIVGELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174 (287)
T ss_dssp EEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTB
T ss_pred EEEEEccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceee
Confidence 9999999999998877664 569999999999999999999999999999999999999754 47999999997543
Q ss_pred CCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccc
Q 012762 239 DNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSF 318 (457)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (457)
..... ....
T Consensus 175 ~~~~~-----------------------------------------------------------------------~~~~ 183 (287)
T 2wei_A 175 QQNTK-----------------------------------------------------------------------MKDR 183 (287)
T ss_dssp CCCSS-----------------------------------------------------------------------CSCH
T ss_pred cCCCc-----------------------------------------------------------------------cccc
Confidence 21110 0123
Q ss_pred cCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCC--CCCCCChHHHHHHHHHhh
Q 012762 319 VGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFP--KEPSVPGPAKDLIAQLLV 396 (457)
Q Consensus 319 ~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ll~~~L~ 396 (457)
.||+.|+|||++.+. ++.++|||||||++|+|++|..||.+.........+......++ ....++.++.++|.+||.
T Consensus 184 ~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 262 (287)
T 2wei_A 184 IGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLT 262 (287)
T ss_dssp HHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHHHHHHHHHHTC
T ss_pred cCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHHHHHHHHHHcc
Confidence 589999999999865 89999999999999999999999999888777777777665443 235688999999999999
Q ss_pred hCCCCCCCCCcChHHHhcCCCCCCCCc
Q 012762 397 KDPTRRMGSKMGATAIKRHQFFNGVNW 423 (457)
Q Consensus 397 ~dP~~Rps~~~~~~~ll~hp~f~~~~~ 423 (457)
.||++||+ +.++++||||+..+|
T Consensus 263 ~dp~~Rps----~~ell~hp~~~~~~~ 285 (287)
T 2wei_A 263 FHPSLRIT----ATQCLEHPWIQKYSS 285 (287)
T ss_dssp SSGGGSCC----HHHHHHSHHHHHHCC
T ss_pred cChhhCcC----HHHHhcCHHHhcccc
Confidence 99999999 999999999986554
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-47 Score=381.26 Aligned_cols=261 Identities=24% Similarity=0.339 Sum_probs=213.7
Q ss_pred CCccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcC-CC-----CCce
Q 012762 77 NPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLD-HP-----FLPT 150 (457)
Q Consensus 77 ~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~-H~-----nIv~ 150 (457)
...-.++|++.+.||+|+||+||+|.++ .+++.||||++.... .....+..|+++++.+. |+ +|++
T Consensus 49 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~----~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~iv~ 120 (382)
T 2vx3_A 49 GEKWMDRYEIDSLIGKGSFGQVVKAYDR----VEQEWVAIKIIKNKK----AFLNQAQIEVRLLELMNKHDTEMKYYIVH 120 (382)
T ss_dssp TCEETTTEEEEEEEEEETTEEEEEEEET----TTTEEEEEEEECSSH----HHHHHHHHHHHHHHHHHHCSSGGGGGBCC
T ss_pred CCEeeeeEEEEEEEeecCCEEEEEEEEc----CCCcEEEEEEEeccH----HHHHHHHHHHHHHHHHHhcccccceeEEE
Confidence 3444679999999999999999999986 478899999997532 23456677899988885 55 4999
Q ss_pred EEEEEEcCCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH--HcCceeecCCCCCeEEc--cCCC
Q 012762 151 LYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLH--MMGIIYRDLKPENVLVR--SDGH 226 (457)
Q Consensus 151 l~~~~~~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH--~~~iiHrDIKp~NIll~--~~~~ 226 (457)
+++++...+..||||||+ +++|.+++.......+++..++.++.||+.||.||| +.|||||||||+||||+ .++.
T Consensus 121 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~ 199 (382)
T 2vx3_A 121 LKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSA 199 (382)
T ss_dssp EEEEEEETTEEEEEEECC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCC
T ss_pred eeeeeccCCceEEEEecC-CCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCc
Confidence 999999999999999999 569999998876677999999999999999999999 57999999999999995 4678
Q ss_pred EEEeccCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcc
Q 012762 227 IMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEI 306 (457)
Q Consensus 227 vkl~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (457)
+||+|||+++.....
T Consensus 200 ~kL~DFG~a~~~~~~----------------------------------------------------------------- 214 (382)
T 2vx3_A 200 IKIVDFGSSCQLGQR----------------------------------------------------------------- 214 (382)
T ss_dssp EEECCCTTCEETTCC-----------------------------------------------------------------
T ss_pred EEEEeccCceecccc-----------------------------------------------------------------
Confidence 999999998644211
Q ss_pred cccCCccccccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCC-------
Q 012762 307 VAEPLDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPK------- 379 (457)
Q Consensus 307 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~------- 379 (457)
....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+....+.+..++......+.
T Consensus 215 --------~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 286 (382)
T 2vx3_A 215 --------IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAP 286 (382)
T ss_dssp --------CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTCT
T ss_pred --------cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhH
Confidence 11246999999999999999999999999999999999999999998877776666543211110
Q ss_pred ------------------------------CCC-------------------------CChHHHHHHHHHhhhCCCCCCC
Q 012762 380 ------------------------------EPS-------------------------VPGPAKDLIAQLLVKDPTRRMG 404 (457)
Q Consensus 380 ------------------------------~~~-------------------------~~~~~~~ll~~~L~~dP~~Rps 404 (457)
... ...++++||.+||+.||++|||
T Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rpt 366 (382)
T 2vx3_A 287 KARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQ 366 (382)
T ss_dssp THHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTSCC
T ss_pred HHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhhCCC
Confidence 000 0026899999999999999999
Q ss_pred CCcChHHHhcCCCCCCCCc
Q 012762 405 SKMGATAIKRHQFFNGVNW 423 (457)
Q Consensus 405 ~~~~~~~ll~hp~f~~~~~ 423 (457)
+.|+|+||||+...|
T Consensus 367 ----a~e~L~hp~f~~~~~ 381 (382)
T 2vx3_A 367 ----PYYALQHSFFKKTAD 381 (382)
T ss_dssp ----HHHHTTSGGGCC---
T ss_pred ----HHHHhcCcccccCCC
Confidence 999999999987543
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-47 Score=377.32 Aligned_cols=266 Identities=19% Similarity=0.275 Sum_probs=221.8
Q ss_pred CCCccCCCceeEEEecccCcceEEEEEEecc-CCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHc-CCCCCceEEE
Q 012762 76 NNPLTLSDLRFVHRLGSGDIGSVYLVQLKSK-SSNNGCFFAAKVMDKRELVSRNKESRARIEREILEML-DHPFLPTLYA 153 (457)
Q Consensus 76 ~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~-~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~~ 153 (457)
.+.+..++|++.+.||+|+||+||+|.+... ...++..||+|++.... .......+.+|+++|+++ +||||+++++
T Consensus 39 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 116 (344)
T 1rjb_A 39 KWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLG 116 (344)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence 4567778999999999999999999997432 22467789999997542 223446788899999999 8999999999
Q ss_pred EEEcCCcEEEEEeecCCCChHHHHHhCCC---------------------CCCCHHHHHHHHHHHHHHHHHHHHcCceee
Q 012762 154 TLDCPRWSCLLTEFCPGGDLHVLRQRQPD---------------------KRFHESAVRFYASEVVVALEFLHMMGIIYR 212 (457)
Q Consensus 154 ~~~~~~~~~lV~E~~~~~sL~~~~~~~~~---------------------~~~~~~~~~~i~~qi~~~L~yLH~~~iiHr 212 (457)
++...+..|+||||+++++|.+++..... ..+++..++.++.||+.||.|||++||+||
T Consensus 117 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~ 196 (344)
T 1rjb_A 117 ACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHR 196 (344)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEET
T ss_pred EEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence 99999999999999999999999876532 247999999999999999999999999999
Q ss_pred cCCCCCeEEccCCCEEEeccCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcch
Q 012762 213 DLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKR 292 (457)
Q Consensus 213 DIKp~NIll~~~~~vkl~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (457)
||||+|||++.++.+||+|||++.........
T Consensus 197 Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~------------------------------------------------ 228 (344)
T 1rjb_A 197 DLAARNVLVTHGKVVKICDFGLARDIMSDSNY------------------------------------------------ 228 (344)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCTTS------------------------------------------------
T ss_pred CCChhhEEEcCCCcEEeCCCccCcccccCccc------------------------------------------------
Confidence 99999999999999999999998644211100
Q ss_pred hccccCCCCCCCcccccCCccccccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHH
Q 012762 293 RRKKKLGNPGTPEIVAEPLDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVV 371 (457)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~ 371 (457)
.......||+.|+|||++.+..++.++|||||||++|+|++ |..||.+.........++
T Consensus 229 --------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~ 288 (344)
T 1rjb_A 229 --------------------VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLI 288 (344)
T ss_dssp --------------------EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHH
T ss_pred --------------------eeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCcHHHHHHHH
Confidence 00112357899999999999999999999999999999998 999999887666666777
Q ss_pred hcccCCCCCCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcC
Q 012762 372 ARALEFPKEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRH 415 (457)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~h 415 (457)
......+....+++++.+||.+||..||.+||+ +.+|++|
T Consensus 289 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps----~~~l~~~ 328 (344)
T 1rjb_A 289 QNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPS----FPNLTSF 328 (344)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred hcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcC----HHHHHHH
Confidence 766666666678999999999999999999999 9999876
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-47 Score=369.58 Aligned_cols=266 Identities=21% Similarity=0.309 Sum_probs=224.5
Q ss_pred CCCccCCCceeEEEecccCcceEEEEEEecc-CCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHc-CCCCCceEEE
Q 012762 76 NNPLTLSDLRFVHRLGSGDIGSVYLVQLKSK-SSNNGCFFAAKVMDKRELVSRNKESRARIEREILEML-DHPFLPTLYA 153 (457)
Q Consensus 76 ~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~-~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~~ 153 (457)
.+.+..++|++.+.||+|+||+||+|++... +..+++.||+|++.... .......+.+|+++|+++ +||||+++++
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~ 94 (313)
T 1t46_A 17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLG 94 (313)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch--hHHHHHHHHHHHHHHhhcccCCCeeeEEE
Confidence 3556778999999999999999999986432 33578899999997543 223456788899999999 9999999999
Q ss_pred EEEcCCcEEEEEeecCCCChHHHHHhCCC----------------CCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCC
Q 012762 154 TLDCPRWSCLLTEFCPGGDLHVLRQRQPD----------------KRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPE 217 (457)
Q Consensus 154 ~~~~~~~~~lV~E~~~~~sL~~~~~~~~~----------------~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~ 217 (457)
++..++..|+||||+++++|.+++..... ..+++..++.++.||+.||.|||++||+||||||+
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~ 174 (313)
T 1t46_A 95 ACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAAR 174 (313)
T ss_dssp EECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred EEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccc
Confidence 99999999999999999999999887532 24899999999999999999999999999999999
Q ss_pred CeEEccCCCEEEeccCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhcccc
Q 012762 218 NVLVRSDGHIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKK 297 (457)
Q Consensus 218 NIll~~~~~vkl~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (457)
|||++.++.+||+|||++..........
T Consensus 175 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~---------------------------------------------------- 202 (313)
T 1t46_A 175 NILLTHGRITKICDFGLARDIKNDSNYV---------------------------------------------------- 202 (313)
T ss_dssp GEEEETTTEEEECCCGGGSCTTSCTTSE----------------------------------------------------
T ss_pred eEEEcCCCCEEEccccccccccccccce----------------------------------------------------
Confidence 9999999999999999986553221100
Q ss_pred CCCCCCCcccccCCccccccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHHhcccC
Q 012762 298 LGNPGTPEIVAEPLDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVVARALE 376 (457)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~ 376 (457)
......||+.|+|||++.+..++.++|||||||++|+|++ |..||.+..........+.....
T Consensus 203 ----------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~ 266 (313)
T 1t46_A 203 ----------------VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFR 266 (313)
T ss_dssp ----------------ECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCC
T ss_pred ----------------eccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHHHHHhccCCC
Confidence 0012357889999999999999999999999999999998 99999987766666666666666
Q ss_pred CCCCCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcC
Q 012762 377 FPKEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRH 415 (457)
Q Consensus 377 ~~~~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~h 415 (457)
......++.++.++|.+||..||.+||+ +.+++++
T Consensus 267 ~~~~~~~~~~l~~li~~~l~~dp~~Rps----~~ell~~ 301 (313)
T 1t46_A 267 MLSPEHAPAEMYDIMKTCWDADPLKRPT----FKQIVQL 301 (313)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred CCCcccCCHHHHHHHHHHcCCCchhCcC----HHHHHHH
Confidence 6666678999999999999999999999 8888764
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=366.37 Aligned_cols=261 Identities=22% Similarity=0.357 Sum_probs=218.9
Q ss_pred cCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEE--c
Q 012762 80 TLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLD--C 157 (457)
Q Consensus 80 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~--~ 157 (457)
..++|++++.||+|+||+||+|.++ .+++.||+|++..... .......+.+|+++++.++||||+++++++. .
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~----~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 78 (279)
T 2w5a_A 4 RAEDYEVLYTIGTGSYGRCQKIRRK----SDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRT 78 (279)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEET----TTCCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGG
T ss_pred chhheeeehhccCCCCcEEEEEEEC----CCCcEEEEEEEEcccC-CHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCC
Confidence 3468999999999999999999986 4788999999976543 2334567888999999999999999999874 4
Q ss_pred CCcEEEEEeecCCCChHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHcC-----ceeecCCCCCeEEccCCCEEEe
Q 012762 158 PRWSCLLTEFCPGGDLHVLRQRQ--PDKRFHESAVRFYASEVVVALEFLHMMG-----IIYRDLKPENVLVRSDGHIMLT 230 (457)
Q Consensus 158 ~~~~~lV~E~~~~~sL~~~~~~~--~~~~~~~~~~~~i~~qi~~~L~yLH~~~-----iiHrDIKp~NIll~~~~~vkl~ 230 (457)
.+..|+||||+++++|.+++... ....+++..++.++.||+.||.|||+.| |+||||||+|||++.++.+||+
T Consensus 79 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~ 158 (279)
T 2w5a_A 79 NTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLG 158 (279)
T ss_dssp GTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEEC
T ss_pred CceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEe
Confidence 67889999999999999988753 2345999999999999999999999999 9999999999999999999999
Q ss_pred ccCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccC
Q 012762 231 DFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEP 310 (457)
Q Consensus 231 DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (457)
|||++........
T Consensus 159 dfg~~~~~~~~~~------------------------------------------------------------------- 171 (279)
T 2w5a_A 159 DFGLARILNHDTS------------------------------------------------------------------- 171 (279)
T ss_dssp CCCHHHHC---CH-------------------------------------------------------------------
T ss_pred cCchheeeccccc-------------------------------------------------------------------
Confidence 9999765432110
Q ss_pred CccccccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHH
Q 012762 311 LDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDL 390 (457)
Q Consensus 311 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 390 (457)
......||+.|+|||++.+..++.++|||||||++|+|++|..||...........+...... .....++.++.++
T Consensus 172 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~-~~~~~~~~~l~~l 247 (279)
T 2w5a_A 172 ---FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFR-RIPYRYSDELNEI 247 (279)
T ss_dssp ---HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC-CCCTTSCHHHHHH
T ss_pred ---cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccc-cCCcccCHHHHHH
Confidence 011236899999999999999999999999999999999999999988777666666655432 2234588999999
Q ss_pred HHHHhhhCCCCCCCCCcChHHHhcCCCCCC
Q 012762 391 IAQLLVKDPTRRMGSKMGATAIKRHQFFNG 420 (457)
Q Consensus 391 l~~~L~~dP~~Rps~~~~~~~ll~hp~f~~ 420 (457)
|.+||..||++||+ +.||++|+|+..
T Consensus 248 i~~~l~~~p~~Rps----~~~ll~~~~~~~ 273 (279)
T 2w5a_A 248 ITRMLNLKDYHRPS----VEEILENPLILE 273 (279)
T ss_dssp HHHHTCSSGGGSCC----HHHHHTSTTCCG
T ss_pred HHHHcCCCcccCCC----HHHHHhChhhhh
Confidence 99999999999999 999999999975
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-47 Score=379.92 Aligned_cols=263 Identities=24% Similarity=0.331 Sum_probs=200.9
Q ss_pred CCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCc
Q 012762 81 LSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRW 160 (457)
Q Consensus 81 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~ 160 (457)
.++|++.+.||+|+||+||+|+++ .+++.||||++..... .......|++.++.++||||+++++++...+.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~----~~~~~vavK~~~~~~~----~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~ 93 (360)
T 3e3p_A 22 MDRFQVERMAGQGTFGTVQLGKEK----STGMSVAIKKVIQDPR----FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGE 93 (360)
T ss_dssp HTTEEEC----------CEEEEET----TTCCEEEEEEEECCTT----CCCHHHHHHHHHHHHCCTTBCCEEEEEEEECS
T ss_pred ccceEEEEEEecCCCeEEEEEEEC----CCCCEEEEEEEecCcc----ccHHHHHHHHHHHhcCCCCcccHHHhhhcccc
Confidence 468999999999999999999986 4788999999865422 22345567888888999999999999965433
Q ss_pred -------EEEEEeecCCCChHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHHH--HcCceeecCCCCCeEEcc-CCCEE
Q 012762 161 -------SCLLTEFCPGGDLHVLRQR--QPDKRFHESAVRFYASEVVVALEFLH--MMGIIYRDLKPENVLVRS-DGHIM 228 (457)
Q Consensus 161 -------~~lV~E~~~~~sL~~~~~~--~~~~~~~~~~~~~i~~qi~~~L~yLH--~~~iiHrDIKp~NIll~~-~~~vk 228 (457)
+|+||||+++ +|...+.. .....+++..++.++.||+.||.||| ++||+||||||+|||++. ++.+|
T Consensus 94 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~k 172 (360)
T 3e3p_A 94 RDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLK 172 (360)
T ss_dssp SCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEE
T ss_pred ccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEE
Confidence 7899999965 55433332 23467899999999999999999999 999999999999999996 89999
Q ss_pred EeccCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccc
Q 012762 229 LTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVA 308 (457)
Q Consensus 229 l~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (457)
|+|||+++.......
T Consensus 173 l~Dfg~a~~~~~~~~----------------------------------------------------------------- 187 (360)
T 3e3p_A 173 LCDFGSAKKLSPSEP----------------------------------------------------------------- 187 (360)
T ss_dssp ECCCTTCBCCCTTSC-----------------------------------------------------------------
T ss_pred EeeCCCceecCCCCC-----------------------------------------------------------------
Confidence 999999865532111
Q ss_pred cCCccccccccCCCCccCchhhcCCC-CCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCC---------
Q 012762 309 EPLDVRSMSFVGTHEYLAPEIISGEG-HGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFP--------- 378 (457)
Q Consensus 309 ~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~--------- 378 (457)
.....||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+......+..++......+
T Consensus 188 ------~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (360)
T 3e3p_A 188 ------NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNP 261 (360)
T ss_dssp ------CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCT
T ss_pred ------cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHhccc
Confidence 11236899999999997665 89999999999999999999999999887777666654221110
Q ss_pred ---------------------CCCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCCCCchhhh
Q 012762 379 ---------------------KEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGVNWALLR 427 (457)
Q Consensus 379 ---------------------~~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~~~~~~~~ 427 (457)
.....+.++.+||.+||+.||.+||+ +.|+|+||||+.+.+....
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt----~~e~l~hp~f~~~~~~~~~ 327 (360)
T 3e3p_A 262 SHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMK----PYEALCHPYFDELHDPATK 327 (360)
T ss_dssp TCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCC----HHHHTTSGGGGGGGCTTCC
T ss_pred chhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCC----HHHHhcCccccccCCcccc
Confidence 01124578999999999999999999 9999999999987665433
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-47 Score=373.14 Aligned_cols=264 Identities=21% Similarity=0.304 Sum_probs=209.5
Q ss_pred cCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEE---
Q 012762 80 TLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLD--- 156 (457)
Q Consensus 80 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~--- 156 (457)
-.++|++++.||+|+||+||+|.++ .+++.||+|++.... ......+.+|+++++.++||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~----~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 81 (320)
T 2i6l_A 9 LGSRYMDLKPLGCGGNGLVFSAVDN----DCDKRVAIKKIVLTD---PQSVKHALREIKIIRRLDHDNIVKVFEILGPSG 81 (320)
T ss_dssp ETTTEEEEEECC-----CEEEEEET----TTTEEEEEEEEECCS---HHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTS
T ss_pred cCCceeEEEEeccCCCeEEEEEEEC----CCCeEEEEEEEecCC---hHHHHHHHHHHHHHHhcCCCCeeEEEEeccccc
Confidence 3468999999999999999999986 478999999987542 344567788999999999999999999874
Q ss_pred -----------cCCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEc-cC
Q 012762 157 -----------CPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVR-SD 224 (457)
Q Consensus 157 -----------~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~-~~ 224 (457)
.....|+||||++ ++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++ .+
T Consensus 82 ~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~ 157 (320)
T 2i6l_A 82 SQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQ---GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTED 157 (320)
T ss_dssp CBCCC----CCSCSEEEEEEECCS-EEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTT
T ss_pred cccccccccccccCceeEEeeccC-CCHHHHhhc---CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCC
Confidence 3467899999996 699888864 5799999999999999999999999999999999999997 56
Q ss_pred CCEEEeccCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCC
Q 012762 225 GHIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTP 304 (457)
Q Consensus 225 ~~vkl~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (457)
+.+||+|||+++........
T Consensus 158 ~~~kl~Dfg~~~~~~~~~~~------------------------------------------------------------ 177 (320)
T 2i6l_A 158 LVLKIGDFGLARIMDPHYSH------------------------------------------------------------ 177 (320)
T ss_dssp TEEEECCCTTCBCC------------------------------------------------------------------
T ss_pred CeEEEccCccccccCCCccc------------------------------------------------------------
Confidence 79999999998654321100
Q ss_pred cccccCCccccccccCCCCccCchhhcC-CCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccC-------
Q 012762 305 EIVAEPLDVRSMSFVGTHEYLAPEIISG-EGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALE------- 376 (457)
Q Consensus 305 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~------- 376 (457)
........||..|+|||++.+ ..++.++|||||||++|||++|+.||.+.........++.....
T Consensus 178 -------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (320)
T 2i6l_A 178 -------KGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQ 250 (320)
T ss_dssp ---------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCCHHHHH
T ss_pred -------ccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCchhhhh
Confidence 000112358999999999876 56899999999999999999999999988776665555433211
Q ss_pred ---------------CCC------CCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCCCCchh
Q 012762 377 ---------------FPK------EPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGVNWAL 425 (457)
Q Consensus 377 ---------------~~~------~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~~~~~~ 425 (457)
.+. ...++.++.+||.+||+.||++||+ +.|+++||||+..+|..
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt----~~ell~hp~~~~~~~p~ 316 (320)
T 2i6l_A 251 ELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLT----AEEALSHPYMSIYSFPM 316 (320)
T ss_dssp HHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCC----HHHHHTSHHHHTTCC--
T ss_pred hhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCC----HHHHhCCcccccccCcc
Confidence 010 1357899999999999999999999 99999999999888753
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-47 Score=374.59 Aligned_cols=281 Identities=20% Similarity=0.273 Sum_probs=206.2
Q ss_pred CCCCccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEE
Q 012762 75 NNNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYAT 154 (457)
Q Consensus 75 ~~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~ 154 (457)
....+..++|++.+.||+|+||+||+|+++... .....||||++..... .......+.+|++++++++||||++++++
T Consensus 16 ~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 93 (323)
T 3qup_A 16 EDVLIPEQQFTLGRMLGKGEFGSVREAQLKQED-GSFVKVAVKMLKADII-ASSDIEEFLREAACMKEFDHPHVAKLVGV 93 (323)
T ss_dssp CTTBCC---CEEEEEEEEETTEEEEEEEC--------CEEEEEEC-------CHHHHHHHHHHHHHTTCCCTTBCCCCEE
T ss_pred hhcccChhHeEEeceecccCCeEEEEEEEcccC-CcceeEEEEEeccccc-CHHHHHHHHHHHHHHHHCCCCceehhhce
Confidence 345567789999999999999999999876321 1224899999976533 23346778889999999999999999999
Q ss_pred EEcCCcE------EEEEeecCCCChHHHHHhCC----CCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccC
Q 012762 155 LDCPRWS------CLLTEFCPGGDLHVLRQRQP----DKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSD 224 (457)
Q Consensus 155 ~~~~~~~------~lV~E~~~~~sL~~~~~~~~----~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~ 224 (457)
+...+.. |+||||+++++|..++.... ...+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 94 ~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~ 173 (323)
T 3qup_A 94 SLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAED 173 (323)
T ss_dssp EECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTT
T ss_pred eeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCC
Confidence 9877655 99999999999998886532 1258999999999999999999999999999999999999999
Q ss_pred CCEEEeccCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCC
Q 012762 225 GHIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTP 304 (457)
Q Consensus 225 ~~vkl~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (457)
+.+||+|||+++.........
T Consensus 174 ~~~kl~Dfg~a~~~~~~~~~~----------------------------------------------------------- 194 (323)
T 3qup_A 174 MTVCVADFGLSRKIYSGDYYR----------------------------------------------------------- 194 (323)
T ss_dssp SCEEECCCCC----------------------------------------------------------------------
T ss_pred CCEEEeecccccccccccccc-----------------------------------------------------------
Confidence 999999999986543211100
Q ss_pred cccccCCccccccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHHhcccCCCCCCCC
Q 012762 305 EIVAEPLDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVVARALEFPKEPSV 383 (457)
Q Consensus 305 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (457)
......|++.|+|||++.+..++.++|||||||++|||++ |..||.+.........+.... ..+....+
T Consensus 195 ---------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~ 264 (323)
T 3qup_A 195 ---------QGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGN-RLKQPPEC 264 (323)
T ss_dssp ---------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC-CCCCCTTC
T ss_pred ---------ccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCC-CCCCCCcc
Confidence 0012247889999999999999999999999999999999 999999888777766665543 34445568
Q ss_pred ChHHHHHHHHHhhhCCCCCCCCCc---ChHHHhcCCCCCCCCchhh
Q 012762 384 PGPAKDLIAQLLVKDPTRRMGSKM---GATAIKRHQFFNGVNWALL 426 (457)
Q Consensus 384 ~~~~~~ll~~~L~~dP~~Rps~~~---~~~~ll~hp~f~~~~~~~~ 426 (457)
+.++.+||.+||+.||++||++.+ .++++++|+|+....+.-+
T Consensus 265 ~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~~pl 310 (323)
T 3qup_A 265 MEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQDPL 310 (323)
T ss_dssp CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-----------
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCCCCC
Confidence 999999999999999999999543 3667789999987655443
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-47 Score=369.99 Aligned_cols=266 Identities=18% Similarity=0.268 Sum_probs=221.7
Q ss_pred CCCCccCCCceeEEEecccCcceEEEEEEeccC-CCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEE
Q 012762 75 NNNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKS-SNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYA 153 (457)
Q Consensus 75 ~~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~-~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~ 153 (457)
..+.+..++|++.+.||+|+||.||+|.+.... ..++..||+|++.... .......+.+|+++|+.++||||+++++
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~ 93 (314)
T 2ivs_A 16 PKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA--SPSELRDLLSEFNVLKQVNHPHVIKLYG 93 (314)
T ss_dssp TTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred cccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCceeeEEE
Confidence 456677889999999999999999999875322 3466899999997542 2344567888999999999999999999
Q ss_pred EEEcCCcEEEEEeecCCCChHHHHHhCCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHcCcee
Q 012762 154 TLDCPRWSCLLTEFCPGGDLHVLRQRQPD----------------------KRFHESAVRFYASEVVVALEFLHMMGIIY 211 (457)
Q Consensus 154 ~~~~~~~~~lV~E~~~~~sL~~~~~~~~~----------------------~~~~~~~~~~i~~qi~~~L~yLH~~~iiH 211 (457)
++...+..|+||||+++++|.+++..... ..+++..++.++.||+.||.|||++||+|
T Consensus 94 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH 173 (314)
T 2ivs_A 94 ACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVH 173 (314)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred EEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcc
Confidence 99999999999999999999999987532 34899999999999999999999999999
Q ss_pred ecCCCCCeEEccCCCEEEeccCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcc
Q 012762 212 RDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPK 291 (457)
Q Consensus 212 rDIKp~NIll~~~~~vkl~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (457)
|||||+|||++.++.+||+|||++..........
T Consensus 174 ~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~---------------------------------------------- 207 (314)
T 2ivs_A 174 RDLAARNILVAEGRKMKISDFGLSRDVYEEDSYV---------------------------------------------- 207 (314)
T ss_dssp CCCSGGGEEEETTTEEEECCCTTCEECTTTSCEE----------------------------------------------
T ss_pred cccchheEEEcCCCCEEEccccccccccccccce----------------------------------------------
Confidence 9999999999999999999999986543221110
Q ss_pred hhccccCCCCCCCcccccCCccccccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHH
Q 012762 292 RRRKKKLGNPGTPEIVAEPLDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANV 370 (457)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~ 370 (457)
......||+.|+|||++.+..++.++|||||||++|||++ |..||.+.........+
T Consensus 208 ----------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~ 265 (314)
T 2ivs_A 208 ----------------------KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLL 265 (314)
T ss_dssp ----------------------CSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH
T ss_pred ----------------------eccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHh
Confidence 0012247889999999999889999999999999999999 99999987766655544
Q ss_pred HhcccCCCCCCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcC
Q 012762 371 VARALEFPKEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRH 415 (457)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~h 415 (457)
... ...+....+++++.++|.+||+.||++||+ +.+|+++
T Consensus 266 ~~~-~~~~~~~~~~~~~~~li~~~l~~dp~~Rps----~~~l~~~ 305 (314)
T 2ivs_A 266 KTG-HRMERPDNCSEEMYRLMLQCWKQEPDKRPV----FADISKD 305 (314)
T ss_dssp HTT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred hcC-CcCCCCccCCHHHHHHHHHHccCChhhCcC----HHHHHHH
Confidence 433 344445568999999999999999999999 8888775
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-47 Score=361.12 Aligned_cols=255 Identities=20% Similarity=0.270 Sum_probs=217.0
Q ss_pred CCccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEE
Q 012762 77 NPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLD 156 (457)
Q Consensus 77 ~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~ 156 (457)
..+..++|++.+.||+|+||+||+|.++ ++..||+|++..... ....+.+|+++++.++||||+++++++.
T Consensus 3 ~~l~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 73 (268)
T 3sxs_A 3 MELKREEITLLKELGSGQFGVVKLGKWK-----GQYDVAVKMIKEGSM----SEDEFFQEAQTMMKLSHPKLVKFYGVCS 73 (268)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEET-----TTEEEEEEEECBTTB----CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred eEechhheeeeeeeccCCCceEEEEEec-----CceeEEEEEeccCCC----cHHHHHHHHHHHHhCCCCCEeeEEEEEc
Confidence 4567789999999999999999999875 567899999976432 3456788999999999999999999999
Q ss_pred cCCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCc
Q 012762 157 CPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSL 236 (457)
Q Consensus 157 ~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~ 236 (457)
..+..|+||||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 74 ~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~ 152 (268)
T 3sxs_A 74 KEYPIYIVTEYISNGCLLNYLRSH-GKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTR 152 (268)
T ss_dssp SSSSEEEEEECCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEE
T ss_pred cCCceEEEEEccCCCcHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccce
Confidence 999999999999999999988764 2459999999999999999999999999999999999999999999999999986
Q ss_pred CCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccc
Q 012762 237 KGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSM 316 (457)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (457)
......... ..
T Consensus 153 ~~~~~~~~~---------------------------------------------------------------------~~ 163 (268)
T 3sxs_A 153 YVLDDQYVS---------------------------------------------------------------------SV 163 (268)
T ss_dssp ECCTTCEEE---------------------------------------------------------------------CC
T ss_pred ecchhhhhc---------------------------------------------------------------------cc
Confidence 543221110 01
Q ss_pred cccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHh
Q 012762 317 SFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLL 395 (457)
Q Consensus 317 ~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L 395 (457)
...||+.|+|||++.+..++.++|||||||++|+|++ |..||...........+.... .......+++.+.+++.+||
T Consensus 164 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l 242 (268)
T 3sxs_A 164 GTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGH-RLYRPHLASDTIYQIMYSCW 242 (268)
T ss_dssp SCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTC-CCCCCTTSCHHHHHHHHHTT
T ss_pred CCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCC-CCCCCCcChHHHHHHHHHHc
Confidence 1246788999999999889999999999999999998 999999888777666655443 33334457899999999999
Q ss_pred hhCCCCCCCCCcChHHHhcC
Q 012762 396 VKDPTRRMGSKMGATAIKRH 415 (457)
Q Consensus 396 ~~dP~~Rps~~~~~~~ll~h 415 (457)
+.||++||+ +.+++++
T Consensus 243 ~~~p~~Rps----~~~ll~~ 258 (268)
T 3sxs_A 243 HELPEKRPT----FQQLLSS 258 (268)
T ss_dssp CSSGGGSCC----HHHHHHH
T ss_pred CCChhhCcC----HHHHHHH
Confidence 999999999 9998876
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-47 Score=360.78 Aligned_cols=253 Identities=19% Similarity=0.312 Sum_probs=219.4
Q ss_pred CCCccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEE
Q 012762 76 NNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATL 155 (457)
Q Consensus 76 ~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~ 155 (457)
...+..++|++.+.||+|+||+||+|++ .+..||+|++..... .......+.+|++++++++||||+++++++
T Consensus 4 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~------~~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 76 (271)
T 3kmu_A 4 HSGIDFKQLNFLTKLNENHSGELWKGRW------QGNDIVVKVLKVRDW-STRKSRDFNEECPRLRIFSHPNVLPVLGAC 76 (271)
T ss_dssp CCCCCGGGCEEEEEEEEETTEEEEEEEE------TTEEEEEEEECCTTC-CHHHHHHHHHHGGGGCCCSCTTEECEEEEE
T ss_pred cCCCCHHHhHHHHHhcCCCcceEEEEEE------CCeeEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCchhheEEEE
Confidence 3567788999999999999999999986 377899999976532 223456788899999999999999999999
Q ss_pred EcC--CcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcC--ceeecCCCCCeEEccCCCEEEec
Q 012762 156 DCP--RWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMG--IIYRDLKPENVLVRSDGHIMLTD 231 (457)
Q Consensus 156 ~~~--~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~--iiHrDIKp~NIll~~~~~vkl~D 231 (457)
... +..++||||+++++|.+++.......+++..++.++.||+.||.|||++| |+||||||+|||++.++.++|+|
T Consensus 77 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~ 156 (271)
T 3kmu_A 77 QSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISM 156 (271)
T ss_dssp CTTTSSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEG
T ss_pred ccCCCCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEe
Confidence 887 78899999999999999998865557999999999999999999999999 99999999999999999999999
Q ss_pred cCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCC
Q 012762 232 FDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPL 311 (457)
Q Consensus 232 FG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (457)
||+......
T Consensus 157 ~~~~~~~~~----------------------------------------------------------------------- 165 (271)
T 3kmu_A 157 ADVKFSFQS----------------------------------------------------------------------- 165 (271)
T ss_dssp GGSCCTTSC-----------------------------------------------------------------------
T ss_pred ccceeeecc-----------------------------------------------------------------------
Confidence 988532210
Q ss_pred ccccccccCCCCccCchhhcCCCCCc---cchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHH
Q 012762 312 DVRSMSFVGTHEYLAPEIISGEGHGN---AVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAK 388 (457)
Q Consensus 312 ~~~~~~~~gt~~y~aPE~l~~~~~~~---~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (457)
....||+.|+|||++.+..++. ++|||||||++|||++|+.||.+.........+............++.++.
T Consensus 166 ----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (271)
T 3kmu_A 166 ----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPHVS 241 (271)
T ss_dssp ----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCCTTCCHHHH
T ss_pred ----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCCCCCCCHHHH
Confidence 0235899999999998876544 799999999999999999999998888877777777666666677999999
Q ss_pred HHHHHHhhhCCCCCCCCCcChHHHhc
Q 012762 389 DLIAQLLVKDPTRRMGSKMGATAIKR 414 (457)
Q Consensus 389 ~ll~~~L~~dP~~Rps~~~~~~~ll~ 414 (457)
++|.+||+.||++||+ +.++++
T Consensus 242 ~li~~~l~~~p~~Rps----~~~il~ 263 (271)
T 3kmu_A 242 KLMKICMNEDPAKRPK----FDMIVP 263 (271)
T ss_dssp HHHHHHTCSSGGGSCC----HHHHHH
T ss_pred HHHHHHcCCChhhCcC----HHHHHH
Confidence 9999999999999999 888875
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-47 Score=377.51 Aligned_cols=258 Identities=25% Similarity=0.368 Sum_probs=206.8
Q ss_pred CCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhh--------hhhhHHHHHHHHHHHHHHcCCCCCceEEE
Q 012762 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKREL--------VSRNKESRARIEREILEMLDHPFLPTLYA 153 (457)
Q Consensus 82 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~--------~~~~~~~~~~~E~~il~~l~H~nIv~l~~ 153 (457)
++|++.+.||+|+||+||+|.+. .++.||||++..... ........+.+|+++|+.++||||+++++
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 96 (362)
T 3pg1_A 22 SPYTVQRFISSGSYGAVCAGVDS-----EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRD 96 (362)
T ss_dssp CSCEEEEEEEEETTEEEEEEECT-----TSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSE
T ss_pred cceEEeEEeccCCCEEEEEEECC-----CCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceee
Confidence 58999999999999999999864 588999999865322 12223477888999999999999999999
Q ss_pred EEEc-----CCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEE
Q 012762 154 TLDC-----PRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIM 228 (457)
Q Consensus 154 ~~~~-----~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vk 228 (457)
++.. ...+|+||||+. ++|..++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+|
T Consensus 97 ~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~k 174 (362)
T 3pg1_A 97 IFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ-RIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDIT 174 (362)
T ss_dssp EEEECCTTTCCEEEEEEECCS-EEHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEE
T ss_pred eEEeccCCCcceEEEEEccCC-CCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEE
Confidence 9843 346899999995 6887777653 35799999999999999999999999999999999999999999999
Q ss_pred EeccCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccc
Q 012762 229 LTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVA 308 (457)
Q Consensus 229 l~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (457)
|+|||++........
T Consensus 175 l~Dfg~~~~~~~~~~----------------------------------------------------------------- 189 (362)
T 3pg1_A 175 ICDFNLAREDTADAN----------------------------------------------------------------- 189 (362)
T ss_dssp ECCTTC--------------------------------------------------------------------------
T ss_pred EEecCcccccccccc-----------------------------------------------------------------
Confidence 999999853321110
Q ss_pred cCCccccccccCCCCccCchhhcC-CCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCC----------
Q 012762 309 EPLDVRSMSFVGTHEYLAPEIISG-EGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEF---------- 377 (457)
Q Consensus 309 ~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~---------- 377 (457)
.....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+......+..++......
T Consensus 190 ------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 263 (362)
T 3pg1_A 190 ------KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSS 263 (362)
T ss_dssp ------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHTSC
T ss_pred ------cceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChHHhhhccc
Confidence 112368999999999987 568999999999999999999999999987766666654321111
Q ss_pred --------------CC------CCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCCC
Q 012762 378 --------------PK------EPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGV 421 (457)
Q Consensus 378 --------------~~------~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~~ 421 (457)
+. ...+++.+.+||.+||+.||++||+ +.|+++||||+.+
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt----~~ell~hp~f~~~ 323 (362)
T 3pg1_A 264 PSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRIS----TEQALRHPYFESL 323 (362)
T ss_dssp HHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCC----HHHHHTSGGGTTT
T ss_pred hhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCC----HHHHHcCchhhhc
Confidence 00 1345788999999999999999999 9999999999985
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-47 Score=363.86 Aligned_cols=257 Identities=20% Similarity=0.311 Sum_probs=216.1
Q ss_pred CCCCccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEE
Q 012762 75 NNNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYAT 154 (457)
Q Consensus 75 ~~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~ 154 (457)
..+.+..++|++++.||+|+||+||+|.++ ++..||+|++..... ....+.+|+++++.++|+||++++++
T Consensus 17 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~ 87 (283)
T 3gen_A 17 GSWEIDPKDLTFLKELGTGQFGVVKYGKWR-----GQYDVAIKMIKEGSM----SEDEFIEEAKVMMNLSHEKLVQLYGV 87 (283)
T ss_dssp CTTBCCGGGEEEEEECC---CEEEEEEEET-----TTEEEEEEEECTTSB----CHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred CCccCCHHHHHhHhhcCCCCCceEEEEEEc-----CCCeEEEEEecCCCC----CHHHHHHHHHHHhcCCCCCEeeEEEE
Confidence 456778889999999999999999999875 577899999976432 34567889999999999999999999
Q ss_pred EEcCCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCC
Q 012762 155 LDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDL 234 (457)
Q Consensus 155 ~~~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~ 234 (457)
+...+..|+||||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 88 ~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~ 166 (283)
T 3gen_A 88 CTKQRPIFIITEYMANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGL 166 (283)
T ss_dssp ECSSSSEEEEECCCTTCBHHHHHHCG-GGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTG
T ss_pred EecCCCeEEEEeccCCCcHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccc
Confidence 99999999999999999999988763 25699999999999999999999999999999999999999999999999999
Q ss_pred CcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccc
Q 012762 235 SLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVR 314 (457)
Q Consensus 235 s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (457)
+......... .
T Consensus 167 ~~~~~~~~~~---------------------------------------------------------------------~ 177 (283)
T 3gen_A 167 SRYVLDDEYT---------------------------------------------------------------------S 177 (283)
T ss_dssp GGGBCCHHHH---------------------------------------------------------------------S
T ss_pred cccccccccc---------------------------------------------------------------------c
Confidence 8654321110 0
Q ss_pred cccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHH
Q 012762 315 SMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQ 393 (457)
Q Consensus 315 ~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~ 393 (457)
.....||+.|+|||++.+..++.++|||||||++|+|++ |+.||...........+... ........+++.+.++|.+
T Consensus 178 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~ 256 (283)
T 3gen_A 178 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG-LRLYRPHLASEKVYTIMYS 256 (283)
T ss_dssp TTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTT-CCCCCCTTCCHHHHHHHHH
T ss_pred ccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcc-cCCCCCCcCCHHHHHHHHH
Confidence 011247889999999999999999999999999999998 99999988877666665544 3334445678999999999
Q ss_pred HhhhCCCCCCCCCcChHHHhcC
Q 012762 394 LLVKDPTRRMGSKMGATAIKRH 415 (457)
Q Consensus 394 ~L~~dP~~Rps~~~~~~~ll~h 415 (457)
||..||++||+ +.++++|
T Consensus 257 ~l~~~p~~Rps----~~~ll~~ 274 (283)
T 3gen_A 257 CWHEKADERPT----FKILLSN 274 (283)
T ss_dssp TTCSSGGGSCC----HHHHHHH
T ss_pred HccCChhHCcC----HHHHHHH
Confidence 99999999999 8988876
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-47 Score=366.80 Aligned_cols=263 Identities=21% Similarity=0.314 Sum_probs=212.3
Q ss_pred CCccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEE
Q 012762 77 NPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLD 156 (457)
Q Consensus 77 ~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~ 156 (457)
..+..++|+++++||+|+||+||+|++...+..+++.||||++... .......+.+|+++|++++||||+++++++.
T Consensus 5 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 81 (295)
T 3ugc_A 5 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYKGVCY 81 (295)
T ss_dssp -CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred CcCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 3566789999999999999999999976555678999999999753 2344567888999999999999999999985
Q ss_pred c--CCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCC
Q 012762 157 C--PRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDL 234 (457)
Q Consensus 157 ~--~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~ 234 (457)
. ...+|+||||+++++|.+++.... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+
T Consensus 82 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~ 160 (295)
T 3ugc_A 82 SAGRRNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGL 160 (295)
T ss_dssp HHHHTSCEEEEECCTTCBHHHHHHHCG-GGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCS
T ss_pred cCCCCceEEEEEeCCCCCHHHHHHhcc-cccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcc
Confidence 4 356899999999999999987752 4599999999999999999999999999999999999999999999999999
Q ss_pred CcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccc
Q 012762 235 SLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVR 314 (457)
Q Consensus 235 s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (457)
+........... .
T Consensus 161 ~~~~~~~~~~~~-------------------------------------------------------------------~ 173 (295)
T 3ugc_A 161 TKVLPQDKEFFK-------------------------------------------------------------------V 173 (295)
T ss_dssp CC------------------------------------------------------------------------------
T ss_pred cccccCCcceee-------------------------------------------------------------------e
Confidence 865532211000 0
Q ss_pred cccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChH---------------HHHHHHHhcccCCCC
Q 012762 315 SMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHE---------------LTLANVVARALEFPK 379 (457)
Q Consensus 315 ~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~---------------~~~~~~~~~~~~~~~ 379 (457)
.....|+..|+|||++.+..++.++|||||||++|||++|..||...... ......+......+.
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (295)
T 3ugc_A 174 KEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPR 253 (295)
T ss_dssp --CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTCCCCC
T ss_pred ccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHHhccCcCCC
Confidence 01124788899999999999999999999999999999999998653211 012233334445566
Q ss_pred CCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhc
Q 012762 380 EPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKR 414 (457)
Q Consensus 380 ~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~ 414 (457)
...+++++.+||.+||..||++||+ +.||++
T Consensus 254 ~~~~~~~l~~li~~~l~~dp~~Rps----~~el~~ 284 (295)
T 3ugc_A 254 PDGCPDEIYMIMTECWNNNVNQRPS----FRDLAL 284 (295)
T ss_dssp CTTCCHHHHHHHHHHSCSSGGGSCC----HHHHHH
T ss_pred CcCcCHHHHHHHHHHcCCChhhCCC----HHHHHH
Confidence 6679999999999999999999999 888765
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-47 Score=372.01 Aligned_cols=263 Identities=16% Similarity=0.197 Sum_probs=211.5
Q ss_pred CCCccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEE
Q 012762 76 NNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATL 155 (457)
Q Consensus 76 ~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~ 155 (457)
...+..++|++++.||+|+||+||+|.+..........||+|++.... .......+.+|+.+++.++||||+++++++
T Consensus 7 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 84 (325)
T 3kex_A 7 ARIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS--GRQSFQAVTDHMLAIGSLDHAHIVRLLGLC 84 (325)
T ss_dssp CCBCCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT--SCSCBCSCCHHHHHHHTCCCTTBCCEEEEE
T ss_pred HhhcCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc--cHHHHHHHHHHHHHHhcCCCCCcCeEEEEE
Confidence 345677899999999999999999999875333333447888775432 122234566799999999999999999998
Q ss_pred EcCCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCC
Q 012762 156 DCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235 (457)
Q Consensus 156 ~~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s 235 (457)
. ++..++||||+.+++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 85 ~-~~~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a 162 (325)
T 3kex_A 85 P-GSSLQLVTQYLPLGSLLDHVRQH-RGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVA 162 (325)
T ss_dssp C-BSSEEEEEECCTTCBSHHHHHSS-GGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGG
T ss_pred c-CCccEEEEEeCCCCCHHHHHHHc-cccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcc
Confidence 6 46789999999999999888764 357899999999999999999999999999999999999999999999999998
Q ss_pred cCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcccc
Q 012762 236 LKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRS 315 (457)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (457)
+......... ..
T Consensus 163 ~~~~~~~~~~--------------------------------------------------------------------~~ 174 (325)
T 3kex_A 163 DLLPPDDKQL--------------------------------------------------------------------LY 174 (325)
T ss_dssp GGSCCCTTCC--------------------------------------------------------------------C-
T ss_pred cccCcccccc--------------------------------------------------------------------cc
Confidence 7653221100 01
Q ss_pred ccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHH
Q 012762 316 MSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQL 394 (457)
Q Consensus 316 ~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~ 394 (457)
....||..|+|||++.+..++.++|||||||++|+|++ |..||.+.........+... ...+....++.++.++|.+|
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~ 253 (325)
T 3kex_A 175 SEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKG-ERLAQPQICTIDVYMVMVKC 253 (325)
T ss_dssp ----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTT-CBCCCCTTBCTTTTHHHHHH
T ss_pred cCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcC-CCCCCCCcCcHHHHHHHHHH
Confidence 12358889999999999999999999999999999999 99999987766655554433 34444455888999999999
Q ss_pred hhhCCCCCCCCCcChHHHhcC
Q 012762 395 LVKDPTRRMGSKMGATAIKRH 415 (457)
Q Consensus 395 L~~dP~~Rps~~~~~~~ll~h 415 (457)
|..||.+||+ +.++++|
T Consensus 254 l~~dp~~Rps----~~el~~~ 270 (325)
T 3kex_A 254 WMIDENIRPT----FKELANE 270 (325)
T ss_dssp TCSCTTTSCC----HHHHHHH
T ss_pred cCCChhhCcC----HHHHHHH
Confidence 9999999999 8887765
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=362.15 Aligned_cols=261 Identities=23% Similarity=0.367 Sum_probs=209.2
Q ss_pred CCCccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEE
Q 012762 76 NNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATL 155 (457)
Q Consensus 76 ~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~ 155 (457)
...+..++|++.+.||+|+||+||+|.+.... ..+..||+|++... ........+.+|+.+++.++||||+++++++
T Consensus 9 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~-~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 85 (281)
T 1mp8_A 9 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPE-NPALAVAIKTCKNC--TSDSVREKFLQEALTMRQFDHPHIVKLIGVI 85 (281)
T ss_dssp CCBCCGGGEEEEEEEEECSSSEEEEEEECCC---CCEEEEEEECTTT--TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred ceEEehHHeEEEeEeeecCCeeEEEEEEecCC-CCceEEEEEecccc--CCHHHHHHHHHHHHHHHhCCCCccceEEEEE
Confidence 45677789999999999999999999986422 35678999998653 2334556788899999999999999999998
Q ss_pred EcCCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCC
Q 012762 156 DCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235 (457)
Q Consensus 156 ~~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s 235 (457)
. ++..|+||||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 86 ~-~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 163 (281)
T 1mp8_A 86 T-ENPVWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLS 163 (281)
T ss_dssp C-SSSCEEEEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC----
T ss_pred c-cCccEEEEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccc
Confidence 5 56789999999999999998764 346999999999999999999999999999999999999999999999999998
Q ss_pred cCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcccc
Q 012762 236 LKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRS 315 (457)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (457)
+......... .
T Consensus 164 ~~~~~~~~~~---------------------------------------------------------------------~ 174 (281)
T 1mp8_A 164 RYMEDSTYYK---------------------------------------------------------------------A 174 (281)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred cccCcccccc---------------------------------------------------------------------c
Confidence 6543211100 0
Q ss_pred ccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHH
Q 012762 316 MSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQL 394 (457)
Q Consensus 316 ~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~ 394 (457)
....+|+.|+|||++.+..++.++|||||||++|||++ |..||.+.........+.... ..+....++.++.++|.+|
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~l~~li~~~ 253 (281)
T 1mp8_A 175 SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE-RLPMPPNCPPTLYSLMTKC 253 (281)
T ss_dssp ----CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC-CCCCCTTCCHHHHHHHHHH
T ss_pred ccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCC-CCCCCCCCCHHHHHHHHHH
Confidence 01247889999999999999999999999999999996 999999887777666655443 3444556899999999999
Q ss_pred hhhCCCCCCCCCcChHHHhcC
Q 012762 395 LVKDPTRRMGSKMGATAIKRH 415 (457)
Q Consensus 395 L~~dP~~Rps~~~~~~~ll~h 415 (457)
|..||++||+ +.+++++
T Consensus 254 l~~~p~~Rps----~~~l~~~ 270 (281)
T 1mp8_A 254 WAYDPSRRPR----FTELKAQ 270 (281)
T ss_dssp TCSSGGGSCC----HHHHHHH
T ss_pred ccCChhhCcC----HHHHHHH
Confidence 9999999999 8888764
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-47 Score=364.70 Aligned_cols=265 Identities=25% Similarity=0.365 Sum_probs=213.3
Q ss_pred CCccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEE
Q 012762 77 NPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLD 156 (457)
Q Consensus 77 ~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~ 156 (457)
..+..++|.....||+|+||+||+|.+. .+++.||+|++.... ......+.+|+++++.++||||+++++++.
T Consensus 17 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 89 (295)
T 2clq_A 17 YDYEYDENGDRVVLGKGTYGIVYAGRDL----SNQVRIAIKEIPERD---SRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89 (295)
T ss_dssp EEECBCTTSSBCEEEECSSSEEEEEEET----TTCCEEEEEEEECCC---C---HHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred ccccccCCCCcEEEeecCcEEEEEEEEC----CCCeEEEEEEccCCc---hHHHHHHHHHHHHHHhCCCCCEeeEeeEEE
Confidence 3455566777779999999999999986 478899999997542 234566888999999999999999999999
Q ss_pred cCCcEEEEEeecCCCChHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEcc-CCCEEEeccCC
Q 012762 157 CPRWSCLLTEFCPGGDLHVLRQRQP-DKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRS-DGHIMLTDFDL 234 (457)
Q Consensus 157 ~~~~~~lV~E~~~~~sL~~~~~~~~-~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~-~~~vkl~DFG~ 234 (457)
..+..++||||+++++|.+++.... ...+++..++.++.||+.||.|||++||+|+||||+|||++. ++.+||+|||+
T Consensus 90 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~ 169 (295)
T 2clq_A 90 ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGT 169 (295)
T ss_dssp ETTEEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTT
T ss_pred eCCcEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeeccc
Confidence 9999999999999999999987753 235678999999999999999999999999999999999987 89999999999
Q ss_pred CcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccc
Q 012762 235 SLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVR 314 (457)
Q Consensus 235 s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (457)
+........ .
T Consensus 170 ~~~~~~~~~----------------------------------------------------------------------~ 179 (295)
T 2clq_A 170 SKRLAGINP----------------------------------------------------------------------C 179 (295)
T ss_dssp CEESCC--------------------------------------------------------------------------
T ss_pred ccccCCCCC----------------------------------------------------------------------c
Confidence 865432110 0
Q ss_pred cccccCCCCccCchhhcCCC--CCccchhhhhhHHHHHHhcCCCCCCCCChHHH-HHHHHhcccCCCCCCCCChHHHHHH
Q 012762 315 SMSFVGTHEYLAPEIISGEG--HGNAVDWWTLGIFIFELFYGTTPFKGIDHELT-LANVVARALEFPKEPSVPGPAKDLI 391 (457)
Q Consensus 315 ~~~~~gt~~y~aPE~l~~~~--~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ll 391 (457)
.....||+.|+|||++.+.. ++.++|||||||++|+|++|+.||........ ................++.++.+||
T Consensus 180 ~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 259 (295)
T 2clq_A 180 TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFI 259 (295)
T ss_dssp -CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSCHHHHHHH
T ss_pred ccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccCCHHHHHHH
Confidence 11235899999999997654 78999999999999999999999976543322 2222222222233456889999999
Q ss_pred HHHhhhCCCCCCCCCcChHHHhcCCCCCCCC
Q 012762 392 AQLLVKDPTRRMGSKMGATAIKRHQFFNGVN 422 (457)
Q Consensus 392 ~~~L~~dP~~Rps~~~~~~~ll~hp~f~~~~ 422 (457)
.+||..||++||+ +.++++||||+...
T Consensus 260 ~~~l~~dp~~Rps----~~~ll~~~~~~~~~ 286 (295)
T 2clq_A 260 LKCFEPDPDKRAC----ANDLLVDEFLKVSS 286 (295)
T ss_dssp HHTTCSSTTTSCC----HHHHHTSGGGCC--
T ss_pred HHHccCChhhCCC----HHHHhcChhhhhcc
Confidence 9999999999999 99999999998644
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-47 Score=369.93 Aligned_cols=265 Identities=22% Similarity=0.327 Sum_probs=211.3
Q ss_pred CccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEc
Q 012762 78 PLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDC 157 (457)
Q Consensus 78 ~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~ 157 (457)
.+..++|++.++||+|+||+||+|.++ .+++.||+|++... .......+.+|+++|++++||||+++++++.+
T Consensus 6 ~~~~~~~~~~~~lG~G~~g~V~~~~~~----~~~~~va~K~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 78 (310)
T 3s95_A 6 IFRPSDLIHGEVLGKGCFGQAIKVTHR----ETGEVMVMKELIRF---DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYK 78 (310)
T ss_dssp EECGGGEEEEEEEECCSSEEEEEEEET----TTCCEEEEEEESCC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred eeChhHeeccceecCCCCEEEEEEEEC----CCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCcCcccEEEEEec
Confidence 356689999999999999999999986 47889999988543 23456678889999999999999999999999
Q ss_pred CCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcC
Q 012762 158 PRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLK 237 (457)
Q Consensus 158 ~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~ 237 (457)
++..|+||||+++++|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 79 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 157 (310)
T 3s95_A 79 DKRLNFITEYIKGGTLRGIIKSM-DSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARL 157 (310)
T ss_dssp TTEEEEEEECCTTCBHHHHHHHC-CTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEE
T ss_pred CCeeEEEEEecCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeeccccee
Confidence 99999999999999999999874 36799999999999999999999999999999999999999999999999999876
Q ss_pred CCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcccccc
Q 012762 238 GDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMS 317 (457)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (457)
........... .....+.......
T Consensus 158 ~~~~~~~~~~~--------------------------------------------------------~~~~~~~~~~~~~ 181 (310)
T 3s95_A 158 MVDEKTQPEGL--------------------------------------------------------RSLKKPDRKKRYT 181 (310)
T ss_dssp CC----------------------------------------------------------------------------CC
T ss_pred ccccccccccc--------------------------------------------------------ccccccccccccc
Confidence 54322111000 0000011112224
Q ss_pred ccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHH-----HHHHHHhcccCCCCCCCCChHHHHHHH
Q 012762 318 FVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHEL-----TLANVVARALEFPKEPSVPGPAKDLIA 392 (457)
Q Consensus 318 ~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~ll~ 392 (457)
.+||+.|+|||++.+..++.++|||||||++|||++|..||....... ........ .....+++.+.++|.
T Consensus 182 ~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~l~~li~ 257 (310)
T 3s95_A 182 VVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDR----YCPPNCPPSFFPITV 257 (310)
T ss_dssp CCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHH----TCCTTCCTTHHHHHH
T ss_pred cCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccccc----cCCCCCCHHHHHHHH
Confidence 579999999999999999999999999999999999999987643211 11111111 123458889999999
Q ss_pred HHhhhCCCCCCCCCcChHHHhc
Q 012762 393 QLLVKDPTRRMGSKMGATAIKR 414 (457)
Q Consensus 393 ~~L~~dP~~Rps~~~~~~~ll~ 414 (457)
+||+.||++||+ +.+|++
T Consensus 258 ~~l~~dP~~Rps----~~~l~~ 275 (310)
T 3s95_A 258 RCCDLDPEKRPS----FVKLEH 275 (310)
T ss_dssp HHTCSSGGGSCC----HHHHHH
T ss_pred HHccCChhhCcC----HHHHHH
Confidence 999999999999 888876
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-47 Score=372.58 Aligned_cols=264 Identities=20% Similarity=0.292 Sum_probs=219.6
Q ss_pred CCccCCCceeEEEecccCcceEEEEEEeccC-CCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEE
Q 012762 77 NPLTLSDLRFVHRLGSGDIGSVYLVQLKSKS-SNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATL 155 (457)
Q Consensus 77 ~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~-~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~ 155 (457)
..+..++|++.+.||+|+||+||+|++.... ..+++.||+|++.... .......+.+|++++++++||||+++++++
T Consensus 42 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 119 (343)
T 1luf_A 42 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVC 119 (343)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred eEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 3456679999999999999999999986321 1356899999997642 234456788899999999999999999999
Q ss_pred EcCCcEEEEEeecCCCChHHHHHhCC----------------------CCCCCHHHHHHHHHHHHHHHHHHHHcCceeec
Q 012762 156 DCPRWSCLLTEFCPGGDLHVLRQRQP----------------------DKRFHESAVRFYASEVVVALEFLHMMGIIYRD 213 (457)
Q Consensus 156 ~~~~~~~lV~E~~~~~sL~~~~~~~~----------------------~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrD 213 (457)
...+..|+||||+++++|.+++.... ...+++..++.++.||+.||.|||++||+|||
T Consensus 120 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~D 199 (343)
T 1luf_A 120 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRD 199 (343)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred ccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence 99999999999999999999987742 15689999999999999999999999999999
Q ss_pred CCCCCeEEccCCCEEEeccCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchh
Q 012762 214 LKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRR 293 (457)
Q Consensus 214 IKp~NIll~~~~~vkl~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (457)
|||+|||++.++.+||+|||+++........
T Consensus 200 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~------------------------------------------------- 230 (343)
T 1luf_A 200 LATRNCLVGENMVVKIADFGLSRNIYSADYY------------------------------------------------- 230 (343)
T ss_dssp CSGGGEEECGGGCEEECCCSCHHHHTGGGCB-------------------------------------------------
T ss_pred CCcceEEECCCCeEEEeecCCCcccccCccc-------------------------------------------------
Confidence 9999999999999999999997543211000
Q ss_pred ccccCCCCCCCcccccCCccccccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHHh
Q 012762 294 RKKKLGNPGTPEIVAEPLDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVVA 372 (457)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~ 372 (457)
.......||+.|+|||++.+..++.++|||||||++|||++ |..||.+.........+..
T Consensus 231 -------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~ 291 (343)
T 1luf_A 231 -------------------KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRD 291 (343)
T ss_dssp -------------------C----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHT
T ss_pred -------------------cccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCChHHHHHHHhC
Confidence 00112358999999999999999999999999999999999 9999999887777766665
Q ss_pred cccCCCCCCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcC
Q 012762 373 RALEFPKEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRH 415 (457)
Q Consensus 373 ~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~h 415 (457)
... .+....++.++.+||.+||..||++||+ +.+++++
T Consensus 292 ~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps----~~~~~~~ 329 (343)
T 1luf_A 292 GNI-LACPENCPLELYNLMRLCWSKLPADRPS----FCSIHRI 329 (343)
T ss_dssp TCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred CCc-CCCCCCCCHHHHHHHHHHcccCcccCCC----HHHHHHH
Confidence 543 2334468899999999999999999999 8888764
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-47 Score=372.39 Aligned_cols=277 Identities=17% Similarity=0.232 Sum_probs=227.4
Q ss_pred CCCCccCCCceeEEEecccCcceEEEEEEec-cCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEE
Q 012762 75 NNNPLTLSDLRFVHRLGSGDIGSVYLVQLKS-KSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYA 153 (457)
Q Consensus 75 ~~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~-~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~ 153 (457)
..+.+..++|++.+.||+|+||+||+|.++. ....+++.||+|++.... .......+.+|+++++.++||||+++++
T Consensus 18 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~ 95 (322)
T 1p4o_A 18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLG 95 (322)
T ss_dssp CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEE
T ss_pred hhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc--CHHHHHHHHHHHHHHHhcCCCCEeeeEE
Confidence 4566777899999999999999999998763 122357889999997542 2234456788999999999999999999
Q ss_pred EEEcCCcEEEEEeecCCCChHHHHHhCC--------CCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCC
Q 012762 154 TLDCPRWSCLLTEFCPGGDLHVLRQRQP--------DKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDG 225 (457)
Q Consensus 154 ~~~~~~~~~lV~E~~~~~sL~~~~~~~~--------~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~ 225 (457)
++...+..|+||||+++++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 96 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~ 175 (322)
T 1p4o_A 96 VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF 175 (322)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTC
T ss_pred EEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCC
Confidence 9999999999999999999998887531 24578999999999999999999999999999999999999999
Q ss_pred CEEEeccCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCc
Q 012762 226 HIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPE 305 (457)
Q Consensus 226 ~vkl~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (457)
.+||+|||+++........
T Consensus 176 ~~kl~Dfg~~~~~~~~~~~------------------------------------------------------------- 194 (322)
T 1p4o_A 176 TVKIGDFGMTRDIYETDYY------------------------------------------------------------- 194 (322)
T ss_dssp CEEECCTTCCCGGGGGGCE-------------------------------------------------------------
T ss_pred eEEECcCcccccccccccc-------------------------------------------------------------
Confidence 9999999997543211100
Q ss_pred ccccCCccccccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHHhcccCCCCCCCCC
Q 012762 306 IVAEPLDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVVARALEFPKEPSVP 384 (457)
Q Consensus 306 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (457)
.......||+.|+|||++.+..++.++|||||||++|+|++ |..||.+.........+..... .+....++
T Consensus 195 -------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~ 266 (322)
T 1p4o_A 195 -------RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGL-LDKPDNCP 266 (322)
T ss_dssp -------EGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCC-CCCCTTCC
T ss_pred -------ccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcCCc-CCCCCCCC
Confidence 00112357899999999999999999999999999999999 8999998877776666655433 33345689
Q ss_pred hHHHHHHHHHhhhCCCCCCCCCcChHHHhcC------CCCCCCCchhh
Q 012762 385 GPAKDLIAQLLVKDPTRRMGSKMGATAIKRH------QFFNGVNWALL 426 (457)
Q Consensus 385 ~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~h------p~f~~~~~~~~ 426 (457)
..+.+||.+||..||++||+ +.++++| ++|+.++|...
T Consensus 267 ~~l~~li~~~l~~dp~~Rps----~~e~l~~L~~~~~~~~~~~~~~~~ 310 (322)
T 1p4o_A 267 DMLFELMRMCWQYNPKMRPS----FLEIISSIKEEMEPGFREVSFYYS 310 (322)
T ss_dssp HHHHHHHHHHTCSSGGGSCC----HHHHHHHHGGGSCTTHHHHCSTTS
T ss_pred HHHHHHHHHHcCCCcccCcC----HHHHHHHHHHhhccCCcccccccc
Confidence 99999999999999999999 8888776 77777776544
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-46 Score=367.84 Aligned_cols=266 Identities=20% Similarity=0.279 Sum_probs=215.9
Q ss_pred CCCCccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEE
Q 012762 75 NNNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYAT 154 (457)
Q Consensus 75 ~~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~ 154 (457)
....+..++|++.+.||+|+||+||+|.++..+...+..||+|++.... .......+.+|+++++.++||||++++++
T Consensus 37 ~~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 114 (333)
T 1mqb_A 37 FTTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGV 114 (333)
T ss_dssp -CCBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccccCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence 3456778899999999999999999999875444456679999997542 23345568889999999999999999999
Q ss_pred EEcCCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCC
Q 012762 155 LDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDL 234 (457)
Q Consensus 155 ~~~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~ 234 (457)
+...+..||||||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 115 ~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 193 (333)
T 1mqb_A 115 ISKYKPMMIITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGL 193 (333)
T ss_dssp ECSSSSEEEEEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred EecCCCcEEEEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCc
Confidence 99999999999999999999998764 35799999999999999999999999999999999999999999999999999
Q ss_pred CcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccc
Q 012762 235 SLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVR 314 (457)
Q Consensus 235 s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (457)
++......... ..
T Consensus 194 ~~~~~~~~~~~-------------------------------------------------------------------~~ 206 (333)
T 1mqb_A 194 SRVLEDDPEAT-------------------------------------------------------------------YT 206 (333)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred chhhccccccc-------------------------------------------------------------------cc
Confidence 86543211100 00
Q ss_pred cccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHH
Q 012762 315 SMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQ 393 (457)
Q Consensus 315 ~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~ 393 (457)
.....||+.|+|||++.+..++.++|||||||++|||++ |..||.+.........+.. ....+....++..+.++|.+
T Consensus 207 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~ 285 (333)
T 1mqb_A 207 TSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIND-GFRLPTPMDCPSAIYQLMMQ 285 (333)
T ss_dssp ----CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT-TCCCCCCTTCBHHHHHHHHH
T ss_pred cCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHC-CCcCCCcccCCHHHHHHHHH
Confidence 001236889999999999999999999999999999998 9999998877666655544 34555556789999999999
Q ss_pred HhhhCCCCCCCCCcChHHHhcC
Q 012762 394 LLVKDPTRRMGSKMGATAIKRH 415 (457)
Q Consensus 394 ~L~~dP~~Rps~~~~~~~ll~h 415 (457)
||..||++||+ +.+++++
T Consensus 286 ~l~~~p~~Rps----~~~l~~~ 303 (333)
T 1mqb_A 286 CWQQERARRPK----FADIVSI 303 (333)
T ss_dssp HTCSSTTTSCC----HHHHHHH
T ss_pred HcCCChhhCcC----HHHHHHH
Confidence 99999999999 7777664
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-47 Score=381.76 Aligned_cols=260 Identities=21% Similarity=0.342 Sum_probs=218.2
Q ss_pred CCCCccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEE
Q 012762 75 NNNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYAT 154 (457)
Q Consensus 75 ~~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~ 154 (457)
..+.+..++|++.+.||+|+||+||+|.++ .+++.||||+++.. ........+.+|+++|+.++||||++++++
T Consensus 107 ~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~----~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 180 (377)
T 3cbl_A 107 DKWVLNHEDLVLGEQIGRGNFGEVFSGRLR----ADNTLVAVKSCRET--LPPDLKAKFLQEARILKQYSHPNIVRLIGV 180 (377)
T ss_dssp CTTBCCGGGEEEEEEEEEETTEEEEEEEET----TTCCEEEEEECCTT--SCHHHHTTTTHHHHHHTTCCCTTBCCEEEE
T ss_pred cccEEchHHeEEeeEeccCCCCeEEEEEEe----cCCeEEEEEEcccc--CCHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence 456778889999999999999999999986 37889999998754 222344567789999999999999999999
Q ss_pred EEcCCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCC
Q 012762 155 LDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDL 234 (457)
Q Consensus 155 ~~~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~ 234 (457)
+...+..||||||+++|+|.+++... ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 181 ~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~ 259 (377)
T 3cbl_A 181 CTQKQPIYIVMELVQGGDFLTFLRTE-GARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGM 259 (377)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGG
T ss_pred EecCCCcEEEEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCC
Confidence 99999999999999999999988764 24589999999999999999999999999999999999999999999999999
Q ss_pred CcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccc
Q 012762 235 SLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVR 314 (457)
Q Consensus 235 s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (457)
++......... .
T Consensus 260 s~~~~~~~~~~--------------------------------------------------------------------~ 271 (377)
T 3cbl_A 260 SREEADGVYAA--------------------------------------------------------------------S 271 (377)
T ss_dssp CEECTTSEEEC--------------------------------------------------------------------C
T ss_pred ceecCCCceee--------------------------------------------------------------------c
Confidence 86433211000 0
Q ss_pred cccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHH
Q 012762 315 SMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQ 393 (457)
Q Consensus 315 ~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~ 393 (457)
.....++..|+|||++.+..++.++|||||||++|||++ |..||.+....+....+ ......+.+..+++++.+||.+
T Consensus 272 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~ 350 (377)
T 3cbl_A 272 GGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFV-EKGGRLPCPELCPDAVFRLMEQ 350 (377)
T ss_dssp SSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHH-HTTCCCCCCTTCCHHHHHHHHH
T ss_pred CCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-HcCCCCCCCCCCCHHHHHHHHH
Confidence 001135778999999998889999999999999999998 99999988776555444 4445566666789999999999
Q ss_pred HhhhCCCCCCCCCcChHHHhc
Q 012762 394 LLVKDPTRRMGSKMGATAIKR 414 (457)
Q Consensus 394 ~L~~dP~~Rps~~~~~~~ll~ 414 (457)
||..||++||+ +.+|++
T Consensus 351 cl~~dP~~Rps----~~~i~~ 367 (377)
T 3cbl_A 351 CWAYEPGQRPS----FSTIYQ 367 (377)
T ss_dssp HTCSSGGGSCC----HHHHHH
T ss_pred HcCCCchhCcC----HHHHHH
Confidence 99999999999 887765
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-46 Score=360.49 Aligned_cols=258 Identities=22% Similarity=0.325 Sum_probs=222.4
Q ss_pred CCCCccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEE
Q 012762 75 NNNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYAT 154 (457)
Q Consensus 75 ~~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~ 154 (457)
..+.+..++|++.+.||+|+||+||+|.++. ++..||+|++.... .....+.+|+++++.++||||++++++
T Consensus 6 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~----~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~ 77 (288)
T 3kfa_A 6 DKWEMERTDITMKHKLGGGQYGEVYEGVWKK----YSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGV 77 (288)
T ss_dssp CTTBCCGGGEEEEEESGGGTTCSEEEEEEGG----GTEEEEEEEECSCS----THHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred hcccccccceeEEeecCCCCceeEEEeEecC----CCEEEEEEecCcCH----HHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 4677888999999999999999999999873 68899999997532 345678889999999999999999999
Q ss_pred EEcCCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCC
Q 012762 155 LDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDL 234 (457)
Q Consensus 155 ~~~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~ 234 (457)
+...+..|+||||+++++|.+++.......+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+
T Consensus 78 ~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~ 157 (288)
T 3kfa_A 78 CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGL 157 (288)
T ss_dssp ECSSSSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCG
T ss_pred EccCCCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCcc
Confidence 99999999999999999999999887667799999999999999999999999999999999999999999999999999
Q ss_pred CcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccc
Q 012762 235 SLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVR 314 (457)
Q Consensus 235 s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (457)
+..........
T Consensus 158 ~~~~~~~~~~~--------------------------------------------------------------------- 168 (288)
T 3kfa_A 158 SRLMTGDTYTA--------------------------------------------------------------------- 168 (288)
T ss_dssp GGTSCSSSSEE---------------------------------------------------------------------
T ss_pred ceeccCCcccc---------------------------------------------------------------------
Confidence 86554221110
Q ss_pred cccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHH
Q 012762 315 SMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQ 393 (457)
Q Consensus 315 ~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~ 393 (457)
.....||+.|+|||++.+..++.++|||||||++|+|++ |..||.+.........+ ......+....+++.+.+||.+
T Consensus 169 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~ 247 (288)
T 3kfa_A 169 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL-EKDYRMERPEGCPEKVYELMRA 247 (288)
T ss_dssp ETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH-HTTCCCCCCTTCCHHHHHHHHH
T ss_pred ccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-hccCCCCCCCCCCHHHHHHHHH
Confidence 112347889999999999999999999999999999999 99999887766555444 3444555556789999999999
Q ss_pred HhhhCCCCCCCCCcChHHHhc
Q 012762 394 LLVKDPTRRMGSKMGATAIKR 414 (457)
Q Consensus 394 ~L~~dP~~Rps~~~~~~~ll~ 414 (457)
||..||.+||+ +.++++
T Consensus 248 ~l~~dp~~Rps----~~~~~~ 264 (288)
T 3kfa_A 248 CWQWNPSDRPS----FAEIHQ 264 (288)
T ss_dssp HTCSSGGGSCC----HHHHHH
T ss_pred HhCCChhhCcC----HHHHHH
Confidence 99999999999 888865
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=384.40 Aligned_cols=251 Identities=20% Similarity=0.337 Sum_probs=214.8
Q ss_pred CCCCccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEE
Q 012762 75 NNNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYAT 154 (457)
Q Consensus 75 ~~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~ 154 (457)
..+.+..++|++.+.||+|+||+||+|.+ .++.||||+++... ....+.+|+++|++++||||++++++
T Consensus 186 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~------~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~ 254 (450)
T 1k9a_A 186 SGWALNMKELKLLQTIGKGEFGDVMLGDY------RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGV 254 (450)
T ss_dssp TTCBCCGGGEEEEEEEEECSSEEEEEEEE------TTEEEEEEEESSCT-----TSHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred cccccChHHeEEEeeecCcCCeeEEEEEe------cCCeEEEEEeCCch-----HHHHHHHHHHHHHhccCCCEEEEEEE
Confidence 34678889999999999999999999986 36789999997542 34568889999999999999999999
Q ss_pred EEcCC-cEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccC
Q 012762 155 LDCPR-WSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFD 233 (457)
Q Consensus 155 ~~~~~-~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG 233 (457)
+...+ .+||||||+++|+|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 255 ~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG 334 (450)
T 1k9a_A 255 IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFG 334 (450)
T ss_dssp EECTTSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCT
T ss_pred EEcCCCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCC
Confidence 87655 79999999999999999987655568999999999999999999999999999999999999999999999999
Q ss_pred CCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcc
Q 012762 234 LSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDV 313 (457)
Q Consensus 234 ~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (457)
+++......
T Consensus 335 ~a~~~~~~~----------------------------------------------------------------------- 343 (450)
T 1k9a_A 335 LTKEASSTQ----------------------------------------------------------------------- 343 (450)
T ss_dssp TCEECC--------------------------------------------------------------------------
T ss_pred Ccccccccc-----------------------------------------------------------------------
Confidence 986432110
Q ss_pred ccccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHH
Q 012762 314 RSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIA 392 (457)
Q Consensus 314 ~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~ 392 (457)
....++..|+|||++.+..++.++|||||||++|||++ |+.||.+....+....+. ...+.+.+..+++++.+||.
T Consensus 344 --~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~-~~~~~~~p~~~~~~l~~li~ 420 (450)
T 1k9a_A 344 --DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-KGYKMDAPDGCPPAVYDVMK 420 (450)
T ss_dssp -----CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHH-TTCCCCCCTTCCHHHHHHHH
T ss_pred --cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCcCCHHHHHHHH
Confidence 01137889999999999999999999999999999998 999999887766665554 34455666679999999999
Q ss_pred HHhhhCCCCCCCCCcChHHHhc
Q 012762 393 QLLVKDPTRRMGSKMGATAIKR 414 (457)
Q Consensus 393 ~~L~~dP~~Rps~~~~~~~ll~ 414 (457)
+||..||++||+ +.+|++
T Consensus 421 ~cl~~dp~~Rpt----~~~l~~ 438 (450)
T 1k9a_A 421 NCWHLDAATRPT----FLQLRE 438 (450)
T ss_dssp HHTCSSGGGSCC----HHHHHH
T ss_pred HHcCCChhHCcC----HHHHHH
Confidence 999999999999 777754
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=369.85 Aligned_cols=262 Identities=19% Similarity=0.259 Sum_probs=210.4
Q ss_pred CCccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEE
Q 012762 77 NPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLD 156 (457)
Q Consensus 77 ~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~ 156 (457)
..+..++|+++++||+|+||+||+|++..........||+|.+.... .......+.+|++++++++||||+++++++.
T Consensus 10 ~~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 87 (327)
T 3poz_A 10 RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICL 87 (327)
T ss_dssp EECCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC---------CHHHHHHHHHHHHHCCBTTBCCEEEEEE
T ss_pred hhcCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEe
Confidence 34566789999999999999999999875333334456888875432 2344567888999999999999999999998
Q ss_pred cCCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCc
Q 012762 157 CPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSL 236 (457)
Q Consensus 157 ~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~ 236 (457)
.+. .++||||+.+|+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 88 ~~~-~~~v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 165 (327)
T 3poz_A 88 TST-VQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAK 165 (327)
T ss_dssp SSS-EEEEEECCTTCBHHHHHHHST-TSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHH
T ss_pred cCC-eEEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCccee
Confidence 754 789999999999999887753 569999999999999999999999999999999999999999999999999986
Q ss_pred CCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccc
Q 012762 237 KGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSM 316 (457)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (457)
......... ...
T Consensus 166 ~~~~~~~~~--------------------------------------------------------------------~~~ 177 (327)
T 3poz_A 166 LLGAEEKEY--------------------------------------------------------------------HAE 177 (327)
T ss_dssp HHTTTCC-------------------------------------------------------------------------
T ss_pred EccCCcccc--------------------------------------------------------------------ccc
Confidence 543211100 001
Q ss_pred cccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHh
Q 012762 317 SFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLL 395 (457)
Q Consensus 317 ~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L 395 (457)
...||+.|+|||++.+..++.++|||||||++|||++ |..||.+........ ++......+....++.++.+++.+||
T Consensus 178 ~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l 256 (327)
T 3poz_A 178 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS-ILEKGERLPQPPICTIDVYMIMVKCW 256 (327)
T ss_dssp --CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH-HHHTTCCCCCCTTBCHHHHHHHHHHT
T ss_pred CCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHH-HHHcCCCCCCCccCCHHHHHHHHHHc
Confidence 2247889999999999999999999999999999999 999999876655444 44444455666678999999999999
Q ss_pred hhCCCCCCCCCcChHHHhcC
Q 012762 396 VKDPTRRMGSKMGATAIKRH 415 (457)
Q Consensus 396 ~~dP~~Rps~~~~~~~ll~h 415 (457)
+.||.+||+ +.+++++
T Consensus 257 ~~~p~~Rps----~~ell~~ 272 (327)
T 3poz_A 257 MIDADSRPK----FRELIIE 272 (327)
T ss_dssp CSCGGGSCC----HHHHHHH
T ss_pred CCChhhCCC----HHHHHHH
Confidence 999999999 8888765
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-47 Score=368.20 Aligned_cols=266 Identities=19% Similarity=0.282 Sum_probs=219.4
Q ss_pred CCCccCCCceeEEEecccCcceEEEEEEecc-CCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHc-CCCCCceEEE
Q 012762 76 NNPLTLSDLRFVHRLGSGDIGSVYLVQLKSK-SSNNGCFFAAKVMDKRELVSRNKESRARIEREILEML-DHPFLPTLYA 153 (457)
Q Consensus 76 ~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~-~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~~ 153 (457)
.+.+..++|++.+.||+|+||+||+|.+... +..+++.||||++.... .......+.+|+++|+++ +||||+++++
T Consensus 21 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 98 (316)
T 2xir_A 21 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLG 98 (316)
T ss_dssp HHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC--CcHHHHHHHHHHHHHHhcccCCCeeeEEE
Confidence 3456678999999999999999999987532 23577899999997642 233456788899999999 7999999999
Q ss_pred EEEcCC-cEEEEEeecCCCChHHHHHhCCC--------------CCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCC
Q 012762 154 TLDCPR-WSCLLTEFCPGGDLHVLRQRQPD--------------KRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPEN 218 (457)
Q Consensus 154 ~~~~~~-~~~lV~E~~~~~sL~~~~~~~~~--------------~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~N 218 (457)
++...+ ..|+||||+++++|.+++..... ..+++..++.++.||+.||.|||++||+||||||+|
T Consensus 99 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~N 178 (316)
T 2xir_A 99 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARN 178 (316)
T ss_dssp EECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred EEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccce
Confidence 987654 58999999999999999987532 128999999999999999999999999999999999
Q ss_pred eEEccCCCEEEeccCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccC
Q 012762 219 VLVRSDGHIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKL 298 (457)
Q Consensus 219 Ill~~~~~vkl~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (457)
||++.++.+||+|||+++........
T Consensus 179 il~~~~~~~kl~Dfg~~~~~~~~~~~------------------------------------------------------ 204 (316)
T 2xir_A 179 ILLSEKNVVKICDFGLARDIYKDPDY------------------------------------------------------ 204 (316)
T ss_dssp EEECGGGCEEECCCGGGSCTTTCTTS------------------------------------------------------
T ss_pred EEECCCCCEEECCCccccccccCccc------------------------------------------------------
Confidence 99999999999999998654321110
Q ss_pred CCCCCCcccccCCccccccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHHhcccCC
Q 012762 299 GNPGTPEIVAEPLDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVVARALEF 377 (457)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~ 377 (457)
.......||+.|+|||++.+..++.++|||||||++|+|++ |..||.+..........+......
T Consensus 205 --------------~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~ 270 (316)
T 2xir_A 205 --------------VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM 270 (316)
T ss_dssp --------------EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCCC
T ss_pred --------------eeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHHHHhccCccC
Confidence 01113358999999999999999999999999999999998 999998876555555555554445
Q ss_pred CCCCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcC
Q 012762 378 PKEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRH 415 (457)
Q Consensus 378 ~~~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~h 415 (457)
+....++.++.++|.+||..||.+||+ +.++++|
T Consensus 271 ~~~~~~~~~l~~li~~~l~~dp~~Rps----~~ell~~ 304 (316)
T 2xir_A 271 RAPDYTTPEMYQTMLDCWHGEPSQRPT----FSELVEH 304 (316)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcC----HHHHHHH
Confidence 555568999999999999999999999 9999876
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-47 Score=377.13 Aligned_cols=260 Identities=23% Similarity=0.362 Sum_probs=209.0
Q ss_pred CCCccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcC-----------
Q 012762 76 NNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLD----------- 144 (457)
Q Consensus 76 ~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~----------- 144 (457)
...+..++|++.+.||+|+||+||+|.++ .+++.||||++.... .....+.+|+++++++.
T Consensus 13 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~----~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~~~ 84 (373)
T 1q8y_A 13 GEPYKDARYILVRKLGWGHFSTVWLAKDM----VNNTHVAMKIVRGDK----VYTEAAEDEIKLLQRVNDADNTKEDSMG 84 (373)
T ss_dssp TCEETTTTEEEEEEEEECSSEEEEEEEET----TTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHTCCSHHHHHH
T ss_pred CCcccCCeEEEEEeeeecCCeEEEEEEec----CCCcEEEEEEecCCc----cchhhhhHHHHHHHHhhcccccchhccc
Confidence 34456689999999999999999999976 478999999997543 23456677999988875
Q ss_pred CCCCceEEEEEEcCC----cEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHc-CceeecCCCCCe
Q 012762 145 HPFLPTLYATLDCPR----WSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMM-GIIYRDLKPENV 219 (457)
Q Consensus 145 H~nIv~l~~~~~~~~----~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~-~iiHrDIKp~NI 219 (457)
|+||+++++++...+ .+++||||+ +++|.+++.......+++..++.++.||+.||.|||++ ||+||||||+||
T Consensus 85 ~~~i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NI 163 (373)
T 1q8y_A 85 ANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENV 163 (373)
T ss_dssp HTTBCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGE
T ss_pred cchHHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHe
Confidence 899999999997654 789999999 99999999887667799999999999999999999998 999999999999
Q ss_pred EEcc------CCCEEEeccCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchh
Q 012762 220 LVRS------DGHIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRR 293 (457)
Q Consensus 220 ll~~------~~~vkl~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (457)
||+. .+.+||+|||++......
T Consensus 164 ll~~~~~~~~~~~~kl~Dfg~a~~~~~~---------------------------------------------------- 191 (373)
T 1q8y_A 164 LMEIVDSPENLIQIKIADLGNACWYDEH---------------------------------------------------- 191 (373)
T ss_dssp EEEEEETTTTEEEEEECCCTTCEETTBC----------------------------------------------------
T ss_pred EEeccCCCcCcceEEEcccccccccCCC----------------------------------------------------
Confidence 9954 347999999998644311
Q ss_pred ccccCCCCCCCcccccCCccccccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCC------hHHHH
Q 012762 294 RKKKLGNPGTPEIVAEPLDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGID------HELTL 367 (457)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~------~~~~~ 367 (457)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.+.. ....+
T Consensus 192 ---------------------~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~ 250 (373)
T 1q8y_A 192 ---------------------YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI 250 (373)
T ss_dssp ---------------------CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred ---------------------CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHH
Confidence 012358999999999999999999999999999999999999998654 22233
Q ss_pred HHHHhcccCCC----------------------------------------CCCCCChHHHHHHHHHhhhCCCCCCCCCc
Q 012762 368 ANVVARALEFP----------------------------------------KEPSVPGPAKDLIAQLLVKDPTRRMGSKM 407 (457)
Q Consensus 368 ~~~~~~~~~~~----------------------------------------~~~~~~~~~~~ll~~~L~~dP~~Rps~~~ 407 (457)
..++......| ....++.++.+||.+||+.||++||+
T Consensus 251 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt--- 327 (373)
T 1q8y_A 251 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD--- 327 (373)
T ss_dssp HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC---
T ss_pred HHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCC---
Confidence 33332111111 01123467889999999999999999
Q ss_pred ChHHHhcCCCCCCC
Q 012762 408 GATAIKRHQFFNGV 421 (457)
Q Consensus 408 ~~~~ll~hp~f~~~ 421 (457)
+.|||+||||+..
T Consensus 328 -~~ell~hp~f~~~ 340 (373)
T 1q8y_A 328 -AGGLVNHPWLKDT 340 (373)
T ss_dssp -HHHHHTCGGGTTC
T ss_pred -HHHHhhChhhhcc
Confidence 9999999999963
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-46 Score=360.21 Aligned_cols=270 Identities=17% Similarity=0.251 Sum_probs=216.1
Q ss_pred CccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHc-CCCCCceEEEEEE
Q 012762 78 PLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEML-DHPFLPTLYATLD 156 (457)
Q Consensus 78 ~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~~~~~ 156 (457)
.+..++|++.+.||+|+||+||+|.+. .+++.||||++.... ....+.+|+++++.+ +|+||+++++++.
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~V~~~~~~----~~~~~vavK~~~~~~-----~~~~~~~e~~~~~~l~~~~~i~~~~~~~~ 76 (298)
T 1csn_A 6 NVVGVHYKVGRRIGEGSFGVIFEGTNL----LNNQQVAIKFEPRRS-----DAPQLRDEYRTYKLLAGCTGIPNVYYFGQ 76 (298)
T ss_dssp CEETTTEEEEEEEEECSSCEEEEEEET----TTTEEEEEEEEECCT-----TSCCHHHHHHHHHHTTTCTTCCCEEEEEE
T ss_pred cccccceEEEEEEeecCCEEEEEEEEC----CCCcEEEEEEeccCC-----ccHHHHHHHHHHHHHhcCCCCCeEEeecC
Confidence 455678999999999999999999976 478999999986542 233467799999999 7999999999999
Q ss_pred cCCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCC-----EEEec
Q 012762 157 CPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGH-----IMLTD 231 (457)
Q Consensus 157 ~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~-----vkl~D 231 (457)
.....|+||||+ +++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|
T Consensus 77 ~~~~~~lv~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~D 154 (298)
T 1csn_A 77 EGLHNVLVIDLL-GPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVD 154 (298)
T ss_dssp ETTEEEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECC
T ss_pred CCceeEEEEEec-CCCHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEE
Confidence 999999999999 99999999875 346999999999999999999999999999999999999987776 99999
Q ss_pred cCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCC
Q 012762 232 FDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPL 311 (457)
Q Consensus 232 FG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (457)
||+++............
T Consensus 155 fg~~~~~~~~~~~~~~~--------------------------------------------------------------- 171 (298)
T 1csn_A 155 FGMVKFYRDPVTKQHIP--------------------------------------------------------------- 171 (298)
T ss_dssp CTTCEESBCTTTCCBCC---------------------------------------------------------------
T ss_pred Ccccccccccccccccc---------------------------------------------------------------
Confidence 99987554321110000
Q ss_pred ccccccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCC---hHHHHHHHHhcccCCCC---CCCCCh
Q 012762 312 DVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGID---HELTLANVVARALEFPK---EPSVPG 385 (457)
Q Consensus 312 ~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~---~~~~~~~~~~~~~~~~~---~~~~~~ 385 (457)
........||+.|+|||++.+..++.++|||||||++|||++|+.||.+.. ....+..+.......+. ...+++
T Consensus 172 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (298)
T 1csn_A 172 YREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPE 251 (298)
T ss_dssp CCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHHTTTSCH
T ss_pred ccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccHHHHHhhCcH
Confidence 001123469999999999999999999999999999999999999998743 33344444433322221 235889
Q ss_pred HHHHHHHHHhhhCCCCCCCCCcChHHHh----------cCCCCCCCCchh
Q 012762 386 PAKDLIAQLLVKDPTRRMGSKMGATAIK----------RHQFFNGVNWAL 425 (457)
Q Consensus 386 ~~~~ll~~~L~~dP~~Rps~~~~~~~ll----------~hp~f~~~~~~~ 425 (457)
++.+|+.+||+.||++||+ +.+|+ +......++|..
T Consensus 252 ~l~~li~~~l~~dp~~RP~----~~~l~~~l~~~~~~~~~~~~~~~dw~~ 297 (298)
T 1csn_A 252 EFYKYMHYARNLAFDATPD----YDYLQGLFSKVLERLNTTEDENFDWNL 297 (298)
T ss_dssp HHHHHHHHHHHCCTTCCCC----HHHHHHHHHHHHHHTTCCSCSCCGGGC
T ss_pred HHHHHHHHHhcCCcccCCC----HHHHHHHHHHHHHhcCCCCCCccccCC
Confidence 9999999999999999999 66664 334555567753
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=362.02 Aligned_cols=254 Identities=20% Similarity=0.235 Sum_probs=207.9
Q ss_pred CccCCCceeEEEecccCcceEEEEEEeccCC---CCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEE
Q 012762 78 PLTLSDLRFVHRLGSGDIGSVYLVQLKSKSS---NNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYAT 154 (457)
Q Consensus 78 ~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~---~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~ 154 (457)
.+..++|++.+.||+|+||+||+|+++.... ..+..||+|++.... ......+.+|++++++++||||++++++
T Consensus 4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 80 (289)
T 4fvq_A 4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH---RNYSESFFEAASMMSKLSHKHLVLNYGV 80 (289)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG---GGGHHHHHHHHHHHHTSCCTTBCCEEEE
T ss_pred EechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc---HHHHHHHHHHHHHHHhCCCCCEeEEEEE
Confidence 4567899999999999999999999874210 012579999997543 3455678889999999999999999999
Q ss_pred EEcCCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCC--------
Q 012762 155 LDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGH-------- 226 (457)
Q Consensus 155 ~~~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~-------- 226 (457)
+..++..|+||||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.
T Consensus 81 ~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~ 159 (289)
T 4fvq_A 81 CVCGDENILVQEFVKFGSLDTYLKKN-KNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPF 159 (289)
T ss_dssp ECCTTCCEEEEECCTTCBHHHHHHHT-GGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCE
T ss_pred EEeCCCCEEEEECCCCCCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccce
Confidence 99999999999999999999999874 234999999999999999999999999999999999999998887
Q ss_pred EEEeccCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcc
Q 012762 227 IMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEI 306 (457)
Q Consensus 227 vkl~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (457)
+||+|||++......
T Consensus 160 ~kl~Dfg~~~~~~~~----------------------------------------------------------------- 174 (289)
T 4fvq_A 160 IKLSDPGISITVLPK----------------------------------------------------------------- 174 (289)
T ss_dssp EEECCCCSCTTTSCH-----------------------------------------------------------------
T ss_pred eeeccCcccccccCc-----------------------------------------------------------------
Confidence 999999997543211
Q ss_pred cccCCccccccccCCCCccCchhhcC-CCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCCCCCCh
Q 012762 307 VAEPLDVRSMSFVGTHEYLAPEIISG-EGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPG 385 (457)
Q Consensus 307 ~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (457)
....||+.|+|||++.+ ..++.++|||||||++|||++|..|+...................+. ..+.
T Consensus 175 ---------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~ 243 (289)
T 4fvq_A 175 ---------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQLPA--PKAA 243 (289)
T ss_dssp ---------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCC--CSSC
T ss_pred ---------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhhccCCCCC--CCCH
Confidence 12358899999999987 66899999999999999999955444443333334444444444443 3678
Q ss_pred HHHHHHHHHhhhCCCCCCCCCcChHHHhcC
Q 012762 386 PAKDLIAQLLVKDPTRRMGSKMGATAIKRH 415 (457)
Q Consensus 386 ~~~~ll~~~L~~dP~~Rps~~~~~~~ll~h 415 (457)
++.+||.+||+.||++||+ +.++++|
T Consensus 244 ~l~~li~~~l~~dp~~Rps----~~~ll~~ 269 (289)
T 4fvq_A 244 ELANLINNCMDYEPDHRPS----FRAIIRD 269 (289)
T ss_dssp TTHHHHHHHSCSSGGGSCC----HHHHHHH
T ss_pred HHHHHHHHHcCCChhHCcC----HHHHHHH
Confidence 8999999999999999999 9999886
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-47 Score=374.49 Aligned_cols=255 Identities=26% Similarity=0.380 Sum_probs=184.8
Q ss_pred ccCCCceeEE-EecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEc
Q 012762 79 LTLSDLRFVH-RLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDC 157 (457)
Q Consensus 79 ~~~~~~~~~~-~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~ 157 (457)
...++|.+.+ .||+|+||+||+|.++ .+++.||||++.... .........++.++||||+++++++..
T Consensus 25 ~~~~~y~i~~~~lG~G~~g~V~~~~~~----~~~~~vavK~~~~~~-------~~~~e~~~~~~~~~h~~i~~~~~~~~~ 93 (336)
T 3fhr_A 25 AVTDDYQLSKQVLGLGVNGKVLECFHR----RTGQKCALKLLYDSP-------KARQEVDHHWQASGGPHIVCILDVYEN 93 (336)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEET----TTCCEEEEEEEESSH-------HHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred cccceeEecceeeeeCCCeEEEEEEEC----CCCCEEEEEEecCcH-------HHHHHHHHHHHhcCCCChHHHHHHHhh
Confidence 3446899965 6999999999999987 478899999996531 111222334666799999999999976
Q ss_pred ----CCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEcc---CCCEEEe
Q 012762 158 ----PRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRS---DGHIMLT 230 (457)
Q Consensus 158 ----~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~---~~~vkl~ 230 (457)
....|+||||++|++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+
T Consensus 94 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~ 173 (336)
T 3fhr_A 94 MHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLT 173 (336)
T ss_dssp EETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEEC
T ss_pred ccCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEe
Confidence 456899999999999999998876668999999999999999999999999999999999999986 4569999
Q ss_pred ccCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccC
Q 012762 231 DFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEP 310 (457)
Q Consensus 231 DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (457)
|||++.......
T Consensus 174 Dfg~~~~~~~~~-------------------------------------------------------------------- 185 (336)
T 3fhr_A 174 DFGFAKETTQNA-------------------------------------------------------------------- 185 (336)
T ss_dssp CCTTCEEC------------------------------------------------------------------------
T ss_pred ccccceeccccc--------------------------------------------------------------------
Confidence 999986433111
Q ss_pred CccccccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHH----HHHHHhcccCC--CCCCCCC
Q 012762 311 LDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELT----LANVVARALEF--PKEPSVP 384 (457)
Q Consensus 311 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~----~~~~~~~~~~~--~~~~~~~ 384 (457)
.....||+.|+|||++.+..++.++|||||||++|+|++|..||........ ...+......+ +....++
T Consensus 186 ----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (336)
T 3fhr_A 186 ----LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVS 261 (336)
T ss_dssp ----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCCTTTSTTCC
T ss_pred ----cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCchhhccCC
Confidence 0123589999999999888899999999999999999999999987654332 22222222222 2335689
Q ss_pred hHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCC
Q 012762 385 GPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNG 420 (457)
Q Consensus 385 ~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~ 420 (457)
.++.+||.+||..||.+||+ +.|+++||||+.
T Consensus 262 ~~~~~li~~~L~~dP~~Rpt----~~ell~hp~~~~ 293 (336)
T 3fhr_A 262 EDAKQLIRLLLKTDPTERLT----ITQFMNHPWINQ 293 (336)
T ss_dssp HHHHHHHHHHSCSSGGGSCC----HHHHHHSHHHHT
T ss_pred HHHHHHHHHHCCCChhHCcC----HHHHhcCccccc
Confidence 99999999999999999999 999999999985
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=375.96 Aligned_cols=263 Identities=21% Similarity=0.304 Sum_probs=209.2
Q ss_pred CCCccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEE
Q 012762 76 NNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATL 155 (457)
Q Consensus 76 ~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~ 155 (457)
...+..++|.+.+.||+|+||+||+|+++.. ...+..||||+++... .......+.+|+++|++++||||+++++++
T Consensus 39 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~-~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 115 (373)
T 2qol_A 39 AKELDATNISIDKVVGAGEFGEVCSGRLKLP-SKKEISVAIKTLKVGY--TEKQRRDFLGEASIMGQFDHPNIIRLEGVV 115 (373)
T ss_dssp SCBCCGGGCCCCEEEEECSSSEEEEC-CBCT-TSCBCCEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred HhhcCHhhceeeeEEeeCCCeEEEEEEEecC-CCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 3456778999999999999999999987632 2367789999997542 234456788899999999999999999999
Q ss_pred EcCCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCC
Q 012762 156 DCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235 (457)
Q Consensus 156 ~~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s 235 (457)
...+..||||||+++++|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 116 ~~~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 194 (373)
T 2qol_A 116 TKSKPVMIVTEYMENGSLDSFLRKH-DAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLG 194 (373)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC---
T ss_pred eeCCceEEEEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccc
Confidence 9999999999999999999998764 357999999999999999999999999999999999999999999999999998
Q ss_pred cCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcccc
Q 012762 236 LKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRS 315 (457)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (457)
+.......... ..
T Consensus 195 ~~~~~~~~~~~-------------------------------------------------------------------~~ 207 (373)
T 2qol_A 195 RVLEDDPEAAY-------------------------------------------------------------------TT 207 (373)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred cccccCCccce-------------------------------------------------------------------ec
Confidence 65532111000 00
Q ss_pred ccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHH
Q 012762 316 MSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQL 394 (457)
Q Consensus 316 ~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~ 394 (457)
....+|..|+|||++.+..++.++|||||||++|||++ |+.||.+.........+. .....+....++..+.+||.+|
T Consensus 208 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~-~~~~~~~~~~~~~~l~~li~~c 286 (373)
T 2qol_A 208 RGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD-EGYRLPPPMDCPAALYQLMLDC 286 (373)
T ss_dssp ------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHH-TTEECCCCTTCBHHHHHHHHHH
T ss_pred cCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCccccHHHHHHHHHH
Confidence 01136788999999999999999999999999999997 999999887766655544 4445555667899999999999
Q ss_pred hhhCCCCCCCCCcChHHHhc
Q 012762 395 LVKDPTRRMGSKMGATAIKR 414 (457)
Q Consensus 395 L~~dP~~Rps~~~~~~~ll~ 414 (457)
|+.||++||+ +.+|++
T Consensus 287 l~~dp~~RPs----~~~i~~ 302 (373)
T 2qol_A 287 WQKDRNNRPK----FEQIVS 302 (373)
T ss_dssp TCSSGGGSCC----HHHHHH
T ss_pred hCcChhhCcC----HHHHHH
Confidence 9999999999 777664
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=389.06 Aligned_cols=258 Identities=21% Similarity=0.322 Sum_probs=221.9
Q ss_pred CCCCccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEE
Q 012762 75 NNNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYAT 154 (457)
Q Consensus 75 ~~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~ 154 (457)
..+.+..++|++.++||+|+||+||+|.++. ++..||||+++... .....+.+|+++|++++||||++++++
T Consensus 213 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~----~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~ 284 (495)
T 1opk_A 213 DKWEMERTDITMKHKLGGGQYGEVYEGVWKK----YSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGV 284 (495)
T ss_dssp SCCBCCGGGEEEEEESGGGTTSSEEEEEEGG----GTEEEEEEECCSSS----SCHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccccCHHHceeeeEecCCCCeEEEEEEEcC----CCeEEEEEEecCcc----cchHHHHHHHHHHHhcCCCCEeeEEEE
Confidence 4567788899999999999999999999873 67899999997542 235678889999999999999999999
Q ss_pred EEcCCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCC
Q 012762 155 LDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDL 234 (457)
Q Consensus 155 ~~~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~ 234 (457)
+...+.+||||||+++|+|.+++.......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+
T Consensus 285 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~ 364 (495)
T 1opk_A 285 CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGL 364 (495)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTC
T ss_pred EecCCcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeeccc
Confidence 99999999999999999999999886667799999999999999999999999999999999999999999999999999
Q ss_pred CcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccc
Q 012762 235 SLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVR 314 (457)
Q Consensus 235 s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (457)
++.........
T Consensus 365 a~~~~~~~~~~--------------------------------------------------------------------- 375 (495)
T 1opk_A 365 SRLMTGDTYTA--------------------------------------------------------------------- 375 (495)
T ss_dssp EECCTTCCEEC---------------------------------------------------------------------
T ss_pred ceeccCCceee---------------------------------------------------------------------
Confidence 87553211100
Q ss_pred cccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHH
Q 012762 315 SMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQ 393 (457)
Q Consensus 315 ~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~ 393 (457)
.....++..|+|||++.+..++.++|||||||++|||++ |..||.+......... +....+.+....++..+.+||.+
T Consensus 376 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~ 454 (495)
T 1opk_A 376 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL-LEKDYRMERPEGCPEKVYELMRA 454 (495)
T ss_dssp CTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH-HHTTCCCCCCTTCCHHHHHHHHH
T ss_pred cCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHH-HHcCCCCCCCCCCCHHHHHHHHH
Confidence 001236789999999998889999999999999999998 9999998776655544 44555666666799999999999
Q ss_pred HhhhCCCCCCCCCcChHHHhc
Q 012762 394 LLVKDPTRRMGSKMGATAIKR 414 (457)
Q Consensus 394 ~L~~dP~~Rps~~~~~~~ll~ 414 (457)
||+.||++||+ +.+|++
T Consensus 455 cl~~dP~~RPs----~~el~~ 471 (495)
T 1opk_A 455 CWQWNPSDRPS----FAEIHQ 471 (495)
T ss_dssp HTCSSGGGSCC----HHHHHH
T ss_pred HcCcChhHCcC----HHHHHH
Confidence 99999999999 777765
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-46 Score=366.21 Aligned_cols=267 Identities=18% Similarity=0.269 Sum_probs=219.8
Q ss_pred CCCCCccCCCceeEEEecccCcceEEEEEEeccC---CCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHc-CCCCCc
Q 012762 74 NNNNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKS---SNNGCFFAAKVMDKRELVSRNKESRARIEREILEML-DHPFLP 149 (457)
Q Consensus 74 ~~~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~---~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l-~H~nIv 149 (457)
...+.+..++|++.+.||+|+||+||+|++...+ ..++..||+|++.... .......+.+|+++++++ +||||+
T Consensus 27 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv 104 (334)
T 2pvf_A 27 DPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNII 104 (334)
T ss_dssp CTTTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC--CHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred CccccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC--cHHHHHHHHHHHHHHHHhhcCCCEe
Confidence 3556778899999999999999999999975322 2467789999997542 233456788899999999 899999
Q ss_pred eEEEEEEcCCcEEEEEeecCCCChHHHHHhCCC--------------CCCCHHHHHHHHHHHHHHHHHHHHcCceeecCC
Q 012762 150 TLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPD--------------KRFHESAVRFYASEVVVALEFLHMMGIIYRDLK 215 (457)
Q Consensus 150 ~l~~~~~~~~~~~lV~E~~~~~sL~~~~~~~~~--------------~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIK 215 (457)
++++++...+..|+||||+++++|.+++..... ..+++..++.++.||+.||.|||++||+|||||
T Consensus 105 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlk 184 (334)
T 2pvf_A 105 NLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLA 184 (334)
T ss_dssp CEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred eEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCc
Confidence 999999999999999999999999999886531 348999999999999999999999999999999
Q ss_pred CCCeEEccCCCEEEeccCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhcc
Q 012762 216 PENVLVRSDGHIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRK 295 (457)
Q Consensus 216 p~NIll~~~~~vkl~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (457)
|+|||++.++.+||+|||++..........
T Consensus 185 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~-------------------------------------------------- 214 (334)
T 2pvf_A 185 ARNVLVTENNVMKIADFGLARDINNIDYYK-------------------------------------------------- 214 (334)
T ss_dssp GGGEEECTTCCEEECCCTTCEECTTTSSEE--------------------------------------------------
T ss_pred cceEEEcCCCCEEEcccccccccccccccc--------------------------------------------------
Confidence 999999999999999999986543211100
Q ss_pred ccCCCCCCCcccccCCccccccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHHhcc
Q 012762 296 KKLGNPGTPEIVAEPLDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVVARA 374 (457)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~ 374 (457)
......||+.|+|||++.+..++.++|||||||++|||++ |..||.+....+....+...
T Consensus 215 ------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~- 275 (334)
T 2pvf_A 215 ------------------KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEG- 275 (334)
T ss_dssp ------------------CCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHT-
T ss_pred ------------------ccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHHHHHhcC-
Confidence 0011247889999999998889999999999999999999 99999988776665555443
Q ss_pred cCCCCCCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcC
Q 012762 375 LEFPKEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRH 415 (457)
Q Consensus 375 ~~~~~~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~h 415 (457)
...+....++.++.++|.+||..||.+||+ +.+++++
T Consensus 276 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps----~~ell~~ 312 (334)
T 2pvf_A 276 HRMDKPANCTNELYMMMRDCWHAVPSQRPT----FKQLVED 312 (334)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred CCCCCCccCCHHHHHHHHHHccCChhhCcC----HHHHHHH
Confidence 334444568999999999999999999999 8888765
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=369.35 Aligned_cols=266 Identities=21% Similarity=0.287 Sum_probs=221.8
Q ss_pred CCCccCCCceeEEEecccCcceEEEEEEeccCC-CCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHc-CCCCCceEEE
Q 012762 76 NNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSS-NNGCFFAAKVMDKRELVSRNKESRARIEREILEML-DHPFLPTLYA 153 (457)
Q Consensus 76 ~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~-~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~~ 153 (457)
.+.+..++|++.+.||+|+||+||+|.+..... .....||+|++.... .......+.+|+++|+.+ +||||+++++
T Consensus 40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~ 117 (333)
T 2i1m_A 40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA--HADEKEALMSELKIMSHLGQHENIVNLLG 117 (333)
T ss_dssp GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc--ChHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence 355677899999999999999999999864321 234589999997642 223456788899999999 8999999999
Q ss_pred EEEcCCcEEEEEeecCCCChHHHHHhCC------------CCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEE
Q 012762 154 TLDCPRWSCLLTEFCPGGDLHVLRQRQP------------DKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLV 221 (457)
Q Consensus 154 ~~~~~~~~~lV~E~~~~~sL~~~~~~~~------------~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll 221 (457)
++...+..|+||||+++|+|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 118 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~ 197 (333)
T 2i1m_A 118 ACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLL 197 (333)
T ss_dssp EECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEE
T ss_pred EEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEE
Confidence 9999999999999999999999887531 3468999999999999999999999999999999999999
Q ss_pred ccCCCEEEeccCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCC
Q 012762 222 RSDGHIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNP 301 (457)
Q Consensus 222 ~~~~~vkl~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (457)
+.++.+||+|||++.........
T Consensus 198 ~~~~~~kl~Dfg~~~~~~~~~~~--------------------------------------------------------- 220 (333)
T 2i1m_A 198 TNGHVAKIGDFGLARDIMNDSNY--------------------------------------------------------- 220 (333)
T ss_dssp EGGGEEEBCCCGGGCCGGGCTTS---------------------------------------------------------
T ss_pred CCCCeEEECccccccccccccce---------------------------------------------------------
Confidence 99999999999998643211100
Q ss_pred CCCcccccCCccccccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHHhcccCCCCC
Q 012762 302 GTPEIVAEPLDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVVARALEFPKE 380 (457)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~ 380 (457)
.......||+.|+|||++.+..++.++|||||||++|||++ |..||.+.........++......+..
T Consensus 221 -----------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 289 (333)
T 2i1m_A 221 -----------IVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQP 289 (333)
T ss_dssp -----------EECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHHHHTCCCCCC
T ss_pred -----------eecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHHhcCCCCCCC
Confidence 00112347889999999999999999999999999999998 999999877666666676666666666
Q ss_pred CCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcC
Q 012762 381 PSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRH 415 (457)
Q Consensus 381 ~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~h 415 (457)
..++..+.+||.+||+.||.+||+ +.+|+++
T Consensus 290 ~~~~~~l~~li~~~l~~~p~~Rps----~~~l~~~ 320 (333)
T 2i1m_A 290 AFAPKNIYSIMQACWALEPTHRPT----FQQICSF 320 (333)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred CCCCHHHHHHHHHHhccChhhCcC----HHHHHHH
Confidence 678999999999999999999999 8888763
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-46 Score=360.65 Aligned_cols=264 Identities=21% Similarity=0.263 Sum_probs=214.6
Q ss_pred CCccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEE
Q 012762 77 NPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLD 156 (457)
Q Consensus 77 ~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~ 156 (457)
..+...+|++++.||+|+||+||+|++...+..+++.||+|++.... .......+.+|+++|+.++||||+++++++.
T Consensus 16 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 93 (302)
T 4e5w_A 16 THFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICT 93 (302)
T ss_dssp TBCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-------CCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred hhhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc--cchhHHHHHHHHHHHHhCCCCCeeeeeeEEe
Confidence 34555679999999999999999999766566789999999997653 2334567888999999999999999999998
Q ss_pred cC--CcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCC
Q 012762 157 CP--RWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDL 234 (457)
Q Consensus 157 ~~--~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~ 234 (457)
.. ..+|+||||+++++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 94 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~ 172 (302)
T 4e5w_A 94 EDGGNGIKLIMEFLPSGSLKEYLPKNK-NKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGL 172 (302)
T ss_dssp C---CCEEEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTT
T ss_pred cCCCceEEEEEEeCCCCcHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcccc
Confidence 76 67899999999999999986542 5699999999999999999999999999999999999999999999999999
Q ss_pred CcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccc
Q 012762 235 SLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVR 314 (457)
Q Consensus 235 s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (457)
+........... .
T Consensus 173 ~~~~~~~~~~~~-------------------------------------------------------------------~ 185 (302)
T 4e5w_A 173 TKAIETDKEYYT-------------------------------------------------------------------V 185 (302)
T ss_dssp CEECCTTCCEEE-------------------------------------------------------------------C
T ss_pred cccccCCCccee-------------------------------------------------------------------c
Confidence 866543221100 0
Q ss_pred cccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCC--------------ChHHHHHHHHhcccCCCCC
Q 012762 315 SMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGI--------------DHELTLANVVARALEFPKE 380 (457)
Q Consensus 315 ~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~--------------~~~~~~~~~~~~~~~~~~~ 380 (457)
.....||..|+|||++.+..++.++|||||||++|+|++|..|+... .........+......+..
T Consensus 186 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (302)
T 4e5w_A 186 KDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCP 265 (302)
T ss_dssp CCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHHTTCCCCCC
T ss_pred cCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHHhccCCCCCC
Confidence 11235888999999999999999999999999999999999876322 2222333444445555666
Q ss_pred CCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhc
Q 012762 381 PSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKR 414 (457)
Q Consensus 381 ~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~ 414 (457)
..+++++.+||.+||..||.+||+ +.++++
T Consensus 266 ~~~~~~l~~li~~~l~~dp~~Rps----~~~ll~ 295 (302)
T 4e5w_A 266 PNCPDEVYQLMRKCWEFQPSNRTS----FQNLIE 295 (302)
T ss_dssp TTCCHHHHHHHHHTTCSSGGGSCC----HHHHHH
T ss_pred CCCCHHHHHHHHHHcCCCCCCCCC----HHHHHH
Confidence 678999999999999999999999 888875
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=386.45 Aligned_cols=256 Identities=20% Similarity=0.320 Sum_probs=217.7
Q ss_pred CCCCccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEE
Q 012762 75 NNNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYAT 154 (457)
Q Consensus 75 ~~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~ 154 (457)
..+.+..++|++.++||+|+||+||+|.++ .+..||||+++... .....+.+|+++|+.++||||++++++
T Consensus 181 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~-----~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~l~~~ 251 (454)
T 1qcf_A 181 DAWEIPRESLKLEKKLGAGQFGEVWMATYN-----KHTKVAVKTMKPGS----MSVEAFLAEANVMKTLQHDKLVKLHAV 251 (454)
T ss_dssp TCSBCCGGGEEEEEEEECCSSEEEEEEEET-----TTEEEEEEEECTTS----BCHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred cceeechHHeEEEEEcccCCceEEEEEEEC-----CccEEEEEEecCCC----ccHHHHHHHHHHHhhCCCCCEeeEEEE
Confidence 456778889999999999999999999875 56789999997643 245678889999999999999999999
Q ss_pred EEcCCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCC
Q 012762 155 LDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDL 234 (457)
Q Consensus 155 ~~~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~ 234 (457)
+. .+..||||||+.+|+|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 252 ~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~ 330 (454)
T 1qcf_A 252 VT-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGL 330 (454)
T ss_dssp EC-SSSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTG
T ss_pred Ee-CCccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCC
Confidence 86 56789999999999999998764334689999999999999999999999999999999999999999999999999
Q ss_pred CcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccc
Q 012762 235 SLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVR 314 (457)
Q Consensus 235 s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (457)
++.........
T Consensus 331 a~~~~~~~~~~--------------------------------------------------------------------- 341 (454)
T 1qcf_A 331 ARVIEDNEYTA--------------------------------------------------------------------- 341 (454)
T ss_dssp GGGBCCHHHHT---------------------------------------------------------------------
T ss_pred ceEcCCCceec---------------------------------------------------------------------
Confidence 86543211000
Q ss_pred cccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHH
Q 012762 315 SMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQ 393 (457)
Q Consensus 315 ~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~ 393 (457)
.....+|..|+|||++.+..++.++|||||||++|||++ |+.||.+....+....+. ...+.+.+..+++++.+||.+
T Consensus 342 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~-~~~~~~~~~~~~~~l~~li~~ 420 (454)
T 1qcf_A 342 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE-RGYRMPRPENCPEELYNIMMR 420 (454)
T ss_dssp TCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH-HTCCCCCCTTSCHHHHHHHHH
T ss_pred cCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHHHHHHHHH
Confidence 001236889999999998899999999999999999999 999999988776666554 445666667799999999999
Q ss_pred HhhhCCCCCCCCCcChHHHhc
Q 012762 394 LLVKDPTRRMGSKMGATAIKR 414 (457)
Q Consensus 394 ~L~~dP~~Rps~~~~~~~ll~ 414 (457)
||..||++||+ +.+|++
T Consensus 421 cl~~dp~~RPt----~~~i~~ 437 (454)
T 1qcf_A 421 CWKNRPEERPT----FEYIQS 437 (454)
T ss_dssp HTCSSGGGSCC----HHHHHH
T ss_pred HccCChhHCcC----HHHHHH
Confidence 99999999999 777754
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-46 Score=360.56 Aligned_cols=272 Identities=25% Similarity=0.375 Sum_probs=207.8
Q ss_pred CCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEc----
Q 012762 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDC---- 157 (457)
Q Consensus 82 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~---- 157 (457)
++|++++.||+|+||+||+|++. .+++.||||++... ......+.+|+++++.++||||+++++++..
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~----~~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 77 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNA----LDSRYYAIKKIRHT----EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNF 77 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEET----TTCCEEEEEEEEEE----HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCC
T ss_pred ccchhhheeccCCcEEEEEEEEc----CCCeEEEEEEEecc----HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcch
Confidence 47999999999999999999976 47889999999653 2345677889999999999999999998854
Q ss_pred ---------CCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEE
Q 012762 158 ---------PRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIM 228 (457)
Q Consensus 158 ---------~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vk 228 (457)
.+..|+||||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+|
T Consensus 78 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~k 156 (303)
T 1zy4_A 78 VKPMTAVKKKSTLFIQMEYCENGTLYDLIHSE-NLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVK 156 (303)
T ss_dssp CC------CEEEEEEEEECCCSCBHHHHHHHS-CGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEE
T ss_pred hhhhcccccCCceEEEEecCCCCCHHHhhhcc-ccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEE
Confidence 35689999999999999999864 35688899999999999999999999999999999999999999999
Q ss_pred EeccCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccc
Q 012762 229 LTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVA 308 (457)
Q Consensus 229 l~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (457)
|+|||++.................
T Consensus 157 l~dfg~~~~~~~~~~~~~~~~~~~-------------------------------------------------------- 180 (303)
T 1zy4_A 157 IGDFGLAKNVHRSLDILKLDSQNL-------------------------------------------------------- 180 (303)
T ss_dssp ECCCCCCSCTTC--------------------------------------------------------------------
T ss_pred EeeCcchhhcccccchhccccccc--------------------------------------------------------
Confidence 999999876543211100000000
Q ss_pred cCCccccccccCCCCccCchhhcCC-CCCccchhhhhhHHHHHHhcCCCCCCCCCh-HHHHHHHHhcccCCCC--CCCCC
Q 012762 309 EPLDVRSMSFVGTHEYLAPEIISGE-GHGNAVDWWTLGIFIFELFYGTTPFKGIDH-ELTLANVVARALEFPK--EPSVP 384 (457)
Q Consensus 309 ~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDiwSlG~il~elltG~~Pf~~~~~-~~~~~~~~~~~~~~~~--~~~~~ 384 (457)
...........||+.|+|||++.+. .++.++|||||||++|+|++ ||..... ......+......++. ....+
T Consensus 181 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (303)
T 1zy4_A 181 PGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILKKLRSVSIEFPPDFDDNKM 257 (303)
T ss_dssp -------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHHHSTTCCCCTTCCTTTS
T ss_pred cccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHHHhccccccccCccccccch
Confidence 0000111234699999999999875 58999999999999999998 5553322 2334444433333332 23466
Q ss_pred hHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCCCCchh
Q 012762 385 GPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGVNWAL 425 (457)
Q Consensus 385 ~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~~~~~~ 425 (457)
..+.++|.+||..||.+||+ +.++++||||+...+..
T Consensus 258 ~~~~~li~~~l~~dp~~Rps----~~~ll~h~~~~~~~~~~ 294 (303)
T 1zy4_A 258 KVEKKIIRLLIDHDPNKRPG----ARTLLNSGWLPVKHQDE 294 (303)
T ss_dssp HHHHHHHHHHTCSSGGGSCC----HHHHHHSSCSCCCCHHH
T ss_pred HHHHHHHHHHHhcCcccCcC----HHHHhCCCCcCCCChHH
Confidence 77999999999999999999 99999999999877653
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-47 Score=370.13 Aligned_cols=257 Identities=24% Similarity=0.346 Sum_probs=214.3
Q ss_pred CccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhh---hHHHHHHHHHHHHHHcC--CCCCceEE
Q 012762 78 PLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSR---NKESRARIEREILEMLD--HPFLPTLY 152 (457)
Q Consensus 78 ~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~---~~~~~~~~E~~il~~l~--H~nIv~l~ 152 (457)
....++|++.+.||+|+||+||+|.+. .+++.||||++........ .....+.+|+++++++. |+||++++
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~ 114 (320)
T 3a99_A 39 EPLESQYQVGPLLGSGGFGSVYSGIRV----SDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLL 114 (320)
T ss_dssp -CCTTTEEEEEECSSSSSCEEEEEEET----TTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEE
T ss_pred CCccCceEEEEEEeeCCCeEEEEEEEC----CCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEE
Confidence 345678999999999999999999876 4789999999977643221 12244567999999996 59999999
Q ss_pred EEEEcCCcEEEEEeecCC-CChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEc-cCCCEEEe
Q 012762 153 ATLDCPRWSCLLTEFCPG-GDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVR-SDGHIMLT 230 (457)
Q Consensus 153 ~~~~~~~~~~lV~E~~~~-~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~-~~~~vkl~ 230 (457)
+++...+..++|||++.+ ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+
T Consensus 115 ~~~~~~~~~~lv~e~~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~ 192 (320)
T 3a99_A 115 DWFERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLI 192 (320)
T ss_dssp EEEECSSEEEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEEC
T ss_pred EEEecCCcEEEEEEcCCCCccHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEe
Confidence 999999999999999976 8999988774 6799999999999999999999999999999999999999 67899999
Q ss_pred ccCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccC
Q 012762 231 DFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEP 310 (457)
Q Consensus 231 DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (457)
|||++.......
T Consensus 193 Dfg~~~~~~~~~-------------------------------------------------------------------- 204 (320)
T 3a99_A 193 DFGSGALLKDTV-------------------------------------------------------------------- 204 (320)
T ss_dssp CCTTCEECCSSC--------------------------------------------------------------------
T ss_pred eCcccccccccc--------------------------------------------------------------------
Confidence 999976543211
Q ss_pred CccccccccCCCCccCchhhcCCCC-CccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHH
Q 012762 311 LDVRSMSFVGTHEYLAPEIISGEGH-GNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKD 389 (457)
Q Consensus 311 ~~~~~~~~~gt~~y~aPE~l~~~~~-~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (457)
.....||+.|+|||++.+..+ +.++|||||||++|||++|+.||.... .+......++ ..++.++.+
T Consensus 205 ----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~~~~~~~~~~--~~~~~~~~~ 272 (320)
T 3a99_A 205 ----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFR--QRVSSECQH 272 (320)
T ss_dssp ----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCCCCS--SCCCHHHHH
T ss_pred ----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------hhhccccccc--ccCCHHHHH
Confidence 012359999999999987775 788999999999999999999997532 2233333333 458999999
Q ss_pred HHHHHhhhCCCCCCCCCcChHHHhcCCCCCCCCch
Q 012762 390 LIAQLLVKDPTRRMGSKMGATAIKRHQFFNGVNWA 424 (457)
Q Consensus 390 ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~~~~~ 424 (457)
||.+||..||++||+ +.+|++||||+.+.+.
T Consensus 273 li~~~l~~dp~~Rps----~~~ll~hp~~~~~~~~ 303 (320)
T 3a99_A 273 LIRWCLALRPSDRPT----FEEIQNHPWMQDVLLP 303 (320)
T ss_dssp HHHHHTCSSGGGSCC----HHHHHTSGGGSSCCCH
T ss_pred HHHHHccCChhhCcC----HHHHhcCHhhcCccCc
Confidence 999999999999999 9999999999987664
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-46 Score=356.66 Aligned_cols=253 Identities=21% Similarity=0.337 Sum_probs=208.9
Q ss_pred CccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhH----HHHHHHHHHHHHHcCCCCCceEEE
Q 012762 78 PLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNK----ESRARIEREILEMLDHPFLPTLYA 153 (457)
Q Consensus 78 ~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~----~~~~~~E~~il~~l~H~nIv~l~~ 153 (457)
.+..++|++.+.||+|+||+||+|+++ .+++.||+|++.......... ...+.+|+++++.++||||+++++
T Consensus 15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~----~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~ 90 (287)
T 4f0f_A 15 TLADNEIEYEKQIGKGGFGLVHKGRLV----KDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYG 90 (287)
T ss_dssp BCCSTTEEEEEECCCCSSSCEEEEEET----TTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred hhhhccceehhccccCCceeEEEEEEc----CCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhhe
Confidence 355678999999999999999999986 478899999986543322211 167888999999999999999999
Q ss_pred EEEcCCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcC--ceeecCCCCCeEEccCCC-----
Q 012762 154 TLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMG--IIYRDLKPENVLVRSDGH----- 226 (457)
Q Consensus 154 ~~~~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~--iiHrDIKp~NIll~~~~~----- 226 (457)
++.+.. ++||||+++++|.+++... ...+++..++.++.||+.||.|||+.| |+||||||+|||++.++.
T Consensus 91 ~~~~~~--~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~ 167 (287)
T 4f0f_A 91 LMHNPP--RMVMEFVPCGDLYHRLLDK-AHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVC 167 (287)
T ss_dssp EETTTT--EEEEECCTTCBHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCC
T ss_pred eecCCC--eEEEEecCCCCHHHHHhcc-cCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCcee
Confidence 997655 6999999999998877654 357999999999999999999999999 999999999999988776
Q ss_pred EEEeccCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcc
Q 012762 227 IMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEI 306 (457)
Q Consensus 227 vkl~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (457)
+||+|||+++.....
T Consensus 168 ~kl~Dfg~~~~~~~~----------------------------------------------------------------- 182 (287)
T 4f0f_A 168 AKVADFGLSQQSVHS----------------------------------------------------------------- 182 (287)
T ss_dssp EEECCCTTCBCCSSC-----------------------------------------------------------------
T ss_pred EEeCCCCcccccccc-----------------------------------------------------------------
Confidence 999999997533211
Q ss_pred cccCCccccccccCCCCccCchhhc--CCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHH--HHHHHhcccCCCCCCC
Q 012762 307 VAEPLDVRSMSFVGTHEYLAPEIIS--GEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELT--LANVVARALEFPKEPS 382 (457)
Q Consensus 307 ~~~~~~~~~~~~~gt~~y~aPE~l~--~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~--~~~~~~~~~~~~~~~~ 382 (457)
.....||+.|+|||++. +..++.++|||||||++|+|++|+.||........ ...+............
T Consensus 183 --------~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (287)
T 4f0f_A 183 --------VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPED 254 (287)
T ss_dssp --------EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCCCCCCTT
T ss_pred --------ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCCCCCCcc
Confidence 11246999999999994 44578999999999999999999999987654333 4444455555555567
Q ss_pred CChHHHHHHHHHhhhCCCCCCCCCcChHHHhc
Q 012762 383 VPGPAKDLIAQLLVKDPTRRMGSKMGATAIKR 414 (457)
Q Consensus 383 ~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~ 414 (457)
+++++.+||.+||+.||++||+ +.++++
T Consensus 255 ~~~~l~~li~~~l~~dp~~Rps----~~~ll~ 282 (287)
T 4f0f_A 255 CPPRLRNVIELCWSGDPKKRPH----FSYIVK 282 (287)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCC----HHHHHH
T ss_pred cCHHHHHHHHHHhcCChhhCcC----HHHHHH
Confidence 8999999999999999999999 888875
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=360.37 Aligned_cols=259 Identities=24% Similarity=0.345 Sum_probs=205.3
Q ss_pred ccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcC
Q 012762 79 LTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCP 158 (457)
Q Consensus 79 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~ 158 (457)
...++|++.+.||+|+||.||+|.+. .+|+.||+|++.............+.+|+++++.++||||+++++++...
T Consensus 29 ~~~~~y~~~~~lg~G~~g~Vy~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 104 (310)
T 2wqm_A 29 NTLANFRIEKKIGRGQFSEVYRAACL----LDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIED 104 (310)
T ss_dssp SSGGGEEEEEEEECC--CEEEEEEET----TTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEET
T ss_pred ccccceEEEEeecCCCCceEEEEEEc----CCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC
Confidence 45578999999999999999999976 37889999999865444445667788899999999999999999999999
Q ss_pred CcEEEEEeecCCCChHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCc
Q 012762 159 RWSCLLTEFCPGGDLHVLRQRQ--PDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSL 236 (457)
Q Consensus 159 ~~~~lV~E~~~~~sL~~~~~~~--~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~ 236 (457)
+..++||||+++++|.+++... ....+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.
T Consensus 105 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~ 184 (310)
T 2wqm_A 105 NELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGR 184 (310)
T ss_dssp TEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC----
T ss_pred CcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEecccee
Confidence 9999999999999999888652 24668999999999999999999999999999999999999999999999999976
Q ss_pred CCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccc
Q 012762 237 KGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSM 316 (457)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (457)
....... ...
T Consensus 185 ~~~~~~~----------------------------------------------------------------------~~~ 194 (310)
T 2wqm_A 185 FFSSKTT----------------------------------------------------------------------AAH 194 (310)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred eecCCCc----------------------------------------------------------------------ccc
Confidence 4432110 011
Q ss_pred cccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCCh--HHHHHHHHhcccCCCCCCCCChHHHHHHHHH
Q 012762 317 SFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDH--ELTLANVVARALEFPKEPSVPGPAKDLIAQL 394 (457)
Q Consensus 317 ~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~ 394 (457)
...||+.|+|||++.+..++.++|||||||++|+|++|..||.+... ......+............++.++.+||.+|
T Consensus 195 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 274 (310)
T 2wqm_A 195 SLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMC 274 (310)
T ss_dssp ----CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTSCHHHHHHHHHH
T ss_pred ccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcccccCHHHHHHHHHH
Confidence 23589999999999999999999999999999999999999976532 2333334333333333356889999999999
Q ss_pred hhhCCCCCCCCCcChHHHhcC
Q 012762 395 LVKDPTRRMGSKMGATAIKRH 415 (457)
Q Consensus 395 L~~dP~~Rps~~~~~~~ll~h 415 (457)
|..||.+||+ +.+++++
T Consensus 275 l~~dp~~Rps----~~~il~~ 291 (310)
T 2wqm_A 275 INPDPEKRPD----VTYVYDV 291 (310)
T ss_dssp TCSSGGGSCC----HHHHHHH
T ss_pred cCCChhhCCC----HHHHHHH
Confidence 9999999999 8888764
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-46 Score=354.31 Aligned_cols=256 Identities=23% Similarity=0.312 Sum_probs=216.9
Q ss_pred CCCccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEE
Q 012762 76 NNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATL 155 (457)
Q Consensus 76 ~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~ 155 (457)
.+.+..++|++.+.||+|+||+||+|.+. ++..||+|++..... ....+.+|+++++.++||||+++++++
T Consensus 2 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~ 72 (267)
T 3t9t_A 2 KWVIDPSELTFVQEIGSGQFGLVHLGYWL-----NKDKVAIKTIREGAM----SEEDFIEEAEVMMKLSHPKLVQLYGVC 72 (267)
T ss_dssp -CBCCGGGEEEEEEEEEETTEEEEEEEET-----TTEEEEEEEECTTTB----CHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred ceEEchhheeeeeEecCCCceeEEEEEec-----CCCeEEEEEccccCC----CHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 35677789999999999999999999875 567899999976532 335678899999999999999999999
Q ss_pred EcCCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCC
Q 012762 156 DCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235 (457)
Q Consensus 156 ~~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s 235 (457)
...+..|+||||+++++|.+++... ...+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++
T Consensus 73 ~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~ 151 (267)
T 3t9t_A 73 LEQAPICLVTEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMT 151 (267)
T ss_dssp CSSSSCEEEECCCTTCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGG
T ss_pred ccCCCeEEEEeCCCCCcHHHHHhhC-cccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEcccccc
Confidence 9999999999999999999998764 356899999999999999999999999999999999999999999999999997
Q ss_pred cCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcccc
Q 012762 236 LKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRS 315 (457)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (457)
......... ..
T Consensus 152 ~~~~~~~~~---------------------------------------------------------------------~~ 162 (267)
T 3t9t_A 152 RFVLDDQYT---------------------------------------------------------------------SS 162 (267)
T ss_dssp GGBCCHHHH---------------------------------------------------------------------ST
T ss_pred ccccccccc---------------------------------------------------------------------cc
Confidence 644321100 00
Q ss_pred ccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHH
Q 012762 316 MSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQL 394 (457)
Q Consensus 316 ~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~ 394 (457)
....|+..|+|||++.+..++.++|||||||++|+|++ |..||...........+... ........++..+.+++.+|
T Consensus 163 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~-~~~~~~~~~~~~l~~li~~~ 241 (267)
T 3t9t_A 163 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG-FRLYKPRLASTHVYQIMNHC 241 (267)
T ss_dssp TSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT-CCCCCCTTSCHHHHHHHHHH
T ss_pred ccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcC-CcCCCCccCcHHHHHHHHHH
Confidence 12247889999999998899999999999999999999 99999988777666665544 33334456889999999999
Q ss_pred hhhCCCCCCCCCcChHHHhcC
Q 012762 395 LVKDPTRRMGSKMGATAIKRH 415 (457)
Q Consensus 395 L~~dP~~Rps~~~~~~~ll~h 415 (457)
|..||++||+ +.+++++
T Consensus 242 l~~~p~~Rps----~~~ll~~ 258 (267)
T 3t9t_A 242 WRERPEDRPA----FSRLLRQ 258 (267)
T ss_dssp TCSSGGGSCC----HHHHHHH
T ss_pred ccCChhhCcC----HHHHHHH
Confidence 9999999999 8888764
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=369.50 Aligned_cols=256 Identities=21% Similarity=0.255 Sum_probs=201.6
Q ss_pred CCCCCccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEE
Q 012762 74 NNNNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYA 153 (457)
Q Consensus 74 ~~~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~ 153 (457)
..+..+..++|++.++||+|+||+||+|++ .++.||||++.... ........|+.+|+.++||||+++++
T Consensus 16 ~~n~~~~~~~y~~~~~lg~G~~g~Vy~~~~------~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~hpniv~~~~ 85 (322)
T 3soc_A 16 TENLYFQSMPLQLLEVKARGRFGCVWKAQL------LNEYVAVKIFPIQD----KQSWQNEYEVYSLPGMKHENILQFIG 85 (322)
T ss_dssp CCCEEETTEEEEEEEEEECSTTCEEEEEEE------TTEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEE
T ss_pred ccccccchhhchhhheecccCceEEEEEEE------CCCEEEEEEeecCc----hHHHHHHHHHHHHhcCCCCCchhhcc
Confidence 355668888999999999999999999986 36899999997543 23344556888899999999999999
Q ss_pred EEEcCC----cEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHc----------CceeecCCCCCe
Q 012762 154 TLDCPR----WSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMM----------GIIYRDLKPENV 219 (457)
Q Consensus 154 ~~~~~~----~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~----------~iiHrDIKp~NI 219 (457)
++.... .+|+||||+++|+|.++++. ..+++..++.++.||+.||.|||+. ||+||||||+||
T Consensus 86 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Ni 162 (322)
T 3soc_A 86 AEKRGTSVDVDLWLITAFHEKGSLSDFLKA---NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNV 162 (322)
T ss_dssp EEEEECSSSEEEEEEEECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGE
T ss_pred eeccCCCCCceEEEEEecCCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhE
Confidence 998754 36999999999999999987 4599999999999999999999999 999999999999
Q ss_pred EEccCCCEEEeccCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCC
Q 012762 220 LVRSDGHIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLG 299 (457)
Q Consensus 220 ll~~~~~vkl~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (457)
|++.++.+||+|||+++........
T Consensus 163 ll~~~~~~kL~DFg~a~~~~~~~~~------------------------------------------------------- 187 (322)
T 3soc_A 163 LLKNNLTACIADFGLALKFEAGKSA------------------------------------------------------- 187 (322)
T ss_dssp EECTTCCEEECCCTTCEEECTTSCC-------------------------------------------------------
T ss_pred EECCCCeEEEccCCcccccccccCc-------------------------------------------------------
Confidence 9999999999999998654321110
Q ss_pred CCCCCcccccCCccccccccCCCCccCchhhcCC-----CCCccchhhhhhHHHHHHhcCCCCCCCCCh-----------
Q 012762 300 NPGTPEIVAEPLDVRSMSFVGTHEYLAPEIISGE-----GHGNAVDWWTLGIFIFELFYGTTPFKGIDH----------- 363 (457)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-----~~~~~sDiwSlG~il~elltG~~Pf~~~~~----------- 363 (457)
......+||+.|+|||++.+. .++.++|||||||++|||++|+.||.+...
T Consensus 188 -------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~ 254 (322)
T 3soc_A 188 -------------GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIG 254 (322)
T ss_dssp -------------CCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHC
T ss_pred -------------cccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhc
Confidence 001124699999999999874 356789999999999999999999976432
Q ss_pred -----HHHHHHHHhcccCCCCCC-----CCChHHHHHHHHHhhhCCCCCCCCCcChHHHhc
Q 012762 364 -----ELTLANVVARALEFPKEP-----SVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKR 414 (457)
Q Consensus 364 -----~~~~~~~~~~~~~~~~~~-----~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~ 414 (457)
......+........... ..+.++.+||.+||+.||++||+ +.+|++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps----~~ell~ 311 (322)
T 3soc_A 255 QHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLS----AGCVGE 311 (322)
T ss_dssp SSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCC----HHHHHH
T ss_pred cCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcC----HHHHHH
Confidence 111222222221111111 11234999999999999999999 888875
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-46 Score=360.87 Aligned_cols=255 Identities=23% Similarity=0.323 Sum_probs=204.7
Q ss_pred cCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCC
Q 012762 80 TLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPR 159 (457)
Q Consensus 80 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~ 159 (457)
..++|++.+.||+|+||+||+|++. .+++.||+|++.............+.+|+++++.++||||+++++++..++
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~----~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~ 107 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDT----VRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDG 107 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEET----TTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEc----CCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCC
Confidence 4578999999999999999999976 478899999998765544455677889999999999999999999999999
Q ss_pred cEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCC
Q 012762 160 WSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGD 239 (457)
Q Consensus 160 ~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~ 239 (457)
..|+||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 108 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 185 (309)
T 2h34_A 108 QLYVDMRLINGVDLAAMLRRQ--GPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATT 185 (309)
T ss_dssp EEEEEEECCCCEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC-----
T ss_pred eEEEEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCcccc
Confidence 999999999999999998875 569999999999999999999999999999999999999999999999999975443
Q ss_pred CCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcccccccc
Q 012762 240 NSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFV 319 (457)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (457)
..... ......
T Consensus 186 ~~~~~---------------------------------------------------------------------~~~~~~ 196 (309)
T 2h34_A 186 DEKLT---------------------------------------------------------------------QLGNTV 196 (309)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred ccccc---------------------------------------------------------------------cccccC
Confidence 21100 011235
Q ss_pred CCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCC--CCCCCChHHHHHHHHHhhh
Q 012762 320 GTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFP--KEPSVPGPAKDLIAQLLVK 397 (457)
Q Consensus 320 gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ll~~~L~~ 397 (457)
||+.|+|||++.+..++.++|||||||++|+|++|+.||.+..... +...+......+ ....++.++.++|.+||..
T Consensus 197 ~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 275 (309)
T 2h34_A 197 GTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSV-MGAHINQAIPRPSTVRPGIPVAFDAVIARGMAK 275 (309)
T ss_dssp CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHH-HHHHHHSCCCCGGGTSTTCCTHHHHHHHHHTCS
T ss_pred CCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHH-HHHHhccCCCCccccCCCCCHHHHHHHHHhccC
Confidence 8999999999999899999999999999999999999998865543 333333332222 2346889999999999999
Q ss_pred CCCCCC-CCCcChHHHhc
Q 012762 398 DPTRRM-GSKMGATAIKR 414 (457)
Q Consensus 398 dP~~Rp-s~~~~~~~ll~ 414 (457)
||++|| + ++++++
T Consensus 276 dP~~Rp~s----~~~l~~ 289 (309)
T 2h34_A 276 NPEDRYVT----CGDLSA 289 (309)
T ss_dssp SGGGSCSS----HHHHHH
T ss_pred CHHHHHHh----HHHHHH
Confidence 999999 6 666654
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-46 Score=362.87 Aligned_cols=263 Identities=23% Similarity=0.342 Sum_probs=212.7
Q ss_pred CCccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcC--CCCCceEEEE
Q 012762 77 NPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLD--HPFLPTLYAT 154 (457)
Q Consensus 77 ~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~--H~nIv~l~~~ 154 (457)
..+..++|++++.||+|+||+||+|.+. +++.||+|++..... .......+.+|+++++.++ |+||++++++
T Consensus 23 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~ 96 (313)
T 3cek_A 23 MSVKGRIYSILKQIGSGGSSKVFQVLNE-----KKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDY 96 (313)
T ss_dssp EEETTEEEEEEEEEECCSSEEEEEEECT-----TCCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHHGGGCTTBCCEEEE
T ss_pred eeeccceEEEEEEecCCCCEEEEEEEcC-----CCcEEEEEEeccccc-cccchHHHHHHHHHHHhccccCCceEEEEEE
Confidence 3445568999999999999999999864 578899999975432 2334567888999999997 5999999999
Q ss_pred EEcCCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCC
Q 012762 155 LDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDL 234 (457)
Q Consensus 155 ~~~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~ 234 (457)
+...+..|+|||+ .+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+
T Consensus 97 ~~~~~~~~lv~e~-~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~ 172 (313)
T 3cek_A 97 EITDQYIYMVMEC-GNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGI 172 (313)
T ss_dssp EECSSEEEEEECC-CSEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSS
T ss_pred eecCCEEEEEEec-CCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeeccc
Confidence 9999999999995 589999998875 5789999999999999999999999999999999999995 58999999999
Q ss_pred CcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccc
Q 012762 235 SLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVR 314 (457)
Q Consensus 235 s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (457)
+.......... .
T Consensus 173 ~~~~~~~~~~~--------------------------------------------------------------------~ 184 (313)
T 3cek_A 173 ANQMQPDTTSV--------------------------------------------------------------------V 184 (313)
T ss_dssp SCC-----------------------------------------------------------------------------
T ss_pred cccccCccccc--------------------------------------------------------------------c
Confidence 86543211100 0
Q ss_pred cccccCCCCccCchhhcC-----------CCCCccchhhhhhHHHHHHhcCCCCCCCCChH-HHHHHHHhcccCCCCCCC
Q 012762 315 SMSFVGTHEYLAPEIISG-----------EGHGNAVDWWTLGIFIFELFYGTTPFKGIDHE-LTLANVVARALEFPKEPS 382 (457)
Q Consensus 315 ~~~~~gt~~y~aPE~l~~-----------~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~ 382 (457)
.....||+.|+|||++.+ ..++.++|||||||++|+|++|..||...... .....++...........
T Consensus 185 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (313)
T 3cek_A 185 KDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDI 264 (313)
T ss_dssp -----CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCCCCC
T ss_pred ccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhcccccCCccc
Confidence 112359999999999976 46888999999999999999999999876443 344444544444444455
Q ss_pred CChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCCC
Q 012762 383 VPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGV 421 (457)
Q Consensus 383 ~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~~ 421 (457)
.+.++.++|.+||..||.+||+ +.|+++||||+..
T Consensus 265 ~~~~l~~li~~~l~~dp~~Rps----~~ell~h~~~~~~ 299 (313)
T 3cek_A 265 PEKDLQDVLKCCLKRDPKQRIS----IPELLAHPYVQIQ 299 (313)
T ss_dssp SCHHHHHHHHHHTCSSTTTSCC----HHHHHTSHHHHCC
T ss_pred chHHHHHHHHHHccCCcccCcC----HHHHhcCccccCC
Confidence 7889999999999999999999 9999999999853
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-46 Score=360.13 Aligned_cols=264 Identities=22% Similarity=0.330 Sum_probs=212.5
Q ss_pred CccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEc
Q 012762 78 PLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDC 157 (457)
Q Consensus 78 ~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~ 157 (457)
.+..++|++.+.||+|+||+||+|.+.... ..+..||+|++.............+.+|+++++.++||||+++++++..
T Consensus 14 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 92 (291)
T 1u46_A 14 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPS-GKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT 92 (291)
T ss_dssp ECCGGGEEEEEECC----CCCEEEEEECTT-SCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ccchhHeeeeeeecCCCceeEEEEEeccCC-CceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcc
Confidence 455678999999999999999999875321 2344799999987654445566788899999999999999999999987
Q ss_pred CCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcC
Q 012762 158 PRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLK 237 (457)
Q Consensus 158 ~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~ 237 (457)
+. .++||||+.+++|.+++... ...+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++..
T Consensus 93 ~~-~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 170 (291)
T 1u46_A 93 PP-MKMVTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRA 170 (291)
T ss_dssp SS-CEEEEECCTTCBHHHHHHHH-GGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred CC-ceeeEecccCCCHHHHHHhc-cCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEcccccccc
Confidence 65 88999999999999888764 25689999999999999999999999999999999999999999999999999865
Q ss_pred CCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcccccc
Q 012762 238 GDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMS 317 (457)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (457)
......... ....
T Consensus 171 ~~~~~~~~~-------------------------------------------------------------------~~~~ 183 (291)
T 1u46_A 171 LPQNDDHYV-------------------------------------------------------------------MQEH 183 (291)
T ss_dssp CCC-CCEEE-------------------------------------------------------------------C---
T ss_pred ccccccchh-------------------------------------------------------------------hhcc
Confidence 532211100 0012
Q ss_pred ccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhh
Q 012762 318 FVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLV 396 (457)
Q Consensus 318 ~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~ 396 (457)
..||..|+|||++.+..++.++|||||||++|+|++ |+.||.+.........+.......+....++.++.++|.+||.
T Consensus 184 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 263 (291)
T 1u46_A 184 RKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWA 263 (291)
T ss_dssp --CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTC
T ss_pred CCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCCCcCcCHHHHHHHHHHcc
Confidence 347889999999998889999999999999999999 9999999888888887777766677777899999999999999
Q ss_pred hCCCCCCCCCcChHHHhcC
Q 012762 397 KDPTRRMGSKMGATAIKRH 415 (457)
Q Consensus 397 ~dP~~Rps~~~~~~~ll~h 415 (457)
.||++||+ +.+++++
T Consensus 264 ~~p~~Rps----~~~l~~~ 278 (291)
T 1u46_A 264 HKPEDRPT----FVALRDF 278 (291)
T ss_dssp SSGGGSCC----HHHHHHH
T ss_pred CCcccCcC----HHHHHHH
Confidence 99999999 8988874
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-46 Score=366.49 Aligned_cols=273 Identities=22% Similarity=0.337 Sum_probs=218.7
Q ss_pred CCCccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEE
Q 012762 76 NNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATL 155 (457)
Q Consensus 76 ~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~ 155 (457)
...+..++|++++.||+|+||+||+|+++..+..+++.||+|++.... ......+.+|+++|++++|+||+++++++
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 93 (327)
T 3lxl_A 17 PTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG---PDQQRDFQREIQILKALHSDFIVKYRGVS 93 (327)
T ss_dssp CCBCCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCC---HHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred hhhhchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCC---HHHHHHHHHHHHHHHhcCCCceeEEEEEE
Confidence 445677899999999999999999999766566789999999997542 23456688899999999999999999988
Q ss_pred E--cCCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccC
Q 012762 156 D--CPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFD 233 (457)
Q Consensus 156 ~--~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG 233 (457)
. ..+..|+||||+++++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 94 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg 172 (327)
T 3lxl_A 94 YGPGRQSLRLVMEYLPSGCLRDFLQRHR-ARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFG 172 (327)
T ss_dssp ECSSSCEEEEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGG
T ss_pred ecCCCceEEEEEeecCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccc
Confidence 6 4567899999999999999987642 469999999999999999999999999999999999999999999999999
Q ss_pred CCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcc
Q 012762 234 LSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDV 313 (457)
Q Consensus 234 ~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (457)
++...........
T Consensus 173 ~~~~~~~~~~~~~------------------------------------------------------------------- 185 (327)
T 3lxl_A 173 LAKLLPLDKDYYV------------------------------------------------------------------- 185 (327)
T ss_dssp GCEECCTTCSEEE-------------------------------------------------------------------
T ss_pred cceecccCCccce-------------------------------------------------------------------
Confidence 9865532211100
Q ss_pred ccccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChH--------------HHHHHHHhcccCCCC
Q 012762 314 RSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHE--------------LTLANVVARALEFPK 379 (457)
Q Consensus 314 ~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~--------------~~~~~~~~~~~~~~~ 379 (457)
......||..|+|||++.+..++.++|||||||++|+|++|..||...... ......+......+.
T Consensus 186 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (327)
T 3lxl_A 186 VREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQRLPA 265 (327)
T ss_dssp CSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHHTTCCCCC
T ss_pred eeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhhcccCCCC
Confidence 011235889999999999998999999999999999999999998653321 223334444555566
Q ss_pred CCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhc---CCCCCCCCc
Q 012762 380 EPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKR---HQFFNGVNW 423 (457)
Q Consensus 380 ~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~---hp~f~~~~~ 423 (457)
...+++++.+||.+||..||++||+ +.+|++ ..|.....|
T Consensus 266 ~~~~~~~l~~li~~~l~~dP~~Rps----~~ell~~L~~~~~~~~~~ 308 (327)
T 3lxl_A 266 PPACPAEVHELMKLCWAPSPQDRPS----FSALGPQLDMLWSGSRGC 308 (327)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCC----HHHHHHHHHHC-------
T ss_pred CCcccHHHHHHHHHHcCCChhhCcC----HHHHHHHHHHHHhhhcCc
Confidence 6679999999999999999999999 888854 344444333
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=353.89 Aligned_cols=261 Identities=21% Similarity=0.304 Sum_probs=215.1
Q ss_pred CCCccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEE
Q 012762 76 NNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATL 155 (457)
Q Consensus 76 ~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~ 155 (457)
...+..++|++.+.||+|+||+||+|.+.... ..+..||+|++.+.. .......+.+|+++++.++||||+++++++
T Consensus 6 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 82 (281)
T 3cc6_A 6 QYGIAREDVVLNRILGEGFFGEVYEGVYTNHK-GEKINVAVKTCKKDC--TLDNKEKFMSEAVIMKNLDHPHIVKLIGII 82 (281)
T ss_dssp CCSCCGGGEEEEEEEEECSSSEEEEEEEECTT-CCEEEEEEEECCTTS--CHHHHHHHHHHHHHHHHHCCTTBCCEEEEE
T ss_pred cceecccceEEEEEEEecCCeeEEEeEEcCCC-CCcceEEEEeccccc--CchHHHHHHHHHHHHHhCCCCCcceEEEEE
Confidence 45667789999999999999999999876422 245679999997642 233456788899999999999999999998
Q ss_pred EcCCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCC
Q 012762 156 DCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235 (457)
Q Consensus 156 ~~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s 235 (457)
..+ ..|+||||+++++|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 83 ~~~-~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 160 (281)
T 3cc6_A 83 EEE-PTWIIMELYPYGELGHYLERN-KNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLS 160 (281)
T ss_dssp CSS-SCEEEEECCTTCBHHHHHHHH-TTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGG
T ss_pred cCC-CCEEEEecCCCCCHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCC
Confidence 754 568999999999999998764 256899999999999999999999999999999999999999999999999998
Q ss_pred cCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcccc
Q 012762 236 LKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRS 315 (457)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (457)
......... ..
T Consensus 161 ~~~~~~~~~---------------------------------------------------------------------~~ 171 (281)
T 3cc6_A 161 RYIEDEDYY---------------------------------------------------------------------KA 171 (281)
T ss_dssp GCC-----------------------------------------------------------------------------
T ss_pred ccccccccc---------------------------------------------------------------------cc
Confidence 654321110 00
Q ss_pred ccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHH
Q 012762 316 MSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQL 394 (457)
Q Consensus 316 ~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~ 394 (457)
....||+.|+|||++.+..++.++|||||||++|+|++ |+.||...........+... ...+....+++.+.++|.+|
T Consensus 172 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~ 250 (281)
T 3cc6_A 172 SVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKG-DRLPKPDLCPPVLYTLMTRC 250 (281)
T ss_dssp -CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHT-CCCCCCTTCCHHHHHHHHHH
T ss_pred ccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcC-CCCCCCCCCCHHHHHHHHHH
Confidence 11247889999999998999999999999999999998 99999887766655554433 34455556899999999999
Q ss_pred hhhCCCCCCCCCcChHHHhcC
Q 012762 395 LVKDPTRRMGSKMGATAIKRH 415 (457)
Q Consensus 395 L~~dP~~Rps~~~~~~~ll~h 415 (457)
|..||++||+ +.+++++
T Consensus 251 l~~~p~~Rps----~~ell~~ 267 (281)
T 3cc6_A 251 WDYDPSDRPR----FTELVCS 267 (281)
T ss_dssp TCSSGGGSCC----HHHHHHH
T ss_pred ccCCchhCcC----HHHHHHH
Confidence 9999999999 8888765
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-46 Score=362.82 Aligned_cols=260 Identities=20% Similarity=0.280 Sum_probs=213.1
Q ss_pred ccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcC
Q 012762 79 LTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCP 158 (457)
Q Consensus 79 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~ 158 (457)
+....|+++++||+|+||+||+|.++..+..+++.||||++... ........+.+|+++|+.++||||+++++++...
T Consensus 28 ~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 105 (318)
T 3lxp_A 28 FHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD--AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDA 105 (318)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT--CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred ecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc--cChHHHHHHHHHHHHHHhCCCcchhhEEEEEecC
Confidence 33334599999999999999999887777778999999999764 2234456788899999999999999999999874
Q ss_pred --CcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCc
Q 012762 159 --RWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSL 236 (457)
Q Consensus 159 --~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~ 236 (457)
..+|+||||+++++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 106 ~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~ 182 (318)
T 3lxp_A 106 GAASLQLVMEYVPLGSLRDYLPR---HSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAK 182 (318)
T ss_dssp TTTEEEEEECCCTTCBHHHHGGG---SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCE
T ss_pred CCceEEEEEecccCCcHHHHHhh---CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCccccc
Confidence 578999999999999999876 459999999999999999999999999999999999999999999999999986
Q ss_pred CCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccc
Q 012762 237 KGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSM 316 (457)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (457)
.......... ...
T Consensus 183 ~~~~~~~~~~-------------------------------------------------------------------~~~ 195 (318)
T 3lxp_A 183 AVPEGHEYYR-------------------------------------------------------------------VRE 195 (318)
T ss_dssp ECCTTCSEEE-------------------------------------------------------------------C--
T ss_pred cccccccccc-------------------------------------------------------------------ccc
Confidence 5542211100 011
Q ss_pred cccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChH--------------HHHHHHHhcccCCCCCCC
Q 012762 317 SFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHE--------------LTLANVVARALEFPKEPS 382 (457)
Q Consensus 317 ~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~--------------~~~~~~~~~~~~~~~~~~ 382 (457)
...||..|+|||++.+..++.++|||||||++|+|++|..||...... ......+......+....
T Consensus 196 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (318)
T 3lxp_A 196 DGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPRPDK 275 (318)
T ss_dssp -CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTTCCCCCCTT
T ss_pred CCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhcccCCCCCcc
Confidence 235888999999999988999999999999999999999999753221 123334444555566667
Q ss_pred CChHHHHHHHHHhhhCCCCCCCCCcChHHHhc
Q 012762 383 VPGPAKDLIAQLLVKDPTRRMGSKMGATAIKR 414 (457)
Q Consensus 383 ~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~ 414 (457)
++.++.+||.+||..||++||+ +.+|++
T Consensus 276 ~~~~l~~li~~~l~~dP~~Rps----~~ell~ 303 (318)
T 3lxp_A 276 CPAEVYHLMKNCWETEASFRPT----FENLIP 303 (318)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCC----HHHHHH
T ss_pred ccHHHHHHHHHHcCCCcccCcC----HHHHHH
Confidence 8999999999999999999999 888875
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=365.60 Aligned_cols=254 Identities=24% Similarity=0.364 Sum_probs=202.9
Q ss_pred cCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhh---hHHHHHHHHHHHHHHc----CCCCCceEE
Q 012762 80 TLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSR---NKESRARIEREILEML----DHPFLPTLY 152 (457)
Q Consensus 80 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~---~~~~~~~~E~~il~~l----~H~nIv~l~ 152 (457)
-.++|++.+.||+|+||+||+|+++ .+++.||||++........ .....+.+|+++++++ +|+||++++
T Consensus 29 ~~~~y~~~~~lg~G~~g~Vy~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~ 104 (312)
T 2iwi_A 29 FEAEYRLGPLLGKGGFGTVFAGHRL----TDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL 104 (312)
T ss_dssp ----CEEEEEEEEETTEEEEEEECT----TTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred hhhceEEeeEEEcCCCEEEEEEEEc----cCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence 3468999999999999999999876 4788999999976543221 1223455689999998 899999999
Q ss_pred EEEEcCCcEEEEEee-cCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEc-cCCCEEEe
Q 012762 153 ATLDCPRWSCLLTEF-CPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVR-SDGHIMLT 230 (457)
Q Consensus 153 ~~~~~~~~~~lV~E~-~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~-~~~~vkl~ 230 (457)
+++...+..++|||+ +.+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+
T Consensus 105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~ 182 (312)
T 2iwi_A 105 DWFETQEGFMLVLERPLPAQDLFDYITEK--GPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLI 182 (312)
T ss_dssp EEC-----CEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEEC
T ss_pred EEEecCCeEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEE
Confidence 999999999999999 7899999998875 5699999999999999999999999999999999999999 78999999
Q ss_pred ccCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccC
Q 012762 231 DFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEP 310 (457)
Q Consensus 231 DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (457)
|||++.......
T Consensus 183 dfg~~~~~~~~~-------------------------------------------------------------------- 194 (312)
T 2iwi_A 183 DFGSGALLHDEP-------------------------------------------------------------------- 194 (312)
T ss_dssp CCSSCEECCSSC--------------------------------------------------------------------
T ss_pred EcchhhhcccCc--------------------------------------------------------------------
Confidence 999976543211
Q ss_pred CccccccccCCCCccCchhhcCCCC-CccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHH
Q 012762 311 LDVRSMSFVGTHEYLAPEIISGEGH-GNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKD 389 (457)
Q Consensus 311 ~~~~~~~~~gt~~y~aPE~l~~~~~-~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (457)
.....||..|+|||++.+..+ +.++|||||||++|+|++|+.||.... .+......++ ..++.++.+
T Consensus 195 ----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~~~~~~~--~~~~~~~~~ 262 (312)
T 2iwi_A 195 ----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------EILEAELHFP--AHVSPDCCA 262 (312)
T ss_dssp ----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHTCCCCC--TTSCHHHHH
T ss_pred ----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------HHhhhccCCc--ccCCHHHHH
Confidence 012358999999999987766 458999999999999999999997532 2333444444 458899999
Q ss_pred HHHHHhhhCCCCCCCCCcChHHHhcCCCCCCCCc
Q 012762 390 LIAQLLVKDPTRRMGSKMGATAIKRHQFFNGVNW 423 (457)
Q Consensus 390 ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~~~~ 423 (457)
||.+||..||++||+ +.|+++||||+....
T Consensus 263 li~~~l~~~p~~Rps----~~e~l~~~~~~~~~~ 292 (312)
T 2iwi_A 263 LIRRCLAPKPSSRPS----LEEILLDPWMQTPAE 292 (312)
T ss_dssp HHHHHTCSSTTTSCC----HHHHHHSTTTCC---
T ss_pred HHHHHccCChhhCcC----HHHHhcChhhcCchh
Confidence 999999999999999 999999999997544
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-46 Score=381.68 Aligned_cols=256 Identities=23% Similarity=0.327 Sum_probs=214.5
Q ss_pred CCCCccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEE
Q 012762 75 NNNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYAT 154 (457)
Q Consensus 75 ~~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~ 154 (457)
..+.+..++|++.++||+|+||+||+|.++ .+..||||+++.... ..+.+.+|+++|++++||||++++++
T Consensus 177 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~-----~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hp~iv~~~~~ 247 (452)
T 1fmk_A 177 DAWEIPRESLRLEVKLGQGCFGEVWMGTWN-----GTTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAV 247 (452)
T ss_dssp TCSBCCGGGEEEEEEEEECSSCEEEEEEET-----TTEEEEEEECCTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccccChhHceeeeeecCCCCeEEEEEEEC-----CCceEEEEEeccCCC----CHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 456778889999999999999999999975 456799999976432 34568889999999999999999999
Q ss_pred EEcCCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCC
Q 012762 155 LDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDL 234 (457)
Q Consensus 155 ~~~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~ 234 (457)
+.. +..||||||+++|+|.+++.......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 248 ~~~-~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~ 326 (452)
T 1fmk_A 248 VSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGL 326 (452)
T ss_dssp ECS-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCT
T ss_pred EcC-CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCcc
Confidence 876 6789999999999999998764445699999999999999999999999999999999999999999999999999
Q ss_pred CcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccc
Q 012762 235 SLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVR 314 (457)
Q Consensus 235 s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (457)
++.........
T Consensus 327 a~~~~~~~~~~--------------------------------------------------------------------- 337 (452)
T 1fmk_A 327 ARLIEDNEYTA--------------------------------------------------------------------- 337 (452)
T ss_dssp TC------------------------------------------------------------------------------
T ss_pred ceecCCCceec---------------------------------------------------------------------
Confidence 86543211000
Q ss_pred cccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHH
Q 012762 315 SMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQ 393 (457)
Q Consensus 315 ~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~ 393 (457)
.....++..|+|||++.+..++.++|||||||++|||++ |+.||.+....+....+. ...+.+....++..+.+||.+
T Consensus 338 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~-~~~~~~~~~~~~~~l~~li~~ 416 (452)
T 1fmk_A 338 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPECPESLHDLMCQ 416 (452)
T ss_dssp -----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCCCCCCTTSCHHHHHHHHH
T ss_pred ccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHHHHHHHHH
Confidence 001247889999999999899999999999999999999 999999988776666554 445566666799999999999
Q ss_pred HhhhCCCCCCCCCcChHHHhc
Q 012762 394 LLVKDPTRRMGSKMGATAIKR 414 (457)
Q Consensus 394 ~L~~dP~~Rps~~~~~~~ll~ 414 (457)
||..||++||+ +++|++
T Consensus 417 cl~~dP~~Rpt----~~~l~~ 433 (452)
T 1fmk_A 417 CWRKEPEERPT----FEYLQA 433 (452)
T ss_dssp HTCSSGGGSCC----HHHHHH
T ss_pred HccCChhhCcC----HHHHHH
Confidence 99999999999 888765
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=363.11 Aligned_cols=261 Identities=19% Similarity=0.253 Sum_probs=209.5
Q ss_pred CccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEc
Q 012762 78 PLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDC 157 (457)
Q Consensus 78 ~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~ 157 (457)
.+..++|+++++||+|+||+||+|++..........||+|.+... ........+.+|+++|+.++||||+++++++..
T Consensus 11 ~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 88 (327)
T 3lzb_A 11 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVDNPHVCRLLGICLT 88 (327)
T ss_dssp ECCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCC--SSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEES
T ss_pred ccCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccc--cCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEec
Confidence 456689999999999999999999987533323334577776432 223456778889999999999999999999987
Q ss_pred CCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcC
Q 012762 158 PRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLK 237 (457)
Q Consensus 158 ~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~ 237 (457)
+. .++||||+.+++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 89 ~~-~~~v~~~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~ 166 (327)
T 3lzb_A 89 ST-VQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp SS-EEEEECCCSSCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC---
T ss_pred CC-ceEEEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeE
Confidence 65 78999999999999988775 35699999999999999999999999999999999999999999999999999865
Q ss_pred CCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcccccc
Q 012762 238 GDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMS 317 (457)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (457)
........ ....
T Consensus 167 ~~~~~~~~--------------------------------------------------------------------~~~~ 178 (327)
T 3lzb_A 167 LGAEEKEY--------------------------------------------------------------------HAEG 178 (327)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred ccCccccc--------------------------------------------------------------------cccC
Confidence 53211100 0011
Q ss_pred ccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhh
Q 012762 318 FVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLV 396 (457)
Q Consensus 318 ~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~ 396 (457)
..||+.|+|||++.+..++.++|||||||++|||++ |..||.+......... +......+....++.++.+||.+||.
T Consensus 179 ~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~~l~ 257 (327)
T 3lzb_A 179 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI-LEKGERLPQPPICTIDVYMIMRKCWM 257 (327)
T ss_dssp -CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH-HHTTCCCCCCTTBCHHHHHHHHHHTC
T ss_pred CCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH-HHcCCCCCCCccCCHHHHHHHHHHcC
Confidence 247889999999999999999999999999999999 9999998776655444 44444556666789999999999999
Q ss_pred hCCCCCCCCCcChHHHhcC
Q 012762 397 KDPTRRMGSKMGATAIKRH 415 (457)
Q Consensus 397 ~dP~~Rps~~~~~~~ll~h 415 (457)
.||.+||+ +.||++.
T Consensus 258 ~dp~~Rps----~~ell~~ 272 (327)
T 3lzb_A 258 IDADSRPK----FRELIIE 272 (327)
T ss_dssp SSGGGSCC----HHHHHHH
T ss_pred CChhHCcC----HHHHHHH
Confidence 99999999 8888763
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=355.13 Aligned_cols=262 Identities=21% Similarity=0.282 Sum_probs=216.0
Q ss_pred CCCccCCCceeEE-EecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEE
Q 012762 76 NNPLTLSDLRFVH-RLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYAT 154 (457)
Q Consensus 76 ~~~~~~~~~~~~~-~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~ 154 (457)
...+..++|.+.+ .||+|+||+||+|.++.. ..+..||+|++.... .......+.+|+++++.++||||++++++
T Consensus 3 ~~~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~--~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 78 (287)
T 1u59_A 3 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMR--KKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGV 78 (287)
T ss_dssp CCBCCGGGEEEEEEEEECCTTEEEEEEEEC-----CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccccHHHhhhhhccccccCceeEEEeEeccC--CCcceEEEEecCCcc--chhHHHHHHHHHHHHHhCCCCCEeEEEEE
Confidence 3456677899987 999999999999986532 367889999997642 23456678889999999999999999999
Q ss_pred EEcCCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCC
Q 012762 155 LDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDL 234 (457)
Q Consensus 155 ~~~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~ 234 (457)
+. .+..|+||||+++++|.+++... ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+
T Consensus 79 ~~-~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~ 156 (287)
T 1u59_A 79 CQ-AEALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGL 156 (287)
T ss_dssp EE-SSSEEEEEECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTT
T ss_pred ec-CCCcEEEEEeCCCCCHHHHHHhC-CccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccc
Confidence 94 56789999999999999988653 35699999999999999999999999999999999999999999999999999
Q ss_pred CcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccc
Q 012762 235 SLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVR 314 (457)
Q Consensus 235 s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (457)
+........... .
T Consensus 157 ~~~~~~~~~~~~-------------------------------------------------------------------~ 169 (287)
T 1u59_A 157 SKALGADDSYYT-------------------------------------------------------------------A 169 (287)
T ss_dssp CEECTTCSCEEC-------------------------------------------------------------------C
T ss_pred eeeeccCcceee-------------------------------------------------------------------c
Confidence 865532211000 0
Q ss_pred cccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHH
Q 012762 315 SMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQ 393 (457)
Q Consensus 315 ~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~ 393 (457)
.....||+.|+|||++.+..++.++|||||||++|||++ |+.||...........+... ...+....+++++.++|.+
T Consensus 170 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~-~~~~~~~~~~~~l~~li~~ 248 (287)
T 1u59_A 170 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG-KRMECPPECPPELYALMSD 248 (287)
T ss_dssp CCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTT-CCCCCCTTCCHHHHHHHHH
T ss_pred cccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcC-CcCCCCCCcCHHHHHHHHH
Confidence 011247899999999998889999999999999999998 99999987776666555443 2334445689999999999
Q ss_pred HhhhCCCCCCCCCcChHHHhcC
Q 012762 394 LLVKDPTRRMGSKMGATAIKRH 415 (457)
Q Consensus 394 ~L~~dP~~Rps~~~~~~~ll~h 415 (457)
||..||++||+ +.++++|
T Consensus 249 ~l~~~p~~Rps----~~~l~~~ 266 (287)
T 1u59_A 249 CWIYKWEDRPD----FLTVEQR 266 (287)
T ss_dssp TTCSSGGGSCC----HHHHHHH
T ss_pred HcCCChhhCcC----HHHHHHH
Confidence 99999999999 9999876
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=368.94 Aligned_cols=267 Identities=24% Similarity=0.332 Sum_probs=194.3
Q ss_pred CCCCccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHH-HHHHcCCCCCceEEE
Q 012762 75 NNNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIERE-ILEMLDHPFLPTLYA 153 (457)
Q Consensus 75 ~~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~-il~~l~H~nIv~l~~ 153 (457)
..+.+..++|++++.||+|+||+||+|.++ .+|+.||||++..... ......+..|+. +++.++||||+++++
T Consensus 15 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~----~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~~~~h~niv~~~~ 88 (327)
T 3aln_A 15 QHWDFTAEDLKDLGEIGRGAYGSVNKMVHK----PSGQIMAVKRIRSTVD--EKEQKQLLMDLDVVMRSSDCPYIVQFYG 88 (327)
T ss_dssp EEECCCSCSEEC-CEEEECSSEEEEEEEET----TTTEEEEEEEEECCCC--HHHHHHHHHHHHHHHSSCCCTTBCCEEE
T ss_pred HhcccCHHHhhehheeccCCCEEEEEEEEc----CCCCEEEEEEeecccC--chHHHHHHHHHHHHHHcCCCCcEeeeee
Confidence 445677899999999999999999999986 4789999999976421 223344445555 667789999999999
Q ss_pred EEEcCCcEEEEEeecCCCChHHHHHh---CCCCCCCHHHHHHHHHHHHHHHHHHHHc-CceeecCCCCCeEEccCCCEEE
Q 012762 154 TLDCPRWSCLLTEFCPGGDLHVLRQR---QPDKRFHESAVRFYASEVVVALEFLHMM-GIIYRDLKPENVLVRSDGHIML 229 (457)
Q Consensus 154 ~~~~~~~~~lV~E~~~~~sL~~~~~~---~~~~~~~~~~~~~i~~qi~~~L~yLH~~-~iiHrDIKp~NIll~~~~~vkl 229 (457)
++...+..|+||||++ ++|..++.. .....+++..+..++.|++.||.|||+. ||+||||||+|||++.++.+||
T Consensus 89 ~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl 167 (327)
T 3aln_A 89 ALFREGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKL 167 (327)
T ss_dssp EEECSSEEEEEECCCS-EEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEE
T ss_pred EEEeCCceEEEEeecC-CChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEE
Confidence 9999999999999996 588766653 2346799999999999999999999998 9999999999999999999999
Q ss_pred eccCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCccccc
Q 012762 230 TDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAE 309 (457)
Q Consensus 230 ~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (457)
+|||+++.......
T Consensus 168 ~Dfg~~~~~~~~~~------------------------------------------------------------------ 181 (327)
T 3aln_A 168 CDFGISGQLVDSIA------------------------------------------------------------------ 181 (327)
T ss_dssp CCCSSSCC------------------------------------------------------------------------
T ss_pred ccCCCceecccccc------------------------------------------------------------------
Confidence 99999865432110
Q ss_pred CCccccccccCCCCccCchhh----cCCCCCccchhhhhhHHHHHHhcCCCCCCCCChH-HHHHHHHhccc-CCC--CCC
Q 012762 310 PLDVRSMSFVGTHEYLAPEII----SGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHE-LTLANVVARAL-EFP--KEP 381 (457)
Q Consensus 310 ~~~~~~~~~~gt~~y~aPE~l----~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~-~~~~~~~~~~~-~~~--~~~ 381 (457)
.....||+.|+|||++ .+..++.++|||||||++|+|++|+.||.+.... ..+..+..... .++ ...
T Consensus 182 -----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (327)
T 3aln_A 182 -----KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEER 256 (327)
T ss_dssp -----------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCCCCCSSC
T ss_pred -----cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCCCCcccc
Confidence 0122589999999999 4566899999999999999999999999875432 12211111111 111 123
Q ss_pred CCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCCCCc
Q 012762 382 SVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGVNW 423 (457)
Q Consensus 382 ~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~~~~ 423 (457)
.++.++.+||.+||..||++||+ +.+|++||||...++
T Consensus 257 ~~~~~l~~li~~~l~~dp~~Rps----~~ell~hp~~~~~~~ 294 (327)
T 3aln_A 257 EFSPSFINFVNLCLTKDESKRPK----YKELLKHPFILMYEE 294 (327)
T ss_dssp CCCHHHHHHHHHHTCSSGGGSCC----HHHHTTSHHHHHHHH
T ss_pred cCCHHHHHHHHHHhhCChhhCcC----HHHHHhChHHHHhHh
Confidence 57889999999999999999999 999999999987544
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-46 Score=354.96 Aligned_cols=256 Identities=20% Similarity=0.305 Sum_probs=214.9
Q ss_pred CCCCccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEE
Q 012762 75 NNNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYAT 154 (457)
Q Consensus 75 ~~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~ 154 (457)
..+.+..++|++++.||+|+||+||+|.+. .+..||+|++.... .....+.+|+++|+.++||||++++++
T Consensus 6 ~~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~ 76 (279)
T 1qpc_A 6 DEWEVPRETLKLVERLGAGQFGEVWMGYYN-----GHTKVAVKSLKQGS----MSPDAFLAEANLMKQLQHQRLVRLYAV 76 (279)
T ss_dssp CTTBCCGGGEEEEEEEEEETTEEEEEEEET-----TTEEEEEEEECTTS----SCHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred hhcccCHHhhhheeeecCCCCeEEEEEEEc-----CCcEEEEEEecCCc----ccHHHHHHHHHHHHhCCCcCcceEEEE
Confidence 457788899999999999999999999864 56789999997543 234567889999999999999999999
Q ss_pred EEcCCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCC
Q 012762 155 LDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDL 234 (457)
Q Consensus 155 ~~~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~ 234 (457)
+.. +..|+||||+++++|.+++.......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 77 ~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~ 155 (279)
T 1qpc_A 77 VTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGL 155 (279)
T ss_dssp ECS-SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred EcC-CCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcc
Confidence 874 5689999999999999988654333699999999999999999999999999999999999999999999999999
Q ss_pred CcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccc
Q 012762 235 SLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVR 314 (457)
Q Consensus 235 s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (457)
+..........
T Consensus 156 ~~~~~~~~~~~--------------------------------------------------------------------- 166 (279)
T 1qpc_A 156 ARLIEDNEYTA--------------------------------------------------------------------- 166 (279)
T ss_dssp CEECSSSCEEC---------------------------------------------------------------------
T ss_pred cccccCccccc---------------------------------------------------------------------
Confidence 86543211100
Q ss_pred cccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHH
Q 012762 315 SMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQ 393 (457)
Q Consensus 315 ~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~ 393 (457)
.....|+..|+|||++.+..++.++|||||||++|||++ |+.||.+....+....+... ........++.++.+++.+
T Consensus 167 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~ 245 (279)
T 1qpc_A 167 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG-YRMVRPDNCPEELYQLMRL 245 (279)
T ss_dssp CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT-CCCCCCTTCCHHHHHHHHH
T ss_pred ccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcc-cCCCCcccccHHHHHHHHH
Confidence 001247889999999998889999999999999999999 99999988776666555443 3444455689999999999
Q ss_pred HhhhCCCCCCCCCcChHHHhc
Q 012762 394 LLVKDPTRRMGSKMGATAIKR 414 (457)
Q Consensus 394 ~L~~dP~~Rps~~~~~~~ll~ 414 (457)
||..||++||+ +.++++
T Consensus 246 ~l~~~p~~Rps----~~~l~~ 262 (279)
T 1qpc_A 246 CWKERPEDRPT----FDYLRS 262 (279)
T ss_dssp HTCSSGGGSCC----HHHHHH
T ss_pred HhccChhhCCC----HHHHHH
Confidence 99999999999 888765
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-46 Score=367.04 Aligned_cols=268 Identities=18% Similarity=0.268 Sum_probs=215.1
Q ss_pred CccCCCceeEEEecccCcceEEEEEEecc-CCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEE
Q 012762 78 PLTLSDLRFVHRLGSGDIGSVYLVQLKSK-SSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLD 156 (457)
Q Consensus 78 ~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~-~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~ 156 (457)
.+..++|++++.||+|+||+||+|++... +..+++.||||++... ........+.+|+.+++.++||||+++++++.
T Consensus 26 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 103 (327)
T 2yfx_A 26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV--CSEQDELDFLMEALIISKFNHQNIVRCIGVSL 103 (327)
T ss_dssp BCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSS--CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccc--cchhhHHHHHHHHHHHhhCCCCCCCeEEEEEc
Confidence 45567899999999999999999986432 2347889999999643 22344567888999999999999999999999
Q ss_pred cCCcEEEEEeecCCCChHHHHHhCCC-----CCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccC---CCEE
Q 012762 157 CPRWSCLLTEFCPGGDLHVLRQRQPD-----KRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSD---GHIM 228 (457)
Q Consensus 157 ~~~~~~lV~E~~~~~sL~~~~~~~~~-----~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~---~~vk 228 (457)
..+..|+||||+++++|.+++..... ..+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+|
T Consensus 104 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~k 183 (327)
T 2yfx_A 104 QSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAK 183 (327)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred CCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEE
Confidence 99999999999999999999987532 358999999999999999999999999999999999999844 4699
Q ss_pred EeccCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccc
Q 012762 229 LTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVA 308 (457)
Q Consensus 229 l~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (457)
|+|||++.........
T Consensus 184 l~Dfg~~~~~~~~~~~---------------------------------------------------------------- 199 (327)
T 2yfx_A 184 IGDFGMARDIYRASYY---------------------------------------------------------------- 199 (327)
T ss_dssp ECCCHHHHHHHC--------------------------------------------------------------------
T ss_pred ECcccccccccccccc----------------------------------------------------------------
Confidence 9999987533211000
Q ss_pred cCCccccccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHHhcccCCCCCCCCChHH
Q 012762 309 EPLDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVVARALEFPKEPSVPGPA 387 (457)
Q Consensus 309 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 387 (457)
.......||+.|+|||++.+..++.++|||||||++|+|++ |..||...........+.... .......++..+
T Consensus 200 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l 274 (327)
T 2yfx_A 200 ----RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG-RMDPPKNCPGPV 274 (327)
T ss_dssp ------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC-CCCCCTTCCHHH
T ss_pred ----ccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCC-CCCCCCCCCHHH
Confidence 00112358999999999999899999999999999999998 999999877766666555443 333445689999
Q ss_pred HHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCC
Q 012762 388 KDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNG 420 (457)
Q Consensus 388 ~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~ 420 (457)
.+||.+||..||.+||+ +.+|++|.|+-.
T Consensus 275 ~~li~~~l~~dp~~Rps----~~~ll~~l~~~~ 303 (327)
T 2yfx_A 275 YRIMTQCWQHQPEDRPN----FAIILERIEYCT 303 (327)
T ss_dssp HHHHHHHTCSSGGGSCC----HHHHHHHHHHHH
T ss_pred HHHHHHHhcCChhhCcC----HHHHHHHHHHHh
Confidence 99999999999999999 999999977543
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=354.82 Aligned_cols=268 Identities=18% Similarity=0.292 Sum_probs=210.0
Q ss_pred CCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEE-EcCCc
Q 012762 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATL-DCPRW 160 (457)
Q Consensus 82 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~-~~~~~ 160 (457)
++|++.+.||+|+||+||+|++. .+++.||||++..... ...+..|+++++.++|++++..+.++ ...+.
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~----~~~~~vavK~~~~~~~-----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~ 79 (296)
T 4hgt_A 9 NRYRLGRKIGSGSFGDIYLGTDI----AAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDY 79 (296)
T ss_dssp --CEEEEEEEECSSSEEEEEEET----TTTEEEEEEEEEC--------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTE
T ss_pred CceEEeeeecCCCCeEEEEEEEc----CCCceEEEEeeccccc-----chHHHHHHHHHHHhcCCCCCCeeeeecCCCCc
Confidence 57999999999999999999976 4788999999765432 23467799999999887766665554 67778
Q ss_pred EEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEE---ccCCCEEEeccCCCcC
Q 012762 161 SCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLV---RSDGHIMLTDFDLSLK 237 (457)
Q Consensus 161 ~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll---~~~~~vkl~DFG~s~~ 237 (457)
.++||||+ +++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.
T Consensus 80 ~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~ 157 (296)
T 4hgt_A 80 NVMVMELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 157 (296)
T ss_dssp EEEEEECC-CCBHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred eEEEEEcc-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCcccee
Confidence 89999999 99999998754 3569999999999999999999999999999999999999 7889999999999875
Q ss_pred CCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcccccc
Q 012762 238 GDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMS 317 (457)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (457)
.......... .......
T Consensus 158 ~~~~~~~~~~---------------------------------------------------------------~~~~~~~ 174 (296)
T 4hgt_A 158 YRDARTHQHI---------------------------------------------------------------PYRENKN 174 (296)
T ss_dssp CBCTTTCCBC---------------------------------------------------------------CCCCSCC
T ss_pred ccCcccCccC---------------------------------------------------------------CCCcccc
Confidence 5432111000 0001113
Q ss_pred ccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCCh---HHHHHHHHhcccCCCC---CCCCChHHHHHH
Q 012762 318 FVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDH---ELTLANVVARALEFPK---EPSVPGPAKDLI 391 (457)
Q Consensus 318 ~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~---~~~~~~~~~~~~~~~~---~~~~~~~~~~ll 391 (457)
..||+.|+|||++.+..++.++|||||||++|+|++|+.||.+... ...+..+.......+. ...+++++.+||
T Consensus 175 ~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 254 (296)
T 4hgt_A 175 LTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYL 254 (296)
T ss_dssp CCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHHTTTSCHHHHHHH
T ss_pred cCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhhhhhccCCHHHHHHH
Confidence 4699999999999999999999999999999999999999987432 2333333333333331 145789999999
Q ss_pred HHHhhhCCCCCCCCCcChHHHhc----------CCCCCCCCchhhh
Q 012762 392 AQLLVKDPTRRMGSKMGATAIKR----------HQFFNGVNWALLR 427 (457)
Q Consensus 392 ~~~L~~dP~~Rps~~~~~~~ll~----------hp~f~~~~~~~~~ 427 (457)
.+||+.||++||+ +.+|++ ..|...++|..++
T Consensus 255 ~~~l~~~p~~Rpt----~~~l~~~l~~~~~~~~~~~~~~~dw~~~~ 296 (296)
T 4hgt_A 255 NFCRSLRFDDKPD----YSYLRQLFRNLFHRQGFSYDYVFDWNMLK 296 (296)
T ss_dssp HHHHTSCTTCCCC----HHHHHHHHHHHHHHHTCCTTCCCGGGGCC
T ss_pred HHHHhcCCCCCCC----HHHHHHHHHHHHHHhCCCccCccchhhcC
Confidence 9999999999999 777754 5677778887653
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=360.77 Aligned_cols=264 Identities=24% Similarity=0.364 Sum_probs=201.5
Q ss_pred CCCccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEE
Q 012762 76 NNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATL 155 (457)
Q Consensus 76 ~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~ 155 (457)
......++|++++.||+|+||+||+|+++ .+|+.||||++...... ......+..+..+++.++||||+++++++
T Consensus 19 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~----~~~~~vavK~~~~~~~~-~~~~~~~~~~~~~~~~~~h~~i~~~~~~~ 93 (318)
T 2dyl_A 19 RYQAEINDLENLGEMGSGTCGQVWKMRFR----KTGHVIAVKQMRRSGNK-EENKRILMDLDVVLKSHDCPYIVQCFGTF 93 (318)
T ss_dssp EEECCGGGEEEEEEC------CEEEEEET----TTCCEEEEEEEETTSCH-HHHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred hhhhhhccccccceeeecCCeeEEEEEEe----cCCeEEEEEEecccccc-hHHHHHHHHHHHHHHhcCCCceeeEEEEE
Confidence 34566789999999999999999999986 37889999999765322 22233344455567888999999999999
Q ss_pred EcCCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHc-CceeecCCCCCeEEccCCCEEEeccCC
Q 012762 156 DCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMM-GIIYRDLKPENVLVRSDGHIMLTDFDL 234 (457)
Q Consensus 156 ~~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~-~iiHrDIKp~NIll~~~~~vkl~DFG~ 234 (457)
..++..|+||||+ ++.+..+.... ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+
T Consensus 94 ~~~~~~~lv~e~~-~~~~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~ 171 (318)
T 2dyl_A 94 ITNTDVFIAMELM-GTCAEKLKKRM-QGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGI 171 (318)
T ss_dssp ECSSEEEEEECCC-SEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTT
T ss_pred ecCCcEEEEEecc-CCcHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCC
Confidence 9999999999999 66676665542 36799999999999999999999995 999999999999999999999999999
Q ss_pred CcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccc
Q 012762 235 SLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVR 314 (457)
Q Consensus 235 s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (457)
+........
T Consensus 172 ~~~~~~~~~----------------------------------------------------------------------- 180 (318)
T 2dyl_A 172 SGRLVDDKA----------------------------------------------------------------------- 180 (318)
T ss_dssp C-------------------------------------------------------------------------------
T ss_pred chhccCCcc-----------------------------------------------------------------------
Confidence 754432110
Q ss_pred cccccCCCCccCchhhc-----CCCCCccchhhhhhHHHHHHhcCCCCCCCC-ChHHHHHHHHhcccC-CCCCCCCChHH
Q 012762 315 SMSFVGTHEYLAPEIIS-----GEGHGNAVDWWTLGIFIFELFYGTTPFKGI-DHELTLANVVARALE-FPKEPSVPGPA 387 (457)
Q Consensus 315 ~~~~~gt~~y~aPE~l~-----~~~~~~~sDiwSlG~il~elltG~~Pf~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~ 387 (457)
.....||+.|+|||++. +..++.++|||||||++|+|++|+.||... .....+..+...... .+....++.++
T Consensus 181 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 260 (318)
T 2dyl_A 181 KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDF 260 (318)
T ss_dssp ------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCCSSSCCCHHH
T ss_pred ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCCccCCCCHHH
Confidence 01235899999999995 456889999999999999999999999874 344455555544322 33334688999
Q ss_pred HHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCCC
Q 012762 388 KDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGV 421 (457)
Q Consensus 388 ~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~~ 421 (457)
.+||.+||..||.+||+ +.+|++||||+..
T Consensus 261 ~~li~~~l~~dp~~Rps----~~~ll~h~~~~~~ 290 (318)
T 2dyl_A 261 QSFVKDCLTKDHRKRPK----YNKLLEHSFIKRY 290 (318)
T ss_dssp HHHHHHHTCSCTTTSCC----HHHHTTSHHHHHH
T ss_pred HHHHHHHccCChhHCcC----HHHHhhCHHHHhc
Confidence 99999999999999999 9999999999853
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=355.13 Aligned_cols=259 Identities=21% Similarity=0.346 Sum_probs=202.3
Q ss_pred CCCCCccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEE
Q 012762 74 NNNNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYA 153 (457)
Q Consensus 74 ~~~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~ 153 (457)
...+++..++|++.++||+|+||+||+|.+. ..||+|+++.... .......+.+|+++|+.++|+||+++++
T Consensus 16 ~~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~-------~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (289)
T 3og7_A 16 ADDWEIPDGQITVGQRIGSGSFGTVYKGKWH-------GDVAVKMLNVTAP-TPQQLQAFKNEVGVLRKTRHVNILLFMG 87 (289)
T ss_dssp --CCBCCTTSCEEEEEEEECSSEEEEEEESS-------SEEEEEEESCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred CCCCccCccceeeeeEecCCCCeEEEEEEEc-------CceEEEEEeccCC-CHHHHHHHHHHHHHHHhCCCCcEEEEEe
Confidence 3456788899999999999999999999753 2499999965432 3345567888999999999999999999
Q ss_pred EEEcCCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccC
Q 012762 154 TLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFD 233 (457)
Q Consensus 154 ~~~~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG 233 (457)
+. ..+..++||||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 88 ~~-~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg 165 (289)
T 3og7_A 88 YS-TAPQLAIVTQWCEGSSLYHHLHAS-ETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFG 165 (289)
T ss_dssp EE-CSSSCEEEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC
T ss_pred ec-cCCccEEEEEecCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccce
Confidence 65 456789999999999999888654 3679999999999999999999999999999999999999999999999999
Q ss_pred CCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcc
Q 012762 234 LSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDV 313 (457)
Q Consensus 234 ~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (457)
++......... .
T Consensus 166 ~~~~~~~~~~~--------------------------------------------------------------------~ 177 (289)
T 3og7_A 166 LATEKSRWSGS--------------------------------------------------------------------H 177 (289)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred ecccccccccc--------------------------------------------------------------------c
Confidence 98644311100 0
Q ss_pred ccccccCCCCccCchhhc---CCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCC----CCCCChH
Q 012762 314 RSMSFVGTHEYLAPEIIS---GEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPK----EPSVPGP 386 (457)
Q Consensus 314 ~~~~~~gt~~y~aPE~l~---~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~----~~~~~~~ 386 (457)
......||+.|+|||++. +..++.++|||||||++|+|++|+.||.+.........++......+. ...+++.
T Consensus 178 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (289)
T 3og7_A 178 QFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKR 257 (289)
T ss_dssp ------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSCTTSCHH
T ss_pred cccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhccccCCHH
Confidence 111346999999999997 566888999999999999999999999887666555555444322222 2357889
Q ss_pred HHHHHHHHhhhCCCCCCCCCcChHHHhc
Q 012762 387 AKDLIAQLLVKDPTRRMGSKMGATAIKR 414 (457)
Q Consensus 387 ~~~ll~~~L~~dP~~Rps~~~~~~~ll~ 414 (457)
+.+||.+||..||.+||+ +.++++
T Consensus 258 l~~li~~~l~~~p~~Rps----~~ell~ 281 (289)
T 3og7_A 258 MKRLMAECLKKKRDERPS----FPRILA 281 (289)
T ss_dssp HHHHHHHHTCSSGGGSCC----HHHHHH
T ss_pred HHHHHHHHccCChhhCCC----HHHHHH
Confidence 999999999999999999 888875
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-46 Score=369.33 Aligned_cols=280 Identities=14% Similarity=0.187 Sum_probs=206.7
Q ss_pred ccCCCceeEEEecccCcceEEEEEEeccC-CCCCceEEEEEeehhhhhhhhH--------HHHHHHHHHHHHHcCCCCCc
Q 012762 79 LTLSDLRFVHRLGSGDIGSVYLVQLKSKS-SNNGCFFAAKVMDKRELVSRNK--------ESRARIEREILEMLDHPFLP 149 (457)
Q Consensus 79 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~-~~~~~~vAvK~~~~~~~~~~~~--------~~~~~~E~~il~~l~H~nIv 149 (457)
+..++|++.+.||+|+||+||+|.++... ...++.||||++.......... ...+..|+.+++.++|+||+
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv 111 (364)
T 3op5_A 32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP 111 (364)
T ss_dssp TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence 44568999999999999999999886422 2246899999987643211111 11223345566677899999
Q ss_pred eEEEEEEcC----CcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEc--c
Q 012762 150 TLYATLDCP----RWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVR--S 223 (457)
Q Consensus 150 ~l~~~~~~~----~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~--~ 223 (457)
++++++... .+.||||||+ |++|.+++... ...+++..++.++.||+.||.|||++||+||||||+||||+ .
T Consensus 112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~ 189 (364)
T 3op5_A 112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN-AKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKN 189 (364)
T ss_dssp CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSC
T ss_pred eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCC
Confidence 999998764 4589999999 99999998774 36799999999999999999999999999999999999999 8
Q ss_pred CCCEEEeccCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCC
Q 012762 224 DGHIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGT 303 (457)
Q Consensus 224 ~~~vkl~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (457)
++.+||+|||+++...........
T Consensus 190 ~~~~kl~DFG~a~~~~~~~~~~~~-------------------------------------------------------- 213 (364)
T 3op5_A 190 PDQVYLVDYGLAYRYCPEGVHKAY-------------------------------------------------------- 213 (364)
T ss_dssp TTCEEECCCTTCEESSGGGCCCCS--------------------------------------------------------
T ss_pred CCeEEEEECCcceecccCCccccc--------------------------------------------------------
Confidence 899999999998765421110000
Q ss_pred CcccccCCccccccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccC-------
Q 012762 304 PEIVAEPLDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALE------- 376 (457)
Q Consensus 304 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~------- 376 (457)
........+||+.|+|||++.+..++.++|||||||++|||++|+.||.+..............+.
T Consensus 214 -------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (364)
T 3op5_A 214 -------AADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVRDSKIRYRENIASLM 286 (364)
T ss_dssp -------SCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHCHHHHH
T ss_pred -------ccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHHHHHHHHHHhhhhHHHHH
Confidence 000112346999999999999999999999999999999999999999864322222111111000
Q ss_pred --CCCCCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHh----------cCCCCCCCCchhhh
Q 012762 377 --FPKEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIK----------RHQFFNGVNWALLR 427 (457)
Q Consensus 377 --~~~~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll----------~hp~f~~~~~~~~~ 427 (457)
......++.++.++|..||..||++||+ +.+|+ ..++...++|....
T Consensus 287 ~~~~~~~~~~~~~~~li~~cl~~~p~~RP~----~~~l~~~l~~~~~~~~~~~~~~~dw~~~~ 345 (364)
T 3op5_A 287 DKCFPAANAPGEIAKYMETVKLLDYTEKPL----YENLRDILLQGLKAIGSKDDGKLDLSVVE 345 (364)
T ss_dssp HHHSCTTCCCHHHHHHHHHHHTCCTTCCCC----HHHHHHHHHHHHHHTTCCCCCCCCC----
T ss_pred HHhcccccCHHHHHHHHHHHhcCCCCCCCC----HHHHHHHHHHHHHHcCCCcCCccceEecc
Confidence 0012457899999999999999999999 66554 34666778897653
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-45 Score=353.39 Aligned_cols=261 Identities=20% Similarity=0.266 Sum_probs=212.7
Q ss_pred CCCccCCCceeEE-EecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEE
Q 012762 76 NNPLTLSDLRFVH-RLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYAT 154 (457)
Q Consensus 76 ~~~~~~~~~~~~~-~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~ 154 (457)
...+..++|++.+ .||+|+||+||+|.+.. ...++.||||++..... .......+.+|+++++.++||||++++++
T Consensus 10 ~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~--~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 86 (291)
T 1xbb_A 10 EVYLDRKLLTLEDKELGSGNFGTVKKGYYQM--KKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGI 86 (291)
T ss_dssp -CBCCGGGEEEEEEEEEECSSEEEEEEEEEC--SSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred eeeecchhhhhccCccccccCeeeEeeeecC--CCceeeEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence 3456667899998 99999999999997642 24678999999976532 23345678889999999999999999999
Q ss_pred EEcCCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCC
Q 012762 155 LDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDL 234 (457)
Q Consensus 155 ~~~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~ 234 (457)
+ ..+..|+||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 87 ~-~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~ 163 (291)
T 1xbb_A 87 C-EAESWMLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGL 163 (291)
T ss_dssp E-ESSSEEEEEECCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTT
T ss_pred E-CCCCcEEEEEeCCCCCHHHHHHhC--cCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCc
Confidence 9 566789999999999999999875 5699999999999999999999999999999999999999999999999999
Q ss_pred CcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccc
Q 012762 235 SLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVR 314 (457)
Q Consensus 235 s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (457)
+........... .
T Consensus 164 ~~~~~~~~~~~~-------------------------------------------------------------------~ 176 (291)
T 1xbb_A 164 SKALRADENYYK-------------------------------------------------------------------A 176 (291)
T ss_dssp CEECCTTCSEEE-------------------------------------------------------------------C
T ss_pred ceeeccCCCccc-------------------------------------------------------------------c
Confidence 865532211100 0
Q ss_pred cccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHH
Q 012762 315 SMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQ 393 (457)
Q Consensus 315 ~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~ 393 (457)
.....||+.|+|||++.+..++.++|||||||++|+|++ |+.||.+.........+... ........++.++.++|.+
T Consensus 177 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~ 255 (291)
T 1xbb_A 177 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG-ERMGCPAGCPREMYDLMNL 255 (291)
T ss_dssp ----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT-CCCCCCTTCCHHHHHHHHH
T ss_pred cccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC-CCCCCCCCCCHHHHHHHHH
Confidence 001236889999999998889999999999999999999 99999988776665555443 3334445689999999999
Q ss_pred HhhhCCCCCCCCCcChHHHhc
Q 012762 394 LLVKDPTRRMGSKMGATAIKR 414 (457)
Q Consensus 394 ~L~~dP~~Rps~~~~~~~ll~ 414 (457)
||..||.+||+ +.++++
T Consensus 256 ~l~~dp~~Rps----~~~l~~ 272 (291)
T 1xbb_A 256 CWTYDVENRPG----FAAVEL 272 (291)
T ss_dssp HTCSSTTTSCC----HHHHHH
T ss_pred HcCCChhhCcC----HHHHHH
Confidence 99999999999 887765
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=362.92 Aligned_cols=256 Identities=22% Similarity=0.330 Sum_probs=211.9
Q ss_pred CccCCCceeEEEecccCcceEEEEEEeccCCCCCce--EEEEEeehhhhhhhhHHHHHHHHHHHHHHc-CCCCCceEEEE
Q 012762 78 PLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCF--FAAKVMDKRELVSRNKESRARIEREILEML-DHPFLPTLYAT 154 (457)
Q Consensus 78 ~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~--vAvK~~~~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~~~ 154 (457)
.+..++|++.+.||+|+||+||+|+++. ++.. +|+|++... ........+.+|+++|+++ +||||++++++
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~----~~~~~~v~iK~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 94 (327)
T 1fvr_A 21 VLDWNDIKFQDVIGEGNFGQVLKARIKK----DGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGA 94 (327)
T ss_dssp BCCGGGCEEEEEEECGGGCEEEEEEEEE----TTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEE
T ss_pred cccHHHccceeeeecCCCceEEEEEEcc----CCcccceeeeeeccc--cchHHHHHHHHHHHHHHhccCCCchhhhcee
Confidence 4666899999999999999999999874 5654 499998643 2233456678899999999 89999999999
Q ss_pred EEcCCcEEEEEeecCCCChHHHHHhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeE
Q 012762 155 LDCPRWSCLLTEFCPGGDLHVLRQRQP--------------DKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVL 220 (457)
Q Consensus 155 ~~~~~~~~lV~E~~~~~sL~~~~~~~~--------------~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIl 220 (457)
+...+..|+||||+++++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 95 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl 174 (327)
T 1fvr_A 95 CEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNIL 174 (327)
T ss_dssp EEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred eeeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEE
Confidence 999999999999999999999987642 246999999999999999999999999999999999999
Q ss_pred EccCCCEEEeccCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCC
Q 012762 221 VRSDGHIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGN 300 (457)
Q Consensus 221 l~~~~~vkl~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (457)
++.++.+||+|||+++......
T Consensus 175 ~~~~~~~kL~Dfg~~~~~~~~~---------------------------------------------------------- 196 (327)
T 1fvr_A 175 VGENYVAKIADFGLSRGQEVYV---------------------------------------------------------- 196 (327)
T ss_dssp ECGGGCEEECCTTCEESSCEEC----------------------------------------------------------
T ss_pred EcCCCeEEEcccCcCccccccc----------------------------------------------------------
Confidence 9999999999999975322100
Q ss_pred CCCCcccccCCccccccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHHhcccCCCC
Q 012762 301 PGTPEIVAEPLDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVVARALEFPK 379 (457)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~ 379 (457)
......+++.|+|||++.+..++.++|||||||++|||++ |..||.+.........+.. ......
T Consensus 197 -------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~-~~~~~~ 262 (327)
T 1fvr_A 197 -------------KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ-GYRLEK 262 (327)
T ss_dssp -------------CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGG-TCCCCC
T ss_pred -------------cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhc-CCCCCC
Confidence 0011247889999999998889999999999999999998 9999998877666555443 334444
Q ss_pred CCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcC
Q 012762 380 EPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRH 415 (457)
Q Consensus 380 ~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~h 415 (457)
...+++++.+||.+||..||.+||+ +.+++++
T Consensus 263 ~~~~~~~l~~li~~~l~~dp~~Rps----~~ell~~ 294 (327)
T 1fvr_A 263 PLNCDDEVYDLMRQCWREKPYERPS----FAQILVS 294 (327)
T ss_dssp CTTBCHHHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred CCCCCHHHHHHHHHHccCChhhCcC----HHHHHHH
Confidence 5568999999999999999999999 8888875
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-45 Score=357.03 Aligned_cols=268 Identities=18% Similarity=0.239 Sum_probs=212.1
Q ss_pred CCCCCCccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEE
Q 012762 73 NNNNNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLY 152 (457)
Q Consensus 73 ~~~~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~ 152 (457)
......+..++|.+.+.||+|+||+||+|.+... ..++..||+|++..... .......+.+|++++++++||||++++
T Consensus 25 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~-~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~ 102 (313)
T 3brb_A 25 KLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQE-DGTSLKVAVKTMKLDNS-SQREIEEFLSEAACMKDFSHPNVIRLL 102 (313)
T ss_dssp CTTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECT-TSCEEEEEEEEC---CC-CHHHHHHHHHHHHHHHTCCCTTBCCCC
T ss_pred hHHhcccCHHHeeeccceeecCCeEEEEEEEecc-CCceeEEEEEEEecccc-chhHHHHHHHHHHHHhcCCCCCeeeee
Confidence 3445566778999999999999999999987642 23567899999975432 233456788899999999999999999
Q ss_pred EEEEcCC-----cEEEEEeecCCCChHHHHHhC----CCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEcc
Q 012762 153 ATLDCPR-----WSCLLTEFCPGGDLHVLRQRQ----PDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRS 223 (457)
Q Consensus 153 ~~~~~~~-----~~~lV~E~~~~~sL~~~~~~~----~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~ 223 (457)
+++...+ ..|+||||+++++|..++... ....+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 103 ~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~ 182 (313)
T 3brb_A 103 GVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRD 182 (313)
T ss_dssp EEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECT
T ss_pred EEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcC
Confidence 9997655 359999999999999888542 3356999999999999999999999999999999999999999
Q ss_pred CCCEEEeccCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCC
Q 012762 224 DGHIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGT 303 (457)
Q Consensus 224 ~~~vkl~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (457)
++.+||+|||++..........
T Consensus 183 ~~~~kl~Dfg~~~~~~~~~~~~---------------------------------------------------------- 204 (313)
T 3brb_A 183 DMTVCVADFGLSKKIYSGDYYR---------------------------------------------------------- 204 (313)
T ss_dssp TSCEEECSCSCC--------------------------------------------------------------------
T ss_pred CCcEEEeecCcceecccccccC----------------------------------------------------------
Confidence 9999999999986543211000
Q ss_pred CcccccCCccccccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHHhcccCCCCCCC
Q 012762 304 PEIVAEPLDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVVARALEFPKEPS 382 (457)
Q Consensus 304 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 382 (457)
......|++.|+|||++.+..++.++|||||||++|+|++ |..||.+.........+.... ..+....
T Consensus 205 ----------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~ 273 (313)
T 3brb_A 205 ----------QGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGH-RLKQPED 273 (313)
T ss_dssp ----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC-CCCCBTT
T ss_pred ----------cccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCC-CCCCCcc
Confidence 0012247889999999999999999999999999999999 999999887776666655443 3344456
Q ss_pred CChHHHHHHHHHhhhCCCCCCCCCcChHHHhcC
Q 012762 383 VPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRH 415 (457)
Q Consensus 383 ~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~h 415 (457)
+++++.++|.+||..||.+||+ +.+|+++
T Consensus 274 ~~~~l~~li~~~l~~dp~~Rps----~~~l~~~ 302 (313)
T 3brb_A 274 CLDELYEIMYSCWRTDPLDRPT----FSVLRLQ 302 (313)
T ss_dssp CCHHHHHHHHHTTCSSGGGSCC----HHHHHHH
T ss_pred ccHHHHHHHHHHcCCChhhCcC----HHHHHHH
Confidence 8899999999999999999999 8888765
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=354.83 Aligned_cols=251 Identities=20% Similarity=0.325 Sum_probs=207.0
Q ss_pred CCCCccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEE
Q 012762 75 NNNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYAT 154 (457)
Q Consensus 75 ~~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~ 154 (457)
..+.+..++|++.+.||+|+||+||+|.+ .|+.||+|++... .....+.+|+++++.++||||++++++
T Consensus 14 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~------~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~h~~iv~~~~~ 82 (278)
T 1byg_A 14 SGWALNMKELKLLQTIGKGEFGDVMLGDY------RGNKVAVKCIKND-----ATAQAFLAEASVMTQLRHSNLVQLLGV 82 (278)
T ss_dssp -CCBCCGGGEEEEEEEEECSSCEEEEEEE------TTEEEEEEECCCC-----C--HHHHHTHHHHTTCCCTTBCCEEEE
T ss_pred ccccCChhhceEEeEEecCCCceEEEEEE------cCCEEEEEEecch-----hHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 34667889999999999999999999975 4778999999653 245667889999999999999999999
Q ss_pred EEcC-CcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccC
Q 012762 155 LDCP-RWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFD 233 (457)
Q Consensus 155 ~~~~-~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG 233 (457)
+... +..|+||||+++++|.+++.......+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg 162 (278)
T 1byg_A 83 IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFG 162 (278)
T ss_dssp ECCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCC
T ss_pred EEcCCCceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeecc
Confidence 7544 578999999999999999876533348999999999999999999999999999999999999999999999999
Q ss_pred CCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcc
Q 012762 234 LSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDV 313 (457)
Q Consensus 234 ~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (457)
++.......
T Consensus 163 ~~~~~~~~~----------------------------------------------------------------------- 171 (278)
T 1byg_A 163 LTKEASSTQ----------------------------------------------------------------------- 171 (278)
T ss_dssp C-------------------------------------------------------------------------------
T ss_pred ccccccccc-----------------------------------------------------------------------
Confidence 875432110
Q ss_pred ccccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHH
Q 012762 314 RSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIA 392 (457)
Q Consensus 314 ~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~ 392 (457)
....+++.|+|||++.+..++.++|||||||++|+|++ |..||...........+.. .........+++.+.++|.
T Consensus 172 --~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~ 248 (278)
T 1byg_A 172 --DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK-GYKMDAPDGCPPAVYEVMK 248 (278)
T ss_dssp ------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTT-TCCCCCCTTCCHHHHHHHH
T ss_pred --cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc-CCCCCCcccCCHHHHHHHH
Confidence 01247889999999999999999999999999999998 9999998776666555443 3344445568999999999
Q ss_pred HHhhhCCCCCCCCCcChHHHhc
Q 012762 393 QLLVKDPTRRMGSKMGATAIKR 414 (457)
Q Consensus 393 ~~L~~dP~~Rps~~~~~~~ll~ 414 (457)
+||..||++||+ +.++++
T Consensus 249 ~~l~~~p~~Rps----~~~l~~ 266 (278)
T 1byg_A 249 NCWHLDAAMRPS----FLQLRE 266 (278)
T ss_dssp HHTCSSGGGSCC----HHHHHH
T ss_pred HHhcCChhhCCC----HHHHHH
Confidence 999999999999 887765
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=378.43 Aligned_cols=272 Identities=18% Similarity=0.291 Sum_probs=216.9
Q ss_pred cCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCC-CCCceEEEEEEcC
Q 012762 80 TLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDH-PFLPTLYATLDCP 158 (457)
Q Consensus 80 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H-~nIv~l~~~~~~~ 158 (457)
..++|+++++||+|+||+||+|++. .+++.||||++.... ....+..|+++++.|+| ++|..+..++...
T Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~----~~~~~vAvK~~~~~~-----~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~ 75 (483)
T 3sv0_A 5 VGNKFRLGRKIGSGSFGEIYLGTNI----QTNEEVAIKLENVKT-----KHPQLLYESKIYRILQGGTGIPNVRWFGVEG 75 (483)
T ss_dssp ETTTEECCCCCEECSSCEEEEEEET----TTCCEEEEEEEETTC-----SSCCHHHHHHHHHHTTTSTTCCCEEEEEEET
T ss_pred cCCcEEEEEEEeeCCCEEEEEEEEC----CCCcEEEEEEecccc-----ccHHHHHHHHHHHHhcCCCCCCeEEEEEeeC
Confidence 3468999999999999999999976 478899999986543 22346779999999976 5666777777888
Q ss_pred CcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEE---ccCCCEEEeccCCC
Q 012762 159 RWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLV---RSDGHIMLTDFDLS 235 (457)
Q Consensus 159 ~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll---~~~~~vkl~DFG~s 235 (457)
+..||||||+ +++|.+++... ...+++..++.++.||+.||.|||++|||||||||+|||| +.++.+||+|||++
T Consensus 76 ~~~~lvme~~-g~sL~~ll~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla 153 (483)
T 3sv0_A 76 DYNVLVMDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153 (483)
T ss_dssp TEEEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTC
T ss_pred CEEEEEEECC-CCCHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcc
Confidence 8999999999 99999998764 3579999999999999999999999999999999999999 58899999999998
Q ss_pred cCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcccc
Q 012762 236 LKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRS 315 (457)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (457)
+............ -...
T Consensus 154 ~~~~~~~~~~~~~---------------------------------------------------------------~~~~ 170 (483)
T 3sv0_A 154 KKYRDTSTHQHIP---------------------------------------------------------------YREN 170 (483)
T ss_dssp EECBCTTTCCBCC---------------------------------------------------------------CCCC
T ss_pred eeccCCccccccc---------------------------------------------------------------cccc
Confidence 7654322110000 0011
Q ss_pred ccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCCh---HHHHHHHHhcccCCCC---CCCCChHHHH
Q 012762 316 MSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDH---ELTLANVVARALEFPK---EPSVPGPAKD 389 (457)
Q Consensus 316 ~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~---~~~~~~~~~~~~~~~~---~~~~~~~~~~ 389 (457)
....||+.|+|||++.+..++.++|||||||+||||++|+.||.+... ...+..+......... ...++.++.+
T Consensus 171 ~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~ 250 (483)
T 3sv0_A 171 KNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEALCRGYPTEFAS 250 (483)
T ss_dssp CCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHHHHTTSCHHHHH
T ss_pred cccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHHHHhcCCcHHHHH
Confidence 135699999999999999999999999999999999999999987543 3333443333222211 1357899999
Q ss_pred HHHHHhhhCCCCCCCCCcChHHHh----------cCCCCCCCCchhhhcc
Q 012762 390 LIAQLLVKDPTRRMGSKMGATAIK----------RHQFFNGVNWALLRCA 429 (457)
Q Consensus 390 ll~~~L~~dP~~Rps~~~~~~~ll----------~hp~f~~~~~~~~~~~ 429 (457)
||.+||..||++||+ +.+|+ .++|+..++|..++..
T Consensus 251 li~~cl~~dP~~RPs----~~el~~~L~~l~~~~~~~~~~~~dW~~~~~~ 296 (483)
T 3sv0_A 251 YFHYCRSLRFDDKPD----YSYLKRLFRDLFIREGFQFDYVFDWTILKYQ 296 (483)
T ss_dssp HHHHHHTCCTTCCCC----HHHHHHHHHHHHHHTTCCCSSCCHHHHHTC-
T ss_pred HHHHHhcCChhhCcC----HHHHHHHHHHHHHHcCCCccCCcCchhhccc
Confidence 999999999999999 55543 5899999999988554
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-45 Score=351.85 Aligned_cols=257 Identities=18% Similarity=0.234 Sum_probs=207.3
Q ss_pred CceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcE-
Q 012762 83 DLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWS- 161 (457)
Q Consensus 83 ~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~- 161 (457)
.|.+.++||+|+||+||+|.+.... .++..||+|++... ........+.+|+++++.++||||+++++++...+..
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~-~~~~~~aiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 98 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQA-QNRIQCAIKSLSRI--TEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLP 98 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSS-SCEEEEEEEEETTC--CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred EEccCceeccCCCceEEEEEEecCC-Cceeeeeeeecccc--ccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCc
Confidence 4667799999999999999976422 34568999998653 2334456788899999999999999999999876655
Q ss_pred EEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCC
Q 012762 162 CLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNS 241 (457)
Q Consensus 162 ~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~ 241 (457)
++||||+.+++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 99 ~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 177 (298)
T 3pls_A 99 HVLLPYMCHGDLLQFIRSP-QRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDR 177 (298)
T ss_dssp EEEECCCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTG
T ss_pred EEEEecccCCCHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCC
Confidence 9999999999999988763 467899999999999999999999999999999999999999999999999998654321
Q ss_pred CcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCC
Q 012762 242 TSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGT 321 (457)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 321 (457)
.... ........||
T Consensus 178 ~~~~------------------------------------------------------------------~~~~~~~~~~ 191 (298)
T 3pls_A 178 EYYS------------------------------------------------------------------VQQHRHARLP 191 (298)
T ss_dssp GGGC------------------------------------------------------------------SCCSSCTTCG
T ss_pred cccc------------------------------------------------------------------cccCcCCCCC
Confidence 1100 0011123588
Q ss_pred CCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCC-CCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhhhCCC
Q 012762 322 HEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTP-FKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDPT 400 (457)
Q Consensus 322 ~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~P-f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~ 400 (457)
+.|+|||++.+..++.++|||||||++|+|++|..| |...... .....+......+....+++.+.++|.+||..||.
T Consensus 192 ~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~ 270 (298)
T 3pls_A 192 VKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPF-DLTHFLAQGRRLPQPEYCPDSLYQVMQQCWEADPA 270 (298)
T ss_dssp GGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGG-GHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGG
T ss_pred ccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHH-HHHHHhhcCCCCCCCccchHHHHHHHHHHccCChh
Confidence 999999999999999999999999999999995555 5444444 44444444445555667899999999999999999
Q ss_pred CCCCCCcChHHHhc
Q 012762 401 RRMGSKMGATAIKR 414 (457)
Q Consensus 401 ~Rps~~~~~~~ll~ 414 (457)
+||+ +.++++
T Consensus 271 ~Rps----~~~ll~ 280 (298)
T 3pls_A 271 VRPT----FRVLVG 280 (298)
T ss_dssp GSCC----HHHHHH
T ss_pred hCcC----HHHHHH
Confidence 9999 877765
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=386.74 Aligned_cols=261 Identities=23% Similarity=0.338 Sum_probs=219.0
Q ss_pred CCCCccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEE
Q 012762 75 NNNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYAT 154 (457)
Q Consensus 75 ~~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~ 154 (457)
..+.+..++|++.++||+|+||+||+|.++ .+..||||+++.... ..+.+.+|+++|++|+|+||++++++
T Consensus 260 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~-----~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~~~~~ 330 (535)
T 2h8h_A 260 DAWEIPRESLRLEVKLGQGCFGEVWMGTWN-----GTTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAV 330 (535)
T ss_dssp TCSBCCGGGEEEEEEEEECSSEEEEEEEET-----TTEEEEEEEECTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cceecchhhhhhheecccCCCeEEEEEEEC-----CCceEEEEEeCCCCC----CHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 345677788999999999999999999975 456799999976432 34568889999999999999999999
Q ss_pred EEcCCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCC
Q 012762 155 LDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDL 234 (457)
Q Consensus 155 ~~~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~ 234 (457)
+.. +.+||||||+++|+|.+++.......+++..++.++.||+.||.|||++|||||||||+||||+.++.+||+|||+
T Consensus 331 ~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~ 409 (535)
T 2h8h_A 331 VSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGL 409 (535)
T ss_dssp ECS-SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTS
T ss_pred Eee-ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEccccc
Confidence 876 6789999999999999998764445699999999999999999999999999999999999999999999999999
Q ss_pred CcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccc
Q 012762 235 SLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVR 314 (457)
Q Consensus 235 s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (457)
++.........
T Consensus 410 a~~~~~~~~~~--------------------------------------------------------------------- 420 (535)
T 2h8h_A 410 ARLIEDNEYTA--------------------------------------------------------------------- 420 (535)
T ss_dssp TTTCCCHHHHT---------------------------------------------------------------------
T ss_pred ceecCCCceec---------------------------------------------------------------------
Confidence 86553211000
Q ss_pred cccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHH
Q 012762 315 SMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQ 393 (457)
Q Consensus 315 ~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~ 393 (457)
.....++..|+|||++.+..++.++|||||||+||||++ |+.||.+....+.+..+. ...+.+....++..+.+||.+
T Consensus 421 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~-~~~~~~~~~~~~~~l~~li~~ 499 (535)
T 2h8h_A 421 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPECPESLHDLMCQ 499 (535)
T ss_dssp TCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHH-TTCCCCCCTTCCHHHHHHHHH
T ss_pred ccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHHHHHHHHH
Confidence 001247889999999999899999999999999999999 999999988777666554 445566666799999999999
Q ss_pred HhhhCCCCCCCCCcChHHHhcC--CCCC
Q 012762 394 LLVKDPTRRMGSKMGATAIKRH--QFFN 419 (457)
Q Consensus 394 ~L~~dP~~Rps~~~~~~~ll~h--p~f~ 419 (457)
||..||++||+ +++|++. .+|.
T Consensus 500 cl~~dP~~RPt----~~~l~~~L~~~~~ 523 (535)
T 2h8h_A 500 CWRKEPEERPT----FEYLQAFLEDYFT 523 (535)
T ss_dssp HTCSSGGGSCC----HHHHHHHHHTSSC
T ss_pred HcCCChhHCcC----HHHHHHHHHHHhh
Confidence 99999999999 8877653 3444
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-45 Score=354.13 Aligned_cols=255 Identities=22% Similarity=0.392 Sum_probs=204.0
Q ss_pred CccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEc
Q 012762 78 PLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDC 157 (457)
Q Consensus 78 ~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~ 157 (457)
.+..++|++.+.||+|+||+||+|.+ .++.||+|++... .....+.+|+++|++++||||+++++++.+
T Consensus 4 ~i~~~~~~~~~~lg~G~~g~V~~~~~------~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 72 (307)
T 2eva_A 4 MIDYKEIEVEEVVGRGAFGVVCKAKW------RAKDVAIKQIESE-----SERKAFIVELRQLSRVNHPNIVKLYGACLN 72 (307)
T ss_dssp BCCGGGEEEEEEEECCSSSEEEEEEE------TTEEEEEEECSST-----THHHHHHHHHHHHHHCCCTTBCCEEEBCTT
T ss_pred cCCHhHeeeeeEeecCCCceEEEEEE------CCeeEEEEEecCh-----hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC
Confidence 35677999999999999999999986 3678999998643 345678889999999999999999998863
Q ss_pred CCcEEEEEeecCCCChHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHH---cCceeecCCCCCeEEccCCC-EEEecc
Q 012762 158 PRWSCLLTEFCPGGDLHVLRQRQPD-KRFHESAVRFYASEVVVALEFLHM---MGIIYRDLKPENVLVRSDGH-IMLTDF 232 (457)
Q Consensus 158 ~~~~~lV~E~~~~~sL~~~~~~~~~-~~~~~~~~~~i~~qi~~~L~yLH~---~~iiHrDIKp~NIll~~~~~-vkl~DF 232 (457)
..|+||||+++++|.+++..... ..+++..+..++.||+.||.|||+ +||+||||||+|||++.++. +||+||
T Consensus 73 --~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Df 150 (307)
T 2eva_A 73 --PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDF 150 (307)
T ss_dssp --TTEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCC
T ss_pred --CcEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccc
Confidence 47999999999999999876422 247899999999999999999999 89999999999999998886 799999
Q ss_pred CCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCc
Q 012762 233 DLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLD 312 (457)
Q Consensus 233 G~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (457)
|++.......
T Consensus 151 g~~~~~~~~~---------------------------------------------------------------------- 160 (307)
T 2eva_A 151 GTACDIQTHM---------------------------------------------------------------------- 160 (307)
T ss_dssp CC------------------------------------------------------------------------------
T ss_pred cccccccccc----------------------------------------------------------------------
Confidence 9975432110
Q ss_pred cccccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHH-HHHHHHhcccCCCCCCCCChHHHHHH
Q 012762 313 VRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHEL-TLANVVARALEFPKEPSVPGPAKDLI 391 (457)
Q Consensus 313 ~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ll 391 (457)
....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ............+....++..+.++|
T Consensus 161 ---~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 237 (307)
T 2eva_A 161 ---TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIESLM 237 (307)
T ss_dssp -------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCCCBTTCCHHHHHHH
T ss_pred ---ccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCCcccccCHHHHHHH
Confidence 01248999999999999999999999999999999999999998653322 22222223333444456899999999
Q ss_pred HHHhhhCCCCCCCCCcChHHHhc-----CCCCCCCC
Q 012762 392 AQLLVKDPTRRMGSKMGATAIKR-----HQFFNGVN 422 (457)
Q Consensus 392 ~~~L~~dP~~Rps~~~~~~~ll~-----hp~f~~~~ 422 (457)
.+||+.||++||+ +.++++ ..+|.+.+
T Consensus 238 ~~~l~~dp~~Rps----~~ell~~L~~~~~~~~~~~ 269 (307)
T 2eva_A 238 TRCWSKDPSQRPS----MEEIVKIMTHLMRYFPGAD 269 (307)
T ss_dssp HHHTCSSGGGSCC----HHHHHHHHHHHGGGCCCTT
T ss_pred HHHhcCChhhCcC----HHHHHHHHHHHHHhccCCC
Confidence 9999999999999 888876 35555433
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-45 Score=385.62 Aligned_cols=260 Identities=20% Similarity=0.278 Sum_probs=212.5
Q ss_pred CCCccCCCceeEE-EecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEE
Q 012762 76 NNPLTLSDLRFVH-RLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYAT 154 (457)
Q Consensus 76 ~~~~~~~~~~~~~-~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~ 154 (457)
.+.+..+++.+.+ +||+|+||+||+|.++.. ..+..||||+++.. ........+.+|+++|++++|||||+++++
T Consensus 329 ~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~--~~~~~vAvK~~~~~--~~~~~~~~~~~E~~il~~l~hpniv~l~~~ 404 (613)
T 2ozo_A 329 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMR--KKQIDVAIKVLKQG--TEKADTEEMMREAQIMHQLDNPYIVRLIGV 404 (613)
T ss_dssp CSBCCTTSEEEEEEEEEECSSSEEEEEEEECS--SCEEEEEEEECCCC--CSSTTHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred ceeccccceeEcCcEEecCCCcEEEEEEEecC--CCcEEEEEEEcCCC--CChHHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 3445666777777 899999999999987632 35678999999764 223456778899999999999999999999
Q ss_pred EEcCCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCC
Q 012762 155 LDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDL 234 (457)
Q Consensus 155 ~~~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~ 234 (457)
+.. +.+|||||||.+|+|.+++... ...+++..++.++.||+.||.|||++|||||||||+||||+.++.+||+|||+
T Consensus 405 ~~~-~~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGl 482 (613)
T 2ozo_A 405 CQA-EALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGL 482 (613)
T ss_dssp EES-SSEEEEEECCTTCBHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCST
T ss_pred ecc-CCeEEEEEeCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccC
Confidence 976 5689999999999999988654 35699999999999999999999999999999999999999999999999999
Q ss_pred CcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccc
Q 012762 235 SLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVR 314 (457)
Q Consensus 235 s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (457)
++.......... .
T Consensus 483 a~~~~~~~~~~~-------------------------------------------------------------------~ 495 (613)
T 2ozo_A 483 SKALGADDSYYT-------------------------------------------------------------------A 495 (613)
T ss_dssp TTTCC---------------------------------------------------------------------------
T ss_pred cccccCCCceee-------------------------------------------------------------------e
Confidence 876532111000 0
Q ss_pred cccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHH
Q 012762 315 SMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQ 393 (457)
Q Consensus 315 ~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~ 393 (457)
.....+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+....+....+..+ .+.+....+++++.+||.+
T Consensus 496 ~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~-~~~~~p~~~~~~l~~li~~ 574 (613)
T 2ozo_A 496 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG-KRMECPPECPPELYALMSD 574 (613)
T ss_dssp ------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTT-CCCCCCTTCCHHHHHHHHH
T ss_pred ccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC-CCCCCCCcCCHHHHHHHHH
Confidence 001136789999999999999999999999999999998 99999998877766665543 3455556799999999999
Q ss_pred HhhhCCCCCCCCCcChHHHh
Q 012762 394 LLVKDPTRRMGSKMGATAIK 413 (457)
Q Consensus 394 ~L~~dP~~Rps~~~~~~~ll 413 (457)
||..||++||+ +.+|+
T Consensus 575 cl~~dP~~RPs----~~~l~ 590 (613)
T 2ozo_A 575 CWIYKWEDRPD----FLTVE 590 (613)
T ss_dssp TTCSSTTTSCC----HHHHH
T ss_pred HcCCChhHCcC----HHHHH
Confidence 99999999999 77764
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=365.82 Aligned_cols=266 Identities=18% Similarity=0.196 Sum_probs=199.4
Q ss_pred ccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhh--------hhHHHHHHHHHHHHHHcCCCCCce
Q 012762 79 LTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVS--------RNKESRARIEREILEMLDHPFLPT 150 (457)
Q Consensus 79 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~--------~~~~~~~~~E~~il~~l~H~nIv~ 150 (457)
+..++|++.+.||+|+||+||+|.+.... .++..||+|++....... ......+.+|+.+++.++||||++
T Consensus 34 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~-~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~ 112 (345)
T 2v62_A 34 MEGNQWVLGKKIGSGGFGLIYLAFPTNKP-EKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPL 112 (345)
T ss_dssp TTSCEEEEEEEC------CEEEEEESSSC-GGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCC
T ss_pred ccCceEEEEeeEeecCCeEEEEEEecCCC-CccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcce
Confidence 44578999999999999999999986321 267889999987543211 111233556888899999999999
Q ss_pred EEEEEEc----CCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCC-
Q 012762 151 LYATLDC----PRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDG- 225 (457)
Q Consensus 151 l~~~~~~----~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~- 225 (457)
+++++.. ....||||||+ +++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~ 189 (345)
T 2v62_A 113 FYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQN--GTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNP 189 (345)
T ss_dssp EEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGG--GBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSST
T ss_pred eecccccccCCCcEEEEEEecc-CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCC
Confidence 9999987 67899999999 99999988765 4799999999999999999999999999999999999999887
Q ss_pred -CEEEeccCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCC
Q 012762 226 -HIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTP 304 (457)
Q Consensus 226 -~vkl~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (457)
.+||+|||+++..........
T Consensus 190 ~~~kL~Dfg~a~~~~~~~~~~~---------------------------------------------------------- 211 (345)
T 2v62_A 190 DQVYLADYGLSYRYCPNGNHKQ---------------------------------------------------------- 211 (345)
T ss_dssp TSEEECCCTTCEESSGGGCCCC----------------------------------------------------------
T ss_pred CcEEEEeCCCceeccccccccc----------------------------------------------------------
Confidence 999999999865532111000
Q ss_pred cccccCCccccccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCCh-HHHHHHHH-hcccCCCC---
Q 012762 305 EIVAEPLDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDH-ELTLANVV-ARALEFPK--- 379 (457)
Q Consensus 305 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~-~~~~~~~~-~~~~~~~~--- 379 (457)
..........||+.|+|||++.+..++.++|||||||++|||++|+.||.+... ........ ......+.
T Consensus 212 -----~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (345)
T 2v62_A 212 -----YQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTAKTNLLDELPQSVL 286 (345)
T ss_dssp -----CCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHHHHHHHHTTTHHHH
T ss_pred -----chhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHHHHHhhcccccHHHH
Confidence 000111234699999999999999999999999999999999999999965322 11111111 11111111
Q ss_pred ----CCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcC
Q 012762 380 ----EPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRH 415 (457)
Q Consensus 380 ----~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~h 415 (457)
...++.++.++|.+||..||++||+ +++|++.
T Consensus 287 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps----~~~l~~~ 322 (345)
T 2v62_A 287 KWAPSGSSCCEIAQFLVCAHSLAYDEKPN----YQALKKI 322 (345)
T ss_dssp HHSCTTSCCHHHHHHHHHHHTCCTTCCCC----HHHHHHH
T ss_pred hhccccccHHHHHHHHHHHhhcCcccCCC----HHHHHHH
Confidence 1258899999999999999999999 8887663
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-46 Score=365.00 Aligned_cols=256 Identities=21% Similarity=0.220 Sum_probs=205.3
Q ss_pred cCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCC
Q 012762 80 TLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPR 159 (457)
Q Consensus 80 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~ 159 (457)
..++|++.+.||+|+||+||+|.++ +++.||||++.... ......+.+|+++|+.++||||+++++++...+
T Consensus 37 ~~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 108 (321)
T 2qkw_B 37 ATNNFDHKFLIGHGVFGKVYKGVLR-----DGAKVALKRRTPES---SQGIEEFETEIETLSFCRHPHLVSLIGFCDERN 108 (321)
T ss_dssp CCCCCSCCCCSCBCSSSEEEEEECT-----TCCEEEEEECCSCC---SSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTT
T ss_pred HHhccCccceeecCCCeeEEEEEEC-----CCCEEEEEEecccC---hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC
Confidence 4578999999999999999999864 68899999986542 234567888999999999999999999999999
Q ss_pred cEEEEEeecCCCChHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcC
Q 012762 160 WSCLLTEFCPGGDLHVLRQRQP--DKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLK 237 (457)
Q Consensus 160 ~~~lV~E~~~~~sL~~~~~~~~--~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~ 237 (457)
..|+||||+++++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 188 (321)
T 2qkw_B 109 EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKK 188 (321)
T ss_dssp CCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEE
T ss_pred eEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeecccccc
Confidence 9999999999999998876542 23589999999999999999999999999999999999999999999999999864
Q ss_pred CCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcccccc
Q 012762 238 GDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMS 317 (457)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (457)
....... .....
T Consensus 189 ~~~~~~~--------------------------------------------------------------------~~~~~ 200 (321)
T 2qkw_B 189 GTELDQT--------------------------------------------------------------------HLSTV 200 (321)
T ss_dssp CSSSSCC--------------------------------------------------------------------CCBCC
T ss_pred ccccccc--------------------------------------------------------------------ccccc
Confidence 3311100 00112
Q ss_pred ccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHH-------HHHHhcccCC--------CCCCC
Q 012762 318 FVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTL-------ANVVARALEF--------PKEPS 382 (457)
Q Consensus 318 ~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~-------~~~~~~~~~~--------~~~~~ 382 (457)
..||+.|+|||++.+..++.++|||||||++|||++|+.||.+....... .......+.. .....
T Consensus 201 ~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (321)
T 2qkw_B 201 VKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPE 280 (321)
T ss_dssp CEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCTTCSCHH
T ss_pred cCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhhccccCHH
Confidence 35899999999999889999999999999999999999999764332111 0111111110 01112
Q ss_pred CChHHHHHHHHHhhhCCCCCCCCCcChHHHhcC
Q 012762 383 VPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRH 415 (457)
Q Consensus 383 ~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~h 415 (457)
.+..+.+++.+||..||++||+ +.|+++|
T Consensus 281 ~~~~l~~li~~~l~~dP~~Rps----~~ell~~ 309 (321)
T 2qkw_B 281 SLRKFGDTAVKCLALSSEDRPS----MGDVLWK 309 (321)
T ss_dssp HHHHHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred HHHHHHHHHHHHcCCCcccCcC----HHHHHHH
Confidence 3456889999999999999999 9998876
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-45 Score=352.42 Aligned_cols=258 Identities=15% Similarity=0.235 Sum_probs=207.5
Q ss_pred CCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEE-EcCCc
Q 012762 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATL-DCPRW 160 (457)
Q Consensus 82 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~-~~~~~ 160 (457)
.+|++.++||+|+||+||+|.+.... ..+..||+|++... ........+.+|++++++++||||+++++++ ..++.
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~-~~~~~~avk~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 101 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDND-GKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGS 101 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC------CEEEEEEEETTC--CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSC
T ss_pred eehhhcceeeecCCceEEEEEEecCC-CceeEEEEEecccC--CCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCc
Confidence 46999999999999999999875322 24457899998653 2334556788899999999999999999985 45668
Q ss_pred EEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCC
Q 012762 161 SCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDN 240 (457)
Q Consensus 161 ~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~ 240 (457)
.|+||||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 102 ~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 180 (298)
T 3f66_A 102 PLVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 180 (298)
T ss_dssp CEEEEECCTTCBHHHHHHCT-TCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred eEEEEeCCCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccccc
Confidence 89999999999999998753 36689999999999999999999999999999999999999999999999999875542
Q ss_pred CCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccC
Q 012762 241 STSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVG 320 (457)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 320 (457)
..... ........|
T Consensus 181 ~~~~~------------------------------------------------------------------~~~~~~~~~ 194 (298)
T 3f66_A 181 KEYYS------------------------------------------------------------------VHNKTGAKL 194 (298)
T ss_dssp GGGCB------------------------------------------------------------------C-----CCB
T ss_pred cchhc------------------------------------------------------------------cccccCCCC
Confidence 21100 000112358
Q ss_pred CCCccCchhhcCCCCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhhhCC
Q 012762 321 THEYLAPEIISGEGHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDP 399 (457)
Q Consensus 321 t~~y~aPE~l~~~~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP 399 (457)
|+.|+|||++.+..++.++|||||||++|+|++ |.+||.+.........+.... .......+++.+.+++.+||..||
T Consensus 195 ~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p 273 (298)
T 3f66_A 195 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR-RLLQPEYCPDPLYEVMLKCWHPKA 273 (298)
T ss_dssp CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTC-CCCCCTTCCHHHHHHHHHHTCSSG
T ss_pred CccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCC-CCCCCccCCHHHHHHHHHHcCCCh
Confidence 899999999999999999999999999999999 677777766665555555443 333345688999999999999999
Q ss_pred CCCCCCCcChHHHhc
Q 012762 400 TRRMGSKMGATAIKR 414 (457)
Q Consensus 400 ~~Rps~~~~~~~ll~ 414 (457)
++||+ +.++++
T Consensus 274 ~~Rps----~~ell~ 284 (298)
T 3f66_A 274 EMRPS----FSELVS 284 (298)
T ss_dssp GGSCC----HHHHHH
T ss_pred hhCcC----HHHHHH
Confidence 99999 888775
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-45 Score=355.00 Aligned_cols=251 Identities=25% Similarity=0.359 Sum_probs=196.6
Q ss_pred ccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHH--cCCCCCceEEEEEE
Q 012762 79 LTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEM--LDHPFLPTLYATLD 156 (457)
Q Consensus 79 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~--l~H~nIv~l~~~~~ 156 (457)
...++|++.+.||+|+||+||+|.+ +++.||||++... ....+..|.+++.. ++||||+++++++.
T Consensus 5 ~~~~~y~~~~~lg~G~~g~V~~~~~------~~~~vavK~~~~~------~~~~~~~e~~~~~~~~l~h~niv~~~~~~~ 72 (301)
T 3q4u_A 5 TVARDITLLECVGKGRYGEVWRGSW------QGENVAVKIFSSR------DEKSWFRETELYNTVMLRHENILGFIASDM 72 (301)
T ss_dssp CCGGGCEEEEEEEECSSEEEEEEEE------TTEEEEEEEECGG------GHHHHHHHHHHHHHTCCCCTTBCCEEEEEE
T ss_pred cccCcEEEEEeeccCCCcEEEEEEE------CCEEEEEEEeccc------cchhhHHHHHHHHHhhccCcCeeeEEEeec
Confidence 3456899999999999999999975 5788999999654 23445567787777 79999999999865
Q ss_pred c----CCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH--------HcCceeecCCCCCeEEccC
Q 012762 157 C----PRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLH--------MMGIIYRDLKPENVLVRSD 224 (457)
Q Consensus 157 ~----~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH--------~~~iiHrDIKp~NIll~~~ 224 (457)
. ....|+||||+++|+|.++++. ..+++..++.++.||+.||.||| +.||+||||||+|||++.+
T Consensus 73 ~~~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~ 149 (301)
T 3q4u_A 73 TSRHSSTQLWLITHYHEMGSLYDYLQL---TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKN 149 (301)
T ss_dssp EEETTEEEEEEEECCCTTCBHHHHHTT---CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTT
T ss_pred cccCCCceeEEehhhccCCCHHHHHhh---cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCC
Confidence 4 3468999999999999999865 57999999999999999999999 9999999999999999999
Q ss_pred CCEEEeccCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCC
Q 012762 225 GHIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTP 304 (457)
Q Consensus 225 ~~vkl~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (457)
+.+||+|||+++.........
T Consensus 150 ~~~kl~Dfg~a~~~~~~~~~~----------------------------------------------------------- 170 (301)
T 3q4u_A 150 GQCCIADLGLAVMHSQSTNQL----------------------------------------------------------- 170 (301)
T ss_dssp SCEEECCCTTCEEEETTTTEE-----------------------------------------------------------
T ss_pred CCEEEeeCCCeeecccccccc-----------------------------------------------------------
Confidence 999999999986543221110
Q ss_pred cccccCCccccccccCCCCccCchhhcCC------CCCccchhhhhhHHHHHHhcC----------CCCCCCCCh----H
Q 012762 305 EIVAEPLDVRSMSFVGTHEYLAPEIISGE------GHGNAVDWWTLGIFIFELFYG----------TTPFKGIDH----E 364 (457)
Q Consensus 305 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~------~~~~~sDiwSlG~il~elltG----------~~Pf~~~~~----~ 364 (457)
.......+||+.|+|||++.+. .++.++|||||||++|||++| ..||..... .
T Consensus 171 -------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~~ 243 (301)
T 3q4u_A 171 -------DVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSF 243 (301)
T ss_dssp -------ECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred -------cccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCcch
Confidence 0011134699999999999877 345799999999999999999 889865422 2
Q ss_pred HHHHHHHhcccCCCCCC------CCChHHHHHHHHHhhhCCCCCCCCCcChHHHhc
Q 012762 365 LTLANVVARALEFPKEP------SVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKR 414 (457)
Q Consensus 365 ~~~~~~~~~~~~~~~~~------~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~ 414 (457)
......+......+..+ .++.++.+||.+||+.||++||+ +.+|++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps----~~~i~~ 295 (301)
T 3q4u_A 244 EDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLT----ALRIKK 295 (301)
T ss_dssp HHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCC----HHHHHH
T ss_pred hhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCC----HHHHHH
Confidence 22333332222222211 13357999999999999999999 888875
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=348.94 Aligned_cols=256 Identities=18% Similarity=0.280 Sum_probs=203.8
Q ss_pred CCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEE-EcCC
Q 012762 81 LSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATL-DCPR 159 (457)
Q Consensus 81 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~-~~~~ 159 (457)
.++|++.+.||+|+||+||+|++. .+++.||+|++.... ....+.+|+++++.++|++++..+.++ ...+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~----~~~~~vavK~~~~~~-----~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~ 78 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDI----AAGEEVAIKLECVKT-----KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGD 78 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEET----TTTEEEEEEEEESCS-----SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETT
T ss_pred ccEEEEEEEEccCCCeEEEEEEEc----CCCcEEEEEEecCCc-----chhHHHHHHHHHHHhhcCCCCCccccccCCCC
Confidence 368999999999999999999976 478999999986542 223577899999999988866555544 6677
Q ss_pred cEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEE---ccCCCEEEeccCCCc
Q 012762 160 WSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLV---RSDGHIMLTDFDLSL 236 (457)
Q Consensus 160 ~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll---~~~~~vkl~DFG~s~ 236 (457)
..|+||||+ +++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.
T Consensus 79 ~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~ 156 (296)
T 3uzp_A 79 YNVMVMELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156 (296)
T ss_dssp EEEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCE
T ss_pred ceEEEEEec-CCCHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcc
Confidence 889999999 99999998754 3579999999999999999999999999999999999999 478899999999986
Q ss_pred CCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccc
Q 012762 237 KGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSM 316 (457)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (457)
........... ......
T Consensus 157 ~~~~~~~~~~~---------------------------------------------------------------~~~~~~ 173 (296)
T 3uzp_A 157 KYRDARTHQHI---------------------------------------------------------------PYRENK 173 (296)
T ss_dssp ECBCTTTCCBC---------------------------------------------------------------CCCCSC
T ss_pred ccccccccccc---------------------------------------------------------------cccccc
Confidence 55432111000 000112
Q ss_pred cccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCC---hHHHHHHHHhcccCCCC---CCCCChHHHHH
Q 012762 317 SFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGID---HELTLANVVARALEFPK---EPSVPGPAKDL 390 (457)
Q Consensus 317 ~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~---~~~~~~~~~~~~~~~~~---~~~~~~~~~~l 390 (457)
...||+.|+|||++.+..++.++|||||||++|||++|+.||.+.. ....+..+.......+. ...+++++.++
T Consensus 174 ~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 253 (296)
T 3uzp_A 174 NLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATY 253 (296)
T ss_dssp CCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHHTTTSCHHHHHH
T ss_pred ccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchHHHHhhCCHHHHHH
Confidence 3469999999999999999999999999999999999999998743 22344444444333331 24588999999
Q ss_pred HHHHhhhCCCCCCCCCcChHHHhc
Q 012762 391 IAQLLVKDPTRRMGSKMGATAIKR 414 (457)
Q Consensus 391 l~~~L~~dP~~Rps~~~~~~~ll~ 414 (457)
+.+||+.||++||+ +.+|++
T Consensus 254 i~~~l~~dp~~Rps----~~~l~~ 273 (296)
T 3uzp_A 254 LNFCRSLRFDDKPD----YSYLRQ 273 (296)
T ss_dssp HHHHHTSCTTCCCC----HHHHHH
T ss_pred HHHHHhcCcCcCCC----HHHHHH
Confidence 99999999999999 666653
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-45 Score=371.83 Aligned_cols=256 Identities=25% Similarity=0.339 Sum_probs=195.4
Q ss_pred CCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHc-CCCCCceEEEEEEcCCc
Q 012762 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEML-DHPFLPTLYATLDCPRW 160 (457)
Q Consensus 82 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~~~~~~~~~ 160 (457)
+.|.+.+.||+|+||+||.+.. .+|+.||||++... ....+.+|+++|+.+ +||||+++++++..++.
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~-----~~g~~vAvK~~~~~------~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~ 83 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGS-----FQGRPVAVKRMLID------FCDIALMEIKLLTESDDHPNVIRYYCSETTDRF 83 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEE-----SSSSEEEEEEEEGG------GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSE
T ss_pred heeeccCeEeeCCCeEEEEEEE-----ECCeEEEEEEEcHH------HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCe
Confidence 3466678899999999987543 36889999998653 234567799999876 89999999999999999
Q ss_pred EEEEEeecCCCChHHHHHhCCCCC-----CCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccC-----------
Q 012762 161 SCLLTEFCPGGDLHVLRQRQPDKR-----FHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSD----------- 224 (457)
Q Consensus 161 ~~lV~E~~~~~sL~~~~~~~~~~~-----~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~----------- 224 (457)
+||||||| +|+|.+++....... ..+..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 84 ~~lv~E~~-~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~ 162 (434)
T 2rio_A 84 LYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGA 162 (434)
T ss_dssp EEEEECCC-SEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCC
T ss_pred EEEEEecC-CCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCC
Confidence 99999999 569999988642211 1233456799999999999999999999999999999754
Q ss_pred --CCEEEeccCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCC
Q 012762 225 --GHIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPG 302 (457)
Q Consensus 225 --~~vkl~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (457)
+.+||+|||+++.........
T Consensus 163 ~~~~~kL~DFG~a~~~~~~~~~~--------------------------------------------------------- 185 (434)
T 2rio_A 163 ENLRILISDFGLCKKLDSGQSSF--------------------------------------------------------- 185 (434)
T ss_dssp CSCEEEECCCTTCEECCC--------------------------------------------------------------
T ss_pred CceEEEEcccccceecCCCCccc---------------------------------------------------------
Confidence 489999999987654221100
Q ss_pred CCcccccCCccccccccCCCCccCchhhcC-------CCCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHHhcc
Q 012762 303 TPEIVAEPLDVRSMSFVGTHEYLAPEIISG-------EGHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVVARA 374 (457)
Q Consensus 303 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-------~~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~ 374 (457)
.......+||+.|+|||++.+ ..++.++|||||||++|||++ |..||....... ..++...
T Consensus 186 ---------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~--~~i~~~~ 254 (434)
T 2rio_A 186 ---------RTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE--SNIIRGI 254 (434)
T ss_dssp ------------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH--HHHHHTC
T ss_pred ---------eeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH--HHHhcCC
Confidence 000113469999999999976 568999999999999999998 999997654332 3444554
Q ss_pred cCCCCCC-----CCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCCC
Q 012762 375 LEFPKEP-----SVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGV 421 (457)
Q Consensus 375 ~~~~~~~-----~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~~ 421 (457)
...+... .++.++.+||.+||+.||.+||+ +.+|++||||...
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps----~~eil~hp~f~~~ 302 (434)
T 2rio_A 255 FSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPT----AMKVLRHPLFWPK 302 (434)
T ss_dssp CCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCC----HHHHHTSGGGSCH
T ss_pred CCcccccccccccchHHHHHHHHHHhhCChhhCCC----HHHHHhCCccCCc
Confidence 4444322 23467999999999999999999 9999999999753
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-45 Score=365.77 Aligned_cols=248 Identities=18% Similarity=0.196 Sum_probs=197.6
Q ss_pred CccCCCceeEEEecccCcceEEEEEEec-cCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcC---CCCCceEEE
Q 012762 78 PLTLSDLRFVHRLGSGDIGSVYLVQLKS-KSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLD---HPFLPTLYA 153 (457)
Q Consensus 78 ~~~~~~~~~~~~LG~G~fg~Vy~a~~~~-~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~---H~nIv~l~~ 153 (457)
.+..++|++.++||+|+||+||+|++.. .+..+++.||+|++... ....+..|+++++.++ |+||+.+++
T Consensus 61 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~------~~~~~~~e~~~~~~l~~~~~~~iv~~~~ 134 (365)
T 3e7e_A 61 QLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA------NPWEFYIGTQLMERLKPSMQHMFMKFYS 134 (365)
T ss_dssp ECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC------CHHHHHHHHHHHHHSCGGGGGGBCCEEE
T ss_pred EECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC------ChhHHHHHHHHHHHhhhhhhhhhhhhhe
Confidence 3455789999999999999999996433 13357889999999653 3445677888888886 999999999
Q ss_pred EEEcCCcEEEEEeecCCCChHHHHHhC---CCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEcc-------
Q 012762 154 TLDCPRWSCLLTEFCPGGDLHVLRQRQ---PDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRS------- 223 (457)
Q Consensus 154 ~~~~~~~~~lV~E~~~~~sL~~~~~~~---~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~------- 223 (457)
++...+..|||||||++|+|.+++... ....+++..++.++.||+.||+|||++|||||||||+||||+.
T Consensus 135 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~ 214 (365)
T 3e7e_A 135 AHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDD 214 (365)
T ss_dssp EEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC--
T ss_pred eeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccc
Confidence 999999999999999999999998752 3467999999999999999999999999999999999999998
Q ss_pred ----CCCEEEeccCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCC
Q 012762 224 ----DGHIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLG 299 (457)
Q Consensus 224 ----~~~vkl~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (457)
++.+||+|||+++.......
T Consensus 215 ~~~~~~~~kl~DFG~a~~~~~~~~-------------------------------------------------------- 238 (365)
T 3e7e_A 215 EDDLSAGLALIDLGQSIDMKLFPK-------------------------------------------------------- 238 (365)
T ss_dssp ----CTTEEECCCTTCEEGGGSCT--------------------------------------------------------
T ss_pred cccccCCEEEeeCchhhhhhccCC--------------------------------------------------------
Confidence 89999999999854321100
Q ss_pred CCCCCcccccCCccccccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCC
Q 012762 300 NPGTPEIVAEPLDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPK 379 (457)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~ 379 (457)
.......+||+.|+|||++.+..|+.++|||||||++|||++|+.||......... ....+..
T Consensus 239 ------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~-----~~~~~~~ 301 (365)
T 3e7e_A 239 ------------GTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECK-----PEGLFRR 301 (365)
T ss_dssp ------------TEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEE-----ECSCCTT
T ss_pred ------------CceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCcee-----echhccc
Confidence 01112346999999999999999999999999999999999999999654321100 0001111
Q ss_pred CCCCChHHHHHHHHHhhhCCCCCCCC
Q 012762 380 EPSVPGPAKDLIAQLLVKDPTRRMGS 405 (457)
Q Consensus 380 ~~~~~~~~~~ll~~~L~~dP~~Rps~ 405 (457)
...++.+.+++..||..+|.+|++.
T Consensus 302 -~~~~~~~~~~~~~~l~~~p~~r~~~ 326 (365)
T 3e7e_A 302 -LPHLDMWNEFFHVMLNIPDCHHLPS 326 (365)
T ss_dssp -CSSHHHHHHHHHHHHCCCCTTCCCC
T ss_pred -cCcHHHHHHHHHHHcCCCCCCcchH
Confidence 1245678999999999999999873
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=386.23 Aligned_cols=258 Identities=20% Similarity=0.284 Sum_probs=209.9
Q ss_pred ccCCCceeE-EEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEc
Q 012762 79 LTLSDLRFV-HRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDC 157 (457)
Q Consensus 79 ~~~~~~~~~-~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~ 157 (457)
+....+.+. ++||+|+||+||+|.+... ..++.||||+++... ........+.+|+++|++++|||||++++++..
T Consensus 365 ~~~~~~~l~~~~LG~G~fG~Vy~~~~~~~--~~~~~vAvK~~~~~~-~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~ 441 (635)
T 4fl3_A 365 LDRKLLTLEDKELGSGNFGTVKKGYYQMK--KVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGICEA 441 (635)
T ss_dssp CCGGGEEEEEEEEEECSSEEEEEEEEECS--SCEEEEEEEEECGGG-GCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES
T ss_pred ccchhccccCCEeccCCCEEEEEEEEcCC--CcceEEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 344445554 4899999999999976532 467899999997653 233446778899999999999999999999975
Q ss_pred CCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcC
Q 012762 158 PRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLK 237 (457)
Q Consensus 158 ~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~ 237 (457)
+..+||||||++|+|.+++... ..+++..++.++.||+.||.|||++|||||||||+||||+.++.+||+|||+++.
T Consensus 442 -~~~~lv~E~~~~g~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~ 518 (635)
T 4fl3_A 442 -ESWMLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKA 518 (635)
T ss_dssp -SSEEEEEECCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHH
T ss_pred -CCEEEEEEccCCCCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccc
Confidence 5688999999999999999775 6799999999999999999999999999999999999999999999999999875
Q ss_pred CCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcccccc
Q 012762 238 GDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMS 317 (457)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (457)
........ .....
T Consensus 519 ~~~~~~~~-------------------------------------------------------------------~~~~~ 531 (635)
T 4fl3_A 519 LRADENYY-------------------------------------------------------------------KAQTH 531 (635)
T ss_dssp TTC-----------------------------------------------------------------------------
T ss_pred cccCcccc-------------------------------------------------------------------ccccC
Confidence 53221100 00011
Q ss_pred ccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhh
Q 012762 318 FVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLV 396 (457)
Q Consensus 318 ~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~ 396 (457)
..||+.|+|||++.+..++.++|||||||++|||++ |+.||.+....+....+..+ ...+....++.++.+||.+||.
T Consensus 532 ~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~-~~~~~p~~~~~~l~~li~~cl~ 610 (635)
T 4fl3_A 532 GKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG-ERMGCPAGCPREMYDLMNLCWT 610 (635)
T ss_dssp ---CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT-CCCCCCTTCCHHHHHHHHHHTC
T ss_pred CCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CCCCCCCCCCHHHHHHHHHHcC
Confidence 247889999999999999999999999999999998 99999998877666655443 3455556799999999999999
Q ss_pred hCCCCCCCCCcChHHHhc
Q 012762 397 KDPTRRMGSKMGATAIKR 414 (457)
Q Consensus 397 ~dP~~Rps~~~~~~~ll~ 414 (457)
.||++||+ +.+|++
T Consensus 611 ~dP~~RPs----~~~l~~ 624 (635)
T 4fl3_A 611 YDVENRPG----FAAVEL 624 (635)
T ss_dssp SSTTTSCC----HHHHHH
T ss_pred CCHhHCcC----HHHHHH
Confidence 99999999 777764
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=367.52 Aligned_cols=259 Identities=22% Similarity=0.267 Sum_probs=204.5
Q ss_pred ccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcC
Q 012762 79 LTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCP 158 (457)
Q Consensus 79 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~ 158 (457)
+..++|++.+.||+|+||+||+|.+. +++.||||++...... .....+.+|+++++.++||||+++++++...
T Consensus 27 ~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 99 (326)
T 3uim_A 27 VASDNFSNKNILGRGGFGKVYKGRLA-----DGTLVAVKRLKEERTQ--GGELQFQTEVEMISMAVHRNLLRLRGFCMTP 99 (326)
T ss_dssp TTTTSSCSTTEEECCSSSEEEEECCS-----SSCCEEEEECCC-------CCCHHHHHHHGGGTCCCTTBCCCCEEECCS
T ss_pred HHhhccccceeEecCCCcEEEEEEec-----CCCEEEEEEeccccCc--hHHHHHHHHHHHHHhccCCCccceEEEEecC
Confidence 34568999999999999999999753 6889999999765322 1223578899999999999999999999999
Q ss_pred CcEEEEEeecCCCChHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHc---CceeecCCCCCeEEccCCCEEEeccC
Q 012762 159 RWSCLLTEFCPGGDLHVLRQRQP--DKRFHESAVRFYASEVVVALEFLHMM---GIIYRDLKPENVLVRSDGHIMLTDFD 233 (457)
Q Consensus 159 ~~~~lV~E~~~~~sL~~~~~~~~--~~~~~~~~~~~i~~qi~~~L~yLH~~---~iiHrDIKp~NIll~~~~~vkl~DFG 233 (457)
+..++||||+++++|.+++.... ...+++..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+|||
T Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg 179 (326)
T 3uim_A 100 TERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 179 (326)
T ss_dssp SCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCS
T ss_pred CceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCc
Confidence 99999999999999999988753 23499999999999999999999999 99999999999999999999999999
Q ss_pred CCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcc
Q 012762 234 LSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDV 313 (457)
Q Consensus 234 ~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (457)
++.........
T Consensus 180 ~~~~~~~~~~~--------------------------------------------------------------------- 190 (326)
T 3uim_A 180 LAKLMDYKDTH--------------------------------------------------------------------- 190 (326)
T ss_dssp SCEECCSSSSC---------------------------------------------------------------------
T ss_pred cccccCccccc---------------------------------------------------------------------
Confidence 98654321110
Q ss_pred ccccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCC----ChHHHHHHHHhcccCCCC----------
Q 012762 314 RSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGI----DHELTLANVVARALEFPK---------- 379 (457)
Q Consensus 314 ~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~----~~~~~~~~~~~~~~~~~~---------- 379 (457)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||... .........+........
T Consensus 191 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (326)
T 3uim_A 191 VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQ 270 (326)
T ss_dssp EECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTTSSCTTCT
T ss_pred ccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhhhhhcChhhc
Confidence 111235999999999999888999999999999999999999999521 111112222222111110
Q ss_pred ---CCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCC
Q 012762 380 ---EPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQF 417 (457)
Q Consensus 380 ---~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~ 417 (457)
....+..+.+++.+||+.||.+||+ +.+|++|-.
T Consensus 271 ~~~~~~~~~~l~~li~~cl~~dP~~Rps----~~ell~~L~ 307 (326)
T 3uim_A 271 GNYKDEEVEQLIQVALLCTQSSPMERPK----MSEVVRMLE 307 (326)
T ss_dssp TSCCHHHHHHHHHHHHHHTCSCGGGSCC----HHHHHHHHH
T ss_pred cccCHHHHHHHHHHHHHHhCcCCccCCC----HHHHHHHhc
Confidence 0112256899999999999999999 999988743
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-45 Score=366.67 Aligned_cols=259 Identities=15% Similarity=0.234 Sum_probs=202.5
Q ss_pred CCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEE-cCCc
Q 012762 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLD-CPRW 160 (457)
Q Consensus 82 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~-~~~~ 160 (457)
..|++.+.||+|+||+||+|++...+ ..+..||+|++... ........+.+|++++++++||||+++++++. .++.
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~ 165 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDND-GKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGS 165 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETT-TEEEEEEEEECCSC--SCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSC
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCC-CcEEEEEEEEcCCC--CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCC
Confidence 35888999999999999999976421 23457899998643 23345677888999999999999999999864 4567
Q ss_pred EEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCC
Q 012762 161 SCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDN 240 (457)
Q Consensus 161 ~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~ 240 (457)
.|+||||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 166 ~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 244 (373)
T 3c1x_A 166 PLVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 244 (373)
T ss_dssp CEEEEECCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred eEEEEECCCCCCHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccccccccc
Confidence 89999999999999998754 35689999999999999999999999999999999999999999999999999865432
Q ss_pred CCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccC
Q 012762 241 STSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVG 320 (457)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 320 (457)
..... ........|
T Consensus 245 ~~~~~------------------------------------------------------------------~~~~~~~~~ 258 (373)
T 3c1x_A 245 KEFDS------------------------------------------------------------------VHNKTGAKL 258 (373)
T ss_dssp -------------------------------------------------------------------------------C
T ss_pred ccccc------------------------------------------------------------------ccccCCCCC
Confidence 11100 000112347
Q ss_pred CCCccCchhhcCCCCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhhhCC
Q 012762 321 THEYLAPEIISGEGHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDP 399 (457)
Q Consensus 321 t~~y~aPE~l~~~~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP 399 (457)
|+.|+|||++.+..++.++|||||||++|||++ |.+||.+....+....+.... ....+..++..+.++|.+||..||
T Consensus 259 ~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~-~~~~p~~~~~~l~~li~~cl~~dp 337 (373)
T 3c1x_A 259 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR-RLLQPEYCPDPLYEVMLKCWHPKA 337 (373)
T ss_dssp CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTC-CCCCCTTCCHHHHHHHHHHTCSSG
T ss_pred cccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCC-CCCCCCCCCHHHHHHHHHHcCCCh
Confidence 889999999999999999999999999999999 788888776655555554433 334445689999999999999999
Q ss_pred CCCCCCCcChHHHhcC
Q 012762 400 TRRMGSKMGATAIKRH 415 (457)
Q Consensus 400 ~~Rps~~~~~~~ll~h 415 (457)
++||+ +.+++++
T Consensus 338 ~~RPs----~~ell~~ 349 (373)
T 3c1x_A 338 EMRPS----FSELVSR 349 (373)
T ss_dssp GGSCC----HHHHHHH
T ss_pred hhCcC----HHHHHHH
Confidence 99999 8887764
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-45 Score=349.87 Aligned_cols=245 Identities=22% Similarity=0.352 Sum_probs=205.1
Q ss_pred CCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEc----
Q 012762 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDC---- 157 (457)
Q Consensus 82 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~---- 157 (457)
.+|++++.||+|+||+||+|.++ .+++.||+|++.... ..+.+|+++++.++||||+++++++..
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~----~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 79 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHR----IDGKTYVIKRVKYNN-------EKAEREVKALAKLDHVNIVHYNGCWDGFDYD 79 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEET----TTCCEEEEEEEECCS-------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC
T ss_pred cccceeeeeccCCceEEEEEEEc----CCCeEEEEEEecccc-------HHHHHHHHHHHhCCCCCEEEEeeeEeccccC
Confidence 47999999999999999999986 378899999997542 245679999999999999999998864
Q ss_pred ------------CCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCC
Q 012762 158 ------------PRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDG 225 (457)
Q Consensus 158 ------------~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~ 225 (457)
...+|+||||+++++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 80 ~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~ 159 (284)
T 2a19_B 80 PETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTK 159 (284)
T ss_dssp ---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT
T ss_pred cccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCC
Confidence 44589999999999999999876557799999999999999999999999999999999999999999
Q ss_pred CEEEeccCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCc
Q 012762 226 HIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPE 305 (457)
Q Consensus 226 ~vkl~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (457)
.+||+|||++........
T Consensus 160 ~~kl~Dfg~~~~~~~~~~-------------------------------------------------------------- 177 (284)
T 2a19_B 160 QVKIGDFGLVTSLKNDGK-------------------------------------------------------------- 177 (284)
T ss_dssp EEEECCCTTCEESSCCSC--------------------------------------------------------------
T ss_pred CEEECcchhheecccccc--------------------------------------------------------------
Confidence 999999999765432110
Q ss_pred ccccCCccccccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCCCCCCh
Q 012762 306 IVAEPLDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPG 385 (457)
Q Consensus 306 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (457)
.....||+.|+|||++.+..++.++|||||||++|+|++|..||... ......+.... ....++.
T Consensus 178 ---------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~--~~~~~~~~~~~----~~~~~~~ 242 (284)
T 2a19_B 178 ---------RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET--SKFFTDLRDGI----ISDIFDK 242 (284)
T ss_dssp ---------CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH--HHHHHHHHTTC----CCTTSCH
T ss_pred ---------ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH--HHHHHHhhccc----ccccCCH
Confidence 01235899999999999999999999999999999999999987532 22222222221 2245889
Q ss_pred HHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCC
Q 012762 386 PAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFF 418 (457)
Q Consensus 386 ~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f 418 (457)
.+.++|.+||..||.+||+ +.|+++|.+.
T Consensus 243 ~~~~li~~~l~~dp~~Rps----~~e~l~~l~~ 271 (284)
T 2a19_B 243 KEKTLLQKLLSKKPEDRPN----TSEILRTLTV 271 (284)
T ss_dssp HHHHHHHHHTCSSGGGSCC----HHHHHHHHHH
T ss_pred HHHHHHHHHccCChhhCcC----HHHHHHHHHH
Confidence 9999999999999999999 9999998653
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=373.99 Aligned_cols=260 Identities=22% Similarity=0.308 Sum_probs=198.5
Q ss_pred ccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHc-CCCCCceEEEEEEc
Q 012762 79 LTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEML-DHPFLPTLYATLDC 157 (457)
Q Consensus 79 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~~~~~~ 157 (457)
+...+|.+.+.||+|+||+||.... .+++.||||++..... ..+.+|+++|+.+ +||||+++++++.+
T Consensus 21 i~~~~y~~~~~LG~G~~G~V~~~~~-----~~~~~vAvK~~~~~~~------~~~~~E~~~l~~l~~HpnIv~l~~~~~~ 89 (432)
T 3p23_A 21 VGKISFCPKDVLGHGAEGTIVYRGM-----FDNRDVAVKRILPECF------SFADREVQLLRESDEHPNVIRYFCTEKD 89 (432)
T ss_dssp ETTEEEEEEEEEEECGGGCEEEEEE-----SSSSEEEEEEECTTTE------EECHHHHHHHHHSCCCTTBCCEEEEEEE
T ss_pred EccEEEecCCeeecCcCEEEEEEEE-----eCCeEEEEEEECHHHH------HHHHHHHHHHHhccCCCCcCeEEEEEec
Confidence 3445699999999999999764332 3688999999965422 1245699999999 79999999999999
Q ss_pred CCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEcc---C--CCEEEecc
Q 012762 158 PRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRS---D--GHIMLTDF 232 (457)
Q Consensus 158 ~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~---~--~~vkl~DF 232 (457)
.+..||||||| +|+|.+++.... ..+.+..++.++.||+.||.|||++||+||||||+||||+. + ..+||+||
T Consensus 90 ~~~~~lv~E~~-~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DF 167 (432)
T 3p23_A 90 RQFQYIAIELC-AATLQEYVEQKD-FAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDF 167 (432)
T ss_dssp TTEEEEEEECC-SEEHHHHHHSSS-CCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCT
T ss_pred CCEEEEEEECC-CCCHHHHHHhcC-CCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecc
Confidence 99999999999 569998887653 34555567889999999999999999999999999999953 2 35889999
Q ss_pred CCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCc
Q 012762 233 DLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLD 312 (457)
Q Consensus 233 G~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (457)
|+++.........
T Consensus 168 G~a~~~~~~~~~~------------------------------------------------------------------- 180 (432)
T 3p23_A 168 GLCKKLAVGRHSF------------------------------------------------------------------- 180 (432)
T ss_dssp TEEECC--------------------------------------------------------------------------
T ss_pred cceeeccCCCcce-------------------------------------------------------------------
Confidence 9986554211100
Q ss_pred cccccccCCCCccCchhhcC---CCCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHHhcccCCCC---CCCCCh
Q 012762 313 VRSMSFVGTHEYLAPEIISG---EGHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVVARALEFPK---EPSVPG 385 (457)
Q Consensus 313 ~~~~~~~gt~~y~aPE~l~~---~~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~---~~~~~~ 385 (457)
......+||+.|+|||++.+ ..++.++|||||||++|||++ |..||......... ++........ ....+.
T Consensus 181 ~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 258 (432)
T 3p23_A 181 SRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQAN--ILLGACSLDCLHPEKHEDV 258 (432)
T ss_dssp -----CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHH--HHTTCCCCTTSCTTCHHHH
T ss_pred eeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHH--HHhccCCccccCccccccH
Confidence 01113469999999999984 557889999999999999999 99999765443322 2222222211 112234
Q ss_pred HHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCCCCch
Q 012762 386 PAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGVNWA 424 (457)
Q Consensus 386 ~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~~~~~ 424 (457)
.+.+||.+||+.||.+||+ +.+|++||||..++|.
T Consensus 259 ~~~~li~~~L~~dP~~Rps----~~evl~hp~f~~~~~~ 293 (432)
T 3p23_A 259 IARELIEKMIAMDPQKRPS----AKHVLKHPFFWSLEKQ 293 (432)
T ss_dssp HHHHHHHHHSCSSGGGSCC----HHHHHTSTTTCCHHHH
T ss_pred HHHHHHHHHHhCCHhhCCC----HHHHHhCccccChHHH
Confidence 5889999999999999999 9999999999998884
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-45 Score=362.12 Aligned_cols=258 Identities=15% Similarity=0.192 Sum_probs=201.6
Q ss_pred CCCceeEEEecccCcceEEEEEEeccCC----CCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCce------
Q 012762 81 LSDLRFVHRLGSGDIGSVYLVQLKSKSS----NNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPT------ 150 (457)
Q Consensus 81 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~----~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~------ 150 (457)
.++|++.+.||+|+||+||+|+++.... ..++.||+|++.+. ..+.+|++++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------~~~~~E~~~l~~l~h~niv~~~~~~~ 112 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNEQNFFQRAAKPLQVNKWKKLY 112 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------STHHHHHHHHHHHCCHHHHHHHHHHT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------chHHHHHHHHHHhcccchhhhhhhhc
Confidence 4789999999999999999999863110 13789999999754 34677999999999999887
Q ss_pred ---------EEEEEEc-CCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeE
Q 012762 151 ---------LYATLDC-PRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVL 220 (457)
Q Consensus 151 ---------l~~~~~~-~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIl 220 (457)
+++++.. ++..||||||+ +++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 113 ~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl 191 (352)
T 2jii_A 113 STPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIF 191 (352)
T ss_dssp TCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEE
T ss_pred cCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEE
Confidence 6777765 67889999999 999999998765577999999999999999999999999999999999999
Q ss_pred EccCC--CEEEeccCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccC
Q 012762 221 VRSDG--HIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKL 298 (457)
Q Consensus 221 l~~~~--~vkl~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (457)
++.++ .+||+|||+++...........
T Consensus 192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~--------------------------------------------------- 220 (352)
T 2jii_A 192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAY--------------------------------------------------- 220 (352)
T ss_dssp EETTEEEEEEECCGGGCBCSSGGGCCCCC---------------------------------------------------
T ss_pred EcCCCCceEEEecCcceeeccCCCccccc---------------------------------------------------
Confidence 99988 8999999998765422110000
Q ss_pred CCCCCCcccccCCccccccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCC-hHHHHHHHHh----c
Q 012762 299 GNPGTPEIVAEPLDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGID-HELTLANVVA----R 373 (457)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~-~~~~~~~~~~----~ 373 (457)
.........||+.|+|||++.+..++.++|||||||++|||++|+.||.... ....+..... .
T Consensus 221 ------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 288 (352)
T 2jii_A 221 ------------VEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTEDIMKQKQKFVDK 288 (352)
T ss_dssp ------------CTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHS
T ss_pred ------------cccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCcCHHHHHHHHHhccCC
Confidence 0001113469999999999999999999999999999999999999998754 2222222221 1
Q ss_pred ccCCCC----CCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhc
Q 012762 374 ALEFPK----EPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKR 414 (457)
Q Consensus 374 ~~~~~~----~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~ 414 (457)
...+.. ...++.++.+||.+||..||++||+ +.+|++
T Consensus 289 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps----~~~l~~ 329 (352)
T 2jii_A 289 PGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPP----YAMLRN 329 (352)
T ss_dssp CCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCC----HHHHHH
T ss_pred hhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCC----HHHHHH
Confidence 111111 1246899999999999999999999 777653
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-46 Score=373.67 Aligned_cols=254 Identities=24% Similarity=0.387 Sum_probs=203.6
Q ss_pred cCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCC
Q 012762 80 TLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPR 159 (457)
Q Consensus 80 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~ 159 (457)
..++|++.++||+|+||+||+|+++ .+++.||||++..... ......+.+|+++|++++||||+++++++...+
T Consensus 7 ~~~~y~i~~~LG~G~~g~Vy~~~~~----~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 80 (396)
T 4eut_A 7 SNHLWLLSDILGQGATANVFRGRHK----KTGDLFAIKVFNNISF--LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETT 80 (396)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEET----TTCCEEEEEEECGGGG--GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTT
T ss_pred CCCceEEEEEEEcCCCeEEEEEEEC----CCCcEEEEEEeccccc--cchHHHHHHHHHHHHhcCCCCCCeEEEeeccCC
Confidence 3468999999999999999999987 4788999999976533 233566778999999999999999999998765
Q ss_pred --cEEEEEeecCCCChHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEE----ccCCCEEEecc
Q 012762 160 --WSCLLTEFCPGGDLHVLRQRQP-DKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLV----RSDGHIMLTDF 232 (457)
Q Consensus 160 --~~~lV~E~~~~~sL~~~~~~~~-~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll----~~~~~vkl~DF 232 (457)
..|+|||||++++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+||
T Consensus 81 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DF 160 (396)
T 4eut_A 81 TRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDF 160 (396)
T ss_dssp TCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCG
T ss_pred CCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecC
Confidence 7899999999999999887642 2349999999999999999999999999999999999999 67778999999
Q ss_pred CCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCc
Q 012762 233 DLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLD 312 (457)
Q Consensus 233 G~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (457)
|+++......
T Consensus 161 G~a~~~~~~~---------------------------------------------------------------------- 170 (396)
T 4eut_A 161 GAARELEDDE---------------------------------------------------------------------- 170 (396)
T ss_dssp GGCEECCCGG----------------------------------------------------------------------
T ss_pred CCceEccCCC----------------------------------------------------------------------
Confidence 9986543211
Q ss_pred cccccccCCCCccCchhhcC--------CCCCccchhhhhhHHHHHHhcCCCCCCCCC----hHHHHHHHHhcccC----
Q 012762 313 VRSMSFVGTHEYLAPEIISG--------EGHGNAVDWWTLGIFIFELFYGTTPFKGID----HELTLANVVARALE---- 376 (457)
Q Consensus 313 ~~~~~~~gt~~y~aPE~l~~--------~~~~~~sDiwSlG~il~elltG~~Pf~~~~----~~~~~~~~~~~~~~---- 376 (457)
.....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.... ....+..++.+...
T Consensus 171 -~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~~~~ 249 (396)
T 4eut_A 171 -QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAIS 249 (396)
T ss_dssp -GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCCTTCCE
T ss_pred -ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCCcccch
Confidence 0113469999999999875 457889999999999999999999997532 33445555543221
Q ss_pred ---------------CCCCCC----CChHHHHHHHHHhhhCCCCCCCCCcChHHHhc
Q 012762 377 ---------------FPKEPS----VPGPAKDLIAQLLVKDPTRRMGSKMGATAIKR 414 (457)
Q Consensus 377 ---------------~~~~~~----~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~ 414 (457)
++.... ++..+.++|.+||..||++||+ +.++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s----~~e~l~ 302 (396)
T 4eut_A 250 GVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWG----FDQFFA 302 (396)
T ss_dssp EEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCC----HHHHHH
T ss_pred hheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhcc----HHHHHH
Confidence 111111 2346889999999999999999 777643
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=354.83 Aligned_cols=263 Identities=21% Similarity=0.309 Sum_probs=213.0
Q ss_pred CCccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEE
Q 012762 77 NPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLD 156 (457)
Q Consensus 77 ~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~ 156 (457)
..+..++|++++.||+|+||+||+|++...+..+++.||+|++... .......+.+|+++|+.++||||+++++++.
T Consensus 36 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 112 (326)
T 2w1i_A 36 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYKGVCY 112 (326)
T ss_dssp -CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC---CSHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred cccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEE
Confidence 4556678999999999999999999876555568999999999753 2344567888999999999999999999986
Q ss_pred cCC--cEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCC
Q 012762 157 CPR--WSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDL 234 (457)
Q Consensus 157 ~~~--~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~ 234 (457)
..+ ..++||||+++++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 113 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~ 191 (326)
T 2w1i_A 113 SAGRRNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGL 191 (326)
T ss_dssp C----CCEEEECCCTTCBHHHHHHHST-TSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTT
T ss_pred ecCCCceEEEEECCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcc
Confidence 654 7899999999999999998753 4699999999999999999999999999999999999999999999999999
Q ss_pred CcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccc
Q 012762 235 SLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVR 314 (457)
Q Consensus 235 s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (457)
+........... .
T Consensus 192 ~~~~~~~~~~~~-------------------------------------------------------------------~ 204 (326)
T 2w1i_A 192 TKVLPQDKEYYK-------------------------------------------------------------------V 204 (326)
T ss_dssp CEECCSSCSEEE-------------------------------------------------------------------C
T ss_pred hhhccccccccc-------------------------------------------------------------------c
Confidence 865542211100 0
Q ss_pred cccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChH---------------HHHHHHHhcccCCCC
Q 012762 315 SMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHE---------------LTLANVVARALEFPK 379 (457)
Q Consensus 315 ~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~---------------~~~~~~~~~~~~~~~ 379 (457)
.....|+..|+|||++.+..++.++|||||||++|||++|..||...... ..+...+......+.
T Consensus 205 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (326)
T 2w1i_A 205 KEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPR 284 (326)
T ss_dssp SSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTCCCCC
T ss_pred ccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhhcCCCCCC
Confidence 00124788899999999888999999999999999999999998643111 012233333444555
Q ss_pred CCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhc
Q 012762 380 EPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKR 414 (457)
Q Consensus 380 ~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~ 414 (457)
...++.++.+||.+||..||++||+ +.+|++
T Consensus 285 ~~~~~~~l~~li~~cl~~dP~~Rps----~~el~~ 315 (326)
T 2w1i_A 285 PDGCPDEIYMIMTECWNNNVNQRPS----FRDLAL 315 (326)
T ss_dssp CTTCCHHHHHHHHHHSCSSGGGSCC----HHHHHH
T ss_pred CCcccHHHHHHHHHHcCCChhhCcC----HHHHHH
Confidence 6678999999999999999999999 888875
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=353.57 Aligned_cols=266 Identities=22% Similarity=0.331 Sum_probs=208.3
Q ss_pred CccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEE-
Q 012762 78 PLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLD- 156 (457)
Q Consensus 78 ~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~- 156 (457)
.+..++|++.+.||+|+||+||+|.++ .+++.||||++... .......+.+|+++++.++||||+++++++.
T Consensus 25 ~i~~~~y~~~~~lg~G~~g~V~~~~~~----~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 97 (317)
T 2buj_A 25 IIDNKHYLFIQKLGEGGFSYVDLVEGL----HDGHFYALKRILCH---EQQDREEAQREADMHRLFNHPNILRLVAYCLR 97 (317)
T ss_dssp EETTEEEEEEEEEEC--CEEEEEEEET----TTCCEEEEEEEEES---SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEE
T ss_pred EECCeEEEEEEEecCCCCeEEEEEEec----CCCcEEEEEEEecC---CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEe
Confidence 345678999999999999999999986 47889999998653 2245567888999999999999999999986
Q ss_pred ---cCCcEEEEEeecCCCChHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEec
Q 012762 157 ---CPRWSCLLTEFCPGGDLHVLRQRQ--PDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTD 231 (457)
Q Consensus 157 ---~~~~~~lV~E~~~~~sL~~~~~~~--~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~D 231 (457)
.....|+||||+.+++|.+++... ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|
T Consensus 98 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~d 177 (317)
T 2buj_A 98 ERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMD 177 (317)
T ss_dssp EETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECC
T ss_pred ccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEe
Confidence 334789999999999999888762 346799999999999999999999999999999999999999999999999
Q ss_pred cCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCC
Q 012762 232 FDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPL 311 (457)
Q Consensus 232 FG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (457)
||++............ ...
T Consensus 178 fg~~~~~~~~~~~~~~-------------------------------------------------------------~~~ 196 (317)
T 2buj_A 178 LGSMNQACIHVEGSRQ-------------------------------------------------------------ALT 196 (317)
T ss_dssp CSSCEESCEEEESHHH-------------------------------------------------------------HHH
T ss_pred cCcchhcccccccccc-------------------------------------------------------------ccc
Confidence 9987543211000000 000
Q ss_pred ccccccccCCCCccCchhhcCCC---CCccchhhhhhHHHHHHhcCCCCCCCCCh-HHHHHHHHhcccCCCCCCCCChHH
Q 012762 312 DVRSMSFVGTHEYLAPEIISGEG---HGNAVDWWTLGIFIFELFYGTTPFKGIDH-ELTLANVVARALEFPKEPSVPGPA 387 (457)
Q Consensus 312 ~~~~~~~~gt~~y~aPE~l~~~~---~~~~sDiwSlG~il~elltG~~Pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 387 (457)
........||+.|+|||++.+.. ++.++|||||||++|+|++|+.||..... .......+......+....++.++
T Consensus 197 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 276 (317)
T 2buj_A 197 LQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIPQSPRHSSAL 276 (317)
T ss_dssp HHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHCC--CCCCTTSCHHH
T ss_pred ccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhccCCCCccccCCHHH
Confidence 00011235899999999998664 68899999999999999999999964211 112223333455566666789999
Q ss_pred HHHHHHHhhhCCCCCCCCCcChHHHhcC
Q 012762 388 KDLIAQLLVKDPTRRMGSKMGATAIKRH 415 (457)
Q Consensus 388 ~~ll~~~L~~dP~~Rps~~~~~~~ll~h 415 (457)
.+||.+||..||.+||+ +.+++++
T Consensus 277 ~~li~~~l~~dp~~Rps----~~~ll~~ 300 (317)
T 2buj_A 277 WQLLNSMMTVDPHQRPH----IPLLLSQ 300 (317)
T ss_dssp HHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred HHHHHHHhhcChhhCCC----HHHHHHH
Confidence 99999999999999999 9999886
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=354.24 Aligned_cols=250 Identities=22% Similarity=0.337 Sum_probs=194.9
Q ss_pred CCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHc--CCCCCceEEEEEEcC
Q 012762 81 LSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEML--DHPFLPTLYATLDCP 158 (457)
Q Consensus 81 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l--~H~nIv~l~~~~~~~ 158 (457)
.++|++.+.||+|+||+||+|++ .++.||||++... .......|.+++..+ +||||+++++++...
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~------~~~~vavK~~~~~------~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~ 103 (337)
T 3mdy_A 36 AKQIQMVKQIGKGRYGEVWMGKW------RGEKVAVKVFFTT------EEASWFRETEIYQTVLMRHENILGFIAADIKG 103 (337)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEE------TTEEEEEEEEEGG------GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEES
T ss_pred ccceEEEeEeecCCCeEEEEEEE------CCceEEEEEEecc------ccchhhhHHHHHHHHhhcCCCeeeEEEEEccC
Confidence 35899999999999999999986 4789999998653 223344566666554 899999999999877
Q ss_pred ----CcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHc--------CceeecCCCCCeEEccCCC
Q 012762 159 ----RWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMM--------GIIYRDLKPENVLVRSDGH 226 (457)
Q Consensus 159 ----~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~--------~iiHrDIKp~NIll~~~~~ 226 (457)
...|+||||+++++|.++++. ..+++..++.++.||+.||.|||+. ||+||||||+|||++.++.
T Consensus 104 ~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~ 180 (337)
T 3mdy_A 104 TGSWTQLYLITDYHENGSLYDYLKS---TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGT 180 (337)
T ss_dssp CGGGCEEEEEECCCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSC
T ss_pred CCCCCceEEEEeccCCCcHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCC
Confidence 688999999999999999977 4699999999999999999999998 9999999999999999999
Q ss_pred EEEeccCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcc
Q 012762 227 IMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEI 306 (457)
Q Consensus 227 vkl~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (457)
+||+|||+++.........
T Consensus 181 ~kl~Dfg~a~~~~~~~~~~------------------------------------------------------------- 199 (337)
T 3mdy_A 181 CCIADLGLAVKFISDTNEV------------------------------------------------------------- 199 (337)
T ss_dssp EEECCCTTCEECC-------------------------------------------------------------------
T ss_pred EEEEeCCCceeeccccccc-------------------------------------------------------------
Confidence 9999999986553221110
Q ss_pred cccCCccccccccCCCCccCchhhcCCCCCcc------chhhhhhHHHHHHhcC----------CCCCCCCCh----HHH
Q 012762 307 VAEPLDVRSMSFVGTHEYLAPEIISGEGHGNA------VDWWTLGIFIFELFYG----------TTPFKGIDH----ELT 366 (457)
Q Consensus 307 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~------sDiwSlG~il~elltG----------~~Pf~~~~~----~~~ 366 (457)
.......+||+.|+|||++.+..+... +|||||||++|||++| +.||..... ...
T Consensus 200 -----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~ 274 (337)
T 3mdy_A 200 -----DIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYED 274 (337)
T ss_dssp --------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHH
T ss_pred -----cCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCCchhh
Confidence 000113469999999999988776655 9999999999999999 777765321 122
Q ss_pred HHHHHh-cccCCCCC-----CCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcC
Q 012762 367 LANVVA-RALEFPKE-----PSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRH 415 (457)
Q Consensus 367 ~~~~~~-~~~~~~~~-----~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~h 415 (457)
....+. ........ ..++.++.+||.+||+.||++||+ +.+|++|
T Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps----~~ell~~ 325 (337)
T 3mdy_A 275 MREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLT----ALRVKKT 325 (337)
T ss_dssp HHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCC----HHHHHHH
T ss_pred hHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCC----HHHHHHH
Confidence 222222 22221111 134456999999999999999999 9998876
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=353.60 Aligned_cols=264 Identities=24% Similarity=0.302 Sum_probs=190.2
Q ss_pred CccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcC-CCCCceEEEEEE
Q 012762 78 PLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLD-HPFLPTLYATLD 156 (457)
Q Consensus 78 ~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~-H~nIv~l~~~~~ 156 (457)
.+...+|++.++||+|+||+||+|+++ .+++.||+|++.... ......+.+|+.+++++. ||||+++++++.
T Consensus 24 ~~~~~~y~~~~~lg~G~~g~V~~~~~~----~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~ 96 (337)
T 3ll6_A 24 ELGELRLRVRRVLAEGGFAFVYEAQDV----GSGREYALKRLLSNE---EEKNRAIIQEVCFMKKLSGHPNIVQFCSAAS 96 (337)
T ss_dssp EETTEEEEEEEEEECCSSEEEEEEEET----TTCCEEEEEEEEESS---HHHHHHHHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred eccCceEEEEEEEccCCceEEEEEEEC----CCCcEEEEEEecCCc---hHHHHHHHHHHHHHHHhccCCChhhcccccc
Confidence 344458999999999999999999986 478899999986542 234566788999999995 999999999994
Q ss_pred --------cCCcEEEEEeecCCCChHHHHHh-CCCCCCCHHHHHHHHHHHHHHHHHHHHcC--ceeecCCCCCeEEccCC
Q 012762 157 --------CPRWSCLLTEFCPGGDLHVLRQR-QPDKRFHESAVRFYASEVVVALEFLHMMG--IIYRDLKPENVLVRSDG 225 (457)
Q Consensus 157 --------~~~~~~lV~E~~~~~sL~~~~~~-~~~~~~~~~~~~~i~~qi~~~L~yLH~~~--iiHrDIKp~NIll~~~~ 225 (457)
....+++||||+ +|+|.+++.. ...+.+++..++.++.||+.||.|||+.| |+||||||+|||++.++
T Consensus 97 ~~~~~~~~~~~~~~lv~e~~-~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~ 175 (337)
T 3ll6_A 97 IGKEESDTGQAEFLLLTELC-KGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQG 175 (337)
T ss_dssp ECTTTSTTSSEEEEEEEECC-SEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTS
T ss_pred ccccccccCCceEEEEEEec-CCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCC
Confidence 334579999999 5788877764 23467999999999999999999999999 99999999999999999
Q ss_pred CEEEeccCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCc
Q 012762 226 HIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPE 305 (457)
Q Consensus 226 ~vkl~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (457)
.+||+|||+++............
T Consensus 176 ~~kl~Dfg~~~~~~~~~~~~~~~--------------------------------------------------------- 198 (337)
T 3ll6_A 176 TIKLCDFGSATTISHYPDYSWSA--------------------------------------------------------- 198 (337)
T ss_dssp CEEBCCCTTCBCCSSCC---------------------------------------------------------------
T ss_pred CEEEecCccceeccccCcccccc---------------------------------------------------------
Confidence 99999999987654321110000
Q ss_pred ccccCCccccccccCCCCccCchhh---cCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCCCC
Q 012762 306 IVAEPLDVRSMSFVGTHEYLAPEII---SGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPS 382 (457)
Q Consensus 306 ~~~~~~~~~~~~~~gt~~y~aPE~l---~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 382 (457)
.............||+.|+|||++ .+..++.++|||||||++|+|++|+.||...... .++......+....
T Consensus 199 -~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~----~~~~~~~~~~~~~~ 273 (337)
T 3ll6_A 199 -QRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL----RIVNGKYSIPPHDT 273 (337)
T ss_dssp --------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----------------CCCCTTCC
T ss_pred -cccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH----HhhcCcccCCcccc
Confidence 000000111234699999999999 5666899999999999999999999999765443 23344455555566
Q ss_pred CChHHHHHHHHHhhhCCCCCCCCCcChHHHhcC
Q 012762 383 VPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRH 415 (457)
Q Consensus 383 ~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~h 415 (457)
.+..+.+||.+||+.||++||+ +.|+++|
T Consensus 274 ~~~~~~~li~~~l~~~p~~Rps----~~e~l~~ 302 (337)
T 3ll6_A 274 QYTVFHSLIRAMLQVNPEERLS----IAEVVHQ 302 (337)
T ss_dssp SSGGGHHHHHHHSCSSGGGSCC----HHHHHHH
T ss_pred cchHHHHHHHHHccCChhhCcC----HHHHHHH
Confidence 7889999999999999999999 9999887
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=349.42 Aligned_cols=233 Identities=27% Similarity=0.416 Sum_probs=189.8
Q ss_pred cCCCceeE-EEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHH-HHcCCCCCceEEEEEEc
Q 012762 80 TLSDLRFV-HRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREIL-EMLDHPFLPTLYATLDC 157 (457)
Q Consensus 80 ~~~~~~~~-~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il-~~l~H~nIv~l~~~~~~ 157 (457)
..++|.+. +.||+|+||+||+|.++ .+++.||+|++... ..+.+|++++ +.++||||+++++++..
T Consensus 15 ~~~~y~~~~~~lg~G~~g~V~~~~~~----~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~~i~~~~~~~~~ 82 (299)
T 3m2w_A 15 IIDDYKVTSQVLGLGINGKVLQIFNK----RTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYEN 82 (299)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEET----TTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred cccchhhcCcccccCCCeEEEEEEEc----CCCcEEEEEEeccc--------HHHHHHHHHHHHhccCCCchhHHhhhhh
Confidence 44678887 78999999999999986 47889999999642 2455688887 55699999999999976
Q ss_pred ----CCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEcc---CCCEEEe
Q 012762 158 ----PRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRS---DGHIMLT 230 (457)
Q Consensus 158 ----~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~---~~~vkl~ 230 (457)
....|+||||+++++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~ 162 (299)
T 3m2w_A 83 LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLT 162 (299)
T ss_dssp EETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEEC
T ss_pred hcCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEe
Confidence 678899999999999999998876668999999999999999999999999999999999999998 7899999
Q ss_pred ccCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccC
Q 012762 231 DFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEP 310 (457)
Q Consensus 231 DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (457)
|||++....
T Consensus 163 Dfg~a~~~~----------------------------------------------------------------------- 171 (299)
T 3m2w_A 163 DFGFAKETT----------------------------------------------------------------------- 171 (299)
T ss_dssp CCTTCEECT-----------------------------------------------------------------------
T ss_pred ccccccccc-----------------------------------------------------------------------
Confidence 999864221
Q ss_pred CccccccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHh----cccCCCC--CCCCC
Q 012762 311 LDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVA----RALEFPK--EPSVP 384 (457)
Q Consensus 311 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~----~~~~~~~--~~~~~ 384 (457)
+..++.++|||||||++|||++|+.||.+.........+.. ....++. ...++
T Consensus 172 ---------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (299)
T 3m2w_A 172 ---------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVS 230 (299)
T ss_dssp ---------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCHHHHTTSC
T ss_pred ---------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCchhcccCC
Confidence 23467899999999999999999999987544332211111 1111111 13578
Q ss_pred hHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCC
Q 012762 385 GPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNG 420 (457)
Q Consensus 385 ~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~ 420 (457)
.++.+||.+||..||++||+ +.|+++||||+.
T Consensus 231 ~~~~~li~~~l~~dP~~Rps----~~e~l~hp~~~~ 262 (299)
T 3m2w_A 231 EEVKMLIRNLLKTEPTQRMT----ITEFMNHPWIMQ 262 (299)
T ss_dssp HHHHHHHHHHTCSSTTTSCC----HHHHHTSHHHHT
T ss_pred HHHHHHHHHHcccChhhCCC----HHHHhcChhhcc
Confidence 89999999999999999999 999999999985
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-44 Score=352.40 Aligned_cols=263 Identities=25% Similarity=0.331 Sum_probs=193.2
Q ss_pred CCccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHH--HHcCCCCCceEEEE
Q 012762 77 NPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREIL--EMLDHPFLPTLYAT 154 (457)
Q Consensus 77 ~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il--~~l~H~nIv~l~~~ 154 (457)
..+..++|++++.||+|+||+||+|.+ +++.||||++.... ...+..|.+++ ..++|+||++++++
T Consensus 8 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~------~~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~h~~i~~~~~~ 75 (336)
T 3g2f_A 8 PSLDLDNLKLLELIGRGRYGAVYKGSL------DERPVAVKVFSFAN------RQNFINEKNIYRVPLMEHDNIARFIVG 75 (336)
T ss_dssp -CCCTTSEEEEEEEEECSSEEEEEEEE------TTEEEEEEEEEGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEE
T ss_pred CCcChHHhheeeecccCCCeEEEEEEE------CCeEEEEEEeeccc------hhhHHHHHHHHHHHhccCcchhhheec
Confidence 456788999999999999999999975 57899999997542 22333455554 45899999999986
Q ss_pred EEc-----CCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHc---------CceeecCCCCCeE
Q 012762 155 LDC-----PRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMM---------GIIYRDLKPENVL 220 (457)
Q Consensus 155 ~~~-----~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~---------~iiHrDIKp~NIl 220 (457)
+.. ...+|||||||++|+|.+++.. ...++..+..++.||+.||.|||+. ||+||||||+|||
T Consensus 76 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nil 152 (336)
T 3g2f_A 76 DERVTADGRMEYLLVMEYYPNGSLXKYLSL---HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVL 152 (336)
T ss_dssp EEEECTTSCEEEEEEECCCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEE
T ss_pred ccccccCCCceEEEEEecCCCCcHHHHHhh---cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEE
Confidence 532 2357899999999999999977 4468999999999999999999999 9999999999999
Q ss_pred EccCCCEEEeccCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCC
Q 012762 221 VRSDGHIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGN 300 (457)
Q Consensus 221 l~~~~~vkl~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (457)
|+.++.+||+|||+++...........
T Consensus 153 l~~~~~~kL~DFG~a~~~~~~~~~~~~----------------------------------------------------- 179 (336)
T 3g2f_A 153 VKNDGTCVISDFGLSMRLTGNRLVRPG----------------------------------------------------- 179 (336)
T ss_dssp ECTTSCEEECCCTTCEECSSSSCC--------------------------------------------------------
T ss_pred EcCCCcEEEeeccceeecccccccCcc-----------------------------------------------------
Confidence 999999999999998765422111000
Q ss_pred CCCCcccccCCccccccccCCCCccCchhhcC-------CCCCccchhhhhhHHHHHHhcCCCCCCCCCh----------
Q 012762 301 PGTPEIVAEPLDVRSMSFVGTHEYLAPEIISG-------EGHGNAVDWWTLGIFIFELFYGTTPFKGIDH---------- 363 (457)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-------~~~~~~sDiwSlG~il~elltG~~Pf~~~~~---------- 363 (457)
.........+||+.|+|||++.+ ..++.++|||||||++|||++|..||.....
T Consensus 180 ---------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~ 250 (336)
T 3g2f_A 180 ---------EEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQT 250 (336)
T ss_dssp ---------------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHH
T ss_pred ---------ccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhhhc
Confidence 00011123469999999999987 3456789999999999999999776643211
Q ss_pred -------HHHHHHHHhcccCCCC-CCC------CChHHHHHHHHHhhhCCCCCCCCCcChHHH------hcCCCCCC
Q 012762 364 -------ELTLANVVARALEFPK-EPS------VPGPAKDLIAQLLVKDPTRRMGSKMGATAI------KRHQFFNG 420 (457)
Q Consensus 364 -------~~~~~~~~~~~~~~~~-~~~------~~~~~~~ll~~~L~~dP~~Rps~~~~~~~l------l~hp~f~~ 420 (457)
.......+......+. ... ++.++.+||.+||..||++||+ +.|+ +.++|-++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps----~~e~l~~L~~ll~~~~~~ 323 (336)
T 3g2f_A 251 EVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLT----AQXAEERMAELMMIWERN 323 (336)
T ss_dssp HHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCC----HHHHHHHHHHHHHCCCC-
T ss_pred ccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcc----hHHHHHHHHHHHHHHHhc
Confidence 1111122222111111 111 2336999999999999999999 8888 44566554
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=354.41 Aligned_cols=261 Identities=20% Similarity=0.239 Sum_probs=210.2
Q ss_pred CCCCccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEE
Q 012762 75 NNNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYAT 154 (457)
Q Consensus 75 ~~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~ 154 (457)
..+.+..++|++.+.||+|+||+||+|.+.. .||+|++..... .......+.+|+++++.++|+||++++++
T Consensus 26 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~-------~~avk~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 97 (319)
T 2y4i_B 26 QEWDIPFEQLEIGELIGKGRFGQVYHGRWHG-------EVAIRLIDIERD-NEDQLKAFKREVMAYRQTRHENVVLFMGA 97 (319)
T ss_dssp GGSSSCCSCEECCCBCCCSSSSEEEEEEESS-------SEEEEECCCCSC-CCCCCCCCCTTGGGGTTCCCTTBCCCCEE
T ss_pred ccccCCHHHeEEeeEeccCCceEEEEEEEcC-------eEEEEEeecCCC-CHHHHHHHHHHHHHHhcCCCCCEeEEEEE
Confidence 4567788999999999999999999998642 499999875432 12233456679999999999999999999
Q ss_pred EEcCCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCC
Q 012762 155 LDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDL 234 (457)
Q Consensus 155 ~~~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~ 234 (457)
+...+..++||||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+
T Consensus 98 ~~~~~~~~iv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~ 175 (319)
T 2y4i_B 98 CMSPPHLAIITSLCKGRTLYSVVRDA-KIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGL 175 (319)
T ss_dssp EECSSCEEEECBCCCSEEHHHHTTSS-CCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSC
T ss_pred EecCCceEEEeecccCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCC
Confidence 99999999999999999999988664 34699999999999999999999999999999999999998 78999999999
Q ss_pred CcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccc
Q 012762 235 SLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVR 314 (457)
Q Consensus 235 s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (457)
+.......... ....
T Consensus 176 ~~~~~~~~~~~-----------------------------------------------------------------~~~~ 190 (319)
T 2y4i_B 176 FSISGVLQAGR-----------------------------------------------------------------REDK 190 (319)
T ss_dssp CC---------------------------------------------------------------------------CCS
T ss_pred ccccccccccc-----------------------------------------------------------------cccc
Confidence 75442111000 0001
Q ss_pred cccccCCCCccCchhhcC---------CCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCCCCCCh
Q 012762 315 SMSFVGTHEYLAPEIISG---------EGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPG 385 (457)
Q Consensus 315 ~~~~~gt~~y~aPE~l~~---------~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (457)
.....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........+............++.
T Consensus 191 ~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (319)
T 2y4i_B 191 LRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLSQIGMGK 270 (319)
T ss_dssp CBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCCCCCCSSCCT
T ss_pred cccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCCCCCcCCCCH
Confidence 112358999999999975 34788999999999999999999999988877777666655444444446888
Q ss_pred HHHHHHHHHhhhCCCCCCCCCcChHHHhc
Q 012762 386 PAKDLIAQLLVKDPTRRMGSKMGATAIKR 414 (457)
Q Consensus 386 ~~~~ll~~~L~~dP~~Rps~~~~~~~ll~ 414 (457)
++.++|.+||..||++||+ +.++++
T Consensus 271 ~l~~li~~~l~~~p~~Rpt----~~~l~~ 295 (319)
T 2y4i_B 271 EISDILLFCWAFEQEERPT----FTKLMD 295 (319)
T ss_dssp THHHHHHHHHCSSTTTSCC----HHHHHH
T ss_pred HHHHHHHHHhcCChhhCcC----HHHHHH
Confidence 9999999999999999999 888876
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=376.37 Aligned_cols=259 Identities=24% Similarity=0.365 Sum_probs=214.8
Q ss_pred CCccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEE
Q 012762 77 NPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLD 156 (457)
Q Consensus 77 ~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~ 156 (457)
..+..++|++.+.||+|+||+||+|.++... ..+..||+|++... ........+.+|+.+|+.++||||+++++++.
T Consensus 385 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~-~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 461 (656)
T 2j0j_A 385 YEIQRERIELGRCIGEGQFGDVHQGIYMSPE-NPAMAVAIKTCKNC--TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT 461 (656)
T ss_dssp TBCCGGGEEEEEEEECCSSCCEEEEEECCSS-SCCEEEEEEECSST--TCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cccccccEEEeeEEeeCCCEEEEEEEEecCC-CccEEEEEEEeccc--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence 4556678999999999999999999986432 25678999998653 23344567888999999999999999999985
Q ss_pred cCCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCc
Q 012762 157 CPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSL 236 (457)
Q Consensus 157 ~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~ 236 (457)
++..|+||||+++|+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 462 -~~~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~ 539 (656)
T 2j0j_A 462 -ENPVWIIMELCTLGELRSFLQVR-KFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR 539 (656)
T ss_dssp -SSSCEEEEECCTTCBHHHHHHHT-TTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCC
T ss_pred -cCceEEEEEcCCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCe
Confidence 45789999999999999998764 2468999999999999999999999999999999999999999999999999987
Q ss_pred CCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccc
Q 012762 237 KGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSM 316 (457)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (457)
......... ..
T Consensus 540 ~~~~~~~~~---------------------------------------------------------------------~~ 550 (656)
T 2j0j_A 540 YMEDSTYYK---------------------------------------------------------------------AS 550 (656)
T ss_dssp SCCC----------------------------------------------------------------------------
T ss_pred ecCCCccee---------------------------------------------------------------------cc
Confidence 553221100 01
Q ss_pred cccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHh
Q 012762 317 SFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLL 395 (457)
Q Consensus 317 ~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L 395 (457)
...||+.|+|||++.+..++.++|||||||++|||++ |..||.+....+....+.... ..+....++..+.+||.+||
T Consensus 551 ~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~l~~li~~~l 629 (656)
T 2j0j_A 551 KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE-RLPMPPNCPPTLYSLMTKCW 629 (656)
T ss_dssp ---CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTC-CCCCCTTCCHHHHHHHHHHT
T ss_pred CCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC-CCCCCccccHHHHHHHHHHc
Confidence 1247889999999999999999999999999999997 999999988777766665543 34445568999999999999
Q ss_pred hhCCCCCCCCCcChHHHhc
Q 012762 396 VKDPTRRMGSKMGATAIKR 414 (457)
Q Consensus 396 ~~dP~~Rps~~~~~~~ll~ 414 (457)
..||++||+ +.+|++
T Consensus 630 ~~dP~~RPs----~~el~~ 644 (656)
T 2j0j_A 630 AYDPSRRPR----FTELKA 644 (656)
T ss_dssp CSSGGGSCC----HHHHHH
T ss_pred CCChhHCcC----HHHHHH
Confidence 999999999 888875
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-44 Score=347.58 Aligned_cols=254 Identities=19% Similarity=0.236 Sum_probs=201.3
Q ss_pred CceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhh-hhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcE
Q 012762 83 DLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKREL-VSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWS 161 (457)
Q Consensus 83 ~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~ 161 (457)
.|...+.||+|+||+||+|.+ +++.||+|++..... ........+.+|+++++.++||||+++++++...+..
T Consensus 32 ~~~~~~~lg~G~~g~Vy~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 105 (307)
T 2nru_A 32 ISVGGNKMGEGGFGVVYKGYV------NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDL 105 (307)
T ss_dssp TTTTCCEEEECSSEEEEEEES------SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred ccccCCccccCCCeEEEEEEE------CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCce
Confidence 356678999999999999974 577899999865422 2234567788899999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCC
Q 012762 162 CLLTEFCPGGDLHVLRQRQ-PDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDN 240 (457)
Q Consensus 162 ~lV~E~~~~~sL~~~~~~~-~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~ 240 (457)
|+||||+++++|.+++... ....+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus 106 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 185 (307)
T 2nru_A 106 CLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEK 185 (307)
T ss_dssp EEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeeccccccccc
Confidence 9999999999999888743 235699999999999999999999999999999999999999999999999999865432
Q ss_pred CCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccC
Q 012762 241 STSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVG 320 (457)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 320 (457)
.... .......|
T Consensus 186 ~~~~--------------------------------------------------------------------~~~~~~~g 197 (307)
T 2nru_A 186 FAQT--------------------------------------------------------------------VMTSRIVG 197 (307)
T ss_dssp CSSC--------------------------------------------------------------------EECSSCCS
T ss_pred cccc--------------------------------------------------------------------ccccccCC
Confidence 1110 00112469
Q ss_pred CCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhc----cc--------CCC-CCCCCChHH
Q 012762 321 THEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVAR----AL--------EFP-KEPSVPGPA 387 (457)
Q Consensus 321 t~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~----~~--------~~~-~~~~~~~~~ 387 (457)
|+.|+|||++.+. ++.++|||||||++|+|++|..||...........+... .. ..+ .....+..+
T Consensus 198 ~~~y~aPE~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 276 (307)
T 2nru_A 198 TTAYMAPEALRGE-ITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAM 276 (307)
T ss_dssp CGGGCCHHHHTTE-ECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSCCCHHHHHHH
T ss_pred CcCcCChHHhcCC-CCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccccccccchHHHHHH
Confidence 9999999998764 789999999999999999999999875543222221111 00 000 111234578
Q ss_pred HHHHHHHhhhCCCCCCCCCcChHHHhcC
Q 012762 388 KDLIAQLLVKDPTRRMGSKMGATAIKRH 415 (457)
Q Consensus 388 ~~ll~~~L~~dP~~Rps~~~~~~~ll~h 415 (457)
.+++.+||..||.+||+ +.+++++
T Consensus 277 ~~li~~cl~~~p~~Rps----~~~l~~~ 300 (307)
T 2nru_A 277 YSVASQCLHEKKNKRPD----IKKVQQL 300 (307)
T ss_dssp HHHHHHHTCSSTTTSCC----HHHHHHH
T ss_pred HHHHHHHcCCCcccCcC----HHHHHHH
Confidence 99999999999999999 8888764
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=350.06 Aligned_cols=249 Identities=22% Similarity=0.309 Sum_probs=198.6
Q ss_pred CCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHH--cCCCCCceEEEEEEcCC
Q 012762 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEM--LDHPFLPTLYATLDCPR 159 (457)
Q Consensus 82 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~--l~H~nIv~l~~~~~~~~ 159 (457)
++|++.+.||+|+||+||+|.+ +++.||||++... ....+.+|+++++. ++||||+++++++....
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~------~~~~vavK~~~~~------~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~ 109 (342)
T 1b6c_B 42 RTIVLQESIGKGRFGEVWRGKW------RGEEVAVKIFSSR------EERSWFREAEIYQTVMLRHENILGFIAADNKDN 109 (342)
T ss_dssp HHCEEEEEEEEETTEEEEEEEE------TTEEEEEEEECGG------GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCC
T ss_pred ccEEEEeeecCCCCcEEEEEEE------cCccEEEEEeCch------hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccC
Confidence 4799999999999999999986 4789999999653 23456778999888 78999999999998876
Q ss_pred ----cEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH--------HcCceeecCCCCCeEEccCCCE
Q 012762 160 ----WSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLH--------MMGIIYRDLKPENVLVRSDGHI 227 (457)
Q Consensus 160 ----~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH--------~~~iiHrDIKp~NIll~~~~~v 227 (457)
..|+||||+++++|.+++.. ..+++..++.++.||+.||.||| +.||+||||||+|||++.++.+
T Consensus 110 ~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~ 186 (342)
T 1b6c_B 110 GTWTQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTC 186 (342)
T ss_dssp SSCCCEEEEECCCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCE
T ss_pred CccceeEEEEeecCCCcHHHHHhc---cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCE
Confidence 78999999999999999976 46999999999999999999999 8999999999999999999999
Q ss_pred EEeccCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCccc
Q 012762 228 MLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIV 307 (457)
Q Consensus 228 kl~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (457)
||+|||++..........
T Consensus 187 kL~Dfg~~~~~~~~~~~~-------------------------------------------------------------- 204 (342)
T 1b6c_B 187 CIADLGLAVRHDSATDTI-------------------------------------------------------------- 204 (342)
T ss_dssp EECCCTTCEEEETTTTEE--------------------------------------------------------------
T ss_pred EEEECCCceecccccccc--------------------------------------------------------------
Confidence 999999986543211100
Q ss_pred ccCCccccccccCCCCccCchhhcCCC------CCccchhhhhhHHHHHHhcC----------CCCCCCCCh-----HHH
Q 012762 308 AEPLDVRSMSFVGTHEYLAPEIISGEG------HGNAVDWWTLGIFIFELFYG----------TTPFKGIDH-----ELT 366 (457)
Q Consensus 308 ~~~~~~~~~~~~gt~~y~aPE~l~~~~------~~~~sDiwSlG~il~elltG----------~~Pf~~~~~-----~~~ 366 (457)
........||+.|+|||++.+.. ++.++|||||||++|||++| ..||..... ...
T Consensus 205 ----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~ 280 (342)
T 1b6c_B 205 ----DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM 280 (342)
T ss_dssp ----EECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHH
T ss_pred ----ccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCcccHHHH
Confidence 00111346999999999998763 33689999999999999999 889876432 222
Q ss_pred HHHHHhcccCCCCCC-----CCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcC
Q 012762 367 LANVVARALEFPKEP-----SVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRH 415 (457)
Q Consensus 367 ~~~~~~~~~~~~~~~-----~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~h 415 (457)
...+........... .+++.+.+||.+||..||++||+ +.+|++|
T Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps----~~~i~~~ 330 (342)
T 1b6c_B 281 RKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLT----ALRIKKT 330 (342)
T ss_dssp HHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCC----HHHHHHH
T ss_pred HHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCC----HHHHHHH
Confidence 333333322222111 22357899999999999999999 8888875
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-45 Score=383.48 Aligned_cols=260 Identities=25% Similarity=0.386 Sum_probs=204.8
Q ss_pred CCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEc---
Q 012762 81 LSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDC--- 157 (457)
Q Consensus 81 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~--- 157 (457)
.++|++.++||+|+||+||+|.++ .+|+.||||++... ........+.+|+++|++++||||+++++++..
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~----~tg~~VAVKvi~~~--~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~ 86 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQ----DTGEQVAIKQCRQE--LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQK 86 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCT----TTTCCEEECCCCSC--CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCC
T ss_pred CCCeEEEEEEeeCCCeEEEEEEEC----CCCcEEEEEEeccc--CCHHHHHHHHHHHHHHHhCCCCCCCceeeeeccccc
Confidence 478999999999999999988865 47889999998654 233455678889999999999999999999765
Q ss_pred ---CCcEEEEEeecCCCChHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCC---EEEe
Q 012762 158 ---PRWSCLLTEFCPGGDLHVLRQRQP-DKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGH---IMLT 230 (457)
Q Consensus 158 ---~~~~~lV~E~~~~~sL~~~~~~~~-~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~---vkl~ 230 (457)
++..|+|||||+|++|.+++.... ...+++..++.++.||+.||.|||+.||+||||||+|||++.++. +||+
T Consensus 87 ~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~ 166 (676)
T 3qa8_A 87 LAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKII 166 (676)
T ss_dssp CCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEEC
T ss_pred ccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEc
Confidence 677899999999999999988743 236899999999999999999999999999999999999997765 9999
Q ss_pred ccCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccC
Q 012762 231 DFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEP 310 (457)
Q Consensus 231 DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (457)
|||++........
T Consensus 167 DFG~a~~~~~~~~------------------------------------------------------------------- 179 (676)
T 3qa8_A 167 DLGYAKELDQGEL------------------------------------------------------------------- 179 (676)
T ss_dssp SCCCCCBTTSCCC-------------------------------------------------------------------
T ss_pred ccccccccccccc-------------------------------------------------------------------
Confidence 9999865432110
Q ss_pred CccccccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHH--------------HHhcccC
Q 012762 311 LDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLAN--------------VVARALE 376 (457)
Q Consensus 311 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~--------------~~~~~~~ 376 (457)
.....||+.|+|||++.+..++.++|||||||++|+|++|..||.+......... ...+...
T Consensus 180 ----~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l~g~~~ 255 (676)
T 3qa8_A 180 ----CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVK 255 (676)
T ss_dssp ----CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCCCSSSCC
T ss_pred ----cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhhhccccc
Confidence 1124699999999999999999999999999999999999999976432211100 0011111
Q ss_pred CCC----C----CCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCCC
Q 012762 377 FPK----E----PSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGV 421 (457)
Q Consensus 377 ~~~----~----~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~~ 421 (457)
+.. . ..++..+.+||.+||..||++||+ +.++++||||+.+
T Consensus 256 ~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPT----a~elL~hp~F~~l 304 (676)
T 3qa8_A 256 FSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGT----DPQNPNVGCFQAL 304 (676)
T ss_dssp CCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---C----CTTCCCCTTHHHH
T ss_pred cccccCCchhhchhhhHHHHHHHHHHccCCHhhCcC----HHHHhcCHHHHHH
Confidence 111 1 124578999999999999999999 9999999999864
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=361.03 Aligned_cols=246 Identities=15% Similarity=0.137 Sum_probs=191.7
Q ss_pred cCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhh-----hhhHHHHHHHHHHHHHHcC---------C
Q 012762 80 TLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELV-----SRNKESRARIEREILEMLD---------H 145 (457)
Q Consensus 80 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~-----~~~~~~~~~~E~~il~~l~---------H 145 (457)
..++|+++++||+|+||+||+|++ +|+.||||++.+.... .......+.+|+++|+.++ |
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h 91 (336)
T 2vuw_A 18 PTEKLQRCEKIGEGVFGEVFQTIA------DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRT 91 (336)
T ss_dssp CHHHHHTCEEEEEETTEEEEEEEE------TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBC
T ss_pred ccccchheeeecccCceEEEEEEe------CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccC
Confidence 346899999999999999999986 5689999999865321 2223467788999998885 8
Q ss_pred CCCceEEEEEE------------------------------cCCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHH
Q 012762 146 PFLPTLYATLD------------------------------CPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYAS 195 (457)
Q Consensus 146 ~nIv~l~~~~~------------------------------~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~ 195 (457)
+||+++.+++. ..+.+|||||||++|++...+.. ..+++..++.++.
T Consensus 92 ~niv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~ 168 (336)
T 2vuw_A 92 EGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILH 168 (336)
T ss_dssp CCBCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHH
T ss_pred CchhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHH
Confidence 88888777643 26789999999999976544433 5689999999999
Q ss_pred HHHHHHHHHH-HcCceeecCCCCCeEEccCC--------------------CEEEeccCCCcCCCCCCcccccccCCCCC
Q 012762 196 EVVVALEFLH-MMGIIYRDLKPENVLVRSDG--------------------HIMLTDFDLSLKGDNSTSTAQLVSDQSPP 254 (457)
Q Consensus 196 qi~~~L~yLH-~~~iiHrDIKp~NIll~~~~--------------------~vkl~DFG~s~~~~~~~~~~~~~~~~~~~ 254 (457)
||+.||.||| ++||+||||||+||||+.++ .+||+|||+++....
T Consensus 169 qi~~aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------------- 234 (336)
T 2vuw_A 169 QLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-------------- 234 (336)
T ss_dssp HHHHHHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET--------------
T ss_pred HHHHHHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC--------------
Confidence 9999999999 99999999999999999887 899999999864321
Q ss_pred CCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCCCCccCchhhcCCC
Q 012762 255 TGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTHEYLAPEIISGEG 334 (457)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 334 (457)
...+||+.|||||++.+..
T Consensus 235 -------------------------------------------------------------~~~~gt~~y~aPE~~~g~~ 253 (336)
T 2vuw_A 235 -------------------------------------------------------------GIVVFCDVSMDEDLFTGDG 253 (336)
T ss_dssp -------------------------------------------------------------TEEECCCCTTCSGGGCCCS
T ss_pred -------------------------------------------------------------CcEEEeecccChhhhcCCC
Confidence 0236999999999999876
Q ss_pred CCccchhhhhhHH-HHHHhcCCCCCCCCCh-HHHHHHHHhc-ccCCCC----CCCCChHHHHHHHHHhhhCCCCCCCCCc
Q 012762 335 HGNAVDWWTLGIF-IFELFYGTTPFKGIDH-ELTLANVVAR-ALEFPK----EPSVPGPAKDLIAQLLVKDPTRRMGSKM 407 (457)
Q Consensus 335 ~~~~sDiwSlG~i-l~elltG~~Pf~~~~~-~~~~~~~~~~-~~~~~~----~~~~~~~~~~ll~~~L~~dP~~Rps~~~ 407 (457)
+.++||||||++ .++++.|..||.+... ......+... ...... ...+++++++||.+||+.| |
T Consensus 254 -~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-----s--- 324 (336)
T 2vuw_A 254 -DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----S--- 324 (336)
T ss_dssp -SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----S---
T ss_pred -ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC-----C---
Confidence 899999998777 7888899999954211 1122222211 111111 1235678999999999987 7
Q ss_pred ChHHHh-cCCCCC
Q 012762 408 GATAIK-RHQFFN 419 (457)
Q Consensus 408 ~~~~ll-~hp~f~ 419 (457)
+.|+| +||||+
T Consensus 325 -a~e~l~~Hp~f~ 336 (336)
T 2vuw_A 325 -ATDLLCQHSLFK 336 (336)
T ss_dssp -HHHHHHHCGGGC
T ss_pred -HHHHHhcCCCcC
Confidence 99999 999995
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=365.80 Aligned_cols=253 Identities=18% Similarity=0.183 Sum_probs=195.4
Q ss_pred CCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCC-CCC-----------
Q 012762 81 LSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDH-PFL----------- 148 (457)
Q Consensus 81 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H-~nI----------- 148 (457)
...|++.+.||+|+||+||+|++. .+|+.||||++...........+.+++|+.+++.+.| .|+
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~----~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~ 152 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQ----ETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIF 152 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEET----TTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCC
T ss_pred ceeEEEecccccCCCEEEEEEEec----CCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhccccc
Confidence 345889999999999999999986 4788999999974433333445678889999998877 221
Q ss_pred ----------ceEEEEEEc-----CCcEEEEEeecCCCChHHHHH-----hCCCCCCCHHHHHHHHHHHHHHHHHHHHcC
Q 012762 149 ----------PTLYATLDC-----PRWSCLLTEFCPGGDLHVLRQ-----RQPDKRFHESAVRFYASEVVVALEFLHMMG 208 (457)
Q Consensus 149 ----------v~l~~~~~~-----~~~~~lV~E~~~~~sL~~~~~-----~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~ 208 (457)
..++.++.. ...++++|+++ +++|.++++ ......+++..+..++.||+.||.|||++|
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ 231 (413)
T 3dzo_A 153 PFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG 231 (413)
T ss_dssp CCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred chhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 111122222 22467888877 899998885 222355788889999999999999999999
Q ss_pred ceeecCCCCCeEEccCCCEEEeccCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCccccc
Q 012762 209 IIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCL 288 (457)
Q Consensus 209 iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (457)
||||||||+||||+.++.+||+|||+++.....
T Consensus 232 iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----------------------------------------------- 264 (413)
T 3dzo_A 232 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----------------------------------------------- 264 (413)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----------------------------------------------
T ss_pred cccCCcccceEEEecCCeEEEEeccceeecCCc-----------------------------------------------
Confidence 999999999999999999999999997643211
Q ss_pred CcchhccccCCCCCCCcccccCCccccccccCCCCccCchhh----------cCCCCCccchhhhhhHHHHHHhcCCCCC
Q 012762 289 HPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTHEYLAPEII----------SGEGHGNAVDWWTLGIFIFELFYGTTPF 358 (457)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l----------~~~~~~~~sDiwSlG~il~elltG~~Pf 358 (457)
....+| +.|+|||++ .+..++.++|||||||++|||++|+.||
T Consensus 265 --------------------------~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf 317 (413)
T 3dzo_A 265 --------------------------AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPN 317 (413)
T ss_dssp --------------------------ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCC
T ss_pred --------------------------cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCC
Confidence 113468 999999999 5556888999999999999999999999
Q ss_pred CCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCCCC
Q 012762 359 KGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGVN 422 (457)
Q Consensus 359 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~~~ 422 (457)
.+.........+ +.....+++++.+||.+||..||++||+ +.++++||||+.+.
T Consensus 318 ~~~~~~~~~~~~------~~~~~~~~~~~~~li~~~l~~dP~~Rpt----~~~~l~~~~~~~~~ 371 (413)
T 3dzo_A 318 TDDAALGGSEWI------FRSCKNIPQPVRALLEGFLRYPKEDRLL----PLQAMETPEYEQLR 371 (413)
T ss_dssp CTTGGGSCSGGG------GSSCCCCCHHHHHHHHHHTCSSGGGSCC----HHHHTTSHHHHHHH
T ss_pred CCcchhhhHHHH------HhhcccCCHHHHHHHHHHccCChhhCcC----HHHHHhCHHHHHHH
Confidence 876544332222 2223458899999999999999999999 99999999998754
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-42 Score=331.19 Aligned_cols=227 Identities=15% Similarity=0.123 Sum_probs=186.9
Q ss_pred ccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcC
Q 012762 79 LTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCP 158 (457)
Q Consensus 79 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~ 158 (457)
+..++|++.+.||+|+||+||+|++. .+++.||||++.............+.+|+++++.++||||+++++++..+
T Consensus 28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~ 103 (286)
T 3uqc_A 28 IANGRYRLLIFHGGVPPLQFWQALDT----ALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTR 103 (286)
T ss_dssp ETTTTEEEEEEEEBSTTCEEEEEEET----TTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEET
T ss_pred EecCcEEEEEEEcccCCeEEEEEEec----CCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEEC
Confidence 44578999999999999999999986 47899999999876544445567788899999999999999999999999
Q ss_pred CcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCC
Q 012762 159 RWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKG 238 (457)
Q Consensus 159 ~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~ 238 (457)
+..||||||++|++|.++++. + .....+..++.||+.||.|||++||+||||||+|||++.+|.+||+++|.
T Consensus 104 ~~~~lv~e~~~g~~L~~~l~~---~-~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~~---- 175 (286)
T 3uqc_A 104 AGGLVVAEWIRGGSLQEVADT---S-PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPAT---- 175 (286)
T ss_dssp TEEEEEEECCCEEEHHHHHTT---C-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCCC----
T ss_pred CcEEEEEEecCCCCHHHHHhc---C-CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEeccc----
Confidence 999999999999999999854 2 45667888999999999999999999999999999999999999985542
Q ss_pred CCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccc
Q 012762 239 DNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSF 318 (457)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (457)
T Consensus 176 -------------------------------------------------------------------------------- 175 (286)
T 3uqc_A 176 -------------------------------------------------------------------------------- 175 (286)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHH---HHHhcccCCC--CCCCCChHHHHHHHH
Q 012762 319 VGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLA---NVVARALEFP--KEPSVPGPAKDLIAQ 393 (457)
Q Consensus 319 ~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~---~~~~~~~~~~--~~~~~~~~~~~ll~~ 393 (457)
++ .++.++|||||||++|||++|+.||.+......+. ..+......+ ....+++++.+||.+
T Consensus 176 ------~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 242 (286)
T 3uqc_A 176 ------MP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVAAR 242 (286)
T ss_dssp ------CT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHHHHHHHH
T ss_pred ------cC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHHHHHHHH
Confidence 22 26889999999999999999999998865432111 1111111110 124588999999999
Q ss_pred HhhhCCCCCCCCCcChHHHhcC
Q 012762 394 LLVKDPTRRMGSKMGATAIKRH 415 (457)
Q Consensus 394 ~L~~dP~~Rps~~~~~~~ll~h 415 (457)
||+.||.+| + +.++++.
T Consensus 243 ~l~~dP~~R-s----~~el~~~ 259 (286)
T 3uqc_A 243 SVQGDGGIR-S----ASTLLNL 259 (286)
T ss_dssp HHCTTSSCC-C----HHHHHHH
T ss_pred HcccCCccC-C----HHHHHHH
Confidence 999999999 9 8887763
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=370.39 Aligned_cols=246 Identities=20% Similarity=0.296 Sum_probs=198.0
Q ss_pred CCccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEE
Q 012762 77 NPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLD 156 (457)
Q Consensus 77 ~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~ 156 (457)
+.+..++|++.+.||+|+||+||+|+++. .+++.||||++.... .......+.+|+++|+.++||||+++++++.
T Consensus 75 g~~~~~~y~i~~~lg~G~~g~Vy~a~~~~---~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 149 (681)
T 2pzi_A 75 GDIVAGQYEVKGCIAHGGLGWIYLALDRN---VNGRPVVLKGLVHSG--DAEAQAMAMAERQFLAEVVHPSIVQIFNFVE 149 (681)
T ss_dssp TCEETTTEEEEEEEEEETTEEEEEEEEGG---GTTEEEEEEESCSSC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEE
T ss_pred CCEeCCceEEEEEEeeCCCeEEEEEEEcC---CCCcEEEEEEeCccC--CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEe
Confidence 34555899999999999999999999863 257899999986532 2234566788999999999999999999998
Q ss_pred cCCc-----EEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEec
Q 012762 157 CPRW-----SCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTD 231 (457)
Q Consensus 157 ~~~~-----~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~D 231 (457)
..+. .||||||++|++|..++.. .+++..++.++.||+.||.|||++|||||||||+|||++.+ .+||+|
T Consensus 150 ~~~~~~~~~~~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~D 224 (681)
T 2pzi_A 150 HTDRHGDPVGYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLID 224 (681)
T ss_dssp EECTTSCEEEEEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECC
T ss_pred ecCCCCCceeEEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEe
Confidence 7665 7999999999999876643 69999999999999999999999999999999999999875 899999
Q ss_pred cCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCC
Q 012762 232 FDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPL 311 (457)
Q Consensus 232 FG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (457)
||+++.....
T Consensus 225 FG~a~~~~~~---------------------------------------------------------------------- 234 (681)
T 2pzi_A 225 LGAVSRINSF---------------------------------------------------------------------- 234 (681)
T ss_dssp CTTCEETTCC----------------------------------------------------------------------
T ss_pred cccchhcccC----------------------------------------------------------------------
Confidence 9998644311
Q ss_pred ccccccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHH
Q 012762 312 DVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLI 391 (457)
Q Consensus 312 ~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll 391 (457)
...+||+.|+|||++.+. ++.++|||||||++|+|++|..||.+..... ..........++.+.+||
T Consensus 235 ----~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~--------~~~~~~~~~~~~~l~~li 301 (681)
T 2pzi_A 235 ----GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDG--------LPEDDPVLKTYDSYGRLL 301 (681)
T ss_dssp ----SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSS--------CCTTCHHHHHCHHHHHHH
T ss_pred ----CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccccccc--------ccccccccccCHHHHHHH
Confidence 123699999999999875 4889999999999999999999987532110 000000011356799999
Q ss_pred HHHhhhCCCCCCCCCcChHHHhcCCCCC
Q 012762 392 AQLLVKDPTRRMGSKMGATAIKRHQFFN 419 (457)
Q Consensus 392 ~~~L~~dP~~Rps~~~~~~~ll~hp~f~ 419 (457)
.+||..||++||+ ..+.+.|+|+.
T Consensus 302 ~~~l~~dP~~R~~----~~~~l~~~l~~ 325 (681)
T 2pzi_A 302 RRAIDPDPRQRFT----TAEEMSAQLTG 325 (681)
T ss_dssp HHHTCSSGGGSCS----SHHHHHHHHHH
T ss_pred hhhccCChhhCCC----HHHHHHHHHHH
Confidence 9999999999999 78888887775
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=311.58 Aligned_cols=189 Identities=16% Similarity=0.093 Sum_probs=132.8
Q ss_pred EecccCcceEEEEEEeccCCCCCceEEEEEeehhhh-------hhhhHHHHHHHHHHHHHHc-CCCCCceEEEEEEcCCc
Q 012762 89 RLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKREL-------VSRNKESRARIEREILEML-DHPFLPTLYATLDCPRW 160 (457)
Q Consensus 89 ~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~-------~~~~~~~~~~~E~~il~~l-~H~nIv~l~~~~~~~~~ 160 (457)
.++.|++|.+..++.. ..|+.||+|++.+... .......++.+|+++|+++ .|+||+++++++++++.
T Consensus 241 ~~~~~~~~~h~~~rr~----~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~ 316 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRY----FFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQS 316 (569)
T ss_dssp C-C--------CCEEE----EECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSE
T ss_pred ccccCCcccccccccc----cccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCE
Confidence 3556666666654433 4788999999976421 1233456788999999999 79999999999999999
Q ss_pred EEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCC
Q 012762 161 SCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDN 240 (457)
Q Consensus 161 ~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~ 240 (457)
.|||||||+|++|.+++... +.+++. .|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+++....
T Consensus 317 ~yLVMEyv~G~~L~d~i~~~--~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~ 391 (569)
T 4azs_A 317 GWLVMEKLPGRLLSDMLAAG--EEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ 391 (569)
T ss_dssp EEEEEECCCSEEHHHHHHTT--CCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred EEEEEecCCCCcHHHHHHhC--CCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence 99999999999999999875 667764 4789999999999999999999999999999999999999999865432
Q ss_pred CCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccC
Q 012762 241 STSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVG 320 (457)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 320 (457)
.. ....+.+|
T Consensus 392 ~~----------------------------------------------------------------------~~~~t~vG 401 (569)
T 4azs_A 392 DC----------------------------------------------------------------------SWPTNLVQ 401 (569)
T ss_dssp ------------------------------------------------------------------------CCSHHHHH
T ss_pred CC----------------------------------------------------------------------ccccCcee
Confidence 11 11224689
Q ss_pred CCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCC
Q 012762 321 THEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTP 357 (457)
Q Consensus 321 t~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~P 357 (457)
|+.|||||++.+. +..++|+||+|+++++|.+|..+
T Consensus 402 Tp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 402 SFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp HHHHHHHHHC------------------CCCCTTHHH
T ss_pred chhhccHHHhCCC-CCCcccccccccchhhhccccch
Confidence 9999999999875 67789999999999988766544
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.5e-29 Score=264.51 Aligned_cols=194 Identities=17% Similarity=0.123 Sum_probs=144.3
Q ss_pred eeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhh-----hhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCC
Q 012762 85 RFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELV-----SRNKESRARIEREILEMLDHPFLPTLYATLDCPR 159 (457)
Q Consensus 85 ~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~-----~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~ 159 (457)
...+.||+|+||+||+|.. .+..+|+|+....... .....+++.+|+++|++++||||+++..++...+
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~------~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~ 412 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY------LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLD 412 (540)
T ss_dssp ---------CCEEEEEEEC------SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETT
T ss_pred CCCCEEeeCCCEEEEEEEE------CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCC
Confidence 3456899999999999953 5678899986543221 1223456789999999999999996555555677
Q ss_pred cEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCC
Q 012762 160 WSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGD 239 (457)
Q Consensus 160 ~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~ 239 (457)
..||||||++|++|.+++.. +..++.||+.||.|||++||+||||||+|||++. .+||+|||+++...
T Consensus 413 ~~~lVmE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~ 480 (540)
T 3en9_A 413 NKRIMMSYINGKLAKDVIED----------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISN 480 (540)
T ss_dssp TTEEEEECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECC
T ss_pred ccEEEEECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECC
Confidence 78999999999999988764 5678999999999999999999999999999988 99999999987654
Q ss_pred CCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcccccccc
Q 012762 240 NSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFV 319 (457)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (457)
....... .......+++
T Consensus 481 ~~~~~~~---------------------------------------------------------------~~~~~~~~~~ 497 (540)
T 3en9_A 481 LDEDKAV---------------------------------------------------------------DLIVFKKAVL 497 (540)
T ss_dssp CHHHHHH---------------------------------------------------------------HHHHHHHHHH
T ss_pred Ccccccc---------------------------------------------------------------chhhhhhhhc
Confidence 3211000 0000112467
Q ss_pred CCCCccCchhhcC--CCCCccchhhhhhHHHHHHhcCCCCCC
Q 012762 320 GTHEYLAPEIISG--EGHGNAVDWWTLGIFIFELFYGTTPFK 359 (457)
Q Consensus 320 gt~~y~aPE~l~~--~~~~~~sDiwSlG~il~elltG~~Pf~ 359 (457)
||+.|||||++.+ ..|+..+|+|+..+-..+.+.++.+|.
T Consensus 498 GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 498 STHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred CCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 9999999999987 568888999999998888887776663
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=8.8e-27 Score=223.88 Aligned_cols=131 Identities=18% Similarity=0.107 Sum_probs=105.0
Q ss_pred eEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhh---------------hHHHHHHHHHHHHHHcCCCCCce
Q 012762 86 FVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSR---------------NKESRARIEREILEMLDHPFLPT 150 (457)
Q Consensus 86 ~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~---------------~~~~~~~~E~~il~~l~H~nIv~ 150 (457)
+.+.||+|+||.||+|.+. +|+.||+|+++....... .....+.+|+++|++++ | ++
T Consensus 94 ~~~~iG~G~~g~Vy~~~~~-----~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~ 165 (282)
T 1zar_A 94 IGKLMGEGKESAVFNCYSE-----KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LA 165 (282)
T ss_dssp EEEEEEECSSEEEEEEEET-----TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SS
T ss_pred ecCEeccCCCceEEEEEeC-----CCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CC
Confidence 3499999999999999872 788999999965432111 13456788999999999 4 55
Q ss_pred EEEEEEcCCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEe
Q 012762 151 LYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLT 230 (457)
Q Consensus 151 l~~~~~~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~ 230 (457)
+.+++.. +..|+||||++|++|.. +.. .....++.||+.||.|||++||+||||||+|||++ +|.+||+
T Consensus 166 v~~~~~~-~~~~lvmE~~~g~~L~~-l~~--------~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~ 234 (282)
T 1zar_A 166 VPKVYAW-EGNAVLMELIDAKELYR-VRV--------ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWII 234 (282)
T ss_dssp SCCEEEE-ETTEEEEECCCCEEGGG-CCC--------SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEEC
T ss_pred cCeEEec-cceEEEEEecCCCcHHH-cch--------hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEE
Confidence 5555544 45699999999999976 311 23457999999999999999999999999999999 9999999
Q ss_pred ccCCC
Q 012762 231 DFDLS 235 (457)
Q Consensus 231 DFG~s 235 (457)
|||++
T Consensus 235 DFG~a 239 (282)
T 1zar_A 235 DFPQS 239 (282)
T ss_dssp CCTTC
T ss_pred ECCCC
Confidence 99987
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=2.6e-22 Score=190.13 Aligned_cols=142 Identities=18% Similarity=0.133 Sum_probs=108.8
Q ss_pred ceeEEEecccCcceEEEEEEeccCCCCCce--EEEEEeehhhhhh---------------------hhHHHHHHHHHHHH
Q 012762 84 LRFVHRLGSGDIGSVYLVQLKSKSSNNGCF--FAAKVMDKRELVS---------------------RNKESRARIEREIL 140 (457)
Q Consensus 84 ~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~--vAvK~~~~~~~~~---------------------~~~~~~~~~E~~il 140 (457)
|.+.+.||+|+||.||+|.+.. +|+. ||||+++...... ......+.+|+++|
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~----~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 124 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVF----DGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNL 124 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEE----TTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcC----CCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHH
Confidence 7889999999999999999852 6888 9999975432110 01124577899999
Q ss_pred HHcCCCCC--ceEEEEEEcCCcEEEEEeecCC-C----ChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH-HcCceee
Q 012762 141 EMLDHPFL--PTLYATLDCPRWSCLLTEFCPG-G----DLHVLRQRQPDKRFHESAVRFYASEVVVALEFLH-MMGIIYR 212 (457)
Q Consensus 141 ~~l~H~nI--v~l~~~~~~~~~~~lV~E~~~~-~----sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH-~~~iiHr 212 (457)
+.+.|++| +.++++ +..||||||+.+ | +|.++... .++..+..++.||+.+|.||| +.|||||
T Consensus 125 ~~l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~givHr 195 (258)
T 1zth_A 125 ERAKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQEAELVHA 195 (258)
T ss_dssp HHHHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHHTSCEECS
T ss_pred HHHHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHHHCCEEeC
Confidence 99988764 445543 356899999932 3 66654322 234567889999999999999 9999999
Q ss_pred cCCCCCeEEccCCCEEEeccCCCcCCCC
Q 012762 213 DLKPENVLVRSDGHIMLTDFDLSLKGDN 240 (457)
Q Consensus 213 DIKp~NIll~~~~~vkl~DFG~s~~~~~ 240 (457)
||||+|||++. .++|+|||++.....
T Consensus 196 Dlkp~NILl~~--~~~liDFG~a~~~~~ 221 (258)
T 1zth_A 196 DLSEYNIMYID--KVYFIDMGQAVTLRH 221 (258)
T ss_dssp SCSTTSEEESS--SEEECCCTTCEETTS
T ss_pred CCCHHHEEEcC--cEEEEECcccccCCC
Confidence 99999999987 899999999976543
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.80 E-value=1.4e-19 Score=179.09 Aligned_cols=139 Identities=14% Similarity=0.162 Sum_probs=102.4
Q ss_pred ceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhh-----------hh--------HHHHHHHHHHHHHHcC
Q 012762 84 LRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVS-----------RN--------KESRARIEREILEMLD 144 (457)
Q Consensus 84 ~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~-----------~~--------~~~~~~~E~~il~~l~ 144 (457)
|.+.++||.|+||.||+|.+. +|+.||||+++...... .. ......+|...|.++.
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~-----~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~ 171 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADE-----KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALY 171 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECT-----TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEecCEeeeCCceEEEEEECC-----CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHH
Confidence 889999999999999999864 68999999976432110 00 0111245777788885
Q ss_pred CCCC--ceEEEEEEcCCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEc
Q 012762 145 HPFL--PTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVR 222 (457)
Q Consensus 145 H~nI--v~l~~~~~~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~ 222 (457)
+.++ ...+++ . ..+|||||++|++|..+.. ......++.||+.+|.|||+.|||||||||.|||++
T Consensus 172 ~~gv~vp~p~~~---~-~~~LVME~i~G~~L~~l~~--------~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~ 239 (397)
T 4gyi_A 172 EEGFPVPEPIAQ---S-RHTIVMSLVDALPMRQVSS--------VPDPASLYADLIALILRLAKHGLIHGDFNEFNILIR 239 (397)
T ss_dssp HTTCSCCCEEEE---E-TTEEEEECCSCEEGGGCCC--------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE
T ss_pred hcCCCCCeeeec---c-CceEEEEecCCccHhhhcc--------cHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEe
Confidence 5544 233332 2 2379999999999864321 123567889999999999999999999999999999
Q ss_pred cCCC----------EEEeccCCCcCCC
Q 012762 223 SDGH----------IMLTDFDLSLKGD 239 (457)
Q Consensus 223 ~~~~----------vkl~DFG~s~~~~ 239 (457)
.+|. +.|+||+.+....
T Consensus 240 ~dgd~~d~~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 240 EEKDAEDPSSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp EEECSSCTTSEEEEEEECCCTTCEETT
T ss_pred CCCCcccccccccceEEEEeCCcccCC
Confidence 8773 8999999876544
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.48 E-value=1.6e-13 Score=129.49 Aligned_cols=139 Identities=17% Similarity=0.122 Sum_probs=110.5
Q ss_pred CCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcC-CCCCceEEEEEEcCCc
Q 012762 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLD-HPFLPTLYATLDCPRW 160 (457)
Q Consensus 82 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~-H~nIv~l~~~~~~~~~ 160 (457)
+.|++...+|.|+++.||++.. .+..+++|+...... .....+.+|.++|+.|. |..+.++++++...+.
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~------~~~~~vlK~~~~~~~---~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~ 84 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVG------ENENLYLKMTDSRYK---GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGW 84 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEEC------SSCEEEEEEECGGGT---TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTE
T ss_pred ccceeEeeccCCCCCeEEEEEC------CCCcEEEEeCCcccC---CCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCc
Confidence 4689999999999999998863 357899999875321 11234778999999984 6788899999998889
Q ss_pred EEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH----------------------------------
Q 012762 161 SCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHM---------------------------------- 206 (457)
Q Consensus 161 ~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~---------------------------------- 206 (457)
.|+||||++|.+|..... +......++.++..+|..||+
T Consensus 85 ~~lv~e~i~G~~l~~~~~-------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (263)
T 3tm0_A 85 SNLLMSEADGVLCSEEYE-------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCEN 157 (263)
T ss_dssp EEEEEECCSSEEHHHHCC-------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGG
T ss_pred eEEEEEecCCeehhhccC-------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccc
Confidence 999999999999875421 112234678899999999998
Q ss_pred -------------------------cCceeecCCCCCeEEccCCCEEEeccCCCc
Q 012762 207 -------------------------MGIIYRDLKPENVLVRSDGHIMLTDFDLSL 236 (457)
Q Consensus 207 -------------------------~~iiHrDIKp~NIll~~~~~vkl~DFG~s~ 236 (457)
..++|+|++|.|||++.++.+.|+||+.+.
T Consensus 158 ~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 158 WEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp GSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 458999999999999765556799999764
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.36 E-value=1.1e-12 Score=123.20 Aligned_cols=134 Identities=14% Similarity=0.048 Sum_probs=98.4
Q ss_pred CCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCC--CceEEEEEEcCC
Q 012762 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPF--LPTLYATLDCPR 159 (457)
Q Consensus 82 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~n--Iv~l~~~~~~~~ 159 (457)
.++.+....+.|..+.||++... +|..+++|+.... ....+..|+++|+.+.+.+ +.+++++...++
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~~-----~g~~~vlK~~~~~------~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~ 88 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSAQ-----GRPVLFVKTDLSG------ALNELQDEAARLSWLATTGVPCAAVLDVVTEAG 88 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEECT-----TSCCEEEEEECSC------TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSS
T ss_pred CCCceEecccCCCCceEEEEecC-----CCCeEEEEeCCcc------cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCC
Confidence 45666554456667999988642 5677999997543 1134667999999985444 567999988888
Q ss_pred cEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcC-------------------------------
Q 012762 160 WSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMG------------------------------- 208 (457)
Q Consensus 160 ~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~------------------------------- 208 (457)
..++||||++|.+|. .. ... ...++.++...|..||+..
T Consensus 89 ~~~~v~e~i~G~~l~--~~-----~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (264)
T 1nd4_A 89 RDWLLLGEVPGQDLL--SS-----HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDL 158 (264)
T ss_dssp CEEEEEECCSSEETT--TS-----CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSC
T ss_pred CCEEEEEecCCcccC--cC-----cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhh
Confidence 899999999998884 11 122 2245677777788887643
Q ss_pred ---------------------------ceeecCCCCCeEEccCCCEEEeccCCCc
Q 012762 209 ---------------------------IIYRDLKPENVLVRSDGHIMLTDFDLSL 236 (457)
Q Consensus 209 ---------------------------iiHrDIKp~NIll~~~~~vkl~DFG~s~ 236 (457)
++|+|++|.|||++.++.+.|+|||.+.
T Consensus 159 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 159 DEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp CGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 9999999999999876666799999864
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.28 E-value=2e-11 Score=120.59 Aligned_cols=142 Identities=15% Similarity=0.227 Sum_probs=106.3
Q ss_pred eeEEEecccCcceEEEEEEeccCCCCCceEEEEEee--hhhhhhhhHHHHHHHHHHHHHHcC--CCCCceEEEEEEcC--
Q 012762 85 RFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMD--KRELVSRNKESRARIEREILEMLD--HPFLPTLYATLDCP-- 158 (457)
Q Consensus 85 ~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~--~~~~~~~~~~~~~~~E~~il~~l~--H~nIv~l~~~~~~~-- 158 (457)
.-++.|+.|.++.||++.. .+..+++|+.. ..... .....+.+|.++|+.|. +..+++++.++.+.
T Consensus 41 ~~~~~l~~G~sn~~y~v~~------~~~~~vlr~~~~p~~~~~--~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~ 112 (359)
T 3dxp_A 41 LSVEQFKGGQSNPTFKLVT------PGQTYVMRAKPGPKSKLL--PSAHAIEREYRVMDALAGTDVPVAKMYALCEDESV 112 (359)
T ss_dssp CEEEECCC-CCSCEEEEEC------SSCEEEEECCCC------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTT
T ss_pred ceEEEcCCcccceEEEEEE------CCceEEEEeCCCCCCCCC--CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCc
Confidence 3477899999999998874 24578889876 43211 12345677999999996 45688999998776
Q ss_pred -CcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH-------------------------------
Q 012762 159 -RWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHM------------------------------- 206 (457)
Q Consensus 159 -~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~------------------------------- 206 (457)
+..|+||||++|..+.+. ....++......++.+++..|..||.
T Consensus 113 ~g~~~~vme~v~G~~l~~~----~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (359)
T 3dxp_A 113 IGRAFYIMEFVSGRVLWDQ----SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKL 188 (359)
T ss_dssp TSSCEEEEECCCCBCCCCT----TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHH
T ss_pred cCCeEEEEEecCCeecCCC----ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHh
Confidence 458999999999887431 11347788888999999999999997
Q ss_pred ---------------------------cCceeecCCCCCeEEccCCC--EEEeccCCCcCC
Q 012762 207 ---------------------------MGIIYRDLKPENVLVRSDGH--IMLTDFDLSLKG 238 (457)
Q Consensus 207 ---------------------------~~iiHrDIKp~NIll~~~~~--vkl~DFG~s~~~ 238 (457)
.+++|+|+++.|||++.++. +.|+||+.+...
T Consensus 189 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 189 SETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp HCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred cCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 35999999999999997753 689999987543
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.09 E-value=1.5e-10 Score=111.62 Aligned_cols=134 Identities=17% Similarity=0.114 Sum_probs=98.4
Q ss_pred EEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHc-CCCC--CceEEEEEEcCC---c
Q 012762 87 VHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEML-DHPF--LPTLYATLDCPR---W 160 (457)
Q Consensus 87 ~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l-~H~n--Iv~l~~~~~~~~---~ 160 (457)
++.++.|.+..||++. ..+++|+.... .....+.+|.++|+.+ .+.. +.+++......+ .
T Consensus 25 i~~~~~G~~n~v~~v~---------~~~vlR~~~~~-----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~ 90 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN---------RDFIFKFPKHS-----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQM 90 (304)
T ss_dssp CCEEEECSSEEEEEST---------TSEEEEEESSH-----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSC
T ss_pred eEecCCCCcceEEEEC---------CEEEEEecCCc-----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCc
Confidence 3458999999999642 35889987543 2345678899999988 3433 455655544333 3
Q ss_pred EEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH----------------------------------
Q 012762 161 SCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHM---------------------------------- 206 (457)
Q Consensus 161 ~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~---------------------------------- 206 (457)
.|+|||+++|.+|..... ..++..+...++.|++..|..||+
T Consensus 91 ~~~vm~~i~G~~l~~~~~----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (304)
T 3sg8_A 91 SFAGFTKIKGVPLTPLLL----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELK 166 (304)
T ss_dssp SCEEEECCCCEECCHHHH----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSC
T ss_pred ceEEEcccCCeECCcccc----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCC
Confidence 489999999999864332 236777888888888888888886
Q ss_pred ------------------------cCceeecCCCCCeEEcc--CCCEEEeccCCCcCC
Q 012762 207 ------------------------MGIIYRDLKPENVLVRS--DGHIMLTDFDLSLKG 238 (457)
Q Consensus 207 ------------------------~~iiHrDIKp~NIll~~--~~~vkl~DFG~s~~~ 238 (457)
..++|+|++|.||+++. ++.+.|+||+.+...
T Consensus 167 ~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~ 224 (304)
T 3sg8_A 167 GPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAIS 224 (304)
T ss_dssp HHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEE
T ss_pred cccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccC
Confidence 13799999999999997 456789999987543
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.77 E-value=1.2e-07 Score=91.38 Aligned_cols=134 Identities=16% Similarity=0.103 Sum_probs=94.1
Q ss_pred EEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCC---CCceEEEEEE-cCCcEE
Q 012762 87 VHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHP---FLPTLYATLD-CPRWSC 162 (457)
Q Consensus 87 ~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~---nIv~l~~~~~-~~~~~~ 162 (457)
++.++.|....||+. +..+++|+.... .....+..|.++|+.|.+. .|.+++.+.. ..+..|
T Consensus 24 v~~l~~G~~n~v~~v---------g~~~VlR~~~~~-----~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~ 89 (306)
T 3tdw_A 24 VESLGEGFRNYAILV---------NGDWVFRFPKSQ-----QGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPF 89 (306)
T ss_dssp EEEEEECSSEEEEEE---------TTTEEEEEESSH-----HHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEE
T ss_pred eeecCCCcceeEEEE---------CCEEEEEecCCc-----hHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceE
Confidence 456888999999975 345888986322 2345678899999999653 3667777774 456678
Q ss_pred EEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHc-----------------------------------
Q 012762 163 LLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMM----------------------------------- 207 (457)
Q Consensus 163 lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~----------------------------------- 207 (457)
+|||+++|..|....- ..++......++.++...|..||+.
T Consensus 90 ~v~e~i~G~~l~~~~~----~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~ 165 (306)
T 3tdw_A 90 VGYRKVQGQILGEDGM----AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLD 165 (306)
T ss_dssp EEEECCCSEECHHHHH----TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSC
T ss_pred EEEeccCCeECchhhh----hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccc
Confidence 9999999998865321 1244555555555555555555532
Q ss_pred -------------------------CceeecCCCCCeEEcc---CCCE-EEeccCCCcCC
Q 012762 208 -------------------------GIIYRDLKPENVLVRS---DGHI-MLTDFDLSLKG 238 (457)
Q Consensus 208 -------------------------~iiHrDIKp~NIll~~---~~~v-kl~DFG~s~~~ 238 (457)
.++|+|+++.|||++. ++.+ .|+||+.+...
T Consensus 166 ~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 166 ESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred hhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 3599999999999987 4554 89999987543
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.74 E-value=1.7e-07 Score=88.30 Aligned_cols=132 Identities=20% Similarity=0.142 Sum_probs=93.9
Q ss_pred EecccCcc-eEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcC-CCCCceEEEEEEcCCcEEEEEe
Q 012762 89 RLGSGDIG-SVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLD-HPFLPTLYATLDCPRWSCLLTE 166 (457)
Q Consensus 89 ~LG~G~fg-~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~-H~nIv~l~~~~~~~~~~~lV~E 166 (457)
.+..|..| .||+.... ..+..+++|+-... ....+..|.++|+.|. +-.|.++++++.+++..|+|||
T Consensus 31 ~~~~G~S~~~v~rl~~~----~~~~~~~lk~~~~~------~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme 100 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGK----PNAPELFLKHGKGS------VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTT 100 (272)
T ss_dssp EEECSSSSCEEEEEECC----TTCCCEEEEEEETH------HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEE
T ss_pred EccCCCcCCeEEEEEec----CCCeEEEEEECCCC------CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEE
Confidence 44556665 68977654 25667999987543 2345677999999884 4457889999999999999999
Q ss_pred ecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHc---------------------------------------
Q 012762 167 FCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMM--------------------------------------- 207 (457)
Q Consensus 167 ~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~--------------------------------------- 207 (457)
+++|.++....... ......++.++...|.-||..
T Consensus 101 ~l~G~~~~~~~~~~------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (272)
T 4gkh_A 101 AIPGKTAFQVLEEY------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGW 174 (272)
T ss_dssp CCCSEEHHHHHHHC------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTC
T ss_pred eeCCccccccccCC------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccch
Confidence 99998886654431 112233445555555555531
Q ss_pred -------------------CceeecCCCCCeEEccCCCEEEeccCCCc
Q 012762 208 -------------------GIIYRDLKPENVLVRSDGHIMLTDFDLSL 236 (457)
Q Consensus 208 -------------------~iiHrDIKp~NIll~~~~~vkl~DFG~s~ 236 (457)
.++|+|+.+.|||++.++.+-|+||+.+.
T Consensus 175 ~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 175 PVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp CHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 27999999999999877777899999875
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.41 E-value=6.5e-07 Score=87.85 Aligned_cols=91 Identities=11% Similarity=0.058 Sum_probs=58.0
Q ss_pred ceeEEEe-cccCcceEEEEEEeccC--CCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcC-C--CCCceEEEEEEc
Q 012762 84 LRFVHRL-GSGDIGSVYLVQLKSKS--SNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLD-H--PFLPTLYATLDC 157 (457)
Q Consensus 84 ~~~~~~L-G~G~fg~Vy~a~~~~~~--~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~-H--~nIv~l~~~~~~ 157 (457)
....+.| +.|....+|+....... ...+..+++|+..............+..|.++|+.|. + -.+.+++.+..+
T Consensus 22 v~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~ 101 (357)
T 3ats_A 22 VTVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETT 101 (357)
T ss_dssp EEEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECS
T ss_pred eEEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccC
Confidence 3446788 88999999988643000 0015678999875432000000134567888888884 2 457888888766
Q ss_pred C---CcEEEEEeecCCCChH
Q 012762 158 P---RWSCLLTEFCPGGDLH 174 (457)
Q Consensus 158 ~---~~~~lV~E~~~~~sL~ 174 (457)
. +..|+|||+++|..+.
T Consensus 102 ~~~~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 102 GDVLGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp STTTSSCEEEEECCCCBCCC
T ss_pred CCccCCceEEEEecCCCChh
Confidence 5 3568999999886653
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.40 E-value=2.6e-06 Score=82.63 Aligned_cols=137 Identities=12% Similarity=0.112 Sum_probs=78.5
Q ss_pred EEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcC--CCCCceEEE------EEEcC
Q 012762 87 VHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLD--HPFLPTLYA------TLDCP 158 (457)
Q Consensus 87 ~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~--H~nIv~l~~------~~~~~ 158 (457)
++.|+.|..+.||++... +| .+++|+.... ...+..|.++++.|. .-.+.+++. +....
T Consensus 37 ~~~l~gG~~n~~~~v~~~-----~~-~~vlk~~~~~-------~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~ 103 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHTD-----SG-AVCLKRIHRP-------EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHG 103 (346)
T ss_dssp EEECC----CEEEEEEET-----TE-EEEEEEECSC-------HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEET
T ss_pred eeeccccccCcEEEEEeC-----CC-CEEEEecCCC-------HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEEC
Confidence 456777788999988742 33 4899998642 122334666666553 123444443 12346
Q ss_pred CcEEEEEeecCCCChH-----------HH---HHh-CCCC--C---------CCHHH-----------------------
Q 012762 159 RWSCLLTEFCPGGDLH-----------VL---RQR-QPDK--R---------FHESA----------------------- 189 (457)
Q Consensus 159 ~~~~lV~E~~~~~sL~-----------~~---~~~-~~~~--~---------~~~~~----------------------- 189 (457)
+..++||||++|..+. .. ++. .... . ..+..
T Consensus 104 ~~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 183 (346)
T 2q83_A 104 SFLFVVYDWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDP 183 (346)
T ss_dssp TEEEEEEECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCH
T ss_pred CEEEEEEEeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCc
Confidence 6789999999886542 01 111 0000 0 01100
Q ss_pred --------HHHHHHHHHHHHHHHHH-------------cCceeecCCCCCeEEccCCCEEEeccCCCc
Q 012762 190 --------VRFYASEVVVALEFLHM-------------MGIIYRDLKPENVLVRSDGHIMLTDFDLSL 236 (457)
Q Consensus 190 --------~~~i~~qi~~~L~yLH~-------------~~iiHrDIKp~NIll~~~~~vkl~DFG~s~ 236 (457)
+..+..++..++.+|++ .+++|+|+++.|||++.++.+.|+||+.+.
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 184 FSQLYLQEIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 11112233445666652 579999999999999888889999999864
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.39 E-value=1.1e-06 Score=87.59 Aligned_cols=80 Identities=18% Similarity=0.191 Sum_probs=50.7
Q ss_pred eEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhh-hh---hhHHHHHHHHHHHHHHcCC--C-CCceEEEEEEcC
Q 012762 86 FVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKREL-VS---RNKESRARIEREILEMLDH--P-FLPTLYATLDCP 158 (457)
Q Consensus 86 ~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~-~~---~~~~~~~~~E~~il~~l~H--~-nIv~l~~~~~~~ 158 (457)
-.+.||.|.++.||++.... .++.|+||....... .. .....++..|.++|+.+.. + .+.+++.+ +.
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~----~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~ 107 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQE----HDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DT 107 (397)
T ss_dssp EEEECCSSSSEEEEEEEC--------CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ET
T ss_pred EEEECCCCceEEEEEEEECC----CCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cC
Confidence 46789999999999997542 457899998653211 00 1123456779999988742 3 34566654 34
Q ss_pred CcEEEEEeecCCC
Q 012762 159 RWSCLLTEFCPGG 171 (457)
Q Consensus 159 ~~~~lV~E~~~~~ 171 (457)
+..++|||+++|.
T Consensus 108 ~~~~lvmE~l~g~ 120 (397)
T 2olc_A 108 EMAVTVMEDLSHL 120 (397)
T ss_dssp TTTEEEECCCTTS
T ss_pred CccEEEEEeCCCc
Confidence 4568999999763
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=98.08 E-value=4.5e-05 Score=73.39 Aligned_cols=77 Identities=21% Similarity=0.244 Sum_probs=61.0
Q ss_pred eeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcC---CCCCceEEEEEEcCCcE
Q 012762 85 RFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLD---HPFLPTLYATLDCPRWS 161 (457)
Q Consensus 85 ~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~---H~nIv~l~~~~~~~~~~ 161 (457)
.-.+.|+.|.+..+|+... .+..+++|+.... ....+..|.+.|+.|. ...+++++.+....+..
T Consensus 39 ~~~~~l~gG~~n~~y~v~~------~~~~~vlK~~~~~------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~ 106 (312)
T 3jr1_A 39 KHKEKLYSGEMNEIWLIND------EVQTVFVKINERS------YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHS 106 (312)
T ss_dssp CEEEEECCSSSSEEEEEES------SSCEEEEEEEEGG------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEE
T ss_pred eeeEEeCCccceeeeEEEE------CCCeEEEEeCCcc------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCce
Confidence 3467899999999998863 3567889987643 2456778999998883 36688999998888889
Q ss_pred EEEEeecCCCCh
Q 012762 162 CLLTEFCPGGDL 173 (457)
Q Consensus 162 ~lV~E~~~~~sL 173 (457)
|+||||++|..+
T Consensus 107 ~lvme~l~G~~~ 118 (312)
T 3jr1_A 107 FLLLEALNKSKN 118 (312)
T ss_dssp EEEEECCCCCCC
T ss_pred EEEEEeccCCCC
Confidence 999999998765
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.95 E-value=3.3e-05 Score=77.56 Aligned_cols=77 Identities=16% Similarity=0.172 Sum_probs=46.7
Q ss_pred eEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhh--hh--hhHHHHHHHHHHHHHHc---CCCCCceEEEEEEcC
Q 012762 86 FVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKREL--VS--RNKESRARIEREILEML---DHPFLPTLYATLDCP 158 (457)
Q Consensus 86 ~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~--~~--~~~~~~~~~E~~il~~l---~H~nIv~l~~~~~~~ 158 (457)
-++.||.|..+.||++.. .+..++||....... .. .....+...|.+++..+ ....+.+++.+. .
T Consensus 38 ~i~~l~~G~~n~vyrv~~------~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~ 109 (420)
T 2pyw_A 38 VIKEVGDGNLNFVFIVVG------SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--R 109 (420)
T ss_dssp EEEECCCSSSCEEEEEEC------SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--T
T ss_pred EEEEccCCCcEEEEEEEc------CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--C
Confidence 367889999999998852 456799994321100 00 00012223355544433 345677888776 4
Q ss_pred CcEEEEEeec-CC
Q 012762 159 RWSCLLTEFC-PG 170 (457)
Q Consensus 159 ~~~~lV~E~~-~~ 170 (457)
+..++|||++ +|
T Consensus 110 ~~~~lv~e~l~~g 122 (420)
T 2pyw_A 110 TMALIGMRYLEPP 122 (420)
T ss_dssp TTTEEEECCCCTT
T ss_pred CccEEEEeecCCc
Confidence 6678999999 77
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.73 E-value=0.00012 Score=69.39 Aligned_cols=79 Identities=18% Similarity=0.127 Sum_probs=56.8
Q ss_pred CceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCC---CCCceEEEEEEcCC
Q 012762 83 DLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDH---PFLPTLYATLDCPR 159 (457)
Q Consensus 83 ~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H---~nIv~l~~~~~~~~ 159 (457)
...-++.+|.|..+.||+.+.. +|+.|++|+...... .....+..|.+.|+.|.- -.+++++++.
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~-----DG~~~~vK~~~~~~~---~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~---- 83 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELA-----DGTPLFVKALPDDAP---ALDGLFRAEALGLDWLGRSFGSPVPQVAGWD---- 83 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEET-----TSCEEEEEECCTTCC---CCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----
T ss_pred CeEEEEecCCCCCeEEEEEEEC-----CCCEEEEEEeCCCCc---chhhHHHHHHHHHHHHHhhCCCCcceEEecc----
Confidence 4666889999999999999864 788899998754321 223456779999998842 2356666653
Q ss_pred cEEEEEeecCCCCh
Q 012762 160 WSCLLTEFCPGGDL 173 (457)
Q Consensus 160 ~~~lV~E~~~~~sL 173 (457)
.-++||||++++..
T Consensus 84 ~~~lv~e~l~~~~~ 97 (288)
T 3f7w_A 84 DRTLAMEWVDERPP 97 (288)
T ss_dssp TTEEEEECCCCCCC
T ss_pred CceEEEEeecccCC
Confidence 24789999987654
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.69 E-value=0.0002 Score=68.79 Aligned_cols=143 Identities=18% Similarity=0.198 Sum_probs=80.3
Q ss_pred CceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCC--CceEEEE------
Q 012762 83 DLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPF--LPTLYAT------ 154 (457)
Q Consensus 83 ~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~n--Iv~l~~~------ 154 (457)
...-++.|+.|....+|++... .| .+++|+..... ....+..|.++++.|...+ +.+++..
T Consensus 23 ~~~~~~~i~~G~~n~~~~v~~~-----~g-~~vlk~~~~~~-----~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~ 91 (322)
T 2ppq_A 23 SLTSYKGIAEGVENSNFLLHTT-----KD-PLILTLYEKRV-----EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELL 91 (322)
T ss_dssp CEEEEEEECC---EEEEEEEES-----SC-CEEEEEECC--------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSC
T ss_pred cceEeeccCCCcccceEEEEeC-----Cc-cEEEEEeCCCC-----CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEE
Confidence 4455678888999999988742 23 68899986531 1223456888887773212 3444321
Q ss_pred EEcCCcEEEEEeecCCCChHH-----------H---HHhC-CC---CC---CCHHHHHHH---------------HHHHH
Q 012762 155 LDCPRWSCLLTEFCPGGDLHV-----------L---RQRQ-PD---KR---FHESAVRFY---------------ASEVV 198 (457)
Q Consensus 155 ~~~~~~~~lV~E~~~~~sL~~-----------~---~~~~-~~---~~---~~~~~~~~i---------------~~qi~ 198 (457)
....+..++||+|++|..+.. . ++.. .. .. ......... ...+.
T Consensus 92 ~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~ 171 (322)
T 2ppq_A 92 GELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIR 171 (322)
T ss_dssp EEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHH
T ss_pred EEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHH
Confidence 123456789999998865410 0 1111 00 00 111100000 01134
Q ss_pred HHHHHHHH-------cCceeecCCCCCeEEccCCCEEEeccCCCc
Q 012762 199 VALEFLHM-------MGIIYRDLKPENVLVRSDGHIMLTDFDLSL 236 (457)
Q Consensus 199 ~~L~yLH~-------~~iiHrDIKp~NIll~~~~~vkl~DFG~s~ 236 (457)
..+++++. .+++|+|+++.|||++.++.+.|+||+.+.
T Consensus 172 ~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 172 PEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp HHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 44555553 369999999999999877656899998764
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.68 E-value=0.00018 Score=68.57 Aligned_cols=71 Identities=10% Similarity=0.013 Sum_probs=45.4
Q ss_pred EEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCC-ceEEEEEEcCCcEEEEE
Q 012762 87 VHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFL-PTLYATLDCPRWSCLLT 165 (457)
Q Consensus 87 ~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nI-v~l~~~~~~~~~~~lV~ 165 (457)
++.|+.|....+|++ ..+++|+...... .. .....|.++++.+...++ .+++++. .+..++|+
T Consensus 23 i~~l~gG~tN~~~~~----------~~~vlR~~~~~~~---~~-~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~ 86 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA----------GDLCLRIPGKGTE---EY-INRANEAVAAREAAKAGVSPEVLHVD--PATGVMVT 86 (301)
T ss_dssp CEEEESCSSEEEEEE----------TTEEEEEECC-------C-CCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEE
T ss_pred eeEcCCcccccccee----------eeEEEECCCCCcc---ce-eCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEE
Confidence 678999999999987 2488998865311 11 112348888877743233 4666543 33457899
Q ss_pred eec-CCCCh
Q 012762 166 EFC-PGGDL 173 (457)
Q Consensus 166 E~~-~~~sL 173 (457)
||+ +|.+|
T Consensus 87 e~i~~g~~l 95 (301)
T 3dxq_A 87 RYIAGAQTM 95 (301)
T ss_dssp ECCTTCEEC
T ss_pred eecCCCccC
Confidence 999 77655
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.67 E-value=0.00013 Score=70.64 Aligned_cols=139 Identities=14% Similarity=0.119 Sum_probs=72.6
Q ss_pred EEEecccCcce-EEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCC--CCCceEEEEEEcCCcEEE
Q 012762 87 VHRLGSGDIGS-VYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDH--PFLPTLYATLDCPRWSCL 163 (457)
Q Consensus 87 ~~~LG~G~fg~-Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H--~nIv~l~~~~~~~~~~~l 163 (457)
++.|+.|.... +|+... .++..+++|...... ...+..|+++++.|.. -.+.+++.+....+ ++
T Consensus 23 ~~~l~gg~s~~~~~r~~~-----~~~~~~vlk~~~~~~------~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~l 89 (333)
T 3csv_A 23 RTPLAGDASSRRYQRLRS-----PTGAKAVLMDWSPEE------GGDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LL 89 (333)
T ss_dssp ECC--------CCEEEEC-----TTCCEEEEEECCTTT------TCCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EE
T ss_pred eeECCCCCCCceEEEEEc-----CCCCeEEEEECCCCC------CccccHHHHHHHHHHhCCCCCCceeeecCCCC--EE
Confidence 44566665554 666542 125667787754321 0223457778777742 33567777643333 78
Q ss_pred EEeecCCCChHHHHHhC---------------------C---CCCCCHHHHH-------H-HH------------HHHHH
Q 012762 164 LTEFCPGGDLHVLRQRQ---------------------P---DKRFHESAVR-------F-YA------------SEVVV 199 (457)
Q Consensus 164 V~E~~~~~sL~~~~~~~---------------------~---~~~~~~~~~~-------~-i~------------~qi~~ 199 (457)
|||++.+..+...+... . ...+...... . +. ..+..
T Consensus 90 l~e~l~~~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~ 169 (333)
T 3csv_A 90 LIEDLGDALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEH 169 (333)
T ss_dssp EECCCCSCBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHH
T ss_pred EEeeCCCcchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHH
Confidence 99999776664333211 0 0112221111 0 00 01112
Q ss_pred HHHHHH------HcCceeecCCCCCeEEccC----CCEEEeccCCCcCC
Q 012762 200 ALEFLH------MMGIIYRDLKPENVLVRSD----GHIMLTDFDLSLKG 238 (457)
Q Consensus 200 ~L~yLH------~~~iiHrDIKp~NIll~~~----~~vkl~DFG~s~~~ 238 (457)
.+..+. ...++|+|+.+.|||++.+ +.+.|+||+.+...
T Consensus 170 ~~~~l~~~~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 170 RFAQILSAQLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp HHHHHHHHHCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred HHHHHHHhcccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 222331 2469999999999999874 67999999987544
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.58 E-value=0.00045 Score=66.45 Aligned_cols=76 Identities=14% Similarity=0.065 Sum_probs=47.6
Q ss_pred EEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCC--CCCceEEEE-----EEcCCc
Q 012762 88 HRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDH--PFLPTLYAT-----LDCPRW 160 (457)
Q Consensus 88 ~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H--~nIv~l~~~-----~~~~~~ 160 (457)
..|+ |....||++... +|+.+++|+...... ....+..|.++++.|.. -.+++++.. ...++.
T Consensus 32 ~~l~-g~~n~~y~v~~~-----~g~~~vlK~~~~~~~----~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~ 101 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDE-----DRRRFVVKFYRPERW----TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGF 101 (328)
T ss_dssp EEEC-CSSSEEEEECCT-----TCCCEEEEEECTTTS----CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTE
T ss_pred Eeec-CcccceEEEEcC-----CCCEEEEEEcCCCCC----CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCE
Confidence 4566 888899987532 456799999864321 23345668888887732 224444443 223456
Q ss_pred EEEEEeecCCCCh
Q 012762 161 SCLLTEFCPGGDL 173 (457)
Q Consensus 161 ~~lV~E~~~~~sL 173 (457)
.++||++++|..+
T Consensus 102 ~~~l~~~i~G~~~ 114 (328)
T 1zyl_A 102 YFAVFPSVGGRQF 114 (328)
T ss_dssp EEEEEECCCCEEC
T ss_pred EEEEEEecCCCCC
Confidence 6899999987543
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.42 E-value=0.00032 Score=70.54 Aligned_cols=79 Identities=24% Similarity=0.299 Sum_probs=50.5
Q ss_pred eEEEecccCcceEEEEEEeccC---CCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCC-CceEEEEEEcCCcE
Q 012762 86 FVHRLGSGDIGSVYLVQLKSKS---SNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPF-LPTLYATLDCPRWS 161 (457)
Q Consensus 86 ~~~~LG~G~fg~Vy~a~~~~~~---~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~n-Iv~l~~~~~~~~~~ 161 (457)
-++.|+.|....||++...... ...+..|++|+..... ....+..|..+++.|...+ ..++++.+.+
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~-----~~~~li~E~~~l~~L~~~g~~P~l~~~~~~---- 147 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE-----TESHLVAESVIFTLLSERHLGPKLYGIFSG---- 147 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC-----CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC-----cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----
Confidence 4567888999999999753210 0124679999984310 1123346888888884333 4677776643
Q ss_pred EEEEeecCCCCh
Q 012762 162 CLLTEFCPGGDL 173 (457)
Q Consensus 162 ~lV~E~~~~~sL 173 (457)
.+||||++|.+|
T Consensus 148 g~v~e~l~G~~l 159 (429)
T 1nw1_A 148 GRLEEYIPSRPL 159 (429)
T ss_dssp EEEECCCCEEEC
T ss_pred CEEEEEeCCccc
Confidence 289999987444
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.38 E-value=0.0005 Score=67.87 Aligned_cols=146 Identities=17% Similarity=0.236 Sum_probs=84.4
Q ss_pred CCceeEEEecccCcceEEEEEEecc---CCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcC-CCCCceEEEEEEc
Q 012762 82 SDLRFVHRLGSGDIGSVYLVQLKSK---SSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLD-HPFLPTLYATLDC 157 (457)
Q Consensus 82 ~~~~~~~~LG~G~fg~Vy~a~~~~~---~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~-H~nIv~l~~~~~~ 157 (457)
+++.+ +.|..|....+|++..... ....+..|++|+..... .......+|.++++.|. +.-..++++++.+
T Consensus 51 ~~l~v-~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~----~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~ 125 (379)
T 3feg_A 51 EELRV-YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL----QGVDSLVLESVMFAILAERSLGPQLYGVFPE 125 (379)
T ss_dssp GGCCC-EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT
T ss_pred CceEE-EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc----chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC
Confidence 34443 5677798999999875310 01134689999974321 12234457999988884 3334677777654
Q ss_pred CCcEEEEEeecCCCChHH--------------HHH---hC--C-CCCC--CHHHHHHHHHHHHH----------------
Q 012762 158 PRWSCLLTEFCPGGDLHV--------------LRQ---RQ--P-DKRF--HESAVRFYASEVVV---------------- 199 (457)
Q Consensus 158 ~~~~~lV~E~~~~~sL~~--------------~~~---~~--~-~~~~--~~~~~~~i~~qi~~---------------- 199 (457)
+ +||||++|..|.. .+. .. + .... -+..+..+..++..
T Consensus 126 g----~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~ 201 (379)
T 3feg_A 126 G----RLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYS 201 (379)
T ss_dssp E----EEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTT
T ss_pred c----cEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHH
Confidence 2 9999998866521 111 11 0 1111 23455555544422
Q ss_pred ---HHHHHHH--------cCceeecCCCCCeEEccC----CCEEEeccCCCc
Q 012762 200 ---ALEFLHM--------MGIIYRDLKPENVLVRSD----GHIMLTDFDLSL 236 (457)
Q Consensus 200 ---~L~yLH~--------~~iiHrDIKp~NIll~~~----~~vkl~DFG~s~ 236 (457)
.+..|.+ ..++|+|+.+.|||++.+ +.+.|+||..+.
T Consensus 202 l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 202 LKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 2334432 259999999999999876 789999999864
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.38 E-value=0.0012 Score=59.25 Aligned_cols=60 Identities=13% Similarity=0.042 Sum_probs=44.7
Q ss_pred CChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCceeecCCCCCeEEccCCCEEEec
Q 012762 171 GDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHM-MGIIYRDLKPENVLVRSDGHIMLTD 231 (457)
Q Consensus 171 ~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~-~~iiHrDIKp~NIll~~~~~vkl~D 231 (457)
.+|.+++... +.+++|++++.++.|.+.+|.-+-. ..-..+=+-|..|+|..+|.|-+.+
T Consensus 33 vSL~eIL~~~-~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~ 93 (229)
T 2yle_A 33 LSLEEILRLY-NQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP 93 (229)
T ss_dssp EEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC
T ss_pred ccHHHHHHHc-CCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc
Confidence 4788888765 4789999999999999999877622 1212333447899999999888764
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.29 E-value=0.0008 Score=66.04 Aligned_cols=80 Identities=19% Similarity=0.171 Sum_probs=45.8
Q ss_pred eEEEecccCcceEEEEEEeccC----CCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCC-CceEEEEEEcCCc
Q 012762 86 FVHRLGSGDIGSVYLVQLKSKS----SNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPF-LPTLYATLDCPRW 160 (457)
Q Consensus 86 ~~~~LG~G~fg~Vy~a~~~~~~----~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~n-Iv~l~~~~~~~~~ 160 (457)
-+..|+.|....+|++...... ...+..+++|+...... .. .....|.++++.|...+ +.++++.+ .
T Consensus 37 ~~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~---~~-~~~~~E~~~l~~L~~~g~~P~~~~~~--~-- 108 (369)
T 3c5i_A 37 RVKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD---EL-YNTISEFEVYKTMSKYKIAPQLLNTF--N-- 108 (369)
T ss_dssp EEEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG---GT-SCHHHHHHHHHHHHHTTSSCCEEEEE--T--
T ss_pred EEEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc---ce-ecHHHHHHHHHHHHhcCCCCceEEec--C--
Confidence 3567888989999998753200 00125788998764311 11 11346888888874333 45777654 2
Q ss_pred EEEEEeecCCCCh
Q 012762 161 SCLLTEFCPGGDL 173 (457)
Q Consensus 161 ~~lV~E~~~~~sL 173 (457)
.++||||++|..+
T Consensus 109 ~~~v~e~i~G~~l 121 (369)
T 3c5i_A 109 GGRIEEWLYGDPL 121 (369)
T ss_dssp TEEEEECCCSEEC
T ss_pred CcEEEEEecCCcC
Confidence 3689999987543
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.25 E-value=0.0012 Score=64.10 Aligned_cols=31 Identities=26% Similarity=0.398 Sum_probs=27.2
Q ss_pred cCceeecCCCCCeEEccCCCEEEeccCCCcC
Q 012762 207 MGIIYRDLKPENVLVRSDGHIMLTDFDLSLK 237 (457)
Q Consensus 207 ~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~ 237 (457)
..++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 3599999999999999888899999987654
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.16 E-value=0.0032 Score=63.65 Aligned_cols=76 Identities=14% Similarity=0.147 Sum_probs=48.7
Q ss_pred eEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCC-ceEEEEEEcCCcEEEE
Q 012762 86 FVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFL-PTLYATLDCPRWSCLL 164 (457)
Q Consensus 86 ~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nI-v~l~~~~~~~~~~~lV 164 (457)
-++.|+.|-...+|++.... .+..|++|+..... ..... ...|..+|+.|...++ .++++++.. .+|
T Consensus 112 ~i~~lsgG~tN~~y~v~~~~----~~~~~vLRi~g~~~---~~~id-R~~E~~vl~~L~~~gl~P~ll~~~~~----G~v 179 (458)
T 2qg7_A 112 EFQIINGGITNILIKVKDMS----KQAKYLIRLYGPKT---DEIIN-REREKKISCILYNKNIAKKIYVFFTN----GRI 179 (458)
T ss_dssp EEEEECC--CEEEEEEEETT----TTEEEEEEEECC-C---CSCSC-HHHHHHHHHHHTTSSSBCCEEEEETT----EEE
T ss_pred EEEEcCCCeEeEEEEEEECC----CCceEEEEECCCCh---hhhcC-HHHHHHHHHHHHhcCCCCCEEEEeCC----eEE
Confidence 35678889999999987531 24678899875431 11111 1468999999865444 577877732 259
Q ss_pred EeecCCCCh
Q 012762 165 TEFCPGGDL 173 (457)
Q Consensus 165 ~E~~~~~sL 173 (457)
|||++|..|
T Consensus 180 ~e~I~G~~l 188 (458)
T 2qg7_A 180 EEFMDGYAL 188 (458)
T ss_dssp EECCCSEEC
T ss_pred EEeeCCccC
Confidence 999987554
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.39 E-value=0.0045 Score=61.89 Aligned_cols=80 Identities=18% Similarity=0.242 Sum_probs=49.5
Q ss_pred eEEEecccCcceEEEEEEeccCC---CCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcC-CCCCceEEEEEEcCCcE
Q 012762 86 FVHRLGSGDIGSVYLVQLKSKSS---NNGCFFAAKVMDKRELVSRNKESRARIEREILEMLD-HPFLPTLYATLDCPRWS 161 (457)
Q Consensus 86 ~~~~LG~G~fg~Vy~a~~~~~~~---~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~-H~nIv~l~~~~~~~~~~ 161 (457)
-++.|..|....+|++....... ..+..|++|+..... ....+ ..+|.++++.|. +.-..++++.+. -
T Consensus 74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t---~~~id-R~~E~~~l~~L~~~gi~P~l~~~~~----~ 145 (424)
T 3mes_A 74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV---GKFYD-SKVELDVFRYLSNINIAPNIIADFP----E 145 (424)
T ss_dssp EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC----CCCC-HHHHHHHHHHHHHTTSSCCEEEEET----T
T ss_pred EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc---chhcC-HHHHHHHHHHHHhcCCCCCEEEEcC----C
Confidence 45677778899999988642110 015789999975431 11111 245888888874 333566776442 2
Q ss_pred EEEEeecCCCCh
Q 012762 162 CLLTEFCPGGDL 173 (457)
Q Consensus 162 ~lV~E~~~~~sL 173 (457)
++||||++|..|
T Consensus 146 ~~I~efI~G~~l 157 (424)
T 3mes_A 146 GRIEEFIDGEPL 157 (424)
T ss_dssp EEEEECCCSEEC
T ss_pred CEEEEEeCCccC
Confidence 689999998664
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=95.99 E-value=0.021 Score=56.63 Aligned_cols=28 Identities=29% Similarity=0.468 Sum_probs=24.1
Q ss_pred ceeecCCCCCeEE------ccCCCEEEeccCCCc
Q 012762 209 IIYRDLKPENVLV------RSDGHIMLTDFDLSL 236 (457)
Q Consensus 209 iiHrDIKp~NIll------~~~~~vkl~DFG~s~ 236 (457)
++|+|+.+.|||+ +.++.+.++||..|.
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 7899999999999 345789999998864
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=83.49 E-value=2.3 Score=37.96 Aligned_cols=82 Identities=7% Similarity=-0.091 Sum_probs=56.6
Q ss_pred CCCCCceEEEEEEcCCcEEEEEeecC-CCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHH-HHHHcCceeecCCCCCeEE
Q 012762 144 DHPFLPTLYATLDCPRWSCLLTEFCP-GGDLHVLRQRQPDKRFHESAVRFYASEVVVALE-FLHMMGIIYRDLKPENVLV 221 (457)
Q Consensus 144 ~H~nIv~l~~~~~~~~~~~lV~E~~~-~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~-yLH~~~iiHrDIKp~NIll 221 (457)
.||++ . ..+-..++.+.+.++.-+ +.++. -+ ..++....+.++.+|+.... ++ ..-+|--|.|+||++
T Consensus 48 ~~~~f-~-~~I~~~eD~~~i~y~~~~~~~~f~-~i-----~~~~~~eKlrll~nl~~L~~~~~--~~r~tf~l~P~NL~f 117 (219)
T 4ano_A 48 VDPCI-V-RDIDVSEDEVKVVIKPPSSFLTFA-AI-----RKTTLLSRIRAAIHLVSKVKHHS--ARRLIFIVCPENLMF 117 (219)
T ss_dssp SCSSS-E-EEEEECSSEEEEEEECCTTCEEHH-HH-----HTSCHHHHHHHHHHHHHHHSSCC--SSSEECCCCGGGEEE
T ss_pred cCCCC-C-eEEEEeCCEEEEEEEcCcccCcHH-HH-----HhcCHHHHHHHHHHHHHHHHHhh--hCceeEEEeCceEEE
Confidence 67887 2 333356666666666542 23333 22 33788888888877776555 33 445777899999999
Q ss_pred ccCCCEEEeccCCC
Q 012762 222 RSDGHIMLTDFDLS 235 (457)
Q Consensus 222 ~~~~~vkl~DFG~s 235 (457)
+.++.+++.-.|+-
T Consensus 118 ~~~~~p~i~hRGi~ 131 (219)
T 4ano_A 118 NRALEPFFLHVGVK 131 (219)
T ss_dssp CTTCCEEESCCEET
T ss_pred eCCCcEEEEEcCCc
Confidence 99999999999985
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=81.13 E-value=0.1 Score=52.68 Aligned_cols=64 Identities=6% Similarity=-0.054 Sum_probs=17.6
Q ss_pred eeEEEecccCcceEEEEEEeccCCCCCceEEE------EEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEE
Q 012762 85 RFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAA------KVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLD 156 (457)
Q Consensus 85 ~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAv------K~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~ 156 (457)
.+.++|| ||.||++.+.. ....||+ |..+.... .......+.+|..+++.++|+|+++.+++..
T Consensus 145 ~l~~~lG---fG~v~~g~~~~----~~~~Vav~~~~~~K~~~~~~~-~~e~~~~~~rea~l~~~~~H~niv~~h~f~~ 214 (463)
T 3cxl_A 145 PIYEHVG---YTTLNREPAYK----KHMPVLKETHDERDSTGQDGV-SEKRLTSLVRRATLKENEQIPKYEKIHNFKV 214 (463)
T ss_dssp CSTTTSS---BCCC-------------CCBGGGC------------------------------------CBCCCEEE
T ss_pred cccccCC---chhhhcccccc----cCCchhhhhccCccccccccc-cccccccccccccccccccccccCCCcceEE
Confidence 3455666 99999998863 2356788 65543322 2233345667888888899999999888754
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=80.35 E-value=1.7 Score=38.63 Aligned_cols=86 Identities=12% Similarity=0.028 Sum_probs=61.5
Q ss_pred CCCCCceEEEEEEcCCcEEEEEeecC-CCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEc
Q 012762 144 DHPFLPTLYATLDCPRWSCLLTEFCP-GGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVR 222 (457)
Q Consensus 144 ~H~nIv~l~~~~~~~~~~~lV~E~~~-~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~ 222 (457)
.||+.+.. .+-..++.+.+.++.-. +.++.. + ..++....+.++.+|+....++ ..-+|--|.|+||+++
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-i-----k~~~~~eKlr~l~ni~~l~~~~--~~r~tf~L~P~NL~f~ 113 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-I-----KSFTKNEKLRYLLNIKNLEEVN--RTRYTFVLAPDELFFT 113 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-G-----GGSCHHHHHHHHHHGGGGGGGG--GSSEECCCSGGGEEEC
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-H-----HhcCHHHHHHHHHHHHHHHHHh--cCceEEEEecceEEEc
Confidence 68888877 55566666666666532 223332 2 3478888888888888877444 3347778999999999
Q ss_pred cCCCEEEeccCCCcCC
Q 012762 223 SDGHIMLTDFDLSLKG 238 (457)
Q Consensus 223 ~~~~vkl~DFG~s~~~ 238 (457)
.++.+++.-.|+-..+
T Consensus 114 ~~~~p~i~~RGik~~l 129 (215)
T 4ann_A 114 RDGLPIAKTRGLQNVV 129 (215)
T ss_dssp TTSCEEESCCEETTTB
T ss_pred CCCCEEEEEccCccCC
Confidence 9999999999985443
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 457 | ||||
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-59 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 4e-44 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 5e-42 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 5e-41 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-39 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-23 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-37 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-18 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-36 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-24 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 7e-35 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-28 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 7e-35 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 5e-19 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 3e-34 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-25 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-33 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-24 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-33 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 5e-29 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-33 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-33 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-20 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 3e-33 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-16 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-32 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-20 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-32 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 4e-18 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 5e-32 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-22 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-31 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-14 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-31 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 3e-31 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 8e-26 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 4e-31 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 5e-31 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-15 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 6e-31 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-30 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 7e-31 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 8e-31 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 9e-31 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 4e-14 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-30 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 8e-17 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-30 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 9e-12 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 4e-30 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 4e-21 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 4e-30 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 6e-30 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-20 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 7e-30 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-16 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-29 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-29 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-17 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-29 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 5e-29 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-16 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 5e-29 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 4e-19 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 6e-29 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 6e-29 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-22 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-28 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 5e-23 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-28 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 8e-14 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-28 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-28 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-10 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 5e-28 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 9e-13 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 8e-28 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 9e-28 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-27 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-27 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 4e-14 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-27 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-25 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-27 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 4e-13 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 4e-27 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-25 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-24 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 9e-13 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-24 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-24 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 8e-19 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 4e-24 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-13 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 9e-24 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-11 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-23 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-13 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 5e-23 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 5e-11 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-22 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 5e-14 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 8e-22 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-14 |
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (495), Expect = 1e-59
Identities = 91/355 (25%), Positives = 143/355 (40%), Gaps = 78/355 (21%)
Query: 83 DLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEM 142
D +F LG G +V L + + +A K+++KR ++ NK ER+++
Sbjct: 9 DFKFGKILGEGSFSTVVLARELA----TSREYAIKILEKRHIIKENKVPYVTRERDVMSR 64
Query: 143 LDHPFLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALE 202
LDHPF LY T + G+L ++ F E+ RFY +E+V ALE
Sbjct: 65 LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALE 122
Query: 203 FLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPND 262
+LH GII+RD LK +N D
Sbjct: 123 YLHGKGIIHRD----------------------LKPENILLN----------------ED 144
Query: 263 CAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTH 322
+ FG + + P E R+ SFVGT
Sbjct: 145 MHIQITDFGTAKVLSP------------------------------ESKQARANSFVGTA 174
Query: 323 EYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPS 382
+Y++PE+++ + + D W LG I++L G PF+ + L ++ +FP++
Sbjct: 175 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEK-- 232
Query: 383 VPGPAKDLIAQLLVKDPTRRMGSK--MGATAIKRHQFFNGVNWALLRCAKPPFIP 435
A+DL+ +LLV D T+R+G + G +K H FF V W L PP +
Sbjct: 233 FFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKLT 287
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 4e-44
Identities = 64/359 (17%), Positives = 107/359 (29%), Gaps = 106/359 (29%)
Query: 90 LGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREI---LEMLDHP 146
LG G G V + K FA K++ + RE+ P
Sbjct: 20 LGLGINGKVLQIFNKR----TQEKFALKMLQDCP----------KARREVELHWRASQCP 65
Query: 147 FLPTLYATLDCPRWS----CLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALE 202
+ + + ++ E GG+L Q + D+ F E + A++
Sbjct: 66 HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 125
Query: 203 FLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPND 262
+LH + I +RD+KPEN ++ T +
Sbjct: 126 YLHSINIAHRDVKPEN--------LLYTSKR---------------------------PN 150
Query: 263 CAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTH 322
+ FG + + + T
Sbjct: 151 AILKLTDFGFAKETTSHN---------------------------------SLTTPCYTP 177
Query: 323 EYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALE------ 376
Y+APE++ E + + D W+LG+ ++ L G PF + R
Sbjct: 178 YYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP 237
Query: 377 FPKEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGVNWALLRCAKPPFIP 435
P+ V K LI LL +PT+R M T H + ++ K P P
Sbjct: 238 NPEWSEVSEEVKMLIRNLLKTEPTQR----MTITEFMNHPWI-------MQSTKVPQTP 285
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 5e-42
Identities = 60/348 (17%), Positives = 107/348 (30%), Gaps = 47/348 (13%)
Query: 79 LTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIERE 138
L D + LG+G+ G V+ V K +G A K++ + ++ E +
Sbjct: 3 LKDDDFEKISELGAGNGGVVFKVSHKP----SGLVMARKLIHLE--IKPAIRNQIIRELQ 56
Query: 139 ILEMLDHPFLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVV 198
+L + P++ Y + E GG L + ++ R E + + V+
Sbjct: 57 VLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVI 114
Query: 199 VALEFLH-MMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQLVSDQ--SPPT 255
L +L I++RD+KP N+LV S G I L DF +S + +S + + + + SP
Sbjct: 115 KGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPER 174
Query: 256 GDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRS 315
D G + ++ P+
Sbjct: 175 LQGTHYSVQSDIWSMG--------LSLVEMAVGRY-------------------PIPPPD 207
Query: 316 MSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARAL 375
E EG YG + L +V
Sbjct: 208 -----AKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPP 262
Query: 376 EFPKEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGVNW 423
+D + + L+K+P R + H F +
Sbjct: 263 PKLPSGVFSLEFQDFVNKCLIKNPAER----ADLKQLMVHAFIKRSDA 306
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 146 bits (368), Expect = 5e-41
Identities = 67/344 (19%), Positives = 109/344 (31%), Gaps = 76/344 (22%)
Query: 60 WKAIKEATSEGNNNNNNNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVM 119
++ EA + +S ++ +G+G+ G V LK F A K +
Sbjct: 9 FEDPNEAV-----REFAKEIDISCVKIEQVIGAGEFGEVCSGHLK-LPGKREIFVAIKTL 62
Query: 120 DKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQR 179
+ + E I+ DHP + L + ++TEF G L R
Sbjct: 63 KSG--YTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSF-LR 119
Query: 180 QPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGD 239
Q D +F + + +++L M ++RDL N+LV S+ ++DF LS
Sbjct: 120 QNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLS---- 175
Query: 240 NSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLG 299
L D S PT LG
Sbjct: 176 -----RFLEDDTSDPT--------------------------------------YTSALG 192
Query: 300 NPGTPEIVAEPLDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELF-YGTTPF 358
A PE I +A D W+ GI ++E+ YG P+
Sbjct: 193 GKIPIRWTA------------------PEAIQYRKFTSASDVWSYGIVMWEVMSYGERPY 234
Query: 359 KGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDPTRR 402
+ ++ + N + + P P L+ KD R
Sbjct: 235 WDMTNQ-DVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHR 277
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 2e-39
Identities = 57/194 (29%), Positives = 86/194 (44%), Gaps = 8/194 (4%)
Query: 80 TLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREI 139
L D LG G G+VYL + K + A KV+ K +L E + R E EI
Sbjct: 4 ALEDFEIGRPLGKGKFGNVYLAREK----QSKFILALKVLFKAQLEKAGVEHQLRREVEI 59
Query: 140 LEMLDHPFLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVV 199
L HP + LY L+ E+ P G ++ Q+ +F E Y +E+
Sbjct: 60 QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELAN 117
Query: 200 ALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQLVSDQ--SPPTGD 257
AL + H +I+RD+KPEN+L+ S G + + DF S+ +S T + P +
Sbjct: 118 ALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIE 177
Query: 258 QQPNDCAVDQPPFG 271
+ +D VD G
Sbjct: 178 GRMHDEKVDLWSLG 191
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.0 bits (241), Expect = 2e-23
Identities = 32/107 (29%), Positives = 50/107 (46%), Gaps = 6/107 (5%)
Query: 314 RSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVAR 373
R + GT +YL PE+I G H VD W+LG+ +E G PF+ ++ T +
Sbjct: 160 RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV 219
Query: 374 ALEFPKEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNG 420
FP V A+DLI++LL +P++R + H +
Sbjct: 220 EFTFP--DFVTEGARDLISRLLKHNPSQR----PMLREVLEHPWITA 260
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (344), Expect = 1e-37
Identities = 54/196 (27%), Positives = 76/196 (38%), Gaps = 17/196 (8%)
Query: 85 RFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLD 144
+ LG G G VY Q K AAKV+D + S + +E +IL D
Sbjct: 15 EIIGELGDGAFGKVYKAQNK----ETSVLAAAKVIDTK---SEEELEDYMVEIDILASCD 67
Query: 145 HPFLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFL 204
HP + L +L EFC GG + + ++ ES ++ + + AL +L
Sbjct: 68 HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLEL-ERPLTESQIQVVCKQTLDALNYL 126
Query: 205 HMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQLVSDQ---------SPPT 255
H II+RDLK N+L DG I L DF +S K + T
Sbjct: 127 HDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCET 186
Query: 256 GDQQPNDCAVDQPPFG 271
+P D D G
Sbjct: 187 SKDRPYDYKADVWSLG 202
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 82.7 bits (204), Expect = 2e-18
Identities = 27/137 (19%), Positives = 51/137 (37%), Gaps = 11/137 (8%)
Query: 297 KLGNPGTPEIVAEPLDVRSMSFVGTHEYLAPEII-----SGEGHGNAVDWWTLGIFIFEL 351
KL + G + R SF+GT ++APE++ + D W+LGI + E+
Sbjct: 150 KLADFGVSAKNTRTIQRRD-SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 208
Query: 352 FYGTTPFKGIDHELTLANVV-ARALEFPKEPSVPGPAKDLIAQLLVKDPTRRMGSKMGAT 410
P ++ L + + + KD + + L K+ R +
Sbjct: 209 AEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDAR----WTTS 264
Query: 411 AIKRHQFFNGVNWALLR 427
+ +H F + +R
Sbjct: 265 QLLQHPFVTVDSNKPIR 281
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 135 bits (341), Expect = 2e-36
Identities = 53/199 (26%), Positives = 88/199 (44%), Gaps = 12/199 (6%)
Query: 79 LTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIERE 138
LT++D +G G G VY + + G +A K +DK+ + + E+ A ER
Sbjct: 1 LTMNDFSVHRIIGRGGFGEVYGCRKA----DTGKMYAMKCLDKKRIKMKQGETLALNERI 56
Query: 139 ILEML---DHPFLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYAS 195
+L ++ D PF+ + P + + GGDLH + F E+ +RFYA+
Sbjct: 57 MLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH--GVFSEADMRFYAA 114
Query: 196 EVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQ---LVSDQS 252
E+++ LE +H ++YRDLKP N+L+ GH+ ++D L+ A
Sbjct: 115 EIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAP 174
Query: 253 PPTGDQQPNDCAVDQPPFG 271
D + D G
Sbjct: 175 EVLQKGVAYDSSADWFSLG 193
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 101 bits (252), Expect = 3e-24
Identities = 37/134 (27%), Positives = 63/134 (47%), Gaps = 5/134 (3%)
Query: 314 RSMSFVGTHEYLAPEII-SGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVA 372
+ + VGTH Y+APE++ G + ++ DW++LG +F+L G +PF+ +
Sbjct: 161 KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM 220
Query: 373 RALEFPKEP-SVPGPAKDLIAQLLVKDPTRRMGS-KMGATAIKRHQFFNGVNWALL--RC 428
+ P S + L+ LL +D RR+G GA +K FF ++W ++ +
Sbjct: 221 TLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQK 280
Query: 429 AKPPFIPRPVTCRD 442
PP IP
Sbjct: 281 YPPPLIPPRGEVNA 294
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 130 bits (327), Expect = 7e-35
Identities = 60/194 (30%), Positives = 103/194 (53%), Gaps = 7/194 (3%)
Query: 80 TLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREI 139
+L D + + LG+G G V+L++ + NG ++A KV+ K +V + ER +
Sbjct: 2 SLQDFQILRTLGTGSFGRVHLIRSRH----NGRYYAMKVLKKEIVVRLKQVEHTNDERLM 57
Query: 140 LEMLDHPFLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVV 199
L ++ HPF+ ++ T + ++ ++ GG+L + +RF +FYA+EV +
Sbjct: 58 LSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELF--SLLRKSQRFPNPVAKFYAAEVCL 115
Query: 200 ALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS-LKGDNSTSTAQLVSDQSPPTGDQ 258
ALE+LH IIYRDLKPEN+L+ +GHI +TDF + D + + +P
Sbjct: 116 ALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCGTPDYIAPEVVST 175
Query: 259 QPNDCAVDQPPFGN 272
+P + ++D FG
Sbjct: 176 KPYNKSIDWWSFGI 189
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 112 bits (280), Expect = 2e-28
Identities = 45/154 (29%), Positives = 81/154 (52%), Gaps = 10/154 (6%)
Query: 297 KLGNPGTPEIVAEPLDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTT 356
K+ + G A+ + + + GT +Y+APE++S + + ++DWW+ GI I+E+ G T
Sbjct: 144 KITDFGF----AKYVPDVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYT 199
Query: 357 PFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDPTRRMGS-KMGATAIKRH 415
PF + T ++ L FP P KDL+++L+ +D ++R+G+ + G +K H
Sbjct: 200 PFYDSNTMKTYEKILNAELRFP--PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257
Query: 416 QFFNGVNWALL--RCAKPPFIPRPVTCRDLTTTN 447
+F V W L R + P+ P P+ T+
Sbjct: 258 PWFKEVVWEKLLSRNIETPYEP-PIQQGQGDTSQ 290
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 129 bits (326), Expect = 7e-35
Identities = 43/190 (22%), Positives = 68/190 (35%), Gaps = 9/190 (4%)
Query: 85 RFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLD 144
+ +G G G+VY + N A K M S K E L+ L
Sbjct: 18 SDLREIGHGSFGAVYFARDVR----NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 145 HPFLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFL 204
HP + L+ E+C G +L + K E + + L +L
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYL 131
Query: 205 HMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTS---TAQLVSDQSPPTGDQQPN 261
H +I+RD+K N+L+ G + L DF + + S T ++ + D+
Sbjct: 132 HSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFVGTPYWMAPEVILAMDEGQY 191
Query: 262 DCAVDQPPFG 271
D VD G
Sbjct: 192 DGKVDVWSLG 201
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 85.0 bits (210), Expect = 5e-19
Identities = 26/108 (24%), Positives = 43/108 (39%), Gaps = 7/108 (6%)
Query: 314 RSMSFVGTHEYLAPEIISGEGHGN---AVDWWTLGIFIFELFYGTTPFKGIDHELTLANV 370
+ SFVGT ++APE+I G VD W+LGI EL P ++ L ++
Sbjct: 167 PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI 226
Query: 371 VARALEFPKEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFF 418
+ ++ + L K P R + + +H+F
Sbjct: 227 AQNESPALQSGHWSEYFRNFVDSCLQKIPQDR----PTSEVLLKHRFV 270
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 129 bits (324), Expect = 3e-34
Identities = 64/230 (27%), Positives = 107/230 (46%), Gaps = 7/230 (3%)
Query: 43 SAAKTHHAPPRCNDDPCWKAIKEATSEGNNNNNNNPLTLSDLRFVHRLGSGDIGSVYLVQ 102
+AA + + KE + + N L + LG+G G V LV+
Sbjct: 2 NAAAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVK 61
Query: 103 LKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWSC 162
K +G +A K++DK+++V + E+ IL+ ++ PFL L +
Sbjct: 62 HKE----SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLY 117
Query: 163 LLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVR 222
++ E+ GG++ +R RF E RFYA+++V+ E+LH + +IYRDLKPEN+L+
Sbjct: 118 MVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID 175
Query: 223 SDGHIMLTDFDLSLKGDNSTSTAQ-LVSDQSPPTGDQQPNDCAVDQPPFG 271
G+I +TDF + + T T +P + + AVD G
Sbjct: 176 QQGYIQVTDFGFAKRVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALG 225
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 104 bits (259), Expect = 2e-25
Identities = 48/133 (36%), Positives = 69/133 (51%), Gaps = 5/133 (3%)
Query: 307 VAEPLDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELT 366
A+ + R+ + GT E LAPEII +G+ AVDWW LG+ I+E+ G PF
Sbjct: 187 FAKRVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI 246
Query: 367 LANVVARALEFPKEPSVPGPAKDLIAQLLVKDPTRRMGS-KMGATAIKRHQFFNGVNWAL 425
+V+ + FP KDL+ LL D T+R G+ K G IK H++F +W
Sbjct: 247 YEKIVSGKVRFP--SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIA 304
Query: 426 L--RCAKPPFIPR 436
+ R + PFIP+
Sbjct: 305 IYQRKVEAPFIPK 317
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 127 bits (321), Expect = 1e-33
Identities = 45/196 (22%), Positives = 74/196 (37%), Gaps = 13/196 (6%)
Query: 81 LSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREIL 140
L LG+G G V+ V ++ G FAAK + + + R E + +
Sbjct: 25 LDHYDIHEELGTGAFGVVHRVTERA----TGNNFAAKFVMTP---HESDKETVRKEIQTM 77
Query: 141 EMLDHPFLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVA 200
+L HP L L+ + ++ EF GG+L + + E Y +V
Sbjct: 78 SVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEH-NKMSEDEAVEYMRQVCKG 136
Query: 201 LEFLHMMGIIYRDLKPENVLVRSD--GHIMLTDFDLSLKGDNSTSTAQLVSD---QSPPT 255
L +H ++ DLKPEN++ + + L DF L+ D S +P
Sbjct: 137 LCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEV 196
Query: 256 GDQQPNDCAVDQPPFG 271
+ +P D G
Sbjct: 197 AEGKPVGYYTDMWSVG 212
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 101 bits (253), Expect = 2e-24
Identities = 38/168 (22%), Positives = 60/168 (35%), Gaps = 8/168 (4%)
Query: 273 SSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTHEYLAPEIISG 332
+ + + P KR + KL + G + GT E+ APE+ G
Sbjct: 142 ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP--KQSVKVTTGTAEFAAPEVAEG 199
Query: 333 EGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKE--PSVPGPAKDL 390
+ G D W++G+ + L G +PF G + + TL NV + + KD
Sbjct: 200 KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDF 259
Query: 391 IAQLLVKDPTRRMGSKMGATAIKRHQFFNGVNWALLRCAKPPFIPRPV 438
I +LL+ DP R M H + N P +
Sbjct: 260 IRKLLLADPNTR----MTIHQALEHPWLTPGNAPGRDSQIPSSRYTKI 303
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (319), Expect = 1e-33
Identities = 60/197 (30%), Positives = 100/197 (50%), Gaps = 10/197 (5%)
Query: 79 LTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIERE 138
+T++D ++ LG G G V LV+ K+ G ++A K++ K ++++++ + E
Sbjct: 2 VTMNDFDYLKLLGKGTFGKVILVREKA----TGRYYAMKILRKEVIIAKDEVAHTVTESR 57
Query: 139 ILEMLDHPFLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVV 198
+L+ HPFL L C + E+ GG+L R+ F E RFY +E+V
Sbjct: 58 VLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER--VFTEERARFYGAEIV 115
Query: 199 VALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQLV----SDQSPP 254
ALE+LH ++YRD+K EN+++ DGHI +TDF L +G + +T + +P
Sbjct: 116 SALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPE 175
Query: 255 TGDQQPNDCAVDQPPFG 271
+ AVD G
Sbjct: 176 VLEDNDYGRAVDWWGLG 192
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (286), Expect = 5e-29
Identities = 49/143 (34%), Positives = 75/143 (52%), Gaps = 6/143 (4%)
Query: 297 KLGNPGTPEIVAEPLDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTT 356
K+ + G + +F GT EYLAPE++ +G AVDWW LG+ ++E+ G
Sbjct: 145 KITDFGLCKEGISD-GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRL 203
Query: 357 PFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDPTRRMGSKM-GATAIKRH 415
PF DHE ++ + FP+ ++ AK L+A LL KDP +R+G A + H
Sbjct: 204 PFYNQDHERLFELILMEEIRFPR--TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261
Query: 416 QFFNGVNWALL--RCAKPPFIPR 436
+FF +NW + + PPF P+
Sbjct: 262 RFFLSINWQDVVQKKLLPPFKPQ 284
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 126 bits (317), Expect = 2e-33
Identities = 72/391 (18%), Positives = 124/391 (31%), Gaps = 76/391 (19%)
Query: 42 PSAAKTHHAPPRCNDDPCWKAIKEATSEGNNNNNNNPLTLSDLRFVHRLGSGDIGSVYLV 101
PS A+ + + + + E N + D + V +LG G V+
Sbjct: 4 PSRARVYTDV-NTHRPREYWDYESHVVEWGNQD--------DYQLVRKLGRGKYSEVFEA 54
Query: 102 QLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEML-DHPFLPTLYATLDCP-- 158
+ N K++ K+ + + E +ILE L P + TL + P
Sbjct: 55 INIT----NNEKVVVKILKPV------KKKKIKREIKILENLRGGPNIITLADIVKDPVS 104
Query: 159 RWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPEN 218
R L+ E D L Q + +RFY E++ AL++ H MGI++RD+KP N
Sbjct: 105 RTPALVFEHVNNTDFKQLYQT-----LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHN 159
Query: 219 VLVRSDG-HIMLTDFDLSLKGDNSTSTAQLVS----DQSPPTGDQQPNDCAVDQPPFGNS 273
V++ + + L D+ L+ V+ D Q D ++D
Sbjct: 160 VMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSL--- 216
Query: 274 SCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTHEYLAPE-IISG 332
++A + + F G Y I
Sbjct: 217 ------------------------------GCMLASMIFRKEPFFHGHDNYDQLVRIAKV 246
Query: 333 EGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIA 392
G + D+ + + + R + + V A D +
Sbjct: 247 LGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWE------RFVHSENQHLVSPEALDFLD 300
Query: 393 QLLVKDPTRRMGSKMGATAIKRHQFFNGVNW 423
+LL D R + A H +F V
Sbjct: 301 KLLRYDHQSR----LTAREAMEHPYFYTVVK 327
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (313), Expect = 2e-33
Identities = 41/167 (24%), Positives = 72/167 (43%), Gaps = 8/167 (4%)
Query: 81 LSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREIL 140
+ D V LG G G V L + A K++D + V + + E I
Sbjct: 4 VEDWDLVQTLGEGAYGEVQLAVNRV----TEEAVAVKIVDMKRAVDCPE--NIKKEICIN 57
Query: 141 EMLDHPFLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVA 200
+ML+H + Y L E+C GG+L + D E + + +++
Sbjct: 58 KMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAG 115
Query: 201 LEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQL 247
+ +LH +GI +RD+KPEN+L+ ++ ++DF L+ + L
Sbjct: 116 VVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL 162
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 88.9 bits (220), Expect = 2e-20
Identities = 26/126 (20%), Positives = 52/126 (41%), Gaps = 7/126 (5%)
Query: 297 KLGNPGTPEIVAEPLDVRSM-SFVGTHEYLAPEIISGEG-HGNAVDWWTLGIFIFELFYG 354
K+ + G + R + GT Y+APE++ H VD W+ GI + + G
Sbjct: 143 KISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 202
Query: 355 TTPFKGI-DHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIK 413
P+ D ++ + + L+ ++LV++P+ R + IK
Sbjct: 203 ELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSAR----ITIPDIK 258
Query: 414 RHQFFN 419
+ +++N
Sbjct: 259 KDRWYN 264
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (313), Expect = 3e-33
Identities = 33/166 (19%), Positives = 65/166 (39%), Gaps = 10/166 (6%)
Query: 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILE 141
+ R+GSG G+VY + A K+++ + + + E +L
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGD-------VAVKMLNVTAPTPQQLQ-AFKNEVGVLR 59
Query: 142 MLDHPFLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVAL 201
H + P ++T++C G L+ + +F + A + +
Sbjct: 60 KTRHVNILLFMGYSTAP-QLAIVTQWCEGSSLYHHLHII-ETKFEMIKLIDIARQTAQGM 117
Query: 202 EFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQL 247
++LH II+RDLK N+ + D + + DF L+ + + Q
Sbjct: 118 DYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQF 163
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 77.3 bits (190), Expect = 1e-16
Identities = 26/114 (22%), Positives = 46/114 (40%), Gaps = 8/114 (7%)
Query: 297 KLGNPGTPEIVAEPLDVRSM-SFVGTHEYLAPEIISGEGHGN---AVDWWTLGIFIFELF 352
K+G+ G + + G+ ++APE+I + D + GI ++EL
Sbjct: 144 KIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELM 203
Query: 353 YGTTPFKGIDHELTLANVVARALEFPK----EPSVPGPAKDLIAQLLVKDPTRR 402
G P+ I++ + +V R P + P K L+A+ L K R
Sbjct: 204 TGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDER 257
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 123 bits (309), Expect = 1e-32
Identities = 44/201 (21%), Positives = 74/201 (36%), Gaps = 13/201 (6%)
Query: 83 DLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKES------RARIE 136
+ LG G V K +A K++D S + E E
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKP----TCKEYAVKIIDVTGGGSFSAEEVQELREATLKE 59
Query: 137 REILEML-DHPFLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYAS 195
+IL + HP + L T + + L+ + G+L + E R
Sbjct: 60 VDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMR 117
Query: 196 EVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQLVSDQSPPT 255
++ + LH + I++RDLKPEN+L+ D +I LTDF S + D ++ S
Sbjct: 118 ALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLA 177
Query: 256 GDQQPNDCAVDQPPFGNSSCI 276
+ + P +G +
Sbjct: 178 PEIIECSMNDNHPGYGKEVDM 198
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 89.0 bits (220), Expect = 1e-20
Identities = 37/130 (28%), Positives = 55/130 (42%), Gaps = 14/130 (10%)
Query: 297 KLGNPGTPEIVAEPLDVRSMSFVGTHEYLAPEIISGE------GHGNAVDWWTLGIFIFE 350
KL + G + + GT YLAPEII G+G VD W+ G+ ++
Sbjct: 150 KLTDFGFSCQLDP--GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYT 207
Query: 351 LFYGTTPFKGIDHELTLANVVARALEF--PKEPSVPGPAKDLIAQLLVKDPTRRMGSKMG 408
L G+ PF L L +++ +F P+ KDL+++ LV P +R
Sbjct: 208 LLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKR----YT 263
Query: 409 ATAIKRHQFF 418
A H FF
Sbjct: 264 AEEALAHPFF 273
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (306), Expect = 2e-32
Identities = 45/202 (22%), Positives = 82/202 (40%), Gaps = 18/202 (8%)
Query: 83 DLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEM 142
D ++ +G+G G ++ KS +G K +D + K+ E +L
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKS----DGKILVWKELDYGSMTEAEKQ-MLVSEVNLLRE 59
Query: 143 LDHPFLPTLYA--TLDCPRWSCLLTEFCPGGDL--HVLRQRQPDKRFHESAVRFYASEVV 198
L HP + Y ++ E+C GGDL + + + + E V +++
Sbjct: 60 LKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLT 119
Query: 199 VALEFLHMMG-----IIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQLVSD--- 250
+AL+ H +++RDLKP NV + ++ L DF L+ ++ TS A+
Sbjct: 120 LALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPY 179
Query: 251 -QSPPTGDQQPNDCAVDQPPFG 271
SP ++ + D G
Sbjct: 180 YMSPEQMNRMSYNEKSDIWSLG 201
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 82.0 bits (202), Expect = 4e-18
Identities = 27/122 (22%), Positives = 47/122 (38%), Gaps = 8/122 (6%)
Query: 297 KLGNPGTPEIVAEPLDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTT 356
KLG+ G I+ +FVGT Y++PE ++ + D W+LG ++EL
Sbjct: 154 KLGDFGLARILNHDTSFAK-AFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMP 212
Query: 357 PFKGIDHELTLANVVARALEFPKEPS-VPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRH 415
PF + + R +F + P ++I ++L R I +
Sbjct: 213 PFTAFSQKELAGKI--REGKFRRIPYRYSDELNEIITRMLNLKDYHR----PSVEEILEN 266
Query: 416 QF 417
Sbjct: 267 PL 268
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 123 bits (309), Expect = 5e-32
Identities = 45/192 (23%), Positives = 77/192 (40%), Gaps = 13/192 (6%)
Query: 85 RFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLD 144
+ LGSG G V+ K+ G F AK ++ + + + E I+ L
Sbjct: 32 DILEELGSGAFGVVHRCVEKA----TGRVFVAKFINTPYPLDKY---TVKNEISIMNQLH 84
Query: 145 HPFLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFL 204
HP L L+ + L+ EF GG+L + D + E+ V Y + L+ +
Sbjct: 85 HPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHM 143
Query: 205 HMMGIIYRDLKPENVLVRS--DGHIMLTDFDLSLKGDNSTSTAQLV---SDQSPPTGDQQ 259
H I++ D+KPEN++ + + + DF L+ K + +P D++
Sbjct: 144 HEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDRE 203
Query: 260 PNDCAVDQPPFG 271
P D G
Sbjct: 204 PVGFYTDMWAIG 215
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 95.9 bits (238), Expect = 2e-22
Identities = 41/142 (28%), Positives = 58/142 (40%), Gaps = 8/142 (5%)
Query: 288 LHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIF 347
K+ K+ + G + D T E+ APEI+ E G D W +G+
Sbjct: 160 CETKKASSVKIIDFGLATKLNP--DEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVL 217
Query: 348 IFELFYGTTPFKGIDHELTLANVVARALEFPKE--PSVPGPAKDLIAQLLVKDPTRRMGS 405
+ L G +PF G D TL NV EF ++ SV AKD I LL K+P +R
Sbjct: 218 GYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKR--- 274
Query: 406 KMGATAIKRHQFFNGVNWALLR 427
+ H + G + L
Sbjct: 275 -LTVHDALEHPWLKGDHSNLTS 295
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (301), Expect = 1e-31
Identities = 41/195 (21%), Positives = 76/195 (38%), Gaps = 13/195 (6%)
Query: 79 LTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIERE 138
L + +L+ + +G G+ G V L + G A K + E
Sbjct: 4 LNMKELKLLQTIGKGEFGDVMLGDYR------GNKVAVKCIKNDA-----TAQAFLAEAS 52
Query: 139 ILEMLDHPFLPTLY-ATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEV 197
++ L H L L ++ ++TE+ G L + + + ++ +V
Sbjct: 53 VMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDV 112
Query: 198 VVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQL-VSDQSPPTG 256
A+E+L ++RDL NVLV D ++DF L+ + ++ T +L V +P
Sbjct: 113 CEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEAL 172
Query: 257 DQQPNDCAVDQPPFG 271
++ D FG
Sbjct: 173 REKKFSTKSDVWSFG 187
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 71.2 bits (174), Expect = 1e-14
Identities = 15/96 (15%), Positives = 35/96 (36%), Gaps = 2/96 (2%)
Query: 308 AEPLDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELF-YGTTPFKGIDHELT 366
+ + ++ APE + + D W+ GI ++E++ +G P+ I +
Sbjct: 150 TKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV 209
Query: 367 LANVVARALEFPKEPSVPGPAKDLIAQLLVKDPTRR 402
+ V + + P +++ D R
Sbjct: 210 VPRVE-KGYKMDAPDGCPPAVYEVMKNCWHLDAAMR 244
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 120 bits (301), Expect = 1e-31
Identities = 45/326 (13%), Positives = 87/326 (26%), Gaps = 78/326 (23%)
Query: 85 RFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLD 144
+ R+G G G ++ N A K +R + + R E ++L
Sbjct: 8 KVGRRIGEGSFGVIFEGTNLL----NNQQVAIKFEPRR-----SDAPQLRDEYRTYKLLA 58
Query: 145 H-PFLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEF 203
+P +Y + L+ + +L ++F V A +++ ++
Sbjct: 59 GCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCG--RKFSVKTVAMAAKQMLARVQS 116
Query: 204 LHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDC 263
+H ++YRD+KP+N ++ N
Sbjct: 117 IHEKSLVYRDIKPDN--------FLIGR-------------------------PNSKNAN 143
Query: 264 AVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTHE 323
+ FG K +P T + + + GT
Sbjct: 144 MIYVVDFGMV----------------------KFYRDPVTKQHIPYR---EKKNLSGTAR 178
Query: 324 YLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPS- 382
Y++ G D LG G+ P++G+ T R E +
Sbjct: 179 YMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAA-TNKQKYERIGEKKQSTPL 237
Query: 383 ------VPGPAKDLIAQLLVKDPTRR 402
P +
Sbjct: 238 RELCAGFPEEFYKYMHYARNLAFDAT 263
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (301), Expect = 3e-31
Identities = 68/218 (31%), Positives = 107/218 (49%), Gaps = 12/218 (5%)
Query: 63 IKEATSEGNNNNNNNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKR 122
+K N + + + + + LG+G G V+LV+ K + G +A KV+ K
Sbjct: 5 VKHELRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVR-KISGHDTGKLYAMKVLKKA 63
Query: 123 ELVSRNKES-RARIEREILEMLDH-PFLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQ 180
+V + K + R ER++LE + PFL TL+ L+ ++ GG+L ++
Sbjct: 64 TIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQR 123
Query: 181 PDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDN 240
RF E V+ Y E+V+ALE LH +GIIYRD+K EN+L+ S+GH++LTDF LS +
Sbjct: 124 E--RFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVA 181
Query: 241 STSTAQLVSDQSPPT-------GDQQPNDCAVDQPPFG 271
+ + G +D AVD G
Sbjct: 182 DETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLG 219
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (261), Expect = 8e-26
Identities = 54/158 (34%), Positives = 76/158 (48%), Gaps = 7/158 (4%)
Query: 286 SCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTHEYLAPEIISG--EGHGNAVDWWT 343
+ L + G + R+ F GT EY+AP+I+ G GH AVDWW+
Sbjct: 158 ENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWS 217
Query: 344 LGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKE--PSVPGPAKDLIAQLLVKDPTR 401
LG+ ++EL G +PF + + A + R L+ + AKDLI +LL+KDP +
Sbjct: 218 LGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKK 277
Query: 402 RMGS-KMGATAIKRHQFFNGVNWALLRCAK--PPFIPR 436
R+G A IK H FF +NW L K PF P
Sbjct: 278 RLGCGPRDADEIKEHLFFQKINWDDLAAKKVPAPFKPV 315
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (299), Expect = 4e-31
Identities = 64/346 (18%), Positives = 116/346 (33%), Gaps = 54/346 (15%)
Query: 81 LSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREIL 140
+S + ++G G G V+ + + G A K + A E +IL
Sbjct: 9 VSKYEKLAKIGQGTFGEVFKARHRK----TGQKVALKKVLMENE-KEGFPITALREIKIL 63
Query: 141 EMLDHPFLPTLY--------ATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRF 192
++L H + L C L+ +FC +L +F S ++
Sbjct: 64 QLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL--VKFTLSEIKR 121
Query: 193 YASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQLVSDQS 252
++ L ++H I++RD+K NVL+ DG + L DF L+ + ++
Sbjct: 122 VMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNR 181
Query: 253 PPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLD 312
T +P + + + +G + + +AE
Sbjct: 182 VVTLWYRPPELLLGERDYGPPIDLWGAGCI------------------------MAEMW- 216
Query: 313 VRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVA 372
RS G E +IS G E++ ++ + +
Sbjct: 217 TRSPIMQGNTEQHQLALIS----------QLCGSITPEVWPNVDNYELYEKLELVKGQKR 266
Query: 373 RALEFPKEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFF 418
+ + K A DLI +LLV DP +R + + H FF
Sbjct: 267 KVKDRLKAYVRDPYALDLIDKLLVLDPAQR----IDSDDALNHDFF 308
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (295), Expect = 5e-31
Identities = 46/195 (23%), Positives = 72/195 (36%), Gaps = 15/195 (7%)
Query: 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILE 141
DL F+ LG+G G V + + A K++ + + E E +++
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWR-----GQYDVAIKMIKEGSM----SEDEFIEEAKVMM 54
Query: 142 MLDHPFLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVAL 201
L H L LY R ++TE+ G L + RF + +V A+
Sbjct: 55 NLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAM 113
Query: 202 EFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS--LKGDNSTSTAQLVSD---QSPPTG 256
E+L ++RDL N LV G + ++DF LS + D TS+ P
Sbjct: 114 EYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVL 173
Query: 257 DQQPNDCAVDQPPFG 271
D FG
Sbjct: 174 MYSKFSSKSDIWAFG 188
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 74.7 bits (183), Expect = 1e-15
Identities = 15/129 (11%), Positives = 41/129 (31%), Gaps = 4/129 (3%)
Query: 275 CIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTHEYLAPEIISGEG 334
+ + + K+ + G V + S+ + PE++
Sbjct: 120 QFLHRDLAA--RNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSK 177
Query: 335 HGNAVDWWTLGIFIFELF-YGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQ 393
+ D W G+ ++E++ G P++ + T ++ + L + ++
Sbjct: 178 FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA-QGLRLYRPHLASEKVYTIMYS 236
Query: 394 LLVKDPTRR 402
+ R
Sbjct: 237 CWHEKADER 245
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (299), Expect = 6e-31
Identities = 57/196 (29%), Positives = 90/196 (45%), Gaps = 11/196 (5%)
Query: 81 LSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREIL 140
+ D LG G G V+L + K FFA K + K ++ + +E+ +L
Sbjct: 1 IEDFILHKMLGKGSFGKVFLAEFKK----TNQFFAIKALKKDVVLMDDDVECTMVEKRVL 56
Query: 141 EM-LDHPFLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVV 199
+ +HPFL ++ T + E+ GGDL Q +F S FYA+E+++
Sbjct: 57 SLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIIL 114
Query: 200 ALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQLV----SDQSPPT 255
L+FLH GI+YRDLK +N+L+ DGHI + DF + + + +P
Sbjct: 115 GLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEI 174
Query: 256 GDQQPNDCAVDQPPFG 271
Q + +VD FG
Sbjct: 175 LLGQKYNHSVDWWSFG 190
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (295), Expect = 2e-30
Identities = 43/134 (32%), Positives = 76/134 (56%), Gaps = 7/134 (5%)
Query: 312 DVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVV 371
D ++ +F GT +Y+APEI+ G+ + ++VDWW+ G+ ++E+ G +PF G D E ++
Sbjct: 157 DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIR 216
Query: 372 ARALEFPKEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGVNWALL--RCA 429
+P+ + AKDL+ +L V++P +R+G I++H F +NW L +
Sbjct: 217 MDNPFYPR--WLEKEAKDLLVKLFVREPEKRLGV---RGDIRQHPLFREINWEELERKEI 271
Query: 430 KPPFIPRPVTCRDL 443
PPF P+ + D
Sbjct: 272 DPPFRPKVKSPFDC 285
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (300), Expect = 7e-31
Identities = 62/360 (17%), Positives = 119/360 (33%), Gaps = 57/360 (15%)
Query: 85 RFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLD 144
+ + +GSG G V A K + + ++ RA E +++ ++
Sbjct: 20 QNLKPIGSGAQGIVCAAYDAV----LDRNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVN 74
Query: 145 HPFLPTLY------ATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVV 198
H + +L TL+ + L+ E V++ +R + + +++
Sbjct: 75 HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHER-----MSYLLYQML 129
Query: 199 VALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQLV---SDQSPPT 255
++ LH GII+RDLKP N++V+SD + + DF L+ S V ++P
Sbjct: 130 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 189
Query: 256 GDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRS 315
VD G CI+ + + +
Sbjct: 190 ILGMGYKENVDIWSVG--------CIMGEMVRHKI----------LFPGRDYIDQWN--- 228
Query: 316 MSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARAL 375
++I G L + + G+ + + A
Sbjct: 229 ------------KVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPA- 275
Query: 376 EFPKEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGVNWALLRCAKPPFIP 435
+ A+DL++++LV DP +R + +H + N A PP I
Sbjct: 276 DSEHNKLKASQARDLLSKMLVIDPAKR----ISVDDALQHPYINVWYDPAEVEAPPPQIY 331
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (299), Expect = 8e-31
Identities = 53/340 (15%), Positives = 103/340 (30%), Gaps = 56/340 (16%)
Query: 85 RFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLD 144
+ +G G G V N A K + E + R E +IL
Sbjct: 11 TNLSYIGEGAYGMVCSAYDNV----NKVRVAIKKISPFE--HQTYCQRTLREIKILLRFR 64
Query: 145 HPFLPTLYATLDCPRWS-----CLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVV 199
H + + + P L+T +L+ + + ++ +++
Sbjct: 65 HENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQ----HLSNDHICYFLYQILR 120
Query: 200 ALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQ 259
L+++H +++RDLKP N+L+ + + + DF L+ D
Sbjct: 121 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH----------------- 163
Query: 260 PNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFV 319
D F P + + + + G I+AE L R +
Sbjct: 164 ------DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGC--ILAEMLSNRPIFPG 215
Query: 320 GTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPK 379
+ I+ G + D + + + P K L
Sbjct: 216 KHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLF----------- 264
Query: 380 EPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFN 419
P+ A DL+ ++L +P +R + H +
Sbjct: 265 -PNADSKALDLLDKMLTFNPHKR----IEVEQALAHPYLE 299
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (294), Expect = 9e-31
Identities = 37/195 (18%), Positives = 71/195 (36%), Gaps = 15/195 (7%)
Query: 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILE 141
L+ V RLG+G G V++ A K + + + E +++
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYN-----GHTKVAVKSLKQGSM----SPDAFLAEANLMK 63
Query: 142 MLDHPFLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVAL 201
L H L LYA + ++TE+ G L + + + + A+++ +
Sbjct: 64 QLQHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGM 122
Query: 202 EFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNS-----TSTAQLVSDQSPPTG 256
F+ I+RDL+ N+LV + DF L+ +++ + +P
Sbjct: 123 AFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAI 182
Query: 257 DQQPNDCAVDQPPFG 271
+ D FG
Sbjct: 183 NYGTFTIKSDVWSFG 197
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 70.1 bits (171), Expect = 4e-14
Identities = 18/130 (13%), Positives = 37/130 (28%), Gaps = 2/130 (1%)
Query: 273 SSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTHEYLAPEIISG 332
I + A + K + + G ++ + ++ APE I+
Sbjct: 127 ERNYIHRDLRAANILVSDTLSCK--IADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY 184
Query: 333 EGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIA 392
D W+ GI + E+ + + R + + P L+
Sbjct: 185 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMR 244
Query: 393 QLLVKDPTRR 402
+ P R
Sbjct: 245 LCWKERPEDR 254
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (293), Expect = 1e-30
Identities = 46/196 (23%), Positives = 71/196 (36%), Gaps = 10/196 (5%)
Query: 83 DLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEM 142
DLR + +LG G G V + S A K + L E +
Sbjct: 9 DLRLLEKLGDGSFGVVRRGEWD-APSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 143 LDHPFLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALE 202
LDH L LY + P ++TE P G L R R+ F + YA +V +
Sbjct: 68 LDHRNLIRLYGVVLTPPM-KMVTELAPLGSLL-DRLRKHQGHFLLGTLSRYAVQVAEGMG 125
Query: 203 FLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQLVSDQ-------SPPT 255
+L I+RDL N+L+ + + + DF L + + + +P +
Sbjct: 126 YLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPES 185
Query: 256 GDQQPNDCAVDQPPFG 271
+ A D FG
Sbjct: 186 LKTRTFSHASDTWMFG 201
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 77.9 bits (191), Expect = 8e-17
Identities = 20/91 (21%), Positives = 35/91 (38%), Gaps = 1/91 (1%)
Query: 313 VRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELF-YGTTPFKGIDHELTLANVV 371
V + APE + +A D W G+ ++E+F YG P+ G++ L +
Sbjct: 169 VMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKID 228
Query: 372 ARALEFPKEPSVPGPAKDLIAQLLVKDPTRR 402
P+ P +++ Q P R
Sbjct: 229 KEGERLPRPEDCPQDIYNVMVQCWAHKPEDR 259
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 116 bits (292), Expect = 3e-30
Identities = 39/167 (23%), Positives = 66/167 (39%), Gaps = 8/167 (4%)
Query: 79 LTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIERE 138
+ +D+ H+LG G G VY K A K + + + E
Sbjct: 14 MERTDITMKHKLGGGQYGEVYEGVWK----KYSLTVAVKTLKE----DTMEVEEFLKEAA 65
Query: 139 ILEMLDHPFLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVV 198
+++ + HP L L ++TEF G+L + + + + A+++
Sbjct: 66 VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQIS 125
Query: 199 VALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTA 245
A+E+L I+RDL N LV + + + DF LS T TA
Sbjct: 126 SAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA 172
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 63.2 bits (153), Expect = 9e-12
Identities = 13/106 (12%), Positives = 34/106 (32%)
Query: 297 KLGNPGTPEIVAEPLDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTT 356
K+ + G ++ ++ APE ++ D W G+ ++E+
Sbjct: 155 KVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGM 214
Query: 357 PFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDPTRR 402
+ ++ + + P +L+ +P+ R
Sbjct: 215 SPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDR 260
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (292), Expect = 4e-30
Identities = 39/186 (20%), Positives = 71/186 (38%), Gaps = 14/186 (7%)
Query: 85 RFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLD 144
++G G G+VY + G A + M+ + + K+ E ++
Sbjct: 23 TRFEKIGQGASGTVYTAMDVA----TGQEVAIRQMNLQ---QQPKKELIINEILVMRENK 75
Query: 145 HPFLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFL 204
+P + + ++ E+ GG L + E + E + ALEFL
Sbjct: 76 NPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFL 132
Query: 205 HMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQLVSD----QSPPTGDQQP 260
H +I+RD+K +N+L+ DG + LTDF + S + +P ++
Sbjct: 133 HSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA 192
Query: 261 NDCAVD 266
VD
Sbjct: 193 YGPKVD 198
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 90.8 bits (225), Expect = 4e-21
Identities = 30/126 (23%), Positives = 53/126 (42%), Gaps = 13/126 (10%)
Query: 314 RSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVAR 373
+ + VGT ++APE+++ + +G VD W+LGI E+ G P+ + L +
Sbjct: 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN 231
Query: 374 A-LEFPKEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGVNWALLRCAKPP 432
E + +D + + L D +R A + +HQF + AKP
Sbjct: 232 GTPELQNPEKLSAIFRDFLNRCLDMDVEKR----GSAKELLQHQFL--------KIAKPL 279
Query: 433 FIPRPV 438
P+
Sbjct: 280 SSLTPL 285
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (290), Expect = 4e-30
Identities = 35/146 (23%), Positives = 60/146 (41%), Gaps = 6/146 (4%)
Query: 90 LGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLP 149
LG G+ GSV + + A KV+ + + E +I+ LD+P++
Sbjct: 17 LGCGNFGSVRQGVYRMR--KKQIDVAIKVLKQG--TEKADTEEMMREAQIMHQLDNPYIV 72
Query: 150 TLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGI 209
L L+ E GG LH + S V +V + +++L
Sbjct: 73 RLIGVCQAEAL-MLVMEMAGGGPLHKFL-VGKREEIPVSNVAELLHQVSMGMKYLEEKNF 130
Query: 210 IYRDLKPENVLVRSDGHIMLTDFDLS 235
++RDL NVL+ + + ++DF LS
Sbjct: 131 VHRDLAARNVLLVNRHYAKISDFGLS 156
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (289), Expect = 6e-30
Identities = 41/169 (24%), Positives = 71/169 (42%), Gaps = 14/169 (8%)
Query: 84 LRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEML 143
L+F +G G +VY A + R+L ++ R + E E+L+ L
Sbjct: 11 LKFDIEIGRGSFKTVYKGLDT----ETTVEVAWCELQDRKLTKSERQ-RFKEEAEMLKGL 65
Query: 144 DHPFLPTLYATLDCP----RWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVV 199
HP + Y + + + L+TE G L +R K +R + +++
Sbjct: 66 QHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILK 123
Query: 200 ALEFLHMMG--IIYRDLKPENVLVRS-DGHIMLTDFDLSLKGDNSTSTA 245
L+FLH II+RDLK +N+ + G + + D L+ S + A
Sbjct: 124 GLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA 172
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 88.5 bits (219), Expect = 2e-20
Identities = 20/106 (18%), Positives = 43/106 (40%), Gaps = 6/106 (5%)
Query: 314 RSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVAR 373
+ + +GT E++APE+ + +VD + G+ + E+ P+ + + V
Sbjct: 169 FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS 227
Query: 374 ALEFPKEPSVPGP-AKDLIAQLLVKDPTRRMGSKMGATAIKRHQFF 418
++ V P K++I + ++ R + H FF
Sbjct: 228 GVKPASFDKVAIPEVKEIIEGCIRQNKDER----YSIKDLLNHAFF 269
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (289), Expect = 7e-30
Identities = 38/195 (19%), Positives = 72/195 (36%), Gaps = 15/195 (7%)
Query: 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILE 141
LR +LG G G V++ A K + E ++++
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWN-----GTTRVAIKTLKP----GTMSPEAFLQEAQVMK 67
Query: 142 MLDHPFLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVAL 201
L H L LYA + ++TE+ G L + + K + A+++ +
Sbjct: 68 KLRHEKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGM 126
Query: 202 EFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQLVSD-----QSPPTG 256
++ M ++RDL+ N+LV + + DF L+ +++ TA+ + +P
Sbjct: 127 AYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAA 186
Query: 257 DQQPNDCAVDQPPFG 271
D FG
Sbjct: 187 LYGRFTIKSDVWSFG 201
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 77.8 bits (191), Expect = 1e-16
Identities = 22/106 (20%), Positives = 35/106 (33%)
Query: 297 KLGNPGTPEIVAEPLDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTT 356
K+ + G ++ + ++ APE D W+ GI + EL
Sbjct: 153 KVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGR 212
Query: 357 PFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDPTRR 402
+ + V R P P P DL+ Q K+P R
Sbjct: 213 VPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEER 258
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (287), Expect = 1e-29
Identities = 55/341 (16%), Positives = 102/341 (29%), Gaps = 64/341 (18%)
Query: 85 RFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLD 144
+ ++G G G+V+ + + A K + + S A E +L+ L
Sbjct: 5 EKLEKIGEGTYGTVFKAKNRE----THEIVALKRVRLDDD-DEGVPSSALREICLLKELK 59
Query: 145 HPFLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFL 204
H + L+ L + L+ EFC + V+ + +++ L F
Sbjct: 60 HKNIVRLHDVLHSDKKLTLVFEFCDQDLKK--YFDSCNGDLDPEIVKSFLFQLLKGLGFC 117
Query: 205 HMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQLVSD-----QSPPTGDQQ 259
H +++RDLKP+N+L+ +G + L +F L+ +
Sbjct: 118 HSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAK 177
Query: 260 PNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFV 319
++D G I AE + F
Sbjct: 178 LYSTSIDMWSAGC---------------------------------IFAELANAGRPLFP 204
Query: 320 GTHEY-LAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFP 378
G I G W ++ Y P +
Sbjct: 205 GNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVV------------ 252
Query: 379 KEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFN 419
P + +DL+ LL +P +R + A +H +F+
Sbjct: 253 --PKLNATGRDLLQNLLKCNPVQR----ISAEEALQHPYFS 287
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (285), Expect = 2e-29
Identities = 41/200 (20%), Positives = 78/200 (39%), Gaps = 17/200 (8%)
Query: 79 LTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIERE 138
LTL D LGSG+ G+V + K A K++ K E + E
Sbjct: 8 LTLED----KELGSGNFGTVKKGYYQMKKV--VKTVAVKIL-KNEANDPALKDELLAEAN 60
Query: 139 ILEMLDHPFLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVV 198
+++ LD+P++ + + W L+ E G L+ Q+ + + + +V
Sbjct: 61 VMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVS 117
Query: 199 VALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQLVSDQ------- 251
+ +++L ++RDL NVL+ + + ++DF LS + + +
Sbjct: 118 MGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY 177
Query: 252 SPPTGDQQPNDCAVDQPPFG 271
+P + D FG
Sbjct: 178 APECINYYKFSSKSDVWSFG 197
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 80.2 bits (197), Expect = 2e-17
Identities = 22/110 (20%), Positives = 42/110 (38%), Gaps = 3/110 (2%)
Query: 315 SMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELF-YGTTPFKGIDHELTLANVVAR 373
++ APE I+ + D W+ G+ ++E F YG P++G+ + ++ +
Sbjct: 167 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS-EVTAMLEK 225
Query: 374 ALEFPKEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGVNW 423
P DL+ D R G R+ +++ VN
Sbjct: 226 GERMGCPAGCPREMYDLMNLCWTYDVENRPGFA-AVELRLRNYYYDVVNE 274
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 114 bits (285), Expect = 2e-29
Identities = 54/334 (16%), Positives = 101/334 (30%), Gaps = 54/334 (16%)
Query: 85 RFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLD 144
+ ++G G G VY Q G FA K + + S E IL+ L
Sbjct: 5 HGLEKIGEGTYGVVYKAQNNY-----GETFALKKIRLEKE-DEGIPSTTIREISILKELK 58
Query: 145 HPFLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFL 204
H + LY + + L+ E +L + + + +++ + +
Sbjct: 59 HSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYC 116
Query: 205 HMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCA 264
H +++RDLKP+N+L+ +G + + DF L+
Sbjct: 117 HDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT------------------ 158
Query: 265 VDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTHEY 324
+ P V K + + G I AE ++ + +
Sbjct: 159 --------HEIVTLWYRAPDVLMGSKKYSTTIDIWSVGC--IFAEMVNGTPLFPGVSEAD 208
Query: 325 LAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVP 384
I G N+ +W + T +
Sbjct: 209 QLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFL--------------KGLD 254
Query: 385 GPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFF 418
DL++++L DP +R + A H +F
Sbjct: 255 ESGIDLLSKMLKLDPNQR----ITAKQALEHAYF 284
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (281), Expect = 5e-29
Identities = 50/195 (25%), Positives = 72/195 (36%), Gaps = 15/195 (7%)
Query: 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILE 141
S+L FV +GSG G V+L N A K + + E E E++
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWL-----NKDKVAIKTIRE----GAMSEEDFIEEAEVMM 55
Query: 142 MLDHPFLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVAL 201
L HP L LY CL+ EF G L + Q F + +V +
Sbjct: 56 KLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRG-LFAAETLLGMCLDVCEGM 114
Query: 202 EFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS--LKGDNSTSTAQLVSD---QSPPTG 256
+L +I+RDL N LV + I ++DF ++ + D TS+ SP
Sbjct: 115 AYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVF 174
Query: 257 DQQPNDCAVDQPPFG 271
D FG
Sbjct: 175 SFSRYSSKSDVWSFG 189
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 77.4 bits (190), Expect = 1e-16
Identities = 15/106 (14%), Positives = 35/106 (33%)
Query: 297 KLGNPGTPEIVAEPLDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTT 356
K+ + G V + S ++ +PE+ S + + D W+ G+ ++E+F
Sbjct: 141 KVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGK 200
Query: 357 PFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDPTRR 402
+ ++ K ++ + P R
Sbjct: 201 IPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDR 246
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 112 bits (282), Expect = 5e-29
Identities = 43/206 (20%), Positives = 74/206 (35%), Gaps = 18/206 (8%)
Query: 78 PLTLSD-LRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIE 136
P LSD LG G + V+L + A KV+ + R R E
Sbjct: 2 PSHLSDRYELGEILGFGGMSEVHLARDLR----LHRDVAVKVLRADLARDPSFYLRFRRE 57
Query: 137 REILEMLDHPFLPTLYATLDCP----RWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRF 192
+ L+HP + +Y T + ++ E+ G L + +
Sbjct: 58 AQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIE 115
Query: 193 YASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQLVSDQ- 251
++ AL F H GII+RD+KP N+++ + + + DF ++ +S ++ +
Sbjct: 116 VIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVI 175
Query: 252 ------SPPTGDQQPNDCAVDQPPFG 271
SP D D G
Sbjct: 176 GTAQYLSPEQARGDSVDARSDVYSLG 201
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 85.2 bits (210), Expect = 4e-19
Identities = 27/138 (19%), Positives = 50/138 (36%), Gaps = 2/138 (1%)
Query: 270 FGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTHEYLAPEI 329
F + + II + PA + K + ++ + +GT +YL+PE
Sbjct: 126 FSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 185
Query: 330 ISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKE--PSVPGPA 387
G+ D ++LG ++E+ G PF G V P +
Sbjct: 186 ARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADL 245
Query: 388 KDLIAQLLVKDPTRRMGS 405
++ + L K+P R +
Sbjct: 246 DAVVLKALAKNPENRYQT 263
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (286), Expect = 6e-29
Identities = 64/361 (17%), Positives = 113/361 (31%), Gaps = 70/361 (19%)
Query: 85 RFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLD 144
R + +GSG G+V G A K + R S RA E +L+ +
Sbjct: 21 RDLQPVGSGAYGAVCSAVDGR----TGAKVAIKKL-YRPFQSELFAKRAYRELRLLKHMR 75
Query: 145 HPFLPTLY------ATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVV 198
H + L TLD L+ F +++ ++ E ++F +++
Sbjct: 76 HENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKH----EKLGEDRIQFLVYQML 131
Query: 199 VALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQLVSDQSPP--TG 256
L ++H GII+RDLKP N+ V D + + DF L+ + D+ + + P
Sbjct: 132 KGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRWYRAPEVIL 191
Query: 257 DQQPNDCAVDQPPFGNSSCIIPNCIV--PAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVR 314
+ VD G CI+ I + K+ + GTP
Sbjct: 192 NWMRYTQTVDIWSVG---CIMAEMITGKTLFKGSDHLDQLKEIMKVTGTP---------- 238
Query: 315 SMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARA 374
P + + G+ E +
Sbjct: 239 ------------PAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPL---------- 276
Query: 375 LEFPKEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGVNWALLRCAKPPFI 434
A +L+ ++LV D +R + A H +F ++ +
Sbjct: 277 ------------AVNLLEKMLVLDAEQR----VTAGEALAHPYFESLHDTEDEPQVQKYD 320
Query: 435 P 435
Sbjct: 321 D 321
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (285), Expect = 6e-29
Identities = 38/187 (20%), Positives = 70/187 (37%), Gaps = 14/187 (7%)
Query: 85 RFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLD 144
LG G+ G V+ S + + AK + + + + E IL +
Sbjct: 8 MIAEDLGRGEFGIVHRCVETS----SKKTYMAKFVKVK----GTDQVLVKKEISILNIAR 59
Query: 145 HPFLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFL 204
H + L+ + + ++ EF G D+ +E + Y +V AL+FL
Sbjct: 60 HRNILHLHESFESMEELVMIFEFISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFL 118
Query: 205 HMMGIIYRDLKPENVLVRSD--GHIMLTDFDLSLK---GDNSTSTAQLVSDQSPPTGDQQ 259
H I + D++PEN++ ++ I + +F + + GDN +P
Sbjct: 119 HSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHD 178
Query: 260 PNDCAVD 266
A D
Sbjct: 179 VVSTATD 185
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.7 bits (235), Expect = 3e-22
Identities = 40/183 (21%), Positives = 67/183 (36%), Gaps = 12/183 (6%)
Query: 273 SSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTHEYLAPEIISG 332
S I I P +R K+ G + EY APE+
Sbjct: 120 SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL--KPGDNFRLLFTAPEYYAPEVHQH 177
Query: 333 EGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKE--PSVPGPAKDL 390
+ A D W+LG ++ L G PF ++ + N++ F +E + A D
Sbjct: 178 DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDF 237
Query: 391 IAQLLVKDPTRRMGSKMGATAIKRHQFFNG----VNWALLRCAKPPFIPRPVTCRDLTTT 446
+ +LLVK+ R M A+ +H + V+ ++R K + +DL
Sbjct: 238 VDRLLVKERKSR----MTASEALQHPWLKQKIERVSTKVIRTLKHRRYYHTLIKKDLNMV 293
Query: 447 NSS 449
S+
Sbjct: 294 VSA 296
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 112 bits (280), Expect = 2e-28
Identities = 53/193 (27%), Positives = 81/193 (41%), Gaps = 14/193 (7%)
Query: 85 RFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLD 144
F LG+G V L + K A K + K+ L KE E +L +
Sbjct: 12 DFRDVLGTGAFSEVILAEDKR----TQKLVAIKCIAKKAL--EGKEGSMENEIAVLHKIK 65
Query: 145 HPFLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFL 204
HP + L + L+ + GG+L + + E +V+ A+++L
Sbjct: 66 HPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEK--GFYTERDASRLIFQVLDAVKYL 123
Query: 205 HMMGIIYRDLKPENVLVRS---DGHIMLTDFDLSLKGDNSTSTAQLVSD---QSPPTGDQ 258
H +GI++RDLKPEN+L S D IM++DF LS D + + +P Q
Sbjct: 124 HDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQ 183
Query: 259 QPNDCAVDQPPFG 271
+P AVD G
Sbjct: 184 KPYSKAVDCWSIG 196
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 96.6 bits (240), Expect = 5e-23
Identities = 34/170 (20%), Positives = 65/170 (38%), Gaps = 10/170 (5%)
Query: 270 FGNSSCIIPNCIVPA-VSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTHEYLAPE 328
+ + I+ + P + K + + G ++ + GT Y+APE
Sbjct: 122 YLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP--GSVLSTACGTPGYVAPE 179
Query: 329 IISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKE--PSVPGP 386
+++ + + AVD W++G+ + L G PF + ++ EF +
Sbjct: 180 VLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDS 239
Query: 387 AKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGVNWALLRCAKPPFIPR 436
AKD I L+ KDP +R +H + G + AL + +
Sbjct: 240 AKDFIRHLMEKDPEKR----FTCEQALQHPWIAG-DTALDKNIHQSVSEQ 284
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (277), Expect = 2e-28
Identities = 36/163 (22%), Positives = 63/163 (38%), Gaps = 5/163 (3%)
Query: 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILE 141
+ +G G G V+ S A + + S + + E +
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMS---PENPALAVAIKTCKNCTSDSVREKFLQEALTMR 63
Query: 142 MLDHPFLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVAL 201
DHP + L + ++ E C G+L Q + +++ YA ++ AL
Sbjct: 64 QFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTAL 121
Query: 202 EFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTST 244
+L ++RD+ NVLV S+ + L DF LS ++ST
Sbjct: 122 AYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY 164
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 69.4 bits (169), Expect = 8e-14
Identities = 25/107 (23%), Positives = 49/107 (45%), Gaps = 2/107 (1%)
Query: 297 KLGNPGTPEIVAEPLDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELF-YGT 355
KLG+ G + + ++ +++APE I+ +A D W G+ ++E+ +G
Sbjct: 148 KLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGV 207
Query: 356 TPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDPTRR 402
PF+G+ + + + P P+ P L+ + DP+RR
Sbjct: 208 KPFQGVKNNDVIGRIE-NGERLPMPPNCPPTLYSLMTKCWAYDPSRR 253
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 111 bits (279), Expect = 2e-28
Identities = 37/196 (18%), Positives = 70/196 (35%), Gaps = 25/196 (12%)
Query: 82 SDLRFVHRLGSGDIGSVYLVQLKS-KSSNNGCFFAAKVMDKRELVSRNKESRARIEREIL 140
+++ +V +G G G V+ + A K++ + S + ++ + E ++
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE--ASADMQADFQREAALM 70
Query: 141 EMLDHPFLPTLYATLDCPRWSCLLTEFCPGGDLH-VLRQRQP------------------ 181
D+P + L + CLL E+ GDL+ LR P
Sbjct: 71 AEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVS 130
Query: 182 ---DKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKG 238
+ A +V + +L ++RDL N LV + + + DF LS
Sbjct: 131 SPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNI 190
Query: 239 DNSTSTAQLVSDQSPP 254
++ +D P
Sbjct: 191 YSADYYKADGNDAIPI 206
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (278), Expect = 3e-28
Identities = 37/193 (19%), Positives = 68/193 (35%), Gaps = 24/193 (12%)
Query: 82 SDLRFVHRLGSGDIGSVYLVQLKSKS-SNNGCFFAAKVMDKRELVSRNKESRARIEREIL 140
+ L F LG+G G V S+ A K++ S + R + E+
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKP----SAHLTEREALMSELK 78
Query: 141 EM---LDHPFLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDK-------------- 183
+ +H + L + ++TE+C GDL +R+ D
Sbjct: 79 VLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDD 138
Query: 184 --RFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNS 241
+ ++ +V + FL I+RDL N+L+ + DF L+ N
Sbjct: 139 ELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKND 198
Query: 242 TSTAQLVSDQSPP 254
++ + + P
Sbjct: 199 SNYVVKGNARLPV 211
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 59.4 bits (143), Expect = 2e-10
Identities = 21/91 (23%), Positives = 39/91 (42%), Gaps = 1/91 (1%)
Query: 313 VRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELF-YGTTPFKGIDHELTLANVV 371
V + +++APE I + D W+ GIF++ELF G++P+ G+ + ++
Sbjct: 202 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMI 261
Query: 372 ARALEFPKEPSVPGPAKDLIAQLLVKDPTRR 402
P D++ DP +R
Sbjct: 262 KEGFRMLSPEHAPAEMYDIMKTCWDADPLKR 292
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (277), Expect = 5e-28
Identities = 40/211 (18%), Positives = 76/211 (36%), Gaps = 22/211 (10%)
Query: 79 LTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIERE 138
L +D++F +G G+ G V ++K +G A + +E S++ E E
Sbjct: 7 LDWNDIKFQDVIGEGNFGQVLKARIK----KDGLRMDAAIKRMKEYASKDDHRDFAGELE 62
Query: 139 ILEML-DHPFLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQR--------------QPDK 183
+L L HP + L + + L E+ P G+L ++
Sbjct: 63 VLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAS 122
Query: 184 RFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTS 243
+ +A++V +++L I+RDL N+LV + + DF LS +
Sbjct: 123 TLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK 182
Query: 244 TAQLV---SDQSPPTGDQQPNDCAVDQPPFG 271
+ + + D +G
Sbjct: 183 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYG 213
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 66.8 bits (162), Expect = 9e-13
Identities = 18/92 (19%), Positives = 36/92 (39%), Gaps = 2/92 (2%)
Query: 312 DVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELF-YGTTPFKGIDHELTLANV 370
V+ ++A E ++ + D W+ G+ ++E+ G TP+ G+ L
Sbjct: 180 YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-ELYEK 238
Query: 371 VARALEFPKEPSVPGPAKDLIAQLLVKDPTRR 402
+ + K + DL+ Q + P R
Sbjct: 239 LPQGYRLEKPLNCDDEVYDLMRQCWREKPYER 270
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (274), Expect = 8e-28
Identities = 62/343 (18%), Positives = 111/343 (32%), Gaps = 54/343 (15%)
Query: 81 LSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREIL 140
+ + + V ++G G G VY + K G A K + + + + S A E +L
Sbjct: 1 MENFQKVEKIGEGTYGVVYKARNKL----TGEVVALKKI-RLDTETEGVPSTAIREISLL 55
Query: 141 EMLDHPFLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVA 200
+ L+HP + L + L+ EF + ++ Y +++
Sbjct: 56 KELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASAL-TGIPLPLIKSYLFQLLQG 114
Query: 201 LEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQP 260
L F H +++RDLKP+N+L+ ++G I L DF L+
Sbjct: 115 LAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR----------------- 157
Query: 261 NDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVG 320
+ P + + + G + + R F G
Sbjct: 158 ---------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLG---CIFAEMVTRRALFPG 205
Query: 321 THEY-LAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPK 379
E I G + V W D++ + +
Sbjct: 206 DSEIDQLFRIFRTLGTPDEVVW-------------PGVTSMPDYKPSFPKWARQDFS-KV 251
Query: 380 EPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGVN 422
P + + L++Q+L DP +R + A A H FF V
Sbjct: 252 VPPLDEDGRSLLSQMLHYDPNKR----ISAKAALAHPFFQDVT 290
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (277), Expect = 9e-28
Identities = 59/354 (16%), Positives = 108/354 (30%), Gaps = 66/354 (18%)
Query: 90 LGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLP 149
+G+G G VY +L ++G A K + + + E +I+ LDH +
Sbjct: 28 IGNGSFGVVYQAKLC----DSGELVAIKKVLQ-------DKRFKNRELQIMRKLDHCNIV 76
Query: 150 TLYATLDCP------RWSCLLTEFCPGGDLHVLRQR-QPDKRFHESAVRFYASEVVVALE 202
L + L+ ++ P V R + + V+ Y ++ +L
Sbjct: 77 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 203 FLHMMGIIYRDLKPENVLVRSDGHIM-LTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPN 261
++H GI +RD+KP+N+L+ D ++ L DF + + + + +
Sbjct: 137 YIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFG 196
Query: 262 DCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGT 321
V + C ++AE L + + +
Sbjct: 197 ATDYTSS-----------IDVWSAGC------------------VLAELLLGQPIFPGDS 227
Query: 322 HEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEP 381
EII G E + A P
Sbjct: 228 GVDQLVEIIKVLGTPTREQIRE--------------MNPNYTEFKFPQIKAHPWTKVFRP 273
Query: 382 SVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGVNWALLRCAKPPFIP 435
P A L ++LL PT R + H FF+ + ++ P
Sbjct: 274 RTPPEAIALCSRLLEYTPTAR----LTPLEACAHSFFDELRDPNVKLPNGRDTP 323
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (274), Expect = 1e-27
Identities = 66/356 (18%), Positives = 110/356 (30%), Gaps = 71/356 (19%)
Query: 90 LGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIERE--ILEMLDHPF 147
LG G +VY + K N A K + RE +L+ L HP
Sbjct: 6 LGEGQFATVYKARDK----NTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPN 61
Query: 148 LPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMM 207
+ L L+ +F +++ S ++ Y + LE+LH
Sbjct: 62 IIGLLDAFGHKSNISLVFDFMETDLEVIIKDNS--LVLTPSHIKAYMLMTLQGLEYLHQH 119
Query: 208 GIIYRDLKPENVLVRSDGHIMLTDFDLS--LKGDNSTSTAQLVSDQ--SPPT-GDQQPND 262
I++RDLKP N+L+ +G + L DF L+ N T Q+V+ +P +
Sbjct: 120 WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYG 179
Query: 263 CAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTH 322
VD G CI+ ++ P G
Sbjct: 180 VGVDMWAVG---CILAELLL-------------------RVP------------FLPGDS 205
Query: 323 EY-LAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEP 381
+ I G W + + + + P + H + A L
Sbjct: 206 DLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDL------ 259
Query: 382 SVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGVNWALLRCAKPPFIPRP 437
I L + +P R + AT + ++F+ +PRP
Sbjct: 260 ---------IQGLFLFNPCAR----ITATQALKMKYFSNRPGP----TPGCQLPRP 298
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (275), Expect = 1e-27
Identities = 39/230 (16%), Positives = 73/230 (31%), Gaps = 39/230 (16%)
Query: 60 WKAIKEATSEGNNNNNNNPLTL----------SDLRFVHRLGSGDIGSVYLVQLK-SKSS 108
+ ++ S N + +L F LGSG G V +
Sbjct: 5 LQMVQVTGSSDNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKT 64
Query: 109 NNGCFFAAKVMDKRELVSRNKESRARIEREI---LEMLDHPFLPTLYATLDCPRWSCLLT 165
A K++ ++ + R + E+ ++ H + L L+
Sbjct: 65 GVSIQVAVKMLKEKA----DSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIF 120
Query: 166 EFCPGGDLH---------------------VLRQRQPDKRFHESAVRFYASEVVVALEFL 204
E+C GDL L + + + +A +V +EFL
Sbjct: 121 EYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFL 180
Query: 205 HMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQLVSDQSPP 254
++RDL NVLV + + DF L+ + ++ + + P
Sbjct: 181 EFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPV 230
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 70.6 bits (172), Expect = 4e-14
Identities = 16/91 (17%), Positives = 35/91 (38%), Gaps = 1/91 (1%)
Query: 313 VRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELF-YGTTPFKGIDHELTLANVV 371
V + +++APE + + D W+ GI ++E+F G P+ GI + ++
Sbjct: 221 VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLI 280
Query: 372 ARALEFPKEPSVPGPAKDLIAQLLVKDPTRR 402
+ + ++ D +R
Sbjct: 281 QNGFKMDQPFYATEEIYIIMQSCWAFDSRKR 311
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (272), Expect = 2e-27
Identities = 51/192 (26%), Positives = 80/192 (41%), Gaps = 16/192 (8%)
Query: 85 RFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELV-SRNKESRARIERE--ILE 141
LGSG V + KS G +AAK + KR SR SR IERE IL+
Sbjct: 13 DTGEELGSGQFAVVKKCREKS----TGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 68
Query: 142 MLDHPFLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVAL 201
+ HP + TL+ + L+ E GG+L + + E + +++ +
Sbjct: 69 EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGV 126
Query: 202 EFLHMMGIIYRDLKPENVLVRSDG----HIMLTDFDLSLKGDNSTSTAQLVSDQ---SPP 254
+LH + I + DLKPEN+++ I + DF L+ K D + +P
Sbjct: 127 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 186
Query: 255 TGDQQPNDCAVD 266
+ +P D
Sbjct: 187 IVNYEPLGLEAD 198
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (259), Expect = 1e-25
Identities = 42/123 (34%), Positives = 59/123 (47%), Gaps = 8/123 (6%)
Query: 314 RSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVAR 373
+ GT E++APEI++ E G D W++G+ + L G +PF G + TLANV A
Sbjct: 172 EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 231
Query: 374 ALEFPKE--PSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGVNW--ALLRCA 429
EF E + AKD I +LLVKDP +R M +H + + AL
Sbjct: 232 NYEFEDEYFSNTSALAKDFIRRLLVKDPKKR----MTIQDSLQHPWIKPKDTQQALSSAW 287
Query: 430 KPP 432
P
Sbjct: 288 SHP 290
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (273), Expect = 2e-27
Identities = 37/176 (21%), Positives = 67/176 (38%), Gaps = 4/176 (2%)
Query: 79 LTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIERE 138
L ++ + + LGSG G+VY + A K + RE S E
Sbjct: 6 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL--REATSPKANKEILDEAY 63
Query: 139 ILEMLDHPFLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVV 198
++ +D+P + L L+T+ P G L + D + + ++
Sbjct: 64 VMASVDNPHVCRLLGICLTSTV-QLITQLMPFGCLLDYVREHKD-NIGSQYLLNWCVQIA 121
Query: 199 VALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQLVSDQSPP 254
+ +L +++RDL NVLV++ H+ +TDF L+ + P
Sbjct: 122 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 177
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 67.5 bits (164), Expect = 4e-13
Identities = 20/108 (18%), Positives = 50/108 (46%), Gaps = 3/108 (2%)
Query: 297 KLGNPGTPEIV-AEPLDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELF-YG 354
K+ + G +++ AE + + +++A E I + + D W+ G+ ++EL +G
Sbjct: 151 KITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFG 210
Query: 355 TTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDPTRR 402
+ P+ GI +++++ + P+ P ++ + + D R
Sbjct: 211 SKPYDGIPAS-EISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSR 257
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (270), Expect = 4e-27
Identities = 65/350 (18%), Positives = 110/350 (31%), Gaps = 69/350 (19%)
Query: 85 RFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEML- 143
V +G G G V+ + N G F A K + + S R E +L L
Sbjct: 10 ECVAEIGEGAYGKVFKARDLK---NGGRFVALKRVRVQTGEEGMPLSTIR-EVAVLRHLE 65
Query: 144 --DHPFLPTLYATLDCPRWS-----CLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASE 196
+HP + L+ R L+ E L + P+ ++ +
Sbjct: 66 TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKV-PEPGVPTETIKDMMFQ 124
Query: 197 VVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQLVSD---QSP 253
++ L+FLH +++RDLKP+N+LV S G I L DF L+ + +V ++P
Sbjct: 125 LLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAP 184
Query: 254 PTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDV 313
Q VD G I AE
Sbjct: 185 EVLLQSSYATPVDLWSVG---------------------------------CIFAEMFRR 211
Query: 314 RSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVAR 373
+ + + +I+ G DW + F+ +
Sbjct: 212 KPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQP-------------- 257
Query: 374 ALEFPKEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGVNW 423
+ KDL+ + L +P +R + A + H +F +
Sbjct: 258 --IEKFVTDIDELGKDLLLKCLTFNPAKR----ISAYSALSHPYFQDLER 301
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (258), Expect = 3e-25
Identities = 63/359 (17%), Positives = 108/359 (30%), Gaps = 66/359 (18%)
Query: 85 RFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLD 144
+ + +GSG GSV G A K + + S R E +L+ +
Sbjct: 21 QNLSPVGSGAYGSVCAAFDTK----TGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMK 75
Query: 145 HPFLPTLYATLDCPRW-----SCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVV 199
H + L R L G DL+ + + Q + + V+F +++
Sbjct: 76 HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILR 132
Query: 200 ALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQLVSDQSPP--TGD 257
L+++H II+RDLKP N+ V D + + DF L+ D+ + P +
Sbjct: 133 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLN 192
Query: 258 QQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMS 317
+ VD G +
Sbjct: 193 WMHYNQTVDIWSVGCIMAELLTGRTL---------------------------------- 218
Query: 318 FVGTHEY-LAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALE 376
F GT I+ G A + + + ++ ANV
Sbjct: 219 FPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQM---PKMNFANVF----- 270
Query: 377 FPKEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGVNWALLRCAKPPFIP 435
A DL+ ++LV D +R + A H +F + P+
Sbjct: 271 ----IGANPLAVDLLEKMLVLDSDKR----ITAAQALAHAYFAQYHDPDDEPVADPYDQ 321
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (251), Expect = 1e-24
Identities = 40/214 (18%), Positives = 69/214 (32%), Gaps = 26/214 (12%)
Query: 82 SDLRFVHRLGSGDIGSVYLVQLKS---KSSNNGCFFAAKVMDKRELVSRNKESRARIERE 138
L LG G G V L + N A K++ + S E E
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD--ATEKDLSDLISEME 70
Query: 139 ILEML-DHPFLPTLYATLDCPRWSCLLTEFCPGGDLHVL--------------RQRQPDK 183
+++M+ H + L ++ E+ G+L P++
Sbjct: 71 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE 130
Query: 184 RFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTS 243
+ + A +V +E+L I+RDL NVLV D + + DF L+ +
Sbjct: 131 QLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY 190
Query: 244 TAQLVSDQSPP------TGDQQPNDCAVDQPPFG 271
+ + + P + D FG
Sbjct: 191 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFG 224
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 66.4 bits (161), Expect = 9e-13
Identities = 19/117 (16%), Positives = 45/117 (38%), Gaps = 2/117 (1%)
Query: 287 CLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGI 346
L + K +I ++ + +++APE + + + D W+ G+
Sbjct: 166 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGV 225
Query: 347 FIFELF-YGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDPTRR 402
++E+F G +P+ G+ E L ++ K + ++ P++R
Sbjct: 226 LLWEIFTLGGSPYPGVPVE-ELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQR 281
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (251), Expect = 2e-24
Identities = 47/332 (14%), Positives = 100/332 (30%), Gaps = 65/332 (19%)
Query: 83 DLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEM 142
+ +G G G V+ + + G A K+ RE S +E E M
Sbjct: 4 TIVLQESIGKGRFGEVWRGKWR------GEEVAVKIFSSREERSWFRE----AEIYQTVM 53
Query: 143 LDHPFLPTLYATLDCPRWS----CLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVV 198
L H + A + + L++++ G L R + A
Sbjct: 54 LRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT---VTVEGMIKLALSTA 110
Query: 199 VALEFLHM--------MGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQLVSD 250
L LHM I +RDLK +N+LV+ +G + D L+++ D++T T + +
Sbjct: 111 SGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPN 170
Query: 251 QSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEP 310
T + P + +++ H + ++
Sbjct: 171 HRVGT-----------------KRYMAPEVLDDSINMKHFESFKR--------------- 198
Query: 311 LDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANV 370
+ + + EI G + + + ++L + + + +
Sbjct: 199 ------ADIYAMGLVFWEIARRCSIGGIHEDY--QLPYYDLVPSDPSVEEMRKVVCEQKL 250
Query: 371 VARALEFPKEPSVPGPAKDLIAQLLVKDPTRR 402
+ ++ + + R
Sbjct: 251 RPNIPNRWQSCEALRVMAKIMRECWYANGAAR 282
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.8 bits (248), Expect = 2e-24
Identities = 40/196 (20%), Positives = 73/196 (37%), Gaps = 14/196 (7%)
Query: 85 RFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNK---ESRARIEREILE 141
+ LGSG GSVY S + A K ++K + + +R +E +L+
Sbjct: 7 QVGPLLGSGGFGSVYSGIRVS----DNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 62
Query: 142 MLD--HPFLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVV 199
+ + L + P L+ E + E R + +V+
Sbjct: 63 KVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLE 121
Query: 200 ALEFLHMMGIIYRDLKPENVLV-RSDGHIMLTDFDLSLKGDNSTSTAQLVSD-QSPP--T 255
A+ H G+++RD+K EN+L+ + G + L DF ++ T + SPP
Sbjct: 122 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWI 181
Query: 256 GDQQPNDCAVDQPPFG 271
+ + + G
Sbjct: 182 RYHRYHGRSAAVWSLG 197
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 84.0 bits (207), Expect = 8e-19
Identities = 32/153 (20%), Positives = 58/153 (37%), Gaps = 17/153 (11%)
Query: 270 FGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTHEYLAPEI 329
++ ++ I + L R + KL + G+ ++ + F GT Y PE
Sbjct: 125 HCHNCGVLHRDIKDE-NILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSPPEW 180
Query: 330 ISGEG-HGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAK 388
I HG + W+LGI ++++ G PF+ + ++ + F V +
Sbjct: 181 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFR--QRVSSECQ 232
Query: 389 DLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGV 421
LI L P+ R I+ H + V
Sbjct: 233 HLIRWCLALRPSDR----PTFEEIQNHPWMQDV 261
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 99 bits (248), Expect = 4e-24
Identities = 34/172 (19%), Positives = 71/172 (41%), Gaps = 15/172 (8%)
Query: 85 RFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLD 144
R ++GSG G +YL + G A K+ + K + IE +I +M+
Sbjct: 10 RLGRKIGSGSFGDIYLGTDIA----AGEEVAIKLECVK-----TKHPQLHIESKIYKMMQ 60
Query: 145 HP-FLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEF 203
+PT+ ++ ++ E ++F V A +++ +E+
Sbjct: 61 GGVGIPTIRWCGAEGDYNVMVMELLGPSLED--LFNFCSRKFSLKTVLLLADQMISRIEY 118
Query: 204 LHMMGIIYRDLKPENVLVRSDGH---IMLTDFDLSLKGDNSTSTAQLVSDQS 252
+H I+RD+KP+N L+ + + DF L+ K ++ + + ++
Sbjct: 119 IHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYREN 170
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 68.3 bits (166), Expect = 2e-13
Identities = 13/95 (13%), Positives = 26/95 (27%), Gaps = 6/95 (6%)
Query: 314 RSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVAR 373
+ + GT Y + G D +LG + G+ P++G+
Sbjct: 169 ENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERI 228
Query: 374 A---LEFPKE---PSVPGPAKDLIAQLLVKDPTRR 402
+ + P E P + +
Sbjct: 229 SEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDK 263
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.8 bits (245), Expect = 9e-24
Identities = 29/182 (15%), Positives = 60/182 (32%), Gaps = 11/182 (6%)
Query: 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSN-NGCFFAAKVMDKRELVSRNKESRARIEREIL 140
+ LG G G VY K + A K +++ S + E ++
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVM 77
Query: 141 EMLDHPFLPTLYATLDCPRWSCLLTEFCPGGDLH--------VLRQRQPDKRFHESAVRF 192
+ + + L + + + ++ E GDL + S +
Sbjct: 78 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 137
Query: 193 YASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQLVSDQS 252
A E+ + +L+ ++RDL N +V D + + DF ++ + +
Sbjct: 138 MAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL 197
Query: 253 PP 254
P
Sbjct: 198 PV 199
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 63.3 bits (153), Expect = 1e-11
Identities = 22/133 (16%), Positives = 50/133 (37%), Gaps = 5/133 (3%)
Query: 272 NSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEP-LDVRSMSFVGTHEYLAPEII 330
N++ + + + K +G+ G + E + + +++PE +
Sbjct: 150 NANKFVHRDLAARNCMVAEDFTVK--IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESL 207
Query: 331 SGEGHGNAVDWWTLGIFIFELF-YGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKD 389
D W+ G+ ++E+ P++G+ +E L V+ L K + P +
Sbjct: 208 KDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGL-LDKPDNCPDMLFE 266
Query: 390 LIAQLLVKDPTRR 402
L+ +P R
Sbjct: 267 LMRMCWQYNPKMR 279
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.8 bits (240), Expect = 3e-23
Identities = 38/174 (21%), Positives = 69/174 (39%), Gaps = 4/174 (2%)
Query: 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILE 141
S + +G+G+ G VY LK+ S A K + + + E I+
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMG 64
Query: 142 MLDHPFLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVAL 201
H + L + + ++TE+ G L R+ D F + + +
Sbjct: 65 QFSHHNIIRLEGVISKYKPMMIITEYMENGALDKF-LREKDGEFSVLQLVGMLRGIAAGM 123
Query: 202 EFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS-LKGDNSTSTAQLVSDQSPP 254
++L M ++RDL N+LV S+ ++DF LS + D+ +T + P
Sbjct: 124 KYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPI 177
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 68.3 bits (166), Expect = 2e-13
Identities = 19/108 (17%), Positives = 37/108 (34%), Gaps = 2/108 (1%)
Query: 297 KLGNPGTPEIVAEPLDVRSMS--FVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYG 354
K+ + G ++ + + + + APE IS +A D W+ GI ++E+
Sbjct: 150 KVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTY 209
Query: 355 TTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDPTRR 402
+ + P P L+ Q ++ RR
Sbjct: 210 GERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARR 257
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.5 bits (239), Expect = 5e-23
Identities = 35/225 (15%), Positives = 73/225 (32%), Gaps = 19/225 (8%)
Query: 82 SDLRFVHRLGSGDIGSVYLVQLK-SKSSNNGCFFAAKVMDKRELVSRNKESRARIEREIL 140
L+ LG G G V + A K++ + S ++ + ++ ++
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKI-LI 71
Query: 141 EMLDHPFLPTL-YATLDCPRWSCLLTEFCPGGDLHVLRQRQPDK--------------RF 185
+ H + L A ++ EFC G+L + + ++
Sbjct: 72 HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 131
Query: 186 HESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTA 245
+ Y+ +V +EFL I+RDL N+L+ + + DF L+
Sbjct: 132 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 191
Query: 246 QLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHP 290
+ + P + D+ S ++ + L
Sbjct: 192 RKGDARLPL--KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA 234
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 61.4 bits (148), Expect = 5e-11
Identities = 18/108 (16%), Positives = 40/108 (37%), Gaps = 2/108 (1%)
Query: 297 KLGNPGTPEIVAEPLD-VRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGT 355
K+ + G + + D VR +++APE I + D W+ G+ ++E+F
Sbjct: 174 KICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLG 233
Query: 356 -TPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDPTRR 402
+P+ G+ + + + +P++R
Sbjct: 234 ASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQR 281
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.0 bits (238), Expect = 1e-22
Identities = 37/197 (18%), Positives = 69/197 (35%), Gaps = 13/197 (6%)
Query: 84 LRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEML 143
+ F +G G G VY L + A K +++ + + S+ E I++
Sbjct: 29 VHFNEVIGRGHFGCVYHGTLL-DNDGKKIHCAVKSLNR--ITDIGEVSQFLTEGIIMKDF 85
Query: 144 DHPFLPTLY-ATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALE 202
HP + +L L ++ + GDL + + + + F +V ++
Sbjct: 86 SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGF-GLQVAKGMK 144
Query: 203 FLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS--------LKGDNSTSTAQLVSDQSPP 254
FL ++RDL N ++ + + DF L+ N T V +
Sbjct: 145 FLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 204
Query: 255 TGDQQPNDCAVDQPPFG 271
+ Q D FG
Sbjct: 205 SLQTQKFTTKSDVWSFG 221
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 70.2 bits (171), Expect = 5e-14
Identities = 11/89 (12%), Positives = 29/89 (32%)
Query: 314 RSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVAR 373
+++A E + + D W+ G+ ++EL P + + + +
Sbjct: 190 NKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ 249
Query: 374 ALEFPKEPSVPGPAKDLIAQLLVKDPTRR 402
+ P P +++ + R
Sbjct: 250 GRRLLQPEYCPDPLYEVMLKCWHPKAEMR 278
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 94.3 bits (233), Expect = 8e-22
Identities = 56/423 (13%), Positives = 120/423 (28%), Gaps = 136/423 (32%)
Query: 80 TLSDLRF--VHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIER 137
D R+ V +LG G +V+L + N A K++ ++ + E ++ +
Sbjct: 9 PYKDARYILVRKLGWGHFSTVWLAKDMV----NNTHVAMKIVRGDKVYTEAAEDEIKLLQ 64
Query: 138 EI-------LEMLDHPFLPTLYATLDCPRWSCL---LTEFCPGGDLHVLRQRQPDKRFHE 187
+ + + + L + + + + G +L L ++ +
Sbjct: 65 RVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPL 124
Query: 188 SAVRFYASEVVVALEFLHM-MGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQ 246
V+ + ++++ L+++H GII+ D+KPEN +++
Sbjct: 125 IYVKQISKQLLLGLDYMHRRCGIIHTDIKPEN--------VLME---------------- 160
Query: 247 LVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEI 306
D N + GN+ +
Sbjct: 161 --------IVDSPENLIQIKIADLGNACWYDEHY-------------------------- 186
Query: 307 VAEPLDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELT 366
+ + T EY +PE++ G G D W+ IFEL G F+ +
Sbjct: 187 ---------TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSY 237
Query: 367 LANVVARAL----------------------------------------------EFPKE 380
+ A ++
Sbjct: 238 TKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFS 297
Query: 381 PSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGVNWALLRCAKPPFIPRPVTC 440
D ++ +L DP +R A + H + + + + P +
Sbjct: 298 KDEAKEISDFLSPMLQLDPRKR----ADAGGLVNHPWLK--DTLGMEEIRVPDRELYGSG 351
Query: 441 RDL 443
D+
Sbjct: 352 SDI 354
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 68.7 bits (167), Expect = 3e-14
Identities = 24/169 (14%), Positives = 44/169 (26%), Gaps = 18/169 (10%)
Query: 89 RLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRN-------KESRARIEREILE 141
+G G +V+ + K + + +
Sbjct: 7 LMGEGKESAVFNCYSE-----KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSA 61
Query: 142 MLDHPFLPTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVAL 201
+ L L + L L + R ++ +
Sbjct: 62 RNEFRALQKLQ---GLAVPKVY--AWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEV 116
Query: 202 EFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQLVSD 250
+ GI++ DL NVLV S+ I + DF S++ L D
Sbjct: 117 AKFYHRGIVHGDLSQYNVLV-SEEGIWIIDFPQSVEVGEEGWREILERD 164
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 457 | |||
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.94 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.66 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.2 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.07 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.42 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.07 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 97.03 |
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-65 Score=492.74 Aligned_cols=280 Identities=34% Similarity=0.609 Sum_probs=245.9
Q ss_pred cCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCC
Q 012762 80 TLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPR 159 (457)
Q Consensus 80 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~ 159 (457)
..++|++++.||+|+||+||+|+++ .+|+.||||++.+...........+.+|+++|++++|||||++++++.+++
T Consensus 6 ~p~dy~i~~~lG~G~fg~Vy~a~~~----~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~ 81 (288)
T d1uu3a_ 6 RPEDFKFGKILGEGSFSTVVLAREL----ATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDE 81 (288)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEET----TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSS
T ss_pred CCCCCEEEEEEeeCCCeEEEEEEEC----CCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECC
Confidence 4478999999999999999999987 478999999999887766677788999999999999999999999999999
Q ss_pred cEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCC
Q 012762 160 WSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGD 239 (457)
Q Consensus 160 ~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~ 239 (457)
.+|||||||+||+|.+++... +.+++..++.++.||+.||+|||++|||||||||+|||++.+|.+||+|||+++...
T Consensus 82 ~~~ivmEy~~gg~L~~~~~~~--~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~ 159 (288)
T d1uu3a_ 82 KLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLS 159 (288)
T ss_dssp EEEEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEEEEccCCCCHHHhhhcc--CCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecc
Confidence 999999999999999888775 679999999999999999999999999999999999999999999999999987654
Q ss_pred CCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcccccccc
Q 012762 240 NSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFV 319 (457)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (457)
.... .....+.+
T Consensus 160 ~~~~--------------------------------------------------------------------~~~~~~~~ 171 (288)
T d1uu3a_ 160 PESK--------------------------------------------------------------------QARANSFV 171 (288)
T ss_dssp ------------------------------------------------------------------------------CC
T ss_pred cCCc--------------------------------------------------------------------cccccccc
Confidence 2111 01122457
Q ss_pred CCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhhhCC
Q 012762 320 GTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDP 399 (457)
Q Consensus 320 gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP 399 (457)
||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+....+.++....+.+|. .+++++++||.+||+.||
T Consensus 172 GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p~--~~s~~~~~li~~~L~~dP 249 (288)
T d1uu3a_ 172 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE--KFFPKARDLVEKLLVLDA 249 (288)
T ss_dssp CCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCT--TCCHHHHHHHHTTSCSSG
T ss_pred CCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCCCc--cCCHHHHHHHHHHccCCH
Confidence 999999999999999999999999999999999999999998888888888888777665 489999999999999999
Q ss_pred CCCCCCCc--ChHHHhcCCCCCCCCchhhhccCCCCCC
Q 012762 400 TRRMGSKM--GATAIKRHQFFNGVNWALLRCAKPPFIP 435 (457)
Q Consensus 400 ~~Rps~~~--~~~~ll~hp~f~~~~~~~~~~~~~~~~~ 435 (457)
++|||..+ ....|++||||++++|..+....||-+|
T Consensus 250 ~~R~t~~e~~~~~~i~~Hpff~~i~w~~l~~~~pP~l~ 287 (288)
T d1uu3a_ 250 TKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKLT 287 (288)
T ss_dssp GGSTTSGGGTCHHHHHTSGGGTTCCCTTGGGSCCCCCC
T ss_pred hHCcCHHHHcCCHHHHcCCccCCCCHHHhhcCCCCCCC
Confidence 99999322 1234799999999999999998888775
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-64 Score=494.72 Aligned_cols=287 Identities=36% Similarity=0.704 Sum_probs=255.9
Q ss_pred ccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcC
Q 012762 79 LTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCP 158 (457)
Q Consensus 79 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~ 158 (457)
+.+++|++++.||+|+||+||+|+++ .+|+.||||++++...........+.+|+++|++++||||+++++++.+.
T Consensus 2 i~l~dy~~~~~lG~G~fg~V~~~~~~----~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 77 (337)
T d1o6la_ 2 VTMNDFDYLKLLGKGTFGKVILVREK----ATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTH 77 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEET----TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECS
T ss_pred CchHhcEEEEEEecCcCeEEEEEEEC----CCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccc
Confidence 56789999999999999999999987 48899999999988776667778889999999999999999999999999
Q ss_pred CcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCC
Q 012762 159 RWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKG 238 (457)
Q Consensus 159 ~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~ 238 (457)
+.+|||||||+||+|..++... +.+++..++.++.||+.||+|||++|||||||||+|||++.+|.+||+|||+++..
T Consensus 78 ~~~~iv~ey~~gg~L~~~~~~~--~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~ 155 (337)
T d1o6la_ 78 DRLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEG 155 (337)
T ss_dssp SEEEEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred cccccceeccCCCchhhhhhcc--cCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeeccccccc
Confidence 9999999999999999988875 67999999999999999999999999999999999999999999999999998754
Q ss_pred CCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccc
Q 012762 239 DNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSF 318 (457)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (457)
.... ....++
T Consensus 156 ~~~~----------------------------------------------------------------------~~~~~~ 165 (337)
T d1o6la_ 156 ISDG----------------------------------------------------------------------ATMKTF 165 (337)
T ss_dssp CCTT----------------------------------------------------------------------CCBCCC
T ss_pred ccCC----------------------------------------------------------------------cccccc
Confidence 3211 112245
Q ss_pred cCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhhhC
Q 012762 319 VGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKD 398 (457)
Q Consensus 319 ~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~d 398 (457)
+||+.|||||++.+..|+.++|||||||++|||++|++||.+.+....+..+....+.+|.. +++++++||.+||+.|
T Consensus 166 ~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p~~--~s~~~~dli~~~L~~d 243 (337)
T d1o6la_ 166 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRT--LSPEAKSLLAGLLKKD 243 (337)
T ss_dssp EECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTT--SCHHHHHHHHHHTCSS
T ss_pred eeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCCCcc--CCHHHHHHHHhhccCC
Confidence 79999999999999999999999999999999999999999999888888888888777754 9999999999999999
Q ss_pred CCCCCCCCc-ChHHHhcCCCCCCCCchhh--hccCCCCCCCCCCcccc
Q 012762 399 PTRRMGSKM-GATAIKRHQFFNGVNWALL--RCAKPPFIPRPVTCRDL 443 (457)
Q Consensus 399 P~~Rps~~~-~~~~ll~hp~f~~~~~~~~--~~~~~~~~~~~~~~~~~ 443 (457)
|.+|++... .++||++||||++++|..+ +...||++|......|.
T Consensus 244 P~~R~~~~~~~~~eil~Hp~f~~i~~~~l~~~~~~~p~~P~~~~~~~~ 291 (337)
T d1o6la_ 244 PKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEVDT 291 (337)
T ss_dssp TTTSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCSSTTCC
T ss_pred chhhcccccccHHHHHcCcccccCCHHHHHhCCCCCCCCCCCCChhhh
Confidence 999996432 3899999999999999877 45678999877655543
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.4e-63 Score=484.12 Aligned_cols=279 Identities=34% Similarity=0.688 Sum_probs=247.6
Q ss_pred cCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCC
Q 012762 80 TLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPR 159 (457)
Q Consensus 80 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~ 159 (457)
.+++|+++++||+|+||+||+|+++ .+|+.||||++++.........+.+.+|+++|+.++|||||++++++.+++
T Consensus 2 sl~dy~i~~~lG~G~fg~Vy~a~~~----~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~ 77 (316)
T d1fota_ 2 SLQDFQILRTLGTGSFGRVHLIRSR----HNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQ 77 (316)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEET----TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSS
T ss_pred chhHeEEEEEEecCcCcEEEEEEEC----CCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCC
Confidence 4678999999999999999999987 478999999999877666667788999999999999999999999999999
Q ss_pred cEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCC
Q 012762 160 WSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGD 239 (457)
Q Consensus 160 ~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~ 239 (457)
.+|+|||||+||+|..++... ..+++..++.++.||+.||+|||++|||||||||+||||+.+|.+||+|||+++...
T Consensus 78 ~~~ivmE~~~gg~l~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~ 155 (316)
T d1fota_ 78 QIFMIMDYIEGGELFSLLRKS--QRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP 155 (316)
T ss_dssp EEEEEECCCCSCBHHHHHHHT--SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred eeeeEeeecCCcccccccccc--ccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEec
Confidence 999999999999999888875 678999999999999999999999999999999999999999999999999986543
Q ss_pred CCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcccccccc
Q 012762 240 NSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFV 319 (457)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (457)
.. ..+.+
T Consensus 156 ~~-------------------------------------------------------------------------~~~~~ 162 (316)
T d1fota_ 156 DV-------------------------------------------------------------------------TYTLC 162 (316)
T ss_dssp SC-------------------------------------------------------------------------BCCCC
T ss_pred cc-------------------------------------------------------------------------ccccc
Confidence 21 11347
Q ss_pred CCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhhhCC
Q 012762 320 GTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDP 399 (457)
Q Consensus 320 gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP 399 (457)
||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..+.+.+++.....+|. .++++++++|.+||..||
T Consensus 163 Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~--~~s~~~~~li~~~L~~dp 240 (316)
T d1fota_ 163 GTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPP--FFNEDVKDLLSRLITRDL 240 (316)
T ss_dssp SCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCT--TSCHHHHHHHHHHTCSCT
T ss_pred CcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCC--CCCHHHHHHHHHHhhhCH
Confidence 999999999999999999999999999999999999999999888888888888776664 489999999999999999
Q ss_pred CCCCCCC-cChHHHhcCCCCCCCCchhh--hccCCCCCCCCCC
Q 012762 400 TRRMGSK-MGATAIKRHQFFNGVNWALL--RCAKPPFIPRPVT 439 (457)
Q Consensus 400 ~~Rps~~-~~~~~ll~hp~f~~~~~~~~--~~~~~~~~~~~~~ 439 (457)
.+|++.. ..+++||+||||++++|..+ +...|||+|....
T Consensus 241 ~~R~~~~r~t~~~il~Hp~f~~i~~~~l~~~~~~~p~~p~~~~ 283 (316)
T d1fota_ 241 SQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETPYEPPIQQ 283 (316)
T ss_dssp TTCTTSSTTTTHHHHTSGGGSSCCHHHHHTTCSCCSCCCCC--
T ss_pred HhccccchhhHHHHHcCcccccCCHHHHHhCCCCcCCCCCcCC
Confidence 9997321 13999999999999999977 4667889886543
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.7e-63 Score=487.98 Aligned_cols=287 Identities=35% Similarity=0.635 Sum_probs=252.9
Q ss_pred CCccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEE
Q 012762 77 NPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLD 156 (457)
Q Consensus 77 ~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~ 156 (457)
....+++|+++++||+|+||+||+|+++ .+|+.||||++.+...........+.+|+++|+.++|||||++++++.
T Consensus 36 ~~~~ld~y~i~~~lG~G~fg~Vy~a~~~----~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~ 111 (350)
T d1rdqe_ 36 NTAQLDQFDRIKTLGTGSFGRVMLVKHK----ESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 111 (350)
T ss_dssp CCCCGGGEEEEEEEEECSSCEEEEEEET----TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred CCCCccCeEEEEEeecCcCcEEEEEEEC----CCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccc
Confidence 3455789999999999999999999987 488999999998877666666778899999999999999999999999
Q ss_pred cCCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCc
Q 012762 157 CPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSL 236 (457)
Q Consensus 157 ~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~ 236 (457)
..+.+|+||||+.||+|..++... +.+++..++.++.||+.||.|||++|||||||||+||||+.+|.+||+|||+++
T Consensus 112 ~~~~~~~v~e~~~~g~l~~~l~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~ 189 (350)
T d1rdqe_ 112 DNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK 189 (350)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred cccccccccccccccchhhhHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeee
Confidence 999999999999999999888775 679999999999999999999999999999999999999999999999999986
Q ss_pred CCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccc
Q 012762 237 KGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSM 316 (457)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (457)
..... ..
T Consensus 190 ~~~~~-------------------------------------------------------------------------~~ 196 (350)
T d1rdqe_ 190 RVKGR-------------------------------------------------------------------------TW 196 (350)
T ss_dssp ECSSC-------------------------------------------------------------------------BC
T ss_pred ecccc-------------------------------------------------------------------------cc
Confidence 54321 11
Q ss_pred cccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhh
Q 012762 317 SFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLV 396 (457)
Q Consensus 317 ~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~ 396 (457)
+++||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+....+.++......++. .+++++.+||.+||.
T Consensus 197 ~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~--~~s~~~~~li~~~L~ 274 (350)
T d1rdqe_ 197 TLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS--HFSSDLKDLLRNLLQ 274 (350)
T ss_dssp CCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT--TCCHHHHHHHHHHSC
T ss_pred cccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCCc--cCCHHHHHHHHHHhh
Confidence 346999999999999999999999999999999999999999998888888888888776664 499999999999999
Q ss_pred hCCCCCCC-CCcChHHHhcCCCCCCCCchhh--hccCCCCCCCCCCccccc
Q 012762 397 KDPTRRMG-SKMGATAIKRHQFFNGVNWALL--RCAKPPFIPRPVTCRDLT 444 (457)
Q Consensus 397 ~dP~~Rps-~~~~~~~ll~hp~f~~~~~~~~--~~~~~~~~~~~~~~~~~~ 444 (457)
.||.+|+. .+..+++|++||||++++|..+ +...|||+|......|.+
T Consensus 275 ~dP~kR~~~~r~t~~ell~Hp~f~~~~~~~~~~~~~~~p~~p~~~~~~d~s 325 (350)
T d1rdqe_ 275 VDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTS 325 (350)
T ss_dssp SCTTTCTTSSTTTTHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCCSTTCCT
T ss_pred hCHHhccccccccHHHHHcCccccCCCHHHHHhcCCCcCccCCCCCcchhh
Confidence 99999951 1223999999999999999876 346789999876555433
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-63 Score=471.58 Aligned_cols=257 Identities=32% Similarity=0.540 Sum_probs=233.3
Q ss_pred cCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCC
Q 012762 80 TLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPR 159 (457)
Q Consensus 80 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~ 159 (457)
.+++|++++.||+|+||+||+|+++ .+++.||+|++.+...........+.+|+++|++++|||||++++++.+++
T Consensus 4 ~l~dy~i~~~iG~G~fg~Vy~~~~~----~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~ 79 (263)
T d2j4za1 4 ALEDFEIGRPLGKGKFGNVYLAREK----QSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDAT 79 (263)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET----TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred chhHeEEEEEEecCCCcEEEEEEEC----CCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECC
Confidence 4679999999999999999999987 478999999999877766667788899999999999999999999999999
Q ss_pred cEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCC
Q 012762 160 WSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGD 239 (457)
Q Consensus 160 ~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~ 239 (457)
.+|||||||+||+|..++... +.+++..++.++.||+.||+|||++|||||||||+|||++.+|.+||+|||+++...
T Consensus 80 ~~~ivmEy~~~g~L~~~l~~~--~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~ 157 (263)
T d2j4za1 80 RVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP 157 (263)
T ss_dssp EEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCC
T ss_pred EEEEEEeecCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecC
Confidence 999999999999999988775 679999999999999999999999999999999999999999999999999986543
Q ss_pred CCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcccccccc
Q 012762 240 NSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFV 319 (457)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (457)
... ....+
T Consensus 158 ~~~------------------------------------------------------------------------~~~~~ 165 (263)
T d2j4za1 158 SSR------------------------------------------------------------------------RTTLC 165 (263)
T ss_dssp CCC------------------------------------------------------------------------CEETT
T ss_pred CCc------------------------------------------------------------------------ccccC
Confidence 211 11346
Q ss_pred CCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhhhCC
Q 012762 320 GTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDP 399 (457)
Q Consensus 320 gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP 399 (457)
||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..+.+..+....+.+|. .+++++++||.+||+.||
T Consensus 166 Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p~--~~s~~~~~li~~~L~~dp 243 (263)
T d2j4za1 166 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD--FVTEGARDLISRLLKHNP 243 (263)
T ss_dssp EEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCT--TSCHHHHHHHHHHTCSSG
T ss_pred CCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCc--cCCHHHHHHHHHHccCCH
Confidence 999999999999999999999999999999999999999998888888888887776665 489999999999999999
Q ss_pred CCCCCCCcChHHHhcCCCCCC
Q 012762 400 TRRMGSKMGATAIKRHQFFNG 420 (457)
Q Consensus 400 ~~Rps~~~~~~~ll~hp~f~~ 420 (457)
++||| ++|+|+||||+.
T Consensus 244 ~~R~t----~~eil~hp~~~~ 260 (263)
T d2j4za1 244 SQRPM----LREVLEHPWITA 260 (263)
T ss_dssp GGSCC----HHHHHTCHHHHH
T ss_pred hHCcC----HHHHHcCcCcCC
Confidence 99999 999999999963
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-62 Score=475.23 Aligned_cols=281 Identities=33% Similarity=0.692 Sum_probs=238.0
Q ss_pred CCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHH-HcCCCCCceEEEEEEcCC
Q 012762 81 LSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILE-MLDHPFLPTLYATLDCPR 159 (457)
Q Consensus 81 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~-~l~H~nIv~l~~~~~~~~ 159 (457)
+++|+++++||+|+||+||+|+++ .+|+.||||++++...........+..|+.++. .++|||||++++++.+++
T Consensus 1 iddy~i~~~iG~G~fg~Vy~~~~~----~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~ 76 (320)
T d1xjda_ 1 IEDFILHKMLGKGSFGKVFLAEFK----KTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE 76 (320)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEET----TTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred CCCeEEeeEEecCCCcEEEEEEEC----CCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCC
Confidence 478999999999999999999987 489999999998876655566666777887765 689999999999999999
Q ss_pred cEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCC
Q 012762 160 WSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGD 239 (457)
Q Consensus 160 ~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~ 239 (457)
.+|||||||+||+|..++... ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus 77 ~~yivmEy~~~g~L~~~i~~~--~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~ 154 (320)
T d1xjda_ 77 NLFFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENM 154 (320)
T ss_dssp EEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred ceeEEEeecCCCcHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcc
Confidence 999999999999999998775 679999999999999999999999999999999999999999999999999986543
Q ss_pred CCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcccccccc
Q 012762 240 NSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFV 319 (457)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (457)
.... .....+
T Consensus 155 ~~~~----------------------------------------------------------------------~~~~~~ 164 (320)
T d1xjda_ 155 LGDA----------------------------------------------------------------------KTNTFC 164 (320)
T ss_dssp CTTC----------------------------------------------------------------------CBCCCC
T ss_pred cccc----------------------------------------------------------------------cccccC
Confidence 2111 111346
Q ss_pred CCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhhhCC
Q 012762 320 GTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDP 399 (457)
Q Consensus 320 gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP 399 (457)
||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..+.+.++......+|. .+++++++||++||..||
T Consensus 165 gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~--~~s~~~~dli~~~L~~dP 242 (320)
T d1xjda_ 165 GTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPR--WLEKEAKDLLVKLFVREP 242 (320)
T ss_dssp SCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT--TSCHHHHHHHHHHSCSSG
T ss_pred CCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc--cCCHHHHHHHHHhcccCC
Confidence 999999999999999999999999999999999999999999888888888877766654 489999999999999999
Q ss_pred CCCCCCCcChH-HHhcCCCCCCCCchhh--hccCCCCCCCCCCcccc
Q 012762 400 TRRMGSKMGAT-AIKRHQFFNGVNWALL--RCAKPPFIPRPVTCRDL 443 (457)
Q Consensus 400 ~~Rps~~~~~~-~ll~hp~f~~~~~~~~--~~~~~~~~~~~~~~~~~ 443 (457)
++||+ +. +|++||||++++|..+ +...||++|+.....|.
T Consensus 243 ~~R~s----~~~~l~~hpff~~~~~~~l~~~~~~pp~~p~~~~~~d~ 285 (320)
T d1xjda_ 243 EKRLG----VRGDIRQHPLFREINWEELERKEIDPPFRPKVKSPFDC 285 (320)
T ss_dssp GGSBT----TBSCGGGSGGGTTCCHHHHHTTCSCC------------
T ss_pred CCCcC----HHHHHHhCchhccCCHHHHHhcCCCCCCCCCCCCccch
Confidence 99999 74 8999999999999876 45678888877654443
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-61 Score=464.60 Aligned_cols=255 Identities=24% Similarity=0.375 Sum_probs=224.0
Q ss_pred CCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcE
Q 012762 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWS 161 (457)
Q Consensus 82 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~ 161 (457)
++|+++++||+|+||+||+|+++ .+|+.||||++.+... ...+.+.+|+++|++++|||||++++++.+++.+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~----~~~~~vAvK~~~~~~~---~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 92 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDV----ATGQEVAIRQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGDEL 92 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBT----TTCCEEEEEEEEGGGC---SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred cccEEEEEEecCcCcEEEEEEEC----CCCCEEEEEEEecccC---hHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEE
Confidence 57999999999999999999976 4789999999986543 3456788999999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCC
Q 012762 162 CLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNS 241 (457)
Q Consensus 162 ~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~ 241 (457)
|||||||+||+|..++.. +.+++..++.++.||+.||.|||++|||||||||+|||++.+|.+||+|||+++.....
T Consensus 93 ~ivmEy~~gg~L~~~~~~---~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~ 169 (293)
T d1yhwa1 93 WVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169 (293)
T ss_dssp EEEEECCTTCBHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCST
T ss_pred EEEEEecCCCcHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeeccc
Confidence 999999999999998876 56999999999999999999999999999999999999999999999999998755321
Q ss_pred CcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCC
Q 012762 242 TSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGT 321 (457)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 321 (457)
.. .....+||
T Consensus 170 ~~----------------------------------------------------------------------~~~~~~gt 179 (293)
T d1yhwa1 170 QS----------------------------------------------------------------------KRSTMVGT 179 (293)
T ss_dssp TC----------------------------------------------------------------------CBCCCCSC
T ss_pred cc----------------------------------------------------------------------cccccccC
Confidence 11 11234799
Q ss_pred CCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcc-cCCCCCCCCChHHHHHHHHHhhhCCC
Q 012762 322 HEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARA-LEFPKEPSVPGPAKDLIAQLLVKDPT 400 (457)
Q Consensus 322 ~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ll~~~L~~dP~ 400 (457)
+.|||||++.+..|+.++|||||||++|+|++|+.||.+......+..+.... ..++.+..+++++++||.+||..||+
T Consensus 180 ~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~ 259 (293)
T d1yhwa1 180 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVE 259 (293)
T ss_dssp GGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHHHHHHTCSSTT
T ss_pred CCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHHHHHHHccCChh
Confidence 99999999999999999999999999999999999999887776666665543 33444456899999999999999999
Q ss_pred CCCCCCcChHHHhcCCCCCC
Q 012762 401 RRMGSKMGATAIKRHQFFNG 420 (457)
Q Consensus 401 ~Rps~~~~~~~ll~hp~f~~ 420 (457)
+||| ++|+|+||||+.
T Consensus 260 ~R~s----~~eil~Hp~~~~ 275 (293)
T d1yhwa1 260 KRGS----AKELLQHQFLKI 275 (293)
T ss_dssp TSCC----HHHHTTCGGGGG
T ss_pred HCcC----HHHHhcCHhhCC
Confidence 9999 999999999974
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-62 Score=463.15 Aligned_cols=260 Identities=23% Similarity=0.396 Sum_probs=218.0
Q ss_pred CCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCc
Q 012762 81 LSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRW 160 (457)
Q Consensus 81 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~ 160 (457)
.++|+++++||+|+||+||+|+++ .+|+.||||++.+... ....+.+.+|+++|++++|||||++++++.+++.
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~----~~~~~vAiK~i~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~ 77 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNR----VTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGNI 77 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEET----TTCCEEEEEEEECC---------CHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred CcceEEEEEEecCcCeEEEEEEEC----CCCCEEEEEEEehhhc--chHHHHHHHHHHHHHhCCCCCEeeEeeeeccCce
Confidence 468999999999999999999987 4789999999976532 2234568889999999999999999999999999
Q ss_pred EEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCC
Q 012762 161 SCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDN 240 (457)
Q Consensus 161 ~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~ 240 (457)
+|||||||+||+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 78 ~~ivmEy~~gg~L~~~l~~~--~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~ 155 (271)
T d1nvra_ 78 QYLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRY 155 (271)
T ss_dssp EEEEEECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEE
T ss_pred eEEEEeccCCCcHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeecc
Confidence 99999999999999888653 6799999999999999999999999999999999999999999999999999875532
Q ss_pred CCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccC
Q 012762 241 STSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVG 320 (457)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 320 (457)
.... ....+.+|
T Consensus 156 ~~~~--------------------------------------------------------------------~~~~~~~G 167 (271)
T d1nvra_ 156 NNRE--------------------------------------------------------------------RLLNKMCG 167 (271)
T ss_dssp TTEE--------------------------------------------------------------------CCBCCCCS
T ss_pred CCcc--------------------------------------------------------------------ccccceee
Confidence 1110 01124579
Q ss_pred CCCccCchhhcCCCC-CccchhhhhhHHHHHHhcCCCCCCCCChHH-HHHHHHhcccCCCCCCCCChHHHHHHHHHhhhC
Q 012762 321 THEYLAPEIISGEGH-GNAVDWWTLGIFIFELFYGTTPFKGIDHEL-TLANVVARALEFPKEPSVPGPAKDLIAQLLVKD 398 (457)
Q Consensus 321 t~~y~aPE~l~~~~~-~~~sDiwSlG~il~elltG~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~d 398 (457)
|+.|||||++.+..+ +.++|||||||++|||++|+.||....... .+..+.......+....+++++.+||.+||+.|
T Consensus 168 T~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~d 247 (271)
T d1nvra_ 168 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVEN 247 (271)
T ss_dssp CGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSS
T ss_pred CcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHHHHHHHHHcCCC
Confidence 999999999998876 678999999999999999999998765443 333333333334444568999999999999999
Q ss_pred CCCCCCCCcChHHHhcCCCCCC
Q 012762 399 PTRRMGSKMGATAIKRHQFFNG 420 (457)
Q Consensus 399 P~~Rps~~~~~~~ll~hp~f~~ 420 (457)
|++||| ++|+|+||||+.
T Consensus 248 P~~R~t----~~eil~hpwf~~ 265 (271)
T d1nvra_ 248 PSARIT----IPDIKKDRWYNK 265 (271)
T ss_dssp TTTSCC----HHHHTTCTTTTC
T ss_pred hhHCcC----HHHHhcCHhhCc
Confidence 999999 999999999974
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=6.8e-61 Score=475.53 Aligned_cols=283 Identities=29% Similarity=0.554 Sum_probs=233.1
Q ss_pred ccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHH---HHHHHHcCCCCCceEEEEE
Q 012762 79 LTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIE---REILEMLDHPFLPTLYATL 155 (457)
Q Consensus 79 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E---~~il~~l~H~nIv~l~~~~ 155 (457)
+.+++|++++.||+|+||+||+|+++ .+|+.||||++.+...........+.+| +++++.++|||||++++++
T Consensus 1 lslddy~i~~~lG~G~fg~Vy~~~~~----~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~ 76 (364)
T d1omwa3 1 LTMNDFSVHRIIGRGGFGEVYGCRKA----DTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF 76 (364)
T ss_dssp CCSTTEEEEEEEEECSSCEEEEEEET----TTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEE
T ss_pred CCHHhCeeeeEEecCCCeEEEEEEEC----CCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEE
Confidence 35789999999999999999999987 4789999999988766555555555555 4555666899999999999
Q ss_pred EcCCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCC
Q 012762 156 DCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235 (457)
Q Consensus 156 ~~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s 235 (457)
.+.+.+|||||||+||+|..++... ..+++..++.++.||+.||+|||++|||||||||+||||+.+|.+||+|||++
T Consensus 77 ~~~~~~~ivmE~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla 154 (364)
T d1omwa3 77 HTPDKLSFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA 154 (364)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTC
T ss_pred EECCEEEEEEEecCCCcHHHHHHhc--ccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeecee
Confidence 9999999999999999999998775 67899999999999999999999999999999999999999999999999998
Q ss_pred cCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcccc
Q 012762 236 LKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRS 315 (457)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (457)
+...... .
T Consensus 155 ~~~~~~~------------------------------------------------------------------------~ 162 (364)
T d1omwa3 155 CDFSKKK------------------------------------------------------------------------P 162 (364)
T ss_dssp EECSSSC------------------------------------------------------------------------C
T ss_pred eecCCCc------------------------------------------------------------------------c
Confidence 6543211 1
Q ss_pred ccccCCCCccCchhhcC-CCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHH-hcccCCCCCCCCChHHHHHHHH
Q 012762 316 MSFVGTHEYLAPEIISG-EGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVV-ARALEFPKEPSVPGPAKDLIAQ 393 (457)
Q Consensus 316 ~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ll~~ 393 (457)
...+||+.|||||++.+ ..|+.++|||||||++|||++|+.||.+........... ........+..+++++++||.+
T Consensus 163 ~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ 242 (364)
T d1omwa3 163 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEG 242 (364)
T ss_dssp CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSCHHHHHHHHH
T ss_pred cccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCHHHHHHHHH
Confidence 13469999999999974 568999999999999999999999998755432222111 1122223334689999999999
Q ss_pred HhhhCCCCCCCCC-cChHHHhcCCCCCCCCchhh--hccCCCCCCCCCC
Q 012762 394 LLVKDPTRRMGSK-MGATAIKRHQFFNGVNWALL--RCAKPPFIPRPVT 439 (457)
Q Consensus 394 ~L~~dP~~Rps~~-~~~~~ll~hp~f~~~~~~~~--~~~~~~~~~~~~~ 439 (457)
||+.||++||+.. ..++||++||||++++|..+ +...||++|....
T Consensus 243 ~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~~~~~~~~~~~~p~~p~~~~ 291 (364)
T d1omwa3 243 LLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPRGE 291 (364)
T ss_dssp HTCSSTTTSTTTSSSTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCC-
T ss_pred HcccCHHHhCCCcccCHHHHHcCccccCCCHHHHhcCCCCcCcCCCCCC
Confidence 9999999999952 35799999999999999866 4567889886543
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-60 Score=458.65 Aligned_cols=264 Identities=30% Similarity=0.433 Sum_probs=228.6
Q ss_pred CCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhh---hHHHHHHHHHHHHHHcCCCCCceEEEEEEcC
Q 012762 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSR---NKESRARIEREILEMLDHPFLPTLYATLDCP 158 (457)
Q Consensus 82 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~---~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~ 158 (457)
++|+++++||+|+||+||+|+++ .+|+.||||++++...... ...+.+.+|+++|++++|||||++++++.++
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~----~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~ 85 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREK----STGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENK 85 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEET----TTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred cCEEEeEEEecCCCeEEEEEEEC----CCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC
Confidence 56999999999999999999987 4889999999987544322 2357788999999999999999999999999
Q ss_pred CcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCC----CEEEeccCC
Q 012762 159 RWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDG----HIMLTDFDL 234 (457)
Q Consensus 159 ~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~----~vkl~DFG~ 234 (457)
+.+|||||||+||+|.+++... +.+++..++.++.||+.||.|||++|||||||||+|||++.++ .+||+|||+
T Consensus 86 ~~~~iv~E~~~gg~L~~~i~~~--~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~ 163 (293)
T d1jksa_ 86 TDVILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 163 (293)
T ss_dssp SEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred CEEEEEEEcCCCccccchhccc--cccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhh
Confidence 9999999999999999998775 6799999999999999999999999999999999999998776 599999999
Q ss_pred CcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccc
Q 012762 235 SLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVR 314 (457)
Q Consensus 235 s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (457)
+....... .
T Consensus 164 a~~~~~~~-----------------------------------------------------------------------~ 172 (293)
T d1jksa_ 164 AHKIDFGN-----------------------------------------------------------------------E 172 (293)
T ss_dssp CEECTTSC-----------------------------------------------------------------------B
T ss_pred hhhcCCCc-----------------------------------------------------------------------c
Confidence 86543211 1
Q ss_pred cccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCC--CCCCChHHHHHHH
Q 012762 315 SMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPK--EPSVPGPAKDLIA 392 (457)
Q Consensus 315 ~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ll~ 392 (457)
..+..||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+.+.++......++. ...++.++++||.
T Consensus 173 ~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 252 (293)
T d1jksa_ 173 FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIR 252 (293)
T ss_dssp CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCHHHHHHHH
T ss_pred ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCCCHHHHHHHH
Confidence 11346999999999999999999999999999999999999999998888888888887766553 2468899999999
Q ss_pred HHhhhCCCCCCCCCcChHHHhcCCCCCCCCchhh
Q 012762 393 QLLVKDPTRRMGSKMGATAIKRHQFFNGVNWALL 426 (457)
Q Consensus 393 ~~L~~dP~~Rps~~~~~~~ll~hp~f~~~~~~~~ 426 (457)
+||..||++||| ++|+|+||||+..+|...
T Consensus 253 ~~L~~dP~~R~s----~~eil~hp~~~~~~~~~~ 282 (293)
T d1jksa_ 253 RLLVKDPKKRMT----IQDSLQHPWIKPKDTQQA 282 (293)
T ss_dssp TTSCSSGGGSCC----HHHHHHSTTTCC------
T ss_pred HHccCChhHCcC----HHHHhcCcccCCCChhHh
Confidence 999999999999 999999999999999654
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.3e-60 Score=461.08 Aligned_cols=257 Identities=28% Similarity=0.463 Sum_probs=213.4
Q ss_pred CCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCc
Q 012762 81 LSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRW 160 (457)
Q Consensus 81 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~ 160 (457)
.+.|++++.||+|+||+||+|+++ .+|+.||||++.+.... .....+.+|+++|++++|||||++++++.+++.
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~----~~~~~vAvK~i~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 81 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDK----RTQKLVAIKCIAKKALE--GKEGSMENEIAVLHKIKHPNIVALDDIYESGGH 81 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEET----TTCCEEEEEEEEC------------CHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred ccceEEEEEEeeccCeEEEEEEEC----CCCCEEEEEEEchHHhh--hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 356999999999999999999987 47889999999876432 234567789999999999999999999999999
Q ss_pred EEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEc---cCCCEEEeccCCCcC
Q 012762 161 SCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVR---SDGHIMLTDFDLSLK 237 (457)
Q Consensus 161 ~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~---~~~~vkl~DFG~s~~ 237 (457)
+|||||||+||+|.+++... +.+++..++.++.||+.||+|||++|||||||||+|||+. .++.+||+|||+++.
T Consensus 82 ~~lvmE~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~ 159 (307)
T d1a06a_ 82 LYLIMQLVSGGELFDRIVEK--GFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM 159 (307)
T ss_dssp EEEEECCCCSCBHHHHHHTC--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-----
T ss_pred EEEEEeccCCCcHHHhhhcc--cCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEE
Confidence 99999999999999998764 6799999999999999999999999999999999999995 478999999999865
Q ss_pred CCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcccccc
Q 012762 238 GDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMS 317 (457)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (457)
..... ...+
T Consensus 160 ~~~~~-----------------------------------------------------------------------~~~~ 168 (307)
T d1a06a_ 160 EDPGS-----------------------------------------------------------------------VLST 168 (307)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred ccCCC-----------------------------------------------------------------------eeee
Confidence 43211 1123
Q ss_pred ccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCC--CCCCChHHHHHHHHHh
Q 012762 318 FVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPK--EPSVPGPAKDLIAQLL 395 (457)
Q Consensus 318 ~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ll~~~L 395 (457)
.+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.........+......++. ...+++++++||.+||
T Consensus 169 ~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L 248 (307)
T d1a06a_ 169 ACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLM 248 (307)
T ss_dssp ----CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHHHS
T ss_pred eeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHHHHHHHHHc
Confidence 57999999999999999999999999999999999999999998888888888887766543 3568999999999999
Q ss_pred hhCCCCCCCCCcChHHHhcCCCCCC
Q 012762 396 VKDPTRRMGSKMGATAIKRHQFFNG 420 (457)
Q Consensus 396 ~~dP~~Rps~~~~~~~ll~hp~f~~ 420 (457)
+.||++||| ++|+|+||||++
T Consensus 249 ~~dP~~R~s----~~eil~hp~~~~ 269 (307)
T d1a06a_ 249 EKDPEKRFT----CEQALQHPWIAG 269 (307)
T ss_dssp CSSGGGSCC----HHHHHHSTTTTS
T ss_pred cCCHhHCcC----HHHHhcCHhhCC
Confidence 999999999 999999999986
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=6e-60 Score=466.06 Aligned_cols=262 Identities=27% Similarity=0.432 Sum_probs=231.3
Q ss_pred cCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCC
Q 012762 80 TLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPR 159 (457)
Q Consensus 80 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~ 159 (457)
.+++|++++.||+|+||+||+|+++ .+|+.||||++.+... ...+.+.+|+++|++|+|||||++++++.+++
T Consensus 24 il~~Y~i~~~lG~G~fg~Vy~~~~~----~~g~~vAvK~i~~~~~---~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~ 96 (350)
T d1koaa2 24 VLDHYDIHEELGTGAFGVVHRVTER----ATGNNFAAKFVMTPHE---SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDN 96 (350)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEET----TTTEEEEEEEECCCSH---HHHHHHHHHHHHHHHTCCTTBCCEEEEEEETT
T ss_pred CccCeEEEEEEecCcCeEEEEEEEC----CCCCEEEEEEEcccch---hhHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 3578999999999999999999987 4899999999976532 34567888999999999999999999999999
Q ss_pred cEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEcc--CCCEEEeccCCCcC
Q 012762 160 WSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRS--DGHIMLTDFDLSLK 237 (457)
Q Consensus 160 ~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~--~~~vkl~DFG~s~~ 237 (457)
.+|||||||+||+|.+++... .+.+++..++.++.||+.||.|||++|||||||||+|||++. ++.+||+|||+++.
T Consensus 97 ~~~ivmE~~~gg~L~~~l~~~-~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~ 175 (350)
T d1koaa2 97 EMVMIYEFMSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAH 175 (350)
T ss_dssp EEEEEECCCCSCBHHHHHTCT-TSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEE
T ss_pred EEEEEEEcCCCCCHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchhee
Confidence 999999999999999888543 357999999999999999999999999999999999999964 57899999999876
Q ss_pred CCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcccccc
Q 012762 238 GDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMS 317 (457)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (457)
...... ..+
T Consensus 176 ~~~~~~-----------------------------------------------------------------------~~~ 184 (350)
T d1koaa2 176 LDPKQS-----------------------------------------------------------------------VKV 184 (350)
T ss_dssp CCTTSC-----------------------------------------------------------------------EEE
T ss_pred cccccc-----------------------------------------------------------------------cce
Confidence 542211 123
Q ss_pred ccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCC--CCCChHHHHHHHHHh
Q 012762 318 FVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKE--PSVPGPAKDLIAQLL 395 (457)
Q Consensus 318 ~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ll~~~L 395 (457)
.+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..+.+..+....+.++.. ..+++++++||.+||
T Consensus 185 ~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L 264 (350)
T d1koaa2 185 TTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLL 264 (350)
T ss_dssp ECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHHHHHHHHC
T ss_pred ecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHc
Confidence 579999999999999999999999999999999999999999988888888888877666543 458899999999999
Q ss_pred hhCCCCCCCCCcChHHHhcCCCCCCCCch
Q 012762 396 VKDPTRRMGSKMGATAIKRHQFFNGVNWA 424 (457)
Q Consensus 396 ~~dP~~Rps~~~~~~~ll~hp~f~~~~~~ 424 (457)
+.||++||| ++|||+||||+..+|.
T Consensus 265 ~~dP~~R~t----~~eil~hp~~~~~~~~ 289 (350)
T d1koaa2 265 LADPNTRMT----IHQALEHPWLTPGNAP 289 (350)
T ss_dssp CSSGGGSCC----HHHHHHSTTTSCTTCC
T ss_pred cCChhHCcC----HHHHhcCcccCCCCCC
Confidence 999999999 9999999999987764
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-61 Score=469.65 Aligned_cols=262 Identities=24% Similarity=0.366 Sum_probs=218.1
Q ss_pred ccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcC
Q 012762 79 LTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCP 158 (457)
Q Consensus 79 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~ 158 (457)
+..++|+++++||+|+||+||+|+++ .+|+.||+|++++.. .......+.+|+++|+.++|||||+++++|.++
T Consensus 3 l~~d~y~~~~~iG~G~fg~V~~~~~~----~~~~~vAiK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 76 (322)
T d1s9ja_ 3 LKDDDFEKISELGAGNGGVVFKVSHK----PSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD 76 (322)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEET----TTTEEEEEEEEECCC--CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECS
T ss_pred CCccCCEEEEEEecCCCeEEEEEEEC----CCCcEEEEEEEChhh--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC
Confidence 45578999999999999999999986 488999999997642 234456788999999999999999999999999
Q ss_pred CcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCceeecCCCCCeEEccCCCEEEeccCCCcC
Q 012762 159 RWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHM-MGIIYRDLKPENVLVRSDGHIMLTDFDLSLK 237 (457)
Q Consensus 159 ~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~-~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~ 237 (457)
+.+|||||||+||+|..++... +.+++..++.++.||+.||.|||+ +||+||||||+||||+.+|.+||+|||+|+.
T Consensus 77 ~~~~iVmEy~~gg~L~~~l~~~--~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~ 154 (322)
T d1s9ja_ 77 GEISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQ 154 (322)
T ss_dssp SEEEEEEECCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHH
T ss_pred CEEEEEEEcCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccc
Confidence 9999999999999999998775 679999999999999999999997 5999999999999999999999999999864
Q ss_pred CCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcccccc
Q 012762 238 GDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMS 317 (457)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (457)
..+ ....+
T Consensus 155 ~~~------------------------------------------------------------------------~~~~~ 162 (322)
T d1s9ja_ 155 LID------------------------------------------------------------------------SMANS 162 (322)
T ss_dssp HHH------------------------------------------------------------------------HTC--
T ss_pred cCC------------------------------------------------------------------------Ccccc
Confidence 321 01124
Q ss_pred ccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHH----------------------------
Q 012762 318 FVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLAN---------------------------- 369 (457)
Q Consensus 318 ~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~---------------------------- 369 (457)
++||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+.......
T Consensus 163 ~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (322)
T d1s9ja_ 163 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGM 242 (322)
T ss_dssp -CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---------------------------
T ss_pred ccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccccccccc
Confidence 5799999999999999999999999999999999999999987553322111
Q ss_pred --------------HHhcccCCCCCCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCCCCch
Q 012762 370 --------------VVARALEFPKEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGVNWA 424 (457)
Q Consensus 370 --------------~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~~~~~ 424 (457)
+............++.++++||.+||..||++||| ++|+|+||||+..+|.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t----a~e~L~Hpf~~~~~~~ 307 (322)
T d1s9ja_ 243 DSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERAD----LKQLMVHAFIKRSDAE 307 (322)
T ss_dssp ---CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCC----HHHHHTSHHHHHHHHS
T ss_pred ccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcC----HHHHhhCHhhCcCCcc
Confidence 00000000011235778999999999999999999 9999999999876664
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-60 Score=457.30 Aligned_cols=257 Identities=28% Similarity=0.434 Sum_probs=222.6
Q ss_pred CCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcE
Q 012762 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWS 161 (457)
Q Consensus 82 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~ 161 (457)
+.|+++++||+|+||+||+|+++ .+|+.||||++.+.. ....+.+.+|+++|++++|||||++++++.+++.+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~----~~~~~vAvK~i~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 84 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNK----ETSVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNL 84 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEET----TTCCEEEEEEEECSS---SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEEC----CCCeEEEEEEECcCC---HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeE
Confidence 46899999999999999999987 478999999997642 23445678899999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCC
Q 012762 162 CLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNS 241 (457)
Q Consensus 162 ~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~ 241 (457)
|||||||+||+|..++... .+.+++..++.++.||+.||.|||++|||||||||+||||+.+|.+||+|||+++.....
T Consensus 85 ~lvmEy~~~g~L~~~~~~~-~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~ 163 (288)
T d2jfla1 85 WILIEFCAGGAVDAVMLEL-ERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT 163 (288)
T ss_dssp EEEEECCTTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHH
T ss_pred EEEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCC
Confidence 9999999999999887653 256999999999999999999999999999999999999999999999999998543211
Q ss_pred CcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCC
Q 012762 242 TSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGT 321 (457)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 321 (457)
. ....+.+||
T Consensus 164 ~----------------------------------------------------------------------~~~~~~~Gt 173 (288)
T d2jfla1 164 I----------------------------------------------------------------------QRRDSFIGT 173 (288)
T ss_dssp H----------------------------------------------------------------------HHHTCCCSC
T ss_pred c----------------------------------------------------------------------ccccccccc
Confidence 0 011235799
Q ss_pred CCccCchhhc-----CCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccC-CCCCCCCChHHHHHHHHHh
Q 012762 322 HEYLAPEIIS-----GEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALE-FPKEPSVPGPAKDLIAQLL 395 (457)
Q Consensus 322 ~~y~aPE~l~-----~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ll~~~L 395 (457)
+.|||||++. +..|+.++|||||||++|||++|+.||.+....+.+.++...... ++....+++++++||.+||
T Consensus 174 ~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~li~~~L 253 (288)
T d2jfla1 174 PYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCL 253 (288)
T ss_dssp CTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCHHHHHHHHHHS
T ss_pred cccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccccCCHHHHHHHHHHc
Confidence 9999999984 445899999999999999999999999998888888887776543 2334568999999999999
Q ss_pred hhCCCCCCCCCcChHHHhcCCCCCC
Q 012762 396 VKDPTRRMGSKMGATAIKRHQFFNG 420 (457)
Q Consensus 396 ~~dP~~Rps~~~~~~~ll~hp~f~~ 420 (457)
+.||++||| ++|||+||||+.
T Consensus 254 ~~dp~~R~t----~~ell~hp~~~~ 274 (288)
T d2jfla1 254 EKNVDARWT----TSQLLQHPFVTV 274 (288)
T ss_dssp CSSTTTSCC----HHHHTTSGGGCC
T ss_pred cCChhHCcC----HHHHhcCcccCC
Confidence 999999999 999999999985
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-60 Score=452.19 Aligned_cols=258 Identities=22% Similarity=0.360 Sum_probs=214.5
Q ss_pred CCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEc--C
Q 012762 81 LSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDC--P 158 (457)
Q Consensus 81 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~--~ 158 (457)
.++|++++.||+|+||+||+|+++ .+|+.||||++.+.... +.....+.+|+++|++++|||||++++++.+ +
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~----~~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 77 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRK----SDGKILVWKELDYGSMT-EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTN 77 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET----TTCCEEEEEEECCTTSC-HHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC---
T ss_pred chhCEEeEEEecCCCeEEEEEEEC----CCCCEEEEEEEChhhCC-HHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCC
Confidence 468999999999999999999987 47899999999876543 3445678889999999999999999999864 4
Q ss_pred CcEEEEEeecCCCChHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHcC-----ceeecCCCCCeEEccCCCEEEec
Q 012762 159 RWSCLLTEFCPGGDLHVLRQRQ--PDKRFHESAVRFYASEVVVALEFLHMMG-----IIYRDLKPENVLVRSDGHIMLTD 231 (457)
Q Consensus 159 ~~~~lV~E~~~~~sL~~~~~~~--~~~~~~~~~~~~i~~qi~~~L~yLH~~~-----iiHrDIKp~NIll~~~~~vkl~D 231 (457)
+.+|||||||+||+|.+++... ....+++..++.++.||+.||.|||++| ||||||||+||||+.+|.+||+|
T Consensus 78 ~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~D 157 (269)
T d2java1 78 TTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGD 157 (269)
T ss_dssp -CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECC
T ss_pred CEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEee
Confidence 5789999999999999988642 2467999999999999999999999976 99999999999999999999999
Q ss_pred cCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCC
Q 012762 232 FDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPL 311 (457)
Q Consensus 232 FG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (457)
||+++.......
T Consensus 158 FG~a~~~~~~~~-------------------------------------------------------------------- 169 (269)
T d2java1 158 FGLARILNHDTS-------------------------------------------------------------------- 169 (269)
T ss_dssp HHHHHHC-------------------------------------------------------------------------
T ss_pred ccceeecccCCC--------------------------------------------------------------------
Confidence 999876532111
Q ss_pred ccccccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHH
Q 012762 312 DVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLI 391 (457)
Q Consensus 312 ~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll 391 (457)
...+.+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..+...++...... +.+..+++++.+||
T Consensus 170 --~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~-~~~~~~s~~l~~li 246 (269)
T d2java1 170 --FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFR-RIPYRYSDELNEII 246 (269)
T ss_dssp --------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC-CCCTTSCHHHHHHH
T ss_pred --ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCC-CCCcccCHHHHHHH
Confidence 111347999999999999999999999999999999999999999998888888877776554 23346899999999
Q ss_pred HHHhhhCCCCCCCCCcChHHHhcCCCC
Q 012762 392 AQLLVKDPTRRMGSKMGATAIKRHQFF 418 (457)
Q Consensus 392 ~~~L~~dP~~Rps~~~~~~~ll~hp~f 418 (457)
.+||+.||.+||| ++||++|||.
T Consensus 247 ~~~L~~dp~~Rps----~~ell~hp~i 269 (269)
T d2java1 247 TRMLNLKDYHRPS----VEEILENPLI 269 (269)
T ss_dssp HHHTCSSGGGSCC----HHHHHTSTTC
T ss_pred HHHcCCChhHCcC----HHHHHhCCcC
Confidence 9999999999999 9999999995
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.9e-60 Score=458.48 Aligned_cols=254 Identities=24% Similarity=0.320 Sum_probs=226.2
Q ss_pred CceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcEE
Q 012762 83 DLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWSC 162 (457)
Q Consensus 83 ~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~ 162 (457)
.|+++++||+|+||+||+|+++ .+|+.||||++.+.........+.+.+|+++|++|+|||||++++++.+++.+|
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~----~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ 91 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDV----RNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAW 91 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEET----TTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred hcEeeEEEecCCCeEEEEEEEC----CCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEE
Confidence 4999999999999999999987 478999999998765555556677889999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCCC
Q 012762 163 LLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNST 242 (457)
Q Consensus 163 lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~~ 242 (457)
||||||.+|+|..++... ..+++..++.++.||+.||.|||++|||||||||+||||+.+|.+||+|||+++....
T Consensus 92 iv~E~~~~g~l~~~~~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~-- 167 (309)
T d1u5ra_ 92 LVMEYCLGSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-- 167 (309)
T ss_dssp EEEECCSEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS--
T ss_pred EEEEecCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC--
Confidence 999999999997666654 6799999999999999999999999999999999999999999999999999864321
Q ss_pred cccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCCC
Q 012762 243 STAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTH 322 (457)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 322 (457)
....+||+
T Consensus 168 ------------------------------------------------------------------------~~~~~GT~ 175 (309)
T d1u5ra_ 168 ------------------------------------------------------------------------ANSFVGTP 175 (309)
T ss_dssp ------------------------------------------------------------------------BCCCCSCG
T ss_pred ------------------------------------------------------------------------CCccccCc
Confidence 01246999
Q ss_pred CccCchhhcC---CCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhhhCC
Q 012762 323 EYLAPEIISG---EGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDP 399 (457)
Q Consensus 323 ~y~aPE~l~~---~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP 399 (457)
.|||||++.+ ..|+.++|||||||++|||++|..||.+......+.++............+++++++||.+||+.||
T Consensus 176 ~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP 255 (309)
T d1u5ra_ 176 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIP 255 (309)
T ss_dssp GGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHHHHHHHHHHTCSSG
T ss_pred cccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHCcCCh
Confidence 9999999975 3589999999999999999999999999888888888887776666666789999999999999999
Q ss_pred CCCCCCCcChHHHhcCCCCCC
Q 012762 400 TRRMGSKMGATAIKRHQFFNG 420 (457)
Q Consensus 400 ~~Rps~~~~~~~ll~hp~f~~ 420 (457)
++||| ++|||+||||..
T Consensus 256 ~~Rpt----~~ell~Hp~~~~ 272 (309)
T d1u5ra_ 256 QDRPT----SEVLLKHRFVLR 272 (309)
T ss_dssp GGSCC----HHHHTTCHHHHS
T ss_pred hHCcC----HHHHHhCHHhcC
Confidence 99999 999999999964
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-59 Score=444.67 Aligned_cols=252 Identities=23% Similarity=0.395 Sum_probs=212.4
Q ss_pred ceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEc----CC
Q 012762 84 LRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDC----PR 159 (457)
Q Consensus 84 ~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~----~~ 159 (457)
|++.++||+|+||+||+|+++ .+++.||+|++..... .......+.+|+++|++++|||||++++++.. ..
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~----~~~~~va~K~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~ 85 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDT----ETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKK 85 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEET----TTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCE
T ss_pred EEeeeEEecCcCcEEEEEEEC----CCCeEEEEEEEchhhC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCC
Confidence 578889999999999999987 4788999999987654 33445678899999999999999999999864 34
Q ss_pred cEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcC--ceeecCCCCCeEEc-cCCCEEEeccCCCc
Q 012762 160 WSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMG--IIYRDLKPENVLVR-SDGHIMLTDFDLSL 236 (457)
Q Consensus 160 ~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~--iiHrDIKp~NIll~-~~~~vkl~DFG~s~ 236 (457)
.+|||||||++|+|.+++... ..+++..++.++.||+.||+|||+++ ||||||||+||||+ .++.+||+|||+++
T Consensus 86 ~~~ivmE~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~ 163 (270)
T d1t4ha_ 86 CIVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 163 (270)
T ss_dssp EEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred EEEEEEeCCCCCcHHHHHhcc--ccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcce
Confidence 689999999999999998775 67999999999999999999999998 99999999999997 47899999999986
Q ss_pred CCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccc
Q 012762 237 KGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSM 316 (457)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (457)
..... ...
T Consensus 164 ~~~~~------------------------------------------------------------------------~~~ 171 (270)
T d1t4ha_ 164 LKRAS------------------------------------------------------------------------FAK 171 (270)
T ss_dssp GCCTT------------------------------------------------------------------------SBE
T ss_pred eccCC------------------------------------------------------------------------ccC
Confidence 43211 112
Q ss_pred cccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHH-HHHhcccCCCCCCCCChHHHHHHHHHh
Q 012762 317 SFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLA-NVVARALEFPKEPSVPGPAKDLIAQLL 395 (457)
Q Consensus 317 ~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ll~~~L 395 (457)
+.+||+.|||||++.+ .|+.++|||||||++|||++|+.||.+......+. .+..+.........+++++++||.+||
T Consensus 172 ~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~l 250 (270)
T d1t4ha_ 172 AVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCI 250 (270)
T ss_dssp ESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHS
T ss_pred CcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCCHHHHHHHHHHc
Confidence 4579999999999976 59999999999999999999999998766554444 443332222233457889999999999
Q ss_pred hhCCCCCCCCCcChHHHhcCCCCC
Q 012762 396 VKDPTRRMGSKMGATAIKRHQFFN 419 (457)
Q Consensus 396 ~~dP~~Rps~~~~~~~ll~hp~f~ 419 (457)
+.||++||| ++|||+||||+
T Consensus 251 ~~dp~~R~s----~~ell~Hp~fk 270 (270)
T d1t4ha_ 251 RQNKDERYS----IKDLLNHAFFQ 270 (270)
T ss_dssp CSSGGGSCC----HHHHHTSGGGC
T ss_pred cCCHhHCcC----HHHHhCCcccC
Confidence 999999999 99999999996
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=3.5e-59 Score=460.89 Aligned_cols=258 Identities=29% Similarity=0.428 Sum_probs=227.9
Q ss_pred CCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCc
Q 012762 81 LSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRW 160 (457)
Q Consensus 81 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~ 160 (457)
.++|+++++||+|+||+||+|+++ .+|+.||||++++... .....+.+|+++|++|+|||||+++++|.+++.
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~----~~~~~vAiK~i~~~~~---~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~ 100 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEK----ATGRVFVAKFINTPYP---LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYE 100 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEET----TTCCEEEEEEEECCSH---HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSE
T ss_pred ccceEEEEEEecCCCeEEEEEEEC----CCCCEEEEEEECCcch---hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 467999999999999999999987 4789999999976532 234567889999999999999999999999999
Q ss_pred EEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEc--cCCCEEEeccCCCcCC
Q 012762 161 SCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVR--SDGHIMLTDFDLSLKG 238 (457)
Q Consensus 161 ~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~--~~~~vkl~DFG~s~~~ 238 (457)
+|||||||+||+|.+++... ...+++..++.++.||+.||.|||++|||||||||+||||+ .++.+||+|||+++..
T Consensus 101 ~~ivmE~~~gg~L~~~~~~~-~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~ 179 (352)
T d1koba_ 101 MVLILEFLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKL 179 (352)
T ss_dssp EEEEEECCCCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEEC
T ss_pred EEEEEEcCCCChHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceec
Confidence 99999999999998766543 35699999999999999999999999999999999999998 5689999999998765
Q ss_pred CCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccc
Q 012762 239 DNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSF 318 (457)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (457)
..... ..+.
T Consensus 180 ~~~~~-----------------------------------------------------------------------~~~~ 188 (352)
T d1koba_ 180 NPDEI-----------------------------------------------------------------------VKVT 188 (352)
T ss_dssp CTTSC-----------------------------------------------------------------------EEEE
T ss_pred CCCCc-----------------------------------------------------------------------eeec
Confidence 42211 1234
Q ss_pred cCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCC--CCCCChHHHHHHHHHhh
Q 012762 319 VGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPK--EPSVPGPAKDLIAQLLV 396 (457)
Q Consensus 319 ~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ll~~~L~ 396 (457)
.||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+....+..+....+.++. ...+++++++||.+||+
T Consensus 189 ~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~ 268 (352)
T d1koba_ 189 TATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQ 268 (352)
T ss_dssp CSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSC
T ss_pred cCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHcc
Confidence 6999999999999999999999999999999999999999999888888888888776654 35689999999999999
Q ss_pred hCCCCCCCCCcChHHHhcCCCCCCC
Q 012762 397 KDPTRRMGSKMGATAIKRHQFFNGV 421 (457)
Q Consensus 397 ~dP~~Rps~~~~~~~ll~hp~f~~~ 421 (457)
.||.+||| ++|+|+||||++.
T Consensus 269 ~dp~~R~s----~~eil~Hp~~~~~ 289 (352)
T d1koba_ 269 KEPRKRLT----VHDALEHPWLKGD 289 (352)
T ss_dssp SSGGGSCC----HHHHHTSTTTSSC
T ss_pred CChhHCcC----HHHHhcCHhhCCC
Confidence 99999999 9999999999874
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=9.5e-58 Score=436.27 Aligned_cols=259 Identities=28% Similarity=0.409 Sum_probs=226.4
Q ss_pred CCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhh------hhHHHHHHHHHHHHHHcC-CCCCceEEE
Q 012762 81 LSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVS------RNKESRARIEREILEMLD-HPFLPTLYA 153 (457)
Q Consensus 81 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~------~~~~~~~~~E~~il~~l~-H~nIv~l~~ 153 (457)
.++|++++.||+|+||+||+|+++ .+|+.||||++.+..... ....+.+.+|+++|++|+ ||||+++++
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~----~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~ 77 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHK----PTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKD 77 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEET----TTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred cccCEEceEEecCcCeEEEEEEEC----CCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEe
Confidence 368999999999999999999876 478999999997754322 223456788999999996 999999999
Q ss_pred EEEcCCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccC
Q 012762 154 TLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFD 233 (457)
Q Consensus 154 ~~~~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG 233 (457)
++.+++++|||||||+||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||
T Consensus 78 ~~~~~~~~~ivmE~~~~g~L~~~l~~~--~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG 155 (277)
T d1phka_ 78 TYETNTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFG 155 (277)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCT
T ss_pred ecccCcceEEEEEcCCCchHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccch
Confidence 999999999999999999999999775 679999999999999999999999999999999999999999999999999
Q ss_pred CCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcc
Q 012762 234 LSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDV 313 (457)
Q Consensus 234 ~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (457)
+++......
T Consensus 156 ~a~~~~~~~----------------------------------------------------------------------- 164 (277)
T d1phka_ 156 FSCQLDPGE----------------------------------------------------------------------- 164 (277)
T ss_dssp TCEECCTTC-----------------------------------------------------------------------
T ss_pred heeEccCCC-----------------------------------------------------------------------
Confidence 986543211
Q ss_pred ccccccCCCCccCchhhcC------CCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCC--CCCCCh
Q 012762 314 RSMSFVGTHEYLAPEIISG------EGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPK--EPSVPG 385 (457)
Q Consensus 314 ~~~~~~gt~~y~aPE~l~~------~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~ 385 (457)
.....+||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+.+.......++.+...++. ...+++
T Consensus 165 ~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 244 (277)
T d1phka_ 165 KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSD 244 (277)
T ss_dssp CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTGGGSCH
T ss_pred ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCcccccCCH
Confidence 1113469999999999963 34688999999999999999999999999888888888887665543 346899
Q ss_pred HHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCC
Q 012762 386 PAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNG 420 (457)
Q Consensus 386 ~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~ 420 (457)
++++||.+||+.||++||+ ++|||+||||+.
T Consensus 245 ~~~~li~~~L~~~p~~R~s----~~eil~h~~~~~ 275 (277)
T d1phka_ 245 TVKDLVSRFLVVQPQKRYT----AEEALAHPFFQQ 275 (277)
T ss_dssp HHHHHHHHHCCSSGGGSCC----HHHHTTSGGGCT
T ss_pred HHHHHHHHHccCChhHCcC----HHHHHcCHHHHH
Confidence 9999999999999999999 999999999985
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-58 Score=441.98 Aligned_cols=258 Identities=24% Similarity=0.308 Sum_probs=210.8
Q ss_pred eEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhh--hHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcEEE
Q 012762 86 FVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSR--NKESRARIEREILEMLDHPFLPTLYATLDCPRWSCL 163 (457)
Q Consensus 86 ~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~--~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~~l 163 (457)
.+++||+|+||+||+|+++ .+|+.||||+++....... .....+.+|+++|+.++|||||++++++.+++++||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~----~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~i 77 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDK----NTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISL 77 (299)
T ss_dssp EEEEEEEETTEEEEEEECS----SCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEE
T ss_pred cceEeccCcCeEEEEEEEC----CCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceee
Confidence 4689999999999999986 4789999999976543221 123567889999999999999999999999999999
Q ss_pred EEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCCCc
Q 012762 164 LTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTS 243 (457)
Q Consensus 164 V~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~~~ 243 (457)
|||||.++++..+... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 78 vmE~~~~~~~~~~~~~--~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~ 155 (299)
T d1ua2a_ 78 VFDFMETDLEVIIKDN--SLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR 155 (299)
T ss_dssp EEECCSEEHHHHHTTC--CSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred hhhhhcchHHhhhhhc--ccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCcc
Confidence 9999988877655443 46799999999999999999999999999999999999999999999999999865432111
Q ss_pred ccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCCCC
Q 012762 244 TAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTHE 323 (457)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 323 (457)
...+.+||+.
T Consensus 156 ----------------------------------------------------------------------~~~~~~gt~~ 165 (299)
T d1ua2a_ 156 ----------------------------------------------------------------------AYTHQVVTRW 165 (299)
T ss_dssp ----------------------------------------------------------------------CCCCSCCCCT
T ss_pred ----------------------------------------------------------------------cccceecChh
Confidence 1113469999
Q ss_pred ccCchhhcCC-CCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCC-----------------------
Q 012762 324 YLAPEIISGE-GHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPK----------------------- 379 (457)
Q Consensus 324 y~aPE~l~~~-~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~----------------------- 379 (457)
|||||++.+. .|+.++|||||||++|||++|.+||.+....+.+.++.........
T Consensus 166 y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (299)
T d1ua2a_ 166 YRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPL 245 (299)
T ss_dssp TCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCH
T ss_pred hccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhccCCCCCh
Confidence 9999999755 5799999999999999999999999998888777776643221110
Q ss_pred ---CCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCCCCc
Q 012762 380 ---EPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGVNW 423 (457)
Q Consensus 380 ---~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~~~~ 423 (457)
...+++++++||.+||+.||++||| ++|+|+||||++...
T Consensus 246 ~~~~~~~s~~~~dll~~~L~~dP~~R~s----a~e~L~Hp~f~~~p~ 288 (299)
T d1ua2a_ 246 HHIFSAAGDDLLDLIQGLFLFNPCARIT----ATQALKMKYFSNRPG 288 (299)
T ss_dssp HHHCTTCCHHHHHHHHHHHCSSTTTSCC----HHHHHTSGGGTSSSC
T ss_pred HHhcccCCHHHHHHHHHHccCChhhCcC----HHHHhCCHhhCCCCC
Confidence 1245788999999999999999999 999999999986443
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-57 Score=445.34 Aligned_cols=256 Identities=23% Similarity=0.364 Sum_probs=226.4
Q ss_pred CCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCc
Q 012762 81 LSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRW 160 (457)
Q Consensus 81 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~ 160 (457)
.++|+++++||+|+||+||+|.++ .+|+.||||++++.. .....+.+|+++|++++|||||+++++|.+++.
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~----~~~~~~AiK~i~~~~----~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~ 75 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVET----SSKKTYMAKFVKVKG----TDQVLVKKEISILNIARHRNILHLHESFESMEE 75 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEET----TTTEEEEEEEECCCT----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTE
T ss_pred ccceEEEEEEecCCCeEEEEEEEC----CCCcEEEEEEEcCCc----ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCE
Confidence 468999999999999999999987 478999999997653 234567789999999999999999999999999
Q ss_pred EEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccC--CCEEEeccCCCcCC
Q 012762 161 SCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSD--GHIMLTDFDLSLKG 238 (457)
Q Consensus 161 ~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~--~~vkl~DFG~s~~~ 238 (457)
+|||||||+||+|.+++... ...+++.+++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++..
T Consensus 76 ~~lvmE~~~gg~L~~~i~~~-~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~ 154 (321)
T d1tkia_ 76 LVMIFEFISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL 154 (321)
T ss_dssp EEEEECCCCCCBHHHHHTSS-SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred EEEEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhcc
Confidence 99999999999999988764 2469999999999999999999999999999999999999854 48999999998654
Q ss_pred CCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccc
Q 012762 239 DNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSF 318 (457)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (457)
.... ...+.
T Consensus 155 ~~~~-----------------------------------------------------------------------~~~~~ 163 (321)
T d1tkia_ 155 KPGD-----------------------------------------------------------------------NFRLL 163 (321)
T ss_dssp CTTC-----------------------------------------------------------------------EEEEE
T ss_pred ccCC-----------------------------------------------------------------------ccccc
Confidence 3211 11234
Q ss_pred cCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCC--CCCChHHHHHHHHHhh
Q 012762 319 VGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKE--PSVPGPAKDLIAQLLV 396 (457)
Q Consensus 319 ~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ll~~~L~ 396 (457)
.||+.|+|||.+.+..|+.++|||||||++|+|++|..||.+.+..+.+.+++...+.++.. ..+++++++||.+||.
T Consensus 164 ~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~ 243 (321)
T d1tkia_ 164 FTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLV 243 (321)
T ss_dssp ESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSC
T ss_pred ccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHHHHHHHHHcc
Confidence 69999999999999999999999999999999999999999999888999998887766542 4689999999999999
Q ss_pred hCCCCCCCCCcChHHHhcCCCCCC
Q 012762 397 KDPTRRMGSKMGATAIKRHQFFNG 420 (457)
Q Consensus 397 ~dP~~Rps~~~~~~~ll~hp~f~~ 420 (457)
.||++||| ++|+|+||||+.
T Consensus 244 ~dp~~R~s----~~eil~hp~~~~ 263 (321)
T d1tkia_ 244 KERKSRMT----ASEALQHPWLKQ 263 (321)
T ss_dssp SSGGGSCC----HHHHHHSHHHHS
T ss_pred CChhHCcC----HHHHhcCHhhcc
Confidence 99999999 999999999974
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=7e-57 Score=432.72 Aligned_cols=259 Identities=20% Similarity=0.257 Sum_probs=224.6
Q ss_pred CCCCccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEE
Q 012762 75 NNNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYAT 154 (457)
Q Consensus 75 ~~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~ 154 (457)
..|++..++|++.++||+|+||+||+|+++. +++.||||++++.. ...+++.+|+++|++++|||||+++++
T Consensus 10 ~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~----~~~~vAvK~i~~~~----~~~~~~~~E~~il~~l~HpnIv~~~~~ 81 (287)
T d1opja_ 10 DKWEMERTDITMKHKLGGGQYGEVYEGVWKK----YSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGV 81 (287)
T ss_dssp CTTBCCGGGEEEEEETTTTTTSSEEEEEEGG----GTEEEEEEECCTTC----SCHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccEecHHHeEEeeEEeeCCCeEEEEEEECC----CCeEEEEEEECCcc----chHHHHHHHHHHHHhCCCCCEecCCcc
Confidence 4578888999999999999999999999873 78899999997543 245678899999999999999999999
Q ss_pred EEcCCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCC
Q 012762 155 LDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDL 234 (457)
Q Consensus 155 ~~~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~ 234 (457)
+.+++.+|||||||++|+|..++.......+++..++.++.||+.||.|||++|||||||||+||||+.++.+||+|||+
T Consensus 82 ~~~~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~ 161 (287)
T d1opja_ 82 CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGL 161 (287)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCC
T ss_pred EeeCCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccc
Confidence 99999999999999999999999887778899999999999999999999999999999999999999999999999999
Q ss_pred CcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccc
Q 012762 235 SLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVR 314 (457)
Q Consensus 235 s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (457)
++.........
T Consensus 162 a~~~~~~~~~~--------------------------------------------------------------------- 172 (287)
T d1opja_ 162 SRLMTGDTYTA--------------------------------------------------------------------- 172 (287)
T ss_dssp TTTCCSSSSEE---------------------------------------------------------------------
T ss_pred eeecCCCCcee---------------------------------------------------------------------
Confidence 87654321110
Q ss_pred cccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHH
Q 012762 315 SMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQL 394 (457)
Q Consensus 315 ~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~ 394 (457)
.....||+.|||||++.+..|+.++|||||||++|||++|..||........+..++......+.+..+++++++||.+|
T Consensus 173 ~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~c 252 (287)
T d1opja_ 173 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRAC 252 (287)
T ss_dssp ETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHH
T ss_pred eccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCCCCccchHHHHHHHHHH
Confidence 11234899999999999999999999999999999999977666555555555566666667777778999999999999
Q ss_pred hhhCCCCCCCCCcChHHHhc
Q 012762 395 LVKDPTRRMGSKMGATAIKR 414 (457)
Q Consensus 395 L~~dP~~Rps~~~~~~~ll~ 414 (457)
|+.||++||| ++||++
T Consensus 253 l~~dP~~Rps----~~ei~~ 268 (287)
T d1opja_ 253 WQWNPSDRPS----FAEIHQ 268 (287)
T ss_dssp TCSSGGGSCC----HHHHHH
T ss_pred cCCCHhHCcC----HHHHHH
Confidence 9999999999 888865
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-56 Score=433.87 Aligned_cols=261 Identities=27% Similarity=0.372 Sum_probs=215.8
Q ss_pred CCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCc
Q 012762 81 LSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRW 160 (457)
Q Consensus 81 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~ 160 (457)
+++|+++++||+|+||+||+|+++ .+|+.||||+++.... ......++.+|+++|++++|||||++++++.+++.
T Consensus 1 ~d~Y~~~~~lG~G~fg~Vy~~~~~----~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~ 75 (298)
T d1gz8a_ 1 MENFQKVEKIGEGTYGVVYKARNK----LTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENK 75 (298)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEET----TTCCEEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTE
T ss_pred CCCCEeccEEecCcCeEEEEEEEC----CCCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCCCCcEEEeccccccccc
Confidence 478999999999999999999987 4788999999976532 22345678889999999999999999999999999
Q ss_pred EEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCC
Q 012762 161 SCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDN 240 (457)
Q Consensus 161 ~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~ 240 (457)
+|||||||. +.+..++.......+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+++....
T Consensus 76 ~~iv~e~~~-~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~ 154 (298)
T d1gz8a_ 76 LYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV 154 (298)
T ss_dssp EEEEEECCS-EEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCC
T ss_pred eeEEEeecC-CchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccC
Confidence 999999995 5555566555567899999999999999999999999999999999999999999999999999864432
Q ss_pred CCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccC
Q 012762 241 STSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVG 320 (457)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 320 (457)
... .....+|
T Consensus 155 ~~~----------------------------------------------------------------------~~~~~~g 164 (298)
T d1gz8a_ 155 PVR----------------------------------------------------------------------TYTHEVV 164 (298)
T ss_dssp CSB----------------------------------------------------------------------CTTCCBC
T ss_pred Ccc----------------------------------------------------------------------cceeecc
Confidence 111 1113469
Q ss_pred CCCccCchhhcCCC-CCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCC--------------------
Q 012762 321 THEYLAPEIISGEG-HGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPK-------------------- 379 (457)
Q Consensus 321 t~~y~aPE~l~~~~-~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~-------------------- 379 (457)
|+.|+|||++.... ++.++|||||||++|+|++|+.||.+.+....+.++.........
T Consensus 165 t~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (298)
T d1gz8a_ 165 TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWA 244 (298)
T ss_dssp CCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTSCCCC
T ss_pred cceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccccccccccccc
Confidence 99999999988776 488999999999999999999999988877766665543221110
Q ss_pred -------CCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCCC
Q 012762 380 -------EPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGV 421 (457)
Q Consensus 380 -------~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~~ 421 (457)
...++.++++||.+||+.||++||| ++|||+||||+.+
T Consensus 245 ~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t----~~ell~H~ff~~~ 289 (298)
T d1gz8a_ 245 RQDFSKVVPPLDEDGRSLLSQMLHYDPNKRIS----AKAALAHPFFQDV 289 (298)
T ss_dssp CCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCC----HHHHHTSGGGTTC
T ss_pred ccchhhhccCCCHHHHHHHHHHccCChhHCcC----HHHHhCCHhhccC
Confidence 1245678999999999999999999 9999999999864
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-57 Score=441.70 Aligned_cols=293 Identities=38% Similarity=0.682 Sum_probs=239.7
Q ss_pred CccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhh-hhHHHHHHHHHHHHHHcCC-CCCceEEEEE
Q 012762 78 PLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVS-RNKESRARIEREILEMLDH-PFLPTLYATL 155 (457)
Q Consensus 78 ~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~-~~~~~~~~~E~~il~~l~H-~nIv~l~~~~ 155 (457)
.+.+++|+++++||+|+||+||+|++.. +..+|+.||||++++..... ....+.+.+|+++|++++| |||+++++++
T Consensus 20 ~~~l~~y~~~~~IG~G~fg~Vy~~~~~~-~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~ 98 (322)
T d1vzoa_ 20 KVGIENFELLKVLGTGAYGKVFLVRKIS-GHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF 98 (322)
T ss_dssp CCCGGGEEEEEEEEETTTEEEEEEEECS-STTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEE
T ss_pred ccchhceEEEEEEecCCCeEEEEEEECc-cCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeee
Confidence 3567899999999999999999998753 23478999999997654322 2234567789999999976 8999999999
Q ss_pred EcCCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCC
Q 012762 156 DCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235 (457)
Q Consensus 156 ~~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s 235 (457)
.+...+|+||||+.+|+|..++... +.+++..++.++.||+.||+|||++|||||||||+|||++.+|.+||+|||++
T Consensus 99 ~~~~~~~~v~e~~~~~~L~~~i~~~--~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a 176 (322)
T d1vzoa_ 99 QTETKLHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLS 176 (322)
T ss_dssp EETTEEEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred ccCCceeeeeecccccHHHHHHHhc--ccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccch
Confidence 9999999999999999999988775 67889999999999999999999999999999999999999999999999998
Q ss_pred cCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcccc
Q 012762 236 LKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRS 315 (457)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (457)
+....... ...
T Consensus 177 ~~~~~~~~---------------------------------------------------------------------~~~ 187 (322)
T d1vzoa_ 177 KEFVADET---------------------------------------------------------------------ERA 187 (322)
T ss_dssp EECCGGGG---------------------------------------------------------------------GGG
T ss_pred hhhccccc---------------------------------------------------------------------ccc
Confidence 65532111 112
Q ss_pred ccccCCCCccCchhhcCCC--CCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhccc--CCCCCCCCChHHHHHH
Q 012762 316 MSFVGTHEYLAPEIISGEG--HGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARAL--EFPKEPSVPGPAKDLI 391 (457)
Q Consensus 316 ~~~~gt~~y~aPE~l~~~~--~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~ll 391 (457)
.+..|++.|+|||.+.+.. ++.++|||||||+||||++|+.||.+.........+..... ..+.+..+++++.+||
T Consensus 188 ~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 267 (322)
T d1vzoa_ 188 YDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLI 267 (322)
T ss_dssp CGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTSCHHHHHHH
T ss_pred cccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCcccCCHHHHHHH
Confidence 2456999999999998654 68899999999999999999999988655444444433321 2233345899999999
Q ss_pred HHHhhhCCCCCCCCCc-ChHHHhcCCCCCCCCchhh--hccCCCCCCCCCCccc
Q 012762 392 AQLLVKDPTRRMGSKM-GATAIKRHQFFNGVNWALL--RCAKPPFIPRPVTCRD 442 (457)
Q Consensus 392 ~~~L~~dP~~Rps~~~-~~~~ll~hp~f~~~~~~~~--~~~~~~~~~~~~~~~~ 442 (457)
.+||..||++||+... .++|+|+||||+.++|..+ +...+||+|+.....|
T Consensus 268 ~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~~~~l~~~~~~~p~~p~~~~~~~ 321 (322)
T d1vzoa_ 268 QRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVPAPFKPVIRDELD 321 (322)
T ss_dssp HHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCCC-CC
T ss_pred HHHcccCHHHcCCCCcccHHHHHcCHhhcCCCHHHHHhCCCCcCCCCCCCCCCC
Confidence 9999999999996432 4899999999999999877 4677899998877665
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-56 Score=438.45 Aligned_cols=266 Identities=20% Similarity=0.268 Sum_probs=224.0
Q ss_pred CCCccCCCceeEEEecccCcceEEEEEEeccCC-CCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHc-CCCCCceEEE
Q 012762 76 NNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSS-NNGCFFAAKVMDKRELVSRNKESRARIEREILEML-DHPFLPTLYA 153 (457)
Q Consensus 76 ~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~-~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~~ 153 (457)
.|++..++|++.++||+|+||+||+|+++.... .....||+|++.... .......+.+|+++|+++ +|||||++++
T Consensus 31 kwei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~l~~ 108 (325)
T d1rjba_ 31 KWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLG 108 (325)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc--CHHHHHHHHHHHHHHHHhcCCCcEeEEEE
Confidence 456778899999999999999999999874322 234579999986543 223445678899999998 8999999999
Q ss_pred EEEcCCcEEEEEeecCCCChHHHHHhCC---------------------CCCCCHHHHHHHHHHHHHHHHHHHHcCceee
Q 012762 154 TLDCPRWSCLLTEFCPGGDLHVLRQRQP---------------------DKRFHESAVRFYASEVVVALEFLHMMGIIYR 212 (457)
Q Consensus 154 ~~~~~~~~~lV~E~~~~~sL~~~~~~~~---------------------~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHr 212 (457)
++.+.+.+|||||||++|+|.++++... ...+++..++.++.||+.||+|||++|||||
T Consensus 109 ~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHR 188 (325)
T d1rjba_ 109 ACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHR 188 (325)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEET
T ss_pred EEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeec
Confidence 9999999999999999999999987642 2358999999999999999999999999999
Q ss_pred cCCCCCeEEccCCCEEEeccCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcch
Q 012762 213 DLKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKR 292 (457)
Q Consensus 213 DIKp~NIll~~~~~vkl~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (457)
||||+|||++.++.+||+|||+|+........
T Consensus 189 DlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~------------------------------------------------ 220 (325)
T d1rjba_ 189 DLAARNVLVTHGKVVKICDFGLARDIMSDSNY------------------------------------------------ 220 (325)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCTTS------------------------------------------------
T ss_pred cCchhccccccCCeEEEeeccccccccCCCce------------------------------------------------
Confidence 99999999999999999999998654321110
Q ss_pred hccccCCCCCCCcccccCCccccccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHH
Q 012762 293 RRKKKLGNPGTPEIVAEPLDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVV 371 (457)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~ 371 (457)
....+..||+.|||||++.+..|+.++|||||||++|||++ |+.||.+......+.+++
T Consensus 221 --------------------~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~~~~~~ 280 (325)
T d1rjba_ 221 --------------------VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLI 280 (325)
T ss_dssp --------------------EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHH
T ss_pred --------------------eeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 01113468999999999999999999999999999999997 899999887777778888
Q ss_pred hcccCCCCCCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcC
Q 012762 372 ARALEFPKEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRH 415 (457)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~h 415 (457)
....+++.+..+++++++||.+||+.||++||| ++||++|
T Consensus 281 ~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt----~~ei~~~ 320 (325)
T d1rjba_ 281 QNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPS----FPNLTSF 320 (325)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred hcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcC----HHHHHHH
Confidence 888887777789999999999999999999999 9999876
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-56 Score=426.59 Aligned_cols=258 Identities=21% Similarity=0.318 Sum_probs=213.7
Q ss_pred CCCccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEE
Q 012762 76 NNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATL 155 (457)
Q Consensus 76 ~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~ 155 (457)
.|++..++|++.++||+|+||+||+|+++ ..||||+++.... .....+.+.+|+++|++++|||||++++++
T Consensus 2 dwei~~~~~~~~~~lG~G~fg~Vy~~~~~-------~~vAvK~~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~ 73 (276)
T d1uwha_ 2 DWEIPDGQITVGQRIGSGSFGTVYKGKWH-------GDVAVKMLNVTAP-TPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73 (276)
T ss_dssp CCBCCTTCCCCCSEEEECSSCEEEEEESS-------SEEEEEECCCSSC-CTTHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred CcccccccEEEEEEEeeCCCcEEEEEEEC-------CEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCEeeeeEEE
Confidence 46788899999999999999999999753 2599999975533 334567888999999999999999999987
Q ss_pred EcCCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCC
Q 012762 156 DCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235 (457)
Q Consensus 156 ~~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s 235 (457)
.. +.+|||||||++|+|.+++... ...+++..+..++.||+.||+|||++|||||||||+||||+.++.+||+|||++
T Consensus 74 ~~-~~~~lv~Ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla 151 (276)
T d1uwha_ 74 TA-PQLAIVTQWCEGSSLYHHLHII-ETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLA 151 (276)
T ss_dssp CS-SSCEEEEECCCEEEHHHHHHTS-CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCS
T ss_pred ec-cEEEEEEecCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccce
Confidence 54 5689999999999999988764 356999999999999999999999999999999999999999999999999998
Q ss_pred cCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcccc
Q 012762 236 LKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRS 315 (457)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (457)
+........ ...
T Consensus 152 ~~~~~~~~~--------------------------------------------------------------------~~~ 163 (276)
T d1uwha_ 152 TVKSRWSGS--------------------------------------------------------------------HQF 163 (276)
T ss_dssp CC------------------------------------------------------------------------------
T ss_pred eeccccCCc--------------------------------------------------------------------ccc
Confidence 655422111 011
Q ss_pred ccccCCCCccCchhhcCC---CCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCC----CCCCChHHH
Q 012762 316 MSFVGTHEYLAPEIISGE---GHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPK----EPSVPGPAK 388 (457)
Q Consensus 316 ~~~~gt~~y~aPE~l~~~---~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~ 388 (457)
.+..||+.|||||++.+. .|+.++|||||||+||||++|+.||.+......+...+......|. ...+++++.
T Consensus 164 ~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~ 243 (276)
T d1uwha_ 164 EQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMK 243 (276)
T ss_dssp --CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTCCHHHH
T ss_pred cccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhccccchHHHH
Confidence 234699999999999753 4899999999999999999999999987776666666655544432 346889999
Q ss_pred HHHHHHhhhCCCCCCCCCcChHHHhcC
Q 012762 389 DLIAQLLVKDPTRRMGSKMGATAIKRH 415 (457)
Q Consensus 389 ~ll~~~L~~dP~~Rps~~~~~~~ll~h 415 (457)
+||.+||..||++||| +.||+++
T Consensus 244 ~li~~cl~~dp~~RPt----~~~il~~ 266 (276)
T d1uwha_ 244 RLMAECLKKKRDERPL----FPQILAS 266 (276)
T ss_dssp HHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred HHHHHHcCCCHhHCcC----HHHHHHH
Confidence 9999999999999999 9998876
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-56 Score=428.30 Aligned_cols=261 Identities=20% Similarity=0.314 Sum_probs=218.8
Q ss_pred CCCCccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEE
Q 012762 75 NNNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYAT 154 (457)
Q Consensus 75 ~~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~ 154 (457)
..|++..++|++.++||+|+||+||+|+++ +++.||||+++... ...+.+.+|+++|++++|||||+++++
T Consensus 6 ~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~-----~~~~vAvK~~~~~~----~~~~~~~~E~~~l~~l~HpnIv~~~g~ 76 (272)
T d1qpca_ 6 DEWEVPRETLKLVERLGAGQFGEVWMGYYN-----GHTKVAVKSLKQGS----MSPDAFLAEANLMKQLQHQRLVRLYAV 76 (272)
T ss_dssp CTTBCCGGGEEEEEEEEEETTEEEEEEEET-----TTEEEEEEEECTTS----SCHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CCeecCHHHeEEeEEEecCCCcEEEEEEEC-----CCCEEEEEEEccCc----CCHHHHHHHHHHHHhCCCCCEeEEEee
Confidence 567788899999999999999999999975 57789999997543 234568899999999999999999998
Q ss_pred EEcCCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCC
Q 012762 155 LDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDL 234 (457)
Q Consensus 155 ~~~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~ 234 (457)
+.+ +..|||||||++|+|.+++.......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+
T Consensus 77 ~~~-~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGl 155 (272)
T d1qpca_ 77 VTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGL 155 (272)
T ss_dssp ECS-SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred ecc-CCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccc
Confidence 864 5679999999999998877654445699999999999999999999999999999999999999999999999999
Q ss_pred CcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccc
Q 012762 235 SLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVR 314 (457)
Q Consensus 235 s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (457)
++........ .
T Consensus 156 a~~~~~~~~~---------------------------------------------------------------------~ 166 (272)
T d1qpca_ 156 ARLIEDNEYT---------------------------------------------------------------------A 166 (272)
T ss_dssp CEECSSSCEE---------------------------------------------------------------------C
T ss_pred eEEccCCccc---------------------------------------------------------------------c
Confidence 8765422111 0
Q ss_pred cccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcC-CCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHH
Q 012762 315 SMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYG-TTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQ 393 (457)
Q Consensus 315 ~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG-~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~ 393 (457)
.....||+.|||||++.+..++.++|||||||++|||+|| .+||......+.+..+. ...+.+.+..+++++.+||.+
T Consensus 167 ~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~-~~~~~~~p~~~~~~l~~li~~ 245 (272)
T d1qpca_ 167 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE-RGYRMVRPDNCPEELYQLMRL 245 (272)
T ss_dssp CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCCCCCCTTCCHHHHHHHHH
T ss_pred ccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHH-hcCCCCCcccChHHHHHHHHH
Confidence 1123589999999999988899999999999999999995 55566555555555544 445555666799999999999
Q ss_pred HhhhCCCCCCCCCcChHHHhc--CCCCC
Q 012762 394 LLVKDPTRRMGSKMGATAIKR--HQFFN 419 (457)
Q Consensus 394 ~L~~dP~~Rps~~~~~~~ll~--hp~f~ 419 (457)
||+.||++||| +++|++ |+||.
T Consensus 246 cl~~~P~~Rpt----~~ei~~~L~~~ft 269 (272)
T d1qpca_ 246 CWKERPEDRPT----FDYLRSVLEDFFT 269 (272)
T ss_dssp HTCSSGGGSCC----HHHHHHHHHHHHH
T ss_pred HcCCCHhHCcC----HHHHHHHhhhhhh
Confidence 99999999999 999987 67775
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-56 Score=439.28 Aligned_cols=254 Identities=27% Similarity=0.396 Sum_probs=210.1
Q ss_pred cCCCceeEE-EecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHc-CCCCCceEEEEEEc
Q 012762 80 TLSDLRFVH-RLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEML-DHPFLPTLYATLDC 157 (457)
Q Consensus 80 ~~~~~~~~~-~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~~~~~~ 157 (457)
-+++|.++. .||+|+||+||+|+++ .+++.||||++++. ..+.+|++++.++ +|||||+++++|.+
T Consensus 9 i~~~y~i~~~~lG~G~fg~Vy~a~~~----~~~~~vAiK~i~~~--------~~~~~E~~~~~~~~~hpnIv~l~~~~~~ 76 (335)
T d2ozaa1 9 IIDDYKVTSQVLGLGINGKVLQIFNK----RTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYEN 76 (335)
T ss_dssp GGGTEEEEEEEEEECSSCEEEEEEET----TTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred cccCEEEeeEEeeeccCeEEEEEEEC----CCCCEEEEEEECCc--------HHHHHHHHHHHHhcCCCCCCeEEEEEee
Confidence 357899886 5999999999999986 47899999999643 3456799987654 89999999999865
Q ss_pred ----CCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEcc---CCCEEEe
Q 012762 158 ----PRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRS---DGHIMLT 230 (457)
Q Consensus 158 ----~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~---~~~vkl~ 230 (457)
+.++|||||||+||+|.+++.......+++.+++.++.||+.||.|||++||+||||||+|||++. ++.+||+
T Consensus 77 ~~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~ 156 (335)
T d2ozaa1 77 LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLT 156 (335)
T ss_dssp EETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEEC
T ss_pred cccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCcccccccccccccccccccccccc
Confidence 467899999999999999998765668999999999999999999999999999999999999985 4679999
Q ss_pred ccCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccC
Q 012762 231 DFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEP 310 (457)
Q Consensus 231 DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (457)
|||+++.......
T Consensus 157 DFG~a~~~~~~~~------------------------------------------------------------------- 169 (335)
T d2ozaa1 157 DFGFAKETTSHNS------------------------------------------------------------------- 169 (335)
T ss_dssp CCTTCEECCCCCC-------------------------------------------------------------------
T ss_pred ccceeeeccCCCc-------------------------------------------------------------------
Confidence 9999865532111
Q ss_pred CccccccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHH----HhcccCCCCC--CCCC
Q 012762 311 LDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANV----VARALEFPKE--PSVP 384 (457)
Q Consensus 311 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~----~~~~~~~~~~--~~~~ 384 (457)
....+||+.|||||++.+..|+.++|||||||++|+|++|+.||.+.........+ ....+.++.. ..++
T Consensus 170 ----~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s 245 (335)
T d2ozaa1 170 ----LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVS 245 (335)
T ss_dssp ----CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCTTHHHHSC
T ss_pred ----cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCcccccCC
Confidence 11346999999999999999999999999999999999999999876544433332 2233334332 3578
Q ss_pred hHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCC
Q 012762 385 GPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNG 420 (457)
Q Consensus 385 ~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~ 420 (457)
+++++||.+||+.||++||+ +.|+++||||..
T Consensus 246 ~~~~~li~~~L~~dP~~R~s----~~eil~hp~~~~ 277 (335)
T d2ozaa1 246 EEVKMLIRNLLKTEPTQRMT----ITEFMNHPWIMQ 277 (335)
T ss_dssp HHHHHHHHHHSCSSTTTSCC----HHHHHHSHHHHT
T ss_pred HHHHHHHHHHccCChhHCcC----HHHHHcCHHhhC
Confidence 89999999999999999999 999999999964
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-56 Score=427.15 Aligned_cols=251 Identities=25% Similarity=0.364 Sum_probs=211.9
Q ss_pred CCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhh---HHHHHHHHHHHHHHcC--CCCCceEEEEEE
Q 012762 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRN---KESRARIEREILEMLD--HPFLPTLYATLD 156 (457)
Q Consensus 82 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~---~~~~~~~E~~il~~l~--H~nIv~l~~~~~ 156 (457)
++|++.+.||+|+||+||+|+++ .+|+.||||++.+....... ...++.+|+++|++++ |||||++++++.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~----~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~ 79 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRV----SDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE 79 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEET----TTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred CeEEEeEEEeeCCCeEEEEEEEC----CCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEe
Confidence 57999999999999999999987 47899999999876543221 1234567999999996 899999999999
Q ss_pred cCCcEEEEEeecCC-CChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccC-CCEEEeccCC
Q 012762 157 CPRWSCLLTEFCPG-GDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSD-GHIMLTDFDL 234 (457)
Q Consensus 157 ~~~~~~lV~E~~~~-~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~-~~vkl~DFG~ 234 (457)
+.+..|+||||+.+ +++..++... ..+++.+++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+
T Consensus 80 ~~~~~~lv~e~~~~~~~l~~~~~~~--~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~ 157 (273)
T d1xwsa_ 80 RPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGS 157 (273)
T ss_dssp CSSEEEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred eCCeEEEEEEeccCcchHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECcccc
Confidence 99999999999976 5777777664 679999999999999999999999999999999999999855 7999999999
Q ss_pred CcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccc
Q 012762 235 SLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVR 314 (457)
Q Consensus 235 s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (457)
++..... .
T Consensus 158 a~~~~~~------------------------------------------------------------------------~ 165 (273)
T d1xwsa_ 158 GALLKDT------------------------------------------------------------------------V 165 (273)
T ss_dssp CEECCSS------------------------------------------------------------------------C
T ss_pred ceecccc------------------------------------------------------------------------c
Confidence 8644311 1
Q ss_pred cccccCCCCccCchhhcCCCC-CccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHH
Q 012762 315 SMSFVGTHEYLAPEIISGEGH-GNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQ 393 (457)
Q Consensus 315 ~~~~~gt~~y~aPE~l~~~~~-~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~ 393 (457)
..+++||+.|||||++.+..+ +.++|||||||++|||++|+.||.+.. .+......++. .+++++++||.+
T Consensus 166 ~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~~~~~~~~--~~s~~~~~li~~ 237 (273)
T d1xwsa_ 166 YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFRQ--RVSSECQHLIRW 237 (273)
T ss_dssp BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCCCCSS--CCCHHHHHHHHH
T ss_pred ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHhhcccCCCC--CCCHHHHHHHHH
Confidence 113569999999999988765 678999999999999999999997632 34445555544 589999999999
Q ss_pred HhhhCCCCCCCCCcChHHHhcCCCCCCCC
Q 012762 394 LLVKDPTRRMGSKMGATAIKRHQFFNGVN 422 (457)
Q Consensus 394 ~L~~dP~~Rps~~~~~~~ll~hp~f~~~~ 422 (457)
||+.||++||| ++|+|+||||+++.
T Consensus 238 ~L~~dp~~R~s----~~eil~hp~~~~~~ 262 (273)
T d1xwsa_ 238 CLALRPSDRPT----FEEIQNHPWMQDVL 262 (273)
T ss_dssp HTCSSGGGSCC----HHHHHTSGGGSSCC
T ss_pred HccCCHhHCcC----HHHHhcCHhhCCCC
Confidence 99999999999 99999999999754
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1e-55 Score=427.01 Aligned_cols=264 Identities=22% Similarity=0.320 Sum_probs=210.6
Q ss_pred CccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEc
Q 012762 78 PLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDC 157 (457)
Q Consensus 78 ~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~ 157 (457)
.+..++|++.++||+|+||+||+|+++... .....||||.+.... .....+.+.+|+++|++++|||||++++++..
T Consensus 22 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~ 98 (299)
T d1jpaa_ 22 EIDISCVKIEQVIGAGEFGEVCSGHLKLPG-KREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTK 98 (299)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECC----CCEEEEEEECCSSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred hhChhhcEEeeEEeeCCCeEEEEEEEeCCC-CEEEEEEEEEECccc--CHHHHHHHHHHHHHHHhCCCCCCccEEEEEee
Confidence 466788999999999999999999986421 133468999886542 23445678899999999999999999999999
Q ss_pred CCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcC
Q 012762 158 PRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLK 237 (457)
Q Consensus 158 ~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~ 237 (457)
++.+|||||||++|+|..++... .+.+++..++.++.||+.||.|||++|||||||||+||||+.++.+||+|||+++.
T Consensus 99 ~~~~~iv~Ey~~~g~L~~~~~~~-~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~ 177 (299)
T d1jpaa_ 99 STPVMIITEFMENGSLDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRF 177 (299)
T ss_dssp SSSCEEEEECCTTEEHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred CCEEEEEEEecCCCcceeeeccc-cCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceE
Confidence 99999999999999999887764 35699999999999999999999999999999999999999999999999999876
Q ss_pred CCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcccccc
Q 012762 238 GDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMS 317 (457)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (457)
......... ......
T Consensus 178 ~~~~~~~~~-----------------------------------------------------------------~~~~~~ 192 (299)
T d1jpaa_ 178 LEDDTSDPT-----------------------------------------------------------------YTSALG 192 (299)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred ccCCCCcce-----------------------------------------------------------------eeeccc
Confidence 543221110 001112
Q ss_pred ccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhh
Q 012762 318 FVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLV 396 (457)
Q Consensus 318 ~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~ 396 (457)
..||+.|||||++.+..|+.++|||||||++|||++ |+.||.+....+....+. ...+.+.+..++.++.+||.+||+
T Consensus 193 ~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~-~~~~~~~~~~~~~~l~~li~~cl~ 271 (299)
T d1jpaa_ 193 GKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIE-QDYRLPPPMDCPSALHQLMLDCWQ 271 (299)
T ss_dssp ---CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTC
T ss_pred ccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCccchHHHHHHHHHHcC
Confidence 358999999999999999999999999999999998 899999988776666554 445566667799999999999999
Q ss_pred hCCCCCCCCCcChHHHhcC
Q 012762 397 KDPTRRMGSKMGATAIKRH 415 (457)
Q Consensus 397 ~dP~~Rps~~~~~~~ll~h 415 (457)
.||++||+ +.||+++
T Consensus 272 ~~P~~RPs----~~ei~~~ 286 (299)
T d1jpaa_ 272 KDRNHRPK----FGQIVNT 286 (299)
T ss_dssp SSTTTSCC----HHHHHHH
T ss_pred CCHhHCcC----HHHHHHH
Confidence 99999999 7777654
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-55 Score=428.39 Aligned_cols=263 Identities=24% Similarity=0.337 Sum_probs=214.7
Q ss_pred CCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHc---CCCCCceEEEEEEc-
Q 012762 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEML---DHPFLPTLYATLDC- 157 (457)
Q Consensus 82 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l---~H~nIv~l~~~~~~- 157 (457)
++|+++++||+|+||+||+|+++. .+++.||||+++..... ......+.+|+++|+.| +||||++++++|..
T Consensus 7 ~~Y~i~~~LG~G~fg~V~~a~~~~---~~~~~vAiK~i~~~~~~-~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~ 82 (305)
T d1blxa_ 7 QQYECVAEIGEGAYGKVFKARDLK---NGGRFVALKRVRVQTGE-EGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVS 82 (305)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETT---TTTEEEEEEEEEEEBCT-TSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEE
T ss_pred CCEEEEEEEecccCeEEEEEEEEC---CCCEEEEEEEEehhhcc-chHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccc
Confidence 689999999999999999999753 24678999999764322 22233455688887766 79999999999853
Q ss_pred ----CCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccC
Q 012762 158 ----PRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFD 233 (457)
Q Consensus 158 ----~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG 233 (457)
..++|++||||+++.+.. ........+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||
T Consensus 83 ~~~~~~~~~~~~e~~~~~~~~~-~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg 161 (305)
T d1blxa_ 83 RTDRETKLTLVFEHVDQDLTTY-LDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFG 161 (305)
T ss_dssp ECSSEEEEEEEEECCSCBHHHH-HHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCC
T ss_pred ccccCceEEEEEEeccCCchhh-hhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchh
Confidence 346899999997776654 344445789999999999999999999999999999999999999999999999999
Q ss_pred CCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcc
Q 012762 234 LSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDV 313 (457)
Q Consensus 234 ~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (457)
+++..... .
T Consensus 162 ~~~~~~~~-----------------------------------------------------------------------~ 170 (305)
T d1blxa_ 162 LARIYSFQ-----------------------------------------------------------------------M 170 (305)
T ss_dssp SCCCCCGG-----------------------------------------------------------------------G
T ss_pred hhhhhccc-----------------------------------------------------------------------c
Confidence 97543211 1
Q ss_pred ccccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCC---------------
Q 012762 314 RSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFP--------------- 378 (457)
Q Consensus 314 ~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~--------------- 378 (457)
.....+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..+.+..++.......
T Consensus 171 ~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 250 (305)
T d1blxa_ 171 ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAF 250 (305)
T ss_dssp GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGS
T ss_pred cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccccchhhhh
Confidence 11234799999999999999999999999999999999999999999888777777654321110
Q ss_pred ----------CCCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCCCCch
Q 012762 379 ----------KEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGVNWA 424 (457)
Q Consensus 379 ----------~~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~~~~~ 424 (457)
....+++.+++||.+||+.||++||| ++|+|+||||++++++
T Consensus 251 ~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~s----a~e~L~Hpff~~i~~~ 302 (305)
T d1blxa_ 251 HSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRIS----AYSALSHPYFQDLERC 302 (305)
T ss_dssp CCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCC----HHHHHTSGGGTTCCCC
T ss_pred ccccccchhhccccCCHHHHHHHHHHCcCChhHCcC----HHHHhcChhhcCchhh
Confidence 11346788999999999999999999 9999999999998764
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-55 Score=418.74 Aligned_cols=253 Identities=23% Similarity=0.311 Sum_probs=208.1
Q ss_pred ccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcC
Q 012762 79 LTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCP 158 (457)
Q Consensus 79 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~ 158 (457)
++.++|+++++||+|+||+||+|+++ ++..||||++++.. ...+.+.+|++++++++|||||++++++..+
T Consensus 2 idp~~~~~~~~iG~G~fg~Vy~~~~~-----~~~~vAvK~i~~~~----~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~ 72 (263)
T d1sm2a_ 2 IDPSELTFVQEIGSGQFGLVHLGYWL-----NKDKVAIKTIREGA----MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ 72 (263)
T ss_dssp BCCSCEEEEEEEECCSSCCEEEEEET-----TTEEEEEEECCSSS----SCHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CChHHcEEEEEEeeCCCeEEEEEEEC-----CCCEEEEEEECCCc----CcHHHHHHHHHHHHhcCCCCcccccceeccC
Confidence 35578999999999999999999975 56789999997643 2345688899999999999999999999999
Q ss_pred CcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCC
Q 012762 159 RWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKG 238 (457)
Q Consensus 159 ~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~ 238 (457)
+..|||||||++|+|.+++... ...+++..++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++..
T Consensus 73 ~~~~lv~E~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~ 151 (263)
T d1sm2a_ 73 APICLVFEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFV 151 (263)
T ss_dssp SSCEEEEECCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC-----
T ss_pred CceEEEEEecCCCcHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheec
Confidence 9999999999999999987664 366899999999999999999999999999999999999999999999999998655
Q ss_pred CCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccc
Q 012762 239 DNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSF 318 (457)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (457)
...... .....
T Consensus 152 ~~~~~~---------------------------------------------------------------------~~~~~ 162 (263)
T d1sm2a_ 152 LDDQYT---------------------------------------------------------------------SSTGT 162 (263)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred cCCCce---------------------------------------------------------------------eecce
Confidence 322111 01123
Q ss_pred cCCCCccCchhhcCCCCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhhh
Q 012762 319 VGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVK 397 (457)
Q Consensus 319 ~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~ 397 (457)
.||+.|||||++.+..|+.++|||||||++|||++ |.+||......+.+..+.. ..+.+.+..+++++.+||.+||+.
T Consensus 163 ~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~-~~~~~~p~~~~~~l~~li~~cl~~ 241 (263)
T d1sm2a_ 163 KFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST-GFRLYKPRLASTHVYQIMNHCWKE 241 (263)
T ss_dssp --CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHH-TCCCCCCTTSCHHHHHHHHHHTCS
T ss_pred ecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHh-cCCCCCccccCHHHHHHHHHHccC
Confidence 58999999999999999999999999999999999 5677776666666665544 344555566899999999999999
Q ss_pred CCCCCCCCCcChHHHhcC
Q 012762 398 DPTRRMGSKMGATAIKRH 415 (457)
Q Consensus 398 dP~~Rps~~~~~~~ll~h 415 (457)
||++||+ ++||++|
T Consensus 242 ~p~~Rps----~~~il~~ 255 (263)
T d1sm2a_ 242 RPEDRPA----FSRLLRQ 255 (263)
T ss_dssp SGGGSCC----HHHHHHH
T ss_pred CHhHCcC----HHHHHHH
Confidence 9999999 9999876
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-56 Score=422.85 Aligned_cols=262 Identities=21% Similarity=0.307 Sum_probs=213.4
Q ss_pred CceeE-EEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCcE
Q 012762 83 DLRFV-HRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRWS 161 (457)
Q Consensus 83 ~~~~~-~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~~ 161 (457)
.+.+. ++||+|+||+||+|.++.. ..++.||||+++... ......+++.+|+++|++++|||||++++++..+ ..
T Consensus 7 ~~~le~k~iG~G~fG~Vy~~~~~~~--~~~~~vAvK~~~~~~-~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~ 82 (277)
T d1xbba_ 7 LLTLEDKELGSGNFGTVKKGYYQMK--KVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SW 82 (277)
T ss_dssp GEEEEEEEEEECSSEEEEEEEEECS--SSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SE
T ss_pred hCeecCCCcccCCCeEEEEEEEccC--CcCeEEEEEEEChhh-CCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CE
Confidence 34444 4699999999999987632 356889999997543 2334457788999999999999999999999754 57
Q ss_pred EEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCC
Q 012762 162 CLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNS 241 (457)
Q Consensus 162 ~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~ 241 (457)
|||||||++|+|.+++... ..+++..+..++.||+.||+|||++|||||||||+||||+.++.+||+|||+++.....
T Consensus 83 ~lvmE~~~~g~L~~~l~~~--~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~ 160 (277)
T d1xbba_ 83 MLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD 160 (277)
T ss_dssp EEEEECCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTT
T ss_pred EEEEEcCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhcccc
Confidence 8999999999999998875 67999999999999999999999999999999999999999999999999998765422
Q ss_pred CcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCC
Q 012762 242 TSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGT 321 (457)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 321 (457)
..... ......||
T Consensus 161 ~~~~~-------------------------------------------------------------------~~~~~~gt 173 (277)
T d1xbba_ 161 ENYYK-------------------------------------------------------------------AQTHGKWP 173 (277)
T ss_dssp CSEEE-------------------------------------------------------------------C----CCC
T ss_pred ccccc-------------------------------------------------------------------cccccCCC
Confidence 11110 01123589
Q ss_pred CCccCchhhcCCCCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhhhCCC
Q 012762 322 HEYLAPEIISGEGHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDPT 400 (457)
Q Consensus 322 ~~y~aPE~l~~~~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~ 400 (457)
+.|||||++.+..++.++|||||||++|||++ |+.||.+....+....+.. ..+.+.+..+|+++.+||.+||+.||+
T Consensus 174 ~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~-~~~~~~p~~~~~~~~~li~~cl~~dp~ 252 (277)
T d1xbba_ 174 VKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK-GERMGCPAGCPREMYDLMNLCWTYDVE 252 (277)
T ss_dssp GGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT-TCCCCCCTTCCHHHHHHHHHHTCSSTT
T ss_pred ceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHc-CCCCCCCcccCHHHHHHHHHHcCCCHh
Confidence 99999999999999999999999999999997 9999999887766655544 345555567999999999999999999
Q ss_pred CCCCCCcChHHH---hcCCCCCCCC
Q 012762 401 RRMGSKMGATAI---KRHQFFNGVN 422 (457)
Q Consensus 401 ~Rps~~~~~~~l---l~hp~f~~~~ 422 (457)
+||+ +++| |+|+|++.++
T Consensus 253 ~RPs----~~~i~~~L~~~~~~~~~ 273 (277)
T d1xbba_ 253 NRPG----FAAVELRLRNYYYDVVN 273 (277)
T ss_dssp TSCC----HHHHHHHHHHHHHHHHH
T ss_pred HCcC----HHHHHHHhhCHHhhcCC
Confidence 9999 7777 5777765433
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-55 Score=420.92 Aligned_cols=263 Identities=22% Similarity=0.319 Sum_probs=217.3
Q ss_pred CCCCCccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEE
Q 012762 74 NNNNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYA 153 (457)
Q Consensus 74 ~~~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~ 153 (457)
...|+++.++|++.+.||+|+||+||+|+++ ++..||||+++... ...+.+.+|+++|++++|||||++++
T Consensus 9 ~~~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~-----~~~~vAiK~l~~~~----~~~~~~~~E~~~l~~l~h~nIv~~~g 79 (285)
T d1fmka3 9 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWN-----GTTRVAIKTLKPGT----MSPEAFLQEAQVMKKLRHEKLVQLYA 79 (285)
T ss_dssp TTCSBCCGGGEEEEEEEEECSSCEEEEEEET-----TTEEEEEEECCTTS----SCHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CcceEcCHHHEEEeeEEeeCCCeEEEEEEEC-----CCCEEEEEEECccc----CCHHHHHHHHHHHHhcccCCEeEEEE
Confidence 3567888999999999999999999999985 45679999997543 23466888999999999999999999
Q ss_pred EEEcCCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccC
Q 012762 154 TLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFD 233 (457)
Q Consensus 154 ~~~~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG 233 (457)
++.+ +.+++|||||++|+|..++.......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||
T Consensus 80 ~~~~-~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfG 158 (285)
T d1fmka3 80 VVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFG 158 (285)
T ss_dssp EECS-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCC
T ss_pred EEec-CCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccc
Confidence 9865 567899999999999888776545679999999999999999999999999999999999999999999999999
Q ss_pred CCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcc
Q 012762 234 LSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDV 313 (457)
Q Consensus 234 ~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (457)
+++........
T Consensus 159 la~~~~~~~~~--------------------------------------------------------------------- 169 (285)
T d1fmka3 159 LARLIEDNEYT--------------------------------------------------------------------- 169 (285)
T ss_dssp TTC-----------------------------------------------------------------------------
T ss_pred hhhhccCCCce---------------------------------------------------------------------
Confidence 98654321110
Q ss_pred ccccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCC-CCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHH
Q 012762 314 RSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGT-TPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIA 392 (457)
Q Consensus 314 ~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~-~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~ 392 (457)
......||+.|+|||++.+..++.++|||||||++|||++|. +||......+.+..+ ......+....++.++++||.
T Consensus 170 ~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i-~~~~~~~~~~~~~~~l~~li~ 248 (285)
T d1fmka3 170 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV-ERGYRMPCPPECPESLHDLMC 248 (285)
T ss_dssp ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH-HTTCCCCCCTTSCHHHHHHHH
T ss_pred eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHH-HhcCCCCCCcccCHHHHHHHH
Confidence 011235899999999999999999999999999999999965 455555555555444 445566667789999999999
Q ss_pred HHhhhCCCCCCCCCcChHHHhc--CCCCCC
Q 012762 393 QLLVKDPTRRMGSKMGATAIKR--HQFFNG 420 (457)
Q Consensus 393 ~~L~~dP~~Rps~~~~~~~ll~--hp~f~~ 420 (457)
+||+.||++||+ +++|++ ++||..
T Consensus 249 ~cl~~dP~~Rps----~~~i~~~L~~~~~~ 274 (285)
T d1fmka3 249 QCWRKEPEERPT----FEYLQAFLEDYFTS 274 (285)
T ss_dssp HHTCSSGGGSCC----HHHHHHHHHTTTSC
T ss_pred HHcccCHhHCcC----HHHHHHHHhhhhcC
Confidence 999999999999 999987 888875
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-55 Score=420.93 Aligned_cols=264 Identities=21% Similarity=0.294 Sum_probs=217.6
Q ss_pred CccCCCceeEE-EecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEE
Q 012762 78 PLTLSDLRFVH-RLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLD 156 (457)
Q Consensus 78 ~~~~~~~~~~~-~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~ 156 (457)
.+..++|.+.+ +||+|+||+||+|.++.. .++..||||++++.. .....+++.+|+++|++++|||||++++++.
T Consensus 4 ~l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~--~~~~~vAvK~l~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~ 79 (285)
T d1u59a_ 4 FLKRDNLLIADIELGCGNFGSVRQGVYRMR--KKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQ 79 (285)
T ss_dssp BCCGGGEEEEEEEEECCTTEEEEEEEEC-----CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred eecccCeEECCcEEecccCeEEEEEEEecC--CCcEEEEEEEEChhc--CHHHHHHHHHHHHHHHhCCCCCEeeEeeeec
Confidence 45667899988 499999999999987632 356689999997542 3345677889999999999999999999997
Q ss_pred cCCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCc
Q 012762 157 CPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSL 236 (457)
Q Consensus 157 ~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~ 236 (457)
. +.+|||||||++|+|.+++... ...+++..++.++.||+.||+|||++|||||||||+||||+.++.+||+|||+++
T Consensus 80 ~-~~~~lvmE~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~ 157 (285)
T d1u59a_ 80 A-EALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSK 157 (285)
T ss_dssp S-SSEEEEEECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCE
T ss_pred c-CeEEEEEEeCCCCcHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhh
Confidence 5 4689999999999999887543 3579999999999999999999999999999999999999999999999999987
Q ss_pred CCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccc
Q 012762 237 KGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSM 316 (457)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (457)
.......... ...
T Consensus 158 ~~~~~~~~~~-------------------------------------------------------------------~~~ 170 (285)
T d1u59a_ 158 ALGADDSYYT-------------------------------------------------------------------ARS 170 (285)
T ss_dssp ECTTCSCEEC-------------------------------------------------------------------CCC
T ss_pred cccccccccc-------------------------------------------------------------------ccc
Confidence 6543221110 011
Q ss_pred cccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHh
Q 012762 317 SFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLL 395 (457)
Q Consensus 317 ~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L 395 (457)
...||+.|||||++.+..++.++|||||||++|||++ |+.||.+....+....+.. ..+.+.+..+|+++.+||.+||
T Consensus 171 ~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~-~~~~~~p~~~~~~l~~li~~cl 249 (285)
T d1u59a_ 171 AGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ-GKRMECPPECPPELYALMSDCW 249 (285)
T ss_dssp SSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHT-TCCCCCCTTCCHHHHHHHHHTT
T ss_pred ccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHc-CCCCCCCCcCCHHHHHHHHHHc
Confidence 2358999999999999999999999999999999998 9999998887766665554 3445555679999999999999
Q ss_pred hhCCCCCCCCCcChHHH---hcCCCCC
Q 012762 396 VKDPTRRMGSKMGATAI---KRHQFFN 419 (457)
Q Consensus 396 ~~dP~~Rps~~~~~~~l---l~hp~f~ 419 (457)
+.||++||+ +.+| |+|+|+.
T Consensus 250 ~~~p~~RPs----~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 250 IYKWEDRPD----FLTVEQRMRACYYS 272 (285)
T ss_dssp CSSGGGSCC----HHHHHHHHHHHHHH
T ss_pred CCCHhHCcC----HHHHHHHHHHHHHH
Confidence 999999999 6655 6777763
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2.2e-55 Score=422.48 Aligned_cols=258 Identities=22% Similarity=0.342 Sum_probs=214.7
Q ss_pred CCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCc
Q 012762 81 LSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRW 160 (457)
Q Consensus 81 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~ 160 (457)
+++|+++++||+|+||+||+|+++ +|+.||||+++.... ......++.+|+++|++++|||||++++++..++.
T Consensus 1 ~~~Y~~~~~iG~G~fg~Vy~~~~~-----~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~ 74 (286)
T d1ob3a_ 1 MEKYHGLEKIGEGTYGVVYKAQNN-----YGETFALKKIRLEKE-DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKR 74 (286)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEET-----TSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSC
T ss_pred CCCceeccEEecCCCcEEEEEEeC-----CCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCc
Confidence 468999999999999999999874 678999999976543 33445778889999999999999999999999999
Q ss_pred EEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCC
Q 012762 161 SCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDN 240 (457)
Q Consensus 161 ~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~ 240 (457)
.|++||++.++.+..+... .+.+++..++.++.||+.||+|||+.|||||||||+|||++.++.+||+|||++.....
T Consensus 75 ~~i~~e~~~~~~~~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~ 152 (286)
T d1ob3a_ 75 LVLVFEHLDQDLKKLLDVC--EGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGI 152 (286)
T ss_dssp EEEEEECCSEEHHHHHHTS--TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC
T ss_pred eeEEEEeehhhhHHHHHhh--cCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceeccc
Confidence 9999999977766665544 37899999999999999999999999999999999999999999999999999765432
Q ss_pred CCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccC
Q 012762 241 STSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVG 320 (457)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 320 (457)
... .....+|
T Consensus 153 ~~~----------------------------------------------------------------------~~~~~~~ 162 (286)
T d1ob3a_ 153 PVR----------------------------------------------------------------------KYTHEIV 162 (286)
T ss_dssp -------------------------------------------------------------------------------C
T ss_pred Ccc----------------------------------------------------------------------ccceecc
Confidence 110 1113468
Q ss_pred CCCccCchhhcCCC-CCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCC---------------------
Q 012762 321 THEYLAPEIISGEG-HGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFP--------------------- 378 (457)
Q Consensus 321 t~~y~aPE~l~~~~-~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~--------------------- 378 (457)
++.|+|||.+.+.. ++.++|||||||++|||++|+.||.+....+.+.++........
T Consensus 163 ~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (286)
T d1ob3a_ 163 TLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYE 242 (286)
T ss_dssp CCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCC
T ss_pred cchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhccccccccc
Confidence 99999999997654 69999999999999999999999998887777666654222111
Q ss_pred ------CCCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCC
Q 012762 379 ------KEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNG 420 (457)
Q Consensus 379 ------~~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~ 420 (457)
....+++++++||.+||+.||++||| +.|||+||||+.
T Consensus 243 ~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s----~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 243 PLPWESFLKGLDESGIDLLSKMLKLDPNQRIT----AKQALEHAYFKE 286 (286)
T ss_dssp CCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCC----HHHHHTSGGGGC
T ss_pred CcchhhhcccCCHHHHHHHHHHccCChhHCcC----HHHHhcCcccCc
Confidence 01345778999999999999999999 999999999973
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-55 Score=414.03 Aligned_cols=252 Identities=21% Similarity=0.317 Sum_probs=219.0
Q ss_pred cCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCC
Q 012762 80 TLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPR 159 (457)
Q Consensus 80 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~ 159 (457)
+.++|+++++||+|+||+||+|+++ +++.||||++++... ..+.+.+|++++++++||||+++++++.+++
T Consensus 2 ~~~~~~~~~~iG~G~fg~Vy~~~~~-----~~~~vAvK~l~~~~~----~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~ 72 (258)
T d1k2pa_ 2 DPKDLTFLKELGTGQFGVVKYGKWR-----GQYDVAIKMIKEGSM----SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQR 72 (258)
T ss_dssp CCCCCCCCCCCCEETTEEEEEEEET-----TTEEEEEEEEESSSS----CHHHHHHHHHHHHTCCCTTBCCEEEEECCSS
T ss_pred ChHHCEEeEEEecCCCeEEEEEEEC-----CCCEEEEEEECcCcC----CHHHHHHHHHHHHhcCCCceeeEEEEEeeCC
Confidence 4578999999999999999999975 678899999986533 3456888999999999999999999999999
Q ss_pred cEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCC
Q 012762 160 WSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGD 239 (457)
Q Consensus 160 ~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~ 239 (457)
.+++||||+++|+|..++... ...+++..++.++.||++||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 73 ~~~iv~Ey~~~g~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~ 151 (258)
T d1k2pa_ 73 PIFIITEYMANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL 151 (258)
T ss_dssp SEEEEEECCTTEEHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCS
T ss_pred ceEEEEEccCCCcHHHhhhcc-ccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheecc
Confidence 999999999999998886554 3568999999999999999999999999999999999999999999999999986554
Q ss_pred CCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcccccccc
Q 012762 240 NSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFV 319 (457)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (457)
..... ......
T Consensus 152 ~~~~~---------------------------------------------------------------------~~~~~~ 162 (258)
T d1k2pa_ 152 DDEYT---------------------------------------------------------------------SSVGSK 162 (258)
T ss_dssp SSSCC---------------------------------------------------------------------CCCCSC
T ss_pred CCCce---------------------------------------------------------------------eecccC
Confidence 22111 011235
Q ss_pred CCCCccCchhhcCCCCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhhhC
Q 012762 320 GTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKD 398 (457)
Q Consensus 320 gt~~y~aPE~l~~~~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~d 398 (457)
||+.|+|||++.+..++.++|||||||++|||+| |+.||.+.+..+....+..+ .+.+.+..++..+.+||.+||+.|
T Consensus 163 ~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~-~~~~~p~~~~~~l~~li~~cl~~d 241 (258)
T d1k2pa_ 163 FPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG-LRLYRPHLASEKVYTIMYSCWHEK 241 (258)
T ss_dssp CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTT-CCCCCCTTCCHHHHHHHHHTTCSS
T ss_pred CCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhC-CCCCCcccccHHHHHHHHHHccCC
Confidence 8999999999999999999999999999999998 89999999888777766654 455566678999999999999999
Q ss_pred CCCCCCCCcChHHHhcC
Q 012762 399 PTRRMGSKMGATAIKRH 415 (457)
Q Consensus 399 P~~Rps~~~~~~~ll~h 415 (457)
|++||| +++|++|
T Consensus 242 P~~RPt----~~eil~~ 254 (258)
T d1k2pa_ 242 ADERPT----FKILLSN 254 (258)
T ss_dssp GGGSCC----HHHHHHH
T ss_pred HhHCcC----HHHHHHH
Confidence 999999 9999886
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=5.4e-55 Score=417.80 Aligned_cols=256 Identities=22% Similarity=0.333 Sum_probs=212.6
Q ss_pred CCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCC--
Q 012762 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPR-- 159 (457)
Q Consensus 82 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~-- 159 (457)
++|++.+.||+|+||+||+|+++ .+|+.||||++++..........++.+|+++|+.++|||||++++++...+
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~----~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~ 82 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDL----RLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPA 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEET----TTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSS
T ss_pred ceeEEeEEEeeCCCeEEEEEEEC----CCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCC
Confidence 57999999999999999999987 479999999998765555556678899999999999999999999997654
Q ss_pred --cEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcC
Q 012762 160 --WSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLK 237 (457)
Q Consensus 160 --~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~ 237 (457)
.+|||||||+|++|..++... +.+++.+++.++.||+.||+|||++|||||||||+|||++.++.++|+|||++..
T Consensus 83 ~~~~~lvmE~~~g~~L~~~~~~~--~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~ 160 (277)
T d1o6ya_ 83 GPLPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARA 160 (277)
T ss_dssp SEEEEEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEE
T ss_pred CceEEEEEECCCCCEehhhhccc--CCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhh
Confidence 379999999999999888765 6799999999999999999999999999999999999999999999999998754
Q ss_pred CCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcccccc
Q 012762 238 GDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMS 317 (457)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (457)
....... .....+
T Consensus 161 ~~~~~~~-------------------------------------------------------------------~~~~~~ 173 (277)
T d1o6ya_ 161 IADSGNS-------------------------------------------------------------------VTQTAA 173 (277)
T ss_dssp CC------------------------------------------------------------------------------
T ss_pred hcccccc-------------------------------------------------------------------cccccc
Confidence 4321110 111224
Q ss_pred ccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCC--CCCCCChHHHHHHHHHh
Q 012762 318 FVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFP--KEPSVPGPAKDLIAQLL 395 (457)
Q Consensus 318 ~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ll~~~L 395 (457)
.+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..+...+++......+ ....+|+++.+||.+||
T Consensus 174 ~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L 253 (277)
T d1o6ya_ 174 VIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKAL 253 (277)
T ss_dssp -----TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSCCHHHHHHHHHHT
T ss_pred ccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccCCCHHHHHHHHHHc
Confidence 5799999999999999999999999999999999999999999888887777777655443 23568999999999999
Q ss_pred hhCCCCCCCCCcChHHHh
Q 012762 396 VKDPTRRMGSKMGATAIK 413 (457)
Q Consensus 396 ~~dP~~Rps~~~~~~~ll 413 (457)
+.||++||+. +++++
T Consensus 254 ~~dp~~R~~s---a~~l~ 268 (277)
T d1o6ya_ 254 AKNPENRYQT---AAEMR 268 (277)
T ss_dssp CSSGGGSCSS---HHHHH
T ss_pred cCCHhHCHhH---HHHHH
Confidence 9999999952 55554
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-54 Score=414.01 Aligned_cols=262 Identities=20% Similarity=0.268 Sum_probs=210.8
Q ss_pred CccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEc
Q 012762 78 PLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDC 157 (457)
Q Consensus 78 ~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~ 157 (457)
++..+.|++.+.||+|+||+||+|.++.........||||++.... .......+.+|+++|++++|||||++++++..
T Consensus 3 ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~ 80 (283)
T d1mqba_ 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK 80 (283)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred cCCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc--ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEec
Confidence 4666789999999999999999999875444445689999996542 23345568889999999999999999999999
Q ss_pred CCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcC
Q 012762 158 PRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLK 237 (457)
Q Consensus 158 ~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~ 237 (457)
.+..++|||||.+++|..++... ...+++..+..++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++.
T Consensus 81 ~~~~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~ 159 (283)
T d1mqba_ 81 YKPMMIITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRV 159 (283)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred CCceEEEEEecccCcchhhhhcc-cccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhc
Confidence 99999999999999998877654 36799999999999999999999999999999999999999999999999999876
Q ss_pred CCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcccccc
Q 012762 238 GDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMS 317 (457)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (457)
........ .....
T Consensus 160 ~~~~~~~~-------------------------------------------------------------------~~~~~ 172 (283)
T d1mqba_ 160 LEDDPEAT-------------------------------------------------------------------YTTSG 172 (283)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred ccCCCccc-------------------------------------------------------------------eEecc
Confidence 54221100 00112
Q ss_pred ccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCC-CCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhh
Q 012762 318 FVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTP-FKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLV 396 (457)
Q Consensus 318 ~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~P-f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~ 396 (457)
..||+.|||||++.+..++.++|||||||++|||++|..| |.+....+.+ ..+....+.+.+..++..+.+||.+||+
T Consensus 173 ~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~-~~i~~~~~~~~~~~~~~~l~~li~~cl~ 251 (283)
T d1mqba_ 173 GKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVM-KAINDGFRLPTPMDCPSAIYQLMMQCWQ 251 (283)
T ss_dssp -CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH-HHHHTTCCCCCCTTCBHHHHHHHHHHTC
T ss_pred CCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHH-HHHhccCCCCCchhhHHHHHHHHHHHCc
Confidence 3589999999999999999999999999999999996554 5554544444 4455556667667799999999999999
Q ss_pred hCCCCCCCCCcChHHHhc
Q 012762 397 KDPTRRMGSKMGATAIKR 414 (457)
Q Consensus 397 ~dP~~Rps~~~~~~~ll~ 414 (457)
.||++||+ +.||++
T Consensus 252 ~~p~~RPt----~~eil~ 265 (283)
T d1mqba_ 252 QERARRPK----FADIVS 265 (283)
T ss_dssp SSTTTSCC----HHHHHH
T ss_pred CCHhHCcC----HHHHHH
Confidence 99999999 888866
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-54 Score=412.33 Aligned_cols=261 Identities=23% Similarity=0.367 Sum_probs=212.1
Q ss_pred CCCccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEE
Q 012762 76 NNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATL 155 (457)
Q Consensus 76 ~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~ 155 (457)
+|++..++|++.+.||+|+||+||+|++...+ ..+..||||+++.. ........+.+|+++|++++|||||++++++
T Consensus 1 ~~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~-~~~~~vaik~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~ 77 (273)
T d1mp8a_ 1 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPE-NPALAVAIKTCKNC--TSDSVREKFLQEALTMRQFDHPHIVKLIGVI 77 (273)
T ss_dssp CCBCCGGGEEEEEEEEECSSSEEEEEEECCC---CCEEEEEEECTTT--TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred CCCcCHHHeEEEEEEeeCCCcEEEEEEEecCC-ceeEEEEEEEeccc--cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 36678889999999999999999999876422 24567899988543 3344567788999999999999999999999
Q ss_pred EcCCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCC
Q 012762 156 DCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235 (457)
Q Consensus 156 ~~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s 235 (457)
. ++.+|||||||++|+|..++... ...+++..++.++.||+.||.|||++|||||||||+||+++.++.+||+|||++
T Consensus 78 ~-~~~~~iv~E~~~~g~l~~~~~~~-~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a 155 (273)
T d1mp8a_ 78 T-ENPVWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLS 155 (273)
T ss_dssp C-SSSCEEEEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC----
T ss_pred e-cCeEEEEEEeccCCcHHhhhhcc-CCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhh
Confidence 6 46789999999999998877654 367999999999999999999999999999999999999999999999999998
Q ss_pred cCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcccc
Q 012762 236 LKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRS 315 (457)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (457)
+........ ..
T Consensus 156 ~~~~~~~~~---------------------------------------------------------------------~~ 166 (273)
T d1mp8a_ 156 RYMEDSTYY---------------------------------------------------------------------KA 166 (273)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred eeccCCcce---------------------------------------------------------------------ec
Confidence 765422111 01
Q ss_pred ccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHH
Q 012762 316 MSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQL 394 (457)
Q Consensus 316 ~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~ 394 (457)
....||+.|+|||++.+..|+.++|||||||++|||++ |.+||.+....+....+..+ ...+.+..+++++.+||.+|
T Consensus 167 ~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~~li~~c 245 (273)
T d1mp8a_ 167 SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG-ERLPMPPNCPPTLYSLMTKC 245 (273)
T ss_dssp ----CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT-CCCCCCTTCCHHHHHHHHHH
T ss_pred cceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcC-CCCCCCCCCCHHHHHHHHHH
Confidence 12358999999999999999999999999999999997 89999998887777776654 34455667999999999999
Q ss_pred hhhCCCCCCCCCcChHHHhcC
Q 012762 395 LVKDPTRRMGSKMGATAIKRH 415 (457)
Q Consensus 395 L~~dP~~Rps~~~~~~~ll~h 415 (457)
|+.||++||| +.||++|
T Consensus 246 l~~dp~~Rps----~~ei~~~ 262 (273)
T d1mp8a_ 246 WAYDPSRRPR----FTELKAQ 262 (273)
T ss_dssp TCSSGGGSCC----HHHHHHH
T ss_pred cCCCHhHCcC----HHHHHHH
Confidence 9999999999 9999876
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-54 Score=425.54 Aligned_cols=258 Identities=28% Similarity=0.376 Sum_probs=211.4
Q ss_pred CCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCC-
Q 012762 81 LSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPR- 159 (457)
Q Consensus 81 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~- 159 (457)
.++|+++++||+|+||+||+|+++ .+|+.||||++++.. ......+.+.+|+++|+.++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~----~~~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~ 91 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDG----RTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDET 91 (346)
T ss_dssp BSSEEEEEEC------CEEEEEET----TTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSS
T ss_pred CCcEEEEEEEecCCCeEEEEEEEC----CCCCEEEEEEEchhh-cChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcc
Confidence 468999999999999999999987 478999999997643 23445677889999999999999999999997655
Q ss_pred -----cEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCC
Q 012762 160 -----WSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDL 234 (457)
Q Consensus 160 -----~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~ 234 (457)
++||||||| +.+|..+.+. ..+++..++.++.||+.||.|||++|||||||||+|||++.++.+|++|||+
T Consensus 92 ~~~~~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~ 167 (346)
T d1cm8a_ 92 LDDFTDFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGL 167 (346)
T ss_dssp TTTCCCCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred ccccceEEEEEecc-cccHHHHHHh---ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccc
Confidence 579999999 7888887766 5799999999999999999999999999999999999999999999999999
Q ss_pred CcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccc
Q 012762 235 SLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVR 314 (457)
Q Consensus 235 s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (457)
++.....
T Consensus 168 a~~~~~~------------------------------------------------------------------------- 174 (346)
T d1cm8a_ 168 ARQADSE------------------------------------------------------------------------- 174 (346)
T ss_dssp CEECCSS-------------------------------------------------------------------------
T ss_pred eeccCCc-------------------------------------------------------------------------
Confidence 8654321
Q ss_pred cccccCCCCccCchhhcCC-CCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCC---------------
Q 012762 315 SMSFVGTHEYLAPEIISGE-GHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFP--------------- 378 (457)
Q Consensus 315 ~~~~~gt~~y~aPE~l~~~-~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~--------------- 378 (457)
....+||+.|+|||++.+. .++.++|||||||++|||++|++||.+.+....+..+.......+
T Consensus 175 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (346)
T d1cm8a_ 175 MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNY 254 (346)
T ss_dssp CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHH
T ss_pred cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhhhhh
Confidence 1134699999999999875 468999999999999999999999998876665555443222111
Q ss_pred --------------CCCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCCCCch
Q 012762 379 --------------KEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGVNWA 424 (457)
Q Consensus 379 --------------~~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~~~~~ 424 (457)
....+++++++||.+||..||.+||| ++|||+||||+.+.+.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~t----a~eiL~Hp~f~~~~~~ 310 (346)
T d1cm8a_ 255 MKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVT----AGEALAHPYFESLHDT 310 (346)
T ss_dssp HHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCC----HHHHHHSGGGTTTC--
T ss_pred hccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcC----HHHHhcChhhCcCCCc
Confidence 11346789999999999999999999 9999999999987654
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-54 Score=411.73 Aligned_cols=262 Identities=22% Similarity=0.319 Sum_probs=213.8
Q ss_pred ccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcC
Q 012762 79 LTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCP 158 (457)
Q Consensus 79 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~ 158 (457)
+..+||++++.||+|+||+||+|++.... .....||||++++.........+.+.+|+++|++++|||||++++++.+
T Consensus 5 i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~-~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~- 82 (273)
T d1u46a_ 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPS-GKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT- 82 (273)
T ss_dssp CCGGGEEEEEECC----CCCEEEEEECTT-SCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred EchHHeEEEEEEecCCCeEEEEEEEECCC-CcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-
Confidence 45578999999999999999999876422 2455799999987766556666788999999999999999999999976
Q ss_pred CcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCC
Q 012762 159 RWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKG 238 (457)
Q Consensus 159 ~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~ 238 (457)
+..++|||||++|+|.+.+... .+.+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++..
T Consensus 83 ~~~~lv~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~ 161 (273)
T d1u46a_ 83 PPMKMVTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRAL 161 (273)
T ss_dssp SSCEEEEECCTTCBHHHHHHHH-GGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred cchheeeeeecCcchhhhhhcc-cCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhc
Confidence 4678999999999998776653 256999999999999999999999999999999999999999999999999998765
Q ss_pred CCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccc
Q 012762 239 DNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSF 318 (457)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (457)
........ .....
T Consensus 162 ~~~~~~~~-------------------------------------------------------------------~~~~~ 174 (273)
T d1u46a_ 162 PQNDDHYV-------------------------------------------------------------------MQEHR 174 (273)
T ss_dssp CC-CCEEE-------------------------------------------------------------------C----
T ss_pred ccCCCcce-------------------------------------------------------------------ecCcc
Confidence 43221110 11123
Q ss_pred cCCCCccCchhhcCCCCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhhh
Q 012762 319 VGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVK 397 (457)
Q Consensus 319 ~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~ 397 (457)
.|+..|+|||++.+..++.++|||||||++|||++ |..||.+.+..+...++......++....+++++.+||.+||..
T Consensus 175 ~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~ 254 (273)
T d1u46a_ 175 KVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAH 254 (273)
T ss_dssp -CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred ccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCcccccHHHHHHHHHHcCC
Confidence 58889999999999999999999999999999998 89999999988888888888877777778999999999999999
Q ss_pred CCCCCCCCCcChHHHhc
Q 012762 398 DPTRRMGSKMGATAIKR 414 (457)
Q Consensus 398 dP~~Rps~~~~~~~ll~ 414 (457)
||++||| +.+|++
T Consensus 255 dp~~RPt----~~ei~~ 267 (273)
T d1u46a_ 255 KPEDRPT----FVALRD 267 (273)
T ss_dssp SGGGSCC----HHHHHH
T ss_pred ChhHCcC----HHHHHH
Confidence 9999999 888864
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-54 Score=414.26 Aligned_cols=265 Identities=18% Similarity=0.267 Sum_probs=212.2
Q ss_pred CCccCCCceeEEEecccCcceEEEEEEeccC-CCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHc-CCCCCceEEEE
Q 012762 77 NPLTLSDLRFVHRLGSGDIGSVYLVQLKSKS-SNNGCFFAAKVMDKRELVSRNKESRARIEREILEML-DHPFLPTLYAT 154 (457)
Q Consensus 77 ~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~-~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~~~ 154 (457)
|++..++|++.++||+|+||+||+|+++... ..+++.||||+++... .......+..|.+++.++ +|+||+.++++
T Consensus 8 wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~ 85 (299)
T d1ywna1 8 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGA 85 (299)
T ss_dssp HBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC------CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--CcHHHHHHHHHHHHHHhhcCCCeEEEeeee
Confidence 4577789999999999999999999987542 3456789999997543 233455677788887776 68999999998
Q ss_pred EEcC-CcEEEEEeecCCCChHHHHHhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCe
Q 012762 155 LDCP-RWSCLLTEFCPGGDLHVLRQRQP--------------DKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENV 219 (457)
Q Consensus 155 ~~~~-~~~~lV~E~~~~~sL~~~~~~~~--------------~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NI 219 (457)
+... ..+|+|||||++|+|.+++.... ...+++..++.++.||+.||.|||++|||||||||+||
T Consensus 86 ~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NI 165 (299)
T d1ywna1 86 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI 165 (299)
T ss_dssp ECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred eccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccce
Confidence 8654 46899999999999999987642 23589999999999999999999999999999999999
Q ss_pred EEccCCCEEEeccCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCC
Q 012762 220 LVRSDGHIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLG 299 (457)
Q Consensus 220 ll~~~~~vkl~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (457)
||+.++.+||+|||+++........
T Consensus 166 Ll~~~~~~Kl~DFGla~~~~~~~~~------------------------------------------------------- 190 (299)
T d1ywna1 166 LLSEKNVVKICDFGLARDIYKDPDY------------------------------------------------------- 190 (299)
T ss_dssp EECGGGCEEECC------CCSCTTS-------------------------------------------------------
T ss_pred eECCCCcEEEccCcchhhccccccc-------------------------------------------------------
Confidence 9999999999999998754322110
Q ss_pred CCCCCcccccCCccccccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcC-CCCCCCCChHHHHHHHHhcccCCC
Q 012762 300 NPGTPEIVAEPLDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYG-TTPFKGIDHELTLANVVARALEFP 378 (457)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG-~~Pf~~~~~~~~~~~~~~~~~~~~ 378 (457)
......+||+.|||||++.+..++.++|||||||++|||++| .+||.+......+..++.....++
T Consensus 191 -------------~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~ 257 (299)
T d1ywna1 191 -------------VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR 257 (299)
T ss_dssp -------------CCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCCCC
T ss_pred -------------cccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCC
Confidence 011234699999999999999999999999999999999986 578888776666666666666666
Q ss_pred CCCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcC
Q 012762 379 KEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRH 415 (457)
Q Consensus 379 ~~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~h 415 (457)
.+..+++++++||.+||+.||++||| ++||++|
T Consensus 258 ~~~~~~~~l~~li~~cl~~dP~~Rpt----~~eil~~ 290 (299)
T d1ywna1 258 APDYTTPEMYQTMLDCWHGEPSQRPT----FSELVEH 290 (299)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred CCccCCHHHHHHHHHHcCCChhHCcC----HHHHHHH
Confidence 66679999999999999999999999 9999987
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-54 Score=417.22 Aligned_cols=264 Identities=25% Similarity=0.332 Sum_probs=211.1
Q ss_pred cCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEc--
Q 012762 80 TLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDC-- 157 (457)
Q Consensus 80 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~-- 157 (457)
.+++|+++++||+|+||+||+|+++ .+|+.||||++.+... .+....++.+|+++|++++||||+++++++..
T Consensus 8 ~~~rY~i~~~LG~G~fg~Vy~a~~~----~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~ 82 (318)
T d3blha1 8 EVSKYEKLAKIGQGTFGEVFKARHR----KTGQKVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKA 82 (318)
T ss_dssp BGGGEEEEEEEEECSSSEEEEEEET----TTCCEEEEEEC----C-TTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--
T ss_pred ccCCEEEEEEEecCcCeEEEEEEEC----CCCCEEEEEEEehhhc-chHHHHHHHHHHHHHHHhcCCCccceEeeeeccc
Confidence 3579999999999999999999986 4789999999976543 23445667889999999999999999998855
Q ss_pred ------CCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEec
Q 012762 158 ------PRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTD 231 (457)
Q Consensus 158 ------~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~D 231 (457)
++.+|+|||||.++.+..+. .....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|
T Consensus 83 ~~~~~~~~~~~iv~e~~~~~~~~~~~--~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~d 160 (318)
T d3blha1 83 SPYNRCKGSIYLVFDFCEHDLAGLLS--NVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLAD 160 (318)
T ss_dssp --------CEEEEEECCCEEHHHHHT--CTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECC
T ss_pred ccccccCceEEEEEeccCCCccchhh--hcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeee
Confidence 34689999999766665433 2346799999999999999999999999999999999999999999999999
Q ss_pred cCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCC
Q 012762 232 FDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPL 311 (457)
Q Consensus 232 FG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (457)
||+++.........
T Consensus 161 fg~~~~~~~~~~~~------------------------------------------------------------------ 174 (318)
T d3blha1 161 FGLARAFSLAKNSQ------------------------------------------------------------------ 174 (318)
T ss_dssp CTTCEECCC-----------------------------------------------------------------------
T ss_pred cceeeecccccccc------------------------------------------------------------------
Confidence 99986554221110
Q ss_pred ccccccccCCCCccCchhhcCC-CCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCCCC---------
Q 012762 312 DVRSMSFVGTHEYLAPEIISGE-GHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPKEP--------- 381 (457)
Q Consensus 312 ~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~--------- 381 (457)
.....+.+||+.|+|||++.+. .|+.++|||||||++|||++|+.||.+.........+......++...
T Consensus 175 ~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 254 (318)
T d3blha1 175 PNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYEL 254 (318)
T ss_dssp CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTCCCC--
T ss_pred cccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhccccchhhh
Confidence 0011234799999999999876 589999999999999999999999998887776666655433322210
Q ss_pred ---------------------CCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCC
Q 012762 382 ---------------------SVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNG 420 (457)
Q Consensus 382 ---------------------~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~ 420 (457)
..++++++||.+||+.||++||| ++|+|+||||+.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~s----a~elL~Hpff~~ 310 (318)
T d3blha1 255 YEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRID----SDDALNHDFFWS 310 (318)
T ss_dssp -----CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCC----HHHHHHSGGGSS
T ss_pred hhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcC----HHHHHcChhhcc
Confidence 02456789999999999999999 999999999985
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=7.9e-54 Score=419.62 Aligned_cols=255 Identities=24% Similarity=0.376 Sum_probs=208.4
Q ss_pred cCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcC-CCCCceEEEEEEc-
Q 012762 80 TLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLD-HPFLPTLYATLDC- 157 (457)
Q Consensus 80 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~-H~nIv~l~~~~~~- 157 (457)
..++|+++++||+|+||+||+|+++ .+|+.||||++++. ...++.+|+++|+.+. ||||++++++|..
T Consensus 33 ~~d~y~i~~~LG~G~fg~V~~a~~~----~~~~~vAiK~i~~~------~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~ 102 (328)
T d3bqca1 33 NQDDYQLVRKLGRGKYSEVFEAINI----TNNEKVVVKILKPV------KKKKIKREIKILENLRGGPNIITLADIVKDP 102 (328)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET----TTTEEEEEEEECSS------CHHHHHHHHHHHHHHTTSTTBCCEEEEEECT
T ss_pred CCcCeEEEEEEecCcCeEEEEEEEC----CCCCEEEEEEECHH------HHHHHHHHHHHHHhccCCCCCcEEEEEEEec
Confidence 3468999999999999999999986 48899999999753 3456788999999995 9999999999974
Q ss_pred -CCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCC-CEEEeccCCC
Q 012762 158 -PRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDG-HIMLTDFDLS 235 (457)
Q Consensus 158 -~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~-~vkl~DFG~s 235 (457)
...+|+|||||.+++|..+. +.+++..++.++.||+.||.|||++|||||||||+||||+.++ .+||+|||++
T Consensus 103 ~~~~~~~v~e~~~~~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a 177 (328)
T d3bqca1 103 VSRTPALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA 177 (328)
T ss_dssp TTCSEEEEEECCCSCBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGC
T ss_pred CCCceeEEEeecCCCcHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccc
Confidence 45799999999999997642 4699999999999999999999999999999999999998765 6899999998
Q ss_pred cCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcccc
Q 012762 236 LKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRS 315 (457)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (457)
+....... .
T Consensus 178 ~~~~~~~~-----------------------------------------------------------------------~ 186 (328)
T d3bqca1 178 EFYHPGQE-----------------------------------------------------------------------Y 186 (328)
T ss_dssp EECCTTCC-----------------------------------------------------------------------C
T ss_pred eeccCCCc-----------------------------------------------------------------------c
Confidence 65432111 1
Q ss_pred ccccCCCCccCchhhcCCC-CCccchhhhhhHHHHHHhcCCCCCCCCChHH-HHHHHHhc-------------c------
Q 012762 316 MSFVGTHEYLAPEIISGEG-HGNAVDWWTLGIFIFELFYGTTPFKGIDHEL-TLANVVAR-------------A------ 374 (457)
Q Consensus 316 ~~~~gt~~y~aPE~l~~~~-~~~~sDiwSlG~il~elltG~~Pf~~~~~~~-~~~~~~~~-------------~------ 374 (457)
...+||+.|+|||.+.+.. ++.++||||+||++|||++|..||....... ....+... .
T Consensus 187 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~ 266 (328)
T d3bqca1 187 NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPR 266 (328)
T ss_dssp CSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGG
T ss_pred cccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCcc
Confidence 1346999999999988764 7999999999999999999999997654332 21111110 0
Q ss_pred ----------------cCCCCCCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCCCCch
Q 012762 375 ----------------LEFPKEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGVNWA 424 (457)
Q Consensus 375 ----------------~~~~~~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~~~~~ 424 (457)
........+++++++||.+||..||++||| ++|+|+||||+++.|.
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~t----a~e~L~Hp~F~~v~~~ 328 (328)
T d3bqca1 267 FNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLT----AREAMEHPYFYTVVKD 328 (328)
T ss_dssp GGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCC----HHHHHTSGGGTTSCCC
T ss_pred cchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcC----HHHHhcCcccCCCCCC
Confidence 000111236788999999999999999999 9999999999999984
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-53 Score=421.89 Aligned_cols=254 Identities=26% Similarity=0.415 Sum_probs=207.7
Q ss_pred CceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEc-----
Q 012762 83 DLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDC----- 157 (457)
Q Consensus 83 ~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~----- 157 (457)
+|+.+++||+|+||+||+|+++ .+|+.||||++.+... ...+|+++|++++|+||++++++|..
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~----~~~~~vAiK~i~~~~~-------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~ 89 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLC----DSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKK 89 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEET----TTCCEEEEEEEECCSS-------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CC
T ss_pred CcEeeeEEeeCcCeEEEEEEEC----CCCCEEEEEEECccch-------HHHHHHHHHHhcCCCCCCcEEEEEEecCccC
Confidence 6999999999999999999987 4789999999976432 22369999999999999999999853
Q ss_pred -CCcEEEEEeecCCCChHHHHHh-CCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCC-CEEEeccCC
Q 012762 158 -PRWSCLLTEFCPGGDLHVLRQR-QPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDG-HIMLTDFDL 234 (457)
Q Consensus 158 -~~~~~lV~E~~~~~sL~~~~~~-~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~-~vkl~DFG~ 234 (457)
..++|||||||+++.+..+... .....+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+
T Consensus 90 ~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~ 169 (350)
T d1q5ka_ 90 DEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGS 169 (350)
T ss_dssp SCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTT
T ss_pred CceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccc
Confidence 3357999999976654444332 2346799999999999999999999999999999999999999875 899999999
Q ss_pred CcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccc
Q 012762 235 SLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVR 314 (457)
Q Consensus 235 s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (457)
++...... .
T Consensus 170 a~~~~~~~-----------------------------------------------------------------------~ 178 (350)
T d1q5ka_ 170 AKQLVRGE-----------------------------------------------------------------------P 178 (350)
T ss_dssp CEECCTTS-----------------------------------------------------------------------C
T ss_pred hhhccCCc-----------------------------------------------------------------------c
Confidence 86543211 1
Q ss_pred cccccCCCCccCchhhcCC-CCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcc-----------------cC
Q 012762 315 SMSFVGTHEYLAPEIISGE-GHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARA-----------------LE 376 (457)
Q Consensus 315 ~~~~~gt~~y~aPE~l~~~-~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~-----------------~~ 376 (457)
..+.+||+.|+|||.+.+. .|+.++|||||||++|||++|+.||......+.+..++... ..
T Consensus 179 ~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~ 258 (350)
T d1q5ka_ 179 NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 258 (350)
T ss_dssp CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---CCC
T ss_pred cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchhhcc
Confidence 1134699999999998764 68999999999999999999999999888777666655321 11
Q ss_pred CC----------CCCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCCCC
Q 012762 377 FP----------KEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGVN 422 (457)
Q Consensus 377 ~~----------~~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~~~ 422 (457)
++ ....+++++.+||.+||..||++||| +.|+|+||||+.+.
T Consensus 259 ~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t----a~e~L~Hp~f~~~~ 310 (350)
T d1q5ka_ 259 FPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLT----PLEACAHSFFDELR 310 (350)
T ss_dssp CCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCC----HHHHHTSGGGGGGG
T ss_pred ccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcC----HHHHhcCHhhcccc
Confidence 11 12346789999999999999999999 99999999998653
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-53 Score=412.61 Aligned_cols=259 Identities=19% Similarity=0.249 Sum_probs=211.4
Q ss_pred cCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCC
Q 012762 80 TLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPR 159 (457)
Q Consensus 80 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~ 159 (457)
..++|+++++||+|+||+||+|.++.........||+|.++.. ......+++.+|+++|++++|||||++++++.++
T Consensus 7 k~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~- 83 (317)
T d1xkka_ 7 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS- 83 (317)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-
T ss_pred CHHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccc--cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-
Confidence 4468999999999999999999987533333456888888643 2334567788999999999999999999999865
Q ss_pred cEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCC
Q 012762 160 WSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGD 239 (457)
Q Consensus 160 ~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~ 239 (457)
..+++|||+.+++|..++... ...+++..++.++.||+.||.|||++|||||||||+||||+.++.+||+|||+++...
T Consensus 84 ~~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~ 162 (317)
T d1xkka_ 84 TVQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 162 (317)
T ss_dssp SEEEEEECCTTCBHHHHHHHT-SSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred CeeEEEEeccCCccccccccc-ccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceecc
Confidence 567888999999998877664 4679999999999999999999999999999999999999999999999999987653
Q ss_pred CCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcccccccc
Q 012762 240 NSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFV 319 (457)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (457)
...... ......
T Consensus 163 ~~~~~~--------------------------------------------------------------------~~~~~~ 174 (317)
T d1xkka_ 163 AEEKEY--------------------------------------------------------------------HAEGGK 174 (317)
T ss_dssp TTCC----------------------------------------------------------------------------
T ss_pred cccccc--------------------------------------------------------------------cccccc
Confidence 211100 011235
Q ss_pred CCCCccCchhhcCCCCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHHHhhhC
Q 012762 320 GTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQLLVKD 398 (457)
Q Consensus 320 gt~~y~aPE~l~~~~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~d 398 (457)
||+.|||||++.+..|+.++|||||||++|||+| |.+||.+.+..+.... +....+.+.+..+++++.+||.+||+.|
T Consensus 175 gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~-i~~~~~~~~p~~~~~~~~~li~~cl~~d 253 (317)
T d1xkka_ 175 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI-LEKGERLPQPPICTIDVYMIMVKCWMID 253 (317)
T ss_dssp CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHH-HHHTCCCCCCTTBCHHHHHHHHHHTCSS
T ss_pred cCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHH-HHcCCCCCCCcccCHHHHHHHHHhCCCC
Confidence 8999999999999999999999999999999998 8999988776665544 4444556666679999999999999999
Q ss_pred CCCCCCCCcChHHHhcC
Q 012762 399 PTRRMGSKMGATAIKRH 415 (457)
Q Consensus 399 P~~Rps~~~~~~~ll~h 415 (457)
|++||+ +.||++|
T Consensus 254 P~~RPs----~~eil~~ 266 (317)
T d1xkka_ 254 ADSRPK----FRELIIE 266 (317)
T ss_dssp GGGSCC----HHHHHHH
T ss_pred hhhCcC----HHHHHHH
Confidence 999999 9999887
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-54 Score=405.75 Aligned_cols=251 Identities=20% Similarity=0.330 Sum_probs=210.0
Q ss_pred CCCccCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEE
Q 012762 76 NNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATL 155 (457)
Q Consensus 76 ~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~ 155 (457)
.|.+..++|+++++||+|+||+||+|.+ .|..||||++++. ...+.+.+|+++|++++||||+++++++
T Consensus 1 ~w~i~~~~~~~~~~lG~G~fg~Vy~~~~------~~~~vAvK~i~~~-----~~~~~~~~E~~~l~~l~HpnIv~~~g~~ 69 (262)
T d1byga_ 1 GWALNMKELKLLQTIGKGEFGDVMLGDY------RGNKVAVKCIKND-----ATAQAFLAEASVMTQLRHSNLVQLLGVI 69 (262)
T ss_dssp CCBCCGGGEEEEEEEEECSSCEEEEEEE------TTEEEEEEECCCC-----C--HHHHHTHHHHTTCCCTTBCCEEEEE
T ss_pred CCccCHHHeEEeEEEecCCCeEEEEEEE------CCeEEEEEEECcH-----HHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 3778899999999999999999999986 3668999999653 3446688999999999999999999998
Q ss_pred Ec-CCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCC
Q 012762 156 DC-PRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDL 234 (457)
Q Consensus 156 ~~-~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~ 234 (457)
.+ .+.+||||||+++|+|.+++.......+++..++.++.||+.||.|||+.+|+||||||+|||++.+|.+||+|||+
T Consensus 70 ~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~ 149 (262)
T d1byga_ 70 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGL 149 (262)
T ss_dssp CCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC
T ss_pred EecCCcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeeccccc
Confidence 54 46689999999999999998764334689999999999999999999999999999999999999999999999999
Q ss_pred CcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccc
Q 012762 235 SLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVR 314 (457)
Q Consensus 235 s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (457)
++.......
T Consensus 150 s~~~~~~~~----------------------------------------------------------------------- 158 (262)
T d1byga_ 150 TKEASSTQD----------------------------------------------------------------------- 158 (262)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred ceecCCCCc-----------------------------------------------------------------------
Confidence 865432111
Q ss_pred cccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHHhcccCCCCCCCCChHHHHHHHH
Q 012762 315 SMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVVARALEFPKEPSVPGPAKDLIAQ 393 (457)
Q Consensus 315 ~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~ 393 (457)
...+|..|+|||++.+..++.++|||||||++|||++ |++||......+....+.. ..+.+....+++.+.+||.+
T Consensus 159 --~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~-~~~~~~~~~~~~~~~~li~~ 235 (262)
T d1byga_ 159 --TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK-GYKMDAPDGCPPAVYEVMKN 235 (262)
T ss_dssp -----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTT-TCCCCCCTTCCHHHHHHHHH
T ss_pred --cccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHc-CCCCCCCccCCHHHHHHHHH
Confidence 2248899999999999999999999999999999998 7999988877777766554 34555556789999999999
Q ss_pred HhhhCCCCCCCCCcChHHHhcC
Q 012762 394 LLVKDPTRRMGSKMGATAIKRH 415 (457)
Q Consensus 394 ~L~~dP~~Rps~~~~~~~ll~h 415 (457)
||..||.+||| +.+|+++
T Consensus 236 cl~~dP~~Rps----~~~l~~~ 253 (262)
T d1byga_ 236 CWHLDAAMRPS----FLQLREQ 253 (262)
T ss_dssp HTCSSGGGSCC----HHHHHHH
T ss_pred HcccCHhHCcC----HHHHHHH
Confidence 99999999999 8888764
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-53 Score=406.00 Aligned_cols=259 Identities=21% Similarity=0.326 Sum_probs=215.1
Q ss_pred CCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCCc
Q 012762 81 LSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPRW 160 (457)
Q Consensus 81 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~~ 160 (457)
+++|+++++||+|+||+||+|+++ .+++.||||+++... .......++.+|+++|+.++||||+++++++.+...
T Consensus 1 ~~ry~~i~~LG~G~fg~V~~~~~~----~~~~~vAvK~i~~~~-~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~ 75 (292)
T d1unla_ 1 MQKYEKLEKIGEGTYGTVFKAKNR----ETHEIVALKRVRLDD-DDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKK 75 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEET----TTCCEEEEEEEESSC-SSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred CCCCEeeeEEecCcCeEEEEEEEC----CCCcEEEEEEEehhh-CChHHHHHHHHHHHHHHhcCcCCEEeeccccccccc
Confidence 368999999999999999999987 488999999997654 234556788899999999999999999999999999
Q ss_pred EEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCC
Q 012762 161 SCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDN 240 (457)
Q Consensus 161 ~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~ 240 (457)
.++|||++.+++|..++... +.+++..++.++.|++.||+|||++|||||||||+|||++.++.+||+|||.++....
T Consensus 76 ~~iv~~~~~~~~l~~~~~~~--~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~ 153 (292)
T d1unla_ 76 LTLVFEFCDQDLKKYFDSCN--GDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGI 153 (292)
T ss_dssp EEEEEECCSEEHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred eeEEeeeccccccccccccc--cccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccC
Confidence 99999999999998877654 7799999999999999999999999999999999999999999999999999865542
Q ss_pred CCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccC
Q 012762 241 STSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVG 320 (457)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 320 (457)
.... .....+
T Consensus 154 ~~~~----------------------------------------------------------------------~~~~~~ 163 (292)
T d1unla_ 154 PVRC----------------------------------------------------------------------YSAEVV 163 (292)
T ss_dssp CCSC----------------------------------------------------------------------CCSCCS
T ss_pred CCcc----------------------------------------------------------------------ceeecc
Confidence 2111 012247
Q ss_pred CCCccCchhhcCCC-CCccchhhhhhHHHHHHhcCCCCCCCCCh-HHHHHHHHhcccCCC--------------------
Q 012762 321 THEYLAPEIISGEG-HGNAVDWWTLGIFIFELFYGTTPFKGIDH-ELTLANVVARALEFP-------------------- 378 (457)
Q Consensus 321 t~~y~aPE~l~~~~-~~~~sDiwSlG~il~elltG~~Pf~~~~~-~~~~~~~~~~~~~~~-------------------- 378 (457)
++.|+|||++.+.. ++.++|||||||++|||++|+.||....+ .+.+..+........
T Consensus 164 ~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (292)
T d1unla_ 164 TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYP 243 (292)
T ss_dssp CGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCC
T ss_pred ccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccccccccccc
Confidence 88999999998765 69999999999999999999998655443 333433332111110
Q ss_pred -------CCCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCC
Q 012762 379 -------KEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNG 420 (457)
Q Consensus 379 -------~~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~ 420 (457)
....++..+.+||.+||+.||.+||| ++|||+||||+.
T Consensus 244 ~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~s----a~e~L~Hp~f~~ 288 (292)
T d1unla_ 244 ATTSLVNVVPKLNATGRDLLQNLLKCNPVQRIS----AEEALQHPYFSD 288 (292)
T ss_dssp TTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCC----HHHHTTSGGGSS
T ss_pred ccchhhhccccCCHHHHHHHHHHccCChhHCcC----HHHHhcChhhcC
Confidence 11345678999999999999999999 999999999985
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-53 Score=414.77 Aligned_cols=259 Identities=22% Similarity=0.348 Sum_probs=207.7
Q ss_pred CCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcCC--
Q 012762 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCPR-- 159 (457)
Q Consensus 82 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~~-- 159 (457)
++|+++++||+|+||+||+|+++ .+|+.||||++.+.. .....+++.+|+++|++|+||||+++++++....
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~----~~~~~vAvK~i~~~~--~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~ 81 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDN----VNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIE 81 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEET----TTCSEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTT
T ss_pred CCeEEEEEEeeccCeEEEEEEEC----CCCcEEEEEEEehhc--ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeecccc
Confidence 46999999999999999999976 478999999997643 2344567888999999999999999999997653
Q ss_pred ---cEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCc
Q 012762 160 ---WSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSL 236 (457)
Q Consensus 160 ---~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~ 236 (457)
.+||+| ++.+|+|.+++.. ..+++..++.++.||+.||+|||++|||||||||+||||+.++.+||+|||+++
T Consensus 82 ~~~~~~l~~-~~~~g~L~~~l~~---~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~ 157 (345)
T d1pmea_ 82 QMKDVYLVT-HLMGADLYKLLKT---QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLAR 157 (345)
T ss_dssp TCCCEEEEE-ECCCEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred ccceEEEEE-eecCCchhhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCcee
Confidence 345555 4559999999876 469999999999999999999999999999999999999999999999999986
Q ss_pred CCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccc
Q 012762 237 KGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSM 316 (457)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (457)
......... ....
T Consensus 158 ~~~~~~~~~-------------------------------------------------------------------~~~~ 170 (345)
T d1pmea_ 158 VADPDHDHT-------------------------------------------------------------------GFLT 170 (345)
T ss_dssp ECCGGGCBC-------------------------------------------------------------------CTTC
T ss_pred eccCCCccc-------------------------------------------------------------------eeec
Confidence 553221110 1112
Q ss_pred cccCCCCccCchhhcC-CCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccC-------------------
Q 012762 317 SFVGTHEYLAPEIISG-EGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALE------------------- 376 (457)
Q Consensus 317 ~~~gt~~y~aPE~l~~-~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~------------------- 376 (457)
..+||+.|+|||++.. ..++.++||||+||++|||++|+.||.+................
T Consensus 171 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (345)
T d1pmea_ 171 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLL 250 (345)
T ss_dssp CCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHH
T ss_pred cccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhhhhcccc
Confidence 3469999999999854 55799999999999999999999999887765554444322111
Q ss_pred -CCC---------CCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCCC
Q 012762 377 -FPK---------EPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGV 421 (457)
Q Consensus 377 -~~~---------~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~~ 421 (457)
.+. .+.++.++++||.+||+.||++||| ++|+|+||||+..
T Consensus 251 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t----a~e~L~hpf~~~~ 301 (345)
T d1pmea_ 251 SLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIE----VEQALAHPYLEQY 301 (345)
T ss_dssp TSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCC----HHHHHTSGGGTTT
T ss_pred cCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcC----HHHHhcCHhhccC
Confidence 111 1346778999999999999999999 9999999999854
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-52 Score=404.29 Aligned_cols=265 Identities=20% Similarity=0.273 Sum_probs=217.7
Q ss_pred CCCCccCCCceeEEEecccCcceEEEEEEeccCC---CCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHc-CCCCCce
Q 012762 75 NNNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKSS---NNGCFFAAKVMDKRELVSRNKESRARIEREILEML-DHPFLPT 150 (457)
Q Consensus 75 ~~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~---~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~ 150 (457)
..|.+..++|+++++||+|+||+||+|++...+. .++..||||++++.. .......+.+|..++.++ +|||||+
T Consensus 6 ~~~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~e~~~l~~~~~HpnIv~ 83 (299)
T d1fgka_ 6 PRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIIN 83 (299)
T ss_dssp TTTBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CcCcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc--ChHHHHHHHHHHHHHHHhcCCCeEEe
Confidence 3477888999999999999999999998764332 344689999997643 233456677898888888 8999999
Q ss_pred EEEEEEcCCcEEEEEeecCCCChHHHHHhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCC
Q 012762 151 LYATLDCPRWSCLLTEFCPGGDLHVLRQRQP--------------DKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKP 216 (457)
Q Consensus 151 l~~~~~~~~~~~lV~E~~~~~sL~~~~~~~~--------------~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp 216 (457)
+++++.+++..|+|||||++|+|.+++.... ...+++..++.++.||+.||+|||+.|||||||||
T Consensus 84 ~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp 163 (299)
T d1fgka_ 84 LLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAA 163 (299)
T ss_dssp EEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred cccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecc
Confidence 9999999999999999999999999987542 24589999999999999999999999999999999
Q ss_pred CCeEEccCCCEEEeccCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccc
Q 012762 217 ENVLVRSDGHIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKK 296 (457)
Q Consensus 217 ~NIll~~~~~vkl~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (457)
+|||++.++.+||+|||+++........
T Consensus 164 ~NiLl~~~~~~kl~dfg~~~~~~~~~~~---------------------------------------------------- 191 (299)
T d1fgka_ 164 RNVLVTEDNVMKIADFGLARDIHHIDYY---------------------------------------------------- 191 (299)
T ss_dssp GGEEECTTCCEEECSTTCCCCGGGCCTT----------------------------------------------------
T ss_pred cceeecCCCCeEeccchhhccccccccc----------------------------------------------------
Confidence 9999999999999999998655322111
Q ss_pred cCCCCCCCcccccCCccccccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHHhccc
Q 012762 297 KLGNPGTPEIVAEPLDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVVARAL 375 (457)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~ 375 (457)
.......||+.|+|||++.+..|+.++|||||||++|||++ |.+||.+.........+. ...
T Consensus 192 ----------------~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~~i~-~~~ 254 (299)
T d1fgka_ 192 ----------------KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK-EGH 254 (299)
T ss_dssp ----------------CCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH-TTC
T ss_pred ----------------cccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHHHHHH-cCC
Confidence 11123468999999999999999999999999999999997 799998877766655544 445
Q ss_pred CCCCCCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhc
Q 012762 376 EFPKEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKR 414 (457)
Q Consensus 376 ~~~~~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~ 414 (457)
.++.+..+++++++||.+||+.||++||| +.||++
T Consensus 255 ~~~~p~~~~~~l~~li~~cl~~dP~~Rps----~~eil~ 289 (299)
T d1fgka_ 255 RMDKPSNCTNELYMMMRDCWHAVPSQRPT----FKQLVE 289 (299)
T ss_dssp CCCCCSSCCHHHHHHHHHHTCSSGGGSCC----HHHHHH
T ss_pred CCCCCccchHHHHHHHHHHccCCHhHCcC----HHHHHH
Confidence 66666679999999999999999999999 888876
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.6e-52 Score=405.32 Aligned_cols=263 Identities=20% Similarity=0.278 Sum_probs=219.9
Q ss_pred CCccCCCceeEEEecccCcceEEEEEEecc-CCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEE
Q 012762 77 NPLTLSDLRFVHRLGSGDIGSVYLVQLKSK-SSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATL 155 (457)
Q Consensus 77 ~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~-~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~ 155 (457)
.++..++|+++++||+|+||+||+|+++.. +..+++.||||+++... ......++.+|+++|++++||||+++++++
T Consensus 8 ~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~il~~l~h~niv~~~~~~ 85 (301)
T d1lufa_ 8 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVC 85 (301)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred ccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc--ChHHHHHHHHHHHHHHhcCCCCcccceeee
Confidence 345667899999999999999999998743 23467899999997542 234466788999999999999999999999
Q ss_pred EcCCcEEEEEeecCCCChHHHHHhCC----------------------CCCCCHHHHHHHHHHHHHHHHHHHHcCceeec
Q 012762 156 DCPRWSCLLTEFCPGGDLHVLRQRQP----------------------DKRFHESAVRFYASEVVVALEFLHMMGIIYRD 213 (457)
Q Consensus 156 ~~~~~~~lV~E~~~~~sL~~~~~~~~----------------------~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrD 213 (457)
...+..++||||+++|+|.+++.... ...+++..++.++.||+.||+|||+++|||||
T Consensus 86 ~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrD 165 (301)
T d1lufa_ 86 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRD 165 (301)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeE
Confidence 99999999999999999999886531 23488999999999999999999999999999
Q ss_pred CCCCCeEEccCCCEEEeccCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchh
Q 012762 214 LKPENVLVRSDGHIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRR 293 (457)
Q Consensus 214 IKp~NIll~~~~~vkl~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (457)
|||+||||+.++.+||+|||+++.......
T Consensus 166 lKp~NILld~~~~~Kl~DFGls~~~~~~~~-------------------------------------------------- 195 (301)
T d1lufa_ 166 LATRNCLVGENMVVKIADFGLSRNIYSADY-------------------------------------------------- 195 (301)
T ss_dssp CSGGGEEECGGGCEEECCCSCHHHHTGGGC--------------------------------------------------
T ss_pred EcccceEECCCCcEEEccchhheeccCCcc--------------------------------------------------
Confidence 999999999999999999999864431110
Q ss_pred ccccCCCCCCCcccccCCccccccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCC-CCCCCCChHHHHHHHHh
Q 012762 294 RKKKLGNPGTPEIVAEPLDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGT-TPFKGIDHELTLANVVA 372 (457)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~-~Pf~~~~~~~~~~~~~~ 372 (457)
.....+..||+.|+|||++.+..|+.++|||||||++|||++|. +||.+....+....+..
T Consensus 196 ------------------~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e~~~~v~~ 257 (301)
T d1lufa_ 196 ------------------YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRD 257 (301)
T ss_dssp ------------------BC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHT
T ss_pred ------------------ccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCHHHHHHHHHc
Confidence 01112346899999999999999999999999999999999985 68988888877777665
Q ss_pred cccCCCCCCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhc
Q 012762 373 RALEFPKEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKR 414 (457)
Q Consensus 373 ~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~ 414 (457)
+. ..+.+..+++++.+||.+||+.||++||| +.||++
T Consensus 258 ~~-~~~~p~~~~~~~~~li~~cl~~~P~~RPt----~~ev~~ 294 (301)
T d1lufa_ 258 GN-ILACPENCPLELYNLMRLCWSKLPADRPS----FCSIHR 294 (301)
T ss_dssp TC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCC----HHHHHH
T ss_pred CC-CCCCCccchHHHHHHHHHHcCCChhHCcC----HHHHHH
Confidence 54 34445578999999999999999999999 888865
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-52 Score=405.38 Aligned_cols=265 Identities=21% Similarity=0.310 Sum_probs=226.6
Q ss_pred CCCccCCCceeEEEecccCcceEEEEEEecc-CCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHc-CCCCCceEEE
Q 012762 76 NNPLTLSDLRFVHRLGSGDIGSVYLVQLKSK-SSNNGCFFAAKVMDKRELVSRNKESRARIEREILEML-DHPFLPTLYA 153 (457)
Q Consensus 76 ~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~-~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~~ 153 (457)
.|++..++|++.++||+|+||+||+|+++.. +..+++.||||++++.. .......+.+|+++++++ +|||||++++
T Consensus 17 ~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~~~~~l~~HpnIv~~~g 94 (311)
T d1t46a_ 17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLG 94 (311)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc--CHHHHHHHHHHHHHHHhccCCCCEEEEEE
Confidence 4667888999999999999999999997642 34678899999997643 234556788899999999 6999999999
Q ss_pred EEEcCCcEEEEEeecCCCChHHHHHhCC----------------CCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCC
Q 012762 154 TLDCPRWSCLLTEFCPGGDLHVLRQRQP----------------DKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPE 217 (457)
Q Consensus 154 ~~~~~~~~~lV~E~~~~~sL~~~~~~~~----------------~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~ 217 (457)
++...+.+|||||||++|+|..++.... ...+++..++.++.||+.||+|||++|||||||||+
T Consensus 95 ~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~ 174 (311)
T d1t46a_ 95 ACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAAR 174 (311)
T ss_dssp EECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred EEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccc
Confidence 9999999999999999999999987642 236899999999999999999999999999999999
Q ss_pred CeEEccCCCEEEeccCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhcccc
Q 012762 218 NVLVRSDGHIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKK 297 (457)
Q Consensus 218 NIll~~~~~vkl~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (457)
|||++.++.+|++|||+++.........
T Consensus 175 NIl~~~~~~~ki~DfG~~~~~~~~~~~~---------------------------------------------------- 202 (311)
T d1t46a_ 175 NILLTHGRITKICDFGLARDIKNDSNYV---------------------------------------------------- 202 (311)
T ss_dssp GEEEETTTEEEECCCGGGSCTTSCTTSE----------------------------------------------------
T ss_pred cccccccCcccccccchheeccCCCcce----------------------------------------------------
Confidence 9999999999999999987654221110
Q ss_pred CCCCCCCcccccCCccccccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhc-CCCCCCCCChHHHHHHHHhcccC
Q 012762 298 LGNPGTPEIVAEPLDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFY-GTTPFKGIDHELTLANVVARALE 376 (457)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~~ 376 (457)
.....+||+.|+|||++.+..++.++|||||||++|||++ |.+||.+......+.+++....+
T Consensus 203 ----------------~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~~i~~~~~ 266 (311)
T d1t46a_ 203 ----------------VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFR 266 (311)
T ss_dssp ----------------ECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCC
T ss_pred ----------------EeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCC
Confidence 1112469999999999999999999999999999999998 77778777776777777777777
Q ss_pred CCCCCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhc
Q 012762 377 FPKEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKR 414 (457)
Q Consensus 377 ~~~~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~ 414 (457)
......++.++.+||.+||+.||++||+ +++|++
T Consensus 267 ~~~~~~~~~~l~~Li~~cl~~dP~~RPs----~~~il~ 300 (311)
T d1t46a_ 267 MLSPEHAPAEMYDIMKTCWDADPLKRPT----FKQIVQ 300 (311)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCC----HHHHHH
T ss_pred CCCcccccHHHHHHHHHHcCCChhHCcC----HHHHHH
Confidence 7777779999999999999999999999 888875
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-52 Score=415.27 Aligned_cols=269 Identities=25% Similarity=0.315 Sum_probs=207.9
Q ss_pred CCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEc---
Q 012762 81 LSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDC--- 157 (457)
Q Consensus 81 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~--- 157 (457)
+++|+++++||+|+||+||+|+++ .+|+.||||++.+... ......++.+|+.+|+.++|||||+++++|..
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~----~t~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~ 90 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDA----VLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKT 90 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEET----TTTEEEEEEEEESTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCS
T ss_pred cCCeEEEEEeecCcCeEEEEEEEC----CCCCEEEEEEEChhhc-CHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccc
Confidence 367999999999999999999987 4799999999976533 34455678899999999999999999999964
Q ss_pred ---CCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCC
Q 012762 158 ---PRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDL 234 (457)
Q Consensus 158 ---~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~ 234 (457)
..++|+|||||.++.+. .+. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+|++|||+
T Consensus 91 ~~~~~~~~iv~Ey~~~~l~~-~~~----~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~ 165 (355)
T d2b1pa1 91 LEEFQDVYLVMELMDANLCQ-VIQ----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_dssp TTTCCEEEEEEECCSEEHHH-HHT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred cccCceeEEEEeccchHHHH-hhh----cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhh
Confidence 36789999999655444 332 4589999999999999999999999999999999999999999999999998
Q ss_pred CcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccc
Q 012762 235 SLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVR 314 (457)
Q Consensus 235 s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (457)
++...... .
T Consensus 166 ~~~~~~~~-----------------------------------------------------------------------~ 174 (355)
T d2b1pa1 166 ARTAGTSF-----------------------------------------------------------------------M 174 (355)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred hhcccccc-----------------------------------------------------------------------c
Confidence 75433111 1
Q ss_pred cccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCC-----------------
Q 012762 315 SMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEF----------------- 377 (457)
Q Consensus 315 ~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~----------------- 377 (457)
....+||+.|+|||++.+..++.++||||+||++|+|++|++||.+.+......+++......
T Consensus 175 ~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 254 (355)
T d2b1pa1 175 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 254 (355)
T ss_dssp ------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHHHHH
T ss_pred cccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHHHhh
Confidence 123469999999999999999999999999999999999999999887666655554322110
Q ss_pred -----CCC------------------CCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCCCCchhhhccCCCCC
Q 012762 378 -----PKE------------------PSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGVNWALLRCAKPPFI 434 (457)
Q Consensus 378 -----~~~------------------~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~~~~~~~~~~~~~~~ 434 (457)
... ...+.++++||.+||..||++||| ++|||+||||+..-+..-....+|.+
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t----a~elL~Hpw~~~~~~~~~~~~~~~~~ 330 (355)
T d2b1pa1 255 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS----VDDALQHPYINVWYDPAEVEAPPPQI 330 (355)
T ss_dssp TSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCC----HHHHHTSTTTGGGCCHHHHTCCCC--
T ss_pred cCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcC----HHHHhcCcccCCCCCcccccCCCCCC
Confidence 000 012356899999999999999999 99999999999754433333444444
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-52 Score=404.90 Aligned_cols=256 Identities=21% Similarity=0.311 Sum_probs=212.6
Q ss_pred CccCCCceeEEEecccCcceEEEEEEeccCCCCCc--eEEEEEeehhhhhhhhHHHHHHHHHHHHHHc-CCCCCceEEEE
Q 012762 78 PLTLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGC--FFAAKVMDKRELVSRNKESRARIEREILEML-DHPFLPTLYAT 154 (457)
Q Consensus 78 ~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~--~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~l~~~ 154 (457)
.++.++|++.++||+|+||+||+|+++. +|. .||||.+... ......+.+.+|+++|.++ +|||||+++++
T Consensus 6 ~i~~~~~~~~~~iG~G~fg~Vy~~~~~~----~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~ 79 (309)
T d1fvra_ 6 VLDWNDIKFQDVIGEGNFGQVLKARIKK----DGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGA 79 (309)
T ss_dssp BCCGGGCEEEEEEECGGGCEEEEEEEEE----TTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEE
T ss_pred ccCHHHcEEEEEEeeCCCcEEEEEEECC----CCeEEEEEEEEECcc--cChHHHHHHHHHHHHHHhccCCCCEeeEEEE
Confidence 3667899999999999999999999874 454 4677776543 2333456788999999998 79999999999
Q ss_pred EEcCCcEEEEEeecCCCChHHHHHhC--------------CCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeE
Q 012762 155 LDCPRWSCLLTEFCPGGDLHVLRQRQ--------------PDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVL 220 (457)
Q Consensus 155 ~~~~~~~~lV~E~~~~~sL~~~~~~~--------------~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIl 220 (457)
+.+++.+|||||||++|+|.++++.. ....+++..+..++.||+.||.|||+++||||||||+|||
T Consensus 80 ~~~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL 159 (309)
T d1fvra_ 80 CEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNIL 159 (309)
T ss_dssp EEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred EecCCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEE
Confidence 99999999999999999999998753 2467999999999999999999999999999999999999
Q ss_pred EccCCCEEEeccCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCC
Q 012762 221 VRSDGHIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGN 300 (457)
Q Consensus 221 l~~~~~vkl~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (457)
++.++.+||+|||+++.......
T Consensus 160 ~~~~~~~kl~DfG~a~~~~~~~~--------------------------------------------------------- 182 (309)
T d1fvra_ 160 VGENYVAKIADFGLSRGQEVYVK--------------------------------------------------------- 182 (309)
T ss_dssp ECGGGCEEECCTTCEESSCEECC---------------------------------------------------------
T ss_pred EcCCCceEEcccccccccccccc---------------------------------------------------------
Confidence 99999999999999864431110
Q ss_pred CCCCcccccCCccccccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCC-CCCCCCChHHHHHHHHhcccCCCC
Q 012762 301 PGTPEIVAEPLDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGT-TPFKGIDHELTLANVVARALEFPK 379 (457)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~-~Pf~~~~~~~~~~~~~~~~~~~~~ 379 (457)
.....||..|+|||.+.+..|+.++|||||||++|||++|. +||.+.+..+....+.. ..+++.
T Consensus 183 --------------~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~-~~~~~~ 247 (309)
T d1fvra_ 183 --------------KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ-GYRLEK 247 (309)
T ss_dssp --------------C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGG-TCCCCC
T ss_pred --------------ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHh-cCCCCC
Confidence 11235899999999999999999999999999999999965 67887776666666544 445555
Q ss_pred CCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcC
Q 012762 380 EPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRH 415 (457)
Q Consensus 380 ~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~h 415 (457)
+..+++++++||.+||+.||++||+ +.+|++|
T Consensus 248 ~~~~~~~~~~li~~cl~~dP~~RPs----~~eil~~ 279 (309)
T d1fvra_ 248 PLNCDDEVYDLMRQCWREKPYERPS----FAQILVS 279 (309)
T ss_dssp CTTBCHHHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred CccCCHHHHHHHHHHcCCChhHCcC----HHHHHHH
Confidence 5679999999999999999999999 9999987
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-52 Score=413.02 Aligned_cols=256 Identities=26% Similarity=0.350 Sum_probs=210.9
Q ss_pred CCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEcC--
Q 012762 81 LSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDCP-- 158 (457)
Q Consensus 81 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~~-- 158 (457)
.++|+++++||+|+||+||+|+++ .+|+.||||++.+... .....+++.+|+++|+.++|||||++++++...
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~----~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~ 91 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDT----KTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS 91 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEET----TTTEEEEEEECSCTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSS
T ss_pred CCCeEEEEEEecCCCeEEEEEEEC----CCCCEEEEEEECchhc-ChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccc
Confidence 368999999999999999999986 4899999999976532 334456788899999999999999999999643
Q ss_pred ---CcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCC
Q 012762 159 ---RWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLS 235 (457)
Q Consensus 159 ---~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s 235 (457)
...++||+++.||+|.+++.. +++++..++.++.||+.||+|||++||+||||||+|||++.+|.+|++|||++
T Consensus 92 ~~~~~~~~i~~~~~gg~L~~~~~~---~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a 168 (348)
T d2gfsa1 92 LEEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA 168 (348)
T ss_dssp TTTCCCCEEEEECCSEEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC---
T ss_pred cccCceEEEEEeecCCchhhhccc---ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchh
Confidence 234566677779999998865 56999999999999999999999999999999999999999999999999997
Q ss_pred cCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcccc
Q 012762 236 LKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRS 315 (457)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (457)
..... ..
T Consensus 169 ~~~~~-------------------------------------------------------------------------~~ 175 (348)
T d2gfsa1 169 RHTDD-------------------------------------------------------------------------EM 175 (348)
T ss_dssp -CCTG-------------------------------------------------------------------------GG
T ss_pred cccCc-------------------------------------------------------------------------cc
Confidence 54321 11
Q ss_pred ccccCCCCccCchhhcCCC-CCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHHHhcccCCCC---------------
Q 012762 316 MSFVGTHEYLAPEIISGEG-HGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANVVARALEFPK--------------- 379 (457)
Q Consensus 316 ~~~~gt~~y~aPE~l~~~~-~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~--------------- 379 (457)
.+..||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+.......+.......+.
T Consensus 176 ~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 255 (348)
T d2gfsa1 176 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 255 (348)
T ss_dssp SSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHHHH
T ss_pred ccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhhhhhh
Confidence 1346999999999987765 689999999999999999999999998877666666543322211
Q ss_pred --------------CCCCChHHHHHHHHHhhhCCCCCCCCCcChHHHhcCCCCCCC
Q 012762 380 --------------EPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRHQFFNGV 421 (457)
Q Consensus 380 --------------~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~hp~f~~~ 421 (457)
...+++++++||.+||..||++||| +.|+|+||||+..
T Consensus 256 ~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~t----a~elL~Hp~f~~~ 307 (348)
T d2gfsa1 256 QSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT----AAQALAHAYFAQY 307 (348)
T ss_dssp TTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCC----HHHHHTSGGGTTT
T ss_pred hhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcC----HHHHhcCHhhCCC
Confidence 1346788999999999999999999 9999999999863
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-52 Score=402.30 Aligned_cols=271 Identities=17% Similarity=0.217 Sum_probs=226.3
Q ss_pred CCCCccCCCceeEEEecccCcceEEEEEEeccC-CCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEE
Q 012762 75 NNNPLTLSDLRFVHRLGSGDIGSVYLVQLKSKS-SNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYA 153 (457)
Q Consensus 75 ~~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~-~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~ 153 (457)
..|.+..++|++.++||+|+||+||+|.++... ...++.||||++++.. .......+.+|++++++++|||||++++
T Consensus 13 ~~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~~~~ 90 (308)
T d1p4oa_ 13 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLG 90 (308)
T ss_dssp CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEE
T ss_pred cceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc--ChHHHHHHHHHHHHHHHcCCCCEeeeee
Confidence 457888999999999999999999999986321 2245789999997542 3345567889999999999999999999
Q ss_pred EEEcCCcEEEEEeecCCCChHHHHHhC--------CCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCC
Q 012762 154 TLDCPRWSCLLTEFCPGGDLHVLRQRQ--------PDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDG 225 (457)
Q Consensus 154 ~~~~~~~~~lV~E~~~~~sL~~~~~~~--------~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~ 225 (457)
++..++..+||||||++|+|..++... ....+++..+..++.||+.||.|||+++|+||||||+||||+.++
T Consensus 91 ~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~ 170 (308)
T d1p4oa_ 91 VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF 170 (308)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTC
T ss_pred EEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCc
Confidence 999999999999999999998887642 123578899999999999999999999999999999999999999
Q ss_pred CEEEeccCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCc
Q 012762 226 HIMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPE 305 (457)
Q Consensus 226 ~vkl~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (457)
++||+|||+++........
T Consensus 171 ~~Kl~DFGla~~~~~~~~~------------------------------------------------------------- 189 (308)
T d1p4oa_ 171 TVKIGDFGMTRDIYETDYY------------------------------------------------------------- 189 (308)
T ss_dssp CEEECCTTCCCGGGGGGCE-------------------------------------------------------------
T ss_pred eEEEeecccceeccCCcce-------------------------------------------------------------
Confidence 9999999998654321110
Q ss_pred ccccCCccccccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcC-CCCCCCCChHHHHHHHHhcccCCCCCCCCC
Q 012762 306 IVAEPLDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYG-TTPFKGIDHELTLANVVARALEFPKEPSVP 384 (457)
Q Consensus 306 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG-~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (457)
.......||+.|+|||.+.+..++.++|||||||++|||++| .+||.+.+..+.+..+..+. ..+....++
T Consensus 190 -------~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~-~~~~p~~~~ 261 (308)
T d1p4oa_ 190 -------RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGG-LLDKPDNCP 261 (308)
T ss_dssp -------EGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTC-CCCCCTTCC
T ss_pred -------eeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCC-CCCCcccch
Confidence 111234689999999999999999999999999999999998 58888888888777766544 444556789
Q ss_pred hHHHHHHHHHhhhCCCCCCCCCcChHHHhc------CCCCCC
Q 012762 385 GPAKDLIAQLLVKDPTRRMGSKMGATAIKR------HQFFNG 420 (457)
Q Consensus 385 ~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~------hp~f~~ 420 (457)
..+.+||.+||+.||++||+ +.+|++ +|+|+.
T Consensus 262 ~~l~~li~~cl~~~P~~RPs----~~~il~~L~~~~~~~~~~ 299 (308)
T d1p4oa_ 262 DMLFELMRMCWQYNPKMRPS----FLEIISSIKEEMEPGFRE 299 (308)
T ss_dssp HHHHHHHHHHTCSSGGGSCC----HHHHHHHHGGGSCTTHHH
T ss_pred HHHHHHHHHHcCCChhHCcC----HHHHHHHHHHhcCCCCcC
Confidence 99999999999999999999 888876 666653
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-50 Score=391.63 Aligned_cols=256 Identities=15% Similarity=0.205 Sum_probs=204.8
Q ss_pred eeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCCceEEEEEEc-CCcEEE
Q 012762 85 RFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFLPTLYATLDC-PRWSCL 163 (457)
Q Consensus 85 ~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~l~~~~~~-~~~~~l 163 (457)
.+.++||+|+||+||+|++.... .....||||++++. .......++.+|+++|++++||||+++++++.. ++..++
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~-~~~~~vAvK~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~l 106 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDND-GKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 106 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC-----CEEEEEEEECCC--CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEE
T ss_pred ccceEEeecCCeEEEEEEEECCC-CEEEEEEEEEECcc--cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEE
Confidence 34689999999999999986422 13446899998643 334556789999999999999999999999764 568899
Q ss_pred EEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEEEeccCCCcCCCCCCc
Q 012762 164 LTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIMLTDFDLSLKGDNSTS 243 (457)
Q Consensus 164 V~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~~~~~~~~ 243 (457)
|||||++++|.+++... ...+++..+..++.|++.||.|||+.+|+||||||+||||+.++.+||+|||+++.......
T Consensus 107 v~E~~~~g~l~~~~~~~-~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~ 185 (311)
T d1r0pa_ 107 VLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 185 (311)
T ss_dssp EEECCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred EEEEeecCchhhhhccc-cccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhcccccc
Confidence 99999999999987754 35678888999999999999999999999999999999999999999999999876543211
Q ss_pred ccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccccccccCCCC
Q 012762 244 TAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMSFVGTHE 323 (457)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 323 (457)
... .......||+.
T Consensus 186 ~~~------------------------------------------------------------------~~~~~~~gt~~ 199 (311)
T d1r0pa_ 186 DSV------------------------------------------------------------------HNKTGAKLPVK 199 (311)
T ss_dssp CCT------------------------------------------------------------------TCTTCSSCCGG
T ss_pred ccc------------------------------------------------------------------eeccccccccc
Confidence 100 00112358999
Q ss_pred ccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChH-HHHHHHHhcccCCCCCCCCChHHHHHHHHHhhhCCCCC
Q 012762 324 YLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHE-LTLANVVARALEFPKEPSVPGPAKDLIAQLLVKDPTRR 402 (457)
Q Consensus 324 y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R 402 (457)
|+|||++.+..++.++|||||||++|||++|..||...... +....+.. ..+.+.+..+++++.+||.+||+.||++|
T Consensus 200 y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~-g~~~~~p~~~~~~l~~li~~cl~~dP~~R 278 (311)
T d1r0pa_ 200 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ-GRRLLQPEYCPDPLYEVMLKCWHPKAEMR 278 (311)
T ss_dssp GSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGS
T ss_pred ccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHc-CCCCCCcccCcHHHHHHHHHHcCCCHhHC
Confidence 99999999999999999999999999999987777654433 33444433 34555556789999999999999999999
Q ss_pred CCCCcChHHHhcC
Q 012762 403 MGSKMGATAIKRH 415 (457)
Q Consensus 403 ps~~~~~~~ll~h 415 (457)
|+ +.||++|
T Consensus 279 Ps----~~ei~~~ 287 (311)
T d1r0pa_ 279 PS----FSELVSR 287 (311)
T ss_dssp CC----HHHHHHH
T ss_pred cC----HHHHHHH
Confidence 99 9999887
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.3e-49 Score=382.75 Aligned_cols=272 Identities=19% Similarity=0.305 Sum_probs=206.2
Q ss_pred CCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCC-CceEEEEEEcCCc
Q 012762 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPF-LPTLYATLDCPRW 160 (457)
Q Consensus 82 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~n-Iv~l~~~~~~~~~ 160 (457)
++|++.++||+|+||+||+|+++ .+|+.||||++.... ...++..|+++++.++|+| |+.+.+++...+.
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~----~~~~~vAvK~~~~~~-----~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~ 77 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDI----AAGEEVAIKLECVKT-----KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDY 77 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEET----TTTEEEEEEEEESCT-----TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTE
T ss_pred CEEEEeEEEeeCCCcEEEEEEEC----CCCCEEEEEEEchhc-----cCHHHHHHHHHHHHccCCCcccEEEEEEecCCE
Confidence 46999999999999999999986 478999999987542 2234677999999997766 5556667788888
Q ss_pred EEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEcc---CCCEEEeccCCCcC
Q 012762 161 SCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRS---DGHIMLTDFDLSLK 237 (457)
Q Consensus 161 ~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~---~~~vkl~DFG~s~~ 237 (457)
.++||||+ +++|...+... ...+++..+..++.||+.||+|||++|||||||||+|||++. +..+||+|||+++.
T Consensus 78 ~~ivme~~-~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~ 155 (299)
T d1ckia_ 78 NVMVMELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 155 (299)
T ss_dssp EEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEE
T ss_pred EEEEEEEc-CCchhhhhhhc-cCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCccee
Confidence 99999999 67776665543 367999999999999999999999999999999999999864 45799999999976
Q ss_pred CCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCcccccc
Q 012762 238 GDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVRSMS 317 (457)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (457)
.......... ......+
T Consensus 156 ~~~~~~~~~~---------------------------------------------------------------~~~~~~~ 172 (299)
T d1ckia_ 156 YRDARTHQHI---------------------------------------------------------------PYRENKN 172 (299)
T ss_dssp CBCTTTCCBC---------------------------------------------------------------CCCBCCS
T ss_pred ccccccccce---------------------------------------------------------------eccccCC
Confidence 6432221100 0111224
Q ss_pred ccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChHHHHHHH---HhcccCCC---CCCCCChHHHHHH
Q 012762 318 FVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHELTLANV---VARALEFP---KEPSVPGPAKDLI 391 (457)
Q Consensus 318 ~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~~~~~~~---~~~~~~~~---~~~~~~~~~~~ll 391 (457)
++||+.|||||++.+..++.++|||||||++|||++|+.||...........+ .......+ ....+|+++.+||
T Consensus 173 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~li 252 (299)
T d1ckia_ 173 LTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYL 252 (299)
T ss_dssp CCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHHHTTTSCHHHHHHH
T ss_pred cCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhHhccCCCHHHHHHH
Confidence 57999999999999999999999999999999999999999876544332222 12222222 1245889999999
Q ss_pred HHHhhhCCCCCCCCCcChHHHhcCCCC-------CCCCchhhhc
Q 012762 392 AQLLVKDPTRRMGSKMGATAIKRHQFF-------NGVNWALLRC 428 (457)
Q Consensus 392 ~~~L~~dP~~Rps~~~~~~~ll~hp~f-------~~~~~~~~~~ 428 (457)
.+||+.||++||++.. +.++|+|+|. ..+||..++.
T Consensus 253 ~~cl~~~p~~RP~~~~-i~~~l~~~~~~~~~~~~~~~Dw~~~~~ 295 (299)
T d1ckia_ 253 NFCRSLRFDDKPDYSY-LRQLFRNLFHRQGFSYDYVFDWNMLKF 295 (299)
T ss_dssp HHHHHSCTTCCCCHHH-HHHHHHHHHHHHTCCCSCCCHHHHGGG
T ss_pred HHHccCChhHCcCHHH-HHHHHHHHHHHcCCCCCCCcCchhhcC
Confidence 9999999999999322 2355666543 3368888764
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=7.6e-49 Score=377.87 Aligned_cols=251 Identities=17% Similarity=0.244 Sum_probs=202.4
Q ss_pred CCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCC-CCCceEEEEEEcCC
Q 012762 81 LSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDH-PFLPTLYATLDCPR 159 (457)
Q Consensus 81 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H-~nIv~l~~~~~~~~ 159 (457)
-++|+++++||+|+||+||+|+++ .+|+.||||++.... ....+++|+++++.|.| +||+.+++++..+.
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~----~~~~~vAvK~~~~~~-----~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~ 74 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNL----LNNQQVAIKFEPRRS-----DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGL 74 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEET----TTTEEEEEEEEECCT-----TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETT
T ss_pred CCceEEEEEEecCCCeEEEEEEEC----CCCCEEEEEEEcccc-----CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCC
Confidence 358999999999999999999987 478999999986542 22346678999999965 89999999999999
Q ss_pred cEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEcc-----CCCEEEeccCC
Q 012762 160 WSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRS-----DGHIMLTDFDL 234 (457)
Q Consensus 160 ~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~-----~~~vkl~DFG~ 234 (457)
..|+||||+ +++|..++... ...+++..+..++.|++.||+|||++|||||||||+|||++. ++.+||+|||+
T Consensus 75 ~~~~vme~~-~~~l~~~~~~~-~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~ 152 (293)
T d1csna_ 75 HNVLVIDLL-GPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGM 152 (293)
T ss_dssp EEEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTT
T ss_pred ccEEEEEec-CCCHHHHHHhh-ccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccce
Confidence 999999999 89998888664 357999999999999999999999999999999999999974 57899999999
Q ss_pred CcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCcccccCCccc
Q 012762 235 SLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIVAEPLDVR 314 (457)
Q Consensus 235 s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (457)
++........... ....
T Consensus 153 a~~~~~~~~~~~~---------------------------------------------------------------~~~~ 169 (293)
T d1csna_ 153 VKFYRDPVTKQHI---------------------------------------------------------------PYRE 169 (293)
T ss_dssp CEESBCTTTCCBC---------------------------------------------------------------CCCC
T ss_pred eEEcccCccccce---------------------------------------------------------------eecc
Confidence 9765432211100 0011
Q ss_pred cccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCCh---HHHHHHHHhcccCCC---CCCCCChHHH
Q 012762 315 SMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDH---ELTLANVVARALEFP---KEPSVPGPAK 388 (457)
Q Consensus 315 ~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~---~~~~~~~~~~~~~~~---~~~~~~~~~~ 388 (457)
...++||+.|||||++.+..++.++|||||||++|||++|..||.+... ......+.......+ ....+|+++.
T Consensus 170 ~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~ 249 (293)
T d1csna_ 170 KKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFY 249 (293)
T ss_dssp CCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHH
T ss_pred cCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCChHHhcCCCCHHHH
Confidence 2245799999999999999999999999999999999999999986543 223333332222221 1245889999
Q ss_pred HHHHHHhhhCCCCCCCC
Q 012762 389 DLIAQLLVKDPTRRMGS 405 (457)
Q Consensus 389 ~ll~~~L~~dP~~Rps~ 405 (457)
+++..|+..+|++||+.
T Consensus 250 ~ii~~~~~~~~~~rP~y 266 (293)
T d1csna_ 250 KYMHYARNLAFDATPDY 266 (293)
T ss_dssp HHHHHHHHCCTTCCCCH
T ss_pred HHHHHHhcCCcccCcCH
Confidence 99999999999999983
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-48 Score=378.41 Aligned_cols=249 Identities=23% Similarity=0.281 Sum_probs=189.7
Q ss_pred CCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHH--HHHHcCCCCCceEEEEEEcCC
Q 012762 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIERE--ILEMLDHPFLPTLYATLDCPR 159 (457)
Q Consensus 82 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~--il~~l~H~nIv~l~~~~~~~~ 159 (457)
.+|.+.++||+|+||+||+|++ +|+.||||+++... ...+.+|.+ .+.+++|||||++++++...+
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~------~g~~vAvK~~~~~~------~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~ 70 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW------RGEEVAVKIFSSRE------ERSWFREAEIYQTVMLRHENILGFIAADNKDN 70 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE------TTEEEEEEEECGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC
T ss_pred cEEEEEEEEeeCCCeEEEEEEE------CCEEEEEEEECccc------hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCC
Confidence 4799999999999999999985 57899999996542 223333444 455689999999999997654
Q ss_pred ----cEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH--------cCceeecCCCCCeEEccCCCE
Q 012762 160 ----WSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHM--------MGIIYRDLKPENVLVRSDGHI 227 (457)
Q Consensus 160 ----~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~--------~~iiHrDIKp~NIll~~~~~v 227 (457)
.+|||||||++|+|..+++. ..+++..+..++.|++.||.|||+ +|||||||||+||||+.++.+
T Consensus 71 ~~~~~~~lv~Ey~~~g~L~~~l~~---~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~ 147 (303)
T d1vjya_ 71 GTWTQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTC 147 (303)
T ss_dssp SSSEEEEEEEECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCE
T ss_pred CcceEEEEEEecccCCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCe
Confidence 57999999999999999987 469999999999999999999996 599999999999999999999
Q ss_pred EEeccCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccCCCCCCCccc
Q 012762 228 MLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKLGNPGTPEIV 307 (457)
Q Consensus 228 kl~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (457)
||+|||+++.........
T Consensus 148 Kl~DFGl~~~~~~~~~~~-------------------------------------------------------------- 165 (303)
T d1vjya_ 148 CIADLGLAVRHDSATDTI-------------------------------------------------------------- 165 (303)
T ss_dssp EECCCTTCEEEETTTTEE--------------------------------------------------------------
T ss_pred EEEecCccccccCCCcce--------------------------------------------------------------
Confidence 999999986553221110
Q ss_pred ccCCccccccccCCCCccCchhhcCCC------CCccchhhhhhHHHHHHhcCCCCCCCCC---------------hHHH
Q 012762 308 AEPLDVRSMSFVGTHEYLAPEIISGEG------HGNAVDWWTLGIFIFELFYGTTPFKGID---------------HELT 366 (457)
Q Consensus 308 ~~~~~~~~~~~~gt~~y~aPE~l~~~~------~~~~sDiwSlG~il~elltG~~Pf~~~~---------------~~~~ 366 (457)
.......+||+.|||||++.+.. ++.++|||||||+||||++|..||.... ....
T Consensus 166 ----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (303)
T d1vjya_ 166 ----DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM 241 (303)
T ss_dssp ----CC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHH
T ss_pred ----eccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchHHHH
Confidence 01112347999999999997653 5678999999999999999988774321 1122
Q ss_pred HHHHHhcccCCCCCCC-----CChHHHHHHHHHhhhCCCCCCCCCcChHHHhcC
Q 012762 367 LANVVARALEFPKEPS-----VPGPAKDLIAQLLVKDPTRRMGSKMGATAIKRH 415 (457)
Q Consensus 367 ~~~~~~~~~~~~~~~~-----~~~~~~~ll~~~L~~dP~~Rps~~~~~~~ll~h 415 (457)
.........+.+.... ....+.+|+.+||+.||++||| +.||+++
T Consensus 242 ~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps----~~ei~~~ 291 (303)
T d1vjya_ 242 RKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLT----ALRIKKT 291 (303)
T ss_dssp HHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCC----HHHHHHH
T ss_pred HHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcC----HHHHHHH
Confidence 2222222322221111 1235889999999999999999 8888763
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4e-46 Score=369.29 Aligned_cols=259 Identities=22% Similarity=0.340 Sum_probs=196.9
Q ss_pred cCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcC-----------CCCC
Q 012762 80 TLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLD-----------HPFL 148 (457)
Q Consensus 80 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~-----------H~nI 148 (457)
.-++|+++++||+|+||+||+|+++ .+|+.||||++++... ..+.+.+|+++|+.++ |+||
T Consensus 11 ~~~rY~i~~~LG~G~fg~Vy~~~~~----~~g~~vAvKvi~~~~~----~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~i 82 (362)
T d1q8ya_ 11 KDARYILVRKLGWGHFSTVWLAKDM----VNNTHVAMKIVRGDKV----YTEAAEDEIKLLQRVNDADNTKEDSMGANHI 82 (362)
T ss_dssp TTTTEEEEEEEEECSSEEEEEEEET----TTTEEEEEEEECSCHH----HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTB
T ss_pred cCCcEEEEEEEeeCCCeEEEEEEEC----CCCCEEEEEEEecccc----chHHHHHHHHHHHHhcchhhhhhhhcCcCce
Confidence 3357999999999999999999987 4899999999986543 3345677888888764 5789
Q ss_pred ceEEEEEEc--CCcEEEEEeecCCCC-hHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCceeecCCCCCeEEccC
Q 012762 149 PTLYATLDC--PRWSCLLTEFCPGGD-LHVLRQRQPDKRFHESAVRFYASEVVVALEFLHM-MGIIYRDLKPENVLVRSD 224 (457)
Q Consensus 149 v~l~~~~~~--~~~~~lV~E~~~~~s-L~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~-~~iiHrDIKp~NIll~~~ 224 (457)
+++++++.. ....+++|+++..+. ............+++..++.++.||+.||+|||+ .||+||||||+||||+.+
T Consensus 83 v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~ 162 (362)
T d1q8ya_ 83 LKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIV 162 (362)
T ss_dssp CCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEE
T ss_pred EEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeecc
Confidence 999988754 345667777664443 3444555566789999999999999999999997 899999999999999876
Q ss_pred CC------EEEeccCCCcCCCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCCcccccCcchhccccC
Q 012762 225 GH------IMLTDFDLSLKGDNSTSTAQLVSDQSPPTGDQQPNDCAVDQPPFGNSSCIIPNCIVPAVSCLHPKRRRKKKL 298 (457)
Q Consensus 225 ~~------vkl~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (457)
+. ++++|||.+......
T Consensus 163 ~~~~~~~~~kl~dfg~s~~~~~~--------------------------------------------------------- 185 (362)
T d1q8ya_ 163 DSPENLIQIKIADLGNACWYDEH--------------------------------------------------------- 185 (362)
T ss_dssp ETTTTEEEEEECCCTTCEETTBC---------------------------------------------------------
T ss_pred CcccccceeeEeecccccccccc---------------------------------------------------------
Confidence 54 999999997543211
Q ss_pred CCCCCCcccccCCccccccccCCCCccCchhhcCCCCCccchhhhhhHHHHHHhcCCCCCCCCChH------HHHHHHHh
Q 012762 299 GNPGTPEIVAEPLDVRSMSFVGTHEYLAPEIISGEGHGNAVDWWTLGIFIFELFYGTTPFKGIDHE------LTLANVVA 372 (457)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG~il~elltG~~Pf~~~~~~------~~~~~~~~ 372 (457)
....+||+.|+|||++.+..|+.++||||+||++++|++|+.||...... ..+...+.
T Consensus 186 ----------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~ 249 (362)
T d1q8ya_ 186 ----------------YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE 249 (362)
T ss_dssp ----------------CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHH
T ss_pred ----------------cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHH
Confidence 11346999999999999999999999999999999999999999754321 11111111
Q ss_pred cccC------------------------CC----------------CCCCCChHHHHHHHHHhhhCCCCCCCCCcChHHH
Q 012762 373 RALE------------------------FP----------------KEPSVPGPAKDLIAQLLVKDPTRRMGSKMGATAI 412 (457)
Q Consensus 373 ~~~~------------------------~~----------------~~~~~~~~~~~ll~~~L~~dP~~Rps~~~~~~~l 412 (457)
.... .. .....++++++||.+||.+||.+||| ++|+
T Consensus 250 ~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpt----a~e~ 325 (362)
T d1q8ya_ 250 LLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD----AGGL 325 (362)
T ss_dssp HHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC----HHHH
T ss_pred HhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcC----HHHH
Confidence 0000 00 00112457899999999999999999 9999
Q ss_pred hcCCCCCCCCc
Q 012762 413 KRHQFFNGVNW 423 (457)
Q Consensus 413 l~hp~f~~~~~ 423 (457)
|+||||+.+.+
T Consensus 326 L~Hp~f~~~~~ 336 (362)
T d1q8ya_ 326 VNHPWLKDTLG 336 (362)
T ss_dssp HTCGGGTTCTT
T ss_pred hcCcccCCCCC
Confidence 99999996543
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.94 E-value=6e-27 Score=209.81 Aligned_cols=137 Identities=21% Similarity=0.172 Sum_probs=107.1
Q ss_pred ceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhh---------------hhhHHHHHHHHHHHHHHcCCCCC
Q 012762 84 LRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELV---------------SRNKESRARIEREILEMLDHPFL 148 (457)
Q Consensus 84 ~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~---------------~~~~~~~~~~E~~il~~l~H~nI 148 (457)
+.+.++||+|+||+||+|++. +|+.||||+++..... ..........|..+|.++.|.++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-----~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v 76 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-----KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAV 76 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-----TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSS
T ss_pred chhCCEeeeCcceEEEEEECC-----CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCc
Confidence 467899999999999999874 6889999987532111 01122344568888999999999
Q ss_pred ceEEEEEEcCCcEEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCCeEEccCCCEE
Q 012762 149 PTLYATLDCPRWSCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLHMMGIIYRDLKPENVLVRSDGHIM 228 (457)
Q Consensus 149 v~l~~~~~~~~~~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~iiHrDIKp~NIll~~~~~vk 228 (457)
+..+++.. .++||||+++..+.. +++..+..++.||+.+|.|||++||+||||||+|||++.++ ++
T Consensus 77 ~~~~~~~~----~~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~~-~~ 142 (191)
T d1zara2 77 PKVYAWEG----NAVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEG-IW 142 (191)
T ss_dssp CCEEEEET----TEEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETTE-EE
T ss_pred ceEEEecC----CEEEEEeeccccccc---------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCCC-EE
Confidence 99887642 379999998766532 44455678999999999999999999999999999998654 89
Q ss_pred EeccCCCcCCC
Q 012762 229 LTDFDLSLKGD 239 (457)
Q Consensus 229 l~DFG~s~~~~ 239 (457)
|+|||+++...
T Consensus 143 liDFG~a~~~~ 153 (191)
T d1zara2 143 IIDFPQSVEVG 153 (191)
T ss_dssp ECCCTTCEETT
T ss_pred EEECCCcccCC
Confidence 99999986543
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.66 E-value=5.9e-08 Score=88.68 Aligned_cols=139 Identities=16% Similarity=0.099 Sum_probs=91.7
Q ss_pred CCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcC-CCCCceEEEEEEcCCc
Q 012762 82 SDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLD-HPFLPTLYATLDCPRW 160 (457)
Q Consensus 82 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~-H~nIv~l~~~~~~~~~ 160 (457)
+.|++.+..+.|+.+.||+... .+..+++|+....... ....+.+|..+|+.|. +--+.+++.+...++.
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~~------~~~~~vlk~~~~~~~~---~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~ 84 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLVG------ENENLYLKMTDSRYKG---TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGW 84 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEEC------SSCEEEEEEECGGGTT---STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTE
T ss_pred hceEEEEcCCCCCCCcEEEEEe------CCCeEEEEEcCCCccc---chhhHHHHHHHHHHHhccCCCCcEEEEEecCCc
Confidence 4577777666566678998762 4556788887654321 2234566888888874 5457888999888899
Q ss_pred EEEEEeecCCCChHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH-----------------------------------
Q 012762 161 SCLLTEFCPGGDLHVLRQRQPDKRFHESAVRFYASEVVVALEFLH----------------------------------- 205 (457)
Q Consensus 161 ~~lV~E~~~~~sL~~~~~~~~~~~~~~~~~~~i~~qi~~~L~yLH----------------------------------- 205 (457)
.|+||++++|..+....... .. ...++.++...|..||
T Consensus 85 ~~lv~~~l~G~~~~~~~~~~----~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (263)
T d1j7la_ 85 SNLLMSEADGVLCSEEYEDE----QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCEN 157 (263)
T ss_dssp EEEEEECCSSEEHHHHTTTC----SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGG
T ss_pred eEEEEEeccccccccccccc----cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhc
Confidence 99999999988774322110 01 1112223333333333
Q ss_pred ------------------H------cCceeecCCCCCeEEccCCCEEEeccCCCc
Q 012762 206 ------------------M------MGIIYRDLKPENVLVRSDGHIMLTDFDLSL 236 (457)
Q Consensus 206 ------------------~------~~iiHrDIKp~NIll~~~~~vkl~DFG~s~ 236 (457)
. ..++|+|+.|.|||++.++.+.|+||+.+.
T Consensus 158 ~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 158 WEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp GSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 1 127999999999999877666799999864
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.20 E-value=3.7e-06 Score=75.88 Aligned_cols=74 Identities=16% Similarity=0.077 Sum_probs=52.8
Q ss_pred EecccCc-ceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcC--CCCCceEEEEEEcCCcEEEEE
Q 012762 89 RLGSGDI-GSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLD--HPFLPTLYATLDCPRWSCLLT 165 (457)
Q Consensus 89 ~LG~G~f-g~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~--H~nIv~l~~~~~~~~~~~lV~ 165 (457)
.+..|.. +.||+.... .+..+++|...... ...+..|.+.|+.|. +-.+.+++.+..+++..++||
T Consensus 17 ~~~~G~s~~~v~r~~~~-----~~~~~vlK~~~~~~------~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~ 85 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQ-----GRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLL 85 (255)
T ss_dssp ECSCTTSSCEEEEEECT-----TSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEE
T ss_pred EcCCcccCCeEEEEEeC-----CCCEEEEEeCCccC------HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEE
Confidence 4455554 688988743 56678899875432 223566888888773 334678888888888999999
Q ss_pred eecCCCCh
Q 012762 166 EFCPGGDL 173 (457)
Q Consensus 166 E~~~~~sL 173 (457)
++++|.++
T Consensus 86 ~~i~G~~~ 93 (255)
T d1nd4a_ 86 GEVPGQDL 93 (255)
T ss_dssp ECCSSEET
T ss_pred Eeeecccc
Confidence 99988765
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.07 E-value=5.5e-06 Score=80.14 Aligned_cols=81 Identities=17% Similarity=0.202 Sum_probs=50.8
Q ss_pred EEEecccCcceEEEEEEeccCCCCCceEEEEEeehhh-hh---hhhHHHHHHHHHHHHHHcC-C--CCCceEEEEEEcCC
Q 012762 87 VHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRE-LV---SRNKESRARIEREILEMLD-H--PFLPTLYATLDCPR 159 (457)
Q Consensus 87 ~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~-~~---~~~~~~~~~~E~~il~~l~-H--~nIv~l~~~~~~~~ 159 (457)
.+.||.|....||++... ..++.|+||.-.... .. ......+...|.++|+.+. + ..+++++.+ +.+
T Consensus 31 ~~eig~G~~N~vfrV~~~----~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~ 104 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQ----EHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTE 104 (392)
T ss_dssp EEECCSSSSEEEEEEEC--------CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETT
T ss_pred EEEeCCCceEeEEEEEeC----CCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCC
Confidence 567899999999998764 356789999654321 11 1123345667888888773 3 346666655 344
Q ss_pred cEEEEEeecCCCCh
Q 012762 160 WSCLLTEFCPGGDL 173 (457)
Q Consensus 160 ~~~lV~E~~~~~sL 173 (457)
..++|||++.+..+
T Consensus 105 ~~~lvmE~L~~~~~ 118 (392)
T d2pula1 105 MAVTVMEDLSHLKI 118 (392)
T ss_dssp TTEEEECCCTTSEE
T ss_pred CCEEEEeccCCccc
Confidence 56799999976543
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.42 E-value=0.00021 Score=68.68 Aligned_cols=82 Identities=22% Similarity=0.310 Sum_probs=53.6
Q ss_pred CCceeEEEecccCcceEEEEEEeccC---CCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcC-CCCCceEEEEEEc
Q 012762 82 SDLRFVHRLGSGDIGSVYLVQLKSKS---SNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLD-HPFLPTLYATLDC 157 (457)
Q Consensus 82 ~~~~~~~~LG~G~fg~Vy~a~~~~~~---~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~-H~nIv~l~~~~~~ 157 (457)
+++++ +.|+.|-.-.+|++...... ......|.+++.... .... ...+|.++++.+. +.-..++++++.+
T Consensus 43 ~~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~----~~~i-dr~~E~~i~~~ls~~gl~Pkll~~~~~ 116 (395)
T d1nw1a_ 43 EHLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP----ETES-HLVAESVIFTLLSERHLGPKLYGIFSG 116 (395)
T ss_dssp GGEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC----CCHH-HHHHHHHHHHHHHHTTSSSCEEEEETT
T ss_pred cceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc----chhh-HHHHHHHHHHHHHhCCCCCeEEEEcCC
Confidence 34544 57888999999999865321 123456788887532 1222 3446888988884 4335688888753
Q ss_pred CCcEEEEEeecCCCCh
Q 012762 158 PRWSCLLTEFCPGGDL 173 (457)
Q Consensus 158 ~~~~~lV~E~~~~~sL 173 (457)
.+||||++|..|
T Consensus 117 ----g~I~efi~g~~l 128 (395)
T d1nw1a_ 117 ----GRLEEYIPSRPL 128 (395)
T ss_dssp ----EEEECCCCEEEC
T ss_pred ----ceEEEEeccccC
Confidence 589999987654
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.07 E-value=0.00026 Score=66.01 Aligned_cols=70 Identities=13% Similarity=0.067 Sum_probs=44.4
Q ss_pred cceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCC--ceEE-----EEEEcCCcEEEEEee
Q 012762 95 IGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFL--PTLY-----ATLDCPRWSCLLTEF 167 (457)
Q Consensus 95 fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nI--v~l~-----~~~~~~~~~~lV~E~ 167 (457)
--.||+++.. +|..|++|+.+.... ...++..|.+.|..|...+| +..+ ..+..++..+.++++
T Consensus 35 EN~vy~v~~~-----dg~~~VlK~~rp~~~----s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~ 105 (325)
T d1zyla1 35 ENRVYQFQDE-----DRRRFVVKFYRPERW----TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPS 105 (325)
T ss_dssp SSEEEEECCT-----TCCCEEEEEECTTTS----CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEEC
T ss_pred cceeEEEEcC-----CCCEEEEEEeCCCCC----CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEee
Confidence 3689988764 788899999875432 23446668888887743222 1111 123445678899999
Q ss_pred cCCCCh
Q 012762 168 CPGGDL 173 (457)
Q Consensus 168 ~~~~sL 173 (457)
+.|..+
T Consensus 106 ~~G~~~ 111 (325)
T d1zyla1 106 VGGRQF 111 (325)
T ss_dssp CCCEEC
T ss_pred cCCcCC
Confidence 976443
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=97.03 E-value=0.0011 Score=61.24 Aligned_cols=146 Identities=17% Similarity=0.122 Sum_probs=76.0
Q ss_pred cCCCceeEEEecccCcceEEEEEEeccCCCCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCCCC--ceEEE----
Q 012762 80 TLSDLRFVHRLGSGDIGSVYLVQLKSKSSNNGCFFAAKVMDKRELVSRNKESRARIEREILEMLDHPFL--PTLYA---- 153 (457)
Q Consensus 80 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~l~H~nI--v~l~~---- 153 (457)
.++...-.+.|..|.--+.|+... ++..|++|+..+.. ....+..|.++|..|...++ ...+.
T Consensus 16 ~lg~~~~~~~i~~G~~N~ny~v~t------~~g~yVLri~~~~~-----~~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g 84 (316)
T d2ppqa1 16 DVGSLTSYKGIAEGVENSNFLLHT------TKDPLILTLYEKRV-----EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDG 84 (316)
T ss_dssp CCCCEEEEEEECC---EEEEEEEE------SSCCEEEEEECC--------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTC
T ss_pred CCCCceEeecCCCCcccCeEEEEE------CCCcEEEEEcCCCC-----CHHHHHHHHHHHHhhhhccccccccceecCC
Confidence 345566667788888889998874 23358999986532 12334457777777743222 11111
Q ss_pred --EEEcCCcEEEEEeecCCCChHH-----------HH---Hh-CC------CCCCCHH------------------HHHH
Q 012762 154 --TLDCPRWSCLLTEFCPGGDLHV-----------LR---QR-QP------DKRFHES------------------AVRF 192 (457)
Q Consensus 154 --~~~~~~~~~lV~E~~~~~sL~~-----------~~---~~-~~------~~~~~~~------------------~~~~ 192 (457)
+....+..+.++.++.|..... ++ +. .. ....... ....
T Consensus 85 ~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (316)
T d2ppqa1 85 ELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLRE 164 (316)
T ss_dssp CSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHH
T ss_pred CcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHH
Confidence 1122344566677665543310 00 00 00 0000110 1111
Q ss_pred HHHHHHHHHHHHH----HcCceeecCCCCCeEEccCCCEEEeccCCCc
Q 012762 193 YASEVVVALEFLH----MMGIIYRDLKPENVLVRSDGHIMLTDFDLSL 236 (457)
Q Consensus 193 i~~qi~~~L~yLH----~~~iiHrDIKp~NIll~~~~~vkl~DFG~s~ 236 (457)
.+..+...+.-.+ ..|+||+|+.++||+++.+...-|+||+.+.
T Consensus 165 ~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 165 EIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp HHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 1222222222222 2479999999999999988777899999874
|